data_2kl2_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kl2 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.205 0 N-CA-C 110.535 -0.172 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -119.67 131.25 55.39 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.166 1.387 . . . . 0.0 107.808 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.6 pt -123.36 177.48 4.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -131.89 130.17 41.28 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 174.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.9 p -96.7 135.73 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 176.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -72.79 -78.02 0.09 Allowed 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 164.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -139.75 -19.47 0.42 Allowed Glycine 0 C--N 1.335 0.489 0 O-C-N 121.767 -0.583 . . . . 0.0 114.144 -173.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.04 -16.42 59.28 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 120.505 2.152 . . . . 0.0 112.599 -154.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.12 14.16 7.84 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 126.378 1.871 . . . . 0.0 107.645 176.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -104.06 -86.91 0.44 Allowed 'General case' 0 C--N 1.351 0.671 0 CA-C-O 117.355 -1.307 . . . . 0.0 109.381 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 42.0 tpt85 -62.39 -59.89 4.34 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-N 120.752 1.614 . . . . 0.0 111.383 -160.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 172.31 69.04 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 106.265 -2.734 . . . . 0.0 106.265 -170.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -117.29 154.87 50.34 Favored Pre-proline 0 N--CA 1.448 -0.544 0 C-N-CA 124.802 1.241 . . . . 0.0 108.392 -175.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.73 -37.11 97.79 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.743 2.962 . . . . 0.0 111.429 -172.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -63.99 -25.18 68.01 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 126.229 1.811 . . . . 0.0 111.939 -172.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -52.17 -34.78 46.57 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.587 1.085 . . . . 0.0 111.423 -170.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.81 -25.92 21.67 Favored 'General case' 0 C--N 1.342 0.276 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -176.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.3 m -57.49 -48.94 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 118.57 0.623 . . . . 0.0 109.544 -176.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 9.0 ptp -79.13 7.25 7.82 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.393 0.677 . . . . 0.0 112.584 -174.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 76.6 mt -99.64 3.23 45.12 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.473 0.709 . . . . 0.0 111.019 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -131.97 109.26 9.92 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 104.388 -2.449 . . . . 0.0 104.388 174.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 23.3 t-80 -54.27 -24.35 18.54 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.063 1.345 . . . . 0.0 111.608 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 m -67.13 -21.86 65.82 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.979 -1.076 . . . . 0.0 112.954 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -85.07 -7.05 59.28 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 119.492 1.042 . . . . 0.0 111.579 167.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 129.19 167.5 12.15 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 126.037 1.779 . . . . 0.0 111.849 175.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -82.38 137.69 34.67 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.29 1.836 . . . . 0.0 109.174 -176.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -133.57 141.96 47.93 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.462 1.105 . . . . 0.0 108.708 162.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -141.29 140.7 33.9 Favored 'General case' 0 C--O 1.231 0.111 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 166.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -67.11 94.65 0.36 Allowed 'General case' 0 C--O 1.232 0.16 0 C-N-CA 125.921 1.689 . . . . 0.0 107.685 177.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -100.19 53.63 0.9 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -176.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.5 -169.15 46.93 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-O 122.677 1.154 . . . . 0.0 111.698 -177.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -143.44 173.0 12.01 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 121.557 -0.966 . . . . 0.0 110.221 -175.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -175.15 -179.92 46.01 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 119.487 -1.339 . . . . 0.0 115.337 -169.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.7 p -140.49 160.51 39.84 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 114.098 -1.051 . . . . 0.0 111.257 167.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.1 p -81.52 94.27 6.84 Favored 'General case' 0 C--O 1.223 -0.291 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 169.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -62.59 -26.43 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 O-C-N 120.657 -1.277 . . . . 0.0 110.893 171.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -65.93 116.99 7.66 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 161.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.03 120.07 18.15 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 126.241 1.816 . . . . 0.0 109.947 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -123.05 162.06 41.35 Favored Pre-proline 0 N--CA 1.466 0.359 0 CA-C-N 120.481 1.491 . . . . 0.0 107.842 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -79.6 94.32 1.05 Allowed 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 124.695 3.597 . . . . 0.0 109.245 172.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.8 tp -89.09 111.76 22.58 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 164.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.5 m -125.59 145.69 32.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.601 1.16 . . . . 0.0 108.347 -176.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 3.3 mt -98.85 121.96 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 176.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.73 -172.19 3.33 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.049 0.94 . . . . 0.0 110.763 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.68 155.67 2.27 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 125.45 1.5 . . . . 0.0 111.664 178.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -79.55 -6.17 56.45 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 121.538 -0.978 . . . . 0.0 111.802 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -106.92 9.33 30.81 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.431 1.093 . . . . 0.0 112.299 174.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.438 HD21 ' HB2' ' A' ' 141' ' ' LEU . 2.3 m120 63.73 61.19 1.0 Allowed 'General case' 0 C--N 1.345 0.401 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 176.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 56.5 mt -107.86 87.6 3.82 Favored Pre-proline 0 N--CA 1.446 -0.673 0 C-N-CA 128.358 2.663 . . . . 0.0 104.01 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . 43.5 Cg_endo -64.54 156.86 58.4 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 CA-C-N 120.832 1.333 . . . . 0.0 109.825 174.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 48.3 m95 -132.21 150.11 52.23 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.9 tp -107.39 102.02 11.34 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 168.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.7 mt -74.39 145.66 43.58 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -81.61 85.6 6.52 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.348 -0.845 . . . . 0.0 109.536 -177.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -137.12 86.49 20.14 Favored Pre-proline 0 C--O 1.234 0.25 0 CA-C-O 118.369 -0.824 . . . . 0.0 110.174 -177.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -60.07 133.98 53.47 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 121.084 1.189 . . . . 0.0 111.201 -177.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.57 17.27 77.85 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-O 118.904 -0.942 . . . . 0.0 114.713 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -118.15 121.52 40.72 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 120.376 2.088 . . . . 0.0 106.131 168.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.484 ' HA2' ' CD2' ' A' ' 129' ' ' TYR . . . 108.95 -139.81 15.37 Favored Glycine 0 CA--C 1.52 0.379 0 CA-C-N 120.208 1.367 . . . . 0.0 112.555 172.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 39.7 m-70 -126.86 171.47 11.24 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 124.044 0.938 . . . . 0.0 112.311 -175.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 57.9 m -88.2 105.49 17.56 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 126.647 1.979 . . . . 0.0 110.428 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 71.1 t -72.95 117.25 16.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 64.8 p -70.81 156.33 39.69 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.865 0.866 . . . . 0.0 109.363 167.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 171.24 -159.04 30.74 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 118.975 0.807 . . . . 0.0 112.312 -172.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -137.35 161.49 36.14 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.992 0.917 . . . . 0.0 110.834 -172.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 70.1 mt -120.54 111.83 33.71 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 -175.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -102.74 129.86 49.51 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 174.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -67.51 141.66 56.83 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 156.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.0 m -137.39 153.44 28.72 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 CA-C-O 121.787 0.803 . . . . 0.0 109.925 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -85.9 174.02 9.57 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 123.873 1.796 . . . . 0.0 109.541 164.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.05 -30.31 70.25 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 112.34 -2.209 . . . . 0.0 112.463 177.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -72.64 -41.98 64.9 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-O 116.681 -1.628 . . . . 0.0 111.242 176.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 19.9 tpp -64.16 -44.44 92.1 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 121.178 1.808 . . . . 0.0 108.513 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.6 tp -60.91 -30.35 70.14 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 177.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 47.1 mtt-85 -80.57 -36.83 32.37 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.873 1.269 . . . . 0.0 113.786 174.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -62.19 -47.66 83.48 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 177.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 85.3 mt -62.77 -24.38 67.68 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.787 -0.571 . . . . 0.0 110.812 175.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.447 ' HA ' ' SG ' ' A' ' 84' ' ' CYS . 4.4 t0 -78.19 10.55 2.9 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.794 1.237 . . . . 0.0 113.165 176.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -143.05 -30.95 0.51 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 125.439 1.496 . . . . 0.0 112.598 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -70.11 -31.92 69.7 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.1 0.96 . . . . 0.0 111.09 172.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -92.86 5.62 50.63 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.436 0.694 . . . . 0.0 112.147 -171.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.0 t70 54.17 15.91 1.04 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.722 2.009 . . . . 0.0 113.867 -175.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.447 ' SG ' ' HA ' ' A' ' 79' ' ' ASP . 2.9 p -62.85 150.03 88.45 Favored Pre-proline 0 N--CA 1.45 -0.474 0 O-C-N 120.181 -1.574 . . . . 0.0 108.252 167.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.94 -8.56 30.09 Favored 'Cis proline' 0 CA--C 1.54 0.813 0 N-CA-C 114.926 1.087 . . . . 0.0 114.926 2.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 12.9 m -60.98 -62.19 2.03 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.792 1.237 . . . . 0.0 110.91 -174.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.3 mtp -72.53 -78.17 0.09 Allowed 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -96.03 175.17 6.58 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.579 1.152 . . . . 0.0 110.253 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 6.7 mp0 -130.19 146.49 51.83 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.98 1.712 . . . . 0.0 107.105 164.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -81.63 133.85 35.42 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 175.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.2 m -140.04 168.85 18.85 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.212 1.005 . . . . 0.0 109.481 -174.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -106.45 138.88 41.83 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.141 1.776 . . . . 0.0 110.372 173.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.4 173.2 11.99 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.155 1.382 . . . . 0.0 113.064 175.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -94.95 126.26 40.17 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.041 1.337 . . . . 0.0 111.884 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.4 t -127.61 119.75 52.71 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 C-N-CA 125.688 1.595 . . . . 0.0 107.773 -175.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -63.13 128.85 37.77 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 105.62 -1.992 . . . . 0.0 105.62 169.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.628 ' CG1' ' HA ' ' A' ' 108' ' ' ASP . 4.9 p -75.55 116.67 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 CA-C-N 114.45 -1.25 . . . . 0.0 107.799 166.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -88.48 -21.56 24.12 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 120.467 -1.396 . . . . 0.0 110.38 170.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -158.27 146.4 18.56 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 170.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -127.93 116.1 19.58 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 125.518 1.527 . . . . 0.0 108.762 177.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -100.39 113.19 25.73 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.16 -167.21 14.84 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 125.453 1.502 . . . . 0.0 112.289 170.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -75.06 171.72 13.61 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.131 0.972 . . . . 0.0 109.201 177.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.11 62.76 2.16 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-O 118.5 -1.167 . . . . 0.0 111.409 176.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -100.38 89.91 1.28 Allowed Pre-proline 0 C--O 1.24 0.561 0 C-N-CA 131.242 3.817 . . . . 0.0 110.095 -163.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -62.92 -4.89 6.65 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 124.476 3.451 . . . . 0.0 115.543 -174.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.94 -177.69 44.81 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 108.846 -1.701 . . . . 0.0 108.846 -163.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.628 ' HA ' ' CG1' ' A' ' 97' ' ' VAL . 1.1 m-20 -72.5 5.12 3.21 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 -169.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.09 160.12 39.9 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 122.374 1.083 . . . . 0.0 110.213 154.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.8 p -128.3 163.87 31.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 126.811 2.044 . . . . 0.0 108.994 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -104.19 103.62 13.42 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.954 1.701 . . . . 0.0 106.545 169.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 60.8 m -97.61 166.95 11.26 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 122.714 0.405 . . . . 0.0 110.035 174.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -92.85 149.52 21.21 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 162.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.3 t -146.72 155.93 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 129.161 2.985 . . . . 0.0 107.067 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -89.71 128.17 36.05 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 166.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 81.9 p -130.09 -177.21 4.21 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.281 1.432 . . . . 0.0 109.291 -178.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -138.1 141.29 40.22 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 165.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -112.71 -4.45 14.06 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.226 1.411 . . . . 0.0 110.911 172.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.1 p -107.74 19.81 19.64 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.937 1.695 . . . . 0.0 111.006 -162.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -71.67 161.49 30.91 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.444 1.497 . . . . 0.0 112.105 -168.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -84.28 151.53 59.79 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 124.979 1.311 . . . . 0.0 109.995 167.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.01 -25.75 51.5 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 123.369 2.713 . . . . 0.0 113.52 -173.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.505 ' HA ' ' CD2' ' A' ' 126' ' ' PHE . 4.5 pm0 -52.69 -30.83 34.19 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.968 0.907 . . . . 0.0 112.382 177.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 45.3 m0 -76.88 -11.65 59.85 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 119.412 -0.327 . . . . 0.0 111.759 -176.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -85.64 -15.68 41.65 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 119.199 0.909 . . . . 0.0 111.713 171.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.505 ' CD2' ' HA ' ' A' ' 123' ' ' GLU . 4.8 m-85 -84.75 -10.28 57.39 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.364 0.984 . . . . 0.0 111.373 173.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 76.6 mt -72.15 158.36 87.73 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 124.844 1.257 . . . . 0.0 110.96 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -76.86 156.23 34.77 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 124.088 3.192 . . . . 0.0 111.887 176.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.484 ' CD2' ' HA2' ' A' ' 60' ' ' GLY . 21.3 m-85 -107.65 151.89 25.04 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.882 1.273 . . . . 0.0 111.95 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -136.29 167.54 21.12 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.766 1.226 . . . . 0.0 110.863 -175.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -113.64 -7.71 13.32 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.587 1.155 . . . . 0.0 112.631 -171.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 83.2 p -154.36 174.7 14.48 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 125.451 1.5 . . . . 0.0 108.381 168.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -137.97 109.18 6.84 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 174.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -140.11 123.27 16.8 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.617 1.167 . . . . 0.0 108.318 -168.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 9.6 t -59.38 -29.8 67.97 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.442 1.097 . . . . 0.0 110.059 176.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -62.74 -17.4 60.84 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.418 -0.801 . . . . 0.0 113.11 177.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -71.16 154.23 51.72 Favored Glycine 0 CA--C 1.537 1.445 0 CA-C-N 120.025 1.284 . . . . 0.0 112.434 -166.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -65.52 -5.99 12.69 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.811 2.341 . . . . 0.0 115.058 -177.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 -49.05 -49.58 40.61 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 120.651 1.569 . . . . 0.0 112.616 -175.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 87.45 1.68 83.35 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 118.258 -1.301 . . . . 0.0 113.689 -168.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.438 ' HB2' HD21 ' A' ' 49' ' ' ASN . 0.7 OUTLIER -103.56 96.37 6.68 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 118.905 1.352 . . . . 0.0 109.519 171.422 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -118.85 162.44 18.48 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.576 -0.702 . . . . 0.0 110.918 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -65.52 144.57 56.92 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -173.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 . . . . . 0 CA--C 1.53 0.192 0 C-N-CA 123.1 0.56 . . . . 0.0 110.12 175.049 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -128.13 129.31 46.35 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 174.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 41.2 pt -125.19 152.57 31.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -108.31 132.2 53.94 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 172.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.6 m -81.39 168.29 1.89 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.447 0 C-N-CA 123.69 0.796 . . . . 0.0 111.31 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -112.46 -29.87 7.35 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.043 0.937 . . . . 0.0 112.515 172.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 148.24 -1.9 0.67 Allowed Glycine 0 CA--C 1.526 0.741 0 CA-C-N 118.412 0.551 . . . . 0.0 113.869 168.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 p -53.62 -36.6 62.19 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 124.775 1.23 . . . . 0.0 111.2 160.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.0 mt -132.25 48.37 2.42 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.597 1.559 . . . . 0.0 109.179 -166.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -150.02 -59.19 0.2 Allowed 'General case' 0 N--CA 1.467 0.42 0 O-C-N 120.243 -1.535 . . . . 0.0 111.738 178.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 -73.03 -86.1 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 119.339 0.972 . . . . 0.0 108.714 174.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -175.23 50.11 0.13 Allowed Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 175.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.36 162.96 3.79 Favored Pre-proline 0 CA--C 1.544 0.745 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 169.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -64.4 -3.7 6.84 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 123.971 3.114 . . . . 0.0 113.255 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -120.3 10.67 11.33 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 126.827 2.051 . . . . 0.0 108.452 -167.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 39.0 p-80 -85.25 -38.82 18.47 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 121.254 1.843 . . . . 0.0 106.684 -168.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -17.35 55.49 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 120.517 -1.364 . . . . 0.0 114.183 -168.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.9 m -59.65 -34.66 55.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 118.445 0.566 . . . . 0.0 110.921 176.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -78.98 3.91 15.83 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.039 0.836 . . . . 0.0 113.113 177.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 35.4 mt -120.06 11.96 11.81 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.811 1.644 . . . . 0.0 110.816 -175.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -132.76 3.94 3.84 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 -171.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . 0.265 25.4 t-80 43.22 28.87 0.18 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 128.294 2.638 . . . . 0.0 113.679 176.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.4 m -117.71 -12.02 10.32 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 121.168 -0.957 . . . . 0.0 111.593 179.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -111.17 -1.43 16.17 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.206 1.802 . . . . 0.0 111.065 174.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 131.45 174.33 13.62 Favored Glycine 0 C--N 1.336 0.553 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 41.5 tp -82.23 139.8 34.04 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 123.169 0.588 . . . . 0.0 110.389 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -146.94 153.69 40.39 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 153.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.67 142.05 23.35 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 126.362 1.865 . . . . 0.0 108.286 169.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -59.99 118.83 6.74 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.212 1.405 . . . . 0.0 108.799 176.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.91 39.46 2.16 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.954 0.797 . . . . 0.0 110.321 -174.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 124.52 111.42 1.91 Allowed Glycine 0 N--CA 1.444 -0.79 0 CA-C-O 121.994 0.774 . . . . 0.0 111.328 166.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -61.06 149.62 36.44 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 121.592 -0.946 . . . . 0.0 108.469 173.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.47 175.33 37.22 Favored Glycine 0 C--O 1.238 0.385 0 C-N-CA 120.771 -0.728 . . . . 0.0 113.365 -169.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.8 p -136.59 147.18 46.83 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 43.4 p -64.48 120.05 11.57 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 158.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.7 t -68.0 -37.09 77.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.641 0.734 . . . . 0.0 109.08 177.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -78.21 140.2 38.93 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 168.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.5 m -60.44 151.05 29.2 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 160.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -134.57 153.84 79.28 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 165.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -76.38 92.08 1.09 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 124.212 3.275 . . . . 0.0 110.133 170.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 28.7 tp -90.63 109.03 20.2 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 118.816 -0.611 . . . . 0.0 109.757 174.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.5 m -123.55 135.75 62.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 124.395 1.078 . . . . 0.0 108.641 -171.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.2 mt -109.89 72.88 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 -172.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.83 179.33 7.06 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 122.613 1.197 . . . . 0.0 110.722 173.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.95 153.85 17.49 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-N 113.044 -1.889 . . . . 0.0 110.473 170.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -68.75 -11.62 60.51 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -166.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 37.5 m-70 -114.16 16.78 18.0 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.5 1.12 . . . . 0.0 112.053 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 50.49 74.02 0.24 Allowed 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.778 2.031 . . . . 0.0 109.369 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 87.6 mt -104.55 88.3 2.12 Favored Pre-proline 0 C--N 1.325 -0.493 0 C-N-CA 128.531 2.733 . . . . 0.0 104.991 -169.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -55.02 107.61 0.24 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.962 2.442 . . . . 0.0 111.148 -178.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -92.02 116.96 29.37 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 124.904 1.281 . . . . 0.0 107.6 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.15 92.15 8.66 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 172.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 11.0 mp -65.52 124.14 21.54 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.525 1.13 . . . . 0.0 108.762 176.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -74.04 84.95 1.79 Allowed 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.065 0.546 . . . . 0.0 110.266 -176.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.55 85.15 17.87 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 125.064 1.346 . . . . 0.0 108.373 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.92 126.68 17.8 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.842 2.361 . . . . 0.0 109.251 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.58 17.3 55.14 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 119.328 -0.707 . . . . 0.0 113.209 175.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -122.81 157.24 32.87 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 119.07 1.435 . . . . 0.0 107.189 172.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.468 ' HA2' ' CD2' ' A' ' 129' ' ' TYR . . . 70.49 -140.04 31.4 Favored Glycine 0 CA--C 1.522 0.511 0 CA-C-N 121.131 1.787 . . . . 0.0 111.603 175.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -131.17 160.24 35.37 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.327 1.064 . . . . 0.0 111.17 -170.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 76.4 m -83.64 106.61 15.5 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.695 -0.628 . . . . 0.0 110.93 -170.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.1 t -78.38 88.59 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 126.708 2.003 . . . . 0.0 111.996 -166.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.9 p -59.56 145.35 44.6 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 120.862 -1.149 . . . . 0.0 111.185 -172.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.03 -150.06 5.98 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-N 118.967 0.803 . . . . 0.0 112.596 -174.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -145.1 157.24 44.16 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.256 1.022 . . . . 0.0 109.058 -178.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 50.2 mt -107.66 91.79 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -80.74 127.16 32.18 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 177.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -74.07 130.45 39.84 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 163.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 23.7 m -144.24 176.3 2.69 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 C-N-CA 125.346 1.458 . . . . 0.0 109.898 -167.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.87 -175.95 3.22 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 122.671 1.224 . . . . 0.0 113.241 177.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -52.85 -52.02 58.8 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.07 1.748 . . . . 0.0 110.841 172.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -62.89 -39.47 94.58 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 117.948 -1.025 . . . . 0.0 110.282 -174.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 38.6 tpp -64.61 -43.64 93.1 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 119.454 1.025 . . . . 0.0 110.289 175.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 13.7 tp -65.03 -42.75 94.08 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.886 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 66.0 mtt180 -58.01 -41.78 83.82 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 124.526 1.13 . . . . 0.0 110.161 174.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -63.62 -52.8 59.3 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -176.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.2 mp -54.05 -39.35 66.14 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.206 0.602 . . . . 0.0 111.305 175.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.508 ' N ' ' HH ' ' A' ' 115' ' ' TYR . 1.3 t70 -57.05 -43.5 82.08 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.714 0.769 . . . . 0.0 110.77 178.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -86.33 -26.9 24.63 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.306 1.443 . . . . 0.0 113.044 -175.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -93.09 -40.15 10.67 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.558 1.143 . . . . 0.0 111.394 -170.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -82.74 7.26 15.47 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 118.348 0.522 . . . . 0.0 110.462 177.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 59.58 29.61 19.19 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.626 1.571 . . . . 0.0 111.962 175.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 1.8 p -73.25 168.22 27.17 Favored Pre-proline 0 CA--C 1.541 0.624 0 O-C-N 120.237 -1.539 . . . . 0.0 108.218 173.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.4 -4.43 7.77 Favored 'Cis proline' 0 CA--C 1.544 0.988 0 CA-C-N 120.21 1.111 . . . . 0.0 113.545 -13.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.5 m -60.84 -61.64 2.44 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 126.093 1.757 . . . . 0.0 111.313 -177.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 2.7 mtm -75.71 -85.18 0.05 OUTLIER 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -83.8 176.81 8.66 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.501 1.12 . . . . 0.0 109.064 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -137.08 136.88 38.74 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.907 1.683 . . . . 0.0 106.84 161.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -70.29 133.68 47.22 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 171.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.0 m -136.67 175.44 9.61 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.772 2.029 . . . . 0.0 108.523 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -118.37 137.33 53.19 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 127.921 2.488 . . . . 0.0 109.747 175.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.43 -179.29 6.2 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.019 1.728 . . . . 0.0 110.512 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -113.22 123.86 51.17 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.627 1.571 . . . . 0.0 110.548 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.411 ' CG2' ' SG ' ' A' ' 112' ' ' CYS . 54.1 t -118.54 145.85 23.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 C-N-CA 125.772 1.629 . . . . 0.0 107.335 -177.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -89.65 136.9 32.77 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 171.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 94.8 t -77.61 95.74 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 127.696 2.398 . . . . 0.0 106.15 168.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.6 mp -72.79 -31.26 64.73 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.586 -0.696 . . . . 0.0 109.483 172.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -148.56 164.3 34.64 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 106.298 -1.742 . . . . 0.0 106.298 167.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 75.5 t-105 -139.88 124.54 18.27 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.64 1.576 . . . . 0.0 108.006 175.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -79.02 113.34 17.06 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 171.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 86.69 -148.6 21.91 Favored Glycine 0 C--O 1.235 0.166 0 CA-C-O 121.696 0.609 . . . . 0.0 112.246 153.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -67.01 160.06 27.31 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 126.426 1.89 . . . . 0.0 111.715 -170.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 60.92 76.03 0.26 Allowed Glycine 0 C--O 1.221 -0.672 0 C-N-CA 124.449 1.023 . . . . 0.0 111.727 170.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -102.87 88.77 1.59 Allowed Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 128.734 2.813 . . . . 0.0 108.211 -168.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -56.08 -22.41 39.28 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 124.601 3.534 . . . . 0.0 114.939 -172.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 123.7 176.46 14.76 Favored Glycine 0 C--N 1.333 0.384 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -173.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -64.11 -17.59 63.58 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 118.515 -0.755 . . . . 0.0 112.518 -172.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 39.7 p -130.57 159.78 36.14 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 120.2 1.364 . . . . 0.0 111.971 168.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 28.4 m -141.95 169.56 13.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 125.443 1.497 . . . . 0.0 108.539 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -104.14 155.75 18.45 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 159.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.411 ' SG ' ' CG2' ' A' ' 95' ' ' VAL . 0.5 OUTLIER -155.04 162.05 41.16 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 129.142 2.977 . . . . 0.0 108.694 -178.37 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -87.24 153.36 21.55 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 169.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.9 t -143.17 150.77 17.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 127.914 2.485 . . . . 0.0 107.2 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.508 ' HH ' ' N ' ' A' ' 79' ' ' ASP . 4.3 m-85 -94.76 102.76 14.65 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 169.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 72.7 p -103.41 -167.88 1.44 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.009 1.324 . . . . 0.0 108.7 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.7 t -136.05 156.05 49.3 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 155.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -123.46 5.44 9.0 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.151 1.381 . . . . 0.0 110.776 171.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.2 t -132.32 53.55 2.0 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 122.93 1.348 . . . . 0.0 109.415 -173.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -67.39 153.63 43.24 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.009 1.323 . . . . 0.0 110.402 175.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.18 149.43 98.46 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 162.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.09 -35.8 40.56 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 121.451 1.434 . . . . 0.0 112.545 -170.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -57.86 -23.68 54.03 Favored 'General case' 0 C--O 1.225 -0.218 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 177.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.4 ' HA ' ' CD2' ' A' ' 127' ' ' LEU . 44.2 m0 -64.93 -16.26 63.09 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 119.863 1.21 . . . . 0.0 112.015 -178.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 53.7 mt -71.9 2.46 5.51 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.846 1.259 . . . . 0.0 112.418 171.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -113.13 -11.69 13.26 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.612 1.565 . . . . 0.0 113.75 178.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.4 ' CD2' ' HA ' ' A' ' 124' ' ' TRP . 1.1 mm? -67.81 146.67 98.47 Favored Pre-proline 0 C--N 1.326 -0.436 0 C-N-CA 126.102 1.761 . . . . 0.0 108.092 -177.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -64.32 149.34 90.35 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.223 1.282 . . . . 0.0 109.269 176.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.468 ' CD2' ' HA2' ' A' ' 60' ' ' GLY . 23.0 m-85 -89.28 152.19 21.69 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 175.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 62.6 m-70 -121.91 134.97 54.86 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -83.37 -15.78 48.53 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.924 0.89 . . . . 0.0 111.007 178.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.1 t -164.2 147.58 9.48 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 163.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -87.37 151.29 23.21 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.3 -0.864 . . . . 0.0 108.695 169.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 35.9 p-10 -153.39 162.25 41.48 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 126.826 2.05 . . . . 0.0 110.797 169.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 9.0 p -93.9 0.74 56.31 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 126.351 1.86 . . . . 0.0 112.791 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -143.04 23.09 1.89 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.954 1.302 . . . . 0.0 109.647 -164.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -94.83 177.74 35.82 Favored Glycine 0 C--O 1.242 0.65 0 C-N-CA 123.876 0.75 . . . . 0.0 113.944 -167.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -64.7 -24.95 61.68 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.689 2.259 . . . . 0.0 111.061 169.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 46.1 m-70 -73.8 80.99 1.6 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.322 1.449 . . . . 0.0 108.401 176.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -59.39 -17.78 40.82 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.639 1.59 . . . . 0.0 114.445 -178.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.91 72.75 0.1 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.213 1.805 . . . . 0.0 111.614 168.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 6.3 mtt85 -99.48 166.03 11.36 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 120.968 -1.083 . . . . 0.0 111.062 -174.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -58.9 142.1 51.67 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -175.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 . . . . . 0 N--CA 1.455 -0.186 0 O-C-N 123.605 0.565 . . . . 0.0 110.143 -175.751 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.5 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.8 m80 -58.96 140.02 56.06 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 124.127 0.971 . . . . 0.0 108.767 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 39.2 pt -134.86 159.92 41.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 C-N-CA 124.694 1.198 . . . . 0.0 109.401 175.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -87.98 138.61 31.3 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 163.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.4 m -72.05 -177.28 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 156.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -133.1 -57.88 0.91 Allowed 'General case' 0 N--CA 1.447 -0.589 0 O-C-N 121.082 -1.011 . . . . 0.0 111.013 176.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -165.69 -41.99 0.02 OUTLIER Glycine 0 C--N 1.33 0.233 0 CA-C-N 118.629 0.649 . . . . 0.0 111.888 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 p -53.55 -29.31 36.28 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.995 1.318 . . . . 0.0 111.727 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.4 mp -133.19 76.78 1.7 Allowed 'General case' 0 C--O 1.221 -0.406 0 C-N-CA 124.502 1.121 . . . . 0.0 108.533 177.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -149.42 -80.01 0.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 O-C-N 120.895 -1.128 . . . . 0.0 108.878 172.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.413 HH21 ' CD ' ' A' ' 136' ' ' GLU . 25.2 ttt85 -67.43 -85.3 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 123.366 0.666 . . . . 0.0 110.429 -177.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -158.31 26.09 0.41 Allowed Glycine 0 C--N 1.336 0.554 0 CA-C-N 119.642 1.11 . . . . 0.0 113.058 -175.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -55.09 163.13 1.66 Allowed Pre-proline 0 N--CA 1.449 -0.521 0 C-N-CA 125.379 1.472 . . . . 0.0 111.411 175.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.15 -16.01 52.57 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.474 2.116 . . . . 0.0 112.842 -172.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -95.16 -17.87 21.41 Favored 'General case' 0 C--O 1.219 -0.512 0 C-N-CA 125.292 1.437 . . . . 0.0 111.245 -164.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -52.78 -40.79 63.5 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 120.088 1.313 . . . . 0.0 112.178 -165.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.96 -25.1 2.98 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -177.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.3 m -68.94 -29.6 43.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 O-C-N 121.296 -0.878 . . . . 0.0 110.748 -177.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.1 ptp -83.27 6.14 20.67 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 119.045 0.839 . . . . 0.0 112.454 174.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 49.7 mt -114.42 26.74 10.0 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.82 1.648 . . . . 0.0 109.365 -177.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -139.26 99.43 3.74 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.248 1.419 . . . . 0.0 108.598 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 25.4 t-80 -63.58 -22.02 66.67 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -162.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.5 m -70.99 -32.6 69.46 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.835 -0.541 . . . . 0.0 111.988 172.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 40.3 m170 -71.32 -37.74 71.73 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 171.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 158.85 173.72 27.62 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-O 121.955 0.753 . . . . 0.0 111.969 156.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 57.5 tp -70.26 141.34 52.45 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.288 0.635 . . . . 0.0 111.214 177.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -150.95 108.43 3.63 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.694 1.197 . . . . 0.0 108.558 160.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -112.41 135.26 53.33 Favored 'General case' 0 CA--C 1.522 -0.112 0 C-N-CA 124.616 1.167 . . . . 0.0 108.633 175.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -63.68 108.54 1.44 Allowed 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.264 1.026 . . . . 0.0 108.577 177.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -106.55 44.39 1.06 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 -178.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.91 -162.2 35.42 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-O 122.515 1.064 . . . . 0.0 111.295 -177.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 63.5 mtp85 -125.57 166.02 17.46 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 121.491 -1.005 . . . . 0.0 110.056 -167.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -168.84 171.31 42.81 Favored Glycine 0 C--N 1.336 0.558 0 C-N-CA 120.234 -0.984 . . . . 0.0 113.637 177.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 91.0 m -138.02 149.57 46.18 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.23 1.012 . . . . 0.0 109.656 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.8 p -69.95 120.81 16.23 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 168.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.6 t -83.11 -48.86 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 -174.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -57.66 130.18 45.24 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 159.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.2 m -57.98 148.68 25.23 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 162.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -134.9 153.26 78.53 Favored Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 163.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -76.35 95.91 1.06 Allowed 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 125.261 3.974 . . . . 0.0 110.893 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.99 109.4 22.16 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -178.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.3 m -121.51 151.53 24.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 119.013 0.824 . . . . 0.0 109.469 175.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.425 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 45.5 mt -88.49 135.22 26.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 165.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.66 167.99 20.95 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 122.371 1.082 . . . . 0.0 110.7 173.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.61 174.76 46.81 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-O 122.829 1.239 . . . . 0.0 113.127 168.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -84.89 -4.59 59.17 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.65 1.18 . . . . 0.0 113.092 -163.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -119.86 10.28 11.54 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.54 1.536 . . . . 0.0 111.803 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 35.3 m-20 58.25 59.24 3.11 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.199 1.8 . . . . 0.0 109.574 176.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 96.8 mt -106.41 88.76 3.49 Favored Pre-proline 0 N--CA 1.455 -0.225 0 C-N-CA 127.142 2.177 . . . . 0.0 107.085 -171.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . 75.9 Cg_endo -58.39 135.14 65.92 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 CA-C-N 119.955 1.02 . . . . 0.0 111.519 172.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 74.7 m95 -101.15 -173.92 2.49 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.084 0.953 . . . . 0.0 108.914 178.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.9 tp -142.53 101.68 3.92 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 159.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.93 132.28 51.55 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 172.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -71.44 92.94 1.12 Allowed 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.15 77.42 12.97 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -57.63 120.01 7.63 Favored 'Trans proline' 0 C--O 1.239 0.546 0 C-N-CA 122.914 2.409 . . . . 0.0 109.145 176.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.51 7.19 51.94 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 125.86 1.695 . . . . 0.0 114.34 176.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -115.81 167.77 10.64 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 119.824 1.812 . . . . 0.0 108.878 171.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.403 ' HA2' ' CD2' ' A' ' 129' ' ' TYR . . . 66.49 -148.28 50.55 Favored Glycine 0 CA--C 1.518 0.258 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -173.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 63.9 m-70 -124.92 176.91 6.33 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.874 1.27 . . . . 0.0 108.399 -177.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 3.6 p -61.73 161.68 9.74 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 120.444 -0.502 . . . . 0.0 109.798 170.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 38.8 t -135.69 114.29 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 169.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 45.9 p -79.19 157.66 27.81 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 123.301 0.64 . . . . 0.0 109.876 -177.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -177.4 -153.0 10.47 Favored Glycine 0 CA--C 1.526 0.74 0 O-C-N 121.222 -0.924 . . . . 0.0 112.568 -176.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -138.68 165.7 26.27 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.21 1.404 . . . . 0.0 110.98 -174.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 62.2 mt -116.35 128.01 73.8 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 -173.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -122.92 126.98 48.3 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.973 0.892 . . . . 0.0 109.284 172.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -62.78 107.05 0.89 Allowed 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 158.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.1 m -115.41 161.04 14.44 Favored 'Isoleucine or valine' 0 C--O 1.244 0.809 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 171.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -113.43 173.22 6.51 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 176.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -52.04 -42.87 63.45 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 124.578 1.151 . . . . 0.0 110.683 -171.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 -62.59 -36.35 82.44 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 118.828 -0.606 . . . . 0.0 111.468 -174.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 20.4 tpp -67.67 -53.99 23.24 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.45 -38.28 80.34 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.267 -175.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.53 -41.9 75.37 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 125.582 1.553 . . . . 0.0 110.918 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -56.7 -51.44 68.79 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 122.974 0.51 . . . . 0.0 110.54 171.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 93.1 mt -60.5 -32.99 71.97 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.396 -0.815 . . . . 0.0 111.783 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.425 ' N ' ' HH ' ' A' ' 115' ' ' TYR . 6.4 t0 -67.11 -6.52 17.89 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.24 1.816 . . . . 0.0 112.736 177.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -107.95 -49.86 3.15 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.939 1.695 . . . . 0.0 109.454 171.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -62.8 -46.56 87.4 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.253 1.021 . . . . 0.0 112.063 -174.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -72.12 6.66 2.05 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.91 0.884 . . . . 0.0 111.324 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 62.62 20.09 11.77 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 126.341 1.856 . . . . 0.0 113.264 167.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 26.5 p -68.91 157.98 87.49 Favored Pre-proline 0 CA--C 1.541 0.622 0 O-C-N 121.138 -0.976 . . . . 0.0 109.232 175.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -72.3 -4.32 12.98 Favored 'Cis proline' 0 CA--C 1.545 1.057 0 CA-C-N 119.978 1.028 . . . . 0.0 114.606 -5.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.5 m -63.96 -59.02 5.02 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 119.527 1.058 . . . . 0.0 111.979 -174.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 37.6 mtp -78.26 -80.65 0.11 Allowed 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -89.11 174.95 7.59 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.749 0.82 . . . . 0.0 109.918 177.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -132.73 -12.48 2.98 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.637 0.775 . . . . 0.0 113.015 173.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? 63.44 133.46 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 129.542 3.137 . . . . 0.0 112.576 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 61.9 m -143.98 160.48 40.78 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 123.969 0.907 . . . . 0.0 109.374 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -89.84 128.51 36.18 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.943 1.697 . . . . 0.0 110.539 170.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.72 178.53 5.64 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 127.365 2.266 . . . . 0.0 110.004 172.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 44.4 tp60 -116.71 128.43 55.32 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.555 1.542 . . . . 0.0 108.933 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.412 ' CG2' ' SG ' ' A' ' 112' ' ' CYS . 41.8 t -122.38 151.53 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 127.239 2.216 . . . . 0.0 107.114 -171.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -88.73 139.41 30.5 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.682 1.593 . . . . 0.0 107.265 171.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.4 t -87.31 126.44 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 170.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 mp -99.07 -36.61 9.65 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.143 1.777 . . . . 0.0 109.95 -176.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -148.44 153.35 38.39 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 130.44 3.496 . . . . 0.0 104.418 174.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . 0.55 ' HE1' ' N ' ' A' ' 104' ' ' GLY . 74.1 t-105 -141.53 123.29 15.23 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -178.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -130.94 109.19 10.36 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 169.69 -120.81 0.89 Allowed Glycine 0 C--N 1.343 0.936 0 C-N-CA 114.489 -3.719 . . . . 0.0 121.192 173.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -64.43 -178.05 0.35 Allowed 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 101.482 -3.525 . . . . 0.0 101.482 126.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.55 ' N ' ' HE1' ' A' ' 100' ' ' TRP . . . -108.76 -75.23 0.86 Allowed Glycine 0 N--CA 1.417 -2.572 1 C-N-CA 111.397 -5.192 . . . . 0.0 106.464 -94.149 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -158.89 88.04 2.19 Favored Pre-proline 0 C--N 1.313 -1.002 1 C-N-CA 133.652 4.781 . . . . 0.0 114.966 163.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -51.41 -30.41 34.48 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.001 2.468 . . . . 0.0 114.082 161.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 111.22 179.39 20.21 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.89 1.233 . . . . 0.0 110.557 -169.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -67.61 -11.91 59.23 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.463 1.105 . . . . 0.0 112.056 -171.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.7 p -130.93 159.73 36.58 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 120.786 -1.196 . . . . 0.0 110.979 172.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.2 p -151.1 146.29 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 124.174 0.99 . . . . 0.0 109.924 177.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -87.77 142.39 27.86 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 173.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.412 ' SG ' ' CG2' ' A' ' 95' ' ' VAL . 0.5 OUTLIER -152.19 168.84 24.02 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.392 1.477 . . . . 0.0 110.011 -178.815 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -92.39 151.79 20.07 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.098 0.559 . . . . 0.0 110.149 172.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 51.2 t -138.39 146.03 27.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 C-N-CA 127.6 2.36 . . . . 0.0 106.265 167.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.425 ' HH ' ' N ' ' A' ' 79' ' ' ASP . 45.0 m-85 -78.02 92.84 4.38 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.711 0.804 . . . . 0.0 109.51 172.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.0 p -104.45 173.47 6.29 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.369 1.468 . . . . 0.0 111.388 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.85 148.57 52.3 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 126.226 1.811 . . . . 0.0 107.089 175.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -112.8 -2.29 14.44 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.456 1.102 . . . . 0.0 111.296 167.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.6 p -111.8 18.26 19.08 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.695 1.598 . . . . 0.0 112.212 -158.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -68.93 158.92 33.66 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.727 1.611 . . . . 0.0 112.314 -170.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.4 157.66 87.67 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 126.343 1.857 . . . . 0.0 111.359 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -52.88 -53.75 6.27 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.533 2.822 . . . . 0.0 113.096 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.477 ' HA ' ' CD2' ' A' ' 126' ' ' PHE . 0.5 OUTLIER -45.67 -33.25 2.82 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 126.458 1.903 . . . . 0.0 114.191 -179.123 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 38.7 m0 -74.28 -3.5 30.47 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.598 -0.688 . . . . 0.0 112.242 -168.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 89.1 mt -97.08 -12.98 22.52 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 118.027 -0.987 . . . . 0.0 113.237 170.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.477 ' CD2' ' HA ' ' A' ' 123' ' ' GLU . 10.3 m-85 -84.34 -30.24 25.66 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 119.511 1.051 . . . . 0.0 110.214 177.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 36.3 mt -58.32 155.55 26.38 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 125.955 1.702 . . . . 0.0 111.428 -174.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.52 156.06 62.14 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 121.693 1.595 . . . . 0.0 109.756 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.403 ' CD2' ' HA2' ' A' ' 60' ' ' GLY . 31.9 m-85 -104.9 161.39 14.23 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.248 1.019 . . . . 0.0 111.945 178.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -138.95 159.9 41.05 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.926 0.891 . . . . 0.0 110.56 -171.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -111.06 -7.65 14.49 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -164.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 33.8 t -164.56 158.67 18.35 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 171.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -103.53 150.06 24.27 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.258 0.552 . . . . 0.0 109.681 172.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -157.9 170.1 23.09 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.515 1.526 . . . . 0.0 108.203 177.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.4 9.44 37.81 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.383 1.873 . . . . 0.0 110.769 167.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.413 ' CD ' HH21 ' A' ' 12' ' ' ARG . 49.5 mt-10 -138.05 4.15 2.47 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.551 1.14 . . . . 0.0 113.719 -167.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -89.3 -171.15 45.28 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 127.127 2.299 . . . . 0.0 111.925 -175.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -71.34 5.95 2.09 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 124.648 3.566 . . . . 0.0 114.997 -178.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -87.12 91.44 8.71 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -53.16 -36.69 52.89 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 121.78 -0.575 . . . . 0.0 113.235 -178.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.481 ' CD2' ' H ' ' A' ' 141' ' ' LEU . 0.7 OUTLIER -68.82 119.46 13.21 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 127.347 2.259 . . . . 0.0 109.646 168.691 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.53 163.51 13.63 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 119.65 1.114 . . . . 0.0 110.772 167.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -54.52 139.99 36.06 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 119.164 0.893 . . . . 0.0 110.057 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 C--O 1.235 0.338 0 C-N-CA 123.295 0.638 . . . . 0.0 110.103 -173.455 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.004 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -130.68 142.9 50.44 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 125.536 1.534 . . . . 0.0 109.346 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.2 pt -125.88 171.64 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 124.313 1.045 . . . . 0.0 109.717 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -121.4 127.74 51.48 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.313 1.445 . . . . 0.0 107.713 174.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.3 m -97.86 155.83 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 123.917 0.887 . . . . 0.0 109.371 170.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -147.08 -19.78 0.4 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.755 2.022 . . . . 0.0 111.479 178.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -120.25 -129.71 3.83 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 127.513 2.482 . . . . 0.0 111.761 -169.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.454 ' HB ' HD21 ' A' ' 16' ' ' ASN . 32.4 p -64.0 -35.95 82.38 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.738 -0.86 . . . . 0.0 112.516 -161.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.1 mt -80.94 3.11 23.97 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.432 0.693 . . . . 0.0 111.911 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -89.29 -81.18 0.28 Allowed 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 117.345 -1.312 . . . . 0.0 110.323 178.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.99 -85.76 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 121.052 1.751 . . . . 0.0 111.073 -174.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -169.7 21.11 0.08 OUTLIER Glycine 0 CA--C 1.525 0.717 0 O-C-N 121.307 -0.871 . . . . 0.0 111.149 -164.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -52.81 162.61 0.95 Allowed Pre-proline 0 N--CA 1.452 -0.372 0 C-N-CA 124.53 1.132 . . . . 0.0 110.621 176.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -65.73 1.89 1.97 Allowed 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 124.911 3.741 . . . . 0.0 113.092 -172.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.454 HD21 ' HB ' ' A' ' 9' ' ' THR . 3.0 m-20 -119.66 -17.68 8.56 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 126.289 1.836 . . . . 0.0 107.92 -171.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -51.38 -37.31 47.49 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 120.192 1.36 . . . . 0.0 109.991 177.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.23 -21.74 3.71 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-O 117.231 -1.366 . . . . 0.0 114.6 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.0 m -61.73 -41.51 90.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 120.994 1.725 . . . . 0.0 110.122 176.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -74.41 -17.68 60.76 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 119.315 0.962 . . . . 0.0 113.114 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 73.0 mt -75.32 -5.08 42.88 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.103 0.561 . . . . 0.0 111.244 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -102.65 103.75 14.05 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.286 0.565 . . . . 0.0 109.687 169.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 -51.33 -19.85 1.47 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.089 1.355 . . . . 0.0 113.963 173.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.5 t -77.19 -30.27 54.72 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.032 -1.043 . . . . 0.0 112.027 176.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -69.22 -30.33 68.46 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.585 1.084 . . . . 0.0 109.464 166.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.53 177.27 26.01 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 110.909 -0.877 . . . . 0.0 110.909 167.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 30.1 tp -77.89 142.05 38.7 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 123.639 0.776 . . . . 0.0 111.056 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -145.7 141.36 27.98 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.397 1.079 . . . . 0.0 110.1 165.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.81 148.02 27.98 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.454 1.502 . . . . 0.0 109.815 166.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -67.62 124.35 23.0 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 125.061 1.344 . . . . 0.0 109.118 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.1 tpp180 -120.07 45.7 2.12 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.652 1.181 . . . . 0.0 108.658 -176.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 89.39 -177.79 44.17 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -174.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.82 172.54 11.55 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.518 -0.99 . . . . 0.0 111.813 -173.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -173.82 -178.02 43.45 Favored Glycine 0 CA--C 1.505 -0.542 0 C-N-CA 120.305 -0.95 . . . . 0.0 114.158 -174.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 22.1 p -146.4 154.84 42.09 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 123.909 0.883 . . . . 0.0 109.45 173.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 44.7 p -78.26 83.23 4.52 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 173.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.6 m -59.58 -30.8 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 118.826 0.739 . . . . 0.0 112.195 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.41 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 7.1 tt0 -74.74 22.99 0.1 Allowed 'General case' 0 C--O 1.205 -1.24 0 C-N-CA 127.861 2.465 . . . . 0.0 111.928 173.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 41.46 114.37 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.616 1 C-N-CA 134.393 5.077 . . . . 0.0 114.025 158.377 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -127.85 154.12 78.12 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 120.194 1.361 . . . . 0.0 111.413 -173.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.38 105.81 1.93 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 124.93 3.753 . . . . 0.0 110.724 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.48 100.91 9.13 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 -178.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.3 m -110.33 144.69 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-N 119.179 0.9 . . . . 0.0 110.154 -172.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.0 mt -91.98 116.4 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 171.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -129.92 179.58 5.78 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 124.332 1.053 . . . . 0.0 108.7 172.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.4 152.68 25.17 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 124.649 1.118 . . . . 0.0 112.809 161.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.76 -17.56 64.93 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -171.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -105.97 9.01 32.73 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 118.512 -0.756 . . . . 0.0 112.423 -177.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 53.42 79.64 0.12 Allowed 'General case' 0 C--N 1.342 0.239 0 C-N-CA 125.769 1.628 . . . . 0.0 108.391 -162.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 62.2 mt -120.04 86.57 37.28 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -61.31 151.68 77.59 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 CA-C-N 120.781 1.315 . . . . 0.0 112.683 174.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -125.77 128.92 48.47 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.448 1.499 . . . . 0.0 107.56 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.7 107.08 18.94 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 174.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.1 mt -87.12 139.2 30.8 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 105.904 -1.888 . . . . 0.0 105.904 -172.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -73.61 96.99 2.55 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 118.774 0.716 . . . . 0.0 109.865 -175.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.08 87.13 4.35 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 124.365 1.066 . . . . 0.0 112.982 177.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 31.5 Cg_endo -59.75 145.18 98.87 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.884 2.389 . . . . 0.0 111.49 176.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 47.65 51.34 17.45 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 129.481 3.419 . . . . 0.0 112.533 -174.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.0 tptm -140.55 143.81 35.56 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 126.072 1.749 . . . . 0.0 106.314 173.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.21 -129.43 20.46 Favored Glycine 0 CA--C 1.519 0.299 0 N-CA-C 109.064 -1.615 . . . . 0.0 109.064 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -138.31 170.53 15.86 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 119.212 1.506 . . . . 0.0 111.606 -167.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 73.1 m -84.53 104.44 14.53 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.381 -0.827 . . . . 0.0 108.995 -176.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.0 t -70.32 110.71 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.9 p -75.09 145.34 42.36 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 120.904 -1.122 . . . . 0.0 110.43 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -167.35 -167.4 27.97 Favored Glycine 0 C--N 1.335 0.473 0 O-C-N 120.446 -1.409 . . . . 0.0 112.364 -169.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -134.93 158.8 43.35 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.222 1.009 . . . . 0.0 109.169 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.8 mt -102.56 132.71 48.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 -177.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -118.21 127.01 53.34 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 118.64 0.654 . . . . 0.0 110.863 172.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -60.25 135.05 57.61 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 150.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.8 m -135.25 173.45 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 170.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.06 -178.27 3.71 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.679 0.752 . . . . 0.0 111.193 160.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -44.46 -55.59 4.94 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 126.61 1.964 . . . . 0.0 111.888 -171.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -71.28 -27.62 63.55 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 117.298 -1.334 . . . . 0.0 111.215 -171.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 24.1 tpp -66.28 -47.81 72.45 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 120.862 1.665 . . . . 0.0 108.595 172.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.09 -28.92 70.4 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 119.403 -0.332 . . . . 0.0 111.581 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -77.67 -37.03 50.65 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.42 1.009 . . . . 0.0 112.297 174.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -67.22 -45.84 75.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 119.475 1.034 . . . . 0.0 109.807 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.13 -32.25 66.16 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.67 -0.644 . . . . 0.0 110.351 171.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.31 -7.92 15.67 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.038 1.335 . . . . 0.0 113.069 177.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -123.97 -27.16 3.94 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.712 2.405 . . . . 0.0 111.773 -176.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -72.83 -29.52 63.3 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.286 -0.884 . . . . 0.0 110.902 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -117.25 30.95 7.02 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.748 1.619 . . . . 0.0 110.406 177.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.0 t0 49.91 26.31 1.93 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.811 2.044 . . . . 0.0 113.431 169.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -71.72 159.89 84.19 Favored Pre-proline 0 CA--C 1.54 0.572 0 O-C-N 120.652 -1.28 . . . . 0.0 109.381 -167.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -68.42 -3.4 5.97 Favored 'Cis proline' 0 CA--C 1.54 0.82 0 CA-C-N 120.979 1.385 . . . . 0.0 113.702 -11.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.4 t -56.34 -68.12 0.24 Allowed 'General case' 0 C--O 1.238 0.488 0 CA-C-N 119.339 0.972 . . . . 0.0 111.443 -173.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 26.8 mtp -77.91 -73.54 0.31 Allowed 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -177.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -97.97 -179.73 4.51 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 124.575 1.15 . . . . 0.0 108.108 173.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -165.45 125.29 1.79 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 -172.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.8 tmm_? -69.92 148.18 49.3 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -173.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.5 m -149.78 168.25 24.22 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 126.37 1.868 . . . . 0.0 107.284 -174.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -123.33 142.62 50.76 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.178 1.791 . . . . 0.0 109.691 172.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.19 174.13 13.61 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.466 1.907 . . . . 0.0 110.53 -173.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -92.63 111.79 23.51 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.973 1.309 . . . . 0.0 109.491 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.1 t -106.17 144.38 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 120.509 1.504 . . . . 0.0 107.754 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -78.81 140.78 38.15 Favored 'General case' 0 C--N 1.341 0.221 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 169.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 40.7 t -93.36 92.57 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 176.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.09 -24.53 67.73 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.876 -0.515 . . . . 0.0 110.746 175.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -165.93 149.52 7.76 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 128.035 2.534 . . . . 0.0 105.546 176.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 63.2 t-105 -125.89 137.72 53.75 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 124.715 1.206 . . . . 0.0 107.794 171.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -108.75 127.12 53.73 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.178 0.991 . . . . 0.0 110.558 174.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.6 -174.9 47.56 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 124.902 1.239 . . . . 0.0 112.385 168.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -62.77 151.82 37.59 Favored 'General case' 0 C--O 1.238 0.48 0 O-C-N 122.709 -0.289 . . . . 0.0 110.623 -170.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 102.56 45.31 1.69 Allowed Glycine 0 CA--C 1.52 0.355 0 CA-C-O 119.393 -0.671 . . . . 0.0 112.785 177.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -101.73 89.51 1.53 Allowed Pre-proline 0 N--CA 1.465 0.283 0 C-N-CA 126.682 1.993 . . . . 0.0 109.525 -156.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -62.35 -29.31 79.44 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 124.03 3.153 . . . . 0.0 112.922 -166.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 120.28 -169.21 13.96 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -163.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -71.39 -10.88 60.48 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.745 1.218 . . . . 0.0 113.039 -168.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.0 p -139.01 165.09 28.03 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 120.252 -1.53 . . . . 0.0 110.277 167.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.9 p -146.3 175.39 2.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 C-N-CA 124.989 1.315 . . . . 0.0 108.048 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -100.71 136.0 41.27 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 155.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 98.0 m -121.81 165.06 16.44 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 165.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -83.31 150.39 26.16 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 160.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.3 t -142.22 160.81 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 129.312 3.045 . . . . 0.0 105.295 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -110.31 108.08 18.04 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 171.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 32.5 p -112.64 -164.74 0.94 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 122.017 0.913 . . . . 0.0 109.286 175.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.52 135.69 28.59 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 174.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -98.69 -3.33 36.16 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.869 1.267 . . . . 0.0 111.309 164.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 16.9 p -92.3 -0.65 57.38 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.461 1.904 . . . . 0.0 113.206 -170.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -55.6 141.23 38.29 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 126.669 1.988 . . . . 0.0 113.171 -164.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.44 147.06 98.87 Favored Pre-proline 0 N--CA 1.446 -0.657 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.137 -177.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -65.19 -22.06 61.56 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.101 1.867 . . . . 0.0 113.307 -178.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.479 ' HA ' ' CE2' ' A' ' 126' ' ' PHE . 1.6 pm0 -70.0 -29.04 66.02 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 170.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 46.6 m0 -72.61 3.58 4.83 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.052 -1.03 . . . . 0.0 111.247 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -81.24 -22.25 38.88 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.663 1.585 . . . . 0.0 113.83 169.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.479 ' CE2' ' HA ' ' A' ' 123' ' ' GLU . 33.7 p90 -107.12 -16.84 14.32 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 120.474 1.488 . . . . 0.0 112.772 -177.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 26.2 mt -56.29 148.14 43.92 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 123.668 0.787 . . . . 0.0 110.091 173.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.67 147.45 45.27 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.601 2.201 . . . . 0.0 111.712 -173.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -91.23 168.94 11.24 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.201 1.4 . . . . 0.0 111.413 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -143.42 164.26 30.8 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.621 1.568 . . . . 0.0 109.41 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -107.45 -1.73 21.16 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.28 1.832 . . . . 0.0 111.626 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.16 167.97 23.28 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 126.182 1.793 . . . . 0.0 106.948 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -135.22 96.77 3.56 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 104.357 -2.46 . . . . 0.0 104.357 176.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -150.24 115.12 5.31 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 122.942 0.497 . . . . 0.0 110.18 -170.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 73.5 m -54.82 -16.68 2.79 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.124 1.37 . . . . 0.0 111.303 171.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -103.89 57.31 0.73 Allowed 'General case' 0 C--O 1.237 0.399 0 C-N-CA 126.439 1.895 . . . . 0.0 109.273 -177.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -146.84 177.26 25.27 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 127.914 2.674 . . . . 0.0 109.437 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -79.95 3.48 7.56 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.793 2.996 . . . . 0.0 114.32 -171.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -120.49 85.3 2.37 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 107.31 -1.366 . . . . 0.0 107.31 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -72.14 52.26 1.37 Allowed Glycine 0 CA--C 1.529 0.938 0 C-N-CA 126.587 2.041 . . . . 0.0 115.089 -167.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.49 58.09 1.25 Allowed 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 126.024 1.73 . . . . 0.0 109.621 -174.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 14.0 mmt85 -119.66 -18.07 8.46 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -176.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -166.86 139.9 3.67 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 125.328 1.451 . . . . 0.0 107.965 163.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 CA--C 1.531 0.22 0 O-C-N 124.422 1.076 . . . . 0.0 108.913 179.127 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.174 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -85.68 122.28 29.55 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 171.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.0 pt -129.05 174.98 11.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 125.329 1.451 . . . . 0.0 111.426 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -105.02 -167.92 1.4 Allowed 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.949 1.699 . . . . 0.0 110.596 172.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.7 p -139.74 148.41 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 123.95 0.9 . . . . 0.0 109.132 166.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -59.56 -32.26 70.18 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.636 1.575 . . . . 0.0 113.173 -177.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 142.32 -31.07 2.07 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.65 1.119 . . . . 0.0 111.179 -168.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 p -59.35 -73.48 0.08 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 130.68 3.592 . . . . 0.0 112.832 -176.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.9 mp -78.72 57.18 2.01 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.843 0.857 . . . . 0.0 108.782 -173.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.59 -66.88 0.36 Allowed 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 127.091 2.156 . . . . 0.0 108.338 -176.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -79.35 -72.59 0.38 Allowed 'General case' 0 C--O 1.223 -0.312 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.703 -178.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -172.84 10.98 0.04 OUTLIER Glycine 0 CA--C 1.531 1.062 0 N-CA-C 115.666 1.027 . . . . 0.0 115.666 -175.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.53 164.99 0.3 Allowed Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 126.569 1.948 . . . . 0.0 114.885 -171.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -56.16 -16.94 18.47 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 124.671 3.581 . . . . 0.0 113.974 -174.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -98.73 -19.58 17.4 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 125.12 1.368 . . . . 0.0 110.769 -165.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -51.36 -40.45 59.19 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.034 0.934 . . . . 0.0 112.413 -162.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.72 -21.68 19.86 Favored 'General case' 0 C--O 1.224 -0.255 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -175.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.5 m -60.49 -40.22 83.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 120.269 1.395 . . . . 0.0 110.905 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.0 ptp -74.22 -13.04 60.73 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 118.645 0.657 . . . . 0.0 112.219 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 72.6 mt -82.7 -4.78 58.34 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 118.574 -0.727 . . . . 0.0 110.61 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -105.35 99.19 8.8 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -178.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 28.3 t-80 -60.7 -18.85 56.75 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.0 t -55.99 -52.71 63.2 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.328 1.051 . . . . 0.0 109.746 168.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -70.67 -21.08 62.64 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.704 0.802 . . . . 0.0 110.87 -177.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.85 177.77 23.34 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 123.992 0.806 . . . . 0.0 111.373 164.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.5 tp -84.27 142.72 30.04 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.63 0.772 . . . . 0.0 110.293 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.28 142.22 31.27 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.248 1.419 . . . . 0.0 107.945 161.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -143.95 131.81 21.46 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.182 1.393 . . . . 0.0 108.111 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -73.84 94.21 2.26 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 127.187 2.195 . . . . 0.0 110.706 -171.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -93.54 61.34 3.18 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 172.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.18 -154.54 53.28 Favored Glycine 0 N--CA 1.441 -0.997 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 174.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 24.5 ptt-85 -143.95 168.13 20.7 Favored 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 122.119 -0.636 . . . . 0.0 112.124 -163.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -173.62 177.51 45.93 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-O 122.432 1.018 . . . . 0.0 114.041 -169.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.7 p -142.54 162.51 35.28 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.947 1.299 . . . . 0.0 109.917 176.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 43.6 p -82.06 95.84 7.57 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 168.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -62.76 -25.41 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 118.43 0.559 . . . . 0.0 111.686 171.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.78 117.32 13.22 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 159.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.4 m -57.1 138.5 54.4 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 172.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -129.27 152.43 79.47 Favored Pre-proline 0 C--O 1.234 0.246 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 164.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -77.71 111.78 3.19 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 124.918 3.745 . . . . 0.0 110.479 172.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 33.5 tp -103.81 86.48 2.61 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.92 1.288 . . . . 0.0 107.769 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.425 HG12 ' HB3' ' A' ' 127' ' ' LEU . 48.3 t -84.21 160.78 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.274 0 C-N-CA 125.186 1.394 . . . . 0.0 107.921 177.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 50.3 mt -132.33 118.8 37.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 176.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.71 -172.87 3.91 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.567 0.747 . . . . 0.0 109.082 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.71 175.97 11.33 Favored Glycine 0 N--CA 1.439 -1.138 0 C-N-CA 125.564 1.555 . . . . 0.0 111.316 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -74.59 -8.45 56.39 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -162.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -132.73 40.28 3.27 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 124.021 0.928 . . . . 0.0 110.759 -176.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.8 m120 48.17 61.05 3.2 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.128 -0.983 . . . . 0.0 110.724 174.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 62.4 mt -102.49 89.97 1.97 Allowed Pre-proline 0 C--N 1.329 -0.294 0 N-CA-C 103.422 -2.807 . . . . 0.0 103.422 -160.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -59.62 120.04 7.61 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 N-CA-C 108.132 -1.526 . . . . 0.0 108.132 -176.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -103.27 115.31 30.31 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 177.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.39 94.75 6.85 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 172.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.402 ' HG ' ' CD2' ' A' ' 120' ' ' TYR . 10.9 mp -65.45 120.23 12.46 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -70.55 83.58 0.6 Allowed 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -176.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.56 85.74 12.84 Favored Pre-proline 0 N--CA 1.465 0.317 0 C-N-CA 124.168 0.987 . . . . 0.0 109.727 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -58.87 141.07 97.71 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 N-CA-C 108.932 -1.218 . . . . 0.0 108.932 174.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.56 18.96 76.92 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 119.607 -0.551 . . . . 0.0 113.681 176.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -126.62 157.08 39.87 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 119.487 1.643 . . . . 0.0 106.798 161.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.97 -137.27 15.36 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 173.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -140.24 171.49 14.09 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.784 1.292 . . . . 0.0 110.493 -173.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 58.3 m -79.93 107.77 12.97 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 123.884 0.874 . . . . 0.0 111.387 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 73.6 t -88.86 116.35 30.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -169.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.6 p -72.61 161.95 30.12 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.493 0.664 . . . . 0.0 109.278 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -169.58 -156.7 11.11 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 108.116 -1.993 . . . . 0.0 108.116 175.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.09 171.76 13.97 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.619 1.968 . . . . 0.0 106.513 177.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 79.5 mt -126.36 127.99 71.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 119.485 1.039 . . . . 0.0 108.512 -170.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -126.08 119.96 28.96 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.456 0.702 . . . . 0.0 111.794 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -66.59 115.66 6.69 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 105.473 -2.047 . . . . 0.0 105.473 156.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.2 m -120.47 165.48 15.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 C-N-CA 123.828 0.851 . . . . 0.0 109.244 178.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -93.56 171.39 8.93 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 122.413 1.101 . . . . 0.0 108.296 169.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -54.07 -37.93 64.74 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.316 -1.311 . . . . 0.0 110.846 167.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -58.68 -40.66 84.22 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.889 0.768 . . . . 0.0 110.943 -176.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 25.8 tpp -72.01 -45.83 59.44 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 176.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.7 tp -58.84 -26.84 64.56 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 50.1 mtt-85 -78.59 -39.27 37.92 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.936 1.694 . . . . 0.0 111.144 173.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -64.15 -50.29 68.79 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 118.881 -0.58 . . . . 0.0 111.351 175.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 91.6 mt -56.41 -36.36 68.85 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 119.106 0.866 . . . . 0.0 110.668 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.73 -23.25 28.09 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.097 1.759 . . . . 0.0 112.891 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -93.22 -31.23 14.82 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.43 1.492 . . . . 0.0 112.287 174.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -71.62 -43.73 65.65 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.333 1.053 . . . . 0.0 109.632 -169.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -92.21 15.41 13.68 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.45 1.1 . . . . 0.0 113.174 176.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.0 t70 44.89 38.29 2.85 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.615 1.566 . . . . 0.0 112.283 -177.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -65.7 158.91 72.33 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 120.075 -1.641 . . . . 0.0 107.403 170.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -74.16 -3.38 17.1 Favored 'Cis proline' 0 N--CA 1.452 -0.953 0 CA-C-N 118.969 0.668 . . . . 0.0 113.488 -13.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.54 -62.81 1.47 Allowed 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.033 1.733 . . . . 0.0 111.8 -175.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 36.5 mtp -86.31 -74.29 0.43 Allowed 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -174.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -89.81 172.91 8.56 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 175.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -134.88 138.66 44.36 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 165.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.49 ' HD3' ' CD1' ' A' ' 113' ' ' PHE . 7.6 tmm_? -74.31 129.94 38.74 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 118.095 -0.955 . . . . 0.0 109.24 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.3 m -133.02 156.27 47.65 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.102 0.865 . . . . 0.0 110.0 -175.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -87.85 139.58 30.38 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.388 1.475 . . . . 0.0 110.426 168.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.444 ' CD2' ' HB ' ' A' ' 114' ' ' VAL . 1.8 pt? -160.92 -179.91 7.94 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.657 1.183 . . . . 0.0 112.809 -177.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 12.1 tp60 -99.2 142.44 30.68 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.371 1.068 . . . . 0.0 113.073 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 45.4 t -137.34 134.6 47.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 126.659 1.984 . . . . 0.0 107.781 174.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -76.66 144.73 39.26 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.282 1.433 . . . . 0.0 108.039 165.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.49 ' CG1' ' HA ' ' A' ' 108' ' ' ASP 0.255 3.5 p -110.93 82.43 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-O 122.366 1.079 . . . . 0.0 108.838 -178.451 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.0 mp -44.79 -42.19 7.6 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 127.057 2.143 . . . . 0.0 110.462 176.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -150.09 152.47 34.83 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 176.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 64.0 t-105 -127.09 137.71 53.06 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 125.59 1.556 . . . . 0.0 107.28 176.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -113.65 106.8 14.95 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 122.964 0.505 . . . . 0.0 110.047 174.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.9 -175.75 16.12 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-O 122.066 0.815 . . . . 0.0 112.304 175.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -79.94 172.76 13.34 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.262 -0.969 . . . . 0.0 109.391 168.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.39 60.44 2.01 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -101.05 88.47 1.06 Allowed Pre-proline 0 CA--C 1.537 0.466 1 C-N-CA 132.721 4.408 . . . . 0.0 109.113 -158.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -73.39 5.04 3.43 Favored 'Trans proline' 0 CA--C 1.544 0.98 1 C-N-CA 126.188 4.592 . . . . 0.0 113.963 -171.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.33 -169.03 54.88 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-N 120.819 1.645 . . . . 0.0 110.031 -163.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.49 ' HA ' ' CG1' ' A' ' 97' ' ' VAL . 26.9 t70 -96.81 5.48 50.51 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 129.456 3.102 . . . . 0.0 116.001 -166.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.2 p -136.81 122.12 19.33 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 122.025 2.193 . . . . 0.0 114.588 152.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 24.8 m -98.41 153.85 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 125.098 1.359 . . . . 0.0 108.891 -179.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -87.12 125.95 34.47 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 163.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 9.9 m -116.88 172.06 7.49 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.522 1.129 . . . . 0.0 110.428 176.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.49 ' CD1' ' HD3' ' A' ' 90' ' ' ARG . 96.2 m-85 -92.62 139.77 30.22 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 152.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.444 ' HB ' ' CD2' ' A' ' 93' ' ' LEU . 24.3 t -142.09 126.05 15.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 129.752 3.221 . . . . 0.0 106.89 172.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -72.23 141.33 48.97 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 170.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 41.9 p -145.12 -170.0 3.32 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 126.633 1.973 . . . . 0.0 107.319 -177.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -131.76 143.76 50.47 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 166.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -107.05 0.66 23.73 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.726 1.61 . . . . 0.0 110.689 168.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.2 p -121.75 20.52 10.93 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 127.101 2.161 . . . . 0.0 111.646 -159.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.402 ' CD2' ' HG ' ' A' ' 54' ' ' LEU . 7.2 p90 -67.04 152.1 46.41 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 125.691 1.596 . . . . 0.0 111.825 -176.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.59 158.87 65.12 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 124.689 1.196 . . . . 0.0 111.568 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -72.7 -33.91 7.65 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.558 1.505 . . . . 0.0 113.175 -177.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -64.66 -26.97 68.62 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.7 0.682 . . . . 0.0 112.39 172.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 45.7 m0 -69.99 -10.78 59.8 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.767 0.712 . . . . 0.0 112.178 -176.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.26 -29.12 69.29 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.674 1.125 . . . . 0.0 110.821 168.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -90.69 -11.41 39.8 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.497 1.119 . . . . 0.0 112.099 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.425 ' HB3' HG12 ' A' ' 43' ' ' VAL . 11.5 mt -62.64 146.67 94.0 Favored Pre-proline 0 C--O 1.235 0.335 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -64.72 143.49 80.79 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.171 1.914 . . . . 0.0 109.861 175.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -96.82 164.27 12.63 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.751 1.22 . . . . 0.0 108.56 176.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -135.27 162.94 31.15 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.8 0.84 . . . . 0.0 110.103 -176.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -106.29 -17.48 14.28 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 121.392 -0.817 . . . . 0.0 110.364 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 95.2 p -139.44 160.03 40.79 Favored 'General case' 0 N--CA 1.444 -0.771 0 O-C-N 121.282 -0.886 . . . . 0.0 111.07 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -141.42 101.76 4.06 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 104.005 -2.591 . . . . 0.0 104.005 178.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -151.72 136.86 17.43 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -178.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.01 -43.76 50.85 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.8 0.84 . . . . 0.0 110.784 174.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -89.29 23.78 2.4 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.838 0.855 . . . . 0.0 112.735 -167.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -82.16 155.26 34.37 Favored Glycine 0 CA--C 1.539 1.542 0 CA-C-O 118.701 -1.055 . . . . 0.0 111.892 174.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -71.5 -22.63 24.42 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 124.288 3.325 . . . . 0.0 112.361 175.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -73.33 80.41 1.36 Allowed 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 127.556 2.342 . . . . 0.0 107.031 172.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -72.57 77.35 0.77 Allowed Glycine 0 CA--C 1.522 0.476 0 C-N-CA 127.033 2.254 . . . . 0.0 111.375 -174.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -161.14 71.58 0.41 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 128.573 2.749 . . . . 0.0 105.642 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -133.56 173.15 11.81 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.32 0.648 . . . . 0.0 109.892 -168.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -69.77 123.81 22.38 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.531 -161.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 . . . . . 0 CA--C 1.516 -0.342 0 C-N-CA 125.077 1.351 . . . . 0.0 109.045 -170.535 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -78.11 142.09 38.32 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -177.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.1 pt -126.79 166.5 23.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 176.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -124.96 130.56 52.61 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.476 0.71 . . . . 0.0 109.679 -177.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.8 p -93.14 164.58 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 125.449 1.5 . . . . 0.0 108.922 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -113.4 -74.43 0.63 Allowed 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -128.1 -34.98 0.52 Allowed Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.164 1.364 . . . . 0.0 111.306 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p -64.12 -32.72 74.4 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 127.127 2.171 . . . . 0.0 114.276 -159.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 mp -133.37 36.46 3.39 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.947 1.299 . . . . 0.0 107.737 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -112.02 -25.17 9.51 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.63 1.172 . . . . 0.0 113.265 -172.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.3 mmt-85 -140.73 -87.93 0.18 Allowed 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 119.687 1.13 . . . . 0.0 109.419 168.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -128.45 2.58 6.6 Favored Glycine 0 C--N 1.334 0.429 0 O-C-N 120.637 -1.29 . . . . 0.0 111.632 -162.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -50.77 151.9 3.93 Favored Pre-proline 0 N--CA 1.438 -1.069 0 C-N-CA 124.79 1.236 . . . . 0.0 109.654 -173.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.7 -18.1 58.4 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 123.275 2.65 . . . . 0.0 112.285 -169.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -90.2 -25.07 20.81 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 126.924 2.09 . . . . 0.0 110.926 -168.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -49.59 -40.45 38.89 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.653 1.181 . . . . 0.0 111.922 -165.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.73 -27.08 1.8 Allowed 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 125.824 1.65 . . . . 0.0 114.472 -177.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.9 m -62.54 -41.0 90.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 119.716 1.144 . . . . 0.0 110.508 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.59 -14.27 61.16 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 67.6 mt -82.47 -15.33 52.9 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.794 0.838 . . . . 0.0 110.189 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -85.77 95.71 9.49 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 -178.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -63.27 -14.32 48.12 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.781 -0.574 . . . . 0.0 112.401 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 68.1 m -71.83 -27.54 62.97 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 120.548 -1.345 . . . . 0.0 112.937 167.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -83.15 2.79 33.73 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.477 1.111 . . . . 0.0 110.891 171.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.31 177.94 19.46 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 125.357 1.456 . . . . 0.0 110.787 173.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 36.9 tp -85.22 144.38 28.18 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.11 0.564 . . . . 0.0 111.308 -175.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -147.53 120.1 8.54 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.39 1.476 . . . . 0.0 109.131 161.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -134.7 150.93 50.66 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 119.008 0.822 . . . . 0.0 110.931 171.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -66.72 109.02 2.7 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 127.079 2.152 . . . . 0.0 110.191 -177.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.7 tpp85 -118.15 42.14 2.76 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.826 1.651 . . . . 0.0 108.464 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 113.5 175.0 19.09 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-O 122.874 1.263 . . . . 0.0 113.027 167.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -108.97 155.4 20.91 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.67 172.35 37.0 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.243 -0.98 . . . . 0.0 115.049 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.5 p -143.53 131.09 21.16 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 175.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 20.6 p -63.36 106.94 0.99 Allowed 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 173.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.45 -19.32 12.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.879 -177.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -65.79 116.71 7.27 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 155.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.26 132.62 34.09 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 117.641 -1.171 . . . . 0.0 107.915 160.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -135.59 156.49 77.58 Favored Pre-proline 0 N--CA 1.449 -0.5 0 CA-C-N 119.159 0.89 . . . . 0.0 108.683 178.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.55 90.89 0.69 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.996 3.13 . . . . 0.0 110.228 164.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 45.0 tp -90.38 107.55 19.22 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 154.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.4 m -101.91 166.59 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 170.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -114.63 129.65 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 170.95 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.55 -170.93 3.41 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.99 0.916 . . . . 0.0 111.7 -176.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.45 -157.65 53.44 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 126.319 1.914 . . . . 0.0 112.336 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.03 -8.35 21.54 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.397 1.479 . . . . 0.0 114.198 -174.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 -127.26 19.6 6.91 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 123.885 0.874 . . . . 0.0 112.677 -170.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 42.8 m-20 55.75 66.6 1.17 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.235 1.814 . . . . 0.0 109.066 -171.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 68.0 mt -104.28 88.94 2.28 Favored Pre-proline 0 N--CA 1.465 0.292 0 C-N-CA 127.695 2.398 . . . . 0.0 106.55 -175.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . 96.2 Cg_endo -66.44 150.28 84.33 Favored 'Trans proline' 0 N--CA 1.44 -1.653 0 CA-C-N 119.749 0.946 . . . . 0.0 112.501 174.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -128.81 118.94 23.61 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.63 102.34 3.27 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 165.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.9 mt -78.67 147.07 33.67 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 173.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -87.2 85.93 7.24 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 120.274 -1.516 . . . . 0.0 110.959 -173.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.2 86.8 11.06 Favored Pre-proline 0 N--CA 1.474 0.74 0 C-N-CA 123.72 0.808 . . . . 0.0 112.848 174.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -58.5 150.42 68.78 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 121.143 1.228 . . . . 0.0 110.395 174.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.81 -2.24 75.03 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 124.391 0.996 . . . . 0.0 113.91 174.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.27 127.8 32.55 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 120.122 1.961 . . . . 0.0 106.127 -174.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.76 -143.13 16.45 Favored Glycine 0 CA--C 1.522 0.527 0 CA-C-O 118.338 -1.257 . . . . 0.0 110.235 -168.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -141.35 170.38 15.84 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.051 1.425 . . . . 0.0 111.324 -177.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 7.1 m -72.31 106.59 4.52 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.161 1.384 . . . . 0.0 111.774 -174.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.6 t -77.73 101.36 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.761 0.824 . . . . 0.0 110.524 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.6 p -70.61 164.25 25.31 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 121.878 -0.514 . . . . 0.0 110.253 -177.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 176.59 -159.98 27.16 Favored Glycine 0 C--N 1.343 0.93 0 CA-C-N 119.392 0.996 . . . . 0.0 112.481 -176.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -139.32 160.03 40.78 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 121.499 -1.001 . . . . 0.0 111.785 -176.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 75.8 mt -114.09 124.41 70.71 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -173.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -113.87 119.93 38.97 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 173.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -57.09 114.13 2.0 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 154.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.9 m -115.37 155.35 16.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 173.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.73 173.23 10.23 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 122.011 0.91 . . . . 0.0 109.593 170.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.47 -49.85 60.98 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 125.72 1.608 . . . . 0.0 110.153 170.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -56.79 -39.25 73.78 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 118.922 -0.561 . . . . 0.0 111.679 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 44.2 tpp -72.35 -48.72 39.64 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 118.799 0.727 . . . . 0.0 109.693 179.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.28 -13.58 39.9 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.063 -1.023 . . . . 0.0 113.156 177.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 89.1 mtt-85 -86.34 -57.23 3.09 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 125.328 1.451 . . . . 0.0 110.467 168.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -53.48 -44.89 69.35 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.523 1.129 . . . . 0.0 112.272 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 90.5 mt -65.84 -27.93 68.6 Favored 'General case' 0 N--CA 1.461 0.113 0 O-C-N 121.347 -0.846 . . . . 0.0 110.526 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.439 ' HA ' ' SG ' ' A' ' 84' ' ' CYS . 1.8 t70 -76.64 10.12 2.36 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.099 1.76 . . . . 0.0 111.184 176.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -126.54 -4.77 6.54 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.516 2.326 . . . . 0.0 110.433 167.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.99 -49.05 7.3 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 104.25 -2.5 . . . . 0.0 104.25 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -74.78 0.79 14.21 Favored 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 124.884 1.274 . . . . 0.0 111.683 -173.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 57.77 19.28 5.48 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.814 1.646 . . . . 0.0 113.192 -176.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.439 ' SG ' ' HA ' ' A' ' 79' ' ' ASP . 1.1 p -57.86 157.6 14.81 Favored Pre-proline 0 CA--C 1.546 0.807 0 O-C-N 119.337 -2.102 . . . . 0.0 109.885 167.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -72.23 -4.51 12.99 Favored 'Cis proline' 0 CA--C 1.543 0.974 0 CA-C-N 119.732 0.94 . . . . 0.0 113.857 -6.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.3 m -59.51 -62.3 1.98 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 120.237 1.38 . . . . 0.0 111.776 -178.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 43.2 mtp -75.39 -58.86 3.03 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 122.326 0.251 . . . . 0.0 110.385 -175.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -119.2 174.71 6.17 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 126.285 1.834 . . . . 0.0 109.096 -176.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -127.4 -14.32 5.33 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 115.702 1.741 . . . . 0.0 115.702 -174.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? 62.08 125.12 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 128.641 2.776 . . . . 0.0 114.064 -174.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.6 m -134.67 167.39 20.92 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -174.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -106.91 123.98 48.95 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.155 1.782 . . . . 0.0 108.786 172.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -126.43 -164.51 1.34 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.083 1.753 . . . . 0.0 112.488 -166.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -132.43 134.24 44.85 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 120.363 1.438 . . . . 0.0 113.195 -179.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.5 p -155.3 117.57 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 118.115 2.635 . . . . 0.0 118.115 -166.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -57.53 132.55 53.51 Favored 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 125.294 1.438 . . . . 0.0 109.263 -173.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 84.8 t -70.4 101.86 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 105.423 -2.065 . . . . 0.0 105.423 163.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.37 -34.35 67.89 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 167.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -163.9 149.44 10.91 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.818 2.047 . . . . 0.0 106.134 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 70.2 t-105 -124.93 132.57 53.27 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 125.555 1.542 . . . . 0.0 107.012 173.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -122.47 103.48 8.75 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.87 -174.01 15.64 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 125.28 1.419 . . . . 0.0 112.394 176.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -50.63 156.84 0.85 Allowed 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 126.03 1.732 . . . . 0.0 114.298 170.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.86 65.61 1.39 Allowed Glycine 0 N--CA 1.436 -1.363 0 N-CA-C 108.886 -1.686 . . . . 0.0 108.886 149.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -102.36 89.09 1.56 Allowed Pre-proline 0 CA--C 1.538 0.506 1 C-N-CA 133.301 4.641 . . . . 0.0 108.928 -155.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -71.81 -16.12 29.71 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 124.332 3.354 . . . . 0.0 116.14 -168.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 107.16 -167.49 13.76 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 120.541 1.518 . . . . 0.0 110.837 -165.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -68.93 -17.42 63.95 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -161.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.3 p -150.28 157.18 42.79 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 121.946 2.157 . . . . 0.0 109.176 -177.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.2 m -128.03 157.38 40.21 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.968 0 C-N-CA 115.795 -2.362 . . . . 0.0 109.272 -167.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -98.76 82.82 2.85 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 164.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 9.2 m -75.22 166.23 23.96 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 114.485 -1.234 . . . . 0.0 107.785 163.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -82.96 137.33 34.22 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 155.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 22.8 t -131.96 127.56 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 127.373 2.269 . . . . 0.0 107.852 174.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -63.69 118.52 8.38 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 170.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 36.0 p -130.85 179.56 5.91 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.551 1.141 . . . . 0.0 108.554 170.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.7 t -130.41 155.25 46.72 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 124.96 1.304 . . . . 0.0 107.801 170.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -120.09 -6.22 9.97 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 127.776 2.43 . . . . 0.0 111.743 175.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.5 t -130.98 69.57 1.47 Allowed 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -174.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.64 9.14 42.45 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.751 1.22 . . . . 0.0 113.703 -170.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 67.84 161.88 0.14 Allowed Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 127.302 2.241 . . . . 0.0 111.858 -177.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -66.97 -32.83 34.36 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 121.456 1.437 . . . . 0.0 113.998 -171.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -61.05 -38.66 86.98 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.568 1.147 . . . . 0.0 112.93 -173.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 46.0 m0 -75.22 -10.07 59.13 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 122.067 -0.396 . . . . 0.0 110.895 -169.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.75 -11.9 60.54 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.22 1.008 . . . . 0.0 111.996 173.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -109.92 -8.81 14.81 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.641 0.776 . . . . 0.0 112.081 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.5 mt -73.09 152.27 90.56 Favored Pre-proline 0 C--O 1.24 0.572 0 O-C-N 121.784 -0.572 . . . . 0.0 109.711 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.75 159.8 38.28 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.89 2.393 . . . . 0.0 110.787 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -102.9 172.79 6.62 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.86 0.864 . . . . 0.0 111.877 -176.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . 0.492 ' HD1' ' CG ' ' A' ' 139' ' ' HIS . 92.0 m-70 -132.35 170.87 14.47 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 126.894 2.077 . . . . 0.0 108.785 -177.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -111.77 -14.9 13.51 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.808 0.843 . . . . 0.0 111.334 174.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 58.6 m -155.31 169.68 23.64 Favored 'General case' 0 C--O 1.233 0.237 0 O-C-N 120.404 -1.435 . . . . 0.0 110.053 170.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -104.0 -160.45 0.77 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 128.165 2.586 . . . . 0.0 106.797 158.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 23.9 t0 78.95 134.19 0.06 Allowed 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 129.492 3.117 . . . . 0.0 112.183 -171.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.8 -31.38 26.99 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.999 1.32 . . . . 0.0 110.974 173.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -67.61 -15.84 63.86 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.594 0.758 . . . . 0.0 112.844 176.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -77.64 155.92 43.84 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.885 1.231 . . . . 0.0 111.364 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.56 -19.18 32.62 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.771 2.314 . . . . 0.0 113.152 -172.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.492 ' CG ' ' HD1' ' A' ' 130' ' ' HIS . 43.4 m-70 -71.45 83.83 0.81 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.986 2.114 . . . . 0.0 109.429 -173.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -61.06 68.75 0.01 OUTLIER Glycine 0 CA--C 1.528 0.891 0 C-N-CA 128.527 2.965 . . . . 0.0 113.735 -177.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -178.1 57.97 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 130.973 3.709 . . . . 0.0 106.21 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -90.21 -168.0 2.0 Allowed 'General case' 0 N--CA 1.463 0.188 0 O-C-N 120.933 -1.104 . . . . 0.0 108.234 -176.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -60.32 136.72 58.12 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.585 1.084 . . . . 0.0 108.208 -176.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 . . . . . 0 N--CA 1.453 -0.311 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 -178.495 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.209 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -99.78 138.76 36.41 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 122.953 0.501 . . . . 0.0 110.463 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.4 pt -132.92 174.1 13.81 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 CA-C-O 122.001 0.905 . . . . 0.0 109.38 167.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -131.35 133.44 45.3 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.349 1.46 . . . . 0.0 108.257 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.2 m -70.0 119.35 15.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-O 122.024 0.916 . . . . 0.0 109.582 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -54.12 -40.55 67.46 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.393 1.477 . . . . 0.0 111.755 172.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 164.12 -44.19 0.31 Allowed Glycine 0 CA--C 1.526 0.757 0 CA-C-O 122.949 1.305 . . . . 0.0 110.583 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.58 -11.8 3.39 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.715 2.406 . . . . 0.0 115.74 -173.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -134.95 31.1 3.31 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 124.763 1.225 . . . . 0.0 110.638 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -117.91 -85.48 0.64 Allowed 'General case' 0 C--O 1.224 -0.239 0 CA-C-O 117.359 -1.305 . . . . 0.0 107.989 170.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.8 mmm180 -45.3 -84.12 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.446 1.498 . . . . 0.0 113.345 -171.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -167.06 15.58 0.08 OUTLIER Glycine 0 CA--C 1.53 0.997 0 C-N-CA 123.588 0.613 . . . . 0.0 112.229 -175.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -51.95 155.44 3.13 Favored Pre-proline 0 C--O 1.233 0.231 0 C-N-CA 125.406 1.482 . . . . 0.0 110.809 177.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -64.76 -3.88 7.61 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 124.171 3.247 . . . . 0.0 113.795 -172.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -110.4 -9.5 14.61 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-O 116.365 -1.779 . . . . 0.0 111.221 -167.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -53.76 -46.63 71.0 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 121.982 2.173 . . . . 0.0 109.725 -172.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.43 ' HA ' ' CD1' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -50.55 -19.34 0.87 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.903 1.681 . . . . 0.0 115.403 175.9 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.9 m -63.48 -24.11 35.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 121.525 1.966 . . . . 0.0 111.566 176.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.1 ptp -89.4 -0.12 57.25 Favored 'General case' 0 C--N 1.345 0.376 0 CA-C-N 120.183 1.356 . . . . 0.0 110.836 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.43 ' CD1' ' HA ' ' A' ' 18' ' ' LYS . 8.3 mp -96.13 9.29 41.37 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.868 2.067 . . . . 0.0 109.909 -169.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -129.95 110.16 11.46 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 119.119 0.872 . . . . 0.0 108.887 -178.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -58.51 -22.91 56.69 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -175.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.6 m -75.53 -26.04 57.7 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.437 -0.789 . . . . 0.0 112.845 173.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 49.0 m170 -69.63 -49.46 53.66 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 161.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 158.04 179.85 33.22 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-O 122.332 0.962 . . . . 0.0 111.863 172.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 28.9 tp -81.57 138.17 35.43 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.64 1.176 . . . . 0.0 111.303 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -149.77 120.95 7.78 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.225 1.01 . . . . 0.0 109.634 163.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.32 125.43 47.01 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 124.415 1.086 . . . . 0.0 109.864 -178.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -62.66 93.25 0.05 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 126.382 1.873 . . . . 0.0 110.588 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -95.55 61.12 2.27 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.212 1.005 . . . . 0.0 108.463 176.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.85 -160.53 51.69 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-O 122.656 1.142 . . . . 0.0 110.946 174.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 57.9 mtm180 -128.83 167.91 16.65 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 121.628 -0.924 . . . . 0.0 110.82 -161.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -177.43 175.47 47.61 Favored Glycine 0 C--N 1.336 0.556 0 O-C-N 121.348 -0.845 . . . . 0.0 114.01 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.1 p -142.89 156.86 44.99 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.965 1.306 . . . . 0.0 109.261 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 44.0 p -69.25 119.1 13.0 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 169.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.9 t -70.6 -44.18 77.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 173.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -58.25 123.27 15.48 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 126.142 1.777 . . . . 0.0 108.329 163.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.1 m -60.01 148.7 34.55 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 162.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -141.98 153.25 63.72 Favored Pre-proline 0 CA--C 1.541 0.61 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 165.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.43 ' HA ' ' HA3' ' A' ' 60' ' ' GLY . 45.2 Cg_endo -79.23 82.74 2.42 Favored 'Trans proline' 0 C--O 1.237 0.474 1 C-N-CA 125.58 4.187 . . . . 0.0 112.583 -178.799 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.98 122.99 26.27 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -134.39 144.7 34.39 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 C-N-CA 123.2 0.6 . . . . 0.0 110.838 174.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.0 mt -88.7 76.34 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 126.226 1.811 . . . . 0.0 106.882 168.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.75 -172.96 3.58 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 168.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.81 142.12 4.98 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.502 1.049 . . . . 0.0 112.187 165.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -76.69 2.27 14.7 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.182 -1.187 . . . . 0.0 112.861 -173.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 29.1 m-70 -120.26 17.75 12.28 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.094 1.358 . . . . 0.0 111.41 169.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 52.53 70.12 0.61 Allowed 'General case' 0 C--N 1.341 0.202 0 C-N-CA 126.166 1.787 . . . . 0.0 108.736 -174.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 72.9 mt -104.98 86.57 1.55 Allowed Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 102.751 -3.055 . . . . 0.0 102.751 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.64 144.47 72.38 Favored 'Trans proline' 0 N--CA 1.443 -1.473 0 CA-C-N 121.037 1.406 . . . . 0.0 110.762 175.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 72.3 m95 -112.43 -169.79 1.54 Allowed 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.939 1.296 . . . . 0.0 109.84 -175.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.2 tp -144.32 92.08 2.27 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 168.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.7 mt -71.78 122.21 20.29 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 -177.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -69.93 89.3 0.59 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.105 0.866 . . . . 0.0 110.561 -177.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.06 77.98 54.5 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 124.808 1.243 . . . . 0.0 108.357 176.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.16 121.28 9.4 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.451 2.101 . . . . 0.0 110.618 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.09 -1.38 51.15 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 126.444 1.973 . . . . 0.0 114.121 175.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -109.11 169.49 8.65 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 119.836 1.818 . . . . 0.0 109.835 172.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.439 ' HA2' ' CD2' ' A' ' 129' ' ' TYR . . . 88.69 -8.06 80.3 Favored Glycine 0 CA--C 1.533 1.165 0 N-CA-C 117.56 1.784 . . . . 0.0 117.56 155.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 75.54 167.39 0.28 Allowed 'General case' 0 C--N 1.322 -0.615 1 C-N-CA 134.818 5.247 . . . . 0.0 111.337 -172.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 76.3 m -69.09 170.81 9.27 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 120.988 -1.07 . . . . 0.0 110.607 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 43.0 t -134.78 104.32 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.9 p -72.46 155.79 39.73 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.62 -0.675 . . . . 0.0 109.706 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.56 -155.55 11.44 Favored Glycine 0 C--N 1.337 0.616 0 O-C-N 120.762 -1.211 . . . . 0.0 110.865 -175.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -144.07 171.22 14.57 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 127.694 2.397 . . . . 0.0 107.786 -179.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 81.8 mt -118.16 139.75 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 120.593 1.542 . . . . 0.0 109.379 -171.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -134.42 125.43 27.48 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.732 0.777 . . . . 0.0 110.082 176.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -72.42 132.94 44.57 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 161.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.6 m -135.38 164.7 32.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 123.755 0.822 . . . . 0.0 110.025 -177.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -115.85 176.14 5.22 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 176.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.33 -37.53 80.93 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 118.99 -0.529 . . . . 0.0 110.121 -168.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 36.0 tp60 -57.82 -40.88 81.03 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.829 0.851 . . . . 0.0 112.152 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 24.4 tpp -69.02 -48.82 62.04 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.5 tp -58.77 -32.85 69.67 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.1 mtt180 -74.64 -33.98 62.65 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.171 -0.956 . . . . 0.0 112.174 177.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -75.95 -49.11 18.67 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.532 0.733 . . . . 0.0 110.121 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.6 mp -55.89 -41.43 74.46 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -177.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.485 ' N ' ' HH ' ' A' ' 115' ' ' TYR . 15.4 t70 -44.87 -47.83 11.13 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.973 1.709 . . . . 0.0 111.234 174.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -71.47 -40.04 70.52 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.068 0.947 . . . . 0.0 111.911 176.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -65.45 -33.19 75.35 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.685 1.194 . . . . 0.0 110.534 -170.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -101.41 20.06 16.65 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 124.72 1.208 . . . . 0.0 113.291 174.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.1 t70 54.04 17.16 1.31 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.314 1.446 . . . . 0.0 112.776 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 16.2 t -61.99 145.38 92.99 Favored Pre-proline 0 N--CA 1.447 -0.58 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 177.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -80.69 -2.53 43.13 Favored 'Cis proline' 0 CA--C 1.54 0.815 0 N-CA-C 116.15 1.558 . . . . 0.0 116.15 0.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.4 m -63.4 -61.34 2.41 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 120.042 1.292 . . . . 0.0 112.572 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 12.3 mtp -83.12 -76.02 0.29 Allowed 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -177.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -85.34 169.83 13.34 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 176.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -146.18 126.6 14.05 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.858 1.663 . . . . 0.0 106.547 176.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -67.2 131.62 46.15 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.353 1.061 . . . . 0.0 110.048 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.7 m -128.82 177.1 7.32 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.604 1.962 . . . . 0.0 107.681 174.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -116.5 146.24 42.73 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.379 1.471 . . . . 0.0 110.053 167.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.34 178.76 7.36 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.556 1.942 . . . . 0.0 111.771 175.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 37.2 tp60 -109.73 115.89 30.69 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.933 1.693 . . . . 0.0 110.683 -178.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 70.5 t -108.99 145.74 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.57 1.148 . . . . 0.0 108.487 -177.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -85.4 142.74 29.06 Favored 'General case' 0 C--N 1.341 0.206 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 169.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.642 ' CG1' ' HA ' ' A' ' 108' ' ' ASP . 1.9 p -89.82 103.08 13.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 124.978 1.311 . . . . 0.0 109.029 172.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.69 -22.0 60.97 Favored 'General case' 0 C--N 1.331 -0.206 0 O-C-N 120.708 -1.245 . . . . 0.0 111.537 172.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -160.17 153.39 21.94 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 119.99 1.268 . . . . 0.0 108.437 177.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 48.5 t-105 -136.85 120.84 17.64 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.296 0.638 . . . . 0.0 109.713 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -108.24 99.56 8.96 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 125.269 1.427 . . . . 0.0 110.995 -177.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.69 -173.32 19.26 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 124.432 1.015 . . . . 0.0 110.936 174.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -67.06 171.12 5.87 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.104 0.562 . . . . 0.0 110.832 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.47 57.48 1.75 Allowed Glycine 0 C--O 1.22 -0.743 0 C-N-CA 125.154 1.359 . . . . 0.0 112.179 174.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -100.6 89.65 1.25 Allowed Pre-proline 0 N--CA 1.471 0.598 0 C-N-CA 126.984 2.114 . . . . 0.0 109.272 -167.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -57.93 -27.25 78.13 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.493 2.796 . . . . 0.0 113.514 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 126.3 -176.52 17.5 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 -161.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.642 ' HA ' ' CG1' ' A' ' 97' ' ' VAL . 36.7 t70 -81.44 4.92 19.25 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -173.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.8 p -137.33 156.23 48.48 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 118.802 -1.159 . . . . 0.0 110.783 156.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.2 p -130.92 152.74 38.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 124.305 1.042 . . . . 0.0 111.021 173.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -86.72 128.27 35.01 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.535 1.534 . . . . 0.0 108.216 170.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -137.06 167.95 20.54 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 127.158 2.183 . . . . 0.0 110.596 178.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -102.42 142.36 33.75 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 173.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 40.4 t -138.08 144.63 30.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 177.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.485 ' HH ' ' N ' ' A' ' 79' ' ' ASP . 61.6 m-85 -78.17 125.82 29.9 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 173.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 71.7 p -120.39 -173.96 2.69 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.965 1.306 . . . . 0.0 107.87 177.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.8 t -145.86 139.2 26.15 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 162.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -105.36 -8.25 18.31 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.439 0.695 . . . . 0.0 110.729 174.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 44.2 p -86.49 14.57 6.58 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.025 1.33 . . . . 0.0 113.251 -166.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -57.44 134.76 56.33 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.137 1.375 . . . . 0.0 113.343 -162.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.16 147.13 98.76 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.27 172.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.5 -27.28 46.56 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 121.753 1.635 . . . . 0.0 113.15 -174.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -50.57 -35.28 29.19 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.339 1.056 . . . . 0.0 111.141 171.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 35.8 m0 -82.66 12.73 4.36 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.542 0.61 . . . . 0.0 111.948 -173.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -91.19 -26.09 19.22 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 120.403 1.456 . . . . 0.0 111.506 163.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -89.16 -25.72 21.67 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 120.123 1.329 . . . . 0.0 112.297 -169.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . 0.459 0.2 OUTLIER -45.43 161.39 0.24 Allowed Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 126.666 1.987 . . . . 0.0 115.178 173.058 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -90.39 142.45 3.58 Favored 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 124.171 3.248 . . . . 0.0 108.557 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.439 ' CD2' ' HA2' ' A' ' 60' ' ' GLY . 9.3 m-30 -98.16 -177.96 3.9 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 124.198 0.999 . . . . 0.0 109.241 -169.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 46.4 m-70 -136.52 -178.69 5.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.608 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -134.24 -15.32 2.24 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 122.96 1.362 . . . . 0.0 111.908 170.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 29.7 p -144.96 153.2 41.27 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 161.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -92.03 157.45 16.77 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 167.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -170.41 139.15 1.63 Allowed 'General case' 0 C--O 1.241 0.607 0 CA-C-N 119.74 1.155 . . . . 0.0 108.989 166.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 66.6 m -81.18 -19.26 43.73 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.245 -0.91 . . . . 0.0 111.164 170.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -88.61 -11.77 44.5 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 120.374 1.443 . . . . 0.0 111.606 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.99 163.49 20.31 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.714 1.149 . . . . 0.0 112.019 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -71.82 -1.35 9.77 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 124.136 3.224 . . . . 0.0 113.637 -176.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -51.38 -29.79 16.78 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 126.425 1.89 . . . . 0.0 115.006 -169.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 74.35 -26.17 1.06 Allowed Glycine 0 CA--C 1.528 0.869 0 CA-C-O 118.458 -1.19 . . . . 0.0 112.963 -177.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.71 120.74 38.65 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 126.162 1.785 . . . . 0.0 109.206 167.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -136.23 162.54 32.68 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 126.475 1.91 . . . . 0.0 109.511 178.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -62.4 119.09 8.44 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 . . . . . 0 N--CA 1.452 -0.336 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -171.053 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.834 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -65.98 123.68 20.5 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -176.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.5 pt -119.13 170.63 8.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 124.418 1.087 . . . . 0.0 108.609 173.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -135.99 141.78 44.44 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.459 HG12 ' H ' ' A' ' 66' ' ' GLU . 2.7 p -97.55 137.93 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -173.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -92.47 -46.63 7.55 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.488 1.515 . . . . 0.0 110.183 -178.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -159.09 6.6 0.14 Allowed Glycine 0 C--N 1.344 0.98 0 CA-C-O 116.909 -2.051 . . . . 0.0 117.821 -168.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p -131.16 -16.7 3.13 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 120.961 2.38 . . . . 0.0 115.995 -161.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.9 mp -140.04 71.17 1.37 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 120.582 1.537 . . . . 0.0 107.915 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.44 -85.46 0.07 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 118.591 -0.719 . . . . 0.0 112.005 -176.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -64.04 -67.42 0.43 Allowed 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.607 1.094 . . . . 0.0 110.152 -177.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 166.21 88.56 0.07 OUTLIER Glycine 0 N--CA 1.429 -1.789 0 N-CA-C 105.607 -2.997 . . . . 0.0 105.607 172.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -129.41 165.34 33.41 Favored Pre-proline 0 N--CA 1.443 -0.79 0 CA-C-O 117.578 -1.201 . . . . 0.0 108.485 -176.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -81.66 61.77 8.07 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.04 1.827 . . . . 0.0 113.973 -159.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -175.21 -5.75 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 129.264 3.026 . . . . 0.0 110.65 -178.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 18.5 t-160 -65.8 -46.15 79.75 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 121.839 2.109 . . . . 0.0 110.598 -177.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.17 -27.35 20.99 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -172.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.1 m -52.69 -42.79 42.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 119.383 0.992 . . . . 0.0 111.467 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.6 ptp -82.44 8.38 11.69 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 120.935 -1.103 . . . . 0.0 112.79 -174.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 20.7 mt -118.75 1.63 11.6 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.645 1.578 . . . . 0.0 110.666 -172.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -125.39 4.98 7.68 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.432 1.493 . . . . 0.0 114.264 -171.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . 0.271 9.5 t-80 42.17 26.45 0.06 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.877 2.471 . . . . 0.0 114.753 177.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.23 -32.51 10.48 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.36 1.064 . . . . 0.0 110.357 175.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -80.05 -35.34 37.3 Favored 'General case' 0 N--CA 1.456 -0.16 0 O-C-N 121.102 -0.999 . . . . 0.0 110.094 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 159.49 -174.56 36.38 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 -175.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -98.65 131.66 44.66 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.277 1.031 . . . . 0.0 109.116 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -132.85 156.87 46.37 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.499 1.52 . . . . 0.0 109.276 159.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -141.02 139.15 34.1 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 168.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -61.38 104.54 0.41 Allowed 'General case' 0 C--O 1.233 0.23 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 169.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.2 tpp180 -114.33 65.23 0.67 Allowed 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 -175.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.87 176.23 49.29 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-O 121.965 0.758 . . . . 0.0 111.814 -176.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -120.57 171.85 8.26 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.621 0.768 . . . . 0.0 109.69 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -177.96 178.85 48.53 Favored Glycine 0 C--N 1.333 0.403 0 O-C-N 121.086 -1.008 . . . . 0.0 114.346 -177.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.4 p -146.42 163.93 34.08 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.294 1.838 . . . . 0.0 108.527 172.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 49.9 p -86.91 103.69 15.54 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 168.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -63.75 -22.33 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 121.774 0.797 . . . . 0.0 111.636 171.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.68 116.44 6.24 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.764 0.792 . . . . 0.0 109.281 159.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.07 129.62 38.73 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.169 1.388 . . . . 0.0 108.219 164.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -138.96 158.35 69.92 Favored Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.15 81.74 2.37 Favored 'Trans proline' 0 N--CA 1.454 -0.85 1 C-N-CA 125.469 4.112 . . . . 0.0 109.165 172.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.37 110.94 16.3 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 162.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.4 m -127.88 127.92 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 118.818 0.736 . . . . 0.0 109.891 -173.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.5 mt -85.05 105.49 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 177.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -138.37 130.9 29.12 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 124.517 1.127 . . . . 0.0 109.464 -173.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.23 166.84 27.81 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-O 122.062 0.812 . . . . 0.0 112.629 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -93.28 -6.09 48.27 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 125.959 1.704 . . . . 0.0 113.569 -145.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -121.42 16.78 11.35 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.528 1.131 . . . . 0.0 110.811 177.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.2 m120 60.44 56.79 3.03 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.422 1.489 . . . . 0.0 109.183 175.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 61.0 mt -104.56 87.14 1.62 Allowed Pre-proline 0 C--N 1.322 -0.608 0 C-N-CA 130.128 3.371 . . . . 0.0 103.708 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -63.23 160.4 34.95 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 CA-C-N 120.721 1.293 . . . . 0.0 110.305 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 68.1 m95 -127.4 138.08 52.91 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.27 98.22 7.16 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.7 mt -80.54 147.79 30.66 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -172.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -83.39 81.31 8.77 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.02 -1.05 . . . . 0.0 109.75 -173.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.6 84.9 32.4 Favored Pre-proline 0 N--CA 1.467 0.424 0 C-N-CA 123.105 0.562 . . . . 0.0 110.03 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -63.46 136.17 53.4 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 121.468 1.445 . . . . 0.0 109.017 178.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.06 13.59 80.79 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 118.597 -1.113 . . . . 0.0 113.635 176.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -127.14 125.61 41.47 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 120.603 2.202 . . . . 0.0 106.538 172.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.28 -140.52 15.09 Favored Glycine 0 N--CA 1.463 0.471 0 CA-C-N 121.13 1.787 . . . . 0.0 111.974 -178.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 46.1 m-70 -133.89 160.99 35.99 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 117.715 0.758 . . . . 0.0 111.649 -166.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 63.2 m -72.45 117.21 13.83 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.166 1.387 . . . . 0.0 109.766 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 44.2 t -85.33 110.58 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.737 1.215 . . . . 0.0 108.671 -174.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 70.7 p -77.3 147.39 36.26 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.923 -1.111 . . . . 0.0 109.803 176.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.77 -150.35 6.25 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 -176.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.459 ' H ' HG12 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -148.49 160.97 42.54 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 126.102 1.761 . . . . 0.0 108.203 170.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 98.5 mt -102.25 134.16 43.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 -171.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -125.93 119.2 27.14 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.1 118.08 17.65 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 104.419 -2.437 . . . . 0.0 104.419 160.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.4 m -123.21 150.45 27.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 124.317 1.047 . . . . 0.0 108.72 -176.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -92.75 165.68 12.82 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 175.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -51.96 -29.99 22.91 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 126.595 1.958 . . . . 0.0 113.446 -174.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 12.0 tp60 -68.15 -42.44 80.08 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 122.244 -0.285 . . . . 0.0 110.701 178.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.2 ttm -71.78 -46.53 58.03 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 118.663 -0.684 . . . . 0.0 109.453 178.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.62 -26.04 67.74 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.39 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 36.6 mtm180 -73.84 -47.84 35.54 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 117.646 -1.169 . . . . 0.0 111.923 171.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -55.72 -47.45 76.85 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.607 1.094 . . . . 0.0 110.515 176.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.6 mp -61.45 -17.82 56.15 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.101 0.961 . . . . 0.0 113.122 176.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -84.5 -5.56 59.3 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.758 1.623 . . . . 0.0 111.972 176.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -125.25 -34.6 2.71 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.428 1.891 . . . . 0.0 111.028 -172.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -58.54 -46.88 85.89 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.582 1.553 . . . . 0.0 111.616 176.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -83.68 4.39 28.81 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 124.887 1.275 . . . . 0.0 112.367 -172.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.1 t0 44.98 25.51 0.16 Allowed 'General case' 0 C--O 1.24 0.554 0 C-N-CA 127.048 2.139 . . . . 0.0 115.497 -164.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 1.6 p -56.96 154.92 17.0 Favored Pre-proline 0 CA--C 1.545 0.776 0 O-C-N 119.592 -1.942 . . . . 0.0 108.56 158.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -74.15 -4.46 18.04 Favored 'Cis proline' 0 CA--C 1.544 0.978 0 N-CA-C 114.541 0.939 . . . . 0.0 114.541 -4.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 10.1 t -62.36 -68.84 0.29 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.506 1.048 . . . . 0.0 110.594 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 28.6 mtp -72.88 -64.57 0.94 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.854 0.862 . . . . 0.0 110.377 -171.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -105.01 176.84 5.03 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.031 0.932 . . . . 0.0 109.084 176.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -139.68 139.28 36.59 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 167.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -78.79 130.08 35.33 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.092 -1.005 . . . . 0.0 108.324 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 86.2 m -135.5 162.83 31.54 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -176.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -98.15 132.58 43.56 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.408 1.083 . . . . 0.0 108.466 173.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.423 ' CD2' ' HB ' ' A' ' 114' ' ' VAL . 2.4 pt? -149.42 -176.19 5.29 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.801 1.64 . . . . 0.0 111.892 -171.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 -105.09 135.36 46.58 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -175.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 84.8 t -134.68 128.77 51.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -69.61 121.42 17.08 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 104.188 -2.523 . . . . 0.0 104.188 163.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.567 ' CG1' ' HA ' ' A' ' 108' ' ' ASP . 14.8 p -63.02 119.47 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 156.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.1 -31.99 21.59 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 120.681 -1.262 . . . . 0.0 108.946 170.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -158.35 147.34 19.11 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 104.424 -2.436 . . . . 0.0 104.424 -175.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 66.2 t-105 -124.68 141.32 52.19 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -104.31 104.62 14.54 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.151 0.98 . . . . 0.0 108.687 173.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.28 -164.14 13.63 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-O 122.568 1.093 . . . . 0.0 114.162 165.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -78.36 161.04 27.47 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 114.509 -0.846 . . . . 0.0 109.325 177.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.86 64.38 1.68 Allowed Glycine 0 C--O 1.223 -0.59 0 C-N-CA 124.662 1.125 . . . . 0.0 110.866 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -102.0 89.25 1.52 Allowed Pre-proline 0 C--O 1.237 0.408 0 C-N-CA 129.98 3.312 . . . . 0.0 108.592 -166.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -66.18 -1.14 4.91 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 124.652 3.568 . . . . 0.0 114.495 -168.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.2 172.27 46.95 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-N 120.226 1.376 . . . . 0.0 110.062 -170.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.567 ' HA ' ' CG1' ' A' ' 97' ' ' VAL . 1.6 m-20 -70.91 -1.29 11.35 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -158.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 92.1 p -133.59 142.22 48.03 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 118.427 -1.309 . . . . 0.0 110.726 150.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.9 p -106.71 153.74 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 C-N-CA 125.806 1.642 . . . . 0.0 107.92 175.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 3.8 tm0? -89.8 112.4 23.71 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 161.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 48.4 m -102.9 175.96 5.31 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.854 0.862 . . . . 0.0 109.046 169.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -93.81 144.67 25.21 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 156.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.423 ' HB ' ' CD2' ' A' ' 93' ' ' LEU . 25.0 t -136.05 150.3 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 127.656 2.382 . . . . 0.0 105.878 173.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -88.4 119.84 29.21 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 171.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 43.2 p -124.12 -169.19 1.92 Allowed 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.983 1.313 . . . . 0.0 108.533 -178.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.04 146.59 31.95 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 169.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -112.93 -9.0 13.66 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.882 1.673 . . . . 0.0 111.274 169.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 11.2 t -98.95 16.63 21.88 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.237 1.415 . . . . 0.0 112.418 -169.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -60.92 154.63 21.8 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 125.137 1.375 . . . . 0.0 113.344 -172.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.27 156.51 91.64 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 125.631 1.572 . . . . 0.0 110.088 171.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -70.14 -36.78 9.2 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 121.764 1.643 . . . . 0.0 112.584 177.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -52.3 -33.89 44.38 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 119.283 0.947 . . . . 0.0 112.693 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 38.6 m0 -74.59 -7.09 52.04 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.68 0.792 . . . . 0.0 112.054 -174.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 60.6 mt -78.69 -26.69 44.95 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 121.238 -0.913 . . . . 0.0 111.838 171.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -92.1 -16.09 26.85 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.347 0.659 . . . . 0.0 111.8 -175.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.4 mt -57.92 157.69 14.89 Favored Pre-proline 0 N--CA 1.465 0.293 0 C-N-CA 125.489 1.516 . . . . 0.0 111.787 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -63.69 157.74 50.07 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.981 2.454 . . . . 0.0 110.113 172.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -111.49 158.95 18.55 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -139.05 148.4 43.31 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.398 0.279 . . . . 0.0 110.656 -177.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -87.13 -5.66 58.93 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.31 1.444 . . . . 0.0 112.175 176.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.6 t -167.69 170.88 10.6 Favored 'General case' 0 C--O 1.237 0.412 0 O-C-N 120.176 -1.577 . . . . 0.0 108.408 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -123.54 92.38 3.67 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 165.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.425 ' C ' ' H ' ' A' ' 136' ' ' GLU . 9.3 p-10 -99.28 97.27 8.36 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 128.512 2.725 . . . . 0.0 108.486 -172.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 7.1 t -65.24 7.74 0.18 Allowed 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.622 -1.299 . . . . 0.0 113.575 177.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.425 ' H ' ' C ' ' A' ' 134' ' ' ASP . 42.5 mt-10 -127.57 13.33 6.99 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.453 1.501 . . . . 0.0 110.45 -167.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -96.13 179.83 35.3 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 125.963 1.744 . . . . 0.0 112.52 -176.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -75.91 -3.55 14.0 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 124.201 3.267 . . . . 0.0 112.754 172.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -64.87 -24.28 67.49 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.462 1.028 . . . . 0.0 113.512 -167.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 79.72 -39.4 2.18 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 125.227 1.394 . . . . 0.0 113.659 172.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.71 100.87 4.81 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.542 1.937 . . . . 0.0 110.133 168.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -122.26 162.85 20.69 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 125.525 1.53 . . . . 0.0 109.502 171.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -63.26 127.98 33.75 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -176.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 . . . . . 0 CA--C 1.533 0.307 0 C-N-CA 123.608 0.763 . . . . 0.0 109.171 -177.287 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.443 ' HA ' ' CE2' ' A' ' 113' ' ' PHE . . . . . . . . 0 CA--C 1.533 0.325 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 71.2 m80 69.95 121.67 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 128.082 2.553 . . . . 0.0 107.392 -157.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.6 pt -87.78 -179.43 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 167.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -129.59 140.84 51.09 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 165.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.4 p -106.1 118.05 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 -178.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -70.86 -63.77 1.03 Allowed 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 172.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.5 -21.23 0.11 Allowed Glycine 0 CA--C 1.526 0.747 0 O-C-N 120.933 -1.105 . . . . 0.0 114.449 -165.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.85 -28.52 22.83 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 -159.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.15 55.38 1.86 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 -174.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -160.03 -63.74 0.07 Allowed 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 124.459 1.103 . . . . 0.0 109.743 -173.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -72.31 -86.31 0.03 OUTLIER 'General case' 0 C--N 1.339 0.14 0 C-N-CA 123.975 0.91 . . . . 0.0 108.575 -168.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -161.16 17.79 0.19 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -62.55 148.27 90.94 Favored Pre-proline 0 C--O 1.238 0.49 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 173.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -64.54 -20.36 65.7 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 123.797 2.998 . . . . 0.0 112.922 -169.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -84.64 -16.13 43.04 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 117.919 -1.038 . . . . 0.0 112.649 -161.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -48.86 -34.39 12.49 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.134 0.974 . . . . 0.0 111.183 -173.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.66 -30.54 5.57 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 178.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.5 m -62.37 -23.36 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 120.148 1.34 . . . . 0.0 112.293 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.24 -10.96 53.61 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 119.788 1.176 . . . . 0.0 111.634 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 21.7 mt -94.27 -38.96 10.76 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 -173.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -75.24 83.77 2.4 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 176.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -49.15 -26.76 3.0 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.002 1.721 . . . . 0.0 114.246 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.52 -36.01 63.78 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.459 1.504 . . . . 0.0 111.379 173.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 45.5 m170 -68.51 -47.35 67.2 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.255 1.022 . . . . 0.0 109.439 171.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 167.19 178.12 39.29 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 174.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 64.4 tp -84.3 139.21 32.46 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 122.218 -0.578 . . . . 0.0 111.457 -176.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -142.29 157.95 44.26 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.018 1.327 . . . . 0.0 109.299 160.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -169.43 147.57 3.65 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 131.46 3.904 . . . . 0.0 108.258 178.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -72.61 106.75 4.77 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.797 1.639 . . . . 0.0 111.094 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.9 tpp180 -107.71 66.43 0.66 Allowed 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 177.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.47 -170.51 55.05 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-O 123.518 1.621 . . . . 0.0 113.266 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 77.8 mtm180 -122.52 165.37 16.52 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 125.064 1.345 . . . . 0.0 110.042 -171.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -168.82 177.57 42.6 Favored Glycine 0 C--N 1.334 0.45 0 O-C-N 121.583 -0.698 . . . . 0.0 112.994 173.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 30.2 p -148.43 153.27 38.3 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.219 1.808 . . . . 0.0 107.696 178.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.1 p -82.18 111.16 18.03 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 121.453 1.933 . . . . 0.0 107.154 173.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -76.02 -29.72 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 O-C-N 121.945 -0.472 . . . . 0.0 111.009 170.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -60.72 113.82 2.68 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 154.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 29.2 m -66.09 144.11 56.9 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 168.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.49 ' CE2' HD12 ' A' ' 93' ' ' LEU . 24.3 m-85 -145.46 154.86 53.43 Favored Pre-proline 0 CA--C 1.547 0.853 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -173.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -84.24 103.79 0.99 Allowed 'Trans proline' 0 CA--C 1.544 1.016 1 C-N-CA 126.224 4.616 . . . . 0.0 115.194 -172.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -105.87 103.23 12.68 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 120.489 -1.382 . . . . 0.0 107.721 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.1 m -124.97 127.83 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 127.007 2.123 . . . . 0.0 112.543 -174.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.0 mt -93.68 93.84 4.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -172.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.44 -179.54 4.52 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.906 1.282 . . . . 0.0 109.475 172.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.59 144.06 6.41 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.459 1.028 . . . . 0.0 111.914 164.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -72.35 -12.33 61.08 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -172.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 41.6 m-70 -106.4 13.81 28.09 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.325 1.05 . . . . 0.0 111.414 172.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.2 m120 58.32 73.6 0.47 Allowed 'General case' 0 C--N 1.341 0.227 0 C-N-CA 127.147 2.179 . . . . 0.0 108.83 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 64.1 mt -110.02 86.76 5.22 Favored Pre-proline 0 N--CA 1.449 -0.516 0 C-N-CA 125.112 1.365 . . . . 0.0 107.834 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -59.58 126.63 21.16 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.44 1.426 . . . . 0.0 111.879 171.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 67.2 m95 -104.81 126.21 51.66 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 128.239 2.615 . . . . 0.0 108.19 173.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -92.08 124.38 36.13 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 168.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.47 149.13 21.75 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -76.55 89.99 3.31 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.81 82.91 19.85 Favored Pre-proline 0 N--CA 1.467 0.392 0 O-C-N 120.901 -1.125 . . . . 0.0 110.229 172.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -61.88 134.73 51.61 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 122.236 1.957 . . . . 0.0 109.568 -177.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.94 -1.31 84.97 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-O 117.027 -1.985 . . . . 0.0 114.337 175.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.5 tppt? -128.11 136.26 50.92 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 121.084 2.442 . . . . 0.0 107.243 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 120.51 -113.08 2.31 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 107.378 -2.289 . . . . 0.0 107.378 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -160.88 172.36 17.1 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.79 1.636 . . . . 0.0 108.785 173.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 41.9 m -73.61 103.27 4.15 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.187 0.995 . . . . 0.0 111.173 170.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.7 t -78.07 107.82 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.733 1.213 . . . . 0.0 111.281 177.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.9 p -65.66 153.46 41.59 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.201 0.6 . . . . 0.0 111.163 177.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -173.58 -157.55 15.53 Favored Glycine 0 C--N 1.343 0.938 0 O-C-N 121.286 -0.884 . . . . 0.0 112.941 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -145.0 167.0 23.7 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.838 1.655 . . . . 0.0 109.569 174.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 71.0 mt -113.69 126.8 71.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 -172.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -117.56 115.52 25.3 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -67.79 81.62 0.19 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.121 1.368 . . . . 0.0 109.049 169.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.2 m -82.6 155.7 3.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 O-C-N 121.047 -1.033 . . . . 0.0 109.088 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.11 -178.8 4.9 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 121.921 0.867 . . . . 0.0 111.544 175.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.86 -45.02 93.78 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.979 1.312 . . . . 0.0 111.452 174.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 42.4 tp60 -59.86 -41.51 91.62 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 119.297 0.953 . . . . 0.0 110.139 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 59.3 tpp -65.88 -51.8 55.64 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 118.596 0.634 . . . . 0.0 110.584 176.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.23 -26.13 66.17 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -76.68 -55.04 5.86 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 123.951 0.9 . . . . 0.0 109.732 171.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -52.68 -48.8 66.29 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.152 0.581 . . . . 0.0 111.255 -177.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.507 ' C ' ' HH ' ' A' ' 115' ' ' TYR . 87.7 mt -62.39 -27.04 68.8 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 118.968 -0.539 . . . . 0.0 111.526 -178.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -67.39 -33.39 75.1 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.993 1.27 . . . . 0.0 109.587 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -75.9 -51.04 13.34 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.65 0.78 . . . . 0.0 110.701 172.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -66.17 -27.48 68.04 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.543 0.737 . . . . 0.0 112.572 -174.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.41 ' HG3' ' CE2' ' A' ' 115' ' ' TYR . 63.3 mm-40 -100.46 15.3 28.34 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.851 0.86 . . . . 0.0 111.093 177.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 52.23 28.09 5.29 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.458 1.903 . . . . 0.0 113.028 163.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 7.5 p -72.54 163.35 68.46 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.508 -1.37 . . . . 0.0 109.091 172.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -70.48 -4.01 9.07 Favored 'Cis proline' 0 CA--C 1.547 1.125 0 CA-C-N 119.99 1.032 . . . . 0.0 114.458 -10.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.1 m -60.1 -63.07 1.43 Allowed 'General case' 0 C--N 1.342 0.273 0 CA-C-N 119.561 1.073 . . . . 0.0 110.509 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 1.4 mtm -74.08 -77.69 0.11 Allowed 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.033 0.933 . . . . 0.0 109.683 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -97.83 -178.47 4.11 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.643 1.177 . . . . 0.0 108.934 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -138.13 -7.01 1.59 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 175.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? 61.28 134.22 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 128.459 2.704 . . . . 0.0 111.962 -173.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.9 m -152.73 153.76 33.86 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 120.463 -1.398 . . . . 0.0 110.501 174.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -84.62 126.93 33.78 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 129.137 2.975 . . . . 0.0 112.785 171.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.49 HD12 ' CE2' ' A' ' 40' ' ' PHE . 2.3 pt? -160.29 170.01 21.98 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 126.748 2.019 . . . . 0.0 112.182 -166.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 11.6 tp60 -94.5 131.35 40.3 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -162.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 35.5 t -135.3 119.79 27.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -177.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -67.48 143.16 56.35 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 168.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.625 ' CG1' ' HA ' ' A' ' 108' ' ' ASP . 2.4 p -90.79 126.13 43.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 176.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.53 -14.62 24.88 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 121.45 -0.782 . . . . 0.0 111.665 177.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -176.03 140.34 0.41 Allowed 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 103.582 -2.747 . . . . 0.0 103.582 -175.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 62.5 t-105 -125.47 139.34 53.71 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 171.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -109.44 114.26 27.76 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 123.848 0.718 . . . . 0.0 109.937 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.11 -165.02 42.9 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-O 121.65 0.583 . . . . 0.0 112.102 169.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -64.61 167.34 7.36 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.591 1.156 . . . . 0.0 111.481 -175.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.21 59.24 3.16 Favored Glycine 0 CA--C 1.525 0.688 0 O-C-N 121.931 -0.481 . . . . 0.0 112.267 173.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -101.71 89.15 1.4 Allowed Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 130.626 3.57 . . . . 0.0 110.656 -168.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -60.93 -14.47 32.94 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 124.081 3.187 . . . . 0.0 114.286 -171.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 95.07 176.19 37.84 Favored Glycine 0 CA--C 1.531 1.081 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -165.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.625 ' HA ' ' CG1' ' A' ' 97' ' ' VAL . 10.6 m-20 -69.82 0.91 4.95 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -162.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 61.8 p -137.74 146.66 43.94 Favored 'General case' 0 N--CA 1.427 -1.588 0 C-N-CA 117.124 -1.83 . . . . 0.0 111.725 150.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.1 p -110.27 159.68 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 114.29 -1.323 . . . . 0.0 109.059 173.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -89.37 112.96 24.2 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 156.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 14.1 m -99.89 171.48 7.83 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 165.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.443 ' CE2' ' HA ' ' A' ' 2' ' ' ALA . 19.6 m-85 -90.84 142.5 27.7 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 161.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.473 ' HB ' ' CD2' ' A' ' 93' ' ' LEU . 53.2 t -129.94 143.73 40.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 172.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.507 ' HH ' ' C ' ' A' ' 78' ' ' LEU . 8.9 m-85 -70.53 95.78 1.11 Allowed 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 167.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 80.5 p -109.42 173.39 6.34 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.948 171.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.7 t -142.19 121.9 13.44 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 175.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -93.0 4.78 53.42 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.359 0.664 . . . . 0.0 111.476 -178.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 47.3 p -118.83 43.56 2.52 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.085 1.354 . . . . 0.0 107.875 -171.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -78.48 171.15 15.52 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.477 -174.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -101.87 151.11 37.91 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 123.839 0.856 . . . . 0.0 110.272 -177.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -66.08 -37.35 25.96 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.916 2.411 . . . . 0.0 110.93 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.94 -0.66 9.73 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.81 1.644 . . . . 0.0 113.172 175.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 44.8 m0 -98.95 -24.72 14.83 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 118.882 0.765 . . . . 0.0 109.491 168.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 12.2 mt -75.89 -30.56 58.86 Favored 'General case' 0 CA--C 1.523 -0.064 0 O-C-N 120.94 -1.1 . . . . 0.0 111.554 177.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -64.25 -24.99 67.86 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.987 0.812 . . . . 0.0 111.965 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.0 mt -64.91 150.99 94.15 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 124.78 1.232 . . . . 0.0 110.429 -172.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -65.52 156.79 61.75 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.932 2.421 . . . . 0.0 110.441 175.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -106.62 159.32 16.28 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.628 0.251 . . . . 0.0 110.497 -172.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -134.06 106.23 7.11 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.754 0.822 . . . . 0.0 111.948 -174.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.33 -13.59 5.58 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.794 1.638 . . . . 0.0 114.173 -174.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 56.8 p -150.4 176.46 10.9 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.293 1.837 . . . . 0.0 107.071 173.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -129.16 166.19 19.82 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 168.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -158.11 164.63 36.45 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.218 1.807 . . . . 0.0 109.688 -175.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.3 t -109.32 -3.38 17.19 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.79 1.636 . . . . 0.0 111.061 167.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -140.14 102.72 4.44 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 128.642 2.777 . . . . 0.0 105.643 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -161.48 165.31 35.49 Favored Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 126.983 2.23 . . . . 0.0 111.836 -173.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.32 -18.78 55.87 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.286 2.657 . . . . 0.0 112.543 164.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -77.2 85.84 3.66 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 169.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.27 43.68 0.1 OUTLIER Glycine 0 CA--C 1.535 1.337 0 C-N-CA 127.749 2.595 . . . . 0.0 115.388 178.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.23 84.25 1.81 Allowed 'General case' 0 C--O 1.236 0.346 0 C-N-CA 127.316 2.246 . . . . 0.0 108.423 -172.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -120.72 155.0 34.84 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 118.193 -0.908 . . . . 0.0 109.727 -169.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -52.13 130.37 30.04 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 124.014 0.821 . . . . 0.0 109.329 -175.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.536 0.409 0 C-N-CA 123.268 0.627 . . . . 0.0 110.808 -169.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.313 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -81.48 124.0 29.08 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 174.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.8 pt -123.77 -176.02 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 123.785 0.834 . . . . 0.0 110.518 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.408 ' HB2' ' HG ' ' A' ' 112' ' ' CYS . 20.4 t80 -124.14 169.43 11.71 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.035 1.334 . . . . 0.0 108.502 174.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.438 HG13 ' H ' ' A' ' 66' ' ' GLU . 7.6 p -122.95 153.54 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 123.837 0.855 . . . . 0.0 109.882 175.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.413 ' CD1' ' N ' ' A' ' 7' ' ' TYR . 0.3 OUTLIER -92.62 -41.11 10.38 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 -171.076 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.408 ' HA3' ' HB3' ' A' ' 133' ' ' TYR . . . 169.45 -19.01 0.07 OUTLIER Glycine 0 CA--C 1.528 0.858 0 C-N-CA 124.743 1.163 . . . . 0.0 113.372 172.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.47 -30.21 71.37 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 128.224 2.609 . . . . 0.0 113.735 -176.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.9 61.1 1.18 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 175.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -151.75 -85.82 0.07 Allowed 'General case' 0 C--O 1.224 -0.279 0 O-C-N 121.239 -0.913 . . . . 0.0 109.86 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 -62.0 -53.62 53.12 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.069 0.85 . . . . 0.0 111.591 -166.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 161.21 30.24 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 -175.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -63.35 155.8 72.89 Favored Pre-proline 0 N--CA 1.45 -0.433 0 C-N-CA 124.83 1.252 . . . . 0.0 108.401 171.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -65.37 -12.58 35.55 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.207 2.604 . . . . 0.0 112.593 -174.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -95.14 24.96 4.53 Favored 'General case' 0 C--O 1.221 -0.415 0 C-N-CA 126.643 1.977 . . . . 0.0 111.454 -175.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -75.89 -55.64 5.43 Favored 'General case' 0 C--N 1.332 -0.18 0 O-C-N 120.442 -1.411 . . . . 0.0 110.116 173.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.04 -24.09 23.11 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -169.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.9 m -60.17 -34.81 58.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 119.675 1.125 . . . . 0.0 112.141 178.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.1 ptp -77.18 -7.7 56.29 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 119.472 1.033 . . . . 0.0 112.76 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 40.5 mt -89.47 7.0 38.32 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.832 1.253 . . . . 0.0 108.974 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -110.23 98.3 7.58 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -59.38 -21.8 60.42 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.867 -0.521 . . . . 0.0 111.563 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.7 t -70.33 -29.19 65.84 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.873 1.269 . . . . 0.0 112.016 175.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 35.1 m170 -79.59 -32.44 41.93 Favored 'General case' 0 CA--C 1.529 0.147 0 O-C-N 121.351 -0.843 . . . . 0.0 109.739 168.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 158.15 175.67 29.34 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 165.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 65.0 tp -74.57 134.0 42.19 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 175.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.8 143.59 31.41 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 155.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -152.01 149.9 29.39 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 165.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -62.18 104.76 0.51 Allowed 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.973 1.709 . . . . 0.0 108.663 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.9 tpp180 -123.56 67.84 1.02 Allowed 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.15 -170.86 45.58 Favored Glycine 0 N--CA 1.435 -1.4 0 CA-C-O 123.824 1.791 . . . . 0.0 111.915 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -131.04 158.91 39.07 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 125.436 1.494 . . . . 0.0 108.257 -170.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.99 173.98 38.4 Favored Glycine 0 CA--C 1.507 -0.463 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.741 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.0 m -141.67 145.95 35.54 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 173.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.2 p -71.65 93.17 1.22 Allowed 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 163.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.9 m -63.41 -38.46 82.25 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.106 0 CA-C-O 121.206 0.527 . . . . 0.0 109.892 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.81 118.23 7.43 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 105.218 -2.141 . . . . 0.0 105.218 170.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.74 145.92 50.96 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -141.25 160.62 56.82 Favored Pre-proline 0 N--CA 1.449 -0.475 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 177.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -80.28 67.45 8.62 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 122.532 2.155 . . . . 0.0 113.987 -175.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 53' ' ' LEU . 34.0 tp -72.72 98.63 2.42 Favored 'General case' 0 CA--C 1.553 1.082 0 O-C-N 119.757 -1.839 . . . . 0.0 111.356 178.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.5 m -121.68 126.74 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 119.625 1.102 . . . . 0.0 112.763 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 51.1 mt -69.84 111.67 3.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 173.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -125.98 175.03 8.0 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.457 1.103 . . . . 0.0 108.782 176.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.01 152.74 7.91 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-O 122.61 1.117 . . . . 0.0 111.544 171.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -70.06 -23.41 63.08 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 123.526 0.731 . . . . 0.0 112.34 -176.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -94.44 13.27 24.36 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.429 0.692 . . . . 0.0 111.391 -177.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.517 HD21 ' HB2' ' A' ' 141' ' ' LEU . 2.1 m120 63.22 56.78 1.67 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.04 1.736 . . . . 0.0 107.592 171.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 80.5 mt -107.29 87.91 3.56 Favored Pre-proline 0 CA--C 1.533 0.288 0 C-N-CA 127.253 2.221 . . . . 0.0 107.476 -167.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -54.33 139.76 73.35 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 120.846 1.03 . . . . 0.0 111.652 169.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 6.2 m95 -123.3 146.29 48.02 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 167.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 42' ' ' LEU 0.295 0.9 OUTLIER -97.16 -8.86 29.07 Favored 'General case' 0 C--O 1.219 -0.529 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 -177.741 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 36.7 mt 44.1 -160.8 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.312 1 C-N-CA 134.825 5.25 . . . . 0.0 110.069 -172.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -130.95 91.43 3.05 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 120.848 -1.158 . . . . 0.0 110.225 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.57 85.72 5.22 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 118.968 -0.539 . . . . 0.0 111.616 168.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -59.75 134.41 57.24 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.754 1.636 . . . . 0.0 109.257 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.74 10.43 81.35 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-O 119.568 -0.573 . . . . 0.0 113.618 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? -123.03 155.03 37.68 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.779 1.79 . . . . 0.0 108.444 172.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.468 ' HA2' ' CD2' ' A' ' 129' ' ' TYR . . . 67.96 -146.39 46.39 Favored Glycine 0 C--N 1.334 0.458 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 -174.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -127.45 169.36 13.73 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 117.833 0.816 . . . . 0.0 108.849 -169.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 5.1 p -59.8 169.67 1.35 Allowed 'General case' 0 CA--C 1.512 -0.486 0 O-C-N 121.665 -0.647 . . . . 0.0 112.122 170.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 54.9 t -135.49 118.41 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.792 168.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 72.5 p -74.72 154.76 38.27 Favored 'General case' 0 C--O 1.239 0.512 0 O-C-N 121.756 -0.59 . . . . 0.0 110.237 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.59 -164.96 28.91 Favored Glycine 0 C--N 1.337 0.608 0 CA-C-O 122.202 0.89 . . . . 0.0 111.761 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.438 ' H ' HG13 ' A' ' 6' ' ' VAL . 0.5 OUTLIER -117.57 156.82 27.43 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 124.886 1.274 . . . . 0.0 108.662 179.206 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 73.2 mt -101.34 130.33 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 170.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -116.45 120.96 40.46 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -62.54 116.18 4.91 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 156.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.3 m -123.89 175.53 6.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 CA-C-N 118.429 0.559 . . . . 0.0 109.978 174.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -125.6 176.18 7.05 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.954 0.902 . . . . 0.0 109.208 169.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -53.13 -37.62 61.95 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.682 1.593 . . . . 0.0 112.204 -175.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 42.8 tp60 -61.15 -41.99 97.75 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 118.465 -0.778 . . . . 0.0 111.133 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -67.04 -44.74 79.44 Favored 'General case' 0 C--O 1.225 -0.232 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.2 tp -62.91 -29.53 70.85 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -176.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 62.3 mtt180 -74.69 -38.58 62.33 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 121.949 -0.47 . . . . 0.0 111.992 172.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -66.65 -48.74 68.47 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 119.23 -0.414 . . . . 0.0 110.228 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.8 mp -51.02 -50.32 58.78 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.353 1.461 . . . . 0.0 110.256 174.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -49.67 -43.6 47.31 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.712 0.805 . . . . 0.0 112.016 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -79.35 -13.74 59.44 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.57 2.348 . . . . 0.0 112.709 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -91.12 -42.99 10.16 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.355 1.462 . . . . 0.0 109.664 -175.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . 0.252 0.4 OUTLIER -90.03 9.46 27.92 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.75 1.22 . . . . 0.0 114.009 170.844 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 61.01 36.04 18.7 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.112 1.365 . . . . 0.0 111.105 167.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 6.5 m -79.03 166.53 41.49 Favored Pre-proline 0 C--N 1.323 -0.585 0 C-N-CA 125.061 1.344 . . . . 0.0 108.796 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -64.94 -3.42 2.81 Favored 'Cis proline' 0 CA--C 1.545 1.027 0 CA-C-N 120.082 1.065 . . . . 0.0 113.598 -17.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.76 -66.57 0.37 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.849 1.66 . . . . 0.0 111.193 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 19.4 mtm -83.33 -63.83 1.28 Allowed 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.83 -0.544 . . . . 0.0 110.362 -176.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -103.91 170.11 8.11 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -177.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.91 137.62 38.2 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 120.406 -1.434 . . . . 0.0 107.138 176.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.416 ' HB2' ' CE1' ' A' ' 115' ' ' TYR . 8.4 tmm_? -78.7 123.36 27.07 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 123.899 0.879 . . . . 0.0 108.984 -174.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.6 m -123.96 160.61 27.2 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 123.855 0.862 . . . . 0.0 108.884 -177.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -98.2 140.6 32.25 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 124.018 0.927 . . . . 0.0 109.212 169.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.15 169.17 23.08 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.963 0.905 . . . . 0.0 111.483 -177.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -95.81 119.86 35.05 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.83 1.652 . . . . 0.0 110.083 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 95.0 t -117.71 136.95 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 177.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -71.9 148.88 45.65 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 123.813 0.845 . . . . 0.0 111.244 172.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.0 t -87.97 95.07 4.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 125.305 1.442 . . . . 0.0 107.306 167.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.35 -24.94 50.64 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.454 1.101 . . . . 0.0 110.724 172.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -162.49 157.32 22.13 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 127.856 2.462 . . . . 0.0 105.096 173.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 75.1 t-105 -145.66 121.83 10.82 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 169.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -105.97 92.55 4.2 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.611 0.764 . . . . 0.0 109.864 176.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 135.66 -179.45 17.76 Favored Glycine 0 C--O 1.227 -0.343 0 C-N-CA 124.233 0.921 . . . . 0.0 112.687 168.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -68.12 155.69 39.06 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 171.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 102.21 56.09 0.84 Allowed Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 124.878 1.228 . . . . 0.0 111.059 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -100.11 91.02 1.5 Allowed Pre-proline 0 C--N 1.327 -0.399 0 C-N-CA 129.591 3.157 . . . . 0.0 106.516 -171.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -66.84 -23.82 47.39 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 124.417 3.411 . . . . 0.0 112.362 -178.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 123.23 -172.66 16.12 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 -165.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.66 -6.6 26.91 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -170.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 67.8 p -151.76 157.91 42.62 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 119.072 0.851 . . . . 0.0 111.816 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.0 m -136.69 169.05 20.7 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 C-N-CA 125.071 1.348 . . . . 0.0 108.571 -171.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -108.65 93.13 4.36 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 177.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.408 ' HG ' ' HB2' ' A' ' 5' ' ' PHE . 95.3 m -79.19 176.97 9.18 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.379 0.609 . . . . 0.0 109.915 177.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -107.72 145.95 32.76 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 158.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.3 t -138.8 143.06 32.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 128.017 2.527 . . . . 0.0 106.44 174.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.416 ' CE1' ' HB2' ' A' ' 90' ' ' ARG . 16.3 m-85 -84.9 104.59 14.99 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 167.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 11.1 p -99.12 -171.49 2.1 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.48 1.912 . . . . 0.0 108.626 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.7 t -147.98 150.88 34.81 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 156.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -114.91 -12.48 12.05 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 128.215 2.606 . . . . 0.0 111.384 176.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 5.8 p -88.81 9.07 25.93 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.329 1.452 . . . . 0.0 113.807 -169.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -69.0 164.36 22.53 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.787 1.235 . . . . 0.0 112.72 -170.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -93.82 153.69 40.99 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 125.258 1.423 . . . . 0.0 110.324 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -62.14 -27.29 78.64 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.587 2.858 . . . . 0.0 113.548 -174.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -49.77 -43.01 47.91 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.243 1.017 . . . . 0.0 112.113 176.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 42.2 m0 -70.55 -15.85 62.82 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 122.485 0.314 . . . . 0.0 111.339 -172.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -82.65 -10.96 58.7 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.059 0.944 . . . . 0.0 112.367 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -96.39 -16.02 21.48 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.685 0.794 . . . . 0.0 110.992 175.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 88.4 mt -68.42 155.85 91.7 Favored Pre-proline 0 N--CA 1.469 0.497 0 C-N-CA 124.149 0.979 . . . . 0.0 109.561 176.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -79.62 154.5 23.84 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 121.786 1.657 . . . . 0.0 110.497 173.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.468 ' CD2' ' HA2' ' A' ' 60' ' ' GLY . 44.5 m-85 -85.79 175.87 8.44 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 126.357 1.863 . . . . 0.0 111.108 177.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . 0.451 ' HD1' ' CE1' ' A' ' 139' ' ' HIS . 55.4 m-70 -142.7 161.11 38.95 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.625 1.97 . . . . 0.0 107.984 -178.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -110.02 -2.65 16.93 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 122.684 1.231 . . . . 0.0 112.544 -177.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.5 t -164.11 154.38 14.91 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.408 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . 7.9 t80 -108.98 116.59 32.28 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.194 167.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -143.51 125.11 14.9 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.576 2.35 . . . . 0.0 108.225 -168.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.2 p -68.64 -47.55 66.31 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 169.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -75.42 43.42 0.23 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.706 2.003 . . . . 0.0 110.61 170.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -110.73 163.03 12.35 Favored Glycine 0 C--N 1.332 0.327 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 166.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.11 -14.61 44.59 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.749 2.3 . . . . 0.0 113.122 -175.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.451 ' CE1' ' HD1' ' A' ' 130' ' ' HIS . 64.0 m-70 -62.79 -14.52 46.17 Favored 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 116.828 2.158 . . . . 0.0 116.828 -162.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 75.53 -29.85 1.23 Allowed Glycine 0 CA--C 1.537 1.409 0 CA-C-N 120.406 1.457 . . . . 0.0 115.295 172.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.517 ' HB2' HD21 ' A' ' 49' ' ' ASN . 0.3 OUTLIER -97.37 97.37 9.06 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 126.339 1.856 . . . . 0.0 110.949 179.325 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -104.58 162.55 13.16 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 120.865 -1.147 . . . . 0.0 109.872 -173.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -57.35 142.17 44.52 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 119.004 -0.522 . . . . 0.0 110.151 -176.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 31.9 t-20 . . . . . 0 C--O 1.234 0.241 0 C-N-CA 125.295 1.438 . . . . 0.0 107.765 176.96 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.316 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -80.57 142.48 34.05 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 118.492 0.587 . . . . 0.0 111.213 -175.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.8 pt -133.62 -176.13 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 124.407 1.083 . . . . 0.0 109.913 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -120.74 164.68 16.2 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.275 1.43 . . . . 0.0 109.011 172.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 p -111.6 148.84 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.771 0.829 . . . . 0.0 112.309 -175.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -92.24 7.04 44.46 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -168.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 106.84 -33.32 6.51 Favored Glycine 0 N--CA 1.467 0.715 0 O-C-N 120.54 -1.35 . . . . 0.0 110.057 -164.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.64 -24.05 66.24 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 129.8 3.24 . . . . 0.0 114.771 -170.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.1 mp -146.07 48.23 1.22 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.471 1.032 . . . . 0.0 109.258 -173.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -130.97 -85.53 0.51 Allowed 'General case' 0 N--CA 1.468 0.452 0 O-C-N 120.254 -1.529 . . . . 0.0 111.582 176.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.11 -66.79 0.42 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.888 1.222 . . . . 0.0 109.383 -178.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 174.82 86.24 0.06 OUTLIER Glycine 0 N--CA 1.431 -1.691 0 N-CA-C 104.957 -3.257 . . . . 0.0 104.957 -178.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -107.5 160.27 27.23 Favored Pre-proline 0 N--CA 1.445 -0.701 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 174.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -61.49 -27.4 82.14 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.937 2.425 . . . . 0.0 112.343 -174.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -73.52 -16.26 61.28 Favored 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 125.182 1.393 . . . . 0.0 110.842 -173.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -64.36 -32.85 74.63 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 120.115 1.325 . . . . 0.0 112.153 -159.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.94 -19.96 47.76 Favored 'General case' 0 C--O 1.224 -0.279 0 O-C-N 121.409 -0.807 . . . . 0.0 113.044 176.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.4 p -55.92 -35.58 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 119.179 0.899 . . . . 0.0 110.956 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.2 ptp -87.97 -4.92 58.77 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -176.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 73.5 mt -90.47 -6.38 54.91 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.505 1.122 . . . . 0.0 110.67 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -106.21 99.91 9.47 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 106.174 -1.788 . . . . 0.0 106.174 172.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 25.6 t-80 -59.03 -18.93 39.11 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.841 1.256 . . . . 0.0 113.285 -176.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.7 m -61.82 -28.34 69.41 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 120.972 -1.08 . . . . 0.0 113.674 169.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -78.69 -1.91 36.7 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 119.241 0.928 . . . . 0.0 111.803 173.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.16 176.65 19.51 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 127.037 2.256 . . . . 0.0 110.571 -176.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -93.76 137.0 33.46 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.521 1.528 . . . . 0.0 110.177 -172.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.16 125.21 15.29 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.474 1.11 . . . . 0.0 110.664 165.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -133.29 126.0 30.51 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 125.228 1.411 . . . . 0.0 109.878 -176.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -60.07 108.53 0.79 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.053 1.741 . . . . 0.0 109.501 -178.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.0 tpp180 -121.15 66.37 0.87 Allowed 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.871 1.268 . . . . 0.0 109.902 -174.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.21 -171.56 55.16 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 176.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.45 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 32.2 mtp85 -123.24 169.19 11.53 Favored 'General case' 0 CA--C 1.511 -0.534 0 O-C-N 121.965 -0.727 . . . . 0.0 111.974 -174.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -166.66 173.52 42.03 Favored Glycine 0 CA--C 1.506 -0.526 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.745 175.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 25.8 p -142.99 161.01 39.25 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.999 -0.6 . . . . 0.0 109.558 171.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.6 p -76.57 103.88 6.79 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 106.328 -1.731 . . . . 0.0 106.328 164.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -62.4 -32.17 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 119.503 1.047 . . . . 0.0 110.435 171.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.23 124.74 23.47 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 167.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.24 131.4 44.84 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 125.479 1.511 . . . . 0.0 108.029 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -140.39 157.1 69.21 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 119.472 1.033 . . . . 0.0 108.406 -177.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -70.04 108.05 2.05 Favored 'Trans proline' 0 N--CA 1.454 -0.851 1 C-N-CA 125.525 4.15 . . . . 0.0 108.438 171.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -117.84 99.38 6.89 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 173.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.6 m -132.58 141.46 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 C-N-CA 126.386 1.874 . . . . 0.0 108.864 -167.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.7 mp -109.73 121.21 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -171.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.3 -170.11 3.0 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.295 1.438 . . . . 0.0 108.707 -173.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.79 164.29 4.33 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.337 0.97 . . . . 0.0 111.145 -174.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -78.5 2.74 18.03 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.598 1.159 . . . . 0.0 113.271 -172.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -132.14 17.08 4.57 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.836 1.254 . . . . 0.0 112.445 -171.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.0 m120 56.7 72.87 0.48 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.351 1.86 . . . . 0.0 111.117 -177.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 94.4 mt -110.49 89.49 8.93 Favored Pre-proline 0 C--N 1.324 -0.518 0 C-N-CA 129.267 3.027 . . . . 0.0 107.488 -169.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -52.65 134.1 52.24 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 CA-C-N 120.872 1.347 . . . . 0.0 111.927 171.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 70.8 m95 -118.29 137.76 52.84 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.171 1.388 . . . . 0.0 107.309 170.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.93 94.61 5.17 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 171.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.6 mt -76.07 143.86 41.09 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 -176.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -79.64 75.86 6.28 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.764 -0.585 . . . . 0.0 110.496 -175.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.64 83.32 53.98 Favored Pre-proline 0 N--CA 1.468 0.428 0 C-N-CA 123.728 0.811 . . . . 0.0 109.887 -176.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -63.62 148.99 92.0 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 121.363 1.375 . . . . 0.0 108.815 178.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.6 2.34 60.14 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-O 117.637 -1.646 . . . . 0.0 114.898 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.2 tppt? -124.94 121.71 35.24 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 121.75 2.775 . . . . 0.0 106.291 177.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.509 ' HA2' ' CD2' ' A' ' 129' ' ' TYR . . . 108.2 -147.07 16.48 Favored Glycine 0 N--CA 1.459 0.228 0 CA-C-N 120.601 1.546 . . . . 0.0 110.766 -176.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -137.01 173.99 11.1 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 123.936 0.894 . . . . 0.0 110.198 -168.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 61.4 m -78.08 113.6 16.16 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.498 0.719 . . . . 0.0 110.251 -178.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 38.2 t -78.34 111.16 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 124.183 0.993 . . . . 0.0 108.339 -177.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 51.6 p -92.92 151.22 20.07 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 119.17 0.895 . . . . 0.0 111.762 -173.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -178.92 -163.83 30.67 Favored Glycine 0 C--N 1.337 0.605 0 O-C-N 121.277 -0.889 . . . . 0.0 113.588 -163.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 1.5 pt-20 -120.73 177.37 5.11 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 87.7 mt -121.69 115.58 46.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 169.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -89.71 130.84 35.92 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 168.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -70.57 130.16 41.09 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 152.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.3 m -134.04 167.92 25.1 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 CA-C-O 121.144 0.497 . . . . 0.0 110.35 177.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.86 -179.42 4.28 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 122.427 1.108 . . . . 0.0 111.046 167.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.3 -42.76 96.22 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 115.85 -2.024 . . . . 0.0 111.527 177.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.1 mm100 -55.05 -43.16 73.56 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 120.522 1.51 . . . . 0.0 110.763 177.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 39.1 tpp -66.1 -51.46 57.83 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 119.09 -0.481 . . . . 0.0 110.36 178.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.04 -28.16 66.17 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 118.831 0.742 . . . . 0.0 112.034 177.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 35.4 mtt180 -75.19 -43.81 49.99 Favored 'General case' 0 C--N 1.337 0.052 0 C-N-CA 125.625 1.57 . . . . 0.0 111.033 179.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -57.94 -54.7 43.94 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 123.541 0.737 . . . . 0.0 109.332 175.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 mp -49.74 -41.15 43.15 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.115 0.966 . . . . 0.0 110.613 178.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -65.94 -1.19 2.79 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.092 1.757 . . . . 0.0 114.277 178.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -129.83 3.85 4.94 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.261 2.224 . . . . 0.0 111.132 178.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -102.59 -47.13 4.54 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.932 1.293 . . . . 0.0 110.166 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.477 ' HB2' ' HG ' ' A' ' 84' ' ' CYS . 8.2 mm-40 -75.17 1.51 13.17 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -175.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.0 t70 54.13 26.2 6.36 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.301 1.441 . . . . 0.0 112.578 -165.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.477 ' HG ' ' HB2' ' A' ' 82' ' ' GLU . 1.5 p -63.98 159.19 57.48 Favored Pre-proline 0 CA--C 1.542 0.672 0 O-C-N 119.411 -2.055 . . . . 0.0 109.154 166.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -73.24 -4.06 15.04 Favored 'Cis proline' 0 CA--C 1.546 1.096 0 CA-C-N 119.417 0.827 . . . . 0.0 113.583 -10.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.63 -63.39 1.3 Allowed 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.262 1.425 . . . . 0.0 112.966 -177.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 4.2 mtm -82.58 -55.85 4.21 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 122.785 0.434 . . . . 0.0 110.35 -172.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -109.8 173.03 6.51 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 127.6 2.36 . . . . 0.0 106.993 176.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 -132.17 157.67 43.69 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 120.867 1.667 . . . . 0.0 108.224 160.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.0 tmm_? -80.6 142.77 33.72 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 118.897 0.771 . . . . 0.0 109.107 172.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.7 m -143.4 161.49 38.24 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.673 0.749 . . . . 0.0 109.312 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -114.3 125.02 53.41 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 126.64 1.976 . . . . 0.0 108.317 171.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.466 ' CD2' ' HB ' ' A' ' 114' ' ' VAL . 2.1 pt? -142.99 -167.0 2.43 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 129.918 3.287 . . . . 0.0 108.688 -166.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 20.7 tp60 -107.5 138.97 42.74 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.491 0.716 . . . . 0.0 111.904 177.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 99.5 t -133.87 135.97 54.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 172.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -76.45 153.3 35.73 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.549 1.539 . . . . 0.0 109.653 169.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 80.7 t -87.33 112.68 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 127.565 2.346 . . . . 0.0 107.58 165.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.5 mp -90.51 -17.87 26.3 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.241 1.416 . . . . 0.0 110.641 171.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -172.18 159.85 4.98 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 129.041 2.936 . . . . 0.0 105.672 173.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 62.7 t-105 -141.81 118.02 10.73 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 119.339 0.972 . . . . 0.0 109.708 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -118.04 62.29 0.76 Allowed 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.914 0.864 . . . . 0.0 112.67 -171.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 150.18 155.15 6.71 Favored Glycine 0 C--O 1.228 -0.254 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 158.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -54.24 149.41 9.85 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.598 1.159 . . . . 0.0 112.079 -162.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 98.16 65.98 0.88 Allowed Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -165.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -100.82 89.1 1.15 Allowed Pre-proline 0 C--O 1.24 0.579 1 C-N-CA 132.509 4.324 . . . . 0.0 108.152 -162.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -72.79 -5.19 16.73 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 124.675 3.584 . . . . 0.0 114.126 -163.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.74 -177.19 44.92 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 109.251 -1.539 . . . . 0.0 109.251 -166.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -64.36 -12.02 38.34 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 -168.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.0 p -137.41 161.79 35.37 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 120.726 1.603 . . . . 0.0 112.457 177.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.5 m -142.65 156.71 18.46 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 125.366 1.466 . . . . 0.0 108.913 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -98.08 98.64 9.93 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.444 -1.688 . . . . 0.0 106.444 160.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 18.6 m -92.05 172.37 8.49 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 168.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -85.68 140.4 30.57 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 162.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.466 ' HB ' ' CD2' ' A' ' 93' ' ' LEU . 25.5 t -134.61 124.9 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 127.461 2.304 . . . . 0.0 106.052 173.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -72.63 141.08 48.33 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 168.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 55.6 p -138.37 -173.2 3.47 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.19 1.796 . . . . 0.0 109.675 -173.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.4 t -134.63 145.04 48.23 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 165.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -113.59 -8.96 13.28 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.864 1.666 . . . . 0.0 112.073 169.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 31.4 p -105.76 15.42 26.81 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.659 1.184 . . . . 0.0 113.11 -172.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -58.9 149.72 26.22 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 125.832 1.653 . . . . 0.0 113.803 -170.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.64 154.59 88.12 Favored Pre-proline 0 CA--C 1.532 0.283 0 C-N-CA 125.444 1.498 . . . . 0.0 110.961 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.08 -30.81 20.22 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.033 1.822 . . . . 0.0 113.335 178.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.07 -30.25 70.23 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 173.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 43.2 m0 -72.36 -17.32 61.84 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 121.453 -0.779 . . . . 0.0 111.446 -171.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -75.29 -21.29 58.6 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 118.48 -0.772 . . . . 0.0 110.978 172.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 8.9 m-30 -86.14 -19.22 30.46 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.175 0.898 . . . . 0.0 111.639 -177.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 97.2 mt -65.77 151.07 95.56 Favored Pre-proline 0 C--O 1.237 0.415 0 C-N-CA 123.836 0.855 . . . . 0.0 110.385 -175.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.67 146.0 53.38 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.834 2.356 . . . . 0.0 109.183 177.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.509 ' CD2' ' HA2' ' A' ' 60' ' ' GLY . 11.6 m-85 -86.96 163.68 16.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 122.079 0.942 . . . . 0.0 110.831 -175.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 26.2 m-70 -136.99 160.22 39.57 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.845 1.658 . . . . 0.0 108.038 177.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -97.5 -5.47 35.86 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.01 1.324 . . . . 0.0 111.192 174.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 80.7 p -169.34 -175.35 2.2 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 120.963 -1.085 . . . . 0.0 109.798 -169.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -158.0 61.85 0.46 Allowed 'General case' 0 C--O 1.239 0.527 0 C-N-CA 126.739 2.016 . . . . 0.0 106.493 -167.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -112.02 122.88 48.99 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 -157.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 5.2 t -59.13 -32.15 69.59 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.728 -168.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -91.72 11.77 23.47 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 117.931 0.332 . . . . 0.0 111.697 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -68.41 167.06 44.53 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.486 1.041 . . . . 0.0 113.251 -175.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -73.4 -9.54 23.1 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.544 2.829 . . . . 0.0 112.187 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -80.23 -18.56 49.15 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -163.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 77.21 -19.47 3.63 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-O 118.244 -1.309 . . . . 0.0 114.261 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.74 101.54 3.12 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.733 1.613 . . . . 0.0 110.244 175.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 9.9 mmt85 -125.33 138.19 54.06 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 117.794 -1.098 . . . . 0.0 110.495 -174.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -58.02 148.09 27.26 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 . . . . . 0 C--N 1.329 -0.292 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -176.963 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.373 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -96.04 121.2 37.54 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 168.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.9 pt -119.4 175.25 4.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 171.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -120.5 137.26 54.46 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 175.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.4 m -78.55 137.46 21.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -67.51 -26.22 66.23 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.009 0.524 . . . . 0.0 112.241 175.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 135.48 -19.96 3.76 Favored Glycine 0 N--CA 1.472 1.036 0 O-C-N 120.134 -1.604 . . . . 0.0 111.958 -169.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.48 -14.95 54.18 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.335 1.854 . . . . 0.0 112.555 -169.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -127.14 41.19 3.57 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 128.592 2.757 . . . . 0.0 106.54 -173.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.79 -85.22 0.18 Allowed 'General case' 0 N--CA 1.469 0.489 0 O-C-N 120.324 -1.485 . . . . 0.0 110.753 -171.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.0 tpt85 -66.42 -69.19 0.32 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 121.149 1.795 . . . . 0.0 111.006 -170.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -155.48 -3.03 0.1 Allowed Glycine 0 N--CA 1.448 -0.504 0 O-C-N 124.157 0.911 . . . . 0.0 114.133 -174.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -49.28 147.52 5.28 Favored Pre-proline 0 N--CA 1.45 -0.438 0 C-N-CA 126.523 1.929 . . . . 0.0 111.847 -167.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -48.99 -29.21 15.02 Favored 'Trans proline' 0 CA--C 1.533 0.436 1 C-N-CA 125.32 4.013 . . . . 0.0 113.967 -176.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -81.34 -23.8 37.53 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 125.958 1.703 . . . . 0.0 112.226 -169.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -53.41 -31.38 44.79 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.975 1.262 . . . . 0.0 111.019 -171.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.31 -23.55 9.48 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.873 1.269 . . . . 0.0 114.031 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.1 m -60.07 -49.53 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 CA-C-N 119.652 1.115 . . . . 0.0 110.628 173.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 6.0 ptp -77.68 5.64 8.89 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.704 0.684 . . . . 0.0 112.726 -174.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 69.9 mt -97.34 -6.08 35.07 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.078 0.951 . . . . 0.0 111.582 176.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -121.7 102.83 8.46 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 104.315 -2.476 . . . . 0.0 104.315 175.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -58.16 -16.93 15.29 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.081 1.352 . . . . 0.0 111.996 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.2 m -60.92 -22.42 64.35 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.756 1.622 . . . . 0.0 113.971 169.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 20.2 m170 -86.08 -15.06 42.43 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.251 -0.906 . . . . 0.0 111.107 170.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.1 170.02 12.91 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 127.203 2.335 . . . . 0.0 111.565 176.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -74.1 139.09 44.36 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 124.803 1.241 . . . . 0.0 112.1 -174.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -139.82 138.63 35.96 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.03 1.732 . . . . 0.0 109.053 165.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.16 139.71 27.45 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.77 1.228 . . . . 0.0 108.865 175.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -72.62 87.55 1.23 Allowed 'General case' 0 C--O 1.238 0.481 0 C-N-CA 125.948 1.699 . . . . 0.0 108.033 178.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.2 tpp180 -93.7 64.85 3.57 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -177.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.66 -167.41 54.8 Favored Glycine 0 N--CA 1.44 -1.058 0 CA-C-O 122.967 1.315 . . . . 0.0 111.463 -173.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.3 ptt85 -139.13 170.64 15.59 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.981 0.913 . . . . 0.0 109.668 -177.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -170.96 173.8 44.68 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 119.876 -1.155 . . . . 0.0 111.807 -172.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.467 ' HB3' ' HA ' ' A' ' 64' ' ' THR . 2.3 m -136.89 158.05 45.34 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 170.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.0 p -74.9 121.61 22.15 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 176.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.0 t -76.6 -43.88 34.51 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -177.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -71.36 121.72 19.04 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 105.774 -1.935 . . . . 0.0 105.774 174.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 m -55.75 142.49 34.33 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 168.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.417 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 20.1 m-85 -135.67 153.41 77.43 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 107.057 -1.461 . . . . 0.0 107.057 178.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 40' ' ' PHE . 3.4 Cg_exo -78.52 91.82 1.17 Allowed 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 124.693 3.595 . . . . 0.0 109.522 176.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.88 88.59 7.73 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 177.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . 0.287 40.1 t -89.71 166.78 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 C-N-CA 126.982 2.113 . . . . 0.0 107.878 -176.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.2 mt -132.65 126.72 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 168.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.88 175.14 10.06 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 122.32 1.057 . . . . 0.0 111.495 -174.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.9 -172.64 53.18 Favored Glycine 0 CA--C 1.539 1.542 0 C-N-CA 125.794 1.664 . . . . 0.0 111.226 170.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -87.19 -18.46 30.28 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 125.851 1.66 . . . . 0.0 113.076 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 56.6 m-70 -109.2 8.98 26.08 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 122.845 0.458 . . . . 0.0 112.005 -171.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 62.86 63.03 0.99 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.648 1.579 . . . . 0.0 108.079 172.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 81.4 mt -104.11 90.23 2.94 Favored Pre-proline 0 N--CA 1.453 -0.283 0 C-N-CA 127.309 2.243 . . . . 0.0 106.14 -169.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -57.08 138.33 85.81 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 CA-C-N 119.725 0.938 . . . . 0.0 110.374 169.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 57.0 m95 -128.82 132.63 47.84 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.505 1.522 . . . . 0.0 108.692 178.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 34.4 tp -86.13 -3.81 59.04 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.957 0.903 . . . . 0.0 113.101 -173.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 12.9 mt 42.03 89.7 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 129.674 3.19 . . . . 0.0 112.367 172.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -49.5 95.68 0.01 OUTLIER 'General case' 0 C--O 1.241 0.631 0 CA-C-N 119.167 0.894 . . . . 0.0 112.989 -162.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -159.49 85.76 2.18 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 119.032 0.833 . . . . 0.0 113.057 -172.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -60.85 147.75 94.35 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.613 2.209 . . . . 0.0 109.739 -177.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.88 15.66 80.82 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 119.074 -0.848 . . . . 0.0 113.056 171.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.38 130.44 32.8 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 119.436 1.618 . . . . 0.0 108.715 -175.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.37 -123.84 7.07 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-N 120.792 1.633 . . . . 0.0 112.628 -178.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 46.4 m-70 -136.32 160.55 38.38 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.889 1.844 . . . . 0.0 112.588 -165.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 77.0 m -91.14 99.49 12.49 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.823 0.849 . . . . 0.0 110.736 -177.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.1 t -72.0 99.19 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 125.97 1.708 . . . . 0.0 113.213 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.467 ' HA ' ' HB3' ' A' ' 35' ' ' CYS . 8.9 p -66.51 157.58 31.83 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.91 0.884 . . . . 0.0 112.631 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -178.05 -147.1 6.71 Favored Glycine 0 C--N 1.343 0.962 0 O-C-N 121.458 -0.776 . . . . 0.0 114.025 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -133.53 171.21 14.4 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.056 1.342 . . . . 0.0 109.253 177.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 92.4 mt -116.59 112.98 41.62 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 -177.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -101.71 115.82 31.37 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 172.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -62.89 136.22 57.73 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 154.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.5 m -135.04 168.69 22.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 C-N-CA 124.732 1.213 . . . . 0.0 108.131 176.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -107.98 172.06 7.05 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 168.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -49.53 -45.73 47.69 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 125.035 1.334 . . . . 0.0 110.244 -176.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.2 tp60 -55.62 -43.57 76.25 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.079 0.952 . . . . 0.0 111.574 -176.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 24.3 tpp -72.48 -48.67 38.9 Favored 'General case' 0 C--O 1.224 -0.264 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.83 -39.4 77.57 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.549 -0.719 . . . . 0.0 110.726 -178.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.56 -44.65 90.09 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 126.918 2.087 . . . . 0.0 110.966 175.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -61.69 -46.35 90.08 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.279 0.632 . . . . 0.0 109.815 177.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 95.2 mt -57.79 -37.48 73.8 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.144 0.577 . . . . 0.0 111.468 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -61.11 -21.98 64.21 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.388 0.995 . . . . 0.0 111.837 177.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -100.25 -2.92 32.57 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.803 2.441 . . . . 0.0 111.5 177.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -103.96 -37.98 7.17 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 120.739 -1.226 . . . . 0.0 108.215 -174.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -107.94 28.88 7.8 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.985 1.314 . . . . 0.0 111.586 174.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 57.97 37.68 26.73 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.247 1.419 . . . . 0.0 112.625 156.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 78.1 m -85.92 163.57 42.86 Favored Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 120.934 -1.104 . . . . 0.0 110.646 -176.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -65.76 -3.95 3.6 Favored 'Cis proline' 0 CA--C 1.547 1.161 0 N-CA-C 114.849 1.057 . . . . 0.0 114.849 -16.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -46.79 -64.55 0.74 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.835 1.654 . . . . 0.0 112.928 178.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 21.5 mtm -88.18 -59.41 2.25 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 119.195 0.907 . . . . 0.0 110.092 -175.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -111.56 178.29 4.37 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 176.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.7 mp0 -133.97 150.28 51.27 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 171.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -77.44 114.26 16.09 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 176.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.2 m -113.55 170.91 7.9 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 126.106 1.763 . . . . 0.0 108.835 -179.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -122.13 143.01 49.8 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.622 1.569 . . . . 0.0 110.277 172.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.44 175.91 11.8 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.269 1.428 . . . . 0.0 111.357 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.4 tp60 -101.53 126.79 48.4 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.703 1.601 . . . . 0.0 111.772 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 64.0 t -122.39 144.74 30.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 125.305 1.442 . . . . 0.0 108.141 -176.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -89.32 144.75 25.85 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 176.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.509 ' CG1' ' HA ' ' A' ' 108' ' ' ASP 0.26 7.2 p -111.48 89.89 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -167.36 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.9 mp -65.44 -23.04 66.83 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 120.716 -1.24 . . . . 0.0 111.512 -177.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -160.95 153.43 20.55 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 104.763 -2.31 . . . . 0.0 104.763 174.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 70.2 t-105 -137.59 107.29 6.22 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 126.3 1.84 . . . . 0.0 108.597 178.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -95.18 108.56 20.69 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -177.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.52 -174.77 15.96 Favored Glycine 0 CA--C 1.519 0.311 0 CA-C-O 121.911 0.729 . . . . 0.0 111.387 174.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -71.31 160.64 32.43 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.604 0.716 . . . . 0.0 110.268 -177.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 90.52 69.13 1.2 Allowed Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 124.618 1.104 . . . . 0.0 111.234 165.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -101.58 89.58 1.5 Allowed Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 129.845 3.258 . . . . 0.0 110.352 -162.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -62.73 4.61 0.35 Allowed 'Trans proline' 0 CA--C 1.544 1.0 1 C-N-CA 125.737 4.291 . . . . 0.0 115.266 -176.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.15 -174.43 54.54 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 -163.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.509 ' HA ' ' CG1' ' A' ' 97' ' ' VAL . 14.5 t70 -69.71 5.69 1.39 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 117.336 2.347 . . . . 0.0 117.336 -168.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 83.5 p -125.25 157.45 36.55 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 121.648 -0.658 . . . . 0.0 112.174 155.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.6 p -132.6 153.05 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 123.628 0.771 . . . . 0.0 109.434 161.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -82.09 152.51 26.54 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 168.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 3.9 p -145.14 -173.37 4.07 Favored 'General case' 0 C--O 1.239 0.515 0 O-C-N 121.575 -0.703 . . . . 0.0 110.629 169.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -109.03 151.44 26.35 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.133 1.373 . . . . 0.0 109.504 162.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.3 t -142.88 146.45 21.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 128.883 2.873 . . . . 0.0 106.605 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -89.91 116.05 27.68 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 168.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -139.16 147.61 42.08 Favored 'General case' 0 C--O 1.225 -0.233 0 C-N-CA 124.077 0.951 . . . . 0.0 111.317 -176.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.5 t -92.5 141.16 28.81 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -177.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -110.57 6.45 21.89 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.235 1.414 . . . . 0.0 111.572 162.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.35 19.73 16.74 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.624 1.97 . . . . 0.0 112.729 -160.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -71.61 159.53 34.26 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.737 1.615 . . . . 0.0 113.16 -174.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.35 149.69 89.11 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 124.749 1.22 . . . . 0.0 110.761 173.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -68.52 -24.8 35.71 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.701 2.268 . . . . 0.0 113.561 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -68.69 -24.95 64.56 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 120.919 -1.113 . . . . 0.0 112.777 173.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 45.0 m0 -72.01 -12.75 61.37 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.426 -0.796 . . . . 0.0 112.241 -177.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -65.89 -18.33 65.26 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.347 -0.846 . . . . 0.0 111.233 171.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -99.95 -8.95 23.33 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.059 0.944 . . . . 0.0 112.791 175.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.7 mt -64.23 147.01 97.38 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -64.84 149.38 89.68 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.087 1.858 . . . . 0.0 110.371 178.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -103.37 166.1 10.63 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 41.0 m-70 -136.5 169.87 16.98 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 125.048 1.339 . . . . 0.0 108.473 178.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -125.26 -17.33 5.7 Favored 'General case' 0 C--O 1.219 -0.511 0 C-N-CA 124.217 1.007 . . . . 0.0 111.837 -166.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -158.19 132.78 8.28 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 164.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -85.59 131.57 34.33 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 169.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -143.87 158.21 43.84 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.756 154.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.5 t -63.71 -35.86 81.94 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 164.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -86.4 68.63 10.27 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 127.467 2.307 . . . . 0.0 107.665 -177.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -152.65 168.09 31.6 Favored Glycine 0 CA--C 1.522 0.499 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.432 163.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -72.91 -6.93 19.89 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.275 2.65 . . . . 0.0 113.735 -166.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -60.24 -42.13 94.61 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 119.407 1.003 . . . . 0.0 113.425 -169.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 93.09 -50.33 2.48 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-O 118.892 -0.949 . . . . 0.0 111.026 -178.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.5 75.61 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.079 1.751 . . . . 0.0 112.265 173.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -109.37 167.7 9.93 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 120.52 -1.362 . . . . 0.0 109.613 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -60.17 164.03 4.44 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 118.786 -0.626 . . . . 0.0 111.276 -169.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.545 0.752 0 CA-C-O 121.614 0.721 . . . . 0.0 112.317 -175.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.261 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -134.39 148.02 50.59 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 13.0 pt -130.83 179.42 4.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 167.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -137.83 133.16 33.62 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.8 m -73.79 134.64 29.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 173.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -73.54 -3.22 26.39 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.77 -0.581 . . . . 0.0 111.701 163.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 136.42 -4.99 3.79 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.95 1.738 . . . . 0.0 112.515 174.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -83.47 -8.62 59.33 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -167.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.0 mp -140.85 58.64 1.55 Allowed 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -139.87 -73.68 0.36 Allowed 'General case' 0 C--N 1.342 0.281 0 CA-C-O 118.463 -0.779 . . . . 0.0 112.346 177.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -67.97 -60.59 2.38 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.911 1.232 . . . . 0.0 109.211 -168.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -177.38 33.33 0.08 OUTLIER Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.5 mp0 -66.25 155.03 88.96 Favored Pre-proline 0 N--CA 1.454 -0.231 0 O-C-N 120.657 -1.496 . . . . 0.0 109.733 -173.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.35 -10.0 19.77 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.649 2.233 . . . . 0.0 113.354 -172.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -99.52 -20.76 16.24 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 127.242 2.217 . . . . 0.0 110.956 -175.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -53.68 -41.67 67.14 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 120.955 1.707 . . . . 0.0 109.839 -171.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.7 -29.48 4.49 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.564 1.546 . . . . 0.0 114.145 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 20.3 m -59.8 -41.79 86.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 120.097 1.317 . . . . 0.0 111.593 178.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.3 ptp -78.0 -8.59 58.36 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 119.149 0.886 . . . . 0.0 111.76 -177.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 39.6 mt -87.41 5.09 40.48 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.283 1.433 . . . . 0.0 110.64 178.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -115.08 97.61 6.32 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 173.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 22.2 t-80 -60.09 -21.22 61.23 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.424 0.69 . . . . 0.0 112.538 -176.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.5 m -69.44 -23.7 63.72 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.385 1.474 . . . . 0.0 114.342 172.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 36.9 m170 -69.77 -31.71 69.81 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.146 -0.971 . . . . 0.0 108.765 165.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.76 179.53 25.66 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 125.839 1.685 . . . . 0.0 110.775 174.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -81.63 135.69 35.54 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.011 0.924 . . . . 0.0 110.096 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.1 100.68 3.68 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.38 1.472 . . . . 0.0 109.646 167.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -107.4 140.9 39.63 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 125.18 1.392 . . . . 0.0 108.798 -177.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -69.98 77.84 0.49 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.589 2.355 . . . . 0.0 109.986 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -87.37 62.38 7.15 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.39 -176.3 48.24 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-O 123.624 1.68 . . . . 0.0 113.984 170.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -118.0 160.29 21.72 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.781 1.232 . . . . 0.0 109.711 -170.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -169.71 177.58 43.12 Favored Glycine 0 C--N 1.34 0.805 0 N-CA-C 116.383 1.313 . . . . 0.0 116.383 177.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 10.6 p -133.4 158.48 42.92 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.44 1.096 . . . . 0.0 108.206 170.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.0 p -78.91 117.28 19.85 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 166.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.3 t -74.24 -41.33 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 175.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -64.89 107.34 1.44 Allowed 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 170.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.0 m -59.63 135.92 57.83 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 106.951 -1.499 . . . . 0.0 106.951 170.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -130.57 153.16 81.39 Favored Pre-proline 0 C--O 1.237 0.422 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -74.29 91.57 0.95 Allowed 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 124.707 3.605 . . . . 0.0 109.675 173.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 tt -81.91 102.94 11.21 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 171.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 m -122.25 133.14 69.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 125.225 1.41 . . . . 0.0 107.451 -175.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 73.8 mt -99.05 100.14 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -176.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -118.01 171.88 7.79 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 122.378 1.085 . . . . 0.0 111.354 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.3 152.73 7.13 Favored Glycine 0 CA--C 1.523 0.534 0 CA-C-N 113.76 -1.564 . . . . 0.0 110.9 173.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.3 tp10 -72.16 -9.3 58.25 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -162.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 44.2 m170 -102.5 12.63 36.19 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.871 0.869 . . . . 0.0 112.076 175.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 55.45 69.73 0.7 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 127.392 2.277 . . . . 0.0 111.228 -178.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.5 mt -104.12 89.87 2.74 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 128.105 2.562 . . . . 0.0 108.072 -166.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -53.03 129.11 31.74 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 121.757 1.638 . . . . 0.0 111.567 177.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 66.3 m95 -126.62 145.56 50.51 Favored 'General case' 0 C--N 1.332 -0.192 0 O-C-N 121.093 -1.005 . . . . 0.0 109.122 176.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.8 mt -96.44 -5.31 39.96 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 117.569 2.433 . . . . 0.0 117.569 -174.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.7 mp 42.37 73.39 0.14 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 111.603 -2.544 . . . . 0.0 112.601 173.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -45.26 92.18 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.014 1.726 . . . . 0.0 114.57 -157.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.42 85.23 7.42 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 125.026 1.33 . . . . 0.0 107.643 -174.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -59.04 139.52 91.16 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 121.986 1.79 . . . . 0.0 108.564 176.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.02 -0.7 88.27 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.191 1.376 . . . . 0.0 114.48 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -97.43 144.02 27.58 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.624 1.712 . . . . 0.0 107.78 173.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.33 -143.7 30.91 Favored Glycine 0 C--N 1.337 0.608 0 CA-C-N 119.235 0.925 . . . . 0.0 111.63 177.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -130.99 176.75 7.98 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.313 1.445 . . . . 0.0 108.203 -169.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.2 p -63.0 167.13 5.05 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.512 0.672 . . . . 0.0 111.406 176.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.1 t -133.08 110.95 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 166.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 69.5 p -69.75 152.33 44.75 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.42 -158.37 12.37 Favored Glycine 0 CA--C 1.527 0.791 0 O-C-N 121.15 -0.969 . . . . 0.0 112.486 -177.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -140.98 151.8 44.44 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.621 1.568 . . . . 0.0 108.454 174.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 76.4 mt -95.55 138.49 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -127.34 126.16 42.04 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 172.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -69.87 136.13 50.33 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 161.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.62 164.54 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.95 177.43 4.85 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 122.804 1.288 . . . . 0.0 111.847 168.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -57.16 -42.36 80.94 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 112.916 -1.947 . . . . 0.0 111.751 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 40.1 tp60 -62.99 -44.91 94.72 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 118.473 -0.775 . . . . 0.0 109.989 179.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 24.8 tpp -62.79 -46.41 88.13 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 118.365 0.53 . . . . 0.0 110.109 176.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.1 tp -65.81 -40.59 92.03 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.647 -174.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 33.9 mtm105 -63.26 -40.16 96.63 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.631 1.173 . . . . 0.0 111.172 173.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -65.97 -50.62 63.7 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 117.984 0.356 . . . . 0.0 110.303 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.409 ' C ' ' HH ' ' A' ' 115' ' ' TYR . 1.7 mp -63.12 -25.87 68.56 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.122 -0.986 . . . . 0.0 111.01 176.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.423 ' HA ' ' SG ' ' A' ' 84' ' ' CYS . 14.8 t70 -73.44 1.3 10.06 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.971 1.309 . . . . 0.0 112.84 176.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -122.04 -47.81 2.14 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 128.352 2.661 . . . . 0.0 110.972 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -65.1 -39.16 92.74 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.445 1.098 . . . . 0.0 112.294 -176.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -77.81 8.56 4.4 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.18 -0.95 . . . . 0.0 111.197 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 58.68 15.44 3.72 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.376 1.871 . . . . 0.0 113.155 178.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.423 ' SG ' ' HA ' ' A' ' 79' ' ' ASP . 1.6 p -61.92 154.12 69.6 Favored Pre-proline 0 N--CA 1.448 -0.558 0 O-C-N 120.518 -1.363 . . . . 0.0 109.219 169.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.39 -4.57 22.09 Favored 'Cis proline' 0 CA--C 1.541 0.826 0 CA-C-N 119.563 0.88 . . . . 0.0 113.638 -2.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.7 -75.42 0.06 Allowed 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.062 1.345 . . . . 0.0 111.095 179.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 38.7 mtp -68.67 -69.09 0.35 Allowed 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -172.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -102.29 174.89 5.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.497 0.665 . . . . 0.0 109.443 179.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -137.89 136.25 36.91 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 165.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -75.03 139.21 42.71 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 175.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.4 m -141.66 154.36 45.31 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -176.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -91.46 137.84 32.05 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.881 0.873 . . . . 0.0 109.7 174.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.27 174.84 11.6 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.01 1.324 . . . . 0.0 112.297 -178.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 30.7 tp60 -100.06 117.15 33.72 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.149 1.78 . . . . 0.0 111.196 -178.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 97.1 t -117.81 124.12 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 125.19 1.396 . . . . 0.0 107.944 -172.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -68.43 141.37 55.69 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 119.582 1.083 . . . . 0.0 108.557 175.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 45.9 t -84.78 95.19 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 172.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.86 -30.06 70.13 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.769 -0.582 . . . . 0.0 109.712 167.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -164.75 153.74 12.85 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 60.2 t-105 -132.03 136.94 47.61 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 172.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -116.92 111.15 19.24 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 171.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 114.81 -172.34 14.18 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 124.518 1.056 . . . . 0.0 112.145 172.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -70.87 168.32 17.09 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 114.919 -0.641 . . . . 0.0 110.619 -178.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.05 69.19 1.42 Allowed Glycine 0 C--O 1.222 -0.635 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 168.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -101.1 87.96 0.97 Allowed Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 130.651 3.581 . . . . 0.0 109.399 -171.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -57.12 -38.1 96.46 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.692 2.928 . . . . 0.0 113.2 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 146.59 -160.95 28.33 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-N 119.436 1.016 . . . . 0.0 111.387 -170.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -64.07 -22.56 66.98 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.937 1.295 . . . . 0.0 111.728 175.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.9 t -139.86 164.19 30.64 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 120.467 -1.396 . . . . 0.0 109.233 175.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 10.9 p -141.06 153.06 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 C-N-CA 125.787 1.635 . . . . 0.0 108.959 -174.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -83.3 119.93 25.21 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 168.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 85.8 m -122.22 176.27 5.93 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.746 0.818 . . . . 0.0 109.23 171.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -106.5 144.09 33.68 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 168.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.2 t -137.45 146.83 27.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 127.137 2.175 . . . . 0.0 106.073 175.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.409 ' HH ' ' C ' ' A' ' 78' ' ' LEU . 44.8 m-85 -76.54 127.76 33.43 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 165.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 72.4 p -131.62 -164.54 1.46 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 126.008 1.723 . . . . 0.0 106.689 172.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.5 t -149.08 153.97 38.57 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 168.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -116.51 -31.92 5.4 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.672 1.589 . . . . 0.0 111.823 175.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 15.4 t -91.72 20.79 5.23 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.941 0.896 . . . . 0.0 111.795 -165.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -72.07 153.9 41.44 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 127.78 2.432 . . . . 0.0 113.155 -174.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.89 160.37 55.82 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 126.622 1.969 . . . . 0.0 112.173 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -68.88 -39.04 8.9 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.125 1.883 . . . . 0.0 112.531 178.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -45.46 -41.66 9.67 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 178.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 30.7 m0 -64.2 -18.17 64.25 Favored 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 125.513 1.525 . . . . 0.0 112.365 -173.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 28.0 mt -67.47 -17.28 64.63 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 117.808 -1.092 . . . . 0.0 111.672 173.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -102.52 -6.22 23.11 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.976 1.262 . . . . 0.0 112.511 -168.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -71.73 156.93 90.62 Favored Pre-proline 0 N--CA 1.448 -0.55 0 C-N-CA 125.651 1.58 . . . . 0.0 108.16 -175.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -61.38 140.31 87.31 Favored 'Trans proline' 0 N--CA 1.449 -1.088 0 C-N-CA 121.586 1.524 . . . . 0.0 108.953 173.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -81.28 158.08 24.9 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 172.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 60.0 m-70 -137.97 155.74 48.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.712 178.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -101.21 -9.04 21.64 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 122.766 1.27 . . . . 0.0 112.932 -175.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -161.23 150.7 16.73 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 126.908 2.083 . . . . 0.0 105.517 175.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -106.27 148.35 28.08 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 167.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.0 170.99 21.06 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.87 -0.1 27.43 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 159.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -133.3 68.36 1.5 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.514 1.926 . . . . 0.0 106.897 -172.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -130.66 -170.98 12.81 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 125.615 1.579 . . . . 0.0 112.725 -171.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -57.83 175.9 0.39 Allowed 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 120.805 1.003 . . . . 0.0 110.129 138.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 30.1 m-70 46.99 90.26 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 128.967 2.907 . . . . 0.0 112.221 -178.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.92 61.81 0.73 Allowed Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.414 1.007 . . . . 0.0 112.406 170.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.27 67.49 1.43 Allowed 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 127.477 2.311 . . . . 0.0 106.866 169.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 -116.37 162.31 17.73 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 120.816 -1.178 . . . . 0.0 110.629 -172.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -61.15 140.56 57.87 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 123.806 0.691 . . . . 0.0 111.723 -159.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 30.4 t30 . . . . . 0 N--CA 1.452 -0.334 0 C-N-CA 124.274 1.03 . . . . 0.0 109.129 -174.708 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.228 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.1 m80 -108.34 130.94 55.18 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 176.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.4 pt -128.32 167.42 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 124.644 1.178 . . . . 0.0 109.403 176.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -126.75 144.73 50.85 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.586 1.154 . . . . 0.0 110.894 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 m -103.61 123.61 57.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.972 1.309 . . . . 0.0 111.038 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -76.39 -48.1 20.99 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -174.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.26 -1.18 0.03 OUTLIER Glycine 0 CA--C 1.531 1.054 0 CA-C-O 117.575 -1.68 . . . . 0.0 116.486 -172.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.404 ' HA ' ' HG2' ' A' ' 14' ' ' GLN . 0.3 OUTLIER -118.75 -6.93 10.58 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 120.309 2.055 . . . . 0.0 114.834 -163.192 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.7 mp -145.59 47.02 1.28 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.342 1.457 . . . . 0.0 108.363 176.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.22 -78.07 0.46 Allowed 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 117.051 -1.452 . . . . 0.0 109.811 170.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.411 ' CB ' HE22 ' A' ' 14' ' ' GLN . 10.7 mtt180 -50.91 -45.5 60.33 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.051 0.94 . . . . 0.0 111.533 -168.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 148.57 68.94 0.01 OUTLIER Glycine 0 C--N 1.333 0.403 0 N-CA-C 106.944 -2.462 . . . . 0.0 106.944 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.411 HE22 ' CB ' ' A' ' 12' ' ' ARG . 25.1 mp0 -102.89 160.84 24.96 Favored Pre-proline 0 N--CA 1.449 -0.507 0 C-N-CA 124.505 1.122 . . . . 0.0 110.464 -178.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.36 -32.67 89.61 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.737 1.625 . . . . 0.0 110.996 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -70.57 -24.27 62.75 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 124.642 1.177 . . . . 0.0 111.618 -176.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -52.0 -35.06 45.47 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.224 1.01 . . . . 0.0 110.779 -167.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.71 -33.56 7.1 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 124.953 1.301 . . . . 0.0 114.264 176.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.3 m -59.61 -35.53 59.97 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 119.95 1.25 . . . . 0.0 111.439 -176.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.406 ' HE2' ' CE2' ' A' ' 68' ' ' TYR . 3.1 ptp -83.09 -12.47 57.05 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 118.979 0.809 . . . . 0.0 112.848 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.2 mt -80.07 -11.82 59.73 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.187 0.595 . . . . 0.0 110.194 177.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -100.17 99.68 10.41 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -177.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 46.3 t-80 -59.32 -19.59 47.74 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.664 1.586 . . . . 0.0 113.376 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.84 -37.35 79.01 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.419 -0.801 . . . . 0.0 111.551 167.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 16.8 m170 -73.98 -35.64 64.48 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 121.393 -0.817 . . . . 0.0 109.475 170.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.93 -175.71 24.4 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.993 1.283 . . . . 0.0 112.738 168.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.5 mt -68.79 149.32 49.13 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.038 0.935 . . . . 0.0 113.144 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -161.95 110.61 1.46 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.091 2.156 . . . . 0.0 108.507 168.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -130.11 146.61 51.77 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.016 0.926 . . . . 0.0 109.848 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -69.01 86.95 0.37 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.568 2.347 . . . . 0.0 109.472 -176.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.07 64.12 0.83 Allowed 'General case' 0 C--O 1.234 0.281 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -178.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.88 -179.12 48.65 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-O 122.053 0.807 . . . . 0.0 112.79 -178.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.4 ptt180 -134.14 172.2 13.18 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.55 -0.971 . . . . 0.0 110.407 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -164.08 -176.79 36.26 Favored Glycine 0 CA--C 1.499 -0.932 0 N-CA-C 115.89 1.116 . . . . 0.0 115.89 -173.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.7 p -145.21 159.56 42.82 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 113.725 -1.237 . . . . 0.0 112.512 166.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.3 p -78.13 101.97 7.28 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 120.086 1.312 . . . . 0.0 107.852 172.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -71.14 -31.05 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 120.576 -1.328 . . . . 0.0 111.894 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -69.99 118.06 12.35 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 152.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.3 m -57.84 146.96 29.92 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 167.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -135.49 153.16 77.56 Favored Pre-proline 0 N--CA 1.466 0.349 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 169.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -77.01 121.63 5.9 Favored 'Trans proline' 0 CA--C 1.533 0.457 1 C-N-CA 125.774 4.316 . . . . 0.0 113.043 177.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.405 ' HG ' ' CE2' ' A' ' 133' ' ' TYR . 35.6 tp -116.38 111.92 20.74 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 126.863 2.065 . . . . 0.0 108.858 -176.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.5 m -128.88 148.09 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 120.26 1.391 . . . . 0.0 111.937 -177.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 40.2 mt -86.93 128.07 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 169.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.59 173.47 11.47 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.54 0.686 . . . . 0.0 112.153 174.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.94 -174.72 55.27 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.544 2.021 . . . . 0.0 113.246 171.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -91.0 -3.45 57.25 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -170.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -118.94 12.63 12.89 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.405 1.082 . . . . 0.0 111.779 176.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 53.51 71.27 0.51 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.015 2.126 . . . . 0.0 110.495 -178.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 88.6 mt -103.9 90.58 3.02 Favored Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 131.265 3.826 . . . . 0.0 108.368 -169.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -60.83 125.08 16.31 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 122.379 2.053 . . . . 0.0 112.602 176.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -116.63 156.97 26.13 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.912 1.685 . . . . 0.0 109.882 176.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.9 tp -115.54 114.76 25.41 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.233 1.413 . . . . 0.0 108.441 167.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 26.0 mt -82.27 144.0 30.94 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 177.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -79.75 89.06 5.19 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 121.593 -0.692 . . . . 0.0 109.389 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.25 85.69 21.36 Favored Pre-proline 0 C--O 1.232 0.18 0 C-N-CA 123.534 0.734 . . . . 0.0 110.024 172.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -60.27 128.95 27.96 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.936 2.424 . . . . 0.0 109.598 -177.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.57 8.77 73.26 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 118.09 -1.395 . . . . 0.0 114.074 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.2 tptt -121.3 164.14 17.48 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 120.372 2.086 . . . . 0.0 107.216 172.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 74.51 -131.13 12.72 Favored Glycine 0 CA--C 1.519 0.288 0 O-C-N 120.613 -1.304 . . . . 0.0 109.945 -176.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -145.01 167.24 23.12 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.12 0.968 . . . . 0.0 111.033 -170.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 31.6 m -92.27 80.63 4.99 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 126.717 2.007 . . . . 0.0 112.448 -173.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.6 p -70.05 136.21 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.117 0 CA-C-O 118.113 -0.946 . . . . 0.0 113.196 -165.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.2 p -91.06 152.46 20.63 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.88 -175.51 32.99 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 178.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -106.25 158.2 17.03 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 125.736 1.615 . . . . 0.0 106.771 173.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 80.8 mt -113.63 110.07 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.406 ' CE2' ' HE2' ' A' ' 20' ' ' MET . 73.6 m-85 -93.17 123.48 36.48 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 118.528 -0.749 . . . . 0.0 109.663 -176.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -68.48 107.93 3.09 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 152.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.8 m -103.72 169.67 2.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 166.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -119.24 177.71 4.79 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 161.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -45.02 -46.43 11.31 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 127.977 2.511 . . . . 0.0 110.835 -170.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -57.64 -45.56 85.31 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.124 0.97 . . . . 0.0 111.367 -175.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.4 tpp -72.52 -45.9 57.18 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -176.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.43 -32.86 73.78 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.778 -178.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 78.0 mtt180 -69.23 -37.73 78.16 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.874 1.215 . . . . 0.0 111.505 176.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -60.19 -48.3 82.32 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 119.113 -0.47 . . . . 0.0 110.002 174.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.6 mp -57.57 -41.37 80.94 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.214 0.461 . . . . 0.0 109.922 176.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -65.9 4.66 0.6 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.054 1.742 . . . . 0.0 114.76 -178.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -129.9 -47.94 1.13 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.323 2.249 . . . . 0.0 109.852 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -63.11 -42.74 99.61 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 125.802 1.641 . . . . 0.0 111.518 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -78.03 11.31 2.32 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.871 0.868 . . . . 0.0 110.808 176.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.2 t0 54.43 16.81 1.38 Allowed 'General case' 0 C--O 1.236 0.387 0 C-N-CA 128.596 2.758 . . . . 0.0 114.625 171.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 6.8 p -62.47 155.76 66.05 Favored Pre-proline 0 N--CA 1.445 -0.721 0 O-C-N 121.227 -0.921 . . . . 0.0 110.035 -178.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -73.76 -4.23 16.71 Favored 'Cis proline' 0 CA--C 1.543 0.93 0 N-CA-C 115.223 1.201 . . . . 0.0 115.223 -2.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 9.5 m -63.96 -63.68 1.09 Allowed 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.072 1.349 . . . . 0.0 112.406 -173.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 27.3 mtp -74.35 -76.7 0.13 Allowed 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -100.01 -176.55 3.27 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 125.354 1.461 . . . . 0.0 109.329 178.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.93 151.55 30.46 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 120.761 -1.212 . . . . 0.0 109.795 158.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -63.93 125.85 25.74 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 118.491 -0.766 . . . . 0.0 109.954 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 43.5 m -132.4 174.79 9.88 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.009 1.724 . . . . 0.0 106.95 167.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -125.23 132.69 52.93 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.711 1.604 . . . . 0.0 109.615 172.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.83 177.29 5.81 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.731 1.612 . . . . 0.0 109.927 -179.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 34.2 tp60 -105.87 114.26 28.31 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.253 2.221 . . . . 0.0 109.685 -178.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 54.3 t -109.29 141.22 25.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 125.65 1.58 . . . . 0.0 107.633 -177.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -76.29 137.29 39.8 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 165.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.495 ' CG1' ' HA ' ' A' ' 108' ' ' ASP 0.254 3.7 p -98.07 83.81 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 179.017 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.66 -22.62 65.45 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 125.471 1.509 . . . . 0.0 111.935 -175.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -154.46 154.52 33.33 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 170.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 -132.69 124.98 29.23 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.247 1.419 . . . . 0.0 107.408 175.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -91.42 115.62 28.18 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.78 0.832 . . . . 0.0 109.15 177.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.88 -169.24 32.21 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 123.307 0.48 . . . . 0.0 112.129 169.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -68.74 171.96 7.06 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.329 1.451 . . . . 0.0 111.224 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 73.56 67.49 1.78 Allowed Glycine 0 C--O 1.226 -0.385 0 O-C-N 120.469 -1.394 . . . . 0.0 112.79 170.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -101.56 89.76 1.56 Allowed Pre-proline 0 C--O 1.238 0.48 0 C-N-CA 128.741 2.816 . . . . 0.0 110.157 -163.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -54.97 -22.52 30.9 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 124.447 3.432 . . . . 0.0 114.388 -172.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 102.8 157.16 25.44 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 -171.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.495 ' HA ' ' CG1' ' A' ' 97' ' ' VAL . 25.2 t70 -63.85 5.08 0.24 Allowed 'General case' 0 CA--C 1.508 -0.638 0 C-N-CA 129.588 3.155 . . . . 0.0 116.698 -163.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.2 p -134.19 152.15 51.68 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 116.566 -2.054 . . . . 0.0 113.004 146.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 34.8 m -136.94 152.06 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 124.644 1.178 . . . . 0.0 109.353 -173.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -89.33 130.19 35.75 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 168.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 12.0 p -129.5 -179.93 5.45 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 118.482 -0.77 . . . . 0.0 109.059 169.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -101.56 159.72 15.06 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.297 0.953 . . . . 0.0 111.103 164.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -163.03 118.02 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 128.911 2.884 . . . . 0.0 104.018 -158.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -83.19 86.18 7.08 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 172.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.1 p -94.45 -179.86 5.04 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.018 0.927 . . . . 0.0 108.659 172.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.1 t -133.33 140.81 47.62 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -103.6 -9.77 18.96 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.948 1.299 . . . . 0.0 111.242 166.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . 0.268 3.2 t -103.56 34.94 2.76 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 122.35 1.072 . . . . 0.0 111.052 -161.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -65.61 164.29 14.56 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.971 1.709 . . . . 0.0 113.173 -174.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -91.12 149.5 40.02 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 125.364 1.466 . . . . 0.0 108.795 167.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.51 -30.16 71.29 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.17 1.913 . . . . 0.0 113.089 -171.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.51 ' HA ' ' CD2' ' A' ' 126' ' ' PHE . 4.6 pm0 -58.1 -29.86 65.8 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.309 1.044 . . . . 0.0 113.06 177.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 46.2 m0 -71.73 -8.34 53.6 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 122.081 -0.387 . . . . 0.0 111.275 -173.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -89.9 -20.26 23.6 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 117.969 -1.015 . . . . 0.0 112.026 171.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.51 ' CD2' ' HA ' ' A' ' 123' ' ' GLU . 18.0 m-85 -68.88 -36.0 77.55 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 120.14 1.336 . . . . 0.0 110.157 174.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.4 mt -58.21 149.92 55.34 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 125.137 1.375 . . . . 0.0 110.439 -176.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.96 166.61 29.23 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.443 2.096 . . . . 0.0 110.237 173.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -118.75 160.14 22.41 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.868 0.867 . . . . 0.0 110.454 -175.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 59.5 m-70 -139.86 166.64 24.1 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.304 0.642 . . . . 0.0 110.895 -175.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -127.32 -4.92 6.06 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.203 1.401 . . . . 0.0 112.228 -170.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.0 p -138.7 -178.8 5.47 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 153.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.405 ' CE2' ' HG ' ' A' ' 42' ' ' LEU . 0.8 OUTLIER -126.58 174.83 8.39 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 122.514 1.149 . . . . 0.0 110.063 157.673 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.35 88.88 1.74 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 113.132 -1.849 . . . . 0.0 107.76 178.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.08 -22.64 65.94 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.045 -1.034 . . . . 0.0 110.216 167.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -105.17 73.01 1.02 Allowed 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 105.018 -2.215 . . . . 0.0 105.018 170.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -143.93 155.01 25.99 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 177.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -73.71 -6.56 18.86 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.009 2.473 . . . . 0.0 113.229 -167.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 51.9 m-70 -51.88 -33.82 38.32 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.596 1.158 . . . . 0.0 113.048 -170.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 98.47 -19.17 55.48 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.714 1.15 . . . . 0.0 113.53 168.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.476 ' HG ' HH21 ' A' ' 142' ' ' ARG . 0.2 OUTLIER -98.89 57.94 1.13 Allowed 'General case' 0 C--O 1.238 0.49 0 C-N-CA 126.865 2.066 . . . . 0.0 109.216 172.451 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.476 HH21 ' HG ' ' A' ' 141' ' ' LEU . 5.9 mmp_? -84.54 169.57 14.31 Favored 'General case' 0 C--O 1.237 0.408 0 O-C-N 120.386 -1.446 . . . . 0.0 109.941 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -61.83 150.79 36.2 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -173.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 . . . . . 0 CA--C 1.534 0.344 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 177.23 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.392 0 CA-C-O 121.553 0.692 . . . . 0.0 109.235 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -125.77 123.97 39.96 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 177.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.8 pt -130.41 173.57 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 122.776 1.274 . . . . 0.0 110.158 -178.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -112.08 155.32 24.04 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 125.744 1.618 . . . . 0.0 107.314 169.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.507 ' CG2' ' HB2' ' A' ' 10' ' ' LEU . 5.0 p -79.3 176.56 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-O 121.785 0.802 . . . . 0.0 109.698 175.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -125.92 174.46 8.38 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 173.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.421 ' HA2' ' CD1' ' A' ' 133' ' ' TYR . . . -60.62 -10.96 20.39 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 115.246 0.858 . . . . 0.0 115.246 -171.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.76 -23.69 36.48 Favored 'General case' 0 N--CA 1.435 -1.184 0 C-N-CA 125.498 1.519 . . . . 0.0 110.876 -175.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.507 ' HB2' ' CG2' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -125.58 -3.23 7.29 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 121.007 1.73 . . . . 0.0 111.915 -169.361 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -82.6 -7.25 59.65 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 -173.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -135.4 -85.96 0.38 Allowed 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 120.652 1.569 . . . . 0.0 107.082 176.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -160.44 15.21 0.19 Allowed Glycine 0 CA--C 1.529 0.922 0 CA-C-O 118.332 -1.26 . . . . 0.0 113.002 -168.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -57.83 164.57 3.08 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 119.709 1.755 . . . . 0.0 109.857 -175.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.12 -2.53 9.03 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 123.874 3.049 . . . . 0.0 113.415 -169.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -96.17 -14.46 22.76 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 127.897 2.479 . . . . 0.0 111.953 -177.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -48.71 -33.28 9.86 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 120.04 1.291 . . . . 0.0 110.609 -175.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.8 pttp -44.52 -32.47 1.42 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.049 1.739 . . . . 0.0 114.22 176.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.2 m -66.64 -11.67 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 123.633 0.773 . . . . 0.0 112.348 -177.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.2 ptp -121.56 14.74 11.08 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.279 1.432 . . . . 0.0 112.219 172.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 56.7 mt -115.05 2.99 14.33 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 124.72 1.208 . . . . 0.0 111.971 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -131.46 96.78 4.07 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 123.967 0.907 . . . . 0.0 108.56 -175.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 -55.7 -20.82 15.64 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.73 1.212 . . . . 0.0 112.31 -176.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 t -62.38 -25.79 68.12 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 120.13 1.332 . . . . 0.0 111.65 174.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -83.38 -1.99 54.72 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.401 -0.812 . . . . 0.0 111.794 174.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.93 177.0 19.25 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 124.874 1.226 . . . . 0.0 111.09 -175.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 35.0 tp -93.22 137.96 32.06 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.833 0.853 . . . . 0.0 111.335 -173.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.27 135.13 47.78 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 159.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.9 136.94 37.56 Favored 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 124.782 1.233 . . . . 0.0 109.323 -177.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -64.46 109.28 1.89 Allowed 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.679 0.792 . . . . 0.0 109.407 -179.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 -116.21 51.86 0.94 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 -175.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.15 -153.03 46.14 Favored Glycine 0 N--CA 1.442 -0.961 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -151.13 170.39 19.55 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.688 -0.89 . . . . 0.0 111.945 -171.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -174.18 178.75 45.91 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.029 -1.081 . . . . 0.0 115.478 -175.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 64.4 m -137.48 132.66 33.62 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 177.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.2 p -65.98 101.78 0.72 Allowed 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -69.83 -29.31 40.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 O-C-N 121.877 -0.514 . . . . 0.0 110.211 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -58.68 109.47 0.81 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 156.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.1 m -55.25 140.1 40.17 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 164.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -139.74 153.44 70.05 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 171.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.38 98.44 1.17 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 124.626 3.551 . . . . 0.0 110.077 173.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 54.1 tp -88.89 117.42 27.88 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 166.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.7 m -128.07 149.81 33.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.2 mt -114.23 98.15 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 -177.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.71 135.06 25.93 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.813 1.645 . . . . 0.0 108.797 -167.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.05 147.14 12.84 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 125.427 1.489 . . . . 0.0 110.739 -172.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -63.13 -26.8 68.99 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.807 1.643 . . . . 0.0 114.094 -164.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -90.13 3.85 52.15 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -174.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 51.75 61.87 3.0 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.064 1.345 . . . . 0.0 110.319 -167.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 52.1 mt -107.16 86.88 2.74 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 128.093 2.557 . . . . 0.0 104.149 172.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -62.22 152.92 73.3 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 121.281 1.32 . . . . 0.0 111.095 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -119.92 157.83 27.95 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.874 1.27 . . . . 0.0 109.702 -177.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.3 tp -122.43 94.2 4.22 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 175.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.6 mt -68.02 131.32 45.25 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -71.64 96.07 1.53 Allowed 'General case' 0 C--O 1.239 0.502 0 C-N-CA 119.825 -0.75 . . . . 0.0 109.476 -176.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.43 85.31 6.81 Favored Pre-proline 0 CA--C 1.535 0.37 0 C-N-CA 123.742 0.817 . . . . 0.0 112.366 175.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -62.89 122.38 10.64 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.073 2.515 . . . . 0.0 109.315 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.75 -4.0 56.2 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 125.713 1.625 . . . . 0.0 114.604 177.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -106.42 167.09 10.07 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 120.552 2.176 . . . . 0.0 109.145 168.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 61.53 -142.54 48.33 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 -170.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -142.04 179.55 6.82 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.583 1.153 . . . . 0.0 110.59 -171.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 77.6 m -77.15 114.51 16.03 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.516 1.126 . . . . 0.0 109.68 178.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.1 t -77.82 112.4 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 172.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.5 p -81.88 145.08 30.55 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.337 -0.852 . . . . 0.0 109.01 177.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -169.81 -172.03 35.95 Favored Glycine 0 C--N 1.342 0.889 0 O-C-N 121.018 -1.051 . . . . 0.0 112.466 -172.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -114.65 161.0 18.68 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 176.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 62.2 mt -111.02 135.46 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 124.709 1.203 . . . . 0.0 108.286 -175.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -124.94 125.06 43.33 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.691 0.796 . . . . 0.0 108.987 175.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -71.39 142.95 50.33 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 158.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.5 m -140.75 153.25 20.98 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -176.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -94.51 174.95 6.86 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 122.585 1.183 . . . . 0.0 111.378 172.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.39 -5.49 40.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 113.493 -1.685 . . . . 0.0 113.051 -175.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -85.62 -46.89 10.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 118.028 -0.986 . . . . 0.0 110.417 164.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 25.3 tpp -63.75 -50.03 70.68 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.772 1.169 . . . . 0.0 111.168 -177.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.06 -17.28 64.82 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 122.237 -0.289 . . . . 0.0 111.071 -175.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 23.6 mtt180 -86.8 -42.94 12.89 Favored 'General case' 0 C--O 1.222 -0.374 0 C-N-CA 127.63 2.372 . . . . 0.0 110.901 172.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -60.57 -44.87 95.7 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.951 1.251 . . . . 0.0 109.562 177.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.5 mp -58.41 -30.73 67.08 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.54 -0.725 . . . . 0.0 110.855 171.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.47 ' HA ' ' SG ' ' A' ' 84' ' ' CYS . 1.1 t70 -70.98 3.71 3.16 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.177 1.391 . . . . 0.0 113.44 176.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -126.97 -43.15 1.69 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 127.129 2.172 . . . . 0.0 109.699 176.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -65.9 -37.98 87.52 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.539 1.536 . . . . 0.0 112.378 177.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -91.01 6.52 44.5 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 123.227 0.611 . . . . 0.0 111.462 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.2 t0 52.06 30.24 7.28 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.776 1.23 . . . . 0.0 113.62 175.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.47 ' SG ' ' HA ' ' A' ' 79' ' ' ASP . 0.8 OUTLIER -74.24 159.63 83.35 Favored Pre-proline 0 CA--C 1.536 0.414 0 O-C-N 118.613 -2.554 . . . . 0.0 109.559 172.024 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -72.77 -4.45 14.16 Favored 'Cis proline' 0 CA--C 1.544 1.011 0 CA-C-N 120.477 1.206 . . . . 0.0 114.205 -6.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.0 m -54.62 -72.33 0.07 Allowed 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.24 1.016 . . . . 0.0 111.625 177.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 8.6 mtm -74.74 -64.61 1.0 Allowed 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -173.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -101.99 172.16 7.08 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.753 0.821 . . . . 0.0 108.983 178.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -135.23 -14.95 1.97 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 178.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 61.45 148.21 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 128.623 2.769 . . . . 0.0 114.635 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.4 m -154.17 170.82 20.3 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -174.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -87.4 159.41 18.72 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.042 1.337 . . . . 0.0 110.196 162.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.509 ' CD2' HG13 ' A' ' 95' ' ' VAL . 0.0 OUTLIER -150.15 -166.6 2.59 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.664 1.185 . . . . 0.0 111.012 176.085 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.77 123.36 32.73 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.022 0.929 . . . . 0.0 110.624 172.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.509 HG13 ' CD2' ' A' ' 93' ' ' LEU . 1.4 p -138.23 111.24 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -170.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -54.03 127.68 27.49 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 124.621 1.168 . . . . 0.0 110.091 -177.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 25.6 t -80.55 82.17 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 C-N-CA 127.503 2.321 . . . . 0.0 107.165 179.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.8 mp -63.1 -30.08 71.31 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.1 0.56 . . . . 0.0 110.227 175.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -154.08 160.48 41.98 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 126.164 1.786 . . . . 0.0 107.741 168.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 54.2 t-105 -144.1 124.56 13.94 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.592 1.557 . . . . 0.0 107.21 174.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -113.48 96.03 5.67 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.482 1.289 . . . . 0.0 114.482 177.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 118.76 -178.92 16.81 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 124.955 1.264 . . . . 0.0 110.868 -176.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -67.85 172.96 4.8 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.67 1.188 . . . . 0.0 110.564 177.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.63 41.18 3.44 Favored Glycine 0 C--O 1.219 -0.84 0 C-N-CA 124.367 0.984 . . . . 0.0 111.689 173.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -101.27 89.17 1.28 Allowed Pre-proline 0 C--N 1.321 -0.647 0 C-N-CA 130.624 3.57 . . . . 0.0 110.02 -155.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -73.81 -26.69 13.19 Favored 'Trans proline' 0 CA--C 1.538 0.708 1 C-N-CA 126.456 4.771 . . . . 0.0 114.807 -159.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 128.71 -164.23 21.92 Favored Glycine 0 CA--C 1.533 1.198 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -160.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -63.96 -23.83 67.49 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 117.932 0.866 . . . . 0.0 113.325 -169.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.75 169.34 17.89 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.878 1.271 . . . . 0.0 109.884 -174.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . 0.289 11.3 p -130.67 153.54 39.25 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 C-N-CA 117.63 -1.628 . . . . 0.0 108.699 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -96.13 77.78 3.11 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 173.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.403 ' SG ' HD22 ' A' ' 93' ' ' LEU . 1.6 p -82.36 -167.55 1.63 Allowed 'General case' 0 C--O 1.237 0.41 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.9 177.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -120.46 136.6 54.7 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.328 0.651 . . . . 0.0 109.272 162.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 95.5 t -124.48 153.42 31.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 169.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -84.23 105.0 14.74 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.051 -1.03 . . . . 0.0 109.354 176.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 70.6 p -86.18 175.98 8.21 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.672 1.189 . . . . 0.0 110.35 172.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.7 t -128.49 146.26 50.87 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 149.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -117.42 5.59 12.54 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.383 1.073 . . . . 0.0 111.381 176.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 11.4 t -126.28 47.04 2.33 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 122.805 1.288 . . . . 0.0 110.058 -176.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 14.8 p90 -78.83 156.2 28.83 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.142 0.977 . . . . 0.0 111.866 -178.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.05 157.26 85.45 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 125.153 1.381 . . . . 0.0 110.515 173.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -59.88 -48.36 12.8 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.063 2.509 . . . . 0.0 112.578 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -51.57 -32.38 28.24 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.674 1.19 . . . . 0.0 113.661 -178.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 44.2 m0 -71.14 -14.86 62.42 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.344 -0.847 . . . . 0.0 111.4 -173.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 78.7 mt -71.36 -20.0 62.22 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 118.061 -0.971 . . . . 0.0 111.842 170.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -95.91 -24.74 16.28 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.632 1.106 . . . . 0.0 110.889 -168.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 77.1 mt -60.25 156.93 36.68 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 126.103 1.761 . . . . 0.0 111.961 -173.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -66.74 151.21 82.98 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 121.916 1.744 . . . . 0.0 109.64 175.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -104.92 162.99 12.86 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.335 1.054 . . . . 0.0 111.542 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -137.67 144.48 41.85 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 123.529 0.731 . . . . 0.0 111.938 -173.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -94.64 -12.7 26.87 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.032 1.333 . . . . 0.0 112.181 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 51.9 p -159.23 172.7 17.55 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 120.61 -1.306 . . . . 0.0 109.743 173.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.421 ' CD1' ' HA2' ' A' ' 8' ' ' GLY . 0.1 OUTLIER -140.61 148.0 40.24 Favored 'General case' 0 N--CA 1.434 -1.245 0 C-N-CA 126.649 1.98 . . . . 0.0 107.227 -178.165 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -156.81 113.68 3.08 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 105.28 -2.118 . . . . 0.0 105.28 172.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.36 1.23 19.56 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.773 -0.579 . . . . 0.0 110.734 173.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -120.35 45.25 2.25 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.013 1.725 . . . . 0.0 106.782 164.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -109.66 155.8 15.91 Favored Glycine 0 CA--C 1.534 1.226 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 166.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -66.76 6.64 0.53 Allowed 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 125.289 3.993 . . . . 0.0 114.71 178.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 61.0 m-70 -58.58 -13.74 6.46 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 120.688 -1.258 . . . . 0.0 114.239 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 86.22 -46.62 3.63 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 124.871 1.224 . . . . 0.0 112.227 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.91 75.55 2.82 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.408 1.083 . . . . 0.0 112.188 179.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -95.92 157.92 15.68 Favored 'General case' 0 N--CA 1.463 0.178 0 O-C-N 121.403 -0.811 . . . . 0.0 110.707 175.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -59.28 156.73 11.99 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.947 1.299 . . . . 0.0 110.834 -176.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 C--O 1.238 0.47 0 C-N-CA 125.748 1.619 . . . . 0.0 107.751 177.575 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.136 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -63.22 138.33 58.51 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 124.698 1.199 . . . . 0.0 109.437 -174.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.3 pt -125.56 167.78 19.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 124.33 1.052 . . . . 0.0 109.221 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -132.69 136.52 46.47 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.474 0.71 . . . . 0.0 109.48 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.5 m -75.34 114.68 15.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 123.353 0.661 . . . . 0.0 109.933 -172.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -66.45 -3.9 7.15 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.044 0.938 . . . . 0.0 113.122 174.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 145.05 -1.04 1.02 Allowed Glycine 0 CA--C 1.528 0.891 0 CA-C-O 118.972 -0.904 . . . . 0.0 115.045 168.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 p -109.81 -16.59 13.85 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 120.198 1.999 . . . . 0.0 113.5 -160.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.68 30.61 6.62 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.874 1.27 . . . . 0.0 110.859 -171.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -132.4 -84.87 0.48 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 117.344 -1.313 . . . . 0.0 109.205 -176.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.4 mmt-85 -50.62 -78.71 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.61 1.564 . . . . 0.0 112.3 -173.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -171.72 10.92 0.04 OUTLIER Glycine 0 CA--C 1.52 0.404 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -162.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.13 150.66 91.83 Favored Pre-proline 0 CA--C 1.537 0.449 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 175.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -68.89 -12.36 34.24 Favored 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 123.694 2.929 . . . . 0.0 112.697 -169.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -85.18 -12.5 52.57 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 116.247 -1.835 . . . . 0.0 112.501 -174.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -49.66 -39.02 34.9 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 121.302 1.864 . . . . 0.0 110.098 -176.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -50.65 -24.79 3.57 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 115.343 1.609 . . . . 0.0 115.343 178.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.4 m -56.18 -45.63 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 120.835 1.652 . . . . 0.0 110.698 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.408 ' HA ' ' CE ' ' A' ' 74' ' ' MET . 2.3 mmm -73.02 -7.45 51.29 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -176.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.1 mt -101.43 11.4 39.21 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.653 1.181 . . . . 0.0 108.487 -175.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -127.15 103.28 7.35 Favored 'General case' 0 CA--C 1.513 -0.466 0 O-C-N 121.307 -0.871 . . . . 0.0 109.942 178.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -66.39 -18.86 65.6 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -175.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 m -66.41 -19.93 65.93 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.29 -0.881 . . . . 0.0 112.403 168.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 39.3 m170 -93.44 -17.49 23.41 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.938 0.895 . . . . 0.0 110.994 169.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 130.96 178.73 15.61 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 124.787 1.184 . . . . 0.0 112.114 169.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 37.5 tp -88.42 147.33 24.75 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.242 0.617 . . . . 0.0 111.352 -175.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.95 158.55 44.21 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.361 1.064 . . . . 0.0 109.243 161.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -143.64 136.46 27.44 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 126.826 2.051 . . . . 0.0 108.931 175.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -75.56 79.08 2.57 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.509 1.924 . . . . 0.0 110.0 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -95.5 63.27 2.48 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 121.14 -0.975 . . . . 0.0 109.935 174.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.17 175.0 27.65 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-O 122.598 1.11 . . . . 0.0 113.975 158.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 44.5 mtp85 -113.82 158.01 21.57 Favored 'General case' 0 CA--C 1.516 -0.34 0 O-C-N 121.586 -0.949 . . . . 0.0 108.686 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -171.42 177.54 44.24 Favored Glycine 0 CA--C 1.506 -0.493 0 CA-C-O 122.235 0.908 . . . . 0.0 112.895 -176.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.3 p -140.09 146.17 38.57 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.101 -1.049 . . . . 0.0 108.47 172.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.2 p -71.2 96.99 1.45 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 104.999 -2.222 . . . . 0.0 104.999 170.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -67.28 -36.45 76.74 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.47 111.55 1.02 Allowed 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 160.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -57.5 142.81 42.99 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 174.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -137.48 153.72 74.65 Favored Pre-proline 0 N--CA 1.45 -0.474 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 169.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -80.17 96.69 1.03 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 1 C-N-CA 125.704 4.269 . . . . 0.0 110.792 177.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 51.0 tp -92.4 114.38 26.92 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 169.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.5 m -126.57 149.38 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 177.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.9 mt -94.16 121.62 44.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 177.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.22 -179.73 6.03 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.554 0.741 . . . . 0.0 110.459 176.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.42 153.88 4.25 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 125.31 1.433 . . . . 0.0 111.849 172.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -67.24 -16.93 64.58 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 121.145 -1.209 . . . . 0.0 113.299 -171.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 24.9 m-70 -100.44 9.56 42.44 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.882 0.873 . . . . 0.0 112.998 -173.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 57.44 66.25 1.18 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.705 1.602 . . . . 0.0 108.716 -172.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 96.3 mt -112.23 87.02 8.52 Favored Pre-proline 0 C--N 1.331 -0.202 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.69 145.55 95.07 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 CA-C-N 121.021 1.4 . . . . 0.0 111.749 170.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 22.1 m95 -123.78 161.18 25.74 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.781 1.232 . . . . 0.0 108.641 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.8 tp -116.51 96.02 5.32 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 174.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.76 135.72 57.78 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 172.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -71.24 93.94 1.14 Allowed 'General case' 0 C--O 1.233 0.237 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.85 74.4 14.72 Favored Pre-proline 0 CA--C 1.537 0.444 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -59.88 120.71 8.67 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.233 1.956 . . . . 0.0 109.401 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.03 -1.84 40.99 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 126.953 2.216 . . . . 0.0 114.242 177.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -112.03 160.94 17.0 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 120.672 2.236 . . . . 0.0 108.016 174.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.09 -142.46 34.47 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 109.739 -1.345 . . . . 0.0 109.739 -173.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -140.95 178.14 7.57 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.421 1.088 . . . . 0.0 110.129 -171.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 68.9 m -76.41 109.71 10.35 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 118.887 0.767 . . . . 0.0 111.076 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.5 t -75.26 108.89 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 174.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 59.2 p -72.2 160.83 31.77 Favored 'General case' 0 C--O 1.24 0.56 0 O-C-N 121.321 -0.862 . . . . 0.0 109.291 174.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 174.46 -157.55 25.2 Favored Glycine 0 C--N 1.335 0.505 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 -176.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -134.99 156.47 48.98 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 125.21 1.404 . . . . 0.0 108.158 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.3 mt -103.99 128.25 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 -176.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -122.98 126.83 47.91 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 172.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -67.89 151.11 47.67 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 155.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.7 m -144.91 162.86 13.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 124.78 1.232 . . . . 0.0 107.862 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -105.54 171.3 7.4 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.995 0.902 . . . . 0.0 109.102 169.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.31 -32.29 68.34 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.393 1.477 . . . . 0.0 112.287 -163.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -69.91 -38.48 76.27 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-O 117.33 -1.319 . . . . 0.0 110.999 176.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.408 ' CE ' ' HA ' ' A' ' 20' ' ' MET . 43.6 tpp -65.69 -47.05 76.73 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 120.438 1.472 . . . . 0.0 109.18 178.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.05 -31.82 73.15 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.052 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -68.39 -45.02 73.82 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.503 1.047 . . . . 0.0 111.708 170.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -60.47 -50.36 73.87 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.682 0.793 . . . . 0.0 110.064 -176.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.6 mt -62.1 -36.3 81.3 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 122.806 0.442 . . . . 0.0 111.342 -175.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -51.54 -54.67 24.91 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.31 1.844 . . . . 0.0 108.757 172.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -68.88 -41.24 78.6 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.352 1.061 . . . . 0.0 112.296 -177.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -60.81 -53.57 55.77 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.271 1.428 . . . . 0.0 110.777 -168.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -74.79 -5.26 42.45 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.019 0.372 . . . . 0.0 111.594 -177.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.0 t0 75.02 25.31 1.38 Allowed 'General case' 0 C--O 1.233 0.2 0 C-N-CA 128.861 2.865 . . . . 0.0 113.782 -174.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -62.4 161.66 24.56 Favored Pre-proline 0 CA--C 1.547 0.858 0 O-C-N 119.837 -1.789 . . . . 0.0 108.44 165.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -72.21 -3.82 12.38 Favored 'Cis proline' 0 CA--C 1.548 1.224 0 CA-C-N 119.392 0.818 . . . . 0.0 113.004 -12.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.16 -59.6 5.2 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.479 1.912 . . . . 0.0 111.083 -175.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 27.5 mtp -82.83 -76.89 0.25 Allowed 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.859 1.263 . . . . 0.0 108.402 178.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -88.92 -177.4 5.47 Favored 'General case' 0 C--O 1.227 -0.122 0 C-N-CA 125.318 1.447 . . . . 0.0 110.319 -179.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 6.7 mp0 -138.21 176.61 8.55 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.605 2.362 . . . . 0.0 106.72 159.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -117.99 126.02 51.51 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.471 1.509 . . . . 0.0 108.382 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.7 m -126.09 150.91 47.86 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.212 0.605 . . . . 0.0 110.032 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.07 137.75 33.98 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.503 1.521 . . . . 0.0 109.533 166.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.443 HD13 ' CG2' ' A' ' 114' ' ' VAL . 0.0 OUTLIER -142.68 -164.64 1.87 Allowed 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 127.852 2.461 . . . . 0.0 108.187 -177.254 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -119.42 139.76 51.5 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 123.613 0.765 . . . . 0.0 110.561 173.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 10.8 t -127.46 149.43 32.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 173.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -87.41 137.23 32.51 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 126.706 2.002 . . . . 0.0 105.656 170.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.505 ' CG1' ' HA ' ' A' ' 108' ' ' ASP 0.324 1.7 p -94.74 92.2 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 176.084 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.68 -45.53 93.59 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 114.358 -1.292 . . . . 0.0 108.802 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -141.58 140.83 33.47 Favored 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 125.651 1.58 . . . . 0.0 107.296 177.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 50.5 t-105 -108.7 141.24 40.97 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 167.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -119.93 101.37 7.81 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 165.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 139.93 177.72 16.09 Favored Glycine 0 C--N 1.331 0.252 0 CA-C-O 122.826 1.237 . . . . 0.0 112.822 164.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -64.67 162.29 16.07 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 168.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 72.44 75.19 0.71 Allowed Glycine 0 CA--C 1.522 0.474 0 O-C-N 120.937 -1.102 . . . . 0.0 111.883 176.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -102.28 90.52 2.12 Favored Pre-proline 0 N--CA 1.471 0.587 0 C-N-CA 128.399 2.68 . . . . 0.0 108.176 -172.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -53.15 -29.67 46.91 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.479 2.119 . . . . 0.0 114.807 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 145.73 -120.29 1.32 Allowed Glycine 0 C--N 1.338 0.694 0 CA-C-N 121.106 1.775 . . . . 0.0 110.729 -175.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.505 ' HA ' ' CG1' ' A' ' 97' ' ' VAL . 0.9 OUTLIER -143.9 1.04 1.12 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.319 1.848 . . . . 0.0 110.812 179.338 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.2 p -131.93 158.17 42.1 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 122.184 0.992 . . . . 0.0 110.62 148.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.4 m -137.74 167.25 22.85 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 C-N-CA 125.67 1.588 . . . . 0.0 108.444 -177.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -95.58 118.96 33.24 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 163.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 80.1 m -109.41 167.64 9.97 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.465 1.029 . . . . 0.0 109.4 165.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -95.13 141.57 28.59 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 163.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.443 ' CG2' HD13 ' A' ' 93' ' ' LEU . 84.9 t -135.64 151.42 29.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 170.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -81.17 134.18 35.58 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 173.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 42.3 p -140.37 -177.7 5.15 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.096 1.359 . . . . 0.0 109.575 -172.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.63 141.4 35.1 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 167.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -103.6 -5.59 22.52 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.209 1.003 . . . . 0.0 110.614 167.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.6 p -107.78 17.75 22.17 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.435 1.894 . . . . 0.0 112.715 -156.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -77.8 162.09 27.17 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.562 1.545 . . . . 0.0 113.343 -167.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -81.45 158.19 69.23 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 126.938 2.095 . . . . 0.0 111.405 175.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -68.01 -33.22 26.39 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.68 2.253 . . . . 0.0 113.35 -174.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.9 pm0 -58.36 -31.74 67.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 118.806 0.73 . . . . 0.0 112.763 177.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 44.2 m0 -69.37 -14.72 63.07 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.318 0.508 . . . . 0.0 111.215 -176.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -78.4 -17.93 55.73 Favored 'General case' 0 CA--C 1.528 0.131 0 O-C-N 121.329 -0.857 . . . . 0.0 111.317 172.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -95.56 -22.7 17.46 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.798 0.727 . . . . 0.0 110.281 -172.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.2 mt -56.91 155.22 15.92 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 126.094 1.758 . . . . 0.0 111.036 178.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -67.64 144.4 66.01 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 121.339 1.359 . . . . 0.0 108.939 177.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -82.16 164.6 21.17 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 122.767 0.427 . . . . 0.0 109.923 172.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 51.8 m-70 -139.47 139.16 36.93 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.296 1.038 . . . . 0.0 109.13 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -82.45 -20.21 37.39 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.914 0.886 . . . . 0.0 112.921 -178.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.04 156.56 7.32 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 119.389 0.995 . . . . 0.0 110.052 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -114.28 127.79 56.04 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.572 1.149 . . . . 0.0 108.768 -175.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -140.18 131.38 26.52 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.434 1.494 . . . . 0.0 108.535 -174.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 7.6 t -69.93 -10.23 57.84 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.951 0.9 . . . . 0.0 110.154 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -131.15 64.22 1.58 Allowed 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 128.567 2.747 . . . . 0.0 104.673 177.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -124.28 171.51 16.53 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.866 1.698 . . . . 0.0 110.871 -176.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -61.96 -22.94 75.25 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.037 2.491 . . . . 0.0 112.877 -172.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -79.7 84.39 5.53 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 128.728 2.811 . . . . 0.0 109.251 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -44.89 -31.56 2.8 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 124.938 1.256 . . . . 0.0 113.683 177.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.5 90.25 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 127.097 2.159 . . . . 0.0 111.37 157.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -102.53 175.93 5.34 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 120.848 -1.158 . . . . 0.0 109.132 166.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -60.13 116.06 3.93 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -173.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 . . . . . 0 C--O 1.226 -0.159 0 C-N-CA 124.05 0.94 . . . . 0.0 109.331 -178.115 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.781 0 N-CA-C 102.514 -3.143 . . . . 0.0 102.514 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -69.91 123.28 21.11 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 -175.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.2 pt -108.18 174.19 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 121.229 -0.919 . . . . 0.0 108.707 176.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -109.57 165.54 11.59 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.429 0.692 . . . . 0.0 109.37 168.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.2 p -121.45 133.99 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -59.58 -52.15 66.8 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.49 0.662 . . . . 0.0 111.843 -177.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.11 -35.29 0.27 Allowed Glycine 0 CA--C 1.526 0.78 0 CA-C-O 123.708 1.727 . . . . 0.0 110.793 -167.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -55.44 -23.73 26.88 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 129.927 3.291 . . . . 0.0 114.202 178.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -134.92 32.32 3.23 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 119.897 1.226 . . . . 0.0 110.157 -179.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.17 8.58 5.15 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 115.559 1.688 . . . . 0.0 115.559 178.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.69 -86.42 0.14 Allowed 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 117.677 -1.154 . . . . 0.0 109.139 174.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -162.6 18.07 0.15 Allowed Glycine 0 C--N 1.337 0.61 0 CA-C-N 119.366 0.985 . . . . 0.0 113.744 177.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -44.88 156.36 0.36 Allowed Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 126.474 1.91 . . . . 0.0 111.82 173.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -64.87 -2.15 5.1 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 124.471 3.447 . . . . 0.0 115.25 -172.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -112.47 -10.52 13.72 Favored 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 125.115 1.366 . . . . 0.0 110.894 -165.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -56.73 -30.15 63.24 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.091 0.859 . . . . 0.0 111.487 -173.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.5 -27.84 27.71 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.1 m -69.14 -11.09 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 118.785 0.72 . . . . 0.0 112.499 -170.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.5 ptp -102.79 -0.58 31.23 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.168 1.787 . . . . 0.0 113.232 171.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.0 mt -102.77 4.41 37.9 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.735 1.614 . . . . 0.0 110.694 -178.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -117.39 77.88 1.17 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 -172.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -58.9 -15.28 11.94 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.094 1.758 . . . . 0.0 114.066 -165.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.3 m -61.02 -37.1 81.36 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 120.499 -1.375 . . . . 0.0 112.013 166.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 45.3 m170 -65.78 -29.25 69.72 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.599 0.636 . . . . 0.0 110.529 175.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.57 -178.4 22.49 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 124.171 0.891 . . . . 0.0 111.184 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 46.3 tp -95.9 144.55 26.14 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.976 0.91 . . . . 0.0 111.996 -173.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.71 147.38 46.73 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.617 1.167 . . . . 0.0 108.288 163.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -146.07 134.33 21.74 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 125.574 1.549 . . . . 0.0 109.655 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.93 93.27 0.4 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.482 1.113 . . . . 0.0 110.11 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.1 tpp180 -110.63 64.87 0.61 Allowed 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 126.05 1.74 . . . . 0.0 108.146 -176.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.52 179.08 43.81 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-O 122.848 1.249 . . . . 0.0 112.442 172.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 38.3 mtp180 -125.3 165.06 19.03 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 123.423 0.689 . . . . 0.0 110.776 173.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -173.59 176.13 46.21 Favored Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 120.39 -0.91 . . . . 0.0 113.564 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 71.6 m -138.85 133.54 32.13 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.371 1.068 . . . . 0.0 108.877 177.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.1 p -63.55 100.87 0.29 Allowed 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -73.12 -23.6 20.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-O 120.83 0.348 . . . . 0.0 110.833 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -60.41 100.74 0.11 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 152.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.5 m -56.6 137.41 53.85 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 167.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -138.58 156.62 73.08 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 -176.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -76.27 94.91 1.02 Allowed 'Trans proline' 0 CA--C 1.538 0.682 1 C-N-CA 126.032 4.488 . . . . 0.0 111.607 177.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 32.0 tp -93.21 114.33 26.78 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 121.134 -0.979 . . . . 0.0 109.96 174.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.4 m -131.66 143.73 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 119.198 0.908 . . . . 0.0 110.463 -173.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 55.6 mt -97.73 108.86 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -178.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -117.62 -179.68 3.8 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.52 0.728 . . . . 0.0 110.346 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.25 161.53 6.6 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 126.424 1.964 . . . . 0.0 115.382 163.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -65.76 -22.54 66.59 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 127.782 2.433 . . . . 0.0 114.303 -170.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 39.1 m-70 -109.85 13.47 23.54 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.813 0.845 . . . . 0.0 111.821 176.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.9 m120 60.38 64.49 1.2 Allowed 'General case' 0 C--N 1.344 0.365 0 CA-C-O 122.262 1.03 . . . . 0.0 108.251 -179.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 55.4 mt -104.72 87.43 1.8 Allowed Pre-proline 0 N--CA 1.45 -0.427 0 C-N-CA 127.874 2.47 . . . . 0.0 105.403 177.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.08 152.0 25.88 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 120.684 0.923 . . . . 0.0 112.825 166.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 22.4 m95 -130.24 166.64 19.9 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.056 1.342 . . . . 0.0 107.391 175.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -138.85 119.7 14.27 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.89 147.43 23.67 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 113.392 -1.731 . . . . 0.0 107.834 -169.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -78.66 87.19 4.59 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.977 -176.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.93 77.57 20.88 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 124.036 0.934 . . . . 0.0 111.103 179.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.68 115.68 4.33 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 124.885 3.723 . . . . 0.0 110.442 -176.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 117.23 11.81 8.67 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 124.751 1.167 . . . . 0.0 113.595 175.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.2 tpmt? -138.0 149.06 45.76 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 119.599 1.699 . . . . 0.0 108.808 -176.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.96 -135.32 14.87 Favored Glycine 0 CA--C 1.521 0.465 0 CA-C-N 120.601 1.546 . . . . 0.0 109.507 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -134.97 169.89 16.72 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 118.889 1.345 . . . . 0.0 111.787 -167.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 59.2 m -85.48 103.47 14.38 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 125.358 1.463 . . . . 0.0 108.543 -178.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.0 t -69.8 106.23 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 51.3 p -81.88 147.51 29.27 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.286 -0.884 . . . . 0.0 110.026 -173.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -173.46 -156.52 13.32 Favored Glycine 0 C--N 1.342 0.898 0 O-C-N 121.402 -0.811 . . . . 0.0 113.097 -172.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -134.73 162.62 31.85 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -176.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 89.5 mt -114.43 103.27 15.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 106.301 -1.741 . . . . 0.0 106.301 -170.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -86.07 114.08 22.65 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 172.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -61.5 131.9 51.66 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 152.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.9 m -135.52 156.24 38.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.42 177.64 5.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 122.209 1.004 . . . . 0.0 111.505 172.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.57 -36.01 75.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.057 -1.429 . . . . 0.0 111.342 177.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 32.1 tp60 -63.87 -44.46 93.01 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.292 0.951 . . . . 0.0 110.13 177.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 35.2 tpp -66.96 -50.46 62.22 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 118.629 0.649 . . . . 0.0 110.938 177.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.2 mt -64.14 -16.65 62.32 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 118.592 0.633 . . . . 0.0 111.34 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 45.4 mtt180 -82.15 -50.59 8.86 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 120.429 -1.42 . . . . 0.0 111.555 165.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -54.14 -48.21 71.07 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 120.338 1.426 . . . . 0.0 111.041 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.3 tp -64.47 -23.22 67.2 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 121.823 -0.548 . . . . 0.0 110.96 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.526 ' HA ' ' SG ' ' A' ' 84' ' ' CYS . 28.0 t70 -75.98 -5.9 48.48 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 120.858 -1.151 . . . . 0.0 112.503 176.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -105.92 -42.87 5.01 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.765 1.626 . . . . 0.0 110.604 172.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -65.68 -38.96 90.72 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.838 0.855 . . . . 0.0 112.139 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.454 ' HG3' ' CE2' ' A' ' 115' ' ' TYR . 7.5 mm-40 -83.34 10.57 8.33 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.164 0.585 . . . . 0.0 111.406 178.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.9 t70 61.3 0.32 0.42 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 128.522 2.729 . . . . 0.0 114.882 178.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.526 ' SG ' ' HA ' ' A' ' 79' ' ' ASP . 24.6 p -65.99 153.04 92.53 Favored Pre-proline 0 N--CA 1.448 -0.57 0 C-N-CA 124.167 0.987 . . . . 0.0 109.757 -167.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -75.41 -4.96 22.51 Favored 'Cis proline' 0 CA--C 1.54 0.797 0 N-CA-C 115.915 1.467 . . . . 0.0 115.915 9.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 m -54.68 -71.31 0.08 Allowed 'General case' 0 C--O 1.237 0.435 0 CA-C-N 119.601 1.092 . . . . 0.0 112.758 -178.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 46.2 mtp -71.86 -64.84 0.85 Allowed 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -173.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -105.7 167.0 10.06 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.31 1.444 . . . . 0.0 108.908 -178.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -127.72 -14.1 5.19 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -177.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? 61.91 145.78 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 128.3 2.64 . . . . 0.0 111.756 -172.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 38.3 m -148.69 178.12 8.92 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 119.797 -1.814 . . . . 0.0 107.261 171.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -116.59 142.09 47.33 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 127.181 2.193 . . . . 0.0 111.062 168.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.456 HD13 ' H ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -136.31 -174.17 3.61 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 129.204 3.001 . . . . 0.0 110.674 -170.798 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -115.75 126.36 53.95 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 126.145 1.778 . . . . 0.0 111.614 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . 0.321 1.4 p -142.29 115.16 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 121.063 3.727 . . . . 0.0 121.063 -167.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -60.92 118.22 6.43 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 113.986 -1.461 . . . . 0.0 107.184 -169.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.439 ' CG1' ' HA ' ' A' ' 108' ' ' ASP 0.331 1.6 p -85.69 87.51 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 O-C-N 124.544 1.153 . . . . 0.0 108.623 -178.284 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -57.95 -40.12 79.78 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 112.919 -1.946 . . . . 0.0 109.694 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -152.15 152.58 32.47 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 -177.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 -140.3 129.65 23.91 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -179.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -118.2 97.62 5.88 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.023 1.329 . . . . 0.0 114.094 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.98 -175.7 21.56 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -178.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -67.41 178.4 1.58 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.494 0.717 . . . . 0.0 111.203 -174.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.38 47.06 3.36 Favored Glycine 0 C--O 1.22 -0.754 0 O-C-N 120.858 -1.151 . . . . 0.0 110.809 169.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -101.63 88.47 1.2 Allowed Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 131.128 3.771 . . . . 0.0 112.228 -153.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -70.91 -32.38 13.89 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 124.295 3.33 . . . . 0.0 114.731 -175.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 143.17 -95.75 0.19 Allowed Glycine 0 C--N 1.339 0.717 0 CA-C-N 120.899 1.681 . . . . 0.0 112.783 -178.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.439 ' HA ' ' CG1' ' A' ' 97' ' ' VAL . 2.1 m-20 -156.44 6.25 0.18 Allowed 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 125.448 1.499 . . . . 0.0 111.066 -172.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -142.86 154.71 44.4 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 117.815 -1.554 . . . . 0.0 109.549 150.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.1 m -126.01 165.31 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.03 0 C-N-CA 117.09 -1.844 . . . . 0.0 109.624 -175.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -101.77 100.2 10.52 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 104.745 -2.317 . . . . 0.0 104.745 167.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 3.0 p -102.36 -166.75 1.32 Allowed 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 172.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -121.79 146.4 47.1 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.677 1.591 . . . . 0.0 108.714 166.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 20.2 t -139.4 137.85 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 129.778 3.231 . . . . 0.0 107.599 177.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.454 ' CE2' ' HG3' ' A' ' 82' ' ' GLU . 4.3 m-85 -79.92 80.33 6.34 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.898 1.279 . . . . 0.0 111.499 -175.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 51.6 p -80.41 175.71 10.42 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.96 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.0 t -136.12 129.79 32.35 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 105.153 -2.166 . . . . 0.0 105.153 162.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -89.67 -0.81 57.77 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.925 0.89 . . . . 0.0 110.709 172.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 10.1 t -116.25 31.75 6.53 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.674 1.989 . . . . 0.0 110.903 -178.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -56.85 163.48 1.92 Allowed 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.672 -0.642 . . . . 0.0 109.819 166.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -98.07 154.97 37.51 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 123.772 0.829 . . . . 0.0 110.572 172.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -64.29 -33.4 59.49 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.572 2.181 . . . . 0.0 111.235 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -67.07 -7.4 22.64 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.918 0.887 . . . . 0.0 112.675 177.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 44.1 m0 -96.88 -18.52 19.46 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 118.809 0.731 . . . . 0.0 111.34 170.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 18.8 mt -79.0 -16.97 56.18 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 120.094 1.315 . . . . 0.0 112.39 175.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -77.74 -25.03 48.92 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.563 0.745 . . . . 0.0 110.722 174.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 88.7 mt -59.79 151.57 62.67 Favored Pre-proline 0 C--N 1.344 0.35 0 C-N-CA 124.569 1.148 . . . . 0.0 110.678 -175.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -74.86 142.47 28.38 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.029 2.486 . . . . 0.0 109.15 179.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -86.78 167.25 14.58 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.893 0.854 . . . . 0.0 111.628 -175.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -136.5 171.2 14.83 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.429 1.492 . . . . 0.0 108.665 175.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 -127.99 -15.27 4.84 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 123.178 1.466 . . . . 0.0 111.572 -167.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 40.1 t -153.89 151.38 29.4 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 163.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -82.95 170.41 14.96 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 162.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 174.92 147.82 0.08 Allowed 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 128.168 2.587 . . . . 0.0 107.771 152.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.53 -31.7 72.89 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 173.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -77.07 66.79 2.95 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 127.911 2.485 . . . . 0.0 107.442 168.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -130.27 154.37 20.56 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 162.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -73.66 -13.78 24.63 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.597 2.198 . . . . 0.0 113.323 -165.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -75.21 -15.66 60.53 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.04 1.336 . . . . 0.0 113.878 -172.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 81.63 -62.0 4.56 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.111 -1.195 . . . . 0.0 110.111 -173.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.7 87.11 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.729 2.012 . . . . 0.0 114.053 -176.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.86 173.69 11.32 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 130.16 3.384 . . . . 0.0 109.256 172.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -64.11 130.61 44.63 Favored 'General case' 0 C--O 1.237 0.404 0 O-C-N 123.605 0.565 . . . . 0.0 110.482 -161.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 . . . . . 0 N--CA 1.453 -0.313 0 O-C-N 124.436 1.085 . . . . 0.0 110.56 -166.095 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.377 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -130.81 152.36 50.23 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 163.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.9 pt -138.59 172.14 14.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 121.849 0.833 . . . . 0.0 109.793 175.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -118.15 133.27 56.05 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.969 1.708 . . . . 0.0 107.882 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.1 m -91.25 138.06 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 118.982 0.81 . . . . 0.0 110.74 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -75.02 -36.03 61.94 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 127.61 2.364 . . . . 0.0 112.156 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 156.29 -37.86 0.59 Allowed Glycine 0 CA--C 1.522 0.505 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -168.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 p -62.13 -23.31 66.49 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.537 1.535 . . . . 0.0 112.993 -167.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.5 mp -134.13 62.51 1.65 Allowed 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 170.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -154.95 -49.2 0.09 Allowed 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.751 1.62 . . . . 0.0 110.647 -176.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -84.45 -86.4 0.12 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.869 0.759 . . . . 0.0 110.221 173.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -172.65 29.87 0.1 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -173.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.61 162.83 13.87 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 125.127 1.371 . . . . 0.0 110.166 -179.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -59.87 -17.48 44.02 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.849 2.366 . . . . 0.0 112.872 -177.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -85.09 -17.05 38.55 Favored 'General case' 0 C--O 1.215 -0.729 0 O-C-N 120.877 -1.139 . . . . 0.0 110.575 -175.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -58.5 -35.9 72.96 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 120.981 1.719 . . . . 0.0 112.272 -163.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.64 -16.74 51.26 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 177.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.7 m -64.08 -38.69 83.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 120.155 1.343 . . . . 0.0 110.54 -176.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.5 ptp -77.31 -10.48 59.46 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.1 mt -82.16 -14.43 55.67 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 122.869 0.468 . . . . 0.0 111.148 -173.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -106.31 100.21 9.76 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 -177.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 22.1 t-80 -56.28 -22.56 30.95 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.334 1.054 . . . . 0.0 113.513 -171.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.9 m -69.37 -20.86 63.83 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 120.482 -1.386 . . . . 0.0 113.539 174.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 30.7 m170 -76.6 -26.46 55.02 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.348 -0.845 . . . . 0.0 109.86 167.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 145.98 175.71 19.25 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 125.333 1.444 . . . . 0.0 111.222 167.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.8 tp -83.59 141.85 31.26 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 124.159 0.984 . . . . 0.0 111.852 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -145.09 92.76 2.3 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.231 1.812 . . . . 0.0 110.234 170.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -103.19 126.97 50.62 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 125.322 1.449 . . . . 0.0 110.072 -174.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -64.68 105.63 1.02 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.119 1.768 . . . . 0.0 110.44 -175.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -119.18 66.36 0.79 Allowed 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 125.755 1.622 . . . . 0.0 109.627 -178.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.65 -177.76 37.59 Favored Glycine 0 CA--C 1.523 0.539 0 CA-C-O 121.727 0.626 . . . . 0.0 112.134 172.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.419 ' CZ ' ' HB2' ' A' ' 99' ' ' GLU . 8.9 ptt180 -131.48 164.49 25.66 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.194 0.998 . . . . 0.0 108.666 178.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -170.75 -178.82 41.66 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 119.447 -1.358 . . . . 0.0 116.417 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 22.6 p -140.73 137.32 33.37 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.88 0.872 . . . . 0.0 110.595 173.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.9 p -68.32 100.78 1.1 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 176.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 m -68.78 -31.84 52.39 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-O 121.011 0.434 . . . . 0.0 111.031 -175.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.88 119.5 11.4 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 163.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.7 159.11 11.4 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 119.173 -1.011 . . . . 0.0 108.892 168.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -150.62 154.6 35.45 Favored Pre-proline 0 C--N 1.316 -0.87 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 176.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -80.93 88.72 1.36 Allowed 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 124.638 3.558 . . . . 0.0 112.435 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.4 tp -83.13 88.67 6.89 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 120.655 -1.278 . . . . 0.0 110.619 -177.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.5 t -92.59 150.82 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.181 0 C-N-CA 126.704 2.002 . . . . 0.0 109.829 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.8 mt -119.5 113.96 42.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 126.312 1.845 . . . . 0.0 107.409 176.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -137.66 158.09 45.11 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.642 0.734 . . . . 0.0 112.051 -172.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.34 169.12 37.09 Favored Glycine 0 CA--C 1.537 1.413 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.818 175.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.9 -28.48 70.08 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -168.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -96.08 2.18 53.07 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.988 0.18 . . . . 0.0 110.813 -161.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.1 m120 67.23 59.32 0.52 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.071 2.148 . . . . 0.0 108.52 176.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 61.7 mt -104.3 91.18 3.68 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 129.794 3.237 . . . . 0.0 108.745 -168.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -56.76 136.82 78.46 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 CA-C-N 120.708 1.288 . . . . 0.0 111.264 172.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -123.83 105.94 10.06 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 126.09 1.756 . . . . 0.0 108.566 -177.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.9 tp -76.76 81.53 3.37 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -175.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.1 mp -50.78 125.97 14.65 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 127.105 2.162 . . . . 0.0 110.027 174.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -73.97 85.01 1.76 Allowed 'General case' 0 C--O 1.239 0.548 0 CA-C-O 119.034 -0.508 . . . . 0.0 111.656 -173.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.44 HD11 ' HE2' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -136.66 80.21 38.43 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 118.672 0.669 . . . . 0.0 110.651 174.965 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -63.53 119.97 7.23 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.788 2.325 . . . . 0.0 111.549 -175.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.69 14.69 57.87 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 125.412 1.482 . . . . 0.0 113.262 178.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.44 ' HE2' HD11 ' A' ' 56' ' ' LEU . 0.9 OUTLIER -122.17 140.87 52.06 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 119.601 1.701 . . . . 0.0 109.172 163.965 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.23 -133.36 11.74 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 118.798 -1.001 . . . . 0.0 110.943 -171.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -141.76 169.6 17.3 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 118.871 1.336 . . . . 0.0 112.523 -157.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 27.3 m -103.33 103.79 13.84 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.621 1.168 . . . . 0.0 112.497 -166.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 14.1 t -70.05 116.25 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 123.825 0.85 . . . . 0.0 109.789 -177.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 67.6 p -80.41 146.9 31.23 Favored 'General case' 0 C--O 1.24 0.562 0 O-C-N 121.619 -0.676 . . . . 0.0 109.72 171.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -170.81 -168.22 32.25 Favored Glycine 0 N--CA 1.447 -0.574 0 O-C-N 121.386 -0.821 . . . . 0.0 111.957 -175.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -129.64 169.57 14.88 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 125.614 1.566 . . . . 0.0 108.548 -176.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.4 mt -122.89 130.57 74.39 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 O-C-N 121.298 -0.876 . . . . 0.0 108.82 -170.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -122.75 121.93 37.51 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 125.125 1.37 . . . . 0.0 107.67 171.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -64.47 135.4 56.02 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 158.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.7 m -135.69 139.01 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -173.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.48 -179.28 5.15 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.7 0.762 . . . . 0.0 110.012 176.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -63.13 -35.08 79.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 118.289 -0.862 . . . . 0.0 111.543 -173.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 44.1 tp60 -64.92 -42.55 94.61 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 118.869 0.758 . . . . 0.0 110.146 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.1 tpp -64.5 -52.37 58.19 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.8 tp -57.67 -44.19 85.57 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 118.688 -0.672 . . . . 0.0 110.822 -176.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.4 mtt180 -64.62 -34.36 78.1 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.674 0.79 . . . . 0.0 112.193 176.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -67.33 -47.5 70.3 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 118.561 0.618 . . . . 0.0 110.416 177.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.7 mt -60.05 -34.95 74.1 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 175.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.98 -6.54 12.99 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.046 1.738 . . . . 0.0 113.787 178.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -115.96 -24.5 8.08 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.501 1.921 . . . . 0.0 110.739 176.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -68.71 -41.02 79.66 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.584 1.154 . . . . 0.0 111.271 -174.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -105.75 14.58 28.05 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.984 0.914 . . . . 0.0 111.258 -170.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 58.13 25.62 12.69 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.21 1.004 . . . . 0.0 112.332 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -70.47 161.62 75.55 Favored Pre-proline 0 CA--C 1.546 0.827 0 O-C-N 119.73 -1.856 . . . . 0.0 109.739 168.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -70.87 -3.76 9.44 Favored 'Cis proline' 0 CA--C 1.545 1.06 0 CA-C-N 119.551 0.875 . . . . 0.0 113.734 -9.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 m -55.16 -60.77 2.93 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.152 1.781 . . . . 0.0 111.277 -176.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 19.2 mtm -81.83 -64.32 1.21 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 122.019 0.914 . . . . 0.0 110.49 -179.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -102.54 169.99 8.31 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 125.525 1.53 . . . . 0.0 109.381 -178.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.1 mp0 -135.34 143.33 46.06 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.975 1.31 . . . . 0.0 108.394 173.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -78.16 130.04 35.86 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 177.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.9 m -132.16 174.29 10.35 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 125.146 1.378 . . . . 0.0 109.052 -175.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -115.44 151.19 35.19 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.485 1.514 . . . . 0.0 111.153 166.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.415 HD11 ' SG ' ' A' ' 112' ' ' CYS . 0.0 OUTLIER -140.24 -160.98 1.13 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.457 1.503 . . . . 0.0 112.351 -178.09 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 38.5 tp60 -136.9 124.11 21.78 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.796 2.039 . . . . 0.0 110.121 174.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.4 p -139.21 116.19 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 116.9 2.185 . . . . 0.0 116.9 -168.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -54.54 122.45 10.58 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 124.939 1.296 . . . . 0.0 109.222 -174.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 93.1 t -76.57 88.64 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 128.654 2.782 . . . . 0.0 106.509 174.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 mp -75.78 -15.56 60.24 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.271 0.628 . . . . 0.0 111.578 177.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.419 ' HB2' ' CZ ' ' A' ' 33' ' ' ARG . 0.4 OUTLIER -160.32 161.33 33.24 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 128.051 2.541 . . . . 0.0 106.626 161.234 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 68.7 t-105 -143.49 102.24 3.91 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.584 1.554 . . . . 0.0 109.62 174.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -95.04 77.82 3.54 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.31 1.044 . . . . 0.0 109.987 -178.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 161.7 178.97 36.07 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-O 122.358 0.977 . . . . 0.0 111.651 174.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -70.21 168.4 15.85 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 168.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.65 65.65 1.65 Allowed Glycine 0 CA--C 1.524 0.594 0 O-C-N 121.377 -0.827 . . . . 0.0 111.646 172.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -101.3 90.11 1.58 Allowed Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 128.002 2.521 . . . . 0.0 109.017 -168.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -68.8 5.06 1.47 Allowed 'Trans proline' 0 CA--C 1.54 0.819 1 C-N-CA 126.361 4.707 . . . . 0.0 114.434 -165.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.05 -174.47 27.63 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 108.921 -1.671 . . . . 0.0 108.921 -168.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -65.56 -14.37 60.95 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 117.759 -1.115 . . . . 0.0 113.963 -168.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 75.6 p -138.82 169.17 18.28 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 121.136 1.789 . . . . 0.0 111.061 174.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.3 p -133.91 144.8 34.59 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.76 0 CA-C-N 121.616 2.007 . . . . 0.0 110.768 -173.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -92.04 84.77 5.35 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 171.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.415 ' SG ' HD11 ' A' ' 93' ' ' LEU . 1.6 p -89.43 -167.75 1.96 Allowed 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 175.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -109.86 151.66 26.75 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 122.736 1.255 . . . . 0.0 112.285 160.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -152.07 119.42 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 104.782 -2.303 . . . . 0.0 104.782 -163.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -67.4 129.5 40.09 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 121.828 -0.545 . . . . 0.0 109.966 167.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.2 p -127.56 -170.05 2.16 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 125.807 1.643 . . . . 0.0 107.059 176.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.2 t -144.14 147.39 33.64 Favored 'General case' 0 C--O 1.239 0.535 0 O-C-N 120.699 -1.251 . . . . 0.0 108.33 161.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -108.33 -10.14 15.38 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.0 1.32 . . . . 0.0 111.727 171.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 9.0 t -98.85 25.52 6.54 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.633 1.173 . . . . 0.0 111.909 -172.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -60.38 146.43 44.36 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.501 1.12 . . . . 0.0 111.329 176.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.66 155.27 89.56 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 124.873 1.269 . . . . 0.0 110.634 173.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.18 -33.6 18.41 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 121.398 1.399 . . . . 0.0 112.759 -178.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -58.52 -25.37 62.36 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.45 -0.781 . . . . 0.0 112.611 172.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 41.5 m0 -80.43 -4.88 55.4 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 120.969 -1.082 . . . . 0.0 112.686 -175.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -72.35 -34.09 67.77 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 119.498 1.044 . . . . 0.0 109.979 168.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -81.96 -21.89 36.95 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.996 0.918 . . . . 0.0 111.394 -177.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 15.9 mt -55.93 149.44 33.65 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 124.036 0.934 . . . . 0.0 110.151 177.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.49 156.76 64.5 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.117 1.878 . . . . 0.0 110.924 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -102.51 162.91 12.55 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 126.559 1.944 . . . . 0.0 107.455 173.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -132.49 177.91 7.24 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 173.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -128.0 -14.5 4.97 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.308 1.443 . . . . 0.0 112.422 -169.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.9 p -154.9 173.93 15.83 Favored 'General case' 0 C--O 1.239 0.542 0 O-C-N 120.652 -1.28 . . . . 0.0 109.854 163.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -120.83 136.18 54.98 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 123.795 0.838 . . . . 0.0 111.452 -177.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -163.19 128.61 3.14 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.325 1.05 . . . . 0.0 109.915 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 49.8 m -75.81 -0.32 20.7 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.257 1.423 . . . . 0.0 113.929 177.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -125.95 22.61 7.34 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.57 1.548 . . . . 0.0 109.287 173.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -79.59 164.73 49.23 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 121.604 -0.685 . . . . 0.0 111.509 177.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -60.66 -18.2 53.81 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.62 2.88 . . . . 0.0 112.865 -177.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -58.45 -17.19 18.9 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 127.427 2.291 . . . . 0.0 115.466 -174.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 79.96 -50.84 3.98 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 119.86 1.209 . . . . 0.0 113.462 174.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.04 110.93 9.75 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.491 1.516 . . . . 0.0 110.306 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.8 mmt85 -117.35 149.45 40.48 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 118.22 -0.895 . . . . 0.0 109.932 -176.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -62.61 135.36 57.35 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.687 1.131 . . . . 0.0 110.199 -176.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 . . . . . 0 CA--C 1.533 0.319 0 C-N-CA 123.821 0.848 . . . . 0.0 110.843 -176.045 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.359 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -75.47 152.03 37.96 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.8 pt -130.66 -177.25 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 175.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -128.98 167.56 17.28 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 124.441 1.097 . . . . 0.0 108.128 169.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.7 p -124.93 130.89 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 177.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -68.4 -36.68 79.47 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 125.072 1.349 . . . . 0.0 110.501 174.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 147.03 29.16 0.07 OUTLIER Glycine 0 C--N 1.339 0.706 0 CA-C-O 116.738 -2.146 . . . . 0.0 116.428 171.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.8 -27.26 13.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 120.195 1.998 . . . . 0.0 110.14 178.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.0 42.72 2.29 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.881 1.272 . . . . 0.0 108.266 -178.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -133.65 -86.53 0.42 Allowed 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.107 -0.996 . . . . 0.0 110.129 -178.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.506 ' HB2' HE22 ' A' ' 14' ' ' GLN . 0.0 OUTLIER -63.03 -63.56 1.17 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.954 0.797 . . . . 0.0 111.529 -163.911 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 171.73 36.7 0.03 OUTLIER Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -174.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.506 HE22 ' HB2' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -102.29 161.08 24.44 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 124.971 1.308 . . . . 0.0 109.052 -174.165 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -85.72 62.46 5.43 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.224 2.616 . . . . 0.0 110.968 -155.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -150.93 -29.87 0.19 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.888 1.675 . . . . 0.0 109.171 179.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -48.4 -34.37 10.74 Favored 'General case' 0 C--N 1.347 0.476 0 C-N-CA 125.481 1.513 . . . . 0.0 111.554 -172.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.56 -34.61 2.19 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 125.755 1.622 . . . . 0.0 115.266 174.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.8 m -62.61 -35.25 69.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 120.188 1.358 . . . . 0.0 110.797 -178.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.8 ptp -94.28 9.22 38.97 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.447 0.567 . . . . 0.0 111.906 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 68.3 mt -100.66 21.45 13.41 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.217 1.007 . . . . 0.0 108.648 169.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -138.37 99.76 3.93 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 173.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 -58.51 -16.93 17.53 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.473 1.109 . . . . 0.0 112.998 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.65 -22.13 62.54 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.332 1.453 . . . . 0.0 112.064 172.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -81.7 -7.02 59.55 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.858 0.754 . . . . 0.0 111.336 165.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.89 172.26 14.19 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 125.471 1.51 . . . . 0.0 112.212 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -77.99 135.83 37.87 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.888 1.275 . . . . 0.0 110.456 -176.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -141.7 108.78 5.47 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.422 1.089 . . . . 0.0 110.004 162.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -119.33 141.41 49.04 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.871 0.868 . . . . 0.0 109.309 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -64.75 110.78 2.51 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.887 1.275 . . . . 0.0 109.726 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.2 tpp180 -118.06 51.31 1.07 Allowed 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.337 1.455 . . . . 0.0 107.505 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.29 -166.76 44.39 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 122.7 1.167 . . . . 0.0 112.637 175.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 27.6 mtp85 -126.4 164.05 21.96 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.318 -1.107 . . . . 0.0 109.346 -164.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -168.81 175.81 43.2 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 118.845 -1.645 . . . . 0.0 115.692 176.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.4 p -141.7 158.7 43.5 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.886 1.675 . . . . 0.0 109.699 173.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.1 p -80.11 99.47 7.75 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 165.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -61.11 -37.79 78.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 O-C-N 121.254 -0.904 . . . . 0.0 110.741 172.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -60.92 106.49 0.59 Allowed 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 158.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -54.22 140.25 33.28 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 171.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -134.08 154.49 80.21 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 174.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -79.89 95.26 1.02 Allowed 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 123.861 3.041 . . . . 0.0 110.911 173.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.29 115.26 21.9 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 168.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.9 m -124.14 133.13 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.325 1.45 . . . . 0.0 108.929 -174.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.5 mt -104.85 89.16 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 -169.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -118.43 166.0 13.2 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 122.3 1.048 . . . . 0.0 112.146 -173.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.58 -172.93 34.86 Favored Glycine 0 CA--C 1.537 1.457 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 -176.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -95.38 -21.84 18.11 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 121.309 -1.112 . . . . 0.0 113.292 -175.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -100.18 8.48 43.81 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -173.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.4 m120 59.94 71.87 0.55 Allowed 'General case' 0 CA--C 1.523 -0.087 0 C-N-CA 127.619 2.368 . . . . 0.0 110.706 -178.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 88.5 mt -106.2 88.38 3.12 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 127.323 2.249 . . . . 0.0 107.069 -177.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -60.61 103.05 0.21 Allowed 'Trans proline' 0 CA--C 1.544 1.025 0 C-N-CA 123.703 2.935 . . . . 0.0 112.086 178.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -89.13 129.87 35.66 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.545 1.138 . . . . 0.0 109.094 -177.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.69 105.26 17.31 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 122.501 1.144 . . . . 0.0 109.567 176.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.449 ' HG ' ' CD1' ' A' ' 120' ' ' TYR . 11.0 mp -79.45 137.82 37.38 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 125.45 1.5 . . . . 0.0 110.066 -178.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -78.96 85.12 4.93 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 120.699 0.285 . . . . 0.0 110.567 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.35 85.38 15.41 Favored Pre-proline 0 CA--C 1.529 0.156 0 C-N-CA 123.877 0.871 . . . . 0.0 108.903 168.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -64.06 142.51 81.33 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 N-CA-C 109.085 -1.16 . . . . 0.0 109.085 177.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.65 14.38 82.48 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-O 119.352 -0.693 . . . . 0.0 113.547 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.3 tppt? -125.01 151.19 45.9 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 119.86 1.83 . . . . 0.0 107.308 168.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.93 -140.09 25.3 Favored Glycine 0 CA--C 1.521 0.463 0 CA-C-N 120.178 1.354 . . . . 0.0 109.999 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -139.59 167.14 22.78 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 118.348 1.074 . . . . 0.0 111.339 -161.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 85.8 m -78.69 98.95 6.41 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 122.848 0.459 . . . . 0.0 111.564 -175.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.1 t -61.64 104.42 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 124.535 1.134 . . . . 0.0 108.508 176.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.6 p -80.9 144.17 32.14 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 121.549 -0.719 . . . . 0.0 110.399 177.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.74 -152.55 6.94 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -167.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -144.97 163.99 32.49 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.878 1.271 . . . . 0.0 109.289 -176.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 84.7 mt -117.75 126.37 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 -176.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -115.07 131.49 56.91 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 175.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -64.06 123.55 19.33 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 103.874 -2.639 . . . . 0.0 103.874 150.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.1 m -122.59 161.52 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 169.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -104.82 172.32 6.85 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 173.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -59.11 -36.17 74.7 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.967 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -57.94 -43.21 86.22 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 119.392 0.996 . . . . 0.0 111.858 176.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.8 tpp -67.6 -49.1 64.75 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.0 tp -58.68 -40.49 83.73 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 119.903 -0.719 . . . . 0.0 111.57 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 35.5 mtt180 -60.01 -56.46 21.43 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 124.641 1.176 . . . . 0.0 109.124 177.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -57.6 -49.21 77.18 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.018 0.927 . . . . 0.0 111.063 -176.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.5 mt -61.33 -25.85 67.41 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 121.906 -0.497 . . . . 0.0 111.196 -177.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -69.39 -20.88 63.81 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.187 0.903 . . . . 0.0 110.986 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -83.92 -50.31 8.17 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.189 1.396 . . . . 0.0 110.254 167.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -58.95 -38.1 78.25 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.718 0.807 . . . . 0.0 111.777 -173.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -95.69 15.66 19.45 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -175.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 48.35 35.79 6.17 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 128.18 2.592 . . . . 0.0 112.109 172.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.402 ' SG ' ' HB2' ' A' ' 88' ' ' TYR . 65.8 m -73.81 162.25 74.96 Favored Pre-proline 0 CA--C 1.54 0.588 0 O-C-N 120.154 -1.591 . . . . 0.0 109.669 175.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -71.46 -4.65 11.3 Favored 'Cis proline' 0 CA--C 1.541 0.874 0 CA-C-N 119.65 0.911 . . . . 0.0 113.66 -9.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 25.7 m -56.0 -72.28 0.08 Allowed 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.264 1.026 . . . . 0.0 111.401 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 5.2 mtm -74.0 -48.48 29.95 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 119.01 -1.076 . . . . 0.0 108.37 -167.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.402 ' HB2' ' SG ' ' A' ' 84' ' ' CYS . 98.6 m-85 -122.1 163.66 19.09 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -122.85 115.5 22.09 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 172.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -63.06 130.36 44.32 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 171.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.6 m -132.45 161.75 32.91 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 126.307 1.843 . . . . 0.0 107.163 -175.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -107.6 126.38 52.49 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 174.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.429 ' CD1' ' HB ' ' A' ' 114' ' ' VAL . 1.8 pt? -142.7 -166.64 2.33 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.865 1.666 . . . . 0.0 109.817 -167.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 15.7 tp60 -125.31 138.57 54.08 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.191 0.996 . . . . 0.0 111.464 -177.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.9 t -136.11 140.19 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 177.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -77.68 132.27 38.11 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 170.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.52 ' CG1' ' HA ' ' A' ' 108' ' ' ASP . 2.6 p -84.55 105.34 13.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 112.932 -1.94 . . . . 0.0 106.872 170.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 mp -78.42 -22.95 46.96 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 113.698 -1.592 . . . . 0.0 110.646 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -161.47 139.17 9.06 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 104.209 -2.515 . . . . 0.0 104.209 -179.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 72.4 t-105 -121.36 129.4 53.04 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 174.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -103.62 121.83 43.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.424 0.69 . . . . 0.0 109.25 173.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 98.46 178.36 32.64 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 124.329 0.966 . . . . 0.0 111.107 170.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -87.94 150.55 23.4 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 122.109 0.957 . . . . 0.0 110.998 178.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 113.0 62.54 0.44 Allowed Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 125.715 1.626 . . . . 0.0 109.963 -177.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -102.11 88.72 1.38 Allowed Pre-proline 0 C--O 1.242 0.674 0 C-N-CA 130.659 3.584 . . . . 0.0 111.393 -159.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -66.29 2.42 1.88 Allowed 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 124.89 3.727 . . . . 0.0 116.202 -177.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.32 176.29 35.2 Favored Glycine 0 CA--C 1.525 0.69 0 O-C-N 120.379 -1.45 . . . . 0.0 109.628 -163.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.52 ' HA ' ' CG1' ' A' ' 97' ' ' VAL . 0.0 OUTLIER -74.48 3.97 6.75 Favored 'General case' 0 CA--C 1.503 -0.857 0 C-N-CA 128.238 2.615 . . . . 0.0 116.375 -156.976 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 56.8 m -143.08 152.54 41.97 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 122.362 2.346 . . . . 0.0 111.809 155.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.6 m -133.34 156.02 41.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 125.284 1.434 . . . . 0.0 109.113 -163.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -92.31 115.72 28.33 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 170.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -121.5 169.64 10.46 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 125.837 1.655 . . . . 0.0 108.487 174.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -90.75 143.16 27.01 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 158.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.429 ' HB ' ' CD1' ' A' ' 93' ' ' LEU . 22.3 t -137.7 139.12 43.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 128.036 2.534 . . . . 0.0 107.789 172.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -73.26 122.58 22.19 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 167.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 11.1 p -123.02 -172.68 2.55 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 173.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.3 t -135.96 146.05 46.84 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 155.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -105.17 -16.64 14.72 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.307 1.843 . . . . 0.0 110.761 171.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.5 t -122.34 71.75 1.03 Allowed 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -175.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.449 ' CD1' ' HG ' ' A' ' 54' ' ' LEU . 0.3 OUTLIER -88.42 -11.55 45.71 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 125.631 1.572 . . . . 0.0 112.366 179.698 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 68.33 158.62 0.15 Allowed Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 126.248 1.819 . . . . 0.0 110.984 -170.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -69.37 -27.26 28.52 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.307 1.338 . . . . 0.0 113.355 -170.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -55.8 -37.95 69.31 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -178.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.407 ' HA ' ' CD2' ' A' ' 127' ' ' LEU . 41.6 m0 -71.98 -10.61 60.02 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 124.646 1.178 . . . . 0.0 111.461 -176.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 38.3 mt -80.39 4.9 16.5 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 120.842 -1.161 . . . . 0.0 112.297 171.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -107.08 -1.66 21.83 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 120.3 1.409 . . . . 0.0 113.235 172.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.407 ' CD2' ' HA ' ' A' ' 124' ' ' TRP . 1.3 mm? -78.62 148.19 72.7 Favored Pre-proline 0 N--CA 1.446 -0.631 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -173.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -65.18 146.9 87.72 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 121.433 1.422 . . . . 0.0 108.989 169.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 19.6 m-30 -87.9 157.02 19.08 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.409 0.623 . . . . 0.0 109.681 173.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -127.52 165.99 18.82 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.247 1.019 . . . . 0.0 109.16 178.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -110.98 -19.46 12.77 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.708 1.203 . . . . 0.0 111.723 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 13.5 p -155.92 149.32 24.74 Favored 'General case' 0 C--O 1.238 0.477 0 O-C-N 121.263 -0.898 . . . . 0.0 109.514 170.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -97.67 133.47 42.16 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 171.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -140.89 156.24 46.14 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.801 2.04 . . . . 0.0 106.676 176.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.51 -22.71 40.65 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.422 1.489 . . . . 0.0 112.308 176.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -127.4 90.26 3.1 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 103.605 -2.739 . . . . 0.0 103.605 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -130.47 154.72 20.78 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-N 113.922 -1.49 . . . . 0.0 110.808 159.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -64.93 -22.92 62.42 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 123.373 2.715 . . . . 0.0 114.223 -161.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -63.04 -19.5 64.44 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.246 1.418 . . . . 0.0 113.374 178.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 77.67 -29.1 1.78 Allowed Glycine 0 CA--C 1.533 1.16 0 O-C-N 120.755 -1.216 . . . . 0.0 114.311 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.65 83.57 0.07 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.168 1.484 . . . . 0.0 112.193 176.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.95 153.71 50.63 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 128.147 2.579 . . . . 0.0 110.167 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -60.49 133.46 56.12 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 124.081 0.863 . . . . 0.0 110.012 -165.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 . . . . . 0 C--O 1.232 0.162 0 C-N-CA 123.455 0.702 . . . . 0.0 110.154 -171.725 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.46 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -111.19 137.55 48.75 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 162.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.2 pt -129.91 168.14 23.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 175.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -133.67 144.21 49.04 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -178.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.507 ' CG2' ' H ' ' A' ' 66' ' ' GLU . 3.8 m -100.52 169.84 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 124.092 0.957 . . . . 0.0 110.301 -176.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -120.01 -27.88 5.26 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.425 1.09 . . . . 0.0 112.289 172.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 171.72 -56.02 0.17 Allowed Glycine 0 C--N 1.339 0.733 0 C-N-CA 120.583 -0.818 . . . . 0.0 113.082 -161.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -45.28 -45.84 12.33 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 126.063 1.745 . . . . 0.0 111.605 178.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.3 mt -125.84 26.36 6.64 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.958 1.303 . . . . 0.0 108.643 -167.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -118.86 -33.32 4.25 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.309 -0.87 . . . . 0.0 113.302 -177.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.507 ' HG3' ' H ' ' A' ' 13' ' ' GLY . 8.9 ptm85 -123.86 -86.39 0.64 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 119.554 1.07 . . . . 0.0 111.176 -178.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.507 ' H ' ' HG3' ' A' ' 12' ' ' ARG . . . -164.63 55.38 0.27 Allowed Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 104.998 -3.241 . . . . 0.0 104.998 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.5 162.36 72.86 Favored Pre-proline 0 N--CA 1.447 -0.618 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 163.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -67.66 4.4 1.4 Allowed 'Trans proline' 0 CA--C 1.53 0.288 0 C-N-CA 123.767 2.978 . . . . 0.0 115.404 -173.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -118.68 -8.62 10.36 Favored 'General case' 0 C--O 1.214 -0.79 0 C-N-CA 125.661 1.584 . . . . 0.0 108.609 -166.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -58.29 -45.79 87.28 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 119.613 1.097 . . . . 0.0 111.213 -171.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.472 ' HA ' ' CD1' ' A' ' 21' ' ' LEU . 0.3 OUTLIER -52.37 -21.3 3.45 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.16 1.384 . . . . 0.0 113.785 178.697 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.7 m -62.27 -18.18 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 120.944 1.702 . . . . 0.0 112.443 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.0 ptp -97.4 -9.07 28.05 Favored 'General case' 0 C--N 1.348 0.508 0 CA-C-N 120.524 1.511 . . . . 0.0 110.948 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.472 ' CD1' ' HA ' ' A' ' 18' ' ' LYS . 8.4 mp -80.77 -31.1 35.97 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.902 1.681 . . . . 0.0 107.477 -174.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -70.36 97.2 1.22 Allowed 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 165.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 41.7 t-80 -61.35 -20.96 63.58 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.719 0.771 . . . . 0.0 111.322 171.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 m -51.29 -33.05 27.02 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.649 1.98 . . . . 0.0 112.193 166.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 45.1 m170 -93.58 10.95 30.49 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.028 1.331 . . . . 0.0 112.299 178.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.2 175.88 18.94 Favored Glycine 0 C--N 1.335 0.519 0 CA-C-O 122.313 0.952 . . . . 0.0 112.153 175.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -90.28 133.01 35.22 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.7 1.2 . . . . 0.0 109.68 -174.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -141.83 106.73 4.91 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.724 1.21 . . . . 0.0 110.907 169.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -116.87 125.6 51.75 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 125.519 1.527 . . . . 0.0 109.245 -169.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -68.24 112.11 4.95 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.694 1.198 . . . . 0.0 109.548 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -117.03 58.77 0.77 Allowed 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 123.899 0.88 . . . . 0.0 108.807 171.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.99 -165.74 53.65 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.905 168.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 36.7 mtp85 -116.73 167.49 11.05 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.623 0.769 . . . . 0.0 109.994 -156.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -164.34 -179.26 38.39 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 116.126 1.21 . . . . 0.0 116.126 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.1 p -152.88 157.84 41.29 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 118.19 -0.91 . . . . 0.0 111.573 172.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 31.1 p -77.02 101.18 5.92 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 119.891 1.223 . . . . 0.0 108.478 167.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -58.91 -52.51 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 119.796 1.18 . . . . 0.0 110.518 173.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -62.92 110.82 1.9 Allowed 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 166.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.6 m -59.33 132.49 54.16 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 178.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -126.75 155.06 75.76 Favored Pre-proline 0 N--CA 1.483 1.2 0 CA-C-N 119.178 0.899 . . . . 0.0 110.621 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -84.27 107.03 1.2 Allowed 'Trans proline' 0 CA--C 1.532 0.401 1 C-N-CA 125.519 4.146 . . . . 0.0 112.382 -170.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.7 tp -106.47 90.72 3.43 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.584 0.754 . . . . 0.0 109.657 -174.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.7 m -108.06 141.93 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.147 0.979 . . . . 0.0 110.206 -167.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.4 mt -103.69 78.51 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -174.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.424 ' HB2' ' CD1' ' A' ' 124' ' ' TRP . . . -110.69 153.67 24.92 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.42 -1.264 . . . . 0.0 110.21 -173.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.87 164.74 39.65 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-O 122.314 0.952 . . . . 0.0 111.537 -175.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -92.18 -7.99 46.77 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.504 1.522 . . . . 0.0 112.986 -166.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 62.5 m-70 -107.87 12.1 27.49 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.1 0.96 . . . . 0.0 111.745 174.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.7 m120 60.79 54.29 3.61 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.731 1.212 . . . . 0.0 110.075 165.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 75.3 mt -103.94 87.81 1.69 Allowed Pre-proline 0 N--CA 1.446 -0.632 0 N-CA-C 103.209 -2.886 . . . . 0.0 103.209 -174.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -62.45 124.2 13.81 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 CA-C-N 120.867 1.345 . . . . 0.0 109.419 -176.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -98.93 132.22 44.42 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -178.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.0 tp -97.66 96.2 8.11 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 169.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.87 150.23 38.02 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 121.042 -1.036 . . . . 0.0 108.389 171.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -80.27 89.58 5.51 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.355 -0.841 . . . . 0.0 108.966 177.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.71 86.58 11.93 Favored Pre-proline 0 N--CA 1.463 0.18 0 C-N-CA 124.597 1.159 . . . . 0.0 111.396 174.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -63.28 147.63 93.61 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 121.603 1.535 . . . . 0.0 109.341 178.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.49 0.76 59.28 Favored Glycine 0 CA--C 1.537 1.463 0 CA-C-O 118.666 -1.074 . . . . 0.0 114.65 176.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.02 112.45 12.38 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 120.833 2.316 . . . . 0.0 108.192 171.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 150.68 -149.78 21.67 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 119.767 -1.206 . . . . 0.0 112.538 -162.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -140.24 168.5 19.67 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 126.938 2.095 . . . . 0.0 109.28 173.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 97.3 m -89.58 78.53 7.02 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 123.596 0.759 . . . . 0.0 111.0 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.8 p -61.14 127.38 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.99 0 CA-C-O 118.513 -0.755 . . . . 0.0 109.863 -175.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.91 151.54 25.92 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 177.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -157.4 175.36 34.8 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 175.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.507 ' H ' ' CG2' ' A' ' 6' ' ' VAL . 0.7 OUTLIER -106.09 163.5 12.73 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 168.018 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 68.8 mt -102.42 121.11 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 105.353 -2.092 . . . . 0.0 105.353 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -108.12 119.61 39.96 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 171.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -69.04 127.68 34.0 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.349 -1.722 . . . . 0.0 106.349 161.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.7 m -135.63 163.83 34.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 123.428 0.691 . . . . 0.0 110.258 -174.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.0 179.97 4.12 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 122.276 1.036 . . . . 0.0 112.708 170.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.57 -41.63 90.64 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 125.48 1.512 . . . . 0.0 112.107 175.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -64.6 -43.34 94.1 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 119.9 1.227 . . . . 0.0 110.807 178.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 19.7 tpp -61.29 -49.4 77.19 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 119.167 0.894 . . . . 0.0 108.67 177.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.4 tp -61.66 -38.79 89.04 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 118.816 -0.611 . . . . 0.0 112.033 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 64.2 mtt-85 -70.81 -38.97 73.33 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.835 1.254 . . . . 0.0 111.804 177.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -63.18 -52.54 61.95 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 177.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.495 ' C ' ' HH ' ' A' ' 115' ' ' TYR . 1.1 mp -62.1 -31.53 71.99 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.693 0.797 . . . . 0.0 110.547 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -62.95 -33.02 74.48 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 124.403 1.081 . . . . 0.0 111.044 176.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -79.72 -45.74 18.36 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.071 0.396 . . . . 0.0 111.561 172.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -63.38 -42.88 98.85 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.569 0.747 . . . . 0.0 112.131 -170.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -79.96 9.09 5.78 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.559 -0.713 . . . . 0.0 111.951 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.2 t0 49.0 24.68 0.92 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 127.454 2.301 . . . . 0.0 113.346 -174.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 9.0 p -65.67 162.03 47.23 Favored Pre-proline 0 CA--C 1.54 0.564 0 O-C-N 119.684 -1.885 . . . . 0.0 107.061 165.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -69.06 -2.74 6.36 Favored 'Cis proline' 0 CA--C 1.547 1.165 0 N-CA-C 114.889 1.073 . . . . 0.0 114.889 -11.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.2 t -65.68 -67.41 0.44 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.884 1.22 . . . . 0.0 111.98 -178.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 20.6 mtp -71.51 -58.29 3.64 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 123.619 0.768 . . . . 0.0 109.52 -173.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -110.11 174.17 5.99 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 126.864 2.066 . . . . 0.0 108.345 177.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -128.66 -15.27 4.47 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 177.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 60.5 130.42 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 128.25 2.62 . . . . 0.0 112.651 -171.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 98.5 m -136.03 162.49 32.73 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.275 1.03 . . . . 0.0 108.237 175.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -94.6 128.16 41.04 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.93 1.292 . . . . 0.0 110.001 172.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.31 179.54 5.41 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.478 1.911 . . . . 0.0 111.432 178.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.8 tp60 -106.63 127.22 53.17 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.655 1.982 . . . . 0.0 109.98 178.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.418 ' CG2' ' SG ' ' A' ' 112' ' ' CYS . 64.3 t -126.27 140.65 48.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 -178.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -72.04 135.84 46.47 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 172.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.6 t -82.13 89.0 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 105.974 -1.861 . . . . 0.0 105.974 167.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.67 -23.68 67.33 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 118.603 -0.713 . . . . 0.0 110.658 177.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -165.53 162.49 19.2 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 128.038 2.535 . . . . 0.0 106.896 171.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 62.6 t-105 -135.2 130.17 34.88 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 125.83 1.652 . . . . 0.0 107.935 176.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -118.2 89.34 3.1 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 121.195 0.521 . . . . 0.0 111.36 176.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 137.33 -172.04 22.89 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-O 123.302 1.501 . . . . 0.0 111.495 173.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.28 125.27 23.02 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 122.35 1.071 . . . . 0.0 113.106 166.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 122.29 81.02 0.56 Allowed Glycine 0 N--CA 1.427 -1.962 0 CA-C-N 111.848 -2.433 . . . . 0.0 110.534 142.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -101.57 89.69 1.54 Allowed Pre-proline 0 C--O 1.24 0.587 0 C-N-CA 131.134 3.774 . . . . 0.0 109.773 -156.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -57.56 -54.52 3.32 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.742 2.294 . . . . 0.0 109.778 -178.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 163.97 -166.8 37.71 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 107.711 -2.156 . . . . 0.0 107.711 -173.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -64.88 -12.13 45.51 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 117.773 0.786 . . . . 0.0 111.969 175.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 61.2 p -133.12 156.39 47.53 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 120.087 1.312 . . . . 0.0 111.615 175.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.9 p -142.48 162.67 18.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 123.889 0.876 . . . . 0.0 109.202 178.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -95.39 135.27 37.23 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.69 1.596 . . . . 0.0 107.94 169.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.418 ' SG ' ' CG2' ' A' ' 95' ' ' VAL . 0.5 OUTLIER -141.27 168.7 19.14 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.797 1.239 . . . . 0.0 110.456 174.593 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -100.28 145.49 28.05 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 172.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 30.9 t -138.54 147.39 25.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 125.193 1.397 . . . . 0.0 107.294 177.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.495 ' HH ' ' C ' ' A' ' 78' ' ' LEU . 42.6 m-85 -70.3 109.14 4.53 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 167.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 68.8 p -125.92 172.43 9.92 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 124.111 0.964 . . . . 0.0 108.937 176.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.93 145.9 51.32 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 172.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -112.25 -12.23 13.63 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.137 1.775 . . . . 0.0 111.264 171.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 12.2 t -123.43 64.7 1.01 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.497 1.519 . . . . 0.0 107.968 -171.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -101.94 161.06 13.96 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 126.411 1.884 . . . . 0.0 110.523 177.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.49 157.86 87.26 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 125.818 1.647 . . . . 0.0 111.407 172.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -73.86 -33.39 6.34 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 121.97 1.78 . . . . 0.0 112.326 -179.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -46.51 -44.4 17.69 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 125.185 1.394 . . . . 0.0 112.588 175.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.424 ' CD1' ' HB2' ' A' ' 45' ' ' ALA . 35.6 m0 -60.48 -22.22 63.27 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 125.723 1.609 . . . . 0.0 112.5 -174.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 32.6 mt -75.22 -10.09 59.15 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 117.699 -1.143 . . . . 0.0 112.787 176.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -95.41 -7.88 37.13 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.437 1.095 . . . . 0.0 112.471 -178.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -72.9 158.74 86.75 Favored Pre-proline 0 N--CA 1.451 -0.413 0 C-N-CA 125.664 1.585 . . . . 0.0 107.864 -174.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -59.52 140.45 94.06 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.626 1.551 . . . . 0.0 108.805 168.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 5.7 m-30 -92.18 156.47 17.31 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.86 0.864 . . . . 0.0 108.8 171.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -141.08 171.95 13.36 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.516 0.726 . . . . 0.0 110.647 -174.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -136.62 1.14 2.55 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.314 1.445 . . . . 0.0 111.085 -172.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 86.0 p -152.86 171.68 17.92 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 124.907 1.283 . . . . 0.0 108.656 166.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -121.77 102.45 8.21 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 165.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -117.66 114.9 24.06 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.117 -171.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 11.2 t -60.48 -23.69 64.68 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 128.635 2.774 . . . . 0.0 111.654 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -120.57 85.35 2.38 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 127.417 2.287 . . . . 0.0 105.487 175.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -152.49 177.0 30.48 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.037 171.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.62 -15.43 24.42 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.024 1.816 . . . . 0.0 114.247 -174.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -44.96 -62.32 1.28 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.8 2.04 . . . . 0.0 111.339 -176.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 109.34 -59.09 0.37 Allowed Glycine 0 N--CA 1.464 0.555 0 C-N-CA 129.284 3.326 . . . . 0.0 110.302 171.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.478 HD11 ' H ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -49.95 73.67 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 130.616 3.567 . . . . 0.0 114.26 163.008 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -98.12 170.25 9.04 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.654 1.582 . . . . 0.0 111.942 172.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -71.31 150.32 45.25 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 123.182 0.301 . . . . 0.0 111.031 -165.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 . . . . . 0 C--O 1.233 0.195 0 C-N-CA 124.71 1.204 . . . . 0.0 108.822 178.079 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ttm . . . . . 0 N--CA 1.466 0.345 0 N-CA-C 110.448 -0.205 . . . . 0.0 110.448 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.6 171.18 14.73 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.834 0.853 . . . . 0.0 110.535 -169.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -119.67 131.25 55.39 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.166 1.387 . . . . 0.0 107.808 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.6 pt -123.36 177.48 4.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -131.89 130.17 41.28 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 174.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.9 p -96.7 135.73 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 176.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -72.79 -78.02 0.09 Allowed 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 164.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -139.75 -19.47 0.42 Allowed Glycine 0 C--N 1.335 0.489 0 O-C-N 121.767 -0.583 . . . . 0.0 114.144 -173.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.04 -16.42 59.28 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 120.505 2.152 . . . . 0.0 112.599 -154.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.12 14.16 7.84 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 126.378 1.871 . . . . 0.0 107.645 176.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -104.06 -86.91 0.44 Allowed 'General case' 0 C--N 1.351 0.671 0 CA-C-O 117.355 -1.307 . . . . 0.0 109.381 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 42.0 tpt85 -62.39 -59.89 4.34 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-N 120.752 1.614 . . . . 0.0 111.383 -160.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 172.31 69.04 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 106.265 -2.734 . . . . 0.0 106.265 -170.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -117.29 154.87 50.34 Favored Pre-proline 0 N--CA 1.448 -0.544 0 C-N-CA 124.802 1.241 . . . . 0.0 108.392 -175.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.73 -37.11 97.79 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.743 2.962 . . . . 0.0 111.429 -172.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -63.99 -25.18 68.01 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 126.229 1.811 . . . . 0.0 111.939 -172.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -52.17 -34.78 46.57 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.587 1.085 . . . . 0.0 111.423 -170.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.81 -25.92 21.67 Favored 'General case' 0 C--N 1.342 0.276 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -176.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.3 m -57.49 -48.94 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 118.57 0.623 . . . . 0.0 109.544 -176.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 9.0 ptp -79.13 7.25 7.82 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.393 0.677 . . . . 0.0 112.584 -174.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 76.6 mt -99.64 3.23 45.12 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.473 0.709 . . . . 0.0 111.019 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -131.97 109.26 9.92 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 104.388 -2.449 . . . . 0.0 104.388 174.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 23.3 t-80 -54.27 -24.35 18.54 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.063 1.345 . . . . 0.0 111.608 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 m -67.13 -21.86 65.82 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.979 -1.076 . . . . 0.0 112.954 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -85.07 -7.05 59.28 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 119.492 1.042 . . . . 0.0 111.579 167.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 129.19 167.5 12.15 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 126.037 1.779 . . . . 0.0 111.849 175.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -82.38 137.69 34.67 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.29 1.836 . . . . 0.0 109.174 -176.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -133.57 141.96 47.93 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.462 1.105 . . . . 0.0 108.708 162.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -141.29 140.7 33.9 Favored 'General case' 0 C--O 1.231 0.111 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 166.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -67.11 94.65 0.36 Allowed 'General case' 0 C--O 1.232 0.16 0 C-N-CA 125.921 1.689 . . . . 0.0 107.685 177.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -100.19 53.63 0.9 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -176.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.5 -169.15 46.93 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-O 122.677 1.154 . . . . 0.0 111.698 -177.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -143.44 173.0 12.01 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 121.557 -0.966 . . . . 0.0 110.221 -175.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -175.15 -179.92 46.01 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 119.487 -1.339 . . . . 0.0 115.337 -169.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.7 p -140.49 160.51 39.84 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 114.098 -1.051 . . . . 0.0 111.257 167.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.1 p -81.52 94.27 6.84 Favored 'General case' 0 C--O 1.223 -0.291 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 169.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -62.59 -26.43 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 O-C-N 120.657 -1.277 . . . . 0.0 110.893 171.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -65.93 116.99 7.66 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 161.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.03 120.07 18.15 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 126.241 1.816 . . . . 0.0 109.947 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -123.05 162.06 41.35 Favored Pre-proline 0 N--CA 1.466 0.359 0 CA-C-N 120.481 1.491 . . . . 0.0 107.842 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -79.6 94.32 1.05 Allowed 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 124.695 3.597 . . . . 0.0 109.245 172.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.8 tp -89.09 111.76 22.58 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 164.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.5 m -125.59 145.69 32.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.601 1.16 . . . . 0.0 108.347 -176.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 3.3 mt -98.85 121.96 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 176.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.73 -172.19 3.33 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.049 0.94 . . . . 0.0 110.763 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.68 155.67 2.27 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 125.45 1.5 . . . . 0.0 111.664 178.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -79.55 -6.17 56.45 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 121.538 -0.978 . . . . 0.0 111.802 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -106.92 9.33 30.81 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.431 1.093 . . . . 0.0 112.299 174.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.438 HD21 ' HB2' ' A' ' 141' ' ' LEU . 2.3 m120 63.73 61.19 1.0 Allowed 'General case' 0 C--N 1.345 0.401 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 176.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 56.5 mt -107.86 87.6 3.82 Favored Pre-proline 0 N--CA 1.446 -0.673 0 C-N-CA 128.358 2.663 . . . . 0.0 104.01 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . 43.5 Cg_endo -64.54 156.86 58.4 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 CA-C-N 120.832 1.333 . . . . 0.0 109.825 174.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 48.3 m95 -132.21 150.11 52.23 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.9 tp -107.39 102.02 11.34 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 168.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.7 mt -74.39 145.66 43.58 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -81.61 85.6 6.52 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.348 -0.845 . . . . 0.0 109.536 -177.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -137.12 86.49 20.14 Favored Pre-proline 0 C--O 1.234 0.25 0 CA-C-O 118.369 -0.824 . . . . 0.0 110.174 -177.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -60.07 133.98 53.47 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 121.084 1.189 . . . . 0.0 111.201 -177.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.57 17.27 77.85 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-O 118.904 -0.942 . . . . 0.0 114.713 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -118.15 121.52 40.72 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 120.376 2.088 . . . . 0.0 106.131 168.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.484 ' HA2' ' CD2' ' A' ' 129' ' ' TYR . . . 108.95 -139.81 15.37 Favored Glycine 0 CA--C 1.52 0.379 0 CA-C-N 120.208 1.367 . . . . 0.0 112.555 172.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 39.7 m-70 -126.86 171.47 11.24 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 124.044 0.938 . . . . 0.0 112.311 -175.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 57.9 m -88.2 105.49 17.56 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 126.647 1.979 . . . . 0.0 110.428 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 71.1 t -72.95 117.25 16.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 64.8 p -70.81 156.33 39.69 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.865 0.866 . . . . 0.0 109.363 167.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 171.24 -159.04 30.74 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 118.975 0.807 . . . . 0.0 112.312 -172.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -137.35 161.49 36.14 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.992 0.917 . . . . 0.0 110.834 -172.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 70.1 mt -120.54 111.83 33.71 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 -175.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -102.74 129.86 49.51 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 174.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -67.51 141.66 56.83 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 156.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.0 m -137.39 153.44 28.72 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 CA-C-O 121.787 0.803 . . . . 0.0 109.925 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -85.9 174.02 9.57 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 123.873 1.796 . . . . 0.0 109.541 164.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.05 -30.31 70.25 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 112.34 -2.209 . . . . 0.0 112.463 177.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -72.64 -41.98 64.9 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-O 116.681 -1.628 . . . . 0.0 111.242 176.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 19.9 tpp -64.16 -44.44 92.1 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 121.178 1.808 . . . . 0.0 108.513 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.6 tp -60.91 -30.35 70.14 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 177.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 47.1 mtt-85 -80.57 -36.83 32.37 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.873 1.269 . . . . 0.0 113.786 174.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -62.19 -47.66 83.48 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 177.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 85.3 mt -62.77 -24.38 67.68 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.787 -0.571 . . . . 0.0 110.812 175.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.447 ' HA ' ' SG ' ' A' ' 84' ' ' CYS . 4.4 t0 -78.19 10.55 2.9 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.794 1.237 . . . . 0.0 113.165 176.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -143.05 -30.95 0.51 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 125.439 1.496 . . . . 0.0 112.598 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -70.11 -31.92 69.7 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.1 0.96 . . . . 0.0 111.09 172.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -92.86 5.62 50.63 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.436 0.694 . . . . 0.0 112.147 -171.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.0 t70 54.17 15.91 1.04 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.722 2.009 . . . . 0.0 113.867 -175.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.447 ' SG ' ' HA ' ' A' ' 79' ' ' ASP . 2.9 p -62.85 150.03 88.45 Favored Pre-proline 0 N--CA 1.45 -0.474 0 O-C-N 120.181 -1.574 . . . . 0.0 108.252 167.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.94 -8.56 30.09 Favored 'Cis proline' 0 CA--C 1.54 0.813 0 N-CA-C 114.926 1.087 . . . . 0.0 114.926 2.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 12.9 m -60.98 -62.19 2.03 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.792 1.237 . . . . 0.0 110.91 -174.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.3 mtp -72.53 -78.17 0.09 Allowed 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -96.03 175.17 6.58 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.579 1.152 . . . . 0.0 110.253 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 6.7 mp0 -130.19 146.49 51.83 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.98 1.712 . . . . 0.0 107.105 164.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -81.63 133.85 35.42 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 175.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.2 m -140.04 168.85 18.85 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.212 1.005 . . . . 0.0 109.481 -174.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -106.45 138.88 41.83 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.141 1.776 . . . . 0.0 110.372 173.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.4 173.2 11.99 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.155 1.382 . . . . 0.0 113.064 175.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -94.95 126.26 40.17 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.041 1.337 . . . . 0.0 111.884 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.4 t -127.61 119.75 52.71 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 C-N-CA 125.688 1.595 . . . . 0.0 107.773 -175.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -63.13 128.85 37.77 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 105.62 -1.992 . . . . 0.0 105.62 169.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.628 ' CG1' ' HA ' ' A' ' 108' ' ' ASP . 4.9 p -75.55 116.67 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 CA-C-N 114.45 -1.25 . . . . 0.0 107.799 166.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -88.48 -21.56 24.12 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 120.467 -1.396 . . . . 0.0 110.38 170.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -158.27 146.4 18.56 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 170.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -127.93 116.1 19.58 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 125.518 1.527 . . . . 0.0 108.762 177.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -100.39 113.19 25.73 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.16 -167.21 14.84 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 125.453 1.502 . . . . 0.0 112.289 170.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -75.06 171.72 13.61 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.131 0.972 . . . . 0.0 109.201 177.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.11 62.76 2.16 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-O 118.5 -1.167 . . . . 0.0 111.409 176.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -100.38 89.91 1.28 Allowed Pre-proline 0 C--O 1.24 0.561 0 C-N-CA 131.242 3.817 . . . . 0.0 110.095 -163.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -62.92 -4.89 6.65 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 124.476 3.451 . . . . 0.0 115.543 -174.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.94 -177.69 44.81 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 108.846 -1.701 . . . . 0.0 108.846 -163.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.628 ' HA ' ' CG1' ' A' ' 97' ' ' VAL . 1.1 m-20 -72.5 5.12 3.21 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 -169.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.09 160.12 39.9 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 122.374 1.083 . . . . 0.0 110.213 154.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.8 p -128.3 163.87 31.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 126.811 2.044 . . . . 0.0 108.994 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -104.19 103.62 13.42 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.954 1.701 . . . . 0.0 106.545 169.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 60.8 m -97.61 166.95 11.26 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 122.714 0.405 . . . . 0.0 110.035 174.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -92.85 149.52 21.21 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 162.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.3 t -146.72 155.93 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 129.161 2.985 . . . . 0.0 107.067 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -89.71 128.17 36.05 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 166.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 81.9 p -130.09 -177.21 4.21 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.281 1.432 . . . . 0.0 109.291 -178.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -138.1 141.29 40.22 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 165.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -112.71 -4.45 14.06 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.226 1.411 . . . . 0.0 110.911 172.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.1 p -107.74 19.81 19.64 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.937 1.695 . . . . 0.0 111.006 -162.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -71.67 161.49 30.91 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.444 1.497 . . . . 0.0 112.105 -168.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -84.28 151.53 59.79 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 124.979 1.311 . . . . 0.0 109.995 167.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.01 -25.75 51.5 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 123.369 2.713 . . . . 0.0 113.52 -173.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.505 ' HA ' ' CD2' ' A' ' 126' ' ' PHE . 4.5 pm0 -52.69 -30.83 34.19 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.968 0.907 . . . . 0.0 112.382 177.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 45.3 m0 -76.88 -11.65 59.85 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 119.412 -0.327 . . . . 0.0 111.759 -176.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -85.64 -15.68 41.65 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 119.199 0.909 . . . . 0.0 111.713 171.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.505 ' CD2' ' HA ' ' A' ' 123' ' ' GLU . 4.8 m-85 -84.75 -10.28 57.39 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.364 0.984 . . . . 0.0 111.373 173.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 76.6 mt -72.15 158.36 87.73 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 124.844 1.257 . . . . 0.0 110.96 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -76.86 156.23 34.77 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 124.088 3.192 . . . . 0.0 111.887 176.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.484 ' CD2' ' HA2' ' A' ' 60' ' ' GLY . 21.3 m-85 -107.65 151.89 25.04 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.882 1.273 . . . . 0.0 111.95 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -136.29 167.54 21.12 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.766 1.226 . . . . 0.0 110.863 -175.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -113.64 -7.71 13.32 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.587 1.155 . . . . 0.0 112.631 -171.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 83.2 p -154.36 174.7 14.48 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 125.451 1.5 . . . . 0.0 108.381 168.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -137.97 109.18 6.84 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 174.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -140.11 123.27 16.8 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.617 1.167 . . . . 0.0 108.318 -168.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 9.6 t -59.38 -29.8 67.97 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.442 1.097 . . . . 0.0 110.059 176.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -62.74 -17.4 60.84 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.418 -0.801 . . . . 0.0 113.11 177.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -71.16 154.23 51.72 Favored Glycine 0 CA--C 1.537 1.445 0 CA-C-N 120.025 1.284 . . . . 0.0 112.434 -166.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -65.52 -5.99 12.69 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.811 2.341 . . . . 0.0 115.058 -177.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 -49.05 -49.58 40.61 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 120.651 1.569 . . . . 0.0 112.616 -175.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 87.45 1.68 83.35 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 118.258 -1.301 . . . . 0.0 113.689 -168.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.438 ' HB2' HD21 ' A' ' 49' ' ' ASN . 0.7 OUTLIER -103.56 96.37 6.68 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 118.905 1.352 . . . . 0.0 109.519 171.422 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -118.85 162.44 18.48 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.576 -0.702 . . . . 0.0 110.918 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -65.52 144.57 56.92 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -173.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -122.13 84.51 45.79 Favored Pre-proline 0 CA--C 1.53 0.192 0 C-N-CA 123.1 0.56 . . . . 0.0 110.12 175.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -91.0 -47.9 0.02 OUTLIER 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 124.063 3.175 . . . . 0.0 114.393 175.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . 0.288 17.3 ttt85 -134.36 3.16 3.33 Favored 'General case' 0 C--O 1.215 -0.714 0 O-C-N 120.201 -1.562 . . . . 0.0 113.827 168.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 44.5 -64.65 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 131.476 3.911 . . . . 0.0 117.384 175.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -53.79 -35.96 61.91 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 127.805 2.442 . . . . 0.0 111.461 161.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 . . . . . 0 C--O 1.252 1.211 0 C-N-CA 128.373 2.669 . . . . 0.0 111.529 179.212 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.6 ttp . . . . . 0 N--CA 1.468 0.461 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.86 166.39 26.86 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 165.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -128.13 129.31 46.35 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 174.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 41.2 pt -125.19 152.57 31.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -108.31 132.2 53.94 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 172.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.6 m -81.39 168.29 1.89 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.447 0 C-N-CA 123.69 0.796 . . . . 0.0 111.31 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -112.46 -29.87 7.35 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.043 0.937 . . . . 0.0 112.515 172.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 148.24 -1.9 0.67 Allowed Glycine 0 CA--C 1.526 0.741 0 CA-C-N 118.412 0.551 . . . . 0.0 113.869 168.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 p -53.62 -36.6 62.19 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 124.775 1.23 . . . . 0.0 111.2 160.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.0 mt -132.25 48.37 2.42 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.597 1.559 . . . . 0.0 109.179 -166.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -150.02 -59.19 0.2 Allowed 'General case' 0 N--CA 1.467 0.42 0 O-C-N 120.243 -1.535 . . . . 0.0 111.738 178.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 -73.03 -86.1 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 119.339 0.972 . . . . 0.0 108.714 174.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -175.23 50.11 0.13 Allowed Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 175.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.36 162.96 3.79 Favored Pre-proline 0 CA--C 1.544 0.745 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 169.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -64.4 -3.7 6.84 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 123.971 3.114 . . . . 0.0 113.255 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -120.3 10.67 11.33 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 126.827 2.051 . . . . 0.0 108.452 -167.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 39.0 p-80 -85.25 -38.82 18.47 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 121.254 1.843 . . . . 0.0 106.684 -168.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -17.35 55.49 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 120.517 -1.364 . . . . 0.0 114.183 -168.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.9 m -59.65 -34.66 55.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 118.445 0.566 . . . . 0.0 110.921 176.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -78.98 3.91 15.83 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.039 0.836 . . . . 0.0 113.113 177.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 35.4 mt -120.06 11.96 11.81 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.811 1.644 . . . . 0.0 110.816 -175.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -132.76 3.94 3.84 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 -171.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . 0.265 25.4 t-80 43.22 28.87 0.18 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 128.294 2.638 . . . . 0.0 113.679 176.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.4 m -117.71 -12.02 10.32 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 121.168 -0.957 . . . . 0.0 111.593 179.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -111.17 -1.43 16.17 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.206 1.802 . . . . 0.0 111.065 174.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 131.45 174.33 13.62 Favored Glycine 0 C--N 1.336 0.553 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 41.5 tp -82.23 139.8 34.04 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 123.169 0.588 . . . . 0.0 110.389 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -146.94 153.69 40.39 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 153.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.67 142.05 23.35 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 126.362 1.865 . . . . 0.0 108.286 169.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -59.99 118.83 6.74 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.212 1.405 . . . . 0.0 108.799 176.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.91 39.46 2.16 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.954 0.797 . . . . 0.0 110.321 -174.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 124.52 111.42 1.91 Allowed Glycine 0 N--CA 1.444 -0.79 0 CA-C-O 121.994 0.774 . . . . 0.0 111.328 166.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -61.06 149.62 36.44 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 121.592 -0.946 . . . . 0.0 108.469 173.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.47 175.33 37.22 Favored Glycine 0 C--O 1.238 0.385 0 C-N-CA 120.771 -0.728 . . . . 0.0 113.365 -169.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.8 p -136.59 147.18 46.83 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 43.4 p -64.48 120.05 11.57 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 158.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.7 t -68.0 -37.09 77.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.641 0.734 . . . . 0.0 109.08 177.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -78.21 140.2 38.93 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 168.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.5 m -60.44 151.05 29.2 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 160.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -134.57 153.84 79.28 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 165.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -76.38 92.08 1.09 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 124.212 3.275 . . . . 0.0 110.133 170.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 28.7 tp -90.63 109.03 20.2 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 118.816 -0.611 . . . . 0.0 109.757 174.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.5 m -123.55 135.75 62.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 124.395 1.078 . . . . 0.0 108.641 -171.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.2 mt -109.89 72.88 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 -172.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.83 179.33 7.06 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 122.613 1.197 . . . . 0.0 110.722 173.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.95 153.85 17.49 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-N 113.044 -1.889 . . . . 0.0 110.473 170.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -68.75 -11.62 60.51 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -166.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 37.5 m-70 -114.16 16.78 18.0 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.5 1.12 . . . . 0.0 112.053 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 50.49 74.02 0.24 Allowed 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.778 2.031 . . . . 0.0 109.369 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 87.6 mt -104.55 88.3 2.12 Favored Pre-proline 0 C--N 1.325 -0.493 0 C-N-CA 128.531 2.733 . . . . 0.0 104.991 -169.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -55.02 107.61 0.24 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.962 2.442 . . . . 0.0 111.148 -178.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -92.02 116.96 29.37 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 124.904 1.281 . . . . 0.0 107.6 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.15 92.15 8.66 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 172.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 11.0 mp -65.52 124.14 21.54 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.525 1.13 . . . . 0.0 108.762 176.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -74.04 84.95 1.79 Allowed 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.065 0.546 . . . . 0.0 110.266 -176.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.55 85.15 17.87 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 125.064 1.346 . . . . 0.0 108.373 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.92 126.68 17.8 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.842 2.361 . . . . 0.0 109.251 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.58 17.3 55.14 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 119.328 -0.707 . . . . 0.0 113.209 175.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -122.81 157.24 32.87 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 119.07 1.435 . . . . 0.0 107.189 172.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.468 ' HA2' ' CD2' ' A' ' 129' ' ' TYR . . . 70.49 -140.04 31.4 Favored Glycine 0 CA--C 1.522 0.511 0 CA-C-N 121.131 1.787 . . . . 0.0 111.603 175.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -131.17 160.24 35.37 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.327 1.064 . . . . 0.0 111.17 -170.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 76.4 m -83.64 106.61 15.5 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.695 -0.628 . . . . 0.0 110.93 -170.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.1 t -78.38 88.59 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 126.708 2.003 . . . . 0.0 111.996 -166.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.9 p -59.56 145.35 44.6 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 120.862 -1.149 . . . . 0.0 111.185 -172.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.03 -150.06 5.98 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-N 118.967 0.803 . . . . 0.0 112.596 -174.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -145.1 157.24 44.16 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.256 1.022 . . . . 0.0 109.058 -178.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 50.2 mt -107.66 91.79 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -80.74 127.16 32.18 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 177.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -74.07 130.45 39.84 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 163.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 23.7 m -144.24 176.3 2.69 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 C-N-CA 125.346 1.458 . . . . 0.0 109.898 -167.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.87 -175.95 3.22 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 122.671 1.224 . . . . 0.0 113.241 177.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -52.85 -52.02 58.8 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.07 1.748 . . . . 0.0 110.841 172.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -62.89 -39.47 94.58 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 117.948 -1.025 . . . . 0.0 110.282 -174.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 38.6 tpp -64.61 -43.64 93.1 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 119.454 1.025 . . . . 0.0 110.289 175.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 13.7 tp -65.03 -42.75 94.08 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.886 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 66.0 mtt180 -58.01 -41.78 83.82 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 124.526 1.13 . . . . 0.0 110.161 174.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -63.62 -52.8 59.3 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -176.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.2 mp -54.05 -39.35 66.14 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.206 0.602 . . . . 0.0 111.305 175.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.508 ' N ' ' HH ' ' A' ' 115' ' ' TYR . 1.3 t70 -57.05 -43.5 82.08 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.714 0.769 . . . . 0.0 110.77 178.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -86.33 -26.9 24.63 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.306 1.443 . . . . 0.0 113.044 -175.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -93.09 -40.15 10.67 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.558 1.143 . . . . 0.0 111.394 -170.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -82.74 7.26 15.47 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 118.348 0.522 . . . . 0.0 110.462 177.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 59.58 29.61 19.19 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.626 1.571 . . . . 0.0 111.962 175.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 1.8 p -73.25 168.22 27.17 Favored Pre-proline 0 CA--C 1.541 0.624 0 O-C-N 120.237 -1.539 . . . . 0.0 108.218 173.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.4 -4.43 7.77 Favored 'Cis proline' 0 CA--C 1.544 0.988 0 CA-C-N 120.21 1.111 . . . . 0.0 113.545 -13.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.5 m -60.84 -61.64 2.44 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 126.093 1.757 . . . . 0.0 111.313 -177.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 2.7 mtm -75.71 -85.18 0.05 OUTLIER 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -83.8 176.81 8.66 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.501 1.12 . . . . 0.0 109.064 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -137.08 136.88 38.74 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.907 1.683 . . . . 0.0 106.84 161.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -70.29 133.68 47.22 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 171.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.0 m -136.67 175.44 9.61 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.772 2.029 . . . . 0.0 108.523 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -118.37 137.33 53.19 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 127.921 2.488 . . . . 0.0 109.747 175.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.43 -179.29 6.2 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.019 1.728 . . . . 0.0 110.512 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -113.22 123.86 51.17 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.627 1.571 . . . . 0.0 110.548 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.411 ' CG2' ' SG ' ' A' ' 112' ' ' CYS . 54.1 t -118.54 145.85 23.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 C-N-CA 125.772 1.629 . . . . 0.0 107.335 -177.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -89.65 136.9 32.77 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 171.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 94.8 t -77.61 95.74 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 127.696 2.398 . . . . 0.0 106.15 168.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.6 mp -72.79 -31.26 64.73 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.586 -0.696 . . . . 0.0 109.483 172.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -148.56 164.3 34.64 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 106.298 -1.742 . . . . 0.0 106.298 167.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 75.5 t-105 -139.88 124.54 18.27 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.64 1.576 . . . . 0.0 108.006 175.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -79.02 113.34 17.06 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 171.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 86.69 -148.6 21.91 Favored Glycine 0 C--O 1.235 0.166 0 CA-C-O 121.696 0.609 . . . . 0.0 112.246 153.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -67.01 160.06 27.31 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 126.426 1.89 . . . . 0.0 111.715 -170.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 60.92 76.03 0.26 Allowed Glycine 0 C--O 1.221 -0.672 0 C-N-CA 124.449 1.023 . . . . 0.0 111.727 170.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -102.87 88.77 1.59 Allowed Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 128.734 2.813 . . . . 0.0 108.211 -168.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -56.08 -22.41 39.28 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 124.601 3.534 . . . . 0.0 114.939 -172.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 123.7 176.46 14.76 Favored Glycine 0 C--N 1.333 0.384 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -173.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -64.11 -17.59 63.58 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 118.515 -0.755 . . . . 0.0 112.518 -172.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 39.7 p -130.57 159.78 36.14 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 120.2 1.364 . . . . 0.0 111.971 168.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 28.4 m -141.95 169.56 13.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 125.443 1.497 . . . . 0.0 108.539 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -104.14 155.75 18.45 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 159.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.411 ' SG ' ' CG2' ' A' ' 95' ' ' VAL . 0.5 OUTLIER -155.04 162.05 41.16 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 129.142 2.977 . . . . 0.0 108.694 -178.37 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -87.24 153.36 21.55 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 169.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.9 t -143.17 150.77 17.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 127.914 2.485 . . . . 0.0 107.2 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.508 ' HH ' ' N ' ' A' ' 79' ' ' ASP . 4.3 m-85 -94.76 102.76 14.65 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 169.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 72.7 p -103.41 -167.88 1.44 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.009 1.324 . . . . 0.0 108.7 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.7 t -136.05 156.05 49.3 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 155.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -123.46 5.44 9.0 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.151 1.381 . . . . 0.0 110.776 171.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.2 t -132.32 53.55 2.0 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 122.93 1.348 . . . . 0.0 109.415 -173.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -67.39 153.63 43.24 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.009 1.323 . . . . 0.0 110.402 175.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.18 149.43 98.46 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 162.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.09 -35.8 40.56 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 121.451 1.434 . . . . 0.0 112.545 -170.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -57.86 -23.68 54.03 Favored 'General case' 0 C--O 1.225 -0.218 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 177.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.4 ' HA ' ' CD2' ' A' ' 127' ' ' LEU . 44.2 m0 -64.93 -16.26 63.09 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 119.863 1.21 . . . . 0.0 112.015 -178.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 53.7 mt -71.9 2.46 5.51 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.846 1.259 . . . . 0.0 112.418 171.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -113.13 -11.69 13.26 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.612 1.565 . . . . 0.0 113.75 178.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.4 ' CD2' ' HA ' ' A' ' 124' ' ' TRP . 1.1 mm? -67.81 146.67 98.47 Favored Pre-proline 0 C--N 1.326 -0.436 0 C-N-CA 126.102 1.761 . . . . 0.0 108.092 -177.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -64.32 149.34 90.35 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.223 1.282 . . . . 0.0 109.269 176.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.468 ' CD2' ' HA2' ' A' ' 60' ' ' GLY . 23.0 m-85 -89.28 152.19 21.69 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 175.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 62.6 m-70 -121.91 134.97 54.86 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -83.37 -15.78 48.53 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.924 0.89 . . . . 0.0 111.007 178.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.1 t -164.2 147.58 9.48 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 163.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -87.37 151.29 23.21 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.3 -0.864 . . . . 0.0 108.695 169.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 35.9 p-10 -153.39 162.25 41.48 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 126.826 2.05 . . . . 0.0 110.797 169.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 9.0 p -93.9 0.74 56.31 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 126.351 1.86 . . . . 0.0 112.791 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -143.04 23.09 1.89 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.954 1.302 . . . . 0.0 109.647 -164.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -94.83 177.74 35.82 Favored Glycine 0 C--O 1.242 0.65 0 C-N-CA 123.876 0.75 . . . . 0.0 113.944 -167.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -64.7 -24.95 61.68 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.689 2.259 . . . . 0.0 111.061 169.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 46.1 m-70 -73.8 80.99 1.6 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.322 1.449 . . . . 0.0 108.401 176.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -59.39 -17.78 40.82 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.639 1.59 . . . . 0.0 114.445 -178.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.91 72.75 0.1 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.213 1.805 . . . . 0.0 111.614 168.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 6.3 mtt85 -99.48 166.03 11.36 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 120.968 -1.083 . . . . 0.0 111.062 -174.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -58.9 142.1 51.67 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -175.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -122.41 84.45 47.35 Favored Pre-proline 0 N--CA 1.455 -0.186 0 O-C-N 123.605 0.565 . . . . 0.0 110.143 -175.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -76.52 -55.34 0.06 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.628 1.552 . . . . 0.0 112.161 176.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.42 14.97 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 117.191 -1.385 . . . . 0.0 112.616 -164.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.36 89.22 0.13 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.844 1.658 . . . . 0.0 109.835 -160.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 52.3 73.78 0.31 Allowed 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.39 1.476 . . . . 0.0 109.308 -159.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 . . . . . 0 C--O 1.248 1.018 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 173.893 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.779 0 CA-C-O 118.168 -0.92 . . . . 0.0 111.439 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.86 91.02 2.77 Favored 'General case' 0 C--O 1.22 -0.5 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 176.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.8 m80 -58.96 140.02 56.06 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 124.127 0.971 . . . . 0.0 108.767 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 39.2 pt -134.86 159.92 41.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 C-N-CA 124.694 1.198 . . . . 0.0 109.401 175.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -87.98 138.61 31.3 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 163.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.4 m -72.05 -177.28 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 156.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -133.1 -57.88 0.91 Allowed 'General case' 0 N--CA 1.447 -0.589 0 O-C-N 121.082 -1.011 . . . . 0.0 111.013 176.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -165.69 -41.99 0.02 OUTLIER Glycine 0 C--N 1.33 0.233 0 CA-C-N 118.629 0.649 . . . . 0.0 111.888 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 p -53.55 -29.31 36.28 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.995 1.318 . . . . 0.0 111.727 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.4 mp -133.19 76.78 1.7 Allowed 'General case' 0 C--O 1.221 -0.406 0 C-N-CA 124.502 1.121 . . . . 0.0 108.533 177.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -149.42 -80.01 0.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 O-C-N 120.895 -1.128 . . . . 0.0 108.878 172.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.413 HH21 ' CD ' ' A' ' 136' ' ' GLU . 25.2 ttt85 -67.43 -85.3 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 123.366 0.666 . . . . 0.0 110.429 -177.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -158.31 26.09 0.41 Allowed Glycine 0 C--N 1.336 0.554 0 CA-C-N 119.642 1.11 . . . . 0.0 113.058 -175.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -55.09 163.13 1.66 Allowed Pre-proline 0 N--CA 1.449 -0.521 0 C-N-CA 125.379 1.472 . . . . 0.0 111.411 175.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.15 -16.01 52.57 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.474 2.116 . . . . 0.0 112.842 -172.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -95.16 -17.87 21.41 Favored 'General case' 0 C--O 1.219 -0.512 0 C-N-CA 125.292 1.437 . . . . 0.0 111.245 -164.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -52.78 -40.79 63.5 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 120.088 1.313 . . . . 0.0 112.178 -165.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.96 -25.1 2.98 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -177.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.3 m -68.94 -29.6 43.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 O-C-N 121.296 -0.878 . . . . 0.0 110.748 -177.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.1 ptp -83.27 6.14 20.67 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 119.045 0.839 . . . . 0.0 112.454 174.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 49.7 mt -114.42 26.74 10.0 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.82 1.648 . . . . 0.0 109.365 -177.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -139.26 99.43 3.74 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.248 1.419 . . . . 0.0 108.598 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 25.4 t-80 -63.58 -22.02 66.67 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -162.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.5 m -70.99 -32.6 69.46 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.835 -0.541 . . . . 0.0 111.988 172.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 40.3 m170 -71.32 -37.74 71.73 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 171.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 158.85 173.72 27.62 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-O 121.955 0.753 . . . . 0.0 111.969 156.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 57.5 tp -70.26 141.34 52.45 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.288 0.635 . . . . 0.0 111.214 177.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -150.95 108.43 3.63 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.694 1.197 . . . . 0.0 108.558 160.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -112.41 135.26 53.33 Favored 'General case' 0 CA--C 1.522 -0.112 0 C-N-CA 124.616 1.167 . . . . 0.0 108.633 175.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -63.68 108.54 1.44 Allowed 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.264 1.026 . . . . 0.0 108.577 177.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -106.55 44.39 1.06 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 -178.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.91 -162.2 35.42 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-O 122.515 1.064 . . . . 0.0 111.295 -177.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 63.5 mtp85 -125.57 166.02 17.46 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 121.491 -1.005 . . . . 0.0 110.056 -167.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -168.84 171.31 42.81 Favored Glycine 0 C--N 1.336 0.558 0 C-N-CA 120.234 -0.984 . . . . 0.0 113.637 177.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 91.0 m -138.02 149.57 46.18 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.23 1.012 . . . . 0.0 109.656 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.8 p -69.95 120.81 16.23 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 168.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.6 t -83.11 -48.86 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 -174.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -57.66 130.18 45.24 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 159.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.2 m -57.98 148.68 25.23 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 162.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -134.9 153.26 78.53 Favored Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 163.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -76.35 95.91 1.06 Allowed 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 125.261 3.974 . . . . 0.0 110.893 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.99 109.4 22.16 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -178.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.3 m -121.51 151.53 24.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 119.013 0.824 . . . . 0.0 109.469 175.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.425 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 45.5 mt -88.49 135.22 26.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 165.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.66 167.99 20.95 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 122.371 1.082 . . . . 0.0 110.7 173.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.61 174.76 46.81 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-O 122.829 1.239 . . . . 0.0 113.127 168.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -84.89 -4.59 59.17 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.65 1.18 . . . . 0.0 113.092 -163.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -119.86 10.28 11.54 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.54 1.536 . . . . 0.0 111.803 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 35.3 m-20 58.25 59.24 3.11 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.199 1.8 . . . . 0.0 109.574 176.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 96.8 mt -106.41 88.76 3.49 Favored Pre-proline 0 N--CA 1.455 -0.225 0 C-N-CA 127.142 2.177 . . . . 0.0 107.085 -171.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . 75.9 Cg_endo -58.39 135.14 65.92 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 CA-C-N 119.955 1.02 . . . . 0.0 111.519 172.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 74.7 m95 -101.15 -173.92 2.49 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.084 0.953 . . . . 0.0 108.914 178.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.9 tp -142.53 101.68 3.92 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 159.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.93 132.28 51.55 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 172.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -71.44 92.94 1.12 Allowed 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.15 77.42 12.97 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -57.63 120.01 7.63 Favored 'Trans proline' 0 C--O 1.239 0.546 0 C-N-CA 122.914 2.409 . . . . 0.0 109.145 176.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.51 7.19 51.94 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 125.86 1.695 . . . . 0.0 114.34 176.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -115.81 167.77 10.64 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 119.824 1.812 . . . . 0.0 108.878 171.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.403 ' HA2' ' CD2' ' A' ' 129' ' ' TYR . . . 66.49 -148.28 50.55 Favored Glycine 0 CA--C 1.518 0.258 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -173.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 63.9 m-70 -124.92 176.91 6.33 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.874 1.27 . . . . 0.0 108.399 -177.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 3.6 p -61.73 161.68 9.74 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 120.444 -0.502 . . . . 0.0 109.798 170.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 38.8 t -135.69 114.29 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 169.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 45.9 p -79.19 157.66 27.81 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 123.301 0.64 . . . . 0.0 109.876 -177.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -177.4 -153.0 10.47 Favored Glycine 0 CA--C 1.526 0.74 0 O-C-N 121.222 -0.924 . . . . 0.0 112.568 -176.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -138.68 165.7 26.27 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.21 1.404 . . . . 0.0 110.98 -174.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 62.2 mt -116.35 128.01 73.8 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 -173.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -122.92 126.98 48.3 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.973 0.892 . . . . 0.0 109.284 172.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -62.78 107.05 0.89 Allowed 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 158.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.1 m -115.41 161.04 14.44 Favored 'Isoleucine or valine' 0 C--O 1.244 0.809 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 171.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -113.43 173.22 6.51 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 176.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -52.04 -42.87 63.45 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 124.578 1.151 . . . . 0.0 110.683 -171.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 -62.59 -36.35 82.44 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 118.828 -0.606 . . . . 0.0 111.468 -174.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 20.4 tpp -67.67 -53.99 23.24 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.45 -38.28 80.34 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.267 -175.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.53 -41.9 75.37 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 125.582 1.553 . . . . 0.0 110.918 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -56.7 -51.44 68.79 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 122.974 0.51 . . . . 0.0 110.54 171.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 93.1 mt -60.5 -32.99 71.97 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.396 -0.815 . . . . 0.0 111.783 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.425 ' N ' ' HH ' ' A' ' 115' ' ' TYR . 6.4 t0 -67.11 -6.52 17.89 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.24 1.816 . . . . 0.0 112.736 177.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -107.95 -49.86 3.15 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.939 1.695 . . . . 0.0 109.454 171.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -62.8 -46.56 87.4 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.253 1.021 . . . . 0.0 112.063 -174.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -72.12 6.66 2.05 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.91 0.884 . . . . 0.0 111.324 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 62.62 20.09 11.77 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 126.341 1.856 . . . . 0.0 113.264 167.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 26.5 p -68.91 157.98 87.49 Favored Pre-proline 0 CA--C 1.541 0.622 0 O-C-N 121.138 -0.976 . . . . 0.0 109.232 175.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -72.3 -4.32 12.98 Favored 'Cis proline' 0 CA--C 1.545 1.057 0 CA-C-N 119.978 1.028 . . . . 0.0 114.606 -5.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.5 m -63.96 -59.02 5.02 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 119.527 1.058 . . . . 0.0 111.979 -174.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 37.6 mtp -78.26 -80.65 0.11 Allowed 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -89.11 174.95 7.59 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.749 0.82 . . . . 0.0 109.918 177.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -132.73 -12.48 2.98 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.637 0.775 . . . . 0.0 113.015 173.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? 63.44 133.46 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 129.542 3.137 . . . . 0.0 112.576 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 61.9 m -143.98 160.48 40.78 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 123.969 0.907 . . . . 0.0 109.374 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -89.84 128.51 36.18 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.943 1.697 . . . . 0.0 110.539 170.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.72 178.53 5.64 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 127.365 2.266 . . . . 0.0 110.004 172.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 44.4 tp60 -116.71 128.43 55.32 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.555 1.542 . . . . 0.0 108.933 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.412 ' CG2' ' SG ' ' A' ' 112' ' ' CYS . 41.8 t -122.38 151.53 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 127.239 2.216 . . . . 0.0 107.114 -171.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -88.73 139.41 30.5 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.682 1.593 . . . . 0.0 107.265 171.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.4 t -87.31 126.44 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 170.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 mp -99.07 -36.61 9.65 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.143 1.777 . . . . 0.0 109.95 -176.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -148.44 153.35 38.39 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 130.44 3.496 . . . . 0.0 104.418 174.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.55 ' HE1' ' N ' ' A' ' 104' ' ' GLY . 74.1 t-105 -141.53 123.29 15.23 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -178.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -130.94 109.19 10.36 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 169.69 -120.81 0.89 Allowed Glycine 0 C--N 1.343 0.936 0 C-N-CA 114.489 -3.719 . . . . 0.0 121.192 173.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -64.43 -178.05 0.35 Allowed 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 101.482 -3.525 . . . . 0.0 101.482 126.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.55 ' N ' ' HE1' ' A' ' 100' ' ' TRP . . . -108.76 -75.23 0.86 Allowed Glycine 0 N--CA 1.417 -2.572 1 C-N-CA 111.397 -5.192 . . . . 0.0 106.464 -94.149 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -158.89 88.04 2.19 Favored Pre-proline 0 C--N 1.313 -1.002 1 C-N-CA 133.652 4.781 . . . . 0.0 114.966 163.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -51.41 -30.41 34.48 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.001 2.468 . . . . 0.0 114.082 161.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 111.22 179.39 20.21 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.89 1.233 . . . . 0.0 110.557 -169.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -67.61 -11.91 59.23 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.463 1.105 . . . . 0.0 112.056 -171.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.7 p -130.93 159.73 36.58 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 120.786 -1.196 . . . . 0.0 110.979 172.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.2 p -151.1 146.29 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 124.174 0.99 . . . . 0.0 109.924 177.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -87.77 142.39 27.86 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 173.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.412 ' SG ' ' CG2' ' A' ' 95' ' ' VAL . 0.5 OUTLIER -152.19 168.84 24.02 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.392 1.477 . . . . 0.0 110.011 -178.815 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -92.39 151.79 20.07 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.098 0.559 . . . . 0.0 110.149 172.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 51.2 t -138.39 146.03 27.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 C-N-CA 127.6 2.36 . . . . 0.0 106.265 167.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.425 ' HH ' ' N ' ' A' ' 79' ' ' ASP . 45.0 m-85 -78.02 92.84 4.38 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.711 0.804 . . . . 0.0 109.51 172.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.0 p -104.45 173.47 6.29 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.369 1.468 . . . . 0.0 111.388 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.85 148.57 52.3 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 126.226 1.811 . . . . 0.0 107.089 175.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -112.8 -2.29 14.44 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.456 1.102 . . . . 0.0 111.296 167.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.6 p -111.8 18.26 19.08 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.695 1.598 . . . . 0.0 112.212 -158.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -68.93 158.92 33.66 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.727 1.611 . . . . 0.0 112.314 -170.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.4 157.66 87.67 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 126.343 1.857 . . . . 0.0 111.359 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -52.88 -53.75 6.27 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.533 2.822 . . . . 0.0 113.096 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.477 ' HA ' ' CD2' ' A' ' 126' ' ' PHE . 0.5 OUTLIER -45.67 -33.25 2.82 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 126.458 1.903 . . . . 0.0 114.191 -179.123 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 38.7 m0 -74.28 -3.5 30.47 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.598 -0.688 . . . . 0.0 112.242 -168.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 89.1 mt -97.08 -12.98 22.52 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 118.027 -0.987 . . . . 0.0 113.237 170.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.477 ' CD2' ' HA ' ' A' ' 123' ' ' GLU . 10.3 m-85 -84.34 -30.24 25.66 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 119.511 1.051 . . . . 0.0 110.214 177.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 36.3 mt -58.32 155.55 26.38 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 125.955 1.702 . . . . 0.0 111.428 -174.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.52 156.06 62.14 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 121.693 1.595 . . . . 0.0 109.756 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.403 ' CD2' ' HA2' ' A' ' 60' ' ' GLY . 31.9 m-85 -104.9 161.39 14.23 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.248 1.019 . . . . 0.0 111.945 178.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -138.95 159.9 41.05 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.926 0.891 . . . . 0.0 110.56 -171.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -111.06 -7.65 14.49 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -164.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 33.8 t -164.56 158.67 18.35 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 171.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -103.53 150.06 24.27 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.258 0.552 . . . . 0.0 109.681 172.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -157.9 170.1 23.09 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.515 1.526 . . . . 0.0 108.203 177.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.4 9.44 37.81 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.383 1.873 . . . . 0.0 110.769 167.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.413 ' CD ' HH21 ' A' ' 12' ' ' ARG . 49.5 mt-10 -138.05 4.15 2.47 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.551 1.14 . . . . 0.0 113.719 -167.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -89.3 -171.15 45.28 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 127.127 2.299 . . . . 0.0 111.925 -175.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -71.34 5.95 2.09 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 124.648 3.566 . . . . 0.0 114.997 -178.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -87.12 91.44 8.71 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -53.16 -36.69 52.89 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 121.78 -0.575 . . . . 0.0 113.235 -178.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.481 ' CD2' ' H ' ' A' ' 141' ' ' LEU . 0.7 OUTLIER -68.82 119.46 13.21 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 127.347 2.259 . . . . 0.0 109.646 168.691 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.53 163.51 13.63 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 119.65 1.114 . . . . 0.0 110.772 167.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -54.52 139.99 36.06 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 119.164 0.893 . . . . 0.0 110.057 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -120.49 78.02 27.88 Favored Pre-proline 0 C--O 1.235 0.338 0 C-N-CA 123.295 0.638 . . . . 0.0 110.103 -173.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -71.88 -38.51 4.04 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.31 2.673 . . . . 0.0 113.276 -176.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -153.01 20.34 0.58 Allowed 'General case' 0 C--N 1.34 0.16 0 CA-C-N 118.636 0.653 . . . . 0.0 112.73 -172.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -59.54 -57.05 14.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 119.229 0.922 . . . . 0.0 109.444 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -117.85 9.53 12.94 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.384 1.074 . . . . 0.0 111.157 -172.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.243 0.736 0 C-N-CA 124.308 1.043 . . . . 0.0 110.139 -149.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.434 ' HA ' ' HA ' ' A' ' 71' ' ' ASP . 46.0 mtt . . . . . 0 N--CA 1.477 0.889 0 CA-C-O 117.825 -1.083 . . . . 0.0 109.273 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 67.36 167.23 0.24 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 127.614 2.366 . . . . 0.0 112.253 -161.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -130.68 142.9 50.44 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 125.536 1.534 . . . . 0.0 109.346 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.2 pt -125.88 171.64 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 124.313 1.045 . . . . 0.0 109.717 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -121.4 127.74 51.48 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.313 1.445 . . . . 0.0 107.713 174.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.3 m -97.86 155.83 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 123.917 0.887 . . . . 0.0 109.371 170.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -147.08 -19.78 0.4 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.755 2.022 . . . . 0.0 111.479 178.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -120.25 -129.71 3.83 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 127.513 2.482 . . . . 0.0 111.761 -169.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.454 ' HB ' HD21 ' A' ' 16' ' ' ASN . 32.4 p -64.0 -35.95 82.38 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.738 -0.86 . . . . 0.0 112.516 -161.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 77.1 mt -80.94 3.11 23.97 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.432 0.693 . . . . 0.0 111.911 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -89.29 -81.18 0.28 Allowed 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 117.345 -1.312 . . . . 0.0 110.323 178.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.99 -85.76 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 121.052 1.751 . . . . 0.0 111.073 -174.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -169.7 21.11 0.08 OUTLIER Glycine 0 CA--C 1.525 0.717 0 O-C-N 121.307 -0.871 . . . . 0.0 111.149 -164.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -52.81 162.61 0.95 Allowed Pre-proline 0 N--CA 1.452 -0.372 0 C-N-CA 124.53 1.132 . . . . 0.0 110.621 176.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -65.73 1.89 1.97 Allowed 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 124.911 3.741 . . . . 0.0 113.092 -172.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.454 HD21 ' HB ' ' A' ' 9' ' ' THR . 3.0 m-20 -119.66 -17.68 8.56 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 126.289 1.836 . . . . 0.0 107.92 -171.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -51.38 -37.31 47.49 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 120.192 1.36 . . . . 0.0 109.991 177.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.23 -21.74 3.71 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-O 117.231 -1.366 . . . . 0.0 114.6 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.0 m -61.73 -41.51 90.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 120.994 1.725 . . . . 0.0 110.122 176.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -74.41 -17.68 60.76 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 119.315 0.962 . . . . 0.0 113.114 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 73.0 mt -75.32 -5.08 42.88 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.103 0.561 . . . . 0.0 111.244 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -102.65 103.75 14.05 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.286 0.565 . . . . 0.0 109.687 169.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 -51.33 -19.85 1.47 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.089 1.355 . . . . 0.0 113.963 173.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.5 t -77.19 -30.27 54.72 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.032 -1.043 . . . . 0.0 112.027 176.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -69.22 -30.33 68.46 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.585 1.084 . . . . 0.0 109.464 166.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.53 177.27 26.01 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 110.909 -0.877 . . . . 0.0 110.909 167.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 30.1 tp -77.89 142.05 38.7 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 123.639 0.776 . . . . 0.0 111.056 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -145.7 141.36 27.98 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.397 1.079 . . . . 0.0 110.1 165.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.81 148.02 27.98 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.454 1.502 . . . . 0.0 109.815 166.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -67.62 124.35 23.0 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 125.061 1.344 . . . . 0.0 109.118 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.1 tpp180 -120.07 45.7 2.12 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.652 1.181 . . . . 0.0 108.658 -176.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 89.39 -177.79 44.17 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -174.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.82 172.54 11.55 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.518 -0.99 . . . . 0.0 111.813 -173.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -173.82 -178.02 43.45 Favored Glycine 0 CA--C 1.505 -0.542 0 C-N-CA 120.305 -0.95 . . . . 0.0 114.158 -174.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 22.1 p -146.4 154.84 42.09 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 123.909 0.883 . . . . 0.0 109.45 173.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 44.7 p -78.26 83.23 4.52 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 173.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.6 m -59.58 -30.8 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 118.826 0.739 . . . . 0.0 112.195 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.41 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 7.1 tt0 -74.74 22.99 0.1 Allowed 'General case' 0 C--O 1.205 -1.24 0 C-N-CA 127.861 2.465 . . . . 0.0 111.928 173.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 41.46 114.37 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.616 1 C-N-CA 134.393 5.077 . . . . 0.0 114.025 158.377 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -127.85 154.12 78.12 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 120.194 1.361 . . . . 0.0 111.413 -173.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.38 105.81 1.93 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 124.93 3.753 . . . . 0.0 110.724 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.48 100.91 9.13 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 -178.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.3 m -110.33 144.69 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-N 119.179 0.9 . . . . 0.0 110.154 -172.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.0 mt -91.98 116.4 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 171.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -129.92 179.58 5.78 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 124.332 1.053 . . . . 0.0 108.7 172.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.4 152.68 25.17 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 124.649 1.118 . . . . 0.0 112.809 161.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.76 -17.56 64.93 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -171.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -105.97 9.01 32.73 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 118.512 -0.756 . . . . 0.0 112.423 -177.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 53.42 79.64 0.12 Allowed 'General case' 0 C--N 1.342 0.239 0 C-N-CA 125.769 1.628 . . . . 0.0 108.391 -162.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 62.2 mt -120.04 86.57 37.28 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -61.31 151.68 77.59 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 CA-C-N 120.781 1.315 . . . . 0.0 112.683 174.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -125.77 128.92 48.47 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.448 1.499 . . . . 0.0 107.56 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.7 107.08 18.94 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 174.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.1 mt -87.12 139.2 30.8 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 105.904 -1.888 . . . . 0.0 105.904 -172.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -73.61 96.99 2.55 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 118.774 0.716 . . . . 0.0 109.865 -175.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.08 87.13 4.35 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 124.365 1.066 . . . . 0.0 112.982 177.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 31.5 Cg_endo -59.75 145.18 98.87 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.884 2.389 . . . . 0.0 111.49 176.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 47.65 51.34 17.45 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 129.481 3.419 . . . . 0.0 112.533 -174.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.0 tptm -140.55 143.81 35.56 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 126.072 1.749 . . . . 0.0 106.314 173.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.21 -129.43 20.46 Favored Glycine 0 CA--C 1.519 0.299 0 N-CA-C 109.064 -1.615 . . . . 0.0 109.064 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -138.31 170.53 15.86 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 119.212 1.506 . . . . 0.0 111.606 -167.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 73.1 m -84.53 104.44 14.53 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.381 -0.827 . . . . 0.0 108.995 -176.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.0 t -70.32 110.71 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.9 p -75.09 145.34 42.36 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 120.904 -1.122 . . . . 0.0 110.43 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -167.35 -167.4 27.97 Favored Glycine 0 C--N 1.335 0.473 0 O-C-N 120.446 -1.409 . . . . 0.0 112.364 -169.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -134.93 158.8 43.35 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.222 1.009 . . . . 0.0 109.169 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.8 mt -102.56 132.71 48.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 -177.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -118.21 127.01 53.34 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 118.64 0.654 . . . . 0.0 110.863 172.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -60.25 135.05 57.61 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 150.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.8 m -135.25 173.45 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 170.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.434 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 0.4 OUTLIER -121.06 -178.27 3.71 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.679 0.752 . . . . 0.0 111.193 160.593 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -44.46 -55.59 4.94 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 126.61 1.964 . . . . 0.0 111.888 -171.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -71.28 -27.62 63.55 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 117.298 -1.334 . . . . 0.0 111.215 -171.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 24.1 tpp -66.28 -47.81 72.45 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 120.862 1.665 . . . . 0.0 108.595 172.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.09 -28.92 70.4 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 119.403 -0.332 . . . . 0.0 111.581 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -77.67 -37.03 50.65 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.42 1.009 . . . . 0.0 112.297 174.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -67.22 -45.84 75.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 119.475 1.034 . . . . 0.0 109.807 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.13 -32.25 66.16 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.67 -0.644 . . . . 0.0 110.351 171.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.31 -7.92 15.67 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.038 1.335 . . . . 0.0 113.069 177.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -123.97 -27.16 3.94 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.712 2.405 . . . . 0.0 111.773 -176.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -72.83 -29.52 63.3 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.286 -0.884 . . . . 0.0 110.902 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -117.25 30.95 7.02 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.748 1.619 . . . . 0.0 110.406 177.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.0 t0 49.91 26.31 1.93 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.811 2.044 . . . . 0.0 113.431 169.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -71.72 159.89 84.19 Favored Pre-proline 0 CA--C 1.54 0.572 0 O-C-N 120.652 -1.28 . . . . 0.0 109.381 -167.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -68.42 -3.4 5.97 Favored 'Cis proline' 0 CA--C 1.54 0.82 0 CA-C-N 120.979 1.385 . . . . 0.0 113.702 -11.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.4 t -56.34 -68.12 0.24 Allowed 'General case' 0 C--O 1.238 0.488 0 CA-C-N 119.339 0.972 . . . . 0.0 111.443 -173.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 26.8 mtp -77.91 -73.54 0.31 Allowed 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -177.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -97.97 -179.73 4.51 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 124.575 1.15 . . . . 0.0 108.108 173.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -165.45 125.29 1.79 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 -172.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.8 tmm_? -69.92 148.18 49.3 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -173.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.5 m -149.78 168.25 24.22 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 126.37 1.868 . . . . 0.0 107.284 -174.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -123.33 142.62 50.76 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.178 1.791 . . . . 0.0 109.691 172.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.19 174.13 13.61 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.466 1.907 . . . . 0.0 110.53 -173.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -92.63 111.79 23.51 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.973 1.309 . . . . 0.0 109.491 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.1 t -106.17 144.38 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 120.509 1.504 . . . . 0.0 107.754 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -78.81 140.78 38.15 Favored 'General case' 0 C--N 1.341 0.221 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 169.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 40.7 t -93.36 92.57 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 176.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.09 -24.53 67.73 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.876 -0.515 . . . . 0.0 110.746 175.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -165.93 149.52 7.76 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 128.035 2.534 . . . . 0.0 105.546 176.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 63.2 t-105 -125.89 137.72 53.75 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 124.715 1.206 . . . . 0.0 107.794 171.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -108.75 127.12 53.73 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.178 0.991 . . . . 0.0 110.558 174.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.6 -174.9 47.56 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 124.902 1.239 . . . . 0.0 112.385 168.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -62.77 151.82 37.59 Favored 'General case' 0 C--O 1.238 0.48 0 O-C-N 122.709 -0.289 . . . . 0.0 110.623 -170.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 102.56 45.31 1.69 Allowed Glycine 0 CA--C 1.52 0.355 0 CA-C-O 119.393 -0.671 . . . . 0.0 112.785 177.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -101.73 89.51 1.53 Allowed Pre-proline 0 N--CA 1.465 0.283 0 C-N-CA 126.682 1.993 . . . . 0.0 109.525 -156.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -62.35 -29.31 79.44 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 124.03 3.153 . . . . 0.0 112.922 -166.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 120.28 -169.21 13.96 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -163.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -71.39 -10.88 60.48 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.745 1.218 . . . . 0.0 113.039 -168.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.0 p -139.01 165.09 28.03 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 120.252 -1.53 . . . . 0.0 110.277 167.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.9 p -146.3 175.39 2.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 C-N-CA 124.989 1.315 . . . . 0.0 108.048 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -100.71 136.0 41.27 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 155.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 98.0 m -121.81 165.06 16.44 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 165.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -83.31 150.39 26.16 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 160.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.3 t -142.22 160.81 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 129.312 3.045 . . . . 0.0 105.295 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -110.31 108.08 18.04 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 171.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 32.5 p -112.64 -164.74 0.94 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 122.017 0.913 . . . . 0.0 109.286 175.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.52 135.69 28.59 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 174.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -98.69 -3.33 36.16 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.869 1.267 . . . . 0.0 111.309 164.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 16.9 p -92.3 -0.65 57.38 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.461 1.904 . . . . 0.0 113.206 -170.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -55.6 141.23 38.29 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 126.669 1.988 . . . . 0.0 113.171 -164.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.44 147.06 98.87 Favored Pre-proline 0 N--CA 1.446 -0.657 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.137 -177.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -65.19 -22.06 61.56 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.101 1.867 . . . . 0.0 113.307 -178.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.479 ' HA ' ' CE2' ' A' ' 126' ' ' PHE . 1.6 pm0 -70.0 -29.04 66.02 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 170.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 46.6 m0 -72.61 3.58 4.83 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.052 -1.03 . . . . 0.0 111.247 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -81.24 -22.25 38.88 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.663 1.585 . . . . 0.0 113.83 169.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.479 ' CE2' ' HA ' ' A' ' 123' ' ' GLU . 33.7 p90 -107.12 -16.84 14.32 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 120.474 1.488 . . . . 0.0 112.772 -177.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 26.2 mt -56.29 148.14 43.92 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 123.668 0.787 . . . . 0.0 110.091 173.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.67 147.45 45.27 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.601 2.201 . . . . 0.0 111.712 -173.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -91.23 168.94 11.24 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.201 1.4 . . . . 0.0 111.413 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -143.42 164.26 30.8 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.621 1.568 . . . . 0.0 109.41 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -107.45 -1.73 21.16 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.28 1.832 . . . . 0.0 111.626 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.16 167.97 23.28 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 126.182 1.793 . . . . 0.0 106.948 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -135.22 96.77 3.56 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 104.357 -2.46 . . . . 0.0 104.357 176.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -150.24 115.12 5.31 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 122.942 0.497 . . . . 0.0 110.18 -170.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 73.5 m -54.82 -16.68 2.79 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.124 1.37 . . . . 0.0 111.303 171.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -103.89 57.31 0.73 Allowed 'General case' 0 C--O 1.237 0.399 0 C-N-CA 126.439 1.895 . . . . 0.0 109.273 -177.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -146.84 177.26 25.27 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 127.914 2.674 . . . . 0.0 109.437 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -79.95 3.48 7.56 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.793 2.996 . . . . 0.0 114.32 -171.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -120.49 85.3 2.37 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 107.31 -1.366 . . . . 0.0 107.31 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -72.14 52.26 1.37 Allowed Glycine 0 CA--C 1.529 0.938 0 C-N-CA 126.587 2.041 . . . . 0.0 115.089 -167.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.49 58.09 1.25 Allowed 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 126.024 1.73 . . . . 0.0 109.621 -174.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 14.0 mmt85 -119.66 -18.07 8.46 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -176.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -166.86 139.9 3.67 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 125.328 1.451 . . . . 0.0 107.965 163.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -121.4 76.1 33.8 Favored Pre-proline 0 CA--C 1.531 0.22 0 O-C-N 124.422 1.076 . . . . 0.0 108.913 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -80.37 -49.24 0.06 OUTLIER 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 123.911 3.074 . . . . 0.0 113.738 176.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.483 ' HE ' ' C ' ' A' ' 149' ' ' ARG . 11.6 ttt180 -149.3 75.41 1.28 Allowed 'General case' 0 CA--C 1.507 -0.702 0 C-N-CA 126.169 1.787 . . . . 0.0 107.775 -166.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -77.16 -39.6 48.48 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 112.672 -2.058 . . . . 0.0 109.855 170.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -151.95 34.49 0.54 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.017 1.727 . . . . 0.0 110.313 -170.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.483 ' C ' ' HE ' ' A' ' 146' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.847 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 154.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.472 0.67 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.37 115.66 28.94 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 -172.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -85.68 122.28 29.55 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 171.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.0 pt -129.05 174.98 11.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 125.329 1.451 . . . . 0.0 111.426 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -105.02 -167.92 1.4 Allowed 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.949 1.699 . . . . 0.0 110.596 172.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.7 p -139.74 148.41 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 123.95 0.9 . . . . 0.0 109.132 166.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -59.56 -32.26 70.18 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.636 1.575 . . . . 0.0 113.173 -177.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 142.32 -31.07 2.07 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.65 1.119 . . . . 0.0 111.179 -168.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 p -59.35 -73.48 0.08 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 130.68 3.592 . . . . 0.0 112.832 -176.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.9 mp -78.72 57.18 2.01 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.843 0.857 . . . . 0.0 108.782 -173.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.59 -66.88 0.36 Allowed 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 127.091 2.156 . . . . 0.0 108.338 -176.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -79.35 -72.59 0.38 Allowed 'General case' 0 C--O 1.223 -0.312 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.703 -178.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -172.84 10.98 0.04 OUTLIER Glycine 0 CA--C 1.531 1.062 0 N-CA-C 115.666 1.027 . . . . 0.0 115.666 -175.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.53 164.99 0.3 Allowed Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 126.569 1.948 . . . . 0.0 114.885 -171.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -56.16 -16.94 18.47 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 124.671 3.581 . . . . 0.0 113.974 -174.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -98.73 -19.58 17.4 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 125.12 1.368 . . . . 0.0 110.769 -165.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -51.36 -40.45 59.19 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.034 0.934 . . . . 0.0 112.413 -162.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.72 -21.68 19.86 Favored 'General case' 0 C--O 1.224 -0.255 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -175.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.5 m -60.49 -40.22 83.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 120.269 1.395 . . . . 0.0 110.905 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.0 ptp -74.22 -13.04 60.73 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 118.645 0.657 . . . . 0.0 112.219 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 72.6 mt -82.7 -4.78 58.34 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 118.574 -0.727 . . . . 0.0 110.61 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -105.35 99.19 8.8 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -178.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 28.3 t-80 -60.7 -18.85 56.75 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.0 t -55.99 -52.71 63.2 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.328 1.051 . . . . 0.0 109.746 168.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -70.67 -21.08 62.64 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.704 0.802 . . . . 0.0 110.87 -177.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.85 177.77 23.34 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 123.992 0.806 . . . . 0.0 111.373 164.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.5 tp -84.27 142.72 30.04 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.63 0.772 . . . . 0.0 110.293 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.28 142.22 31.27 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.248 1.419 . . . . 0.0 107.945 161.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -143.95 131.81 21.46 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.182 1.393 . . . . 0.0 108.111 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -73.84 94.21 2.26 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 127.187 2.195 . . . . 0.0 110.706 -171.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -93.54 61.34 3.18 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 172.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.18 -154.54 53.28 Favored Glycine 0 N--CA 1.441 -0.997 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 174.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 24.5 ptt-85 -143.95 168.13 20.7 Favored 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 122.119 -0.636 . . . . 0.0 112.124 -163.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -173.62 177.51 45.93 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-O 122.432 1.018 . . . . 0.0 114.041 -169.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.7 p -142.54 162.51 35.28 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.947 1.299 . . . . 0.0 109.917 176.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 43.6 p -82.06 95.84 7.57 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 168.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -62.76 -25.41 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 118.43 0.559 . . . . 0.0 111.686 171.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.78 117.32 13.22 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 159.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.4 m -57.1 138.5 54.4 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 172.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -129.27 152.43 79.47 Favored Pre-proline 0 C--O 1.234 0.246 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 164.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -77.71 111.78 3.19 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 124.918 3.745 . . . . 0.0 110.479 172.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 33.5 tp -103.81 86.48 2.61 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.92 1.288 . . . . 0.0 107.769 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.425 HG12 ' HB3' ' A' ' 127' ' ' LEU . 48.3 t -84.21 160.78 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.274 0 C-N-CA 125.186 1.394 . . . . 0.0 107.921 177.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 50.3 mt -132.33 118.8 37.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 176.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.71 -172.87 3.91 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.567 0.747 . . . . 0.0 109.082 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.71 175.97 11.33 Favored Glycine 0 N--CA 1.439 -1.138 0 C-N-CA 125.564 1.555 . . . . 0.0 111.316 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -74.59 -8.45 56.39 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -162.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -132.73 40.28 3.27 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 124.021 0.928 . . . . 0.0 110.759 -176.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.8 m120 48.17 61.05 3.2 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.128 -0.983 . . . . 0.0 110.724 174.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 62.4 mt -102.49 89.97 1.97 Allowed Pre-proline 0 C--N 1.329 -0.294 0 N-CA-C 103.422 -2.807 . . . . 0.0 103.422 -160.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -59.62 120.04 7.61 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 N-CA-C 108.132 -1.526 . . . . 0.0 108.132 -176.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -103.27 115.31 30.31 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 177.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.39 94.75 6.85 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 172.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.402 ' HG ' ' CD2' ' A' ' 120' ' ' TYR . 10.9 mp -65.45 120.23 12.46 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -70.55 83.58 0.6 Allowed 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -176.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.56 85.74 12.84 Favored Pre-proline 0 N--CA 1.465 0.317 0 C-N-CA 124.168 0.987 . . . . 0.0 109.727 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -58.87 141.07 97.71 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 N-CA-C 108.932 -1.218 . . . . 0.0 108.932 174.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.56 18.96 76.92 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 119.607 -0.551 . . . . 0.0 113.681 176.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -126.62 157.08 39.87 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 119.487 1.643 . . . . 0.0 106.798 161.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.97 -137.27 15.36 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 173.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -140.24 171.49 14.09 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.784 1.292 . . . . 0.0 110.493 -173.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 58.3 m -79.93 107.77 12.97 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 123.884 0.874 . . . . 0.0 111.387 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 73.6 t -88.86 116.35 30.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -169.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.6 p -72.61 161.95 30.12 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.493 0.664 . . . . 0.0 109.278 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -169.58 -156.7 11.11 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 108.116 -1.993 . . . . 0.0 108.116 175.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.09 171.76 13.97 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.619 1.968 . . . . 0.0 106.513 177.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 79.5 mt -126.36 127.99 71.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 119.485 1.039 . . . . 0.0 108.512 -170.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -126.08 119.96 28.96 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.456 0.702 . . . . 0.0 111.794 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -66.59 115.66 6.69 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 105.473 -2.047 . . . . 0.0 105.473 156.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.2 m -120.47 165.48 15.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 C-N-CA 123.828 0.851 . . . . 0.0 109.244 178.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -93.56 171.39 8.93 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 122.413 1.101 . . . . 0.0 108.296 169.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -54.07 -37.93 64.74 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.316 -1.311 . . . . 0.0 110.846 167.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -58.68 -40.66 84.22 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.889 0.768 . . . . 0.0 110.943 -176.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 25.8 tpp -72.01 -45.83 59.44 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 176.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.7 tp -58.84 -26.84 64.56 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 50.1 mtt-85 -78.59 -39.27 37.92 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.936 1.694 . . . . 0.0 111.144 173.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -64.15 -50.29 68.79 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 118.881 -0.58 . . . . 0.0 111.351 175.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 91.6 mt -56.41 -36.36 68.85 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 119.106 0.866 . . . . 0.0 110.668 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.73 -23.25 28.09 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.097 1.759 . . . . 0.0 112.891 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -93.22 -31.23 14.82 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.43 1.492 . . . . 0.0 112.287 174.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -71.62 -43.73 65.65 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.333 1.053 . . . . 0.0 109.632 -169.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -92.21 15.41 13.68 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.45 1.1 . . . . 0.0 113.174 176.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.0 t70 44.89 38.29 2.85 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.615 1.566 . . . . 0.0 112.283 -177.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -65.7 158.91 72.33 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 120.075 -1.641 . . . . 0.0 107.403 170.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -74.16 -3.38 17.1 Favored 'Cis proline' 0 N--CA 1.452 -0.953 0 CA-C-N 118.969 0.668 . . . . 0.0 113.488 -13.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.54 -62.81 1.47 Allowed 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.033 1.733 . . . . 0.0 111.8 -175.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 36.5 mtp -86.31 -74.29 0.43 Allowed 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -174.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -89.81 172.91 8.56 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 175.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -134.88 138.66 44.36 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 165.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.49 ' HD3' ' CD1' ' A' ' 113' ' ' PHE . 7.6 tmm_? -74.31 129.94 38.74 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 118.095 -0.955 . . . . 0.0 109.24 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.3 m -133.02 156.27 47.65 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.102 0.865 . . . . 0.0 110.0 -175.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -87.85 139.58 30.38 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.388 1.475 . . . . 0.0 110.426 168.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.444 ' CD2' ' HB ' ' A' ' 114' ' ' VAL . 1.8 pt? -160.92 -179.91 7.94 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.657 1.183 . . . . 0.0 112.809 -177.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 12.1 tp60 -99.2 142.44 30.68 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.371 1.068 . . . . 0.0 113.073 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 45.4 t -137.34 134.6 47.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 126.659 1.984 . . . . 0.0 107.781 174.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -76.66 144.73 39.26 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.282 1.433 . . . . 0.0 108.039 165.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.49 ' CG1' ' HA ' ' A' ' 108' ' ' ASP 0.255 3.5 p -110.93 82.43 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-O 122.366 1.079 . . . . 0.0 108.838 -178.451 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.0 mp -44.79 -42.19 7.6 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 127.057 2.143 . . . . 0.0 110.462 176.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -150.09 152.47 34.83 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 176.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 64.0 t-105 -127.09 137.71 53.06 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 125.59 1.556 . . . . 0.0 107.28 176.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -113.65 106.8 14.95 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 122.964 0.505 . . . . 0.0 110.047 174.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.9 -175.75 16.12 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-O 122.066 0.815 . . . . 0.0 112.304 175.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -79.94 172.76 13.34 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.262 -0.969 . . . . 0.0 109.391 168.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.39 60.44 2.01 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -101.05 88.47 1.06 Allowed Pre-proline 0 CA--C 1.537 0.466 1 C-N-CA 132.721 4.408 . . . . 0.0 109.113 -158.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -73.39 5.04 3.43 Favored 'Trans proline' 0 CA--C 1.544 0.98 1 C-N-CA 126.188 4.592 . . . . 0.0 113.963 -171.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.33 -169.03 54.88 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-N 120.819 1.645 . . . . 0.0 110.031 -163.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.49 ' HA ' ' CG1' ' A' ' 97' ' ' VAL . 26.9 t70 -96.81 5.48 50.51 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 129.456 3.102 . . . . 0.0 116.001 -166.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.2 p -136.81 122.12 19.33 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 122.025 2.193 . . . . 0.0 114.588 152.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 24.8 m -98.41 153.85 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 125.098 1.359 . . . . 0.0 108.891 -179.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -87.12 125.95 34.47 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 163.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 9.9 m -116.88 172.06 7.49 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.522 1.129 . . . . 0.0 110.428 176.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.49 ' CD1' ' HD3' ' A' ' 90' ' ' ARG . 96.2 m-85 -92.62 139.77 30.22 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 152.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.444 ' HB ' ' CD2' ' A' ' 93' ' ' LEU . 24.3 t -142.09 126.05 15.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 129.752 3.221 . . . . 0.0 106.89 172.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -72.23 141.33 48.97 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 170.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 41.9 p -145.12 -170.0 3.32 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 126.633 1.973 . . . . 0.0 107.319 -177.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -131.76 143.76 50.47 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 166.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -107.05 0.66 23.73 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.726 1.61 . . . . 0.0 110.689 168.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.2 p -121.75 20.52 10.93 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 127.101 2.161 . . . . 0.0 111.646 -159.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.402 ' CD2' ' HG ' ' A' ' 54' ' ' LEU . 7.2 p90 -67.04 152.1 46.41 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 125.691 1.596 . . . . 0.0 111.825 -176.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.59 158.87 65.12 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 124.689 1.196 . . . . 0.0 111.568 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -72.7 -33.91 7.65 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.558 1.505 . . . . 0.0 113.175 -177.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -64.66 -26.97 68.62 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.7 0.682 . . . . 0.0 112.39 172.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 45.7 m0 -69.99 -10.78 59.8 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.767 0.712 . . . . 0.0 112.178 -176.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.26 -29.12 69.29 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.674 1.125 . . . . 0.0 110.821 168.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -90.69 -11.41 39.8 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.497 1.119 . . . . 0.0 112.099 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.425 ' HB3' HG12 ' A' ' 43' ' ' VAL . 11.5 mt -62.64 146.67 94.0 Favored Pre-proline 0 C--O 1.235 0.335 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -64.72 143.49 80.79 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.171 1.914 . . . . 0.0 109.861 175.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -96.82 164.27 12.63 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.751 1.22 . . . . 0.0 108.56 176.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -135.27 162.94 31.15 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.8 0.84 . . . . 0.0 110.103 -176.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -106.29 -17.48 14.28 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 121.392 -0.817 . . . . 0.0 110.364 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 95.2 p -139.44 160.03 40.79 Favored 'General case' 0 N--CA 1.444 -0.771 0 O-C-N 121.282 -0.886 . . . . 0.0 111.07 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -141.42 101.76 4.06 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 104.005 -2.591 . . . . 0.0 104.005 178.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -151.72 136.86 17.43 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -178.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.01 -43.76 50.85 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.8 0.84 . . . . 0.0 110.784 174.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -89.29 23.78 2.4 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.838 0.855 . . . . 0.0 112.735 -167.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -82.16 155.26 34.37 Favored Glycine 0 CA--C 1.539 1.542 0 CA-C-O 118.701 -1.055 . . . . 0.0 111.892 174.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -71.5 -22.63 24.42 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 124.288 3.325 . . . . 0.0 112.361 175.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -73.33 80.41 1.36 Allowed 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 127.556 2.342 . . . . 0.0 107.031 172.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -72.57 77.35 0.77 Allowed Glycine 0 CA--C 1.522 0.476 0 C-N-CA 127.033 2.254 . . . . 0.0 111.375 -174.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -161.14 71.58 0.41 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 128.573 2.749 . . . . 0.0 105.642 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -133.56 173.15 11.81 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.32 0.648 . . . . 0.0 109.892 -168.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -69.77 123.81 22.38 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.531 -161.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -119.76 80.28 24.36 Favored Pre-proline 0 CA--C 1.516 -0.342 0 C-N-CA 125.077 1.351 . . . . 0.0 109.045 -170.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -75.4 -15.21 20.02 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 121.54 1.493 . . . . 0.0 111.727 170.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.02 3.33 0.11 Allowed 'General case' 0 C--N 1.345 0.394 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -167.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -73.56 -7.36 51.59 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 120.475 -1.391 . . . . 0.0 113.72 -174.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -121.67 16.02 11.1 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.094 1.757 . . . . 0.0 110.215 -178.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 0.99 0 C-N-CA 125.496 1.518 . . . . 0.0 109.786 -177.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 mmt . . . . . 0 CA--C 1.515 -0.394 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.45 103.09 4.63 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 127.228 2.211 . . . . 0.0 105.413 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -78.11 142.09 38.32 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -177.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.1 pt -126.79 166.5 23.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 176.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -124.96 130.56 52.61 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.476 0.71 . . . . 0.0 109.679 -177.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.8 p -93.14 164.58 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 125.449 1.5 . . . . 0.0 108.922 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -113.4 -74.43 0.63 Allowed 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -128.1 -34.98 0.52 Allowed Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.164 1.364 . . . . 0.0 111.306 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p -64.12 -32.72 74.4 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 127.127 2.171 . . . . 0.0 114.276 -159.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 mp -133.37 36.46 3.39 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.947 1.299 . . . . 0.0 107.737 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -112.02 -25.17 9.51 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.63 1.172 . . . . 0.0 113.265 -172.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.3 mmt-85 -140.73 -87.93 0.18 Allowed 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 119.687 1.13 . . . . 0.0 109.419 168.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -128.45 2.58 6.6 Favored Glycine 0 C--N 1.334 0.429 0 O-C-N 120.637 -1.29 . . . . 0.0 111.632 -162.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -50.77 151.9 3.93 Favored Pre-proline 0 N--CA 1.438 -1.069 0 C-N-CA 124.79 1.236 . . . . 0.0 109.654 -173.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.7 -18.1 58.4 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 123.275 2.65 . . . . 0.0 112.285 -169.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -90.2 -25.07 20.81 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 126.924 2.09 . . . . 0.0 110.926 -168.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -49.59 -40.45 38.89 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.653 1.181 . . . . 0.0 111.922 -165.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.73 -27.08 1.8 Allowed 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 125.824 1.65 . . . . 0.0 114.472 -177.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.9 m -62.54 -41.0 90.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 119.716 1.144 . . . . 0.0 110.508 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.59 -14.27 61.16 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 67.6 mt -82.47 -15.33 52.9 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.794 0.838 . . . . 0.0 110.189 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -85.77 95.71 9.49 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 -178.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -63.27 -14.32 48.12 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.781 -0.574 . . . . 0.0 112.401 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 68.1 m -71.83 -27.54 62.97 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 120.548 -1.345 . . . . 0.0 112.937 167.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -83.15 2.79 33.73 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.477 1.111 . . . . 0.0 110.891 171.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.31 177.94 19.46 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 125.357 1.456 . . . . 0.0 110.787 173.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 36.9 tp -85.22 144.38 28.18 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.11 0.564 . . . . 0.0 111.308 -175.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -147.53 120.1 8.54 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.39 1.476 . . . . 0.0 109.131 161.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -134.7 150.93 50.66 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 119.008 0.822 . . . . 0.0 110.931 171.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -66.72 109.02 2.7 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 127.079 2.152 . . . . 0.0 110.191 -177.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.7 tpp85 -118.15 42.14 2.76 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.826 1.651 . . . . 0.0 108.464 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 113.5 175.0 19.09 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-O 122.874 1.263 . . . . 0.0 113.027 167.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -108.97 155.4 20.91 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.67 172.35 37.0 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.243 -0.98 . . . . 0.0 115.049 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.5 p -143.53 131.09 21.16 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 175.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 20.6 p -63.36 106.94 0.99 Allowed 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 173.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.45 -19.32 12.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.879 -177.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -65.79 116.71 7.27 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 155.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.26 132.62 34.09 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 117.641 -1.171 . . . . 0.0 107.915 160.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -135.59 156.49 77.58 Favored Pre-proline 0 N--CA 1.449 -0.5 0 CA-C-N 119.159 0.89 . . . . 0.0 108.683 178.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.55 90.89 0.69 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.996 3.13 . . . . 0.0 110.228 164.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 45.0 tp -90.38 107.55 19.22 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 154.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.4 m -101.91 166.59 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 170.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -114.63 129.65 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 170.95 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.55 -170.93 3.41 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.99 0.916 . . . . 0.0 111.7 -176.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.45 -157.65 53.44 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 126.319 1.914 . . . . 0.0 112.336 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.03 -8.35 21.54 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.397 1.479 . . . . 0.0 114.198 -174.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 -127.26 19.6 6.91 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 123.885 0.874 . . . . 0.0 112.677 -170.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 42.8 m-20 55.75 66.6 1.17 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.235 1.814 . . . . 0.0 109.066 -171.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 68.0 mt -104.28 88.94 2.28 Favored Pre-proline 0 N--CA 1.465 0.292 0 C-N-CA 127.695 2.398 . . . . 0.0 106.55 -175.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . 96.2 Cg_endo -66.44 150.28 84.33 Favored 'Trans proline' 0 N--CA 1.44 -1.653 0 CA-C-N 119.749 0.946 . . . . 0.0 112.501 174.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -128.81 118.94 23.61 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.63 102.34 3.27 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 165.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.9 mt -78.67 147.07 33.67 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 173.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -87.2 85.93 7.24 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 120.274 -1.516 . . . . 0.0 110.959 -173.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.2 86.8 11.06 Favored Pre-proline 0 N--CA 1.474 0.74 0 C-N-CA 123.72 0.808 . . . . 0.0 112.848 174.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -58.5 150.42 68.78 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 121.143 1.228 . . . . 0.0 110.395 174.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.81 -2.24 75.03 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 124.391 0.996 . . . . 0.0 113.91 174.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.27 127.8 32.55 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 120.122 1.961 . . . . 0.0 106.127 -174.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.76 -143.13 16.45 Favored Glycine 0 CA--C 1.522 0.527 0 CA-C-O 118.338 -1.257 . . . . 0.0 110.235 -168.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -141.35 170.38 15.84 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.051 1.425 . . . . 0.0 111.324 -177.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 7.1 m -72.31 106.59 4.52 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.161 1.384 . . . . 0.0 111.774 -174.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.6 t -77.73 101.36 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.761 0.824 . . . . 0.0 110.524 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.6 p -70.61 164.25 25.31 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 121.878 -0.514 . . . . 0.0 110.253 -177.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 176.59 -159.98 27.16 Favored Glycine 0 C--N 1.343 0.93 0 CA-C-N 119.392 0.996 . . . . 0.0 112.481 -176.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -139.32 160.03 40.78 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 121.499 -1.001 . . . . 0.0 111.785 -176.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 75.8 mt -114.09 124.41 70.71 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -173.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -113.87 119.93 38.97 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 173.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -57.09 114.13 2.0 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 154.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.9 m -115.37 155.35 16.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 173.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.73 173.23 10.23 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 122.011 0.91 . . . . 0.0 109.593 170.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.47 -49.85 60.98 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 125.72 1.608 . . . . 0.0 110.153 170.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -56.79 -39.25 73.78 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 118.922 -0.561 . . . . 0.0 111.679 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 44.2 tpp -72.35 -48.72 39.64 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 118.799 0.727 . . . . 0.0 109.693 179.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.28 -13.58 39.9 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.063 -1.023 . . . . 0.0 113.156 177.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 89.1 mtt-85 -86.34 -57.23 3.09 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 125.328 1.451 . . . . 0.0 110.467 168.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -53.48 -44.89 69.35 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.523 1.129 . . . . 0.0 112.272 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 90.5 mt -65.84 -27.93 68.6 Favored 'General case' 0 N--CA 1.461 0.113 0 O-C-N 121.347 -0.846 . . . . 0.0 110.526 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.439 ' HA ' ' SG ' ' A' ' 84' ' ' CYS . 1.8 t70 -76.64 10.12 2.36 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.099 1.76 . . . . 0.0 111.184 176.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -126.54 -4.77 6.54 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.516 2.326 . . . . 0.0 110.433 167.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.99 -49.05 7.3 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 104.25 -2.5 . . . . 0.0 104.25 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -74.78 0.79 14.21 Favored 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 124.884 1.274 . . . . 0.0 111.683 -173.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 57.77 19.28 5.48 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.814 1.646 . . . . 0.0 113.192 -176.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.439 ' SG ' ' HA ' ' A' ' 79' ' ' ASP . 1.1 p -57.86 157.6 14.81 Favored Pre-proline 0 CA--C 1.546 0.807 0 O-C-N 119.337 -2.102 . . . . 0.0 109.885 167.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -72.23 -4.51 12.99 Favored 'Cis proline' 0 CA--C 1.543 0.974 0 CA-C-N 119.732 0.94 . . . . 0.0 113.857 -6.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.3 m -59.51 -62.3 1.98 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 120.237 1.38 . . . . 0.0 111.776 -178.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 43.2 mtp -75.39 -58.86 3.03 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 122.326 0.251 . . . . 0.0 110.385 -175.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -119.2 174.71 6.17 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 126.285 1.834 . . . . 0.0 109.096 -176.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -127.4 -14.32 5.33 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 115.702 1.741 . . . . 0.0 115.702 -174.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? 62.08 125.12 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 128.641 2.776 . . . . 0.0 114.064 -174.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.6 m -134.67 167.39 20.92 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -174.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -106.91 123.98 48.95 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.155 1.782 . . . . 0.0 108.786 172.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -126.43 -164.51 1.34 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.083 1.753 . . . . 0.0 112.488 -166.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -132.43 134.24 44.85 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 120.363 1.438 . . . . 0.0 113.195 -179.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.5 p -155.3 117.57 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 118.115 2.635 . . . . 0.0 118.115 -166.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -57.53 132.55 53.51 Favored 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 125.294 1.438 . . . . 0.0 109.263 -173.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 84.8 t -70.4 101.86 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 105.423 -2.065 . . . . 0.0 105.423 163.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.37 -34.35 67.89 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 167.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -163.9 149.44 10.91 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.818 2.047 . . . . 0.0 106.134 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 70.2 t-105 -124.93 132.57 53.27 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 125.555 1.542 . . . . 0.0 107.012 173.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -122.47 103.48 8.75 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.87 -174.01 15.64 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 125.28 1.419 . . . . 0.0 112.394 176.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -50.63 156.84 0.85 Allowed 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 126.03 1.732 . . . . 0.0 114.298 170.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.86 65.61 1.39 Allowed Glycine 0 N--CA 1.436 -1.363 0 N-CA-C 108.886 -1.686 . . . . 0.0 108.886 149.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -102.36 89.09 1.56 Allowed Pre-proline 0 CA--C 1.538 0.506 1 C-N-CA 133.301 4.641 . . . . 0.0 108.928 -155.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -71.81 -16.12 29.71 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 124.332 3.354 . . . . 0.0 116.14 -168.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 107.16 -167.49 13.76 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 120.541 1.518 . . . . 0.0 110.837 -165.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -68.93 -17.42 63.95 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -161.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.3 p -150.28 157.18 42.79 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 121.946 2.157 . . . . 0.0 109.176 -177.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.2 m -128.03 157.38 40.21 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.968 0 C-N-CA 115.795 -2.362 . . . . 0.0 109.272 -167.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -98.76 82.82 2.85 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 164.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 9.2 m -75.22 166.23 23.96 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 114.485 -1.234 . . . . 0.0 107.785 163.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -82.96 137.33 34.22 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 155.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 22.8 t -131.96 127.56 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 127.373 2.269 . . . . 0.0 107.852 174.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -63.69 118.52 8.38 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 170.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 36.0 p -130.85 179.56 5.91 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.551 1.141 . . . . 0.0 108.554 170.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.7 t -130.41 155.25 46.72 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 124.96 1.304 . . . . 0.0 107.801 170.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -120.09 -6.22 9.97 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 127.776 2.43 . . . . 0.0 111.743 175.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.5 t -130.98 69.57 1.47 Allowed 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -174.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.64 9.14 42.45 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.751 1.22 . . . . 0.0 113.703 -170.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 67.84 161.88 0.14 Allowed Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 127.302 2.241 . . . . 0.0 111.858 -177.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -66.97 -32.83 34.36 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 121.456 1.437 . . . . 0.0 113.998 -171.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -61.05 -38.66 86.98 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.568 1.147 . . . . 0.0 112.93 -173.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 46.0 m0 -75.22 -10.07 59.13 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 122.067 -0.396 . . . . 0.0 110.895 -169.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.75 -11.9 60.54 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.22 1.008 . . . . 0.0 111.996 173.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -109.92 -8.81 14.81 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.641 0.776 . . . . 0.0 112.081 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.5 mt -73.09 152.27 90.56 Favored Pre-proline 0 C--O 1.24 0.572 0 O-C-N 121.784 -0.572 . . . . 0.0 109.711 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.75 159.8 38.28 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.89 2.393 . . . . 0.0 110.787 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -102.9 172.79 6.62 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.86 0.864 . . . . 0.0 111.877 -176.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.492 ' HD1' ' CG ' ' A' ' 139' ' ' HIS . 92.0 m-70 -132.35 170.87 14.47 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 126.894 2.077 . . . . 0.0 108.785 -177.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -111.77 -14.9 13.51 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.808 0.843 . . . . 0.0 111.334 174.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 58.6 m -155.31 169.68 23.64 Favored 'General case' 0 C--O 1.233 0.237 0 O-C-N 120.404 -1.435 . . . . 0.0 110.053 170.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -104.0 -160.45 0.77 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 128.165 2.586 . . . . 0.0 106.797 158.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 23.9 t0 78.95 134.19 0.06 Allowed 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 129.492 3.117 . . . . 0.0 112.183 -171.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.8 -31.38 26.99 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.999 1.32 . . . . 0.0 110.974 173.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -67.61 -15.84 63.86 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.594 0.758 . . . . 0.0 112.844 176.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -77.64 155.92 43.84 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.885 1.231 . . . . 0.0 111.364 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.56 -19.18 32.62 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.771 2.314 . . . . 0.0 113.152 -172.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.492 ' CG ' ' HD1' ' A' ' 130' ' ' HIS . 43.4 m-70 -71.45 83.83 0.81 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.986 2.114 . . . . 0.0 109.429 -173.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -61.06 68.75 0.01 OUTLIER Glycine 0 CA--C 1.528 0.891 0 C-N-CA 128.527 2.965 . . . . 0.0 113.735 -177.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -178.1 57.97 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 130.973 3.709 . . . . 0.0 106.21 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -90.21 -168.0 2.0 Allowed 'General case' 0 N--CA 1.463 0.188 0 O-C-N 120.933 -1.104 . . . . 0.0 108.234 -176.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -60.32 136.72 58.12 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.585 1.084 . . . . 0.0 108.208 -176.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.51 ' ND2' HD22 ' A' ' 148' ' ' ASN . 35.6 m-20 -114.95 78.66 5.54 Favored Pre-proline 0 N--CA 1.453 -0.311 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 -178.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -70.35 -49.18 0.5 Allowed 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.012 1.808 . . . . 0.0 109.336 175.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 24.1 ttt180 -164.15 19.59 0.06 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.205 1.402 . . . . 0.0 111.422 -162.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -61.44 -33.25 73.41 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.466 -0.772 . . . . 0.0 110.727 175.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.51 HD22 ' ND2' ' A' ' 144' ' ' ASN . 12.1 p30 -146.11 5.45 0.98 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 127.266 2.227 . . . . 0.0 111.897 -162.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.143 0 C-N-CA 126.131 1.772 . . . . 0.0 112.163 -178.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 mtt . . . . . 0 N--CA 1.456 -0.139 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.98 158.38 43.83 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.933 1.293 . . . . 0.0 108.647 170.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -99.78 138.76 36.41 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 122.953 0.501 . . . . 0.0 110.463 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.4 pt -132.92 174.1 13.81 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 CA-C-O 122.001 0.905 . . . . 0.0 109.38 167.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -131.35 133.44 45.3 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.349 1.46 . . . . 0.0 108.257 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.2 m -70.0 119.35 15.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-O 122.024 0.916 . . . . 0.0 109.582 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -54.12 -40.55 67.46 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.393 1.477 . . . . 0.0 111.755 172.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 164.12 -44.19 0.31 Allowed Glycine 0 CA--C 1.526 0.757 0 CA-C-O 122.949 1.305 . . . . 0.0 110.583 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.58 -11.8 3.39 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.715 2.406 . . . . 0.0 115.74 -173.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -134.95 31.1 3.31 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 124.763 1.225 . . . . 0.0 110.638 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -117.91 -85.48 0.64 Allowed 'General case' 0 C--O 1.224 -0.239 0 CA-C-O 117.359 -1.305 . . . . 0.0 107.989 170.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.8 mmm180 -45.3 -84.12 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.446 1.498 . . . . 0.0 113.345 -171.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -167.06 15.58 0.08 OUTLIER Glycine 0 CA--C 1.53 0.997 0 C-N-CA 123.588 0.613 . . . . 0.0 112.229 -175.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -51.95 155.44 3.13 Favored Pre-proline 0 C--O 1.233 0.231 0 C-N-CA 125.406 1.482 . . . . 0.0 110.809 177.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -64.76 -3.88 7.61 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 124.171 3.247 . . . . 0.0 113.795 -172.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -110.4 -9.5 14.61 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-O 116.365 -1.779 . . . . 0.0 111.221 -167.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -53.76 -46.63 71.0 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 121.982 2.173 . . . . 0.0 109.725 -172.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.43 ' HA ' ' CD1' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -50.55 -19.34 0.87 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.903 1.681 . . . . 0.0 115.403 175.9 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.9 m -63.48 -24.11 35.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 121.525 1.966 . . . . 0.0 111.566 176.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.1 ptp -89.4 -0.12 57.25 Favored 'General case' 0 C--N 1.345 0.376 0 CA-C-N 120.183 1.356 . . . . 0.0 110.836 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.43 ' CD1' ' HA ' ' A' ' 18' ' ' LYS . 8.3 mp -96.13 9.29 41.37 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.868 2.067 . . . . 0.0 109.909 -169.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -129.95 110.16 11.46 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 119.119 0.872 . . . . 0.0 108.887 -178.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -58.51 -22.91 56.69 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -175.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.6 m -75.53 -26.04 57.7 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.437 -0.789 . . . . 0.0 112.845 173.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 49.0 m170 -69.63 -49.46 53.66 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 161.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 158.04 179.85 33.22 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-O 122.332 0.962 . . . . 0.0 111.863 172.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 28.9 tp -81.57 138.17 35.43 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.64 1.176 . . . . 0.0 111.303 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -149.77 120.95 7.78 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.225 1.01 . . . . 0.0 109.634 163.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.32 125.43 47.01 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 124.415 1.086 . . . . 0.0 109.864 -178.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -62.66 93.25 0.05 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 126.382 1.873 . . . . 0.0 110.588 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -95.55 61.12 2.27 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.212 1.005 . . . . 0.0 108.463 176.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.85 -160.53 51.69 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-O 122.656 1.142 . . . . 0.0 110.946 174.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 57.9 mtm180 -128.83 167.91 16.65 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 121.628 -0.924 . . . . 0.0 110.82 -161.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -177.43 175.47 47.61 Favored Glycine 0 C--N 1.336 0.556 0 O-C-N 121.348 -0.845 . . . . 0.0 114.01 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.1 p -142.89 156.86 44.99 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.965 1.306 . . . . 0.0 109.261 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 44.0 p -69.25 119.1 13.0 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 169.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.9 t -70.6 -44.18 77.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 173.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -58.25 123.27 15.48 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 126.142 1.777 . . . . 0.0 108.329 163.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.1 m -60.01 148.7 34.55 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 162.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -141.98 153.25 63.72 Favored Pre-proline 0 CA--C 1.541 0.61 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 165.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.43 ' HA ' ' HA3' ' A' ' 60' ' ' GLY . 45.2 Cg_endo -79.23 82.74 2.42 Favored 'Trans proline' 0 C--O 1.237 0.474 1 C-N-CA 125.58 4.187 . . . . 0.0 112.583 -178.799 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.98 122.99 26.27 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -134.39 144.7 34.39 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 C-N-CA 123.2 0.6 . . . . 0.0 110.838 174.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.0 mt -88.7 76.34 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 126.226 1.811 . . . . 0.0 106.882 168.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.75 -172.96 3.58 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 168.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.81 142.12 4.98 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.502 1.049 . . . . 0.0 112.187 165.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -76.69 2.27 14.7 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.182 -1.187 . . . . 0.0 112.861 -173.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 29.1 m-70 -120.26 17.75 12.28 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.094 1.358 . . . . 0.0 111.41 169.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 52.53 70.12 0.61 Allowed 'General case' 0 C--N 1.341 0.202 0 C-N-CA 126.166 1.787 . . . . 0.0 108.736 -174.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 72.9 mt -104.98 86.57 1.55 Allowed Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 102.751 -3.055 . . . . 0.0 102.751 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.64 144.47 72.38 Favored 'Trans proline' 0 N--CA 1.443 -1.473 0 CA-C-N 121.037 1.406 . . . . 0.0 110.762 175.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 72.3 m95 -112.43 -169.79 1.54 Allowed 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.939 1.296 . . . . 0.0 109.84 -175.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.2 tp -144.32 92.08 2.27 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 168.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.7 mt -71.78 122.21 20.29 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 -177.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -69.93 89.3 0.59 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.105 0.866 . . . . 0.0 110.561 -177.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.06 77.98 54.5 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 124.808 1.243 . . . . 0.0 108.357 176.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.16 121.28 9.4 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.451 2.101 . . . . 0.0 110.618 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.09 -1.38 51.15 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 126.444 1.973 . . . . 0.0 114.121 175.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -109.11 169.49 8.65 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 119.836 1.818 . . . . 0.0 109.835 172.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.439 ' HA2' ' CD2' ' A' ' 129' ' ' TYR . . . 88.69 -8.06 80.3 Favored Glycine 0 CA--C 1.533 1.165 0 N-CA-C 117.56 1.784 . . . . 0.0 117.56 155.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 75.54 167.39 0.28 Allowed 'General case' 0 C--N 1.322 -0.615 1 C-N-CA 134.818 5.247 . . . . 0.0 111.337 -172.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 76.3 m -69.09 170.81 9.27 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 120.988 -1.07 . . . . 0.0 110.607 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 43.0 t -134.78 104.32 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.9 p -72.46 155.79 39.73 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.62 -0.675 . . . . 0.0 109.706 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.56 -155.55 11.44 Favored Glycine 0 C--N 1.337 0.616 0 O-C-N 120.762 -1.211 . . . . 0.0 110.865 -175.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -144.07 171.22 14.57 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 127.694 2.397 . . . . 0.0 107.786 -179.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 81.8 mt -118.16 139.75 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 120.593 1.542 . . . . 0.0 109.379 -171.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -134.42 125.43 27.48 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.732 0.777 . . . . 0.0 110.082 176.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -72.42 132.94 44.57 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 161.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.6 m -135.38 164.7 32.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 123.755 0.822 . . . . 0.0 110.025 -177.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -115.85 176.14 5.22 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 176.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.33 -37.53 80.93 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 118.99 -0.529 . . . . 0.0 110.121 -168.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 36.0 tp60 -57.82 -40.88 81.03 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.829 0.851 . . . . 0.0 112.152 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 24.4 tpp -69.02 -48.82 62.04 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.5 tp -58.77 -32.85 69.67 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.1 mtt180 -74.64 -33.98 62.65 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.171 -0.956 . . . . 0.0 112.174 177.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -75.95 -49.11 18.67 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.532 0.733 . . . . 0.0 110.121 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.6 mp -55.89 -41.43 74.46 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -177.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.485 ' N ' ' HH ' ' A' ' 115' ' ' TYR . 15.4 t70 -44.87 -47.83 11.13 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.973 1.709 . . . . 0.0 111.234 174.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -71.47 -40.04 70.52 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.068 0.947 . . . . 0.0 111.911 176.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -65.45 -33.19 75.35 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.685 1.194 . . . . 0.0 110.534 -170.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -101.41 20.06 16.65 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 124.72 1.208 . . . . 0.0 113.291 174.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.1 t70 54.04 17.16 1.31 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.314 1.446 . . . . 0.0 112.776 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 16.2 t -61.99 145.38 92.99 Favored Pre-proline 0 N--CA 1.447 -0.58 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 177.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -80.69 -2.53 43.13 Favored 'Cis proline' 0 CA--C 1.54 0.815 0 N-CA-C 116.15 1.558 . . . . 0.0 116.15 0.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.4 m -63.4 -61.34 2.41 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 120.042 1.292 . . . . 0.0 112.572 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 12.3 mtp -83.12 -76.02 0.29 Allowed 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -177.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -85.34 169.83 13.34 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 176.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -146.18 126.6 14.05 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.858 1.663 . . . . 0.0 106.547 176.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -67.2 131.62 46.15 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.353 1.061 . . . . 0.0 110.048 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.7 m -128.82 177.1 7.32 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.604 1.962 . . . . 0.0 107.681 174.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -116.5 146.24 42.73 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.379 1.471 . . . . 0.0 110.053 167.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.34 178.76 7.36 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.556 1.942 . . . . 0.0 111.771 175.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 37.2 tp60 -109.73 115.89 30.69 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.933 1.693 . . . . 0.0 110.683 -178.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 70.5 t -108.99 145.74 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.57 1.148 . . . . 0.0 108.487 -177.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -85.4 142.74 29.06 Favored 'General case' 0 C--N 1.341 0.206 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 169.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.642 ' CG1' ' HA ' ' A' ' 108' ' ' ASP . 1.9 p -89.82 103.08 13.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 124.978 1.311 . . . . 0.0 109.029 172.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.69 -22.0 60.97 Favored 'General case' 0 C--N 1.331 -0.206 0 O-C-N 120.708 -1.245 . . . . 0.0 111.537 172.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -160.17 153.39 21.94 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 119.99 1.268 . . . . 0.0 108.437 177.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 48.5 t-105 -136.85 120.84 17.64 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.296 0.638 . . . . 0.0 109.713 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -108.24 99.56 8.96 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 125.269 1.427 . . . . 0.0 110.995 -177.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.69 -173.32 19.26 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 124.432 1.015 . . . . 0.0 110.936 174.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -67.06 171.12 5.87 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.104 0.562 . . . . 0.0 110.832 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.47 57.48 1.75 Allowed Glycine 0 C--O 1.22 -0.743 0 C-N-CA 125.154 1.359 . . . . 0.0 112.179 174.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -100.6 89.65 1.25 Allowed Pre-proline 0 N--CA 1.471 0.598 0 C-N-CA 126.984 2.114 . . . . 0.0 109.272 -167.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -57.93 -27.25 78.13 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.493 2.796 . . . . 0.0 113.514 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 126.3 -176.52 17.5 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 -161.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.642 ' HA ' ' CG1' ' A' ' 97' ' ' VAL . 36.7 t70 -81.44 4.92 19.25 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -173.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.8 p -137.33 156.23 48.48 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 118.802 -1.159 . . . . 0.0 110.783 156.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.2 p -130.92 152.74 38.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 124.305 1.042 . . . . 0.0 111.021 173.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -86.72 128.27 35.01 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.535 1.534 . . . . 0.0 108.216 170.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -137.06 167.95 20.54 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 127.158 2.183 . . . . 0.0 110.596 178.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -102.42 142.36 33.75 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 173.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 40.4 t -138.08 144.63 30.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 177.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.485 ' HH ' ' N ' ' A' ' 79' ' ' ASP . 61.6 m-85 -78.17 125.82 29.9 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 173.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 71.7 p -120.39 -173.96 2.69 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.965 1.306 . . . . 0.0 107.87 177.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.8 t -145.86 139.2 26.15 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 162.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -105.36 -8.25 18.31 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.439 0.695 . . . . 0.0 110.729 174.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 44.2 p -86.49 14.57 6.58 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.025 1.33 . . . . 0.0 113.251 -166.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -57.44 134.76 56.33 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.137 1.375 . . . . 0.0 113.343 -162.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.16 147.13 98.76 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.27 172.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.5 -27.28 46.56 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 121.753 1.635 . . . . 0.0 113.15 -174.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -50.57 -35.28 29.19 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.339 1.056 . . . . 0.0 111.141 171.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 35.8 m0 -82.66 12.73 4.36 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.542 0.61 . . . . 0.0 111.948 -173.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -91.19 -26.09 19.22 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 120.403 1.456 . . . . 0.0 111.506 163.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -89.16 -25.72 21.67 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 120.123 1.329 . . . . 0.0 112.297 -169.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . 0.459 0.2 OUTLIER -45.43 161.39 0.24 Allowed Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 126.666 1.987 . . . . 0.0 115.178 173.058 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -90.39 142.45 3.58 Favored 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 124.171 3.248 . . . . 0.0 108.557 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.439 ' CD2' ' HA2' ' A' ' 60' ' ' GLY . 9.3 m-30 -98.16 -177.96 3.9 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 124.198 0.999 . . . . 0.0 109.241 -169.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 46.4 m-70 -136.52 -178.69 5.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.608 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -134.24 -15.32 2.24 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 122.96 1.362 . . . . 0.0 111.908 170.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 29.7 p -144.96 153.2 41.27 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 161.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -92.03 157.45 16.77 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 167.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -170.41 139.15 1.63 Allowed 'General case' 0 C--O 1.241 0.607 0 CA-C-N 119.74 1.155 . . . . 0.0 108.989 166.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 66.6 m -81.18 -19.26 43.73 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.245 -0.91 . . . . 0.0 111.164 170.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -88.61 -11.77 44.5 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 120.374 1.443 . . . . 0.0 111.606 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.99 163.49 20.31 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.714 1.149 . . . . 0.0 112.019 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -71.82 -1.35 9.77 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 124.136 3.224 . . . . 0.0 113.637 -176.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -51.38 -29.79 16.78 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 126.425 1.89 . . . . 0.0 115.006 -169.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 74.35 -26.17 1.06 Allowed Glycine 0 CA--C 1.528 0.869 0 CA-C-O 118.458 -1.19 . . . . 0.0 112.963 -177.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.71 120.74 38.65 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 126.162 1.785 . . . . 0.0 109.206 167.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -136.23 162.54 32.68 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 126.475 1.91 . . . . 0.0 109.511 178.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -62.4 119.09 8.44 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -119.92 74.56 19.83 Favored Pre-proline 0 N--CA 1.452 -0.336 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -171.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -67.69 -54.97 0.3 Allowed 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 123.047 2.498 . . . . 0.0 111.837 -173.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -157.94 13.5 0.21 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -174.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.05 -3.44 35.86 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 128.385 2.674 . . . . 0.0 113.239 -178.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 19.5 p30 -136.89 -14.96 1.57 Allowed 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 26.9 mmm-85 . . . . . 0 C--O 1.247 0.967 0 C-N-CA 126.775 2.03 . . . . 0.0 112.134 168.771 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.46 ' HA ' ' OE2' ' A' ' 69' ' ' GLU . 42.9 mtt . . . . . 0 N--CA 1.47 0.545 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.02 97.04 2.64 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 127.071 2.148 . . . . 0.0 105.325 -177.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -65.98 123.68 20.5 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -176.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.5 pt -119.13 170.63 8.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 124.418 1.087 . . . . 0.0 108.609 173.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -135.99 141.78 44.44 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.459 HG12 ' H ' ' A' ' 66' ' ' GLU . 2.7 p -97.55 137.93 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -173.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -92.47 -46.63 7.55 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.488 1.515 . . . . 0.0 110.183 -178.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -159.09 6.6 0.14 Allowed Glycine 0 C--N 1.344 0.98 0 CA-C-O 116.909 -2.051 . . . . 0.0 117.821 -168.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p -131.16 -16.7 3.13 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 120.961 2.38 . . . . 0.0 115.995 -161.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.9 mp -140.04 71.17 1.37 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 120.582 1.537 . . . . 0.0 107.915 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.44 -85.46 0.07 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 118.591 -0.719 . . . . 0.0 112.005 -176.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -64.04 -67.42 0.43 Allowed 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.607 1.094 . . . . 0.0 110.152 -177.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 166.21 88.56 0.07 OUTLIER Glycine 0 N--CA 1.429 -1.789 0 N-CA-C 105.607 -2.997 . . . . 0.0 105.607 172.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -129.41 165.34 33.41 Favored Pre-proline 0 N--CA 1.443 -0.79 0 CA-C-O 117.578 -1.201 . . . . 0.0 108.485 -176.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -81.66 61.77 8.07 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.04 1.827 . . . . 0.0 113.973 -159.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -175.21 -5.75 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 129.264 3.026 . . . . 0.0 110.65 -178.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 18.5 t-160 -65.8 -46.15 79.75 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 121.839 2.109 . . . . 0.0 110.598 -177.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.17 -27.35 20.99 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -172.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.1 m -52.69 -42.79 42.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 119.383 0.992 . . . . 0.0 111.467 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.6 ptp -82.44 8.38 11.69 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 120.935 -1.103 . . . . 0.0 112.79 -174.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 20.7 mt -118.75 1.63 11.6 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.645 1.578 . . . . 0.0 110.666 -172.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -125.39 4.98 7.68 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.432 1.493 . . . . 0.0 114.264 -171.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . 0.271 9.5 t-80 42.17 26.45 0.06 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.877 2.471 . . . . 0.0 114.753 177.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.23 -32.51 10.48 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.36 1.064 . . . . 0.0 110.357 175.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -80.05 -35.34 37.3 Favored 'General case' 0 N--CA 1.456 -0.16 0 O-C-N 121.102 -0.999 . . . . 0.0 110.094 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 159.49 -174.56 36.38 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 -175.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -98.65 131.66 44.66 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.277 1.031 . . . . 0.0 109.116 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -132.85 156.87 46.37 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.499 1.52 . . . . 0.0 109.276 159.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -141.02 139.15 34.1 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 168.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -61.38 104.54 0.41 Allowed 'General case' 0 C--O 1.233 0.23 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 169.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.2 tpp180 -114.33 65.23 0.67 Allowed 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 -175.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.87 176.23 49.29 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-O 121.965 0.758 . . . . 0.0 111.814 -176.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -120.57 171.85 8.26 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.621 0.768 . . . . 0.0 109.69 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -177.96 178.85 48.53 Favored Glycine 0 C--N 1.333 0.403 0 O-C-N 121.086 -1.008 . . . . 0.0 114.346 -177.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.4 p -146.42 163.93 34.08 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.294 1.838 . . . . 0.0 108.527 172.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 49.9 p -86.91 103.69 15.54 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 168.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -63.75 -22.33 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 121.774 0.797 . . . . 0.0 111.636 171.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.68 116.44 6.24 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.764 0.792 . . . . 0.0 109.281 159.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.07 129.62 38.73 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.169 1.388 . . . . 0.0 108.219 164.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -138.96 158.35 69.92 Favored Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.15 81.74 2.37 Favored 'Trans proline' 0 N--CA 1.454 -0.85 1 C-N-CA 125.469 4.112 . . . . 0.0 109.165 172.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.37 110.94 16.3 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 162.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.4 m -127.88 127.92 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 118.818 0.736 . . . . 0.0 109.891 -173.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.5 mt -85.05 105.49 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 177.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -138.37 130.9 29.12 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 124.517 1.127 . . . . 0.0 109.464 -173.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.23 166.84 27.81 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-O 122.062 0.812 . . . . 0.0 112.629 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -93.28 -6.09 48.27 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 125.959 1.704 . . . . 0.0 113.569 -145.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -121.42 16.78 11.35 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.528 1.131 . . . . 0.0 110.811 177.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.2 m120 60.44 56.79 3.03 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.422 1.489 . . . . 0.0 109.183 175.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 61.0 mt -104.56 87.14 1.62 Allowed Pre-proline 0 C--N 1.322 -0.608 0 C-N-CA 130.128 3.371 . . . . 0.0 103.708 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -63.23 160.4 34.95 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 CA-C-N 120.721 1.293 . . . . 0.0 110.305 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 68.1 m95 -127.4 138.08 52.91 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.27 98.22 7.16 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.7 mt -80.54 147.79 30.66 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -172.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -83.39 81.31 8.77 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.02 -1.05 . . . . 0.0 109.75 -173.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.6 84.9 32.4 Favored Pre-proline 0 N--CA 1.467 0.424 0 C-N-CA 123.105 0.562 . . . . 0.0 110.03 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -63.46 136.17 53.4 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 121.468 1.445 . . . . 0.0 109.017 178.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.06 13.59 80.79 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 118.597 -1.113 . . . . 0.0 113.635 176.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -127.14 125.61 41.47 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 120.603 2.202 . . . . 0.0 106.538 172.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.28 -140.52 15.09 Favored Glycine 0 N--CA 1.463 0.471 0 CA-C-N 121.13 1.787 . . . . 0.0 111.974 -178.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 46.1 m-70 -133.89 160.99 35.99 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 117.715 0.758 . . . . 0.0 111.649 -166.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 63.2 m -72.45 117.21 13.83 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.166 1.387 . . . . 0.0 109.766 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 44.2 t -85.33 110.58 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.737 1.215 . . . . 0.0 108.671 -174.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 70.7 p -77.3 147.39 36.26 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.923 -1.111 . . . . 0.0 109.803 176.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.77 -150.35 6.25 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 -176.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.459 ' H ' HG12 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -148.49 160.97 42.54 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 126.102 1.761 . . . . 0.0 108.203 170.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 98.5 mt -102.25 134.16 43.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 -171.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -125.93 119.2 27.14 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.46 ' OE2' ' HA ' ' A' ' 1' ' ' MET . 0.7 OUTLIER -75.1 118.08 17.65 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 104.419 -2.437 . . . . 0.0 104.419 160.198 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.4 m -123.21 150.45 27.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 124.317 1.047 . . . . 0.0 108.72 -176.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -92.75 165.68 12.82 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 175.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -51.96 -29.99 22.91 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 126.595 1.958 . . . . 0.0 113.446 -174.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 12.0 tp60 -68.15 -42.44 80.08 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 122.244 -0.285 . . . . 0.0 110.701 178.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.2 ttm -71.78 -46.53 58.03 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 118.663 -0.684 . . . . 0.0 109.453 178.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.62 -26.04 67.74 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.39 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 36.6 mtm180 -73.84 -47.84 35.54 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 117.646 -1.169 . . . . 0.0 111.923 171.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -55.72 -47.45 76.85 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.607 1.094 . . . . 0.0 110.515 176.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.6 mp -61.45 -17.82 56.15 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.101 0.961 . . . . 0.0 113.122 176.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -84.5 -5.56 59.3 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.758 1.623 . . . . 0.0 111.972 176.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -125.25 -34.6 2.71 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.428 1.891 . . . . 0.0 111.028 -172.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -58.54 -46.88 85.89 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.582 1.553 . . . . 0.0 111.616 176.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -83.68 4.39 28.81 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 124.887 1.275 . . . . 0.0 112.367 -172.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.1 t0 44.98 25.51 0.16 Allowed 'General case' 0 C--O 1.24 0.554 0 C-N-CA 127.048 2.139 . . . . 0.0 115.497 -164.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 1.6 p -56.96 154.92 17.0 Favored Pre-proline 0 CA--C 1.545 0.776 0 O-C-N 119.592 -1.942 . . . . 0.0 108.56 158.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -74.15 -4.46 18.04 Favored 'Cis proline' 0 CA--C 1.544 0.978 0 N-CA-C 114.541 0.939 . . . . 0.0 114.541 -4.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 10.1 t -62.36 -68.84 0.29 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.506 1.048 . . . . 0.0 110.594 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 28.6 mtp -72.88 -64.57 0.94 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.854 0.862 . . . . 0.0 110.377 -171.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -105.01 176.84 5.03 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.031 0.932 . . . . 0.0 109.084 176.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -139.68 139.28 36.59 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 167.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -78.79 130.08 35.33 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.092 -1.005 . . . . 0.0 108.324 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 86.2 m -135.5 162.83 31.54 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -176.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -98.15 132.58 43.56 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.408 1.083 . . . . 0.0 108.466 173.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.423 ' CD2' ' HB ' ' A' ' 114' ' ' VAL . 2.4 pt? -149.42 -176.19 5.29 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.801 1.64 . . . . 0.0 111.892 -171.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 -105.09 135.36 46.58 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -175.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 84.8 t -134.68 128.77 51.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -69.61 121.42 17.08 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 104.188 -2.523 . . . . 0.0 104.188 163.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.567 ' CG1' ' HA ' ' A' ' 108' ' ' ASP . 14.8 p -63.02 119.47 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 156.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.1 -31.99 21.59 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 120.681 -1.262 . . . . 0.0 108.946 170.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -158.35 147.34 19.11 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 104.424 -2.436 . . . . 0.0 104.424 -175.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 66.2 t-105 -124.68 141.32 52.19 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -104.31 104.62 14.54 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.151 0.98 . . . . 0.0 108.687 173.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.28 -164.14 13.63 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-O 122.568 1.093 . . . . 0.0 114.162 165.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -78.36 161.04 27.47 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 114.509 -0.846 . . . . 0.0 109.325 177.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.86 64.38 1.68 Allowed Glycine 0 C--O 1.223 -0.59 0 C-N-CA 124.662 1.125 . . . . 0.0 110.866 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -102.0 89.25 1.52 Allowed Pre-proline 0 C--O 1.237 0.408 0 C-N-CA 129.98 3.312 . . . . 0.0 108.592 -166.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -66.18 -1.14 4.91 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 124.652 3.568 . . . . 0.0 114.495 -168.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.2 172.27 46.95 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-N 120.226 1.376 . . . . 0.0 110.062 -170.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.567 ' HA ' ' CG1' ' A' ' 97' ' ' VAL . 1.6 m-20 -70.91 -1.29 11.35 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -158.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 92.1 p -133.59 142.22 48.03 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 118.427 -1.309 . . . . 0.0 110.726 150.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.9 p -106.71 153.74 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 C-N-CA 125.806 1.642 . . . . 0.0 107.92 175.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 3.8 tm0? -89.8 112.4 23.71 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 161.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 48.4 m -102.9 175.96 5.31 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.854 0.862 . . . . 0.0 109.046 169.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -93.81 144.67 25.21 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 156.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.423 ' HB ' ' CD2' ' A' ' 93' ' ' LEU . 25.0 t -136.05 150.3 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 127.656 2.382 . . . . 0.0 105.878 173.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -88.4 119.84 29.21 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 171.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 43.2 p -124.12 -169.19 1.92 Allowed 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.983 1.313 . . . . 0.0 108.533 -178.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.04 146.59 31.95 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 169.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -112.93 -9.0 13.66 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.882 1.673 . . . . 0.0 111.274 169.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 11.2 t -98.95 16.63 21.88 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.237 1.415 . . . . 0.0 112.418 -169.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -60.92 154.63 21.8 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 125.137 1.375 . . . . 0.0 113.344 -172.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.27 156.51 91.64 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 125.631 1.572 . . . . 0.0 110.088 171.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -70.14 -36.78 9.2 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 121.764 1.643 . . . . 0.0 112.584 177.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -52.3 -33.89 44.38 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 119.283 0.947 . . . . 0.0 112.693 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 38.6 m0 -74.59 -7.09 52.04 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.68 0.792 . . . . 0.0 112.054 -174.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 60.6 mt -78.69 -26.69 44.95 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 121.238 -0.913 . . . . 0.0 111.838 171.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -92.1 -16.09 26.85 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.347 0.659 . . . . 0.0 111.8 -175.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.4 mt -57.92 157.69 14.89 Favored Pre-proline 0 N--CA 1.465 0.293 0 C-N-CA 125.489 1.516 . . . . 0.0 111.787 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -63.69 157.74 50.07 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.981 2.454 . . . . 0.0 110.113 172.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -111.49 158.95 18.55 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -139.05 148.4 43.31 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.398 0.279 . . . . 0.0 110.656 -177.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -87.13 -5.66 58.93 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.31 1.444 . . . . 0.0 112.175 176.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.6 t -167.69 170.88 10.6 Favored 'General case' 0 C--O 1.237 0.412 0 O-C-N 120.176 -1.577 . . . . 0.0 108.408 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -123.54 92.38 3.67 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 165.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.425 ' C ' ' H ' ' A' ' 136' ' ' GLU . 9.3 p-10 -99.28 97.27 8.36 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 128.512 2.725 . . . . 0.0 108.486 -172.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 7.1 t -65.24 7.74 0.18 Allowed 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.622 -1.299 . . . . 0.0 113.575 177.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.425 ' H ' ' C ' ' A' ' 134' ' ' ASP . 42.5 mt-10 -127.57 13.33 6.99 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.453 1.501 . . . . 0.0 110.45 -167.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -96.13 179.83 35.3 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 125.963 1.744 . . . . 0.0 112.52 -176.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -75.91 -3.55 14.0 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 124.201 3.267 . . . . 0.0 112.754 172.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -64.87 -24.28 67.49 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.462 1.028 . . . . 0.0 113.512 -167.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 79.72 -39.4 2.18 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 125.227 1.394 . . . . 0.0 113.659 172.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.71 100.87 4.81 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.542 1.937 . . . . 0.0 110.133 168.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -122.26 162.85 20.69 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 125.525 1.53 . . . . 0.0 109.502 171.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -63.26 127.98 33.75 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -176.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -119.24 76.95 17.05 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 123.608 0.763 . . . . 0.0 109.171 -177.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -76.27 -42.98 0.33 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.56 2.84 . . . . 0.0 113.381 178.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 5.9 ttt180 -135.79 -1.72 2.45 Favored 'General case' 0 CA--C 1.514 -0.427 0 O-C-N 121.541 -0.725 . . . . 0.0 112.709 -172.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -67.32 -34.4 77.28 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 127.103 2.161 . . . . 0.0 108.354 -171.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -132.11 29.73 4.33 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.553 2.341 . . . . 0.0 110.86 169.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 51.8 mmt-85 . . . . . 0 C--O 1.247 0.968 0 C-N-CA 125.314 1.446 . . . . 0.0 111.859 -172.369 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.1 ttt . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.443 ' HA ' ' CE2' ' A' ' 113' ' ' PHE . . . 45.34 -153.88 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -160.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 71.2 m80 69.95 121.67 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 128.082 2.553 . . . . 0.0 107.392 -157.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.6 pt -87.78 -179.43 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 167.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -129.59 140.84 51.09 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 165.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.4 p -106.1 118.05 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 -178.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -70.86 -63.77 1.03 Allowed 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 172.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.5 -21.23 0.11 Allowed Glycine 0 CA--C 1.526 0.747 0 O-C-N 120.933 -1.105 . . . . 0.0 114.449 -165.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.85 -28.52 22.83 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 -159.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.15 55.38 1.86 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 -174.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -160.03 -63.74 0.07 Allowed 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 124.459 1.103 . . . . 0.0 109.743 -173.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -72.31 -86.31 0.03 OUTLIER 'General case' 0 C--N 1.339 0.14 0 C-N-CA 123.975 0.91 . . . . 0.0 108.575 -168.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -161.16 17.79 0.19 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -62.55 148.27 90.94 Favored Pre-proline 0 C--O 1.238 0.49 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 173.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -64.54 -20.36 65.7 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 123.797 2.998 . . . . 0.0 112.922 -169.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -84.64 -16.13 43.04 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 117.919 -1.038 . . . . 0.0 112.649 -161.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -48.86 -34.39 12.49 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.134 0.974 . . . . 0.0 111.183 -173.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.66 -30.54 5.57 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 178.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.5 m -62.37 -23.36 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 120.148 1.34 . . . . 0.0 112.293 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.24 -10.96 53.61 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 119.788 1.176 . . . . 0.0 111.634 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 21.7 mt -94.27 -38.96 10.76 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 -173.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -75.24 83.77 2.4 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 176.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -49.15 -26.76 3.0 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.002 1.721 . . . . 0.0 114.246 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.52 -36.01 63.78 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.459 1.504 . . . . 0.0 111.379 173.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 45.5 m170 -68.51 -47.35 67.2 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.255 1.022 . . . . 0.0 109.439 171.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 167.19 178.12 39.29 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 174.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 64.4 tp -84.3 139.21 32.46 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 122.218 -0.578 . . . . 0.0 111.457 -176.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -142.29 157.95 44.26 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.018 1.327 . . . . 0.0 109.299 160.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -169.43 147.57 3.65 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 131.46 3.904 . . . . 0.0 108.258 178.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -72.61 106.75 4.77 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.797 1.639 . . . . 0.0 111.094 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.9 tpp180 -107.71 66.43 0.66 Allowed 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 177.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.47 -170.51 55.05 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-O 123.518 1.621 . . . . 0.0 113.266 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 77.8 mtm180 -122.52 165.37 16.52 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 125.064 1.345 . . . . 0.0 110.042 -171.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -168.82 177.57 42.6 Favored Glycine 0 C--N 1.334 0.45 0 O-C-N 121.583 -0.698 . . . . 0.0 112.994 173.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 30.2 p -148.43 153.27 38.3 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.219 1.808 . . . . 0.0 107.696 178.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.1 p -82.18 111.16 18.03 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 121.453 1.933 . . . . 0.0 107.154 173.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -76.02 -29.72 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 O-C-N 121.945 -0.472 . . . . 0.0 111.009 170.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -60.72 113.82 2.68 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 154.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 29.2 m -66.09 144.11 56.9 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 168.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.49 ' CE2' HD12 ' A' ' 93' ' ' LEU . 24.3 m-85 -145.46 154.86 53.43 Favored Pre-proline 0 CA--C 1.547 0.853 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -173.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -84.24 103.79 0.99 Allowed 'Trans proline' 0 CA--C 1.544 1.016 1 C-N-CA 126.224 4.616 . . . . 0.0 115.194 -172.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -105.87 103.23 12.68 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 120.489 -1.382 . . . . 0.0 107.721 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.1 m -124.97 127.83 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 127.007 2.123 . . . . 0.0 112.543 -174.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.0 mt -93.68 93.84 4.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -172.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.44 -179.54 4.52 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.906 1.282 . . . . 0.0 109.475 172.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.59 144.06 6.41 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.459 1.028 . . . . 0.0 111.914 164.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -72.35 -12.33 61.08 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -172.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 41.6 m-70 -106.4 13.81 28.09 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.325 1.05 . . . . 0.0 111.414 172.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.2 m120 58.32 73.6 0.47 Allowed 'General case' 0 C--N 1.341 0.227 0 C-N-CA 127.147 2.179 . . . . 0.0 108.83 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 64.1 mt -110.02 86.76 5.22 Favored Pre-proline 0 N--CA 1.449 -0.516 0 C-N-CA 125.112 1.365 . . . . 0.0 107.834 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -59.58 126.63 21.16 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.44 1.426 . . . . 0.0 111.879 171.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 67.2 m95 -104.81 126.21 51.66 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 128.239 2.615 . . . . 0.0 108.19 173.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -92.08 124.38 36.13 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 168.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.47 149.13 21.75 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -76.55 89.99 3.31 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.81 82.91 19.85 Favored Pre-proline 0 N--CA 1.467 0.392 0 O-C-N 120.901 -1.125 . . . . 0.0 110.229 172.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -61.88 134.73 51.61 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 122.236 1.957 . . . . 0.0 109.568 -177.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.94 -1.31 84.97 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-O 117.027 -1.985 . . . . 0.0 114.337 175.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.5 tppt? -128.11 136.26 50.92 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 121.084 2.442 . . . . 0.0 107.243 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 120.51 -113.08 2.31 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 107.378 -2.289 . . . . 0.0 107.378 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -160.88 172.36 17.1 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.79 1.636 . . . . 0.0 108.785 173.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 41.9 m -73.61 103.27 4.15 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.187 0.995 . . . . 0.0 111.173 170.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.7 t -78.07 107.82 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.733 1.213 . . . . 0.0 111.281 177.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.9 p -65.66 153.46 41.59 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.201 0.6 . . . . 0.0 111.163 177.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -173.58 -157.55 15.53 Favored Glycine 0 C--N 1.343 0.938 0 O-C-N 121.286 -0.884 . . . . 0.0 112.941 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -145.0 167.0 23.7 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.838 1.655 . . . . 0.0 109.569 174.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 71.0 mt -113.69 126.8 71.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 -172.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -117.56 115.52 25.3 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -67.79 81.62 0.19 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.121 1.368 . . . . 0.0 109.049 169.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.2 m -82.6 155.7 3.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 O-C-N 121.047 -1.033 . . . . 0.0 109.088 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.11 -178.8 4.9 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 121.921 0.867 . . . . 0.0 111.544 175.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.86 -45.02 93.78 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.979 1.312 . . . . 0.0 111.452 174.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 42.4 tp60 -59.86 -41.51 91.62 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 119.297 0.953 . . . . 0.0 110.139 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 59.3 tpp -65.88 -51.8 55.64 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 118.596 0.634 . . . . 0.0 110.584 176.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.23 -26.13 66.17 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -76.68 -55.04 5.86 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 123.951 0.9 . . . . 0.0 109.732 171.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -52.68 -48.8 66.29 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.152 0.581 . . . . 0.0 111.255 -177.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.507 ' C ' ' HH ' ' A' ' 115' ' ' TYR . 87.7 mt -62.39 -27.04 68.8 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 118.968 -0.539 . . . . 0.0 111.526 -178.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -67.39 -33.39 75.1 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.993 1.27 . . . . 0.0 109.587 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -75.9 -51.04 13.34 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.65 0.78 . . . . 0.0 110.701 172.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -66.17 -27.48 68.04 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.543 0.737 . . . . 0.0 112.572 -174.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.41 ' HG3' ' CE2' ' A' ' 115' ' ' TYR . 63.3 mm-40 -100.46 15.3 28.34 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.851 0.86 . . . . 0.0 111.093 177.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 52.23 28.09 5.29 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.458 1.903 . . . . 0.0 113.028 163.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 7.5 p -72.54 163.35 68.46 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.508 -1.37 . . . . 0.0 109.091 172.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -70.48 -4.01 9.07 Favored 'Cis proline' 0 CA--C 1.547 1.125 0 CA-C-N 119.99 1.032 . . . . 0.0 114.458 -10.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.1 m -60.1 -63.07 1.43 Allowed 'General case' 0 C--N 1.342 0.273 0 CA-C-N 119.561 1.073 . . . . 0.0 110.509 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 1.4 mtm -74.08 -77.69 0.11 Allowed 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.033 0.933 . . . . 0.0 109.683 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -97.83 -178.47 4.11 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.643 1.177 . . . . 0.0 108.934 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -138.13 -7.01 1.59 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 175.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? 61.28 134.22 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 128.459 2.704 . . . . 0.0 111.962 -173.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.9 m -152.73 153.76 33.86 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 120.463 -1.398 . . . . 0.0 110.501 174.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -84.62 126.93 33.78 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 129.137 2.975 . . . . 0.0 112.785 171.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.49 HD12 ' CE2' ' A' ' 40' ' ' PHE . 2.3 pt? -160.29 170.01 21.98 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 126.748 2.019 . . . . 0.0 112.182 -166.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 11.6 tp60 -94.5 131.35 40.3 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -162.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 35.5 t -135.3 119.79 27.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -177.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -67.48 143.16 56.35 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 168.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.625 ' CG1' ' HA ' ' A' ' 108' ' ' ASP . 2.4 p -90.79 126.13 43.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 176.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.53 -14.62 24.88 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 121.45 -0.782 . . . . 0.0 111.665 177.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -176.03 140.34 0.41 Allowed 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 103.582 -2.747 . . . . 0.0 103.582 -175.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 62.5 t-105 -125.47 139.34 53.71 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 171.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -109.44 114.26 27.76 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 123.848 0.718 . . . . 0.0 109.937 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.11 -165.02 42.9 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-O 121.65 0.583 . . . . 0.0 112.102 169.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -64.61 167.34 7.36 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.591 1.156 . . . . 0.0 111.481 -175.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.21 59.24 3.16 Favored Glycine 0 CA--C 1.525 0.688 0 O-C-N 121.931 -0.481 . . . . 0.0 112.267 173.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -101.71 89.15 1.4 Allowed Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 130.626 3.57 . . . . 0.0 110.656 -168.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -60.93 -14.47 32.94 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 124.081 3.187 . . . . 0.0 114.286 -171.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 95.07 176.19 37.84 Favored Glycine 0 CA--C 1.531 1.081 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -165.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.625 ' HA ' ' CG1' ' A' ' 97' ' ' VAL . 10.6 m-20 -69.82 0.91 4.95 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -162.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 61.8 p -137.74 146.66 43.94 Favored 'General case' 0 N--CA 1.427 -1.588 0 C-N-CA 117.124 -1.83 . . . . 0.0 111.725 150.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.1 p -110.27 159.68 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 114.29 -1.323 . . . . 0.0 109.059 173.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -89.37 112.96 24.2 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 156.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 14.1 m -99.89 171.48 7.83 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 165.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.443 ' CE2' ' HA ' ' A' ' 2' ' ' ALA . 19.6 m-85 -90.84 142.5 27.7 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 161.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.473 ' HB ' ' CD2' ' A' ' 93' ' ' LEU . 53.2 t -129.94 143.73 40.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 172.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.507 ' HH ' ' C ' ' A' ' 78' ' ' LEU . 8.9 m-85 -70.53 95.78 1.11 Allowed 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 167.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 80.5 p -109.42 173.39 6.34 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.948 171.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.7 t -142.19 121.9 13.44 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 175.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -93.0 4.78 53.42 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.359 0.664 . . . . 0.0 111.476 -178.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 47.3 p -118.83 43.56 2.52 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.085 1.354 . . . . 0.0 107.875 -171.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -78.48 171.15 15.52 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.477 -174.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -101.87 151.11 37.91 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 123.839 0.856 . . . . 0.0 110.272 -177.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -66.08 -37.35 25.96 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.916 2.411 . . . . 0.0 110.93 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.94 -0.66 9.73 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.81 1.644 . . . . 0.0 113.172 175.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 44.8 m0 -98.95 -24.72 14.83 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 118.882 0.765 . . . . 0.0 109.491 168.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 12.2 mt -75.89 -30.56 58.86 Favored 'General case' 0 CA--C 1.523 -0.064 0 O-C-N 120.94 -1.1 . . . . 0.0 111.554 177.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -64.25 -24.99 67.86 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.987 0.812 . . . . 0.0 111.965 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.0 mt -64.91 150.99 94.15 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 124.78 1.232 . . . . 0.0 110.429 -172.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -65.52 156.79 61.75 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.932 2.421 . . . . 0.0 110.441 175.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -106.62 159.32 16.28 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.628 0.251 . . . . 0.0 110.497 -172.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -134.06 106.23 7.11 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.754 0.822 . . . . 0.0 111.948 -174.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.33 -13.59 5.58 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.794 1.638 . . . . 0.0 114.173 -174.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 56.8 p -150.4 176.46 10.9 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.293 1.837 . . . . 0.0 107.071 173.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -129.16 166.19 19.82 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 168.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -158.11 164.63 36.45 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.218 1.807 . . . . 0.0 109.688 -175.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.3 t -109.32 -3.38 17.19 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.79 1.636 . . . . 0.0 111.061 167.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -140.14 102.72 4.44 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 128.642 2.777 . . . . 0.0 105.643 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -161.48 165.31 35.49 Favored Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 126.983 2.23 . . . . 0.0 111.836 -173.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.32 -18.78 55.87 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.286 2.657 . . . . 0.0 112.543 164.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -77.2 85.84 3.66 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 169.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.27 43.68 0.1 OUTLIER Glycine 0 CA--C 1.535 1.337 0 C-N-CA 127.749 2.595 . . . . 0.0 115.388 178.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.23 84.25 1.81 Allowed 'General case' 0 C--O 1.236 0.346 0 C-N-CA 127.316 2.246 . . . . 0.0 108.423 -172.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -120.72 155.0 34.84 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 118.193 -0.908 . . . . 0.0 109.727 -169.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -52.13 130.37 30.04 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 124.014 0.821 . . . . 0.0 109.329 -175.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -119.08 64.5 6.93 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 123.268 0.627 . . . . 0.0 110.808 -169.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.17 -48.39 0.36 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 123.125 2.55 . . . . 0.0 111.716 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.0 tpt180 -150.25 26.91 0.77 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.872 0.869 . . . . 0.0 110.886 -169.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -68.14 -67.08 0.49 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 169.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -98.82 2.13 46.5 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.89 0.876 . . . . 0.0 112.722 -176.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.998 0 CA-C-O 115.512 -2.185 . . . . 0.0 107.914 -155.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.499 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.56 117.24 28.45 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 167.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -81.48 124.0 29.08 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 174.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.8 pt -123.77 -176.02 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 123.785 0.834 . . . . 0.0 110.518 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.408 ' HB2' ' HG ' ' A' ' 112' ' ' CYS . 20.4 t80 -124.14 169.43 11.71 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.035 1.334 . . . . 0.0 108.502 174.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.438 HG13 ' H ' ' A' ' 66' ' ' GLU . 7.6 p -122.95 153.54 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 123.837 0.855 . . . . 0.0 109.882 175.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.413 ' CD1' ' N ' ' A' ' 7' ' ' TYR . 0.3 OUTLIER -92.62 -41.11 10.38 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 -171.076 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.408 ' HA3' ' HB3' ' A' ' 133' ' ' TYR . . . 169.45 -19.01 0.07 OUTLIER Glycine 0 CA--C 1.528 0.858 0 C-N-CA 124.743 1.163 . . . . 0.0 113.372 172.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.47 -30.21 71.37 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 128.224 2.609 . . . . 0.0 113.735 -176.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.9 61.1 1.18 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 175.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -151.75 -85.82 0.07 Allowed 'General case' 0 C--O 1.224 -0.279 0 O-C-N 121.239 -0.913 . . . . 0.0 109.86 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 -62.0 -53.62 53.12 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.069 0.85 . . . . 0.0 111.591 -166.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 161.21 30.24 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 -175.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -63.35 155.8 72.89 Favored Pre-proline 0 N--CA 1.45 -0.433 0 C-N-CA 124.83 1.252 . . . . 0.0 108.401 171.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -65.37 -12.58 35.55 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.207 2.604 . . . . 0.0 112.593 -174.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -95.14 24.96 4.53 Favored 'General case' 0 C--O 1.221 -0.415 0 C-N-CA 126.643 1.977 . . . . 0.0 111.454 -175.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -75.89 -55.64 5.43 Favored 'General case' 0 C--N 1.332 -0.18 0 O-C-N 120.442 -1.411 . . . . 0.0 110.116 173.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.04 -24.09 23.11 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -169.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.9 m -60.17 -34.81 58.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 119.675 1.125 . . . . 0.0 112.141 178.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.1 ptp -77.18 -7.7 56.29 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 119.472 1.033 . . . . 0.0 112.76 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 40.5 mt -89.47 7.0 38.32 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.832 1.253 . . . . 0.0 108.974 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -110.23 98.3 7.58 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -59.38 -21.8 60.42 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.867 -0.521 . . . . 0.0 111.563 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.7 t -70.33 -29.19 65.84 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.873 1.269 . . . . 0.0 112.016 175.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 35.1 m170 -79.59 -32.44 41.93 Favored 'General case' 0 CA--C 1.529 0.147 0 O-C-N 121.351 -0.843 . . . . 0.0 109.739 168.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 158.15 175.67 29.34 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 165.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 65.0 tp -74.57 134.0 42.19 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 175.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.8 143.59 31.41 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 155.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -152.01 149.9 29.39 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 165.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -62.18 104.76 0.51 Allowed 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.973 1.709 . . . . 0.0 108.663 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.9 tpp180 -123.56 67.84 1.02 Allowed 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.15 -170.86 45.58 Favored Glycine 0 N--CA 1.435 -1.4 0 CA-C-O 123.824 1.791 . . . . 0.0 111.915 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -131.04 158.91 39.07 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 125.436 1.494 . . . . 0.0 108.257 -170.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.99 173.98 38.4 Favored Glycine 0 CA--C 1.507 -0.463 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.741 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.0 m -141.67 145.95 35.54 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 173.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.2 p -71.65 93.17 1.22 Allowed 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 163.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.9 m -63.41 -38.46 82.25 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.106 0 CA-C-O 121.206 0.527 . . . . 0.0 109.892 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.81 118.23 7.43 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 105.218 -2.141 . . . . 0.0 105.218 170.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.74 145.92 50.96 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -141.25 160.62 56.82 Favored Pre-proline 0 N--CA 1.449 -0.475 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 177.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -80.28 67.45 8.62 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 122.532 2.155 . . . . 0.0 113.987 -175.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 53' ' ' LEU . 34.0 tp -72.72 98.63 2.42 Favored 'General case' 0 CA--C 1.553 1.082 0 O-C-N 119.757 -1.839 . . . . 0.0 111.356 178.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.5 m -121.68 126.74 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 119.625 1.102 . . . . 0.0 112.763 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 51.1 mt -69.84 111.67 3.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 173.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -125.98 175.03 8.0 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.457 1.103 . . . . 0.0 108.782 176.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.01 152.74 7.91 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-O 122.61 1.117 . . . . 0.0 111.544 171.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -70.06 -23.41 63.08 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 123.526 0.731 . . . . 0.0 112.34 -176.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -94.44 13.27 24.36 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.429 0.692 . . . . 0.0 111.391 -177.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.517 HD21 ' HB2' ' A' ' 141' ' ' LEU . 2.1 m120 63.22 56.78 1.67 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.04 1.736 . . . . 0.0 107.592 171.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 80.5 mt -107.29 87.91 3.56 Favored Pre-proline 0 CA--C 1.533 0.288 0 C-N-CA 127.253 2.221 . . . . 0.0 107.476 -167.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -54.33 139.76 73.35 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 120.846 1.03 . . . . 0.0 111.652 169.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 6.2 m95 -123.3 146.29 48.02 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 167.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 42' ' ' LEU 0.295 0.9 OUTLIER -97.16 -8.86 29.07 Favored 'General case' 0 C--O 1.219 -0.529 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 -177.741 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 36.7 mt 44.1 -160.8 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.312 1 C-N-CA 134.825 5.25 . . . . 0.0 110.069 -172.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -130.95 91.43 3.05 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 120.848 -1.158 . . . . 0.0 110.225 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.57 85.72 5.22 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 118.968 -0.539 . . . . 0.0 111.616 168.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -59.75 134.41 57.24 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.754 1.636 . . . . 0.0 109.257 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.74 10.43 81.35 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-O 119.568 -0.573 . . . . 0.0 113.618 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? -123.03 155.03 37.68 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.779 1.79 . . . . 0.0 108.444 172.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.468 ' HA2' ' CD2' ' A' ' 129' ' ' TYR . . . 67.96 -146.39 46.39 Favored Glycine 0 C--N 1.334 0.458 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 -174.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -127.45 169.36 13.73 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 117.833 0.816 . . . . 0.0 108.849 -169.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 5.1 p -59.8 169.67 1.35 Allowed 'General case' 0 CA--C 1.512 -0.486 0 O-C-N 121.665 -0.647 . . . . 0.0 112.122 170.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 54.9 t -135.49 118.41 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.792 168.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 72.5 p -74.72 154.76 38.27 Favored 'General case' 0 C--O 1.239 0.512 0 O-C-N 121.756 -0.59 . . . . 0.0 110.237 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.59 -164.96 28.91 Favored Glycine 0 C--N 1.337 0.608 0 CA-C-O 122.202 0.89 . . . . 0.0 111.761 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.438 ' H ' HG13 ' A' ' 6' ' ' VAL . 0.5 OUTLIER -117.57 156.82 27.43 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 124.886 1.274 . . . . 0.0 108.662 179.206 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 73.2 mt -101.34 130.33 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 170.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -116.45 120.96 40.46 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -62.54 116.18 4.91 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 156.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.3 m -123.89 175.53 6.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 CA-C-N 118.429 0.559 . . . . 0.0 109.978 174.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -125.6 176.18 7.05 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.954 0.902 . . . . 0.0 109.208 169.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -53.13 -37.62 61.95 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.682 1.593 . . . . 0.0 112.204 -175.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 42.8 tp60 -61.15 -41.99 97.75 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 118.465 -0.778 . . . . 0.0 111.133 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -67.04 -44.74 79.44 Favored 'General case' 0 C--O 1.225 -0.232 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.2 tp -62.91 -29.53 70.85 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -176.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 62.3 mtt180 -74.69 -38.58 62.33 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 121.949 -0.47 . . . . 0.0 111.992 172.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -66.65 -48.74 68.47 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 119.23 -0.414 . . . . 0.0 110.228 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.8 mp -51.02 -50.32 58.78 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.353 1.461 . . . . 0.0 110.256 174.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -49.67 -43.6 47.31 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.712 0.805 . . . . 0.0 112.016 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -79.35 -13.74 59.44 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.57 2.348 . . . . 0.0 112.709 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -91.12 -42.99 10.16 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.355 1.462 . . . . 0.0 109.664 -175.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . 0.252 0.4 OUTLIER -90.03 9.46 27.92 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.75 1.22 . . . . 0.0 114.009 170.844 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 61.01 36.04 18.7 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.112 1.365 . . . . 0.0 111.105 167.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 6.5 m -79.03 166.53 41.49 Favored Pre-proline 0 C--N 1.323 -0.585 0 C-N-CA 125.061 1.344 . . . . 0.0 108.796 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -64.94 -3.42 2.81 Favored 'Cis proline' 0 CA--C 1.545 1.027 0 CA-C-N 120.082 1.065 . . . . 0.0 113.598 -17.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.76 -66.57 0.37 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.849 1.66 . . . . 0.0 111.193 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 19.4 mtm -83.33 -63.83 1.28 Allowed 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.83 -0.544 . . . . 0.0 110.362 -176.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -103.91 170.11 8.11 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -177.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.91 137.62 38.2 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 120.406 -1.434 . . . . 0.0 107.138 176.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.416 ' HB2' ' CE1' ' A' ' 115' ' ' TYR . 8.4 tmm_? -78.7 123.36 27.07 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 123.899 0.879 . . . . 0.0 108.984 -174.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.6 m -123.96 160.61 27.2 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 123.855 0.862 . . . . 0.0 108.884 -177.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -98.2 140.6 32.25 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 124.018 0.927 . . . . 0.0 109.212 169.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.15 169.17 23.08 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.963 0.905 . . . . 0.0 111.483 -177.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -95.81 119.86 35.05 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.83 1.652 . . . . 0.0 110.083 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 95.0 t -117.71 136.95 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 177.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -71.9 148.88 45.65 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 123.813 0.845 . . . . 0.0 111.244 172.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.0 t -87.97 95.07 4.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 125.305 1.442 . . . . 0.0 107.306 167.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.35 -24.94 50.64 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.454 1.101 . . . . 0.0 110.724 172.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -162.49 157.32 22.13 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 127.856 2.462 . . . . 0.0 105.096 173.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 75.1 t-105 -145.66 121.83 10.82 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 169.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -105.97 92.55 4.2 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.611 0.764 . . . . 0.0 109.864 176.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 135.66 -179.45 17.76 Favored Glycine 0 C--O 1.227 -0.343 0 C-N-CA 124.233 0.921 . . . . 0.0 112.687 168.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -68.12 155.69 39.06 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 171.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 102.21 56.09 0.84 Allowed Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 124.878 1.228 . . . . 0.0 111.059 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -100.11 91.02 1.5 Allowed Pre-proline 0 C--N 1.327 -0.399 0 C-N-CA 129.591 3.157 . . . . 0.0 106.516 -171.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -66.84 -23.82 47.39 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 124.417 3.411 . . . . 0.0 112.362 -178.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 123.23 -172.66 16.12 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 -165.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.66 -6.6 26.91 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -170.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 67.8 p -151.76 157.91 42.62 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 119.072 0.851 . . . . 0.0 111.816 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.0 m -136.69 169.05 20.7 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 C-N-CA 125.071 1.348 . . . . 0.0 108.571 -171.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -108.65 93.13 4.36 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 177.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.408 ' HG ' ' HB2' ' A' ' 5' ' ' PHE . 95.3 m -79.19 176.97 9.18 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.379 0.609 . . . . 0.0 109.915 177.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -107.72 145.95 32.76 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 158.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.3 t -138.8 143.06 32.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 128.017 2.527 . . . . 0.0 106.44 174.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.416 ' CE1' ' HB2' ' A' ' 90' ' ' ARG . 16.3 m-85 -84.9 104.59 14.99 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 167.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 11.1 p -99.12 -171.49 2.1 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.48 1.912 . . . . 0.0 108.626 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.7 t -147.98 150.88 34.81 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 156.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -114.91 -12.48 12.05 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 128.215 2.606 . . . . 0.0 111.384 176.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 5.8 p -88.81 9.07 25.93 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.329 1.452 . . . . 0.0 113.807 -169.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -69.0 164.36 22.53 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.787 1.235 . . . . 0.0 112.72 -170.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -93.82 153.69 40.99 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 125.258 1.423 . . . . 0.0 110.324 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -62.14 -27.29 78.64 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.587 2.858 . . . . 0.0 113.548 -174.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -49.77 -43.01 47.91 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.243 1.017 . . . . 0.0 112.113 176.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 42.2 m0 -70.55 -15.85 62.82 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 122.485 0.314 . . . . 0.0 111.339 -172.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -82.65 -10.96 58.7 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.059 0.944 . . . . 0.0 112.367 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -96.39 -16.02 21.48 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.685 0.794 . . . . 0.0 110.992 175.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 88.4 mt -68.42 155.85 91.7 Favored Pre-proline 0 N--CA 1.469 0.497 0 C-N-CA 124.149 0.979 . . . . 0.0 109.561 176.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -79.62 154.5 23.84 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 121.786 1.657 . . . . 0.0 110.497 173.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.468 ' CD2' ' HA2' ' A' ' 60' ' ' GLY . 44.5 m-85 -85.79 175.87 8.44 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 126.357 1.863 . . . . 0.0 111.108 177.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.451 ' HD1' ' CE1' ' A' ' 139' ' ' HIS . 55.4 m-70 -142.7 161.11 38.95 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.625 1.97 . . . . 0.0 107.984 -178.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -110.02 -2.65 16.93 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 122.684 1.231 . . . . 0.0 112.544 -177.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.5 t -164.11 154.38 14.91 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.408 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . 7.9 t80 -108.98 116.59 32.28 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.194 167.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -143.51 125.11 14.9 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.576 2.35 . . . . 0.0 108.225 -168.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.2 p -68.64 -47.55 66.31 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 169.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -75.42 43.42 0.23 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.706 2.003 . . . . 0.0 110.61 170.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -110.73 163.03 12.35 Favored Glycine 0 C--N 1.332 0.327 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 166.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.11 -14.61 44.59 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.749 2.3 . . . . 0.0 113.122 -175.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.451 ' CE1' ' HD1' ' A' ' 130' ' ' HIS . 64.0 m-70 -62.79 -14.52 46.17 Favored 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 116.828 2.158 . . . . 0.0 116.828 -162.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 75.53 -29.85 1.23 Allowed Glycine 0 CA--C 1.537 1.409 0 CA-C-N 120.406 1.457 . . . . 0.0 115.295 172.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.517 ' HB2' HD21 ' A' ' 49' ' ' ASN . 0.3 OUTLIER -97.37 97.37 9.06 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 126.339 1.856 . . . . 0.0 110.949 179.325 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -104.58 162.55 13.16 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 120.865 -1.147 . . . . 0.0 109.872 -173.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -57.35 142.17 44.52 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 119.004 -0.522 . . . . 0.0 110.151 -176.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 31.9 t-20 -114.93 85.17 11.5 Favored Pre-proline 0 C--O 1.234 0.241 0 C-N-CA 125.295 1.438 . . . . 0.0 107.765 176.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.66 -45.33 0.55 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.327 2.018 . . . . 0.0 111.039 172.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -163.18 14.83 0.07 Allowed 'General case' 0 C--O 1.224 -0.285 0 C-N-CA 125.744 1.618 . . . . 0.0 111.622 -174.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -63.73 -13.59 44.81 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 -165.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -131.25 16.7 5.01 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 129.263 3.025 . . . . 0.0 110.849 -178.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.127 0 C-N-CA 124.773 1.229 . . . . 0.0 108.936 -170.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.468 0.434 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.06 121.5 1.24 Allowed 'General case' 0 C--O 1.235 0.316 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 168.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -80.57 142.48 34.05 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 118.492 0.587 . . . . 0.0 111.213 -175.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.8 pt -133.62 -176.13 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 124.407 1.083 . . . . 0.0 109.913 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -120.74 164.68 16.2 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.275 1.43 . . . . 0.0 109.011 172.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 p -111.6 148.84 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.771 0.829 . . . . 0.0 112.309 -175.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -92.24 7.04 44.46 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -168.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 106.84 -33.32 6.51 Favored Glycine 0 N--CA 1.467 0.715 0 O-C-N 120.54 -1.35 . . . . 0.0 110.057 -164.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.64 -24.05 66.24 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 129.8 3.24 . . . . 0.0 114.771 -170.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.1 mp -146.07 48.23 1.22 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.471 1.032 . . . . 0.0 109.258 -173.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -130.97 -85.53 0.51 Allowed 'General case' 0 N--CA 1.468 0.452 0 O-C-N 120.254 -1.529 . . . . 0.0 111.582 176.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.11 -66.79 0.42 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.888 1.222 . . . . 0.0 109.383 -178.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 174.82 86.24 0.06 OUTLIER Glycine 0 N--CA 1.431 -1.691 0 N-CA-C 104.957 -3.257 . . . . 0.0 104.957 -178.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -107.5 160.27 27.23 Favored Pre-proline 0 N--CA 1.445 -0.701 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 174.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -61.49 -27.4 82.14 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.937 2.425 . . . . 0.0 112.343 -174.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -73.52 -16.26 61.28 Favored 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 125.182 1.393 . . . . 0.0 110.842 -173.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -64.36 -32.85 74.63 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 120.115 1.325 . . . . 0.0 112.153 -159.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.94 -19.96 47.76 Favored 'General case' 0 C--O 1.224 -0.279 0 O-C-N 121.409 -0.807 . . . . 0.0 113.044 176.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.4 p -55.92 -35.58 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 119.179 0.899 . . . . 0.0 110.956 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.2 ptp -87.97 -4.92 58.77 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -176.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 73.5 mt -90.47 -6.38 54.91 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.505 1.122 . . . . 0.0 110.67 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -106.21 99.91 9.47 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 106.174 -1.788 . . . . 0.0 106.174 172.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 25.6 t-80 -59.03 -18.93 39.11 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.841 1.256 . . . . 0.0 113.285 -176.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.7 m -61.82 -28.34 69.41 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 120.972 -1.08 . . . . 0.0 113.674 169.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -78.69 -1.91 36.7 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 119.241 0.928 . . . . 0.0 111.803 173.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.16 176.65 19.51 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 127.037 2.256 . . . . 0.0 110.571 -176.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -93.76 137.0 33.46 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.521 1.528 . . . . 0.0 110.177 -172.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.16 125.21 15.29 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.474 1.11 . . . . 0.0 110.664 165.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -133.29 126.0 30.51 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 125.228 1.411 . . . . 0.0 109.878 -176.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -60.07 108.53 0.79 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.053 1.741 . . . . 0.0 109.501 -178.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.0 tpp180 -121.15 66.37 0.87 Allowed 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.871 1.268 . . . . 0.0 109.902 -174.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.21 -171.56 55.16 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 176.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.45 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 32.2 mtp85 -123.24 169.19 11.53 Favored 'General case' 0 CA--C 1.511 -0.534 0 O-C-N 121.965 -0.727 . . . . 0.0 111.974 -174.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -166.66 173.52 42.03 Favored Glycine 0 CA--C 1.506 -0.526 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.745 175.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 25.8 p -142.99 161.01 39.25 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.999 -0.6 . . . . 0.0 109.558 171.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.6 p -76.57 103.88 6.79 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 106.328 -1.731 . . . . 0.0 106.328 164.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -62.4 -32.17 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 119.503 1.047 . . . . 0.0 110.435 171.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.23 124.74 23.47 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 167.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.24 131.4 44.84 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 125.479 1.511 . . . . 0.0 108.029 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -140.39 157.1 69.21 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 119.472 1.033 . . . . 0.0 108.406 -177.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -70.04 108.05 2.05 Favored 'Trans proline' 0 N--CA 1.454 -0.851 1 C-N-CA 125.525 4.15 . . . . 0.0 108.438 171.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -117.84 99.38 6.89 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 173.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.6 m -132.58 141.46 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 C-N-CA 126.386 1.874 . . . . 0.0 108.864 -167.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.7 mp -109.73 121.21 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -171.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.3 -170.11 3.0 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.295 1.438 . . . . 0.0 108.707 -173.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.79 164.29 4.33 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.337 0.97 . . . . 0.0 111.145 -174.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -78.5 2.74 18.03 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.598 1.159 . . . . 0.0 113.271 -172.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -132.14 17.08 4.57 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.836 1.254 . . . . 0.0 112.445 -171.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.0 m120 56.7 72.87 0.48 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.351 1.86 . . . . 0.0 111.117 -177.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 94.4 mt -110.49 89.49 8.93 Favored Pre-proline 0 C--N 1.324 -0.518 0 C-N-CA 129.267 3.027 . . . . 0.0 107.488 -169.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -52.65 134.1 52.24 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 CA-C-N 120.872 1.347 . . . . 0.0 111.927 171.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 70.8 m95 -118.29 137.76 52.84 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.171 1.388 . . . . 0.0 107.309 170.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.93 94.61 5.17 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 171.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.6 mt -76.07 143.86 41.09 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 -176.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -79.64 75.86 6.28 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.764 -0.585 . . . . 0.0 110.496 -175.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.64 83.32 53.98 Favored Pre-proline 0 N--CA 1.468 0.428 0 C-N-CA 123.728 0.811 . . . . 0.0 109.887 -176.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -63.62 148.99 92.0 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 121.363 1.375 . . . . 0.0 108.815 178.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.6 2.34 60.14 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-O 117.637 -1.646 . . . . 0.0 114.898 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.2 tppt? -124.94 121.71 35.24 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 121.75 2.775 . . . . 0.0 106.291 177.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.509 ' HA2' ' CD2' ' A' ' 129' ' ' TYR . . . 108.2 -147.07 16.48 Favored Glycine 0 N--CA 1.459 0.228 0 CA-C-N 120.601 1.546 . . . . 0.0 110.766 -176.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -137.01 173.99 11.1 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 123.936 0.894 . . . . 0.0 110.198 -168.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 61.4 m -78.08 113.6 16.16 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.498 0.719 . . . . 0.0 110.251 -178.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 38.2 t -78.34 111.16 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 124.183 0.993 . . . . 0.0 108.339 -177.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 51.6 p -92.92 151.22 20.07 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 119.17 0.895 . . . . 0.0 111.762 -173.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -178.92 -163.83 30.67 Favored Glycine 0 C--N 1.337 0.605 0 O-C-N 121.277 -0.889 . . . . 0.0 113.588 -163.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 1.5 pt-20 -120.73 177.37 5.11 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 87.7 mt -121.69 115.58 46.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 169.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -89.71 130.84 35.92 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 168.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -70.57 130.16 41.09 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 152.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.3 m -134.04 167.92 25.1 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 CA-C-O 121.144 0.497 . . . . 0.0 110.35 177.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.86 -179.42 4.28 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 122.427 1.108 . . . . 0.0 111.046 167.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.3 -42.76 96.22 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 115.85 -2.024 . . . . 0.0 111.527 177.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.1 mm100 -55.05 -43.16 73.56 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 120.522 1.51 . . . . 0.0 110.763 177.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 39.1 tpp -66.1 -51.46 57.83 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 119.09 -0.481 . . . . 0.0 110.36 178.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.04 -28.16 66.17 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 118.831 0.742 . . . . 0.0 112.034 177.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 35.4 mtt180 -75.19 -43.81 49.99 Favored 'General case' 0 C--N 1.337 0.052 0 C-N-CA 125.625 1.57 . . . . 0.0 111.033 179.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -57.94 -54.7 43.94 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 123.541 0.737 . . . . 0.0 109.332 175.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 mp -49.74 -41.15 43.15 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.115 0.966 . . . . 0.0 110.613 178.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -65.94 -1.19 2.79 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.092 1.757 . . . . 0.0 114.277 178.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -129.83 3.85 4.94 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.261 2.224 . . . . 0.0 111.132 178.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -102.59 -47.13 4.54 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.932 1.293 . . . . 0.0 110.166 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.477 ' HB2' ' HG ' ' A' ' 84' ' ' CYS . 8.2 mm-40 -75.17 1.51 13.17 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -175.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.0 t70 54.13 26.2 6.36 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.301 1.441 . . . . 0.0 112.578 -165.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.477 ' HG ' ' HB2' ' A' ' 82' ' ' GLU . 1.5 p -63.98 159.19 57.48 Favored Pre-proline 0 CA--C 1.542 0.672 0 O-C-N 119.411 -2.055 . . . . 0.0 109.154 166.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -73.24 -4.06 15.04 Favored 'Cis proline' 0 CA--C 1.546 1.096 0 CA-C-N 119.417 0.827 . . . . 0.0 113.583 -10.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.63 -63.39 1.3 Allowed 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.262 1.425 . . . . 0.0 112.966 -177.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 4.2 mtm -82.58 -55.85 4.21 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 122.785 0.434 . . . . 0.0 110.35 -172.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -109.8 173.03 6.51 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 127.6 2.36 . . . . 0.0 106.993 176.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 -132.17 157.67 43.69 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 120.867 1.667 . . . . 0.0 108.224 160.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.0 tmm_? -80.6 142.77 33.72 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 118.897 0.771 . . . . 0.0 109.107 172.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.7 m -143.4 161.49 38.24 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.673 0.749 . . . . 0.0 109.312 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -114.3 125.02 53.41 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 126.64 1.976 . . . . 0.0 108.317 171.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.466 ' CD2' ' HB ' ' A' ' 114' ' ' VAL . 2.1 pt? -142.99 -167.0 2.43 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 129.918 3.287 . . . . 0.0 108.688 -166.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 20.7 tp60 -107.5 138.97 42.74 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.491 0.716 . . . . 0.0 111.904 177.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 99.5 t -133.87 135.97 54.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 172.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -76.45 153.3 35.73 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.549 1.539 . . . . 0.0 109.653 169.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 80.7 t -87.33 112.68 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 127.565 2.346 . . . . 0.0 107.58 165.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.5 mp -90.51 -17.87 26.3 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.241 1.416 . . . . 0.0 110.641 171.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -172.18 159.85 4.98 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 129.041 2.936 . . . . 0.0 105.672 173.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 62.7 t-105 -141.81 118.02 10.73 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 119.339 0.972 . . . . 0.0 109.708 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -118.04 62.29 0.76 Allowed 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.914 0.864 . . . . 0.0 112.67 -171.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 150.18 155.15 6.71 Favored Glycine 0 C--O 1.228 -0.254 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 158.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -54.24 149.41 9.85 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.598 1.159 . . . . 0.0 112.079 -162.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 98.16 65.98 0.88 Allowed Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -165.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -100.82 89.1 1.15 Allowed Pre-proline 0 C--O 1.24 0.579 1 C-N-CA 132.509 4.324 . . . . 0.0 108.152 -162.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -72.79 -5.19 16.73 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 124.675 3.584 . . . . 0.0 114.126 -163.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.74 -177.19 44.92 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 109.251 -1.539 . . . . 0.0 109.251 -166.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -64.36 -12.02 38.34 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 -168.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.0 p -137.41 161.79 35.37 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 120.726 1.603 . . . . 0.0 112.457 177.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.5 m -142.65 156.71 18.46 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 125.366 1.466 . . . . 0.0 108.913 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -98.08 98.64 9.93 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.444 -1.688 . . . . 0.0 106.444 160.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 18.6 m -92.05 172.37 8.49 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 168.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -85.68 140.4 30.57 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 162.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.466 ' HB ' ' CD2' ' A' ' 93' ' ' LEU . 25.5 t -134.61 124.9 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 127.461 2.304 . . . . 0.0 106.052 173.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -72.63 141.08 48.33 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 168.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 55.6 p -138.37 -173.2 3.47 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.19 1.796 . . . . 0.0 109.675 -173.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.4 t -134.63 145.04 48.23 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 165.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -113.59 -8.96 13.28 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.864 1.666 . . . . 0.0 112.073 169.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 31.4 p -105.76 15.42 26.81 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.659 1.184 . . . . 0.0 113.11 -172.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -58.9 149.72 26.22 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 125.832 1.653 . . . . 0.0 113.803 -170.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.64 154.59 88.12 Favored Pre-proline 0 CA--C 1.532 0.283 0 C-N-CA 125.444 1.498 . . . . 0.0 110.961 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.08 -30.81 20.22 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.033 1.822 . . . . 0.0 113.335 178.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.07 -30.25 70.23 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 173.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 43.2 m0 -72.36 -17.32 61.84 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 121.453 -0.779 . . . . 0.0 111.446 -171.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -75.29 -21.29 58.6 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 118.48 -0.772 . . . . 0.0 110.978 172.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 8.9 m-30 -86.14 -19.22 30.46 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.175 0.898 . . . . 0.0 111.639 -177.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 97.2 mt -65.77 151.07 95.56 Favored Pre-proline 0 C--O 1.237 0.415 0 C-N-CA 123.836 0.855 . . . . 0.0 110.385 -175.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.67 146.0 53.38 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.834 2.356 . . . . 0.0 109.183 177.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.509 ' CD2' ' HA2' ' A' ' 60' ' ' GLY . 11.6 m-85 -86.96 163.68 16.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 122.079 0.942 . . . . 0.0 110.831 -175.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 26.2 m-70 -136.99 160.22 39.57 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.845 1.658 . . . . 0.0 108.038 177.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -97.5 -5.47 35.86 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.01 1.324 . . . . 0.0 111.192 174.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 80.7 p -169.34 -175.35 2.2 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 120.963 -1.085 . . . . 0.0 109.798 -169.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -158.0 61.85 0.46 Allowed 'General case' 0 C--O 1.239 0.527 0 C-N-CA 126.739 2.016 . . . . 0.0 106.493 -167.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -112.02 122.88 48.99 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 -157.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 5.2 t -59.13 -32.15 69.59 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.728 -168.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -91.72 11.77 23.47 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 117.931 0.332 . . . . 0.0 111.697 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -68.41 167.06 44.53 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.486 1.041 . . . . 0.0 113.251 -175.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -73.4 -9.54 23.1 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.544 2.829 . . . . 0.0 112.187 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -80.23 -18.56 49.15 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -163.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 77.21 -19.47 3.63 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-O 118.244 -1.309 . . . . 0.0 114.261 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.74 101.54 3.12 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.733 1.613 . . . . 0.0 110.244 175.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 9.9 mmt85 -125.33 138.19 54.06 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 117.794 -1.098 . . . . 0.0 110.495 -174.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -58.02 148.09 27.26 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -133.34 85.47 43.89 Favored Pre-proline 0 C--N 1.329 -0.292 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -176.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -70.6 4.39 2.58 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 124.524 3.483 . . . . 0.0 113.836 176.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 26.1 ttt180 61.77 43.35 9.68 Favored 'General case' 0 C--N 1.343 0.285 0 C-N-CA 125.936 1.695 . . . . 0.0 111.174 177.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -56.12 -47.09 78.79 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 121.444 -0.785 . . . . 0.0 111.444 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -143.42 31.32 1.35 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.535 1.134 . . . . 0.0 110.626 -169.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 5.0 ttt-85 . . . . . 0 C--O 1.246 0.875 0 CA-C-O 118.76 -0.638 . . . . 0.0 111.864 -169.459 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.1 mtt . . . . . 0 N--CA 1.472 0.664 0 CA-C-O 119.313 -0.375 . . . . 0.0 110.521 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -94.15 142.82 26.96 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -176.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -96.04 121.2 37.54 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 168.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.9 pt -119.4 175.25 4.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 171.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -120.5 137.26 54.46 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 175.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.4 m -78.55 137.46 21.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -67.51 -26.22 66.23 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.009 0.524 . . . . 0.0 112.241 175.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 135.48 -19.96 3.76 Favored Glycine 0 N--CA 1.472 1.036 0 O-C-N 120.134 -1.604 . . . . 0.0 111.958 -169.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.48 -14.95 54.18 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.335 1.854 . . . . 0.0 112.555 -169.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -127.14 41.19 3.57 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 128.592 2.757 . . . . 0.0 106.54 -173.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.79 -85.22 0.18 Allowed 'General case' 0 N--CA 1.469 0.489 0 O-C-N 120.324 -1.485 . . . . 0.0 110.753 -171.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.0 tpt85 -66.42 -69.19 0.32 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 121.149 1.795 . . . . 0.0 111.006 -170.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -155.48 -3.03 0.1 Allowed Glycine 0 N--CA 1.448 -0.504 0 O-C-N 124.157 0.911 . . . . 0.0 114.133 -174.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -49.28 147.52 5.28 Favored Pre-proline 0 N--CA 1.45 -0.438 0 C-N-CA 126.523 1.929 . . . . 0.0 111.847 -167.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -48.99 -29.21 15.02 Favored 'Trans proline' 0 CA--C 1.533 0.436 1 C-N-CA 125.32 4.013 . . . . 0.0 113.967 -176.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -81.34 -23.8 37.53 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 125.958 1.703 . . . . 0.0 112.226 -169.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -53.41 -31.38 44.79 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.975 1.262 . . . . 0.0 111.019 -171.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.31 -23.55 9.48 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.873 1.269 . . . . 0.0 114.031 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.1 m -60.07 -49.53 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 CA-C-N 119.652 1.115 . . . . 0.0 110.628 173.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 6.0 ptp -77.68 5.64 8.89 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.704 0.684 . . . . 0.0 112.726 -174.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 69.9 mt -97.34 -6.08 35.07 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.078 0.951 . . . . 0.0 111.582 176.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -121.7 102.83 8.46 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 104.315 -2.476 . . . . 0.0 104.315 175.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -58.16 -16.93 15.29 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.081 1.352 . . . . 0.0 111.996 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.2 m -60.92 -22.42 64.35 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.756 1.622 . . . . 0.0 113.971 169.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 20.2 m170 -86.08 -15.06 42.43 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.251 -0.906 . . . . 0.0 111.107 170.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.1 170.02 12.91 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 127.203 2.335 . . . . 0.0 111.565 176.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -74.1 139.09 44.36 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 124.803 1.241 . . . . 0.0 112.1 -174.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -139.82 138.63 35.96 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.03 1.732 . . . . 0.0 109.053 165.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.16 139.71 27.45 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.77 1.228 . . . . 0.0 108.865 175.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -72.62 87.55 1.23 Allowed 'General case' 0 C--O 1.238 0.481 0 C-N-CA 125.948 1.699 . . . . 0.0 108.033 178.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.2 tpp180 -93.7 64.85 3.57 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -177.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.66 -167.41 54.8 Favored Glycine 0 N--CA 1.44 -1.058 0 CA-C-O 122.967 1.315 . . . . 0.0 111.463 -173.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.3 ptt85 -139.13 170.64 15.59 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.981 0.913 . . . . 0.0 109.668 -177.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -170.96 173.8 44.68 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 119.876 -1.155 . . . . 0.0 111.807 -172.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.467 ' HB3' ' HA ' ' A' ' 64' ' ' THR . 2.3 m -136.89 158.05 45.34 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 170.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.0 p -74.9 121.61 22.15 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 176.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.0 t -76.6 -43.88 34.51 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -177.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -71.36 121.72 19.04 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 105.774 -1.935 . . . . 0.0 105.774 174.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 m -55.75 142.49 34.33 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 168.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.417 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 20.1 m-85 -135.67 153.41 77.43 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 107.057 -1.461 . . . . 0.0 107.057 178.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 40' ' ' PHE . 3.4 Cg_exo -78.52 91.82 1.17 Allowed 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 124.693 3.595 . . . . 0.0 109.522 176.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.88 88.59 7.73 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 177.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . 0.287 40.1 t -89.71 166.78 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 C-N-CA 126.982 2.113 . . . . 0.0 107.878 -176.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.2 mt -132.65 126.72 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 168.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.88 175.14 10.06 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 122.32 1.057 . . . . 0.0 111.495 -174.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.9 -172.64 53.18 Favored Glycine 0 CA--C 1.539 1.542 0 C-N-CA 125.794 1.664 . . . . 0.0 111.226 170.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -87.19 -18.46 30.28 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 125.851 1.66 . . . . 0.0 113.076 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 56.6 m-70 -109.2 8.98 26.08 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 122.845 0.458 . . . . 0.0 112.005 -171.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 62.86 63.03 0.99 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.648 1.579 . . . . 0.0 108.079 172.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 81.4 mt -104.11 90.23 2.94 Favored Pre-proline 0 N--CA 1.453 -0.283 0 C-N-CA 127.309 2.243 . . . . 0.0 106.14 -169.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -57.08 138.33 85.81 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 CA-C-N 119.725 0.938 . . . . 0.0 110.374 169.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 57.0 m95 -128.82 132.63 47.84 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.505 1.522 . . . . 0.0 108.692 178.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 34.4 tp -86.13 -3.81 59.04 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.957 0.903 . . . . 0.0 113.101 -173.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 12.9 mt 42.03 89.7 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 129.674 3.19 . . . . 0.0 112.367 172.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -49.5 95.68 0.01 OUTLIER 'General case' 0 C--O 1.241 0.631 0 CA-C-N 119.167 0.894 . . . . 0.0 112.989 -162.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -159.49 85.76 2.18 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 119.032 0.833 . . . . 0.0 113.057 -172.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -60.85 147.75 94.35 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.613 2.209 . . . . 0.0 109.739 -177.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.88 15.66 80.82 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 119.074 -0.848 . . . . 0.0 113.056 171.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.38 130.44 32.8 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 119.436 1.618 . . . . 0.0 108.715 -175.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.37 -123.84 7.07 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-N 120.792 1.633 . . . . 0.0 112.628 -178.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 46.4 m-70 -136.32 160.55 38.38 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.889 1.844 . . . . 0.0 112.588 -165.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 77.0 m -91.14 99.49 12.49 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.823 0.849 . . . . 0.0 110.736 -177.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.1 t -72.0 99.19 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 125.97 1.708 . . . . 0.0 113.213 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.467 ' HA ' ' HB3' ' A' ' 35' ' ' CYS . 8.9 p -66.51 157.58 31.83 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.91 0.884 . . . . 0.0 112.631 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -178.05 -147.1 6.71 Favored Glycine 0 C--N 1.343 0.962 0 O-C-N 121.458 -0.776 . . . . 0.0 114.025 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -133.53 171.21 14.4 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.056 1.342 . . . . 0.0 109.253 177.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 92.4 mt -116.59 112.98 41.62 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 -177.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -101.71 115.82 31.37 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 172.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -62.89 136.22 57.73 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 154.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.5 m -135.04 168.69 22.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 C-N-CA 124.732 1.213 . . . . 0.0 108.131 176.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -107.98 172.06 7.05 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 168.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -49.53 -45.73 47.69 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 125.035 1.334 . . . . 0.0 110.244 -176.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.2 tp60 -55.62 -43.57 76.25 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.079 0.952 . . . . 0.0 111.574 -176.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 24.3 tpp -72.48 -48.67 38.9 Favored 'General case' 0 C--O 1.224 -0.264 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.83 -39.4 77.57 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.549 -0.719 . . . . 0.0 110.726 -178.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.56 -44.65 90.09 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 126.918 2.087 . . . . 0.0 110.966 175.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -61.69 -46.35 90.08 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.279 0.632 . . . . 0.0 109.815 177.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 95.2 mt -57.79 -37.48 73.8 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.144 0.577 . . . . 0.0 111.468 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -61.11 -21.98 64.21 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.388 0.995 . . . . 0.0 111.837 177.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -100.25 -2.92 32.57 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.803 2.441 . . . . 0.0 111.5 177.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -103.96 -37.98 7.17 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 120.739 -1.226 . . . . 0.0 108.215 -174.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -107.94 28.88 7.8 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.985 1.314 . . . . 0.0 111.586 174.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 57.97 37.68 26.73 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.247 1.419 . . . . 0.0 112.625 156.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 78.1 m -85.92 163.57 42.86 Favored Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 120.934 -1.104 . . . . 0.0 110.646 -176.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -65.76 -3.95 3.6 Favored 'Cis proline' 0 CA--C 1.547 1.161 0 N-CA-C 114.849 1.057 . . . . 0.0 114.849 -16.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -46.79 -64.55 0.74 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.835 1.654 . . . . 0.0 112.928 178.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 21.5 mtm -88.18 -59.41 2.25 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 119.195 0.907 . . . . 0.0 110.092 -175.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -111.56 178.29 4.37 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 176.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.7 mp0 -133.97 150.28 51.27 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 171.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -77.44 114.26 16.09 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 176.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.2 m -113.55 170.91 7.9 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 126.106 1.763 . . . . 0.0 108.835 -179.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -122.13 143.01 49.8 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.622 1.569 . . . . 0.0 110.277 172.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.44 175.91 11.8 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.269 1.428 . . . . 0.0 111.357 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.4 tp60 -101.53 126.79 48.4 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.703 1.601 . . . . 0.0 111.772 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 64.0 t -122.39 144.74 30.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 125.305 1.442 . . . . 0.0 108.141 -176.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -89.32 144.75 25.85 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 176.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.509 ' CG1' ' HA ' ' A' ' 108' ' ' ASP 0.26 7.2 p -111.48 89.89 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -167.36 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.9 mp -65.44 -23.04 66.83 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 120.716 -1.24 . . . . 0.0 111.512 -177.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -160.95 153.43 20.55 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 104.763 -2.31 . . . . 0.0 104.763 174.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 70.2 t-105 -137.59 107.29 6.22 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 126.3 1.84 . . . . 0.0 108.597 178.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -95.18 108.56 20.69 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -177.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.52 -174.77 15.96 Favored Glycine 0 CA--C 1.519 0.311 0 CA-C-O 121.911 0.729 . . . . 0.0 111.387 174.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -71.31 160.64 32.43 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.604 0.716 . . . . 0.0 110.268 -177.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 90.52 69.13 1.2 Allowed Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 124.618 1.104 . . . . 0.0 111.234 165.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -101.58 89.58 1.5 Allowed Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 129.845 3.258 . . . . 0.0 110.352 -162.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -62.73 4.61 0.35 Allowed 'Trans proline' 0 CA--C 1.544 1.0 1 C-N-CA 125.737 4.291 . . . . 0.0 115.266 -176.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.15 -174.43 54.54 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 -163.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.509 ' HA ' ' CG1' ' A' ' 97' ' ' VAL . 14.5 t70 -69.71 5.69 1.39 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 117.336 2.347 . . . . 0.0 117.336 -168.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 83.5 p -125.25 157.45 36.55 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 121.648 -0.658 . . . . 0.0 112.174 155.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.6 p -132.6 153.05 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 123.628 0.771 . . . . 0.0 109.434 161.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -82.09 152.51 26.54 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 168.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 3.9 p -145.14 -173.37 4.07 Favored 'General case' 0 C--O 1.239 0.515 0 O-C-N 121.575 -0.703 . . . . 0.0 110.629 169.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -109.03 151.44 26.35 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.133 1.373 . . . . 0.0 109.504 162.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.3 t -142.88 146.45 21.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 128.883 2.873 . . . . 0.0 106.605 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -89.91 116.05 27.68 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 168.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -139.16 147.61 42.08 Favored 'General case' 0 C--O 1.225 -0.233 0 C-N-CA 124.077 0.951 . . . . 0.0 111.317 -176.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.5 t -92.5 141.16 28.81 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -177.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -110.57 6.45 21.89 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.235 1.414 . . . . 0.0 111.572 162.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.35 19.73 16.74 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.624 1.97 . . . . 0.0 112.729 -160.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -71.61 159.53 34.26 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.737 1.615 . . . . 0.0 113.16 -174.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.35 149.69 89.11 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 124.749 1.22 . . . . 0.0 110.761 173.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -68.52 -24.8 35.71 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.701 2.268 . . . . 0.0 113.561 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -68.69 -24.95 64.56 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 120.919 -1.113 . . . . 0.0 112.777 173.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 45.0 m0 -72.01 -12.75 61.37 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.426 -0.796 . . . . 0.0 112.241 -177.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -65.89 -18.33 65.26 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.347 -0.846 . . . . 0.0 111.233 171.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -99.95 -8.95 23.33 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.059 0.944 . . . . 0.0 112.791 175.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.7 mt -64.23 147.01 97.38 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -64.84 149.38 89.68 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.087 1.858 . . . . 0.0 110.371 178.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -103.37 166.1 10.63 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 41.0 m-70 -136.5 169.87 16.98 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 125.048 1.339 . . . . 0.0 108.473 178.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -125.26 -17.33 5.7 Favored 'General case' 0 C--O 1.219 -0.511 0 C-N-CA 124.217 1.007 . . . . 0.0 111.837 -166.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -158.19 132.78 8.28 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 164.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -85.59 131.57 34.33 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 169.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -143.87 158.21 43.84 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.756 154.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.5 t -63.71 -35.86 81.94 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 164.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -86.4 68.63 10.27 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 127.467 2.307 . . . . 0.0 107.665 -177.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -152.65 168.09 31.6 Favored Glycine 0 CA--C 1.522 0.499 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.432 163.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -72.91 -6.93 19.89 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.275 2.65 . . . . 0.0 113.735 -166.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -60.24 -42.13 94.61 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 119.407 1.003 . . . . 0.0 113.425 -169.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 93.09 -50.33 2.48 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-O 118.892 -0.949 . . . . 0.0 111.026 -178.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.5 75.61 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.079 1.751 . . . . 0.0 112.265 173.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -109.37 167.7 9.93 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 120.52 -1.362 . . . . 0.0 109.613 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -60.17 164.03 4.44 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 118.786 -0.626 . . . . 0.0 111.276 -169.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -113.42 66.76 1.19 Allowed Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 121.614 0.721 . . . . 0.0 112.317 -175.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -75.49 -17.72 18.27 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 122.017 1.811 . . . . 0.0 113.793 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -168.59 22.28 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.176 1.39 . . . . 0.0 110.653 -172.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -66.87 -46.0 76.34 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 174.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -127.18 -0.62 6.43 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.057 1.743 . . . . 0.0 111.979 -173.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? . . . . . 0 C--O 1.248 0.998 0 C-N-CA 128.227 2.611 . . . . 0.0 112.7 -175.57 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.3 tpt . . . . . 0 N--CA 1.469 0.508 0 N-CA-C 111.197 0.073 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.72 178.45 7.06 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.581 1.552 . . . . 0.0 107.12 178.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -134.39 148.02 50.59 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 13.0 pt -130.83 179.42 4.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 167.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -137.83 133.16 33.62 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.8 m -73.79 134.64 29.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 173.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -73.54 -3.22 26.39 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.77 -0.581 . . . . 0.0 111.701 163.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 136.42 -4.99 3.79 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.95 1.738 . . . . 0.0 112.515 174.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -83.47 -8.62 59.33 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -167.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.0 mp -140.85 58.64 1.55 Allowed 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -139.87 -73.68 0.36 Allowed 'General case' 0 C--N 1.342 0.281 0 CA-C-O 118.463 -0.779 . . . . 0.0 112.346 177.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -67.97 -60.59 2.38 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.911 1.232 . . . . 0.0 109.211 -168.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -177.38 33.33 0.08 OUTLIER Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.5 mp0 -66.25 155.03 88.96 Favored Pre-proline 0 N--CA 1.454 -0.231 0 O-C-N 120.657 -1.496 . . . . 0.0 109.733 -173.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.35 -10.0 19.77 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.649 2.233 . . . . 0.0 113.354 -172.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -99.52 -20.76 16.24 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 127.242 2.217 . . . . 0.0 110.956 -175.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -53.68 -41.67 67.14 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 120.955 1.707 . . . . 0.0 109.839 -171.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.7 -29.48 4.49 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.564 1.546 . . . . 0.0 114.145 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 20.3 m -59.8 -41.79 86.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 120.097 1.317 . . . . 0.0 111.593 178.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.3 ptp -78.0 -8.59 58.36 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 119.149 0.886 . . . . 0.0 111.76 -177.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 39.6 mt -87.41 5.09 40.48 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.283 1.433 . . . . 0.0 110.64 178.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -115.08 97.61 6.32 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 173.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 22.2 t-80 -60.09 -21.22 61.23 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.424 0.69 . . . . 0.0 112.538 -176.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.5 m -69.44 -23.7 63.72 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.385 1.474 . . . . 0.0 114.342 172.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 36.9 m170 -69.77 -31.71 69.81 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.146 -0.971 . . . . 0.0 108.765 165.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.76 179.53 25.66 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 125.839 1.685 . . . . 0.0 110.775 174.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -81.63 135.69 35.54 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.011 0.924 . . . . 0.0 110.096 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.1 100.68 3.68 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.38 1.472 . . . . 0.0 109.646 167.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -107.4 140.9 39.63 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 125.18 1.392 . . . . 0.0 108.798 -177.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -69.98 77.84 0.49 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.589 2.355 . . . . 0.0 109.986 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -87.37 62.38 7.15 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.39 -176.3 48.24 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-O 123.624 1.68 . . . . 0.0 113.984 170.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -118.0 160.29 21.72 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.781 1.232 . . . . 0.0 109.711 -170.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -169.71 177.58 43.12 Favored Glycine 0 C--N 1.34 0.805 0 N-CA-C 116.383 1.313 . . . . 0.0 116.383 177.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 10.6 p -133.4 158.48 42.92 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.44 1.096 . . . . 0.0 108.206 170.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.0 p -78.91 117.28 19.85 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 166.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.3 t -74.24 -41.33 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 175.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -64.89 107.34 1.44 Allowed 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 170.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.0 m -59.63 135.92 57.83 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 106.951 -1.499 . . . . 0.0 106.951 170.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -130.57 153.16 81.39 Favored Pre-proline 0 C--O 1.237 0.422 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -74.29 91.57 0.95 Allowed 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 124.707 3.605 . . . . 0.0 109.675 173.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 tt -81.91 102.94 11.21 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 171.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.6 m -122.25 133.14 69.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 125.225 1.41 . . . . 0.0 107.451 -175.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 73.8 mt -99.05 100.14 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -176.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -118.01 171.88 7.79 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 122.378 1.085 . . . . 0.0 111.354 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.3 152.73 7.13 Favored Glycine 0 CA--C 1.523 0.534 0 CA-C-N 113.76 -1.564 . . . . 0.0 110.9 173.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.3 tp10 -72.16 -9.3 58.25 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -162.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 44.2 m170 -102.5 12.63 36.19 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.871 0.869 . . . . 0.0 112.076 175.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 55.45 69.73 0.7 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 127.392 2.277 . . . . 0.0 111.228 -178.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.5 mt -104.12 89.87 2.74 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 128.105 2.562 . . . . 0.0 108.072 -166.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -53.03 129.11 31.74 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 121.757 1.638 . . . . 0.0 111.567 177.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 66.3 m95 -126.62 145.56 50.51 Favored 'General case' 0 C--N 1.332 -0.192 0 O-C-N 121.093 -1.005 . . . . 0.0 109.122 176.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.8 mt -96.44 -5.31 39.96 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 117.569 2.433 . . . . 0.0 117.569 -174.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.7 mp 42.37 73.39 0.14 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 111.603 -2.544 . . . . 0.0 112.601 173.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -45.26 92.18 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.014 1.726 . . . . 0.0 114.57 -157.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.42 85.23 7.42 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 125.026 1.33 . . . . 0.0 107.643 -174.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -59.04 139.52 91.16 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 121.986 1.79 . . . . 0.0 108.564 176.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.02 -0.7 88.27 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.191 1.376 . . . . 0.0 114.48 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -97.43 144.02 27.58 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.624 1.712 . . . . 0.0 107.78 173.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.33 -143.7 30.91 Favored Glycine 0 C--N 1.337 0.608 0 CA-C-N 119.235 0.925 . . . . 0.0 111.63 177.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -130.99 176.75 7.98 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.313 1.445 . . . . 0.0 108.203 -169.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.2 p -63.0 167.13 5.05 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.512 0.672 . . . . 0.0 111.406 176.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.1 t -133.08 110.95 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 166.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 69.5 p -69.75 152.33 44.75 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.42 -158.37 12.37 Favored Glycine 0 CA--C 1.527 0.791 0 O-C-N 121.15 -0.969 . . . . 0.0 112.486 -177.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -140.98 151.8 44.44 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.621 1.568 . . . . 0.0 108.454 174.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 76.4 mt -95.55 138.49 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -127.34 126.16 42.04 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 172.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -69.87 136.13 50.33 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 161.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.62 164.54 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.95 177.43 4.85 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 122.804 1.288 . . . . 0.0 111.847 168.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -57.16 -42.36 80.94 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 112.916 -1.947 . . . . 0.0 111.751 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 40.1 tp60 -62.99 -44.91 94.72 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 118.473 -0.775 . . . . 0.0 109.989 179.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 24.8 tpp -62.79 -46.41 88.13 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 118.365 0.53 . . . . 0.0 110.109 176.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.1 tp -65.81 -40.59 92.03 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.647 -174.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 33.9 mtm105 -63.26 -40.16 96.63 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.631 1.173 . . . . 0.0 111.172 173.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -65.97 -50.62 63.7 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 117.984 0.356 . . . . 0.0 110.303 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.409 ' C ' ' HH ' ' A' ' 115' ' ' TYR . 1.7 mp -63.12 -25.87 68.56 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.122 -0.986 . . . . 0.0 111.01 176.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.423 ' HA ' ' SG ' ' A' ' 84' ' ' CYS . 14.8 t70 -73.44 1.3 10.06 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.971 1.309 . . . . 0.0 112.84 176.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -122.04 -47.81 2.14 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 128.352 2.661 . . . . 0.0 110.972 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -65.1 -39.16 92.74 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.445 1.098 . . . . 0.0 112.294 -176.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -77.81 8.56 4.4 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.18 -0.95 . . . . 0.0 111.197 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 58.68 15.44 3.72 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.376 1.871 . . . . 0.0 113.155 178.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.423 ' SG ' ' HA ' ' A' ' 79' ' ' ASP . 1.6 p -61.92 154.12 69.6 Favored Pre-proline 0 N--CA 1.448 -0.558 0 O-C-N 120.518 -1.363 . . . . 0.0 109.219 169.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.39 -4.57 22.09 Favored 'Cis proline' 0 CA--C 1.541 0.826 0 CA-C-N 119.563 0.88 . . . . 0.0 113.638 -2.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.7 -75.42 0.06 Allowed 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.062 1.345 . . . . 0.0 111.095 179.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 38.7 mtp -68.67 -69.09 0.35 Allowed 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -172.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -102.29 174.89 5.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.497 0.665 . . . . 0.0 109.443 179.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -137.89 136.25 36.91 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 165.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -75.03 139.21 42.71 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 175.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.4 m -141.66 154.36 45.31 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -176.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -91.46 137.84 32.05 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.881 0.873 . . . . 0.0 109.7 174.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.27 174.84 11.6 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.01 1.324 . . . . 0.0 112.297 -178.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 30.7 tp60 -100.06 117.15 33.72 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.149 1.78 . . . . 0.0 111.196 -178.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 97.1 t -117.81 124.12 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 125.19 1.396 . . . . 0.0 107.944 -172.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -68.43 141.37 55.69 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 119.582 1.083 . . . . 0.0 108.557 175.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 45.9 t -84.78 95.19 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 172.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.86 -30.06 70.13 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.769 -0.582 . . . . 0.0 109.712 167.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -164.75 153.74 12.85 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 60.2 t-105 -132.03 136.94 47.61 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 172.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -116.92 111.15 19.24 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 171.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 114.81 -172.34 14.18 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 124.518 1.056 . . . . 0.0 112.145 172.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -70.87 168.32 17.09 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 114.919 -0.641 . . . . 0.0 110.619 -178.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.05 69.19 1.42 Allowed Glycine 0 C--O 1.222 -0.635 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 168.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -101.1 87.96 0.97 Allowed Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 130.651 3.581 . . . . 0.0 109.399 -171.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -57.12 -38.1 96.46 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.692 2.928 . . . . 0.0 113.2 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 146.59 -160.95 28.33 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-N 119.436 1.016 . . . . 0.0 111.387 -170.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -64.07 -22.56 66.98 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.937 1.295 . . . . 0.0 111.728 175.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.9 t -139.86 164.19 30.64 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 120.467 -1.396 . . . . 0.0 109.233 175.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 10.9 p -141.06 153.06 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 C-N-CA 125.787 1.635 . . . . 0.0 108.959 -174.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -83.3 119.93 25.21 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 168.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 85.8 m -122.22 176.27 5.93 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.746 0.818 . . . . 0.0 109.23 171.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -106.5 144.09 33.68 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 168.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.2 t -137.45 146.83 27.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 127.137 2.175 . . . . 0.0 106.073 175.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.409 ' HH ' ' C ' ' A' ' 78' ' ' LEU . 44.8 m-85 -76.54 127.76 33.43 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 165.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 72.4 p -131.62 -164.54 1.46 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 126.008 1.723 . . . . 0.0 106.689 172.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.5 t -149.08 153.97 38.57 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 168.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -116.51 -31.92 5.4 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.672 1.589 . . . . 0.0 111.823 175.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 15.4 t -91.72 20.79 5.23 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.941 0.896 . . . . 0.0 111.795 -165.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -72.07 153.9 41.44 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 127.78 2.432 . . . . 0.0 113.155 -174.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.89 160.37 55.82 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 126.622 1.969 . . . . 0.0 112.173 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -68.88 -39.04 8.9 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.125 1.883 . . . . 0.0 112.531 178.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -45.46 -41.66 9.67 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 178.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 30.7 m0 -64.2 -18.17 64.25 Favored 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 125.513 1.525 . . . . 0.0 112.365 -173.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 28.0 mt -67.47 -17.28 64.63 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 117.808 -1.092 . . . . 0.0 111.672 173.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -102.52 -6.22 23.11 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.976 1.262 . . . . 0.0 112.511 -168.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -71.73 156.93 90.62 Favored Pre-proline 0 N--CA 1.448 -0.55 0 C-N-CA 125.651 1.58 . . . . 0.0 108.16 -175.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -61.38 140.31 87.31 Favored 'Trans proline' 0 N--CA 1.449 -1.088 0 C-N-CA 121.586 1.524 . . . . 0.0 108.953 173.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -81.28 158.08 24.9 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 172.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 60.0 m-70 -137.97 155.74 48.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.712 178.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -101.21 -9.04 21.64 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 122.766 1.27 . . . . 0.0 112.932 -175.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -161.23 150.7 16.73 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 126.908 2.083 . . . . 0.0 105.517 175.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -106.27 148.35 28.08 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 167.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.0 170.99 21.06 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.87 -0.1 27.43 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 159.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -133.3 68.36 1.5 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.514 1.926 . . . . 0.0 106.897 -172.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -130.66 -170.98 12.81 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 125.615 1.579 . . . . 0.0 112.725 -171.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -57.83 175.9 0.39 Allowed 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 120.805 1.003 . . . . 0.0 110.129 138.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 30.1 m-70 46.99 90.26 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 128.967 2.907 . . . . 0.0 112.221 -178.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.92 61.81 0.73 Allowed Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.414 1.007 . . . . 0.0 112.406 170.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.27 67.49 1.43 Allowed 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 127.477 2.311 . . . . 0.0 106.866 169.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 -116.37 162.31 17.73 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 120.816 -1.178 . . . . 0.0 110.629 -172.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -61.15 140.56 57.87 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 123.806 0.691 . . . . 0.0 111.723 -159.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -128.51 85.33 60.64 Favored Pre-proline 0 N--CA 1.452 -0.334 0 C-N-CA 124.274 1.03 . . . . 0.0 109.129 -174.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.78 5.62 3.3 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 123.579 2.853 . . . . 0.0 112.872 167.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 61.83 67.97 0.72 Allowed 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 126.82 2.048 . . . . 0.0 111.545 -173.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.419 ' HG3' ' H ' ' A' ' 148' ' ' ASN . 0.4 OUTLIER -99.73 -71.97 0.68 Allowed 'General case' 0 N--CA 1.436 -1.175 0 C-N-CA 127.925 2.49 . . . . 0.0 111.973 -178.004 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.419 ' H ' ' HG3' ' A' ' 147' ' ' GLU . 13.5 p30 -74.37 -6.99 51.35 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.281 1.032 . . . . 0.0 113.258 -179.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.435 ' C ' ' HD3' ' A' ' 149' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.459 -2.541 1 C-N-CA 131.908 4.083 . . . . 0.0 103.558 177.611 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 mmm . . . . . 0 N--CA 1.47 0.548 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.96 155.15 49.65 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 120.586 1.539 . . . . 0.0 107.49 148.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.1 m80 -108.34 130.94 55.18 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 176.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.4 pt -128.32 167.42 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 124.644 1.178 . . . . 0.0 109.403 176.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -126.75 144.73 50.85 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.586 1.154 . . . . 0.0 110.894 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 m -103.61 123.61 57.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.972 1.309 . . . . 0.0 111.038 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -76.39 -48.1 20.99 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -174.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.26 -1.18 0.03 OUTLIER Glycine 0 CA--C 1.531 1.054 0 CA-C-O 117.575 -1.68 . . . . 0.0 116.486 -172.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.404 ' HA ' ' HG2' ' A' ' 14' ' ' GLN . 0.3 OUTLIER -118.75 -6.93 10.58 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 120.309 2.055 . . . . 0.0 114.834 -163.192 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.7 mp -145.59 47.02 1.28 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.342 1.457 . . . . 0.0 108.363 176.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.22 -78.07 0.46 Allowed 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 117.051 -1.452 . . . . 0.0 109.811 170.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.411 ' CB ' HE22 ' A' ' 14' ' ' GLN . 10.7 mtt180 -50.91 -45.5 60.33 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.051 0.94 . . . . 0.0 111.533 -168.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 148.57 68.94 0.01 OUTLIER Glycine 0 C--N 1.333 0.403 0 N-CA-C 106.944 -2.462 . . . . 0.0 106.944 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.411 HE22 ' CB ' ' A' ' 12' ' ' ARG . 25.1 mp0 -102.89 160.84 24.96 Favored Pre-proline 0 N--CA 1.449 -0.507 0 C-N-CA 124.505 1.122 . . . . 0.0 110.464 -178.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.36 -32.67 89.61 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.737 1.625 . . . . 0.0 110.996 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -70.57 -24.27 62.75 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 124.642 1.177 . . . . 0.0 111.618 -176.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -52.0 -35.06 45.47 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.224 1.01 . . . . 0.0 110.779 -167.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.71 -33.56 7.1 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 124.953 1.301 . . . . 0.0 114.264 176.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.3 m -59.61 -35.53 59.97 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 119.95 1.25 . . . . 0.0 111.439 -176.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.406 ' HE2' ' CE2' ' A' ' 68' ' ' TYR . 3.1 ptp -83.09 -12.47 57.05 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 118.979 0.809 . . . . 0.0 112.848 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.2 mt -80.07 -11.82 59.73 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.187 0.595 . . . . 0.0 110.194 177.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -100.17 99.68 10.41 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -177.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 46.3 t-80 -59.32 -19.59 47.74 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.664 1.586 . . . . 0.0 113.376 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.84 -37.35 79.01 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.419 -0.801 . . . . 0.0 111.551 167.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 16.8 m170 -73.98 -35.64 64.48 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 121.393 -0.817 . . . . 0.0 109.475 170.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.93 -175.71 24.4 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.993 1.283 . . . . 0.0 112.738 168.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.5 mt -68.79 149.32 49.13 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.038 0.935 . . . . 0.0 113.144 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -161.95 110.61 1.46 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.091 2.156 . . . . 0.0 108.507 168.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -130.11 146.61 51.77 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.016 0.926 . . . . 0.0 109.848 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -69.01 86.95 0.37 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.568 2.347 . . . . 0.0 109.472 -176.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.07 64.12 0.83 Allowed 'General case' 0 C--O 1.234 0.281 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -178.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.88 -179.12 48.65 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-O 122.053 0.807 . . . . 0.0 112.79 -178.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.4 ptt180 -134.14 172.2 13.18 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.55 -0.971 . . . . 0.0 110.407 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -164.08 -176.79 36.26 Favored Glycine 0 CA--C 1.499 -0.932 0 N-CA-C 115.89 1.116 . . . . 0.0 115.89 -173.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.7 p -145.21 159.56 42.82 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 113.725 -1.237 . . . . 0.0 112.512 166.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.3 p -78.13 101.97 7.28 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 120.086 1.312 . . . . 0.0 107.852 172.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -71.14 -31.05 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 120.576 -1.328 . . . . 0.0 111.894 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -69.99 118.06 12.35 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 152.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.3 m -57.84 146.96 29.92 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 167.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -135.49 153.16 77.56 Favored Pre-proline 0 N--CA 1.466 0.349 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 169.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -77.01 121.63 5.9 Favored 'Trans proline' 0 CA--C 1.533 0.457 1 C-N-CA 125.774 4.316 . . . . 0.0 113.043 177.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.405 ' HG ' ' CE2' ' A' ' 133' ' ' TYR . 35.6 tp -116.38 111.92 20.74 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 126.863 2.065 . . . . 0.0 108.858 -176.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.5 m -128.88 148.09 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 120.26 1.391 . . . . 0.0 111.937 -177.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 40.2 mt -86.93 128.07 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 169.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.59 173.47 11.47 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.54 0.686 . . . . 0.0 112.153 174.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.94 -174.72 55.27 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.544 2.021 . . . . 0.0 113.246 171.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -91.0 -3.45 57.25 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -170.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -118.94 12.63 12.89 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.405 1.082 . . . . 0.0 111.779 176.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 53.51 71.27 0.51 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.015 2.126 . . . . 0.0 110.495 -178.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 88.6 mt -103.9 90.58 3.02 Favored Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 131.265 3.826 . . . . 0.0 108.368 -169.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -60.83 125.08 16.31 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 122.379 2.053 . . . . 0.0 112.602 176.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -116.63 156.97 26.13 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.912 1.685 . . . . 0.0 109.882 176.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.9 tp -115.54 114.76 25.41 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.233 1.413 . . . . 0.0 108.441 167.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 26.0 mt -82.27 144.0 30.94 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 177.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -79.75 89.06 5.19 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 121.593 -0.692 . . . . 0.0 109.389 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.25 85.69 21.36 Favored Pre-proline 0 C--O 1.232 0.18 0 C-N-CA 123.534 0.734 . . . . 0.0 110.024 172.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -60.27 128.95 27.96 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.936 2.424 . . . . 0.0 109.598 -177.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.57 8.77 73.26 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 118.09 -1.395 . . . . 0.0 114.074 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.2 tptt -121.3 164.14 17.48 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 120.372 2.086 . . . . 0.0 107.216 172.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 74.51 -131.13 12.72 Favored Glycine 0 CA--C 1.519 0.288 0 O-C-N 120.613 -1.304 . . . . 0.0 109.945 -176.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -145.01 167.24 23.12 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.12 0.968 . . . . 0.0 111.033 -170.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 31.6 m -92.27 80.63 4.99 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 126.717 2.007 . . . . 0.0 112.448 -173.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.6 p -70.05 136.21 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.117 0 CA-C-O 118.113 -0.946 . . . . 0.0 113.196 -165.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.2 p -91.06 152.46 20.63 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.88 -175.51 32.99 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 178.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -106.25 158.2 17.03 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 125.736 1.615 . . . . 0.0 106.771 173.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 80.8 mt -113.63 110.07 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.406 ' CE2' ' HE2' ' A' ' 20' ' ' MET . 73.6 m-85 -93.17 123.48 36.48 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 118.528 -0.749 . . . . 0.0 109.663 -176.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -68.48 107.93 3.09 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 152.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.8 m -103.72 169.67 2.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 166.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -119.24 177.71 4.79 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 161.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -45.02 -46.43 11.31 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 127.977 2.511 . . . . 0.0 110.835 -170.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -57.64 -45.56 85.31 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.124 0.97 . . . . 0.0 111.367 -175.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.4 tpp -72.52 -45.9 57.18 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -176.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.43 -32.86 73.78 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.778 -178.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 78.0 mtt180 -69.23 -37.73 78.16 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.874 1.215 . . . . 0.0 111.505 176.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -60.19 -48.3 82.32 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 119.113 -0.47 . . . . 0.0 110.002 174.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.6 mp -57.57 -41.37 80.94 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.214 0.461 . . . . 0.0 109.922 176.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -65.9 4.66 0.6 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.054 1.742 . . . . 0.0 114.76 -178.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -129.9 -47.94 1.13 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.323 2.249 . . . . 0.0 109.852 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -63.11 -42.74 99.61 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 125.802 1.641 . . . . 0.0 111.518 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -78.03 11.31 2.32 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.871 0.868 . . . . 0.0 110.808 176.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.2 t0 54.43 16.81 1.38 Allowed 'General case' 0 C--O 1.236 0.387 0 C-N-CA 128.596 2.758 . . . . 0.0 114.625 171.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 6.8 p -62.47 155.76 66.05 Favored Pre-proline 0 N--CA 1.445 -0.721 0 O-C-N 121.227 -0.921 . . . . 0.0 110.035 -178.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -73.76 -4.23 16.71 Favored 'Cis proline' 0 CA--C 1.543 0.93 0 N-CA-C 115.223 1.201 . . . . 0.0 115.223 -2.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 9.5 m -63.96 -63.68 1.09 Allowed 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.072 1.349 . . . . 0.0 112.406 -173.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 27.3 mtp -74.35 -76.7 0.13 Allowed 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -100.01 -176.55 3.27 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 125.354 1.461 . . . . 0.0 109.329 178.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.93 151.55 30.46 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 120.761 -1.212 . . . . 0.0 109.795 158.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -63.93 125.85 25.74 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 118.491 -0.766 . . . . 0.0 109.954 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 43.5 m -132.4 174.79 9.88 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.009 1.724 . . . . 0.0 106.95 167.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -125.23 132.69 52.93 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.711 1.604 . . . . 0.0 109.615 172.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.83 177.29 5.81 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.731 1.612 . . . . 0.0 109.927 -179.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 34.2 tp60 -105.87 114.26 28.31 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.253 2.221 . . . . 0.0 109.685 -178.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 54.3 t -109.29 141.22 25.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 125.65 1.58 . . . . 0.0 107.633 -177.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -76.29 137.29 39.8 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 165.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.495 ' CG1' ' HA ' ' A' ' 108' ' ' ASP 0.254 3.7 p -98.07 83.81 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 179.017 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.66 -22.62 65.45 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 125.471 1.509 . . . . 0.0 111.935 -175.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -154.46 154.52 33.33 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 170.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 -132.69 124.98 29.23 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.247 1.419 . . . . 0.0 107.408 175.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -91.42 115.62 28.18 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.78 0.832 . . . . 0.0 109.15 177.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.88 -169.24 32.21 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 123.307 0.48 . . . . 0.0 112.129 169.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -68.74 171.96 7.06 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.329 1.451 . . . . 0.0 111.224 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 73.56 67.49 1.78 Allowed Glycine 0 C--O 1.226 -0.385 0 O-C-N 120.469 -1.394 . . . . 0.0 112.79 170.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -101.56 89.76 1.56 Allowed Pre-proline 0 C--O 1.238 0.48 0 C-N-CA 128.741 2.816 . . . . 0.0 110.157 -163.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -54.97 -22.52 30.9 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 124.447 3.432 . . . . 0.0 114.388 -172.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 102.8 157.16 25.44 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 -171.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.495 ' HA ' ' CG1' ' A' ' 97' ' ' VAL . 25.2 t70 -63.85 5.08 0.24 Allowed 'General case' 0 CA--C 1.508 -0.638 0 C-N-CA 129.588 3.155 . . . . 0.0 116.698 -163.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.2 p -134.19 152.15 51.68 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 116.566 -2.054 . . . . 0.0 113.004 146.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 34.8 m -136.94 152.06 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 124.644 1.178 . . . . 0.0 109.353 -173.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -89.33 130.19 35.75 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 168.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 12.0 p -129.5 -179.93 5.45 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 118.482 -0.77 . . . . 0.0 109.059 169.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -101.56 159.72 15.06 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.297 0.953 . . . . 0.0 111.103 164.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -163.03 118.02 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 128.911 2.884 . . . . 0.0 104.018 -158.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -83.19 86.18 7.08 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 172.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.1 p -94.45 -179.86 5.04 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.018 0.927 . . . . 0.0 108.659 172.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.1 t -133.33 140.81 47.62 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -103.6 -9.77 18.96 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.948 1.299 . . . . 0.0 111.242 166.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . 0.268 3.2 t -103.56 34.94 2.76 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 122.35 1.072 . . . . 0.0 111.052 -161.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -65.61 164.29 14.56 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.971 1.709 . . . . 0.0 113.173 -174.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -91.12 149.5 40.02 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 125.364 1.466 . . . . 0.0 108.795 167.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.51 -30.16 71.29 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.17 1.913 . . . . 0.0 113.089 -171.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.51 ' HA ' ' CD2' ' A' ' 126' ' ' PHE . 4.6 pm0 -58.1 -29.86 65.8 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.309 1.044 . . . . 0.0 113.06 177.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 46.2 m0 -71.73 -8.34 53.6 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 122.081 -0.387 . . . . 0.0 111.275 -173.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -89.9 -20.26 23.6 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 117.969 -1.015 . . . . 0.0 112.026 171.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.51 ' CD2' ' HA ' ' A' ' 123' ' ' GLU . 18.0 m-85 -68.88 -36.0 77.55 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 120.14 1.336 . . . . 0.0 110.157 174.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.4 mt -58.21 149.92 55.34 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 125.137 1.375 . . . . 0.0 110.439 -176.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.96 166.61 29.23 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.443 2.096 . . . . 0.0 110.237 173.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -118.75 160.14 22.41 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.868 0.867 . . . . 0.0 110.454 -175.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 59.5 m-70 -139.86 166.64 24.1 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.304 0.642 . . . . 0.0 110.895 -175.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -127.32 -4.92 6.06 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.203 1.401 . . . . 0.0 112.228 -170.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.0 p -138.7 -178.8 5.47 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 153.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.405 ' CE2' ' HG ' ' A' ' 42' ' ' LEU . 0.8 OUTLIER -126.58 174.83 8.39 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 122.514 1.149 . . . . 0.0 110.063 157.673 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.35 88.88 1.74 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 113.132 -1.849 . . . . 0.0 107.76 178.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.08 -22.64 65.94 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.045 -1.034 . . . . 0.0 110.216 167.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -105.17 73.01 1.02 Allowed 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 105.018 -2.215 . . . . 0.0 105.018 170.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -143.93 155.01 25.99 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 177.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -73.71 -6.56 18.86 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.009 2.473 . . . . 0.0 113.229 -167.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 51.9 m-70 -51.88 -33.82 38.32 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.596 1.158 . . . . 0.0 113.048 -170.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 98.47 -19.17 55.48 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.714 1.15 . . . . 0.0 113.53 168.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.476 ' HG ' HH21 ' A' ' 142' ' ' ARG . 0.2 OUTLIER -98.89 57.94 1.13 Allowed 'General case' 0 C--O 1.238 0.49 0 C-N-CA 126.865 2.066 . . . . 0.0 109.216 172.451 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.476 HH21 ' HG ' ' A' ' 141' ' ' LEU . 5.9 mmp_? -84.54 169.57 14.31 Favored 'General case' 0 C--O 1.237 0.408 0 O-C-N 120.386 -1.446 . . . . 0.0 109.941 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -61.83 150.79 36.2 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -173.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -114.34 79.33 5.16 Favored Pre-proline 0 CA--C 1.534 0.344 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 177.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.16 -41.18 13.5 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.773 2.315 . . . . 0.0 111.546 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 30.7 ttt-85 -151.15 5.57 0.48 Allowed 'General case' 0 CA--C 1.526 0.057 0 C-N-CA 124.959 1.304 . . . . 0.0 112.195 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -57.78 -42.24 83.71 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.581 1.552 . . . . 0.0 111.93 -164.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -121.75 30.4 6.7 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.552 1.141 . . . . 0.0 109.631 174.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 . . . . . 0 C--O 1.253 1.238 0 CA-C-O 115.823 -2.037 . . . . 0.0 108.472 -157.254 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 mtt . . . . . 0 N--CA 1.467 0.42 0 CA-C-O 118.188 -0.91 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.26 164.5 26.39 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 118.737 0.699 . . . . 0.0 109.235 172.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -125.77 123.97 39.96 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 177.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.8 pt -130.41 173.57 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 122.776 1.274 . . . . 0.0 110.158 -178.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -112.08 155.32 24.04 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 125.744 1.618 . . . . 0.0 107.314 169.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.507 ' CG2' ' HB2' ' A' ' 10' ' ' LEU . 5.0 p -79.3 176.56 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-O 121.785 0.802 . . . . 0.0 109.698 175.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -125.92 174.46 8.38 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 173.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.421 ' HA2' ' CD1' ' A' ' 133' ' ' TYR . . . -60.62 -10.96 20.39 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 115.246 0.858 . . . . 0.0 115.246 -171.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.76 -23.69 36.48 Favored 'General case' 0 N--CA 1.435 -1.184 0 C-N-CA 125.498 1.519 . . . . 0.0 110.876 -175.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.507 ' HB2' ' CG2' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -125.58 -3.23 7.29 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 121.007 1.73 . . . . 0.0 111.915 -169.361 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -82.6 -7.25 59.65 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 -173.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -135.4 -85.96 0.38 Allowed 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 120.652 1.569 . . . . 0.0 107.082 176.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -160.44 15.21 0.19 Allowed Glycine 0 CA--C 1.529 0.922 0 CA-C-O 118.332 -1.26 . . . . 0.0 113.002 -168.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -57.83 164.57 3.08 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 119.709 1.755 . . . . 0.0 109.857 -175.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.12 -2.53 9.03 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 123.874 3.049 . . . . 0.0 113.415 -169.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -96.17 -14.46 22.76 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 127.897 2.479 . . . . 0.0 111.953 -177.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -48.71 -33.28 9.86 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 120.04 1.291 . . . . 0.0 110.609 -175.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.8 pttp -44.52 -32.47 1.42 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.049 1.739 . . . . 0.0 114.22 176.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.2 m -66.64 -11.67 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 123.633 0.773 . . . . 0.0 112.348 -177.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.2 ptp -121.56 14.74 11.08 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.279 1.432 . . . . 0.0 112.219 172.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 56.7 mt -115.05 2.99 14.33 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 124.72 1.208 . . . . 0.0 111.971 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -131.46 96.78 4.07 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 123.967 0.907 . . . . 0.0 108.56 -175.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 -55.7 -20.82 15.64 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.73 1.212 . . . . 0.0 112.31 -176.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 t -62.38 -25.79 68.12 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 120.13 1.332 . . . . 0.0 111.65 174.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -83.38 -1.99 54.72 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.401 -0.812 . . . . 0.0 111.794 174.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.93 177.0 19.25 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 124.874 1.226 . . . . 0.0 111.09 -175.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 35.0 tp -93.22 137.96 32.06 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.833 0.853 . . . . 0.0 111.335 -173.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.27 135.13 47.78 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 159.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.9 136.94 37.56 Favored 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 124.782 1.233 . . . . 0.0 109.323 -177.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -64.46 109.28 1.89 Allowed 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.679 0.792 . . . . 0.0 109.407 -179.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 -116.21 51.86 0.94 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 -175.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.15 -153.03 46.14 Favored Glycine 0 N--CA 1.442 -0.961 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -151.13 170.39 19.55 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.688 -0.89 . . . . 0.0 111.945 -171.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -174.18 178.75 45.91 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.029 -1.081 . . . . 0.0 115.478 -175.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 64.4 m -137.48 132.66 33.62 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 177.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.2 p -65.98 101.78 0.72 Allowed 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -69.83 -29.31 40.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 O-C-N 121.877 -0.514 . . . . 0.0 110.211 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -58.68 109.47 0.81 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 156.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.1 m -55.25 140.1 40.17 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 164.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -139.74 153.44 70.05 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 171.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.38 98.44 1.17 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 124.626 3.551 . . . . 0.0 110.077 173.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 54.1 tp -88.89 117.42 27.88 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 166.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.7 m -128.07 149.81 33.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.2 mt -114.23 98.15 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 -177.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.71 135.06 25.93 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.813 1.645 . . . . 0.0 108.797 -167.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.05 147.14 12.84 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 125.427 1.489 . . . . 0.0 110.739 -172.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -63.13 -26.8 68.99 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.807 1.643 . . . . 0.0 114.094 -164.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -90.13 3.85 52.15 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -174.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 51.75 61.87 3.0 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.064 1.345 . . . . 0.0 110.319 -167.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 52.1 mt -107.16 86.88 2.74 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 128.093 2.557 . . . . 0.0 104.149 172.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -62.22 152.92 73.3 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 121.281 1.32 . . . . 0.0 111.095 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -119.92 157.83 27.95 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.874 1.27 . . . . 0.0 109.702 -177.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.3 tp -122.43 94.2 4.22 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 175.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.6 mt -68.02 131.32 45.25 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -71.64 96.07 1.53 Allowed 'General case' 0 C--O 1.239 0.502 0 C-N-CA 119.825 -0.75 . . . . 0.0 109.476 -176.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.43 85.31 6.81 Favored Pre-proline 0 CA--C 1.535 0.37 0 C-N-CA 123.742 0.817 . . . . 0.0 112.366 175.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -62.89 122.38 10.64 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.073 2.515 . . . . 0.0 109.315 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.75 -4.0 56.2 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 125.713 1.625 . . . . 0.0 114.604 177.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -106.42 167.09 10.07 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 120.552 2.176 . . . . 0.0 109.145 168.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 61.53 -142.54 48.33 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 -170.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -142.04 179.55 6.82 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.583 1.153 . . . . 0.0 110.59 -171.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 77.6 m -77.15 114.51 16.03 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.516 1.126 . . . . 0.0 109.68 178.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.1 t -77.82 112.4 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 172.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.5 p -81.88 145.08 30.55 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.337 -0.852 . . . . 0.0 109.01 177.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -169.81 -172.03 35.95 Favored Glycine 0 C--N 1.342 0.889 0 O-C-N 121.018 -1.051 . . . . 0.0 112.466 -172.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -114.65 161.0 18.68 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 176.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 62.2 mt -111.02 135.46 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 124.709 1.203 . . . . 0.0 108.286 -175.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -124.94 125.06 43.33 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.691 0.796 . . . . 0.0 108.987 175.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -71.39 142.95 50.33 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 158.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.5 m -140.75 153.25 20.98 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -176.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -94.51 174.95 6.86 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 122.585 1.183 . . . . 0.0 111.378 172.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.39 -5.49 40.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 113.493 -1.685 . . . . 0.0 113.051 -175.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -85.62 -46.89 10.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 118.028 -0.986 . . . . 0.0 110.417 164.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 25.3 tpp -63.75 -50.03 70.68 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.772 1.169 . . . . 0.0 111.168 -177.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.06 -17.28 64.82 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 122.237 -0.289 . . . . 0.0 111.071 -175.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 23.6 mtt180 -86.8 -42.94 12.89 Favored 'General case' 0 C--O 1.222 -0.374 0 C-N-CA 127.63 2.372 . . . . 0.0 110.901 172.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -60.57 -44.87 95.7 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.951 1.251 . . . . 0.0 109.562 177.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.5 mp -58.41 -30.73 67.08 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.54 -0.725 . . . . 0.0 110.855 171.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.47 ' HA ' ' SG ' ' A' ' 84' ' ' CYS . 1.1 t70 -70.98 3.71 3.16 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.177 1.391 . . . . 0.0 113.44 176.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -126.97 -43.15 1.69 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 127.129 2.172 . . . . 0.0 109.699 176.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -65.9 -37.98 87.52 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.539 1.536 . . . . 0.0 112.378 177.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -91.01 6.52 44.5 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 123.227 0.611 . . . . 0.0 111.462 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.2 t0 52.06 30.24 7.28 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.776 1.23 . . . . 0.0 113.62 175.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.47 ' SG ' ' HA ' ' A' ' 79' ' ' ASP . 0.8 OUTLIER -74.24 159.63 83.35 Favored Pre-proline 0 CA--C 1.536 0.414 0 O-C-N 118.613 -2.554 . . . . 0.0 109.559 172.024 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -72.77 -4.45 14.16 Favored 'Cis proline' 0 CA--C 1.544 1.011 0 CA-C-N 120.477 1.206 . . . . 0.0 114.205 -6.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.0 m -54.62 -72.33 0.07 Allowed 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.24 1.016 . . . . 0.0 111.625 177.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 8.6 mtm -74.74 -64.61 1.0 Allowed 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -173.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -101.99 172.16 7.08 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.753 0.821 . . . . 0.0 108.983 178.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -135.23 -14.95 1.97 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 178.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 61.45 148.21 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 128.623 2.769 . . . . 0.0 114.635 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.4 m -154.17 170.82 20.3 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -174.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -87.4 159.41 18.72 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.042 1.337 . . . . 0.0 110.196 162.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.509 ' CD2' HG13 ' A' ' 95' ' ' VAL . 0.0 OUTLIER -150.15 -166.6 2.59 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.664 1.185 . . . . 0.0 111.012 176.085 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.77 123.36 32.73 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.022 0.929 . . . . 0.0 110.624 172.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.509 HG13 ' CD2' ' A' ' 93' ' ' LEU . 1.4 p -138.23 111.24 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -170.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -54.03 127.68 27.49 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 124.621 1.168 . . . . 0.0 110.091 -177.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 25.6 t -80.55 82.17 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 C-N-CA 127.503 2.321 . . . . 0.0 107.165 179.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.8 mp -63.1 -30.08 71.31 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.1 0.56 . . . . 0.0 110.227 175.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -154.08 160.48 41.98 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 126.164 1.786 . . . . 0.0 107.741 168.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 54.2 t-105 -144.1 124.56 13.94 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.592 1.557 . . . . 0.0 107.21 174.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -113.48 96.03 5.67 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.482 1.289 . . . . 0.0 114.482 177.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 118.76 -178.92 16.81 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 124.955 1.264 . . . . 0.0 110.868 -176.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -67.85 172.96 4.8 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.67 1.188 . . . . 0.0 110.564 177.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.63 41.18 3.44 Favored Glycine 0 C--O 1.219 -0.84 0 C-N-CA 124.367 0.984 . . . . 0.0 111.689 173.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -101.27 89.17 1.28 Allowed Pre-proline 0 C--N 1.321 -0.647 0 C-N-CA 130.624 3.57 . . . . 0.0 110.02 -155.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -73.81 -26.69 13.19 Favored 'Trans proline' 0 CA--C 1.538 0.708 1 C-N-CA 126.456 4.771 . . . . 0.0 114.807 -159.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 128.71 -164.23 21.92 Favored Glycine 0 CA--C 1.533 1.198 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -160.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -63.96 -23.83 67.49 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 117.932 0.866 . . . . 0.0 113.325 -169.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.75 169.34 17.89 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.878 1.271 . . . . 0.0 109.884 -174.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . 0.289 11.3 p -130.67 153.54 39.25 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 C-N-CA 117.63 -1.628 . . . . 0.0 108.699 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -96.13 77.78 3.11 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 173.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.403 ' SG ' HD22 ' A' ' 93' ' ' LEU . 1.6 p -82.36 -167.55 1.63 Allowed 'General case' 0 C--O 1.237 0.41 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.9 177.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -120.46 136.6 54.7 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.328 0.651 . . . . 0.0 109.272 162.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 95.5 t -124.48 153.42 31.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 169.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -84.23 105.0 14.74 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.051 -1.03 . . . . 0.0 109.354 176.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 70.6 p -86.18 175.98 8.21 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.672 1.189 . . . . 0.0 110.35 172.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.7 t -128.49 146.26 50.87 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 149.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -117.42 5.59 12.54 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.383 1.073 . . . . 0.0 111.381 176.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 11.4 t -126.28 47.04 2.33 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 122.805 1.288 . . . . 0.0 110.058 -176.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 14.8 p90 -78.83 156.2 28.83 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.142 0.977 . . . . 0.0 111.866 -178.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.05 157.26 85.45 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 125.153 1.381 . . . . 0.0 110.515 173.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -59.88 -48.36 12.8 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.063 2.509 . . . . 0.0 112.578 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -51.57 -32.38 28.24 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.674 1.19 . . . . 0.0 113.661 -178.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 44.2 m0 -71.14 -14.86 62.42 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.344 -0.847 . . . . 0.0 111.4 -173.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 78.7 mt -71.36 -20.0 62.22 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 118.061 -0.971 . . . . 0.0 111.842 170.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -95.91 -24.74 16.28 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.632 1.106 . . . . 0.0 110.889 -168.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 77.1 mt -60.25 156.93 36.68 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 126.103 1.761 . . . . 0.0 111.961 -173.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -66.74 151.21 82.98 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 121.916 1.744 . . . . 0.0 109.64 175.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -104.92 162.99 12.86 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.335 1.054 . . . . 0.0 111.542 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -137.67 144.48 41.85 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 123.529 0.731 . . . . 0.0 111.938 -173.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -94.64 -12.7 26.87 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.032 1.333 . . . . 0.0 112.181 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 51.9 p -159.23 172.7 17.55 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 120.61 -1.306 . . . . 0.0 109.743 173.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.421 ' CD1' ' HA2' ' A' ' 8' ' ' GLY . 0.1 OUTLIER -140.61 148.0 40.24 Favored 'General case' 0 N--CA 1.434 -1.245 0 C-N-CA 126.649 1.98 . . . . 0.0 107.227 -178.165 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -156.81 113.68 3.08 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 105.28 -2.118 . . . . 0.0 105.28 172.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.36 1.23 19.56 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.773 -0.579 . . . . 0.0 110.734 173.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -120.35 45.25 2.25 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.013 1.725 . . . . 0.0 106.782 164.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -109.66 155.8 15.91 Favored Glycine 0 CA--C 1.534 1.226 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 166.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -66.76 6.64 0.53 Allowed 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 125.289 3.993 . . . . 0.0 114.71 178.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 61.0 m-70 -58.58 -13.74 6.46 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 120.688 -1.258 . . . . 0.0 114.239 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 86.22 -46.62 3.63 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 124.871 1.224 . . . . 0.0 112.227 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.91 75.55 2.82 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.408 1.083 . . . . 0.0 112.188 179.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -95.92 157.92 15.68 Favored 'General case' 0 N--CA 1.463 0.178 0 O-C-N 121.403 -0.811 . . . . 0.0 110.707 175.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -59.28 156.73 11.99 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.947 1.299 . . . . 0.0 110.834 -176.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -114.28 85.1 10.1 Favored Pre-proline 0 C--O 1.238 0.47 0 C-N-CA 125.748 1.619 . . . . 0.0 107.751 177.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -77.1 -46.84 0.14 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 123.761 2.974 . . . . 0.0 111.499 178.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.643 ' CB ' ' HD3' ' A' ' 149' ' ' ARG . 8.8 tpt180 -137.74 -4.07 1.81 Allowed 'General case' 0 CA--C 1.508 -0.646 0 CA-C-O 123.595 1.664 . . . . 0.0 114.385 -176.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 57.07 -1.29 0.06 Allowed 'General case' 0 N--CA 1.425 -1.702 1 C-N-CA 131.988 4.115 . . . . 0.0 114.735 -174.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.475 ' H ' ' C ' ' A' ' 146' ' ' ARG . 68.6 m-80 -159.58 10.03 0.12 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.108 2.163 . . . . 0.0 111.578 -159.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.643 ' HD3' ' CB ' ' A' ' 146' ' ' ARG . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 117.388 -1.291 . . . . 0.0 108.85 178.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.409 ' HA ' ' OE2' ' A' ' 69' ' ' GLU . 8.8 mtt . . . . . 0 N--CA 1.471 0.584 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.81 83.04 1.34 Allowed 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 125.083 1.353 . . . . 0.0 108.011 -169.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -63.22 138.33 58.51 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 124.698 1.199 . . . . 0.0 109.437 -174.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.3 pt -125.56 167.78 19.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 124.33 1.052 . . . . 0.0 109.221 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -132.69 136.52 46.47 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.474 0.71 . . . . 0.0 109.48 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.5 m -75.34 114.68 15.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 123.353 0.661 . . . . 0.0 109.933 -172.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -66.45 -3.9 7.15 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.044 0.938 . . . . 0.0 113.122 174.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 145.05 -1.04 1.02 Allowed Glycine 0 CA--C 1.528 0.891 0 CA-C-O 118.972 -0.904 . . . . 0.0 115.045 168.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 p -109.81 -16.59 13.85 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 120.198 1.999 . . . . 0.0 113.5 -160.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.68 30.61 6.62 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.874 1.27 . . . . 0.0 110.859 -171.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -132.4 -84.87 0.48 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 117.344 -1.313 . . . . 0.0 109.205 -176.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.4 mmt-85 -50.62 -78.71 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.61 1.564 . . . . 0.0 112.3 -173.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -171.72 10.92 0.04 OUTLIER Glycine 0 CA--C 1.52 0.404 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -162.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.13 150.66 91.83 Favored Pre-proline 0 CA--C 1.537 0.449 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 175.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -68.89 -12.36 34.24 Favored 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 123.694 2.929 . . . . 0.0 112.697 -169.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -85.18 -12.5 52.57 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 116.247 -1.835 . . . . 0.0 112.501 -174.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -49.66 -39.02 34.9 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 121.302 1.864 . . . . 0.0 110.098 -176.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -50.65 -24.79 3.57 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 115.343 1.609 . . . . 0.0 115.343 178.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.4 m -56.18 -45.63 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 120.835 1.652 . . . . 0.0 110.698 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.408 ' HA ' ' CE ' ' A' ' 74' ' ' MET . 2.3 mmm -73.02 -7.45 51.29 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -176.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.1 mt -101.43 11.4 39.21 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.653 1.181 . . . . 0.0 108.487 -175.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -127.15 103.28 7.35 Favored 'General case' 0 CA--C 1.513 -0.466 0 O-C-N 121.307 -0.871 . . . . 0.0 109.942 178.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -66.39 -18.86 65.6 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -175.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 m -66.41 -19.93 65.93 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.29 -0.881 . . . . 0.0 112.403 168.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 39.3 m170 -93.44 -17.49 23.41 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.938 0.895 . . . . 0.0 110.994 169.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 130.96 178.73 15.61 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 124.787 1.184 . . . . 0.0 112.114 169.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 37.5 tp -88.42 147.33 24.75 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.242 0.617 . . . . 0.0 111.352 -175.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.95 158.55 44.21 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.361 1.064 . . . . 0.0 109.243 161.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -143.64 136.46 27.44 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 126.826 2.051 . . . . 0.0 108.931 175.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -75.56 79.08 2.57 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.509 1.924 . . . . 0.0 110.0 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -95.5 63.27 2.48 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 121.14 -0.975 . . . . 0.0 109.935 174.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.17 175.0 27.65 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-O 122.598 1.11 . . . . 0.0 113.975 158.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 44.5 mtp85 -113.82 158.01 21.57 Favored 'General case' 0 CA--C 1.516 -0.34 0 O-C-N 121.586 -0.949 . . . . 0.0 108.686 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -171.42 177.54 44.24 Favored Glycine 0 CA--C 1.506 -0.493 0 CA-C-O 122.235 0.908 . . . . 0.0 112.895 -176.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.3 p -140.09 146.17 38.57 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.101 -1.049 . . . . 0.0 108.47 172.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.2 p -71.2 96.99 1.45 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 104.999 -2.222 . . . . 0.0 104.999 170.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -67.28 -36.45 76.74 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.47 111.55 1.02 Allowed 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 160.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -57.5 142.81 42.99 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 174.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -137.48 153.72 74.65 Favored Pre-proline 0 N--CA 1.45 -0.474 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 169.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -80.17 96.69 1.03 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 1 C-N-CA 125.704 4.269 . . . . 0.0 110.792 177.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 51.0 tp -92.4 114.38 26.92 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 169.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.5 m -126.57 149.38 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 177.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.9 mt -94.16 121.62 44.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 177.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.22 -179.73 6.03 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.554 0.741 . . . . 0.0 110.459 176.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.42 153.88 4.25 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 125.31 1.433 . . . . 0.0 111.849 172.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -67.24 -16.93 64.58 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 121.145 -1.209 . . . . 0.0 113.299 -171.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 24.9 m-70 -100.44 9.56 42.44 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.882 0.873 . . . . 0.0 112.998 -173.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 57.44 66.25 1.18 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.705 1.602 . . . . 0.0 108.716 -172.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 96.3 mt -112.23 87.02 8.52 Favored Pre-proline 0 C--N 1.331 -0.202 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.69 145.55 95.07 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 CA-C-N 121.021 1.4 . . . . 0.0 111.749 170.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 22.1 m95 -123.78 161.18 25.74 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.781 1.232 . . . . 0.0 108.641 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.8 tp -116.51 96.02 5.32 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 174.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.76 135.72 57.78 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 172.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -71.24 93.94 1.14 Allowed 'General case' 0 C--O 1.233 0.237 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.85 74.4 14.72 Favored Pre-proline 0 CA--C 1.537 0.444 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -59.88 120.71 8.67 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.233 1.956 . . . . 0.0 109.401 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.03 -1.84 40.99 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 126.953 2.216 . . . . 0.0 114.242 177.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -112.03 160.94 17.0 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 120.672 2.236 . . . . 0.0 108.016 174.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.09 -142.46 34.47 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 109.739 -1.345 . . . . 0.0 109.739 -173.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -140.95 178.14 7.57 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.421 1.088 . . . . 0.0 110.129 -171.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 68.9 m -76.41 109.71 10.35 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 118.887 0.767 . . . . 0.0 111.076 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.5 t -75.26 108.89 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 174.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 59.2 p -72.2 160.83 31.77 Favored 'General case' 0 C--O 1.24 0.56 0 O-C-N 121.321 -0.862 . . . . 0.0 109.291 174.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 174.46 -157.55 25.2 Favored Glycine 0 C--N 1.335 0.505 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 -176.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -134.99 156.47 48.98 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 125.21 1.404 . . . . 0.0 108.158 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.3 mt -103.99 128.25 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 -176.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -122.98 126.83 47.91 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 172.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.409 ' OE2' ' HA ' ' A' ' 1' ' ' MET . 4.7 tp10 -67.89 151.11 47.67 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 155.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.7 m -144.91 162.86 13.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 124.78 1.232 . . . . 0.0 107.862 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -105.54 171.3 7.4 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.995 0.902 . . . . 0.0 109.102 169.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.31 -32.29 68.34 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.393 1.477 . . . . 0.0 112.287 -163.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -69.91 -38.48 76.27 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-O 117.33 -1.319 . . . . 0.0 110.999 176.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.408 ' CE ' ' HA ' ' A' ' 20' ' ' MET . 43.6 tpp -65.69 -47.05 76.73 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 120.438 1.472 . . . . 0.0 109.18 178.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.05 -31.82 73.15 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.052 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -68.39 -45.02 73.82 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.503 1.047 . . . . 0.0 111.708 170.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -60.47 -50.36 73.87 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.682 0.793 . . . . 0.0 110.064 -176.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.6 mt -62.1 -36.3 81.3 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 122.806 0.442 . . . . 0.0 111.342 -175.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -51.54 -54.67 24.91 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.31 1.844 . . . . 0.0 108.757 172.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -68.88 -41.24 78.6 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.352 1.061 . . . . 0.0 112.296 -177.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -60.81 -53.57 55.77 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.271 1.428 . . . . 0.0 110.777 -168.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -74.79 -5.26 42.45 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.019 0.372 . . . . 0.0 111.594 -177.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.0 t0 75.02 25.31 1.38 Allowed 'General case' 0 C--O 1.233 0.2 0 C-N-CA 128.861 2.865 . . . . 0.0 113.782 -174.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -62.4 161.66 24.56 Favored Pre-proline 0 CA--C 1.547 0.858 0 O-C-N 119.837 -1.789 . . . . 0.0 108.44 165.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -72.21 -3.82 12.38 Favored 'Cis proline' 0 CA--C 1.548 1.224 0 CA-C-N 119.392 0.818 . . . . 0.0 113.004 -12.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.16 -59.6 5.2 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.479 1.912 . . . . 0.0 111.083 -175.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 27.5 mtp -82.83 -76.89 0.25 Allowed 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.859 1.263 . . . . 0.0 108.402 178.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -88.92 -177.4 5.47 Favored 'General case' 0 C--O 1.227 -0.122 0 C-N-CA 125.318 1.447 . . . . 0.0 110.319 -179.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 6.7 mp0 -138.21 176.61 8.55 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.605 2.362 . . . . 0.0 106.72 159.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -117.99 126.02 51.51 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.471 1.509 . . . . 0.0 108.382 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.7 m -126.09 150.91 47.86 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.212 0.605 . . . . 0.0 110.032 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.07 137.75 33.98 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.503 1.521 . . . . 0.0 109.533 166.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.443 HD13 ' CG2' ' A' ' 114' ' ' VAL . 0.0 OUTLIER -142.68 -164.64 1.87 Allowed 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 127.852 2.461 . . . . 0.0 108.187 -177.254 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -119.42 139.76 51.5 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 123.613 0.765 . . . . 0.0 110.561 173.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 10.8 t -127.46 149.43 32.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 173.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -87.41 137.23 32.51 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 126.706 2.002 . . . . 0.0 105.656 170.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.505 ' CG1' ' HA ' ' A' ' 108' ' ' ASP 0.324 1.7 p -94.74 92.2 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 176.084 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.68 -45.53 93.59 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 114.358 -1.292 . . . . 0.0 108.802 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -141.58 140.83 33.47 Favored 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 125.651 1.58 . . . . 0.0 107.296 177.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 50.5 t-105 -108.7 141.24 40.97 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 167.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -119.93 101.37 7.81 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 165.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 139.93 177.72 16.09 Favored Glycine 0 C--N 1.331 0.252 0 CA-C-O 122.826 1.237 . . . . 0.0 112.822 164.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -64.67 162.29 16.07 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 168.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 72.44 75.19 0.71 Allowed Glycine 0 CA--C 1.522 0.474 0 O-C-N 120.937 -1.102 . . . . 0.0 111.883 176.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -102.28 90.52 2.12 Favored Pre-proline 0 N--CA 1.471 0.587 0 C-N-CA 128.399 2.68 . . . . 0.0 108.176 -172.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -53.15 -29.67 46.91 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.479 2.119 . . . . 0.0 114.807 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 145.73 -120.29 1.32 Allowed Glycine 0 C--N 1.338 0.694 0 CA-C-N 121.106 1.775 . . . . 0.0 110.729 -175.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.505 ' HA ' ' CG1' ' A' ' 97' ' ' VAL . 0.9 OUTLIER -143.9 1.04 1.12 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.319 1.848 . . . . 0.0 110.812 179.338 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.2 p -131.93 158.17 42.1 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 122.184 0.992 . . . . 0.0 110.62 148.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.4 m -137.74 167.25 22.85 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 C-N-CA 125.67 1.588 . . . . 0.0 108.444 -177.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -95.58 118.96 33.24 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 163.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 80.1 m -109.41 167.64 9.97 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.465 1.029 . . . . 0.0 109.4 165.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -95.13 141.57 28.59 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 163.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.443 ' CG2' HD13 ' A' ' 93' ' ' LEU . 84.9 t -135.64 151.42 29.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 170.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -81.17 134.18 35.58 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 173.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 42.3 p -140.37 -177.7 5.15 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.096 1.359 . . . . 0.0 109.575 -172.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.63 141.4 35.1 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 167.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -103.6 -5.59 22.52 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.209 1.003 . . . . 0.0 110.614 167.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.6 p -107.78 17.75 22.17 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.435 1.894 . . . . 0.0 112.715 -156.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -77.8 162.09 27.17 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.562 1.545 . . . . 0.0 113.343 -167.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -81.45 158.19 69.23 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 126.938 2.095 . . . . 0.0 111.405 175.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -68.01 -33.22 26.39 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.68 2.253 . . . . 0.0 113.35 -174.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.9 pm0 -58.36 -31.74 67.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 118.806 0.73 . . . . 0.0 112.763 177.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 44.2 m0 -69.37 -14.72 63.07 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.318 0.508 . . . . 0.0 111.215 -176.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -78.4 -17.93 55.73 Favored 'General case' 0 CA--C 1.528 0.131 0 O-C-N 121.329 -0.857 . . . . 0.0 111.317 172.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -95.56 -22.7 17.46 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.798 0.727 . . . . 0.0 110.281 -172.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.2 mt -56.91 155.22 15.92 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 126.094 1.758 . . . . 0.0 111.036 178.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -67.64 144.4 66.01 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 121.339 1.359 . . . . 0.0 108.939 177.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -82.16 164.6 21.17 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 122.767 0.427 . . . . 0.0 109.923 172.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 51.8 m-70 -139.47 139.16 36.93 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.296 1.038 . . . . 0.0 109.13 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -82.45 -20.21 37.39 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.914 0.886 . . . . 0.0 112.921 -178.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.04 156.56 7.32 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 119.389 0.995 . . . . 0.0 110.052 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -114.28 127.79 56.04 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.572 1.149 . . . . 0.0 108.768 -175.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -140.18 131.38 26.52 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.434 1.494 . . . . 0.0 108.535 -174.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 7.6 t -69.93 -10.23 57.84 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.951 0.9 . . . . 0.0 110.154 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -131.15 64.22 1.58 Allowed 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 128.567 2.747 . . . . 0.0 104.673 177.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -124.28 171.51 16.53 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.866 1.698 . . . . 0.0 110.871 -176.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -61.96 -22.94 75.25 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.037 2.491 . . . . 0.0 112.877 -172.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -79.7 84.39 5.53 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 128.728 2.811 . . . . 0.0 109.251 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -44.89 -31.56 2.8 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 124.938 1.256 . . . . 0.0 113.683 177.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.5 90.25 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 127.097 2.159 . . . . 0.0 111.37 157.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -102.53 175.93 5.34 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 120.848 -1.158 . . . . 0.0 109.132 166.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -60.13 116.06 3.93 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -173.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -121.24 67.96 18.26 Favored Pre-proline 0 C--O 1.226 -0.159 0 C-N-CA 124.05 0.94 . . . . 0.0 109.331 -178.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -73.16 -22.65 18.94 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 121.89 1.726 . . . . 0.0 112.703 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.16 33.22 0.09 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.824 0.849 . . . . 0.0 110.469 -169.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -84.38 99.72 10.82 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 56.39 26.03 10.22 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.998 2.119 . . . . 0.0 114.589 -178.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.045 0 C-N-CA 126.912 2.085 . . . . 0.0 109.577 -176.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 tmm? . . . . . 0 N--CA 1.466 0.328 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.2 96.62 1.21 Allowed 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 102.514 -3.143 . . . . 0.0 102.514 -171.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -69.91 123.28 21.11 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 -175.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.2 pt -108.18 174.19 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 121.229 -0.919 . . . . 0.0 108.707 176.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -109.57 165.54 11.59 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.429 0.692 . . . . 0.0 109.37 168.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.2 p -121.45 133.99 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -59.58 -52.15 66.8 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.49 0.662 . . . . 0.0 111.843 -177.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.11 -35.29 0.27 Allowed Glycine 0 CA--C 1.526 0.78 0 CA-C-O 123.708 1.727 . . . . 0.0 110.793 -167.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -55.44 -23.73 26.88 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 129.927 3.291 . . . . 0.0 114.202 178.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -134.92 32.32 3.23 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 119.897 1.226 . . . . 0.0 110.157 -179.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.17 8.58 5.15 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 115.559 1.688 . . . . 0.0 115.559 178.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.69 -86.42 0.14 Allowed 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 117.677 -1.154 . . . . 0.0 109.139 174.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -162.6 18.07 0.15 Allowed Glycine 0 C--N 1.337 0.61 0 CA-C-N 119.366 0.985 . . . . 0.0 113.744 177.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -44.88 156.36 0.36 Allowed Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 126.474 1.91 . . . . 0.0 111.82 173.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -64.87 -2.15 5.1 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 124.471 3.447 . . . . 0.0 115.25 -172.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -112.47 -10.52 13.72 Favored 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 125.115 1.366 . . . . 0.0 110.894 -165.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -56.73 -30.15 63.24 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.091 0.859 . . . . 0.0 111.487 -173.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.5 -27.84 27.71 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.1 m -69.14 -11.09 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 118.785 0.72 . . . . 0.0 112.499 -170.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.5 ptp -102.79 -0.58 31.23 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.168 1.787 . . . . 0.0 113.232 171.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.0 mt -102.77 4.41 37.9 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.735 1.614 . . . . 0.0 110.694 -178.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -117.39 77.88 1.17 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 -172.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -58.9 -15.28 11.94 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.094 1.758 . . . . 0.0 114.066 -165.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.3 m -61.02 -37.1 81.36 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 120.499 -1.375 . . . . 0.0 112.013 166.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 45.3 m170 -65.78 -29.25 69.72 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.599 0.636 . . . . 0.0 110.529 175.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.57 -178.4 22.49 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 124.171 0.891 . . . . 0.0 111.184 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 46.3 tp -95.9 144.55 26.14 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.976 0.91 . . . . 0.0 111.996 -173.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.71 147.38 46.73 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.617 1.167 . . . . 0.0 108.288 163.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -146.07 134.33 21.74 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 125.574 1.549 . . . . 0.0 109.655 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.93 93.27 0.4 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.482 1.113 . . . . 0.0 110.11 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.1 tpp180 -110.63 64.87 0.61 Allowed 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 126.05 1.74 . . . . 0.0 108.146 -176.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.52 179.08 43.81 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-O 122.848 1.249 . . . . 0.0 112.442 172.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 38.3 mtp180 -125.3 165.06 19.03 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 123.423 0.689 . . . . 0.0 110.776 173.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -173.59 176.13 46.21 Favored Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 120.39 -0.91 . . . . 0.0 113.564 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 71.6 m -138.85 133.54 32.13 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.371 1.068 . . . . 0.0 108.877 177.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.1 p -63.55 100.87 0.29 Allowed 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -73.12 -23.6 20.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-O 120.83 0.348 . . . . 0.0 110.833 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -60.41 100.74 0.11 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 152.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.5 m -56.6 137.41 53.85 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 167.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -138.58 156.62 73.08 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 -176.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -76.27 94.91 1.02 Allowed 'Trans proline' 0 CA--C 1.538 0.682 1 C-N-CA 126.032 4.488 . . . . 0.0 111.607 177.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 32.0 tp -93.21 114.33 26.78 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 121.134 -0.979 . . . . 0.0 109.96 174.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.4 m -131.66 143.73 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 119.198 0.908 . . . . 0.0 110.463 -173.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 55.6 mt -97.73 108.86 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -178.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -117.62 -179.68 3.8 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.52 0.728 . . . . 0.0 110.346 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.25 161.53 6.6 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 126.424 1.964 . . . . 0.0 115.382 163.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -65.76 -22.54 66.59 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 127.782 2.433 . . . . 0.0 114.303 -170.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 39.1 m-70 -109.85 13.47 23.54 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.813 0.845 . . . . 0.0 111.821 176.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.9 m120 60.38 64.49 1.2 Allowed 'General case' 0 C--N 1.344 0.365 0 CA-C-O 122.262 1.03 . . . . 0.0 108.251 -179.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 55.4 mt -104.72 87.43 1.8 Allowed Pre-proline 0 N--CA 1.45 -0.427 0 C-N-CA 127.874 2.47 . . . . 0.0 105.403 177.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.08 152.0 25.88 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 120.684 0.923 . . . . 0.0 112.825 166.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 22.4 m95 -130.24 166.64 19.9 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.056 1.342 . . . . 0.0 107.391 175.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -138.85 119.7 14.27 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.89 147.43 23.67 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 113.392 -1.731 . . . . 0.0 107.834 -169.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -78.66 87.19 4.59 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.977 -176.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.93 77.57 20.88 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 124.036 0.934 . . . . 0.0 111.103 179.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.68 115.68 4.33 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 124.885 3.723 . . . . 0.0 110.442 -176.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 117.23 11.81 8.67 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 124.751 1.167 . . . . 0.0 113.595 175.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.2 tpmt? -138.0 149.06 45.76 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 119.599 1.699 . . . . 0.0 108.808 -176.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.96 -135.32 14.87 Favored Glycine 0 CA--C 1.521 0.465 0 CA-C-N 120.601 1.546 . . . . 0.0 109.507 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -134.97 169.89 16.72 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 118.889 1.345 . . . . 0.0 111.787 -167.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 59.2 m -85.48 103.47 14.38 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 125.358 1.463 . . . . 0.0 108.543 -178.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.0 t -69.8 106.23 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 51.3 p -81.88 147.51 29.27 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.286 -0.884 . . . . 0.0 110.026 -173.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -173.46 -156.52 13.32 Favored Glycine 0 C--N 1.342 0.898 0 O-C-N 121.402 -0.811 . . . . 0.0 113.097 -172.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -134.73 162.62 31.85 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -176.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 89.5 mt -114.43 103.27 15.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 106.301 -1.741 . . . . 0.0 106.301 -170.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -86.07 114.08 22.65 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 172.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -61.5 131.9 51.66 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 152.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.9 m -135.52 156.24 38.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.42 177.64 5.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 122.209 1.004 . . . . 0.0 111.505 172.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.57 -36.01 75.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.057 -1.429 . . . . 0.0 111.342 177.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 32.1 tp60 -63.87 -44.46 93.01 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.292 0.951 . . . . 0.0 110.13 177.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 35.2 tpp -66.96 -50.46 62.22 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 118.629 0.649 . . . . 0.0 110.938 177.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.2 mt -64.14 -16.65 62.32 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 118.592 0.633 . . . . 0.0 111.34 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 45.4 mtt180 -82.15 -50.59 8.86 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 120.429 -1.42 . . . . 0.0 111.555 165.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -54.14 -48.21 71.07 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 120.338 1.426 . . . . 0.0 111.041 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.3 tp -64.47 -23.22 67.2 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 121.823 -0.548 . . . . 0.0 110.96 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.526 ' HA ' ' SG ' ' A' ' 84' ' ' CYS . 28.0 t70 -75.98 -5.9 48.48 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 120.858 -1.151 . . . . 0.0 112.503 176.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -105.92 -42.87 5.01 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.765 1.626 . . . . 0.0 110.604 172.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -65.68 -38.96 90.72 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.838 0.855 . . . . 0.0 112.139 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.454 ' HG3' ' CE2' ' A' ' 115' ' ' TYR . 7.5 mm-40 -83.34 10.57 8.33 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.164 0.585 . . . . 0.0 111.406 178.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.9 t70 61.3 0.32 0.42 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 128.522 2.729 . . . . 0.0 114.882 178.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.526 ' SG ' ' HA ' ' A' ' 79' ' ' ASP . 24.6 p -65.99 153.04 92.53 Favored Pre-proline 0 N--CA 1.448 -0.57 0 C-N-CA 124.167 0.987 . . . . 0.0 109.757 -167.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -75.41 -4.96 22.51 Favored 'Cis proline' 0 CA--C 1.54 0.797 0 N-CA-C 115.915 1.467 . . . . 0.0 115.915 9.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 m -54.68 -71.31 0.08 Allowed 'General case' 0 C--O 1.237 0.435 0 CA-C-N 119.601 1.092 . . . . 0.0 112.758 -178.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 46.2 mtp -71.86 -64.84 0.85 Allowed 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -173.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -105.7 167.0 10.06 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.31 1.444 . . . . 0.0 108.908 -178.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -127.72 -14.1 5.19 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -177.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? 61.91 145.78 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 128.3 2.64 . . . . 0.0 111.756 -172.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 38.3 m -148.69 178.12 8.92 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 119.797 -1.814 . . . . 0.0 107.261 171.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -116.59 142.09 47.33 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 127.181 2.193 . . . . 0.0 111.062 168.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.456 HD13 ' H ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -136.31 -174.17 3.61 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 129.204 3.001 . . . . 0.0 110.674 -170.798 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -115.75 126.36 53.95 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 126.145 1.778 . . . . 0.0 111.614 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . 0.321 1.4 p -142.29 115.16 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 121.063 3.727 . . . . 0.0 121.063 -167.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -60.92 118.22 6.43 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 113.986 -1.461 . . . . 0.0 107.184 -169.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.439 ' CG1' ' HA ' ' A' ' 108' ' ' ASP 0.331 1.6 p -85.69 87.51 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 O-C-N 124.544 1.153 . . . . 0.0 108.623 -178.284 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -57.95 -40.12 79.78 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 112.919 -1.946 . . . . 0.0 109.694 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -152.15 152.58 32.47 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 -177.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 -140.3 129.65 23.91 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -179.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -118.2 97.62 5.88 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.023 1.329 . . . . 0.0 114.094 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.98 -175.7 21.56 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -178.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -67.41 178.4 1.58 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.494 0.717 . . . . 0.0 111.203 -174.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.38 47.06 3.36 Favored Glycine 0 C--O 1.22 -0.754 0 O-C-N 120.858 -1.151 . . . . 0.0 110.809 169.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -101.63 88.47 1.2 Allowed Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 131.128 3.771 . . . . 0.0 112.228 -153.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -70.91 -32.38 13.89 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 124.295 3.33 . . . . 0.0 114.731 -175.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 143.17 -95.75 0.19 Allowed Glycine 0 C--N 1.339 0.717 0 CA-C-N 120.899 1.681 . . . . 0.0 112.783 -178.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.439 ' HA ' ' CG1' ' A' ' 97' ' ' VAL . 2.1 m-20 -156.44 6.25 0.18 Allowed 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 125.448 1.499 . . . . 0.0 111.066 -172.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -142.86 154.71 44.4 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 117.815 -1.554 . . . . 0.0 109.549 150.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.1 m -126.01 165.31 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.03 0 C-N-CA 117.09 -1.844 . . . . 0.0 109.624 -175.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -101.77 100.2 10.52 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 104.745 -2.317 . . . . 0.0 104.745 167.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 3.0 p -102.36 -166.75 1.32 Allowed 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 172.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -121.79 146.4 47.1 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.677 1.591 . . . . 0.0 108.714 166.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 20.2 t -139.4 137.85 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 129.778 3.231 . . . . 0.0 107.599 177.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.454 ' CE2' ' HG3' ' A' ' 82' ' ' GLU . 4.3 m-85 -79.92 80.33 6.34 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.898 1.279 . . . . 0.0 111.499 -175.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 51.6 p -80.41 175.71 10.42 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.96 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.0 t -136.12 129.79 32.35 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 105.153 -2.166 . . . . 0.0 105.153 162.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -89.67 -0.81 57.77 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.925 0.89 . . . . 0.0 110.709 172.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 10.1 t -116.25 31.75 6.53 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.674 1.989 . . . . 0.0 110.903 -178.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -56.85 163.48 1.92 Allowed 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.672 -0.642 . . . . 0.0 109.819 166.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -98.07 154.97 37.51 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 123.772 0.829 . . . . 0.0 110.572 172.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -64.29 -33.4 59.49 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.572 2.181 . . . . 0.0 111.235 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -67.07 -7.4 22.64 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.918 0.887 . . . . 0.0 112.675 177.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 44.1 m0 -96.88 -18.52 19.46 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 118.809 0.731 . . . . 0.0 111.34 170.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 18.8 mt -79.0 -16.97 56.18 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 120.094 1.315 . . . . 0.0 112.39 175.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -77.74 -25.03 48.92 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.563 0.745 . . . . 0.0 110.722 174.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 88.7 mt -59.79 151.57 62.67 Favored Pre-proline 0 C--N 1.344 0.35 0 C-N-CA 124.569 1.148 . . . . 0.0 110.678 -175.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -74.86 142.47 28.38 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.029 2.486 . . . . 0.0 109.15 179.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -86.78 167.25 14.58 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.893 0.854 . . . . 0.0 111.628 -175.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -136.5 171.2 14.83 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.429 1.492 . . . . 0.0 108.665 175.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 -127.99 -15.27 4.84 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 123.178 1.466 . . . . 0.0 111.572 -167.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 40.1 t -153.89 151.38 29.4 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 163.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -82.95 170.41 14.96 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 162.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 174.92 147.82 0.08 Allowed 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 128.168 2.587 . . . . 0.0 107.771 152.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.53 -31.7 72.89 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 173.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -77.07 66.79 2.95 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 127.911 2.485 . . . . 0.0 107.442 168.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -130.27 154.37 20.56 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 162.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -73.66 -13.78 24.63 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.597 2.198 . . . . 0.0 113.323 -165.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -75.21 -15.66 60.53 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.04 1.336 . . . . 0.0 113.878 -172.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 81.63 -62.0 4.56 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.111 -1.195 . . . . 0.0 110.111 -173.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.7 87.11 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.729 2.012 . . . . 0.0 114.053 -176.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.86 173.69 11.32 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 130.16 3.384 . . . . 0.0 109.256 172.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -64.11 130.61 44.63 Favored 'General case' 0 C--O 1.237 0.404 0 O-C-N 123.605 0.565 . . . . 0.0 110.482 -161.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -123.65 81.94 54.41 Favored Pre-proline 0 N--CA 1.453 -0.313 0 O-C-N 124.436 1.085 . . . . 0.0 110.56 -166.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -86.55 -19.43 2.87 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.791 2.994 . . . . 0.0 113.752 177.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.7 -3.9 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 118.096 2.628 . . . . 0.0 118.096 -172.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.44 -34.41 77.15 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 123.033 0.533 . . . . 0.0 110.022 -168.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 -128.53 74.04 1.53 Allowed 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 128.107 2.563 . . . . 0.0 104.193 165.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 5.6 tpt85 . . . . . 0 C--O 1.242 0.678 0 CA-C-O 116.87 -1.538 . . . . 0.0 108.582 169.195 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.8 mtt . . . . . 0 N--CA 1.47 0.552 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.59 176.69 12.29 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.129 1.772 . . . . 0.0 108.093 171.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -130.81 152.36 50.23 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 163.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.9 pt -138.59 172.14 14.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 121.849 0.833 . . . . 0.0 109.793 175.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -118.15 133.27 56.05 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.969 1.708 . . . . 0.0 107.882 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.1 m -91.25 138.06 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 118.982 0.81 . . . . 0.0 110.74 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -75.02 -36.03 61.94 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 127.61 2.364 . . . . 0.0 112.156 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 156.29 -37.86 0.59 Allowed Glycine 0 CA--C 1.522 0.505 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -168.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 p -62.13 -23.31 66.49 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.537 1.535 . . . . 0.0 112.993 -167.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.5 mp -134.13 62.51 1.65 Allowed 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 170.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -154.95 -49.2 0.09 Allowed 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.751 1.62 . . . . 0.0 110.647 -176.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -84.45 -86.4 0.12 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.869 0.759 . . . . 0.0 110.221 173.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -172.65 29.87 0.1 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -173.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.61 162.83 13.87 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 125.127 1.371 . . . . 0.0 110.166 -179.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -59.87 -17.48 44.02 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.849 2.366 . . . . 0.0 112.872 -177.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -85.09 -17.05 38.55 Favored 'General case' 0 C--O 1.215 -0.729 0 O-C-N 120.877 -1.139 . . . . 0.0 110.575 -175.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -58.5 -35.9 72.96 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 120.981 1.719 . . . . 0.0 112.272 -163.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.64 -16.74 51.26 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 177.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.7 m -64.08 -38.69 83.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 120.155 1.343 . . . . 0.0 110.54 -176.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.5 ptp -77.31 -10.48 59.46 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.1 mt -82.16 -14.43 55.67 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 122.869 0.468 . . . . 0.0 111.148 -173.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -106.31 100.21 9.76 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 -177.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 22.1 t-80 -56.28 -22.56 30.95 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.334 1.054 . . . . 0.0 113.513 -171.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.9 m -69.37 -20.86 63.83 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 120.482 -1.386 . . . . 0.0 113.539 174.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 30.7 m170 -76.6 -26.46 55.02 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.348 -0.845 . . . . 0.0 109.86 167.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 145.98 175.71 19.25 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 125.333 1.444 . . . . 0.0 111.222 167.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.8 tp -83.59 141.85 31.26 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 124.159 0.984 . . . . 0.0 111.852 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -145.09 92.76 2.3 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.231 1.812 . . . . 0.0 110.234 170.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -103.19 126.97 50.62 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 125.322 1.449 . . . . 0.0 110.072 -174.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -64.68 105.63 1.02 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.119 1.768 . . . . 0.0 110.44 -175.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -119.18 66.36 0.79 Allowed 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 125.755 1.622 . . . . 0.0 109.627 -178.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.65 -177.76 37.59 Favored Glycine 0 CA--C 1.523 0.539 0 CA-C-O 121.727 0.626 . . . . 0.0 112.134 172.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.419 ' CZ ' ' HB2' ' A' ' 99' ' ' GLU . 8.9 ptt180 -131.48 164.49 25.66 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.194 0.998 . . . . 0.0 108.666 178.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -170.75 -178.82 41.66 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 119.447 -1.358 . . . . 0.0 116.417 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 22.6 p -140.73 137.32 33.37 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.88 0.872 . . . . 0.0 110.595 173.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.9 p -68.32 100.78 1.1 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 176.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 m -68.78 -31.84 52.39 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-O 121.011 0.434 . . . . 0.0 111.031 -175.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.88 119.5 11.4 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 163.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.7 159.11 11.4 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 119.173 -1.011 . . . . 0.0 108.892 168.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -150.62 154.6 35.45 Favored Pre-proline 0 C--N 1.316 -0.87 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 176.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -80.93 88.72 1.36 Allowed 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 124.638 3.558 . . . . 0.0 112.435 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.4 tp -83.13 88.67 6.89 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 120.655 -1.278 . . . . 0.0 110.619 -177.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.5 t -92.59 150.82 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.181 0 C-N-CA 126.704 2.002 . . . . 0.0 109.829 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.8 mt -119.5 113.96 42.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 126.312 1.845 . . . . 0.0 107.409 176.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -137.66 158.09 45.11 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.642 0.734 . . . . 0.0 112.051 -172.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.34 169.12 37.09 Favored Glycine 0 CA--C 1.537 1.413 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.818 175.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.9 -28.48 70.08 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -168.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -96.08 2.18 53.07 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.988 0.18 . . . . 0.0 110.813 -161.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.1 m120 67.23 59.32 0.52 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.071 2.148 . . . . 0.0 108.52 176.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 61.7 mt -104.3 91.18 3.68 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 129.794 3.237 . . . . 0.0 108.745 -168.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -56.76 136.82 78.46 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 CA-C-N 120.708 1.288 . . . . 0.0 111.264 172.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -123.83 105.94 10.06 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 126.09 1.756 . . . . 0.0 108.566 -177.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.9 tp -76.76 81.53 3.37 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -175.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.1 mp -50.78 125.97 14.65 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 127.105 2.162 . . . . 0.0 110.027 174.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -73.97 85.01 1.76 Allowed 'General case' 0 C--O 1.239 0.548 0 CA-C-O 119.034 -0.508 . . . . 0.0 111.656 -173.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.44 HD11 ' HE2' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -136.66 80.21 38.43 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 118.672 0.669 . . . . 0.0 110.651 174.965 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -63.53 119.97 7.23 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.788 2.325 . . . . 0.0 111.549 -175.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.69 14.69 57.87 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 125.412 1.482 . . . . 0.0 113.262 178.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.44 ' HE2' HD11 ' A' ' 56' ' ' LEU . 0.9 OUTLIER -122.17 140.87 52.06 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 119.601 1.701 . . . . 0.0 109.172 163.965 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.23 -133.36 11.74 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 118.798 -1.001 . . . . 0.0 110.943 -171.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -141.76 169.6 17.3 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 118.871 1.336 . . . . 0.0 112.523 -157.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 27.3 m -103.33 103.79 13.84 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.621 1.168 . . . . 0.0 112.497 -166.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 14.1 t -70.05 116.25 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 123.825 0.85 . . . . 0.0 109.789 -177.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 67.6 p -80.41 146.9 31.23 Favored 'General case' 0 C--O 1.24 0.562 0 O-C-N 121.619 -0.676 . . . . 0.0 109.72 171.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -170.81 -168.22 32.25 Favored Glycine 0 N--CA 1.447 -0.574 0 O-C-N 121.386 -0.821 . . . . 0.0 111.957 -175.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -129.64 169.57 14.88 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 125.614 1.566 . . . . 0.0 108.548 -176.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.4 mt -122.89 130.57 74.39 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 O-C-N 121.298 -0.876 . . . . 0.0 108.82 -170.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -122.75 121.93 37.51 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 125.125 1.37 . . . . 0.0 107.67 171.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -64.47 135.4 56.02 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 158.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.7 m -135.69 139.01 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -173.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.48 -179.28 5.15 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.7 0.762 . . . . 0.0 110.012 176.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -63.13 -35.08 79.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 118.289 -0.862 . . . . 0.0 111.543 -173.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 44.1 tp60 -64.92 -42.55 94.61 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 118.869 0.758 . . . . 0.0 110.146 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.1 tpp -64.5 -52.37 58.19 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.8 tp -57.67 -44.19 85.57 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 118.688 -0.672 . . . . 0.0 110.822 -176.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.4 mtt180 -64.62 -34.36 78.1 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.674 0.79 . . . . 0.0 112.193 176.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -67.33 -47.5 70.3 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 118.561 0.618 . . . . 0.0 110.416 177.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.7 mt -60.05 -34.95 74.1 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 175.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.98 -6.54 12.99 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.046 1.738 . . . . 0.0 113.787 178.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -115.96 -24.5 8.08 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.501 1.921 . . . . 0.0 110.739 176.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -68.71 -41.02 79.66 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.584 1.154 . . . . 0.0 111.271 -174.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -105.75 14.58 28.05 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.984 0.914 . . . . 0.0 111.258 -170.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 58.13 25.62 12.69 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.21 1.004 . . . . 0.0 112.332 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -70.47 161.62 75.55 Favored Pre-proline 0 CA--C 1.546 0.827 0 O-C-N 119.73 -1.856 . . . . 0.0 109.739 168.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -70.87 -3.76 9.44 Favored 'Cis proline' 0 CA--C 1.545 1.06 0 CA-C-N 119.551 0.875 . . . . 0.0 113.734 -9.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 m -55.16 -60.77 2.93 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.152 1.781 . . . . 0.0 111.277 -176.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 19.2 mtm -81.83 -64.32 1.21 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 122.019 0.914 . . . . 0.0 110.49 -179.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -102.54 169.99 8.31 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 125.525 1.53 . . . . 0.0 109.381 -178.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.1 mp0 -135.34 143.33 46.06 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.975 1.31 . . . . 0.0 108.394 173.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -78.16 130.04 35.86 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 177.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.9 m -132.16 174.29 10.35 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 125.146 1.378 . . . . 0.0 109.052 -175.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -115.44 151.19 35.19 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.485 1.514 . . . . 0.0 111.153 166.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.415 HD11 ' SG ' ' A' ' 112' ' ' CYS . 0.0 OUTLIER -140.24 -160.98 1.13 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.457 1.503 . . . . 0.0 112.351 -178.09 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 38.5 tp60 -136.9 124.11 21.78 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.796 2.039 . . . . 0.0 110.121 174.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.4 p -139.21 116.19 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 116.9 2.185 . . . . 0.0 116.9 -168.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -54.54 122.45 10.58 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 124.939 1.296 . . . . 0.0 109.222 -174.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 93.1 t -76.57 88.64 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 128.654 2.782 . . . . 0.0 106.509 174.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 mp -75.78 -15.56 60.24 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.271 0.628 . . . . 0.0 111.578 177.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.419 ' HB2' ' CZ ' ' A' ' 33' ' ' ARG . 0.4 OUTLIER -160.32 161.33 33.24 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 128.051 2.541 . . . . 0.0 106.626 161.234 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 68.7 t-105 -143.49 102.24 3.91 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.584 1.554 . . . . 0.0 109.62 174.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -95.04 77.82 3.54 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.31 1.044 . . . . 0.0 109.987 -178.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 161.7 178.97 36.07 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-O 122.358 0.977 . . . . 0.0 111.651 174.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -70.21 168.4 15.85 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 168.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.65 65.65 1.65 Allowed Glycine 0 CA--C 1.524 0.594 0 O-C-N 121.377 -0.827 . . . . 0.0 111.646 172.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -101.3 90.11 1.58 Allowed Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 128.002 2.521 . . . . 0.0 109.017 -168.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -68.8 5.06 1.47 Allowed 'Trans proline' 0 CA--C 1.54 0.819 1 C-N-CA 126.361 4.707 . . . . 0.0 114.434 -165.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.05 -174.47 27.63 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 108.921 -1.671 . . . . 0.0 108.921 -168.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -65.56 -14.37 60.95 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 117.759 -1.115 . . . . 0.0 113.963 -168.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 75.6 p -138.82 169.17 18.28 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 121.136 1.789 . . . . 0.0 111.061 174.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.3 p -133.91 144.8 34.59 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.76 0 CA-C-N 121.616 2.007 . . . . 0.0 110.768 -173.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -92.04 84.77 5.35 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 171.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.415 ' SG ' HD11 ' A' ' 93' ' ' LEU . 1.6 p -89.43 -167.75 1.96 Allowed 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 175.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -109.86 151.66 26.75 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 122.736 1.255 . . . . 0.0 112.285 160.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -152.07 119.42 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 104.782 -2.303 . . . . 0.0 104.782 -163.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -67.4 129.5 40.09 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 121.828 -0.545 . . . . 0.0 109.966 167.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.2 p -127.56 -170.05 2.16 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 125.807 1.643 . . . . 0.0 107.059 176.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.2 t -144.14 147.39 33.64 Favored 'General case' 0 C--O 1.239 0.535 0 O-C-N 120.699 -1.251 . . . . 0.0 108.33 161.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -108.33 -10.14 15.38 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.0 1.32 . . . . 0.0 111.727 171.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 9.0 t -98.85 25.52 6.54 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.633 1.173 . . . . 0.0 111.909 -172.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -60.38 146.43 44.36 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.501 1.12 . . . . 0.0 111.329 176.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.66 155.27 89.56 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 124.873 1.269 . . . . 0.0 110.634 173.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.18 -33.6 18.41 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 121.398 1.399 . . . . 0.0 112.759 -178.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -58.52 -25.37 62.36 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.45 -0.781 . . . . 0.0 112.611 172.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 41.5 m0 -80.43 -4.88 55.4 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 120.969 -1.082 . . . . 0.0 112.686 -175.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -72.35 -34.09 67.77 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 119.498 1.044 . . . . 0.0 109.979 168.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -81.96 -21.89 36.95 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.996 0.918 . . . . 0.0 111.394 -177.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 15.9 mt -55.93 149.44 33.65 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 124.036 0.934 . . . . 0.0 110.151 177.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.49 156.76 64.5 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.117 1.878 . . . . 0.0 110.924 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -102.51 162.91 12.55 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 126.559 1.944 . . . . 0.0 107.455 173.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -132.49 177.91 7.24 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 173.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -128.0 -14.5 4.97 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.308 1.443 . . . . 0.0 112.422 -169.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.9 p -154.9 173.93 15.83 Favored 'General case' 0 C--O 1.239 0.542 0 O-C-N 120.652 -1.28 . . . . 0.0 109.854 163.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -120.83 136.18 54.98 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 123.795 0.838 . . . . 0.0 111.452 -177.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -163.19 128.61 3.14 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.325 1.05 . . . . 0.0 109.915 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 49.8 m -75.81 -0.32 20.7 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.257 1.423 . . . . 0.0 113.929 177.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -125.95 22.61 7.34 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.57 1.548 . . . . 0.0 109.287 173.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -79.59 164.73 49.23 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 121.604 -0.685 . . . . 0.0 111.509 177.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -60.66 -18.2 53.81 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.62 2.88 . . . . 0.0 112.865 -177.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -58.45 -17.19 18.9 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 127.427 2.291 . . . . 0.0 115.466 -174.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 79.96 -50.84 3.98 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 119.86 1.209 . . . . 0.0 113.462 174.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.04 110.93 9.75 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.491 1.516 . . . . 0.0 110.306 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.8 mmt85 -117.35 149.45 40.48 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 118.22 -0.895 . . . . 0.0 109.932 -176.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -62.61 135.36 57.35 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.687 1.131 . . . . 0.0 110.199 -176.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -131.7 78.65 70.21 Favored Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 123.821 0.848 . . . . 0.0 110.843 -176.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -80.42 -36.17 0.52 Allowed 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 123.609 2.873 . . . . 0.0 112.547 178.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -144.92 -6.01 0.69 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.56 1.144 . . . . 0.0 113.523 -175.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.271 5.5 mt-10 59.27 -58.61 0.05 Allowed 'General case' 0 N--CA 1.424 -1.732 1 C-N-CA 134.294 5.038 . . . . 0.0 112.994 175.191 . . . . . . . . 3 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -159.55 0.86 0.08 Allowed 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 125.915 1.686 . . . . 0.0 111.807 -171.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? . . . . . 0 C--O 1.252 1.185 0 C-N-CA 126.691 1.996 . . . . 0.0 109.711 -160.327 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ptt? . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.79 105.42 1.6 Allowed 'General case' 0 C--O 1.236 0.359 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -75.47 152.03 37.96 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.8 pt -130.66 -177.25 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 175.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -128.98 167.56 17.28 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 124.441 1.097 . . . . 0.0 108.128 169.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.7 p -124.93 130.89 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 177.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -68.4 -36.68 79.47 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 125.072 1.349 . . . . 0.0 110.501 174.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 147.03 29.16 0.07 OUTLIER Glycine 0 C--N 1.339 0.706 0 CA-C-O 116.738 -2.146 . . . . 0.0 116.428 171.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.8 -27.26 13.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 120.195 1.998 . . . . 0.0 110.14 178.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.0 42.72 2.29 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.881 1.272 . . . . 0.0 108.266 -178.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -133.65 -86.53 0.42 Allowed 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.107 -0.996 . . . . 0.0 110.129 -178.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.506 ' HB2' HE22 ' A' ' 14' ' ' GLN . 0.0 OUTLIER -63.03 -63.56 1.17 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.954 0.797 . . . . 0.0 111.529 -163.911 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 171.73 36.7 0.03 OUTLIER Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -174.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.506 HE22 ' HB2' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -102.29 161.08 24.44 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 124.971 1.308 . . . . 0.0 109.052 -174.165 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -85.72 62.46 5.43 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.224 2.616 . . . . 0.0 110.968 -155.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -150.93 -29.87 0.19 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.888 1.675 . . . . 0.0 109.171 179.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -48.4 -34.37 10.74 Favored 'General case' 0 C--N 1.347 0.476 0 C-N-CA 125.481 1.513 . . . . 0.0 111.554 -172.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.56 -34.61 2.19 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 125.755 1.622 . . . . 0.0 115.266 174.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.8 m -62.61 -35.25 69.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 120.188 1.358 . . . . 0.0 110.797 -178.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.8 ptp -94.28 9.22 38.97 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.447 0.567 . . . . 0.0 111.906 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 68.3 mt -100.66 21.45 13.41 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.217 1.007 . . . . 0.0 108.648 169.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -138.37 99.76 3.93 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 173.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 -58.51 -16.93 17.53 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.473 1.109 . . . . 0.0 112.998 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.65 -22.13 62.54 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.332 1.453 . . . . 0.0 112.064 172.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -81.7 -7.02 59.55 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.858 0.754 . . . . 0.0 111.336 165.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.89 172.26 14.19 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 125.471 1.51 . . . . 0.0 112.212 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -77.99 135.83 37.87 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.888 1.275 . . . . 0.0 110.456 -176.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -141.7 108.78 5.47 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.422 1.089 . . . . 0.0 110.004 162.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -119.33 141.41 49.04 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.871 0.868 . . . . 0.0 109.309 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -64.75 110.78 2.51 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.887 1.275 . . . . 0.0 109.726 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.2 tpp180 -118.06 51.31 1.07 Allowed 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.337 1.455 . . . . 0.0 107.505 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.29 -166.76 44.39 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 122.7 1.167 . . . . 0.0 112.637 175.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 27.6 mtp85 -126.4 164.05 21.96 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.318 -1.107 . . . . 0.0 109.346 -164.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -168.81 175.81 43.2 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 118.845 -1.645 . . . . 0.0 115.692 176.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.4 p -141.7 158.7 43.5 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.886 1.675 . . . . 0.0 109.699 173.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.1 p -80.11 99.47 7.75 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 165.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -61.11 -37.79 78.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 O-C-N 121.254 -0.904 . . . . 0.0 110.741 172.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -60.92 106.49 0.59 Allowed 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 158.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -54.22 140.25 33.28 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 171.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -134.08 154.49 80.21 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 174.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -79.89 95.26 1.02 Allowed 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 123.861 3.041 . . . . 0.0 110.911 173.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.29 115.26 21.9 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 168.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.9 m -124.14 133.13 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.325 1.45 . . . . 0.0 108.929 -174.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.5 mt -104.85 89.16 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 -169.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -118.43 166.0 13.2 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 122.3 1.048 . . . . 0.0 112.146 -173.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.58 -172.93 34.86 Favored Glycine 0 CA--C 1.537 1.457 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 -176.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -95.38 -21.84 18.11 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 121.309 -1.112 . . . . 0.0 113.292 -175.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -100.18 8.48 43.81 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -173.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.4 m120 59.94 71.87 0.55 Allowed 'General case' 0 CA--C 1.523 -0.087 0 C-N-CA 127.619 2.368 . . . . 0.0 110.706 -178.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 88.5 mt -106.2 88.38 3.12 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 127.323 2.249 . . . . 0.0 107.069 -177.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -60.61 103.05 0.21 Allowed 'Trans proline' 0 CA--C 1.544 1.025 0 C-N-CA 123.703 2.935 . . . . 0.0 112.086 178.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -89.13 129.87 35.66 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.545 1.138 . . . . 0.0 109.094 -177.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.69 105.26 17.31 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 122.501 1.144 . . . . 0.0 109.567 176.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.449 ' HG ' ' CD1' ' A' ' 120' ' ' TYR . 11.0 mp -79.45 137.82 37.38 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 125.45 1.5 . . . . 0.0 110.066 -178.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -78.96 85.12 4.93 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 120.699 0.285 . . . . 0.0 110.567 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.35 85.38 15.41 Favored Pre-proline 0 CA--C 1.529 0.156 0 C-N-CA 123.877 0.871 . . . . 0.0 108.903 168.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -64.06 142.51 81.33 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 N-CA-C 109.085 -1.16 . . . . 0.0 109.085 177.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.65 14.38 82.48 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-O 119.352 -0.693 . . . . 0.0 113.547 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.3 tppt? -125.01 151.19 45.9 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 119.86 1.83 . . . . 0.0 107.308 168.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.93 -140.09 25.3 Favored Glycine 0 CA--C 1.521 0.463 0 CA-C-N 120.178 1.354 . . . . 0.0 109.999 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -139.59 167.14 22.78 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 118.348 1.074 . . . . 0.0 111.339 -161.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 85.8 m -78.69 98.95 6.41 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 122.848 0.459 . . . . 0.0 111.564 -175.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.1 t -61.64 104.42 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 124.535 1.134 . . . . 0.0 108.508 176.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.6 p -80.9 144.17 32.14 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 121.549 -0.719 . . . . 0.0 110.399 177.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.74 -152.55 6.94 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -167.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -144.97 163.99 32.49 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.878 1.271 . . . . 0.0 109.289 -176.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 84.7 mt -117.75 126.37 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 -176.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -115.07 131.49 56.91 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 175.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -64.06 123.55 19.33 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 103.874 -2.639 . . . . 0.0 103.874 150.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.1 m -122.59 161.52 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 169.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -104.82 172.32 6.85 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 173.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -59.11 -36.17 74.7 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.967 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -57.94 -43.21 86.22 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 119.392 0.996 . . . . 0.0 111.858 176.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.8 tpp -67.6 -49.1 64.75 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.0 tp -58.68 -40.49 83.73 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 119.903 -0.719 . . . . 0.0 111.57 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 35.5 mtt180 -60.01 -56.46 21.43 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 124.641 1.176 . . . . 0.0 109.124 177.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -57.6 -49.21 77.18 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.018 0.927 . . . . 0.0 111.063 -176.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.5 mt -61.33 -25.85 67.41 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 121.906 -0.497 . . . . 0.0 111.196 -177.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -69.39 -20.88 63.81 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.187 0.903 . . . . 0.0 110.986 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -83.92 -50.31 8.17 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.189 1.396 . . . . 0.0 110.254 167.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -58.95 -38.1 78.25 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.718 0.807 . . . . 0.0 111.777 -173.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -95.69 15.66 19.45 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -175.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 48.35 35.79 6.17 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 128.18 2.592 . . . . 0.0 112.109 172.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.402 ' SG ' ' HB2' ' A' ' 88' ' ' TYR . 65.8 m -73.81 162.25 74.96 Favored Pre-proline 0 CA--C 1.54 0.588 0 O-C-N 120.154 -1.591 . . . . 0.0 109.669 175.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -71.46 -4.65 11.3 Favored 'Cis proline' 0 CA--C 1.541 0.874 0 CA-C-N 119.65 0.911 . . . . 0.0 113.66 -9.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 25.7 m -56.0 -72.28 0.08 Allowed 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.264 1.026 . . . . 0.0 111.401 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 5.2 mtm -74.0 -48.48 29.95 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 119.01 -1.076 . . . . 0.0 108.37 -167.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.402 ' HB2' ' SG ' ' A' ' 84' ' ' CYS . 98.6 m-85 -122.1 163.66 19.09 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -122.85 115.5 22.09 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 172.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -63.06 130.36 44.32 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 171.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.6 m -132.45 161.75 32.91 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 126.307 1.843 . . . . 0.0 107.163 -175.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -107.6 126.38 52.49 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 174.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.429 ' CD1' ' HB ' ' A' ' 114' ' ' VAL . 1.8 pt? -142.7 -166.64 2.33 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.865 1.666 . . . . 0.0 109.817 -167.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 15.7 tp60 -125.31 138.57 54.08 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.191 0.996 . . . . 0.0 111.464 -177.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.9 t -136.11 140.19 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 177.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -77.68 132.27 38.11 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 170.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.52 ' CG1' ' HA ' ' A' ' 108' ' ' ASP . 2.6 p -84.55 105.34 13.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 112.932 -1.94 . . . . 0.0 106.872 170.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 mp -78.42 -22.95 46.96 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 113.698 -1.592 . . . . 0.0 110.646 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -161.47 139.17 9.06 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 104.209 -2.515 . . . . 0.0 104.209 -179.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 72.4 t-105 -121.36 129.4 53.04 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 174.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -103.62 121.83 43.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.424 0.69 . . . . 0.0 109.25 173.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 98.46 178.36 32.64 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 124.329 0.966 . . . . 0.0 111.107 170.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -87.94 150.55 23.4 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 122.109 0.957 . . . . 0.0 110.998 178.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 113.0 62.54 0.44 Allowed Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 125.715 1.626 . . . . 0.0 109.963 -177.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -102.11 88.72 1.38 Allowed Pre-proline 0 C--O 1.242 0.674 0 C-N-CA 130.659 3.584 . . . . 0.0 111.393 -159.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -66.29 2.42 1.88 Allowed 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 124.89 3.727 . . . . 0.0 116.202 -177.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.32 176.29 35.2 Favored Glycine 0 CA--C 1.525 0.69 0 O-C-N 120.379 -1.45 . . . . 0.0 109.628 -163.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.52 ' HA ' ' CG1' ' A' ' 97' ' ' VAL . 0.0 OUTLIER -74.48 3.97 6.75 Favored 'General case' 0 CA--C 1.503 -0.857 0 C-N-CA 128.238 2.615 . . . . 0.0 116.375 -156.976 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 56.8 m -143.08 152.54 41.97 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 122.362 2.346 . . . . 0.0 111.809 155.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.6 m -133.34 156.02 41.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 125.284 1.434 . . . . 0.0 109.113 -163.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -92.31 115.72 28.33 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 170.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -121.5 169.64 10.46 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 125.837 1.655 . . . . 0.0 108.487 174.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -90.75 143.16 27.01 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 158.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.429 ' HB ' ' CD1' ' A' ' 93' ' ' LEU . 22.3 t -137.7 139.12 43.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 128.036 2.534 . . . . 0.0 107.789 172.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -73.26 122.58 22.19 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 167.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 11.1 p -123.02 -172.68 2.55 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 173.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.3 t -135.96 146.05 46.84 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 155.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -105.17 -16.64 14.72 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.307 1.843 . . . . 0.0 110.761 171.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.5 t -122.34 71.75 1.03 Allowed 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -175.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.449 ' CD1' ' HG ' ' A' ' 54' ' ' LEU . 0.3 OUTLIER -88.42 -11.55 45.71 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 125.631 1.572 . . . . 0.0 112.366 179.698 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 68.33 158.62 0.15 Allowed Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 126.248 1.819 . . . . 0.0 110.984 -170.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -69.37 -27.26 28.52 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.307 1.338 . . . . 0.0 113.355 -170.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -55.8 -37.95 69.31 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -178.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.407 ' HA ' ' CD2' ' A' ' 127' ' ' LEU . 41.6 m0 -71.98 -10.61 60.02 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 124.646 1.178 . . . . 0.0 111.461 -176.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 38.3 mt -80.39 4.9 16.5 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 120.842 -1.161 . . . . 0.0 112.297 171.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -107.08 -1.66 21.83 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 120.3 1.409 . . . . 0.0 113.235 172.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.407 ' CD2' ' HA ' ' A' ' 124' ' ' TRP . 1.3 mm? -78.62 148.19 72.7 Favored Pre-proline 0 N--CA 1.446 -0.631 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -173.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -65.18 146.9 87.72 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 121.433 1.422 . . . . 0.0 108.989 169.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 19.6 m-30 -87.9 157.02 19.08 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.409 0.623 . . . . 0.0 109.681 173.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -127.52 165.99 18.82 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.247 1.019 . . . . 0.0 109.16 178.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -110.98 -19.46 12.77 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.708 1.203 . . . . 0.0 111.723 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 13.5 p -155.92 149.32 24.74 Favored 'General case' 0 C--O 1.238 0.477 0 O-C-N 121.263 -0.898 . . . . 0.0 109.514 170.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -97.67 133.47 42.16 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 171.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -140.89 156.24 46.14 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.801 2.04 . . . . 0.0 106.676 176.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.51 -22.71 40.65 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.422 1.489 . . . . 0.0 112.308 176.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -127.4 90.26 3.1 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 103.605 -2.739 . . . . 0.0 103.605 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -130.47 154.72 20.78 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-N 113.922 -1.49 . . . . 0.0 110.808 159.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -64.93 -22.92 62.42 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 123.373 2.715 . . . . 0.0 114.223 -161.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -63.04 -19.5 64.44 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.246 1.418 . . . . 0.0 113.374 178.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 77.67 -29.1 1.78 Allowed Glycine 0 CA--C 1.533 1.16 0 O-C-N 120.755 -1.216 . . . . 0.0 114.311 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.65 83.57 0.07 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.168 1.484 . . . . 0.0 112.193 176.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.95 153.71 50.63 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 128.147 2.579 . . . . 0.0 110.167 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -60.49 133.46 56.12 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 124.081 0.863 . . . . 0.0 110.012 -165.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -121.43 76.99 35.01 Favored Pre-proline 0 C--O 1.232 0.162 0 C-N-CA 123.455 0.702 . . . . 0.0 110.154 -171.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.97 -31.57 2.99 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 122.916 2.411 . . . . 0.0 112.9 176.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -138.9 2.69 2.17 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -168.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -83.2 -24.74 32.28 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.179 -148.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -121.54 24.03 10.02 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 128.079 2.552 . . . . 0.0 107.139 165.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.8 mmm-85 . . . . . 0 C--O 1.252 1.226 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -132.835 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.8 mtt . . . . . 0 N--CA 1.468 0.458 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.49 154.42 38.61 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 158.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -111.19 137.55 48.75 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 162.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.2 pt -129.91 168.14 23.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 175.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -133.67 144.21 49.04 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -178.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.507 ' CG2' ' H ' ' A' ' 66' ' ' GLU . 3.8 m -100.52 169.84 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 124.092 0.957 . . . . 0.0 110.301 -176.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -120.01 -27.88 5.26 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.425 1.09 . . . . 0.0 112.289 172.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 171.72 -56.02 0.17 Allowed Glycine 0 C--N 1.339 0.733 0 C-N-CA 120.583 -0.818 . . . . 0.0 113.082 -161.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -45.28 -45.84 12.33 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 126.063 1.745 . . . . 0.0 111.605 178.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.3 mt -125.84 26.36 6.64 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.958 1.303 . . . . 0.0 108.643 -167.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -118.86 -33.32 4.25 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.309 -0.87 . . . . 0.0 113.302 -177.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.507 ' HG3' ' H ' ' A' ' 13' ' ' GLY . 8.9 ptm85 -123.86 -86.39 0.64 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 119.554 1.07 . . . . 0.0 111.176 -178.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.507 ' H ' ' HG3' ' A' ' 12' ' ' ARG . . . -164.63 55.38 0.27 Allowed Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 104.998 -3.241 . . . . 0.0 104.998 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.5 162.36 72.86 Favored Pre-proline 0 N--CA 1.447 -0.618 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 163.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -67.66 4.4 1.4 Allowed 'Trans proline' 0 CA--C 1.53 0.288 0 C-N-CA 123.767 2.978 . . . . 0.0 115.404 -173.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -118.68 -8.62 10.36 Favored 'General case' 0 C--O 1.214 -0.79 0 C-N-CA 125.661 1.584 . . . . 0.0 108.609 -166.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -58.29 -45.79 87.28 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 119.613 1.097 . . . . 0.0 111.213 -171.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.472 ' HA ' ' CD1' ' A' ' 21' ' ' LEU . 0.3 OUTLIER -52.37 -21.3 3.45 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.16 1.384 . . . . 0.0 113.785 178.697 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.7 m -62.27 -18.18 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 120.944 1.702 . . . . 0.0 112.443 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.0 ptp -97.4 -9.07 28.05 Favored 'General case' 0 C--N 1.348 0.508 0 CA-C-N 120.524 1.511 . . . . 0.0 110.948 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.472 ' CD1' ' HA ' ' A' ' 18' ' ' LYS . 8.4 mp -80.77 -31.1 35.97 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.902 1.681 . . . . 0.0 107.477 -174.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -70.36 97.2 1.22 Allowed 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 165.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 41.7 t-80 -61.35 -20.96 63.58 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.719 0.771 . . . . 0.0 111.322 171.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 m -51.29 -33.05 27.02 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.649 1.98 . . . . 0.0 112.193 166.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 45.1 m170 -93.58 10.95 30.49 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.028 1.331 . . . . 0.0 112.299 178.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.2 175.88 18.94 Favored Glycine 0 C--N 1.335 0.519 0 CA-C-O 122.313 0.952 . . . . 0.0 112.153 175.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -90.28 133.01 35.22 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.7 1.2 . . . . 0.0 109.68 -174.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -141.83 106.73 4.91 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.724 1.21 . . . . 0.0 110.907 169.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -116.87 125.6 51.75 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 125.519 1.527 . . . . 0.0 109.245 -169.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -68.24 112.11 4.95 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.694 1.198 . . . . 0.0 109.548 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -117.03 58.77 0.77 Allowed 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 123.899 0.88 . . . . 0.0 108.807 171.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.99 -165.74 53.65 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.905 168.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 36.7 mtp85 -116.73 167.49 11.05 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.623 0.769 . . . . 0.0 109.994 -156.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -164.34 -179.26 38.39 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 116.126 1.21 . . . . 0.0 116.126 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.1 p -152.88 157.84 41.29 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 118.19 -0.91 . . . . 0.0 111.573 172.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 31.1 p -77.02 101.18 5.92 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 119.891 1.223 . . . . 0.0 108.478 167.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -58.91 -52.51 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 119.796 1.18 . . . . 0.0 110.518 173.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -62.92 110.82 1.9 Allowed 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 166.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.6 m -59.33 132.49 54.16 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 178.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -126.75 155.06 75.76 Favored Pre-proline 0 N--CA 1.483 1.2 0 CA-C-N 119.178 0.899 . . . . 0.0 110.621 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -84.27 107.03 1.2 Allowed 'Trans proline' 0 CA--C 1.532 0.401 1 C-N-CA 125.519 4.146 . . . . 0.0 112.382 -170.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.7 tp -106.47 90.72 3.43 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.584 0.754 . . . . 0.0 109.657 -174.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.7 m -108.06 141.93 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.147 0.979 . . . . 0.0 110.206 -167.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.4 mt -103.69 78.51 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -174.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.424 ' HB2' ' CD1' ' A' ' 124' ' ' TRP . . . -110.69 153.67 24.92 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.42 -1.264 . . . . 0.0 110.21 -173.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.87 164.74 39.65 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-O 122.314 0.952 . . . . 0.0 111.537 -175.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -92.18 -7.99 46.77 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.504 1.522 . . . . 0.0 112.986 -166.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 62.5 m-70 -107.87 12.1 27.49 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.1 0.96 . . . . 0.0 111.745 174.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.7 m120 60.79 54.29 3.61 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.731 1.212 . . . . 0.0 110.075 165.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 75.3 mt -103.94 87.81 1.69 Allowed Pre-proline 0 N--CA 1.446 -0.632 0 N-CA-C 103.209 -2.886 . . . . 0.0 103.209 -174.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -62.45 124.2 13.81 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 CA-C-N 120.867 1.345 . . . . 0.0 109.419 -176.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -98.93 132.22 44.42 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -178.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.0 tp -97.66 96.2 8.11 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 169.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.87 150.23 38.02 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 121.042 -1.036 . . . . 0.0 108.389 171.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -80.27 89.58 5.51 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.355 -0.841 . . . . 0.0 108.966 177.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.71 86.58 11.93 Favored Pre-proline 0 N--CA 1.463 0.18 0 C-N-CA 124.597 1.159 . . . . 0.0 111.396 174.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -63.28 147.63 93.61 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 121.603 1.535 . . . . 0.0 109.341 178.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.49 0.76 59.28 Favored Glycine 0 CA--C 1.537 1.463 0 CA-C-O 118.666 -1.074 . . . . 0.0 114.65 176.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.02 112.45 12.38 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 120.833 2.316 . . . . 0.0 108.192 171.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 150.68 -149.78 21.67 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 119.767 -1.206 . . . . 0.0 112.538 -162.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -140.24 168.5 19.67 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 126.938 2.095 . . . . 0.0 109.28 173.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 97.3 m -89.58 78.53 7.02 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 123.596 0.759 . . . . 0.0 111.0 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.8 p -61.14 127.38 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.99 0 CA-C-O 118.513 -0.755 . . . . 0.0 109.863 -175.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.91 151.54 25.92 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 177.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -157.4 175.36 34.8 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 175.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.507 ' H ' ' CG2' ' A' ' 6' ' ' VAL . 0.7 OUTLIER -106.09 163.5 12.73 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 168.018 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 68.8 mt -102.42 121.11 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 105.353 -2.092 . . . . 0.0 105.353 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -108.12 119.61 39.96 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 171.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -69.04 127.68 34.0 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.349 -1.722 . . . . 0.0 106.349 161.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.7 m -135.63 163.83 34.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 123.428 0.691 . . . . 0.0 110.258 -174.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.0 179.97 4.12 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 122.276 1.036 . . . . 0.0 112.708 170.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.57 -41.63 90.64 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 125.48 1.512 . . . . 0.0 112.107 175.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -64.6 -43.34 94.1 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 119.9 1.227 . . . . 0.0 110.807 178.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 19.7 tpp -61.29 -49.4 77.19 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 119.167 0.894 . . . . 0.0 108.67 177.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.4 tp -61.66 -38.79 89.04 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 118.816 -0.611 . . . . 0.0 112.033 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 64.2 mtt-85 -70.81 -38.97 73.33 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.835 1.254 . . . . 0.0 111.804 177.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -63.18 -52.54 61.95 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 177.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.495 ' C ' ' HH ' ' A' ' 115' ' ' TYR . 1.1 mp -62.1 -31.53 71.99 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.693 0.797 . . . . 0.0 110.547 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -62.95 -33.02 74.48 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 124.403 1.081 . . . . 0.0 111.044 176.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -79.72 -45.74 18.36 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.071 0.396 . . . . 0.0 111.561 172.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -63.38 -42.88 98.85 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.569 0.747 . . . . 0.0 112.131 -170.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -79.96 9.09 5.78 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.559 -0.713 . . . . 0.0 111.951 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.2 t0 49.0 24.68 0.92 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 127.454 2.301 . . . . 0.0 113.346 -174.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 9.0 p -65.67 162.03 47.23 Favored Pre-proline 0 CA--C 1.54 0.564 0 O-C-N 119.684 -1.885 . . . . 0.0 107.061 165.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -69.06 -2.74 6.36 Favored 'Cis proline' 0 CA--C 1.547 1.165 0 N-CA-C 114.889 1.073 . . . . 0.0 114.889 -11.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.2 t -65.68 -67.41 0.44 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.884 1.22 . . . . 0.0 111.98 -178.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 20.6 mtp -71.51 -58.29 3.64 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 123.619 0.768 . . . . 0.0 109.52 -173.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -110.11 174.17 5.99 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 126.864 2.066 . . . . 0.0 108.345 177.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -128.66 -15.27 4.47 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 177.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 60.5 130.42 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 128.25 2.62 . . . . 0.0 112.651 -171.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 98.5 m -136.03 162.49 32.73 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.275 1.03 . . . . 0.0 108.237 175.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -94.6 128.16 41.04 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.93 1.292 . . . . 0.0 110.001 172.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.31 179.54 5.41 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.478 1.911 . . . . 0.0 111.432 178.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.8 tp60 -106.63 127.22 53.17 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.655 1.982 . . . . 0.0 109.98 178.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.418 ' CG2' ' SG ' ' A' ' 112' ' ' CYS . 64.3 t -126.27 140.65 48.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 -178.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -72.04 135.84 46.47 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 172.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.6 t -82.13 89.0 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 105.974 -1.861 . . . . 0.0 105.974 167.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.67 -23.68 67.33 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 118.603 -0.713 . . . . 0.0 110.658 177.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -165.53 162.49 19.2 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 128.038 2.535 . . . . 0.0 106.896 171.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 62.6 t-105 -135.2 130.17 34.88 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 125.83 1.652 . . . . 0.0 107.935 176.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -118.2 89.34 3.1 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 121.195 0.521 . . . . 0.0 111.36 176.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 137.33 -172.04 22.89 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-O 123.302 1.501 . . . . 0.0 111.495 173.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.28 125.27 23.02 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 122.35 1.071 . . . . 0.0 113.106 166.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 122.29 81.02 0.56 Allowed Glycine 0 N--CA 1.427 -1.962 0 CA-C-N 111.848 -2.433 . . . . 0.0 110.534 142.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -101.57 89.69 1.54 Allowed Pre-proline 0 C--O 1.24 0.587 0 C-N-CA 131.134 3.774 . . . . 0.0 109.773 -156.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -57.56 -54.52 3.32 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.742 2.294 . . . . 0.0 109.778 -178.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 163.97 -166.8 37.71 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 107.711 -2.156 . . . . 0.0 107.711 -173.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -64.88 -12.13 45.51 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 117.773 0.786 . . . . 0.0 111.969 175.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 61.2 p -133.12 156.39 47.53 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 120.087 1.312 . . . . 0.0 111.615 175.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.9 p -142.48 162.67 18.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 123.889 0.876 . . . . 0.0 109.202 178.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -95.39 135.27 37.23 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.69 1.596 . . . . 0.0 107.94 169.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.418 ' SG ' ' CG2' ' A' ' 95' ' ' VAL . 0.5 OUTLIER -141.27 168.7 19.14 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.797 1.239 . . . . 0.0 110.456 174.593 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -100.28 145.49 28.05 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 172.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 30.9 t -138.54 147.39 25.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 125.193 1.397 . . . . 0.0 107.294 177.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.495 ' HH ' ' C ' ' A' ' 78' ' ' LEU . 42.6 m-85 -70.3 109.14 4.53 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 167.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 68.8 p -125.92 172.43 9.92 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 124.111 0.964 . . . . 0.0 108.937 176.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.93 145.9 51.32 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 172.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -112.25 -12.23 13.63 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.137 1.775 . . . . 0.0 111.264 171.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 12.2 t -123.43 64.7 1.01 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.497 1.519 . . . . 0.0 107.968 -171.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -101.94 161.06 13.96 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 126.411 1.884 . . . . 0.0 110.523 177.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.49 157.86 87.26 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 125.818 1.647 . . . . 0.0 111.407 172.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -73.86 -33.39 6.34 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 121.97 1.78 . . . . 0.0 112.326 -179.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -46.51 -44.4 17.69 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 125.185 1.394 . . . . 0.0 112.588 175.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.424 ' CD1' ' HB2' ' A' ' 45' ' ' ALA . 35.6 m0 -60.48 -22.22 63.27 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 125.723 1.609 . . . . 0.0 112.5 -174.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 32.6 mt -75.22 -10.09 59.15 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 117.699 -1.143 . . . . 0.0 112.787 176.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -95.41 -7.88 37.13 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.437 1.095 . . . . 0.0 112.471 -178.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -72.9 158.74 86.75 Favored Pre-proline 0 N--CA 1.451 -0.413 0 C-N-CA 125.664 1.585 . . . . 0.0 107.864 -174.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -59.52 140.45 94.06 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.626 1.551 . . . . 0.0 108.805 168.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 5.7 m-30 -92.18 156.47 17.31 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.86 0.864 . . . . 0.0 108.8 171.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -141.08 171.95 13.36 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.516 0.726 . . . . 0.0 110.647 -174.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -136.62 1.14 2.55 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.314 1.445 . . . . 0.0 111.085 -172.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 86.0 p -152.86 171.68 17.92 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 124.907 1.283 . . . . 0.0 108.656 166.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -121.77 102.45 8.21 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 165.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -117.66 114.9 24.06 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.117 -171.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 11.2 t -60.48 -23.69 64.68 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 128.635 2.774 . . . . 0.0 111.654 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -120.57 85.35 2.38 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 127.417 2.287 . . . . 0.0 105.487 175.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -152.49 177.0 30.48 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.037 171.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.62 -15.43 24.42 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.024 1.816 . . . . 0.0 114.247 -174.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -44.96 -62.32 1.28 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.8 2.04 . . . . 0.0 111.339 -176.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 109.34 -59.09 0.37 Allowed Glycine 0 N--CA 1.464 0.555 0 C-N-CA 129.284 3.326 . . . . 0.0 110.302 171.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.478 HD11 ' H ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -49.95 73.67 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 130.616 3.567 . . . . 0.0 114.26 163.008 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -98.12 170.25 9.04 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.654 1.582 . . . . 0.0 111.942 172.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -71.31 150.32 45.25 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 123.182 0.301 . . . . 0.0 111.031 -165.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -122.92 83.39 50.17 Favored Pre-proline 0 C--O 1.233 0.195 0 C-N-CA 124.71 1.204 . . . . 0.0 108.822 178.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.79 -0.15 9.88 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 123.611 2.874 . . . . 0.0 112.095 168.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 48.56 31.29 2.84 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.964 -1.085 . . . . 0.0 112.778 -169.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -57.91 -20.67 38.89 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.951 1.7 . . . . 0.0 114.683 -172.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -156.55 12.41 0.27 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 128.755 2.822 . . . . 0.0 110.342 -169.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.013 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 174.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.205 0 N-CA-C 110.535 -0.172 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -119.67 131.25 55.39 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.166 1.387 . . . . 0.0 107.808 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.409 HG22 ' HB2' ' A' ' 113' ' ' PHE . 44.6 pt -123.36 177.48 4.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -131.89 130.17 41.28 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 174.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.9 p -96.7 135.73 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 176.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -72.79 -78.02 0.09 Allowed 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 164.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -139.75 -19.47 0.42 Allowed Glycine 0 C--N 1.335 0.489 0 O-C-N 121.767 -0.583 . . . . 0.0 114.144 -173.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.457 ' C ' HD22 ' A' ' 10' ' ' LEU . 0.8 OUTLIER -77.04 -16.42 59.28 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 120.505 2.152 . . . . 0.0 112.599 -154.333 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.457 HD22 ' C ' ' A' ' 9' ' ' THR . 0.1 OUTLIER -126.12 14.16 7.84 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 126.378 1.871 . . . . 0.0 107.645 176.944 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -104.06 -86.91 0.44 Allowed 'General case' 0 C--N 1.351 0.671 0 CA-C-O 117.355 -1.307 . . . . 0.0 109.381 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.482 ' HB3' HE22 ' A' ' 14' ' ' GLN . 42.0 tpt85 -62.39 -59.89 4.34 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-N 120.752 1.614 . . . . 0.0 111.383 -160.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 172.31 69.04 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 106.265 -2.734 . . . . 0.0 106.265 -170.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.482 HE22 ' HB3' ' A' ' 12' ' ' ARG . 2.2 mp0 -117.29 154.87 50.34 Favored Pre-proline 0 N--CA 1.448 -0.544 0 C-N-CA 124.802 1.241 . . . . 0.0 108.392 -175.453 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.73 -37.11 97.79 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.743 2.962 . . . . 0.0 111.429 -172.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.411 ' O ' HG22 ' A' ' 19' ' ' VAL . 8.7 m-80 -63.99 -25.18 68.01 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 126.229 1.811 . . . . 0.0 111.939 -172.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -52.17 -34.78 46.57 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.587 1.085 . . . . 0.0 111.423 -170.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.81 -25.92 21.67 Favored 'General case' 0 C--N 1.342 0.276 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -176.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 16' ' ' ASN . 34.3 m -57.49 -48.94 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 118.57 0.623 . . . . 0.0 109.544 -176.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 9.0 ptp -79.13 7.25 7.82 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.393 0.677 . . . . 0.0 112.584 -174.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 76.6 mt -99.64 3.23 45.12 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.473 0.709 . . . . 0.0 111.019 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -131.97 109.26 9.92 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 104.388 -2.449 . . . . 0.0 104.388 174.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 23.3 t-80 -54.27 -24.35 18.54 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.063 1.345 . . . . 0.0 111.608 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 m -67.13 -21.86 65.82 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.979 -1.076 . . . . 0.0 112.954 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -85.07 -7.05 59.28 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 119.492 1.042 . . . . 0.0 111.579 167.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 129.19 167.5 12.15 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 126.037 1.779 . . . . 0.0 111.849 175.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -82.38 137.69 34.67 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.29 1.836 . . . . 0.0 109.174 -176.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -133.57 141.96 47.93 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.462 1.105 . . . . 0.0 108.708 162.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -141.29 140.7 33.9 Favored 'General case' 0 C--O 1.231 0.111 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 166.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -67.11 94.65 0.36 Allowed 'General case' 0 C--O 1.232 0.16 0 C-N-CA 125.921 1.689 . . . . 0.0 107.685 177.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -100.19 53.63 0.9 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -176.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.5 -169.15 46.93 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-O 122.677 1.154 . . . . 0.0 111.698 -177.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -143.44 173.0 12.01 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 121.557 -0.966 . . . . 0.0 110.221 -175.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -175.15 -179.92 46.01 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 119.487 -1.339 . . . . 0.0 115.337 -169.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.7 p -140.49 160.51 39.84 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 114.098 -1.051 . . . . 0.0 111.257 167.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.1 p -81.52 94.27 6.84 Favored 'General case' 0 C--O 1.223 -0.291 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 169.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -62.59 -26.43 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 O-C-N 120.657 -1.277 . . . . 0.0 110.893 171.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -65.93 116.99 7.66 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 161.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.03 120.07 18.15 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 126.241 1.816 . . . . 0.0 109.947 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -123.05 162.06 41.35 Favored Pre-proline 0 N--CA 1.466 0.359 0 CA-C-N 120.481 1.491 . . . . 0.0 107.842 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -79.6 94.32 1.05 Allowed 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 124.695 3.597 . . . . 0.0 109.245 172.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.8 tp -89.09 111.76 22.58 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 164.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.5 m -125.59 145.69 32.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.601 1.16 . . . . 0.0 108.347 -176.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.401 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 3.3 mt -98.85 121.96 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 176.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.73 -172.19 3.33 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.049 0.94 . . . . 0.0 110.763 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.68 155.67 2.27 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 125.45 1.5 . . . . 0.0 111.664 178.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -79.55 -6.17 56.45 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 121.538 -0.978 . . . . 0.0 111.802 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -106.92 9.33 30.81 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.431 1.093 . . . . 0.0 112.299 174.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.433 HD22 ' HB2' ' A' ' 141' ' ' LEU . 2.3 m120 63.73 61.19 1.0 Allowed 'General case' 0 C--N 1.345 0.401 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 176.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 56.5 mt -107.86 87.6 3.82 Favored Pre-proline 0 N--CA 1.446 -0.673 0 C-N-CA 128.358 2.663 . . . . 0.0 104.01 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . 43.5 Cg_endo -64.54 156.86 58.4 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 CA-C-N 120.832 1.333 . . . . 0.0 109.825 174.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 48.3 m95 -132.21 150.11 52.23 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.9 tp -107.39 102.02 11.34 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 168.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.7 mt -74.39 145.66 43.58 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -81.61 85.6 6.52 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.348 -0.845 . . . . 0.0 109.536 -177.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -137.12 86.49 20.14 Favored Pre-proline 0 C--O 1.234 0.25 0 CA-C-O 118.369 -0.824 . . . . 0.0 110.174 -177.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -60.07 133.98 53.47 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 121.084 1.189 . . . . 0.0 111.201 -177.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.57 17.27 77.85 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-O 118.904 -0.942 . . . . 0.0 114.713 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -118.15 121.52 40.72 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 120.376 2.088 . . . . 0.0 106.131 168.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.561 ' HA2' ' CD2' ' A' ' 129' ' ' TYR . . . 108.95 -139.81 15.37 Favored Glycine 0 CA--C 1.52 0.379 0 CA-C-N 120.208 1.367 . . . . 0.0 112.555 172.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 39.7 m-70 -126.86 171.47 11.24 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 124.044 0.938 . . . . 0.0 112.311 -175.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 57.9 m -88.2 105.49 17.56 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 126.647 1.979 . . . . 0.0 110.428 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 71.1 t -72.95 117.25 16.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 64.8 p -70.81 156.33 39.69 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.865 0.866 . . . . 0.0 109.363 167.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 171.24 -159.04 30.74 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 118.975 0.807 . . . . 0.0 112.312 -172.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -137.35 161.49 36.14 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.992 0.917 . . . . 0.0 110.834 -172.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 70.1 mt -120.54 111.83 33.71 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 -175.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -102.74 129.86 49.51 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 174.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -67.51 141.66 56.83 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 156.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.0 m -137.39 153.44 28.72 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 CA-C-O 121.787 0.803 . . . . 0.0 109.925 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -85.9 174.02 9.57 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 123.873 1.796 . . . . 0.0 109.541 164.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.05 -30.31 70.25 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 112.34 -2.209 . . . . 0.0 112.463 177.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -72.64 -41.98 64.9 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-O 116.681 -1.628 . . . . 0.0 111.242 176.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 19.9 tpp -64.16 -44.44 92.1 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 121.178 1.808 . . . . 0.0 108.513 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.6 tp -60.91 -30.35 70.14 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 177.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 47.1 mtt-85 -80.57 -36.83 32.37 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.873 1.269 . . . . 0.0 113.786 174.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -62.19 -47.66 83.48 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 177.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 85.3 mt -62.77 -24.38 67.68 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.787 -0.571 . . . . 0.0 110.812 175.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.484 ' HA ' ' SG ' ' A' ' 84' ' ' CYS . 4.4 t0 -78.19 10.55 2.9 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.794 1.237 . . . . 0.0 113.165 176.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -143.05 -30.95 0.51 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 125.439 1.496 . . . . 0.0 112.598 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -70.11 -31.92 69.7 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.1 0.96 . . . . 0.0 111.09 172.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -92.86 5.62 50.63 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.436 0.694 . . . . 0.0 112.147 -171.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.0 t70 54.17 15.91 1.04 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.722 2.009 . . . . 0.0 113.867 -175.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.484 ' SG ' ' HA ' ' A' ' 79' ' ' ASP . 2.9 p -62.85 150.03 88.45 Favored Pre-proline 0 N--CA 1.45 -0.474 0 O-C-N 120.181 -1.574 . . . . 0.0 108.252 167.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.94 -8.56 30.09 Favored 'Cis proline' 0 CA--C 1.54 0.813 0 N-CA-C 114.926 1.087 . . . . 0.0 114.926 2.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 12.9 m -60.98 -62.19 2.03 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.792 1.237 . . . . 0.0 110.91 -174.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.3 mtp -72.53 -78.17 0.09 Allowed 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -96.03 175.17 6.58 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.579 1.152 . . . . 0.0 110.253 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 6.7 mp0 -130.19 146.49 51.83 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.98 1.712 . . . . 0.0 107.105 164.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -81.63 133.85 35.42 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 175.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.2 m -140.04 168.85 18.85 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.212 1.005 . . . . 0.0 109.481 -174.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -106.45 138.88 41.83 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.141 1.776 . . . . 0.0 110.372 173.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.4 173.2 11.99 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.155 1.382 . . . . 0.0 113.064 175.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -94.95 126.26 40.17 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.041 1.337 . . . . 0.0 111.884 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.4 t -127.61 119.75 52.71 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 C-N-CA 125.688 1.595 . . . . 0.0 107.773 -175.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -63.13 128.85 37.77 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 105.62 -1.992 . . . . 0.0 105.62 169.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.552 HG12 ' C ' ' A' ' 108' ' ' ASP . 4.9 p -75.55 116.67 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 CA-C-N 114.45 -1.25 . . . . 0.0 107.799 166.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.434 HD13 ' HA ' ' A' ' 98' ' ' LEU . 0.7 OUTLIER -88.48 -21.56 24.12 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 120.467 -1.396 . . . . 0.0 110.38 170.241 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -158.27 146.4 18.56 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 170.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -127.93 116.1 19.58 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 125.518 1.527 . . . . 0.0 108.762 177.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -100.39 113.19 25.73 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.16 -167.21 14.84 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 125.453 1.502 . . . . 0.0 112.289 170.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -75.06 171.72 13.61 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.131 0.972 . . . . 0.0 109.201 177.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.11 62.76 2.16 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-O 118.5 -1.167 . . . . 0.0 111.409 176.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -100.38 89.91 1.28 Allowed Pre-proline 0 C--O 1.24 0.561 0 C-N-CA 131.242 3.817 . . . . 0.0 110.095 -163.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -62.92 -4.89 6.65 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 124.476 3.451 . . . . 0.0 115.543 -174.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.94 -177.69 44.81 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 108.846 -1.701 . . . . 0.0 108.846 -163.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.552 ' C ' HG12 ' A' ' 97' ' ' VAL . 1.1 m-20 -72.5 5.12 3.21 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 -169.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.09 160.12 39.9 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 122.374 1.083 . . . . 0.0 110.213 154.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.8 p -128.3 163.87 31.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 126.811 2.044 . . . . 0.0 108.994 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -104.19 103.62 13.42 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.954 1.701 . . . . 0.0 106.545 169.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 60.8 m -97.61 166.95 11.26 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 122.714 0.405 . . . . 0.0 110.035 174.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.409 ' HB2' HG22 ' A' ' 4' ' ' ILE . 69.7 m-85 -92.85 149.52 21.21 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 162.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.3 t -146.72 155.93 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 129.161 2.985 . . . . 0.0 107.067 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -89.71 128.17 36.05 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 166.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 81.9 p -130.09 -177.21 4.21 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.281 1.432 . . . . 0.0 109.291 -178.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -138.1 141.29 40.22 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 165.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -112.71 -4.45 14.06 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.226 1.411 . . . . 0.0 110.911 172.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.1 p -107.74 19.81 19.64 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.937 1.695 . . . . 0.0 111.006 -162.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -71.67 161.49 30.91 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.444 1.497 . . . . 0.0 112.105 -168.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -84.28 151.53 59.79 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 124.979 1.311 . . . . 0.0 109.995 167.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.01 -25.75 51.5 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 123.369 2.713 . . . . 0.0 113.52 -173.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.523 ' HA ' ' CD2' ' A' ' 126' ' ' PHE . 4.5 pm0 -52.69 -30.83 34.19 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.968 0.907 . . . . 0.0 112.382 177.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 45.3 m0 -76.88 -11.65 59.85 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 119.412 -0.327 . . . . 0.0 111.759 -176.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -85.64 -15.68 41.65 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 119.199 0.909 . . . . 0.0 111.713 171.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.523 ' CD2' ' HA ' ' A' ' 123' ' ' GLU . 4.8 m-85 -84.75 -10.28 57.39 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.364 0.984 . . . . 0.0 111.373 173.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 76.6 mt -72.15 158.36 87.73 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 124.844 1.257 . . . . 0.0 110.96 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -76.86 156.23 34.77 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 124.088 3.192 . . . . 0.0 111.887 176.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.561 ' CD2' ' HA2' ' A' ' 60' ' ' GLY . 21.3 m-85 -107.65 151.89 25.04 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.882 1.273 . . . . 0.0 111.95 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -136.29 167.54 21.12 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.766 1.226 . . . . 0.0 110.863 -175.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -113.64 -7.71 13.32 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.587 1.155 . . . . 0.0 112.631 -171.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 83.2 p -154.36 174.7 14.48 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 125.451 1.5 . . . . 0.0 108.381 168.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -137.97 109.18 6.84 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 174.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -140.11 123.27 16.8 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.617 1.167 . . . . 0.0 108.318 -168.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 9.6 t -59.38 -29.8 67.97 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.442 1.097 . . . . 0.0 110.059 176.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -62.74 -17.4 60.84 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.418 -0.801 . . . . 0.0 113.11 177.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -71.16 154.23 51.72 Favored Glycine 0 CA--C 1.537 1.445 0 CA-C-N 120.025 1.284 . . . . 0.0 112.434 -166.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -65.52 -5.99 12.69 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.811 2.341 . . . . 0.0 115.058 -177.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 -49.05 -49.58 40.61 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 120.651 1.569 . . . . 0.0 112.616 -175.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 87.45 1.68 83.35 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 118.258 -1.301 . . . . 0.0 113.689 -168.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.433 ' HB2' HD22 ' A' ' 49' ' ' ASN . 0.7 OUTLIER -103.56 96.37 6.68 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 118.905 1.352 . . . . 0.0 109.519 171.422 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -118.85 162.44 18.48 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.576 -0.702 . . . . 0.0 110.918 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -65.52 144.57 56.92 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -173.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 . . . . . 0 CA--C 1.53 0.192 0 C-N-CA 123.1 0.56 . . . . 0.0 110.12 175.049 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -128.13 129.31 46.35 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 174.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 41.2 pt -125.19 152.57 31.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -108.31 132.2 53.94 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 172.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.424 HG22 ' H ' ' A' ' 6' ' ' VAL . 2.6 m -81.39 168.29 1.89 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.447 0 C-N-CA 123.69 0.796 . . . . 0.0 111.31 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -112.46 -29.87 7.35 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.043 0.937 . . . . 0.0 112.515 172.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 148.24 -1.9 0.67 Allowed Glycine 0 CA--C 1.526 0.741 0 CA-C-N 118.412 0.551 . . . . 0.0 113.869 168.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 p -53.62 -36.6 62.19 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 124.775 1.23 . . . . 0.0 111.2 160.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.551 HD23 ' HA ' ' A' ' 17' ' ' HIS . 4.0 mt -132.25 48.37 2.42 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.597 1.559 . . . . 0.0 109.179 -166.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -150.02 -59.19 0.2 Allowed 'General case' 0 N--CA 1.467 0.42 0 O-C-N 120.243 -1.535 . . . . 0.0 111.738 178.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 -73.03 -86.1 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 119.339 0.972 . . . . 0.0 108.714 174.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -175.23 50.11 0.13 Allowed Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 175.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.36 162.96 3.79 Favored Pre-proline 0 CA--C 1.544 0.745 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 169.364 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -64.4 -3.7 6.84 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 123.971 3.114 . . . . 0.0 113.255 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -120.3 10.67 11.33 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 126.827 2.051 . . . . 0.0 108.452 -167.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.551 ' HA ' HD23 ' A' ' 10' ' ' LEU . 39.0 p-80 -85.25 -38.82 18.47 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 121.254 1.843 . . . . 0.0 106.684 -168.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -17.35 55.49 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 120.517 -1.364 . . . . 0.0 114.183 -168.196 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.434 ' H ' HG22 ' A' ' 19' ' ' VAL . 2.9 m -59.65 -34.66 55.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 118.445 0.566 . . . . 0.0 110.921 176.364 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -78.98 3.91 15.83 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.039 0.836 . . . . 0.0 113.113 177.208 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 35.4 mt -120.06 11.96 11.81 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.811 1.644 . . . . 0.0 110.816 -175.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -132.76 3.94 3.84 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 -171.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . 0.265 25.4 t-80 43.22 28.87 0.18 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 128.294 2.638 . . . . 0.0 113.679 176.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.4 m -117.71 -12.02 10.32 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 121.168 -0.957 . . . . 0.0 111.593 179.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -111.17 -1.43 16.17 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.206 1.802 . . . . 0.0 111.065 174.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 131.45 174.33 13.62 Favored Glycine 0 C--N 1.336 0.553 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 41.5 tp -82.23 139.8 34.04 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 123.169 0.588 . . . . 0.0 110.389 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -146.94 153.69 40.39 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 153.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.67 142.05 23.35 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 126.362 1.865 . . . . 0.0 108.286 169.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -59.99 118.83 6.74 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.212 1.405 . . . . 0.0 108.799 176.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.91 39.46 2.16 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.954 0.797 . . . . 0.0 110.321 -174.252 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 124.52 111.42 1.91 Allowed Glycine 0 N--CA 1.444 -0.79 0 CA-C-O 121.994 0.774 . . . . 0.0 111.328 166.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -61.06 149.62 36.44 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 121.592 -0.946 . . . . 0.0 108.469 173.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.47 175.33 37.22 Favored Glycine 0 C--O 1.238 0.385 0 C-N-CA 120.771 -0.728 . . . . 0.0 113.365 -169.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.407 ' SG ' ' HB3' ' A' ' 96' ' ' GLN . 1.8 p -136.59 147.18 46.83 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 43.4 p -64.48 120.05 11.57 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 158.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.422 HG22 ' HB2' ' A' ' 96' ' ' GLN . 16.7 t -68.0 -37.09 77.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.641 0.734 . . . . 0.0 109.08 177.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -78.21 140.2 38.93 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 168.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.5 m -60.44 151.05 29.2 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 160.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -134.57 153.84 79.28 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 165.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -76.38 92.08 1.09 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 124.212 3.275 . . . . 0.0 110.133 170.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 28.7 tp -90.63 109.03 20.2 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 118.816 -0.611 . . . . 0.0 109.757 174.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.444 ' CG2' HD13 ' A' ' 54' ' ' LEU . 13.5 m -123.55 135.75 62.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 124.395 1.078 . . . . 0.0 108.641 -171.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.2 mt -109.89 72.88 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 -172.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.83 179.33 7.06 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 122.613 1.197 . . . . 0.0 110.722 173.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.95 153.85 17.49 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-N 113.044 -1.889 . . . . 0.0 110.473 170.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -68.75 -11.62 60.51 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -166.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 37.5 m-70 -114.16 16.78 18.0 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.5 1.12 . . . . 0.0 112.053 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 50.49 74.02 0.24 Allowed 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.778 2.031 . . . . 0.0 109.369 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 87.6 mt -104.55 88.3 2.12 Favored Pre-proline 0 C--N 1.325 -0.493 0 C-N-CA 128.531 2.733 . . . . 0.0 104.991 -169.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.401 ' HG3' ' CE2' ' A' ' 133' ' ' TYR . 55.9 Cg_endo -55.02 107.61 0.24 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.962 2.442 . . . . 0.0 111.148 -178.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -92.02 116.96 29.37 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 124.904 1.281 . . . . 0.0 107.6 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.15 92.15 8.66 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 172.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.444 HD13 ' CG2' ' A' ' 43' ' ' VAL . 11.0 mp -65.52 124.14 21.54 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.525 1.13 . . . . 0.0 108.762 176.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -74.04 84.95 1.79 Allowed 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.065 0.546 . . . . 0.0 110.266 -176.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.55 85.15 17.87 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 125.064 1.346 . . . . 0.0 108.373 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.92 126.68 17.8 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.842 2.361 . . . . 0.0 109.251 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.58 17.3 55.14 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 119.328 -0.707 . . . . 0.0 113.209 175.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -122.81 157.24 32.87 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 119.07 1.435 . . . . 0.0 107.189 172.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.516 ' HA2' ' CD2' ' A' ' 129' ' ' TYR . . . 70.49 -140.04 31.4 Favored Glycine 0 CA--C 1.522 0.511 0 CA-C-N 121.131 1.787 . . . . 0.0 111.603 175.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -131.17 160.24 35.37 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.327 1.064 . . . . 0.0 111.17 -170.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 76.4 m -83.64 106.61 15.5 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.695 -0.628 . . . . 0.0 110.93 -170.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.1 t -78.38 88.59 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 126.708 2.003 . . . . 0.0 111.996 -166.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.9 p -59.56 145.35 44.6 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 120.862 -1.149 . . . . 0.0 111.185 -172.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.03 -150.06 5.98 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-N 118.967 0.803 . . . . 0.0 112.596 -174.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -145.1 157.24 44.16 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.256 1.022 . . . . 0.0 109.058 -178.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 50.2 mt -107.66 91.79 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -80.74 127.16 32.18 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 177.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -74.07 130.45 39.84 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 163.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 23.7 m -144.24 176.3 2.69 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 C-N-CA 125.346 1.458 . . . . 0.0 109.898 -167.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.87 -175.95 3.22 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 122.671 1.224 . . . . 0.0 113.241 177.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -52.85 -52.02 58.8 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.07 1.748 . . . . 0.0 110.841 172.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -62.89 -39.47 94.58 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 117.948 -1.025 . . . . 0.0 110.282 -174.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 38.6 tpp -64.61 -43.64 93.1 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 119.454 1.025 . . . . 0.0 110.289 175.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 13.7 tp -65.03 -42.75 94.08 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.886 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 66.0 mtt180 -58.01 -41.78 83.82 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 124.526 1.13 . . . . 0.0 110.161 174.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -63.62 -52.8 59.3 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -176.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.2 mp -54.05 -39.35 66.14 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.206 0.602 . . . . 0.0 111.305 175.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -57.05 -43.5 82.08 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.714 0.769 . . . . 0.0 110.77 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -86.33 -26.9 24.63 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.306 1.443 . . . . 0.0 113.044 -175.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -93.09 -40.15 10.67 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.558 1.143 . . . . 0.0 111.394 -170.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -82.74 7.26 15.47 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 118.348 0.522 . . . . 0.0 110.462 177.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 59.58 29.61 19.19 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.626 1.571 . . . . 0.0 111.962 175.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 1.8 p -73.25 168.22 27.17 Favored Pre-proline 0 CA--C 1.541 0.624 0 O-C-N 120.237 -1.539 . . . . 0.0 108.218 173.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.4 -4.43 7.77 Favored 'Cis proline' 0 CA--C 1.544 0.988 0 CA-C-N 120.21 1.111 . . . . 0.0 113.545 -13.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.5 m -60.84 -61.64 2.44 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 126.093 1.757 . . . . 0.0 111.313 -177.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 2.7 mtm -75.71 -85.18 0.05 OUTLIER 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -83.8 176.81 8.66 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.501 1.12 . . . . 0.0 109.064 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -137.08 136.88 38.74 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.907 1.683 . . . . 0.0 106.84 161.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -70.29 133.68 47.22 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 171.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.0 m -136.67 175.44 9.61 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.772 2.029 . . . . 0.0 108.523 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -118.37 137.33 53.19 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 127.921 2.488 . . . . 0.0 109.747 175.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.43 -179.29 6.2 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.019 1.728 . . . . 0.0 110.512 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -113.22 123.86 51.17 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.627 1.571 . . . . 0.0 110.548 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.411 ' CG2' ' SG ' ' A' ' 112' ' ' CYS . 54.1 t -118.54 145.85 23.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 C-N-CA 125.772 1.629 . . . . 0.0 107.335 -177.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.422 ' HB2' HG22 ' A' ' 37' ' ' VAL . 35.3 tt0 -89.65 136.9 32.77 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 171.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 94.8 t -77.61 95.74 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 127.696 2.398 . . . . 0.0 106.15 168.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.6 mp -72.79 -31.26 64.73 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.586 -0.696 . . . . 0.0 109.483 172.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -148.56 164.3 34.64 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 106.298 -1.742 . . . . 0.0 106.298 167.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 75.5 t-105 -139.88 124.54 18.27 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.64 1.576 . . . . 0.0 108.006 175.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -79.02 113.34 17.06 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 171.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 86.69 -148.6 21.91 Favored Glycine 0 C--O 1.235 0.166 0 CA-C-O 121.696 0.609 . . . . 0.0 112.246 153.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -67.01 160.06 27.31 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 126.426 1.89 . . . . 0.0 111.715 -170.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 60.92 76.03 0.26 Allowed Glycine 0 C--O 1.221 -0.672 0 C-N-CA 124.449 1.023 . . . . 0.0 111.727 170.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -102.87 88.77 1.59 Allowed Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 128.734 2.813 . . . . 0.0 108.211 -168.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -56.08 -22.41 39.28 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 124.601 3.534 . . . . 0.0 114.939 -172.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 123.7 176.46 14.76 Favored Glycine 0 C--N 1.333 0.384 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -173.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -64.11 -17.59 63.58 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 118.515 -0.755 . . . . 0.0 112.518 -172.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 39.7 p -130.57 159.78 36.14 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 120.2 1.364 . . . . 0.0 111.971 168.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 28.4 m -141.95 169.56 13.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 125.443 1.497 . . . . 0.0 108.539 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -104.14 155.75 18.45 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 159.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.411 ' SG ' ' CG2' ' A' ' 95' ' ' VAL . 0.5 OUTLIER -155.04 162.05 41.16 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 129.142 2.977 . . . . 0.0 108.694 -178.37 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -87.24 153.36 21.55 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 169.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.449 HG12 HG23 ' A' ' 116' ' ' THR . 24.9 t -143.17 150.77 17.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 127.914 2.485 . . . . 0.0 107.2 176.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -94.76 102.76 14.65 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 169.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.449 HG23 HG12 ' A' ' 114' ' ' VAL . 72.7 p -103.41 -167.88 1.44 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.009 1.324 . . . . 0.0 108.7 177.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.7 t -136.05 156.05 49.3 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 155.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -123.46 5.44 9.0 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.151 1.381 . . . . 0.0 110.776 171.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.2 t -132.32 53.55 2.0 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 122.93 1.348 . . . . 0.0 109.415 -173.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -67.39 153.63 43.24 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.009 1.323 . . . . 0.0 110.402 175.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.18 149.43 98.46 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 162.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.09 -35.8 40.56 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 121.451 1.434 . . . . 0.0 112.545 -170.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -57.86 -23.68 54.03 Favored 'General case' 0 C--O 1.225 -0.218 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 177.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 0.571 ' HA ' HD23 ' A' ' 127' ' ' LEU . 44.2 m0 -64.93 -16.26 63.09 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 119.863 1.21 . . . . 0.0 112.015 -178.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 53.7 mt -71.9 2.46 5.51 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.846 1.259 . . . . 0.0 112.418 171.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -113.13 -11.69 13.26 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.612 1.565 . . . . 0.0 113.75 178.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.571 HD23 ' HA ' ' A' ' 124' ' ' TRP . 1.1 mm? -67.81 146.67 98.47 Favored Pre-proline 0 C--N 1.326 -0.436 0 C-N-CA 126.102 1.761 . . . . 0.0 108.092 -177.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -64.32 149.34 90.35 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.223 1.282 . . . . 0.0 109.269 176.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.516 ' CD2' ' HA2' ' A' ' 60' ' ' GLY . 23.0 m-85 -89.28 152.19 21.69 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 175.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 62.6 m-70 -121.91 134.97 54.86 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -83.37 -15.78 48.53 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.924 0.89 . . . . 0.0 111.007 178.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.1 t -164.2 147.58 9.48 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 163.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.401 ' CE2' ' HG3' ' A' ' 51' ' ' PRO . 17.6 t80 -87.37 151.29 23.21 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.3 -0.864 . . . . 0.0 108.695 169.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 35.9 p-10 -153.39 162.25 41.48 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 126.826 2.05 . . . . 0.0 110.797 169.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 9.0 p -93.9 0.74 56.31 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 126.351 1.86 . . . . 0.0 112.791 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -143.04 23.09 1.89 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.954 1.302 . . . . 0.0 109.647 -164.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -94.83 177.74 35.82 Favored Glycine 0 C--O 1.242 0.65 0 C-N-CA 123.876 0.75 . . . . 0.0 113.944 -167.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -64.7 -24.95 61.68 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.689 2.259 . . . . 0.0 111.061 169.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 46.1 m-70 -73.8 80.99 1.6 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.322 1.449 . . . . 0.0 108.401 176.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -59.39 -17.78 40.82 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.639 1.59 . . . . 0.0 114.445 -178.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.91 72.75 0.1 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.213 1.805 . . . . 0.0 111.614 168.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 6.3 mtt85 -99.48 166.03 11.36 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 120.968 -1.083 . . . . 0.0 111.062 -174.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -58.9 142.1 51.67 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -175.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 . . . . . 0 N--CA 1.455 -0.186 0 O-C-N 123.605 0.565 . . . . 0.0 110.143 -175.751 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.5 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.8 m80 -58.96 140.02 56.06 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 124.127 0.971 . . . . 0.0 108.767 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 39.2 pt -134.86 159.92 41.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 C-N-CA 124.694 1.198 . . . . 0.0 109.401 175.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -87.98 138.61 31.3 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 163.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.4 m -72.05 -177.28 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 156.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -133.1 -57.88 0.91 Allowed 'General case' 0 N--CA 1.447 -0.589 0 O-C-N 121.082 -1.011 . . . . 0.0 111.013 176.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -165.69 -41.99 0.02 OUTLIER Glycine 0 C--N 1.33 0.233 0 CA-C-N 118.629 0.649 . . . . 0.0 111.888 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 p -53.55 -29.31 36.28 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.995 1.318 . . . . 0.0 111.727 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.4 mp -133.19 76.78 1.7 Allowed 'General case' 0 C--O 1.221 -0.406 0 C-N-CA 124.502 1.121 . . . . 0.0 108.533 177.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -149.42 -80.01 0.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 O-C-N 120.895 -1.128 . . . . 0.0 108.878 172.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 25.2 ttt85 -67.43 -85.3 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 123.366 0.666 . . . . 0.0 110.429 -177.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -158.31 26.09 0.41 Allowed Glycine 0 C--N 1.336 0.554 0 CA-C-N 119.642 1.11 . . . . 0.0 113.058 -175.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -55.09 163.13 1.66 Allowed Pre-proline 0 N--CA 1.449 -0.521 0 C-N-CA 125.379 1.472 . . . . 0.0 111.411 175.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.15 -16.01 52.57 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.474 2.116 . . . . 0.0 112.842 -172.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.492 ' O ' HG22 ' A' ' 19' ' ' VAL . 5.1 m-80 -95.16 -17.87 21.41 Favored 'General case' 0 C--O 1.219 -0.512 0 C-N-CA 125.292 1.437 . . . . 0.0 111.245 -164.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -52.78 -40.79 63.5 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 120.088 1.313 . . . . 0.0 112.178 -165.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.96 -25.1 2.98 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -177.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 16' ' ' ASN . 14.3 m -68.94 -29.6 43.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 O-C-N 121.296 -0.878 . . . . 0.0 110.748 -177.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.1 ptp -83.27 6.14 20.67 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 119.045 0.839 . . . . 0.0 112.454 174.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 49.7 mt -114.42 26.74 10.0 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.82 1.648 . . . . 0.0 109.365 -177.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -139.26 99.43 3.74 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.248 1.419 . . . . 0.0 108.598 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 25.4 t-80 -63.58 -22.02 66.67 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -162.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.5 m -70.99 -32.6 69.46 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.835 -0.541 . . . . 0.0 111.988 172.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 40.3 m170 -71.32 -37.74 71.73 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 171.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 158.85 173.72 27.62 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-O 121.955 0.753 . . . . 0.0 111.969 156.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 57.5 tp -70.26 141.34 52.45 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.288 0.635 . . . . 0.0 111.214 177.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -150.95 108.43 3.63 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.694 1.197 . . . . 0.0 108.558 160.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -112.41 135.26 53.33 Favored 'General case' 0 CA--C 1.522 -0.112 0 C-N-CA 124.616 1.167 . . . . 0.0 108.633 175.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -63.68 108.54 1.44 Allowed 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.264 1.026 . . . . 0.0 108.577 177.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.456 ' NH1' ' H ' ' A' ' 103' ' ' ASP . 0.7 OUTLIER -106.55 44.39 1.06 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 -178.722 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.91 -162.2 35.42 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-O 122.515 1.064 . . . . 0.0 111.295 -177.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 63.5 mtp85 -125.57 166.02 17.46 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 121.491 -1.005 . . . . 0.0 110.056 -167.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -168.84 171.31 42.81 Favored Glycine 0 C--N 1.336 0.558 0 C-N-CA 120.234 -0.984 . . . . 0.0 113.637 177.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 91.0 m -138.02 149.57 46.18 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.23 1.012 . . . . 0.0 109.656 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.8 p -69.95 120.81 16.23 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 168.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.6 t -83.11 -48.86 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 -174.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -57.66 130.18 45.24 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 159.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.2 m -57.98 148.68 25.23 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 162.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -134.9 153.26 78.53 Favored Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 163.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -76.35 95.91 1.06 Allowed 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 125.261 3.974 . . . . 0.0 110.893 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.99 109.4 22.16 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -178.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.3 m -121.51 151.53 24.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 119.013 0.824 . . . . 0.0 109.469 175.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.5 mt -88.49 135.22 26.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 165.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.66 167.99 20.95 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 122.371 1.082 . . . . 0.0 110.7 173.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.61 174.76 46.81 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-O 122.829 1.239 . . . . 0.0 113.127 168.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -84.89 -4.59 59.17 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.65 1.18 . . . . 0.0 113.092 -163.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -119.86 10.28 11.54 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.54 1.536 . . . . 0.0 111.803 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 35.3 m-20 58.25 59.24 3.11 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.199 1.8 . . . . 0.0 109.574 176.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 96.8 mt -106.41 88.76 3.49 Favored Pre-proline 0 N--CA 1.455 -0.225 0 C-N-CA 127.142 2.177 . . . . 0.0 107.085 -171.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -58.39 135.14 65.92 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 CA-C-N 119.955 1.02 . . . . 0.0 111.519 172.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 74.7 m95 -101.15 -173.92 2.49 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.084 0.953 . . . . 0.0 108.914 178.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 53' ' ' LEU . 13.9 tp -142.53 101.68 3.92 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 159.043 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.403 HD13 ' N ' ' A' ' 54' ' ' LEU . 0.1 OUTLIER -62.93 132.28 51.55 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 172.453 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -71.44 92.94 1.12 Allowed 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.451 HD13 ' HA ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -145.15 77.42 12.97 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.699 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -57.63 120.01 7.63 Favored 'Trans proline' 0 C--O 1.239 0.546 0 C-N-CA 122.914 2.409 . . . . 0.0 109.145 176.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.51 7.19 51.94 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 125.86 1.695 . . . . 0.0 114.34 176.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -115.81 167.77 10.64 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 119.824 1.812 . . . . 0.0 108.878 171.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.422 ' HA2' ' CD2' ' A' ' 129' ' ' TYR . . . 66.49 -148.28 50.55 Favored Glycine 0 CA--C 1.518 0.258 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -173.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 63.9 m-70 -124.92 176.91 6.33 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.874 1.27 . . . . 0.0 108.399 -177.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 3.6 p -61.73 161.68 9.74 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 120.444 -0.502 . . . . 0.0 109.798 170.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 38.8 t -135.69 114.29 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 169.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 45.9 p -79.19 157.66 27.81 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 123.301 0.64 . . . . 0.0 109.876 -177.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -177.4 -153.0 10.47 Favored Glycine 0 CA--C 1.526 0.74 0 O-C-N 121.222 -0.924 . . . . 0.0 112.568 -176.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -138.68 165.7 26.27 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.21 1.404 . . . . 0.0 110.98 -174.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.407 HG22 ' HB3' ' A' ' 31' ' ' ARG . 62.2 mt -116.35 128.01 73.8 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 -173.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -122.92 126.98 48.3 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.973 0.892 . . . . 0.0 109.284 172.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -62.78 107.05 0.89 Allowed 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 158.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.1 m -115.41 161.04 14.44 Favored 'Isoleucine or valine' 0 C--O 1.244 0.809 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 171.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -113.43 173.22 6.51 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 176.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -52.04 -42.87 63.45 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 124.578 1.151 . . . . 0.0 110.683 -171.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 -62.59 -36.35 82.44 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 118.828 -0.606 . . . . 0.0 111.468 -174.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 20.4 tpp -67.67 -53.99 23.24 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.45 -38.28 80.34 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.267 -175.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.53 -41.9 75.37 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 125.582 1.553 . . . . 0.0 110.918 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -56.7 -51.44 68.79 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 122.974 0.51 . . . . 0.0 110.54 171.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 93.1 mt -60.5 -32.99 71.97 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.396 -0.815 . . . . 0.0 111.783 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -67.11 -6.52 17.89 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.24 1.816 . . . . 0.0 112.736 177.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -107.95 -49.86 3.15 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.939 1.695 . . . . 0.0 109.454 171.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -62.8 -46.56 87.4 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.253 1.021 . . . . 0.0 112.063 -174.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -72.12 6.66 2.05 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.91 0.884 . . . . 0.0 111.324 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 62.62 20.09 11.77 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 126.341 1.856 . . . . 0.0 113.264 167.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 26.5 p -68.91 157.98 87.49 Favored Pre-proline 0 CA--C 1.541 0.622 0 O-C-N 121.138 -0.976 . . . . 0.0 109.232 175.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -72.3 -4.32 12.98 Favored 'Cis proline' 0 CA--C 1.545 1.057 0 CA-C-N 119.978 1.028 . . . . 0.0 114.606 -5.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.5 m -63.96 -59.02 5.02 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 119.527 1.058 . . . . 0.0 111.979 -174.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 37.6 mtp -78.26 -80.65 0.11 Allowed 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -89.11 174.95 7.59 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.749 0.82 . . . . 0.0 109.918 177.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -132.73 -12.48 2.98 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.637 0.775 . . . . 0.0 113.015 173.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? 63.44 133.46 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 129.542 3.137 . . . . 0.0 112.576 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 61.9 m -143.98 160.48 40.78 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 123.969 0.907 . . . . 0.0 109.374 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -89.84 128.51 36.18 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.943 1.697 . . . . 0.0 110.539 170.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.72 178.53 5.64 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 127.365 2.266 . . . . 0.0 110.004 172.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -116.71 128.43 55.32 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.555 1.542 . . . . 0.0 108.933 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.412 ' CG2' ' SG ' ' A' ' 112' ' ' CYS . 41.8 t -122.38 151.53 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 127.239 2.216 . . . . 0.0 107.114 -171.049 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -88.73 139.41 30.5 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.682 1.593 . . . . 0.0 107.265 171.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.4 t -87.31 126.44 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 170.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 mp -99.07 -36.61 9.65 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.143 1.777 . . . . 0.0 109.95 -176.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -148.44 153.35 38.39 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 130.44 3.496 . . . . 0.0 104.418 174.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' TRP . . . . . 0.552 ' HE1' ' N ' ' A' ' 104' ' ' GLY . 74.1 t-105 -141.53 123.29 15.23 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -178.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -130.94 109.19 10.36 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.441 ' HA3' ' HD2' ' A' ' 31' ' ' ARG . . . 169.69 -120.81 0.89 Allowed Glycine 0 C--N 1.343 0.936 0 C-N-CA 114.489 -3.719 . . . . 0.0 121.192 173.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.456 ' H ' ' NH1' ' A' ' 31' ' ' ARG . 37.0 t0 -64.43 -178.05 0.35 Allowed 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 101.482 -3.525 . . . . 0.0 101.482 126.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.552 ' N ' ' HE1' ' A' ' 100' ' ' TRP . . . -108.76 -75.23 0.86 Allowed Glycine 0 N--CA 1.417 -2.572 1 C-N-CA 111.397 -5.192 . . . . 0.0 106.464 -94.149 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -158.89 88.04 2.19 Favored Pre-proline 0 C--N 1.313 -1.002 1 C-N-CA 133.652 4.781 . . . . 0.0 114.966 163.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -51.41 -30.41 34.48 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.001 2.468 . . . . 0.0 114.082 161.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 111.22 179.39 20.21 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.89 1.233 . . . . 0.0 110.557 -169.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -67.61 -11.91 59.23 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.463 1.105 . . . . 0.0 112.056 -171.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.7 p -130.93 159.73 36.58 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 120.786 -1.196 . . . . 0.0 110.979 172.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.2 p -151.1 146.29 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 124.174 0.99 . . . . 0.0 109.924 177.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.77 142.39 27.86 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 173.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.412 ' SG ' ' CG2' ' A' ' 95' ' ' VAL . 0.5 OUTLIER -152.19 168.84 24.02 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.392 1.477 . . . . 0.0 110.011 -178.815 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -92.39 151.79 20.07 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.098 0.559 . . . . 0.0 110.149 172.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 51.2 t -138.39 146.03 27.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 C-N-CA 127.6 2.36 . . . . 0.0 106.265 167.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -78.02 92.84 4.38 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.711 0.804 . . . . 0.0 109.51 172.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.0 p -104.45 173.47 6.29 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.369 1.468 . . . . 0.0 111.388 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.85 148.57 52.3 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 126.226 1.811 . . . . 0.0 107.089 175.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -112.8 -2.29 14.44 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.456 1.102 . . . . 0.0 111.296 167.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.6 p -111.8 18.26 19.08 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.695 1.598 . . . . 0.0 112.212 -158.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -68.93 158.92 33.66 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.727 1.611 . . . . 0.0 112.314 -170.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.4 157.66 87.67 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 126.343 1.857 . . . . 0.0 111.359 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -52.88 -53.75 6.27 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.533 2.822 . . . . 0.0 113.096 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.493 ' HA ' ' CD2' ' A' ' 126' ' ' PHE . 0.5 OUTLIER -45.67 -33.25 2.82 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 126.458 1.903 . . . . 0.0 114.191 -179.123 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 38.7 m0 -74.28 -3.5 30.47 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.598 -0.688 . . . . 0.0 112.242 -168.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 89.1 mt -97.08 -12.98 22.52 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 118.027 -0.987 . . . . 0.0 113.237 170.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.493 ' CD2' ' HA ' ' A' ' 123' ' ' GLU . 10.3 m-85 -84.34 -30.24 25.66 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 119.511 1.051 . . . . 0.0 110.214 177.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 36.3 mt -58.32 155.55 26.38 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 125.955 1.702 . . . . 0.0 111.428 -174.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.52 156.06 62.14 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 121.693 1.595 . . . . 0.0 109.756 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.422 ' CD2' ' HA2' ' A' ' 60' ' ' GLY . 31.9 m-85 -104.9 161.39 14.23 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.248 1.019 . . . . 0.0 111.945 178.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -138.95 159.9 41.05 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.926 0.891 . . . . 0.0 110.56 -171.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -111.06 -7.65 14.49 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -164.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 33.8 t -164.56 158.67 18.35 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 171.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -103.53 150.06 24.27 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.258 0.552 . . . . 0.0 109.681 172.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -157.9 170.1 23.09 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.515 1.526 . . . . 0.0 108.203 177.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.4 9.44 37.81 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.383 1.873 . . . . 0.0 110.769 167.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -138.05 4.15 2.47 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.551 1.14 . . . . 0.0 113.719 -167.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -89.3 -171.15 45.28 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 127.127 2.299 . . . . 0.0 111.925 -175.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -71.34 5.95 2.09 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 124.648 3.566 . . . . 0.0 114.997 -178.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -87.12 91.44 8.71 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -53.16 -36.69 52.89 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 121.78 -0.575 . . . . 0.0 113.235 -178.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.517 ' CD2' ' H ' ' A' ' 141' ' ' LEU . 0.7 OUTLIER -68.82 119.46 13.21 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 127.347 2.259 . . . . 0.0 109.646 168.691 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.53 163.51 13.63 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 119.65 1.114 . . . . 0.0 110.772 167.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -54.52 139.99 36.06 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 119.164 0.893 . . . . 0.0 110.057 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 C--O 1.235 0.338 0 C-N-CA 123.295 0.638 . . . . 0.0 110.103 -173.455 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.004 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -130.68 142.9 50.44 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 125.536 1.534 . . . . 0.0 109.346 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.2 pt -125.88 171.64 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 124.313 1.045 . . . . 0.0 109.717 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -121.4 127.74 51.48 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.313 1.445 . . . . 0.0 107.713 174.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.3 m -97.86 155.83 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 123.917 0.887 . . . . 0.0 109.371 170.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -147.08 -19.78 0.4 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.755 2.022 . . . . 0.0 111.479 178.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.403 ' HA3' ' CD2' ' A' ' 133' ' ' TYR . . . -120.25 -129.71 3.83 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 127.513 2.482 . . . . 0.0 111.761 -169.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.4 p -64.0 -35.95 82.38 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.738 -0.86 . . . . 0.0 112.516 -161.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.721 HD23 ' HA ' ' A' ' 17' ' ' HIS . 77.1 mt -80.94 3.11 23.97 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.432 0.693 . . . . 0.0 111.911 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -89.29 -81.18 0.28 Allowed 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 117.345 -1.312 . . . . 0.0 110.323 178.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.99 -85.76 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 121.052 1.751 . . . . 0.0 111.073 -174.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -169.7 21.11 0.08 OUTLIER Glycine 0 CA--C 1.525 0.717 0 O-C-N 121.307 -0.871 . . . . 0.0 111.149 -164.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -52.81 162.61 0.95 Allowed Pre-proline 0 N--CA 1.452 -0.372 0 C-N-CA 124.53 1.132 . . . . 0.0 110.621 176.178 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -65.73 1.89 1.97 Allowed 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 124.911 3.741 . . . . 0.0 113.092 -172.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -119.66 -17.68 8.56 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 126.289 1.836 . . . . 0.0 107.92 -171.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.721 ' HA ' HD23 ' A' ' 10' ' ' LEU . 6.2 t60 -51.38 -37.31 47.49 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 120.192 1.36 . . . . 0.0 109.991 177.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.23 -21.74 3.71 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-O 117.231 -1.366 . . . . 0.0 114.6 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.514 HG22 HD21 ' A' ' 10' ' ' LEU . 22.0 m -61.73 -41.51 90.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 120.994 1.725 . . . . 0.0 110.122 176.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -74.41 -17.68 60.76 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 119.315 0.962 . . . . 0.0 113.114 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 73.0 mt -75.32 -5.08 42.88 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.103 0.561 . . . . 0.0 111.244 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -102.65 103.75 14.05 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.286 0.565 . . . . 0.0 109.687 169.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 -51.33 -19.85 1.47 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.089 1.355 . . . . 0.0 113.963 173.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.5 t -77.19 -30.27 54.72 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.032 -1.043 . . . . 0.0 112.027 176.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -69.22 -30.33 68.46 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.585 1.084 . . . . 0.0 109.464 166.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.53 177.27 26.01 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 110.909 -0.877 . . . . 0.0 110.909 167.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 30.1 tp -77.89 142.05 38.7 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 123.639 0.776 . . . . 0.0 111.056 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -145.7 141.36 27.98 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.397 1.079 . . . . 0.0 110.1 165.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.81 148.02 27.98 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.454 1.502 . . . . 0.0 109.815 166.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -67.62 124.35 23.0 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 125.061 1.344 . . . . 0.0 109.118 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.1 tpp180 -120.07 45.7 2.12 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.652 1.181 . . . . 0.0 108.658 -176.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 89.39 -177.79 44.17 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -174.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.82 172.54 11.55 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.518 -0.99 . . . . 0.0 111.813 -173.011 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -173.82 -178.02 43.45 Favored Glycine 0 CA--C 1.505 -0.542 0 C-N-CA 120.305 -0.95 . . . . 0.0 114.158 -174.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 22.1 p -146.4 154.84 42.09 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 123.909 0.883 . . . . 0.0 109.45 173.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 44.7 p -78.26 83.23 4.52 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 173.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.6 m -59.58 -30.8 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 118.826 0.739 . . . . 0.0 112.195 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.41 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 7.1 tt0 -74.74 22.99 0.1 Allowed 'General case' 0 C--O 1.205 -1.24 0 C-N-CA 127.861 2.465 . . . . 0.0 111.928 173.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 41.46 114.37 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.616 1 C-N-CA 134.393 5.077 . . . . 0.0 114.025 158.377 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.552 ' HB3' HD21 ' A' ' 53' ' ' LEU . 30.5 m-85 -127.85 154.12 78.12 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 120.194 1.361 . . . . 0.0 111.413 -173.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.38 105.81 1.93 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 124.93 3.753 . . . . 0.0 110.724 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.48 100.91 9.13 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 -178.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.3 m -110.33 144.69 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-N 119.179 0.9 . . . . 0.0 110.154 -172.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.0 mt -91.98 116.4 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 171.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -129.92 179.58 5.78 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 124.332 1.053 . . . . 0.0 108.7 172.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.4 152.68 25.17 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 124.649 1.118 . . . . 0.0 112.809 161.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.76 -17.56 64.93 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -171.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -105.97 9.01 32.73 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 118.512 -0.756 . . . . 0.0 112.423 -177.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 53.42 79.64 0.12 Allowed 'General case' 0 C--N 1.342 0.239 0 C-N-CA 125.769 1.628 . . . . 0.0 108.391 -162.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 62.2 mt -120.04 86.57 37.28 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -61.31 151.68 77.59 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 CA-C-N 120.781 1.315 . . . . 0.0 112.683 174.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -125.77 128.92 48.47 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.448 1.499 . . . . 0.0 107.56 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.552 HD21 ' HB3' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -92.7 107.08 18.94 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 174.053 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.1 mt -87.12 139.2 30.8 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 105.904 -1.888 . . . . 0.0 105.904 -172.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -73.61 96.99 2.55 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 118.774 0.716 . . . . 0.0 109.865 -175.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.434 HD23 ' HD2' ' A' ' 57' ' ' PRO . 0.4 OUTLIER -152.08 87.13 4.35 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 124.365 1.066 . . . . 0.0 112.982 177.818 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.434 ' HD2' HD23 ' A' ' 56' ' ' LEU . 31.5 Cg_endo -59.75 145.18 98.87 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.884 2.389 . . . . 0.0 111.49 176.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 47.65 51.34 17.45 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 129.481 3.419 . . . . 0.0 112.533 -174.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.0 tptm -140.55 143.81 35.56 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 126.072 1.749 . . . . 0.0 106.314 173.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.21 -129.43 20.46 Favored Glycine 0 CA--C 1.519 0.299 0 N-CA-C 109.064 -1.615 . . . . 0.0 109.064 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -138.31 170.53 15.86 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 119.212 1.506 . . . . 0.0 111.606 -167.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 73.1 m -84.53 104.44 14.53 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.381 -0.827 . . . . 0.0 108.995 -176.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.0 t -70.32 110.71 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.9 p -75.09 145.34 42.36 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 120.904 -1.122 . . . . 0.0 110.43 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -167.35 -167.4 27.97 Favored Glycine 0 C--N 1.335 0.473 0 O-C-N 120.446 -1.409 . . . . 0.0 112.364 -169.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -134.93 158.8 43.35 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.222 1.009 . . . . 0.0 109.169 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.8 mt -102.56 132.71 48.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 -177.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -118.21 127.01 53.34 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 118.64 0.654 . . . . 0.0 110.863 172.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -60.25 135.05 57.61 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 150.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.8 m -135.25 173.45 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 170.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.06 -178.27 3.71 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.679 0.752 . . . . 0.0 111.193 160.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -44.46 -55.59 4.94 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 126.61 1.964 . . . . 0.0 111.888 -171.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -71.28 -27.62 63.55 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 117.298 -1.334 . . . . 0.0 111.215 -171.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 24.1 tpp -66.28 -47.81 72.45 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 120.862 1.665 . . . . 0.0 108.595 172.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.09 -28.92 70.4 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 119.403 -0.332 . . . . 0.0 111.581 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -77.67 -37.03 50.65 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.42 1.009 . . . . 0.0 112.297 174.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -67.22 -45.84 75.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 119.475 1.034 . . . . 0.0 109.807 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.13 -32.25 66.16 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.67 -0.644 . . . . 0.0 110.351 171.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.428 ' HA ' ' SG ' ' A' ' 84' ' ' CYS . 0.7 OUTLIER -65.31 -7.92 15.67 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.038 1.335 . . . . 0.0 113.069 177.038 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -123.97 -27.16 3.94 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.712 2.405 . . . . 0.0 111.773 -176.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -72.83 -29.52 63.3 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.286 -0.884 . . . . 0.0 110.902 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -117.25 30.95 7.02 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.748 1.619 . . . . 0.0 110.406 177.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.0 t0 49.91 26.31 1.93 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.811 2.044 . . . . 0.0 113.431 169.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.428 ' SG ' ' HA ' ' A' ' 79' ' ' ASP . 0.8 OUTLIER -71.72 159.89 84.19 Favored Pre-proline 0 CA--C 1.54 0.572 0 O-C-N 120.652 -1.28 . . . . 0.0 109.381 -167.934 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -68.42 -3.4 5.97 Favored 'Cis proline' 0 CA--C 1.54 0.82 0 CA-C-N 120.979 1.385 . . . . 0.0 113.702 -11.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.4 t -56.34 -68.12 0.24 Allowed 'General case' 0 C--O 1.238 0.488 0 CA-C-N 119.339 0.972 . . . . 0.0 111.443 -173.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 26.8 mtp -77.91 -73.54 0.31 Allowed 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -177.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -97.97 -179.73 4.51 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 124.575 1.15 . . . . 0.0 108.108 173.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -165.45 125.29 1.79 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 -172.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.8 tmm_? -69.92 148.18 49.3 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -173.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.5 m -149.78 168.25 24.22 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 126.37 1.868 . . . . 0.0 107.284 -174.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -123.33 142.62 50.76 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.178 1.791 . . . . 0.0 109.691 172.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.19 174.13 13.61 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.466 1.907 . . . . 0.0 110.53 -173.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -92.63 111.79 23.51 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.973 1.309 . . . . 0.0 109.491 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.1 t -106.17 144.38 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 120.509 1.504 . . . . 0.0 107.754 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -78.81 140.78 38.15 Favored 'General case' 0 C--N 1.341 0.221 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 169.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 40.7 t -93.36 92.57 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 176.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.09 -24.53 67.73 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.876 -0.515 . . . . 0.0 110.746 175.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -165.93 149.52 7.76 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 128.035 2.534 . . . . 0.0 105.546 176.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 63.2 t-105 -125.89 137.72 53.75 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 124.715 1.206 . . . . 0.0 107.794 171.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -108.75 127.12 53.73 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.178 0.991 . . . . 0.0 110.558 174.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.6 -174.9 47.56 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 124.902 1.239 . . . . 0.0 112.385 168.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -62.77 151.82 37.59 Favored 'General case' 0 C--O 1.238 0.48 0 O-C-N 122.709 -0.289 . . . . 0.0 110.623 -170.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 102.56 45.31 1.69 Allowed Glycine 0 CA--C 1.52 0.355 0 CA-C-O 119.393 -0.671 . . . . 0.0 112.785 177.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -101.73 89.51 1.53 Allowed Pre-proline 0 N--CA 1.465 0.283 0 C-N-CA 126.682 1.993 . . . . 0.0 109.525 -156.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -62.35 -29.31 79.44 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 124.03 3.153 . . . . 0.0 112.922 -166.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 120.28 -169.21 13.96 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -163.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -71.39 -10.88 60.48 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.745 1.218 . . . . 0.0 113.039 -168.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.0 p -139.01 165.09 28.03 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 120.252 -1.53 . . . . 0.0 110.277 167.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.9 p -146.3 175.39 2.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 C-N-CA 124.989 1.315 . . . . 0.0 108.048 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -100.71 136.0 41.27 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 155.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 98.0 m -121.81 165.06 16.44 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 165.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -83.31 150.39 26.16 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 160.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.505 HG12 HG23 ' A' ' 116' ' ' THR . 27.3 t -142.22 160.81 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 129.312 3.045 . . . . 0.0 105.295 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -110.31 108.08 18.04 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 171.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.505 HG23 HG12 ' A' ' 114' ' ' VAL . 32.5 p -112.64 -164.74 0.94 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 122.017 0.913 . . . . 0.0 109.286 175.398 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.52 135.69 28.59 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 174.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -98.69 -3.33 36.16 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.869 1.267 . . . . 0.0 111.309 164.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 16.9 p -92.3 -0.65 57.38 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.461 1.904 . . . . 0.0 113.206 -170.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -55.6 141.23 38.29 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 126.669 1.988 . . . . 0.0 113.171 -164.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.44 147.06 98.87 Favored Pre-proline 0 N--CA 1.446 -0.657 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.137 -177.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.486 ' HA ' HD23 ' A' ' 125' ' ' LEU . 27.8 Cg_endo -65.19 -22.06 61.56 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.101 1.867 . . . . 0.0 113.307 -178.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.481 ' HA ' ' CE2' ' A' ' 126' ' ' PHE . 1.6 pm0 -70.0 -29.04 66.02 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 170.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 46.6 m0 -72.61 3.58 4.83 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.052 -1.03 . . . . 0.0 111.247 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.486 HD23 ' HA ' ' A' ' 122' ' ' PRO . 4.5 mm? -81.24 -22.25 38.88 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.663 1.585 . . . . 0.0 113.83 169.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.481 ' CE2' ' HA ' ' A' ' 123' ' ' GLU . 33.7 p90 -107.12 -16.84 14.32 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 120.474 1.488 . . . . 0.0 112.772 -177.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 26.2 mt -56.29 148.14 43.92 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 123.668 0.787 . . . . 0.0 110.091 173.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.67 147.45 45.27 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.601 2.201 . . . . 0.0 111.712 -173.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -91.23 168.94 11.24 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.201 1.4 . . . . 0.0 111.413 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -143.42 164.26 30.8 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.621 1.568 . . . . 0.0 109.41 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -107.45 -1.73 21.16 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.28 1.832 . . . . 0.0 111.626 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.16 167.97 23.28 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 126.182 1.793 . . . . 0.0 106.948 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.403 ' CD2' ' HA3' ' A' ' 8' ' ' GLY . 1.1 t80 -135.22 96.77 3.56 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 104.357 -2.46 . . . . 0.0 104.357 176.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -150.24 115.12 5.31 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 122.942 0.497 . . . . 0.0 110.18 -170.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 73.5 m -54.82 -16.68 2.79 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.124 1.37 . . . . 0.0 111.303 171.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -103.89 57.31 0.73 Allowed 'General case' 0 C--O 1.237 0.399 0 C-N-CA 126.439 1.895 . . . . 0.0 109.273 -177.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -146.84 177.26 25.27 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 127.914 2.674 . . . . 0.0 109.437 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -79.95 3.48 7.56 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.793 2.996 . . . . 0.0 114.32 -171.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -120.49 85.3 2.37 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 107.31 -1.366 . . . . 0.0 107.31 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -72.14 52.26 1.37 Allowed Glycine 0 CA--C 1.529 0.938 0 C-N-CA 126.587 2.041 . . . . 0.0 115.089 -167.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.49 58.09 1.25 Allowed 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 126.024 1.73 . . . . 0.0 109.621 -174.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 14.0 mmt85 -119.66 -18.07 8.46 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -176.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -166.86 139.9 3.67 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 125.328 1.451 . . . . 0.0 107.965 163.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 CA--C 1.531 0.22 0 O-C-N 124.422 1.076 . . . . 0.0 108.913 179.127 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.174 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -85.68 122.28 29.55 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 171.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.412 HG22 ' HB2' ' A' ' 113' ' ' PHE . 8.0 pt -129.05 174.98 11.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 125.329 1.451 . . . . 0.0 111.426 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -105.02 -167.92 1.4 Allowed 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.949 1.699 . . . . 0.0 110.596 172.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.613 HG12 ' H ' ' A' ' 66' ' ' GLU . 10.7 p -139.74 148.41 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 123.95 0.9 . . . . 0.0 109.132 166.204 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -59.56 -32.26 70.18 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.636 1.575 . . . . 0.0 113.173 -177.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 142.32 -31.07 2.07 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.65 1.119 . . . . 0.0 111.179 -168.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.425 HG23 ' CE2' ' A' ' 133' ' ' TYR . 2.3 p -59.35 -73.48 0.08 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 130.68 3.592 . . . . 0.0 112.832 -176.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.9 mp -78.72 57.18 2.01 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.843 0.857 . . . . 0.0 108.782 -173.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.59 -66.88 0.36 Allowed 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 127.091 2.156 . . . . 0.0 108.338 -176.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -79.35 -72.59 0.38 Allowed 'General case' 0 C--O 1.223 -0.312 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.703 -178.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -172.84 10.98 0.04 OUTLIER Glycine 0 CA--C 1.531 1.062 0 N-CA-C 115.666 1.027 . . . . 0.0 115.666 -175.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.53 164.99 0.3 Allowed Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 126.569 1.948 . . . . 0.0 114.885 -171.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -56.16 -16.94 18.47 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 124.671 3.581 . . . . 0.0 113.974 -174.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -98.73 -19.58 17.4 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 125.12 1.368 . . . . 0.0 110.769 -165.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -51.36 -40.45 59.19 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.034 0.934 . . . . 0.0 112.413 -162.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.72 -21.68 19.86 Favored 'General case' 0 C--O 1.224 -0.255 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -175.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.5 m -60.49 -40.22 83.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 120.269 1.395 . . . . 0.0 110.905 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.0 ptp -74.22 -13.04 60.73 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 118.645 0.657 . . . . 0.0 112.219 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 72.6 mt -82.7 -4.78 58.34 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 118.574 -0.727 . . . . 0.0 110.61 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -105.35 99.19 8.8 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -178.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 28.3 t-80 -60.7 -18.85 56.75 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.0 t -55.99 -52.71 63.2 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.328 1.051 . . . . 0.0 109.746 168.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -70.67 -21.08 62.64 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.704 0.802 . . . . 0.0 110.87 -177.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.85 177.77 23.34 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 123.992 0.806 . . . . 0.0 111.373 164.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.5 tp -84.27 142.72 30.04 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.63 0.772 . . . . 0.0 110.293 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.28 142.22 31.27 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.248 1.419 . . . . 0.0 107.945 161.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -143.95 131.81 21.46 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.182 1.393 . . . . 0.0 108.111 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -73.84 94.21 2.26 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 127.187 2.195 . . . . 0.0 110.706 -171.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -93.54 61.34 3.18 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 172.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.18 -154.54 53.28 Favored Glycine 0 N--CA 1.441 -0.997 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 174.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 24.5 ptt-85 -143.95 168.13 20.7 Favored 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 122.119 -0.636 . . . . 0.0 112.124 -163.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -173.62 177.51 45.93 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-O 122.432 1.018 . . . . 0.0 114.041 -169.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.7 p -142.54 162.51 35.28 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.947 1.299 . . . . 0.0 109.917 176.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 43.6 p -82.06 95.84 7.57 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 168.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.401 HG22 ' H ' ' A' ' 37' ' ' VAL . 0.2 OUTLIER -62.76 -25.41 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 118.43 0.559 . . . . 0.0 111.686 171.019 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.78 117.32 13.22 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 159.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.4 m -57.1 138.5 54.4 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 172.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.478 ' HB3' ' CD2' ' A' ' 53' ' ' LEU . 36.0 m-85 -129.27 152.43 79.47 Favored Pre-proline 0 C--O 1.234 0.246 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 164.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -77.71 111.78 3.19 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 124.918 3.745 . . . . 0.0 110.479 172.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 33.5 tp -103.81 86.48 2.61 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.92 1.288 . . . . 0.0 107.769 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.556 HG13 ' HB3' ' A' ' 127' ' ' LEU . 48.3 t -84.21 160.78 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.274 0 C-N-CA 125.186 1.394 . . . . 0.0 107.921 177.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 50.3 mt -132.33 118.8 37.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 176.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.71 -172.87 3.91 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.567 0.747 . . . . 0.0 109.082 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.71 175.97 11.33 Favored Glycine 0 N--CA 1.439 -1.138 0 C-N-CA 125.564 1.555 . . . . 0.0 111.316 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -74.59 -8.45 56.39 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -162.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -132.73 40.28 3.27 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 124.021 0.928 . . . . 0.0 110.759 -176.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.8 m120 48.17 61.05 3.2 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.128 -0.983 . . . . 0.0 110.724 174.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 62.4 mt -102.49 89.97 1.97 Allowed Pre-proline 0 C--N 1.329 -0.294 0 N-CA-C 103.422 -2.807 . . . . 0.0 103.422 -160.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -59.62 120.04 7.61 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 N-CA-C 108.132 -1.526 . . . . 0.0 108.132 -176.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -103.27 115.31 30.31 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 177.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.478 ' CD2' ' HB3' ' A' ' 40' ' ' PHE . 0.3 OUTLIER -81.39 94.75 6.85 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 172.737 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.436 ' HG ' ' CD2' ' A' ' 120' ' ' TYR . 10.9 mp -65.45 120.23 12.46 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -70.55 83.58 0.6 Allowed 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -176.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.56 85.74 12.84 Favored Pre-proline 0 N--CA 1.465 0.317 0 C-N-CA 124.168 0.987 . . . . 0.0 109.727 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -58.87 141.07 97.71 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 N-CA-C 108.932 -1.218 . . . . 0.0 108.932 174.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.56 18.96 76.92 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 119.607 -0.551 . . . . 0.0 113.681 176.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -126.62 157.08 39.87 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 119.487 1.643 . . . . 0.0 106.798 161.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.97 -137.27 15.36 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 173.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -140.24 171.49 14.09 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.784 1.292 . . . . 0.0 110.493 -173.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 58.3 m -79.93 107.77 12.97 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 123.884 0.874 . . . . 0.0 111.387 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 73.6 t -88.86 116.35 30.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -169.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.6 p -72.61 161.95 30.12 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.493 0.664 . . . . 0.0 109.278 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -169.58 -156.7 11.11 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 108.116 -1.993 . . . . 0.0 108.116 175.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.613 ' H ' HG12 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -135.09 171.76 13.97 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.619 1.968 . . . . 0.0 106.513 177.603 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 79.5 mt -126.36 127.99 71.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 119.485 1.039 . . . . 0.0 108.512 -170.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -126.08 119.96 28.96 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.456 0.702 . . . . 0.0 111.794 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -66.59 115.66 6.69 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 105.473 -2.047 . . . . 0.0 105.473 156.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.2 m -120.47 165.48 15.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 C-N-CA 123.828 0.851 . . . . 0.0 109.244 178.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -93.56 171.39 8.93 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 122.413 1.101 . . . . 0.0 108.296 169.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -54.07 -37.93 64.74 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.316 -1.311 . . . . 0.0 110.846 167.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -58.68 -40.66 84.22 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.889 0.768 . . . . 0.0 110.943 -176.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 25.8 tpp -72.01 -45.83 59.44 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 176.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.7 tp -58.84 -26.84 64.56 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 50.1 mtt-85 -78.59 -39.27 37.92 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.936 1.694 . . . . 0.0 111.144 173.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -64.15 -50.29 68.79 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 118.881 -0.58 . . . . 0.0 111.351 175.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 91.6 mt -56.41 -36.36 68.85 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 119.106 0.866 . . . . 0.0 110.668 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.73 -23.25 28.09 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.097 1.759 . . . . 0.0 112.891 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -93.22 -31.23 14.82 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.43 1.492 . . . . 0.0 112.287 174.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -71.62 -43.73 65.65 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.333 1.053 . . . . 0.0 109.632 -169.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -92.21 15.41 13.68 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.45 1.1 . . . . 0.0 113.174 176.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.0 t70 44.89 38.29 2.85 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.615 1.566 . . . . 0.0 112.283 -177.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -65.7 158.91 72.33 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 120.075 -1.641 . . . . 0.0 107.403 170.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -74.16 -3.38 17.1 Favored 'Cis proline' 0 N--CA 1.452 -0.953 0 CA-C-N 118.969 0.668 . . . . 0.0 113.488 -13.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.54 -62.81 1.47 Allowed 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.033 1.733 . . . . 0.0 111.8 -175.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 36.5 mtp -86.31 -74.29 0.43 Allowed 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -174.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -89.81 172.91 8.56 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 175.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -134.88 138.66 44.36 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 165.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.574 ' HD3' ' CD1' ' A' ' 113' ' ' PHE . 7.6 tmm_? -74.31 129.94 38.74 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 118.095 -0.955 . . . . 0.0 109.24 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.3 m -133.02 156.27 47.65 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.102 0.865 . . . . 0.0 110.0 -175.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -87.85 139.58 30.38 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.388 1.475 . . . . 0.0 110.426 168.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.495 HD21 HG23 ' A' ' 114' ' ' VAL . 1.8 pt? -160.92 -179.91 7.94 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.657 1.183 . . . . 0.0 112.809 -177.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 12.1 tp60 -99.2 142.44 30.68 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.371 1.068 . . . . 0.0 113.073 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 45.4 t -137.34 134.6 47.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 126.659 1.984 . . . . 0.0 107.781 174.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -76.66 144.73 39.26 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.282 1.433 . . . . 0.0 108.039 165.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.592 HG13 ' HA ' ' A' ' 108' ' ' ASP 0.255 3.5 p -110.93 82.43 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-O 122.366 1.079 . . . . 0.0 108.838 -178.451 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.0 mp -44.79 -42.19 7.6 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 127.057 2.143 . . . . 0.0 110.462 176.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -150.09 152.47 34.83 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 176.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 64.0 t-105 -127.09 137.71 53.06 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 125.59 1.556 . . . . 0.0 107.28 176.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -113.65 106.8 14.95 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 122.964 0.505 . . . . 0.0 110.047 174.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.9 -175.75 16.12 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-O 122.066 0.815 . . . . 0.0 112.304 175.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -79.94 172.76 13.34 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.262 -0.969 . . . . 0.0 109.391 168.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.39 60.44 2.01 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -101.05 88.47 1.06 Allowed Pre-proline 0 CA--C 1.537 0.466 1 C-N-CA 132.721 4.408 . . . . 0.0 109.113 -158.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -73.39 5.04 3.43 Favored 'Trans proline' 0 CA--C 1.544 0.98 1 C-N-CA 126.188 4.592 . . . . 0.0 113.963 -171.002 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.33 -169.03 54.88 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-N 120.819 1.645 . . . . 0.0 110.031 -163.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.592 ' HA ' HG13 ' A' ' 97' ' ' VAL . 26.9 t70 -96.81 5.48 50.51 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 129.456 3.102 . . . . 0.0 116.001 -166.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.2 p -136.81 122.12 19.33 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 122.025 2.193 . . . . 0.0 114.588 152.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 24.8 m -98.41 153.85 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 125.098 1.359 . . . . 0.0 108.891 -179.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -87.12 125.95 34.47 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 163.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 9.9 m -116.88 172.06 7.49 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.522 1.129 . . . . 0.0 110.428 176.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.574 ' CD1' ' HD3' ' A' ' 90' ' ' ARG . 96.2 m-85 -92.62 139.77 30.22 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 152.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.495 HG23 HD21 ' A' ' 93' ' ' LEU . 24.3 t -142.09 126.05 15.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 129.752 3.221 . . . . 0.0 106.89 172.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -72.23 141.33 48.97 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 170.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.414 HG22 HD13 ' A' ' 53' ' ' LEU . 41.9 p -145.12 -170.0 3.32 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 126.633 1.973 . . . . 0.0 107.319 -177.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -131.76 143.76 50.47 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 166.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -107.05 0.66 23.73 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.726 1.61 . . . . 0.0 110.689 168.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.2 p -121.75 20.52 10.93 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 127.101 2.161 . . . . 0.0 111.646 -159.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.436 ' CD2' ' HG ' ' A' ' 54' ' ' LEU . 7.2 p90 -67.04 152.1 46.41 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 125.691 1.596 . . . . 0.0 111.825 -176.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.59 158.87 65.12 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 124.689 1.196 . . . . 0.0 111.568 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -72.7 -33.91 7.65 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.558 1.505 . . . . 0.0 113.175 -177.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -64.66 -26.97 68.62 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.7 0.682 . . . . 0.0 112.39 172.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 45.7 m0 -69.99 -10.78 59.8 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.767 0.712 . . . . 0.0 112.178 -176.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.26 -29.12 69.29 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.674 1.125 . . . . 0.0 110.821 168.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -90.69 -11.41 39.8 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.497 1.119 . . . . 0.0 112.099 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.556 ' HB3' HG13 ' A' ' 43' ' ' VAL . 11.5 mt -62.64 146.67 94.0 Favored Pre-proline 0 C--O 1.235 0.335 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -64.72 143.49 80.79 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.171 1.914 . . . . 0.0 109.861 175.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -96.82 164.27 12.63 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.751 1.22 . . . . 0.0 108.56 176.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -135.27 162.94 31.15 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.8 0.84 . . . . 0.0 110.103 -176.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -106.29 -17.48 14.28 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 121.392 -0.817 . . . . 0.0 110.364 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 95.2 p -139.44 160.03 40.79 Favored 'General case' 0 N--CA 1.444 -0.771 0 O-C-N 121.282 -0.886 . . . . 0.0 111.07 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.425 ' CE2' HG23 ' A' ' 9' ' ' THR . 3.4 t80 -141.42 101.76 4.06 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 104.005 -2.591 . . . . 0.0 104.005 178.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -151.72 136.86 17.43 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -178.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.01 -43.76 50.85 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.8 0.84 . . . . 0.0 110.784 174.184 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -89.29 23.78 2.4 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.838 0.855 . . . . 0.0 112.735 -167.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -82.16 155.26 34.37 Favored Glycine 0 CA--C 1.539 1.542 0 CA-C-O 118.701 -1.055 . . . . 0.0 111.892 174.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -71.5 -22.63 24.42 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 124.288 3.325 . . . . 0.0 112.361 175.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -73.33 80.41 1.36 Allowed 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 127.556 2.342 . . . . 0.0 107.031 172.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -72.57 77.35 0.77 Allowed Glycine 0 CA--C 1.522 0.476 0 C-N-CA 127.033 2.254 . . . . 0.0 111.375 -174.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -161.14 71.58 0.41 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 128.573 2.749 . . . . 0.0 105.642 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -133.56 173.15 11.81 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.32 0.648 . . . . 0.0 109.892 -168.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -69.77 123.81 22.38 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.531 -161.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 . . . . . 0 CA--C 1.516 -0.342 0 C-N-CA 125.077 1.351 . . . . 0.0 109.045 -170.535 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -78.11 142.09 38.32 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -177.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.1 pt -126.79 166.5 23.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 176.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -124.96 130.56 52.61 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.476 0.71 . . . . 0.0 109.679 -177.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.8 p -93.14 164.58 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 125.449 1.5 . . . . 0.0 108.922 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.401 ' CE1' HG13 ' A' ' 114' ' ' VAL . 0.4 OUTLIER -113.4 -74.43 0.63 Allowed 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -179.593 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -128.1 -34.98 0.52 Allowed Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.164 1.364 . . . . 0.0 111.306 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p -64.12 -32.72 74.4 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 127.127 2.171 . . . . 0.0 114.276 -159.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 mp -133.37 36.46 3.39 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.947 1.299 . . . . 0.0 107.737 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -112.02 -25.17 9.51 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.63 1.172 . . . . 0.0 113.265 -172.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.3 mmt-85 -140.73 -87.93 0.18 Allowed 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 119.687 1.13 . . . . 0.0 109.419 168.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -128.45 2.58 6.6 Favored Glycine 0 C--N 1.334 0.429 0 O-C-N 120.637 -1.29 . . . . 0.0 111.632 -162.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -50.77 151.9 3.93 Favored Pre-proline 0 N--CA 1.438 -1.069 0 C-N-CA 124.79 1.236 . . . . 0.0 109.654 -173.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.7 -18.1 58.4 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 123.275 2.65 . . . . 0.0 112.285 -169.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -90.2 -25.07 20.81 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 126.924 2.09 . . . . 0.0 110.926 -168.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -49.59 -40.45 38.89 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.653 1.181 . . . . 0.0 111.922 -165.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.73 -27.08 1.8 Allowed 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 125.824 1.65 . . . . 0.0 114.472 -177.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.9 m -62.54 -41.0 90.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 119.716 1.144 . . . . 0.0 110.508 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.59 -14.27 61.16 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 67.6 mt -82.47 -15.33 52.9 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.794 0.838 . . . . 0.0 110.189 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -85.77 95.71 9.49 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 -178.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -63.27 -14.32 48.12 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.781 -0.574 . . . . 0.0 112.401 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 68.1 m -71.83 -27.54 62.97 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 120.548 -1.345 . . . . 0.0 112.937 167.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -83.15 2.79 33.73 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.477 1.111 . . . . 0.0 110.891 171.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.31 177.94 19.46 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 125.357 1.456 . . . . 0.0 110.787 173.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 36.9 tp -85.22 144.38 28.18 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.11 0.564 . . . . 0.0 111.308 -175.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -147.53 120.1 8.54 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.39 1.476 . . . . 0.0 109.131 161.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -134.7 150.93 50.66 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 119.008 0.822 . . . . 0.0 110.931 171.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -66.72 109.02 2.7 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 127.079 2.152 . . . . 0.0 110.191 -177.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.7 tpp85 -118.15 42.14 2.76 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.826 1.651 . . . . 0.0 108.464 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 113.5 175.0 19.09 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-O 122.874 1.263 . . . . 0.0 113.027 167.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -108.97 155.4 20.91 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.67 172.35 37.0 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.243 -0.98 . . . . 0.0 115.049 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.5 p -143.53 131.09 21.16 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 175.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 20.6 p -63.36 106.94 0.99 Allowed 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 173.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.45 -19.32 12.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.879 -177.105 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -65.79 116.71 7.27 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 155.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.26 132.62 34.09 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 117.641 -1.171 . . . . 0.0 107.915 160.159 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -135.59 156.49 77.58 Favored Pre-proline 0 N--CA 1.449 -0.5 0 CA-C-N 119.159 0.89 . . . . 0.0 108.683 178.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.467 ' HG2' ' HB2' ' A' ' 54' ' ' LEU . 60.1 Cg_endo -71.55 90.89 0.69 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.996 3.13 . . . . 0.0 110.228 164.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.54 HD11 ' HB2' ' A' ' 51' ' ' PRO . 45.0 tp -90.38 107.55 19.22 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 154.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.4 m -101.91 166.59 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 170.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.42 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -114.63 129.65 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 170.95 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.55 -170.93 3.41 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.99 0.916 . . . . 0.0 111.7 -176.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.45 -157.65 53.44 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 126.319 1.914 . . . . 0.0 112.336 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.03 -8.35 21.54 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.397 1.479 . . . . 0.0 114.198 -174.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 -127.26 19.6 6.91 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 123.885 0.874 . . . . 0.0 112.677 -170.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 42.8 m-20 55.75 66.6 1.17 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.235 1.814 . . . . 0.0 109.066 -171.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 68.0 mt -104.28 88.94 2.28 Favored Pre-proline 0 N--CA 1.465 0.292 0 C-N-CA 127.695 2.398 . . . . 0.0 106.55 -175.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.54 ' HB2' HD11 ' A' ' 42' ' ' LEU . 96.2 Cg_endo -66.44 150.28 84.33 Favored 'Trans proline' 0 N--CA 1.44 -1.653 0 CA-C-N 119.749 0.946 . . . . 0.0 112.501 174.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -128.81 118.94 23.61 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.63 102.34 3.27 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 165.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.467 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 2.9 mt -78.67 147.07 33.67 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 173.227 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -87.2 85.93 7.24 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 120.274 -1.516 . . . . 0.0 110.959 -173.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.2 86.8 11.06 Favored Pre-proline 0 N--CA 1.474 0.74 0 C-N-CA 123.72 0.808 . . . . 0.0 112.848 174.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -58.5 150.42 68.78 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 121.143 1.228 . . . . 0.0 110.395 174.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.81 -2.24 75.03 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 124.391 0.996 . . . . 0.0 113.91 174.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.27 127.8 32.55 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 120.122 1.961 . . . . 0.0 106.127 -174.119 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.76 -143.13 16.45 Favored Glycine 0 CA--C 1.522 0.527 0 CA-C-O 118.338 -1.257 . . . . 0.0 110.235 -168.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -141.35 170.38 15.84 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.051 1.425 . . . . 0.0 111.324 -177.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 7.1 m -72.31 106.59 4.52 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.161 1.384 . . . . 0.0 111.774 -174.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.6 t -77.73 101.36 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.761 0.824 . . . . 0.0 110.524 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.6 p -70.61 164.25 25.31 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 121.878 -0.514 . . . . 0.0 110.253 -177.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 176.59 -159.98 27.16 Favored Glycine 0 C--N 1.343 0.93 0 CA-C-N 119.392 0.996 . . . . 0.0 112.481 -176.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -139.32 160.03 40.78 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 121.499 -1.001 . . . . 0.0 111.785 -176.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 75.8 mt -114.09 124.41 70.71 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -173.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -113.87 119.93 38.97 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 173.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -57.09 114.13 2.0 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 154.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.9 m -115.37 155.35 16.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 173.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.73 173.23 10.23 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 122.011 0.91 . . . . 0.0 109.593 170.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.47 -49.85 60.98 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 125.72 1.608 . . . . 0.0 110.153 170.213 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -56.79 -39.25 73.78 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 118.922 -0.561 . . . . 0.0 111.679 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 44.2 tpp -72.35 -48.72 39.64 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 118.799 0.727 . . . . 0.0 109.693 179.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.28 -13.58 39.9 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.063 -1.023 . . . . 0.0 113.156 177.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 89.1 mtt-85 -86.34 -57.23 3.09 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 125.328 1.451 . . . . 0.0 110.467 168.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -53.48 -44.89 69.35 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.523 1.129 . . . . 0.0 112.272 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 90.5 mt -65.84 -27.93 68.6 Favored 'General case' 0 N--CA 1.461 0.113 0 O-C-N 121.347 -0.846 . . . . 0.0 110.526 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.472 ' HA ' ' SG ' ' A' ' 84' ' ' CYS . 1.8 t70 -76.64 10.12 2.36 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.099 1.76 . . . . 0.0 111.184 176.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -126.54 -4.77 6.54 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.516 2.326 . . . . 0.0 110.433 167.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.99 -49.05 7.3 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 104.25 -2.5 . . . . 0.0 104.25 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -74.78 0.79 14.21 Favored 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 124.884 1.274 . . . . 0.0 111.683 -173.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 57.77 19.28 5.48 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.814 1.646 . . . . 0.0 113.192 -176.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.472 ' SG ' ' HA ' ' A' ' 79' ' ' ASP . 1.1 p -57.86 157.6 14.81 Favored Pre-proline 0 CA--C 1.546 0.807 0 O-C-N 119.337 -2.102 . . . . 0.0 109.885 167.314 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -72.23 -4.51 12.99 Favored 'Cis proline' 0 CA--C 1.543 0.974 0 CA-C-N 119.732 0.94 . . . . 0.0 113.857 -6.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.3 m -59.51 -62.3 1.98 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 120.237 1.38 . . . . 0.0 111.776 -178.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 43.2 mtp -75.39 -58.86 3.03 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 122.326 0.251 . . . . 0.0 110.385 -175.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -119.2 174.71 6.17 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 126.285 1.834 . . . . 0.0 109.096 -176.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -127.4 -14.32 5.33 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 115.702 1.741 . . . . 0.0 115.702 -174.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? 62.08 125.12 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 128.641 2.776 . . . . 0.0 114.064 -174.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.6 m -134.67 167.39 20.92 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -174.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -106.91 123.98 48.95 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.155 1.782 . . . . 0.0 108.786 172.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -126.43 -164.51 1.34 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.083 1.753 . . . . 0.0 112.488 -166.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -132.43 134.24 44.85 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 120.363 1.438 . . . . 0.0 113.195 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.624 HG13 HG22 ' A' ' 110' ' ' VAL . 1.5 p -155.3 117.57 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 118.115 2.635 . . . . 0.0 118.115 -166.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -57.53 132.55 53.51 Favored 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 125.294 1.438 . . . . 0.0 109.263 -173.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 84.8 t -70.4 101.86 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 105.423 -2.065 . . . . 0.0 105.423 163.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.37 -34.35 67.89 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 167.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -163.9 149.44 10.91 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.818 2.047 . . . . 0.0 106.134 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 70.2 t-105 -124.93 132.57 53.27 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 125.555 1.542 . . . . 0.0 107.012 173.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -122.47 103.48 8.75 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.87 -174.01 15.64 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 125.28 1.419 . . . . 0.0 112.394 176.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -50.63 156.84 0.85 Allowed 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 126.03 1.732 . . . . 0.0 114.298 170.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.86 65.61 1.39 Allowed Glycine 0 N--CA 1.436 -1.363 0 N-CA-C 108.886 -1.686 . . . . 0.0 108.886 149.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -102.36 89.09 1.56 Allowed Pre-proline 0 CA--C 1.538 0.506 1 C-N-CA 133.301 4.641 . . . . 0.0 108.928 -155.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.468 ' CG ' HG12 ' A' ' 110' ' ' VAL . 87.2 Cg_endo -71.81 -16.12 29.71 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 124.332 3.354 . . . . 0.0 116.14 -168.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 107.16 -167.49 13.76 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 120.541 1.518 . . . . 0.0 110.837 -165.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -68.93 -17.42 63.95 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -161.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.3 p -150.28 157.18 42.79 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 121.946 2.157 . . . . 0.0 109.176 -177.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.624 HG22 HG13 ' A' ' 95' ' ' VAL . 4.2 m -128.03 157.38 40.21 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.968 0 C-N-CA 115.795 -2.362 . . . . 0.0 109.272 -167.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -98.76 82.82 2.85 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 164.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 9.2 m -75.22 166.23 23.96 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 114.485 -1.234 . . . . 0.0 107.785 163.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -82.96 137.33 34.22 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 155.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.401 HG13 ' CE1' ' A' ' 7' ' ' TYR . 22.8 t -131.96 127.56 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 127.373 2.269 . . . . 0.0 107.852 174.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -63.69 118.52 8.38 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 170.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 36.0 p -130.85 179.56 5.91 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.551 1.141 . . . . 0.0 108.554 170.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.7 t -130.41 155.25 46.72 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 124.96 1.304 . . . . 0.0 107.801 170.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -120.09 -6.22 9.97 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 127.776 2.43 . . . . 0.0 111.743 175.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.5 t -130.98 69.57 1.47 Allowed 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -174.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.64 9.14 42.45 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.751 1.22 . . . . 0.0 113.703 -170.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.405 ' HB1' ' HD2' ' A' ' 122' ' ' PRO . . . 67.84 161.88 0.14 Allowed Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 127.302 2.241 . . . . 0.0 111.858 -177.079 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.405 ' HD2' ' HB1' ' A' ' 121' ' ' ALA . 21.4 Cg_endo -66.97 -32.83 34.36 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 121.456 1.437 . . . . 0.0 113.998 -171.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -61.05 -38.66 86.98 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.568 1.147 . . . . 0.0 112.93 -173.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 46.0 m0 -75.22 -10.07 59.13 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 122.067 -0.396 . . . . 0.0 110.895 -169.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.75 -11.9 60.54 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.22 1.008 . . . . 0.0 111.996 173.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -109.92 -8.81 14.81 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.641 0.776 . . . . 0.0 112.081 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.5 mt -73.09 152.27 90.56 Favored Pre-proline 0 C--O 1.24 0.572 0 O-C-N 121.784 -0.572 . . . . 0.0 109.711 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.75 159.8 38.28 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.89 2.393 . . . . 0.0 110.787 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -102.9 172.79 6.62 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.86 0.864 . . . . 0.0 111.877 -176.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.514 ' CE1' HD11 ' A' ' 141' ' ' LEU . 92.0 m-70 -132.35 170.87 14.47 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 126.894 2.077 . . . . 0.0 108.785 -177.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -111.77 -14.9 13.51 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.808 0.843 . . . . 0.0 111.334 174.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 58.6 m -155.31 169.68 23.64 Favored 'General case' 0 C--O 1.233 0.237 0 O-C-N 120.404 -1.435 . . . . 0.0 110.053 170.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -104.0 -160.45 0.77 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 128.165 2.586 . . . . 0.0 106.797 158.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 23.9 t0 78.95 134.19 0.06 Allowed 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 129.492 3.117 . . . . 0.0 112.183 -171.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.8 -31.38 26.99 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.999 1.32 . . . . 0.0 110.974 173.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -67.61 -15.84 63.86 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.594 0.758 . . . . 0.0 112.844 176.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -77.64 155.92 43.84 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.885 1.231 . . . . 0.0 111.364 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.56 -19.18 32.62 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.771 2.314 . . . . 0.0 113.152 -172.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 43.4 m-70 -71.45 83.83 0.81 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.986 2.114 . . . . 0.0 109.429 -173.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -61.06 68.75 0.01 OUTLIER Glycine 0 CA--C 1.528 0.891 0 C-N-CA 128.527 2.965 . . . . 0.0 113.735 -177.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.514 HD11 ' CE1' ' A' ' 130' ' ' HIS . 0.4 OUTLIER -178.1 57.97 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 130.973 3.709 . . . . 0.0 106.21 179.363 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -90.21 -168.0 2.0 Allowed 'General case' 0 N--CA 1.463 0.188 0 O-C-N 120.933 -1.104 . . . . 0.0 108.234 -176.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -60.32 136.72 58.12 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.585 1.084 . . . . 0.0 108.208 -176.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 . . . . . 0 N--CA 1.453 -0.311 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 -178.495 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.209 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -99.78 138.76 36.41 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 122.953 0.501 . . . . 0.0 110.463 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.4 pt -132.92 174.1 13.81 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 CA-C-O 122.001 0.905 . . . . 0.0 109.38 167.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -131.35 133.44 45.3 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.349 1.46 . . . . 0.0 108.257 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.422 HG21 ' HB2' ' A' ' 11' ' ' LYS . 13.2 m -70.0 119.35 15.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-O 122.024 0.916 . . . . 0.0 109.582 -178.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -54.12 -40.55 67.46 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.393 1.477 . . . . 0.0 111.755 172.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 164.12 -44.19 0.31 Allowed Glycine 0 CA--C 1.526 0.757 0 CA-C-O 122.949 1.305 . . . . 0.0 110.583 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.58 -11.8 3.39 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.715 2.406 . . . . 0.0 115.74 -173.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -134.95 31.1 3.31 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 124.763 1.225 . . . . 0.0 110.638 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.422 ' HB2' HG21 ' A' ' 6' ' ' VAL . 13.7 tmtt? -117.91 -85.48 0.64 Allowed 'General case' 0 C--O 1.224 -0.239 0 CA-C-O 117.359 -1.305 . . . . 0.0 107.989 170.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.8 mmm180 -45.3 -84.12 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.446 1.498 . . . . 0.0 113.345 -171.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -167.06 15.58 0.08 OUTLIER Glycine 0 CA--C 1.53 0.997 0 C-N-CA 123.588 0.613 . . . . 0.0 112.229 -175.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.565 HE22 ' HA ' ' A' ' 134' ' ' ASP . 9.2 mp0 -51.95 155.44 3.13 Favored Pre-proline 0 C--O 1.233 0.231 0 C-N-CA 125.406 1.482 . . . . 0.0 110.809 177.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -64.76 -3.88 7.61 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 124.171 3.247 . . . . 0.0 113.795 -172.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.661 ' O ' HG22 ' A' ' 19' ' ' VAL . 4.2 m-80 -110.4 -9.5 14.61 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-O 116.365 -1.779 . . . . 0.0 111.221 -167.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -53.76 -46.63 71.0 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 121.982 2.173 . . . . 0.0 109.725 -172.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.874 ' HA ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -50.55 -19.34 0.87 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.903 1.681 . . . . 0.0 115.403 175.9 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.661 HG22 ' O ' ' A' ' 16' ' ' ASN . 30.9 m -63.48 -24.11 35.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 121.525 1.966 . . . . 0.0 111.566 176.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.703 ' HG3' HD12 ' A' ' 21' ' ' LEU . 4.1 ptp -89.4 -0.12 57.25 Favored 'General case' 0 C--N 1.345 0.376 0 CA-C-N 120.183 1.356 . . . . 0.0 110.836 -179.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.874 HD13 ' HA ' ' A' ' 18' ' ' LYS . 8.3 mp -96.13 9.29 41.37 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.868 2.067 . . . . 0.0 109.909 -169.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -129.95 110.16 11.46 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 119.119 0.872 . . . . 0.0 108.887 -178.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -58.51 -22.91 56.69 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -175.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.6 m -75.53 -26.04 57.7 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.437 -0.789 . . . . 0.0 112.845 173.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 49.0 m170 -69.63 -49.46 53.66 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 161.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 158.04 179.85 33.22 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-O 122.332 0.962 . . . . 0.0 111.863 172.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 28.9 tp -81.57 138.17 35.43 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.64 1.176 . . . . 0.0 111.303 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -149.77 120.95 7.78 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.225 1.01 . . . . 0.0 109.634 163.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.32 125.43 47.01 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 124.415 1.086 . . . . 0.0 109.864 -178.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -62.66 93.25 0.05 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 126.382 1.873 . . . . 0.0 110.588 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -95.55 61.12 2.27 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.212 1.005 . . . . 0.0 108.463 176.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.85 -160.53 51.69 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-O 122.656 1.142 . . . . 0.0 110.946 174.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.406 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 57.9 mtm180 -128.83 167.91 16.65 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 121.628 -0.924 . . . . 0.0 110.82 -161.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.484 ' HA2' ' H ' ' A' ' 98' ' ' LEU . . . -177.43 175.47 47.61 Favored Glycine 0 C--N 1.336 0.556 0 O-C-N 121.348 -0.845 . . . . 0.0 114.01 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.1 p -142.89 156.86 44.99 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.965 1.306 . . . . 0.0 109.261 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 44.0 p -69.25 119.1 13.0 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 169.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.9 t -70.6 -44.18 77.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 173.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -58.25 123.27 15.48 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 126.142 1.777 . . . . 0.0 108.329 163.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.1 m -60.01 148.7 34.55 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 162.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -141.98 153.25 63.72 Favored Pre-proline 0 CA--C 1.541 0.61 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 165.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.487 ' HA ' ' HA3' ' A' ' 60' ' ' GLY . 45.2 Cg_endo -79.23 82.74 2.42 Favored 'Trans proline' 0 C--O 1.237 0.474 1 C-N-CA 125.58 4.187 . . . . 0.0 112.583 -178.799 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.98 122.99 26.27 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 1.053 HG11 HD13 ' A' ' 127' ' ' LEU . 0.1 OUTLIER -134.39 144.7 34.39 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 C-N-CA 123.2 0.6 . . . . 0.0 110.838 174.926 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.0 mt -88.7 76.34 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 126.226 1.811 . . . . 0.0 106.882 168.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.75 -172.96 3.58 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 168.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.81 142.12 4.98 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.502 1.049 . . . . 0.0 112.187 165.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -76.69 2.27 14.7 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.182 -1.187 . . . . 0.0 112.861 -173.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 29.1 m-70 -120.26 17.75 12.28 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.094 1.358 . . . . 0.0 111.41 169.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 52.53 70.12 0.61 Allowed 'General case' 0 C--N 1.341 0.202 0 C-N-CA 126.166 1.787 . . . . 0.0 108.736 -174.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 72.9 mt -104.98 86.57 1.55 Allowed Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 102.751 -3.055 . . . . 0.0 102.751 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 37.3 Cg_endo -66.64 144.47 72.38 Favored 'Trans proline' 0 N--CA 1.443 -1.473 0 CA-C-N 121.037 1.406 . . . . 0.0 110.762 175.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 72.3 m95 -112.43 -169.79 1.54 Allowed 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.939 1.296 . . . . 0.0 109.84 -175.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.2 tp -144.32 92.08 2.27 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 168.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.424 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 3.7 mt -71.78 122.21 20.29 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 -177.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -69.93 89.3 0.59 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.105 0.866 . . . . 0.0 110.561 -177.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.06 77.98 54.5 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 124.808 1.243 . . . . 0.0 108.357 176.056 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.16 121.28 9.4 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.451 2.101 . . . . 0.0 110.618 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.09 -1.38 51.15 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 126.444 1.973 . . . . 0.0 114.121 175.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -109.11 169.49 8.65 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 119.836 1.818 . . . . 0.0 109.835 172.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.487 ' HA3' ' HA ' ' A' ' 41' ' ' PRO . . . 88.69 -8.06 80.3 Favored Glycine 0 CA--C 1.533 1.165 0 N-CA-C 117.56 1.784 . . . . 0.0 117.56 155.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 75.54 167.39 0.28 Allowed 'General case' 0 C--N 1.322 -0.615 1 C-N-CA 134.818 5.247 . . . . 0.0 111.337 -172.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 76.3 m -69.09 170.81 9.27 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 120.988 -1.07 . . . . 0.0 110.607 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 43.0 t -134.78 104.32 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.9 p -72.46 155.79 39.73 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.62 -0.675 . . . . 0.0 109.706 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.56 -155.55 11.44 Favored Glycine 0 C--N 1.337 0.616 0 O-C-N 120.762 -1.211 . . . . 0.0 110.865 -175.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 43.0 mt-10 -144.07 171.22 14.57 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 127.694 2.397 . . . . 0.0 107.786 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 81.8 mt -118.16 139.75 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 120.593 1.542 . . . . 0.0 109.379 -171.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -134.42 125.43 27.48 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.732 0.777 . . . . 0.0 110.082 176.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -72.42 132.94 44.57 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 161.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.6 m -135.38 164.7 32.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 123.755 0.822 . . . . 0.0 110.025 -177.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -115.85 176.14 5.22 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 176.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.33 -37.53 80.93 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 118.99 -0.529 . . . . 0.0 110.121 -168.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 36.0 tp60 -57.82 -40.88 81.03 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.829 0.851 . . . . 0.0 112.152 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.451 ' HE1' ' HA ' ' A' ' 20' ' ' MET . 24.4 tpp -69.02 -48.82 62.04 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.5 tp -58.77 -32.85 69.67 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.1 mtt180 -74.64 -33.98 62.65 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.171 -0.956 . . . . 0.0 112.174 177.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -75.95 -49.11 18.67 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.532 0.733 . . . . 0.0 110.121 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.6 mp -55.89 -41.43 74.46 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -177.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -44.87 -47.83 11.13 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.973 1.709 . . . . 0.0 111.234 174.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -71.47 -40.04 70.52 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.068 0.947 . . . . 0.0 111.911 176.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -65.45 -33.19 75.35 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.685 1.194 . . . . 0.0 110.534 -170.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -101.41 20.06 16.65 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 124.72 1.208 . . . . 0.0 113.291 174.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.1 t70 54.04 17.16 1.31 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.314 1.446 . . . . 0.0 112.776 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 16.2 t -61.99 145.38 92.99 Favored Pre-proline 0 N--CA 1.447 -0.58 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 177.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -80.69 -2.53 43.13 Favored 'Cis proline' 0 CA--C 1.54 0.815 0 N-CA-C 116.15 1.558 . . . . 0.0 116.15 0.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.4 m -63.4 -61.34 2.41 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 120.042 1.292 . . . . 0.0 112.572 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 12.3 mtp -83.12 -76.02 0.29 Allowed 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -177.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -85.34 169.83 13.34 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 176.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -146.18 126.6 14.05 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.858 1.663 . . . . 0.0 106.547 176.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -67.2 131.62 46.15 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.353 1.061 . . . . 0.0 110.048 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.7 m -128.82 177.1 7.32 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.604 1.962 . . . . 0.0 107.681 174.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -116.5 146.24 42.73 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.379 1.471 . . . . 0.0 110.053 167.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.34 178.76 7.36 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.556 1.942 . . . . 0.0 111.771 175.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 37.2 tp60 -109.73 115.89 30.69 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.933 1.693 . . . . 0.0 110.683 -178.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 70.5 t -108.99 145.74 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.57 1.148 . . . . 0.0 108.487 -177.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -85.4 142.74 29.06 Favored 'General case' 0 C--N 1.341 0.206 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 169.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.593 ' CG1' ' HA ' ' A' ' 108' ' ' ASP . 1.9 p -89.82 103.08 13.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 124.978 1.311 . . . . 0.0 109.029 172.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.484 ' H ' ' HA2' ' A' ' 34' ' ' GLY . 0.3 OUTLIER -72.69 -22.0 60.97 Favored 'General case' 0 C--N 1.331 -0.206 0 O-C-N 120.708 -1.245 . . . . 0.0 111.537 172.281 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -160.17 153.39 21.94 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 119.99 1.268 . . . . 0.0 108.437 177.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 48.5 t-105 -136.85 120.84 17.64 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.296 0.638 . . . . 0.0 109.713 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -108.24 99.56 8.96 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 125.269 1.427 . . . . 0.0 110.995 -177.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.69 -173.32 19.26 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 124.432 1.015 . . . . 0.0 110.936 174.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -67.06 171.12 5.87 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.104 0.562 . . . . 0.0 110.832 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.47 57.48 1.75 Allowed Glycine 0 C--O 1.22 -0.743 0 C-N-CA 125.154 1.359 . . . . 0.0 112.179 174.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -100.6 89.65 1.25 Allowed Pre-proline 0 N--CA 1.471 0.598 0 C-N-CA 126.984 2.114 . . . . 0.0 109.272 -167.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -57.93 -27.25 78.13 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.493 2.796 . . . . 0.0 113.514 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 126.3 -176.52 17.5 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 -161.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.593 ' HA ' ' CG1' ' A' ' 97' ' ' VAL . 36.7 t70 -81.44 4.92 19.25 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -173.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.8 p -137.33 156.23 48.48 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 118.802 -1.159 . . . . 0.0 110.783 156.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.2 p -130.92 152.74 38.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 124.305 1.042 . . . . 0.0 111.021 173.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -86.72 128.27 35.01 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.535 1.534 . . . . 0.0 108.216 170.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -137.06 167.95 20.54 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 127.158 2.183 . . . . 0.0 110.596 178.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -102.42 142.36 33.75 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 173.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 40.4 t -138.08 144.63 30.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 177.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -78.17 125.82 29.9 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 173.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 71.7 p -120.39 -173.96 2.69 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.965 1.306 . . . . 0.0 107.87 177.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.8 t -145.86 139.2 26.15 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 162.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -105.36 -8.25 18.31 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.439 0.695 . . . . 0.0 110.729 174.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 44.2 p -86.49 14.57 6.58 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.025 1.33 . . . . 0.0 113.251 -166.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -57.44 134.76 56.33 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.137 1.375 . . . . 0.0 113.343 -162.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.16 147.13 98.76 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.27 172.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.5 -27.28 46.56 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 121.753 1.635 . . . . 0.0 113.15 -174.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -50.57 -35.28 29.19 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.339 1.056 . . . . 0.0 111.141 171.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 0.617 ' O ' HD11 ' A' ' 127' ' ' LEU . 35.8 m0 -82.66 12.73 4.36 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.542 0.61 . . . . 0.0 111.948 -173.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -91.19 -26.09 19.22 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 120.403 1.456 . . . . 0.0 111.506 163.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -89.16 -25.72 21.67 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 120.123 1.329 . . . . 0.0 112.297 -169.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 1.053 HD13 HG11 ' A' ' 43' ' ' VAL 0.459 0.2 OUTLIER -45.43 161.39 0.24 Allowed Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 126.666 1.987 . . . . 0.0 115.178 173.058 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -90.39 142.45 3.58 Favored 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 124.171 3.248 . . . . 0.0 108.557 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.45 ' CD2' ' HA2' ' A' ' 60' ' ' GLY . 9.3 m-30 -98.16 -177.96 3.9 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 124.198 0.999 . . . . 0.0 109.241 -169.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 66.7 m80 -136.52 -178.69 5.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.608 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -134.24 -15.32 2.24 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 122.96 1.362 . . . . 0.0 111.908 170.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 29.7 p -144.96 153.2 41.27 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 161.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -92.03 157.45 16.77 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 167.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.565 ' HA ' HE22 ' A' ' 14' ' ' GLN . 42.8 t0 -170.41 139.15 1.63 Allowed 'General case' 0 C--O 1.241 0.607 0 CA-C-N 119.74 1.155 . . . . 0.0 108.989 166.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 66.6 m -81.18 -19.26 43.73 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.245 -0.91 . . . . 0.0 111.164 170.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -88.61 -11.77 44.5 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 120.374 1.443 . . . . 0.0 111.606 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.99 163.49 20.31 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.714 1.149 . . . . 0.0 112.019 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -71.82 -1.35 9.77 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 124.136 3.224 . . . . 0.0 113.637 -176.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -51.38 -29.79 16.78 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 126.425 1.89 . . . . 0.0 115.006 -169.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 74.35 -26.17 1.06 Allowed Glycine 0 CA--C 1.528 0.869 0 CA-C-O 118.458 -1.19 . . . . 0.0 112.963 -177.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.71 120.74 38.65 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 126.162 1.785 . . . . 0.0 109.206 167.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -136.23 162.54 32.68 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 126.475 1.91 . . . . 0.0 109.511 178.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -62.4 119.09 8.44 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 . . . . . 0 N--CA 1.452 -0.336 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -171.053 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.834 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -65.98 123.68 20.5 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -176.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.446 HG22 ' HB2' ' A' ' 113' ' ' PHE . 18.5 pt -119.13 170.63 8.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 124.418 1.087 . . . . 0.0 108.609 173.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -135.99 141.78 44.44 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.572 HG12 ' H ' ' A' ' 66' ' ' GLU . 2.7 p -97.55 137.93 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -173.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -92.47 -46.63 7.55 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.488 1.515 . . . . 0.0 110.183 -178.15 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -159.09 6.6 0.14 Allowed Glycine 0 C--N 1.344 0.98 0 CA-C-O 116.909 -2.051 . . . . 0.0 117.821 -168.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.478 ' HA ' ' HG3' ' A' ' 14' ' ' GLN . 1.1 p -131.16 -16.7 3.13 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 120.961 2.38 . . . . 0.0 115.995 -161.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.9 mp -140.04 71.17 1.37 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 120.582 1.537 . . . . 0.0 107.915 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.44 -85.46 0.07 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 118.591 -0.719 . . . . 0.0 112.005 -176.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -64.04 -67.42 0.43 Allowed 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.607 1.094 . . . . 0.0 110.152 -177.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 166.21 88.56 0.07 OUTLIER Glycine 0 N--CA 1.429 -1.789 0 N-CA-C 105.607 -2.997 . . . . 0.0 105.607 172.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.478 ' HG3' ' HA ' ' A' ' 9' ' ' THR . 0.3 OUTLIER -129.41 165.34 33.41 Favored Pre-proline 0 N--CA 1.443 -0.79 0 CA-C-O 117.578 -1.201 . . . . 0.0 108.485 -176.321 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -81.66 61.77 8.07 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.04 1.827 . . . . 0.0 113.973 -159.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.517 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -175.21 -5.75 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 129.264 3.026 . . . . 0.0 110.65 -178.061 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 18.5 t-160 -65.8 -46.15 79.75 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 121.839 2.109 . . . . 0.0 110.598 -177.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.407 ' HA ' HD12 ' A' ' 21' ' ' LEU . 0.6 OUTLIER -53.17 -27.35 20.99 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -172.465 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 16' ' ' ASN . 21.1 m -52.69 -42.79 42.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 119.383 0.992 . . . . 0.0 111.467 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.6 ptp -82.44 8.38 11.69 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 120.935 -1.103 . . . . 0.0 112.79 -174.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 18' ' ' LYS . 20.7 mt -118.75 1.63 11.6 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.645 1.578 . . . . 0.0 110.666 -172.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -125.39 4.98 7.68 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.432 1.493 . . . . 0.0 114.264 -171.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . 0.271 9.5 t-80 42.17 26.45 0.06 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.877 2.471 . . . . 0.0 114.753 177.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.23 -32.51 10.48 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.36 1.064 . . . . 0.0 110.357 175.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -80.05 -35.34 37.3 Favored 'General case' 0 N--CA 1.456 -0.16 0 O-C-N 121.102 -0.999 . . . . 0.0 110.094 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 159.49 -174.56 36.38 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 -175.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -98.65 131.66 44.66 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.277 1.031 . . . . 0.0 109.116 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -132.85 156.87 46.37 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.499 1.52 . . . . 0.0 109.276 159.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -141.02 139.15 34.1 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 168.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -61.38 104.54 0.41 Allowed 'General case' 0 C--O 1.233 0.23 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 169.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.2 tpp180 -114.33 65.23 0.67 Allowed 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 -175.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.87 176.23 49.29 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-O 121.965 0.758 . . . . 0.0 111.814 -176.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -120.57 171.85 8.26 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.621 0.768 . . . . 0.0 109.69 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -177.96 178.85 48.53 Favored Glycine 0 C--N 1.333 0.403 0 O-C-N 121.086 -1.008 . . . . 0.0 114.346 -177.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.4 p -146.42 163.93 34.08 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.294 1.838 . . . . 0.0 108.527 172.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 49.9 p -86.91 103.69 15.54 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 168.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.414 HG22 ' H ' ' A' ' 37' ' ' VAL . 0.2 OUTLIER -63.75 -22.33 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 121.774 0.797 . . . . 0.0 111.636 171.935 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.68 116.44 6.24 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.764 0.792 . . . . 0.0 109.281 159.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.07 129.62 38.73 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.169 1.388 . . . . 0.0 108.219 164.097 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -138.96 158.35 69.92 Favored Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.15 81.74 2.37 Favored 'Trans proline' 0 N--CA 1.454 -0.85 1 C-N-CA 125.469 4.112 . . . . 0.0 109.165 172.201 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -80.37 110.94 16.3 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 162.381 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.4 m -127.88 127.92 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 118.818 0.736 . . . . 0.0 109.891 -173.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.5 mt -85.05 105.49 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 177.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.454 ' HB2' ' CD1' ' A' ' 127' ' ' LEU . . . -138.37 130.9 29.12 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 124.517 1.127 . . . . 0.0 109.464 -173.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.23 166.84 27.81 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-O 122.062 0.812 . . . . 0.0 112.629 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -93.28 -6.09 48.27 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 125.959 1.704 . . . . 0.0 113.569 -145.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -121.42 16.78 11.35 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.528 1.131 . . . . 0.0 110.811 177.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.2 m120 60.44 56.79 3.03 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.422 1.489 . . . . 0.0 109.183 175.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 61.0 mt -104.56 87.14 1.62 Allowed Pre-proline 0 C--N 1.322 -0.608 0 C-N-CA 130.128 3.371 . . . . 0.0 103.708 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -63.23 160.4 34.95 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 CA-C-N 120.721 1.293 . . . . 0.0 110.305 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 68.1 m95 -127.4 138.08 52.91 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.449 HD13 HG22 ' A' ' 116' ' ' THR . 0.0 OUTLIER -112.27 98.22 7.16 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 179.334 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.7 mt -80.54 147.79 30.66 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -172.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -83.39 81.31 8.77 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.02 -1.05 . . . . 0.0 109.75 -173.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.6 84.9 32.4 Favored Pre-proline 0 N--CA 1.467 0.424 0 C-N-CA 123.105 0.562 . . . . 0.0 110.03 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -63.46 136.17 53.4 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 121.468 1.445 . . . . 0.0 109.017 178.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.06 13.59 80.79 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 118.597 -1.113 . . . . 0.0 113.635 176.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -127.14 125.61 41.47 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 120.603 2.202 . . . . 0.0 106.538 172.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.28 -140.52 15.09 Favored Glycine 0 N--CA 1.463 0.471 0 CA-C-N 121.13 1.787 . . . . 0.0 111.974 -178.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 46.1 m-70 -133.89 160.99 35.99 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 117.715 0.758 . . . . 0.0 111.649 -166.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 63.2 m -72.45 117.21 13.83 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.166 1.387 . . . . 0.0 109.766 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 44.2 t -85.33 110.58 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.737 1.215 . . . . 0.0 108.671 -174.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 70.7 p -77.3 147.39 36.26 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.923 -1.111 . . . . 0.0 109.803 176.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.77 -150.35 6.25 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 -176.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.572 ' H ' HG12 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -148.49 160.97 42.54 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 126.102 1.761 . . . . 0.0 108.203 170.977 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 98.5 mt -102.25 134.16 43.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 -171.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -125.93 119.2 27.14 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.1 118.08 17.65 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 104.419 -2.437 . . . . 0.0 104.419 160.198 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.4 m -123.21 150.45 27.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 124.317 1.047 . . . . 0.0 108.72 -176.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -92.75 165.68 12.82 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 175.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -51.96 -29.99 22.91 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 126.595 1.958 . . . . 0.0 113.446 -174.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 12.0 tp60 -68.15 -42.44 80.08 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 122.244 -0.285 . . . . 0.0 110.701 178.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.2 ttm -71.78 -46.53 58.03 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 118.663 -0.684 . . . . 0.0 109.453 178.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.62 -26.04 67.74 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.39 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 36.6 mtm180 -73.84 -47.84 35.54 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 117.646 -1.169 . . . . 0.0 111.923 171.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -55.72 -47.45 76.85 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.607 1.094 . . . . 0.0 110.515 176.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.6 mp -61.45 -17.82 56.15 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.101 0.961 . . . . 0.0 113.122 176.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -84.5 -5.56 59.3 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.758 1.623 . . . . 0.0 111.972 176.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -125.25 -34.6 2.71 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.428 1.891 . . . . 0.0 111.028 -172.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -58.54 -46.88 85.89 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.582 1.553 . . . . 0.0 111.616 176.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -83.68 4.39 28.81 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 124.887 1.275 . . . . 0.0 112.367 -172.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.1 t0 44.98 25.51 0.16 Allowed 'General case' 0 C--O 1.24 0.554 0 C-N-CA 127.048 2.139 . . . . 0.0 115.497 -164.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 1.6 p -56.96 154.92 17.0 Favored Pre-proline 0 CA--C 1.545 0.776 0 O-C-N 119.592 -1.942 . . . . 0.0 108.56 158.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -74.15 -4.46 18.04 Favored 'Cis proline' 0 CA--C 1.544 0.978 0 N-CA-C 114.541 0.939 . . . . 0.0 114.541 -4.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 10.1 t -62.36 -68.84 0.29 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.506 1.048 . . . . 0.0 110.594 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 28.6 mtp -72.88 -64.57 0.94 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.854 0.862 . . . . 0.0 110.377 -171.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -105.01 176.84 5.03 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.031 0.932 . . . . 0.0 109.084 176.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -139.68 139.28 36.59 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 167.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -78.79 130.08 35.33 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.092 -1.005 . . . . 0.0 108.324 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 86.2 m -135.5 162.83 31.54 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -176.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -98.15 132.58 43.56 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.408 1.083 . . . . 0.0 108.466 173.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.54 HD21 HG23 ' A' ' 114' ' ' VAL . 2.4 pt? -149.42 -176.19 5.29 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.801 1.64 . . . . 0.0 111.892 -171.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 -105.09 135.36 46.58 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -175.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 84.8 t -134.68 128.77 51.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -69.61 121.42 17.08 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 104.188 -2.523 . . . . 0.0 104.188 163.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.49 ' CG1' ' HA ' ' A' ' 108' ' ' ASP . 14.8 p -63.02 119.47 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 156.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.1 -31.99 21.59 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 120.681 -1.262 . . . . 0.0 108.946 170.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -158.35 147.34 19.11 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 104.424 -2.436 . . . . 0.0 104.424 -175.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 66.2 t-105 -124.68 141.32 52.19 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -104.31 104.62 14.54 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.151 0.98 . . . . 0.0 108.687 173.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.28 -164.14 13.63 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-O 122.568 1.093 . . . . 0.0 114.162 165.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -78.36 161.04 27.47 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 114.509 -0.846 . . . . 0.0 109.325 177.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.86 64.38 1.68 Allowed Glycine 0 C--O 1.223 -0.59 0 C-N-CA 124.662 1.125 . . . . 0.0 110.866 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -102.0 89.25 1.52 Allowed Pre-proline 0 C--O 1.237 0.408 0 C-N-CA 129.98 3.312 . . . . 0.0 108.592 -166.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -66.18 -1.14 4.91 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 124.652 3.568 . . . . 0.0 114.495 -168.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.2 172.27 46.95 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-N 120.226 1.376 . . . . 0.0 110.062 -170.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.49 ' HA ' ' CG1' ' A' ' 97' ' ' VAL . 1.6 m-20 -70.91 -1.29 11.35 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -158.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 92.1 p -133.59 142.22 48.03 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 118.427 -1.309 . . . . 0.0 110.726 150.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.9 p -106.71 153.74 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 C-N-CA 125.806 1.642 . . . . 0.0 107.92 175.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 3.8 tm0? -89.8 112.4 23.71 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 161.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 48.4 m -102.9 175.96 5.31 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.854 0.862 . . . . 0.0 109.046 169.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.446 ' HB2' HG22 ' A' ' 4' ' ' ILE . 66.2 m-85 -93.81 144.67 25.21 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 156.104 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.54 HG23 HD21 ' A' ' 93' ' ' LEU . 25.0 t -136.05 150.3 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 127.656 2.382 . . . . 0.0 105.878 173.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -88.4 119.84 29.21 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 171.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.449 HG22 HD13 ' A' ' 53' ' ' LEU . 43.2 p -124.12 -169.19 1.92 Allowed 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.983 1.313 . . . . 0.0 108.533 -178.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.04 146.59 31.95 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 169.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -112.93 -9.0 13.66 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.882 1.673 . . . . 0.0 111.274 169.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 11.2 t -98.95 16.63 21.88 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.237 1.415 . . . . 0.0 112.418 -169.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -60.92 154.63 21.8 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 125.137 1.375 . . . . 0.0 113.344 -172.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.27 156.51 91.64 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 125.631 1.572 . . . . 0.0 110.088 171.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -70.14 -36.78 9.2 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 121.764 1.643 . . . . 0.0 112.584 177.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -52.3 -33.89 44.38 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 119.283 0.947 . . . . 0.0 112.693 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 38.6 m0 -74.59 -7.09 52.04 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.68 0.792 . . . . 0.0 112.054 -174.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 60.6 mt -78.69 -26.69 44.95 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 121.238 -0.913 . . . . 0.0 111.838 171.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -92.1 -16.09 26.85 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.347 0.659 . . . . 0.0 111.8 -175.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.454 ' CD1' ' HB2' ' A' ' 45' ' ' ALA . 48.4 mt -57.92 157.69 14.89 Favored Pre-proline 0 N--CA 1.465 0.293 0 C-N-CA 125.489 1.516 . . . . 0.0 111.787 -178.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -63.69 157.74 50.07 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.981 2.454 . . . . 0.0 110.113 172.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -111.49 158.95 18.55 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -139.05 148.4 43.31 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.398 0.279 . . . . 0.0 110.656 -177.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -87.13 -5.66 58.93 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.31 1.444 . . . . 0.0 112.175 176.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.6 t -167.69 170.88 10.6 Favored 'General case' 0 C--O 1.237 0.412 0 O-C-N 120.176 -1.577 . . . . 0.0 108.408 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -123.54 92.38 3.67 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 165.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -99.28 97.27 8.36 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 128.512 2.725 . . . . 0.0 108.486 -172.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 7.1 t -65.24 7.74 0.18 Allowed 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.622 -1.299 . . . . 0.0 113.575 177.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -127.57 13.33 6.99 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.453 1.501 . . . . 0.0 110.45 -167.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -96.13 179.83 35.3 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 125.963 1.744 . . . . 0.0 112.52 -176.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -75.91 -3.55 14.0 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 124.201 3.267 . . . . 0.0 112.754 172.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -64.87 -24.28 67.49 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.462 1.028 . . . . 0.0 113.512 -167.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 79.72 -39.4 2.18 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 125.227 1.394 . . . . 0.0 113.659 172.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.71 100.87 4.81 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.542 1.937 . . . . 0.0 110.133 168.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -122.26 162.85 20.69 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 125.525 1.53 . . . . 0.0 109.502 171.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -63.26 127.98 33.75 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -176.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 . . . . . 0 CA--C 1.533 0.307 0 C-N-CA 123.608 0.763 . . . . 0.0 109.171 -177.287 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.428 ' HA ' ' CE2' ' A' ' 113' ' ' PHE . . . . . . . . 0 CA--C 1.533 0.325 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 71.2 m80 69.95 121.67 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 128.082 2.553 . . . . 0.0 107.392 -157.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.6 pt -87.78 -179.43 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 167.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -129.59 140.84 51.09 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 165.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.4 p -106.1 118.05 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 -178.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -70.86 -63.77 1.03 Allowed 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 172.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.5 -21.23 0.11 Allowed Glycine 0 CA--C 1.526 0.747 0 O-C-N 120.933 -1.105 . . . . 0.0 114.449 -165.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.85 -28.52 22.83 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 -159.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.15 55.38 1.86 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 -174.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -160.03 -63.74 0.07 Allowed 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 124.459 1.103 . . . . 0.0 109.743 -173.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -72.31 -86.31 0.03 OUTLIER 'General case' 0 C--N 1.339 0.14 0 C-N-CA 123.975 0.91 . . . . 0.0 108.575 -168.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -161.16 17.79 0.19 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -62.55 148.27 90.94 Favored Pre-proline 0 C--O 1.238 0.49 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 173.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -64.54 -20.36 65.7 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 123.797 2.998 . . . . 0.0 112.922 -169.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.613 ' O ' HG22 ' A' ' 19' ' ' VAL . 47.0 m-80 -84.64 -16.13 43.04 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 117.919 -1.038 . . . . 0.0 112.649 -161.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -48.86 -34.39 12.49 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.134 0.974 . . . . 0.0 111.183 -173.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.66 -30.54 5.57 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 178.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.613 HG22 ' O ' ' A' ' 16' ' ' ASN . 5.5 m -62.37 -23.36 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 120.148 1.34 . . . . 0.0 112.293 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.24 -10.96 53.61 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 119.788 1.176 . . . . 0.0 111.634 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 21.7 mt -94.27 -38.96 10.76 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 -173.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -75.24 83.77 2.4 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 176.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -49.15 -26.76 3.0 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.002 1.721 . . . . 0.0 114.246 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.52 -36.01 63.78 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.459 1.504 . . . . 0.0 111.379 173.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 45.5 m170 -68.51 -47.35 67.2 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.255 1.022 . . . . 0.0 109.439 171.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 167.19 178.12 39.29 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 174.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 64.4 tp -84.3 139.21 32.46 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 122.218 -0.578 . . . . 0.0 111.457 -176.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -142.29 157.95 44.26 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.018 1.327 . . . . 0.0 109.299 160.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -169.43 147.57 3.65 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 131.46 3.904 . . . . 0.0 108.258 178.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -72.61 106.75 4.77 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.797 1.639 . . . . 0.0 111.094 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.9 tpp180 -107.71 66.43 0.66 Allowed 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 177.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.47 -170.51 55.05 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-O 123.518 1.621 . . . . 0.0 113.266 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 77.8 mtm180 -122.52 165.37 16.52 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 125.064 1.345 . . . . 0.0 110.042 -171.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -168.82 177.57 42.6 Favored Glycine 0 C--N 1.334 0.45 0 O-C-N 121.583 -0.698 . . . . 0.0 112.994 173.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 30.2 p -148.43 153.27 38.3 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.219 1.808 . . . . 0.0 107.696 178.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.1 p -82.18 111.16 18.03 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 121.453 1.933 . . . . 0.0 107.154 173.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -76.02 -29.72 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 O-C-N 121.945 -0.472 . . . . 0.0 111.009 170.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -60.72 113.82 2.68 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 154.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 29.2 m -66.09 144.11 56.9 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 168.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.638 ' HB3' HD21 ' A' ' 53' ' ' LEU . 24.3 m-85 -145.46 154.86 53.43 Favored Pre-proline 0 CA--C 1.547 0.853 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -173.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.446 ' HG2' ' HB2' ' A' ' 54' ' ' LEU . 82.0 Cg_endo -84.24 103.79 0.99 Allowed 'Trans proline' 0 CA--C 1.544 1.016 1 C-N-CA 126.224 4.616 . . . . 0.0 115.194 -172.433 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.417 ' HB2' ' HE1' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -105.87 103.23 12.68 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 120.489 -1.382 . . . . 0.0 107.721 179.814 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.1 m -124.97 127.83 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 127.007 2.123 . . . . 0.0 112.543 -174.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.423 HG21 HD12 ' A' ' 141' ' ' LEU . 9.0 mt -93.68 93.84 4.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -172.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.44 -179.54 4.52 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.906 1.282 . . . . 0.0 109.475 172.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.59 144.06 6.41 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.459 1.028 . . . . 0.0 111.914 164.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -72.35 -12.33 61.08 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -172.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 41.6 m-70 -106.4 13.81 28.09 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.325 1.05 . . . . 0.0 111.414 172.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.2 m120 58.32 73.6 0.47 Allowed 'General case' 0 C--N 1.341 0.227 0 C-N-CA 127.147 2.179 . . . . 0.0 108.83 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 64.1 mt -110.02 86.76 5.22 Favored Pre-proline 0 N--CA 1.449 -0.516 0 C-N-CA 125.112 1.365 . . . . 0.0 107.834 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -59.58 126.63 21.16 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.44 1.426 . . . . 0.0 111.879 171.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 67.2 m95 -104.81 126.21 51.66 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 128.239 2.615 . . . . 0.0 108.19 173.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.638 HD21 ' HB3' ' A' ' 40' ' ' PHE . 1.2 tm? -92.08 124.38 36.13 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 168.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.446 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 0.3 OUTLIER -95.47 149.13 21.75 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -179.809 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -76.55 89.99 3.31 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.81 82.91 19.85 Favored Pre-proline 0 N--CA 1.467 0.392 0 O-C-N 120.901 -1.125 . . . . 0.0 110.229 172.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -61.88 134.73 51.61 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 122.236 1.957 . . . . 0.0 109.568 -177.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.94 -1.31 84.97 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-O 117.027 -1.985 . . . . 0.0 114.337 175.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.5 tppt? -128.11 136.26 50.92 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 121.084 2.442 . . . . 0.0 107.243 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 120.51 -113.08 2.31 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 107.378 -2.289 . . . . 0.0 107.378 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.477 ' HB2' ' HG3' ' A' ' 131' ' ' GLU . 2.6 p80 -160.88 172.36 17.1 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.79 1.636 . . . . 0.0 108.785 173.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 41.9 m -73.61 103.27 4.15 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.187 0.995 . . . . 0.0 111.173 170.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.7 t -78.07 107.82 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.733 1.213 . . . . 0.0 111.281 177.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.9 p -65.66 153.46 41.59 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.201 0.6 . . . . 0.0 111.163 177.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -173.58 -157.55 15.53 Favored Glycine 0 C--N 1.343 0.938 0 O-C-N 121.286 -0.884 . . . . 0.0 112.941 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -145.0 167.0 23.7 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.838 1.655 . . . . 0.0 109.569 174.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 71.0 mt -113.69 126.8 71.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 -172.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -117.56 115.52 25.3 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -67.79 81.62 0.19 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.121 1.368 . . . . 0.0 109.049 169.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.2 m -82.6 155.7 3.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 O-C-N 121.047 -1.033 . . . . 0.0 109.088 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.11 -178.8 4.9 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 121.921 0.867 . . . . 0.0 111.544 175.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.86 -45.02 93.78 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.979 1.312 . . . . 0.0 111.452 174.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 42.4 tp60 -59.86 -41.51 91.62 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 119.297 0.953 . . . . 0.0 110.139 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 59.3 tpp -65.88 -51.8 55.64 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 118.596 0.634 . . . . 0.0 110.584 176.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.23 -26.13 66.17 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -76.68 -55.04 5.86 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 123.951 0.9 . . . . 0.0 109.732 171.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -52.68 -48.8 66.29 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.152 0.581 . . . . 0.0 111.255 -177.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 87.7 mt -62.39 -27.04 68.8 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 118.968 -0.539 . . . . 0.0 111.526 -178.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -67.39 -33.39 75.1 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.993 1.27 . . . . 0.0 109.587 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -75.9 -51.04 13.34 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.65 0.78 . . . . 0.0 110.701 172.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -66.17 -27.48 68.04 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.543 0.737 . . . . 0.0 112.572 -174.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.438 ' HG3' ' CE2' ' A' ' 115' ' ' TYR . 63.3 mm-40 -100.46 15.3 28.34 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.851 0.86 . . . . 0.0 111.093 177.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 52.23 28.09 5.29 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.458 1.903 . . . . 0.0 113.028 163.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 7.5 p -72.54 163.35 68.46 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.508 -1.37 . . . . 0.0 109.091 172.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -70.48 -4.01 9.07 Favored 'Cis proline' 0 CA--C 1.547 1.125 0 CA-C-N 119.99 1.032 . . . . 0.0 114.458 -10.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.1 m -60.1 -63.07 1.43 Allowed 'General case' 0 C--N 1.342 0.273 0 CA-C-N 119.561 1.073 . . . . 0.0 110.509 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 1.4 mtm -74.08 -77.69 0.11 Allowed 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.033 0.933 . . . . 0.0 109.683 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -97.83 -178.47 4.11 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.643 1.177 . . . . 0.0 108.934 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -138.13 -7.01 1.59 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 175.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? 61.28 134.22 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 128.459 2.704 . . . . 0.0 111.962 -173.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.9 m -152.73 153.76 33.86 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 120.463 -1.398 . . . . 0.0 110.501 174.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -84.62 126.93 33.78 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 129.137 2.975 . . . . 0.0 112.785 171.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.687 HD21 ' HB ' ' A' ' 114' ' ' VAL . 2.3 pt? -160.29 170.01 21.98 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 126.748 2.019 . . . . 0.0 112.182 -166.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 11.6 tp60 -94.5 131.35 40.3 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -162.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 35.5 t -135.3 119.79 27.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -177.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -67.48 143.16 56.35 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 168.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.597 ' CG1' ' HA ' ' A' ' 108' ' ' ASP . 2.4 p -90.79 126.13 43.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 176.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.53 -14.62 24.88 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 121.45 -0.782 . . . . 0.0 111.665 177.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -176.03 140.34 0.41 Allowed 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 103.582 -2.747 . . . . 0.0 103.582 -175.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 62.5 t-105 -125.47 139.34 53.71 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 171.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -109.44 114.26 27.76 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 123.848 0.718 . . . . 0.0 109.937 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.11 -165.02 42.9 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-O 121.65 0.583 . . . . 0.0 112.102 169.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -64.61 167.34 7.36 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.591 1.156 . . . . 0.0 111.481 -175.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.21 59.24 3.16 Favored Glycine 0 CA--C 1.525 0.688 0 O-C-N 121.931 -0.481 . . . . 0.0 112.267 173.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -101.71 89.15 1.4 Allowed Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 130.626 3.57 . . . . 0.0 110.656 -168.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -60.93 -14.47 32.94 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 124.081 3.187 . . . . 0.0 114.286 -171.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 95.07 176.19 37.84 Favored Glycine 0 CA--C 1.531 1.081 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -165.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.597 ' HA ' ' CG1' ' A' ' 97' ' ' VAL . 10.6 m-20 -69.82 0.91 4.95 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -162.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 61.8 p -137.74 146.66 43.94 Favored 'General case' 0 N--CA 1.427 -1.588 0 C-N-CA 117.124 -1.83 . . . . 0.0 111.725 150.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.1 p -110.27 159.68 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 114.29 -1.323 . . . . 0.0 109.059 173.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -89.37 112.96 24.2 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 156.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 14.1 m -99.89 171.48 7.83 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 165.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.428 ' CE2' ' HA ' ' A' ' 2' ' ' ALA . 19.6 m-85 -90.84 142.5 27.7 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 161.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.687 ' HB ' HD21 ' A' ' 93' ' ' LEU . 53.2 t -129.94 143.73 40.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 172.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.438 ' CE2' ' HG3' ' A' ' 82' ' ' GLU . 8.9 m-85 -70.53 95.78 1.11 Allowed 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 167.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 80.5 p -109.42 173.39 6.34 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.948 171.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.7 t -142.19 121.9 13.44 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 175.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -93.0 4.78 53.42 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.359 0.664 . . . . 0.0 111.476 -178.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 47.3 p -118.83 43.56 2.52 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.085 1.354 . . . . 0.0 107.875 -171.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.407 ' HB3' HD12 ' A' ' 54' ' ' LEU . 40.2 p90 -78.48 171.15 15.52 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.477 -174.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -101.87 151.11 37.91 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 123.839 0.856 . . . . 0.0 110.272 -177.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -66.08 -37.35 25.96 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.916 2.411 . . . . 0.0 110.93 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.94 -0.66 9.73 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.81 1.644 . . . . 0.0 113.172 175.223 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 44.8 m0 -98.95 -24.72 14.83 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 118.882 0.765 . . . . 0.0 109.491 168.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 12.2 mt -75.89 -30.56 58.86 Favored 'General case' 0 CA--C 1.523 -0.064 0 O-C-N 120.94 -1.1 . . . . 0.0 111.554 177.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -64.25 -24.99 67.86 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.987 0.812 . . . . 0.0 111.965 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.0 mt -64.91 150.99 94.15 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 124.78 1.232 . . . . 0.0 110.429 -172.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -65.52 156.79 61.75 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.932 2.421 . . . . 0.0 110.441 175.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -106.62 159.32 16.28 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.628 0.251 . . . . 0.0 110.497 -172.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -134.06 106.23 7.11 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.754 0.822 . . . . 0.0 111.948 -174.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.477 ' HG3' ' HB2' ' A' ' 61' ' ' HIS . 0.5 OUTLIER -58.33 -13.59 5.58 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.794 1.638 . . . . 0.0 114.173 -174.02 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 56.8 p -150.4 176.46 10.9 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.293 1.837 . . . . 0.0 107.071 173.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -129.16 166.19 19.82 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 168.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -158.11 164.63 36.45 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.218 1.807 . . . . 0.0 109.688 -175.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.3 t -109.32 -3.38 17.19 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.79 1.636 . . . . 0.0 111.061 167.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -140.14 102.72 4.44 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 128.642 2.777 . . . . 0.0 105.643 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -161.48 165.31 35.49 Favored Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 126.983 2.23 . . . . 0.0 111.836 -173.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.32 -18.78 55.87 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.286 2.657 . . . . 0.0 112.543 164.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -77.2 85.84 3.66 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 169.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.27 43.68 0.1 OUTLIER Glycine 0 CA--C 1.535 1.337 0 C-N-CA 127.749 2.595 . . . . 0.0 115.388 178.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.423 HD12 HG21 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -143.23 84.25 1.81 Allowed 'General case' 0 C--O 1.236 0.346 0 C-N-CA 127.316 2.246 . . . . 0.0 108.423 -172.271 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -120.72 155.0 34.84 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 118.193 -0.908 . . . . 0.0 109.727 -169.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -52.13 130.37 30.04 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 124.014 0.821 . . . . 0.0 109.329 -175.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.536 0.409 0 C-N-CA 123.268 0.627 . . . . 0.0 110.808 -169.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.313 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -81.48 124.0 29.08 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 174.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.8 pt -123.77 -176.02 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 123.785 0.834 . . . . 0.0 110.518 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.578 ' CE2' HG23 ' A' ' 36' ' ' THR . 20.4 t80 -124.14 169.43 11.71 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.035 1.334 . . . . 0.0 108.502 174.061 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.444 HG12 ' H ' ' A' ' 66' ' ' GLU . 7.6 p -122.95 153.54 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 123.837 0.855 . . . . 0.0 109.882 175.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.413 ' CD1' ' N ' ' A' ' 7' ' ' TYR . 0.3 OUTLIER -92.62 -41.11 10.38 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 -171.076 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.444 ' HA3' ' HB3' ' A' ' 133' ' ' TYR . . . 169.45 -19.01 0.07 OUTLIER Glycine 0 CA--C 1.528 0.858 0 C-N-CA 124.743 1.163 . . . . 0.0 113.372 172.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.47 -30.21 71.37 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 128.224 2.609 . . . . 0.0 113.735 -176.117 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.9 61.1 1.18 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 175.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -151.75 -85.82 0.07 Allowed 'General case' 0 C--O 1.224 -0.279 0 O-C-N 121.239 -0.913 . . . . 0.0 109.86 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 -62.0 -53.62 53.12 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.069 0.85 . . . . 0.0 111.591 -166.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 161.21 30.24 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 -175.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -63.35 155.8 72.89 Favored Pre-proline 0 N--CA 1.45 -0.433 0 C-N-CA 124.83 1.252 . . . . 0.0 108.401 171.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -65.37 -12.58 35.55 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.207 2.604 . . . . 0.0 112.593 -174.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -95.14 24.96 4.53 Favored 'General case' 0 C--O 1.221 -0.415 0 C-N-CA 126.643 1.977 . . . . 0.0 111.454 -175.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -75.89 -55.64 5.43 Favored 'General case' 0 C--N 1.332 -0.18 0 O-C-N 120.442 -1.411 . . . . 0.0 110.116 173.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.04 -24.09 23.11 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -169.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.9 m -60.17 -34.81 58.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 119.675 1.125 . . . . 0.0 112.141 178.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.1 ptp -77.18 -7.7 56.29 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 119.472 1.033 . . . . 0.0 112.76 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 40.5 mt -89.47 7.0 38.32 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.832 1.253 . . . . 0.0 108.974 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -110.23 98.3 7.58 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -59.38 -21.8 60.42 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.867 -0.521 . . . . 0.0 111.563 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.7 t -70.33 -29.19 65.84 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.873 1.269 . . . . 0.0 112.016 175.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 35.1 m170 -79.59 -32.44 41.93 Favored 'General case' 0 CA--C 1.529 0.147 0 O-C-N 121.351 -0.843 . . . . 0.0 109.739 168.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 158.15 175.67 29.34 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 165.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 65.0 tp -74.57 134.0 42.19 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 175.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.8 143.59 31.41 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 155.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -152.01 149.9 29.39 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 165.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -62.18 104.76 0.51 Allowed 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.973 1.709 . . . . 0.0 108.663 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.9 tpp180 -123.56 67.84 1.02 Allowed 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.15 -170.86 45.58 Favored Glycine 0 N--CA 1.435 -1.4 0 CA-C-O 123.824 1.791 . . . . 0.0 111.915 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -131.04 158.91 39.07 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 125.436 1.494 . . . . 0.0 108.257 -170.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.99 173.98 38.4 Favored Glycine 0 CA--C 1.507 -0.463 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.741 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.0 m -141.67 145.95 35.54 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 173.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.578 HG23 ' CE2' ' A' ' 5' ' ' PHE . 25.2 p -71.65 93.17 1.22 Allowed 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 163.017 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.9 m -63.41 -38.46 82.25 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.106 0 CA-C-O 121.206 0.527 . . . . 0.0 109.892 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.81 118.23 7.43 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 105.218 -2.141 . . . . 0.0 105.218 170.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.74 145.92 50.96 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -141.25 160.62 56.82 Favored Pre-proline 0 N--CA 1.449 -0.475 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 177.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -80.28 67.45 8.62 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 122.532 2.155 . . . . 0.0 113.987 -175.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 53' ' ' LEU . 34.0 tp -72.72 98.63 2.42 Favored 'General case' 0 CA--C 1.553 1.082 0 O-C-N 119.757 -1.839 . . . . 0.0 111.356 178.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.5 m -121.68 126.74 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 119.625 1.102 . . . . 0.0 112.763 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 51.1 mt -69.84 111.67 3.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 173.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -125.98 175.03 8.0 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.457 1.103 . . . . 0.0 108.782 176.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.01 152.74 7.91 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-O 122.61 1.117 . . . . 0.0 111.544 171.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -70.06 -23.41 63.08 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 123.526 0.731 . . . . 0.0 112.34 -176.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -94.44 13.27 24.36 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.429 0.692 . . . . 0.0 111.391 -177.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.567 HD22 ' HB2' ' A' ' 141' ' ' LEU . 2.1 m120 63.22 56.78 1.67 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.04 1.736 . . . . 0.0 107.592 171.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 80.5 mt -107.29 87.91 3.56 Favored Pre-proline 0 CA--C 1.533 0.288 0 C-N-CA 127.253 2.221 . . . . 0.0 107.476 -167.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -54.33 139.76 73.35 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 120.846 1.03 . . . . 0.0 111.652 169.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 6.2 m95 -123.3 146.29 48.02 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 167.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 42' ' ' LEU 0.295 0.9 OUTLIER -97.16 -8.86 29.07 Favored 'General case' 0 C--O 1.219 -0.529 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 -177.741 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 36.7 mt 44.1 -160.8 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.312 1 C-N-CA 134.825 5.25 . . . . 0.0 110.069 -172.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -130.95 91.43 3.05 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 120.848 -1.158 . . . . 0.0 110.225 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.57 85.72 5.22 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 118.968 -0.539 . . . . 0.0 111.616 168.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -59.75 134.41 57.24 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.754 1.636 . . . . 0.0 109.257 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.74 10.43 81.35 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-O 119.568 -0.573 . . . . 0.0 113.618 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? -123.03 155.03 37.68 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.779 1.79 . . . . 0.0 108.444 172.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.54 ' HA2' ' CD2' ' A' ' 129' ' ' TYR . . . 67.96 -146.39 46.39 Favored Glycine 0 C--N 1.334 0.458 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 -174.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -127.45 169.36 13.73 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 117.833 0.816 . . . . 0.0 108.849 -169.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 5.1 p -59.8 169.67 1.35 Allowed 'General case' 0 CA--C 1.512 -0.486 0 O-C-N 121.665 -0.647 . . . . 0.0 112.122 170.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 54.9 t -135.49 118.41 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.792 168.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 72.5 p -74.72 154.76 38.27 Favored 'General case' 0 C--O 1.239 0.512 0 O-C-N 121.756 -0.59 . . . . 0.0 110.237 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.59 -164.96 28.91 Favored Glycine 0 C--N 1.337 0.608 0 CA-C-O 122.202 0.89 . . . . 0.0 111.761 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.444 ' H ' HG12 ' A' ' 6' ' ' VAL . 0.5 OUTLIER -117.57 156.82 27.43 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 124.886 1.274 . . . . 0.0 108.662 179.206 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 73.2 mt -101.34 130.33 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 170.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -116.45 120.96 40.46 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -62.54 116.18 4.91 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 156.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.3 m -123.89 175.53 6.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 CA-C-N 118.429 0.559 . . . . 0.0 109.978 174.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -125.6 176.18 7.05 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.954 0.902 . . . . 0.0 109.208 169.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -53.13 -37.62 61.95 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.682 1.593 . . . . 0.0 112.204 -175.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 42.8 tp60 -61.15 -41.99 97.75 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 118.465 -0.778 . . . . 0.0 111.133 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -67.04 -44.74 79.44 Favored 'General case' 0 C--O 1.225 -0.232 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.2 tp -62.91 -29.53 70.85 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -176.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 62.3 mtt180 -74.69 -38.58 62.33 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 121.949 -0.47 . . . . 0.0 111.992 172.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -66.65 -48.74 68.47 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 119.23 -0.414 . . . . 0.0 110.228 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.8 mp -51.02 -50.32 58.78 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.353 1.461 . . . . 0.0 110.256 174.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -49.67 -43.6 47.31 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.712 0.805 . . . . 0.0 112.016 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -79.35 -13.74 59.44 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.57 2.348 . . . . 0.0 112.709 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -91.12 -42.99 10.16 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.355 1.462 . . . . 0.0 109.664 -175.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . 0.252 0.4 OUTLIER -90.03 9.46 27.92 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.75 1.22 . . . . 0.0 114.009 170.844 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 61.01 36.04 18.7 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.112 1.365 . . . . 0.0 111.105 167.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 6.5 m -79.03 166.53 41.49 Favored Pre-proline 0 C--N 1.323 -0.585 0 C-N-CA 125.061 1.344 . . . . 0.0 108.796 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -64.94 -3.42 2.81 Favored 'Cis proline' 0 CA--C 1.545 1.027 0 CA-C-N 120.082 1.065 . . . . 0.0 113.598 -17.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.76 -66.57 0.37 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.849 1.66 . . . . 0.0 111.193 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 19.4 mtm -83.33 -63.83 1.28 Allowed 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.83 -0.544 . . . . 0.0 110.362 -176.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -103.91 170.11 8.11 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -177.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -137.91 137.62 38.2 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 120.406 -1.434 . . . . 0.0 107.138 176.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.415 ' HB2' ' CE1' ' A' ' 115' ' ' TYR . 8.4 tmm_? -78.7 123.36 27.07 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 123.899 0.879 . . . . 0.0 108.984 -174.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.6 m -123.96 160.61 27.2 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 123.855 0.862 . . . . 0.0 108.884 -177.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -98.2 140.6 32.25 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 124.018 0.927 . . . . 0.0 109.212 169.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.502 HD11 HG23 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -152.15 169.17 23.08 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.963 0.905 . . . . 0.0 111.483 -177.81 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -95.81 119.86 35.05 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.83 1.652 . . . . 0.0 110.083 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 95.0 t -117.71 136.95 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 177.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -71.9 148.88 45.65 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 123.813 0.845 . . . . 0.0 111.244 172.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.0 t -87.97 95.07 4.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 125.305 1.442 . . . . 0.0 107.306 167.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.35 -24.94 50.64 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.454 1.101 . . . . 0.0 110.724 172.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -162.49 157.32 22.13 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 127.856 2.462 . . . . 0.0 105.096 173.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 75.1 t-105 -145.66 121.83 10.82 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 169.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -105.97 92.55 4.2 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.611 0.764 . . . . 0.0 109.864 176.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 135.66 -179.45 17.76 Favored Glycine 0 C--O 1.227 -0.343 0 C-N-CA 124.233 0.921 . . . . 0.0 112.687 168.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -68.12 155.69 39.06 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 171.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 102.21 56.09 0.84 Allowed Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 124.878 1.228 . . . . 0.0 111.059 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -100.11 91.02 1.5 Allowed Pre-proline 0 C--N 1.327 -0.399 0 C-N-CA 129.591 3.157 . . . . 0.0 106.516 -171.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.567 ' CG ' HG12 ' A' ' 110' ' ' VAL . 61.8 Cg_endo -66.84 -23.82 47.39 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 124.417 3.411 . . . . 0.0 112.362 -178.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 123.23 -172.66 16.12 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 -165.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.66 -6.6 26.91 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -170.166 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 67.8 p -151.76 157.91 42.62 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 119.072 0.851 . . . . 0.0 111.816 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.567 HG12 ' CG ' ' A' ' 106' ' ' PRO . 3.0 m -136.69 169.05 20.7 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 C-N-CA 125.071 1.348 . . . . 0.0 108.571 -171.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -108.65 93.13 4.36 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 177.185 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 95.3 m -79.19 176.97 9.18 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.379 0.609 . . . . 0.0 109.915 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -107.72 145.95 32.76 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 158.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.502 HG23 HD11 ' A' ' 93' ' ' LEU . 24.3 t -138.8 143.06 32.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 128.017 2.527 . . . . 0.0 106.44 174.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.415 ' CE1' ' HB2' ' A' ' 90' ' ' ARG . 16.3 m-85 -84.9 104.59 14.99 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 167.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 11.1 p -99.12 -171.49 2.1 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.48 1.912 . . . . 0.0 108.626 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.7 t -147.98 150.88 34.81 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 156.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -114.91 -12.48 12.05 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 128.215 2.606 . . . . 0.0 111.384 176.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 5.8 p -88.81 9.07 25.93 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.329 1.452 . . . . 0.0 113.807 -169.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.549 ' CE1' HD21 ' A' ' 125' ' ' LEU . 30.3 p90 -69.0 164.36 22.53 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.787 1.235 . . . . 0.0 112.72 -170.004 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -93.82 153.69 40.99 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 125.258 1.423 . . . . 0.0 110.324 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.6 ' HA ' HD23 ' A' ' 125' ' ' LEU . 36.8 Cg_endo -62.14 -27.29 78.64 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.587 2.858 . . . . 0.0 113.548 -174.195 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -49.77 -43.01 47.91 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.243 1.017 . . . . 0.0 112.113 176.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 42.2 m0 -70.55 -15.85 62.82 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 122.485 0.314 . . . . 0.0 111.339 -172.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.6 HD23 ' HA ' ' A' ' 122' ' ' PRO . 2.7 mm? -82.65 -10.96 58.7 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.059 0.944 . . . . 0.0 112.367 178.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -96.39 -16.02 21.48 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.685 0.794 . . . . 0.0 110.992 175.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 88.4 mt -68.42 155.85 91.7 Favored Pre-proline 0 N--CA 1.469 0.497 0 C-N-CA 124.149 0.979 . . . . 0.0 109.561 176.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -79.62 154.5 23.84 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 121.786 1.657 . . . . 0.0 110.497 173.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.54 ' CD2' ' HA2' ' A' ' 60' ' ' GLY . 44.5 m-85 -85.79 175.87 8.44 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 126.357 1.863 . . . . 0.0 111.108 177.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -142.7 161.11 38.95 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.625 1.97 . . . . 0.0 107.984 -178.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -110.02 -2.65 16.93 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 122.684 1.231 . . . . 0.0 112.544 -177.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.5 t -164.11 154.38 14.91 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.444 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . 7.9 t80 -108.98 116.59 32.28 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.194 167.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -143.51 125.11 14.9 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.576 2.35 . . . . 0.0 108.225 -168.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.2 p -68.64 -47.55 66.31 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 169.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -75.42 43.42 0.23 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.706 2.003 . . . . 0.0 110.61 170.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -110.73 163.03 12.35 Favored Glycine 0 C--N 1.332 0.327 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 166.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.11 -14.61 44.59 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.749 2.3 . . . . 0.0 113.122 -175.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 64.0 m-70 -62.79 -14.52 46.17 Favored 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 116.828 2.158 . . . . 0.0 116.828 -162.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 75.53 -29.85 1.23 Allowed Glycine 0 CA--C 1.537 1.409 0 CA-C-N 120.406 1.457 . . . . 0.0 115.295 172.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.567 ' HB2' HD22 ' A' ' 49' ' ' ASN . 0.3 OUTLIER -97.37 97.37 9.06 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 126.339 1.856 . . . . 0.0 110.949 179.325 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -104.58 162.55 13.16 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 120.865 -1.147 . . . . 0.0 109.872 -173.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -57.35 142.17 44.52 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 119.004 -0.522 . . . . 0.0 110.151 -176.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 31.9 t-20 . . . . . 0 C--O 1.234 0.241 0 C-N-CA 125.295 1.438 . . . . 0.0 107.765 176.96 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.316 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -80.57 142.48 34.05 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 118.492 0.587 . . . . 0.0 111.213 -175.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.419 HG22 ' HB2' ' A' ' 113' ' ' PHE . 21.8 pt -133.62 -176.13 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 124.407 1.083 . . . . 0.0 109.913 178.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.486 ' HB3' HG22 ' A' ' 114' ' ' VAL . 12.4 t80 -120.74 164.68 16.2 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.275 1.43 . . . . 0.0 109.011 172.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 p -111.6 148.84 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.771 0.829 . . . . 0.0 112.309 -175.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -92.24 7.04 44.46 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -168.087 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 106.84 -33.32 6.51 Favored Glycine 0 N--CA 1.467 0.715 0 O-C-N 120.54 -1.35 . . . . 0.0 110.057 -164.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.64 -24.05 66.24 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 129.8 3.24 . . . . 0.0 114.771 -170.264 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.407 HD21 HG12 ' A' ' 19' ' ' VAL . 4.1 mp -146.07 48.23 1.22 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.471 1.032 . . . . 0.0 109.258 -173.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -130.97 -85.53 0.51 Allowed 'General case' 0 N--CA 1.468 0.452 0 O-C-N 120.254 -1.529 . . . . 0.0 111.582 176.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.11 -66.79 0.42 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.888 1.222 . . . . 0.0 109.383 -178.216 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 174.82 86.24 0.06 OUTLIER Glycine 0 N--CA 1.431 -1.691 0 N-CA-C 104.957 -3.257 . . . . 0.0 104.957 -178.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.449 ' HG3' ' HD2' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -107.5 160.27 27.23 Favored Pre-proline 0 N--CA 1.445 -0.701 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 174.211 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.449 ' HD2' ' HG3' ' A' ' 14' ' ' GLN . 12.2 Cg_endo -61.49 -27.4 82.14 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.937 2.425 . . . . 0.0 112.343 -174.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -73.52 -16.26 61.28 Favored 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 125.182 1.393 . . . . 0.0 110.842 -173.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -64.36 -32.85 74.63 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 120.115 1.325 . . . . 0.0 112.153 -159.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.94 -19.96 47.76 Favored 'General case' 0 C--O 1.224 -0.279 0 O-C-N 121.409 -0.807 . . . . 0.0 113.044 176.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.487 HG21 ' CE2' ' A' ' 77' ' ' PHE . 1.4 p -55.92 -35.58 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 119.179 0.899 . . . . 0.0 110.956 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.2 ptp -87.97 -4.92 58.77 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -176.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 73.5 mt -90.47 -6.38 54.91 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.505 1.122 . . . . 0.0 110.67 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -106.21 99.91 9.47 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 106.174 -1.788 . . . . 0.0 106.174 172.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 25.6 t-80 -59.03 -18.93 39.11 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.841 1.256 . . . . 0.0 113.285 -176.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.7 m -61.82 -28.34 69.41 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 120.972 -1.08 . . . . 0.0 113.674 169.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -78.69 -1.91 36.7 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 119.241 0.928 . . . . 0.0 111.803 173.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.16 176.65 19.51 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 127.037 2.256 . . . . 0.0 110.571 -176.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -93.76 137.0 33.46 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.521 1.528 . . . . 0.0 110.177 -172.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.16 125.21 15.29 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.474 1.11 . . . . 0.0 110.664 165.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -133.29 126.0 30.51 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 125.228 1.411 . . . . 0.0 109.878 -176.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -60.07 108.53 0.79 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.053 1.741 . . . . 0.0 109.501 -178.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.0 tpp180 -121.15 66.37 0.87 Allowed 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.871 1.268 . . . . 0.0 109.902 -174.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.21 -171.56 55.16 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 176.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.524 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 32.2 mtp85 -123.24 169.19 11.53 Favored 'General case' 0 CA--C 1.511 -0.534 0 O-C-N 121.965 -0.727 . . . . 0.0 111.974 -174.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -166.66 173.52 42.03 Favored Glycine 0 CA--C 1.506 -0.526 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.745 175.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 25.8 p -142.99 161.01 39.25 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.999 -0.6 . . . . 0.0 109.558 171.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.6 p -76.57 103.88 6.79 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 106.328 -1.731 . . . . 0.0 106.328 164.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -62.4 -32.17 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 119.503 1.047 . . . . 0.0 110.435 171.015 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.23 124.74 23.47 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 167.407 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.24 131.4 44.84 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 125.479 1.511 . . . . 0.0 108.029 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -140.39 157.1 69.21 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 119.472 1.033 . . . . 0.0 108.406 -177.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -70.04 108.05 2.05 Favored 'Trans proline' 0 N--CA 1.454 -0.851 1 C-N-CA 125.525 4.15 . . . . 0.0 108.438 171.356 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.492 HD21 ' CE2' ' A' ' 133' ' ' TYR . 3.0 tm? -117.84 99.38 6.89 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 173.085 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.6 m -132.58 141.46 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 C-N-CA 126.386 1.874 . . . . 0.0 108.864 -167.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.529 ' HB ' HD22 ' A' ' 141' ' ' LEU . 4.7 mp -109.73 121.21 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -171.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.3 -170.11 3.0 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.295 1.438 . . . . 0.0 108.707 -173.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.79 164.29 4.33 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.337 0.97 . . . . 0.0 111.145 -174.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -78.5 2.74 18.03 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.598 1.159 . . . . 0.0 113.271 -172.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -132.14 17.08 4.57 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.836 1.254 . . . . 0.0 112.445 -171.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.0 m120 56.7 72.87 0.48 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.351 1.86 . . . . 0.0 111.117 -177.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 94.4 mt -110.49 89.49 8.93 Favored Pre-proline 0 C--N 1.324 -0.518 0 C-N-CA 129.267 3.027 . . . . 0.0 107.488 -169.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -52.65 134.1 52.24 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 CA-C-N 120.872 1.347 . . . . 0.0 111.927 171.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 70.8 m95 -118.29 137.76 52.84 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.171 1.388 . . . . 0.0 107.309 170.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.469 ' HG ' HD23 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -107.93 94.61 5.17 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 171.661 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.6 mt -76.07 143.86 41.09 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 -176.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -79.64 75.86 6.28 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.764 -0.585 . . . . 0.0 110.496 -175.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.64 83.32 53.98 Favored Pre-proline 0 N--CA 1.468 0.428 0 C-N-CA 123.728 0.811 . . . . 0.0 109.887 -176.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -63.62 148.99 92.0 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 121.363 1.375 . . . . 0.0 108.815 178.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.6 2.34 60.14 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-O 117.637 -1.646 . . . . 0.0 114.898 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.2 tppt? -124.94 121.71 35.24 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 121.75 2.775 . . . . 0.0 106.291 177.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.531 ' HA2' ' CD2' ' A' ' 129' ' ' TYR . . . 108.2 -147.07 16.48 Favored Glycine 0 N--CA 1.459 0.228 0 CA-C-N 120.601 1.546 . . . . 0.0 110.766 -176.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -137.01 173.99 11.1 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 123.936 0.894 . . . . 0.0 110.198 -168.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 61.4 m -78.08 113.6 16.16 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.498 0.719 . . . . 0.0 110.251 -178.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 38.2 t -78.34 111.16 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 124.183 0.993 . . . . 0.0 108.339 -177.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 51.6 p -92.92 151.22 20.07 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 119.17 0.895 . . . . 0.0 111.762 -173.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -178.92 -163.83 30.67 Favored Glycine 0 C--N 1.337 0.605 0 O-C-N 121.277 -0.889 . . . . 0.0 113.588 -163.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 1.5 pt-20 -120.73 177.37 5.11 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 87.7 mt -121.69 115.58 46.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 169.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -89.71 130.84 35.92 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 168.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -70.57 130.16 41.09 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 152.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.3 m -134.04 167.92 25.1 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 CA-C-O 121.144 0.497 . . . . 0.0 110.35 177.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.86 -179.42 4.28 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 122.427 1.108 . . . . 0.0 111.046 167.025 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.3 -42.76 96.22 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 115.85 -2.024 . . . . 0.0 111.527 177.325 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.1 mm100 -55.05 -43.16 73.56 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 120.522 1.51 . . . . 0.0 110.763 177.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 39.1 tpp -66.1 -51.46 57.83 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 119.09 -0.481 . . . . 0.0 110.36 178.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.04 -28.16 66.17 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 118.831 0.742 . . . . 0.0 112.034 177.034 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 35.4 mtt180 -75.19 -43.81 49.99 Favored 'General case' 0 C--N 1.337 0.052 0 C-N-CA 125.625 1.57 . . . . 0.0 111.033 179.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.487 ' CE2' HG21 ' A' ' 19' ' ' VAL . 9.0 t80 -57.94 -54.7 43.94 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 123.541 0.737 . . . . 0.0 109.332 175.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 mp -49.74 -41.15 43.15 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.115 0.966 . . . . 0.0 110.613 178.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -65.94 -1.19 2.79 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.092 1.757 . . . . 0.0 114.277 178.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -129.83 3.85 4.94 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.261 2.224 . . . . 0.0 111.132 178.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -102.59 -47.13 4.54 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.932 1.293 . . . . 0.0 110.166 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -75.17 1.51 13.17 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -175.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.0 t70 54.13 26.2 6.36 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.301 1.441 . . . . 0.0 112.578 -165.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 1.5 p -63.98 159.19 57.48 Favored Pre-proline 0 CA--C 1.542 0.672 0 O-C-N 119.411 -2.055 . . . . 0.0 109.154 166.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -73.24 -4.06 15.04 Favored 'Cis proline' 0 CA--C 1.546 1.096 0 CA-C-N 119.417 0.827 . . . . 0.0 113.583 -10.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.63 -63.39 1.3 Allowed 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.262 1.425 . . . . 0.0 112.966 -177.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 4.2 mtm -82.58 -55.85 4.21 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 122.785 0.434 . . . . 0.0 110.35 -172.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -109.8 173.03 6.51 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 127.6 2.36 . . . . 0.0 106.993 176.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 -132.17 157.67 43.69 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 120.867 1.667 . . . . 0.0 108.224 160.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.0 tmm_? -80.6 142.77 33.72 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 118.897 0.771 . . . . 0.0 109.107 172.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.7 m -143.4 161.49 38.24 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.673 0.749 . . . . 0.0 109.312 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -114.3 125.02 53.41 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 126.64 1.976 . . . . 0.0 108.317 171.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.428 HD21 ' CG2' ' A' ' 114' ' ' VAL . 2.1 pt? -142.99 -167.0 2.43 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 129.918 3.287 . . . . 0.0 108.688 -166.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 20.7 tp60 -107.5 138.97 42.74 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.491 0.716 . . . . 0.0 111.904 177.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 99.5 t -133.87 135.97 54.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 172.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -76.45 153.3 35.73 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.549 1.539 . . . . 0.0 109.653 169.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 80.7 t -87.33 112.68 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 127.565 2.346 . . . . 0.0 107.58 165.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.5 mp -90.51 -17.87 26.3 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.241 1.416 . . . . 0.0 110.641 171.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -172.18 159.85 4.98 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 129.041 2.936 . . . . 0.0 105.672 173.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 62.7 t-105 -141.81 118.02 10.73 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 119.339 0.972 . . . . 0.0 109.708 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -118.04 62.29 0.76 Allowed 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.914 0.864 . . . . 0.0 112.67 -171.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 150.18 155.15 6.71 Favored Glycine 0 C--O 1.228 -0.254 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 158.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -54.24 149.41 9.85 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.598 1.159 . . . . 0.0 112.079 -162.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 98.16 65.98 0.88 Allowed Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -165.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -100.82 89.1 1.15 Allowed Pre-proline 0 C--O 1.24 0.579 1 C-N-CA 132.509 4.324 . . . . 0.0 108.152 -162.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -72.79 -5.19 16.73 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 124.675 3.584 . . . . 0.0 114.126 -163.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.74 -177.19 44.92 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 109.251 -1.539 . . . . 0.0 109.251 -166.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -64.36 -12.02 38.34 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 -168.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.0 p -137.41 161.79 35.37 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 120.726 1.603 . . . . 0.0 112.457 177.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.5 m -142.65 156.71 18.46 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 125.366 1.466 . . . . 0.0 108.913 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -98.08 98.64 9.93 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.444 -1.688 . . . . 0.0 106.444 160.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 18.6 m -92.05 172.37 8.49 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 168.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.419 ' HB2' HG22 ' A' ' 4' ' ' ILE . 69.0 m-85 -85.68 140.4 30.57 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 162.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.486 HG22 ' HB3' ' A' ' 5' ' ' PHE . 25.5 t -134.61 124.9 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 127.461 2.304 . . . . 0.0 106.052 173.143 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -72.63 141.08 48.33 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 168.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 55.6 p -138.37 -173.2 3.47 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.19 1.796 . . . . 0.0 109.675 -173.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.4 t -134.63 145.04 48.23 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 165.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -113.59 -8.96 13.28 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.864 1.666 . . . . 0.0 112.073 169.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 31.4 p -105.76 15.42 26.81 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.659 1.184 . . . . 0.0 113.11 -172.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -58.9 149.72 26.22 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 125.832 1.653 . . . . 0.0 113.803 -170.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.64 154.59 88.12 Favored Pre-proline 0 CA--C 1.532 0.283 0 C-N-CA 125.444 1.498 . . . . 0.0 110.961 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.08 -30.81 20.22 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.033 1.822 . . . . 0.0 113.335 178.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.07 -30.25 70.23 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 173.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 43.2 m0 -72.36 -17.32 61.84 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 121.453 -0.779 . . . . 0.0 111.446 -171.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -75.29 -21.29 58.6 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 118.48 -0.772 . . . . 0.0 110.978 172.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 8.9 m-30 -86.14 -19.22 30.46 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.175 0.898 . . . . 0.0 111.639 -177.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 97.2 mt -65.77 151.07 95.56 Favored Pre-proline 0 C--O 1.237 0.415 0 C-N-CA 123.836 0.855 . . . . 0.0 110.385 -175.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.67 146.0 53.38 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.834 2.356 . . . . 0.0 109.183 177.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.531 ' CD2' ' HA2' ' A' ' 60' ' ' GLY . 11.6 m-85 -86.96 163.68 16.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 122.079 0.942 . . . . 0.0 110.831 -175.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -136.99 160.22 39.57 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.845 1.658 . . . . 0.0 108.038 177.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -97.5 -5.47 35.86 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.01 1.324 . . . . 0.0 111.192 174.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 80.7 p -169.34 -175.35 2.2 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 120.963 -1.085 . . . . 0.0 109.798 -169.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.492 ' CE2' HD21 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -158.0 61.85 0.46 Allowed 'General case' 0 C--O 1.239 0.527 0 C-N-CA 126.739 2.016 . . . . 0.0 106.493 -167.713 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -112.02 122.88 48.99 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 -157.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 5.2 t -59.13 -32.15 69.59 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.728 -168.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -91.72 11.77 23.47 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 117.931 0.332 . . . . 0.0 111.697 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -68.41 167.06 44.53 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.486 1.041 . . . . 0.0 113.251 -175.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -73.4 -9.54 23.1 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.544 2.829 . . . . 0.0 112.187 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -80.23 -18.56 49.15 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -163.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 77.21 -19.47 3.63 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-O 118.244 -1.309 . . . . 0.0 114.261 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.529 HD22 ' HB ' ' A' ' 44' ' ' ILE . 0.5 OUTLIER -72.74 101.54 3.12 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.733 1.613 . . . . 0.0 110.244 175.358 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 9.9 mmt85 -125.33 138.19 54.06 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 117.794 -1.098 . . . . 0.0 110.495 -174.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -58.02 148.09 27.26 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 . . . . . 0 C--N 1.329 -0.292 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -176.963 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.373 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -96.04 121.2 37.54 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 168.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.9 pt -119.4 175.25 4.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 171.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -120.5 137.26 54.46 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 175.143 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.4 m -78.55 137.46 21.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -67.51 -26.22 66.23 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.009 0.524 . . . . 0.0 112.241 175.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 135.48 -19.96 3.76 Favored Glycine 0 N--CA 1.472 1.036 0 O-C-N 120.134 -1.604 . . . . 0.0 111.958 -169.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.48 -14.95 54.18 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.335 1.854 . . . . 0.0 112.555 -169.618 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.737 HD13 ' HA ' ' A' ' 17' ' ' HIS . 3.3 mm? -127.14 41.19 3.57 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 128.592 2.757 . . . . 0.0 106.54 -173.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.79 -85.22 0.18 Allowed 'General case' 0 N--CA 1.469 0.489 0 O-C-N 120.324 -1.485 . . . . 0.0 110.753 -171.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.0 tpt85 -66.42 -69.19 0.32 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 121.149 1.795 . . . . 0.0 111.006 -170.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -155.48 -3.03 0.1 Allowed Glycine 0 N--CA 1.448 -0.504 0 O-C-N 124.157 0.911 . . . . 0.0 114.133 -174.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -49.28 147.52 5.28 Favored Pre-proline 0 N--CA 1.45 -0.438 0 C-N-CA 126.523 1.929 . . . . 0.0 111.847 -167.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -48.99 -29.21 15.02 Favored 'Trans proline' 0 CA--C 1.533 0.436 1 C-N-CA 125.32 4.013 . . . . 0.0 113.967 -176.256 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.466 ' O ' HG22 ' A' ' 19' ' ' VAL . 17.2 m120 -81.34 -23.8 37.53 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 125.958 1.703 . . . . 0.0 112.226 -169.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.737 ' HA ' HD13 ' A' ' 10' ' ' LEU . 4.8 t60 -53.41 -31.38 44.79 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.975 1.262 . . . . 0.0 111.019 -171.116 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.31 -23.55 9.48 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.873 1.269 . . . . 0.0 114.031 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 16' ' ' ASN . 34.1 m -60.07 -49.53 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 CA-C-N 119.652 1.115 . . . . 0.0 110.628 173.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.612 ' HE3' HD12 ' A' ' 10' ' ' LEU . 6.0 ptp -77.68 5.64 8.89 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.704 0.684 . . . . 0.0 112.726 -174.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 69.9 mt -97.34 -6.08 35.07 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.078 0.951 . . . . 0.0 111.582 176.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -121.7 102.83 8.46 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 104.315 -2.476 . . . . 0.0 104.315 175.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -58.16 -16.93 15.29 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.081 1.352 . . . . 0.0 111.996 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.2 m -60.92 -22.42 64.35 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.756 1.622 . . . . 0.0 113.971 169.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 20.2 m170 -86.08 -15.06 42.43 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.251 -0.906 . . . . 0.0 111.107 170.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.1 170.02 12.91 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 127.203 2.335 . . . . 0.0 111.565 176.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -74.1 139.09 44.36 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 124.803 1.241 . . . . 0.0 112.1 -174.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -139.82 138.63 35.96 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.03 1.732 . . . . 0.0 109.053 165.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.16 139.71 27.45 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.77 1.228 . . . . 0.0 108.865 175.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -72.62 87.55 1.23 Allowed 'General case' 0 C--O 1.238 0.481 0 C-N-CA 125.948 1.699 . . . . 0.0 108.033 178.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.2 tpp180 -93.7 64.85 3.57 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -177.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.66 -167.41 54.8 Favored Glycine 0 N--CA 1.44 -1.058 0 CA-C-O 122.967 1.315 . . . . 0.0 111.463 -173.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.3 ptt85 -139.13 170.64 15.59 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.981 0.913 . . . . 0.0 109.668 -177.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.404 ' HA2' ' H ' ' A' ' 98' ' ' LEU . . . -170.96 173.8 44.68 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 119.876 -1.155 . . . . 0.0 111.807 -172.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.468 ' HB3' ' HA ' ' A' ' 64' ' ' THR . 2.3 m -136.89 158.05 45.34 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 170.211 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.0 p -74.9 121.61 22.15 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 176.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.552 HG22 ' HB2' ' A' ' 96' ' ' GLN . 2.0 t -76.6 -43.88 34.51 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -177.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -71.36 121.72 19.04 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 105.774 -1.935 . . . . 0.0 105.774 174.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 m -55.75 142.49 34.33 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 168.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -135.67 153.41 77.43 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 107.057 -1.461 . . . . 0.0 107.057 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -78.52 91.82 1.17 Allowed 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 124.693 3.595 . . . . 0.0 109.522 176.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.88 88.59 7.73 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 177.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.434 HG13 ' HB3' ' A' ' 127' ' ' LEU 0.287 40.1 t -89.71 166.78 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 C-N-CA 126.982 2.113 . . . . 0.0 107.878 -176.906 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.2 mt -132.65 126.72 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 168.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.88 175.14 10.06 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 122.32 1.057 . . . . 0.0 111.495 -174.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.9 -172.64 53.18 Favored Glycine 0 CA--C 1.539 1.542 0 C-N-CA 125.794 1.664 . . . . 0.0 111.226 170.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -87.19 -18.46 30.28 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 125.851 1.66 . . . . 0.0 113.076 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 56.6 m-70 -109.2 8.98 26.08 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 122.845 0.458 . . . . 0.0 112.005 -171.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 62.86 63.03 0.99 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.648 1.579 . . . . 0.0 108.079 172.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 81.4 mt -104.11 90.23 2.94 Favored Pre-proline 0 N--CA 1.453 -0.283 0 C-N-CA 127.309 2.243 . . . . 0.0 106.14 -169.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -57.08 138.33 85.81 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 CA-C-N 119.725 0.938 . . . . 0.0 110.374 169.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 57.0 m95 -128.82 132.63 47.84 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.505 1.522 . . . . 0.0 108.692 178.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 34.4 tp -86.13 -3.81 59.04 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.957 0.903 . . . . 0.0 113.101 -173.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 12.9 mt 42.03 89.7 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 129.674 3.19 . . . . 0.0 112.367 172.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -49.5 95.68 0.01 OUTLIER 'General case' 0 C--O 1.241 0.631 0 CA-C-N 119.167 0.894 . . . . 0.0 112.989 -162.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -159.49 85.76 2.18 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 119.032 0.833 . . . . 0.0 113.057 -172.498 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -60.85 147.75 94.35 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.613 2.209 . . . . 0.0 109.739 -177.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.88 15.66 80.82 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 119.074 -0.848 . . . . 0.0 113.056 171.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.38 130.44 32.8 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 119.436 1.618 . . . . 0.0 108.715 -175.141 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.37 -123.84 7.07 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-N 120.792 1.633 . . . . 0.0 112.628 -178.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 46.4 m-70 -136.32 160.55 38.38 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.889 1.844 . . . . 0.0 112.588 -165.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 77.0 m -91.14 99.49 12.49 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.823 0.849 . . . . 0.0 110.736 -177.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.1 t -72.0 99.19 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 125.97 1.708 . . . . 0.0 113.213 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.468 ' HA ' ' HB3' ' A' ' 35' ' ' CYS . 8.9 p -66.51 157.58 31.83 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.91 0.884 . . . . 0.0 112.631 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -178.05 -147.1 6.71 Favored Glycine 0 C--N 1.343 0.962 0 O-C-N 121.458 -0.776 . . . . 0.0 114.025 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -133.53 171.21 14.4 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.056 1.342 . . . . 0.0 109.253 177.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 92.4 mt -116.59 112.98 41.62 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 -177.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -101.71 115.82 31.37 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 172.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -62.89 136.22 57.73 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 154.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.5 m -135.04 168.69 22.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 C-N-CA 124.732 1.213 . . . . 0.0 108.131 176.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -107.98 172.06 7.05 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 168.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.419 ' HG2' ' HE ' ' A' ' 76' ' ' ARG . 2.5 mt-10 -49.53 -45.73 47.69 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 125.035 1.334 . . . . 0.0 110.244 -176.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.2 tp60 -55.62 -43.57 76.25 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.079 0.952 . . . . 0.0 111.574 -176.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 24.3 tpp -72.48 -48.67 38.9 Favored 'General case' 0 C--O 1.224 -0.264 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.83 -39.4 77.57 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.549 -0.719 . . . . 0.0 110.726 -178.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.419 ' HE ' ' HG2' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -64.56 -44.65 90.09 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 126.918 2.087 . . . . 0.0 110.966 175.451 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -61.69 -46.35 90.08 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.279 0.632 . . . . 0.0 109.815 177.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 95.2 mt -57.79 -37.48 73.8 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.144 0.577 . . . . 0.0 111.468 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -61.11 -21.98 64.21 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.388 0.995 . . . . 0.0 111.837 177.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -100.25 -2.92 32.57 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.803 2.441 . . . . 0.0 111.5 177.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -103.96 -37.98 7.17 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 120.739 -1.226 . . . . 0.0 108.215 -174.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -107.94 28.88 7.8 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.985 1.314 . . . . 0.0 111.586 174.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 57.97 37.68 26.73 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.247 1.419 . . . . 0.0 112.625 156.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 78.1 m -85.92 163.57 42.86 Favored Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 120.934 -1.104 . . . . 0.0 110.646 -176.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 58.0 Cg_endo -65.76 -3.95 3.6 Favored 'Cis proline' 0 CA--C 1.547 1.161 0 N-CA-C 114.849 1.057 . . . . 0.0 114.849 -16.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -46.79 -64.55 0.74 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.835 1.654 . . . . 0.0 112.928 178.188 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 21.5 mtm -88.18 -59.41 2.25 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 119.195 0.907 . . . . 0.0 110.092 -175.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.409 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 75.0 m-85 -111.56 178.29 4.37 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 176.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.7 mp0 -133.97 150.28 51.27 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 171.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -77.44 114.26 16.09 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 176.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.2 m -113.55 170.91 7.9 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 126.106 1.763 . . . . 0.0 108.835 -179.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -122.13 143.01 49.8 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.622 1.569 . . . . 0.0 110.277 172.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.44 175.91 11.8 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.269 1.428 . . . . 0.0 111.357 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.4 tp60 -101.53 126.79 48.4 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.703 1.601 . . . . 0.0 111.772 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 64.0 t -122.39 144.74 30.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 125.305 1.442 . . . . 0.0 108.141 -176.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.552 ' HB2' HG22 ' A' ' 37' ' ' VAL . 49.4 tt0 -89.32 144.75 25.85 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 176.122 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.535 HG12 ' C ' ' A' ' 108' ' ' ASP 0.26 7.2 p -111.48 89.89 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -167.36 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.404 ' H ' ' HA2' ' A' ' 34' ' ' GLY . 3.9 mp -65.44 -23.04 66.83 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 120.716 -1.24 . . . . 0.0 111.512 -177.361 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -160.95 153.43 20.55 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 104.763 -2.31 . . . . 0.0 104.763 174.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 70.2 t-105 -137.59 107.29 6.22 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 126.3 1.84 . . . . 0.0 108.597 178.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -95.18 108.56 20.69 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -177.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.52 -174.77 15.96 Favored Glycine 0 CA--C 1.519 0.311 0 CA-C-O 121.911 0.729 . . . . 0.0 111.387 174.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -71.31 160.64 32.43 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.604 0.716 . . . . 0.0 110.268 -177.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 90.52 69.13 1.2 Allowed Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 124.618 1.104 . . . . 0.0 111.234 165.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -101.58 89.58 1.5 Allowed Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 129.845 3.258 . . . . 0.0 110.352 -162.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -62.73 4.61 0.35 Allowed 'Trans proline' 0 CA--C 1.544 1.0 1 C-N-CA 125.737 4.291 . . . . 0.0 115.266 -176.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.15 -174.43 54.54 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 -163.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.535 ' C ' HG12 ' A' ' 97' ' ' VAL . 14.5 t70 -69.71 5.69 1.39 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 117.336 2.347 . . . . 0.0 117.336 -168.062 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 83.5 p -125.25 157.45 36.55 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 121.648 -0.658 . . . . 0.0 112.174 155.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.6 p -132.6 153.05 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 123.628 0.771 . . . . 0.0 109.434 161.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -82.09 152.51 26.54 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 168.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 3.9 p -145.14 -173.37 4.07 Favored 'General case' 0 C--O 1.239 0.515 0 O-C-N 121.575 -0.703 . . . . 0.0 110.629 169.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -109.03 151.44 26.35 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.133 1.373 . . . . 0.0 109.504 162.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.3 t -142.88 146.45 21.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 128.883 2.873 . . . . 0.0 106.605 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -89.91 116.05 27.68 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 168.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -139.16 147.61 42.08 Favored 'General case' 0 C--O 1.225 -0.233 0 C-N-CA 124.077 0.951 . . . . 0.0 111.317 -176.145 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.5 t -92.5 141.16 28.81 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -177.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -110.57 6.45 21.89 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.235 1.414 . . . . 0.0 111.572 162.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.35 19.73 16.74 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.624 1.97 . . . . 0.0 112.729 -160.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -71.61 159.53 34.26 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.737 1.615 . . . . 0.0 113.16 -174.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.35 149.69 89.11 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 124.749 1.22 . . . . 0.0 110.761 173.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -68.52 -24.8 35.71 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.701 2.268 . . . . 0.0 113.561 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -68.69 -24.95 64.56 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 120.919 -1.113 . . . . 0.0 112.777 173.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 45.0 m0 -72.01 -12.75 61.37 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.426 -0.796 . . . . 0.0 112.241 -177.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -65.89 -18.33 65.26 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.347 -0.846 . . . . 0.0 111.233 171.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -99.95 -8.95 23.33 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.059 0.944 . . . . 0.0 112.791 175.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.434 ' HB3' HG13 ' A' ' 43' ' ' VAL . 14.7 mt -64.23 147.01 97.38 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.217 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -64.84 149.38 89.68 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.087 1.858 . . . . 0.0 110.371 178.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -103.37 166.1 10.63 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 41.0 m-70 -136.5 169.87 16.98 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 125.048 1.339 . . . . 0.0 108.473 178.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -125.26 -17.33 5.7 Favored 'General case' 0 C--O 1.219 -0.511 0 C-N-CA 124.217 1.007 . . . . 0.0 111.837 -166.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -158.19 132.78 8.28 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 164.453 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -85.59 131.57 34.33 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 169.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -143.87 158.21 43.84 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.756 154.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.5 t -63.71 -35.86 81.94 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 164.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -86.4 68.63 10.27 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 127.467 2.307 . . . . 0.0 107.665 -177.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -152.65 168.09 31.6 Favored Glycine 0 CA--C 1.522 0.499 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.432 163.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -72.91 -6.93 19.89 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.275 2.65 . . . . 0.0 113.735 -166.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -60.24 -42.13 94.61 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 119.407 1.003 . . . . 0.0 113.425 -169.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 93.09 -50.33 2.48 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-O 118.892 -0.949 . . . . 0.0 111.026 -178.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.5 75.61 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.079 1.751 . . . . 0.0 112.265 173.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -109.37 167.7 9.93 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 120.52 -1.362 . . . . 0.0 109.613 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -60.17 164.03 4.44 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 118.786 -0.626 . . . . 0.0 111.276 -169.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 50.2 p-10 . . . . . 0 CA--C 1.545 0.752 0 CA-C-O 121.614 0.721 . . . . 0.0 112.317 -175.646 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.261 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -134.39 148.02 50.59 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 13.0 pt -130.83 179.42 4.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 167.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.561 ' CE2' HG23 ' A' ' 36' ' ' THR . 90.3 t80 -137.83 133.16 33.62 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 176.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.8 m -73.79 134.64 29.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 173.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -73.54 -3.22 26.39 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.77 -0.581 . . . . 0.0 111.701 163.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 136.42 -4.99 3.79 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.95 1.738 . . . . 0.0 112.515 174.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -83.47 -8.62 59.33 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -167.092 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.0 mp -140.85 58.64 1.55 Allowed 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -139.87 -73.68 0.36 Allowed 'General case' 0 C--N 1.342 0.281 0 CA-C-O 118.463 -0.779 . . . . 0.0 112.346 177.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -67.97 -60.59 2.38 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.911 1.232 . . . . 0.0 109.211 -168.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -177.38 33.33 0.08 OUTLIER Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.611 HE21 ' H ' ' A' ' 135' ' ' SER . 10.5 mp0 -66.25 155.03 88.96 Favored Pre-proline 0 N--CA 1.454 -0.231 0 O-C-N 120.657 -1.496 . . . . 0.0 109.733 -173.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.35 -10.0 19.77 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.649 2.233 . . . . 0.0 113.354 -172.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.515 ' O ' HG22 ' A' ' 19' ' ' VAL . 3.3 m-80 -99.52 -20.76 16.24 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 127.242 2.217 . . . . 0.0 110.956 -175.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -53.68 -41.67 67.14 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 120.955 1.707 . . . . 0.0 109.839 -171.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.7 -29.48 4.49 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.564 1.546 . . . . 0.0 114.145 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 16' ' ' ASN . 20.3 m -59.8 -41.79 86.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 120.097 1.317 . . . . 0.0 111.593 178.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.3 ptp -78.0 -8.59 58.36 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 119.149 0.886 . . . . 0.0 111.76 -177.075 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 39.6 mt -87.41 5.09 40.48 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.283 1.433 . . . . 0.0 110.64 178.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -115.08 97.61 6.32 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 173.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 22.2 t-80 -60.09 -21.22 61.23 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.424 0.69 . . . . 0.0 112.538 -176.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.5 m -69.44 -23.7 63.72 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.385 1.474 . . . . 0.0 114.342 172.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 36.9 m170 -69.77 -31.71 69.81 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.146 -0.971 . . . . 0.0 108.765 165.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.76 179.53 25.66 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 125.839 1.685 . . . . 0.0 110.775 174.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -81.63 135.69 35.54 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.011 0.924 . . . . 0.0 110.096 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.1 100.68 3.68 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.38 1.472 . . . . 0.0 109.646 167.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -107.4 140.9 39.63 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 125.18 1.392 . . . . 0.0 108.798 -177.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -69.98 77.84 0.49 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.589 2.355 . . . . 0.0 109.986 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -87.37 62.38 7.15 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.39 -176.3 48.24 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-O 123.624 1.68 . . . . 0.0 113.984 170.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -118.0 160.29 21.72 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.781 1.232 . . . . 0.0 109.711 -170.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -169.71 177.58 43.12 Favored Glycine 0 C--N 1.34 0.805 0 N-CA-C 116.383 1.313 . . . . 0.0 116.383 177.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 10.6 p -133.4 158.48 42.92 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.44 1.096 . . . . 0.0 108.206 170.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.561 HG23 ' CE2' ' A' ' 5' ' ' PHE . 3.0 p -78.91 117.28 19.85 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 166.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.3 t -74.24 -41.33 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 175.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -64.89 107.34 1.44 Allowed 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 170.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.0 m -59.63 135.92 57.83 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 106.951 -1.499 . . . . 0.0 106.951 170.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.74 ' HB3' HD22 ' A' ' 53' ' ' LEU . 27.8 m-85 -130.57 153.16 81.39 Favored Pre-proline 0 C--O 1.237 0.422 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -74.29 91.57 0.95 Allowed 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 124.707 3.605 . . . . 0.0 109.675 173.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 tt -81.91 102.94 11.21 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 171.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.569 ' CG2' HD13 ' A' ' 54' ' ' LEU . 2.6 m -122.25 133.14 69.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 125.225 1.41 . . . . 0.0 107.451 -175.201 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 73.8 mt -99.05 100.14 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -176.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -118.01 171.88 7.79 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 122.378 1.085 . . . . 0.0 111.354 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.3 152.73 7.13 Favored Glycine 0 CA--C 1.523 0.534 0 CA-C-N 113.76 -1.564 . . . . 0.0 110.9 173.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.3 tp10 -72.16 -9.3 58.25 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -162.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 44.2 m170 -102.5 12.63 36.19 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.871 0.869 . . . . 0.0 112.076 175.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 55.45 69.73 0.7 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 127.392 2.277 . . . . 0.0 111.228 -178.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.5 mt -104.12 89.87 2.74 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 128.105 2.562 . . . . 0.0 108.072 -166.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -53.03 129.11 31.74 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 121.757 1.638 . . . . 0.0 111.567 177.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 66.3 m95 -126.62 145.56 50.51 Favored 'General case' 0 C--N 1.332 -0.192 0 O-C-N 121.093 -1.005 . . . . 0.0 109.122 176.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.74 HD22 ' HB3' ' A' ' 40' ' ' PHE . 1.8 mt -96.44 -5.31 39.96 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 117.569 2.433 . . . . 0.0 117.569 -174.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.569 HD13 ' CG2' ' A' ' 43' ' ' VAL . 8.7 mp 42.37 73.39 0.14 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 111.603 -2.544 . . . . 0.0 112.601 173.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -45.26 92.18 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.014 1.726 . . . . 0.0 114.57 -157.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.42 85.23 7.42 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 125.026 1.33 . . . . 0.0 107.643 -174.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -59.04 139.52 91.16 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 121.986 1.79 . . . . 0.0 108.564 176.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.02 -0.7 88.27 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.191 1.376 . . . . 0.0 114.48 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -97.43 144.02 27.58 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.624 1.712 . . . . 0.0 107.78 173.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.33 -143.7 30.91 Favored Glycine 0 C--N 1.337 0.608 0 CA-C-N 119.235 0.925 . . . . 0.0 111.63 177.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -130.99 176.75 7.98 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.313 1.445 . . . . 0.0 108.203 -169.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.2 p -63.0 167.13 5.05 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.512 0.672 . . . . 0.0 111.406 176.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.1 t -133.08 110.95 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 166.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 69.5 p -69.75 152.33 44.75 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.42 -158.37 12.37 Favored Glycine 0 CA--C 1.527 0.791 0 O-C-N 121.15 -0.969 . . . . 0.0 112.486 -177.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -140.98 151.8 44.44 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.621 1.568 . . . . 0.0 108.454 174.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 76.4 mt -95.55 138.49 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -127.34 126.16 42.04 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 172.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -69.87 136.13 50.33 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 161.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.62 164.54 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.95 177.43 4.85 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 122.804 1.288 . . . . 0.0 111.847 168.156 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -57.16 -42.36 80.94 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 112.916 -1.947 . . . . 0.0 111.751 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 40.1 tp60 -62.99 -44.91 94.72 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 118.473 -0.775 . . . . 0.0 109.989 179.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 24.8 tpp -62.79 -46.41 88.13 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 118.365 0.53 . . . . 0.0 110.109 176.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 75' ' ' LEU . 11.1 tp -65.81 -40.59 92.03 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.647 -174.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 33.9 mtm105 -63.26 -40.16 96.63 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.631 1.173 . . . . 0.0 111.172 173.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -65.97 -50.62 63.7 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 117.984 0.356 . . . . 0.0 110.303 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.7 mp -63.12 -25.87 68.56 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.122 -0.986 . . . . 0.0 111.01 176.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.473 ' HA ' ' SG ' ' A' ' 84' ' ' CYS . 14.8 t70 -73.44 1.3 10.06 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.971 1.309 . . . . 0.0 112.84 176.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -122.04 -47.81 2.14 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 128.352 2.661 . . . . 0.0 110.972 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -65.1 -39.16 92.74 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.445 1.098 . . . . 0.0 112.294 -176.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -77.81 8.56 4.4 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.18 -0.95 . . . . 0.0 111.197 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 58.68 15.44 3.72 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.376 1.871 . . . . 0.0 113.155 178.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.473 ' SG ' ' HA ' ' A' ' 79' ' ' ASP . 1.6 p -61.92 154.12 69.6 Favored Pre-proline 0 N--CA 1.448 -0.558 0 O-C-N 120.518 -1.363 . . . . 0.0 109.219 169.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.39 -4.57 22.09 Favored 'Cis proline' 0 CA--C 1.541 0.826 0 CA-C-N 119.563 0.88 . . . . 0.0 113.638 -2.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.7 -75.42 0.06 Allowed 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.062 1.345 . . . . 0.0 111.095 179.055 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 38.7 mtp -68.67 -69.09 0.35 Allowed 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -172.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -102.29 174.89 5.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.497 0.665 . . . . 0.0 109.443 179.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -137.89 136.25 36.91 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 165.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -75.03 139.21 42.71 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 175.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.4 m -141.66 154.36 45.31 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -176.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -91.46 137.84 32.05 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.881 0.873 . . . . 0.0 109.7 174.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.504 HD11 HG23 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -148.27 174.84 11.6 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.01 1.324 . . . . 0.0 112.297 -178.961 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 30.7 tp60 -100.06 117.15 33.72 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.149 1.78 . . . . 0.0 111.196 -178.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 97.1 t -117.81 124.12 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 125.19 1.396 . . . . 0.0 107.944 -172.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -68.43 141.37 55.69 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 119.582 1.083 . . . . 0.0 108.557 175.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 45.9 t -84.78 95.19 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 172.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.86 -30.06 70.13 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.769 -0.582 . . . . 0.0 109.712 167.15 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -164.75 153.74 12.85 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 60.2 t-105 -132.03 136.94 47.61 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 172.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -116.92 111.15 19.24 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 171.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 114.81 -172.34 14.18 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 124.518 1.056 . . . . 0.0 112.145 172.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -70.87 168.32 17.09 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 114.919 -0.641 . . . . 0.0 110.619 -178.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.05 69.19 1.42 Allowed Glycine 0 C--O 1.222 -0.635 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 168.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -101.1 87.96 0.97 Allowed Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 130.651 3.581 . . . . 0.0 109.399 -171.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -57.12 -38.1 96.46 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.692 2.928 . . . . 0.0 113.2 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 146.59 -160.95 28.33 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-N 119.436 1.016 . . . . 0.0 111.387 -170.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -64.07 -22.56 66.98 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.937 1.295 . . . . 0.0 111.728 175.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.9 t -139.86 164.19 30.64 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 120.467 -1.396 . . . . 0.0 109.233 175.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 10.9 p -141.06 153.06 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 C-N-CA 125.787 1.635 . . . . 0.0 108.959 -174.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -83.3 119.93 25.21 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 168.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 85.8 m -122.22 176.27 5.93 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.746 0.818 . . . . 0.0 109.23 171.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -106.5 144.09 33.68 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 168.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.504 HG23 HD11 ' A' ' 93' ' ' LEU . 27.2 t -137.45 146.83 27.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 127.137 2.175 . . . . 0.0 106.073 175.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -76.54 127.76 33.43 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 165.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 72.4 p -131.62 -164.54 1.46 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 126.008 1.723 . . . . 0.0 106.689 172.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.5 t -149.08 153.97 38.57 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 168.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -116.51 -31.92 5.4 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.672 1.589 . . . . 0.0 111.823 175.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 15.4 t -91.72 20.79 5.23 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.941 0.896 . . . . 0.0 111.795 -165.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.416 ' CG ' ' HG ' ' A' ' 54' ' ' LEU . 31.9 p90 -72.07 153.9 41.44 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 127.78 2.432 . . . . 0.0 113.155 -174.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.89 160.37 55.82 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 126.622 1.969 . . . . 0.0 112.173 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -68.88 -39.04 8.9 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.125 1.883 . . . . 0.0 112.531 178.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -45.46 -41.66 9.67 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 178.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 0.561 ' HA ' HD23 ' A' ' 127' ' ' LEU . 30.7 m0 -64.2 -18.17 64.25 Favored 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 125.513 1.525 . . . . 0.0 112.365 -173.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 28.0 mt -67.47 -17.28 64.63 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 117.808 -1.092 . . . . 0.0 111.672 173.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -102.52 -6.22 23.11 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.976 1.262 . . . . 0.0 112.511 -168.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.561 HD23 ' HA ' ' A' ' 124' ' ' TRP . 1.9 mm? -71.73 156.93 90.62 Favored Pre-proline 0 N--CA 1.448 -0.55 0 C-N-CA 125.651 1.58 . . . . 0.0 108.16 -175.187 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -61.38 140.31 87.31 Favored 'Trans proline' 0 N--CA 1.449 -1.088 0 C-N-CA 121.586 1.524 . . . . 0.0 108.953 173.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -81.28 158.08 24.9 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 172.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 60.0 m-70 -137.97 155.74 48.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.712 178.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -101.21 -9.04 21.64 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 122.766 1.27 . . . . 0.0 112.932 -175.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -161.23 150.7 16.73 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 126.908 2.083 . . . . 0.0 105.517 175.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -106.27 148.35 28.08 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 167.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.0 170.99 21.06 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.611 ' H ' HE21 ' A' ' 14' ' ' GLN . 0.3 OUTLIER -104.87 -0.1 27.43 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 159.625 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -133.3 68.36 1.5 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.514 1.926 . . . . 0.0 106.897 -172.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -130.66 -170.98 12.81 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 125.615 1.579 . . . . 0.0 112.725 -171.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -57.83 175.9 0.39 Allowed 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 120.805 1.003 . . . . 0.0 110.129 138.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 30.1 m-70 46.99 90.26 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 128.967 2.907 . . . . 0.0 112.221 -178.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.92 61.81 0.73 Allowed Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.414 1.007 . . . . 0.0 112.406 170.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.27 67.49 1.43 Allowed 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 127.477 2.311 . . . . 0.0 106.866 169.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 -116.37 162.31 17.73 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 120.816 -1.178 . . . . 0.0 110.629 -172.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -61.15 140.56 57.87 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 123.806 0.691 . . . . 0.0 111.723 -159.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 30.4 t30 . . . . . 0 N--CA 1.452 -0.334 0 C-N-CA 124.274 1.03 . . . . 0.0 109.129 -174.708 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.228 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.1 m80 -108.34 130.94 55.18 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 176.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.461 HG22 ' HB2' ' A' ' 113' ' ' PHE . 17.4 pt -128.32 167.42 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 124.644 1.178 . . . . 0.0 109.403 176.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -126.75 144.73 50.85 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.586 1.154 . . . . 0.0 110.894 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 m -103.61 123.61 57.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.972 1.309 . . . . 0.0 111.038 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -76.39 -48.1 20.99 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -174.04 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.26 -1.18 0.03 OUTLIER Glycine 0 CA--C 1.531 1.054 0 CA-C-O 117.575 -1.68 . . . . 0.0 116.486 -172.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.417 ' HA ' ' HG2' ' A' ' 14' ' ' GLN . 0.3 OUTLIER -118.75 -6.93 10.58 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 120.309 2.055 . . . . 0.0 114.834 -163.192 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.7 mp -145.59 47.02 1.28 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.342 1.457 . . . . 0.0 108.363 176.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.22 -78.07 0.46 Allowed 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 117.051 -1.452 . . . . 0.0 109.811 170.008 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.429 ' CB ' HE22 ' A' ' 14' ' ' GLN . 10.7 mtt180 -50.91 -45.5 60.33 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.051 0.94 . . . . 0.0 111.533 -168.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 148.57 68.94 0.01 OUTLIER Glycine 0 C--N 1.333 0.403 0 N-CA-C 106.944 -2.462 . . . . 0.0 106.944 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.429 HE22 ' CB ' ' A' ' 12' ' ' ARG . 25.1 mp0 -102.89 160.84 24.96 Favored Pre-proline 0 N--CA 1.449 -0.507 0 C-N-CA 124.505 1.122 . . . . 0.0 110.464 -178.033 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.36 -32.67 89.61 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.737 1.625 . . . . 0.0 110.996 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -70.57 -24.27 62.75 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 124.642 1.177 . . . . 0.0 111.618 -176.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -52.0 -35.06 45.47 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.224 1.01 . . . . 0.0 110.779 -167.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.71 -33.56 7.1 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 124.953 1.301 . . . . 0.0 114.264 176.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.3 m -59.61 -35.53 59.97 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 119.95 1.25 . . . . 0.0 111.439 -176.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.1 ptp -83.09 -12.47 57.05 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 118.979 0.809 . . . . 0.0 112.848 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.2 mt -80.07 -11.82 59.73 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.187 0.595 . . . . 0.0 110.194 177.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -100.17 99.68 10.41 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -177.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 46.3 t-80 -59.32 -19.59 47.74 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.664 1.586 . . . . 0.0 113.376 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.84 -37.35 79.01 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.419 -0.801 . . . . 0.0 111.551 167.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 16.8 m170 -73.98 -35.64 64.48 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 121.393 -0.817 . . . . 0.0 109.475 170.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.93 -175.71 24.4 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.993 1.283 . . . . 0.0 112.738 168.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.5 mt -68.79 149.32 49.13 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.038 0.935 . . . . 0.0 113.144 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -161.95 110.61 1.46 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.091 2.156 . . . . 0.0 108.507 168.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -130.11 146.61 51.77 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.016 0.926 . . . . 0.0 109.848 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -69.01 86.95 0.37 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.568 2.347 . . . . 0.0 109.472 -176.269 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.07 64.12 0.83 Allowed 'General case' 0 C--O 1.234 0.281 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -178.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.88 -179.12 48.65 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-O 122.053 0.807 . . . . 0.0 112.79 -178.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.4 ptt180 -134.14 172.2 13.18 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.55 -0.971 . . . . 0.0 110.407 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -164.08 -176.79 36.26 Favored Glycine 0 CA--C 1.499 -0.932 0 N-CA-C 115.89 1.116 . . . . 0.0 115.89 -173.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.7 p -145.21 159.56 42.82 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 113.725 -1.237 . . . . 0.0 112.512 166.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.506 HG23 HG13 ' A' ' 63' ' ' VAL . 8.3 p -78.13 101.97 7.28 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 120.086 1.312 . . . . 0.0 107.852 172.292 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -71.14 -31.05 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 120.576 -1.328 . . . . 0.0 111.894 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -69.99 118.06 12.35 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 152.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.3 m -57.84 146.96 29.92 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 167.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -135.49 153.16 77.56 Favored Pre-proline 0 N--CA 1.466 0.349 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 169.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.441 ' HG2' ' HB2' ' A' ' 54' ' ' LEU . 40.9 Cg_endo -77.01 121.63 5.9 Favored 'Trans proline' 0 CA--C 1.533 0.457 1 C-N-CA 125.774 4.316 . . . . 0.0 113.043 177.293 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.6 tp -116.38 111.92 20.74 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 126.863 2.065 . . . . 0.0 108.858 -176.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.5 m -128.88 148.09 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 120.26 1.391 . . . . 0.0 111.937 -177.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 40.2 mt -86.93 128.07 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 169.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.59 173.47 11.47 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.54 0.686 . . . . 0.0 112.153 174.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.94 -174.72 55.27 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.544 2.021 . . . . 0.0 113.246 171.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -91.0 -3.45 57.25 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -170.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -118.94 12.63 12.89 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.405 1.082 . . . . 0.0 111.779 176.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 53.51 71.27 0.51 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.015 2.126 . . . . 0.0 110.495 -178.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 88.6 mt -103.9 90.58 3.02 Favored Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 131.265 3.826 . . . . 0.0 108.368 -169.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -60.83 125.08 16.31 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 122.379 2.053 . . . . 0.0 112.602 176.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -116.63 156.97 26.13 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.912 1.685 . . . . 0.0 109.882 176.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.9 tp -115.54 114.76 25.41 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.233 1.413 . . . . 0.0 108.441 167.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.548 HD23 HG23 ' A' ' 117' ' ' THR . 26.0 mt -82.27 144.0 30.94 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 177.276 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -79.75 89.06 5.19 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 121.593 -0.692 . . . . 0.0 109.389 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.25 85.69 21.36 Favored Pre-proline 0 C--O 1.232 0.18 0 C-N-CA 123.534 0.734 . . . . 0.0 110.024 172.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -60.27 128.95 27.96 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.936 2.424 . . . . 0.0 109.598 -177.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.57 8.77 73.26 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 118.09 -1.395 . . . . 0.0 114.074 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.2 tptt -121.3 164.14 17.48 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 120.372 2.086 . . . . 0.0 107.216 172.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 74.51 -131.13 12.72 Favored Glycine 0 CA--C 1.519 0.288 0 O-C-N 120.613 -1.304 . . . . 0.0 109.945 -176.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -145.01 167.24 23.12 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.12 0.968 . . . . 0.0 111.033 -170.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 31.6 m -92.27 80.63 4.99 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 126.717 2.007 . . . . 0.0 112.448 -173.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.506 HG13 HG23 ' A' ' 36' ' ' THR . 1.6 p -70.05 136.21 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.117 0 CA-C-O 118.113 -0.946 . . . . 0.0 113.196 -165.048 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.2 p -91.06 152.46 20.63 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.88 -175.51 32.99 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 178.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -106.25 158.2 17.03 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 125.736 1.615 . . . . 0.0 106.771 173.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 80.8 mt -113.63 110.07 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -93.17 123.48 36.48 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 118.528 -0.749 . . . . 0.0 109.663 -176.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -68.48 107.93 3.09 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 152.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.8 m -103.72 169.67 2.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 166.098 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -119.24 177.71 4.79 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 161.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -45.02 -46.43 11.31 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 127.977 2.511 . . . . 0.0 110.835 -170.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -57.64 -45.56 85.31 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.124 0.97 . . . . 0.0 111.367 -175.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.4 tpp -72.52 -45.9 57.18 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -176.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.43 -32.86 73.78 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.778 -178.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 78.0 mtt180 -69.23 -37.73 78.16 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.874 1.215 . . . . 0.0 111.505 176.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -60.19 -48.3 82.32 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 119.113 -0.47 . . . . 0.0 110.002 174.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.6 mp -57.57 -41.37 80.94 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.214 0.461 . . . . 0.0 109.922 176.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -65.9 4.66 0.6 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.054 1.742 . . . . 0.0 114.76 -178.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -129.9 -47.94 1.13 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.323 2.249 . . . . 0.0 109.852 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -63.11 -42.74 99.61 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 125.802 1.641 . . . . 0.0 111.518 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -78.03 11.31 2.32 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.871 0.868 . . . . 0.0 110.808 176.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.2 t0 54.43 16.81 1.38 Allowed 'General case' 0 C--O 1.236 0.387 0 C-N-CA 128.596 2.758 . . . . 0.0 114.625 171.018 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 6.8 p -62.47 155.76 66.05 Favored Pre-proline 0 N--CA 1.445 -0.721 0 O-C-N 121.227 -0.921 . . . . 0.0 110.035 -178.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -73.76 -4.23 16.71 Favored 'Cis proline' 0 CA--C 1.543 0.93 0 N-CA-C 115.223 1.201 . . . . 0.0 115.223 -2.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 9.5 m -63.96 -63.68 1.09 Allowed 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.072 1.349 . . . . 0.0 112.406 -173.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 27.3 mtp -74.35 -76.7 0.13 Allowed 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -100.01 -176.55 3.27 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 125.354 1.461 . . . . 0.0 109.329 178.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.93 151.55 30.46 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 120.761 -1.212 . . . . 0.0 109.795 158.205 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -63.93 125.85 25.74 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 118.491 -0.766 . . . . 0.0 109.954 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 43.5 m -132.4 174.79 9.88 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.009 1.724 . . . . 0.0 106.95 167.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -125.23 132.69 52.93 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.711 1.604 . . . . 0.0 109.615 172.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.447 ' CD1' HG11 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -123.83 177.29 5.81 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.731 1.612 . . . . 0.0 109.927 -179.207 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 34.2 tp60 -105.87 114.26 28.31 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.253 2.221 . . . . 0.0 109.685 -178.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 54.3 t -109.29 141.22 25.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 125.65 1.58 . . . . 0.0 107.633 -177.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -76.29 137.29 39.8 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 165.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.523 ' CG1' ' HA ' ' A' ' 108' ' ' ASP 0.254 3.7 p -98.07 83.81 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 179.017 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -61.66 -22.62 65.45 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 125.471 1.509 . . . . 0.0 111.935 -175.734 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -154.46 154.52 33.33 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 170.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 -132.69 124.98 29.23 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.247 1.419 . . . . 0.0 107.408 175.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -91.42 115.62 28.18 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.78 0.832 . . . . 0.0 109.15 177.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.88 -169.24 32.21 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 123.307 0.48 . . . . 0.0 112.129 169.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -68.74 171.96 7.06 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.329 1.451 . . . . 0.0 111.224 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 73.56 67.49 1.78 Allowed Glycine 0 C--O 1.226 -0.385 0 O-C-N 120.469 -1.394 . . . . 0.0 112.79 170.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -101.56 89.76 1.56 Allowed Pre-proline 0 C--O 1.238 0.48 0 C-N-CA 128.741 2.816 . . . . 0.0 110.157 -163.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -54.97 -22.52 30.9 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 124.447 3.432 . . . . 0.0 114.388 -172.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 102.8 157.16 25.44 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 -171.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.523 ' HA ' ' CG1' ' A' ' 97' ' ' VAL . 25.2 t70 -63.85 5.08 0.24 Allowed 'General case' 0 CA--C 1.508 -0.638 0 C-N-CA 129.588 3.155 . . . . 0.0 116.698 -163.385 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.2 p -134.19 152.15 51.68 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 116.566 -2.054 . . . . 0.0 113.004 146.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 34.8 m -136.94 152.06 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 124.644 1.178 . . . . 0.0 109.353 -173.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -89.33 130.19 35.75 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 168.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 12.0 p -129.5 -179.93 5.45 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 118.482 -0.77 . . . . 0.0 109.059 169.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.461 ' HB2' HG22 ' A' ' 4' ' ' ILE . 40.7 m-85 -101.56 159.72 15.06 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.297 0.953 . . . . 0.0 111.103 164.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.447 HG11 ' CD1' ' A' ' 93' ' ' LEU . 0.1 OUTLIER -163.03 118.02 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 128.911 2.884 . . . . 0.0 104.018 -158.837 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -83.19 86.18 7.08 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 172.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.1 p -94.45 -179.86 5.04 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.018 0.927 . . . . 0.0 108.659 172.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.548 HG23 HD23 ' A' ' 54' ' ' LEU . 1.1 t -133.33 140.81 47.62 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.012 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -103.6 -9.77 18.96 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.948 1.299 . . . . 0.0 111.242 166.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . 0.268 3.2 t -103.56 34.94 2.76 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 122.35 1.072 . . . . 0.0 111.052 -161.161 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.504 ' HB3' HD22 ' A' ' 54' ' ' LEU . 39.4 p90 -65.61 164.29 14.56 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.971 1.709 . . . . 0.0 113.173 -174.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -91.12 149.5 40.02 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 125.364 1.466 . . . . 0.0 108.795 167.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.51 -30.16 71.29 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.17 1.913 . . . . 0.0 113.089 -171.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.511 ' HA ' ' CD2' ' A' ' 126' ' ' PHE . 4.6 pm0 -58.1 -29.86 65.8 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.309 1.044 . . . . 0.0 113.06 177.171 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 46.2 m0 -71.73 -8.34 53.6 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 122.081 -0.387 . . . . 0.0 111.275 -173.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -89.9 -20.26 23.6 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 117.969 -1.015 . . . . 0.0 112.026 171.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.511 ' CD2' ' HA ' ' A' ' 123' ' ' GLU . 18.0 m-85 -68.88 -36.0 77.55 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 120.14 1.336 . . . . 0.0 110.157 174.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.4 mt -58.21 149.92 55.34 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 125.137 1.375 . . . . 0.0 110.439 -176.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.96 166.61 29.23 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.443 2.096 . . . . 0.0 110.237 173.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -118.75 160.14 22.41 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.868 0.867 . . . . 0.0 110.454 -175.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -139.86 166.64 24.1 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.304 0.642 . . . . 0.0 110.895 -175.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -127.32 -4.92 6.06 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.203 1.401 . . . . 0.0 112.228 -170.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.0 p -138.7 -178.8 5.47 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 153.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -126.58 174.83 8.39 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 122.514 1.149 . . . . 0.0 110.063 157.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.35 88.88 1.74 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 113.132 -1.849 . . . . 0.0 107.76 178.223 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.08 -22.64 65.94 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.045 -1.034 . . . . 0.0 110.216 167.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -105.17 73.01 1.02 Allowed 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 105.018 -2.215 . . . . 0.0 105.018 170.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -143.93 155.01 25.99 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 177.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -73.71 -6.56 18.86 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.009 2.473 . . . . 0.0 113.229 -167.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 51.9 m-70 -51.88 -33.82 38.32 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.596 1.158 . . . . 0.0 113.048 -170.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 98.47 -19.17 55.48 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.714 1.15 . . . . 0.0 113.53 168.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.545 ' HG ' HH21 ' A' ' 142' ' ' ARG . 0.2 OUTLIER -98.89 57.94 1.13 Allowed 'General case' 0 C--O 1.238 0.49 0 C-N-CA 126.865 2.066 . . . . 0.0 109.216 172.451 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.545 HH21 ' HG ' ' A' ' 141' ' ' LEU . 5.9 mmp_? -84.54 169.57 14.31 Favored 'General case' 0 C--O 1.237 0.408 0 O-C-N 120.386 -1.446 . . . . 0.0 109.941 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -61.83 150.79 36.2 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -173.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 . . . . . 0 CA--C 1.534 0.344 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 177.23 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.392 0 CA-C-O 121.553 0.692 . . . . 0.0 109.235 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -125.77 123.97 39.96 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 177.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.8 pt -130.41 173.57 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 122.776 1.274 . . . . 0.0 110.158 -178.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.41 ' HB3' HG22 ' A' ' 114' ' ' VAL . 37.4 t80 -112.08 155.32 24.04 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 125.744 1.618 . . . . 0.0 107.314 169.421 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.554 ' CG2' ' HB2' ' A' ' 10' ' ' LEU . 5.0 p -79.3 176.56 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-O 121.785 0.802 . . . . 0.0 109.698 175.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -125.92 174.46 8.38 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 173.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.62 -10.96 20.39 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 115.246 0.858 . . . . 0.0 115.246 -171.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.76 -23.69 36.48 Favored 'General case' 0 N--CA 1.435 -1.184 0 C-N-CA 125.498 1.519 . . . . 0.0 110.876 -175.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.554 ' HB2' ' CG2' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -125.58 -3.23 7.29 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 121.007 1.73 . . . . 0.0 111.915 -169.361 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -82.6 -7.25 59.65 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 -173.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -135.4 -85.96 0.38 Allowed 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 120.652 1.569 . . . . 0.0 107.082 176.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -160.44 15.21 0.19 Allowed Glycine 0 CA--C 1.529 0.922 0 CA-C-O 118.332 -1.26 . . . . 0.0 113.002 -168.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.465 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 3.1 mm-40 -57.83 164.57 3.08 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 119.709 1.755 . . . . 0.0 109.857 -175.212 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 14' ' ' GLN . 58.8 Cg_endo -68.12 -2.53 9.03 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 123.874 3.049 . . . . 0.0 113.415 -169.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -96.17 -14.46 22.76 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 127.897 2.479 . . . . 0.0 111.953 -177.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -48.71 -33.28 9.86 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 120.04 1.291 . . . . 0.0 110.609 -175.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.8 pttp -44.52 -32.47 1.42 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.049 1.739 . . . . 0.0 114.22 176.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.2 m -66.64 -11.67 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 123.633 0.773 . . . . 0.0 112.348 -177.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.2 ptp -121.56 14.74 11.08 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.279 1.432 . . . . 0.0 112.219 172.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 56.7 mt -115.05 2.99 14.33 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 124.72 1.208 . . . . 0.0 111.971 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -131.46 96.78 4.07 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 123.967 0.907 . . . . 0.0 108.56 -175.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 -55.7 -20.82 15.64 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.73 1.212 . . . . 0.0 112.31 -176.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 t -62.38 -25.79 68.12 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 120.13 1.332 . . . . 0.0 111.65 174.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -83.38 -1.99 54.72 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.401 -0.812 . . . . 0.0 111.794 174.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.93 177.0 19.25 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 124.874 1.226 . . . . 0.0 111.09 -175.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 35.0 tp -93.22 137.96 32.06 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.833 0.853 . . . . 0.0 111.335 -173.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.27 135.13 47.78 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 159.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.9 136.94 37.56 Favored 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 124.782 1.233 . . . . 0.0 109.323 -177.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -64.46 109.28 1.89 Allowed 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.679 0.792 . . . . 0.0 109.407 -179.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 -116.21 51.86 0.94 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 -175.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.15 -153.03 46.14 Favored Glycine 0 N--CA 1.442 -0.961 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -151.13 170.39 19.55 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.688 -0.89 . . . . 0.0 111.945 -171.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -174.18 178.75 45.91 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.029 -1.081 . . . . 0.0 115.478 -175.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 64.4 m -137.48 132.66 33.62 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 177.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.2 p -65.98 101.78 0.72 Allowed 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -69.83 -29.31 40.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 O-C-N 121.877 -0.514 . . . . 0.0 110.211 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -58.68 109.47 0.81 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 156.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.1 m -55.25 140.1 40.17 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 164.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -139.74 153.44 70.05 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 171.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.38 98.44 1.17 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 124.626 3.551 . . . . 0.0 110.077 173.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 54.1 tp -88.89 117.42 27.88 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 166.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.7 m -128.07 149.81 33.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.2 mt -114.23 98.15 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 -177.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.71 135.06 25.93 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.813 1.645 . . . . 0.0 108.797 -167.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.05 147.14 12.84 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 125.427 1.489 . . . . 0.0 110.739 -172.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -63.13 -26.8 68.99 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.807 1.643 . . . . 0.0 114.094 -164.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -90.13 3.85 52.15 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -174.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 51.75 61.87 3.0 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.064 1.345 . . . . 0.0 110.319 -167.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 52.1 mt -107.16 86.88 2.74 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 128.093 2.557 . . . . 0.0 104.149 172.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -62.22 152.92 73.3 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 121.281 1.32 . . . . 0.0 111.095 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -119.92 157.83 27.95 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.874 1.27 . . . . 0.0 109.702 -177.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.3 tp -122.43 94.2 4.22 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 175.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.6 mt -68.02 131.32 45.25 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.567 ' CE1' HG21 ' A' ' 91' ' ' THR . 58.9 t80 -71.64 96.07 1.53 Allowed 'General case' 0 C--O 1.239 0.502 0 C-N-CA 119.825 -0.75 . . . . 0.0 109.476 -176.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.43 85.31 6.81 Favored Pre-proline 0 CA--C 1.535 0.37 0 C-N-CA 123.742 0.817 . . . . 0.0 112.366 175.106 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -62.89 122.38 10.64 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.073 2.515 . . . . 0.0 109.315 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.75 -4.0 56.2 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 125.713 1.625 . . . . 0.0 114.604 177.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -106.42 167.09 10.07 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 120.552 2.176 . . . . 0.0 109.145 168.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 61.53 -142.54 48.33 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 -170.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -142.04 179.55 6.82 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.583 1.153 . . . . 0.0 110.59 -171.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 77.6 m -77.15 114.51 16.03 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.516 1.126 . . . . 0.0 109.68 178.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.1 t -77.82 112.4 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 172.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.5 p -81.88 145.08 30.55 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.337 -0.852 . . . . 0.0 109.01 177.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -169.81 -172.03 35.95 Favored Glycine 0 C--N 1.342 0.889 0 O-C-N 121.018 -1.051 . . . . 0.0 112.466 -172.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -114.65 161.0 18.68 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 176.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 62.2 mt -111.02 135.46 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 124.709 1.203 . . . . 0.0 108.286 -175.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -124.94 125.06 43.33 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.691 0.796 . . . . 0.0 108.987 175.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -71.39 142.95 50.33 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 158.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.5 m -140.75 153.25 20.98 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -176.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -94.51 174.95 6.86 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 122.585 1.183 . . . . 0.0 111.378 172.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.39 -5.49 40.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 113.493 -1.685 . . . . 0.0 113.051 -175.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 45.7 tp60 -85.62 -46.89 10.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 118.028 -0.986 . . . . 0.0 110.417 164.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 25.3 tpp -63.75 -50.03 70.68 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.772 1.169 . . . . 0.0 111.168 -177.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.06 -17.28 64.82 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 122.237 -0.289 . . . . 0.0 111.071 -175.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 23.6 mtt180 -86.8 -42.94 12.89 Favored 'General case' 0 C--O 1.222 -0.374 0 C-N-CA 127.63 2.372 . . . . 0.0 110.901 172.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -60.57 -44.87 95.7 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.951 1.251 . . . . 0.0 109.562 177.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.5 mp -58.41 -30.73 67.08 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.54 -0.725 . . . . 0.0 110.855 171.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.489 ' HA ' ' SG ' ' A' ' 84' ' ' CYS . 1.1 t70 -70.98 3.71 3.16 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.177 1.391 . . . . 0.0 113.44 176.28 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -126.97 -43.15 1.69 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 127.129 2.172 . . . . 0.0 109.699 176.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -65.9 -37.98 87.52 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.539 1.536 . . . . 0.0 112.378 177.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -91.01 6.52 44.5 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 123.227 0.611 . . . . 0.0 111.462 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 86' ' ' SER . 10.2 t0 52.06 30.24 7.28 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.776 1.23 . . . . 0.0 113.62 175.304 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.489 ' SG ' ' HA ' ' A' ' 79' ' ' ASP . 0.8 OUTLIER -74.24 159.63 83.35 Favored Pre-proline 0 CA--C 1.536 0.414 0 O-C-N 118.613 -2.554 . . . . 0.0 109.559 172.024 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -72.77 -4.45 14.16 Favored 'Cis proline' 0 CA--C 1.544 1.011 0 CA-C-N 120.477 1.206 . . . . 0.0 114.205 -6.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 3.0 m -54.62 -72.33 0.07 Allowed 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.24 1.016 . . . . 0.0 111.625 177.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.404 ' HG3' ' HB3' ' A' ' 83' ' ' ASP . 8.6 mtm -74.74 -64.61 1.0 Allowed 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -173.175 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -101.99 172.16 7.08 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.753 0.821 . . . . 0.0 108.983 178.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -135.23 -14.95 1.97 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 178.383 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 61.45 148.21 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 128.623 2.769 . . . . 0.0 114.635 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.567 HG21 ' CE1' ' A' ' 55' ' ' TYR . 17.4 m -154.17 170.82 20.3 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -174.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.41 ' O ' HG22 ' A' ' 91' ' ' THR . . . -87.4 159.41 18.72 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.042 1.337 . . . . 0.0 110.196 162.164 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.606 HD21 ' SG ' ' A' ' 112' ' ' CYS . 0.0 OUTLIER -150.15 -166.6 2.59 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.664 1.185 . . . . 0.0 111.012 176.085 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -128.77 123.36 32.73 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.022 0.929 . . . . 0.0 110.624 172.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.474 HG13 ' CG1' ' A' ' 110' ' ' VAL . 1.4 p -138.23 111.24 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -170.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -54.03 127.68 27.49 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 124.621 1.168 . . . . 0.0 110.091 -177.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 25.6 t -80.55 82.17 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 C-N-CA 127.503 2.321 . . . . 0.0 107.165 179.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.8 mp -63.1 -30.08 71.31 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.1 0.56 . . . . 0.0 110.227 175.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -154.08 160.48 41.98 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 126.164 1.786 . . . . 0.0 107.741 168.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 54.2 t-105 -144.1 124.56 13.94 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.592 1.557 . . . . 0.0 107.21 174.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -113.48 96.03 5.67 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.482 1.289 . . . . 0.0 114.482 177.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 118.76 -178.92 16.81 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 124.955 1.264 . . . . 0.0 110.868 -176.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -67.85 172.96 4.8 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.67 1.188 . . . . 0.0 110.564 177.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.63 41.18 3.44 Favored Glycine 0 C--O 1.219 -0.84 0 C-N-CA 124.367 0.984 . . . . 0.0 111.689 173.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -101.27 89.17 1.28 Allowed Pre-proline 0 C--N 1.321 -0.647 0 C-N-CA 130.624 3.57 . . . . 0.0 110.02 -155.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -73.81 -26.69 13.19 Favored 'Trans proline' 0 CA--C 1.538 0.708 1 C-N-CA 126.456 4.771 . . . . 0.0 114.807 -159.347 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 128.71 -164.23 21.92 Favored Glycine 0 CA--C 1.533 1.198 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -160.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -63.96 -23.83 67.49 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 117.932 0.866 . . . . 0.0 113.325 -169.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.75 169.34 17.89 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.878 1.271 . . . . 0.0 109.884 -174.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.474 ' CG1' HG13 ' A' ' 95' ' ' VAL 0.289 11.3 p -130.67 153.54 39.25 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 C-N-CA 117.63 -1.628 . . . . 0.0 108.699 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -96.13 77.78 3.11 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 173.169 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.606 ' SG ' HD21 ' A' ' 93' ' ' LEU . 1.6 p -82.36 -167.55 1.63 Allowed 'General case' 0 C--O 1.237 0.41 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.9 177.461 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -120.46 136.6 54.7 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.328 0.651 . . . . 0.0 109.272 162.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.437 HG23 HD11 ' A' ' 93' ' ' LEU . 95.5 t -124.48 153.42 31.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 169.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -84.23 105.0 14.74 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.051 -1.03 . . . . 0.0 109.354 176.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 70.6 p -86.18 175.98 8.21 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.672 1.189 . . . . 0.0 110.35 172.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.7 t -128.49 146.26 50.87 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 149.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -117.42 5.59 12.54 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.383 1.073 . . . . 0.0 111.381 176.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 11.4 t -126.28 47.04 2.33 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 122.805 1.288 . . . . 0.0 110.058 -176.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 14.8 p90 -78.83 156.2 28.83 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.142 0.977 . . . . 0.0 111.866 -178.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.05 157.26 85.45 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 125.153 1.381 . . . . 0.0 110.515 173.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -59.88 -48.36 12.8 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.063 2.509 . . . . 0.0 112.578 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -51.57 -32.38 28.24 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.674 1.19 . . . . 0.0 113.661 -178.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 44.2 m0 -71.14 -14.86 62.42 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.344 -0.847 . . . . 0.0 111.4 -173.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 78.7 mt -71.36 -20.0 62.22 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 118.061 -0.971 . . . . 0.0 111.842 170.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -95.91 -24.74 16.28 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.632 1.106 . . . . 0.0 110.889 -168.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 77.1 mt -60.25 156.93 36.68 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 126.103 1.761 . . . . 0.0 111.961 -173.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -66.74 151.21 82.98 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 121.916 1.744 . . . . 0.0 109.64 175.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -104.92 162.99 12.86 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.335 1.054 . . . . 0.0 111.542 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -137.67 144.48 41.85 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 123.529 0.731 . . . . 0.0 111.938 -173.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -94.64 -12.7 26.87 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.032 1.333 . . . . 0.0 112.181 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 51.9 p -159.23 172.7 17.55 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 120.61 -1.306 . . . . 0.0 109.743 173.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.61 148.0 40.24 Favored 'General case' 0 N--CA 1.434 -1.245 0 C-N-CA 126.649 1.98 . . . . 0.0 107.227 -178.165 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -156.81 113.68 3.08 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 105.28 -2.118 . . . . 0.0 105.28 172.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.36 1.23 19.56 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.773 -0.579 . . . . 0.0 110.734 173.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -120.35 45.25 2.25 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.013 1.725 . . . . 0.0 106.782 164.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -109.66 155.8 15.91 Favored Glycine 0 CA--C 1.534 1.226 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 166.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -66.76 6.64 0.53 Allowed 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 125.289 3.993 . . . . 0.0 114.71 178.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 61.0 m-70 -58.58 -13.74 6.46 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 120.688 -1.258 . . . . 0.0 114.239 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 86.22 -46.62 3.63 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 124.871 1.224 . . . . 0.0 112.227 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.91 75.55 2.82 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.408 1.083 . . . . 0.0 112.188 179.108 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -95.92 157.92 15.68 Favored 'General case' 0 N--CA 1.463 0.178 0 O-C-N 121.403 -0.811 . . . . 0.0 110.707 175.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -59.28 156.73 11.99 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.947 1.299 . . . . 0.0 110.834 -176.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 C--O 1.238 0.47 0 C-N-CA 125.748 1.619 . . . . 0.0 107.751 177.575 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.136 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -63.22 138.33 58.51 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 124.698 1.199 . . . . 0.0 109.437 -174.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.3 pt -125.56 167.78 19.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 124.33 1.052 . . . . 0.0 109.221 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -132.69 136.52 46.47 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.474 0.71 . . . . 0.0 109.48 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.599 HG22 ' H ' ' A' ' 66' ' ' GLU . 34.5 m -75.34 114.68 15.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 123.353 0.661 . . . . 0.0 109.933 -172.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -66.45 -3.9 7.15 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.044 0.938 . . . . 0.0 113.122 174.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 145.05 -1.04 1.02 Allowed Glycine 0 CA--C 1.528 0.891 0 CA-C-O 118.972 -0.904 . . . . 0.0 115.045 168.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 p -109.81 -16.59 13.85 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 120.198 1.999 . . . . 0.0 113.5 -160.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.68 30.61 6.62 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.874 1.27 . . . . 0.0 110.859 -171.437 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.493 ' HB2' HG21 ' A' ' 6' ' ' VAL . 1.8 tmtm? -132.4 -84.87 0.48 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 117.344 -1.313 . . . . 0.0 109.205 -176.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.4 mmt-85 -50.62 -78.71 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.61 1.564 . . . . 0.0 112.3 -173.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -171.72 10.92 0.04 OUTLIER Glycine 0 CA--C 1.52 0.404 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -162.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.13 150.66 91.83 Favored Pre-proline 0 CA--C 1.537 0.449 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 175.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -68.89 -12.36 34.24 Favored 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 123.694 2.929 . . . . 0.0 112.697 -169.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -85.18 -12.5 52.57 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 116.247 -1.835 . . . . 0.0 112.501 -174.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -49.66 -39.02 34.9 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 121.302 1.864 . . . . 0.0 110.098 -176.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -50.65 -24.79 3.57 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 115.343 1.609 . . . . 0.0 115.343 178.187 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.4 m -56.18 -45.63 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 120.835 1.652 . . . . 0.0 110.698 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.426 ' HA ' ' CE ' ' A' ' 74' ' ' MET . 2.3 mmm -73.02 -7.45 51.29 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -176.503 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.1 mt -101.43 11.4 39.21 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.653 1.181 . . . . 0.0 108.487 -175.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -127.15 103.28 7.35 Favored 'General case' 0 CA--C 1.513 -0.466 0 O-C-N 121.307 -0.871 . . . . 0.0 109.942 178.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -66.39 -18.86 65.6 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -175.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 m -66.41 -19.93 65.93 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.29 -0.881 . . . . 0.0 112.403 168.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 39.3 m170 -93.44 -17.49 23.41 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.938 0.895 . . . . 0.0 110.994 169.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 130.96 178.73 15.61 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 124.787 1.184 . . . . 0.0 112.114 169.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 37.5 tp -88.42 147.33 24.75 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.242 0.617 . . . . 0.0 111.352 -175.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.95 158.55 44.21 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.361 1.064 . . . . 0.0 109.243 161.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -143.64 136.46 27.44 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 126.826 2.051 . . . . 0.0 108.931 175.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -75.56 79.08 2.57 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.509 1.924 . . . . 0.0 110.0 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -95.5 63.27 2.48 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 121.14 -0.975 . . . . 0.0 109.935 174.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.17 175.0 27.65 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-O 122.598 1.11 . . . . 0.0 113.975 158.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 44.5 mtp85 -113.82 158.01 21.57 Favored 'General case' 0 CA--C 1.516 -0.34 0 O-C-N 121.586 -0.949 . . . . 0.0 108.686 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -171.42 177.54 44.24 Favored Glycine 0 CA--C 1.506 -0.493 0 CA-C-O 122.235 0.908 . . . . 0.0 112.895 -176.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.3 p -140.09 146.17 38.57 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.101 -1.049 . . . . 0.0 108.47 172.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.2 p -71.2 96.99 1.45 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 104.999 -2.222 . . . . 0.0 104.999 170.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -67.28 -36.45 76.74 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.47 111.55 1.02 Allowed 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 160.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -57.5 142.81 42.99 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 174.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -137.48 153.72 74.65 Favored Pre-proline 0 N--CA 1.45 -0.474 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 169.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -80.17 96.69 1.03 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 1 C-N-CA 125.704 4.269 . . . . 0.0 110.792 177.383 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 51.0 tp -92.4 114.38 26.92 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 169.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.5 m -126.57 149.38 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 177.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.9 mt -94.16 121.62 44.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 177.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.22 -179.73 6.03 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.554 0.741 . . . . 0.0 110.459 176.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.42 153.88 4.25 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 125.31 1.433 . . . . 0.0 111.849 172.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -67.24 -16.93 64.58 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 121.145 -1.209 . . . . 0.0 113.299 -171.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 24.9 m-70 -100.44 9.56 42.44 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.882 0.873 . . . . 0.0 112.998 -173.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 57.44 66.25 1.18 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.705 1.602 . . . . 0.0 108.716 -172.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 96.3 mt -112.23 87.02 8.52 Favored Pre-proline 0 C--N 1.331 -0.202 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.69 145.55 95.07 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 CA-C-N 121.021 1.4 . . . . 0.0 111.749 170.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 22.1 m95 -123.78 161.18 25.74 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.781 1.232 . . . . 0.0 108.641 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.8 tp -116.51 96.02 5.32 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 174.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.76 135.72 57.78 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 172.328 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -71.24 93.94 1.14 Allowed 'General case' 0 C--O 1.233 0.237 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.85 74.4 14.72 Favored Pre-proline 0 CA--C 1.537 0.444 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.007 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -59.88 120.71 8.67 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.233 1.956 . . . . 0.0 109.401 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.03 -1.84 40.99 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 126.953 2.216 . . . . 0.0 114.242 177.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -112.03 160.94 17.0 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 120.672 2.236 . . . . 0.0 108.016 174.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.09 -142.46 34.47 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 109.739 -1.345 . . . . 0.0 109.739 -173.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -140.95 178.14 7.57 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.421 1.088 . . . . 0.0 110.129 -171.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 68.9 m -76.41 109.71 10.35 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 118.887 0.767 . . . . 0.0 111.076 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.5 t -75.26 108.89 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 174.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 59.2 p -72.2 160.83 31.77 Favored 'General case' 0 C--O 1.24 0.56 0 O-C-N 121.321 -0.862 . . . . 0.0 109.291 174.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 174.46 -157.55 25.2 Favored Glycine 0 C--N 1.335 0.505 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 -176.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.599 ' H ' HG22 ' A' ' 6' ' ' VAL . 9.8 mt-10 -134.99 156.47 48.98 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 125.21 1.404 . . . . 0.0 108.158 178.443 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.3 mt -103.99 128.25 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 -176.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -122.98 126.83 47.91 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 172.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -67.89 151.11 47.67 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 155.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.7 m -144.91 162.86 13.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 124.78 1.232 . . . . 0.0 107.862 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -105.54 171.3 7.4 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.995 0.902 . . . . 0.0 109.102 169.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.31 -32.29 68.34 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.393 1.477 . . . . 0.0 112.287 -163.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -69.91 -38.48 76.27 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-O 117.33 -1.319 . . . . 0.0 110.999 176.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.426 ' CE ' ' HA ' ' A' ' 20' ' ' MET . 43.6 tpp -65.69 -47.05 76.73 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 120.438 1.472 . . . . 0.0 109.18 178.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.05 -31.82 73.15 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.052 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -68.39 -45.02 73.82 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.503 1.047 . . . . 0.0 111.708 170.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -60.47 -50.36 73.87 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.682 0.793 . . . . 0.0 110.064 -176.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.6 mt -62.1 -36.3 81.3 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 122.806 0.442 . . . . 0.0 111.342 -175.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -51.54 -54.67 24.91 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.31 1.844 . . . . 0.0 108.757 172.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -68.88 -41.24 78.6 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.352 1.061 . . . . 0.0 112.296 -177.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -60.81 -53.57 55.77 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.271 1.428 . . . . 0.0 110.777 -168.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -74.79 -5.26 42.45 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.019 0.372 . . . . 0.0 111.594 -177.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.0 t0 75.02 25.31 1.38 Allowed 'General case' 0 C--O 1.233 0.2 0 C-N-CA 128.861 2.865 . . . . 0.0 113.782 -174.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -62.4 161.66 24.56 Favored Pre-proline 0 CA--C 1.547 0.858 0 O-C-N 119.837 -1.789 . . . . 0.0 108.44 165.422 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -72.21 -3.82 12.38 Favored 'Cis proline' 0 CA--C 1.548 1.224 0 CA-C-N 119.392 0.818 . . . . 0.0 113.004 -12.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.16 -59.6 5.2 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.479 1.912 . . . . 0.0 111.083 -175.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 27.5 mtp -82.83 -76.89 0.25 Allowed 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.859 1.263 . . . . 0.0 108.402 178.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -88.92 -177.4 5.47 Favored 'General case' 0 C--O 1.227 -0.122 0 C-N-CA 125.318 1.447 . . . . 0.0 110.319 -179.107 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 6.7 mp0 -138.21 176.61 8.55 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.605 2.362 . . . . 0.0 106.72 159.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -117.99 126.02 51.51 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.471 1.509 . . . . 0.0 108.382 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.7 m -126.09 150.91 47.86 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.212 0.605 . . . . 0.0 110.032 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.07 137.75 33.98 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.503 1.521 . . . . 0.0 109.533 166.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.599 HD11 HG23 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -142.68 -164.64 1.87 Allowed 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 127.852 2.461 . . . . 0.0 108.187 -177.254 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -119.42 139.76 51.5 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 123.613 0.765 . . . . 0.0 110.561 173.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 10.8 t -127.46 149.43 32.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 173.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -87.41 137.23 32.51 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 126.706 2.002 . . . . 0.0 105.656 170.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.751 HG13 ' HA ' ' A' ' 108' ' ' ASP 0.324 1.7 p -94.74 92.2 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 176.084 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.68 -45.53 93.59 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 114.358 -1.292 . . . . 0.0 108.802 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -141.58 140.83 33.47 Favored 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 125.651 1.58 . . . . 0.0 107.296 177.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 50.5 t-105 -108.7 141.24 40.97 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 167.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -119.93 101.37 7.81 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 165.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 139.93 177.72 16.09 Favored Glycine 0 C--N 1.331 0.252 0 CA-C-O 122.826 1.237 . . . . 0.0 112.822 164.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -64.67 162.29 16.07 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 168.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 72.44 75.19 0.71 Allowed Glycine 0 CA--C 1.522 0.474 0 O-C-N 120.937 -1.102 . . . . 0.0 111.883 176.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -102.28 90.52 2.12 Favored Pre-proline 0 N--CA 1.471 0.587 0 C-N-CA 128.399 2.68 . . . . 0.0 108.176 -172.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -53.15 -29.67 46.91 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.479 2.119 . . . . 0.0 114.807 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 145.73 -120.29 1.32 Allowed Glycine 0 C--N 1.338 0.694 0 CA-C-N 121.106 1.775 . . . . 0.0 110.729 -175.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.751 ' HA ' HG13 ' A' ' 97' ' ' VAL . 0.9 OUTLIER -143.9 1.04 1.12 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.319 1.848 . . . . 0.0 110.812 179.338 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.2 p -131.93 158.17 42.1 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 122.184 0.992 . . . . 0.0 110.62 148.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.4 m -137.74 167.25 22.85 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 C-N-CA 125.67 1.588 . . . . 0.0 108.444 -177.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -95.58 118.96 33.24 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 163.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 80.1 m -109.41 167.64 9.97 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.465 1.029 . . . . 0.0 109.4 165.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -95.13 141.57 28.59 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 163.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.599 HG23 HD11 ' A' ' 93' ' ' LEU . 84.9 t -135.64 151.42 29.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 170.658 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -81.17 134.18 35.58 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 173.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 42.3 p -140.37 -177.7 5.15 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.096 1.359 . . . . 0.0 109.575 -172.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.63 141.4 35.1 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 167.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -103.6 -5.59 22.52 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.209 1.003 . . . . 0.0 110.614 167.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.6 p -107.78 17.75 22.17 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.435 1.894 . . . . 0.0 112.715 -156.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -77.8 162.09 27.17 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.562 1.545 . . . . 0.0 113.343 -167.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -81.45 158.19 69.23 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 126.938 2.095 . . . . 0.0 111.405 175.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.464 ' HA ' HD23 ' A' ' 125' ' ' LEU . 46.7 Cg_endo -68.01 -33.22 26.39 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.68 2.253 . . . . 0.0 113.35 -174.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.9 pm0 -58.36 -31.74 67.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 118.806 0.73 . . . . 0.0 112.763 177.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 44.2 m0 -69.37 -14.72 63.07 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.318 0.508 . . . . 0.0 111.215 -176.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.464 HD23 ' HA ' ' A' ' 122' ' ' PRO . 3.4 mm? -78.4 -17.93 55.73 Favored 'General case' 0 CA--C 1.528 0.131 0 O-C-N 121.329 -0.857 . . . . 0.0 111.317 172.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -95.56 -22.7 17.46 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.798 0.727 . . . . 0.0 110.281 -172.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.2 mt -56.91 155.22 15.92 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 126.094 1.758 . . . . 0.0 111.036 178.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -67.64 144.4 66.01 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 121.339 1.359 . . . . 0.0 108.939 177.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -82.16 164.6 21.17 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 122.767 0.427 . . . . 0.0 109.923 172.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 51.8 m-70 -139.47 139.16 36.93 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.296 1.038 . . . . 0.0 109.13 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -82.45 -20.21 37.39 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.914 0.886 . . . . 0.0 112.921 -178.19 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.04 156.56 7.32 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 119.389 0.995 . . . . 0.0 110.052 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -114.28 127.79 56.04 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.572 1.149 . . . . 0.0 108.768 -175.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -140.18 131.38 26.52 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.434 1.494 . . . . 0.0 108.535 -174.095 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 7.6 t -69.93 -10.23 57.84 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.951 0.9 . . . . 0.0 110.154 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -131.15 64.22 1.58 Allowed 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 128.567 2.747 . . . . 0.0 104.673 177.394 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -124.28 171.51 16.53 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.866 1.698 . . . . 0.0 110.871 -176.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -61.96 -22.94 75.25 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.037 2.491 . . . . 0.0 112.877 -172.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -79.7 84.39 5.53 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 128.728 2.811 . . . . 0.0 109.251 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -44.89 -31.56 2.8 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 124.938 1.256 . . . . 0.0 113.683 177.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.5 90.25 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 127.097 2.159 . . . . 0.0 111.37 157.211 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -102.53 175.93 5.34 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 120.848 -1.158 . . . . 0.0 109.132 166.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -60.13 116.06 3.93 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -173.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 . . . . . 0 C--O 1.226 -0.159 0 C-N-CA 124.05 0.94 . . . . 0.0 109.331 -178.115 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.781 0 N-CA-C 102.514 -3.143 . . . . 0.0 102.514 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -69.91 123.28 21.11 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 -175.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.2 pt -108.18 174.19 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 121.229 -0.919 . . . . 0.0 108.707 176.311 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.443 ' HB2' ' SG ' ' A' ' 112' ' ' CYS . 14.4 t80 -109.57 165.54 11.59 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.429 0.692 . . . . 0.0 109.37 168.25 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.2 p -121.45 133.99 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -59.58 -52.15 66.8 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.49 0.662 . . . . 0.0 111.843 -177.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.11 -35.29 0.27 Allowed Glycine 0 CA--C 1.526 0.78 0 CA-C-O 123.708 1.727 . . . . 0.0 110.793 -167.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -55.44 -23.73 26.88 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 129.927 3.291 . . . . 0.0 114.202 178.464 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -134.92 32.32 3.23 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 119.897 1.226 . . . . 0.0 110.157 -179.21 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.17 8.58 5.15 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 115.559 1.688 . . . . 0.0 115.559 178.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.69 -86.42 0.14 Allowed 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 117.677 -1.154 . . . . 0.0 109.139 174.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -162.6 18.07 0.15 Allowed Glycine 0 C--N 1.337 0.61 0 CA-C-N 119.366 0.985 . . . . 0.0 113.744 177.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -44.88 156.36 0.36 Allowed Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 126.474 1.91 . . . . 0.0 111.82 173.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -64.87 -2.15 5.1 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 124.471 3.447 . . . . 0.0 115.25 -172.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.512 ' O ' HG22 ' A' ' 19' ' ' VAL . 11.0 m120 -112.47 -10.52 13.72 Favored 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 125.115 1.366 . . . . 0.0 110.894 -165.271 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -56.73 -30.15 63.24 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.091 0.859 . . . . 0.0 111.487 -173.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.5 -27.84 27.71 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.512 HG22 ' O ' ' A' ' 16' ' ' ASN . 17.1 m -69.14 -11.09 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 118.785 0.72 . . . . 0.0 112.499 -170.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.5 ptp -102.79 -0.58 31.23 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.168 1.787 . . . . 0.0 113.232 171.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.0 mt -102.77 4.41 37.9 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.735 1.614 . . . . 0.0 110.694 -178.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -117.39 77.88 1.17 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 -172.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -58.9 -15.28 11.94 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.094 1.758 . . . . 0.0 114.066 -165.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.3 m -61.02 -37.1 81.36 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 120.499 -1.375 . . . . 0.0 112.013 166.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 45.3 m170 -65.78 -29.25 69.72 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.599 0.636 . . . . 0.0 110.529 175.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.57 -178.4 22.49 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 124.171 0.891 . . . . 0.0 111.184 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 46.3 tp -95.9 144.55 26.14 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.976 0.91 . . . . 0.0 111.996 -173.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.71 147.38 46.73 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.617 1.167 . . . . 0.0 108.288 163.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -146.07 134.33 21.74 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 125.574 1.549 . . . . 0.0 109.655 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.93 93.27 0.4 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.482 1.113 . . . . 0.0 110.11 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.1 tpp180 -110.63 64.87 0.61 Allowed 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 126.05 1.74 . . . . 0.0 108.146 -176.031 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.52 179.08 43.81 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-O 122.848 1.249 . . . . 0.0 112.442 172.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 38.3 mtp180 -125.3 165.06 19.03 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 123.423 0.689 . . . . 0.0 110.776 173.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -173.59 176.13 46.21 Favored Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 120.39 -0.91 . . . . 0.0 113.564 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.448 ' C ' HG23 ' A' ' 95' ' ' VAL . 71.6 m -138.85 133.54 32.13 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.371 1.068 . . . . 0.0 108.877 177.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.1 p -63.55 100.87 0.29 Allowed 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -73.12 -23.6 20.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-O 120.83 0.348 . . . . 0.0 110.833 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -60.41 100.74 0.11 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 152.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.5 m -56.6 137.41 53.85 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 167.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.686 ' HB3' HD21 ' A' ' 53' ' ' LEU . 25.0 m-85 -138.58 156.62 73.08 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 -176.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.441 ' HG2' ' HB2' ' A' ' 54' ' ' LEU . 54.9 Cg_endo -76.27 94.91 1.02 Allowed 'Trans proline' 0 CA--C 1.538 0.682 1 C-N-CA 126.032 4.488 . . . . 0.0 111.607 177.342 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 32.0 tp -93.21 114.33 26.78 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 121.134 -0.979 . . . . 0.0 109.96 174.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.4 m -131.66 143.73 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 119.198 0.908 . . . . 0.0 110.463 -173.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 55.6 mt -97.73 108.86 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -178.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -117.62 -179.68 3.8 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.52 0.728 . . . . 0.0 110.346 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.25 161.53 6.6 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 126.424 1.964 . . . . 0.0 115.382 163.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -65.76 -22.54 66.59 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 127.782 2.433 . . . . 0.0 114.303 -170.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 39.1 m-70 -109.85 13.47 23.54 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.813 0.845 . . . . 0.0 111.821 176.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.9 m120 60.38 64.49 1.2 Allowed 'General case' 0 C--N 1.344 0.365 0 CA-C-O 122.262 1.03 . . . . 0.0 108.251 -179.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 55.4 mt -104.72 87.43 1.8 Allowed Pre-proline 0 N--CA 1.45 -0.427 0 C-N-CA 127.874 2.47 . . . . 0.0 105.403 177.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.08 152.0 25.88 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 120.684 0.923 . . . . 0.0 112.825 166.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 22.4 m95 -130.24 166.64 19.9 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.056 1.342 . . . . 0.0 107.391 175.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.686 HD21 ' HB3' ' A' ' 40' ' ' PHE . 1.2 tm? -138.85 119.7 14.27 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.441 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 0.1 OUTLIER -95.89 147.43 23.67 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 113.392 -1.731 . . . . 0.0 107.834 -169.499 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -78.66 87.19 4.59 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.977 -176.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -140.93 77.57 20.88 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 124.036 0.934 . . . . 0.0 111.103 179.024 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.68 115.68 4.33 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 124.885 3.723 . . . . 0.0 110.442 -176.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 117.23 11.81 8.67 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 124.751 1.167 . . . . 0.0 113.595 175.172 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.2 tpmt? -138.0 149.06 45.76 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 119.599 1.699 . . . . 0.0 108.808 -176.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.96 -135.32 14.87 Favored Glycine 0 CA--C 1.521 0.465 0 CA-C-N 120.601 1.546 . . . . 0.0 109.507 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -134.97 169.89 16.72 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 118.889 1.345 . . . . 0.0 111.787 -167.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 59.2 m -85.48 103.47 14.38 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 125.358 1.463 . . . . 0.0 108.543 -178.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.0 t -69.8 106.23 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 51.3 p -81.88 147.51 29.27 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.286 -0.884 . . . . 0.0 110.026 -173.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -173.46 -156.52 13.32 Favored Glycine 0 C--N 1.342 0.898 0 O-C-N 121.402 -0.811 . . . . 0.0 113.097 -172.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -134.73 162.62 31.85 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -176.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 89.5 mt -114.43 103.27 15.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 106.301 -1.741 . . . . 0.0 106.301 -170.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -86.07 114.08 22.65 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 172.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -61.5 131.9 51.66 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 152.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.9 m -135.52 156.24 38.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.42 177.64 5.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 122.209 1.004 . . . . 0.0 111.505 172.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.57 -36.01 75.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.057 -1.429 . . . . 0.0 111.342 177.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 32.1 tp60 -63.87 -44.46 93.01 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.292 0.951 . . . . 0.0 110.13 177.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 35.2 tpp -66.96 -50.46 62.22 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 118.629 0.649 . . . . 0.0 110.938 177.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.2 mt -64.14 -16.65 62.32 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 118.592 0.633 . . . . 0.0 111.34 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 45.4 mtt180 -82.15 -50.59 8.86 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 120.429 -1.42 . . . . 0.0 111.555 165.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -54.14 -48.21 71.07 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 120.338 1.426 . . . . 0.0 111.041 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.3 tp -64.47 -23.22 67.2 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 121.823 -0.548 . . . . 0.0 110.96 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.545 ' HA ' ' SG ' ' A' ' 84' ' ' CYS . 28.0 t70 -75.98 -5.9 48.48 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 120.858 -1.151 . . . . 0.0 112.503 176.561 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -105.92 -42.87 5.01 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.765 1.626 . . . . 0.0 110.604 172.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -65.68 -38.96 90.72 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.838 0.855 . . . . 0.0 112.139 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.497 ' HG3' ' CE2' ' A' ' 115' ' ' TYR . 7.5 mm-40 -83.34 10.57 8.33 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.164 0.585 . . . . 0.0 111.406 178.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.9 t70 61.3 0.32 0.42 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 128.522 2.729 . . . . 0.0 114.882 178.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.545 ' SG ' ' HA ' ' A' ' 79' ' ' ASP . 24.6 p -65.99 153.04 92.53 Favored Pre-proline 0 N--CA 1.448 -0.57 0 C-N-CA 124.167 0.987 . . . . 0.0 109.757 -167.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -75.41 -4.96 22.51 Favored 'Cis proline' 0 CA--C 1.54 0.797 0 N-CA-C 115.915 1.467 . . . . 0.0 115.915 9.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 m -54.68 -71.31 0.08 Allowed 'General case' 0 C--O 1.237 0.435 0 CA-C-N 119.601 1.092 . . . . 0.0 112.758 -178.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 46.2 mtp -71.86 -64.84 0.85 Allowed 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -173.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -105.7 167.0 10.06 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.31 1.444 . . . . 0.0 108.908 -178.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -127.72 -14.1 5.19 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -177.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? 61.91 145.78 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 128.3 2.64 . . . . 0.0 111.756 -172.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.402 HG22 ' N ' ' A' ' 92' ' ' ALA . 38.3 m -148.69 178.12 8.92 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 119.797 -1.814 . . . . 0.0 107.261 171.235 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.402 ' N ' HG22 ' A' ' 91' ' ' THR . . . -116.59 142.09 47.33 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 127.181 2.193 . . . . 0.0 111.062 168.366 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.497 HD21 ' SG ' ' A' ' 112' ' ' CYS . 0.0 OUTLIER -136.31 -174.17 3.61 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 129.204 3.001 . . . . 0.0 110.674 -170.798 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -115.75 126.36 53.95 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 126.145 1.778 . . . . 0.0 111.614 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.65 HG13 HG22 ' A' ' 110' ' ' VAL 0.321 1.4 p -142.29 115.16 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 121.063 3.727 . . . . 0.0 121.063 -167.085 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.436 ' HA ' ' O ' ' A' ' 108' ' ' ASP . 59.0 tt0 -60.92 118.22 6.43 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 113.986 -1.461 . . . . 0.0 107.184 -169.065 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.584 HG13 ' HA ' ' A' ' 108' ' ' ASP 0.331 1.6 p -85.69 87.51 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 O-C-N 124.544 1.153 . . . . 0.0 108.623 -178.284 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.425 HD13 ' HA ' ' A' ' 98' ' ' LEU . 1.7 mm? -57.95 -40.12 79.78 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 112.919 -1.946 . . . . 0.0 109.694 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -152.15 152.58 32.47 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 -177.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 -140.3 129.65 23.91 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -179.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -118.2 97.62 5.88 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.023 1.329 . . . . 0.0 114.094 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.98 -175.7 21.56 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -178.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -67.41 178.4 1.58 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.494 0.717 . . . . 0.0 111.203 -174.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.403 ' O ' ' HD3' ' A' ' 106' ' ' PRO . . . 92.38 47.06 3.36 Favored Glycine 0 C--O 1.22 -0.754 0 O-C-N 120.858 -1.151 . . . . 0.0 110.809 169.429 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -101.63 88.47 1.2 Allowed Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 131.128 3.771 . . . . 0.0 112.228 -153.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.558 ' CG ' HG12 ' A' ' 110' ' ' VAL . 89.8 Cg_endo -70.91 -32.38 13.89 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 124.295 3.33 . . . . 0.0 114.731 -175.398 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 143.17 -95.75 0.19 Allowed Glycine 0 C--N 1.339 0.717 0 CA-C-N 120.899 1.681 . . . . 0.0 112.783 -178.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.584 ' HA ' HG13 ' A' ' 97' ' ' VAL . 2.1 m-20 -156.44 6.25 0.18 Allowed 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 125.448 1.499 . . . . 0.0 111.066 -172.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -142.86 154.71 44.4 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 117.815 -1.554 . . . . 0.0 109.549 150.187 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.65 HG22 HG13 ' A' ' 95' ' ' VAL . 3.1 m -126.01 165.31 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.03 0 C-N-CA 117.09 -1.844 . . . . 0.0 109.624 -175.02 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -101.77 100.2 10.52 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 104.745 -2.317 . . . . 0.0 104.745 167.486 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.497 ' SG ' HD21 ' A' ' 93' ' ' LEU . 3.0 p -102.36 -166.75 1.32 Allowed 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 172.372 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -121.79 146.4 47.1 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.677 1.591 . . . . 0.0 108.714 166.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 20.2 t -139.4 137.85 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 129.778 3.231 . . . . 0.0 107.599 177.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.497 ' CE2' ' HG3' ' A' ' 82' ' ' GLU . 4.3 m-85 -79.92 80.33 6.34 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.898 1.279 . . . . 0.0 111.499 -175.103 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 51.6 p -80.41 175.71 10.42 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.96 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.0 t -136.12 129.79 32.35 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 105.153 -2.166 . . . . 0.0 105.153 162.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -89.67 -0.81 57.77 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.925 0.89 . . . . 0.0 110.709 172.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 10.1 t -116.25 31.75 6.53 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.674 1.989 . . . . 0.0 110.903 -178.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -56.85 163.48 1.92 Allowed 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.672 -0.642 . . . . 0.0 109.819 166.03 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -98.07 154.97 37.51 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 123.772 0.829 . . . . 0.0 110.572 172.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -64.29 -33.4 59.49 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.572 2.181 . . . . 0.0 111.235 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -67.07 -7.4 22.64 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.918 0.887 . . . . 0.0 112.675 177.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 44.1 m0 -96.88 -18.52 19.46 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 118.809 0.731 . . . . 0.0 111.34 170.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 18.8 mt -79.0 -16.97 56.18 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 120.094 1.315 . . . . 0.0 112.39 175.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -77.74 -25.03 48.92 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.563 0.745 . . . . 0.0 110.722 174.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 88.7 mt -59.79 151.57 62.67 Favored Pre-proline 0 C--N 1.344 0.35 0 C-N-CA 124.569 1.148 . . . . 0.0 110.678 -175.074 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -74.86 142.47 28.38 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.029 2.486 . . . . 0.0 109.15 179.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -86.78 167.25 14.58 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.893 0.854 . . . . 0.0 111.628 -175.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -136.5 171.2 14.83 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.429 1.492 . . . . 0.0 108.665 175.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 -127.99 -15.27 4.84 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 123.178 1.466 . . . . 0.0 111.572 -167.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 40.1 t -153.89 151.38 29.4 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 163.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -82.95 170.41 14.96 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 162.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 174.92 147.82 0.08 Allowed 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 128.168 2.587 . . . . 0.0 107.771 152.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.53 -31.7 72.89 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 173.369 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -77.07 66.79 2.95 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 127.911 2.485 . . . . 0.0 107.442 168.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -130.27 154.37 20.56 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 162.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -73.66 -13.78 24.63 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.597 2.198 . . . . 0.0 113.323 -165.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -75.21 -15.66 60.53 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.04 1.336 . . . . 0.0 113.878 -172.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 81.63 -62.0 4.56 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.111 -1.195 . . . . 0.0 110.111 -173.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.7 87.11 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.729 2.012 . . . . 0.0 114.053 -176.257 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.86 173.69 11.32 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 130.16 3.384 . . . . 0.0 109.256 172.729 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -64.11 130.61 44.63 Favored 'General case' 0 C--O 1.237 0.404 0 O-C-N 123.605 0.565 . . . . 0.0 110.482 -161.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 . . . . . 0 N--CA 1.453 -0.313 0 O-C-N 124.436 1.085 . . . . 0.0 110.56 -166.095 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.377 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -130.81 152.36 50.23 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 163.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.9 pt -138.59 172.14 14.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 121.849 0.833 . . . . 0.0 109.793 175.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.594 ' CE2' HG23 ' A' ' 36' ' ' THR . 63.8 t80 -118.15 133.27 56.05 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.969 1.708 . . . . 0.0 107.882 179.155 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.1 m -91.25 138.06 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 118.982 0.81 . . . . 0.0 110.74 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.617 ' HE1' HD22 ' A' ' 53' ' ' LEU . 87.1 m-85 -75.02 -36.03 61.94 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 127.61 2.364 . . . . 0.0 112.156 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 156.29 -37.86 0.59 Allowed Glycine 0 CA--C 1.522 0.505 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -168.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 p -62.13 -23.31 66.49 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.537 1.535 . . . . 0.0 112.993 -167.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.5 mp -134.13 62.51 1.65 Allowed 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 170.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -154.95 -49.2 0.09 Allowed 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.751 1.62 . . . . 0.0 110.647 -176.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -84.45 -86.4 0.12 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.869 0.759 . . . . 0.0 110.221 173.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -172.65 29.87 0.1 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -173.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.61 162.83 13.87 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 125.127 1.371 . . . . 0.0 110.166 -179.127 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -59.87 -17.48 44.02 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.849 2.366 . . . . 0.0 112.872 -177.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.684 ' O ' HG22 ' A' ' 19' ' ' VAL . 4.6 m-80 -85.09 -17.05 38.55 Favored 'General case' 0 C--O 1.215 -0.729 0 O-C-N 120.877 -1.139 . . . . 0.0 110.575 -175.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -58.5 -35.9 72.96 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 120.981 1.719 . . . . 0.0 112.272 -163.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.64 -16.74 51.26 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 177.096 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.684 HG22 ' O ' ' A' ' 16' ' ' ASN . 31.7 m -64.08 -38.69 83.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 120.155 1.343 . . . . 0.0 110.54 -176.502 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.5 ptp -77.31 -10.48 59.46 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.1 mt -82.16 -14.43 55.67 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 122.869 0.468 . . . . 0.0 111.148 -173.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -106.31 100.21 9.76 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 -177.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 22.1 t-80 -56.28 -22.56 30.95 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.334 1.054 . . . . 0.0 113.513 -171.105 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.9 m -69.37 -20.86 63.83 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 120.482 -1.386 . . . . 0.0 113.539 174.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 30.7 m170 -76.6 -26.46 55.02 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.348 -0.845 . . . . 0.0 109.86 167.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 145.98 175.71 19.25 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 125.333 1.444 . . . . 0.0 111.222 167.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.8 tp -83.59 141.85 31.26 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 124.159 0.984 . . . . 0.0 111.852 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -145.09 92.76 2.3 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.231 1.812 . . . . 0.0 110.234 170.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -103.19 126.97 50.62 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 125.322 1.449 . . . . 0.0 110.072 -174.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -64.68 105.63 1.02 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.119 1.768 . . . . 0.0 110.44 -175.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.438 ' HG3' ' HB2' ' A' ' 69' ' ' GLU . 32.6 mmt180 -119.18 66.36 0.79 Allowed 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 125.755 1.622 . . . . 0.0 109.627 -178.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.65 -177.76 37.59 Favored Glycine 0 CA--C 1.523 0.539 0 CA-C-O 121.727 0.626 . . . . 0.0 112.134 172.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 8.9 ptt180 -131.48 164.49 25.66 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.194 0.998 . . . . 0.0 108.666 178.236 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -170.75 -178.82 41.66 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 119.447 -1.358 . . . . 0.0 116.417 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.423 ' C ' HG23 ' A' ' 95' ' ' VAL . 22.6 p -140.73 137.32 33.37 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.88 0.872 . . . . 0.0 110.595 173.362 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.594 HG23 ' CE2' ' A' ' 5' ' ' PHE . 9.9 p -68.32 100.78 1.1 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 176.406 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.439 ' CG1' ' HB2' ' A' ' 96' ' ' GLN . 2.2 m -68.78 -31.84 52.39 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-O 121.011 0.434 . . . . 0.0 111.031 -175.433 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.88 119.5 11.4 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 163.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.7 159.11 11.4 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 119.173 -1.011 . . . . 0.0 108.892 168.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -150.62 154.6 35.45 Favored Pre-proline 0 C--N 1.316 -0.87 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 176.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -80.93 88.72 1.36 Allowed 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 124.638 3.558 . . . . 0.0 112.435 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.4 tp -83.13 88.67 6.89 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 120.655 -1.278 . . . . 0.0 110.619 -177.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.537 HG13 ' HB3' ' A' ' 127' ' ' LEU . 61.5 t -92.59 150.82 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.181 0 C-N-CA 126.704 2.002 . . . . 0.0 109.829 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.8 mt -119.5 113.96 42.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 126.312 1.845 . . . . 0.0 107.409 176.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -137.66 158.09 45.11 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.642 0.734 . . . . 0.0 112.051 -172.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.34 169.12 37.09 Favored Glycine 0 CA--C 1.537 1.413 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.818 175.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.9 -28.48 70.08 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -168.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -96.08 2.18 53.07 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.988 0.18 . . . . 0.0 110.813 -161.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 67.23 59.32 0.52 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.071 2.148 . . . . 0.0 108.52 176.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 61.7 mt -104.3 91.18 3.68 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 129.794 3.237 . . . . 0.0 108.745 -168.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -56.76 136.82 78.46 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 CA-C-N 120.708 1.288 . . . . 0.0 111.264 172.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -123.83 105.94 10.06 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 126.09 1.756 . . . . 0.0 108.566 -177.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.617 HD22 ' HE1' ' A' ' 7' ' ' TYR . 7.9 tp -76.76 81.53 3.37 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -175.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.1 mp -50.78 125.97 14.65 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 127.105 2.162 . . . . 0.0 110.027 174.261 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -73.97 85.01 1.76 Allowed 'General case' 0 C--O 1.239 0.548 0 CA-C-O 119.034 -0.508 . . . . 0.0 111.656 -173.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.411 HD11 ' HE2' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -136.66 80.21 38.43 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 118.672 0.669 . . . . 0.0 110.651 174.965 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -63.53 119.97 7.23 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.788 2.325 . . . . 0.0 111.549 -175.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.69 14.69 57.87 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 125.412 1.482 . . . . 0.0 113.262 178.085 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.411 ' HE2' HD11 ' A' ' 56' ' ' LEU . 0.9 OUTLIER -122.17 140.87 52.06 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 119.601 1.701 . . . . 0.0 109.172 163.965 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.23 -133.36 11.74 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 118.798 -1.001 . . . . 0.0 110.943 -171.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -141.76 169.6 17.3 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 118.871 1.336 . . . . 0.0 112.523 -157.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 27.3 m -103.33 103.79 13.84 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.621 1.168 . . . . 0.0 112.497 -166.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 14.1 t -70.05 116.25 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 123.825 0.85 . . . . 0.0 109.789 -177.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 67.6 p -80.41 146.9 31.23 Favored 'General case' 0 C--O 1.24 0.562 0 O-C-N 121.619 -0.676 . . . . 0.0 109.72 171.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -170.81 -168.22 32.25 Favored Glycine 0 N--CA 1.447 -0.574 0 O-C-N 121.386 -0.821 . . . . 0.0 111.957 -175.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 17.5 mt-10 -129.64 169.57 14.88 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 125.614 1.566 . . . . 0.0 108.548 -176.591 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.4 mt -122.89 130.57 74.39 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 O-C-N 121.298 -0.876 . . . . 0.0 108.82 -170.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -122.75 121.93 37.51 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 125.125 1.37 . . . . 0.0 107.67 171.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.438 ' HB2' ' HG3' ' A' ' 31' ' ' ARG . 78.5 tt0 -64.47 135.4 56.02 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 158.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.7 m -135.69 139.01 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -173.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.48 -179.28 5.15 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.7 0.762 . . . . 0.0 110.012 176.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -63.13 -35.08 79.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 118.289 -0.862 . . . . 0.0 111.543 -173.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 44.1 tp60 -64.92 -42.55 94.61 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 118.869 0.758 . . . . 0.0 110.146 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.1 tpp -64.5 -52.37 58.19 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.8 tp -57.67 -44.19 85.57 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 118.688 -0.672 . . . . 0.0 110.822 -176.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.4 mtt180 -64.62 -34.36 78.1 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.674 0.79 . . . . 0.0 112.193 176.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -67.33 -47.5 70.3 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 118.561 0.618 . . . . 0.0 110.416 177.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.7 mt -60.05 -34.95 74.1 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 175.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.98 -6.54 12.99 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.046 1.738 . . . . 0.0 113.787 178.176 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -115.96 -24.5 8.08 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.501 1.921 . . . . 0.0 110.739 176.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -68.71 -41.02 79.66 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.584 1.154 . . . . 0.0 111.271 -174.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -105.75 14.58 28.05 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.984 0.914 . . . . 0.0 111.258 -170.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 58.13 25.62 12.69 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.21 1.004 . . . . 0.0 112.332 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -70.47 161.62 75.55 Favored Pre-proline 0 CA--C 1.546 0.827 0 O-C-N 119.73 -1.856 . . . . 0.0 109.739 168.31 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -70.87 -3.76 9.44 Favored 'Cis proline' 0 CA--C 1.545 1.06 0 CA-C-N 119.551 0.875 . . . . 0.0 113.734 -9.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 m -55.16 -60.77 2.93 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.152 1.781 . . . . 0.0 111.277 -176.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 19.2 mtm -81.83 -64.32 1.21 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 122.019 0.914 . . . . 0.0 110.49 -179.008 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -102.54 169.99 8.31 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 125.525 1.53 . . . . 0.0 109.381 -178.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.1 mp0 -135.34 143.33 46.06 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.975 1.31 . . . . 0.0 108.394 173.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -78.16 130.04 35.86 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 177.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.9 m -132.16 174.29 10.35 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 125.146 1.378 . . . . 0.0 109.052 -175.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -115.44 151.19 35.19 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.485 1.514 . . . . 0.0 111.153 166.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.573 ' HG ' HG21 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -140.24 -160.98 1.13 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.457 1.503 . . . . 0.0 112.351 -178.09 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -136.9 124.11 21.78 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.796 2.039 . . . . 0.0 110.121 174.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.501 HG21 ' CD1' ' A' ' 5' ' ' PHE . 1.4 p -139.21 116.19 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 116.9 2.185 . . . . 0.0 116.9 -168.009 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.439 ' HB2' ' CG1' ' A' ' 37' ' ' VAL . 9.9 tt0 -54.54 122.45 10.58 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 124.939 1.296 . . . . 0.0 109.222 -174.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.414 ' CG1' ' HB2' ' A' ' 100' ' ' TRP . 93.1 t -76.57 88.64 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 128.654 2.782 . . . . 0.0 106.509 174.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 mp -75.78 -15.56 60.24 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.271 0.628 . . . . 0.0 111.578 177.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.436 ' HB2' ' CZ ' ' A' ' 33' ' ' ARG . 0.4 OUTLIER -160.32 161.33 33.24 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 128.051 2.541 . . . . 0.0 106.626 161.234 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 100' ' ' TRP . . . . . 0.414 ' HB2' ' CG1' ' A' ' 97' ' ' VAL . 68.7 t-105 -143.49 102.24 3.91 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.584 1.554 . . . . 0.0 109.62 174.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -95.04 77.82 3.54 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.31 1.044 . . . . 0.0 109.987 -178.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 161.7 178.97 36.07 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-O 122.358 0.977 . . . . 0.0 111.651 174.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -70.21 168.4 15.85 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 168.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.65 65.65 1.65 Allowed Glycine 0 CA--C 1.524 0.594 0 O-C-N 121.377 -0.827 . . . . 0.0 111.646 172.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -101.3 90.11 1.58 Allowed Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 128.002 2.521 . . . . 0.0 109.017 -168.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -68.8 5.06 1.47 Allowed 'Trans proline' 0 CA--C 1.54 0.819 1 C-N-CA 126.361 4.707 . . . . 0.0 114.434 -165.253 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.05 -174.47 27.63 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 108.921 -1.671 . . . . 0.0 108.921 -168.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -65.56 -14.37 60.95 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 117.759 -1.115 . . . . 0.0 113.963 -168.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 75.6 p -138.82 169.17 18.28 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 121.136 1.789 . . . . 0.0 111.061 174.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.455 ' CG1' HG13 ' A' ' 95' ' ' VAL . 14.3 p -133.91 144.8 34.59 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.76 0 CA-C-N 121.616 2.007 . . . . 0.0 110.768 -173.334 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -92.04 84.77 5.35 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 171.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.463 ' SG ' HD11 ' A' ' 93' ' ' LEU . 1.6 p -89.43 -167.75 1.96 Allowed 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 175.408 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -109.86 151.66 26.75 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 122.736 1.255 . . . . 0.0 112.285 160.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.573 HG21 ' HG ' ' A' ' 93' ' ' LEU . 0.1 OUTLIER -152.07 119.42 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 104.782 -2.303 . . . . 0.0 104.782 -163.738 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -67.4 129.5 40.09 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 121.828 -0.545 . . . . 0.0 109.966 167.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.579 HG22 HD23 ' A' ' 53' ' ' LEU . 14.2 p -127.56 -170.05 2.16 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 125.807 1.643 . . . . 0.0 107.059 176.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.2 t -144.14 147.39 33.64 Favored 'General case' 0 C--O 1.239 0.535 0 O-C-N 120.699 -1.251 . . . . 0.0 108.33 161.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -108.33 -10.14 15.38 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.0 1.32 . . . . 0.0 111.727 171.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 9.0 t -98.85 25.52 6.54 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.633 1.173 . . . . 0.0 111.909 -172.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -60.38 146.43 44.36 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.501 1.12 . . . . 0.0 111.329 176.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.66 155.27 89.56 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 124.873 1.269 . . . . 0.0 110.634 173.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.18 -33.6 18.41 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 121.398 1.399 . . . . 0.0 112.759 -178.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -58.52 -25.37 62.36 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.45 -0.781 . . . . 0.0 112.611 172.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 41.5 m0 -80.43 -4.88 55.4 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 120.969 -1.082 . . . . 0.0 112.686 -175.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -72.35 -34.09 67.77 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 119.498 1.044 . . . . 0.0 109.979 168.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -81.96 -21.89 36.95 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.996 0.918 . . . . 0.0 111.394 -177.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.537 ' HB3' HG13 ' A' ' 43' ' ' VAL . 15.9 mt -55.93 149.44 33.65 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 124.036 0.934 . . . . 0.0 110.151 177.079 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.49 156.76 64.5 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.117 1.878 . . . . 0.0 110.924 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -102.51 162.91 12.55 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 126.559 1.944 . . . . 0.0 107.455 173.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -132.49 177.91 7.24 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 173.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -128.0 -14.5 4.97 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.308 1.443 . . . . 0.0 112.422 -169.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.9 p -154.9 173.93 15.83 Favored 'General case' 0 C--O 1.239 0.542 0 O-C-N 120.652 -1.28 . . . . 0.0 109.854 163.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -120.83 136.18 54.98 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 123.795 0.838 . . . . 0.0 111.452 -177.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -163.19 128.61 3.14 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.325 1.05 . . . . 0.0 109.915 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 49.8 m -75.81 -0.32 20.7 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.257 1.423 . . . . 0.0 113.929 177.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -125.95 22.61 7.34 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.57 1.548 . . . . 0.0 109.287 173.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -79.59 164.73 49.23 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 121.604 -0.685 . . . . 0.0 111.509 177.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -60.66 -18.2 53.81 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.62 2.88 . . . . 0.0 112.865 -177.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -58.45 -17.19 18.9 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 127.427 2.291 . . . . 0.0 115.466 -174.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 79.96 -50.84 3.98 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 119.86 1.209 . . . . 0.0 113.462 174.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.04 110.93 9.75 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.491 1.516 . . . . 0.0 110.306 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.8 mmt85 -117.35 149.45 40.48 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 118.22 -0.895 . . . . 0.0 109.932 -176.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -62.61 135.36 57.35 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.687 1.131 . . . . 0.0 110.199 -176.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 . . . . . 0 CA--C 1.533 0.319 0 C-N-CA 123.821 0.848 . . . . 0.0 110.843 -176.045 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.359 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -75.47 152.03 37.96 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.8 pt -130.66 -177.25 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 175.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.444 ' CD1' HG11 ' A' ' 95' ' ' VAL . 63.5 t80 -128.98 167.56 17.28 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 124.441 1.097 . . . . 0.0 108.128 169.152 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.7 p -124.93 130.89 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 177.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -68.4 -36.68 79.47 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 125.072 1.349 . . . . 0.0 110.501 174.267 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 147.03 29.16 0.07 OUTLIER Glycine 0 C--N 1.339 0.706 0 CA-C-O 116.738 -2.146 . . . . 0.0 116.428 171.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.8 -27.26 13.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 120.195 1.998 . . . . 0.0 110.14 178.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.0 42.72 2.29 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.881 1.272 . . . . 0.0 108.266 -178.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -133.65 -86.53 0.42 Allowed 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.107 -0.996 . . . . 0.0 110.129 -178.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.518 ' HB2' HE22 ' A' ' 14' ' ' GLN . 0.0 OUTLIER -63.03 -63.56 1.17 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.954 0.797 . . . . 0.0 111.529 -163.911 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 171.73 36.7 0.03 OUTLIER Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -174.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.518 HE22 ' HB2' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -102.29 161.08 24.44 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 124.971 1.308 . . . . 0.0 109.052 -174.165 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -85.72 62.46 5.43 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.224 2.616 . . . . 0.0 110.968 -155.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -150.93 -29.87 0.19 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.888 1.675 . . . . 0.0 109.171 179.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -48.4 -34.37 10.74 Favored 'General case' 0 C--N 1.347 0.476 0 C-N-CA 125.481 1.513 . . . . 0.0 111.554 -172.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.56 -34.61 2.19 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 125.755 1.622 . . . . 0.0 115.266 174.291 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.8 m -62.61 -35.25 69.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 120.188 1.358 . . . . 0.0 110.797 -178.015 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.8 ptp -94.28 9.22 38.97 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.447 0.567 . . . . 0.0 111.906 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 68.3 mt -100.66 21.45 13.41 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.217 1.007 . . . . 0.0 108.648 169.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -138.37 99.76 3.93 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 173.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 -58.51 -16.93 17.53 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.473 1.109 . . . . 0.0 112.998 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.65 -22.13 62.54 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.332 1.453 . . . . 0.0 112.064 172.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -81.7 -7.02 59.55 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.858 0.754 . . . . 0.0 111.336 165.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.89 172.26 14.19 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 125.471 1.51 . . . . 0.0 112.212 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -77.99 135.83 37.87 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.888 1.275 . . . . 0.0 110.456 -176.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -141.7 108.78 5.47 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.422 1.089 . . . . 0.0 110.004 162.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -119.33 141.41 49.04 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.871 0.868 . . . . 0.0 109.309 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -64.75 110.78 2.51 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.887 1.275 . . . . 0.0 109.726 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.2 tpp180 -118.06 51.31 1.07 Allowed 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.337 1.455 . . . . 0.0 107.505 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.29 -166.76 44.39 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 122.7 1.167 . . . . 0.0 112.637 175.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 27.6 mtp85 -126.4 164.05 21.96 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.318 -1.107 . . . . 0.0 109.346 -164.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -168.81 175.81 43.2 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 118.845 -1.645 . . . . 0.0 115.692 176.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.4 p -141.7 158.7 43.5 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.886 1.675 . . . . 0.0 109.699 173.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.1 p -80.11 99.47 7.75 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 165.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -61.11 -37.79 78.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 O-C-N 121.254 -0.904 . . . . 0.0 110.741 172.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -60.92 106.49 0.59 Allowed 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 158.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -54.22 140.25 33.28 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 171.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.482 ' HB3' HD21 ' A' ' 53' ' ' LEU . 28.5 m-85 -134.08 154.49 80.21 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 174.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -79.89 95.26 1.02 Allowed 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 123.861 3.041 . . . . 0.0 110.911 173.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.29 115.26 21.9 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 168.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.477 ' CG2' HD13 ' A' ' 54' ' ' LEU . 5.9 m -124.14 133.13 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.325 1.45 . . . . 0.0 108.929 -174.217 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.5 mt -104.85 89.16 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 -169.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -118.43 166.0 13.2 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 122.3 1.048 . . . . 0.0 112.146 -173.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.58 -172.93 34.86 Favored Glycine 0 CA--C 1.537 1.457 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 -176.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -95.38 -21.84 18.11 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 121.309 -1.112 . . . . 0.0 113.292 -175.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -100.18 8.48 43.81 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -173.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.4 m120 59.94 71.87 0.55 Allowed 'General case' 0 CA--C 1.523 -0.087 0 C-N-CA 127.619 2.368 . . . . 0.0 110.706 -178.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 88.5 mt -106.2 88.38 3.12 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 127.323 2.249 . . . . 0.0 107.069 -177.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -60.61 103.05 0.21 Allowed 'Trans proline' 0 CA--C 1.544 1.025 0 C-N-CA 123.703 2.935 . . . . 0.0 112.086 178.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -89.13 129.87 35.66 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.545 1.138 . . . . 0.0 109.094 -177.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.482 HD21 ' HB3' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -93.69 105.26 17.31 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 122.501 1.144 . . . . 0.0 109.567 176.565 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.5 ' HG ' ' CD1' ' A' ' 120' ' ' TYR . 11.0 mp -79.45 137.82 37.38 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 125.45 1.5 . . . . 0.0 110.066 -178.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -78.96 85.12 4.93 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 120.699 0.285 . . . . 0.0 110.567 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.35 85.38 15.41 Favored Pre-proline 0 CA--C 1.529 0.156 0 C-N-CA 123.877 0.871 . . . . 0.0 108.903 168.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -64.06 142.51 81.33 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 N-CA-C 109.085 -1.16 . . . . 0.0 109.085 177.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.65 14.38 82.48 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-O 119.352 -0.693 . . . . 0.0 113.547 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.3 tppt? -125.01 151.19 45.9 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 119.86 1.83 . . . . 0.0 107.308 168.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.93 -140.09 25.3 Favored Glycine 0 CA--C 1.521 0.463 0 CA-C-N 120.178 1.354 . . . . 0.0 109.999 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -139.59 167.14 22.78 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 118.348 1.074 . . . . 0.0 111.339 -161.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 85.8 m -78.69 98.95 6.41 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 122.848 0.459 . . . . 0.0 111.564 -175.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.1 t -61.64 104.42 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 124.535 1.134 . . . . 0.0 108.508 176.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.6 p -80.9 144.17 32.14 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 121.549 -0.719 . . . . 0.0 110.399 177.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.74 -152.55 6.94 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -167.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -144.97 163.99 32.49 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.878 1.271 . . . . 0.0 109.289 -176.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 84.7 mt -117.75 126.37 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 -176.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -115.07 131.49 56.91 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 175.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -64.06 123.55 19.33 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 103.874 -2.639 . . . . 0.0 103.874 150.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.1 m -122.59 161.52 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 169.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -104.82 172.32 6.85 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 173.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -59.11 -36.17 74.7 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.967 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -57.94 -43.21 86.22 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 119.392 0.996 . . . . 0.0 111.858 176.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.8 tpp -67.6 -49.1 64.75 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.0 tp -58.68 -40.49 83.73 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 119.903 -0.719 . . . . 0.0 111.57 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 35.5 mtt180 -60.01 -56.46 21.43 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 124.641 1.176 . . . . 0.0 109.124 177.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -57.6 -49.21 77.18 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.018 0.927 . . . . 0.0 111.063 -176.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.5 mt -61.33 -25.85 67.41 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 121.906 -0.497 . . . . 0.0 111.196 -177.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -69.39 -20.88 63.81 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.187 0.903 . . . . 0.0 110.986 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -83.92 -50.31 8.17 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.189 1.396 . . . . 0.0 110.254 167.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -58.95 -38.1 78.25 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.718 0.807 . . . . 0.0 111.777 -173.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -95.69 15.66 19.45 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -175.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.429 ' O ' ' HB2' ' A' ' 86' ' ' SER . 20.4 m-20 48.35 35.79 6.17 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 128.18 2.592 . . . . 0.0 112.109 172.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.422 ' SG ' ' HB2' ' A' ' 88' ' ' TYR . 65.8 m -73.81 162.25 74.96 Favored Pre-proline 0 CA--C 1.54 0.588 0 O-C-N 120.154 -1.591 . . . . 0.0 109.669 175.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -71.46 -4.65 11.3 Favored 'Cis proline' 0 CA--C 1.541 0.874 0 CA-C-N 119.65 0.911 . . . . 0.0 113.66 -9.076 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.429 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 25.7 m -56.0 -72.28 0.08 Allowed 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.264 1.026 . . . . 0.0 111.401 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 5.2 mtm -74.0 -48.48 29.95 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 119.01 -1.076 . . . . 0.0 108.37 -167.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.422 ' HB2' ' SG ' ' A' ' 84' ' ' CYS . 98.6 m-85 -122.1 163.66 19.09 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.461 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -122.85 115.5 22.09 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 172.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -63.06 130.36 44.32 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 171.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.6 m -132.45 161.75 32.91 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 126.307 1.843 . . . . 0.0 107.163 -175.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -107.6 126.38 52.49 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 174.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.498 HD21 HG23 ' A' ' 114' ' ' VAL . 1.8 pt? -142.7 -166.64 2.33 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.865 1.666 . . . . 0.0 109.817 -167.214 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -125.31 138.57 54.08 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.191 0.996 . . . . 0.0 111.464 -177.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.444 HG11 ' CD1' ' A' ' 5' ' ' PHE . 42.9 t -136.11 140.19 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 177.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -77.68 132.27 38.11 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 170.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.669 HG13 ' HA ' ' A' ' 108' ' ' ASP . 2.6 p -84.55 105.34 13.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 112.932 -1.94 . . . . 0.0 106.872 170.396 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 mp -78.42 -22.95 46.96 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 113.698 -1.592 . . . . 0.0 110.646 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -161.47 139.17 9.06 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 104.209 -2.515 . . . . 0.0 104.209 -179.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 72.4 t-105 -121.36 129.4 53.04 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 174.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -103.62 121.83 43.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.424 0.69 . . . . 0.0 109.25 173.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 98.46 178.36 32.64 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 124.329 0.966 . . . . 0.0 111.107 170.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -87.94 150.55 23.4 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 122.109 0.957 . . . . 0.0 110.998 178.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 113.0 62.54 0.44 Allowed Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 125.715 1.626 . . . . 0.0 109.963 -177.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -102.11 88.72 1.38 Allowed Pre-proline 0 C--O 1.242 0.674 0 C-N-CA 130.659 3.584 . . . . 0.0 111.393 -159.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -66.29 2.42 1.88 Allowed 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 124.89 3.727 . . . . 0.0 116.202 -177.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.32 176.29 35.2 Favored Glycine 0 CA--C 1.525 0.69 0 O-C-N 120.379 -1.45 . . . . 0.0 109.628 -163.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.669 ' HA ' HG13 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -74.48 3.97 6.75 Favored 'General case' 0 CA--C 1.503 -0.857 0 C-N-CA 128.238 2.615 . . . . 0.0 116.375 -156.976 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 56.8 m -143.08 152.54 41.97 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 122.362 2.346 . . . . 0.0 111.809 155.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.6 m -133.34 156.02 41.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 125.284 1.434 . . . . 0.0 109.113 -163.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -92.31 115.72 28.33 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 170.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -121.5 169.64 10.46 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 125.837 1.655 . . . . 0.0 108.487 174.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -90.75 143.16 27.01 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 158.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.498 HG23 HD21 ' A' ' 93' ' ' LEU . 22.3 t -137.7 139.12 43.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 128.036 2.534 . . . . 0.0 107.789 172.607 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -73.26 122.58 22.19 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 167.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 11.1 p -123.02 -172.68 2.55 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 173.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.3 t -135.96 146.05 46.84 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 155.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -105.17 -16.64 14.72 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.307 1.843 . . . . 0.0 110.761 171.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.5 t -122.34 71.75 1.03 Allowed 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -175.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.5 ' CD1' ' HG ' ' A' ' 54' ' ' LEU . 0.3 OUTLIER -88.42 -11.55 45.71 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 125.631 1.572 . . . . 0.0 112.366 179.698 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 68.33 158.62 0.15 Allowed Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 126.248 1.819 . . . . 0.0 110.984 -170.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -69.37 -27.26 28.52 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.307 1.338 . . . . 0.0 113.355 -170.02 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -55.8 -37.95 69.31 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -178.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 0.547 ' HA ' HD23 ' A' ' 127' ' ' LEU . 41.6 m0 -71.98 -10.61 60.02 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 124.646 1.178 . . . . 0.0 111.461 -176.119 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 38.3 mt -80.39 4.9 16.5 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 120.842 -1.161 . . . . 0.0 112.297 171.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -107.08 -1.66 21.83 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 120.3 1.409 . . . . 0.0 113.235 172.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.547 HD23 ' HA ' ' A' ' 124' ' ' TRP . 1.3 mm? -78.62 148.19 72.7 Favored Pre-proline 0 N--CA 1.446 -0.631 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -173.397 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -65.18 146.9 87.72 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 121.433 1.422 . . . . 0.0 108.989 169.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 19.6 m-30 -87.9 157.02 19.08 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.409 0.623 . . . . 0.0 109.681 173.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -127.52 165.99 18.82 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.247 1.019 . . . . 0.0 109.16 178.105 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -110.98 -19.46 12.77 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.708 1.203 . . . . 0.0 111.723 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 13.5 p -155.92 149.32 24.74 Favored 'General case' 0 C--O 1.238 0.477 0 O-C-N 121.263 -0.898 . . . . 0.0 109.514 170.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -97.67 133.47 42.16 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 171.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -140.89 156.24 46.14 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.801 2.04 . . . . 0.0 106.676 176.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.51 -22.71 40.65 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.422 1.489 . . . . 0.0 112.308 176.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -127.4 90.26 3.1 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 103.605 -2.739 . . . . 0.0 103.605 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -130.47 154.72 20.78 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-N 113.922 -1.49 . . . . 0.0 110.808 159.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -64.93 -22.92 62.42 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 123.373 2.715 . . . . 0.0 114.223 -161.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -63.04 -19.5 64.44 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.246 1.418 . . . . 0.0 113.374 178.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 77.67 -29.1 1.78 Allowed Glycine 0 CA--C 1.533 1.16 0 O-C-N 120.755 -1.216 . . . . 0.0 114.311 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.65 83.57 0.07 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.168 1.484 . . . . 0.0 112.193 176.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.95 153.71 50.63 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 128.147 2.579 . . . . 0.0 110.167 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -60.49 133.46 56.12 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 124.081 0.863 . . . . 0.0 110.012 -165.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 . . . . . 0 C--O 1.232 0.162 0 C-N-CA 123.455 0.702 . . . . 0.0 110.154 -171.725 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.46 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -111.19 137.55 48.75 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 162.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.2 pt -129.91 168.14 23.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 175.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -133.67 144.21 49.04 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -178.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.458 ' CG2' ' H ' ' A' ' 66' ' ' GLU . 3.8 m -100.52 169.84 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 124.092 0.957 . . . . 0.0 110.301 -176.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -120.01 -27.88 5.26 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.425 1.09 . . . . 0.0 112.289 172.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 171.72 -56.02 0.17 Allowed Glycine 0 C--N 1.339 0.733 0 C-N-CA 120.583 -0.818 . . . . 0.0 113.082 -161.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -45.28 -45.84 12.33 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 126.063 1.745 . . . . 0.0 111.605 178.092 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.3 mt -125.84 26.36 6.64 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.958 1.303 . . . . 0.0 108.643 -167.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -118.86 -33.32 4.25 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.309 -0.87 . . . . 0.0 113.302 -177.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.562 ' HG3' ' H ' ' A' ' 13' ' ' GLY . 8.9 ptm85 -123.86 -86.39 0.64 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 119.554 1.07 . . . . 0.0 111.176 -178.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.562 ' H ' ' HG3' ' A' ' 12' ' ' ARG . . . -164.63 55.38 0.27 Allowed Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 104.998 -3.241 . . . . 0.0 104.998 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.5 162.36 72.86 Favored Pre-proline 0 N--CA 1.447 -0.618 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 163.444 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -67.66 4.4 1.4 Allowed 'Trans proline' 0 CA--C 1.53 0.288 0 C-N-CA 123.767 2.978 . . . . 0.0 115.404 -173.058 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.738 ' O ' HG22 ' A' ' 19' ' ' VAL . 8.2 m120 -118.68 -8.62 10.36 Favored 'General case' 0 C--O 1.214 -0.79 0 C-N-CA 125.661 1.584 . . . . 0.0 108.609 -166.103 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -58.29 -45.79 87.28 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 119.613 1.097 . . . . 0.0 111.213 -171.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.895 ' HA ' HD13 ' A' ' 21' ' ' LEU . 0.3 OUTLIER -52.37 -21.3 3.45 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.16 1.384 . . . . 0.0 113.785 178.697 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.738 HG22 ' O ' ' A' ' 16' ' ' ASN . 34.7 m -62.27 -18.18 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 120.944 1.702 . . . . 0.0 112.443 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.625 ' HG3' HD12 ' A' ' 21' ' ' LEU . 3.0 ptp -97.4 -9.07 28.05 Favored 'General case' 0 C--N 1.348 0.508 0 CA-C-N 120.524 1.511 . . . . 0.0 110.948 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.895 HD13 ' HA ' ' A' ' 18' ' ' LYS . 8.4 mp -80.77 -31.1 35.97 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.902 1.681 . . . . 0.0 107.477 -174.448 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -70.36 97.2 1.22 Allowed 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 165.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 41.7 t-80 -61.35 -20.96 63.58 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.719 0.771 . . . . 0.0 111.322 171.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 m -51.29 -33.05 27.02 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.649 1.98 . . . . 0.0 112.193 166.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 45.1 m170 -93.58 10.95 30.49 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.028 1.331 . . . . 0.0 112.299 178.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.2 175.88 18.94 Favored Glycine 0 C--N 1.335 0.519 0 CA-C-O 122.313 0.952 . . . . 0.0 112.153 175.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -90.28 133.01 35.22 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.7 1.2 . . . . 0.0 109.68 -174.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -141.83 106.73 4.91 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.724 1.21 . . . . 0.0 110.907 169.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -116.87 125.6 51.75 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 125.519 1.527 . . . . 0.0 109.245 -169.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -68.24 112.11 4.95 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.694 1.198 . . . . 0.0 109.548 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -117.03 58.77 0.77 Allowed 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 123.899 0.88 . . . . 0.0 108.807 171.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.99 -165.74 53.65 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.905 168.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 36.7 mtp85 -116.73 167.49 11.05 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.623 0.769 . . . . 0.0 109.994 -156.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 96' ' ' GLN . . . -164.34 -179.26 38.39 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 116.126 1.21 . . . . 0.0 116.126 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.1 p -152.88 157.84 41.29 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 118.19 -0.91 . . . . 0.0 111.573 172.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.598 HG23 HG13 ' A' ' 63' ' ' VAL . 31.1 p -77.02 101.18 5.92 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 119.891 1.223 . . . . 0.0 108.478 167.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.424 HG13 ' HB2' ' A' ' 96' ' ' GLN . 0.3 OUTLIER -58.91 -52.51 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 119.796 1.18 . . . . 0.0 110.518 173.403 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.407 ' H ' HG23 ' A' ' 37' ' ' VAL . 2.8 mp0 -62.92 110.82 1.9 Allowed 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 166.138 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.6 m -59.33 132.49 54.16 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 178.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -126.75 155.06 75.76 Favored Pre-proline 0 N--CA 1.483 1.2 0 CA-C-N 119.178 0.899 . . . . 0.0 110.621 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.42 ' HG2' ' HB2' ' A' ' 54' ' ' LEU . 72.8 Cg_endo -84.27 107.03 1.2 Allowed 'Trans proline' 0 CA--C 1.532 0.401 1 C-N-CA 125.519 4.146 . . . . 0.0 112.382 -170.696 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.7 tp -106.47 90.72 3.43 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.584 0.754 . . . . 0.0 109.657 -174.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.7 m -108.06 141.93 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.147 0.979 . . . . 0.0 110.206 -167.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.4 mt -103.69 78.51 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -174.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.436 ' HB1' ' CD1' ' A' ' 124' ' ' TRP . . . -110.69 153.67 24.92 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.42 -1.264 . . . . 0.0 110.21 -173.391 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.87 164.74 39.65 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-O 122.314 0.952 . . . . 0.0 111.537 -175.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -92.18 -7.99 46.77 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.504 1.522 . . . . 0.0 112.986 -166.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 62.5 m-70 -107.87 12.1 27.49 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.1 0.96 . . . . 0.0 111.745 174.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 60.79 54.29 3.61 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.731 1.212 . . . . 0.0 110.075 165.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 75.3 mt -103.94 87.81 1.69 Allowed Pre-proline 0 N--CA 1.446 -0.632 0 N-CA-C 103.209 -2.886 . . . . 0.0 103.209 -174.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -62.45 124.2 13.81 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 CA-C-N 120.867 1.345 . . . . 0.0 109.419 -176.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -98.93 132.22 44.42 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -178.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.0 tp -97.66 96.2 8.11 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 169.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.42 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 0.3 OUTLIER -61.87 150.23 38.02 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 121.042 -1.036 . . . . 0.0 108.389 171.679 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -80.27 89.58 5.51 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.355 -0.841 . . . . 0.0 108.966 177.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.71 86.58 11.93 Favored Pre-proline 0 N--CA 1.463 0.18 0 C-N-CA 124.597 1.159 . . . . 0.0 111.396 174.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -63.28 147.63 93.61 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 121.603 1.535 . . . . 0.0 109.341 178.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.49 0.76 59.28 Favored Glycine 0 CA--C 1.537 1.463 0 CA-C-O 118.666 -1.074 . . . . 0.0 114.65 176.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.02 112.45 12.38 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 120.833 2.316 . . . . 0.0 108.192 171.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 150.68 -149.78 21.67 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 119.767 -1.206 . . . . 0.0 112.538 -162.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -140.24 168.5 19.67 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 126.938 2.095 . . . . 0.0 109.28 173.156 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 97.3 m -89.58 78.53 7.02 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 123.596 0.759 . . . . 0.0 111.0 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.598 HG13 HG23 ' A' ' 36' ' ' THR . 1.8 p -61.14 127.38 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.99 0 CA-C-O 118.513 -0.755 . . . . 0.0 109.863 -175.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.91 151.54 25.92 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 177.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -157.4 175.36 34.8 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 175.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.458 ' H ' ' CG2' ' A' ' 6' ' ' VAL . 0.7 OUTLIER -106.09 163.5 12.73 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 168.018 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 68.8 mt -102.42 121.11 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 105.353 -2.092 . . . . 0.0 105.353 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -108.12 119.61 39.96 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 171.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -69.04 127.68 34.0 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.349 -1.722 . . . . 0.0 106.349 161.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.7 m -135.63 163.83 34.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 123.428 0.691 . . . . 0.0 110.258 -174.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.0 179.97 4.12 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 122.276 1.036 . . . . 0.0 112.708 170.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.57 -41.63 90.64 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 125.48 1.512 . . . . 0.0 112.107 175.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -64.6 -43.34 94.1 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 119.9 1.227 . . . . 0.0 110.807 178.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 19.7 tpp -61.29 -49.4 77.19 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 119.167 0.894 . . . . 0.0 108.67 177.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.4 tp -61.66 -38.79 89.04 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 118.816 -0.611 . . . . 0.0 112.033 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 64.2 mtt-85 -70.81 -38.97 73.33 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.835 1.254 . . . . 0.0 111.804 177.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -63.18 -52.54 61.95 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 177.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.1 mp -62.1 -31.53 71.99 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.693 0.797 . . . . 0.0 110.547 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -62.95 -33.02 74.48 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 124.403 1.081 . . . . 0.0 111.044 176.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -79.72 -45.74 18.36 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.071 0.396 . . . . 0.0 111.561 172.028 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -63.38 -42.88 98.85 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.569 0.747 . . . . 0.0 112.131 -170.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -79.96 9.09 5.78 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.559 -0.713 . . . . 0.0 111.951 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.2 t0 49.0 24.68 0.92 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 127.454 2.301 . . . . 0.0 113.346 -174.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 9.0 p -65.67 162.03 47.23 Favored Pre-proline 0 CA--C 1.54 0.564 0 O-C-N 119.684 -1.885 . . . . 0.0 107.061 165.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -69.06 -2.74 6.36 Favored 'Cis proline' 0 CA--C 1.547 1.165 0 N-CA-C 114.889 1.073 . . . . 0.0 114.889 -11.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.2 t -65.68 -67.41 0.44 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.884 1.22 . . . . 0.0 111.98 -178.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 20.6 mtp -71.51 -58.29 3.64 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 123.619 0.768 . . . . 0.0 109.52 -173.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -110.11 174.17 5.99 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 126.864 2.066 . . . . 0.0 108.345 177.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -128.66 -15.27 4.47 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 177.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 60.5 130.42 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 128.25 2.62 . . . . 0.0 112.651 -171.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 98.5 m -136.03 162.49 32.73 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.275 1.03 . . . . 0.0 108.237 175.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -94.6 128.16 41.04 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.93 1.292 . . . . 0.0 110.001 172.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.31 179.54 5.41 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.478 1.911 . . . . 0.0 111.432 178.24 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.8 tp60 -106.63 127.22 53.17 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.655 1.982 . . . . 0.0 109.98 178.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.418 ' CG2' ' SG ' ' A' ' 112' ' ' CYS . 64.3 t -126.27 140.65 48.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 -178.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.424 ' HB2' HG13 ' A' ' 37' ' ' VAL . 46.6 tt0 -72.04 135.84 46.47 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 172.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.6 t -82.13 89.0 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 105.974 -1.861 . . . . 0.0 105.974 167.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.67 -23.68 67.33 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 118.603 -0.713 . . . . 0.0 110.658 177.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -165.53 162.49 19.2 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 128.038 2.535 . . . . 0.0 106.896 171.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 62.6 t-105 -135.2 130.17 34.88 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 125.83 1.652 . . . . 0.0 107.935 176.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -118.2 89.34 3.1 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 121.195 0.521 . . . . 0.0 111.36 176.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 137.33 -172.04 22.89 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-O 123.302 1.501 . . . . 0.0 111.495 173.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.28 125.27 23.02 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 122.35 1.071 . . . . 0.0 113.106 166.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 122.29 81.02 0.56 Allowed Glycine 0 N--CA 1.427 -1.962 0 CA-C-N 111.848 -2.433 . . . . 0.0 110.534 142.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -101.57 89.69 1.54 Allowed Pre-proline 0 C--O 1.24 0.587 0 C-N-CA 131.134 3.774 . . . . 0.0 109.773 -156.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -57.56 -54.52 3.32 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.742 2.294 . . . . 0.0 109.778 -178.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 163.97 -166.8 37.71 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 107.711 -2.156 . . . . 0.0 107.711 -173.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -64.88 -12.13 45.51 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 117.773 0.786 . . . . 0.0 111.969 175.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 61.2 p -133.12 156.39 47.53 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 120.087 1.312 . . . . 0.0 111.615 175.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.9 p -142.48 162.67 18.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 123.889 0.876 . . . . 0.0 109.202 178.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -95.39 135.27 37.23 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.69 1.596 . . . . 0.0 107.94 169.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.418 ' SG ' ' CG2' ' A' ' 95' ' ' VAL . 0.5 OUTLIER -141.27 168.7 19.14 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.797 1.239 . . . . 0.0 110.456 174.593 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -100.28 145.49 28.05 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 172.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 30.9 t -138.54 147.39 25.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 125.193 1.397 . . . . 0.0 107.294 177.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -70.3 109.14 4.53 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 167.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 68.8 p -125.92 172.43 9.92 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 124.111 0.964 . . . . 0.0 108.937 176.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.93 145.9 51.32 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 172.493 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -112.25 -12.23 13.63 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.137 1.775 . . . . 0.0 111.264 171.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 12.2 t -123.43 64.7 1.01 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.497 1.519 . . . . 0.0 107.968 -171.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -101.94 161.06 13.96 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 126.411 1.884 . . . . 0.0 110.523 177.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.49 157.86 87.26 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 125.818 1.647 . . . . 0.0 111.407 172.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -73.86 -33.39 6.34 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 121.97 1.78 . . . . 0.0 112.326 -179.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -46.51 -44.4 17.69 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 125.185 1.394 . . . . 0.0 112.588 175.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 0.436 ' CD1' ' HB1' ' A' ' 45' ' ' ALA . 35.6 m0 -60.48 -22.22 63.27 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 125.723 1.609 . . . . 0.0 112.5 -174.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 32.6 mt -75.22 -10.09 59.15 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 117.699 -1.143 . . . . 0.0 112.787 176.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -95.41 -7.88 37.13 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.437 1.095 . . . . 0.0 112.471 -178.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 124' ' ' TRP . 1.1 mm? -72.9 158.74 86.75 Favored Pre-proline 0 N--CA 1.451 -0.413 0 C-N-CA 125.664 1.585 . . . . 0.0 107.864 -174.465 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -59.52 140.45 94.06 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.626 1.551 . . . . 0.0 108.805 168.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 5.7 m-30 -92.18 156.47 17.31 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.86 0.864 . . . . 0.0 108.8 171.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -141.08 171.95 13.36 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.516 0.726 . . . . 0.0 110.647 -174.248 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -136.62 1.14 2.55 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.314 1.445 . . . . 0.0 111.085 -172.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 86.0 p -152.86 171.68 17.92 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 124.907 1.283 . . . . 0.0 108.656 166.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -121.77 102.45 8.21 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 165.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -117.66 114.9 24.06 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.117 -171.062 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 11.2 t -60.48 -23.69 64.68 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 128.635 2.774 . . . . 0.0 111.654 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -120.57 85.35 2.38 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 127.417 2.287 . . . . 0.0 105.487 175.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -152.49 177.0 30.48 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.037 171.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.62 -15.43 24.42 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.024 1.816 . . . . 0.0 114.247 -174.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -44.96 -62.32 1.28 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.8 2.04 . . . . 0.0 111.339 -176.49 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 109.34 -59.09 0.37 Allowed Glycine 0 N--CA 1.464 0.555 0 C-N-CA 129.284 3.326 . . . . 0.0 110.302 171.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.613 HD13 ' H ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -49.95 73.67 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 130.616 3.567 . . . . 0.0 114.26 163.008 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -98.12 170.25 9.04 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.654 1.582 . . . . 0.0 111.942 172.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -71.31 150.32 45.25 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 123.182 0.301 . . . . 0.0 111.031 -165.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 . . . . . 0 C--O 1.233 0.195 0 C-N-CA 124.71 1.204 . . . . 0.0 108.822 178.079 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ttm . . . . . 0 N--CA 1.466 0.345 0 N-CA-C 110.448 -0.205 . . . . 0.0 110.448 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.6 171.18 14.73 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.834 0.853 . . . . 0.0 110.535 -169.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -119.67 131.25 55.39 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.166 1.387 . . . . 0.0 107.808 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.409 HG22 ' HB2' ' A' ' 113' ' ' PHE . 44.6 pt -123.36 177.48 4.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -131.89 130.17 41.28 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 174.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.9 p -96.7 135.73 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 176.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -72.79 -78.02 0.09 Allowed 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 164.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -139.75 -19.47 0.42 Allowed Glycine 0 C--N 1.335 0.489 0 O-C-N 121.767 -0.583 . . . . 0.0 114.144 -173.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.457 ' C ' HD22 ' A' ' 10' ' ' LEU . 0.8 OUTLIER -77.04 -16.42 59.28 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 120.505 2.152 . . . . 0.0 112.599 -154.333 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.457 HD22 ' C ' ' A' ' 9' ' ' THR . 0.1 OUTLIER -126.12 14.16 7.84 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 126.378 1.871 . . . . 0.0 107.645 176.944 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -104.06 -86.91 0.44 Allowed 'General case' 0 C--N 1.351 0.671 0 CA-C-O 117.355 -1.307 . . . . 0.0 109.381 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.482 ' HB3' HE22 ' A' ' 14' ' ' GLN . 42.0 tpt85 -62.39 -59.89 4.34 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-N 120.752 1.614 . . . . 0.0 111.383 -160.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 172.31 69.04 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 106.265 -2.734 . . . . 0.0 106.265 -170.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.482 HE22 ' HB3' ' A' ' 12' ' ' ARG . 2.2 mp0 -117.29 154.87 50.34 Favored Pre-proline 0 N--CA 1.448 -0.544 0 C-N-CA 124.802 1.241 . . . . 0.0 108.392 -175.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.73 -37.11 97.79 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.743 2.962 . . . . 0.0 111.429 -172.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.411 ' O ' HG22 ' A' ' 19' ' ' VAL . 8.7 m-80 -63.99 -25.18 68.01 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 126.229 1.811 . . . . 0.0 111.939 -172.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -52.17 -34.78 46.57 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.587 1.085 . . . . 0.0 111.423 -170.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.81 -25.92 21.67 Favored 'General case' 0 C--N 1.342 0.276 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -176.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 16' ' ' ASN . 34.3 m -57.49 -48.94 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 118.57 0.623 . . . . 0.0 109.544 -176.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 9.0 ptp -79.13 7.25 7.82 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.393 0.677 . . . . 0.0 112.584 -174.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 76.6 mt -99.64 3.23 45.12 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.473 0.709 . . . . 0.0 111.019 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -131.97 109.26 9.92 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 104.388 -2.449 . . . . 0.0 104.388 174.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 23.3 t-80 -54.27 -24.35 18.54 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.063 1.345 . . . . 0.0 111.608 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 m -67.13 -21.86 65.82 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.979 -1.076 . . . . 0.0 112.954 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -85.07 -7.05 59.28 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 119.492 1.042 . . . . 0.0 111.579 167.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 129.19 167.5 12.15 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 126.037 1.779 . . . . 0.0 111.849 175.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -82.38 137.69 34.67 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.29 1.836 . . . . 0.0 109.174 -176.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -133.57 141.96 47.93 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.462 1.105 . . . . 0.0 108.708 162.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -141.29 140.7 33.9 Favored 'General case' 0 C--O 1.231 0.111 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 166.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -67.11 94.65 0.36 Allowed 'General case' 0 C--O 1.232 0.16 0 C-N-CA 125.921 1.689 . . . . 0.0 107.685 177.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -100.19 53.63 0.9 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -176.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.5 -169.15 46.93 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-O 122.677 1.154 . . . . 0.0 111.698 -177.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -143.44 173.0 12.01 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 121.557 -0.966 . . . . 0.0 110.221 -175.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -175.15 -179.92 46.01 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 119.487 -1.339 . . . . 0.0 115.337 -169.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.7 p -140.49 160.51 39.84 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 114.098 -1.051 . . . . 0.0 111.257 167.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.1 p -81.52 94.27 6.84 Favored 'General case' 0 C--O 1.223 -0.291 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 169.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -62.59 -26.43 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 O-C-N 120.657 -1.277 . . . . 0.0 110.893 171.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -65.93 116.99 7.66 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 161.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.03 120.07 18.15 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 126.241 1.816 . . . . 0.0 109.947 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -123.05 162.06 41.35 Favored Pre-proline 0 N--CA 1.466 0.359 0 CA-C-N 120.481 1.491 . . . . 0.0 107.842 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -79.6 94.32 1.05 Allowed 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 124.695 3.597 . . . . 0.0 109.245 172.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.8 tp -89.09 111.76 22.58 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 164.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.5 m -125.59 145.69 32.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.601 1.16 . . . . 0.0 108.347 -176.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.401 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 3.3 mt -98.85 121.96 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 176.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.73 -172.19 3.33 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.049 0.94 . . . . 0.0 110.763 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.68 155.67 2.27 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 125.45 1.5 . . . . 0.0 111.664 178.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -79.55 -6.17 56.45 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 121.538 -0.978 . . . . 0.0 111.802 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -106.92 9.33 30.81 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.431 1.093 . . . . 0.0 112.299 174.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.433 HD22 ' HB2' ' A' ' 141' ' ' LEU . 2.3 m120 63.73 61.19 1.0 Allowed 'General case' 0 C--N 1.345 0.401 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 176.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 56.5 mt -107.86 87.6 3.82 Favored Pre-proline 0 N--CA 1.446 -0.673 0 C-N-CA 128.358 2.663 . . . . 0.0 104.01 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . 43.5 Cg_endo -64.54 156.86 58.4 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 CA-C-N 120.832 1.333 . . . . 0.0 109.825 174.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 48.3 m95 -132.21 150.11 52.23 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.9 tp -107.39 102.02 11.34 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 168.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.7 mt -74.39 145.66 43.58 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -81.61 85.6 6.52 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.348 -0.845 . . . . 0.0 109.536 -177.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -137.12 86.49 20.14 Favored Pre-proline 0 C--O 1.234 0.25 0 CA-C-O 118.369 -0.824 . . . . 0.0 110.174 -177.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -60.07 133.98 53.47 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 121.084 1.189 . . . . 0.0 111.201 -177.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.57 17.27 77.85 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-O 118.904 -0.942 . . . . 0.0 114.713 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -118.15 121.52 40.72 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 120.376 2.088 . . . . 0.0 106.131 168.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.561 ' HA2' ' CD2' ' A' ' 129' ' ' TYR . . . 108.95 -139.81 15.37 Favored Glycine 0 CA--C 1.52 0.379 0 CA-C-N 120.208 1.367 . . . . 0.0 112.555 172.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 39.7 m-70 -126.86 171.47 11.24 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 124.044 0.938 . . . . 0.0 112.311 -175.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 57.9 m -88.2 105.49 17.56 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 126.647 1.979 . . . . 0.0 110.428 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 71.1 t -72.95 117.25 16.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 64.8 p -70.81 156.33 39.69 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.865 0.866 . . . . 0.0 109.363 167.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 171.24 -159.04 30.74 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 118.975 0.807 . . . . 0.0 112.312 -172.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -137.35 161.49 36.14 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.992 0.917 . . . . 0.0 110.834 -172.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 70.1 mt -120.54 111.83 33.71 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 -175.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -102.74 129.86 49.51 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 174.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -67.51 141.66 56.83 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 156.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.0 m -137.39 153.44 28.72 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 CA-C-O 121.787 0.803 . . . . 0.0 109.925 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -85.9 174.02 9.57 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 123.873 1.796 . . . . 0.0 109.541 164.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.05 -30.31 70.25 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 112.34 -2.209 . . . . 0.0 112.463 177.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -72.64 -41.98 64.9 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-O 116.681 -1.628 . . . . 0.0 111.242 176.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 19.9 tpp -64.16 -44.44 92.1 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 121.178 1.808 . . . . 0.0 108.513 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.6 tp -60.91 -30.35 70.14 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 177.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 47.1 mtt-85 -80.57 -36.83 32.37 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.873 1.269 . . . . 0.0 113.786 174.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -62.19 -47.66 83.48 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 177.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 85.3 mt -62.77 -24.38 67.68 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.787 -0.571 . . . . 0.0 110.812 175.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.484 ' HA ' ' SG ' ' A' ' 84' ' ' CYS . 4.4 t0 -78.19 10.55 2.9 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.794 1.237 . . . . 0.0 113.165 176.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -143.05 -30.95 0.51 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 125.439 1.496 . . . . 0.0 112.598 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -70.11 -31.92 69.7 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.1 0.96 . . . . 0.0 111.09 172.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -92.86 5.62 50.63 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.436 0.694 . . . . 0.0 112.147 -171.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.0 t70 54.17 15.91 1.04 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.722 2.009 . . . . 0.0 113.867 -175.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.484 ' SG ' ' HA ' ' A' ' 79' ' ' ASP . 2.9 p -62.85 150.03 88.45 Favored Pre-proline 0 N--CA 1.45 -0.474 0 O-C-N 120.181 -1.574 . . . . 0.0 108.252 167.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.94 -8.56 30.09 Favored 'Cis proline' 0 CA--C 1.54 0.813 0 N-CA-C 114.926 1.087 . . . . 0.0 114.926 2.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 12.9 m -60.98 -62.19 2.03 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.792 1.237 . . . . 0.0 110.91 -174.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.3 mtp -72.53 -78.17 0.09 Allowed 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -96.03 175.17 6.58 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.579 1.152 . . . . 0.0 110.253 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 6.7 mp0 -130.19 146.49 51.83 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.98 1.712 . . . . 0.0 107.105 164.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -81.63 133.85 35.42 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 175.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.2 m -140.04 168.85 18.85 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.212 1.005 . . . . 0.0 109.481 -174.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -106.45 138.88 41.83 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.141 1.776 . . . . 0.0 110.372 173.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.4 173.2 11.99 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.155 1.382 . . . . 0.0 113.064 175.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -94.95 126.26 40.17 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.041 1.337 . . . . 0.0 111.884 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.4 t -127.61 119.75 52.71 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 C-N-CA 125.688 1.595 . . . . 0.0 107.773 -175.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -63.13 128.85 37.77 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 105.62 -1.992 . . . . 0.0 105.62 169.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.552 HG12 ' C ' ' A' ' 108' ' ' ASP . 4.9 p -75.55 116.67 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 CA-C-N 114.45 -1.25 . . . . 0.0 107.799 166.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.434 HD13 ' HA ' ' A' ' 98' ' ' LEU . 0.7 OUTLIER -88.48 -21.56 24.12 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 120.467 -1.396 . . . . 0.0 110.38 170.241 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -158.27 146.4 18.56 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 170.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -127.93 116.1 19.58 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 125.518 1.527 . . . . 0.0 108.762 177.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -100.39 113.19 25.73 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.16 -167.21 14.84 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 125.453 1.502 . . . . 0.0 112.289 170.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -75.06 171.72 13.61 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.131 0.972 . . . . 0.0 109.201 177.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.11 62.76 2.16 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-O 118.5 -1.167 . . . . 0.0 111.409 176.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -100.38 89.91 1.28 Allowed Pre-proline 0 C--O 1.24 0.561 0 C-N-CA 131.242 3.817 . . . . 0.0 110.095 -163.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -62.92 -4.89 6.65 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 124.476 3.451 . . . . 0.0 115.543 -174.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.94 -177.69 44.81 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 108.846 -1.701 . . . . 0.0 108.846 -163.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.552 ' C ' HG12 ' A' ' 97' ' ' VAL . 1.1 m-20 -72.5 5.12 3.21 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 -169.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.09 160.12 39.9 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 122.374 1.083 . . . . 0.0 110.213 154.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.8 p -128.3 163.87 31.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 126.811 2.044 . . . . 0.0 108.994 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -104.19 103.62 13.42 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.954 1.701 . . . . 0.0 106.545 169.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 60.8 m -97.61 166.95 11.26 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 122.714 0.405 . . . . 0.0 110.035 174.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.409 ' HB2' HG22 ' A' ' 4' ' ' ILE . 69.7 m-85 -92.85 149.52 21.21 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 162.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.3 t -146.72 155.93 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 129.161 2.985 . . . . 0.0 107.067 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -89.71 128.17 36.05 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 166.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 81.9 p -130.09 -177.21 4.21 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.281 1.432 . . . . 0.0 109.291 -178.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -138.1 141.29 40.22 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 165.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -112.71 -4.45 14.06 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.226 1.411 . . . . 0.0 110.911 172.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.1 p -107.74 19.81 19.64 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.937 1.695 . . . . 0.0 111.006 -162.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -71.67 161.49 30.91 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.444 1.497 . . . . 0.0 112.105 -168.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -84.28 151.53 59.79 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 124.979 1.311 . . . . 0.0 109.995 167.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.01 -25.75 51.5 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 123.369 2.713 . . . . 0.0 113.52 -173.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.523 ' HA ' ' CD2' ' A' ' 126' ' ' PHE . 4.5 pm0 -52.69 -30.83 34.19 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.968 0.907 . . . . 0.0 112.382 177.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 45.3 m0 -76.88 -11.65 59.85 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 119.412 -0.327 . . . . 0.0 111.759 -176.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -85.64 -15.68 41.65 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 119.199 0.909 . . . . 0.0 111.713 171.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.523 ' CD2' ' HA ' ' A' ' 123' ' ' GLU . 4.8 m-85 -84.75 -10.28 57.39 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.364 0.984 . . . . 0.0 111.373 173.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 76.6 mt -72.15 158.36 87.73 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 124.844 1.257 . . . . 0.0 110.96 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -76.86 156.23 34.77 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 124.088 3.192 . . . . 0.0 111.887 176.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.561 ' CD2' ' HA2' ' A' ' 60' ' ' GLY . 21.3 m-85 -107.65 151.89 25.04 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.882 1.273 . . . . 0.0 111.95 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -136.29 167.54 21.12 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.766 1.226 . . . . 0.0 110.863 -175.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -113.64 -7.71 13.32 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.587 1.155 . . . . 0.0 112.631 -171.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 83.2 p -154.36 174.7 14.48 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 125.451 1.5 . . . . 0.0 108.381 168.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -137.97 109.18 6.84 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 174.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -140.11 123.27 16.8 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.617 1.167 . . . . 0.0 108.318 -168.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 9.6 t -59.38 -29.8 67.97 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.442 1.097 . . . . 0.0 110.059 176.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -62.74 -17.4 60.84 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.418 -0.801 . . . . 0.0 113.11 177.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -71.16 154.23 51.72 Favored Glycine 0 CA--C 1.537 1.445 0 CA-C-N 120.025 1.284 . . . . 0.0 112.434 -166.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -65.52 -5.99 12.69 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.811 2.341 . . . . 0.0 115.058 -177.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 -49.05 -49.58 40.61 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 120.651 1.569 . . . . 0.0 112.616 -175.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 87.45 1.68 83.35 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 118.258 -1.301 . . . . 0.0 113.689 -168.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.433 ' HB2' HD22 ' A' ' 49' ' ' ASN . 0.7 OUTLIER -103.56 96.37 6.68 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 118.905 1.352 . . . . 0.0 109.519 171.422 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -118.85 162.44 18.48 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.576 -0.702 . . . . 0.0 110.918 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -65.52 144.57 56.92 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -173.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -122.13 84.51 45.79 Favored Pre-proline 0 CA--C 1.53 0.192 0 C-N-CA 123.1 0.56 . . . . 0.0 110.12 175.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -91.0 -47.9 0.02 OUTLIER 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 124.063 3.175 . . . . 0.0 114.393 175.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.502 ' HB3' ' HD2' ' A' ' 149' ' ' ARG 0.288 17.3 ttt85 -134.36 3.16 3.33 Favored 'General case' 0 C--O 1.215 -0.714 0 O-C-N 120.201 -1.562 . . . . 0.0 113.827 168.299 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 44.5 -64.65 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 131.476 3.911 . . . . 0.0 117.384 175.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -53.79 -35.96 61.91 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 127.805 2.442 . . . . 0.0 111.461 161.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.502 ' HD2' ' HB3' ' A' ' 146' ' ' ARG . 24.5 mmm180 . . . . . 0 C--O 1.252 1.211 0 C-N-CA 128.373 2.669 . . . . 0.0 111.529 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.6 ttp . . . . . 0 N--CA 1.468 0.461 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.86 166.39 26.86 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 165.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -128.13 129.31 46.35 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 174.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 41.2 pt -125.19 152.57 31.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -108.31 132.2 53.94 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 172.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.424 HG22 ' H ' ' A' ' 6' ' ' VAL . 2.6 m -81.39 168.29 1.89 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.447 0 C-N-CA 123.69 0.796 . . . . 0.0 111.31 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -112.46 -29.87 7.35 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.043 0.937 . . . . 0.0 112.515 172.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 148.24 -1.9 0.67 Allowed Glycine 0 CA--C 1.526 0.741 0 CA-C-N 118.412 0.551 . . . . 0.0 113.869 168.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 p -53.62 -36.6 62.19 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 124.775 1.23 . . . . 0.0 111.2 160.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.551 HD23 ' HA ' ' A' ' 17' ' ' HIS . 4.0 mt -132.25 48.37 2.42 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.597 1.559 . . . . 0.0 109.179 -166.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -150.02 -59.19 0.2 Allowed 'General case' 0 N--CA 1.467 0.42 0 O-C-N 120.243 -1.535 . . . . 0.0 111.738 178.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 -73.03 -86.1 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 119.339 0.972 . . . . 0.0 108.714 174.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -175.23 50.11 0.13 Allowed Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 175.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.36 162.96 3.79 Favored Pre-proline 0 CA--C 1.544 0.745 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 169.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -64.4 -3.7 6.84 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 123.971 3.114 . . . . 0.0 113.255 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -120.3 10.67 11.33 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 126.827 2.051 . . . . 0.0 108.452 -167.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.551 ' HA ' HD23 ' A' ' 10' ' ' LEU . 39.0 p-80 -85.25 -38.82 18.47 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 121.254 1.843 . . . . 0.0 106.684 -168.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -17.35 55.49 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 120.517 -1.364 . . . . 0.0 114.183 -168.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.434 ' H ' HG22 ' A' ' 19' ' ' VAL . 2.9 m -59.65 -34.66 55.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 118.445 0.566 . . . . 0.0 110.921 176.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -78.98 3.91 15.83 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.039 0.836 . . . . 0.0 113.113 177.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 35.4 mt -120.06 11.96 11.81 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.811 1.644 . . . . 0.0 110.816 -175.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -132.76 3.94 3.84 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 -171.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . 0.265 25.4 t-80 43.22 28.87 0.18 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 128.294 2.638 . . . . 0.0 113.679 176.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.4 m -117.71 -12.02 10.32 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 121.168 -0.957 . . . . 0.0 111.593 179.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -111.17 -1.43 16.17 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.206 1.802 . . . . 0.0 111.065 174.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 131.45 174.33 13.62 Favored Glycine 0 C--N 1.336 0.553 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 41.5 tp -82.23 139.8 34.04 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 123.169 0.588 . . . . 0.0 110.389 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -146.94 153.69 40.39 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 153.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.67 142.05 23.35 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 126.362 1.865 . . . . 0.0 108.286 169.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -59.99 118.83 6.74 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.212 1.405 . . . . 0.0 108.799 176.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.91 39.46 2.16 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.954 0.797 . . . . 0.0 110.321 -174.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 124.52 111.42 1.91 Allowed Glycine 0 N--CA 1.444 -0.79 0 CA-C-O 121.994 0.774 . . . . 0.0 111.328 166.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -61.06 149.62 36.44 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 121.592 -0.946 . . . . 0.0 108.469 173.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.47 175.33 37.22 Favored Glycine 0 C--O 1.238 0.385 0 C-N-CA 120.771 -0.728 . . . . 0.0 113.365 -169.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.407 ' SG ' ' HB3' ' A' ' 96' ' ' GLN . 1.8 p -136.59 147.18 46.83 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 43.4 p -64.48 120.05 11.57 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 158.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.422 HG22 ' HB2' ' A' ' 96' ' ' GLN . 16.7 t -68.0 -37.09 77.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.641 0.734 . . . . 0.0 109.08 177.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -78.21 140.2 38.93 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 168.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.5 m -60.44 151.05 29.2 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 160.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -134.57 153.84 79.28 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 165.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -76.38 92.08 1.09 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 124.212 3.275 . . . . 0.0 110.133 170.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 28.7 tp -90.63 109.03 20.2 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 118.816 -0.611 . . . . 0.0 109.757 174.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.444 ' CG2' HD13 ' A' ' 54' ' ' LEU . 13.5 m -123.55 135.75 62.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 124.395 1.078 . . . . 0.0 108.641 -171.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.2 mt -109.89 72.88 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 -172.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.83 179.33 7.06 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 122.613 1.197 . . . . 0.0 110.722 173.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.95 153.85 17.49 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-N 113.044 -1.889 . . . . 0.0 110.473 170.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -68.75 -11.62 60.51 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -166.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 37.5 m-70 -114.16 16.78 18.0 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.5 1.12 . . . . 0.0 112.053 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 50.49 74.02 0.24 Allowed 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.778 2.031 . . . . 0.0 109.369 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 87.6 mt -104.55 88.3 2.12 Favored Pre-proline 0 C--N 1.325 -0.493 0 C-N-CA 128.531 2.733 . . . . 0.0 104.991 -169.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.401 ' HG3' ' CE2' ' A' ' 133' ' ' TYR . 55.9 Cg_endo -55.02 107.61 0.24 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.962 2.442 . . . . 0.0 111.148 -178.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -92.02 116.96 29.37 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 124.904 1.281 . . . . 0.0 107.6 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.15 92.15 8.66 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 172.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.444 HD13 ' CG2' ' A' ' 43' ' ' VAL . 11.0 mp -65.52 124.14 21.54 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.525 1.13 . . . . 0.0 108.762 176.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -74.04 84.95 1.79 Allowed 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.065 0.546 . . . . 0.0 110.266 -176.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.55 85.15 17.87 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 125.064 1.346 . . . . 0.0 108.373 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.92 126.68 17.8 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.842 2.361 . . . . 0.0 109.251 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.58 17.3 55.14 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 119.328 -0.707 . . . . 0.0 113.209 175.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -122.81 157.24 32.87 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 119.07 1.435 . . . . 0.0 107.189 172.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.516 ' HA2' ' CD2' ' A' ' 129' ' ' TYR . . . 70.49 -140.04 31.4 Favored Glycine 0 CA--C 1.522 0.511 0 CA-C-N 121.131 1.787 . . . . 0.0 111.603 175.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -131.17 160.24 35.37 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.327 1.064 . . . . 0.0 111.17 -170.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 76.4 m -83.64 106.61 15.5 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.695 -0.628 . . . . 0.0 110.93 -170.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.1 t -78.38 88.59 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 126.708 2.003 . . . . 0.0 111.996 -166.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.9 p -59.56 145.35 44.6 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 120.862 -1.149 . . . . 0.0 111.185 -172.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.03 -150.06 5.98 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-N 118.967 0.803 . . . . 0.0 112.596 -174.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -145.1 157.24 44.16 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.256 1.022 . . . . 0.0 109.058 -178.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 50.2 mt -107.66 91.79 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -80.74 127.16 32.18 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 177.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -74.07 130.45 39.84 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 163.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 23.7 m -144.24 176.3 2.69 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 C-N-CA 125.346 1.458 . . . . 0.0 109.898 -167.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.87 -175.95 3.22 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 122.671 1.224 . . . . 0.0 113.241 177.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -52.85 -52.02 58.8 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.07 1.748 . . . . 0.0 110.841 172.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -62.89 -39.47 94.58 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 117.948 -1.025 . . . . 0.0 110.282 -174.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 38.6 tpp -64.61 -43.64 93.1 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 119.454 1.025 . . . . 0.0 110.289 175.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 13.7 tp -65.03 -42.75 94.08 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.886 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 66.0 mtt180 -58.01 -41.78 83.82 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 124.526 1.13 . . . . 0.0 110.161 174.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -63.62 -52.8 59.3 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -176.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.2 mp -54.05 -39.35 66.14 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.206 0.602 . . . . 0.0 111.305 175.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -57.05 -43.5 82.08 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.714 0.769 . . . . 0.0 110.77 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -86.33 -26.9 24.63 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.306 1.443 . . . . 0.0 113.044 -175.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -93.09 -40.15 10.67 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.558 1.143 . . . . 0.0 111.394 -170.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -82.74 7.26 15.47 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 118.348 0.522 . . . . 0.0 110.462 177.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 59.58 29.61 19.19 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.626 1.571 . . . . 0.0 111.962 175.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 1.8 p -73.25 168.22 27.17 Favored Pre-proline 0 CA--C 1.541 0.624 0 O-C-N 120.237 -1.539 . . . . 0.0 108.218 173.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.4 -4.43 7.77 Favored 'Cis proline' 0 CA--C 1.544 0.988 0 CA-C-N 120.21 1.111 . . . . 0.0 113.545 -13.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.5 m -60.84 -61.64 2.44 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 126.093 1.757 . . . . 0.0 111.313 -177.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 2.7 mtm -75.71 -85.18 0.05 OUTLIER 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -83.8 176.81 8.66 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.501 1.12 . . . . 0.0 109.064 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -137.08 136.88 38.74 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.907 1.683 . . . . 0.0 106.84 161.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -70.29 133.68 47.22 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 171.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.0 m -136.67 175.44 9.61 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.772 2.029 . . . . 0.0 108.523 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -118.37 137.33 53.19 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 127.921 2.488 . . . . 0.0 109.747 175.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.43 -179.29 6.2 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.019 1.728 . . . . 0.0 110.512 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -113.22 123.86 51.17 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.627 1.571 . . . . 0.0 110.548 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.411 ' CG2' ' SG ' ' A' ' 112' ' ' CYS . 54.1 t -118.54 145.85 23.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 C-N-CA 125.772 1.629 . . . . 0.0 107.335 -177.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.422 ' HB2' HG22 ' A' ' 37' ' ' VAL . 35.3 tt0 -89.65 136.9 32.77 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 171.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 94.8 t -77.61 95.74 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 127.696 2.398 . . . . 0.0 106.15 168.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.6 mp -72.79 -31.26 64.73 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.586 -0.696 . . . . 0.0 109.483 172.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -148.56 164.3 34.64 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 106.298 -1.742 . . . . 0.0 106.298 167.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 75.5 t-105 -139.88 124.54 18.27 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.64 1.576 . . . . 0.0 108.006 175.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -79.02 113.34 17.06 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 171.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 86.69 -148.6 21.91 Favored Glycine 0 C--O 1.235 0.166 0 CA-C-O 121.696 0.609 . . . . 0.0 112.246 153.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -67.01 160.06 27.31 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 126.426 1.89 . . . . 0.0 111.715 -170.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 60.92 76.03 0.26 Allowed Glycine 0 C--O 1.221 -0.672 0 C-N-CA 124.449 1.023 . . . . 0.0 111.727 170.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -102.87 88.77 1.59 Allowed Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 128.734 2.813 . . . . 0.0 108.211 -168.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -56.08 -22.41 39.28 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 124.601 3.534 . . . . 0.0 114.939 -172.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 123.7 176.46 14.76 Favored Glycine 0 C--N 1.333 0.384 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -173.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -64.11 -17.59 63.58 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 118.515 -0.755 . . . . 0.0 112.518 -172.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 39.7 p -130.57 159.78 36.14 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 120.2 1.364 . . . . 0.0 111.971 168.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 28.4 m -141.95 169.56 13.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 125.443 1.497 . . . . 0.0 108.539 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -104.14 155.75 18.45 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 159.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.411 ' SG ' ' CG2' ' A' ' 95' ' ' VAL . 0.5 OUTLIER -155.04 162.05 41.16 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 129.142 2.977 . . . . 0.0 108.694 -178.37 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -87.24 153.36 21.55 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 169.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.449 HG12 HG23 ' A' ' 116' ' ' THR . 24.9 t -143.17 150.77 17.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 127.914 2.485 . . . . 0.0 107.2 176.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -94.76 102.76 14.65 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 169.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.449 HG23 HG12 ' A' ' 114' ' ' VAL . 72.7 p -103.41 -167.88 1.44 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.009 1.324 . . . . 0.0 108.7 177.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.7 t -136.05 156.05 49.3 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 155.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -123.46 5.44 9.0 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.151 1.381 . . . . 0.0 110.776 171.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.2 t -132.32 53.55 2.0 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 122.93 1.348 . . . . 0.0 109.415 -173.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -67.39 153.63 43.24 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.009 1.323 . . . . 0.0 110.402 175.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.18 149.43 98.46 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 162.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.09 -35.8 40.56 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 121.451 1.434 . . . . 0.0 112.545 -170.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -57.86 -23.68 54.03 Favored 'General case' 0 C--O 1.225 -0.218 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 177.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 0.571 ' HA ' HD23 ' A' ' 127' ' ' LEU . 44.2 m0 -64.93 -16.26 63.09 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 119.863 1.21 . . . . 0.0 112.015 -178.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 53.7 mt -71.9 2.46 5.51 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.846 1.259 . . . . 0.0 112.418 171.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -113.13 -11.69 13.26 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.612 1.565 . . . . 0.0 113.75 178.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.571 HD23 ' HA ' ' A' ' 124' ' ' TRP . 1.1 mm? -67.81 146.67 98.47 Favored Pre-proline 0 C--N 1.326 -0.436 0 C-N-CA 126.102 1.761 . . . . 0.0 108.092 -177.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -64.32 149.34 90.35 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.223 1.282 . . . . 0.0 109.269 176.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.516 ' CD2' ' HA2' ' A' ' 60' ' ' GLY . 23.0 m-85 -89.28 152.19 21.69 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 175.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 62.6 m-70 -121.91 134.97 54.86 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -83.37 -15.78 48.53 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.924 0.89 . . . . 0.0 111.007 178.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.1 t -164.2 147.58 9.48 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 163.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.401 ' CE2' ' HG3' ' A' ' 51' ' ' PRO . 17.6 t80 -87.37 151.29 23.21 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.3 -0.864 . . . . 0.0 108.695 169.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 35.9 p-10 -153.39 162.25 41.48 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 126.826 2.05 . . . . 0.0 110.797 169.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 9.0 p -93.9 0.74 56.31 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 126.351 1.86 . . . . 0.0 112.791 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -143.04 23.09 1.89 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.954 1.302 . . . . 0.0 109.647 -164.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -94.83 177.74 35.82 Favored Glycine 0 C--O 1.242 0.65 0 C-N-CA 123.876 0.75 . . . . 0.0 113.944 -167.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -64.7 -24.95 61.68 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.689 2.259 . . . . 0.0 111.061 169.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 46.1 m-70 -73.8 80.99 1.6 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.322 1.449 . . . . 0.0 108.401 176.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -59.39 -17.78 40.82 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.639 1.59 . . . . 0.0 114.445 -178.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.91 72.75 0.1 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.213 1.805 . . . . 0.0 111.614 168.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 6.3 mtt85 -99.48 166.03 11.36 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 120.968 -1.083 . . . . 0.0 111.062 -174.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -58.9 142.1 51.67 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -175.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -122.41 84.45 47.35 Favored Pre-proline 0 N--CA 1.455 -0.186 0 O-C-N 123.605 0.565 . . . . 0.0 110.143 -175.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -76.52 -55.34 0.06 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.628 1.552 . . . . 0.0 112.161 176.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.42 14.97 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 117.191 -1.385 . . . . 0.0 112.616 -164.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.36 89.22 0.13 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.844 1.658 . . . . 0.0 109.835 -160.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 52.3 73.78 0.31 Allowed 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.39 1.476 . . . . 0.0 109.308 -159.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 . . . . . 0 C--O 1.248 1.018 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 173.893 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.779 0 CA-C-O 118.168 -0.92 . . . . 0.0 111.439 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.86 91.02 2.77 Favored 'General case' 0 C--O 1.22 -0.5 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 176.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.8 m80 -58.96 140.02 56.06 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 124.127 0.971 . . . . 0.0 108.767 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 39.2 pt -134.86 159.92 41.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 C-N-CA 124.694 1.198 . . . . 0.0 109.401 175.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -87.98 138.61 31.3 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 163.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.4 m -72.05 -177.28 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 156.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -133.1 -57.88 0.91 Allowed 'General case' 0 N--CA 1.447 -0.589 0 O-C-N 121.082 -1.011 . . . . 0.0 111.013 176.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -165.69 -41.99 0.02 OUTLIER Glycine 0 C--N 1.33 0.233 0 CA-C-N 118.629 0.649 . . . . 0.0 111.888 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 p -53.55 -29.31 36.28 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.995 1.318 . . . . 0.0 111.727 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.4 mp -133.19 76.78 1.7 Allowed 'General case' 0 C--O 1.221 -0.406 0 C-N-CA 124.502 1.121 . . . . 0.0 108.533 177.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -149.42 -80.01 0.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 O-C-N 120.895 -1.128 . . . . 0.0 108.878 172.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 25.2 ttt85 -67.43 -85.3 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 123.366 0.666 . . . . 0.0 110.429 -177.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -158.31 26.09 0.41 Allowed Glycine 0 C--N 1.336 0.554 0 CA-C-N 119.642 1.11 . . . . 0.0 113.058 -175.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -55.09 163.13 1.66 Allowed Pre-proline 0 N--CA 1.449 -0.521 0 C-N-CA 125.379 1.472 . . . . 0.0 111.411 175.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.15 -16.01 52.57 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.474 2.116 . . . . 0.0 112.842 -172.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.492 ' O ' HG22 ' A' ' 19' ' ' VAL . 5.1 m-80 -95.16 -17.87 21.41 Favored 'General case' 0 C--O 1.219 -0.512 0 C-N-CA 125.292 1.437 . . . . 0.0 111.245 -164.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -52.78 -40.79 63.5 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 120.088 1.313 . . . . 0.0 112.178 -165.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.96 -25.1 2.98 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -177.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 16' ' ' ASN . 14.3 m -68.94 -29.6 43.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 O-C-N 121.296 -0.878 . . . . 0.0 110.748 -177.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.1 ptp -83.27 6.14 20.67 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 119.045 0.839 . . . . 0.0 112.454 174.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 49.7 mt -114.42 26.74 10.0 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.82 1.648 . . . . 0.0 109.365 -177.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -139.26 99.43 3.74 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.248 1.419 . . . . 0.0 108.598 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 25.4 t-80 -63.58 -22.02 66.67 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -162.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.5 m -70.99 -32.6 69.46 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.835 -0.541 . . . . 0.0 111.988 172.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 40.3 m170 -71.32 -37.74 71.73 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 171.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 158.85 173.72 27.62 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-O 121.955 0.753 . . . . 0.0 111.969 156.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 57.5 tp -70.26 141.34 52.45 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.288 0.635 . . . . 0.0 111.214 177.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -150.95 108.43 3.63 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.694 1.197 . . . . 0.0 108.558 160.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -112.41 135.26 53.33 Favored 'General case' 0 CA--C 1.522 -0.112 0 C-N-CA 124.616 1.167 . . . . 0.0 108.633 175.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -63.68 108.54 1.44 Allowed 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.264 1.026 . . . . 0.0 108.577 177.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.456 ' NH1' ' H ' ' A' ' 103' ' ' ASP . 0.7 OUTLIER -106.55 44.39 1.06 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 -178.722 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.91 -162.2 35.42 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-O 122.515 1.064 . . . . 0.0 111.295 -177.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 63.5 mtp85 -125.57 166.02 17.46 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 121.491 -1.005 . . . . 0.0 110.056 -167.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -168.84 171.31 42.81 Favored Glycine 0 C--N 1.336 0.558 0 C-N-CA 120.234 -0.984 . . . . 0.0 113.637 177.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 91.0 m -138.02 149.57 46.18 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.23 1.012 . . . . 0.0 109.656 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.8 p -69.95 120.81 16.23 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 168.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.6 t -83.11 -48.86 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 -174.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -57.66 130.18 45.24 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 159.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.2 m -57.98 148.68 25.23 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 162.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -134.9 153.26 78.53 Favored Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 163.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -76.35 95.91 1.06 Allowed 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 125.261 3.974 . . . . 0.0 110.893 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.99 109.4 22.16 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -178.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.3 m -121.51 151.53 24.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 119.013 0.824 . . . . 0.0 109.469 175.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.5 mt -88.49 135.22 26.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 165.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.66 167.99 20.95 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 122.371 1.082 . . . . 0.0 110.7 173.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.61 174.76 46.81 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-O 122.829 1.239 . . . . 0.0 113.127 168.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -84.89 -4.59 59.17 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.65 1.18 . . . . 0.0 113.092 -163.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -119.86 10.28 11.54 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.54 1.536 . . . . 0.0 111.803 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 35.3 m-20 58.25 59.24 3.11 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.199 1.8 . . . . 0.0 109.574 176.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 96.8 mt -106.41 88.76 3.49 Favored Pre-proline 0 N--CA 1.455 -0.225 0 C-N-CA 127.142 2.177 . . . . 0.0 107.085 -171.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -58.39 135.14 65.92 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 CA-C-N 119.955 1.02 . . . . 0.0 111.519 172.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 74.7 m95 -101.15 -173.92 2.49 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.084 0.953 . . . . 0.0 108.914 178.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 53' ' ' LEU . 13.9 tp -142.53 101.68 3.92 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 159.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.403 HD13 ' N ' ' A' ' 54' ' ' LEU . 0.1 OUTLIER -62.93 132.28 51.55 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 172.453 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -71.44 92.94 1.12 Allowed 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.451 HD13 ' HA ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -145.15 77.42 12.97 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.699 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -57.63 120.01 7.63 Favored 'Trans proline' 0 C--O 1.239 0.546 0 C-N-CA 122.914 2.409 . . . . 0.0 109.145 176.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.51 7.19 51.94 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 125.86 1.695 . . . . 0.0 114.34 176.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -115.81 167.77 10.64 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 119.824 1.812 . . . . 0.0 108.878 171.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.422 ' HA2' ' CD2' ' A' ' 129' ' ' TYR . . . 66.49 -148.28 50.55 Favored Glycine 0 CA--C 1.518 0.258 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -173.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 63.9 m-70 -124.92 176.91 6.33 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.874 1.27 . . . . 0.0 108.399 -177.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 3.6 p -61.73 161.68 9.74 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 120.444 -0.502 . . . . 0.0 109.798 170.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 38.8 t -135.69 114.29 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 169.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 45.9 p -79.19 157.66 27.81 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 123.301 0.64 . . . . 0.0 109.876 -177.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -177.4 -153.0 10.47 Favored Glycine 0 CA--C 1.526 0.74 0 O-C-N 121.222 -0.924 . . . . 0.0 112.568 -176.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -138.68 165.7 26.27 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.21 1.404 . . . . 0.0 110.98 -174.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.407 HG22 ' HB3' ' A' ' 31' ' ' ARG . 62.2 mt -116.35 128.01 73.8 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 -173.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -122.92 126.98 48.3 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.973 0.892 . . . . 0.0 109.284 172.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -62.78 107.05 0.89 Allowed 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 158.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.1 m -115.41 161.04 14.44 Favored 'Isoleucine or valine' 0 C--O 1.244 0.809 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 171.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -113.43 173.22 6.51 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 176.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -52.04 -42.87 63.45 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 124.578 1.151 . . . . 0.0 110.683 -171.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 -62.59 -36.35 82.44 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 118.828 -0.606 . . . . 0.0 111.468 -174.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 20.4 tpp -67.67 -53.99 23.24 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.45 -38.28 80.34 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.267 -175.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.53 -41.9 75.37 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 125.582 1.553 . . . . 0.0 110.918 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -56.7 -51.44 68.79 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 122.974 0.51 . . . . 0.0 110.54 171.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 93.1 mt -60.5 -32.99 71.97 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.396 -0.815 . . . . 0.0 111.783 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -67.11 -6.52 17.89 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.24 1.816 . . . . 0.0 112.736 177.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -107.95 -49.86 3.15 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.939 1.695 . . . . 0.0 109.454 171.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -62.8 -46.56 87.4 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.253 1.021 . . . . 0.0 112.063 -174.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -72.12 6.66 2.05 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.91 0.884 . . . . 0.0 111.324 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 62.62 20.09 11.77 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 126.341 1.856 . . . . 0.0 113.264 167.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 26.5 p -68.91 157.98 87.49 Favored Pre-proline 0 CA--C 1.541 0.622 0 O-C-N 121.138 -0.976 . . . . 0.0 109.232 175.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -72.3 -4.32 12.98 Favored 'Cis proline' 0 CA--C 1.545 1.057 0 CA-C-N 119.978 1.028 . . . . 0.0 114.606 -5.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.5 m -63.96 -59.02 5.02 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 119.527 1.058 . . . . 0.0 111.979 -174.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 37.6 mtp -78.26 -80.65 0.11 Allowed 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -89.11 174.95 7.59 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.749 0.82 . . . . 0.0 109.918 177.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -132.73 -12.48 2.98 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.637 0.775 . . . . 0.0 113.015 173.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? 63.44 133.46 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 129.542 3.137 . . . . 0.0 112.576 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 61.9 m -143.98 160.48 40.78 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 123.969 0.907 . . . . 0.0 109.374 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -89.84 128.51 36.18 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.943 1.697 . . . . 0.0 110.539 170.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.72 178.53 5.64 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 127.365 2.266 . . . . 0.0 110.004 172.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -116.71 128.43 55.32 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.555 1.542 . . . . 0.0 108.933 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.412 ' CG2' ' SG ' ' A' ' 112' ' ' CYS . 41.8 t -122.38 151.53 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 127.239 2.216 . . . . 0.0 107.114 -171.049 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -88.73 139.41 30.5 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.682 1.593 . . . . 0.0 107.265 171.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.4 t -87.31 126.44 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 170.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 mp -99.07 -36.61 9.65 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.143 1.777 . . . . 0.0 109.95 -176.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -148.44 153.35 38.39 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 130.44 3.496 . . . . 0.0 104.418 174.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.552 ' HE1' ' N ' ' A' ' 104' ' ' GLY . 74.1 t-105 -141.53 123.29 15.23 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -178.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -130.94 109.19 10.36 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.441 ' HA3' ' HD2' ' A' ' 31' ' ' ARG . . . 169.69 -120.81 0.89 Allowed Glycine 0 C--N 1.343 0.936 0 C-N-CA 114.489 -3.719 . . . . 0.0 121.192 173.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.456 ' H ' ' NH1' ' A' ' 31' ' ' ARG . 37.0 t0 -64.43 -178.05 0.35 Allowed 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 101.482 -3.525 . . . . 0.0 101.482 126.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.552 ' N ' ' HE1' ' A' ' 100' ' ' TRP . . . -108.76 -75.23 0.86 Allowed Glycine 0 N--CA 1.417 -2.572 1 C-N-CA 111.397 -5.192 . . . . 0.0 106.464 -94.149 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -158.89 88.04 2.19 Favored Pre-proline 0 C--N 1.313 -1.002 1 C-N-CA 133.652 4.781 . . . . 0.0 114.966 163.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -51.41 -30.41 34.48 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.001 2.468 . . . . 0.0 114.082 161.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 111.22 179.39 20.21 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.89 1.233 . . . . 0.0 110.557 -169.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -67.61 -11.91 59.23 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.463 1.105 . . . . 0.0 112.056 -171.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.7 p -130.93 159.73 36.58 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 120.786 -1.196 . . . . 0.0 110.979 172.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.2 p -151.1 146.29 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 124.174 0.99 . . . . 0.0 109.924 177.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.77 142.39 27.86 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 173.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.412 ' SG ' ' CG2' ' A' ' 95' ' ' VAL . 0.5 OUTLIER -152.19 168.84 24.02 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.392 1.477 . . . . 0.0 110.011 -178.815 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -92.39 151.79 20.07 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.098 0.559 . . . . 0.0 110.149 172.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 51.2 t -138.39 146.03 27.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 C-N-CA 127.6 2.36 . . . . 0.0 106.265 167.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -78.02 92.84 4.38 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.711 0.804 . . . . 0.0 109.51 172.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.0 p -104.45 173.47 6.29 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.369 1.468 . . . . 0.0 111.388 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.85 148.57 52.3 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 126.226 1.811 . . . . 0.0 107.089 175.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -112.8 -2.29 14.44 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.456 1.102 . . . . 0.0 111.296 167.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.6 p -111.8 18.26 19.08 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.695 1.598 . . . . 0.0 112.212 -158.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -68.93 158.92 33.66 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.727 1.611 . . . . 0.0 112.314 -170.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.4 157.66 87.67 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 126.343 1.857 . . . . 0.0 111.359 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -52.88 -53.75 6.27 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.533 2.822 . . . . 0.0 113.096 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.493 ' HA ' ' CD2' ' A' ' 126' ' ' PHE . 0.5 OUTLIER -45.67 -33.25 2.82 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 126.458 1.903 . . . . 0.0 114.191 -179.123 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 38.7 m0 -74.28 -3.5 30.47 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.598 -0.688 . . . . 0.0 112.242 -168.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 89.1 mt -97.08 -12.98 22.52 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 118.027 -0.987 . . . . 0.0 113.237 170.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.493 ' CD2' ' HA ' ' A' ' 123' ' ' GLU . 10.3 m-85 -84.34 -30.24 25.66 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 119.511 1.051 . . . . 0.0 110.214 177.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 36.3 mt -58.32 155.55 26.38 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 125.955 1.702 . . . . 0.0 111.428 -174.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.52 156.06 62.14 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 121.693 1.595 . . . . 0.0 109.756 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.422 ' CD2' ' HA2' ' A' ' 60' ' ' GLY . 31.9 m-85 -104.9 161.39 14.23 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.248 1.019 . . . . 0.0 111.945 178.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -138.95 159.9 41.05 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.926 0.891 . . . . 0.0 110.56 -171.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -111.06 -7.65 14.49 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -164.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 33.8 t -164.56 158.67 18.35 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 171.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -103.53 150.06 24.27 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.258 0.552 . . . . 0.0 109.681 172.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -157.9 170.1 23.09 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.515 1.526 . . . . 0.0 108.203 177.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.4 9.44 37.81 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.383 1.873 . . . . 0.0 110.769 167.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -138.05 4.15 2.47 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.551 1.14 . . . . 0.0 113.719 -167.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -89.3 -171.15 45.28 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 127.127 2.299 . . . . 0.0 111.925 -175.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -71.34 5.95 2.09 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 124.648 3.566 . . . . 0.0 114.997 -178.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -87.12 91.44 8.71 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -53.16 -36.69 52.89 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 121.78 -0.575 . . . . 0.0 113.235 -178.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.517 ' CD2' ' H ' ' A' ' 141' ' ' LEU . 0.7 OUTLIER -68.82 119.46 13.21 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 127.347 2.259 . . . . 0.0 109.646 168.691 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.53 163.51 13.63 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 119.65 1.114 . . . . 0.0 110.772 167.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -54.52 139.99 36.06 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 119.164 0.893 . . . . 0.0 110.057 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -120.49 78.02 27.88 Favored Pre-proline 0 C--O 1.235 0.338 0 C-N-CA 123.295 0.638 . . . . 0.0 110.103 -173.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -71.88 -38.51 4.04 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.31 2.673 . . . . 0.0 113.276 -176.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -153.01 20.34 0.58 Allowed 'General case' 0 C--N 1.34 0.16 0 CA-C-N 118.636 0.653 . . . . 0.0 112.73 -172.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -59.54 -57.05 14.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 119.229 0.922 . . . . 0.0 109.444 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -117.85 9.53 12.94 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.384 1.074 . . . . 0.0 111.157 -172.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.243 0.736 0 C-N-CA 124.308 1.043 . . . . 0.0 110.139 -149.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.464 ' HA ' ' HA ' ' A' ' 71' ' ' ASP . 46.0 mtt . . . . . 0 N--CA 1.477 0.889 0 CA-C-O 117.825 -1.083 . . . . 0.0 109.273 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 67.36 167.23 0.24 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 127.614 2.366 . . . . 0.0 112.253 -161.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -130.68 142.9 50.44 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 125.536 1.534 . . . . 0.0 109.346 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.2 pt -125.88 171.64 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 124.313 1.045 . . . . 0.0 109.717 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -121.4 127.74 51.48 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.313 1.445 . . . . 0.0 107.713 174.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.3 m -97.86 155.83 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 123.917 0.887 . . . . 0.0 109.371 170.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -147.08 -19.78 0.4 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.755 2.022 . . . . 0.0 111.479 178.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.403 ' HA3' ' CD2' ' A' ' 133' ' ' TYR . . . -120.25 -129.71 3.83 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 127.513 2.482 . . . . 0.0 111.761 -169.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.4 p -64.0 -35.95 82.38 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.738 -0.86 . . . . 0.0 112.516 -161.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.721 HD23 ' HA ' ' A' ' 17' ' ' HIS . 77.1 mt -80.94 3.11 23.97 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.432 0.693 . . . . 0.0 111.911 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -89.29 -81.18 0.28 Allowed 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 117.345 -1.312 . . . . 0.0 110.323 178.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.99 -85.76 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 121.052 1.751 . . . . 0.0 111.073 -174.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -169.7 21.11 0.08 OUTLIER Glycine 0 CA--C 1.525 0.717 0 O-C-N 121.307 -0.871 . . . . 0.0 111.149 -164.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -52.81 162.61 0.95 Allowed Pre-proline 0 N--CA 1.452 -0.372 0 C-N-CA 124.53 1.132 . . . . 0.0 110.621 176.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -65.73 1.89 1.97 Allowed 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 124.911 3.741 . . . . 0.0 113.092 -172.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -119.66 -17.68 8.56 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 126.289 1.836 . . . . 0.0 107.92 -171.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.721 ' HA ' HD23 ' A' ' 10' ' ' LEU . 6.2 t60 -51.38 -37.31 47.49 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 120.192 1.36 . . . . 0.0 109.991 177.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.23 -21.74 3.71 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-O 117.231 -1.366 . . . . 0.0 114.6 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.514 HG22 HD21 ' A' ' 10' ' ' LEU . 22.0 m -61.73 -41.51 90.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 120.994 1.725 . . . . 0.0 110.122 176.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -74.41 -17.68 60.76 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 119.315 0.962 . . . . 0.0 113.114 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 73.0 mt -75.32 -5.08 42.88 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.103 0.561 . . . . 0.0 111.244 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -102.65 103.75 14.05 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.286 0.565 . . . . 0.0 109.687 169.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 -51.33 -19.85 1.47 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.089 1.355 . . . . 0.0 113.963 173.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.5 t -77.19 -30.27 54.72 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.032 -1.043 . . . . 0.0 112.027 176.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -69.22 -30.33 68.46 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.585 1.084 . . . . 0.0 109.464 166.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.53 177.27 26.01 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 110.909 -0.877 . . . . 0.0 110.909 167.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 30.1 tp -77.89 142.05 38.7 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 123.639 0.776 . . . . 0.0 111.056 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -145.7 141.36 27.98 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.397 1.079 . . . . 0.0 110.1 165.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.81 148.02 27.98 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.454 1.502 . . . . 0.0 109.815 166.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -67.62 124.35 23.0 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 125.061 1.344 . . . . 0.0 109.118 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.1 tpp180 -120.07 45.7 2.12 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.652 1.181 . . . . 0.0 108.658 -176.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 89.39 -177.79 44.17 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -174.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.82 172.54 11.55 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.518 -0.99 . . . . 0.0 111.813 -173.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -173.82 -178.02 43.45 Favored Glycine 0 CA--C 1.505 -0.542 0 C-N-CA 120.305 -0.95 . . . . 0.0 114.158 -174.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 22.1 p -146.4 154.84 42.09 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 123.909 0.883 . . . . 0.0 109.45 173.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 44.7 p -78.26 83.23 4.52 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 173.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.6 m -59.58 -30.8 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 118.826 0.739 . . . . 0.0 112.195 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.41 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 7.1 tt0 -74.74 22.99 0.1 Allowed 'General case' 0 C--O 1.205 -1.24 0 C-N-CA 127.861 2.465 . . . . 0.0 111.928 173.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 41.46 114.37 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.616 1 C-N-CA 134.393 5.077 . . . . 0.0 114.025 158.377 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.552 ' HB3' HD21 ' A' ' 53' ' ' LEU . 30.5 m-85 -127.85 154.12 78.12 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 120.194 1.361 . . . . 0.0 111.413 -173.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.38 105.81 1.93 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 124.93 3.753 . . . . 0.0 110.724 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.48 100.91 9.13 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 -178.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.3 m -110.33 144.69 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-N 119.179 0.9 . . . . 0.0 110.154 -172.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.0 mt -91.98 116.4 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 171.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -129.92 179.58 5.78 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 124.332 1.053 . . . . 0.0 108.7 172.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.4 152.68 25.17 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 124.649 1.118 . . . . 0.0 112.809 161.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.76 -17.56 64.93 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -171.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -105.97 9.01 32.73 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 118.512 -0.756 . . . . 0.0 112.423 -177.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 53.42 79.64 0.12 Allowed 'General case' 0 C--N 1.342 0.239 0 C-N-CA 125.769 1.628 . . . . 0.0 108.391 -162.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 62.2 mt -120.04 86.57 37.28 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -61.31 151.68 77.59 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 CA-C-N 120.781 1.315 . . . . 0.0 112.683 174.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -125.77 128.92 48.47 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.448 1.499 . . . . 0.0 107.56 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.552 HD21 ' HB3' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -92.7 107.08 18.94 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 174.053 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.1 mt -87.12 139.2 30.8 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 105.904 -1.888 . . . . 0.0 105.904 -172.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -73.61 96.99 2.55 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 118.774 0.716 . . . . 0.0 109.865 -175.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.434 HD23 ' HD2' ' A' ' 57' ' ' PRO . 0.4 OUTLIER -152.08 87.13 4.35 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 124.365 1.066 . . . . 0.0 112.982 177.818 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.434 ' HD2' HD23 ' A' ' 56' ' ' LEU . 31.5 Cg_endo -59.75 145.18 98.87 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.884 2.389 . . . . 0.0 111.49 176.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 47.65 51.34 17.45 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 129.481 3.419 . . . . 0.0 112.533 -174.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.0 tptm -140.55 143.81 35.56 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 126.072 1.749 . . . . 0.0 106.314 173.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.21 -129.43 20.46 Favored Glycine 0 CA--C 1.519 0.299 0 N-CA-C 109.064 -1.615 . . . . 0.0 109.064 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -138.31 170.53 15.86 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 119.212 1.506 . . . . 0.0 111.606 -167.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 73.1 m -84.53 104.44 14.53 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.381 -0.827 . . . . 0.0 108.995 -176.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.0 t -70.32 110.71 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.9 p -75.09 145.34 42.36 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 120.904 -1.122 . . . . 0.0 110.43 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -167.35 -167.4 27.97 Favored Glycine 0 C--N 1.335 0.473 0 O-C-N 120.446 -1.409 . . . . 0.0 112.364 -169.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -134.93 158.8 43.35 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.222 1.009 . . . . 0.0 109.169 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.8 mt -102.56 132.71 48.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 -177.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -118.21 127.01 53.34 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 118.64 0.654 . . . . 0.0 110.863 172.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -60.25 135.05 57.61 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 150.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.8 m -135.25 173.45 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 170.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.464 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 0.4 OUTLIER -121.06 -178.27 3.71 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.679 0.752 . . . . 0.0 111.193 160.593 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -44.46 -55.59 4.94 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 126.61 1.964 . . . . 0.0 111.888 -171.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -71.28 -27.62 63.55 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 117.298 -1.334 . . . . 0.0 111.215 -171.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 24.1 tpp -66.28 -47.81 72.45 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 120.862 1.665 . . . . 0.0 108.595 172.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.09 -28.92 70.4 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 119.403 -0.332 . . . . 0.0 111.581 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -77.67 -37.03 50.65 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.42 1.009 . . . . 0.0 112.297 174.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -67.22 -45.84 75.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 119.475 1.034 . . . . 0.0 109.807 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.13 -32.25 66.16 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.67 -0.644 . . . . 0.0 110.351 171.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.428 ' HA ' ' SG ' ' A' ' 84' ' ' CYS . 0.7 OUTLIER -65.31 -7.92 15.67 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.038 1.335 . . . . 0.0 113.069 177.038 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -123.97 -27.16 3.94 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.712 2.405 . . . . 0.0 111.773 -176.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -72.83 -29.52 63.3 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.286 -0.884 . . . . 0.0 110.902 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -117.25 30.95 7.02 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.748 1.619 . . . . 0.0 110.406 177.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.0 t0 49.91 26.31 1.93 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.811 2.044 . . . . 0.0 113.431 169.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.428 ' SG ' ' HA ' ' A' ' 79' ' ' ASP . 0.8 OUTLIER -71.72 159.89 84.19 Favored Pre-proline 0 CA--C 1.54 0.572 0 O-C-N 120.652 -1.28 . . . . 0.0 109.381 -167.934 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -68.42 -3.4 5.97 Favored 'Cis proline' 0 CA--C 1.54 0.82 0 CA-C-N 120.979 1.385 . . . . 0.0 113.702 -11.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.4 t -56.34 -68.12 0.24 Allowed 'General case' 0 C--O 1.238 0.488 0 CA-C-N 119.339 0.972 . . . . 0.0 111.443 -173.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 26.8 mtp -77.91 -73.54 0.31 Allowed 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -177.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -97.97 -179.73 4.51 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 124.575 1.15 . . . . 0.0 108.108 173.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -165.45 125.29 1.79 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 -172.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.8 tmm_? -69.92 148.18 49.3 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -173.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.5 m -149.78 168.25 24.22 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 126.37 1.868 . . . . 0.0 107.284 -174.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -123.33 142.62 50.76 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.178 1.791 . . . . 0.0 109.691 172.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.19 174.13 13.61 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.466 1.907 . . . . 0.0 110.53 -173.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -92.63 111.79 23.51 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.973 1.309 . . . . 0.0 109.491 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.1 t -106.17 144.38 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 120.509 1.504 . . . . 0.0 107.754 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -78.81 140.78 38.15 Favored 'General case' 0 C--N 1.341 0.221 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 169.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 40.7 t -93.36 92.57 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 176.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.09 -24.53 67.73 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.876 -0.515 . . . . 0.0 110.746 175.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -165.93 149.52 7.76 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 128.035 2.534 . . . . 0.0 105.546 176.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 63.2 t-105 -125.89 137.72 53.75 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 124.715 1.206 . . . . 0.0 107.794 171.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -108.75 127.12 53.73 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.178 0.991 . . . . 0.0 110.558 174.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.6 -174.9 47.56 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 124.902 1.239 . . . . 0.0 112.385 168.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -62.77 151.82 37.59 Favored 'General case' 0 C--O 1.238 0.48 0 O-C-N 122.709 -0.289 . . . . 0.0 110.623 -170.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 102.56 45.31 1.69 Allowed Glycine 0 CA--C 1.52 0.355 0 CA-C-O 119.393 -0.671 . . . . 0.0 112.785 177.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -101.73 89.51 1.53 Allowed Pre-proline 0 N--CA 1.465 0.283 0 C-N-CA 126.682 1.993 . . . . 0.0 109.525 -156.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -62.35 -29.31 79.44 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 124.03 3.153 . . . . 0.0 112.922 -166.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 120.28 -169.21 13.96 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -163.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -71.39 -10.88 60.48 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.745 1.218 . . . . 0.0 113.039 -168.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.0 p -139.01 165.09 28.03 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 120.252 -1.53 . . . . 0.0 110.277 167.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.9 p -146.3 175.39 2.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 C-N-CA 124.989 1.315 . . . . 0.0 108.048 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -100.71 136.0 41.27 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 155.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 98.0 m -121.81 165.06 16.44 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 165.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -83.31 150.39 26.16 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 160.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.505 HG12 HG23 ' A' ' 116' ' ' THR . 27.3 t -142.22 160.81 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 129.312 3.045 . . . . 0.0 105.295 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -110.31 108.08 18.04 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 171.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.505 HG23 HG12 ' A' ' 114' ' ' VAL . 32.5 p -112.64 -164.74 0.94 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 122.017 0.913 . . . . 0.0 109.286 175.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.52 135.69 28.59 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 174.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -98.69 -3.33 36.16 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.869 1.267 . . . . 0.0 111.309 164.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 16.9 p -92.3 -0.65 57.38 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.461 1.904 . . . . 0.0 113.206 -170.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -55.6 141.23 38.29 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 126.669 1.988 . . . . 0.0 113.171 -164.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.44 147.06 98.87 Favored Pre-proline 0 N--CA 1.446 -0.657 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.137 -177.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.486 ' HA ' HD23 ' A' ' 125' ' ' LEU . 27.8 Cg_endo -65.19 -22.06 61.56 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.101 1.867 . . . . 0.0 113.307 -178.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.481 ' HA ' ' CE2' ' A' ' 126' ' ' PHE . 1.6 pm0 -70.0 -29.04 66.02 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 170.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 46.6 m0 -72.61 3.58 4.83 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.052 -1.03 . . . . 0.0 111.247 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.486 HD23 ' HA ' ' A' ' 122' ' ' PRO . 4.5 mm? -81.24 -22.25 38.88 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.663 1.585 . . . . 0.0 113.83 169.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.481 ' CE2' ' HA ' ' A' ' 123' ' ' GLU . 33.7 p90 -107.12 -16.84 14.32 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 120.474 1.488 . . . . 0.0 112.772 -177.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 26.2 mt -56.29 148.14 43.92 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 123.668 0.787 . . . . 0.0 110.091 173.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.67 147.45 45.27 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.601 2.201 . . . . 0.0 111.712 -173.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -91.23 168.94 11.24 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.201 1.4 . . . . 0.0 111.413 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -143.42 164.26 30.8 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.621 1.568 . . . . 0.0 109.41 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -107.45 -1.73 21.16 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.28 1.832 . . . . 0.0 111.626 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.16 167.97 23.28 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 126.182 1.793 . . . . 0.0 106.948 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.403 ' CD2' ' HA3' ' A' ' 8' ' ' GLY . 1.1 t80 -135.22 96.77 3.56 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 104.357 -2.46 . . . . 0.0 104.357 176.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -150.24 115.12 5.31 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 122.942 0.497 . . . . 0.0 110.18 -170.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 73.5 m -54.82 -16.68 2.79 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.124 1.37 . . . . 0.0 111.303 171.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -103.89 57.31 0.73 Allowed 'General case' 0 C--O 1.237 0.399 0 C-N-CA 126.439 1.895 . . . . 0.0 109.273 -177.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -146.84 177.26 25.27 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 127.914 2.674 . . . . 0.0 109.437 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -79.95 3.48 7.56 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.793 2.996 . . . . 0.0 114.32 -171.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -120.49 85.3 2.37 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 107.31 -1.366 . . . . 0.0 107.31 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -72.14 52.26 1.37 Allowed Glycine 0 CA--C 1.529 0.938 0 C-N-CA 126.587 2.041 . . . . 0.0 115.089 -167.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.49 58.09 1.25 Allowed 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 126.024 1.73 . . . . 0.0 109.621 -174.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 14.0 mmt85 -119.66 -18.07 8.46 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -176.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -166.86 139.9 3.67 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 125.328 1.451 . . . . 0.0 107.965 163.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -121.4 76.1 33.8 Favored Pre-proline 0 CA--C 1.531 0.22 0 O-C-N 124.422 1.076 . . . . 0.0 108.913 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -80.37 -49.24 0.06 OUTLIER 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 123.911 3.074 . . . . 0.0 113.738 176.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.478 ' HE ' ' C ' ' A' ' 149' ' ' ARG . 11.6 ttt180 -149.3 75.41 1.28 Allowed 'General case' 0 CA--C 1.507 -0.702 0 C-N-CA 126.169 1.787 . . . . 0.0 107.775 -166.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -77.16 -39.6 48.48 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 112.672 -2.058 . . . . 0.0 109.855 170.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -151.95 34.49 0.54 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.017 1.727 . . . . 0.0 110.313 -170.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.478 ' C ' ' HE ' ' A' ' 146' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.847 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 154.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.472 0.67 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.37 115.66 28.94 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 -172.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -85.68 122.28 29.55 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 171.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.412 HG22 ' HB2' ' A' ' 113' ' ' PHE . 8.0 pt -129.05 174.98 11.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 125.329 1.451 . . . . 0.0 111.426 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -105.02 -167.92 1.4 Allowed 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.949 1.699 . . . . 0.0 110.596 172.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.613 HG12 ' H ' ' A' ' 66' ' ' GLU . 10.7 p -139.74 148.41 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 123.95 0.9 . . . . 0.0 109.132 166.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -59.56 -32.26 70.18 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.636 1.575 . . . . 0.0 113.173 -177.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 142.32 -31.07 2.07 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.65 1.119 . . . . 0.0 111.179 -168.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.425 HG23 ' CE2' ' A' ' 133' ' ' TYR . 2.3 p -59.35 -73.48 0.08 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 130.68 3.592 . . . . 0.0 112.832 -176.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.9 mp -78.72 57.18 2.01 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.843 0.857 . . . . 0.0 108.782 -173.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.59 -66.88 0.36 Allowed 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 127.091 2.156 . . . . 0.0 108.338 -176.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -79.35 -72.59 0.38 Allowed 'General case' 0 C--O 1.223 -0.312 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.703 -178.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -172.84 10.98 0.04 OUTLIER Glycine 0 CA--C 1.531 1.062 0 N-CA-C 115.666 1.027 . . . . 0.0 115.666 -175.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.53 164.99 0.3 Allowed Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 126.569 1.948 . . . . 0.0 114.885 -171.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -56.16 -16.94 18.47 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 124.671 3.581 . . . . 0.0 113.974 -174.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -98.73 -19.58 17.4 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 125.12 1.368 . . . . 0.0 110.769 -165.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -51.36 -40.45 59.19 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.034 0.934 . . . . 0.0 112.413 -162.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.72 -21.68 19.86 Favored 'General case' 0 C--O 1.224 -0.255 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -175.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.5 m -60.49 -40.22 83.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 120.269 1.395 . . . . 0.0 110.905 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.0 ptp -74.22 -13.04 60.73 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 118.645 0.657 . . . . 0.0 112.219 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 72.6 mt -82.7 -4.78 58.34 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 118.574 -0.727 . . . . 0.0 110.61 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -105.35 99.19 8.8 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -178.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 28.3 t-80 -60.7 -18.85 56.75 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.0 t -55.99 -52.71 63.2 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.328 1.051 . . . . 0.0 109.746 168.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -70.67 -21.08 62.64 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.704 0.802 . . . . 0.0 110.87 -177.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.85 177.77 23.34 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 123.992 0.806 . . . . 0.0 111.373 164.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.5 tp -84.27 142.72 30.04 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.63 0.772 . . . . 0.0 110.293 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.28 142.22 31.27 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.248 1.419 . . . . 0.0 107.945 161.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -143.95 131.81 21.46 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.182 1.393 . . . . 0.0 108.111 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -73.84 94.21 2.26 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 127.187 2.195 . . . . 0.0 110.706 -171.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -93.54 61.34 3.18 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 172.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.18 -154.54 53.28 Favored Glycine 0 N--CA 1.441 -0.997 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 174.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 24.5 ptt-85 -143.95 168.13 20.7 Favored 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 122.119 -0.636 . . . . 0.0 112.124 -163.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -173.62 177.51 45.93 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-O 122.432 1.018 . . . . 0.0 114.041 -169.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.7 p -142.54 162.51 35.28 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.947 1.299 . . . . 0.0 109.917 176.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 43.6 p -82.06 95.84 7.57 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 168.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.401 HG22 ' H ' ' A' ' 37' ' ' VAL . 0.2 OUTLIER -62.76 -25.41 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 118.43 0.559 . . . . 0.0 111.686 171.019 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.78 117.32 13.22 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 159.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.4 m -57.1 138.5 54.4 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 172.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.478 ' HB3' ' CD2' ' A' ' 53' ' ' LEU . 36.0 m-85 -129.27 152.43 79.47 Favored Pre-proline 0 C--O 1.234 0.246 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 164.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -77.71 111.78 3.19 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 124.918 3.745 . . . . 0.0 110.479 172.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 33.5 tp -103.81 86.48 2.61 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.92 1.288 . . . . 0.0 107.769 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.556 HG13 ' HB3' ' A' ' 127' ' ' LEU . 48.3 t -84.21 160.78 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.274 0 C-N-CA 125.186 1.394 . . . . 0.0 107.921 177.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 50.3 mt -132.33 118.8 37.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 176.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.71 -172.87 3.91 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.567 0.747 . . . . 0.0 109.082 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.71 175.97 11.33 Favored Glycine 0 N--CA 1.439 -1.138 0 C-N-CA 125.564 1.555 . . . . 0.0 111.316 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -74.59 -8.45 56.39 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -162.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -132.73 40.28 3.27 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 124.021 0.928 . . . . 0.0 110.759 -176.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.8 m120 48.17 61.05 3.2 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.128 -0.983 . . . . 0.0 110.724 174.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 62.4 mt -102.49 89.97 1.97 Allowed Pre-proline 0 C--N 1.329 -0.294 0 N-CA-C 103.422 -2.807 . . . . 0.0 103.422 -160.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -59.62 120.04 7.61 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 N-CA-C 108.132 -1.526 . . . . 0.0 108.132 -176.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -103.27 115.31 30.31 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 177.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.478 ' CD2' ' HB3' ' A' ' 40' ' ' PHE . 0.3 OUTLIER -81.39 94.75 6.85 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 172.737 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.436 ' HG ' ' CD2' ' A' ' 120' ' ' TYR . 10.9 mp -65.45 120.23 12.46 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -70.55 83.58 0.6 Allowed 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -176.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.56 85.74 12.84 Favored Pre-proline 0 N--CA 1.465 0.317 0 C-N-CA 124.168 0.987 . . . . 0.0 109.727 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -58.87 141.07 97.71 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 N-CA-C 108.932 -1.218 . . . . 0.0 108.932 174.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.56 18.96 76.92 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 119.607 -0.551 . . . . 0.0 113.681 176.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -126.62 157.08 39.87 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 119.487 1.643 . . . . 0.0 106.798 161.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.97 -137.27 15.36 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 173.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -140.24 171.49 14.09 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.784 1.292 . . . . 0.0 110.493 -173.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 58.3 m -79.93 107.77 12.97 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 123.884 0.874 . . . . 0.0 111.387 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 73.6 t -88.86 116.35 30.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -169.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.6 p -72.61 161.95 30.12 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.493 0.664 . . . . 0.0 109.278 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -169.58 -156.7 11.11 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 108.116 -1.993 . . . . 0.0 108.116 175.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.613 ' H ' HG12 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -135.09 171.76 13.97 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.619 1.968 . . . . 0.0 106.513 177.603 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 79.5 mt -126.36 127.99 71.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 119.485 1.039 . . . . 0.0 108.512 -170.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -126.08 119.96 28.96 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.456 0.702 . . . . 0.0 111.794 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -66.59 115.66 6.69 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 105.473 -2.047 . . . . 0.0 105.473 156.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.2 m -120.47 165.48 15.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 C-N-CA 123.828 0.851 . . . . 0.0 109.244 178.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -93.56 171.39 8.93 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 122.413 1.101 . . . . 0.0 108.296 169.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -54.07 -37.93 64.74 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.316 -1.311 . . . . 0.0 110.846 167.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -58.68 -40.66 84.22 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.889 0.768 . . . . 0.0 110.943 -176.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 25.8 tpp -72.01 -45.83 59.44 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 176.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.7 tp -58.84 -26.84 64.56 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 50.1 mtt-85 -78.59 -39.27 37.92 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.936 1.694 . . . . 0.0 111.144 173.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -64.15 -50.29 68.79 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 118.881 -0.58 . . . . 0.0 111.351 175.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 91.6 mt -56.41 -36.36 68.85 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 119.106 0.866 . . . . 0.0 110.668 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.73 -23.25 28.09 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.097 1.759 . . . . 0.0 112.891 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -93.22 -31.23 14.82 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.43 1.492 . . . . 0.0 112.287 174.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -71.62 -43.73 65.65 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.333 1.053 . . . . 0.0 109.632 -169.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -92.21 15.41 13.68 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.45 1.1 . . . . 0.0 113.174 176.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.0 t70 44.89 38.29 2.85 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.615 1.566 . . . . 0.0 112.283 -177.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -65.7 158.91 72.33 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 120.075 -1.641 . . . . 0.0 107.403 170.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -74.16 -3.38 17.1 Favored 'Cis proline' 0 N--CA 1.452 -0.953 0 CA-C-N 118.969 0.668 . . . . 0.0 113.488 -13.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.54 -62.81 1.47 Allowed 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.033 1.733 . . . . 0.0 111.8 -175.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 36.5 mtp -86.31 -74.29 0.43 Allowed 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -174.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -89.81 172.91 8.56 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 175.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -134.88 138.66 44.36 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 165.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.574 ' HD3' ' CD1' ' A' ' 113' ' ' PHE . 7.6 tmm_? -74.31 129.94 38.74 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 118.095 -0.955 . . . . 0.0 109.24 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.3 m -133.02 156.27 47.65 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.102 0.865 . . . . 0.0 110.0 -175.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -87.85 139.58 30.38 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.388 1.475 . . . . 0.0 110.426 168.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.495 HD21 HG23 ' A' ' 114' ' ' VAL . 1.8 pt? -160.92 -179.91 7.94 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.657 1.183 . . . . 0.0 112.809 -177.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 12.1 tp60 -99.2 142.44 30.68 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.371 1.068 . . . . 0.0 113.073 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 45.4 t -137.34 134.6 47.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 126.659 1.984 . . . . 0.0 107.781 174.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -76.66 144.73 39.26 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.282 1.433 . . . . 0.0 108.039 165.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.592 HG13 ' HA ' ' A' ' 108' ' ' ASP 0.255 3.5 p -110.93 82.43 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-O 122.366 1.079 . . . . 0.0 108.838 -178.451 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.0 mp -44.79 -42.19 7.6 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 127.057 2.143 . . . . 0.0 110.462 176.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -150.09 152.47 34.83 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 176.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 64.0 t-105 -127.09 137.71 53.06 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 125.59 1.556 . . . . 0.0 107.28 176.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -113.65 106.8 14.95 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 122.964 0.505 . . . . 0.0 110.047 174.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.9 -175.75 16.12 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-O 122.066 0.815 . . . . 0.0 112.304 175.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -79.94 172.76 13.34 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.262 -0.969 . . . . 0.0 109.391 168.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.39 60.44 2.01 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -101.05 88.47 1.06 Allowed Pre-proline 0 CA--C 1.537 0.466 1 C-N-CA 132.721 4.408 . . . . 0.0 109.113 -158.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -73.39 5.04 3.43 Favored 'Trans proline' 0 CA--C 1.544 0.98 1 C-N-CA 126.188 4.592 . . . . 0.0 113.963 -171.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.33 -169.03 54.88 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-N 120.819 1.645 . . . . 0.0 110.031 -163.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.592 ' HA ' HG13 ' A' ' 97' ' ' VAL . 26.9 t70 -96.81 5.48 50.51 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 129.456 3.102 . . . . 0.0 116.001 -166.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.2 p -136.81 122.12 19.33 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 122.025 2.193 . . . . 0.0 114.588 152.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 24.8 m -98.41 153.85 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 125.098 1.359 . . . . 0.0 108.891 -179.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -87.12 125.95 34.47 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 163.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 9.9 m -116.88 172.06 7.49 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.522 1.129 . . . . 0.0 110.428 176.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.574 ' CD1' ' HD3' ' A' ' 90' ' ' ARG . 96.2 m-85 -92.62 139.77 30.22 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 152.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.495 HG23 HD21 ' A' ' 93' ' ' LEU . 24.3 t -142.09 126.05 15.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 129.752 3.221 . . . . 0.0 106.89 172.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -72.23 141.33 48.97 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 170.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.414 HG22 HD13 ' A' ' 53' ' ' LEU . 41.9 p -145.12 -170.0 3.32 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 126.633 1.973 . . . . 0.0 107.319 -177.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -131.76 143.76 50.47 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 166.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -107.05 0.66 23.73 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.726 1.61 . . . . 0.0 110.689 168.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.2 p -121.75 20.52 10.93 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 127.101 2.161 . . . . 0.0 111.646 -159.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.436 ' CD2' ' HG ' ' A' ' 54' ' ' LEU . 7.2 p90 -67.04 152.1 46.41 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 125.691 1.596 . . . . 0.0 111.825 -176.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.59 158.87 65.12 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 124.689 1.196 . . . . 0.0 111.568 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -72.7 -33.91 7.65 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.558 1.505 . . . . 0.0 113.175 -177.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -64.66 -26.97 68.62 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.7 0.682 . . . . 0.0 112.39 172.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 45.7 m0 -69.99 -10.78 59.8 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.767 0.712 . . . . 0.0 112.178 -176.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.26 -29.12 69.29 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.674 1.125 . . . . 0.0 110.821 168.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -90.69 -11.41 39.8 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.497 1.119 . . . . 0.0 112.099 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.556 ' HB3' HG13 ' A' ' 43' ' ' VAL . 11.5 mt -62.64 146.67 94.0 Favored Pre-proline 0 C--O 1.235 0.335 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -64.72 143.49 80.79 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.171 1.914 . . . . 0.0 109.861 175.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -96.82 164.27 12.63 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.751 1.22 . . . . 0.0 108.56 176.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -135.27 162.94 31.15 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.8 0.84 . . . . 0.0 110.103 -176.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -106.29 -17.48 14.28 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 121.392 -0.817 . . . . 0.0 110.364 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 95.2 p -139.44 160.03 40.79 Favored 'General case' 0 N--CA 1.444 -0.771 0 O-C-N 121.282 -0.886 . . . . 0.0 111.07 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.425 ' CE2' HG23 ' A' ' 9' ' ' THR . 3.4 t80 -141.42 101.76 4.06 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 104.005 -2.591 . . . . 0.0 104.005 178.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -151.72 136.86 17.43 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -178.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.01 -43.76 50.85 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.8 0.84 . . . . 0.0 110.784 174.184 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -89.29 23.78 2.4 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.838 0.855 . . . . 0.0 112.735 -167.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -82.16 155.26 34.37 Favored Glycine 0 CA--C 1.539 1.542 0 CA-C-O 118.701 -1.055 . . . . 0.0 111.892 174.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -71.5 -22.63 24.42 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 124.288 3.325 . . . . 0.0 112.361 175.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -73.33 80.41 1.36 Allowed 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 127.556 2.342 . . . . 0.0 107.031 172.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -72.57 77.35 0.77 Allowed Glycine 0 CA--C 1.522 0.476 0 C-N-CA 127.033 2.254 . . . . 0.0 111.375 -174.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -161.14 71.58 0.41 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 128.573 2.749 . . . . 0.0 105.642 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -133.56 173.15 11.81 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.32 0.648 . . . . 0.0 109.892 -168.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -69.77 123.81 22.38 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.531 -161.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -119.76 80.28 24.36 Favored Pre-proline 0 CA--C 1.516 -0.342 0 C-N-CA 125.077 1.351 . . . . 0.0 109.045 -170.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -75.4 -15.21 20.02 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 121.54 1.493 . . . . 0.0 111.727 170.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.02 3.33 0.11 Allowed 'General case' 0 C--N 1.345 0.394 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -167.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -73.56 -7.36 51.59 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 120.475 -1.391 . . . . 0.0 113.72 -174.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 -121.67 16.02 11.1 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.094 1.757 . . . . 0.0 110.215 -178.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 0.99 0 C-N-CA 125.496 1.518 . . . . 0.0 109.786 -177.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 mmt . . . . . 0 CA--C 1.515 -0.394 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.45 103.09 4.63 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 127.228 2.211 . . . . 0.0 105.413 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -78.11 142.09 38.32 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -177.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.1 pt -126.79 166.5 23.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 176.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -124.96 130.56 52.61 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.476 0.71 . . . . 0.0 109.679 -177.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.8 p -93.14 164.58 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 125.449 1.5 . . . . 0.0 108.922 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.401 ' CE1' HG13 ' A' ' 114' ' ' VAL . 0.4 OUTLIER -113.4 -74.43 0.63 Allowed 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -179.593 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -128.1 -34.98 0.52 Allowed Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.164 1.364 . . . . 0.0 111.306 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p -64.12 -32.72 74.4 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 127.127 2.171 . . . . 0.0 114.276 -159.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 mp -133.37 36.46 3.39 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.947 1.299 . . . . 0.0 107.737 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -112.02 -25.17 9.51 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.63 1.172 . . . . 0.0 113.265 -172.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.3 mmt-85 -140.73 -87.93 0.18 Allowed 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 119.687 1.13 . . . . 0.0 109.419 168.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -128.45 2.58 6.6 Favored Glycine 0 C--N 1.334 0.429 0 O-C-N 120.637 -1.29 . . . . 0.0 111.632 -162.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -50.77 151.9 3.93 Favored Pre-proline 0 N--CA 1.438 -1.069 0 C-N-CA 124.79 1.236 . . . . 0.0 109.654 -173.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.7 -18.1 58.4 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 123.275 2.65 . . . . 0.0 112.285 -169.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -90.2 -25.07 20.81 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 126.924 2.09 . . . . 0.0 110.926 -168.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -49.59 -40.45 38.89 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.653 1.181 . . . . 0.0 111.922 -165.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.73 -27.08 1.8 Allowed 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 125.824 1.65 . . . . 0.0 114.472 -177.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.9 m -62.54 -41.0 90.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 119.716 1.144 . . . . 0.0 110.508 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.59 -14.27 61.16 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 67.6 mt -82.47 -15.33 52.9 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.794 0.838 . . . . 0.0 110.189 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -85.77 95.71 9.49 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 -178.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -63.27 -14.32 48.12 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.781 -0.574 . . . . 0.0 112.401 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 68.1 m -71.83 -27.54 62.97 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 120.548 -1.345 . . . . 0.0 112.937 167.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -83.15 2.79 33.73 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.477 1.111 . . . . 0.0 110.891 171.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.31 177.94 19.46 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 125.357 1.456 . . . . 0.0 110.787 173.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 36.9 tp -85.22 144.38 28.18 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.11 0.564 . . . . 0.0 111.308 -175.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -147.53 120.1 8.54 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.39 1.476 . . . . 0.0 109.131 161.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -134.7 150.93 50.66 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 119.008 0.822 . . . . 0.0 110.931 171.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -66.72 109.02 2.7 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 127.079 2.152 . . . . 0.0 110.191 -177.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.7 tpp85 -118.15 42.14 2.76 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.826 1.651 . . . . 0.0 108.464 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 113.5 175.0 19.09 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-O 122.874 1.263 . . . . 0.0 113.027 167.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -108.97 155.4 20.91 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.67 172.35 37.0 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.243 -0.98 . . . . 0.0 115.049 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.5 p -143.53 131.09 21.16 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 175.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 20.6 p -63.36 106.94 0.99 Allowed 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 173.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.45 -19.32 12.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.879 -177.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -65.79 116.71 7.27 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 155.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.26 132.62 34.09 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 117.641 -1.171 . . . . 0.0 107.915 160.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -135.59 156.49 77.58 Favored Pre-proline 0 N--CA 1.449 -0.5 0 CA-C-N 119.159 0.89 . . . . 0.0 108.683 178.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.467 ' HG2' ' HB2' ' A' ' 54' ' ' LEU . 60.1 Cg_endo -71.55 90.89 0.69 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.996 3.13 . . . . 0.0 110.228 164.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.54 HD11 ' HB2' ' A' ' 51' ' ' PRO . 45.0 tp -90.38 107.55 19.22 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 154.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.4 m -101.91 166.59 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 170.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.42 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -114.63 129.65 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 170.95 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.55 -170.93 3.41 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.99 0.916 . . . . 0.0 111.7 -176.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.45 -157.65 53.44 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 126.319 1.914 . . . . 0.0 112.336 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.03 -8.35 21.54 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.397 1.479 . . . . 0.0 114.198 -174.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 -127.26 19.6 6.91 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 123.885 0.874 . . . . 0.0 112.677 -170.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 42.8 m-20 55.75 66.6 1.17 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.235 1.814 . . . . 0.0 109.066 -171.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 68.0 mt -104.28 88.94 2.28 Favored Pre-proline 0 N--CA 1.465 0.292 0 C-N-CA 127.695 2.398 . . . . 0.0 106.55 -175.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.54 ' HB2' HD11 ' A' ' 42' ' ' LEU . 96.2 Cg_endo -66.44 150.28 84.33 Favored 'Trans proline' 0 N--CA 1.44 -1.653 0 CA-C-N 119.749 0.946 . . . . 0.0 112.501 174.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -128.81 118.94 23.61 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.63 102.34 3.27 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 165.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.467 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 2.9 mt -78.67 147.07 33.67 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 173.227 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -87.2 85.93 7.24 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 120.274 -1.516 . . . . 0.0 110.959 -173.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.2 86.8 11.06 Favored Pre-proline 0 N--CA 1.474 0.74 0 C-N-CA 123.72 0.808 . . . . 0.0 112.848 174.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -58.5 150.42 68.78 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 121.143 1.228 . . . . 0.0 110.395 174.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.81 -2.24 75.03 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 124.391 0.996 . . . . 0.0 113.91 174.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.27 127.8 32.55 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 120.122 1.961 . . . . 0.0 106.127 -174.119 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.76 -143.13 16.45 Favored Glycine 0 CA--C 1.522 0.527 0 CA-C-O 118.338 -1.257 . . . . 0.0 110.235 -168.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -141.35 170.38 15.84 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.051 1.425 . . . . 0.0 111.324 -177.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 7.1 m -72.31 106.59 4.52 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.161 1.384 . . . . 0.0 111.774 -174.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.6 t -77.73 101.36 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.761 0.824 . . . . 0.0 110.524 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.6 p -70.61 164.25 25.31 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 121.878 -0.514 . . . . 0.0 110.253 -177.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 176.59 -159.98 27.16 Favored Glycine 0 C--N 1.343 0.93 0 CA-C-N 119.392 0.996 . . . . 0.0 112.481 -176.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -139.32 160.03 40.78 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 121.499 -1.001 . . . . 0.0 111.785 -176.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 75.8 mt -114.09 124.41 70.71 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -173.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -113.87 119.93 38.97 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 173.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -57.09 114.13 2.0 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 154.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.9 m -115.37 155.35 16.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 173.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.73 173.23 10.23 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 122.011 0.91 . . . . 0.0 109.593 170.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.47 -49.85 60.98 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 125.72 1.608 . . . . 0.0 110.153 170.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -56.79 -39.25 73.78 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 118.922 -0.561 . . . . 0.0 111.679 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 44.2 tpp -72.35 -48.72 39.64 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 118.799 0.727 . . . . 0.0 109.693 179.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.28 -13.58 39.9 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.063 -1.023 . . . . 0.0 113.156 177.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 89.1 mtt-85 -86.34 -57.23 3.09 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 125.328 1.451 . . . . 0.0 110.467 168.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -53.48 -44.89 69.35 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.523 1.129 . . . . 0.0 112.272 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 90.5 mt -65.84 -27.93 68.6 Favored 'General case' 0 N--CA 1.461 0.113 0 O-C-N 121.347 -0.846 . . . . 0.0 110.526 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.472 ' HA ' ' SG ' ' A' ' 84' ' ' CYS . 1.8 t70 -76.64 10.12 2.36 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.099 1.76 . . . . 0.0 111.184 176.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -126.54 -4.77 6.54 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.516 2.326 . . . . 0.0 110.433 167.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.99 -49.05 7.3 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 104.25 -2.5 . . . . 0.0 104.25 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -74.78 0.79 14.21 Favored 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 124.884 1.274 . . . . 0.0 111.683 -173.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 57.77 19.28 5.48 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.814 1.646 . . . . 0.0 113.192 -176.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.472 ' SG ' ' HA ' ' A' ' 79' ' ' ASP . 1.1 p -57.86 157.6 14.81 Favored Pre-proline 0 CA--C 1.546 0.807 0 O-C-N 119.337 -2.102 . . . . 0.0 109.885 167.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -72.23 -4.51 12.99 Favored 'Cis proline' 0 CA--C 1.543 0.974 0 CA-C-N 119.732 0.94 . . . . 0.0 113.857 -6.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.3 m -59.51 -62.3 1.98 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 120.237 1.38 . . . . 0.0 111.776 -178.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 43.2 mtp -75.39 -58.86 3.03 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 122.326 0.251 . . . . 0.0 110.385 -175.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -119.2 174.71 6.17 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 126.285 1.834 . . . . 0.0 109.096 -176.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -127.4 -14.32 5.33 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 115.702 1.741 . . . . 0.0 115.702 -174.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? 62.08 125.12 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 128.641 2.776 . . . . 0.0 114.064 -174.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.6 m -134.67 167.39 20.92 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -174.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -106.91 123.98 48.95 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.155 1.782 . . . . 0.0 108.786 172.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -126.43 -164.51 1.34 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.083 1.753 . . . . 0.0 112.488 -166.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -132.43 134.24 44.85 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 120.363 1.438 . . . . 0.0 113.195 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.624 HG13 HG22 ' A' ' 110' ' ' VAL . 1.5 p -155.3 117.57 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 118.115 2.635 . . . . 0.0 118.115 -166.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -57.53 132.55 53.51 Favored 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 125.294 1.438 . . . . 0.0 109.263 -173.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 84.8 t -70.4 101.86 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 105.423 -2.065 . . . . 0.0 105.423 163.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.37 -34.35 67.89 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 167.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -163.9 149.44 10.91 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.818 2.047 . . . . 0.0 106.134 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 70.2 t-105 -124.93 132.57 53.27 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 125.555 1.542 . . . . 0.0 107.012 173.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -122.47 103.48 8.75 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.87 -174.01 15.64 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 125.28 1.419 . . . . 0.0 112.394 176.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -50.63 156.84 0.85 Allowed 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 126.03 1.732 . . . . 0.0 114.298 170.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.86 65.61 1.39 Allowed Glycine 0 N--CA 1.436 -1.363 0 N-CA-C 108.886 -1.686 . . . . 0.0 108.886 149.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -102.36 89.09 1.56 Allowed Pre-proline 0 CA--C 1.538 0.506 1 C-N-CA 133.301 4.641 . . . . 0.0 108.928 -155.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.468 ' CG ' HG12 ' A' ' 110' ' ' VAL . 87.2 Cg_endo -71.81 -16.12 29.71 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 124.332 3.354 . . . . 0.0 116.14 -168.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 107.16 -167.49 13.76 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 120.541 1.518 . . . . 0.0 110.837 -165.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -68.93 -17.42 63.95 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -161.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.3 p -150.28 157.18 42.79 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 121.946 2.157 . . . . 0.0 109.176 -177.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.624 HG22 HG13 ' A' ' 95' ' ' VAL . 4.2 m -128.03 157.38 40.21 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.968 0 C-N-CA 115.795 -2.362 . . . . 0.0 109.272 -167.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -98.76 82.82 2.85 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 164.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 9.2 m -75.22 166.23 23.96 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 114.485 -1.234 . . . . 0.0 107.785 163.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -82.96 137.33 34.22 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 155.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.401 HG13 ' CE1' ' A' ' 7' ' ' TYR . 22.8 t -131.96 127.56 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 127.373 2.269 . . . . 0.0 107.852 174.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -63.69 118.52 8.38 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 170.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 36.0 p -130.85 179.56 5.91 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.551 1.141 . . . . 0.0 108.554 170.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.7 t -130.41 155.25 46.72 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 124.96 1.304 . . . . 0.0 107.801 170.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -120.09 -6.22 9.97 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 127.776 2.43 . . . . 0.0 111.743 175.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.5 t -130.98 69.57 1.47 Allowed 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -174.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.64 9.14 42.45 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.751 1.22 . . . . 0.0 113.703 -170.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.405 ' HB1' ' HD2' ' A' ' 122' ' ' PRO . . . 67.84 161.88 0.14 Allowed Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 127.302 2.241 . . . . 0.0 111.858 -177.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.405 ' HD2' ' HB1' ' A' ' 121' ' ' ALA . 21.4 Cg_endo -66.97 -32.83 34.36 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 121.456 1.437 . . . . 0.0 113.998 -171.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -61.05 -38.66 86.98 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.568 1.147 . . . . 0.0 112.93 -173.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 46.0 m0 -75.22 -10.07 59.13 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 122.067 -0.396 . . . . 0.0 110.895 -169.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.75 -11.9 60.54 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.22 1.008 . . . . 0.0 111.996 173.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -109.92 -8.81 14.81 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.641 0.776 . . . . 0.0 112.081 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.5 mt -73.09 152.27 90.56 Favored Pre-proline 0 C--O 1.24 0.572 0 O-C-N 121.784 -0.572 . . . . 0.0 109.711 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.75 159.8 38.28 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.89 2.393 . . . . 0.0 110.787 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -102.9 172.79 6.62 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.86 0.864 . . . . 0.0 111.877 -176.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.514 ' CE1' HD11 ' A' ' 141' ' ' LEU . 92.0 m-70 -132.35 170.87 14.47 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 126.894 2.077 . . . . 0.0 108.785 -177.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -111.77 -14.9 13.51 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.808 0.843 . . . . 0.0 111.334 174.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 58.6 m -155.31 169.68 23.64 Favored 'General case' 0 C--O 1.233 0.237 0 O-C-N 120.404 -1.435 . . . . 0.0 110.053 170.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -104.0 -160.45 0.77 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 128.165 2.586 . . . . 0.0 106.797 158.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 23.9 t0 78.95 134.19 0.06 Allowed 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 129.492 3.117 . . . . 0.0 112.183 -171.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.8 -31.38 26.99 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.999 1.32 . . . . 0.0 110.974 173.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -67.61 -15.84 63.86 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.594 0.758 . . . . 0.0 112.844 176.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -77.64 155.92 43.84 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.885 1.231 . . . . 0.0 111.364 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.56 -19.18 32.62 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.771 2.314 . . . . 0.0 113.152 -172.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 43.4 m-70 -71.45 83.83 0.81 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.986 2.114 . . . . 0.0 109.429 -173.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -61.06 68.75 0.01 OUTLIER Glycine 0 CA--C 1.528 0.891 0 C-N-CA 128.527 2.965 . . . . 0.0 113.735 -177.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.514 HD11 ' CE1' ' A' ' 130' ' ' HIS . 0.4 OUTLIER -178.1 57.97 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 130.973 3.709 . . . . 0.0 106.21 179.363 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -90.21 -168.0 2.0 Allowed 'General case' 0 N--CA 1.463 0.188 0 O-C-N 120.933 -1.104 . . . . 0.0 108.234 -176.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -60.32 136.72 58.12 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.585 1.084 . . . . 0.0 108.208 -176.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -114.95 78.66 5.54 Favored Pre-proline 0 N--CA 1.453 -0.311 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 -178.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -70.35 -49.18 0.5 Allowed 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.012 1.808 . . . . 0.0 109.336 175.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 24.1 ttt180 -164.15 19.59 0.06 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.205 1.402 . . . . 0.0 111.422 -162.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -61.44 -33.25 73.41 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.466 -0.772 . . . . 0.0 110.727 175.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -146.11 5.45 0.98 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 127.266 2.227 . . . . 0.0 111.897 -162.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.143 0 C-N-CA 126.131 1.772 . . . . 0.0 112.163 -178.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 mtt . . . . . 0 N--CA 1.456 -0.139 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.98 158.38 43.83 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.933 1.293 . . . . 0.0 108.647 170.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -99.78 138.76 36.41 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 122.953 0.501 . . . . 0.0 110.463 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.4 pt -132.92 174.1 13.81 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 CA-C-O 122.001 0.905 . . . . 0.0 109.38 167.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -131.35 133.44 45.3 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.349 1.46 . . . . 0.0 108.257 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.422 HG21 ' HB2' ' A' ' 11' ' ' LYS . 13.2 m -70.0 119.35 15.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-O 122.024 0.916 . . . . 0.0 109.582 -178.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -54.12 -40.55 67.46 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.393 1.477 . . . . 0.0 111.755 172.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 164.12 -44.19 0.31 Allowed Glycine 0 CA--C 1.526 0.757 0 CA-C-O 122.949 1.305 . . . . 0.0 110.583 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.58 -11.8 3.39 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.715 2.406 . . . . 0.0 115.74 -173.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -134.95 31.1 3.31 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 124.763 1.225 . . . . 0.0 110.638 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.422 ' HB2' HG21 ' A' ' 6' ' ' VAL . 13.7 tmtt? -117.91 -85.48 0.64 Allowed 'General case' 0 C--O 1.224 -0.239 0 CA-C-O 117.359 -1.305 . . . . 0.0 107.989 170.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.8 mmm180 -45.3 -84.12 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.446 1.498 . . . . 0.0 113.345 -171.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -167.06 15.58 0.08 OUTLIER Glycine 0 CA--C 1.53 0.997 0 C-N-CA 123.588 0.613 . . . . 0.0 112.229 -175.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.565 HE22 ' HA ' ' A' ' 134' ' ' ASP . 9.2 mp0 -51.95 155.44 3.13 Favored Pre-proline 0 C--O 1.233 0.231 0 C-N-CA 125.406 1.482 . . . . 0.0 110.809 177.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -64.76 -3.88 7.61 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 124.171 3.247 . . . . 0.0 113.795 -172.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.661 ' O ' HG22 ' A' ' 19' ' ' VAL . 4.2 m-80 -110.4 -9.5 14.61 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-O 116.365 -1.779 . . . . 0.0 111.221 -167.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -53.76 -46.63 71.0 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 121.982 2.173 . . . . 0.0 109.725 -172.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.874 ' HA ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -50.55 -19.34 0.87 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.903 1.681 . . . . 0.0 115.403 175.9 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.661 HG22 ' O ' ' A' ' 16' ' ' ASN . 30.9 m -63.48 -24.11 35.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 121.525 1.966 . . . . 0.0 111.566 176.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.703 ' HG3' HD12 ' A' ' 21' ' ' LEU . 4.1 ptp -89.4 -0.12 57.25 Favored 'General case' 0 C--N 1.345 0.376 0 CA-C-N 120.183 1.356 . . . . 0.0 110.836 -179.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.874 HD13 ' HA ' ' A' ' 18' ' ' LYS . 8.3 mp -96.13 9.29 41.37 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.868 2.067 . . . . 0.0 109.909 -169.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -129.95 110.16 11.46 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 119.119 0.872 . . . . 0.0 108.887 -178.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -58.51 -22.91 56.69 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -175.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.6 m -75.53 -26.04 57.7 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.437 -0.789 . . . . 0.0 112.845 173.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 49.0 m170 -69.63 -49.46 53.66 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 161.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 158.04 179.85 33.22 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-O 122.332 0.962 . . . . 0.0 111.863 172.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 28.9 tp -81.57 138.17 35.43 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.64 1.176 . . . . 0.0 111.303 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -149.77 120.95 7.78 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.225 1.01 . . . . 0.0 109.634 163.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.32 125.43 47.01 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 124.415 1.086 . . . . 0.0 109.864 -178.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -62.66 93.25 0.05 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 126.382 1.873 . . . . 0.0 110.588 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -95.55 61.12 2.27 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.212 1.005 . . . . 0.0 108.463 176.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.85 -160.53 51.69 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-O 122.656 1.142 . . . . 0.0 110.946 174.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.406 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 57.9 mtm180 -128.83 167.91 16.65 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 121.628 -0.924 . . . . 0.0 110.82 -161.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.484 ' HA2' ' H ' ' A' ' 98' ' ' LEU . . . -177.43 175.47 47.61 Favored Glycine 0 C--N 1.336 0.556 0 O-C-N 121.348 -0.845 . . . . 0.0 114.01 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.1 p -142.89 156.86 44.99 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.965 1.306 . . . . 0.0 109.261 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 44.0 p -69.25 119.1 13.0 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 169.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.9 t -70.6 -44.18 77.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 173.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -58.25 123.27 15.48 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 126.142 1.777 . . . . 0.0 108.329 163.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.1 m -60.01 148.7 34.55 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 162.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -141.98 153.25 63.72 Favored Pre-proline 0 CA--C 1.541 0.61 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 165.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.487 ' HA ' ' HA3' ' A' ' 60' ' ' GLY . 45.2 Cg_endo -79.23 82.74 2.42 Favored 'Trans proline' 0 C--O 1.237 0.474 1 C-N-CA 125.58 4.187 . . . . 0.0 112.583 -178.799 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.98 122.99 26.27 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 1.053 HG11 HD13 ' A' ' 127' ' ' LEU . 0.1 OUTLIER -134.39 144.7 34.39 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 C-N-CA 123.2 0.6 . . . . 0.0 110.838 174.926 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.0 mt -88.7 76.34 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 126.226 1.811 . . . . 0.0 106.882 168.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.75 -172.96 3.58 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 168.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.81 142.12 4.98 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.502 1.049 . . . . 0.0 112.187 165.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -76.69 2.27 14.7 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.182 -1.187 . . . . 0.0 112.861 -173.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 29.1 m-70 -120.26 17.75 12.28 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.094 1.358 . . . . 0.0 111.41 169.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 52.53 70.12 0.61 Allowed 'General case' 0 C--N 1.341 0.202 0 C-N-CA 126.166 1.787 . . . . 0.0 108.736 -174.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 72.9 mt -104.98 86.57 1.55 Allowed Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 102.751 -3.055 . . . . 0.0 102.751 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 37.3 Cg_endo -66.64 144.47 72.38 Favored 'Trans proline' 0 N--CA 1.443 -1.473 0 CA-C-N 121.037 1.406 . . . . 0.0 110.762 175.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 72.3 m95 -112.43 -169.79 1.54 Allowed 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.939 1.296 . . . . 0.0 109.84 -175.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.2 tp -144.32 92.08 2.27 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 168.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.424 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 3.7 mt -71.78 122.21 20.29 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 -177.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -69.93 89.3 0.59 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.105 0.866 . . . . 0.0 110.561 -177.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.06 77.98 54.5 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 124.808 1.243 . . . . 0.0 108.357 176.056 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.16 121.28 9.4 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.451 2.101 . . . . 0.0 110.618 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.09 -1.38 51.15 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 126.444 1.973 . . . . 0.0 114.121 175.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -109.11 169.49 8.65 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 119.836 1.818 . . . . 0.0 109.835 172.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.487 ' HA3' ' HA ' ' A' ' 41' ' ' PRO . . . 88.69 -8.06 80.3 Favored Glycine 0 CA--C 1.533 1.165 0 N-CA-C 117.56 1.784 . . . . 0.0 117.56 155.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 75.54 167.39 0.28 Allowed 'General case' 0 C--N 1.322 -0.615 1 C-N-CA 134.818 5.247 . . . . 0.0 111.337 -172.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 76.3 m -69.09 170.81 9.27 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 120.988 -1.07 . . . . 0.0 110.607 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 43.0 t -134.78 104.32 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.9 p -72.46 155.79 39.73 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.62 -0.675 . . . . 0.0 109.706 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.56 -155.55 11.44 Favored Glycine 0 C--N 1.337 0.616 0 O-C-N 120.762 -1.211 . . . . 0.0 110.865 -175.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 43.0 mt-10 -144.07 171.22 14.57 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 127.694 2.397 . . . . 0.0 107.786 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 81.8 mt -118.16 139.75 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 120.593 1.542 . . . . 0.0 109.379 -171.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -134.42 125.43 27.48 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.732 0.777 . . . . 0.0 110.082 176.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -72.42 132.94 44.57 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 161.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.6 m -135.38 164.7 32.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 123.755 0.822 . . . . 0.0 110.025 -177.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -115.85 176.14 5.22 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 176.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.33 -37.53 80.93 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 118.99 -0.529 . . . . 0.0 110.121 -168.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 36.0 tp60 -57.82 -40.88 81.03 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.829 0.851 . . . . 0.0 112.152 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.451 ' HE1' ' HA ' ' A' ' 20' ' ' MET . 24.4 tpp -69.02 -48.82 62.04 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.5 tp -58.77 -32.85 69.67 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.1 mtt180 -74.64 -33.98 62.65 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.171 -0.956 . . . . 0.0 112.174 177.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -75.95 -49.11 18.67 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.532 0.733 . . . . 0.0 110.121 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.6 mp -55.89 -41.43 74.46 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -177.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -44.87 -47.83 11.13 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.973 1.709 . . . . 0.0 111.234 174.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -71.47 -40.04 70.52 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.068 0.947 . . . . 0.0 111.911 176.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -65.45 -33.19 75.35 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.685 1.194 . . . . 0.0 110.534 -170.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -101.41 20.06 16.65 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 124.72 1.208 . . . . 0.0 113.291 174.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.1 t70 54.04 17.16 1.31 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.314 1.446 . . . . 0.0 112.776 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 16.2 t -61.99 145.38 92.99 Favored Pre-proline 0 N--CA 1.447 -0.58 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 177.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -80.69 -2.53 43.13 Favored 'Cis proline' 0 CA--C 1.54 0.815 0 N-CA-C 116.15 1.558 . . . . 0.0 116.15 0.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.4 m -63.4 -61.34 2.41 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 120.042 1.292 . . . . 0.0 112.572 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 12.3 mtp -83.12 -76.02 0.29 Allowed 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -177.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -85.34 169.83 13.34 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 176.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -146.18 126.6 14.05 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.858 1.663 . . . . 0.0 106.547 176.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -67.2 131.62 46.15 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.353 1.061 . . . . 0.0 110.048 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.7 m -128.82 177.1 7.32 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.604 1.962 . . . . 0.0 107.681 174.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -116.5 146.24 42.73 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.379 1.471 . . . . 0.0 110.053 167.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.34 178.76 7.36 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.556 1.942 . . . . 0.0 111.771 175.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 37.2 tp60 -109.73 115.89 30.69 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.933 1.693 . . . . 0.0 110.683 -178.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 70.5 t -108.99 145.74 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.57 1.148 . . . . 0.0 108.487 -177.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -85.4 142.74 29.06 Favored 'General case' 0 C--N 1.341 0.206 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 169.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.593 ' CG1' ' HA ' ' A' ' 108' ' ' ASP . 1.9 p -89.82 103.08 13.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 124.978 1.311 . . . . 0.0 109.029 172.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.484 ' H ' ' HA2' ' A' ' 34' ' ' GLY . 0.3 OUTLIER -72.69 -22.0 60.97 Favored 'General case' 0 C--N 1.331 -0.206 0 O-C-N 120.708 -1.245 . . . . 0.0 111.537 172.281 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -160.17 153.39 21.94 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 119.99 1.268 . . . . 0.0 108.437 177.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 48.5 t-105 -136.85 120.84 17.64 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.296 0.638 . . . . 0.0 109.713 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -108.24 99.56 8.96 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 125.269 1.427 . . . . 0.0 110.995 -177.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.69 -173.32 19.26 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 124.432 1.015 . . . . 0.0 110.936 174.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -67.06 171.12 5.87 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.104 0.562 . . . . 0.0 110.832 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.47 57.48 1.75 Allowed Glycine 0 C--O 1.22 -0.743 0 C-N-CA 125.154 1.359 . . . . 0.0 112.179 174.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -100.6 89.65 1.25 Allowed Pre-proline 0 N--CA 1.471 0.598 0 C-N-CA 126.984 2.114 . . . . 0.0 109.272 -167.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -57.93 -27.25 78.13 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.493 2.796 . . . . 0.0 113.514 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 126.3 -176.52 17.5 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 -161.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.593 ' HA ' ' CG1' ' A' ' 97' ' ' VAL . 36.7 t70 -81.44 4.92 19.25 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -173.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.8 p -137.33 156.23 48.48 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 118.802 -1.159 . . . . 0.0 110.783 156.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.2 p -130.92 152.74 38.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 124.305 1.042 . . . . 0.0 111.021 173.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -86.72 128.27 35.01 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.535 1.534 . . . . 0.0 108.216 170.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -137.06 167.95 20.54 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 127.158 2.183 . . . . 0.0 110.596 178.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -102.42 142.36 33.75 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 173.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 40.4 t -138.08 144.63 30.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 177.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -78.17 125.82 29.9 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 173.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 71.7 p -120.39 -173.96 2.69 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.965 1.306 . . . . 0.0 107.87 177.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.8 t -145.86 139.2 26.15 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 162.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -105.36 -8.25 18.31 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.439 0.695 . . . . 0.0 110.729 174.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 44.2 p -86.49 14.57 6.58 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.025 1.33 . . . . 0.0 113.251 -166.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -57.44 134.76 56.33 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.137 1.375 . . . . 0.0 113.343 -162.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.16 147.13 98.76 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.27 172.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.5 -27.28 46.56 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 121.753 1.635 . . . . 0.0 113.15 -174.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -50.57 -35.28 29.19 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.339 1.056 . . . . 0.0 111.141 171.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 0.617 ' O ' HD11 ' A' ' 127' ' ' LEU . 35.8 m0 -82.66 12.73 4.36 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.542 0.61 . . . . 0.0 111.948 -173.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -91.19 -26.09 19.22 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 120.403 1.456 . . . . 0.0 111.506 163.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -89.16 -25.72 21.67 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 120.123 1.329 . . . . 0.0 112.297 -169.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 1.053 HD13 HG11 ' A' ' 43' ' ' VAL 0.459 0.2 OUTLIER -45.43 161.39 0.24 Allowed Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 126.666 1.987 . . . . 0.0 115.178 173.058 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -90.39 142.45 3.58 Favored 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 124.171 3.248 . . . . 0.0 108.557 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.45 ' CD2' ' HA2' ' A' ' 60' ' ' GLY . 9.3 m-30 -98.16 -177.96 3.9 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 124.198 0.999 . . . . 0.0 109.241 -169.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 66.7 m80 -136.52 -178.69 5.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.608 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -134.24 -15.32 2.24 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 122.96 1.362 . . . . 0.0 111.908 170.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 29.7 p -144.96 153.2 41.27 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 161.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -92.03 157.45 16.77 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 167.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.565 ' HA ' HE22 ' A' ' 14' ' ' GLN . 42.8 t0 -170.41 139.15 1.63 Allowed 'General case' 0 C--O 1.241 0.607 0 CA-C-N 119.74 1.155 . . . . 0.0 108.989 166.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 66.6 m -81.18 -19.26 43.73 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.245 -0.91 . . . . 0.0 111.164 170.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -88.61 -11.77 44.5 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 120.374 1.443 . . . . 0.0 111.606 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.99 163.49 20.31 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.714 1.149 . . . . 0.0 112.019 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -71.82 -1.35 9.77 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 124.136 3.224 . . . . 0.0 113.637 -176.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -51.38 -29.79 16.78 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 126.425 1.89 . . . . 0.0 115.006 -169.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 74.35 -26.17 1.06 Allowed Glycine 0 CA--C 1.528 0.869 0 CA-C-O 118.458 -1.19 . . . . 0.0 112.963 -177.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.71 120.74 38.65 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 126.162 1.785 . . . . 0.0 109.206 167.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -136.23 162.54 32.68 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 126.475 1.91 . . . . 0.0 109.511 178.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -62.4 119.09 8.44 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -119.92 74.56 19.83 Favored Pre-proline 0 N--CA 1.452 -0.336 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -171.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -67.69 -54.97 0.3 Allowed 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 123.047 2.498 . . . . 0.0 111.837 -173.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -157.94 13.5 0.21 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -174.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.05 -3.44 35.86 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 128.385 2.674 . . . . 0.0 113.239 -178.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 19.5 p30 -136.89 -14.96 1.57 Allowed 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 26.9 mmm-85 . . . . . 0 C--O 1.247 0.967 0 C-N-CA 126.775 2.03 . . . . 0.0 112.134 168.771 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.44 ' HA ' ' OE2' ' A' ' 69' ' ' GLU . 42.9 mtt . . . . . 0 N--CA 1.47 0.545 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.02 97.04 2.64 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 127.071 2.148 . . . . 0.0 105.325 -177.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -65.98 123.68 20.5 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -176.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.446 HG22 ' HB2' ' A' ' 113' ' ' PHE . 18.5 pt -119.13 170.63 8.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 124.418 1.087 . . . . 0.0 108.609 173.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -135.99 141.78 44.44 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.572 HG12 ' H ' ' A' ' 66' ' ' GLU . 2.7 p -97.55 137.93 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -173.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -92.47 -46.63 7.55 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.488 1.515 . . . . 0.0 110.183 -178.15 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -159.09 6.6 0.14 Allowed Glycine 0 C--N 1.344 0.98 0 CA-C-O 116.909 -2.051 . . . . 0.0 117.821 -168.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.478 ' HA ' ' HG3' ' A' ' 14' ' ' GLN . 1.1 p -131.16 -16.7 3.13 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 120.961 2.38 . . . . 0.0 115.995 -161.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.9 mp -140.04 71.17 1.37 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 120.582 1.537 . . . . 0.0 107.915 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.44 -85.46 0.07 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 118.591 -0.719 . . . . 0.0 112.005 -176.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -64.04 -67.42 0.43 Allowed 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.607 1.094 . . . . 0.0 110.152 -177.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 166.21 88.56 0.07 OUTLIER Glycine 0 N--CA 1.429 -1.789 0 N-CA-C 105.607 -2.997 . . . . 0.0 105.607 172.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.478 ' HG3' ' HA ' ' A' ' 9' ' ' THR . 0.3 OUTLIER -129.41 165.34 33.41 Favored Pre-proline 0 N--CA 1.443 -0.79 0 CA-C-O 117.578 -1.201 . . . . 0.0 108.485 -176.321 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -81.66 61.77 8.07 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.04 1.827 . . . . 0.0 113.973 -159.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.517 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -175.21 -5.75 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 129.264 3.026 . . . . 0.0 110.65 -178.061 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 18.5 t-160 -65.8 -46.15 79.75 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 121.839 2.109 . . . . 0.0 110.598 -177.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.407 ' HA ' HD12 ' A' ' 21' ' ' LEU . 0.6 OUTLIER -53.17 -27.35 20.99 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -172.465 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 16' ' ' ASN . 21.1 m -52.69 -42.79 42.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 119.383 0.992 . . . . 0.0 111.467 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.6 ptp -82.44 8.38 11.69 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 120.935 -1.103 . . . . 0.0 112.79 -174.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 18' ' ' LYS . 20.7 mt -118.75 1.63 11.6 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.645 1.578 . . . . 0.0 110.666 -172.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -125.39 4.98 7.68 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.432 1.493 . . . . 0.0 114.264 -171.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . 0.271 9.5 t-80 42.17 26.45 0.06 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.877 2.471 . . . . 0.0 114.753 177.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.23 -32.51 10.48 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.36 1.064 . . . . 0.0 110.357 175.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -80.05 -35.34 37.3 Favored 'General case' 0 N--CA 1.456 -0.16 0 O-C-N 121.102 -0.999 . . . . 0.0 110.094 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 159.49 -174.56 36.38 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 -175.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -98.65 131.66 44.66 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.277 1.031 . . . . 0.0 109.116 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -132.85 156.87 46.37 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.499 1.52 . . . . 0.0 109.276 159.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -141.02 139.15 34.1 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 168.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -61.38 104.54 0.41 Allowed 'General case' 0 C--O 1.233 0.23 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 169.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.2 tpp180 -114.33 65.23 0.67 Allowed 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 -175.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.87 176.23 49.29 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-O 121.965 0.758 . . . . 0.0 111.814 -176.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -120.57 171.85 8.26 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.621 0.768 . . . . 0.0 109.69 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -177.96 178.85 48.53 Favored Glycine 0 C--N 1.333 0.403 0 O-C-N 121.086 -1.008 . . . . 0.0 114.346 -177.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.4 p -146.42 163.93 34.08 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.294 1.838 . . . . 0.0 108.527 172.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 49.9 p -86.91 103.69 15.54 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 168.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.414 HG22 ' H ' ' A' ' 37' ' ' VAL . 0.2 OUTLIER -63.75 -22.33 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 121.774 0.797 . . . . 0.0 111.636 171.935 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.68 116.44 6.24 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.764 0.792 . . . . 0.0 109.281 159.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.07 129.62 38.73 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.169 1.388 . . . . 0.0 108.219 164.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -138.96 158.35 69.92 Favored Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.15 81.74 2.37 Favored 'Trans proline' 0 N--CA 1.454 -0.85 1 C-N-CA 125.469 4.112 . . . . 0.0 109.165 172.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -80.37 110.94 16.3 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 162.381 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.4 m -127.88 127.92 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 118.818 0.736 . . . . 0.0 109.891 -173.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.5 mt -85.05 105.49 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 177.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.454 ' HB2' ' CD1' ' A' ' 127' ' ' LEU . . . -138.37 130.9 29.12 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 124.517 1.127 . . . . 0.0 109.464 -173.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.23 166.84 27.81 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-O 122.062 0.812 . . . . 0.0 112.629 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -93.28 -6.09 48.27 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 125.959 1.704 . . . . 0.0 113.569 -145.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -121.42 16.78 11.35 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.528 1.131 . . . . 0.0 110.811 177.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.2 m120 60.44 56.79 3.03 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.422 1.489 . . . . 0.0 109.183 175.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 61.0 mt -104.56 87.14 1.62 Allowed Pre-proline 0 C--N 1.322 -0.608 0 C-N-CA 130.128 3.371 . . . . 0.0 103.708 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -63.23 160.4 34.95 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 CA-C-N 120.721 1.293 . . . . 0.0 110.305 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 68.1 m95 -127.4 138.08 52.91 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.449 HD13 HG22 ' A' ' 116' ' ' THR . 0.0 OUTLIER -112.27 98.22 7.16 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 179.334 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.7 mt -80.54 147.79 30.66 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -172.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -83.39 81.31 8.77 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.02 -1.05 . . . . 0.0 109.75 -173.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.6 84.9 32.4 Favored Pre-proline 0 N--CA 1.467 0.424 0 C-N-CA 123.105 0.562 . . . . 0.0 110.03 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -63.46 136.17 53.4 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 121.468 1.445 . . . . 0.0 109.017 178.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.06 13.59 80.79 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 118.597 -1.113 . . . . 0.0 113.635 176.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -127.14 125.61 41.47 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 120.603 2.202 . . . . 0.0 106.538 172.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.28 -140.52 15.09 Favored Glycine 0 N--CA 1.463 0.471 0 CA-C-N 121.13 1.787 . . . . 0.0 111.974 -178.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 46.1 m-70 -133.89 160.99 35.99 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 117.715 0.758 . . . . 0.0 111.649 -166.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 63.2 m -72.45 117.21 13.83 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.166 1.387 . . . . 0.0 109.766 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 44.2 t -85.33 110.58 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.737 1.215 . . . . 0.0 108.671 -174.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 70.7 p -77.3 147.39 36.26 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.923 -1.111 . . . . 0.0 109.803 176.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.77 -150.35 6.25 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 -176.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.572 ' H ' HG12 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -148.49 160.97 42.54 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 126.102 1.761 . . . . 0.0 108.203 170.977 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 98.5 mt -102.25 134.16 43.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 -171.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -125.93 119.2 27.14 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.44 ' OE2' ' HA ' ' A' ' 1' ' ' MET . 0.7 OUTLIER -75.1 118.08 17.65 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 104.419 -2.437 . . . . 0.0 104.419 160.198 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.4 m -123.21 150.45 27.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 124.317 1.047 . . . . 0.0 108.72 -176.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -92.75 165.68 12.82 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 175.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -51.96 -29.99 22.91 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 126.595 1.958 . . . . 0.0 113.446 -174.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 12.0 tp60 -68.15 -42.44 80.08 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 122.244 -0.285 . . . . 0.0 110.701 178.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.2 ttm -71.78 -46.53 58.03 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 118.663 -0.684 . . . . 0.0 109.453 178.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.62 -26.04 67.74 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.39 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 36.6 mtm180 -73.84 -47.84 35.54 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 117.646 -1.169 . . . . 0.0 111.923 171.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -55.72 -47.45 76.85 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.607 1.094 . . . . 0.0 110.515 176.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.6 mp -61.45 -17.82 56.15 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.101 0.961 . . . . 0.0 113.122 176.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -84.5 -5.56 59.3 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.758 1.623 . . . . 0.0 111.972 176.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -125.25 -34.6 2.71 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.428 1.891 . . . . 0.0 111.028 -172.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -58.54 -46.88 85.89 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.582 1.553 . . . . 0.0 111.616 176.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -83.68 4.39 28.81 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 124.887 1.275 . . . . 0.0 112.367 -172.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.1 t0 44.98 25.51 0.16 Allowed 'General case' 0 C--O 1.24 0.554 0 C-N-CA 127.048 2.139 . . . . 0.0 115.497 -164.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 1.6 p -56.96 154.92 17.0 Favored Pre-proline 0 CA--C 1.545 0.776 0 O-C-N 119.592 -1.942 . . . . 0.0 108.56 158.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -74.15 -4.46 18.04 Favored 'Cis proline' 0 CA--C 1.544 0.978 0 N-CA-C 114.541 0.939 . . . . 0.0 114.541 -4.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 10.1 t -62.36 -68.84 0.29 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.506 1.048 . . . . 0.0 110.594 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 28.6 mtp -72.88 -64.57 0.94 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.854 0.862 . . . . 0.0 110.377 -171.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -105.01 176.84 5.03 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.031 0.932 . . . . 0.0 109.084 176.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -139.68 139.28 36.59 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 167.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -78.79 130.08 35.33 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.092 -1.005 . . . . 0.0 108.324 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 86.2 m -135.5 162.83 31.54 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -176.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -98.15 132.58 43.56 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.408 1.083 . . . . 0.0 108.466 173.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.54 HD21 HG23 ' A' ' 114' ' ' VAL . 2.4 pt? -149.42 -176.19 5.29 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.801 1.64 . . . . 0.0 111.892 -171.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 -105.09 135.36 46.58 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -175.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 84.8 t -134.68 128.77 51.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -69.61 121.42 17.08 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 104.188 -2.523 . . . . 0.0 104.188 163.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.49 ' CG1' ' HA ' ' A' ' 108' ' ' ASP . 14.8 p -63.02 119.47 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 156.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.1 -31.99 21.59 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 120.681 -1.262 . . . . 0.0 108.946 170.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -158.35 147.34 19.11 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 104.424 -2.436 . . . . 0.0 104.424 -175.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 66.2 t-105 -124.68 141.32 52.19 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -104.31 104.62 14.54 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.151 0.98 . . . . 0.0 108.687 173.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.28 -164.14 13.63 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-O 122.568 1.093 . . . . 0.0 114.162 165.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -78.36 161.04 27.47 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 114.509 -0.846 . . . . 0.0 109.325 177.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.86 64.38 1.68 Allowed Glycine 0 C--O 1.223 -0.59 0 C-N-CA 124.662 1.125 . . . . 0.0 110.866 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -102.0 89.25 1.52 Allowed Pre-proline 0 C--O 1.237 0.408 0 C-N-CA 129.98 3.312 . . . . 0.0 108.592 -166.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -66.18 -1.14 4.91 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 124.652 3.568 . . . . 0.0 114.495 -168.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.2 172.27 46.95 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-N 120.226 1.376 . . . . 0.0 110.062 -170.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.49 ' HA ' ' CG1' ' A' ' 97' ' ' VAL . 1.6 m-20 -70.91 -1.29 11.35 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -158.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 92.1 p -133.59 142.22 48.03 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 118.427 -1.309 . . . . 0.0 110.726 150.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.9 p -106.71 153.74 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 C-N-CA 125.806 1.642 . . . . 0.0 107.92 175.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 3.8 tm0? -89.8 112.4 23.71 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 161.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 48.4 m -102.9 175.96 5.31 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.854 0.862 . . . . 0.0 109.046 169.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.446 ' HB2' HG22 ' A' ' 4' ' ' ILE . 66.2 m-85 -93.81 144.67 25.21 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 156.104 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.54 HG23 HD21 ' A' ' 93' ' ' LEU . 25.0 t -136.05 150.3 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 127.656 2.382 . . . . 0.0 105.878 173.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -88.4 119.84 29.21 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 171.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.449 HG22 HD13 ' A' ' 53' ' ' LEU . 43.2 p -124.12 -169.19 1.92 Allowed 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.983 1.313 . . . . 0.0 108.533 -178.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.04 146.59 31.95 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 169.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -112.93 -9.0 13.66 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.882 1.673 . . . . 0.0 111.274 169.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 11.2 t -98.95 16.63 21.88 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.237 1.415 . . . . 0.0 112.418 -169.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -60.92 154.63 21.8 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 125.137 1.375 . . . . 0.0 113.344 -172.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.27 156.51 91.64 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 125.631 1.572 . . . . 0.0 110.088 171.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -70.14 -36.78 9.2 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 121.764 1.643 . . . . 0.0 112.584 177.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -52.3 -33.89 44.38 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 119.283 0.947 . . . . 0.0 112.693 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 38.6 m0 -74.59 -7.09 52.04 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.68 0.792 . . . . 0.0 112.054 -174.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 60.6 mt -78.69 -26.69 44.95 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 121.238 -0.913 . . . . 0.0 111.838 171.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -92.1 -16.09 26.85 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.347 0.659 . . . . 0.0 111.8 -175.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.454 ' CD1' ' HB2' ' A' ' 45' ' ' ALA . 48.4 mt -57.92 157.69 14.89 Favored Pre-proline 0 N--CA 1.465 0.293 0 C-N-CA 125.489 1.516 . . . . 0.0 111.787 -178.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -63.69 157.74 50.07 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.981 2.454 . . . . 0.0 110.113 172.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -111.49 158.95 18.55 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -139.05 148.4 43.31 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.398 0.279 . . . . 0.0 110.656 -177.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -87.13 -5.66 58.93 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.31 1.444 . . . . 0.0 112.175 176.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.6 t -167.69 170.88 10.6 Favored 'General case' 0 C--O 1.237 0.412 0 O-C-N 120.176 -1.577 . . . . 0.0 108.408 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -123.54 92.38 3.67 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 165.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -99.28 97.27 8.36 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 128.512 2.725 . . . . 0.0 108.486 -172.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 7.1 t -65.24 7.74 0.18 Allowed 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.622 -1.299 . . . . 0.0 113.575 177.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -127.57 13.33 6.99 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.453 1.501 . . . . 0.0 110.45 -167.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -96.13 179.83 35.3 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 125.963 1.744 . . . . 0.0 112.52 -176.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -75.91 -3.55 14.0 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 124.201 3.267 . . . . 0.0 112.754 172.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -64.87 -24.28 67.49 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.462 1.028 . . . . 0.0 113.512 -167.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 79.72 -39.4 2.18 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 125.227 1.394 . . . . 0.0 113.659 172.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.71 100.87 4.81 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.542 1.937 . . . . 0.0 110.133 168.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -122.26 162.85 20.69 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 125.525 1.53 . . . . 0.0 109.502 171.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -63.26 127.98 33.75 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -176.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -119.24 76.95 17.05 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 123.608 0.763 . . . . 0.0 109.171 -177.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -76.27 -42.98 0.33 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.56 2.84 . . . . 0.0 113.381 178.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 5.9 ttt180 -135.79 -1.72 2.45 Favored 'General case' 0 CA--C 1.514 -0.427 0 O-C-N 121.541 -0.725 . . . . 0.0 112.709 -172.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -67.32 -34.4 77.28 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 127.103 2.161 . . . . 0.0 108.354 -171.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -132.11 29.73 4.33 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.553 2.341 . . . . 0.0 110.86 169.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 51.8 mmt-85 . . . . . 0 C--O 1.247 0.968 0 C-N-CA 125.314 1.446 . . . . 0.0 111.859 -172.369 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.442 ' HG2' ' H ' ' A' ' 2' ' ' ALA . 8.1 ttt . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.442 ' H ' ' HG2' ' A' ' 1' ' ' MET . . . 45.34 -153.88 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -160.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 71.2 m80 69.95 121.67 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 128.082 2.553 . . . . 0.0 107.392 -157.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.6 pt -87.78 -179.43 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 167.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -129.59 140.84 51.09 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 165.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.4 p -106.1 118.05 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 -178.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -70.86 -63.77 1.03 Allowed 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 172.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.5 -21.23 0.11 Allowed Glycine 0 CA--C 1.526 0.747 0 O-C-N 120.933 -1.105 . . . . 0.0 114.449 -165.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.85 -28.52 22.83 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 -159.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.15 55.38 1.86 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 -174.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -160.03 -63.74 0.07 Allowed 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 124.459 1.103 . . . . 0.0 109.743 -173.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -72.31 -86.31 0.03 OUTLIER 'General case' 0 C--N 1.339 0.14 0 C-N-CA 123.975 0.91 . . . . 0.0 108.575 -168.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -161.16 17.79 0.19 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -62.55 148.27 90.94 Favored Pre-proline 0 C--O 1.238 0.49 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 173.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -64.54 -20.36 65.7 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 123.797 2.998 . . . . 0.0 112.922 -169.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.613 ' O ' HG22 ' A' ' 19' ' ' VAL . 47.0 m-80 -84.64 -16.13 43.04 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 117.919 -1.038 . . . . 0.0 112.649 -161.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -48.86 -34.39 12.49 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.134 0.974 . . . . 0.0 111.183 -173.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.66 -30.54 5.57 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 178.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.613 HG22 ' O ' ' A' ' 16' ' ' ASN . 5.5 m -62.37 -23.36 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 120.148 1.34 . . . . 0.0 112.293 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.24 -10.96 53.61 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 119.788 1.176 . . . . 0.0 111.634 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 21.7 mt -94.27 -38.96 10.76 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 -173.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -75.24 83.77 2.4 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 176.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -49.15 -26.76 3.0 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.002 1.721 . . . . 0.0 114.246 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.52 -36.01 63.78 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.459 1.504 . . . . 0.0 111.379 173.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 45.5 m170 -68.51 -47.35 67.2 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.255 1.022 . . . . 0.0 109.439 171.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 167.19 178.12 39.29 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 174.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 64.4 tp -84.3 139.21 32.46 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 122.218 -0.578 . . . . 0.0 111.457 -176.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -142.29 157.95 44.26 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.018 1.327 . . . . 0.0 109.299 160.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -169.43 147.57 3.65 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 131.46 3.904 . . . . 0.0 108.258 178.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -72.61 106.75 4.77 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.797 1.639 . . . . 0.0 111.094 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.9 tpp180 -107.71 66.43 0.66 Allowed 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 177.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.47 -170.51 55.05 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-O 123.518 1.621 . . . . 0.0 113.266 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 77.8 mtm180 -122.52 165.37 16.52 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 125.064 1.345 . . . . 0.0 110.042 -171.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -168.82 177.57 42.6 Favored Glycine 0 C--N 1.334 0.45 0 O-C-N 121.583 -0.698 . . . . 0.0 112.994 173.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 30.2 p -148.43 153.27 38.3 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.219 1.808 . . . . 0.0 107.696 178.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.1 p -82.18 111.16 18.03 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 121.453 1.933 . . . . 0.0 107.154 173.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -76.02 -29.72 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 O-C-N 121.945 -0.472 . . . . 0.0 111.009 170.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -60.72 113.82 2.68 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 154.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 29.2 m -66.09 144.11 56.9 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 168.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.638 ' HB3' HD21 ' A' ' 53' ' ' LEU . 24.3 m-85 -145.46 154.86 53.43 Favored Pre-proline 0 CA--C 1.547 0.853 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -173.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.446 ' HG2' ' HB2' ' A' ' 54' ' ' LEU . 82.0 Cg_endo -84.24 103.79 0.99 Allowed 'Trans proline' 0 CA--C 1.544 1.016 1 C-N-CA 126.224 4.616 . . . . 0.0 115.194 -172.433 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.417 ' HB2' ' HE1' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -105.87 103.23 12.68 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 120.489 -1.382 . . . . 0.0 107.721 179.814 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.1 m -124.97 127.83 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 127.007 2.123 . . . . 0.0 112.543 -174.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.423 HG21 HD12 ' A' ' 141' ' ' LEU . 9.0 mt -93.68 93.84 4.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -172.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.44 -179.54 4.52 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.906 1.282 . . . . 0.0 109.475 172.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.59 144.06 6.41 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.459 1.028 . . . . 0.0 111.914 164.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -72.35 -12.33 61.08 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -172.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 41.6 m-70 -106.4 13.81 28.09 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.325 1.05 . . . . 0.0 111.414 172.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.2 m120 58.32 73.6 0.47 Allowed 'General case' 0 C--N 1.341 0.227 0 C-N-CA 127.147 2.179 . . . . 0.0 108.83 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 64.1 mt -110.02 86.76 5.22 Favored Pre-proline 0 N--CA 1.449 -0.516 0 C-N-CA 125.112 1.365 . . . . 0.0 107.834 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -59.58 126.63 21.16 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.44 1.426 . . . . 0.0 111.879 171.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 67.2 m95 -104.81 126.21 51.66 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 128.239 2.615 . . . . 0.0 108.19 173.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.638 HD21 ' HB3' ' A' ' 40' ' ' PHE . 1.2 tm? -92.08 124.38 36.13 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 168.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.446 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 0.3 OUTLIER -95.47 149.13 21.75 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -179.809 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -76.55 89.99 3.31 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.81 82.91 19.85 Favored Pre-proline 0 N--CA 1.467 0.392 0 O-C-N 120.901 -1.125 . . . . 0.0 110.229 172.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -61.88 134.73 51.61 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 122.236 1.957 . . . . 0.0 109.568 -177.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.94 -1.31 84.97 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-O 117.027 -1.985 . . . . 0.0 114.337 175.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.5 tppt? -128.11 136.26 50.92 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 121.084 2.442 . . . . 0.0 107.243 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 120.51 -113.08 2.31 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 107.378 -2.289 . . . . 0.0 107.378 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.477 ' HB2' ' HG3' ' A' ' 131' ' ' GLU . 2.6 p80 -160.88 172.36 17.1 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.79 1.636 . . . . 0.0 108.785 173.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 41.9 m -73.61 103.27 4.15 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.187 0.995 . . . . 0.0 111.173 170.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.7 t -78.07 107.82 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.733 1.213 . . . . 0.0 111.281 177.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.9 p -65.66 153.46 41.59 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.201 0.6 . . . . 0.0 111.163 177.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -173.58 -157.55 15.53 Favored Glycine 0 C--N 1.343 0.938 0 O-C-N 121.286 -0.884 . . . . 0.0 112.941 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -145.0 167.0 23.7 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.838 1.655 . . . . 0.0 109.569 174.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 71.0 mt -113.69 126.8 71.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 -172.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -117.56 115.52 25.3 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -67.79 81.62 0.19 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.121 1.368 . . . . 0.0 109.049 169.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.2 m -82.6 155.7 3.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 O-C-N 121.047 -1.033 . . . . 0.0 109.088 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.11 -178.8 4.9 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 121.921 0.867 . . . . 0.0 111.544 175.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.86 -45.02 93.78 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.979 1.312 . . . . 0.0 111.452 174.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 42.4 tp60 -59.86 -41.51 91.62 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 119.297 0.953 . . . . 0.0 110.139 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 59.3 tpp -65.88 -51.8 55.64 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 118.596 0.634 . . . . 0.0 110.584 176.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.23 -26.13 66.17 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -76.68 -55.04 5.86 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 123.951 0.9 . . . . 0.0 109.732 171.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -52.68 -48.8 66.29 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.152 0.581 . . . . 0.0 111.255 -177.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 87.7 mt -62.39 -27.04 68.8 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 118.968 -0.539 . . . . 0.0 111.526 -178.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -67.39 -33.39 75.1 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.993 1.27 . . . . 0.0 109.587 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -75.9 -51.04 13.34 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.65 0.78 . . . . 0.0 110.701 172.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -66.17 -27.48 68.04 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.543 0.737 . . . . 0.0 112.572 -174.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.438 ' HG3' ' CE2' ' A' ' 115' ' ' TYR . 63.3 mm-40 -100.46 15.3 28.34 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.851 0.86 . . . . 0.0 111.093 177.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 52.23 28.09 5.29 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.458 1.903 . . . . 0.0 113.028 163.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 7.5 p -72.54 163.35 68.46 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.508 -1.37 . . . . 0.0 109.091 172.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -70.48 -4.01 9.07 Favored 'Cis proline' 0 CA--C 1.547 1.125 0 CA-C-N 119.99 1.032 . . . . 0.0 114.458 -10.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.1 m -60.1 -63.07 1.43 Allowed 'General case' 0 C--N 1.342 0.273 0 CA-C-N 119.561 1.073 . . . . 0.0 110.509 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 1.4 mtm -74.08 -77.69 0.11 Allowed 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.033 0.933 . . . . 0.0 109.683 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -97.83 -178.47 4.11 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.643 1.177 . . . . 0.0 108.934 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -138.13 -7.01 1.59 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 175.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? 61.28 134.22 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 128.459 2.704 . . . . 0.0 111.962 -173.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.9 m -152.73 153.76 33.86 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 120.463 -1.398 . . . . 0.0 110.501 174.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -84.62 126.93 33.78 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 129.137 2.975 . . . . 0.0 112.785 171.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.687 HD21 ' HB ' ' A' ' 114' ' ' VAL . 2.3 pt? -160.29 170.01 21.98 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 126.748 2.019 . . . . 0.0 112.182 -166.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 11.6 tp60 -94.5 131.35 40.3 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -162.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 35.5 t -135.3 119.79 27.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -177.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -67.48 143.16 56.35 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 168.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.597 ' CG1' ' HA ' ' A' ' 108' ' ' ASP . 2.4 p -90.79 126.13 43.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 176.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.53 -14.62 24.88 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 121.45 -0.782 . . . . 0.0 111.665 177.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -176.03 140.34 0.41 Allowed 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 103.582 -2.747 . . . . 0.0 103.582 -175.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 62.5 t-105 -125.47 139.34 53.71 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 171.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -109.44 114.26 27.76 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 123.848 0.718 . . . . 0.0 109.937 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.11 -165.02 42.9 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-O 121.65 0.583 . . . . 0.0 112.102 169.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -64.61 167.34 7.36 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.591 1.156 . . . . 0.0 111.481 -175.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.21 59.24 3.16 Favored Glycine 0 CA--C 1.525 0.688 0 O-C-N 121.931 -0.481 . . . . 0.0 112.267 173.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -101.71 89.15 1.4 Allowed Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 130.626 3.57 . . . . 0.0 110.656 -168.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -60.93 -14.47 32.94 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 124.081 3.187 . . . . 0.0 114.286 -171.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 95.07 176.19 37.84 Favored Glycine 0 CA--C 1.531 1.081 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -165.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.597 ' HA ' ' CG1' ' A' ' 97' ' ' VAL . 10.6 m-20 -69.82 0.91 4.95 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -162.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 61.8 p -137.74 146.66 43.94 Favored 'General case' 0 N--CA 1.427 -1.588 0 C-N-CA 117.124 -1.83 . . . . 0.0 111.725 150.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.1 p -110.27 159.68 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 114.29 -1.323 . . . . 0.0 109.059 173.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -89.37 112.96 24.2 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 156.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 14.1 m -99.89 171.48 7.83 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 165.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.428 ' CE2' ' HA ' ' A' ' 2' ' ' ALA . 19.6 m-85 -90.84 142.5 27.7 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 161.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.687 ' HB ' HD21 ' A' ' 93' ' ' LEU . 53.2 t -129.94 143.73 40.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 172.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.438 ' CE2' ' HG3' ' A' ' 82' ' ' GLU . 8.9 m-85 -70.53 95.78 1.11 Allowed 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 167.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 80.5 p -109.42 173.39 6.34 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.948 171.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.7 t -142.19 121.9 13.44 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 175.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -93.0 4.78 53.42 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.359 0.664 . . . . 0.0 111.476 -178.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 47.3 p -118.83 43.56 2.52 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.085 1.354 . . . . 0.0 107.875 -171.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.407 ' HB3' HD12 ' A' ' 54' ' ' LEU . 40.2 p90 -78.48 171.15 15.52 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.477 -174.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -101.87 151.11 37.91 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 123.839 0.856 . . . . 0.0 110.272 -177.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -66.08 -37.35 25.96 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.916 2.411 . . . . 0.0 110.93 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.94 -0.66 9.73 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.81 1.644 . . . . 0.0 113.172 175.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 44.8 m0 -98.95 -24.72 14.83 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 118.882 0.765 . . . . 0.0 109.491 168.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 12.2 mt -75.89 -30.56 58.86 Favored 'General case' 0 CA--C 1.523 -0.064 0 O-C-N 120.94 -1.1 . . . . 0.0 111.554 177.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -64.25 -24.99 67.86 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.987 0.812 . . . . 0.0 111.965 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.0 mt -64.91 150.99 94.15 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 124.78 1.232 . . . . 0.0 110.429 -172.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -65.52 156.79 61.75 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.932 2.421 . . . . 0.0 110.441 175.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -106.62 159.32 16.28 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.628 0.251 . . . . 0.0 110.497 -172.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -134.06 106.23 7.11 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.754 0.822 . . . . 0.0 111.948 -174.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.477 ' HG3' ' HB2' ' A' ' 61' ' ' HIS . 0.5 OUTLIER -58.33 -13.59 5.58 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.794 1.638 . . . . 0.0 114.173 -174.02 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 56.8 p -150.4 176.46 10.9 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.293 1.837 . . . . 0.0 107.071 173.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -129.16 166.19 19.82 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 168.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -158.11 164.63 36.45 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.218 1.807 . . . . 0.0 109.688 -175.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.3 t -109.32 -3.38 17.19 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.79 1.636 . . . . 0.0 111.061 167.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -140.14 102.72 4.44 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 128.642 2.777 . . . . 0.0 105.643 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -161.48 165.31 35.49 Favored Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 126.983 2.23 . . . . 0.0 111.836 -173.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.32 -18.78 55.87 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.286 2.657 . . . . 0.0 112.543 164.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -77.2 85.84 3.66 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 169.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.27 43.68 0.1 OUTLIER Glycine 0 CA--C 1.535 1.337 0 C-N-CA 127.749 2.595 . . . . 0.0 115.388 178.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.423 HD12 HG21 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -143.23 84.25 1.81 Allowed 'General case' 0 C--O 1.236 0.346 0 C-N-CA 127.316 2.246 . . . . 0.0 108.423 -172.271 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -120.72 155.0 34.84 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 118.193 -0.908 . . . . 0.0 109.727 -169.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -52.13 130.37 30.04 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 124.014 0.821 . . . . 0.0 109.329 -175.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -119.08 64.5 6.93 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 123.268 0.627 . . . . 0.0 110.808 -169.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.17 -48.39 0.36 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 123.125 2.55 . . . . 0.0 111.716 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.0 tpt180 -150.25 26.91 0.77 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.872 0.869 . . . . 0.0 110.886 -169.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -68.14 -67.08 0.49 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 169.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -98.82 2.13 46.5 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.89 0.876 . . . . 0.0 112.722 -176.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.998 0 CA-C-O 115.512 -2.185 . . . . 0.0 107.914 -155.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.499 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.56 117.24 28.45 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 167.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -81.48 124.0 29.08 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 174.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.8 pt -123.77 -176.02 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 123.785 0.834 . . . . 0.0 110.518 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.578 ' CE2' HG23 ' A' ' 36' ' ' THR . 20.4 t80 -124.14 169.43 11.71 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.035 1.334 . . . . 0.0 108.502 174.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.444 HG12 ' H ' ' A' ' 66' ' ' GLU . 7.6 p -122.95 153.54 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 123.837 0.855 . . . . 0.0 109.882 175.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.413 ' CD1' ' N ' ' A' ' 7' ' ' TYR . 0.3 OUTLIER -92.62 -41.11 10.38 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 -171.076 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.444 ' HA3' ' HB3' ' A' ' 133' ' ' TYR . . . 169.45 -19.01 0.07 OUTLIER Glycine 0 CA--C 1.528 0.858 0 C-N-CA 124.743 1.163 . . . . 0.0 113.372 172.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.47 -30.21 71.37 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 128.224 2.609 . . . . 0.0 113.735 -176.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.9 61.1 1.18 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 175.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -151.75 -85.82 0.07 Allowed 'General case' 0 C--O 1.224 -0.279 0 O-C-N 121.239 -0.913 . . . . 0.0 109.86 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 -62.0 -53.62 53.12 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.069 0.85 . . . . 0.0 111.591 -166.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 161.21 30.24 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 -175.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -63.35 155.8 72.89 Favored Pre-proline 0 N--CA 1.45 -0.433 0 C-N-CA 124.83 1.252 . . . . 0.0 108.401 171.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -65.37 -12.58 35.55 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.207 2.604 . . . . 0.0 112.593 -174.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -95.14 24.96 4.53 Favored 'General case' 0 C--O 1.221 -0.415 0 C-N-CA 126.643 1.977 . . . . 0.0 111.454 -175.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -75.89 -55.64 5.43 Favored 'General case' 0 C--N 1.332 -0.18 0 O-C-N 120.442 -1.411 . . . . 0.0 110.116 173.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.04 -24.09 23.11 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -169.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.9 m -60.17 -34.81 58.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 119.675 1.125 . . . . 0.0 112.141 178.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.1 ptp -77.18 -7.7 56.29 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 119.472 1.033 . . . . 0.0 112.76 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 40.5 mt -89.47 7.0 38.32 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.832 1.253 . . . . 0.0 108.974 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -110.23 98.3 7.58 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -59.38 -21.8 60.42 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.867 -0.521 . . . . 0.0 111.563 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.7 t -70.33 -29.19 65.84 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.873 1.269 . . . . 0.0 112.016 175.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 35.1 m170 -79.59 -32.44 41.93 Favored 'General case' 0 CA--C 1.529 0.147 0 O-C-N 121.351 -0.843 . . . . 0.0 109.739 168.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 158.15 175.67 29.34 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 165.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 65.0 tp -74.57 134.0 42.19 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 175.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.8 143.59 31.41 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 155.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -152.01 149.9 29.39 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 165.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -62.18 104.76 0.51 Allowed 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.973 1.709 . . . . 0.0 108.663 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.9 tpp180 -123.56 67.84 1.02 Allowed 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.15 -170.86 45.58 Favored Glycine 0 N--CA 1.435 -1.4 0 CA-C-O 123.824 1.791 . . . . 0.0 111.915 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -131.04 158.91 39.07 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 125.436 1.494 . . . . 0.0 108.257 -170.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.99 173.98 38.4 Favored Glycine 0 CA--C 1.507 -0.463 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.741 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.0 m -141.67 145.95 35.54 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 173.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.578 HG23 ' CE2' ' A' ' 5' ' ' PHE . 25.2 p -71.65 93.17 1.22 Allowed 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 163.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.9 m -63.41 -38.46 82.25 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.106 0 CA-C-O 121.206 0.527 . . . . 0.0 109.892 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.81 118.23 7.43 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 105.218 -2.141 . . . . 0.0 105.218 170.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.74 145.92 50.96 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -141.25 160.62 56.82 Favored Pre-proline 0 N--CA 1.449 -0.475 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 177.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -80.28 67.45 8.62 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 122.532 2.155 . . . . 0.0 113.987 -175.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 53' ' ' LEU . 34.0 tp -72.72 98.63 2.42 Favored 'General case' 0 CA--C 1.553 1.082 0 O-C-N 119.757 -1.839 . . . . 0.0 111.356 178.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.5 m -121.68 126.74 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 119.625 1.102 . . . . 0.0 112.763 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 51.1 mt -69.84 111.67 3.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 173.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -125.98 175.03 8.0 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.457 1.103 . . . . 0.0 108.782 176.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.01 152.74 7.91 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-O 122.61 1.117 . . . . 0.0 111.544 171.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -70.06 -23.41 63.08 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 123.526 0.731 . . . . 0.0 112.34 -176.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -94.44 13.27 24.36 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.429 0.692 . . . . 0.0 111.391 -177.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.567 HD22 ' HB2' ' A' ' 141' ' ' LEU . 2.1 m120 63.22 56.78 1.67 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.04 1.736 . . . . 0.0 107.592 171.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 80.5 mt -107.29 87.91 3.56 Favored Pre-proline 0 CA--C 1.533 0.288 0 C-N-CA 127.253 2.221 . . . . 0.0 107.476 -167.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -54.33 139.76 73.35 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 120.846 1.03 . . . . 0.0 111.652 169.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 6.2 m95 -123.3 146.29 48.02 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 167.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 42' ' ' LEU 0.295 0.9 OUTLIER -97.16 -8.86 29.07 Favored 'General case' 0 C--O 1.219 -0.529 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 -177.741 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 36.7 mt 44.1 -160.8 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.312 1 C-N-CA 134.825 5.25 . . . . 0.0 110.069 -172.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -130.95 91.43 3.05 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 120.848 -1.158 . . . . 0.0 110.225 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.57 85.72 5.22 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 118.968 -0.539 . . . . 0.0 111.616 168.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -59.75 134.41 57.24 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.754 1.636 . . . . 0.0 109.257 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.74 10.43 81.35 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-O 119.568 -0.573 . . . . 0.0 113.618 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? -123.03 155.03 37.68 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.779 1.79 . . . . 0.0 108.444 172.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.54 ' HA2' ' CD2' ' A' ' 129' ' ' TYR . . . 67.96 -146.39 46.39 Favored Glycine 0 C--N 1.334 0.458 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 -174.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -127.45 169.36 13.73 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 117.833 0.816 . . . . 0.0 108.849 -169.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 5.1 p -59.8 169.67 1.35 Allowed 'General case' 0 CA--C 1.512 -0.486 0 O-C-N 121.665 -0.647 . . . . 0.0 112.122 170.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 54.9 t -135.49 118.41 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.792 168.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 72.5 p -74.72 154.76 38.27 Favored 'General case' 0 C--O 1.239 0.512 0 O-C-N 121.756 -0.59 . . . . 0.0 110.237 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.59 -164.96 28.91 Favored Glycine 0 C--N 1.337 0.608 0 CA-C-O 122.202 0.89 . . . . 0.0 111.761 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.444 ' H ' HG12 ' A' ' 6' ' ' VAL . 0.5 OUTLIER -117.57 156.82 27.43 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 124.886 1.274 . . . . 0.0 108.662 179.206 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 73.2 mt -101.34 130.33 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 170.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -116.45 120.96 40.46 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -62.54 116.18 4.91 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 156.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.3 m -123.89 175.53 6.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 CA-C-N 118.429 0.559 . . . . 0.0 109.978 174.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -125.6 176.18 7.05 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.954 0.902 . . . . 0.0 109.208 169.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -53.13 -37.62 61.95 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.682 1.593 . . . . 0.0 112.204 -175.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 42.8 tp60 -61.15 -41.99 97.75 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 118.465 -0.778 . . . . 0.0 111.133 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -67.04 -44.74 79.44 Favored 'General case' 0 C--O 1.225 -0.232 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.2 tp -62.91 -29.53 70.85 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -176.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 62.3 mtt180 -74.69 -38.58 62.33 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 121.949 -0.47 . . . . 0.0 111.992 172.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -66.65 -48.74 68.47 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 119.23 -0.414 . . . . 0.0 110.228 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.8 mp -51.02 -50.32 58.78 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.353 1.461 . . . . 0.0 110.256 174.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -49.67 -43.6 47.31 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.712 0.805 . . . . 0.0 112.016 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -79.35 -13.74 59.44 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.57 2.348 . . . . 0.0 112.709 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -91.12 -42.99 10.16 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.355 1.462 . . . . 0.0 109.664 -175.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . 0.252 0.4 OUTLIER -90.03 9.46 27.92 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.75 1.22 . . . . 0.0 114.009 170.844 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 61.01 36.04 18.7 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.112 1.365 . . . . 0.0 111.105 167.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 6.5 m -79.03 166.53 41.49 Favored Pre-proline 0 C--N 1.323 -0.585 0 C-N-CA 125.061 1.344 . . . . 0.0 108.796 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -64.94 -3.42 2.81 Favored 'Cis proline' 0 CA--C 1.545 1.027 0 CA-C-N 120.082 1.065 . . . . 0.0 113.598 -17.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.76 -66.57 0.37 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.849 1.66 . . . . 0.0 111.193 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 19.4 mtm -83.33 -63.83 1.28 Allowed 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.83 -0.544 . . . . 0.0 110.362 -176.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -103.91 170.11 8.11 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -177.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -137.91 137.62 38.2 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 120.406 -1.434 . . . . 0.0 107.138 176.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.415 ' HB2' ' CE1' ' A' ' 115' ' ' TYR . 8.4 tmm_? -78.7 123.36 27.07 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 123.899 0.879 . . . . 0.0 108.984 -174.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.6 m -123.96 160.61 27.2 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 123.855 0.862 . . . . 0.0 108.884 -177.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -98.2 140.6 32.25 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 124.018 0.927 . . . . 0.0 109.212 169.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.502 HD11 HG23 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -152.15 169.17 23.08 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.963 0.905 . . . . 0.0 111.483 -177.81 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -95.81 119.86 35.05 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.83 1.652 . . . . 0.0 110.083 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 95.0 t -117.71 136.95 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 177.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -71.9 148.88 45.65 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 123.813 0.845 . . . . 0.0 111.244 172.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.0 t -87.97 95.07 4.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 125.305 1.442 . . . . 0.0 107.306 167.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.35 -24.94 50.64 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.454 1.101 . . . . 0.0 110.724 172.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -162.49 157.32 22.13 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 127.856 2.462 . . . . 0.0 105.096 173.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 75.1 t-105 -145.66 121.83 10.82 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 169.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -105.97 92.55 4.2 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.611 0.764 . . . . 0.0 109.864 176.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 135.66 -179.45 17.76 Favored Glycine 0 C--O 1.227 -0.343 0 C-N-CA 124.233 0.921 . . . . 0.0 112.687 168.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -68.12 155.69 39.06 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 171.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 102.21 56.09 0.84 Allowed Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 124.878 1.228 . . . . 0.0 111.059 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -100.11 91.02 1.5 Allowed Pre-proline 0 C--N 1.327 -0.399 0 C-N-CA 129.591 3.157 . . . . 0.0 106.516 -171.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.567 ' CG ' HG12 ' A' ' 110' ' ' VAL . 61.8 Cg_endo -66.84 -23.82 47.39 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 124.417 3.411 . . . . 0.0 112.362 -178.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 123.23 -172.66 16.12 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 -165.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.66 -6.6 26.91 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -170.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 67.8 p -151.76 157.91 42.62 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 119.072 0.851 . . . . 0.0 111.816 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.567 HG12 ' CG ' ' A' ' 106' ' ' PRO . 3.0 m -136.69 169.05 20.7 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 C-N-CA 125.071 1.348 . . . . 0.0 108.571 -171.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -108.65 93.13 4.36 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 177.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 95.3 m -79.19 176.97 9.18 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.379 0.609 . . . . 0.0 109.915 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -107.72 145.95 32.76 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 158.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.502 HG23 HD11 ' A' ' 93' ' ' LEU . 24.3 t -138.8 143.06 32.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 128.017 2.527 . . . . 0.0 106.44 174.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.415 ' CE1' ' HB2' ' A' ' 90' ' ' ARG . 16.3 m-85 -84.9 104.59 14.99 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 167.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 11.1 p -99.12 -171.49 2.1 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.48 1.912 . . . . 0.0 108.626 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.7 t -147.98 150.88 34.81 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 156.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -114.91 -12.48 12.05 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 128.215 2.606 . . . . 0.0 111.384 176.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 5.8 p -88.81 9.07 25.93 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.329 1.452 . . . . 0.0 113.807 -169.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.549 ' CE1' HD21 ' A' ' 125' ' ' LEU . 30.3 p90 -69.0 164.36 22.53 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.787 1.235 . . . . 0.0 112.72 -170.004 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -93.82 153.69 40.99 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 125.258 1.423 . . . . 0.0 110.324 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.6 ' HA ' HD23 ' A' ' 125' ' ' LEU . 36.8 Cg_endo -62.14 -27.29 78.64 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.587 2.858 . . . . 0.0 113.548 -174.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -49.77 -43.01 47.91 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.243 1.017 . . . . 0.0 112.113 176.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 42.2 m0 -70.55 -15.85 62.82 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 122.485 0.314 . . . . 0.0 111.339 -172.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.6 HD23 ' HA ' ' A' ' 122' ' ' PRO . 2.7 mm? -82.65 -10.96 58.7 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.059 0.944 . . . . 0.0 112.367 178.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -96.39 -16.02 21.48 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.685 0.794 . . . . 0.0 110.992 175.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 88.4 mt -68.42 155.85 91.7 Favored Pre-proline 0 N--CA 1.469 0.497 0 C-N-CA 124.149 0.979 . . . . 0.0 109.561 176.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -79.62 154.5 23.84 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 121.786 1.657 . . . . 0.0 110.497 173.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.54 ' CD2' ' HA2' ' A' ' 60' ' ' GLY . 44.5 m-85 -85.79 175.87 8.44 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 126.357 1.863 . . . . 0.0 111.108 177.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -142.7 161.11 38.95 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.625 1.97 . . . . 0.0 107.984 -178.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -110.02 -2.65 16.93 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 122.684 1.231 . . . . 0.0 112.544 -177.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.5 t -164.11 154.38 14.91 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.444 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . 7.9 t80 -108.98 116.59 32.28 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.194 167.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -143.51 125.11 14.9 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.576 2.35 . . . . 0.0 108.225 -168.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.2 p -68.64 -47.55 66.31 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 169.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -75.42 43.42 0.23 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.706 2.003 . . . . 0.0 110.61 170.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -110.73 163.03 12.35 Favored Glycine 0 C--N 1.332 0.327 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 166.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.11 -14.61 44.59 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.749 2.3 . . . . 0.0 113.122 -175.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 64.0 m-70 -62.79 -14.52 46.17 Favored 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 116.828 2.158 . . . . 0.0 116.828 -162.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 75.53 -29.85 1.23 Allowed Glycine 0 CA--C 1.537 1.409 0 CA-C-N 120.406 1.457 . . . . 0.0 115.295 172.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.567 ' HB2' HD22 ' A' ' 49' ' ' ASN . 0.3 OUTLIER -97.37 97.37 9.06 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 126.339 1.856 . . . . 0.0 110.949 179.325 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -104.58 162.55 13.16 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 120.865 -1.147 . . . . 0.0 109.872 -173.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -57.35 142.17 44.52 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 119.004 -0.522 . . . . 0.0 110.151 -176.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 31.9 t-20 -114.93 85.17 11.5 Favored Pre-proline 0 C--O 1.234 0.241 0 C-N-CA 125.295 1.438 . . . . 0.0 107.765 176.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.66 -45.33 0.55 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.327 2.018 . . . . 0.0 111.039 172.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -163.18 14.83 0.07 Allowed 'General case' 0 C--O 1.224 -0.285 0 C-N-CA 125.744 1.618 . . . . 0.0 111.622 -174.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -63.73 -13.59 44.81 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 -165.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -131.25 16.7 5.01 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 129.263 3.025 . . . . 0.0 110.849 -178.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.127 0 C-N-CA 124.773 1.229 . . . . 0.0 108.936 -170.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.468 0.434 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.06 121.5 1.24 Allowed 'General case' 0 C--O 1.235 0.316 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 168.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -80.57 142.48 34.05 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 118.492 0.587 . . . . 0.0 111.213 -175.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.419 HG22 ' HB2' ' A' ' 113' ' ' PHE . 21.8 pt -133.62 -176.13 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 124.407 1.083 . . . . 0.0 109.913 178.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.486 ' HB3' HG22 ' A' ' 114' ' ' VAL . 12.4 t80 -120.74 164.68 16.2 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.275 1.43 . . . . 0.0 109.011 172.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 p -111.6 148.84 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.771 0.829 . . . . 0.0 112.309 -175.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -92.24 7.04 44.46 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -168.087 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 106.84 -33.32 6.51 Favored Glycine 0 N--CA 1.467 0.715 0 O-C-N 120.54 -1.35 . . . . 0.0 110.057 -164.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.64 -24.05 66.24 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 129.8 3.24 . . . . 0.0 114.771 -170.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.407 HD21 HG12 ' A' ' 19' ' ' VAL . 4.1 mp -146.07 48.23 1.22 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.471 1.032 . . . . 0.0 109.258 -173.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -130.97 -85.53 0.51 Allowed 'General case' 0 N--CA 1.468 0.452 0 O-C-N 120.254 -1.529 . . . . 0.0 111.582 176.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.11 -66.79 0.42 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.888 1.222 . . . . 0.0 109.383 -178.216 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 174.82 86.24 0.06 OUTLIER Glycine 0 N--CA 1.431 -1.691 0 N-CA-C 104.957 -3.257 . . . . 0.0 104.957 -178.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.449 ' HG3' ' HD2' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -107.5 160.27 27.23 Favored Pre-proline 0 N--CA 1.445 -0.701 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 174.211 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.449 ' HD2' ' HG3' ' A' ' 14' ' ' GLN . 12.2 Cg_endo -61.49 -27.4 82.14 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.937 2.425 . . . . 0.0 112.343 -174.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -73.52 -16.26 61.28 Favored 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 125.182 1.393 . . . . 0.0 110.842 -173.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -64.36 -32.85 74.63 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 120.115 1.325 . . . . 0.0 112.153 -159.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.94 -19.96 47.76 Favored 'General case' 0 C--O 1.224 -0.279 0 O-C-N 121.409 -0.807 . . . . 0.0 113.044 176.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.487 HG21 ' CE2' ' A' ' 77' ' ' PHE . 1.4 p -55.92 -35.58 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 119.179 0.899 . . . . 0.0 110.956 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.2 ptp -87.97 -4.92 58.77 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -176.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 73.5 mt -90.47 -6.38 54.91 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.505 1.122 . . . . 0.0 110.67 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -106.21 99.91 9.47 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 106.174 -1.788 . . . . 0.0 106.174 172.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 25.6 t-80 -59.03 -18.93 39.11 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.841 1.256 . . . . 0.0 113.285 -176.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.7 m -61.82 -28.34 69.41 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 120.972 -1.08 . . . . 0.0 113.674 169.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -78.69 -1.91 36.7 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 119.241 0.928 . . . . 0.0 111.803 173.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.16 176.65 19.51 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 127.037 2.256 . . . . 0.0 110.571 -176.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -93.76 137.0 33.46 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.521 1.528 . . . . 0.0 110.177 -172.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.16 125.21 15.29 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.474 1.11 . . . . 0.0 110.664 165.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -133.29 126.0 30.51 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 125.228 1.411 . . . . 0.0 109.878 -176.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -60.07 108.53 0.79 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.053 1.741 . . . . 0.0 109.501 -178.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.0 tpp180 -121.15 66.37 0.87 Allowed 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.871 1.268 . . . . 0.0 109.902 -174.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.21 -171.56 55.16 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 176.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.524 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 32.2 mtp85 -123.24 169.19 11.53 Favored 'General case' 0 CA--C 1.511 -0.534 0 O-C-N 121.965 -0.727 . . . . 0.0 111.974 -174.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -166.66 173.52 42.03 Favored Glycine 0 CA--C 1.506 -0.526 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.745 175.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 25.8 p -142.99 161.01 39.25 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.999 -0.6 . . . . 0.0 109.558 171.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.6 p -76.57 103.88 6.79 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 106.328 -1.731 . . . . 0.0 106.328 164.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -62.4 -32.17 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 119.503 1.047 . . . . 0.0 110.435 171.015 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.23 124.74 23.47 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 167.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.24 131.4 44.84 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 125.479 1.511 . . . . 0.0 108.029 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -140.39 157.1 69.21 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 119.472 1.033 . . . . 0.0 108.406 -177.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -70.04 108.05 2.05 Favored 'Trans proline' 0 N--CA 1.454 -0.851 1 C-N-CA 125.525 4.15 . . . . 0.0 108.438 171.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.492 HD21 ' CE2' ' A' ' 133' ' ' TYR . 3.0 tm? -117.84 99.38 6.89 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 173.085 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.6 m -132.58 141.46 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 C-N-CA 126.386 1.874 . . . . 0.0 108.864 -167.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.529 ' HB ' HD22 ' A' ' 141' ' ' LEU . 4.7 mp -109.73 121.21 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -171.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.3 -170.11 3.0 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.295 1.438 . . . . 0.0 108.707 -173.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.79 164.29 4.33 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.337 0.97 . . . . 0.0 111.145 -174.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -78.5 2.74 18.03 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.598 1.159 . . . . 0.0 113.271 -172.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -132.14 17.08 4.57 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.836 1.254 . . . . 0.0 112.445 -171.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.0 m120 56.7 72.87 0.48 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.351 1.86 . . . . 0.0 111.117 -177.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 94.4 mt -110.49 89.49 8.93 Favored Pre-proline 0 C--N 1.324 -0.518 0 C-N-CA 129.267 3.027 . . . . 0.0 107.488 -169.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -52.65 134.1 52.24 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 CA-C-N 120.872 1.347 . . . . 0.0 111.927 171.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 70.8 m95 -118.29 137.76 52.84 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.171 1.388 . . . . 0.0 107.309 170.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.469 ' HG ' HD23 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -107.93 94.61 5.17 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 171.661 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.6 mt -76.07 143.86 41.09 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 -176.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -79.64 75.86 6.28 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.764 -0.585 . . . . 0.0 110.496 -175.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.64 83.32 53.98 Favored Pre-proline 0 N--CA 1.468 0.428 0 C-N-CA 123.728 0.811 . . . . 0.0 109.887 -176.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -63.62 148.99 92.0 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 121.363 1.375 . . . . 0.0 108.815 178.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.6 2.34 60.14 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-O 117.637 -1.646 . . . . 0.0 114.898 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.2 tppt? -124.94 121.71 35.24 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 121.75 2.775 . . . . 0.0 106.291 177.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.531 ' HA2' ' CD2' ' A' ' 129' ' ' TYR . . . 108.2 -147.07 16.48 Favored Glycine 0 N--CA 1.459 0.228 0 CA-C-N 120.601 1.546 . . . . 0.0 110.766 -176.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -137.01 173.99 11.1 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 123.936 0.894 . . . . 0.0 110.198 -168.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 61.4 m -78.08 113.6 16.16 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.498 0.719 . . . . 0.0 110.251 -178.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 38.2 t -78.34 111.16 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 124.183 0.993 . . . . 0.0 108.339 -177.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 51.6 p -92.92 151.22 20.07 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 119.17 0.895 . . . . 0.0 111.762 -173.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -178.92 -163.83 30.67 Favored Glycine 0 C--N 1.337 0.605 0 O-C-N 121.277 -0.889 . . . . 0.0 113.588 -163.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 1.5 pt-20 -120.73 177.37 5.11 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 87.7 mt -121.69 115.58 46.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 169.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -89.71 130.84 35.92 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 168.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -70.57 130.16 41.09 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 152.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.3 m -134.04 167.92 25.1 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 CA-C-O 121.144 0.497 . . . . 0.0 110.35 177.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.86 -179.42 4.28 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 122.427 1.108 . . . . 0.0 111.046 167.025 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.3 -42.76 96.22 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 115.85 -2.024 . . . . 0.0 111.527 177.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.1 mm100 -55.05 -43.16 73.56 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 120.522 1.51 . . . . 0.0 110.763 177.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 39.1 tpp -66.1 -51.46 57.83 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 119.09 -0.481 . . . . 0.0 110.36 178.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.04 -28.16 66.17 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 118.831 0.742 . . . . 0.0 112.034 177.034 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 35.4 mtt180 -75.19 -43.81 49.99 Favored 'General case' 0 C--N 1.337 0.052 0 C-N-CA 125.625 1.57 . . . . 0.0 111.033 179.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.487 ' CE2' HG21 ' A' ' 19' ' ' VAL . 9.0 t80 -57.94 -54.7 43.94 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 123.541 0.737 . . . . 0.0 109.332 175.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 mp -49.74 -41.15 43.15 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.115 0.966 . . . . 0.0 110.613 178.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -65.94 -1.19 2.79 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.092 1.757 . . . . 0.0 114.277 178.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -129.83 3.85 4.94 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.261 2.224 . . . . 0.0 111.132 178.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -102.59 -47.13 4.54 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.932 1.293 . . . . 0.0 110.166 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -75.17 1.51 13.17 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -175.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.0 t70 54.13 26.2 6.36 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.301 1.441 . . . . 0.0 112.578 -165.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 1.5 p -63.98 159.19 57.48 Favored Pre-proline 0 CA--C 1.542 0.672 0 O-C-N 119.411 -2.055 . . . . 0.0 109.154 166.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -73.24 -4.06 15.04 Favored 'Cis proline' 0 CA--C 1.546 1.096 0 CA-C-N 119.417 0.827 . . . . 0.0 113.583 -10.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.63 -63.39 1.3 Allowed 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.262 1.425 . . . . 0.0 112.966 -177.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 4.2 mtm -82.58 -55.85 4.21 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 122.785 0.434 . . . . 0.0 110.35 -172.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -109.8 173.03 6.51 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 127.6 2.36 . . . . 0.0 106.993 176.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 -132.17 157.67 43.69 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 120.867 1.667 . . . . 0.0 108.224 160.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.0 tmm_? -80.6 142.77 33.72 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 118.897 0.771 . . . . 0.0 109.107 172.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.7 m -143.4 161.49 38.24 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.673 0.749 . . . . 0.0 109.312 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -114.3 125.02 53.41 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 126.64 1.976 . . . . 0.0 108.317 171.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.428 HD21 ' CG2' ' A' ' 114' ' ' VAL . 2.1 pt? -142.99 -167.0 2.43 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 129.918 3.287 . . . . 0.0 108.688 -166.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 20.7 tp60 -107.5 138.97 42.74 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.491 0.716 . . . . 0.0 111.904 177.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 99.5 t -133.87 135.97 54.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 172.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -76.45 153.3 35.73 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.549 1.539 . . . . 0.0 109.653 169.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 80.7 t -87.33 112.68 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 127.565 2.346 . . . . 0.0 107.58 165.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.5 mp -90.51 -17.87 26.3 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.241 1.416 . . . . 0.0 110.641 171.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -172.18 159.85 4.98 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 129.041 2.936 . . . . 0.0 105.672 173.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 62.7 t-105 -141.81 118.02 10.73 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 119.339 0.972 . . . . 0.0 109.708 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -118.04 62.29 0.76 Allowed 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.914 0.864 . . . . 0.0 112.67 -171.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 150.18 155.15 6.71 Favored Glycine 0 C--O 1.228 -0.254 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 158.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -54.24 149.41 9.85 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.598 1.159 . . . . 0.0 112.079 -162.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 98.16 65.98 0.88 Allowed Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -165.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -100.82 89.1 1.15 Allowed Pre-proline 0 C--O 1.24 0.579 1 C-N-CA 132.509 4.324 . . . . 0.0 108.152 -162.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -72.79 -5.19 16.73 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 124.675 3.584 . . . . 0.0 114.126 -163.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.74 -177.19 44.92 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 109.251 -1.539 . . . . 0.0 109.251 -166.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -64.36 -12.02 38.34 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 -168.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.0 p -137.41 161.79 35.37 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 120.726 1.603 . . . . 0.0 112.457 177.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.5 m -142.65 156.71 18.46 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 125.366 1.466 . . . . 0.0 108.913 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -98.08 98.64 9.93 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.444 -1.688 . . . . 0.0 106.444 160.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 18.6 m -92.05 172.37 8.49 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 168.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.419 ' HB2' HG22 ' A' ' 4' ' ' ILE . 69.0 m-85 -85.68 140.4 30.57 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 162.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.486 HG22 ' HB3' ' A' ' 5' ' ' PHE . 25.5 t -134.61 124.9 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 127.461 2.304 . . . . 0.0 106.052 173.143 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -72.63 141.08 48.33 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 168.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 55.6 p -138.37 -173.2 3.47 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.19 1.796 . . . . 0.0 109.675 -173.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.4 t -134.63 145.04 48.23 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 165.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -113.59 -8.96 13.28 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.864 1.666 . . . . 0.0 112.073 169.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 31.4 p -105.76 15.42 26.81 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.659 1.184 . . . . 0.0 113.11 -172.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -58.9 149.72 26.22 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 125.832 1.653 . . . . 0.0 113.803 -170.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.64 154.59 88.12 Favored Pre-proline 0 CA--C 1.532 0.283 0 C-N-CA 125.444 1.498 . . . . 0.0 110.961 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.08 -30.81 20.22 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.033 1.822 . . . . 0.0 113.335 178.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.07 -30.25 70.23 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 173.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 43.2 m0 -72.36 -17.32 61.84 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 121.453 -0.779 . . . . 0.0 111.446 -171.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -75.29 -21.29 58.6 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 118.48 -0.772 . . . . 0.0 110.978 172.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 8.9 m-30 -86.14 -19.22 30.46 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.175 0.898 . . . . 0.0 111.639 -177.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 97.2 mt -65.77 151.07 95.56 Favored Pre-proline 0 C--O 1.237 0.415 0 C-N-CA 123.836 0.855 . . . . 0.0 110.385 -175.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.67 146.0 53.38 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.834 2.356 . . . . 0.0 109.183 177.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.531 ' CD2' ' HA2' ' A' ' 60' ' ' GLY . 11.6 m-85 -86.96 163.68 16.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 122.079 0.942 . . . . 0.0 110.831 -175.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -136.99 160.22 39.57 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.845 1.658 . . . . 0.0 108.038 177.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -97.5 -5.47 35.86 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.01 1.324 . . . . 0.0 111.192 174.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 80.7 p -169.34 -175.35 2.2 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 120.963 -1.085 . . . . 0.0 109.798 -169.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.492 ' CE2' HD21 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -158.0 61.85 0.46 Allowed 'General case' 0 C--O 1.239 0.527 0 C-N-CA 126.739 2.016 . . . . 0.0 106.493 -167.713 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -112.02 122.88 48.99 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 -157.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 5.2 t -59.13 -32.15 69.59 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.728 -168.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -91.72 11.77 23.47 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 117.931 0.332 . . . . 0.0 111.697 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -68.41 167.06 44.53 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.486 1.041 . . . . 0.0 113.251 -175.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -73.4 -9.54 23.1 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.544 2.829 . . . . 0.0 112.187 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -80.23 -18.56 49.15 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -163.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 77.21 -19.47 3.63 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-O 118.244 -1.309 . . . . 0.0 114.261 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.529 HD22 ' HB ' ' A' ' 44' ' ' ILE . 0.5 OUTLIER -72.74 101.54 3.12 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.733 1.613 . . . . 0.0 110.244 175.358 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 9.9 mmt85 -125.33 138.19 54.06 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 117.794 -1.098 . . . . 0.0 110.495 -174.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -58.02 148.09 27.26 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -133.34 85.47 43.89 Favored Pre-proline 0 C--N 1.329 -0.292 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -176.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -70.6 4.39 2.58 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 124.524 3.483 . . . . 0.0 113.836 176.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 26.1 ttt180 61.77 43.35 9.68 Favored 'General case' 0 C--N 1.343 0.285 0 C-N-CA 125.936 1.695 . . . . 0.0 111.174 177.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -56.12 -47.09 78.79 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 121.444 -0.785 . . . . 0.0 111.444 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -143.42 31.32 1.35 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.535 1.134 . . . . 0.0 110.626 -169.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 5.0 ttt-85 . . . . . 0 C--O 1.246 0.875 0 CA-C-O 118.76 -0.638 . . . . 0.0 111.864 -169.459 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.1 mtt . . . . . 0 N--CA 1.472 0.664 0 CA-C-O 119.313 -0.375 . . . . 0.0 110.521 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -94.15 142.82 26.96 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -176.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -96.04 121.2 37.54 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 168.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.9 pt -119.4 175.25 4.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 171.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -120.5 137.26 54.46 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 175.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.4 m -78.55 137.46 21.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -67.51 -26.22 66.23 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.009 0.524 . . . . 0.0 112.241 175.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 135.48 -19.96 3.76 Favored Glycine 0 N--CA 1.472 1.036 0 O-C-N 120.134 -1.604 . . . . 0.0 111.958 -169.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.48 -14.95 54.18 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.335 1.854 . . . . 0.0 112.555 -169.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.737 HD13 ' HA ' ' A' ' 17' ' ' HIS . 3.3 mm? -127.14 41.19 3.57 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 128.592 2.757 . . . . 0.0 106.54 -173.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.79 -85.22 0.18 Allowed 'General case' 0 N--CA 1.469 0.489 0 O-C-N 120.324 -1.485 . . . . 0.0 110.753 -171.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.0 tpt85 -66.42 -69.19 0.32 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 121.149 1.795 . . . . 0.0 111.006 -170.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -155.48 -3.03 0.1 Allowed Glycine 0 N--CA 1.448 -0.504 0 O-C-N 124.157 0.911 . . . . 0.0 114.133 -174.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -49.28 147.52 5.28 Favored Pre-proline 0 N--CA 1.45 -0.438 0 C-N-CA 126.523 1.929 . . . . 0.0 111.847 -167.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -48.99 -29.21 15.02 Favored 'Trans proline' 0 CA--C 1.533 0.436 1 C-N-CA 125.32 4.013 . . . . 0.0 113.967 -176.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.466 ' O ' HG22 ' A' ' 19' ' ' VAL . 17.2 m120 -81.34 -23.8 37.53 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 125.958 1.703 . . . . 0.0 112.226 -169.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.737 ' HA ' HD13 ' A' ' 10' ' ' LEU . 4.8 t60 -53.41 -31.38 44.79 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.975 1.262 . . . . 0.0 111.019 -171.116 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.31 -23.55 9.48 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.873 1.269 . . . . 0.0 114.031 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 16' ' ' ASN . 34.1 m -60.07 -49.53 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 CA-C-N 119.652 1.115 . . . . 0.0 110.628 173.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.612 ' HE3' HD12 ' A' ' 10' ' ' LEU . 6.0 ptp -77.68 5.64 8.89 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.704 0.684 . . . . 0.0 112.726 -174.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 69.9 mt -97.34 -6.08 35.07 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.078 0.951 . . . . 0.0 111.582 176.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -121.7 102.83 8.46 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 104.315 -2.476 . . . . 0.0 104.315 175.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -58.16 -16.93 15.29 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.081 1.352 . . . . 0.0 111.996 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.2 m -60.92 -22.42 64.35 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.756 1.622 . . . . 0.0 113.971 169.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 20.2 m170 -86.08 -15.06 42.43 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.251 -0.906 . . . . 0.0 111.107 170.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.1 170.02 12.91 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 127.203 2.335 . . . . 0.0 111.565 176.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -74.1 139.09 44.36 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 124.803 1.241 . . . . 0.0 112.1 -174.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -139.82 138.63 35.96 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.03 1.732 . . . . 0.0 109.053 165.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.16 139.71 27.45 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.77 1.228 . . . . 0.0 108.865 175.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -72.62 87.55 1.23 Allowed 'General case' 0 C--O 1.238 0.481 0 C-N-CA 125.948 1.699 . . . . 0.0 108.033 178.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.2 tpp180 -93.7 64.85 3.57 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -177.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.66 -167.41 54.8 Favored Glycine 0 N--CA 1.44 -1.058 0 CA-C-O 122.967 1.315 . . . . 0.0 111.463 -173.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.3 ptt85 -139.13 170.64 15.59 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.981 0.913 . . . . 0.0 109.668 -177.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.404 ' HA2' ' H ' ' A' ' 98' ' ' LEU . . . -170.96 173.8 44.68 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 119.876 -1.155 . . . . 0.0 111.807 -172.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.468 ' HB3' ' HA ' ' A' ' 64' ' ' THR . 2.3 m -136.89 158.05 45.34 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 170.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.0 p -74.9 121.61 22.15 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 176.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.552 HG22 ' HB2' ' A' ' 96' ' ' GLN . 2.0 t -76.6 -43.88 34.51 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -177.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -71.36 121.72 19.04 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 105.774 -1.935 . . . . 0.0 105.774 174.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 m -55.75 142.49 34.33 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 168.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -135.67 153.41 77.43 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 107.057 -1.461 . . . . 0.0 107.057 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -78.52 91.82 1.17 Allowed 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 124.693 3.595 . . . . 0.0 109.522 176.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.88 88.59 7.73 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 177.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.434 HG13 ' HB3' ' A' ' 127' ' ' LEU 0.287 40.1 t -89.71 166.78 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 C-N-CA 126.982 2.113 . . . . 0.0 107.878 -176.906 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.2 mt -132.65 126.72 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 168.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.88 175.14 10.06 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 122.32 1.057 . . . . 0.0 111.495 -174.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.9 -172.64 53.18 Favored Glycine 0 CA--C 1.539 1.542 0 C-N-CA 125.794 1.664 . . . . 0.0 111.226 170.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -87.19 -18.46 30.28 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 125.851 1.66 . . . . 0.0 113.076 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 56.6 m-70 -109.2 8.98 26.08 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 122.845 0.458 . . . . 0.0 112.005 -171.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 62.86 63.03 0.99 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.648 1.579 . . . . 0.0 108.079 172.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 81.4 mt -104.11 90.23 2.94 Favored Pre-proline 0 N--CA 1.453 -0.283 0 C-N-CA 127.309 2.243 . . . . 0.0 106.14 -169.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -57.08 138.33 85.81 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 CA-C-N 119.725 0.938 . . . . 0.0 110.374 169.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 57.0 m95 -128.82 132.63 47.84 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.505 1.522 . . . . 0.0 108.692 178.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 34.4 tp -86.13 -3.81 59.04 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.957 0.903 . . . . 0.0 113.101 -173.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 12.9 mt 42.03 89.7 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 129.674 3.19 . . . . 0.0 112.367 172.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -49.5 95.68 0.01 OUTLIER 'General case' 0 C--O 1.241 0.631 0 CA-C-N 119.167 0.894 . . . . 0.0 112.989 -162.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -159.49 85.76 2.18 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 119.032 0.833 . . . . 0.0 113.057 -172.498 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -60.85 147.75 94.35 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.613 2.209 . . . . 0.0 109.739 -177.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.88 15.66 80.82 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 119.074 -0.848 . . . . 0.0 113.056 171.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.38 130.44 32.8 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 119.436 1.618 . . . . 0.0 108.715 -175.141 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.37 -123.84 7.07 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-N 120.792 1.633 . . . . 0.0 112.628 -178.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 46.4 m-70 -136.32 160.55 38.38 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.889 1.844 . . . . 0.0 112.588 -165.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 77.0 m -91.14 99.49 12.49 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.823 0.849 . . . . 0.0 110.736 -177.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.1 t -72.0 99.19 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 125.97 1.708 . . . . 0.0 113.213 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.468 ' HA ' ' HB3' ' A' ' 35' ' ' CYS . 8.9 p -66.51 157.58 31.83 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.91 0.884 . . . . 0.0 112.631 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -178.05 -147.1 6.71 Favored Glycine 0 C--N 1.343 0.962 0 O-C-N 121.458 -0.776 . . . . 0.0 114.025 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -133.53 171.21 14.4 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.056 1.342 . . . . 0.0 109.253 177.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 92.4 mt -116.59 112.98 41.62 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 -177.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -101.71 115.82 31.37 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 172.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -62.89 136.22 57.73 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 154.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.5 m -135.04 168.69 22.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 C-N-CA 124.732 1.213 . . . . 0.0 108.131 176.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -107.98 172.06 7.05 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 168.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.419 ' HG2' ' HE ' ' A' ' 76' ' ' ARG . 2.5 mt-10 -49.53 -45.73 47.69 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 125.035 1.334 . . . . 0.0 110.244 -176.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.2 tp60 -55.62 -43.57 76.25 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.079 0.952 . . . . 0.0 111.574 -176.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 24.3 tpp -72.48 -48.67 38.9 Favored 'General case' 0 C--O 1.224 -0.264 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.83 -39.4 77.57 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.549 -0.719 . . . . 0.0 110.726 -178.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.419 ' HE ' ' HG2' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -64.56 -44.65 90.09 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 126.918 2.087 . . . . 0.0 110.966 175.451 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -61.69 -46.35 90.08 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.279 0.632 . . . . 0.0 109.815 177.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 95.2 mt -57.79 -37.48 73.8 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.144 0.577 . . . . 0.0 111.468 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -61.11 -21.98 64.21 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.388 0.995 . . . . 0.0 111.837 177.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -100.25 -2.92 32.57 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.803 2.441 . . . . 0.0 111.5 177.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -103.96 -37.98 7.17 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 120.739 -1.226 . . . . 0.0 108.215 -174.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -107.94 28.88 7.8 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.985 1.314 . . . . 0.0 111.586 174.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 57.97 37.68 26.73 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.247 1.419 . . . . 0.0 112.625 156.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 78.1 m -85.92 163.57 42.86 Favored Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 120.934 -1.104 . . . . 0.0 110.646 -176.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 58.0 Cg_endo -65.76 -3.95 3.6 Favored 'Cis proline' 0 CA--C 1.547 1.161 0 N-CA-C 114.849 1.057 . . . . 0.0 114.849 -16.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -46.79 -64.55 0.74 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.835 1.654 . . . . 0.0 112.928 178.188 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 21.5 mtm -88.18 -59.41 2.25 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 119.195 0.907 . . . . 0.0 110.092 -175.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.409 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 75.0 m-85 -111.56 178.29 4.37 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 176.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.7 mp0 -133.97 150.28 51.27 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 171.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -77.44 114.26 16.09 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 176.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.2 m -113.55 170.91 7.9 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 126.106 1.763 . . . . 0.0 108.835 -179.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -122.13 143.01 49.8 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.622 1.569 . . . . 0.0 110.277 172.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.44 175.91 11.8 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.269 1.428 . . . . 0.0 111.357 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.4 tp60 -101.53 126.79 48.4 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.703 1.601 . . . . 0.0 111.772 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 64.0 t -122.39 144.74 30.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 125.305 1.442 . . . . 0.0 108.141 -176.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.552 ' HB2' HG22 ' A' ' 37' ' ' VAL . 49.4 tt0 -89.32 144.75 25.85 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 176.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.535 HG12 ' C ' ' A' ' 108' ' ' ASP 0.26 7.2 p -111.48 89.89 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -167.36 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.404 ' H ' ' HA2' ' A' ' 34' ' ' GLY . 3.9 mp -65.44 -23.04 66.83 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 120.716 -1.24 . . . . 0.0 111.512 -177.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -160.95 153.43 20.55 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 104.763 -2.31 . . . . 0.0 104.763 174.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 70.2 t-105 -137.59 107.29 6.22 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 126.3 1.84 . . . . 0.0 108.597 178.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -95.18 108.56 20.69 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -177.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.52 -174.77 15.96 Favored Glycine 0 CA--C 1.519 0.311 0 CA-C-O 121.911 0.729 . . . . 0.0 111.387 174.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -71.31 160.64 32.43 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.604 0.716 . . . . 0.0 110.268 -177.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 90.52 69.13 1.2 Allowed Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 124.618 1.104 . . . . 0.0 111.234 165.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -101.58 89.58 1.5 Allowed Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 129.845 3.258 . . . . 0.0 110.352 -162.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -62.73 4.61 0.35 Allowed 'Trans proline' 0 CA--C 1.544 1.0 1 C-N-CA 125.737 4.291 . . . . 0.0 115.266 -176.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.15 -174.43 54.54 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 -163.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.535 ' C ' HG12 ' A' ' 97' ' ' VAL . 14.5 t70 -69.71 5.69 1.39 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 117.336 2.347 . . . . 0.0 117.336 -168.062 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 83.5 p -125.25 157.45 36.55 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 121.648 -0.658 . . . . 0.0 112.174 155.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.6 p -132.6 153.05 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 123.628 0.771 . . . . 0.0 109.434 161.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -82.09 152.51 26.54 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 168.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 3.9 p -145.14 -173.37 4.07 Favored 'General case' 0 C--O 1.239 0.515 0 O-C-N 121.575 -0.703 . . . . 0.0 110.629 169.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -109.03 151.44 26.35 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.133 1.373 . . . . 0.0 109.504 162.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.3 t -142.88 146.45 21.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 128.883 2.873 . . . . 0.0 106.605 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -89.91 116.05 27.68 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 168.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -139.16 147.61 42.08 Favored 'General case' 0 C--O 1.225 -0.233 0 C-N-CA 124.077 0.951 . . . . 0.0 111.317 -176.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.5 t -92.5 141.16 28.81 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -177.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -110.57 6.45 21.89 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.235 1.414 . . . . 0.0 111.572 162.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.35 19.73 16.74 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.624 1.97 . . . . 0.0 112.729 -160.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -71.61 159.53 34.26 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.737 1.615 . . . . 0.0 113.16 -174.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.35 149.69 89.11 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 124.749 1.22 . . . . 0.0 110.761 173.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -68.52 -24.8 35.71 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.701 2.268 . . . . 0.0 113.561 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -68.69 -24.95 64.56 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 120.919 -1.113 . . . . 0.0 112.777 173.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 45.0 m0 -72.01 -12.75 61.37 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.426 -0.796 . . . . 0.0 112.241 -177.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -65.89 -18.33 65.26 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.347 -0.846 . . . . 0.0 111.233 171.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -99.95 -8.95 23.33 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.059 0.944 . . . . 0.0 112.791 175.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.434 ' HB3' HG13 ' A' ' 43' ' ' VAL . 14.7 mt -64.23 147.01 97.38 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.217 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -64.84 149.38 89.68 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.087 1.858 . . . . 0.0 110.371 178.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -103.37 166.1 10.63 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 41.0 m-70 -136.5 169.87 16.98 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 125.048 1.339 . . . . 0.0 108.473 178.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -125.26 -17.33 5.7 Favored 'General case' 0 C--O 1.219 -0.511 0 C-N-CA 124.217 1.007 . . . . 0.0 111.837 -166.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -158.19 132.78 8.28 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 164.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -85.59 131.57 34.33 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 169.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -143.87 158.21 43.84 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.756 154.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.5 t -63.71 -35.86 81.94 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 164.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -86.4 68.63 10.27 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 127.467 2.307 . . . . 0.0 107.665 -177.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -152.65 168.09 31.6 Favored Glycine 0 CA--C 1.522 0.499 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.432 163.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -72.91 -6.93 19.89 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.275 2.65 . . . . 0.0 113.735 -166.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -60.24 -42.13 94.61 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 119.407 1.003 . . . . 0.0 113.425 -169.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 93.09 -50.33 2.48 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-O 118.892 -0.949 . . . . 0.0 111.026 -178.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.5 75.61 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.079 1.751 . . . . 0.0 112.265 173.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -109.37 167.7 9.93 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 120.52 -1.362 . . . . 0.0 109.613 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -60.17 164.03 4.44 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 118.786 -0.626 . . . . 0.0 111.276 -169.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 50.2 p-10 -113.42 66.76 1.19 Allowed Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 121.614 0.721 . . . . 0.0 112.317 -175.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -75.49 -17.72 18.27 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 122.017 1.811 . . . . 0.0 113.793 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -168.59 22.28 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.176 1.39 . . . . 0.0 110.653 -172.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -66.87 -46.0 76.34 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 174.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -127.18 -0.62 6.43 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.057 1.743 . . . . 0.0 111.979 -173.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? . . . . . 0 C--O 1.248 0.998 0 C-N-CA 128.227 2.611 . . . . 0.0 112.7 -175.57 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.3 tpt . . . . . 0 N--CA 1.469 0.508 0 N-CA-C 111.197 0.073 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.72 178.45 7.06 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.581 1.552 . . . . 0.0 107.12 178.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -134.39 148.02 50.59 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 13.0 pt -130.83 179.42 4.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 167.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.561 ' CE2' HG23 ' A' ' 36' ' ' THR . 90.3 t80 -137.83 133.16 33.62 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 176.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.8 m -73.79 134.64 29.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 173.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -73.54 -3.22 26.39 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.77 -0.581 . . . . 0.0 111.701 163.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 136.42 -4.99 3.79 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.95 1.738 . . . . 0.0 112.515 174.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -83.47 -8.62 59.33 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -167.092 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.0 mp -140.85 58.64 1.55 Allowed 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -139.87 -73.68 0.36 Allowed 'General case' 0 C--N 1.342 0.281 0 CA-C-O 118.463 -0.779 . . . . 0.0 112.346 177.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -67.97 -60.59 2.38 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.911 1.232 . . . . 0.0 109.211 -168.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -177.38 33.33 0.08 OUTLIER Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.611 HE21 ' H ' ' A' ' 135' ' ' SER . 10.5 mp0 -66.25 155.03 88.96 Favored Pre-proline 0 N--CA 1.454 -0.231 0 O-C-N 120.657 -1.496 . . . . 0.0 109.733 -173.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.35 -10.0 19.77 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.649 2.233 . . . . 0.0 113.354 -172.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.515 ' O ' HG22 ' A' ' 19' ' ' VAL . 3.3 m-80 -99.52 -20.76 16.24 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 127.242 2.217 . . . . 0.0 110.956 -175.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -53.68 -41.67 67.14 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 120.955 1.707 . . . . 0.0 109.839 -171.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.7 -29.48 4.49 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.564 1.546 . . . . 0.0 114.145 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 16' ' ' ASN . 20.3 m -59.8 -41.79 86.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 120.097 1.317 . . . . 0.0 111.593 178.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.3 ptp -78.0 -8.59 58.36 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 119.149 0.886 . . . . 0.0 111.76 -177.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 39.6 mt -87.41 5.09 40.48 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.283 1.433 . . . . 0.0 110.64 178.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -115.08 97.61 6.32 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 173.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 22.2 t-80 -60.09 -21.22 61.23 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.424 0.69 . . . . 0.0 112.538 -176.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.5 m -69.44 -23.7 63.72 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.385 1.474 . . . . 0.0 114.342 172.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 36.9 m170 -69.77 -31.71 69.81 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.146 -0.971 . . . . 0.0 108.765 165.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.76 179.53 25.66 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 125.839 1.685 . . . . 0.0 110.775 174.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -81.63 135.69 35.54 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.011 0.924 . . . . 0.0 110.096 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.1 100.68 3.68 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.38 1.472 . . . . 0.0 109.646 167.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -107.4 140.9 39.63 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 125.18 1.392 . . . . 0.0 108.798 -177.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -69.98 77.84 0.49 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.589 2.355 . . . . 0.0 109.986 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -87.37 62.38 7.15 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.39 -176.3 48.24 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-O 123.624 1.68 . . . . 0.0 113.984 170.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -118.0 160.29 21.72 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.781 1.232 . . . . 0.0 109.711 -170.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -169.71 177.58 43.12 Favored Glycine 0 C--N 1.34 0.805 0 N-CA-C 116.383 1.313 . . . . 0.0 116.383 177.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 10.6 p -133.4 158.48 42.92 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.44 1.096 . . . . 0.0 108.206 170.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.561 HG23 ' CE2' ' A' ' 5' ' ' PHE . 3.0 p -78.91 117.28 19.85 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 166.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.3 t -74.24 -41.33 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 175.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -64.89 107.34 1.44 Allowed 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 170.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.0 m -59.63 135.92 57.83 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 106.951 -1.499 . . . . 0.0 106.951 170.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.74 ' HB3' HD22 ' A' ' 53' ' ' LEU . 27.8 m-85 -130.57 153.16 81.39 Favored Pre-proline 0 C--O 1.237 0.422 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -74.29 91.57 0.95 Allowed 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 124.707 3.605 . . . . 0.0 109.675 173.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 tt -81.91 102.94 11.21 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 171.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.569 ' CG2' HD13 ' A' ' 54' ' ' LEU . 2.6 m -122.25 133.14 69.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 125.225 1.41 . . . . 0.0 107.451 -175.201 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 73.8 mt -99.05 100.14 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -176.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -118.01 171.88 7.79 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 122.378 1.085 . . . . 0.0 111.354 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.3 152.73 7.13 Favored Glycine 0 CA--C 1.523 0.534 0 CA-C-N 113.76 -1.564 . . . . 0.0 110.9 173.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.3 tp10 -72.16 -9.3 58.25 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -162.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 44.2 m170 -102.5 12.63 36.19 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.871 0.869 . . . . 0.0 112.076 175.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 55.45 69.73 0.7 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 127.392 2.277 . . . . 0.0 111.228 -178.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.5 mt -104.12 89.87 2.74 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 128.105 2.562 . . . . 0.0 108.072 -166.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -53.03 129.11 31.74 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 121.757 1.638 . . . . 0.0 111.567 177.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 66.3 m95 -126.62 145.56 50.51 Favored 'General case' 0 C--N 1.332 -0.192 0 O-C-N 121.093 -1.005 . . . . 0.0 109.122 176.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.74 HD22 ' HB3' ' A' ' 40' ' ' PHE . 1.8 mt -96.44 -5.31 39.96 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 117.569 2.433 . . . . 0.0 117.569 -174.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.569 HD13 ' CG2' ' A' ' 43' ' ' VAL . 8.7 mp 42.37 73.39 0.14 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 111.603 -2.544 . . . . 0.0 112.601 173.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -45.26 92.18 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.014 1.726 . . . . 0.0 114.57 -157.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.42 85.23 7.42 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 125.026 1.33 . . . . 0.0 107.643 -174.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -59.04 139.52 91.16 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 121.986 1.79 . . . . 0.0 108.564 176.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.02 -0.7 88.27 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.191 1.376 . . . . 0.0 114.48 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -97.43 144.02 27.58 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.624 1.712 . . . . 0.0 107.78 173.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.33 -143.7 30.91 Favored Glycine 0 C--N 1.337 0.608 0 CA-C-N 119.235 0.925 . . . . 0.0 111.63 177.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -130.99 176.75 7.98 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.313 1.445 . . . . 0.0 108.203 -169.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.2 p -63.0 167.13 5.05 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.512 0.672 . . . . 0.0 111.406 176.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.1 t -133.08 110.95 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 166.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 69.5 p -69.75 152.33 44.75 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.42 -158.37 12.37 Favored Glycine 0 CA--C 1.527 0.791 0 O-C-N 121.15 -0.969 . . . . 0.0 112.486 -177.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -140.98 151.8 44.44 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.621 1.568 . . . . 0.0 108.454 174.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 76.4 mt -95.55 138.49 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -127.34 126.16 42.04 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 172.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -69.87 136.13 50.33 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 161.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.62 164.54 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.95 177.43 4.85 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 122.804 1.288 . . . . 0.0 111.847 168.156 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -57.16 -42.36 80.94 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 112.916 -1.947 . . . . 0.0 111.751 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 40.1 tp60 -62.99 -44.91 94.72 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 118.473 -0.775 . . . . 0.0 109.989 179.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 24.8 tpp -62.79 -46.41 88.13 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 118.365 0.53 . . . . 0.0 110.109 176.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 75' ' ' LEU . 11.1 tp -65.81 -40.59 92.03 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.647 -174.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 33.9 mtm105 -63.26 -40.16 96.63 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.631 1.173 . . . . 0.0 111.172 173.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -65.97 -50.62 63.7 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 117.984 0.356 . . . . 0.0 110.303 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.7 mp -63.12 -25.87 68.56 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.122 -0.986 . . . . 0.0 111.01 176.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.473 ' HA ' ' SG ' ' A' ' 84' ' ' CYS . 14.8 t70 -73.44 1.3 10.06 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.971 1.309 . . . . 0.0 112.84 176.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -122.04 -47.81 2.14 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 128.352 2.661 . . . . 0.0 110.972 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -65.1 -39.16 92.74 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.445 1.098 . . . . 0.0 112.294 -176.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -77.81 8.56 4.4 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.18 -0.95 . . . . 0.0 111.197 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 58.68 15.44 3.72 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.376 1.871 . . . . 0.0 113.155 178.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.473 ' SG ' ' HA ' ' A' ' 79' ' ' ASP . 1.6 p -61.92 154.12 69.6 Favored Pre-proline 0 N--CA 1.448 -0.558 0 O-C-N 120.518 -1.363 . . . . 0.0 109.219 169.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.39 -4.57 22.09 Favored 'Cis proline' 0 CA--C 1.541 0.826 0 CA-C-N 119.563 0.88 . . . . 0.0 113.638 -2.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.7 -75.42 0.06 Allowed 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.062 1.345 . . . . 0.0 111.095 179.055 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 38.7 mtp -68.67 -69.09 0.35 Allowed 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -172.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -102.29 174.89 5.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.497 0.665 . . . . 0.0 109.443 179.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -137.89 136.25 36.91 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 165.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -75.03 139.21 42.71 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 175.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.4 m -141.66 154.36 45.31 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -176.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -91.46 137.84 32.05 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.881 0.873 . . . . 0.0 109.7 174.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.504 HD11 HG23 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -148.27 174.84 11.6 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.01 1.324 . . . . 0.0 112.297 -178.961 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 30.7 tp60 -100.06 117.15 33.72 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.149 1.78 . . . . 0.0 111.196 -178.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 97.1 t -117.81 124.12 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 125.19 1.396 . . . . 0.0 107.944 -172.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -68.43 141.37 55.69 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 119.582 1.083 . . . . 0.0 108.557 175.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 45.9 t -84.78 95.19 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 172.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.86 -30.06 70.13 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.769 -0.582 . . . . 0.0 109.712 167.15 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -164.75 153.74 12.85 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 60.2 t-105 -132.03 136.94 47.61 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 172.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -116.92 111.15 19.24 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 171.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 114.81 -172.34 14.18 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 124.518 1.056 . . . . 0.0 112.145 172.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -70.87 168.32 17.09 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 114.919 -0.641 . . . . 0.0 110.619 -178.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.05 69.19 1.42 Allowed Glycine 0 C--O 1.222 -0.635 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 168.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -101.1 87.96 0.97 Allowed Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 130.651 3.581 . . . . 0.0 109.399 -171.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -57.12 -38.1 96.46 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.692 2.928 . . . . 0.0 113.2 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 146.59 -160.95 28.33 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-N 119.436 1.016 . . . . 0.0 111.387 -170.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -64.07 -22.56 66.98 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.937 1.295 . . . . 0.0 111.728 175.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.9 t -139.86 164.19 30.64 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 120.467 -1.396 . . . . 0.0 109.233 175.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 10.9 p -141.06 153.06 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 C-N-CA 125.787 1.635 . . . . 0.0 108.959 -174.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -83.3 119.93 25.21 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 168.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 85.8 m -122.22 176.27 5.93 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.746 0.818 . . . . 0.0 109.23 171.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -106.5 144.09 33.68 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 168.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.504 HG23 HD11 ' A' ' 93' ' ' LEU . 27.2 t -137.45 146.83 27.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 127.137 2.175 . . . . 0.0 106.073 175.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -76.54 127.76 33.43 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 165.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 72.4 p -131.62 -164.54 1.46 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 126.008 1.723 . . . . 0.0 106.689 172.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.5 t -149.08 153.97 38.57 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 168.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -116.51 -31.92 5.4 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.672 1.589 . . . . 0.0 111.823 175.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 15.4 t -91.72 20.79 5.23 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.941 0.896 . . . . 0.0 111.795 -165.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.416 ' CG ' ' HG ' ' A' ' 54' ' ' LEU . 31.9 p90 -72.07 153.9 41.44 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 127.78 2.432 . . . . 0.0 113.155 -174.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.89 160.37 55.82 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 126.622 1.969 . . . . 0.0 112.173 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -68.88 -39.04 8.9 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.125 1.883 . . . . 0.0 112.531 178.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -45.46 -41.66 9.67 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 178.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 0.561 ' HA ' HD23 ' A' ' 127' ' ' LEU . 30.7 m0 -64.2 -18.17 64.25 Favored 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 125.513 1.525 . . . . 0.0 112.365 -173.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 28.0 mt -67.47 -17.28 64.63 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 117.808 -1.092 . . . . 0.0 111.672 173.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -102.52 -6.22 23.11 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.976 1.262 . . . . 0.0 112.511 -168.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.561 HD23 ' HA ' ' A' ' 124' ' ' TRP . 1.9 mm? -71.73 156.93 90.62 Favored Pre-proline 0 N--CA 1.448 -0.55 0 C-N-CA 125.651 1.58 . . . . 0.0 108.16 -175.187 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -61.38 140.31 87.31 Favored 'Trans proline' 0 N--CA 1.449 -1.088 0 C-N-CA 121.586 1.524 . . . . 0.0 108.953 173.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -81.28 158.08 24.9 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 172.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 60.0 m-70 -137.97 155.74 48.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.712 178.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -101.21 -9.04 21.64 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 122.766 1.27 . . . . 0.0 112.932 -175.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -161.23 150.7 16.73 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 126.908 2.083 . . . . 0.0 105.517 175.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -106.27 148.35 28.08 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 167.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.0 170.99 21.06 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.611 ' H ' HE21 ' A' ' 14' ' ' GLN . 0.3 OUTLIER -104.87 -0.1 27.43 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 159.625 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -133.3 68.36 1.5 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.514 1.926 . . . . 0.0 106.897 -172.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -130.66 -170.98 12.81 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 125.615 1.579 . . . . 0.0 112.725 -171.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -57.83 175.9 0.39 Allowed 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 120.805 1.003 . . . . 0.0 110.129 138.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 30.1 m-70 46.99 90.26 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 128.967 2.907 . . . . 0.0 112.221 -178.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.92 61.81 0.73 Allowed Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.414 1.007 . . . . 0.0 112.406 170.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.27 67.49 1.43 Allowed 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 127.477 2.311 . . . . 0.0 106.866 169.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 -116.37 162.31 17.73 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 120.816 -1.178 . . . . 0.0 110.629 -172.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -61.15 140.56 57.87 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 123.806 0.691 . . . . 0.0 111.723 -159.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -128.51 85.33 60.64 Favored Pre-proline 0 N--CA 1.452 -0.334 0 C-N-CA 124.274 1.03 . . . . 0.0 109.129 -174.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.78 5.62 3.3 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 123.579 2.853 . . . . 0.0 112.872 167.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 61.83 67.97 0.72 Allowed 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 126.82 2.048 . . . . 0.0 111.545 -173.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.73 -71.97 0.68 Allowed 'General case' 0 N--CA 1.436 -1.175 0 C-N-CA 127.925 2.49 . . . . 0.0 111.973 -178.004 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -74.37 -6.99 51.35 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.281 1.032 . . . . 0.0 113.258 -179.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.414 ' C ' ' HD3' ' A' ' 149' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.459 -2.541 1 C-N-CA 131.908 4.083 . . . . 0.0 103.558 177.611 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 mmm . . . . . 0 N--CA 1.47 0.548 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.96 155.15 49.65 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 120.586 1.539 . . . . 0.0 107.49 148.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.1 m80 -108.34 130.94 55.18 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 176.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.461 HG22 ' HB2' ' A' ' 113' ' ' PHE . 17.4 pt -128.32 167.42 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 124.644 1.178 . . . . 0.0 109.403 176.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -126.75 144.73 50.85 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.586 1.154 . . . . 0.0 110.894 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 m -103.61 123.61 57.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.972 1.309 . . . . 0.0 111.038 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -76.39 -48.1 20.99 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -174.04 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.26 -1.18 0.03 OUTLIER Glycine 0 CA--C 1.531 1.054 0 CA-C-O 117.575 -1.68 . . . . 0.0 116.486 -172.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.417 ' HA ' ' HG2' ' A' ' 14' ' ' GLN . 0.3 OUTLIER -118.75 -6.93 10.58 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 120.309 2.055 . . . . 0.0 114.834 -163.192 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.7 mp -145.59 47.02 1.28 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.342 1.457 . . . . 0.0 108.363 176.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.22 -78.07 0.46 Allowed 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 117.051 -1.452 . . . . 0.0 109.811 170.008 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.429 ' CB ' HE22 ' A' ' 14' ' ' GLN . 10.7 mtt180 -50.91 -45.5 60.33 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.051 0.94 . . . . 0.0 111.533 -168.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 148.57 68.94 0.01 OUTLIER Glycine 0 C--N 1.333 0.403 0 N-CA-C 106.944 -2.462 . . . . 0.0 106.944 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.429 HE22 ' CB ' ' A' ' 12' ' ' ARG . 25.1 mp0 -102.89 160.84 24.96 Favored Pre-proline 0 N--CA 1.449 -0.507 0 C-N-CA 124.505 1.122 . . . . 0.0 110.464 -178.033 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.36 -32.67 89.61 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.737 1.625 . . . . 0.0 110.996 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -70.57 -24.27 62.75 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 124.642 1.177 . . . . 0.0 111.618 -176.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -52.0 -35.06 45.47 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.224 1.01 . . . . 0.0 110.779 -167.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.71 -33.56 7.1 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 124.953 1.301 . . . . 0.0 114.264 176.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.3 m -59.61 -35.53 59.97 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 119.95 1.25 . . . . 0.0 111.439 -176.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.1 ptp -83.09 -12.47 57.05 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 118.979 0.809 . . . . 0.0 112.848 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.2 mt -80.07 -11.82 59.73 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.187 0.595 . . . . 0.0 110.194 177.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -100.17 99.68 10.41 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -177.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 46.3 t-80 -59.32 -19.59 47.74 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.664 1.586 . . . . 0.0 113.376 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.84 -37.35 79.01 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.419 -0.801 . . . . 0.0 111.551 167.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 16.8 m170 -73.98 -35.64 64.48 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 121.393 -0.817 . . . . 0.0 109.475 170.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.93 -175.71 24.4 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.993 1.283 . . . . 0.0 112.738 168.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.5 mt -68.79 149.32 49.13 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.038 0.935 . . . . 0.0 113.144 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -161.95 110.61 1.46 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.091 2.156 . . . . 0.0 108.507 168.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -130.11 146.61 51.77 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.016 0.926 . . . . 0.0 109.848 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -69.01 86.95 0.37 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.568 2.347 . . . . 0.0 109.472 -176.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.07 64.12 0.83 Allowed 'General case' 0 C--O 1.234 0.281 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -178.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.88 -179.12 48.65 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-O 122.053 0.807 . . . . 0.0 112.79 -178.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.4 ptt180 -134.14 172.2 13.18 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.55 -0.971 . . . . 0.0 110.407 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -164.08 -176.79 36.26 Favored Glycine 0 CA--C 1.499 -0.932 0 N-CA-C 115.89 1.116 . . . . 0.0 115.89 -173.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.7 p -145.21 159.56 42.82 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 113.725 -1.237 . . . . 0.0 112.512 166.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.506 HG23 HG13 ' A' ' 63' ' ' VAL . 8.3 p -78.13 101.97 7.28 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 120.086 1.312 . . . . 0.0 107.852 172.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -71.14 -31.05 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 120.576 -1.328 . . . . 0.0 111.894 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -69.99 118.06 12.35 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 152.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.3 m -57.84 146.96 29.92 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 167.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -135.49 153.16 77.56 Favored Pre-proline 0 N--CA 1.466 0.349 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 169.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.441 ' HG2' ' HB2' ' A' ' 54' ' ' LEU . 40.9 Cg_endo -77.01 121.63 5.9 Favored 'Trans proline' 0 CA--C 1.533 0.457 1 C-N-CA 125.774 4.316 . . . . 0.0 113.043 177.293 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.6 tp -116.38 111.92 20.74 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 126.863 2.065 . . . . 0.0 108.858 -176.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.5 m -128.88 148.09 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 120.26 1.391 . . . . 0.0 111.937 -177.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 40.2 mt -86.93 128.07 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 169.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.59 173.47 11.47 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.54 0.686 . . . . 0.0 112.153 174.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.94 -174.72 55.27 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.544 2.021 . . . . 0.0 113.246 171.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -91.0 -3.45 57.25 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -170.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -118.94 12.63 12.89 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.405 1.082 . . . . 0.0 111.779 176.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 53.51 71.27 0.51 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.015 2.126 . . . . 0.0 110.495 -178.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 88.6 mt -103.9 90.58 3.02 Favored Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 131.265 3.826 . . . . 0.0 108.368 -169.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -60.83 125.08 16.31 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 122.379 2.053 . . . . 0.0 112.602 176.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -116.63 156.97 26.13 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.912 1.685 . . . . 0.0 109.882 176.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.9 tp -115.54 114.76 25.41 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.233 1.413 . . . . 0.0 108.441 167.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.548 HD23 HG23 ' A' ' 117' ' ' THR . 26.0 mt -82.27 144.0 30.94 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 177.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -79.75 89.06 5.19 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 121.593 -0.692 . . . . 0.0 109.389 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.25 85.69 21.36 Favored Pre-proline 0 C--O 1.232 0.18 0 C-N-CA 123.534 0.734 . . . . 0.0 110.024 172.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -60.27 128.95 27.96 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.936 2.424 . . . . 0.0 109.598 -177.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.57 8.77 73.26 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 118.09 -1.395 . . . . 0.0 114.074 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.2 tptt -121.3 164.14 17.48 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 120.372 2.086 . . . . 0.0 107.216 172.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 74.51 -131.13 12.72 Favored Glycine 0 CA--C 1.519 0.288 0 O-C-N 120.613 -1.304 . . . . 0.0 109.945 -176.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -145.01 167.24 23.12 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.12 0.968 . . . . 0.0 111.033 -170.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 31.6 m -92.27 80.63 4.99 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 126.717 2.007 . . . . 0.0 112.448 -173.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.506 HG13 HG23 ' A' ' 36' ' ' THR . 1.6 p -70.05 136.21 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.117 0 CA-C-O 118.113 -0.946 . . . . 0.0 113.196 -165.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.2 p -91.06 152.46 20.63 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.88 -175.51 32.99 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 178.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -106.25 158.2 17.03 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 125.736 1.615 . . . . 0.0 106.771 173.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 80.8 mt -113.63 110.07 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -93.17 123.48 36.48 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 118.528 -0.749 . . . . 0.0 109.663 -176.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -68.48 107.93 3.09 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 152.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.8 m -103.72 169.67 2.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 166.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -119.24 177.71 4.79 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 161.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -45.02 -46.43 11.31 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 127.977 2.511 . . . . 0.0 110.835 -170.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -57.64 -45.56 85.31 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.124 0.97 . . . . 0.0 111.367 -175.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.4 tpp -72.52 -45.9 57.18 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -176.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.43 -32.86 73.78 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.778 -178.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 78.0 mtt180 -69.23 -37.73 78.16 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.874 1.215 . . . . 0.0 111.505 176.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -60.19 -48.3 82.32 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 119.113 -0.47 . . . . 0.0 110.002 174.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.6 mp -57.57 -41.37 80.94 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.214 0.461 . . . . 0.0 109.922 176.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -65.9 4.66 0.6 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.054 1.742 . . . . 0.0 114.76 -178.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -129.9 -47.94 1.13 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.323 2.249 . . . . 0.0 109.852 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -63.11 -42.74 99.61 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 125.802 1.641 . . . . 0.0 111.518 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -78.03 11.31 2.32 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.871 0.868 . . . . 0.0 110.808 176.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.2 t0 54.43 16.81 1.38 Allowed 'General case' 0 C--O 1.236 0.387 0 C-N-CA 128.596 2.758 . . . . 0.0 114.625 171.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 6.8 p -62.47 155.76 66.05 Favored Pre-proline 0 N--CA 1.445 -0.721 0 O-C-N 121.227 -0.921 . . . . 0.0 110.035 -178.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -73.76 -4.23 16.71 Favored 'Cis proline' 0 CA--C 1.543 0.93 0 N-CA-C 115.223 1.201 . . . . 0.0 115.223 -2.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 9.5 m -63.96 -63.68 1.09 Allowed 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.072 1.349 . . . . 0.0 112.406 -173.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 27.3 mtp -74.35 -76.7 0.13 Allowed 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -100.01 -176.55 3.27 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 125.354 1.461 . . . . 0.0 109.329 178.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.93 151.55 30.46 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 120.761 -1.212 . . . . 0.0 109.795 158.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -63.93 125.85 25.74 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 118.491 -0.766 . . . . 0.0 109.954 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 43.5 m -132.4 174.79 9.88 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.009 1.724 . . . . 0.0 106.95 167.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -125.23 132.69 52.93 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.711 1.604 . . . . 0.0 109.615 172.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.447 ' CD1' HG11 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -123.83 177.29 5.81 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.731 1.612 . . . . 0.0 109.927 -179.207 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 34.2 tp60 -105.87 114.26 28.31 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.253 2.221 . . . . 0.0 109.685 -178.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 54.3 t -109.29 141.22 25.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 125.65 1.58 . . . . 0.0 107.633 -177.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -76.29 137.29 39.8 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 165.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.523 ' CG1' ' HA ' ' A' ' 108' ' ' ASP 0.254 3.7 p -98.07 83.81 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 179.017 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -61.66 -22.62 65.45 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 125.471 1.509 . . . . 0.0 111.935 -175.734 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -154.46 154.52 33.33 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 170.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 -132.69 124.98 29.23 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.247 1.419 . . . . 0.0 107.408 175.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -91.42 115.62 28.18 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.78 0.832 . . . . 0.0 109.15 177.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.88 -169.24 32.21 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 123.307 0.48 . . . . 0.0 112.129 169.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -68.74 171.96 7.06 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.329 1.451 . . . . 0.0 111.224 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 73.56 67.49 1.78 Allowed Glycine 0 C--O 1.226 -0.385 0 O-C-N 120.469 -1.394 . . . . 0.0 112.79 170.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -101.56 89.76 1.56 Allowed Pre-proline 0 C--O 1.238 0.48 0 C-N-CA 128.741 2.816 . . . . 0.0 110.157 -163.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -54.97 -22.52 30.9 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 124.447 3.432 . . . . 0.0 114.388 -172.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 102.8 157.16 25.44 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 -171.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.523 ' HA ' ' CG1' ' A' ' 97' ' ' VAL . 25.2 t70 -63.85 5.08 0.24 Allowed 'General case' 0 CA--C 1.508 -0.638 0 C-N-CA 129.588 3.155 . . . . 0.0 116.698 -163.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.2 p -134.19 152.15 51.68 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 116.566 -2.054 . . . . 0.0 113.004 146.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 34.8 m -136.94 152.06 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 124.644 1.178 . . . . 0.0 109.353 -173.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -89.33 130.19 35.75 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 168.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 12.0 p -129.5 -179.93 5.45 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 118.482 -0.77 . . . . 0.0 109.059 169.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.461 ' HB2' HG22 ' A' ' 4' ' ' ILE . 40.7 m-85 -101.56 159.72 15.06 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.297 0.953 . . . . 0.0 111.103 164.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.447 HG11 ' CD1' ' A' ' 93' ' ' LEU . 0.1 OUTLIER -163.03 118.02 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 128.911 2.884 . . . . 0.0 104.018 -158.837 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -83.19 86.18 7.08 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 172.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.1 p -94.45 -179.86 5.04 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.018 0.927 . . . . 0.0 108.659 172.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.548 HG23 HD23 ' A' ' 54' ' ' LEU . 1.1 t -133.33 140.81 47.62 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.012 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -103.6 -9.77 18.96 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.948 1.299 . . . . 0.0 111.242 166.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . 0.268 3.2 t -103.56 34.94 2.76 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 122.35 1.072 . . . . 0.0 111.052 -161.161 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.504 ' HB3' HD22 ' A' ' 54' ' ' LEU . 39.4 p90 -65.61 164.29 14.56 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.971 1.709 . . . . 0.0 113.173 -174.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -91.12 149.5 40.02 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 125.364 1.466 . . . . 0.0 108.795 167.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.51 -30.16 71.29 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.17 1.913 . . . . 0.0 113.089 -171.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.511 ' HA ' ' CD2' ' A' ' 126' ' ' PHE . 4.6 pm0 -58.1 -29.86 65.8 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.309 1.044 . . . . 0.0 113.06 177.171 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 46.2 m0 -71.73 -8.34 53.6 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 122.081 -0.387 . . . . 0.0 111.275 -173.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -89.9 -20.26 23.6 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 117.969 -1.015 . . . . 0.0 112.026 171.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.511 ' CD2' ' HA ' ' A' ' 123' ' ' GLU . 18.0 m-85 -68.88 -36.0 77.55 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 120.14 1.336 . . . . 0.0 110.157 174.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.4 mt -58.21 149.92 55.34 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 125.137 1.375 . . . . 0.0 110.439 -176.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.96 166.61 29.23 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.443 2.096 . . . . 0.0 110.237 173.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -118.75 160.14 22.41 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.868 0.867 . . . . 0.0 110.454 -175.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -139.86 166.64 24.1 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.304 0.642 . . . . 0.0 110.895 -175.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -127.32 -4.92 6.06 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.203 1.401 . . . . 0.0 112.228 -170.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.0 p -138.7 -178.8 5.47 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 153.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -126.58 174.83 8.39 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 122.514 1.149 . . . . 0.0 110.063 157.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.35 88.88 1.74 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 113.132 -1.849 . . . . 0.0 107.76 178.223 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.08 -22.64 65.94 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.045 -1.034 . . . . 0.0 110.216 167.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -105.17 73.01 1.02 Allowed 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 105.018 -2.215 . . . . 0.0 105.018 170.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -143.93 155.01 25.99 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 177.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -73.71 -6.56 18.86 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.009 2.473 . . . . 0.0 113.229 -167.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 51.9 m-70 -51.88 -33.82 38.32 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.596 1.158 . . . . 0.0 113.048 -170.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 98.47 -19.17 55.48 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.714 1.15 . . . . 0.0 113.53 168.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.545 ' HG ' HH21 ' A' ' 142' ' ' ARG . 0.2 OUTLIER -98.89 57.94 1.13 Allowed 'General case' 0 C--O 1.238 0.49 0 C-N-CA 126.865 2.066 . . . . 0.0 109.216 172.451 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.545 HH21 ' HG ' ' A' ' 141' ' ' LEU . 5.9 mmp_? -84.54 169.57 14.31 Favored 'General case' 0 C--O 1.237 0.408 0 O-C-N 120.386 -1.446 . . . . 0.0 109.941 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -61.83 150.79 36.2 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -173.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -114.34 79.33 5.16 Favored Pre-proline 0 CA--C 1.534 0.344 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 177.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.16 -41.18 13.5 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.773 2.315 . . . . 0.0 111.546 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 30.7 ttt-85 -151.15 5.57 0.48 Allowed 'General case' 0 CA--C 1.526 0.057 0 C-N-CA 124.959 1.304 . . . . 0.0 112.195 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -57.78 -42.24 83.71 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.581 1.552 . . . . 0.0 111.93 -164.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -121.75 30.4 6.7 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.552 1.141 . . . . 0.0 109.631 174.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 . . . . . 0 C--O 1.253 1.238 0 CA-C-O 115.823 -2.037 . . . . 0.0 108.472 -157.254 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 mtt . . . . . 0 N--CA 1.467 0.42 0 CA-C-O 118.188 -0.91 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.26 164.5 26.39 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 118.737 0.699 . . . . 0.0 109.235 172.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -125.77 123.97 39.96 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 177.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.8 pt -130.41 173.57 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 122.776 1.274 . . . . 0.0 110.158 -178.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.41 ' HB3' HG22 ' A' ' 114' ' ' VAL . 37.4 t80 -112.08 155.32 24.04 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 125.744 1.618 . . . . 0.0 107.314 169.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.554 ' CG2' ' HB2' ' A' ' 10' ' ' LEU . 5.0 p -79.3 176.56 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-O 121.785 0.802 . . . . 0.0 109.698 175.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -125.92 174.46 8.38 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 173.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.62 -10.96 20.39 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 115.246 0.858 . . . . 0.0 115.246 -171.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.76 -23.69 36.48 Favored 'General case' 0 N--CA 1.435 -1.184 0 C-N-CA 125.498 1.519 . . . . 0.0 110.876 -175.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.554 ' HB2' ' CG2' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -125.58 -3.23 7.29 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 121.007 1.73 . . . . 0.0 111.915 -169.361 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -82.6 -7.25 59.65 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 -173.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -135.4 -85.96 0.38 Allowed 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 120.652 1.569 . . . . 0.0 107.082 176.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -160.44 15.21 0.19 Allowed Glycine 0 CA--C 1.529 0.922 0 CA-C-O 118.332 -1.26 . . . . 0.0 113.002 -168.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.465 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 3.1 mm-40 -57.83 164.57 3.08 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 119.709 1.755 . . . . 0.0 109.857 -175.212 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 14' ' ' GLN . 58.8 Cg_endo -68.12 -2.53 9.03 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 123.874 3.049 . . . . 0.0 113.415 -169.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -96.17 -14.46 22.76 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 127.897 2.479 . . . . 0.0 111.953 -177.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -48.71 -33.28 9.86 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 120.04 1.291 . . . . 0.0 110.609 -175.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.8 pttp -44.52 -32.47 1.42 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.049 1.739 . . . . 0.0 114.22 176.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.2 m -66.64 -11.67 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 123.633 0.773 . . . . 0.0 112.348 -177.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.2 ptp -121.56 14.74 11.08 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.279 1.432 . . . . 0.0 112.219 172.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 56.7 mt -115.05 2.99 14.33 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 124.72 1.208 . . . . 0.0 111.971 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -131.46 96.78 4.07 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 123.967 0.907 . . . . 0.0 108.56 -175.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 -55.7 -20.82 15.64 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.73 1.212 . . . . 0.0 112.31 -176.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 t -62.38 -25.79 68.12 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 120.13 1.332 . . . . 0.0 111.65 174.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -83.38 -1.99 54.72 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.401 -0.812 . . . . 0.0 111.794 174.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.93 177.0 19.25 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 124.874 1.226 . . . . 0.0 111.09 -175.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 35.0 tp -93.22 137.96 32.06 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.833 0.853 . . . . 0.0 111.335 -173.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.27 135.13 47.78 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 159.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.9 136.94 37.56 Favored 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 124.782 1.233 . . . . 0.0 109.323 -177.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -64.46 109.28 1.89 Allowed 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.679 0.792 . . . . 0.0 109.407 -179.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 -116.21 51.86 0.94 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 -175.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.15 -153.03 46.14 Favored Glycine 0 N--CA 1.442 -0.961 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -151.13 170.39 19.55 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.688 -0.89 . . . . 0.0 111.945 -171.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -174.18 178.75 45.91 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.029 -1.081 . . . . 0.0 115.478 -175.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 64.4 m -137.48 132.66 33.62 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 177.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.2 p -65.98 101.78 0.72 Allowed 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -69.83 -29.31 40.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 O-C-N 121.877 -0.514 . . . . 0.0 110.211 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -58.68 109.47 0.81 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 156.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.1 m -55.25 140.1 40.17 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 164.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -139.74 153.44 70.05 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 171.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.38 98.44 1.17 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 124.626 3.551 . . . . 0.0 110.077 173.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 54.1 tp -88.89 117.42 27.88 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 166.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.7 m -128.07 149.81 33.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.2 mt -114.23 98.15 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 -177.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.71 135.06 25.93 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.813 1.645 . . . . 0.0 108.797 -167.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.05 147.14 12.84 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 125.427 1.489 . . . . 0.0 110.739 -172.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -63.13 -26.8 68.99 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.807 1.643 . . . . 0.0 114.094 -164.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -90.13 3.85 52.15 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -174.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 51.75 61.87 3.0 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.064 1.345 . . . . 0.0 110.319 -167.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 52.1 mt -107.16 86.88 2.74 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 128.093 2.557 . . . . 0.0 104.149 172.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -62.22 152.92 73.3 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 121.281 1.32 . . . . 0.0 111.095 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -119.92 157.83 27.95 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.874 1.27 . . . . 0.0 109.702 -177.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.3 tp -122.43 94.2 4.22 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 175.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.6 mt -68.02 131.32 45.25 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.567 ' CE1' HG21 ' A' ' 91' ' ' THR . 58.9 t80 -71.64 96.07 1.53 Allowed 'General case' 0 C--O 1.239 0.502 0 C-N-CA 119.825 -0.75 . . . . 0.0 109.476 -176.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.43 85.31 6.81 Favored Pre-proline 0 CA--C 1.535 0.37 0 C-N-CA 123.742 0.817 . . . . 0.0 112.366 175.106 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -62.89 122.38 10.64 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.073 2.515 . . . . 0.0 109.315 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.75 -4.0 56.2 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 125.713 1.625 . . . . 0.0 114.604 177.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -106.42 167.09 10.07 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 120.552 2.176 . . . . 0.0 109.145 168.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 61.53 -142.54 48.33 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 -170.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -142.04 179.55 6.82 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.583 1.153 . . . . 0.0 110.59 -171.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 77.6 m -77.15 114.51 16.03 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.516 1.126 . . . . 0.0 109.68 178.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.1 t -77.82 112.4 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 172.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.5 p -81.88 145.08 30.55 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.337 -0.852 . . . . 0.0 109.01 177.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -169.81 -172.03 35.95 Favored Glycine 0 C--N 1.342 0.889 0 O-C-N 121.018 -1.051 . . . . 0.0 112.466 -172.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -114.65 161.0 18.68 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 176.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 62.2 mt -111.02 135.46 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 124.709 1.203 . . . . 0.0 108.286 -175.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -124.94 125.06 43.33 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.691 0.796 . . . . 0.0 108.987 175.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -71.39 142.95 50.33 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 158.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.5 m -140.75 153.25 20.98 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -176.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -94.51 174.95 6.86 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 122.585 1.183 . . . . 0.0 111.378 172.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.39 -5.49 40.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 113.493 -1.685 . . . . 0.0 113.051 -175.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 45.7 tp60 -85.62 -46.89 10.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 118.028 -0.986 . . . . 0.0 110.417 164.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 25.3 tpp -63.75 -50.03 70.68 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.772 1.169 . . . . 0.0 111.168 -177.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.06 -17.28 64.82 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 122.237 -0.289 . . . . 0.0 111.071 -175.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 23.6 mtt180 -86.8 -42.94 12.89 Favored 'General case' 0 C--O 1.222 -0.374 0 C-N-CA 127.63 2.372 . . . . 0.0 110.901 172.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -60.57 -44.87 95.7 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.951 1.251 . . . . 0.0 109.562 177.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.5 mp -58.41 -30.73 67.08 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.54 -0.725 . . . . 0.0 110.855 171.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.489 ' HA ' ' SG ' ' A' ' 84' ' ' CYS . 1.1 t70 -70.98 3.71 3.16 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.177 1.391 . . . . 0.0 113.44 176.28 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -126.97 -43.15 1.69 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 127.129 2.172 . . . . 0.0 109.699 176.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -65.9 -37.98 87.52 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.539 1.536 . . . . 0.0 112.378 177.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -91.01 6.52 44.5 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 123.227 0.611 . . . . 0.0 111.462 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 86' ' ' SER . 10.2 t0 52.06 30.24 7.28 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.776 1.23 . . . . 0.0 113.62 175.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.489 ' SG ' ' HA ' ' A' ' 79' ' ' ASP . 0.8 OUTLIER -74.24 159.63 83.35 Favored Pre-proline 0 CA--C 1.536 0.414 0 O-C-N 118.613 -2.554 . . . . 0.0 109.559 172.024 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -72.77 -4.45 14.16 Favored 'Cis proline' 0 CA--C 1.544 1.011 0 CA-C-N 120.477 1.206 . . . . 0.0 114.205 -6.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 3.0 m -54.62 -72.33 0.07 Allowed 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.24 1.016 . . . . 0.0 111.625 177.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.404 ' HG3' ' HB3' ' A' ' 83' ' ' ASP . 8.6 mtm -74.74 -64.61 1.0 Allowed 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -173.175 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -101.99 172.16 7.08 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.753 0.821 . . . . 0.0 108.983 178.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -135.23 -14.95 1.97 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 178.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 61.45 148.21 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 128.623 2.769 . . . . 0.0 114.635 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.567 HG21 ' CE1' ' A' ' 55' ' ' TYR . 17.4 m -154.17 170.82 20.3 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -174.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.41 ' O ' HG22 ' A' ' 91' ' ' THR . . . -87.4 159.41 18.72 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.042 1.337 . . . . 0.0 110.196 162.164 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.606 HD21 ' SG ' ' A' ' 112' ' ' CYS . 0.0 OUTLIER -150.15 -166.6 2.59 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.664 1.185 . . . . 0.0 111.012 176.085 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -128.77 123.36 32.73 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.022 0.929 . . . . 0.0 110.624 172.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.474 HG13 ' CG1' ' A' ' 110' ' ' VAL . 1.4 p -138.23 111.24 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -170.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -54.03 127.68 27.49 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 124.621 1.168 . . . . 0.0 110.091 -177.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 25.6 t -80.55 82.17 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 C-N-CA 127.503 2.321 . . . . 0.0 107.165 179.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.8 mp -63.1 -30.08 71.31 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.1 0.56 . . . . 0.0 110.227 175.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -154.08 160.48 41.98 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 126.164 1.786 . . . . 0.0 107.741 168.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 54.2 t-105 -144.1 124.56 13.94 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.592 1.557 . . . . 0.0 107.21 174.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -113.48 96.03 5.67 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.482 1.289 . . . . 0.0 114.482 177.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 118.76 -178.92 16.81 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 124.955 1.264 . . . . 0.0 110.868 -176.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -67.85 172.96 4.8 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.67 1.188 . . . . 0.0 110.564 177.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.63 41.18 3.44 Favored Glycine 0 C--O 1.219 -0.84 0 C-N-CA 124.367 0.984 . . . . 0.0 111.689 173.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -101.27 89.17 1.28 Allowed Pre-proline 0 C--N 1.321 -0.647 0 C-N-CA 130.624 3.57 . . . . 0.0 110.02 -155.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -73.81 -26.69 13.19 Favored 'Trans proline' 0 CA--C 1.538 0.708 1 C-N-CA 126.456 4.771 . . . . 0.0 114.807 -159.347 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 128.71 -164.23 21.92 Favored Glycine 0 CA--C 1.533 1.198 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -160.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -63.96 -23.83 67.49 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 117.932 0.866 . . . . 0.0 113.325 -169.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.75 169.34 17.89 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.878 1.271 . . . . 0.0 109.884 -174.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.474 ' CG1' HG13 ' A' ' 95' ' ' VAL 0.289 11.3 p -130.67 153.54 39.25 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 C-N-CA 117.63 -1.628 . . . . 0.0 108.699 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -96.13 77.78 3.11 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 173.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.606 ' SG ' HD21 ' A' ' 93' ' ' LEU . 1.6 p -82.36 -167.55 1.63 Allowed 'General case' 0 C--O 1.237 0.41 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.9 177.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -120.46 136.6 54.7 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.328 0.651 . . . . 0.0 109.272 162.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.437 HG23 HD11 ' A' ' 93' ' ' LEU . 95.5 t -124.48 153.42 31.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 169.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -84.23 105.0 14.74 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.051 -1.03 . . . . 0.0 109.354 176.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 70.6 p -86.18 175.98 8.21 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.672 1.189 . . . . 0.0 110.35 172.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.7 t -128.49 146.26 50.87 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 149.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -117.42 5.59 12.54 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.383 1.073 . . . . 0.0 111.381 176.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 11.4 t -126.28 47.04 2.33 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 122.805 1.288 . . . . 0.0 110.058 -176.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 14.8 p90 -78.83 156.2 28.83 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.142 0.977 . . . . 0.0 111.866 -178.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.05 157.26 85.45 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 125.153 1.381 . . . . 0.0 110.515 173.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -59.88 -48.36 12.8 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.063 2.509 . . . . 0.0 112.578 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -51.57 -32.38 28.24 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.674 1.19 . . . . 0.0 113.661 -178.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 44.2 m0 -71.14 -14.86 62.42 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.344 -0.847 . . . . 0.0 111.4 -173.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 78.7 mt -71.36 -20.0 62.22 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 118.061 -0.971 . . . . 0.0 111.842 170.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -95.91 -24.74 16.28 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.632 1.106 . . . . 0.0 110.889 -168.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 77.1 mt -60.25 156.93 36.68 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 126.103 1.761 . . . . 0.0 111.961 -173.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -66.74 151.21 82.98 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 121.916 1.744 . . . . 0.0 109.64 175.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -104.92 162.99 12.86 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.335 1.054 . . . . 0.0 111.542 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -137.67 144.48 41.85 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 123.529 0.731 . . . . 0.0 111.938 -173.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -94.64 -12.7 26.87 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.032 1.333 . . . . 0.0 112.181 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 51.9 p -159.23 172.7 17.55 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 120.61 -1.306 . . . . 0.0 109.743 173.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.61 148.0 40.24 Favored 'General case' 0 N--CA 1.434 -1.245 0 C-N-CA 126.649 1.98 . . . . 0.0 107.227 -178.165 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -156.81 113.68 3.08 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 105.28 -2.118 . . . . 0.0 105.28 172.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.36 1.23 19.56 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.773 -0.579 . . . . 0.0 110.734 173.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -120.35 45.25 2.25 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.013 1.725 . . . . 0.0 106.782 164.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -109.66 155.8 15.91 Favored Glycine 0 CA--C 1.534 1.226 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 166.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -66.76 6.64 0.53 Allowed 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 125.289 3.993 . . . . 0.0 114.71 178.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 61.0 m-70 -58.58 -13.74 6.46 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 120.688 -1.258 . . . . 0.0 114.239 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 86.22 -46.62 3.63 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 124.871 1.224 . . . . 0.0 112.227 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.91 75.55 2.82 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.408 1.083 . . . . 0.0 112.188 179.108 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -95.92 157.92 15.68 Favored 'General case' 0 N--CA 1.463 0.178 0 O-C-N 121.403 -0.811 . . . . 0.0 110.707 175.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -59.28 156.73 11.99 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.947 1.299 . . . . 0.0 110.834 -176.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -114.28 85.1 10.1 Favored Pre-proline 0 C--O 1.238 0.47 0 C-N-CA 125.748 1.619 . . . . 0.0 107.751 177.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -77.1 -46.84 0.14 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 123.761 2.974 . . . . 0.0 111.499 178.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.679 ' HB2' ' HD3' ' A' ' 149' ' ' ARG . 8.8 tpt180 -137.74 -4.07 1.81 Allowed 'General case' 0 CA--C 1.508 -0.646 0 CA-C-O 123.595 1.664 . . . . 0.0 114.385 -176.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 57.07 -1.29 0.06 Allowed 'General case' 0 N--CA 1.425 -1.702 1 C-N-CA 131.988 4.115 . . . . 0.0 114.735 -174.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -159.58 10.03 0.12 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.108 2.163 . . . . 0.0 111.578 -159.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.679 ' HD3' ' HB2' ' A' ' 146' ' ' ARG . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 117.388 -1.291 . . . . 0.0 108.85 178.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.438 ' HA ' ' OE2' ' A' ' 69' ' ' GLU . 8.8 mtt . . . . . 0 N--CA 1.471 0.584 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.81 83.04 1.34 Allowed 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 125.083 1.353 . . . . 0.0 108.011 -169.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -63.22 138.33 58.51 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 124.698 1.199 . . . . 0.0 109.437 -174.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.3 pt -125.56 167.78 19.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 124.33 1.052 . . . . 0.0 109.221 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -132.69 136.52 46.47 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.474 0.71 . . . . 0.0 109.48 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.599 HG22 ' H ' ' A' ' 66' ' ' GLU . 34.5 m -75.34 114.68 15.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 123.353 0.661 . . . . 0.0 109.933 -172.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -66.45 -3.9 7.15 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.044 0.938 . . . . 0.0 113.122 174.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 145.05 -1.04 1.02 Allowed Glycine 0 CA--C 1.528 0.891 0 CA-C-O 118.972 -0.904 . . . . 0.0 115.045 168.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 p -109.81 -16.59 13.85 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 120.198 1.999 . . . . 0.0 113.5 -160.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.68 30.61 6.62 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.874 1.27 . . . . 0.0 110.859 -171.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.493 ' HB2' HG21 ' A' ' 6' ' ' VAL . 1.8 tmtm? -132.4 -84.87 0.48 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 117.344 -1.313 . . . . 0.0 109.205 -176.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.4 mmt-85 -50.62 -78.71 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.61 1.564 . . . . 0.0 112.3 -173.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -171.72 10.92 0.04 OUTLIER Glycine 0 CA--C 1.52 0.404 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -162.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.13 150.66 91.83 Favored Pre-proline 0 CA--C 1.537 0.449 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 175.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -68.89 -12.36 34.24 Favored 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 123.694 2.929 . . . . 0.0 112.697 -169.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -85.18 -12.5 52.57 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 116.247 -1.835 . . . . 0.0 112.501 -174.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -49.66 -39.02 34.9 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 121.302 1.864 . . . . 0.0 110.098 -176.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -50.65 -24.79 3.57 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 115.343 1.609 . . . . 0.0 115.343 178.187 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.4 m -56.18 -45.63 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 120.835 1.652 . . . . 0.0 110.698 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.426 ' HA ' ' CE ' ' A' ' 74' ' ' MET . 2.3 mmm -73.02 -7.45 51.29 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -176.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.1 mt -101.43 11.4 39.21 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.653 1.181 . . . . 0.0 108.487 -175.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -127.15 103.28 7.35 Favored 'General case' 0 CA--C 1.513 -0.466 0 O-C-N 121.307 -0.871 . . . . 0.0 109.942 178.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -66.39 -18.86 65.6 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -175.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 m -66.41 -19.93 65.93 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.29 -0.881 . . . . 0.0 112.403 168.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 39.3 m170 -93.44 -17.49 23.41 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.938 0.895 . . . . 0.0 110.994 169.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 130.96 178.73 15.61 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 124.787 1.184 . . . . 0.0 112.114 169.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 37.5 tp -88.42 147.33 24.75 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.242 0.617 . . . . 0.0 111.352 -175.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.95 158.55 44.21 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.361 1.064 . . . . 0.0 109.243 161.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -143.64 136.46 27.44 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 126.826 2.051 . . . . 0.0 108.931 175.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -75.56 79.08 2.57 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.509 1.924 . . . . 0.0 110.0 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -95.5 63.27 2.48 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 121.14 -0.975 . . . . 0.0 109.935 174.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.17 175.0 27.65 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-O 122.598 1.11 . . . . 0.0 113.975 158.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 44.5 mtp85 -113.82 158.01 21.57 Favored 'General case' 0 CA--C 1.516 -0.34 0 O-C-N 121.586 -0.949 . . . . 0.0 108.686 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -171.42 177.54 44.24 Favored Glycine 0 CA--C 1.506 -0.493 0 CA-C-O 122.235 0.908 . . . . 0.0 112.895 -176.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.3 p -140.09 146.17 38.57 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.101 -1.049 . . . . 0.0 108.47 172.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.2 p -71.2 96.99 1.45 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 104.999 -2.222 . . . . 0.0 104.999 170.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -67.28 -36.45 76.74 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.47 111.55 1.02 Allowed 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 160.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -57.5 142.81 42.99 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 174.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -137.48 153.72 74.65 Favored Pre-proline 0 N--CA 1.45 -0.474 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 169.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -80.17 96.69 1.03 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 1 C-N-CA 125.704 4.269 . . . . 0.0 110.792 177.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 51.0 tp -92.4 114.38 26.92 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 169.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.5 m -126.57 149.38 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 177.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.9 mt -94.16 121.62 44.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 177.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.22 -179.73 6.03 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.554 0.741 . . . . 0.0 110.459 176.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.42 153.88 4.25 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 125.31 1.433 . . . . 0.0 111.849 172.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -67.24 -16.93 64.58 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 121.145 -1.209 . . . . 0.0 113.299 -171.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 24.9 m-70 -100.44 9.56 42.44 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.882 0.873 . . . . 0.0 112.998 -173.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 57.44 66.25 1.18 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.705 1.602 . . . . 0.0 108.716 -172.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 96.3 mt -112.23 87.02 8.52 Favored Pre-proline 0 C--N 1.331 -0.202 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.69 145.55 95.07 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 CA-C-N 121.021 1.4 . . . . 0.0 111.749 170.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 22.1 m95 -123.78 161.18 25.74 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.781 1.232 . . . . 0.0 108.641 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.8 tp -116.51 96.02 5.32 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 174.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.76 135.72 57.78 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 172.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -71.24 93.94 1.14 Allowed 'General case' 0 C--O 1.233 0.237 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.85 74.4 14.72 Favored Pre-proline 0 CA--C 1.537 0.444 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.007 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -59.88 120.71 8.67 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.233 1.956 . . . . 0.0 109.401 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.03 -1.84 40.99 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 126.953 2.216 . . . . 0.0 114.242 177.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -112.03 160.94 17.0 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 120.672 2.236 . . . . 0.0 108.016 174.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.09 -142.46 34.47 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 109.739 -1.345 . . . . 0.0 109.739 -173.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -140.95 178.14 7.57 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.421 1.088 . . . . 0.0 110.129 -171.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 68.9 m -76.41 109.71 10.35 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 118.887 0.767 . . . . 0.0 111.076 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.5 t -75.26 108.89 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 174.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 59.2 p -72.2 160.83 31.77 Favored 'General case' 0 C--O 1.24 0.56 0 O-C-N 121.321 -0.862 . . . . 0.0 109.291 174.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 174.46 -157.55 25.2 Favored Glycine 0 C--N 1.335 0.505 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 -176.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.599 ' H ' HG22 ' A' ' 6' ' ' VAL . 9.8 mt-10 -134.99 156.47 48.98 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 125.21 1.404 . . . . 0.0 108.158 178.443 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.3 mt -103.99 128.25 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 -176.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -122.98 126.83 47.91 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 172.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.438 ' OE2' ' HA ' ' A' ' 1' ' ' MET . 4.7 tp10 -67.89 151.11 47.67 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 155.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.7 m -144.91 162.86 13.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 124.78 1.232 . . . . 0.0 107.862 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -105.54 171.3 7.4 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.995 0.902 . . . . 0.0 109.102 169.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.31 -32.29 68.34 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.393 1.477 . . . . 0.0 112.287 -163.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -69.91 -38.48 76.27 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-O 117.33 -1.319 . . . . 0.0 110.999 176.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.426 ' CE ' ' HA ' ' A' ' 20' ' ' MET . 43.6 tpp -65.69 -47.05 76.73 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 120.438 1.472 . . . . 0.0 109.18 178.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.05 -31.82 73.15 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.052 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -68.39 -45.02 73.82 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.503 1.047 . . . . 0.0 111.708 170.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -60.47 -50.36 73.87 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.682 0.793 . . . . 0.0 110.064 -176.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.6 mt -62.1 -36.3 81.3 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 122.806 0.442 . . . . 0.0 111.342 -175.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -51.54 -54.67 24.91 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.31 1.844 . . . . 0.0 108.757 172.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -68.88 -41.24 78.6 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.352 1.061 . . . . 0.0 112.296 -177.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -60.81 -53.57 55.77 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.271 1.428 . . . . 0.0 110.777 -168.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -74.79 -5.26 42.45 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.019 0.372 . . . . 0.0 111.594 -177.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.0 t0 75.02 25.31 1.38 Allowed 'General case' 0 C--O 1.233 0.2 0 C-N-CA 128.861 2.865 . . . . 0.0 113.782 -174.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -62.4 161.66 24.56 Favored Pre-proline 0 CA--C 1.547 0.858 0 O-C-N 119.837 -1.789 . . . . 0.0 108.44 165.422 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -72.21 -3.82 12.38 Favored 'Cis proline' 0 CA--C 1.548 1.224 0 CA-C-N 119.392 0.818 . . . . 0.0 113.004 -12.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.16 -59.6 5.2 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.479 1.912 . . . . 0.0 111.083 -175.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 27.5 mtp -82.83 -76.89 0.25 Allowed 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.859 1.263 . . . . 0.0 108.402 178.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -88.92 -177.4 5.47 Favored 'General case' 0 C--O 1.227 -0.122 0 C-N-CA 125.318 1.447 . . . . 0.0 110.319 -179.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 6.7 mp0 -138.21 176.61 8.55 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.605 2.362 . . . . 0.0 106.72 159.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -117.99 126.02 51.51 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.471 1.509 . . . . 0.0 108.382 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.7 m -126.09 150.91 47.86 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.212 0.605 . . . . 0.0 110.032 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.07 137.75 33.98 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.503 1.521 . . . . 0.0 109.533 166.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.599 HD11 HG23 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -142.68 -164.64 1.87 Allowed 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 127.852 2.461 . . . . 0.0 108.187 -177.254 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -119.42 139.76 51.5 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 123.613 0.765 . . . . 0.0 110.561 173.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 10.8 t -127.46 149.43 32.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 173.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -87.41 137.23 32.51 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 126.706 2.002 . . . . 0.0 105.656 170.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.751 HG13 ' HA ' ' A' ' 108' ' ' ASP 0.324 1.7 p -94.74 92.2 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 176.084 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.68 -45.53 93.59 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 114.358 -1.292 . . . . 0.0 108.802 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -141.58 140.83 33.47 Favored 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 125.651 1.58 . . . . 0.0 107.296 177.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 50.5 t-105 -108.7 141.24 40.97 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 167.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -119.93 101.37 7.81 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 165.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 139.93 177.72 16.09 Favored Glycine 0 C--N 1.331 0.252 0 CA-C-O 122.826 1.237 . . . . 0.0 112.822 164.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -64.67 162.29 16.07 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 168.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 72.44 75.19 0.71 Allowed Glycine 0 CA--C 1.522 0.474 0 O-C-N 120.937 -1.102 . . . . 0.0 111.883 176.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -102.28 90.52 2.12 Favored Pre-proline 0 N--CA 1.471 0.587 0 C-N-CA 128.399 2.68 . . . . 0.0 108.176 -172.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -53.15 -29.67 46.91 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.479 2.119 . . . . 0.0 114.807 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 145.73 -120.29 1.32 Allowed Glycine 0 C--N 1.338 0.694 0 CA-C-N 121.106 1.775 . . . . 0.0 110.729 -175.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.751 ' HA ' HG13 ' A' ' 97' ' ' VAL . 0.9 OUTLIER -143.9 1.04 1.12 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.319 1.848 . . . . 0.0 110.812 179.338 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.2 p -131.93 158.17 42.1 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 122.184 0.992 . . . . 0.0 110.62 148.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.4 m -137.74 167.25 22.85 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 C-N-CA 125.67 1.588 . . . . 0.0 108.444 -177.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -95.58 118.96 33.24 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 163.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 80.1 m -109.41 167.64 9.97 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.465 1.029 . . . . 0.0 109.4 165.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -95.13 141.57 28.59 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 163.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.599 HG23 HD11 ' A' ' 93' ' ' LEU . 84.9 t -135.64 151.42 29.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 170.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -81.17 134.18 35.58 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 173.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 42.3 p -140.37 -177.7 5.15 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.096 1.359 . . . . 0.0 109.575 -172.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.63 141.4 35.1 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 167.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -103.6 -5.59 22.52 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.209 1.003 . . . . 0.0 110.614 167.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.6 p -107.78 17.75 22.17 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.435 1.894 . . . . 0.0 112.715 -156.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -77.8 162.09 27.17 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.562 1.545 . . . . 0.0 113.343 -167.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -81.45 158.19 69.23 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 126.938 2.095 . . . . 0.0 111.405 175.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.464 ' HA ' HD23 ' A' ' 125' ' ' LEU . 46.7 Cg_endo -68.01 -33.22 26.39 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.68 2.253 . . . . 0.0 113.35 -174.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.9 pm0 -58.36 -31.74 67.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 118.806 0.73 . . . . 0.0 112.763 177.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 44.2 m0 -69.37 -14.72 63.07 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.318 0.508 . . . . 0.0 111.215 -176.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.464 HD23 ' HA ' ' A' ' 122' ' ' PRO . 3.4 mm? -78.4 -17.93 55.73 Favored 'General case' 0 CA--C 1.528 0.131 0 O-C-N 121.329 -0.857 . . . . 0.0 111.317 172.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -95.56 -22.7 17.46 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.798 0.727 . . . . 0.0 110.281 -172.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.2 mt -56.91 155.22 15.92 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 126.094 1.758 . . . . 0.0 111.036 178.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -67.64 144.4 66.01 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 121.339 1.359 . . . . 0.0 108.939 177.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -82.16 164.6 21.17 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 122.767 0.427 . . . . 0.0 109.923 172.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 51.8 m-70 -139.47 139.16 36.93 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.296 1.038 . . . . 0.0 109.13 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -82.45 -20.21 37.39 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.914 0.886 . . . . 0.0 112.921 -178.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.04 156.56 7.32 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 119.389 0.995 . . . . 0.0 110.052 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -114.28 127.79 56.04 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.572 1.149 . . . . 0.0 108.768 -175.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -140.18 131.38 26.52 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.434 1.494 . . . . 0.0 108.535 -174.095 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 7.6 t -69.93 -10.23 57.84 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.951 0.9 . . . . 0.0 110.154 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -131.15 64.22 1.58 Allowed 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 128.567 2.747 . . . . 0.0 104.673 177.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -124.28 171.51 16.53 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.866 1.698 . . . . 0.0 110.871 -176.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -61.96 -22.94 75.25 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.037 2.491 . . . . 0.0 112.877 -172.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -79.7 84.39 5.53 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 128.728 2.811 . . . . 0.0 109.251 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -44.89 -31.56 2.8 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 124.938 1.256 . . . . 0.0 113.683 177.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.5 90.25 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 127.097 2.159 . . . . 0.0 111.37 157.211 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -102.53 175.93 5.34 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 120.848 -1.158 . . . . 0.0 109.132 166.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -60.13 116.06 3.93 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -173.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -121.24 67.96 18.26 Favored Pre-proline 0 C--O 1.226 -0.159 0 C-N-CA 124.05 0.94 . . . . 0.0 109.331 -178.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -73.16 -22.65 18.94 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 121.89 1.726 . . . . 0.0 112.703 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.16 33.22 0.09 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.824 0.849 . . . . 0.0 110.469 -169.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -84.38 99.72 10.82 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 56.39 26.03 10.22 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.998 2.119 . . . . 0.0 114.589 -178.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.045 0 C-N-CA 126.912 2.085 . . . . 0.0 109.577 -176.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 tmm? . . . . . 0 N--CA 1.466 0.328 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.2 96.62 1.21 Allowed 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 102.514 -3.143 . . . . 0.0 102.514 -171.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -69.91 123.28 21.11 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 -175.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.2 pt -108.18 174.19 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 121.229 -0.919 . . . . 0.0 108.707 176.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.443 ' HB2' ' SG ' ' A' ' 112' ' ' CYS . 14.4 t80 -109.57 165.54 11.59 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.429 0.692 . . . . 0.0 109.37 168.25 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.2 p -121.45 133.99 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -59.58 -52.15 66.8 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.49 0.662 . . . . 0.0 111.843 -177.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.11 -35.29 0.27 Allowed Glycine 0 CA--C 1.526 0.78 0 CA-C-O 123.708 1.727 . . . . 0.0 110.793 -167.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -55.44 -23.73 26.88 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 129.927 3.291 . . . . 0.0 114.202 178.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -134.92 32.32 3.23 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 119.897 1.226 . . . . 0.0 110.157 -179.21 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.17 8.58 5.15 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 115.559 1.688 . . . . 0.0 115.559 178.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.69 -86.42 0.14 Allowed 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 117.677 -1.154 . . . . 0.0 109.139 174.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -162.6 18.07 0.15 Allowed Glycine 0 C--N 1.337 0.61 0 CA-C-N 119.366 0.985 . . . . 0.0 113.744 177.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -44.88 156.36 0.36 Allowed Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 126.474 1.91 . . . . 0.0 111.82 173.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -64.87 -2.15 5.1 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 124.471 3.447 . . . . 0.0 115.25 -172.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.512 ' O ' HG22 ' A' ' 19' ' ' VAL . 11.0 m120 -112.47 -10.52 13.72 Favored 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 125.115 1.366 . . . . 0.0 110.894 -165.271 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -56.73 -30.15 63.24 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.091 0.859 . . . . 0.0 111.487 -173.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.5 -27.84 27.71 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.512 HG22 ' O ' ' A' ' 16' ' ' ASN . 17.1 m -69.14 -11.09 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 118.785 0.72 . . . . 0.0 112.499 -170.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.5 ptp -102.79 -0.58 31.23 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.168 1.787 . . . . 0.0 113.232 171.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.0 mt -102.77 4.41 37.9 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.735 1.614 . . . . 0.0 110.694 -178.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -117.39 77.88 1.17 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 -172.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -58.9 -15.28 11.94 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.094 1.758 . . . . 0.0 114.066 -165.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.3 m -61.02 -37.1 81.36 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 120.499 -1.375 . . . . 0.0 112.013 166.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 45.3 m170 -65.78 -29.25 69.72 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.599 0.636 . . . . 0.0 110.529 175.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.57 -178.4 22.49 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 124.171 0.891 . . . . 0.0 111.184 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 46.3 tp -95.9 144.55 26.14 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.976 0.91 . . . . 0.0 111.996 -173.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.71 147.38 46.73 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.617 1.167 . . . . 0.0 108.288 163.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -146.07 134.33 21.74 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 125.574 1.549 . . . . 0.0 109.655 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.93 93.27 0.4 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.482 1.113 . . . . 0.0 110.11 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.1 tpp180 -110.63 64.87 0.61 Allowed 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 126.05 1.74 . . . . 0.0 108.146 -176.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.52 179.08 43.81 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-O 122.848 1.249 . . . . 0.0 112.442 172.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 38.3 mtp180 -125.3 165.06 19.03 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 123.423 0.689 . . . . 0.0 110.776 173.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -173.59 176.13 46.21 Favored Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 120.39 -0.91 . . . . 0.0 113.564 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.448 ' C ' HG23 ' A' ' 95' ' ' VAL . 71.6 m -138.85 133.54 32.13 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.371 1.068 . . . . 0.0 108.877 177.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.1 p -63.55 100.87 0.29 Allowed 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -73.12 -23.6 20.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-O 120.83 0.348 . . . . 0.0 110.833 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -60.41 100.74 0.11 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 152.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.5 m -56.6 137.41 53.85 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 167.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.686 ' HB3' HD21 ' A' ' 53' ' ' LEU . 25.0 m-85 -138.58 156.62 73.08 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 -176.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.441 ' HG2' ' HB2' ' A' ' 54' ' ' LEU . 54.9 Cg_endo -76.27 94.91 1.02 Allowed 'Trans proline' 0 CA--C 1.538 0.682 1 C-N-CA 126.032 4.488 . . . . 0.0 111.607 177.342 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 32.0 tp -93.21 114.33 26.78 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 121.134 -0.979 . . . . 0.0 109.96 174.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.4 m -131.66 143.73 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 119.198 0.908 . . . . 0.0 110.463 -173.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 55.6 mt -97.73 108.86 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -178.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -117.62 -179.68 3.8 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.52 0.728 . . . . 0.0 110.346 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.25 161.53 6.6 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 126.424 1.964 . . . . 0.0 115.382 163.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -65.76 -22.54 66.59 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 127.782 2.433 . . . . 0.0 114.303 -170.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 39.1 m-70 -109.85 13.47 23.54 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.813 0.845 . . . . 0.0 111.821 176.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.9 m120 60.38 64.49 1.2 Allowed 'General case' 0 C--N 1.344 0.365 0 CA-C-O 122.262 1.03 . . . . 0.0 108.251 -179.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 55.4 mt -104.72 87.43 1.8 Allowed Pre-proline 0 N--CA 1.45 -0.427 0 C-N-CA 127.874 2.47 . . . . 0.0 105.403 177.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.08 152.0 25.88 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 120.684 0.923 . . . . 0.0 112.825 166.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 22.4 m95 -130.24 166.64 19.9 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.056 1.342 . . . . 0.0 107.391 175.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.686 HD21 ' HB3' ' A' ' 40' ' ' PHE . 1.2 tm? -138.85 119.7 14.27 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.441 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 0.1 OUTLIER -95.89 147.43 23.67 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 113.392 -1.731 . . . . 0.0 107.834 -169.499 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -78.66 87.19 4.59 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.977 -176.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -140.93 77.57 20.88 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 124.036 0.934 . . . . 0.0 111.103 179.024 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.68 115.68 4.33 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 124.885 3.723 . . . . 0.0 110.442 -176.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 117.23 11.81 8.67 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 124.751 1.167 . . . . 0.0 113.595 175.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.2 tpmt? -138.0 149.06 45.76 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 119.599 1.699 . . . . 0.0 108.808 -176.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.96 -135.32 14.87 Favored Glycine 0 CA--C 1.521 0.465 0 CA-C-N 120.601 1.546 . . . . 0.0 109.507 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -134.97 169.89 16.72 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 118.889 1.345 . . . . 0.0 111.787 -167.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 59.2 m -85.48 103.47 14.38 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 125.358 1.463 . . . . 0.0 108.543 -178.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.0 t -69.8 106.23 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 51.3 p -81.88 147.51 29.27 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.286 -0.884 . . . . 0.0 110.026 -173.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -173.46 -156.52 13.32 Favored Glycine 0 C--N 1.342 0.898 0 O-C-N 121.402 -0.811 . . . . 0.0 113.097 -172.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -134.73 162.62 31.85 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -176.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 89.5 mt -114.43 103.27 15.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 106.301 -1.741 . . . . 0.0 106.301 -170.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -86.07 114.08 22.65 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 172.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -61.5 131.9 51.66 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 152.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.9 m -135.52 156.24 38.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.42 177.64 5.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 122.209 1.004 . . . . 0.0 111.505 172.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.57 -36.01 75.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.057 -1.429 . . . . 0.0 111.342 177.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 32.1 tp60 -63.87 -44.46 93.01 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.292 0.951 . . . . 0.0 110.13 177.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 35.2 tpp -66.96 -50.46 62.22 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 118.629 0.649 . . . . 0.0 110.938 177.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.2 mt -64.14 -16.65 62.32 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 118.592 0.633 . . . . 0.0 111.34 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 45.4 mtt180 -82.15 -50.59 8.86 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 120.429 -1.42 . . . . 0.0 111.555 165.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -54.14 -48.21 71.07 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 120.338 1.426 . . . . 0.0 111.041 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.3 tp -64.47 -23.22 67.2 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 121.823 -0.548 . . . . 0.0 110.96 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.545 ' HA ' ' SG ' ' A' ' 84' ' ' CYS . 28.0 t70 -75.98 -5.9 48.48 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 120.858 -1.151 . . . . 0.0 112.503 176.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -105.92 -42.87 5.01 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.765 1.626 . . . . 0.0 110.604 172.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -65.68 -38.96 90.72 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.838 0.855 . . . . 0.0 112.139 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.497 ' HG3' ' CE2' ' A' ' 115' ' ' TYR . 7.5 mm-40 -83.34 10.57 8.33 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.164 0.585 . . . . 0.0 111.406 178.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.9 t70 61.3 0.32 0.42 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 128.522 2.729 . . . . 0.0 114.882 178.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.545 ' SG ' ' HA ' ' A' ' 79' ' ' ASP . 24.6 p -65.99 153.04 92.53 Favored Pre-proline 0 N--CA 1.448 -0.57 0 C-N-CA 124.167 0.987 . . . . 0.0 109.757 -167.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -75.41 -4.96 22.51 Favored 'Cis proline' 0 CA--C 1.54 0.797 0 N-CA-C 115.915 1.467 . . . . 0.0 115.915 9.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 m -54.68 -71.31 0.08 Allowed 'General case' 0 C--O 1.237 0.435 0 CA-C-N 119.601 1.092 . . . . 0.0 112.758 -178.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 46.2 mtp -71.86 -64.84 0.85 Allowed 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -173.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -105.7 167.0 10.06 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.31 1.444 . . . . 0.0 108.908 -178.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -127.72 -14.1 5.19 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -177.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? 61.91 145.78 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 128.3 2.64 . . . . 0.0 111.756 -172.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.402 HG22 ' N ' ' A' ' 92' ' ' ALA . 38.3 m -148.69 178.12 8.92 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 119.797 -1.814 . . . . 0.0 107.261 171.235 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.402 ' N ' HG22 ' A' ' 91' ' ' THR . . . -116.59 142.09 47.33 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 127.181 2.193 . . . . 0.0 111.062 168.366 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.497 HD21 ' SG ' ' A' ' 112' ' ' CYS . 0.0 OUTLIER -136.31 -174.17 3.61 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 129.204 3.001 . . . . 0.0 110.674 -170.798 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -115.75 126.36 53.95 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 126.145 1.778 . . . . 0.0 111.614 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.65 HG13 HG22 ' A' ' 110' ' ' VAL 0.321 1.4 p -142.29 115.16 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 121.063 3.727 . . . . 0.0 121.063 -167.085 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.436 ' HA ' ' O ' ' A' ' 108' ' ' ASP . 59.0 tt0 -60.92 118.22 6.43 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 113.986 -1.461 . . . . 0.0 107.184 -169.065 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.584 HG13 ' HA ' ' A' ' 108' ' ' ASP 0.331 1.6 p -85.69 87.51 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 O-C-N 124.544 1.153 . . . . 0.0 108.623 -178.284 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.425 HD13 ' HA ' ' A' ' 98' ' ' LEU . 1.7 mm? -57.95 -40.12 79.78 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 112.919 -1.946 . . . . 0.0 109.694 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -152.15 152.58 32.47 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 -177.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 -140.3 129.65 23.91 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -179.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -118.2 97.62 5.88 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.023 1.329 . . . . 0.0 114.094 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.98 -175.7 21.56 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -178.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -67.41 178.4 1.58 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.494 0.717 . . . . 0.0 111.203 -174.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.403 ' O ' ' HD3' ' A' ' 106' ' ' PRO . . . 92.38 47.06 3.36 Favored Glycine 0 C--O 1.22 -0.754 0 O-C-N 120.858 -1.151 . . . . 0.0 110.809 169.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -101.63 88.47 1.2 Allowed Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 131.128 3.771 . . . . 0.0 112.228 -153.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.558 ' CG ' HG12 ' A' ' 110' ' ' VAL . 89.8 Cg_endo -70.91 -32.38 13.89 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 124.295 3.33 . . . . 0.0 114.731 -175.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 143.17 -95.75 0.19 Allowed Glycine 0 C--N 1.339 0.717 0 CA-C-N 120.899 1.681 . . . . 0.0 112.783 -178.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.584 ' HA ' HG13 ' A' ' 97' ' ' VAL . 2.1 m-20 -156.44 6.25 0.18 Allowed 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 125.448 1.499 . . . . 0.0 111.066 -172.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -142.86 154.71 44.4 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 117.815 -1.554 . . . . 0.0 109.549 150.187 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.65 HG22 HG13 ' A' ' 95' ' ' VAL . 3.1 m -126.01 165.31 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.03 0 C-N-CA 117.09 -1.844 . . . . 0.0 109.624 -175.02 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -101.77 100.2 10.52 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 104.745 -2.317 . . . . 0.0 104.745 167.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.497 ' SG ' HD21 ' A' ' 93' ' ' LEU . 3.0 p -102.36 -166.75 1.32 Allowed 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 172.372 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -121.79 146.4 47.1 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.677 1.591 . . . . 0.0 108.714 166.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 20.2 t -139.4 137.85 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 129.778 3.231 . . . . 0.0 107.599 177.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.497 ' CE2' ' HG3' ' A' ' 82' ' ' GLU . 4.3 m-85 -79.92 80.33 6.34 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.898 1.279 . . . . 0.0 111.499 -175.103 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 51.6 p -80.41 175.71 10.42 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.96 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.0 t -136.12 129.79 32.35 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 105.153 -2.166 . . . . 0.0 105.153 162.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -89.67 -0.81 57.77 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.925 0.89 . . . . 0.0 110.709 172.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 10.1 t -116.25 31.75 6.53 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.674 1.989 . . . . 0.0 110.903 -178.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -56.85 163.48 1.92 Allowed 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.672 -0.642 . . . . 0.0 109.819 166.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -98.07 154.97 37.51 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 123.772 0.829 . . . . 0.0 110.572 172.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -64.29 -33.4 59.49 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.572 2.181 . . . . 0.0 111.235 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -67.07 -7.4 22.64 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.918 0.887 . . . . 0.0 112.675 177.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 44.1 m0 -96.88 -18.52 19.46 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 118.809 0.731 . . . . 0.0 111.34 170.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 18.8 mt -79.0 -16.97 56.18 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 120.094 1.315 . . . . 0.0 112.39 175.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -77.74 -25.03 48.92 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.563 0.745 . . . . 0.0 110.722 174.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 88.7 mt -59.79 151.57 62.67 Favored Pre-proline 0 C--N 1.344 0.35 0 C-N-CA 124.569 1.148 . . . . 0.0 110.678 -175.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -74.86 142.47 28.38 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.029 2.486 . . . . 0.0 109.15 179.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -86.78 167.25 14.58 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.893 0.854 . . . . 0.0 111.628 -175.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -136.5 171.2 14.83 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.429 1.492 . . . . 0.0 108.665 175.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 -127.99 -15.27 4.84 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 123.178 1.466 . . . . 0.0 111.572 -167.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 40.1 t -153.89 151.38 29.4 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 163.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -82.95 170.41 14.96 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 162.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 174.92 147.82 0.08 Allowed 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 128.168 2.587 . . . . 0.0 107.771 152.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.53 -31.7 72.89 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 173.369 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -77.07 66.79 2.95 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 127.911 2.485 . . . . 0.0 107.442 168.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -130.27 154.37 20.56 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 162.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -73.66 -13.78 24.63 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.597 2.198 . . . . 0.0 113.323 -165.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -75.21 -15.66 60.53 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.04 1.336 . . . . 0.0 113.878 -172.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 81.63 -62.0 4.56 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.111 -1.195 . . . . 0.0 110.111 -173.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.7 87.11 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.729 2.012 . . . . 0.0 114.053 -176.257 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.86 173.69 11.32 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 130.16 3.384 . . . . 0.0 109.256 172.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -64.11 130.61 44.63 Favored 'General case' 0 C--O 1.237 0.404 0 O-C-N 123.605 0.565 . . . . 0.0 110.482 -161.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -123.65 81.94 54.41 Favored Pre-proline 0 N--CA 1.453 -0.313 0 O-C-N 124.436 1.085 . . . . 0.0 110.56 -166.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -86.55 -19.43 2.87 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.791 2.994 . . . . 0.0 113.752 177.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.7 -3.9 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 118.096 2.628 . . . . 0.0 118.096 -172.174 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.424 ' HG3' ' H ' ' A' ' 147' ' ' GLU . 0.0 OUTLIER -67.44 -34.41 77.15 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 123.033 0.533 . . . . 0.0 110.022 -168.028 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 -128.53 74.04 1.53 Allowed 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 128.107 2.563 . . . . 0.0 104.193 165.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 5.6 tpt85 . . . . . 0 C--O 1.242 0.678 0 CA-C-O 116.87 -1.538 . . . . 0.0 108.582 169.195 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.8 mtt . . . . . 0 N--CA 1.47 0.552 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.59 176.69 12.29 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.129 1.772 . . . . 0.0 108.093 171.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -130.81 152.36 50.23 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 163.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.9 pt -138.59 172.14 14.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 121.849 0.833 . . . . 0.0 109.793 175.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.594 ' CE2' HG23 ' A' ' 36' ' ' THR . 63.8 t80 -118.15 133.27 56.05 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.969 1.708 . . . . 0.0 107.882 179.155 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.1 m -91.25 138.06 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 118.982 0.81 . . . . 0.0 110.74 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.617 ' HE1' HD22 ' A' ' 53' ' ' LEU . 87.1 m-85 -75.02 -36.03 61.94 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 127.61 2.364 . . . . 0.0 112.156 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 156.29 -37.86 0.59 Allowed Glycine 0 CA--C 1.522 0.505 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -168.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 p -62.13 -23.31 66.49 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.537 1.535 . . . . 0.0 112.993 -167.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.5 mp -134.13 62.51 1.65 Allowed 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 170.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -154.95 -49.2 0.09 Allowed 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.751 1.62 . . . . 0.0 110.647 -176.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -84.45 -86.4 0.12 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.869 0.759 . . . . 0.0 110.221 173.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -172.65 29.87 0.1 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -173.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.61 162.83 13.87 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 125.127 1.371 . . . . 0.0 110.166 -179.127 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -59.87 -17.48 44.02 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.849 2.366 . . . . 0.0 112.872 -177.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.684 ' O ' HG22 ' A' ' 19' ' ' VAL . 4.6 m-80 -85.09 -17.05 38.55 Favored 'General case' 0 C--O 1.215 -0.729 0 O-C-N 120.877 -1.139 . . . . 0.0 110.575 -175.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -58.5 -35.9 72.96 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 120.981 1.719 . . . . 0.0 112.272 -163.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.64 -16.74 51.26 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 177.096 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.684 HG22 ' O ' ' A' ' 16' ' ' ASN . 31.7 m -64.08 -38.69 83.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 120.155 1.343 . . . . 0.0 110.54 -176.502 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.5 ptp -77.31 -10.48 59.46 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.1 mt -82.16 -14.43 55.67 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 122.869 0.468 . . . . 0.0 111.148 -173.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -106.31 100.21 9.76 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 -177.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 22.1 t-80 -56.28 -22.56 30.95 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.334 1.054 . . . . 0.0 113.513 -171.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.9 m -69.37 -20.86 63.83 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 120.482 -1.386 . . . . 0.0 113.539 174.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 30.7 m170 -76.6 -26.46 55.02 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.348 -0.845 . . . . 0.0 109.86 167.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 145.98 175.71 19.25 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 125.333 1.444 . . . . 0.0 111.222 167.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.8 tp -83.59 141.85 31.26 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 124.159 0.984 . . . . 0.0 111.852 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -145.09 92.76 2.3 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.231 1.812 . . . . 0.0 110.234 170.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -103.19 126.97 50.62 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 125.322 1.449 . . . . 0.0 110.072 -174.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -64.68 105.63 1.02 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.119 1.768 . . . . 0.0 110.44 -175.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.438 ' HG3' ' HB2' ' A' ' 69' ' ' GLU . 32.6 mmt180 -119.18 66.36 0.79 Allowed 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 125.755 1.622 . . . . 0.0 109.627 -178.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.65 -177.76 37.59 Favored Glycine 0 CA--C 1.523 0.539 0 CA-C-O 121.727 0.626 . . . . 0.0 112.134 172.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 8.9 ptt180 -131.48 164.49 25.66 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.194 0.998 . . . . 0.0 108.666 178.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -170.75 -178.82 41.66 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 119.447 -1.358 . . . . 0.0 116.417 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.423 ' C ' HG23 ' A' ' 95' ' ' VAL . 22.6 p -140.73 137.32 33.37 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.88 0.872 . . . . 0.0 110.595 173.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.594 HG23 ' CE2' ' A' ' 5' ' ' PHE . 9.9 p -68.32 100.78 1.1 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 176.406 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.439 ' CG1' ' HB2' ' A' ' 96' ' ' GLN . 2.2 m -68.78 -31.84 52.39 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-O 121.011 0.434 . . . . 0.0 111.031 -175.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.88 119.5 11.4 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 163.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.7 159.11 11.4 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 119.173 -1.011 . . . . 0.0 108.892 168.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -150.62 154.6 35.45 Favored Pre-proline 0 C--N 1.316 -0.87 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 176.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -80.93 88.72 1.36 Allowed 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 124.638 3.558 . . . . 0.0 112.435 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.4 tp -83.13 88.67 6.89 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 120.655 -1.278 . . . . 0.0 110.619 -177.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.537 HG13 ' HB3' ' A' ' 127' ' ' LEU . 61.5 t -92.59 150.82 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.181 0 C-N-CA 126.704 2.002 . . . . 0.0 109.829 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.8 mt -119.5 113.96 42.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 126.312 1.845 . . . . 0.0 107.409 176.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -137.66 158.09 45.11 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.642 0.734 . . . . 0.0 112.051 -172.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.34 169.12 37.09 Favored Glycine 0 CA--C 1.537 1.413 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.818 175.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.9 -28.48 70.08 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -168.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -96.08 2.18 53.07 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.988 0.18 . . . . 0.0 110.813 -161.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 67.23 59.32 0.52 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.071 2.148 . . . . 0.0 108.52 176.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 61.7 mt -104.3 91.18 3.68 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 129.794 3.237 . . . . 0.0 108.745 -168.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -56.76 136.82 78.46 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 CA-C-N 120.708 1.288 . . . . 0.0 111.264 172.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -123.83 105.94 10.06 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 126.09 1.756 . . . . 0.0 108.566 -177.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.617 HD22 ' HE1' ' A' ' 7' ' ' TYR . 7.9 tp -76.76 81.53 3.37 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -175.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.1 mp -50.78 125.97 14.65 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 127.105 2.162 . . . . 0.0 110.027 174.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -73.97 85.01 1.76 Allowed 'General case' 0 C--O 1.239 0.548 0 CA-C-O 119.034 -0.508 . . . . 0.0 111.656 -173.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.411 HD11 ' HE2' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -136.66 80.21 38.43 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 118.672 0.669 . . . . 0.0 110.651 174.965 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -63.53 119.97 7.23 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.788 2.325 . . . . 0.0 111.549 -175.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.69 14.69 57.87 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 125.412 1.482 . . . . 0.0 113.262 178.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.411 ' HE2' HD11 ' A' ' 56' ' ' LEU . 0.9 OUTLIER -122.17 140.87 52.06 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 119.601 1.701 . . . . 0.0 109.172 163.965 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.23 -133.36 11.74 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 118.798 -1.001 . . . . 0.0 110.943 -171.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -141.76 169.6 17.3 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 118.871 1.336 . . . . 0.0 112.523 -157.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 27.3 m -103.33 103.79 13.84 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.621 1.168 . . . . 0.0 112.497 -166.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 14.1 t -70.05 116.25 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 123.825 0.85 . . . . 0.0 109.789 -177.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 67.6 p -80.41 146.9 31.23 Favored 'General case' 0 C--O 1.24 0.562 0 O-C-N 121.619 -0.676 . . . . 0.0 109.72 171.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -170.81 -168.22 32.25 Favored Glycine 0 N--CA 1.447 -0.574 0 O-C-N 121.386 -0.821 . . . . 0.0 111.957 -175.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 17.5 mt-10 -129.64 169.57 14.88 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 125.614 1.566 . . . . 0.0 108.548 -176.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.4 mt -122.89 130.57 74.39 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 O-C-N 121.298 -0.876 . . . . 0.0 108.82 -170.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -122.75 121.93 37.51 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 125.125 1.37 . . . . 0.0 107.67 171.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.438 ' HB2' ' HG3' ' A' ' 31' ' ' ARG . 78.5 tt0 -64.47 135.4 56.02 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 158.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.7 m -135.69 139.01 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -173.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.48 -179.28 5.15 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.7 0.762 . . . . 0.0 110.012 176.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -63.13 -35.08 79.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 118.289 -0.862 . . . . 0.0 111.543 -173.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 44.1 tp60 -64.92 -42.55 94.61 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 118.869 0.758 . . . . 0.0 110.146 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.1 tpp -64.5 -52.37 58.19 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.8 tp -57.67 -44.19 85.57 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 118.688 -0.672 . . . . 0.0 110.822 -176.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.4 mtt180 -64.62 -34.36 78.1 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.674 0.79 . . . . 0.0 112.193 176.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -67.33 -47.5 70.3 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 118.561 0.618 . . . . 0.0 110.416 177.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.7 mt -60.05 -34.95 74.1 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 175.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.98 -6.54 12.99 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.046 1.738 . . . . 0.0 113.787 178.176 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -115.96 -24.5 8.08 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.501 1.921 . . . . 0.0 110.739 176.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -68.71 -41.02 79.66 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.584 1.154 . . . . 0.0 111.271 -174.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -105.75 14.58 28.05 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.984 0.914 . . . . 0.0 111.258 -170.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 58.13 25.62 12.69 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.21 1.004 . . . . 0.0 112.332 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -70.47 161.62 75.55 Favored Pre-proline 0 CA--C 1.546 0.827 0 O-C-N 119.73 -1.856 . . . . 0.0 109.739 168.31 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -70.87 -3.76 9.44 Favored 'Cis proline' 0 CA--C 1.545 1.06 0 CA-C-N 119.551 0.875 . . . . 0.0 113.734 -9.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 m -55.16 -60.77 2.93 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.152 1.781 . . . . 0.0 111.277 -176.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 19.2 mtm -81.83 -64.32 1.21 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 122.019 0.914 . . . . 0.0 110.49 -179.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -102.54 169.99 8.31 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 125.525 1.53 . . . . 0.0 109.381 -178.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.1 mp0 -135.34 143.33 46.06 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.975 1.31 . . . . 0.0 108.394 173.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -78.16 130.04 35.86 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 177.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.9 m -132.16 174.29 10.35 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 125.146 1.378 . . . . 0.0 109.052 -175.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -115.44 151.19 35.19 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.485 1.514 . . . . 0.0 111.153 166.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.573 ' HG ' HG21 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -140.24 -160.98 1.13 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.457 1.503 . . . . 0.0 112.351 -178.09 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -136.9 124.11 21.78 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.796 2.039 . . . . 0.0 110.121 174.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.501 HG21 ' CD1' ' A' ' 5' ' ' PHE . 1.4 p -139.21 116.19 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 116.9 2.185 . . . . 0.0 116.9 -168.009 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.439 ' HB2' ' CG1' ' A' ' 37' ' ' VAL . 9.9 tt0 -54.54 122.45 10.58 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 124.939 1.296 . . . . 0.0 109.222 -174.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.414 ' CG1' ' HB2' ' A' ' 100' ' ' TRP . 93.1 t -76.57 88.64 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 128.654 2.782 . . . . 0.0 106.509 174.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 mp -75.78 -15.56 60.24 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.271 0.628 . . . . 0.0 111.578 177.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.436 ' HB2' ' CZ ' ' A' ' 33' ' ' ARG . 0.4 OUTLIER -160.32 161.33 33.24 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 128.051 2.541 . . . . 0.0 106.626 161.234 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.414 ' HB2' ' CG1' ' A' ' 97' ' ' VAL . 68.7 t-105 -143.49 102.24 3.91 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.584 1.554 . . . . 0.0 109.62 174.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -95.04 77.82 3.54 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.31 1.044 . . . . 0.0 109.987 -178.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 161.7 178.97 36.07 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-O 122.358 0.977 . . . . 0.0 111.651 174.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -70.21 168.4 15.85 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 168.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.65 65.65 1.65 Allowed Glycine 0 CA--C 1.524 0.594 0 O-C-N 121.377 -0.827 . . . . 0.0 111.646 172.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -101.3 90.11 1.58 Allowed Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 128.002 2.521 . . . . 0.0 109.017 -168.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -68.8 5.06 1.47 Allowed 'Trans proline' 0 CA--C 1.54 0.819 1 C-N-CA 126.361 4.707 . . . . 0.0 114.434 -165.253 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.05 -174.47 27.63 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 108.921 -1.671 . . . . 0.0 108.921 -168.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -65.56 -14.37 60.95 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 117.759 -1.115 . . . . 0.0 113.963 -168.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 75.6 p -138.82 169.17 18.28 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 121.136 1.789 . . . . 0.0 111.061 174.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.455 ' CG1' HG13 ' A' ' 95' ' ' VAL . 14.3 p -133.91 144.8 34.59 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.76 0 CA-C-N 121.616 2.007 . . . . 0.0 110.768 -173.334 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -92.04 84.77 5.35 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 171.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.463 ' SG ' HD11 ' A' ' 93' ' ' LEU . 1.6 p -89.43 -167.75 1.96 Allowed 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 175.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -109.86 151.66 26.75 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 122.736 1.255 . . . . 0.0 112.285 160.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.573 HG21 ' HG ' ' A' ' 93' ' ' LEU . 0.1 OUTLIER -152.07 119.42 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 104.782 -2.303 . . . . 0.0 104.782 -163.738 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -67.4 129.5 40.09 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 121.828 -0.545 . . . . 0.0 109.966 167.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.579 HG22 HD23 ' A' ' 53' ' ' LEU . 14.2 p -127.56 -170.05 2.16 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 125.807 1.643 . . . . 0.0 107.059 176.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.2 t -144.14 147.39 33.64 Favored 'General case' 0 C--O 1.239 0.535 0 O-C-N 120.699 -1.251 . . . . 0.0 108.33 161.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -108.33 -10.14 15.38 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.0 1.32 . . . . 0.0 111.727 171.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 9.0 t -98.85 25.52 6.54 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.633 1.173 . . . . 0.0 111.909 -172.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -60.38 146.43 44.36 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.501 1.12 . . . . 0.0 111.329 176.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.66 155.27 89.56 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 124.873 1.269 . . . . 0.0 110.634 173.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.18 -33.6 18.41 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 121.398 1.399 . . . . 0.0 112.759 -178.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -58.52 -25.37 62.36 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.45 -0.781 . . . . 0.0 112.611 172.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 41.5 m0 -80.43 -4.88 55.4 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 120.969 -1.082 . . . . 0.0 112.686 -175.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -72.35 -34.09 67.77 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 119.498 1.044 . . . . 0.0 109.979 168.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -81.96 -21.89 36.95 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.996 0.918 . . . . 0.0 111.394 -177.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.537 ' HB3' HG13 ' A' ' 43' ' ' VAL . 15.9 mt -55.93 149.44 33.65 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 124.036 0.934 . . . . 0.0 110.151 177.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.49 156.76 64.5 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.117 1.878 . . . . 0.0 110.924 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -102.51 162.91 12.55 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 126.559 1.944 . . . . 0.0 107.455 173.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -132.49 177.91 7.24 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 173.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -128.0 -14.5 4.97 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.308 1.443 . . . . 0.0 112.422 -169.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.9 p -154.9 173.93 15.83 Favored 'General case' 0 C--O 1.239 0.542 0 O-C-N 120.652 -1.28 . . . . 0.0 109.854 163.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -120.83 136.18 54.98 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 123.795 0.838 . . . . 0.0 111.452 -177.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -163.19 128.61 3.14 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.325 1.05 . . . . 0.0 109.915 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 49.8 m -75.81 -0.32 20.7 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.257 1.423 . . . . 0.0 113.929 177.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -125.95 22.61 7.34 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.57 1.548 . . . . 0.0 109.287 173.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -79.59 164.73 49.23 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 121.604 -0.685 . . . . 0.0 111.509 177.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -60.66 -18.2 53.81 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.62 2.88 . . . . 0.0 112.865 -177.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -58.45 -17.19 18.9 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 127.427 2.291 . . . . 0.0 115.466 -174.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 79.96 -50.84 3.98 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 119.86 1.209 . . . . 0.0 113.462 174.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.04 110.93 9.75 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.491 1.516 . . . . 0.0 110.306 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.8 mmt85 -117.35 149.45 40.48 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 118.22 -0.895 . . . . 0.0 109.932 -176.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -62.61 135.36 57.35 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.687 1.131 . . . . 0.0 110.199 -176.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -131.7 78.65 70.21 Favored Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 123.821 0.848 . . . . 0.0 110.843 -176.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -80.42 -36.17 0.52 Allowed 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 123.609 2.873 . . . . 0.0 112.547 178.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -144.92 -6.01 0.69 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.56 1.144 . . . . 0.0 113.523 -175.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.271 5.5 mt-10 59.27 -58.61 0.05 Allowed 'General case' 0 N--CA 1.424 -1.732 1 C-N-CA 134.294 5.038 . . . . 0.0 112.994 175.191 . . . . . . . . 3 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -159.55 0.86 0.08 Allowed 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 125.915 1.686 . . . . 0.0 111.807 -171.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? . . . . . 0 C--O 1.252 1.185 0 C-N-CA 126.691 1.996 . . . . 0.0 109.711 -160.327 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ptt? . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.79 105.42 1.6 Allowed 'General case' 0 C--O 1.236 0.359 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -75.47 152.03 37.96 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.8 pt -130.66 -177.25 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 175.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.444 ' CD1' HG11 ' A' ' 95' ' ' VAL . 63.5 t80 -128.98 167.56 17.28 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 124.441 1.097 . . . . 0.0 108.128 169.152 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.7 p -124.93 130.89 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 177.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -68.4 -36.68 79.47 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 125.072 1.349 . . . . 0.0 110.501 174.267 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 147.03 29.16 0.07 OUTLIER Glycine 0 C--N 1.339 0.706 0 CA-C-O 116.738 -2.146 . . . . 0.0 116.428 171.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.8 -27.26 13.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 120.195 1.998 . . . . 0.0 110.14 178.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.0 42.72 2.29 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.881 1.272 . . . . 0.0 108.266 -178.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -133.65 -86.53 0.42 Allowed 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.107 -0.996 . . . . 0.0 110.129 -178.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.518 ' HB2' HE22 ' A' ' 14' ' ' GLN . 0.0 OUTLIER -63.03 -63.56 1.17 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.954 0.797 . . . . 0.0 111.529 -163.911 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 171.73 36.7 0.03 OUTLIER Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -174.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.518 HE22 ' HB2' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -102.29 161.08 24.44 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 124.971 1.308 . . . . 0.0 109.052 -174.165 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -85.72 62.46 5.43 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.224 2.616 . . . . 0.0 110.968 -155.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -150.93 -29.87 0.19 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.888 1.675 . . . . 0.0 109.171 179.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -48.4 -34.37 10.74 Favored 'General case' 0 C--N 1.347 0.476 0 C-N-CA 125.481 1.513 . . . . 0.0 111.554 -172.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.56 -34.61 2.19 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 125.755 1.622 . . . . 0.0 115.266 174.291 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.8 m -62.61 -35.25 69.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 120.188 1.358 . . . . 0.0 110.797 -178.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.8 ptp -94.28 9.22 38.97 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.447 0.567 . . . . 0.0 111.906 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 68.3 mt -100.66 21.45 13.41 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.217 1.007 . . . . 0.0 108.648 169.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -138.37 99.76 3.93 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 173.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 -58.51 -16.93 17.53 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.473 1.109 . . . . 0.0 112.998 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.65 -22.13 62.54 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.332 1.453 . . . . 0.0 112.064 172.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -81.7 -7.02 59.55 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.858 0.754 . . . . 0.0 111.336 165.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.89 172.26 14.19 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 125.471 1.51 . . . . 0.0 112.212 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -77.99 135.83 37.87 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.888 1.275 . . . . 0.0 110.456 -176.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -141.7 108.78 5.47 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.422 1.089 . . . . 0.0 110.004 162.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -119.33 141.41 49.04 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.871 0.868 . . . . 0.0 109.309 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -64.75 110.78 2.51 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.887 1.275 . . . . 0.0 109.726 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.2 tpp180 -118.06 51.31 1.07 Allowed 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.337 1.455 . . . . 0.0 107.505 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.29 -166.76 44.39 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 122.7 1.167 . . . . 0.0 112.637 175.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 27.6 mtp85 -126.4 164.05 21.96 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.318 -1.107 . . . . 0.0 109.346 -164.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -168.81 175.81 43.2 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 118.845 -1.645 . . . . 0.0 115.692 176.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.4 p -141.7 158.7 43.5 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.886 1.675 . . . . 0.0 109.699 173.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.1 p -80.11 99.47 7.75 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 165.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -61.11 -37.79 78.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 O-C-N 121.254 -0.904 . . . . 0.0 110.741 172.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -60.92 106.49 0.59 Allowed 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 158.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -54.22 140.25 33.28 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 171.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.482 ' HB3' HD21 ' A' ' 53' ' ' LEU . 28.5 m-85 -134.08 154.49 80.21 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 174.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -79.89 95.26 1.02 Allowed 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 123.861 3.041 . . . . 0.0 110.911 173.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.29 115.26 21.9 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 168.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.477 ' CG2' HD13 ' A' ' 54' ' ' LEU . 5.9 m -124.14 133.13 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.325 1.45 . . . . 0.0 108.929 -174.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.5 mt -104.85 89.16 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 -169.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -118.43 166.0 13.2 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 122.3 1.048 . . . . 0.0 112.146 -173.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.58 -172.93 34.86 Favored Glycine 0 CA--C 1.537 1.457 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 -176.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -95.38 -21.84 18.11 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 121.309 -1.112 . . . . 0.0 113.292 -175.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -100.18 8.48 43.81 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -173.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.4 m120 59.94 71.87 0.55 Allowed 'General case' 0 CA--C 1.523 -0.087 0 C-N-CA 127.619 2.368 . . . . 0.0 110.706 -178.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 88.5 mt -106.2 88.38 3.12 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 127.323 2.249 . . . . 0.0 107.069 -177.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -60.61 103.05 0.21 Allowed 'Trans proline' 0 CA--C 1.544 1.025 0 C-N-CA 123.703 2.935 . . . . 0.0 112.086 178.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -89.13 129.87 35.66 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.545 1.138 . . . . 0.0 109.094 -177.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.482 HD21 ' HB3' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -93.69 105.26 17.31 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 122.501 1.144 . . . . 0.0 109.567 176.565 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.5 ' HG ' ' CD1' ' A' ' 120' ' ' TYR . 11.0 mp -79.45 137.82 37.38 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 125.45 1.5 . . . . 0.0 110.066 -178.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -78.96 85.12 4.93 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 120.699 0.285 . . . . 0.0 110.567 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.35 85.38 15.41 Favored Pre-proline 0 CA--C 1.529 0.156 0 C-N-CA 123.877 0.871 . . . . 0.0 108.903 168.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -64.06 142.51 81.33 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 N-CA-C 109.085 -1.16 . . . . 0.0 109.085 177.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.65 14.38 82.48 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-O 119.352 -0.693 . . . . 0.0 113.547 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.3 tppt? -125.01 151.19 45.9 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 119.86 1.83 . . . . 0.0 107.308 168.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.93 -140.09 25.3 Favored Glycine 0 CA--C 1.521 0.463 0 CA-C-N 120.178 1.354 . . . . 0.0 109.999 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -139.59 167.14 22.78 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 118.348 1.074 . . . . 0.0 111.339 -161.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 85.8 m -78.69 98.95 6.41 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 122.848 0.459 . . . . 0.0 111.564 -175.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.1 t -61.64 104.42 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 124.535 1.134 . . . . 0.0 108.508 176.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.6 p -80.9 144.17 32.14 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 121.549 -0.719 . . . . 0.0 110.399 177.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.74 -152.55 6.94 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -167.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -144.97 163.99 32.49 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.878 1.271 . . . . 0.0 109.289 -176.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 84.7 mt -117.75 126.37 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 -176.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -115.07 131.49 56.91 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 175.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -64.06 123.55 19.33 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 103.874 -2.639 . . . . 0.0 103.874 150.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.1 m -122.59 161.52 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 169.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -104.82 172.32 6.85 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 173.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -59.11 -36.17 74.7 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.967 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -57.94 -43.21 86.22 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 119.392 0.996 . . . . 0.0 111.858 176.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.8 tpp -67.6 -49.1 64.75 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.0 tp -58.68 -40.49 83.73 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 119.903 -0.719 . . . . 0.0 111.57 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 35.5 mtt180 -60.01 -56.46 21.43 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 124.641 1.176 . . . . 0.0 109.124 177.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -57.6 -49.21 77.18 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.018 0.927 . . . . 0.0 111.063 -176.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.5 mt -61.33 -25.85 67.41 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 121.906 -0.497 . . . . 0.0 111.196 -177.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -69.39 -20.88 63.81 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.187 0.903 . . . . 0.0 110.986 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -83.92 -50.31 8.17 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.189 1.396 . . . . 0.0 110.254 167.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -58.95 -38.1 78.25 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.718 0.807 . . . . 0.0 111.777 -173.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -95.69 15.66 19.45 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -175.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.429 ' O ' ' HB2' ' A' ' 86' ' ' SER . 20.4 m-20 48.35 35.79 6.17 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 128.18 2.592 . . . . 0.0 112.109 172.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.422 ' SG ' ' HB2' ' A' ' 88' ' ' TYR . 65.8 m -73.81 162.25 74.96 Favored Pre-proline 0 CA--C 1.54 0.588 0 O-C-N 120.154 -1.591 . . . . 0.0 109.669 175.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -71.46 -4.65 11.3 Favored 'Cis proline' 0 CA--C 1.541 0.874 0 CA-C-N 119.65 0.911 . . . . 0.0 113.66 -9.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.429 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 25.7 m -56.0 -72.28 0.08 Allowed 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.264 1.026 . . . . 0.0 111.401 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 5.2 mtm -74.0 -48.48 29.95 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 119.01 -1.076 . . . . 0.0 108.37 -167.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.422 ' HB2' ' SG ' ' A' ' 84' ' ' CYS . 98.6 m-85 -122.1 163.66 19.09 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -122.85 115.5 22.09 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 172.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -63.06 130.36 44.32 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 171.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.6 m -132.45 161.75 32.91 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 126.307 1.843 . . . . 0.0 107.163 -175.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -107.6 126.38 52.49 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 174.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.498 HD21 HG23 ' A' ' 114' ' ' VAL . 1.8 pt? -142.7 -166.64 2.33 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.865 1.666 . . . . 0.0 109.817 -167.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -125.31 138.57 54.08 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.191 0.996 . . . . 0.0 111.464 -177.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.444 HG11 ' CD1' ' A' ' 5' ' ' PHE . 42.9 t -136.11 140.19 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 177.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -77.68 132.27 38.11 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 170.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.669 HG13 ' HA ' ' A' ' 108' ' ' ASP . 2.6 p -84.55 105.34 13.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 112.932 -1.94 . . . . 0.0 106.872 170.396 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 mp -78.42 -22.95 46.96 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 113.698 -1.592 . . . . 0.0 110.646 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -161.47 139.17 9.06 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 104.209 -2.515 . . . . 0.0 104.209 -179.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 72.4 t-105 -121.36 129.4 53.04 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 174.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -103.62 121.83 43.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.424 0.69 . . . . 0.0 109.25 173.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 98.46 178.36 32.64 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 124.329 0.966 . . . . 0.0 111.107 170.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -87.94 150.55 23.4 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 122.109 0.957 . . . . 0.0 110.998 178.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 113.0 62.54 0.44 Allowed Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 125.715 1.626 . . . . 0.0 109.963 -177.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -102.11 88.72 1.38 Allowed Pre-proline 0 C--O 1.242 0.674 0 C-N-CA 130.659 3.584 . . . . 0.0 111.393 -159.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -66.29 2.42 1.88 Allowed 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 124.89 3.727 . . . . 0.0 116.202 -177.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.32 176.29 35.2 Favored Glycine 0 CA--C 1.525 0.69 0 O-C-N 120.379 -1.45 . . . . 0.0 109.628 -163.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.669 ' HA ' HG13 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -74.48 3.97 6.75 Favored 'General case' 0 CA--C 1.503 -0.857 0 C-N-CA 128.238 2.615 . . . . 0.0 116.375 -156.976 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 56.8 m -143.08 152.54 41.97 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 122.362 2.346 . . . . 0.0 111.809 155.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.6 m -133.34 156.02 41.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 125.284 1.434 . . . . 0.0 109.113 -163.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -92.31 115.72 28.33 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 170.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -121.5 169.64 10.46 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 125.837 1.655 . . . . 0.0 108.487 174.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -90.75 143.16 27.01 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 158.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.498 HG23 HD21 ' A' ' 93' ' ' LEU . 22.3 t -137.7 139.12 43.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 128.036 2.534 . . . . 0.0 107.789 172.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -73.26 122.58 22.19 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 167.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 11.1 p -123.02 -172.68 2.55 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 173.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.3 t -135.96 146.05 46.84 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 155.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -105.17 -16.64 14.72 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.307 1.843 . . . . 0.0 110.761 171.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.5 t -122.34 71.75 1.03 Allowed 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -175.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.5 ' CD1' ' HG ' ' A' ' 54' ' ' LEU . 0.3 OUTLIER -88.42 -11.55 45.71 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 125.631 1.572 . . . . 0.0 112.366 179.698 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 68.33 158.62 0.15 Allowed Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 126.248 1.819 . . . . 0.0 110.984 -170.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -69.37 -27.26 28.52 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.307 1.338 . . . . 0.0 113.355 -170.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -55.8 -37.95 69.31 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -178.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 0.547 ' HA ' HD23 ' A' ' 127' ' ' LEU . 41.6 m0 -71.98 -10.61 60.02 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 124.646 1.178 . . . . 0.0 111.461 -176.119 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 38.3 mt -80.39 4.9 16.5 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 120.842 -1.161 . . . . 0.0 112.297 171.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -107.08 -1.66 21.83 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 120.3 1.409 . . . . 0.0 113.235 172.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.547 HD23 ' HA ' ' A' ' 124' ' ' TRP . 1.3 mm? -78.62 148.19 72.7 Favored Pre-proline 0 N--CA 1.446 -0.631 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -173.397 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -65.18 146.9 87.72 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 121.433 1.422 . . . . 0.0 108.989 169.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 19.6 m-30 -87.9 157.02 19.08 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.409 0.623 . . . . 0.0 109.681 173.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -127.52 165.99 18.82 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.247 1.019 . . . . 0.0 109.16 178.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -110.98 -19.46 12.77 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.708 1.203 . . . . 0.0 111.723 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 13.5 p -155.92 149.32 24.74 Favored 'General case' 0 C--O 1.238 0.477 0 O-C-N 121.263 -0.898 . . . . 0.0 109.514 170.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -97.67 133.47 42.16 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 171.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -140.89 156.24 46.14 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.801 2.04 . . . . 0.0 106.676 176.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.51 -22.71 40.65 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.422 1.489 . . . . 0.0 112.308 176.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -127.4 90.26 3.1 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 103.605 -2.739 . . . . 0.0 103.605 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -130.47 154.72 20.78 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-N 113.922 -1.49 . . . . 0.0 110.808 159.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -64.93 -22.92 62.42 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 123.373 2.715 . . . . 0.0 114.223 -161.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -63.04 -19.5 64.44 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.246 1.418 . . . . 0.0 113.374 178.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 77.67 -29.1 1.78 Allowed Glycine 0 CA--C 1.533 1.16 0 O-C-N 120.755 -1.216 . . . . 0.0 114.311 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.65 83.57 0.07 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.168 1.484 . . . . 0.0 112.193 176.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.95 153.71 50.63 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 128.147 2.579 . . . . 0.0 110.167 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -60.49 133.46 56.12 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 124.081 0.863 . . . . 0.0 110.012 -165.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -121.43 76.99 35.01 Favored Pre-proline 0 C--O 1.232 0.162 0 C-N-CA 123.455 0.702 . . . . 0.0 110.154 -171.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.97 -31.57 2.99 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 122.916 2.411 . . . . 0.0 112.9 176.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -138.9 2.69 2.17 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -168.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -83.2 -24.74 32.28 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.179 -148.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -121.54 24.03 10.02 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 128.079 2.552 . . . . 0.0 107.139 165.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.8 mmm-85 . . . . . 0 C--O 1.252 1.226 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -132.835 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.8 mtt . . . . . 0 N--CA 1.468 0.458 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.49 154.42 38.61 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 158.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -111.19 137.55 48.75 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 162.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.2 pt -129.91 168.14 23.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 175.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -133.67 144.21 49.04 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -178.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.458 ' CG2' ' H ' ' A' ' 66' ' ' GLU . 3.8 m -100.52 169.84 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 124.092 0.957 . . . . 0.0 110.301 -176.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -120.01 -27.88 5.26 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.425 1.09 . . . . 0.0 112.289 172.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 171.72 -56.02 0.17 Allowed Glycine 0 C--N 1.339 0.733 0 C-N-CA 120.583 -0.818 . . . . 0.0 113.082 -161.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -45.28 -45.84 12.33 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 126.063 1.745 . . . . 0.0 111.605 178.092 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.3 mt -125.84 26.36 6.64 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.958 1.303 . . . . 0.0 108.643 -167.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -118.86 -33.32 4.25 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.309 -0.87 . . . . 0.0 113.302 -177.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.562 ' HG3' ' H ' ' A' ' 13' ' ' GLY . 8.9 ptm85 -123.86 -86.39 0.64 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 119.554 1.07 . . . . 0.0 111.176 -178.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.562 ' H ' ' HG3' ' A' ' 12' ' ' ARG . . . -164.63 55.38 0.27 Allowed Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 104.998 -3.241 . . . . 0.0 104.998 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.5 162.36 72.86 Favored Pre-proline 0 N--CA 1.447 -0.618 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 163.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -67.66 4.4 1.4 Allowed 'Trans proline' 0 CA--C 1.53 0.288 0 C-N-CA 123.767 2.978 . . . . 0.0 115.404 -173.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.738 ' O ' HG22 ' A' ' 19' ' ' VAL . 8.2 m120 -118.68 -8.62 10.36 Favored 'General case' 0 C--O 1.214 -0.79 0 C-N-CA 125.661 1.584 . . . . 0.0 108.609 -166.103 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -58.29 -45.79 87.28 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 119.613 1.097 . . . . 0.0 111.213 -171.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.895 ' HA ' HD13 ' A' ' 21' ' ' LEU . 0.3 OUTLIER -52.37 -21.3 3.45 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.16 1.384 . . . . 0.0 113.785 178.697 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.738 HG22 ' O ' ' A' ' 16' ' ' ASN . 34.7 m -62.27 -18.18 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 120.944 1.702 . . . . 0.0 112.443 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.625 ' HG3' HD12 ' A' ' 21' ' ' LEU . 3.0 ptp -97.4 -9.07 28.05 Favored 'General case' 0 C--N 1.348 0.508 0 CA-C-N 120.524 1.511 . . . . 0.0 110.948 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.895 HD13 ' HA ' ' A' ' 18' ' ' LYS . 8.4 mp -80.77 -31.1 35.97 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.902 1.681 . . . . 0.0 107.477 -174.448 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -70.36 97.2 1.22 Allowed 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 165.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 41.7 t-80 -61.35 -20.96 63.58 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.719 0.771 . . . . 0.0 111.322 171.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 m -51.29 -33.05 27.02 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.649 1.98 . . . . 0.0 112.193 166.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 45.1 m170 -93.58 10.95 30.49 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.028 1.331 . . . . 0.0 112.299 178.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.2 175.88 18.94 Favored Glycine 0 C--N 1.335 0.519 0 CA-C-O 122.313 0.952 . . . . 0.0 112.153 175.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -90.28 133.01 35.22 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.7 1.2 . . . . 0.0 109.68 -174.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -141.83 106.73 4.91 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.724 1.21 . . . . 0.0 110.907 169.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -116.87 125.6 51.75 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 125.519 1.527 . . . . 0.0 109.245 -169.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -68.24 112.11 4.95 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.694 1.198 . . . . 0.0 109.548 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -117.03 58.77 0.77 Allowed 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 123.899 0.88 . . . . 0.0 108.807 171.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.99 -165.74 53.65 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.905 168.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 36.7 mtp85 -116.73 167.49 11.05 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.623 0.769 . . . . 0.0 109.994 -156.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 96' ' ' GLN . . . -164.34 -179.26 38.39 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 116.126 1.21 . . . . 0.0 116.126 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.1 p -152.88 157.84 41.29 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 118.19 -0.91 . . . . 0.0 111.573 172.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.598 HG23 HG13 ' A' ' 63' ' ' VAL . 31.1 p -77.02 101.18 5.92 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 119.891 1.223 . . . . 0.0 108.478 167.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.424 HG13 ' HB2' ' A' ' 96' ' ' GLN . 0.3 OUTLIER -58.91 -52.51 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 119.796 1.18 . . . . 0.0 110.518 173.403 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.407 ' H ' HG23 ' A' ' 37' ' ' VAL . 2.8 mp0 -62.92 110.82 1.9 Allowed 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 166.138 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.6 m -59.33 132.49 54.16 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 178.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -126.75 155.06 75.76 Favored Pre-proline 0 N--CA 1.483 1.2 0 CA-C-N 119.178 0.899 . . . . 0.0 110.621 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.42 ' HG2' ' HB2' ' A' ' 54' ' ' LEU . 72.8 Cg_endo -84.27 107.03 1.2 Allowed 'Trans proline' 0 CA--C 1.532 0.401 1 C-N-CA 125.519 4.146 . . . . 0.0 112.382 -170.696 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.7 tp -106.47 90.72 3.43 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.584 0.754 . . . . 0.0 109.657 -174.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.7 m -108.06 141.93 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.147 0.979 . . . . 0.0 110.206 -167.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.4 mt -103.69 78.51 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -174.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.436 ' HB1' ' CD1' ' A' ' 124' ' ' TRP . . . -110.69 153.67 24.92 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.42 -1.264 . . . . 0.0 110.21 -173.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.87 164.74 39.65 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-O 122.314 0.952 . . . . 0.0 111.537 -175.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -92.18 -7.99 46.77 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.504 1.522 . . . . 0.0 112.986 -166.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 62.5 m-70 -107.87 12.1 27.49 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.1 0.96 . . . . 0.0 111.745 174.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 60.79 54.29 3.61 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.731 1.212 . . . . 0.0 110.075 165.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 75.3 mt -103.94 87.81 1.69 Allowed Pre-proline 0 N--CA 1.446 -0.632 0 N-CA-C 103.209 -2.886 . . . . 0.0 103.209 -174.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -62.45 124.2 13.81 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 CA-C-N 120.867 1.345 . . . . 0.0 109.419 -176.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -98.93 132.22 44.42 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -178.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.0 tp -97.66 96.2 8.11 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 169.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.42 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 0.3 OUTLIER -61.87 150.23 38.02 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 121.042 -1.036 . . . . 0.0 108.389 171.679 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -80.27 89.58 5.51 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.355 -0.841 . . . . 0.0 108.966 177.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.71 86.58 11.93 Favored Pre-proline 0 N--CA 1.463 0.18 0 C-N-CA 124.597 1.159 . . . . 0.0 111.396 174.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -63.28 147.63 93.61 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 121.603 1.535 . . . . 0.0 109.341 178.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.49 0.76 59.28 Favored Glycine 0 CA--C 1.537 1.463 0 CA-C-O 118.666 -1.074 . . . . 0.0 114.65 176.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.02 112.45 12.38 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 120.833 2.316 . . . . 0.0 108.192 171.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 150.68 -149.78 21.67 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 119.767 -1.206 . . . . 0.0 112.538 -162.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -140.24 168.5 19.67 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 126.938 2.095 . . . . 0.0 109.28 173.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 97.3 m -89.58 78.53 7.02 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 123.596 0.759 . . . . 0.0 111.0 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.598 HG13 HG23 ' A' ' 36' ' ' THR . 1.8 p -61.14 127.38 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.99 0 CA-C-O 118.513 -0.755 . . . . 0.0 109.863 -175.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.91 151.54 25.92 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 177.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -157.4 175.36 34.8 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 175.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.458 ' H ' ' CG2' ' A' ' 6' ' ' VAL . 0.7 OUTLIER -106.09 163.5 12.73 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 168.018 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 68.8 mt -102.42 121.11 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 105.353 -2.092 . . . . 0.0 105.353 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -108.12 119.61 39.96 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 171.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -69.04 127.68 34.0 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.349 -1.722 . . . . 0.0 106.349 161.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.7 m -135.63 163.83 34.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 123.428 0.691 . . . . 0.0 110.258 -174.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.0 179.97 4.12 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 122.276 1.036 . . . . 0.0 112.708 170.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.57 -41.63 90.64 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 125.48 1.512 . . . . 0.0 112.107 175.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -64.6 -43.34 94.1 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 119.9 1.227 . . . . 0.0 110.807 178.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 19.7 tpp -61.29 -49.4 77.19 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 119.167 0.894 . . . . 0.0 108.67 177.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.4 tp -61.66 -38.79 89.04 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 118.816 -0.611 . . . . 0.0 112.033 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 64.2 mtt-85 -70.81 -38.97 73.33 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.835 1.254 . . . . 0.0 111.804 177.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -63.18 -52.54 61.95 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 177.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.1 mp -62.1 -31.53 71.99 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.693 0.797 . . . . 0.0 110.547 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -62.95 -33.02 74.48 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 124.403 1.081 . . . . 0.0 111.044 176.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -79.72 -45.74 18.36 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.071 0.396 . . . . 0.0 111.561 172.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -63.38 -42.88 98.85 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.569 0.747 . . . . 0.0 112.131 -170.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -79.96 9.09 5.78 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.559 -0.713 . . . . 0.0 111.951 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.2 t0 49.0 24.68 0.92 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 127.454 2.301 . . . . 0.0 113.346 -174.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 9.0 p -65.67 162.03 47.23 Favored Pre-proline 0 CA--C 1.54 0.564 0 O-C-N 119.684 -1.885 . . . . 0.0 107.061 165.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -69.06 -2.74 6.36 Favored 'Cis proline' 0 CA--C 1.547 1.165 0 N-CA-C 114.889 1.073 . . . . 0.0 114.889 -11.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.2 t -65.68 -67.41 0.44 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.884 1.22 . . . . 0.0 111.98 -178.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 20.6 mtp -71.51 -58.29 3.64 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 123.619 0.768 . . . . 0.0 109.52 -173.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -110.11 174.17 5.99 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 126.864 2.066 . . . . 0.0 108.345 177.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -128.66 -15.27 4.47 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 177.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 60.5 130.42 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 128.25 2.62 . . . . 0.0 112.651 -171.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 98.5 m -136.03 162.49 32.73 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.275 1.03 . . . . 0.0 108.237 175.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -94.6 128.16 41.04 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.93 1.292 . . . . 0.0 110.001 172.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.31 179.54 5.41 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.478 1.911 . . . . 0.0 111.432 178.24 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.8 tp60 -106.63 127.22 53.17 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.655 1.982 . . . . 0.0 109.98 178.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.418 ' CG2' ' SG ' ' A' ' 112' ' ' CYS . 64.3 t -126.27 140.65 48.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 -178.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.424 ' HB2' HG13 ' A' ' 37' ' ' VAL . 46.6 tt0 -72.04 135.84 46.47 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 172.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.6 t -82.13 89.0 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 105.974 -1.861 . . . . 0.0 105.974 167.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.67 -23.68 67.33 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 118.603 -0.713 . . . . 0.0 110.658 177.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -165.53 162.49 19.2 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 128.038 2.535 . . . . 0.0 106.896 171.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 62.6 t-105 -135.2 130.17 34.88 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 125.83 1.652 . . . . 0.0 107.935 176.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -118.2 89.34 3.1 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 121.195 0.521 . . . . 0.0 111.36 176.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 137.33 -172.04 22.89 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-O 123.302 1.501 . . . . 0.0 111.495 173.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.28 125.27 23.02 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 122.35 1.071 . . . . 0.0 113.106 166.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 122.29 81.02 0.56 Allowed Glycine 0 N--CA 1.427 -1.962 0 CA-C-N 111.848 -2.433 . . . . 0.0 110.534 142.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -101.57 89.69 1.54 Allowed Pre-proline 0 C--O 1.24 0.587 0 C-N-CA 131.134 3.774 . . . . 0.0 109.773 -156.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -57.56 -54.52 3.32 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.742 2.294 . . . . 0.0 109.778 -178.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 163.97 -166.8 37.71 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 107.711 -2.156 . . . . 0.0 107.711 -173.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -64.88 -12.13 45.51 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 117.773 0.786 . . . . 0.0 111.969 175.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 61.2 p -133.12 156.39 47.53 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 120.087 1.312 . . . . 0.0 111.615 175.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.9 p -142.48 162.67 18.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 123.889 0.876 . . . . 0.0 109.202 178.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -95.39 135.27 37.23 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.69 1.596 . . . . 0.0 107.94 169.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.418 ' SG ' ' CG2' ' A' ' 95' ' ' VAL . 0.5 OUTLIER -141.27 168.7 19.14 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.797 1.239 . . . . 0.0 110.456 174.593 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -100.28 145.49 28.05 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 172.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 30.9 t -138.54 147.39 25.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 125.193 1.397 . . . . 0.0 107.294 177.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -70.3 109.14 4.53 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 167.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 68.8 p -125.92 172.43 9.92 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 124.111 0.964 . . . . 0.0 108.937 176.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.93 145.9 51.32 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 172.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -112.25 -12.23 13.63 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.137 1.775 . . . . 0.0 111.264 171.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 12.2 t -123.43 64.7 1.01 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.497 1.519 . . . . 0.0 107.968 -171.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -101.94 161.06 13.96 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 126.411 1.884 . . . . 0.0 110.523 177.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.49 157.86 87.26 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 125.818 1.647 . . . . 0.0 111.407 172.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -73.86 -33.39 6.34 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 121.97 1.78 . . . . 0.0 112.326 -179.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -46.51 -44.4 17.69 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 125.185 1.394 . . . . 0.0 112.588 175.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 0.436 ' CD1' ' HB1' ' A' ' 45' ' ' ALA . 35.6 m0 -60.48 -22.22 63.27 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 125.723 1.609 . . . . 0.0 112.5 -174.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 32.6 mt -75.22 -10.09 59.15 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 117.699 -1.143 . . . . 0.0 112.787 176.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -95.41 -7.88 37.13 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.437 1.095 . . . . 0.0 112.471 -178.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 124' ' ' TRP . 1.1 mm? -72.9 158.74 86.75 Favored Pre-proline 0 N--CA 1.451 -0.413 0 C-N-CA 125.664 1.585 . . . . 0.0 107.864 -174.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -59.52 140.45 94.06 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.626 1.551 . . . . 0.0 108.805 168.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 5.7 m-30 -92.18 156.47 17.31 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.86 0.864 . . . . 0.0 108.8 171.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -141.08 171.95 13.36 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.516 0.726 . . . . 0.0 110.647 -174.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -136.62 1.14 2.55 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.314 1.445 . . . . 0.0 111.085 -172.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 86.0 p -152.86 171.68 17.92 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 124.907 1.283 . . . . 0.0 108.656 166.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -121.77 102.45 8.21 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 165.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -117.66 114.9 24.06 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.117 -171.062 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 11.2 t -60.48 -23.69 64.68 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 128.635 2.774 . . . . 0.0 111.654 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -120.57 85.35 2.38 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 127.417 2.287 . . . . 0.0 105.487 175.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -152.49 177.0 30.48 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.037 171.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.62 -15.43 24.42 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.024 1.816 . . . . 0.0 114.247 -174.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -44.96 -62.32 1.28 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.8 2.04 . . . . 0.0 111.339 -176.49 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 109.34 -59.09 0.37 Allowed Glycine 0 N--CA 1.464 0.555 0 C-N-CA 129.284 3.326 . . . . 0.0 110.302 171.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.613 HD13 ' H ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -49.95 73.67 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 130.616 3.567 . . . . 0.0 114.26 163.008 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -98.12 170.25 9.04 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.654 1.582 . . . . 0.0 111.942 172.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -71.31 150.32 45.25 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 123.182 0.301 . . . . 0.0 111.031 -165.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -122.92 83.39 50.17 Favored Pre-proline 0 C--O 1.233 0.195 0 C-N-CA 124.71 1.204 . . . . 0.0 108.822 178.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.79 -0.15 9.88 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 123.611 2.874 . . . . 0.0 112.095 168.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 48.56 31.29 2.84 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.964 -1.085 . . . . 0.0 112.778 -169.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -57.91 -20.67 38.89 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.951 1.7 . . . . 0.0 114.683 -172.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -156.55 12.41 0.27 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 128.755 2.822 . . . . 0.0 110.342 -169.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.013 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 174.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.205 0 N-CA-C 110.535 -0.172 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -119.67 131.25 55.39 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.166 1.387 . . . . 0.0 107.808 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.409 HG22 ' HB2' ' A' ' 113' ' ' PHE . 44.6 pt -123.36 177.48 4.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -131.89 130.17 41.28 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 174.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.9 p -96.7 135.73 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 176.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -72.79 -78.02 0.09 Allowed 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 164.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -139.75 -19.47 0.42 Allowed Glycine 0 C--N 1.335 0.489 0 O-C-N 121.767 -0.583 . . . . 0.0 114.144 -173.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.457 ' C ' HD22 ' A' ' 10' ' ' LEU . 0.8 OUTLIER -77.04 -16.42 59.28 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 120.505 2.152 . . . . 0.0 112.599 -154.333 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.457 HD22 ' C ' ' A' ' 9' ' ' THR . 0.1 OUTLIER -126.12 14.16 7.84 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 126.378 1.871 . . . . 0.0 107.645 176.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -104.06 -86.91 0.44 Allowed 'General case' 0 C--N 1.351 0.671 0 CA-C-O 117.355 -1.307 . . . . 0.0 109.381 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.482 ' HB3' HE22 ' A' ' 14' ' ' GLN . 42.0 tpt85 -62.39 -59.89 4.34 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-N 120.752 1.614 . . . . 0.0 111.383 -160.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 172.31 69.04 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 106.265 -2.734 . . . . 0.0 106.265 -170.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.482 HE22 ' HB3' ' A' ' 12' ' ' ARG . 2.2 mp0 -117.29 154.87 50.34 Favored Pre-proline 0 N--CA 1.448 -0.544 0 C-N-CA 124.802 1.241 . . . . 0.0 108.392 -175.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.73 -37.11 97.79 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.743 2.962 . . . . 0.0 111.429 -172.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.411 ' O ' HG22 ' A' ' 19' ' ' VAL . 8.7 m-80 -63.99 -25.18 68.01 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 126.229 1.811 . . . . 0.0 111.939 -172.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -52.17 -34.78 46.57 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.587 1.085 . . . . 0.0 111.423 -170.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.81 -25.92 21.67 Favored 'General case' 0 C--N 1.342 0.276 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -176.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 16' ' ' ASN . 34.3 m -57.49 -48.94 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 118.57 0.623 . . . . 0.0 109.544 -176.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 9.0 ptp -79.13 7.25 7.82 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.393 0.677 . . . . 0.0 112.584 -174.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 76.6 mt -99.64 3.23 45.12 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.473 0.709 . . . . 0.0 111.019 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -131.97 109.26 9.92 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 104.388 -2.449 . . . . 0.0 104.388 174.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 23.3 t-80 -54.27 -24.35 18.54 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.063 1.345 . . . . 0.0 111.608 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 m -67.13 -21.86 65.82 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.979 -1.076 . . . . 0.0 112.954 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -85.07 -7.05 59.28 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 119.492 1.042 . . . . 0.0 111.579 167.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 129.19 167.5 12.15 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 126.037 1.779 . . . . 0.0 111.849 175.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -82.38 137.69 34.67 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.29 1.836 . . . . 0.0 109.174 -176.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -133.57 141.96 47.93 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.462 1.105 . . . . 0.0 108.708 162.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -141.29 140.7 33.9 Favored 'General case' 0 C--O 1.231 0.111 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 166.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -67.11 94.65 0.36 Allowed 'General case' 0 C--O 1.232 0.16 0 C-N-CA 125.921 1.689 . . . . 0.0 107.685 177.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -100.19 53.63 0.9 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -176.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.5 -169.15 46.93 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-O 122.677 1.154 . . . . 0.0 111.698 -177.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -143.44 173.0 12.01 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 121.557 -0.966 . . . . 0.0 110.221 -175.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -175.15 -179.92 46.01 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 119.487 -1.339 . . . . 0.0 115.337 -169.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.7 p -140.49 160.51 39.84 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 114.098 -1.051 . . . . 0.0 111.257 167.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.1 p -81.52 94.27 6.84 Favored 'General case' 0 C--O 1.223 -0.291 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 169.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -62.59 -26.43 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 O-C-N 120.657 -1.277 . . . . 0.0 110.893 171.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -65.93 116.99 7.66 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 161.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.03 120.07 18.15 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 126.241 1.816 . . . . 0.0 109.947 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -123.05 162.06 41.35 Favored Pre-proline 0 N--CA 1.466 0.359 0 CA-C-N 120.481 1.491 . . . . 0.0 107.842 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -79.6 94.32 1.05 Allowed 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 124.695 3.597 . . . . 0.0 109.245 172.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.8 tp -89.09 111.76 22.58 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 164.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.5 m -125.59 145.69 32.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.601 1.16 . . . . 0.0 108.347 -176.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.401 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 3.3 mt -98.85 121.96 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 176.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.73 -172.19 3.33 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.049 0.94 . . . . 0.0 110.763 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.68 155.67 2.27 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 125.45 1.5 . . . . 0.0 111.664 178.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -79.55 -6.17 56.45 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 121.538 -0.978 . . . . 0.0 111.802 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -106.92 9.33 30.81 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.431 1.093 . . . . 0.0 112.299 174.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.433 HD22 ' HB2' ' A' ' 141' ' ' LEU . 2.3 m120 63.73 61.19 1.0 Allowed 'General case' 0 C--N 1.345 0.401 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 176.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 56.5 mt -107.86 87.6 3.82 Favored Pre-proline 0 N--CA 1.446 -0.673 0 C-N-CA 128.358 2.663 . . . . 0.0 104.01 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . 43.5 Cg_endo -64.54 156.86 58.4 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 CA-C-N 120.832 1.333 . . . . 0.0 109.825 174.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 48.3 m95 -132.21 150.11 52.23 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.9 tp -107.39 102.02 11.34 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 168.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.7 mt -74.39 145.66 43.58 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -81.61 85.6 6.52 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.348 -0.845 . . . . 0.0 109.536 -177.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -137.12 86.49 20.14 Favored Pre-proline 0 C--O 1.234 0.25 0 CA-C-O 118.369 -0.824 . . . . 0.0 110.174 -177.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -60.07 133.98 53.47 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 121.084 1.189 . . . . 0.0 111.201 -177.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.57 17.27 77.85 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-O 118.904 -0.942 . . . . 0.0 114.713 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -118.15 121.52 40.72 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 120.376 2.088 . . . . 0.0 106.131 168.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.561 ' HA2' ' CD2' ' A' ' 129' ' ' TYR . . . 108.95 -139.81 15.37 Favored Glycine 0 CA--C 1.52 0.379 0 CA-C-N 120.208 1.367 . . . . 0.0 112.555 172.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 39.7 m-70 -126.86 171.47 11.24 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 124.044 0.938 . . . . 0.0 112.311 -175.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 57.9 m -88.2 105.49 17.56 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 126.647 1.979 . . . . 0.0 110.428 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 71.1 t -72.95 117.25 16.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 64.8 p -70.81 156.33 39.69 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.865 0.866 . . . . 0.0 109.363 167.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 171.24 -159.04 30.74 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 118.975 0.807 . . . . 0.0 112.312 -172.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -137.35 161.49 36.14 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.992 0.917 . . . . 0.0 110.834 -172.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 70.1 mt -120.54 111.83 33.71 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 -175.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -102.74 129.86 49.51 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 174.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -67.51 141.66 56.83 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 156.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.0 m -137.39 153.44 28.72 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 CA-C-O 121.787 0.803 . . . . 0.0 109.925 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -85.9 174.02 9.57 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 123.873 1.796 . . . . 0.0 109.541 164.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.05 -30.31 70.25 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 112.34 -2.209 . . . . 0.0 112.463 177.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -72.64 -41.98 64.9 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-O 116.681 -1.628 . . . . 0.0 111.242 176.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 19.9 tpp -64.16 -44.44 92.1 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 121.178 1.808 . . . . 0.0 108.513 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.6 tp -60.91 -30.35 70.14 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 177.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 47.1 mtt-85 -80.57 -36.83 32.37 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.873 1.269 . . . . 0.0 113.786 174.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -62.19 -47.66 83.48 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 177.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 85.3 mt -62.77 -24.38 67.68 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.787 -0.571 . . . . 0.0 110.812 175.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.484 ' HA ' ' SG ' ' A' ' 84' ' ' CYS . 4.4 t0 -78.19 10.55 2.9 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.794 1.237 . . . . 0.0 113.165 176.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -143.05 -30.95 0.51 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 125.439 1.496 . . . . 0.0 112.598 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -70.11 -31.92 69.7 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.1 0.96 . . . . 0.0 111.09 172.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -92.86 5.62 50.63 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.436 0.694 . . . . 0.0 112.147 -171.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.0 t70 54.17 15.91 1.04 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.722 2.009 . . . . 0.0 113.867 -175.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.484 ' SG ' ' HA ' ' A' ' 79' ' ' ASP . 2.9 p -62.85 150.03 88.45 Favored Pre-proline 0 N--CA 1.45 -0.474 0 O-C-N 120.181 -1.574 . . . . 0.0 108.252 167.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.94 -8.56 30.09 Favored 'Cis proline' 0 CA--C 1.54 0.813 0 N-CA-C 114.926 1.087 . . . . 0.0 114.926 2.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 12.9 m -60.98 -62.19 2.03 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.792 1.237 . . . . 0.0 110.91 -174.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.3 mtp -72.53 -78.17 0.09 Allowed 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -96.03 175.17 6.58 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.579 1.152 . . . . 0.0 110.253 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 6.7 mp0 -130.19 146.49 51.83 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.98 1.712 . . . . 0.0 107.105 164.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -81.63 133.85 35.42 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 175.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.2 m -140.04 168.85 18.85 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.212 1.005 . . . . 0.0 109.481 -174.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -106.45 138.88 41.83 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.141 1.776 . . . . 0.0 110.372 173.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.4 173.2 11.99 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.155 1.382 . . . . 0.0 113.064 175.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -94.95 126.26 40.17 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.041 1.337 . . . . 0.0 111.884 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.4 t -127.61 119.75 52.71 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 C-N-CA 125.688 1.595 . . . . 0.0 107.773 -175.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -63.13 128.85 37.77 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 105.62 -1.992 . . . . 0.0 105.62 169.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.552 HG12 ' C ' ' A' ' 108' ' ' ASP . 4.9 p -75.55 116.67 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 CA-C-N 114.45 -1.25 . . . . 0.0 107.799 166.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.434 HD13 ' HA ' ' A' ' 98' ' ' LEU . 0.7 OUTLIER -88.48 -21.56 24.12 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 120.467 -1.396 . . . . 0.0 110.38 170.241 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -158.27 146.4 18.56 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 170.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -127.93 116.1 19.58 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 125.518 1.527 . . . . 0.0 108.762 177.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -100.39 113.19 25.73 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.16 -167.21 14.84 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 125.453 1.502 . . . . 0.0 112.289 170.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -75.06 171.72 13.61 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.131 0.972 . . . . 0.0 109.201 177.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.11 62.76 2.16 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-O 118.5 -1.167 . . . . 0.0 111.409 176.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -100.38 89.91 1.28 Allowed Pre-proline 0 C--O 1.24 0.561 0 C-N-CA 131.242 3.817 . . . . 0.0 110.095 -163.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -62.92 -4.89 6.65 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 124.476 3.451 . . . . 0.0 115.543 -174.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.94 -177.69 44.81 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 108.846 -1.701 . . . . 0.0 108.846 -163.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.552 ' C ' HG12 ' A' ' 97' ' ' VAL . 1.1 m-20 -72.5 5.12 3.21 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 -169.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.09 160.12 39.9 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 122.374 1.083 . . . . 0.0 110.213 154.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.8 p -128.3 163.87 31.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 126.811 2.044 . . . . 0.0 108.994 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -104.19 103.62 13.42 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.954 1.701 . . . . 0.0 106.545 169.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 60.8 m -97.61 166.95 11.26 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 122.714 0.405 . . . . 0.0 110.035 174.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.409 ' HB2' HG22 ' A' ' 4' ' ' ILE . 69.7 m-85 -92.85 149.52 21.21 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 162.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.3 t -146.72 155.93 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 129.161 2.985 . . . . 0.0 107.067 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -89.71 128.17 36.05 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 166.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 81.9 p -130.09 -177.21 4.21 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.281 1.432 . . . . 0.0 109.291 -178.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -138.1 141.29 40.22 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 165.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -112.71 -4.45 14.06 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.226 1.411 . . . . 0.0 110.911 172.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.1 p -107.74 19.81 19.64 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.937 1.695 . . . . 0.0 111.006 -162.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -71.67 161.49 30.91 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.444 1.497 . . . . 0.0 112.105 -168.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -84.28 151.53 59.79 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 124.979 1.311 . . . . 0.0 109.995 167.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.01 -25.75 51.5 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 123.369 2.713 . . . . 0.0 113.52 -173.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.523 ' HA ' ' CD2' ' A' ' 126' ' ' PHE . 4.5 pm0 -52.69 -30.83 34.19 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.968 0.907 . . . . 0.0 112.382 177.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 45.3 m0 -76.88 -11.65 59.85 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 119.412 -0.327 . . . . 0.0 111.759 -176.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -85.64 -15.68 41.65 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 119.199 0.909 . . . . 0.0 111.713 171.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.523 ' CD2' ' HA ' ' A' ' 123' ' ' GLU . 4.8 m-85 -84.75 -10.28 57.39 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.364 0.984 . . . . 0.0 111.373 173.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 76.6 mt -72.15 158.36 87.73 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 124.844 1.257 . . . . 0.0 110.96 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -76.86 156.23 34.77 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 124.088 3.192 . . . . 0.0 111.887 176.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.561 ' CD2' ' HA2' ' A' ' 60' ' ' GLY . 21.3 m-85 -107.65 151.89 25.04 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.882 1.273 . . . . 0.0 111.95 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -136.29 167.54 21.12 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.766 1.226 . . . . 0.0 110.863 -175.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -113.64 -7.71 13.32 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.587 1.155 . . . . 0.0 112.631 -171.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 83.2 p -154.36 174.7 14.48 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 125.451 1.5 . . . . 0.0 108.381 168.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -137.97 109.18 6.84 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 174.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -140.11 123.27 16.8 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.617 1.167 . . . . 0.0 108.318 -168.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 9.6 t -59.38 -29.8 67.97 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.442 1.097 . . . . 0.0 110.059 176.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -62.74 -17.4 60.84 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.418 -0.801 . . . . 0.0 113.11 177.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -71.16 154.23 51.72 Favored Glycine 0 CA--C 1.537 1.445 0 CA-C-N 120.025 1.284 . . . . 0.0 112.434 -166.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -65.52 -5.99 12.69 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.811 2.341 . . . . 0.0 115.058 -177.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 -49.05 -49.58 40.61 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 120.651 1.569 . . . . 0.0 112.616 -175.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 87.45 1.68 83.35 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 118.258 -1.301 . . . . 0.0 113.689 -168.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.433 ' HB2' HD22 ' A' ' 49' ' ' ASN . 0.7 OUTLIER -103.56 96.37 6.68 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 118.905 1.352 . . . . 0.0 109.519 171.422 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -118.85 162.44 18.48 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.576 -0.702 . . . . 0.0 110.918 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -65.52 144.57 56.92 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -173.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 . . . . . 0 CA--C 1.53 0.192 0 C-N-CA 123.1 0.56 . . . . 0.0 110.12 175.049 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -128.13 129.31 46.35 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 174.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 41.2 pt -125.19 152.57 31.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -108.31 132.2 53.94 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 172.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.424 HG22 ' H ' ' A' ' 6' ' ' VAL . 2.6 m -81.39 168.29 1.89 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.447 0 C-N-CA 123.69 0.796 . . . . 0.0 111.31 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -112.46 -29.87 7.35 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.043 0.937 . . . . 0.0 112.515 172.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 148.24 -1.9 0.67 Allowed Glycine 0 CA--C 1.526 0.741 0 CA-C-N 118.412 0.551 . . . . 0.0 113.869 168.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 p -53.62 -36.6 62.19 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 124.775 1.23 . . . . 0.0 111.2 160.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.551 HD23 ' HA ' ' A' ' 17' ' ' HIS . 4.0 mt -132.25 48.37 2.42 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.597 1.559 . . . . 0.0 109.179 -166.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -150.02 -59.19 0.2 Allowed 'General case' 0 N--CA 1.467 0.42 0 O-C-N 120.243 -1.535 . . . . 0.0 111.738 178.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 -73.03 -86.1 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 119.339 0.972 . . . . 0.0 108.714 174.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -175.23 50.11 0.13 Allowed Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 175.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.36 162.96 3.79 Favored Pre-proline 0 CA--C 1.544 0.745 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 169.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -64.4 -3.7 6.84 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 123.971 3.114 . . . . 0.0 113.255 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -120.3 10.67 11.33 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 126.827 2.051 . . . . 0.0 108.452 -167.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.551 ' HA ' HD23 ' A' ' 10' ' ' LEU . 39.0 p-80 -85.25 -38.82 18.47 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 121.254 1.843 . . . . 0.0 106.684 -168.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -17.35 55.49 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 120.517 -1.364 . . . . 0.0 114.183 -168.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.434 ' H ' HG22 ' A' ' 19' ' ' VAL . 2.9 m -59.65 -34.66 55.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 118.445 0.566 . . . . 0.0 110.921 176.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -78.98 3.91 15.83 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.039 0.836 . . . . 0.0 113.113 177.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 35.4 mt -120.06 11.96 11.81 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.811 1.644 . . . . 0.0 110.816 -175.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -132.76 3.94 3.84 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 -171.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . 0.265 25.4 t-80 43.22 28.87 0.18 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 128.294 2.638 . . . . 0.0 113.679 176.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.4 m -117.71 -12.02 10.32 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 121.168 -0.957 . . . . 0.0 111.593 179.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -111.17 -1.43 16.17 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.206 1.802 . . . . 0.0 111.065 174.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 131.45 174.33 13.62 Favored Glycine 0 C--N 1.336 0.553 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 41.5 tp -82.23 139.8 34.04 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 123.169 0.588 . . . . 0.0 110.389 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -146.94 153.69 40.39 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 153.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.67 142.05 23.35 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 126.362 1.865 . . . . 0.0 108.286 169.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -59.99 118.83 6.74 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.212 1.405 . . . . 0.0 108.799 176.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.91 39.46 2.16 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.954 0.797 . . . . 0.0 110.321 -174.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 124.52 111.42 1.91 Allowed Glycine 0 N--CA 1.444 -0.79 0 CA-C-O 121.994 0.774 . . . . 0.0 111.328 166.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -61.06 149.62 36.44 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 121.592 -0.946 . . . . 0.0 108.469 173.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.47 175.33 37.22 Favored Glycine 0 C--O 1.238 0.385 0 C-N-CA 120.771 -0.728 . . . . 0.0 113.365 -169.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.407 ' SG ' ' HB3' ' A' ' 96' ' ' GLN . 1.8 p -136.59 147.18 46.83 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 43.4 p -64.48 120.05 11.57 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 158.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.422 HG22 ' HB2' ' A' ' 96' ' ' GLN . 16.7 t -68.0 -37.09 77.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.641 0.734 . . . . 0.0 109.08 177.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -78.21 140.2 38.93 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 168.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.5 m -60.44 151.05 29.2 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 160.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -134.57 153.84 79.28 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 165.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -76.38 92.08 1.09 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 124.212 3.275 . . . . 0.0 110.133 170.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 28.7 tp -90.63 109.03 20.2 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 118.816 -0.611 . . . . 0.0 109.757 174.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.444 ' CG2' HD13 ' A' ' 54' ' ' LEU . 13.5 m -123.55 135.75 62.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 124.395 1.078 . . . . 0.0 108.641 -171.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.2 mt -109.89 72.88 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 -172.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.83 179.33 7.06 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 122.613 1.197 . . . . 0.0 110.722 173.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.95 153.85 17.49 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-N 113.044 -1.889 . . . . 0.0 110.473 170.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -68.75 -11.62 60.51 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -166.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 37.5 m-70 -114.16 16.78 18.0 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.5 1.12 . . . . 0.0 112.053 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 50.49 74.02 0.24 Allowed 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.778 2.031 . . . . 0.0 109.369 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 87.6 mt -104.55 88.3 2.12 Favored Pre-proline 0 C--N 1.325 -0.493 0 C-N-CA 128.531 2.733 . . . . 0.0 104.991 -169.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.401 ' HG3' ' CE2' ' A' ' 133' ' ' TYR . 55.9 Cg_endo -55.02 107.61 0.24 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.962 2.442 . . . . 0.0 111.148 -178.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -92.02 116.96 29.37 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 124.904 1.281 . . . . 0.0 107.6 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.15 92.15 8.66 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 172.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.444 HD13 ' CG2' ' A' ' 43' ' ' VAL . 11.0 mp -65.52 124.14 21.54 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.525 1.13 . . . . 0.0 108.762 176.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -74.04 84.95 1.79 Allowed 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.065 0.546 . . . . 0.0 110.266 -176.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.55 85.15 17.87 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 125.064 1.346 . . . . 0.0 108.373 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.92 126.68 17.8 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.842 2.361 . . . . 0.0 109.251 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.58 17.3 55.14 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 119.328 -0.707 . . . . 0.0 113.209 175.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -122.81 157.24 32.87 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 119.07 1.435 . . . . 0.0 107.189 172.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.516 ' HA2' ' CD2' ' A' ' 129' ' ' TYR . . . 70.49 -140.04 31.4 Favored Glycine 0 CA--C 1.522 0.511 0 CA-C-N 121.131 1.787 . . . . 0.0 111.603 175.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -131.17 160.24 35.37 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.327 1.064 . . . . 0.0 111.17 -170.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 76.4 m -83.64 106.61 15.5 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.695 -0.628 . . . . 0.0 110.93 -170.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.1 t -78.38 88.59 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 126.708 2.003 . . . . 0.0 111.996 -166.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.9 p -59.56 145.35 44.6 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 120.862 -1.149 . . . . 0.0 111.185 -172.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.03 -150.06 5.98 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-N 118.967 0.803 . . . . 0.0 112.596 -174.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -145.1 157.24 44.16 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.256 1.022 . . . . 0.0 109.058 -178.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 50.2 mt -107.66 91.79 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -80.74 127.16 32.18 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 177.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -74.07 130.45 39.84 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 163.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 23.7 m -144.24 176.3 2.69 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 C-N-CA 125.346 1.458 . . . . 0.0 109.898 -167.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.87 -175.95 3.22 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 122.671 1.224 . . . . 0.0 113.241 177.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -52.85 -52.02 58.8 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.07 1.748 . . . . 0.0 110.841 172.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -62.89 -39.47 94.58 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 117.948 -1.025 . . . . 0.0 110.282 -174.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 38.6 tpp -64.61 -43.64 93.1 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 119.454 1.025 . . . . 0.0 110.289 175.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 13.7 tp -65.03 -42.75 94.08 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.886 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 66.0 mtt180 -58.01 -41.78 83.82 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 124.526 1.13 . . . . 0.0 110.161 174.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -63.62 -52.8 59.3 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -176.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.2 mp -54.05 -39.35 66.14 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.206 0.602 . . . . 0.0 111.305 175.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -57.05 -43.5 82.08 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.714 0.769 . . . . 0.0 110.77 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -86.33 -26.9 24.63 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.306 1.443 . . . . 0.0 113.044 -175.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -93.09 -40.15 10.67 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.558 1.143 . . . . 0.0 111.394 -170.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -82.74 7.26 15.47 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 118.348 0.522 . . . . 0.0 110.462 177.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 59.58 29.61 19.19 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.626 1.571 . . . . 0.0 111.962 175.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 1.8 p -73.25 168.22 27.17 Favored Pre-proline 0 CA--C 1.541 0.624 0 O-C-N 120.237 -1.539 . . . . 0.0 108.218 173.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.4 -4.43 7.77 Favored 'Cis proline' 0 CA--C 1.544 0.988 0 CA-C-N 120.21 1.111 . . . . 0.0 113.545 -13.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.5 m -60.84 -61.64 2.44 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 126.093 1.757 . . . . 0.0 111.313 -177.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 2.7 mtm -75.71 -85.18 0.05 OUTLIER 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -83.8 176.81 8.66 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.501 1.12 . . . . 0.0 109.064 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -137.08 136.88 38.74 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.907 1.683 . . . . 0.0 106.84 161.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -70.29 133.68 47.22 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 171.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.0 m -136.67 175.44 9.61 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.772 2.029 . . . . 0.0 108.523 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.418 ' HB1' ' NE2' ' A' ' 111' ' ' GLN . . . -118.37 137.33 53.19 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 127.921 2.488 . . . . 0.0 109.747 175.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.43 -179.29 6.2 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.019 1.728 . . . . 0.0 110.512 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -113.22 123.86 51.17 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.627 1.571 . . . . 0.0 110.548 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.411 ' CG2' ' SG ' ' A' ' 112' ' ' CYS . 54.1 t -118.54 145.85 23.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 C-N-CA 125.772 1.629 . . . . 0.0 107.335 -177.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.422 ' HB2' HG22 ' A' ' 37' ' ' VAL . 35.3 tt0 -89.65 136.9 32.77 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 171.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 94.8 t -77.61 95.74 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 127.696 2.398 . . . . 0.0 106.15 168.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.6 mp -72.79 -31.26 64.73 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.586 -0.696 . . . . 0.0 109.483 172.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -148.56 164.3 34.64 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 106.298 -1.742 . . . . 0.0 106.298 167.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 75.5 t-105 -139.88 124.54 18.27 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.64 1.576 . . . . 0.0 108.006 175.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -79.02 113.34 17.06 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 171.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 86.69 -148.6 21.91 Favored Glycine 0 C--O 1.235 0.166 0 CA-C-O 121.696 0.609 . . . . 0.0 112.246 153.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -67.01 160.06 27.31 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 126.426 1.89 . . . . 0.0 111.715 -170.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 60.92 76.03 0.26 Allowed Glycine 0 C--O 1.221 -0.672 0 C-N-CA 124.449 1.023 . . . . 0.0 111.727 170.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -102.87 88.77 1.59 Allowed Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 128.734 2.813 . . . . 0.0 108.211 -168.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -56.08 -22.41 39.28 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 124.601 3.534 . . . . 0.0 114.939 -172.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 123.7 176.46 14.76 Favored Glycine 0 C--N 1.333 0.384 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -173.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -64.11 -17.59 63.58 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 118.515 -0.755 . . . . 0.0 112.518 -172.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 39.7 p -130.57 159.78 36.14 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 120.2 1.364 . . . . 0.0 111.971 168.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 28.4 m -141.95 169.56 13.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 125.443 1.497 . . . . 0.0 108.539 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.418 ' NE2' ' HB1' ' A' ' 92' ' ' ALA . 7.0 tt0 -104.14 155.75 18.45 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 159.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.411 ' SG ' ' CG2' ' A' ' 95' ' ' VAL . 0.5 OUTLIER -155.04 162.05 41.16 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 129.142 2.977 . . . . 0.0 108.694 -178.37 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -87.24 153.36 21.55 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 169.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.449 HG12 HG23 ' A' ' 116' ' ' THR . 24.9 t -143.17 150.77 17.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 127.914 2.485 . . . . 0.0 107.2 176.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -94.76 102.76 14.65 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 169.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.449 HG23 HG12 ' A' ' 114' ' ' VAL . 72.7 p -103.41 -167.88 1.44 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.009 1.324 . . . . 0.0 108.7 177.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.7 t -136.05 156.05 49.3 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 155.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -123.46 5.44 9.0 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.151 1.381 . . . . 0.0 110.776 171.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.2 t -132.32 53.55 2.0 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 122.93 1.348 . . . . 0.0 109.415 -173.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -67.39 153.63 43.24 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.009 1.323 . . . . 0.0 110.402 175.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.18 149.43 98.46 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 162.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.09 -35.8 40.56 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 121.451 1.434 . . . . 0.0 112.545 -170.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -57.86 -23.68 54.03 Favored 'General case' 0 C--O 1.225 -0.218 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 177.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 0.571 ' HA ' HD23 ' A' ' 127' ' ' LEU . 44.2 m0 -64.93 -16.26 63.09 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 119.863 1.21 . . . . 0.0 112.015 -178.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 53.7 mt -71.9 2.46 5.51 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.846 1.259 . . . . 0.0 112.418 171.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -113.13 -11.69 13.26 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.612 1.565 . . . . 0.0 113.75 178.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.571 HD23 ' HA ' ' A' ' 124' ' ' TRP . 1.1 mm? -67.81 146.67 98.47 Favored Pre-proline 0 C--N 1.326 -0.436 0 C-N-CA 126.102 1.761 . . . . 0.0 108.092 -177.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -64.32 149.34 90.35 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.223 1.282 . . . . 0.0 109.269 176.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.516 ' CD2' ' HA2' ' A' ' 60' ' ' GLY . 23.0 m-85 -89.28 152.19 21.69 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 175.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 62.6 m-70 -121.91 134.97 54.86 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -83.37 -15.78 48.53 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.924 0.89 . . . . 0.0 111.007 178.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.1 t -164.2 147.58 9.48 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 163.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.401 ' CE2' ' HG3' ' A' ' 51' ' ' PRO . 17.6 t80 -87.37 151.29 23.21 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.3 -0.864 . . . . 0.0 108.695 169.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 35.9 p-10 -153.39 162.25 41.48 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 126.826 2.05 . . . . 0.0 110.797 169.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 9.0 p -93.9 0.74 56.31 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 126.351 1.86 . . . . 0.0 112.791 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -143.04 23.09 1.89 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.954 1.302 . . . . 0.0 109.647 -164.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -94.83 177.74 35.82 Favored Glycine 0 C--O 1.242 0.65 0 C-N-CA 123.876 0.75 . . . . 0.0 113.944 -167.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -64.7 -24.95 61.68 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.689 2.259 . . . . 0.0 111.061 169.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 46.1 m-70 -73.8 80.99 1.6 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.322 1.449 . . . . 0.0 108.401 176.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -59.39 -17.78 40.82 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.639 1.59 . . . . 0.0 114.445 -178.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.91 72.75 0.1 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.213 1.805 . . . . 0.0 111.614 168.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 6.3 mtt85 -99.48 166.03 11.36 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 120.968 -1.083 . . . . 0.0 111.062 -174.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -58.9 142.1 51.67 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -175.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 . . . . . 0 N--CA 1.455 -0.186 0 O-C-N 123.605 0.565 . . . . 0.0 110.143 -175.751 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.5 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.8 m80 -58.96 140.02 56.06 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 124.127 0.971 . . . . 0.0 108.767 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 39.2 pt -134.86 159.92 41.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 C-N-CA 124.694 1.198 . . . . 0.0 109.401 175.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -87.98 138.61 31.3 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 163.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.4 m -72.05 -177.28 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 156.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -133.1 -57.88 0.91 Allowed 'General case' 0 N--CA 1.447 -0.589 0 O-C-N 121.082 -1.011 . . . . 0.0 111.013 176.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -165.69 -41.99 0.02 OUTLIER Glycine 0 C--N 1.33 0.233 0 CA-C-N 118.629 0.649 . . . . 0.0 111.888 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 p -53.55 -29.31 36.28 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.995 1.318 . . . . 0.0 111.727 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.4 mp -133.19 76.78 1.7 Allowed 'General case' 0 C--O 1.221 -0.406 0 C-N-CA 124.502 1.121 . . . . 0.0 108.533 177.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -149.42 -80.01 0.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 O-C-N 120.895 -1.128 . . . . 0.0 108.878 172.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 25.2 ttt85 -67.43 -85.3 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 123.366 0.666 . . . . 0.0 110.429 -177.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -158.31 26.09 0.41 Allowed Glycine 0 C--N 1.336 0.554 0 CA-C-N 119.642 1.11 . . . . 0.0 113.058 -175.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -55.09 163.13 1.66 Allowed Pre-proline 0 N--CA 1.449 -0.521 0 C-N-CA 125.379 1.472 . . . . 0.0 111.411 175.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.15 -16.01 52.57 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.474 2.116 . . . . 0.0 112.842 -172.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.492 ' O ' HG22 ' A' ' 19' ' ' VAL . 5.1 m-80 -95.16 -17.87 21.41 Favored 'General case' 0 C--O 1.219 -0.512 0 C-N-CA 125.292 1.437 . . . . 0.0 111.245 -164.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -52.78 -40.79 63.5 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 120.088 1.313 . . . . 0.0 112.178 -165.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.96 -25.1 2.98 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -177.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 16' ' ' ASN . 14.3 m -68.94 -29.6 43.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 O-C-N 121.296 -0.878 . . . . 0.0 110.748 -177.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.1 ptp -83.27 6.14 20.67 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 119.045 0.839 . . . . 0.0 112.454 174.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 49.7 mt -114.42 26.74 10.0 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.82 1.648 . . . . 0.0 109.365 -177.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -139.26 99.43 3.74 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.248 1.419 . . . . 0.0 108.598 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 25.4 t-80 -63.58 -22.02 66.67 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -162.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.5 m -70.99 -32.6 69.46 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.835 -0.541 . . . . 0.0 111.988 172.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 40.3 m170 -71.32 -37.74 71.73 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 171.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 158.85 173.72 27.62 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-O 121.955 0.753 . . . . 0.0 111.969 156.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 57.5 tp -70.26 141.34 52.45 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.288 0.635 . . . . 0.0 111.214 177.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -150.95 108.43 3.63 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.694 1.197 . . . . 0.0 108.558 160.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -112.41 135.26 53.33 Favored 'General case' 0 CA--C 1.522 -0.112 0 C-N-CA 124.616 1.167 . . . . 0.0 108.633 175.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -63.68 108.54 1.44 Allowed 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.264 1.026 . . . . 0.0 108.577 177.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.456 ' NH1' ' H ' ' A' ' 103' ' ' ASP . 0.7 OUTLIER -106.55 44.39 1.06 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 -178.722 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.91 -162.2 35.42 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-O 122.515 1.064 . . . . 0.0 111.295 -177.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 63.5 mtp85 -125.57 166.02 17.46 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 121.491 -1.005 . . . . 0.0 110.056 -167.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -168.84 171.31 42.81 Favored Glycine 0 C--N 1.336 0.558 0 C-N-CA 120.234 -0.984 . . . . 0.0 113.637 177.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 91.0 m -138.02 149.57 46.18 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.23 1.012 . . . . 0.0 109.656 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.8 p -69.95 120.81 16.23 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 168.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.6 t -83.11 -48.86 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 -174.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -57.66 130.18 45.24 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 159.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.2 m -57.98 148.68 25.23 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 162.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -134.9 153.26 78.53 Favored Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 163.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -76.35 95.91 1.06 Allowed 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 125.261 3.974 . . . . 0.0 110.893 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.99 109.4 22.16 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -178.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.3 m -121.51 151.53 24.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 119.013 0.824 . . . . 0.0 109.469 175.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.5 mt -88.49 135.22 26.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 165.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.66 167.99 20.95 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 122.371 1.082 . . . . 0.0 110.7 173.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.61 174.76 46.81 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-O 122.829 1.239 . . . . 0.0 113.127 168.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -84.89 -4.59 59.17 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.65 1.18 . . . . 0.0 113.092 -163.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -119.86 10.28 11.54 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.54 1.536 . . . . 0.0 111.803 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 35.3 m-20 58.25 59.24 3.11 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.199 1.8 . . . . 0.0 109.574 176.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 96.8 mt -106.41 88.76 3.49 Favored Pre-proline 0 N--CA 1.455 -0.225 0 C-N-CA 127.142 2.177 . . . . 0.0 107.085 -171.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -58.39 135.14 65.92 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 CA-C-N 119.955 1.02 . . . . 0.0 111.519 172.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 74.7 m95 -101.15 -173.92 2.49 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.084 0.953 . . . . 0.0 108.914 178.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 53' ' ' LEU . 13.9 tp -142.53 101.68 3.92 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 159.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.403 HD13 ' N ' ' A' ' 54' ' ' LEU . 0.1 OUTLIER -62.93 132.28 51.55 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 172.453 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -71.44 92.94 1.12 Allowed 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.451 HD13 ' HA ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -145.15 77.42 12.97 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.699 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -57.63 120.01 7.63 Favored 'Trans proline' 0 C--O 1.239 0.546 0 C-N-CA 122.914 2.409 . . . . 0.0 109.145 176.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.51 7.19 51.94 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 125.86 1.695 . . . . 0.0 114.34 176.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -115.81 167.77 10.64 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 119.824 1.812 . . . . 0.0 108.878 171.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.422 ' HA2' ' CD2' ' A' ' 129' ' ' TYR . . . 66.49 -148.28 50.55 Favored Glycine 0 CA--C 1.518 0.258 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -173.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 63.9 m-70 -124.92 176.91 6.33 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.874 1.27 . . . . 0.0 108.399 -177.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 3.6 p -61.73 161.68 9.74 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 120.444 -0.502 . . . . 0.0 109.798 170.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 38.8 t -135.69 114.29 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 169.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 45.9 p -79.19 157.66 27.81 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 123.301 0.64 . . . . 0.0 109.876 -177.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -177.4 -153.0 10.47 Favored Glycine 0 CA--C 1.526 0.74 0 O-C-N 121.222 -0.924 . . . . 0.0 112.568 -176.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -138.68 165.7 26.27 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.21 1.404 . . . . 0.0 110.98 -174.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.407 HG22 ' HB3' ' A' ' 31' ' ' ARG . 62.2 mt -116.35 128.01 73.8 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 -173.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -122.92 126.98 48.3 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.973 0.892 . . . . 0.0 109.284 172.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -62.78 107.05 0.89 Allowed 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 158.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.1 m -115.41 161.04 14.44 Favored 'Isoleucine or valine' 0 C--O 1.244 0.809 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 171.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -113.43 173.22 6.51 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 176.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -52.04 -42.87 63.45 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 124.578 1.151 . . . . 0.0 110.683 -171.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 -62.59 -36.35 82.44 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 118.828 -0.606 . . . . 0.0 111.468 -174.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 20.4 tpp -67.67 -53.99 23.24 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.45 -38.28 80.34 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.267 -175.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.53 -41.9 75.37 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 125.582 1.553 . . . . 0.0 110.918 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -56.7 -51.44 68.79 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 122.974 0.51 . . . . 0.0 110.54 171.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 93.1 mt -60.5 -32.99 71.97 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.396 -0.815 . . . . 0.0 111.783 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -67.11 -6.52 17.89 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.24 1.816 . . . . 0.0 112.736 177.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -107.95 -49.86 3.15 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.939 1.695 . . . . 0.0 109.454 171.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -62.8 -46.56 87.4 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.253 1.021 . . . . 0.0 112.063 -174.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -72.12 6.66 2.05 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.91 0.884 . . . . 0.0 111.324 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 62.62 20.09 11.77 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 126.341 1.856 . . . . 0.0 113.264 167.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 26.5 p -68.91 157.98 87.49 Favored Pre-proline 0 CA--C 1.541 0.622 0 O-C-N 121.138 -0.976 . . . . 0.0 109.232 175.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -72.3 -4.32 12.98 Favored 'Cis proline' 0 CA--C 1.545 1.057 0 CA-C-N 119.978 1.028 . . . . 0.0 114.606 -5.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.5 m -63.96 -59.02 5.02 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 119.527 1.058 . . . . 0.0 111.979 -174.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 37.6 mtp -78.26 -80.65 0.11 Allowed 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -89.11 174.95 7.59 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.749 0.82 . . . . 0.0 109.918 177.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -132.73 -12.48 2.98 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.637 0.775 . . . . 0.0 113.015 173.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? 63.44 133.46 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 129.542 3.137 . . . . 0.0 112.576 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 61.9 m -143.98 160.48 40.78 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 123.969 0.907 . . . . 0.0 109.374 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -89.84 128.51 36.18 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.943 1.697 . . . . 0.0 110.539 170.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.72 178.53 5.64 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 127.365 2.266 . . . . 0.0 110.004 172.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 44.4 tp60 -116.71 128.43 55.32 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.555 1.542 . . . . 0.0 108.933 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.412 ' CG2' ' SG ' ' A' ' 112' ' ' CYS . 41.8 t -122.38 151.53 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 127.239 2.216 . . . . 0.0 107.114 -171.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -88.73 139.41 30.5 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.682 1.593 . . . . 0.0 107.265 171.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.4 t -87.31 126.44 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 170.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 mp -99.07 -36.61 9.65 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.143 1.777 . . . . 0.0 109.95 -176.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -148.44 153.35 38.39 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 130.44 3.496 . . . . 0.0 104.418 174.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . 0.552 ' HE1' ' N ' ' A' ' 104' ' ' GLY . 74.1 t-105 -141.53 123.29 15.23 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -178.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -130.94 109.19 10.36 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.441 ' HA3' ' HD2' ' A' ' 31' ' ' ARG . . . 169.69 -120.81 0.89 Allowed Glycine 0 C--N 1.343 0.936 0 C-N-CA 114.489 -3.719 . . . . 0.0 121.192 173.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.456 ' H ' ' NH1' ' A' ' 31' ' ' ARG . 37.0 t0 -64.43 -178.05 0.35 Allowed 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 101.482 -3.525 . . . . 0.0 101.482 126.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.552 ' N ' ' HE1' ' A' ' 100' ' ' TRP . . . -108.76 -75.23 0.86 Allowed Glycine 0 N--CA 1.417 -2.572 1 C-N-CA 111.397 -5.192 . . . . 0.0 106.464 -94.149 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -158.89 88.04 2.19 Favored Pre-proline 0 C--N 1.313 -1.002 1 C-N-CA 133.652 4.781 . . . . 0.0 114.966 163.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -51.41 -30.41 34.48 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.001 2.468 . . . . 0.0 114.082 161.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 111.22 179.39 20.21 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.89 1.233 . . . . 0.0 110.557 -169.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -67.61 -11.91 59.23 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.463 1.105 . . . . 0.0 112.056 -171.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.7 p -130.93 159.73 36.58 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 120.786 -1.196 . . . . 0.0 110.979 172.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.2 p -151.1 146.29 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 124.174 0.99 . . . . 0.0 109.924 177.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -87.77 142.39 27.86 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 173.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.412 ' SG ' ' CG2' ' A' ' 95' ' ' VAL . 0.5 OUTLIER -152.19 168.84 24.02 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.392 1.477 . . . . 0.0 110.011 -178.815 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -92.39 151.79 20.07 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.098 0.559 . . . . 0.0 110.149 172.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 51.2 t -138.39 146.03 27.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 C-N-CA 127.6 2.36 . . . . 0.0 106.265 167.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -78.02 92.84 4.38 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.711 0.804 . . . . 0.0 109.51 172.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.0 p -104.45 173.47 6.29 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.369 1.468 . . . . 0.0 111.388 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.85 148.57 52.3 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 126.226 1.811 . . . . 0.0 107.089 175.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -112.8 -2.29 14.44 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.456 1.102 . . . . 0.0 111.296 167.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.6 p -111.8 18.26 19.08 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.695 1.598 . . . . 0.0 112.212 -158.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -68.93 158.92 33.66 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.727 1.611 . . . . 0.0 112.314 -170.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.4 157.66 87.67 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 126.343 1.857 . . . . 0.0 111.359 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -52.88 -53.75 6.27 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.533 2.822 . . . . 0.0 113.096 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.493 ' HA ' ' CD2' ' A' ' 126' ' ' PHE . 0.5 OUTLIER -45.67 -33.25 2.82 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 126.458 1.903 . . . . 0.0 114.191 -179.123 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 38.7 m0 -74.28 -3.5 30.47 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.598 -0.688 . . . . 0.0 112.242 -168.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 89.1 mt -97.08 -12.98 22.52 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 118.027 -0.987 . . . . 0.0 113.237 170.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.493 ' CD2' ' HA ' ' A' ' 123' ' ' GLU . 10.3 m-85 -84.34 -30.24 25.66 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 119.511 1.051 . . . . 0.0 110.214 177.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 36.3 mt -58.32 155.55 26.38 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 125.955 1.702 . . . . 0.0 111.428 -174.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.52 156.06 62.14 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 121.693 1.595 . . . . 0.0 109.756 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.422 ' CD2' ' HA2' ' A' ' 60' ' ' GLY . 31.9 m-85 -104.9 161.39 14.23 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.248 1.019 . . . . 0.0 111.945 178.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -138.95 159.9 41.05 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.926 0.891 . . . . 0.0 110.56 -171.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -111.06 -7.65 14.49 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -164.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 33.8 t -164.56 158.67 18.35 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 171.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -103.53 150.06 24.27 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.258 0.552 . . . . 0.0 109.681 172.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -157.9 170.1 23.09 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.515 1.526 . . . . 0.0 108.203 177.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.4 9.44 37.81 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.383 1.873 . . . . 0.0 110.769 167.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -138.05 4.15 2.47 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.551 1.14 . . . . 0.0 113.719 -167.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -89.3 -171.15 45.28 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 127.127 2.299 . . . . 0.0 111.925 -175.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -71.34 5.95 2.09 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 124.648 3.566 . . . . 0.0 114.997 -178.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -87.12 91.44 8.71 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -53.16 -36.69 52.89 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 121.78 -0.575 . . . . 0.0 113.235 -178.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.517 ' CD2' ' H ' ' A' ' 141' ' ' LEU . 0.7 OUTLIER -68.82 119.46 13.21 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 127.347 2.259 . . . . 0.0 109.646 168.691 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.53 163.51 13.63 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 119.65 1.114 . . . . 0.0 110.772 167.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -54.52 139.99 36.06 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 119.164 0.893 . . . . 0.0 110.057 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 C--O 1.235 0.338 0 C-N-CA 123.295 0.638 . . . . 0.0 110.103 -173.455 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.004 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -130.68 142.9 50.44 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 125.536 1.534 . . . . 0.0 109.346 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.2 pt -125.88 171.64 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 124.313 1.045 . . . . 0.0 109.717 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -121.4 127.74 51.48 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.313 1.445 . . . . 0.0 107.713 174.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.3 m -97.86 155.83 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 123.917 0.887 . . . . 0.0 109.371 170.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -147.08 -19.78 0.4 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.755 2.022 . . . . 0.0 111.479 178.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.403 ' HA3' ' CD2' ' A' ' 133' ' ' TYR . . . -120.25 -129.71 3.83 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 127.513 2.482 . . . . 0.0 111.761 -169.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.523 ' HB ' HD22 ' A' ' 16' ' ' ASN . 32.4 p -64.0 -35.95 82.38 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.738 -0.86 . . . . 0.0 112.516 -161.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.721 HD23 ' HA ' ' A' ' 17' ' ' HIS . 77.1 mt -80.94 3.11 23.97 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.432 0.693 . . . . 0.0 111.911 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -89.29 -81.18 0.28 Allowed 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 117.345 -1.312 . . . . 0.0 110.323 178.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.99 -85.76 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 121.052 1.751 . . . . 0.0 111.073 -174.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -169.7 21.11 0.08 OUTLIER Glycine 0 CA--C 1.525 0.717 0 O-C-N 121.307 -0.871 . . . . 0.0 111.149 -164.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -52.81 162.61 0.95 Allowed Pre-proline 0 N--CA 1.452 -0.372 0 C-N-CA 124.53 1.132 . . . . 0.0 110.621 176.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -65.73 1.89 1.97 Allowed 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 124.911 3.741 . . . . 0.0 113.092 -172.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.523 HD22 ' HB ' ' A' ' 9' ' ' THR . 3.0 m-20 -119.66 -17.68 8.56 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 126.289 1.836 . . . . 0.0 107.92 -171.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.721 ' HA ' HD23 ' A' ' 10' ' ' LEU . 6.2 t60 -51.38 -37.31 47.49 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 120.192 1.36 . . . . 0.0 109.991 177.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.23 -21.74 3.71 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-O 117.231 -1.366 . . . . 0.0 114.6 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.514 HG22 HD21 ' A' ' 10' ' ' LEU . 22.0 m -61.73 -41.51 90.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 120.994 1.725 . . . . 0.0 110.122 176.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -74.41 -17.68 60.76 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 119.315 0.962 . . . . 0.0 113.114 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 73.0 mt -75.32 -5.08 42.88 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.103 0.561 . . . . 0.0 111.244 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -102.65 103.75 14.05 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.286 0.565 . . . . 0.0 109.687 169.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 -51.33 -19.85 1.47 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.089 1.355 . . . . 0.0 113.963 173.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.5 t -77.19 -30.27 54.72 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.032 -1.043 . . . . 0.0 112.027 176.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -69.22 -30.33 68.46 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.585 1.084 . . . . 0.0 109.464 166.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.53 177.27 26.01 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 110.909 -0.877 . . . . 0.0 110.909 167.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 30.1 tp -77.89 142.05 38.7 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 123.639 0.776 . . . . 0.0 111.056 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -145.7 141.36 27.98 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.397 1.079 . . . . 0.0 110.1 165.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.81 148.02 27.98 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.454 1.502 . . . . 0.0 109.815 166.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -67.62 124.35 23.0 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 125.061 1.344 . . . . 0.0 109.118 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.1 tpp180 -120.07 45.7 2.12 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.652 1.181 . . . . 0.0 108.658 -176.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 89.39 -177.79 44.17 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -174.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.82 172.54 11.55 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.518 -0.99 . . . . 0.0 111.813 -173.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -173.82 -178.02 43.45 Favored Glycine 0 CA--C 1.505 -0.542 0 C-N-CA 120.305 -0.95 . . . . 0.0 114.158 -174.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 22.1 p -146.4 154.84 42.09 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 123.909 0.883 . . . . 0.0 109.45 173.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 44.7 p -78.26 83.23 4.52 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 173.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.6 m -59.58 -30.8 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 118.826 0.739 . . . . 0.0 112.195 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.41 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 7.1 tt0 -74.74 22.99 0.1 Allowed 'General case' 0 C--O 1.205 -1.24 0 C-N-CA 127.861 2.465 . . . . 0.0 111.928 173.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 41.46 114.37 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.616 1 C-N-CA 134.393 5.077 . . . . 0.0 114.025 158.377 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.552 ' HB3' HD21 ' A' ' 53' ' ' LEU . 30.5 m-85 -127.85 154.12 78.12 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 120.194 1.361 . . . . 0.0 111.413 -173.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.38 105.81 1.93 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 124.93 3.753 . . . . 0.0 110.724 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.48 100.91 9.13 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 -178.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.3 m -110.33 144.69 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-N 119.179 0.9 . . . . 0.0 110.154 -172.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.0 mt -91.98 116.4 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 171.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -129.92 179.58 5.78 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 124.332 1.053 . . . . 0.0 108.7 172.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.4 152.68 25.17 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 124.649 1.118 . . . . 0.0 112.809 161.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.76 -17.56 64.93 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -171.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -105.97 9.01 32.73 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 118.512 -0.756 . . . . 0.0 112.423 -177.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 53.42 79.64 0.12 Allowed 'General case' 0 C--N 1.342 0.239 0 C-N-CA 125.769 1.628 . . . . 0.0 108.391 -162.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 62.2 mt -120.04 86.57 37.28 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -61.31 151.68 77.59 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 CA-C-N 120.781 1.315 . . . . 0.0 112.683 174.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -125.77 128.92 48.47 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.448 1.499 . . . . 0.0 107.56 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.552 HD21 ' HB3' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -92.7 107.08 18.94 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 174.053 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.1 mt -87.12 139.2 30.8 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 105.904 -1.888 . . . . 0.0 105.904 -172.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -73.61 96.99 2.55 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 118.774 0.716 . . . . 0.0 109.865 -175.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.434 HD23 ' HD2' ' A' ' 57' ' ' PRO . 0.4 OUTLIER -152.08 87.13 4.35 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 124.365 1.066 . . . . 0.0 112.982 177.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.434 ' HD2' HD23 ' A' ' 56' ' ' LEU . 31.5 Cg_endo -59.75 145.18 98.87 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.884 2.389 . . . . 0.0 111.49 176.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 47.65 51.34 17.45 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 129.481 3.419 . . . . 0.0 112.533 -174.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.0 tptm -140.55 143.81 35.56 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 126.072 1.749 . . . . 0.0 106.314 173.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.21 -129.43 20.46 Favored Glycine 0 CA--C 1.519 0.299 0 N-CA-C 109.064 -1.615 . . . . 0.0 109.064 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -138.31 170.53 15.86 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 119.212 1.506 . . . . 0.0 111.606 -167.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 73.1 m -84.53 104.44 14.53 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.381 -0.827 . . . . 0.0 108.995 -176.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.0 t -70.32 110.71 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.9 p -75.09 145.34 42.36 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 120.904 -1.122 . . . . 0.0 110.43 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -167.35 -167.4 27.97 Favored Glycine 0 C--N 1.335 0.473 0 O-C-N 120.446 -1.409 . . . . 0.0 112.364 -169.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -134.93 158.8 43.35 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.222 1.009 . . . . 0.0 109.169 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.8 mt -102.56 132.71 48.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 -177.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -118.21 127.01 53.34 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 118.64 0.654 . . . . 0.0 110.863 172.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -60.25 135.05 57.61 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 150.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.8 m -135.25 173.45 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 170.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.06 -178.27 3.71 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.679 0.752 . . . . 0.0 111.193 160.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -44.46 -55.59 4.94 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 126.61 1.964 . . . . 0.0 111.888 -171.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -71.28 -27.62 63.55 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 117.298 -1.334 . . . . 0.0 111.215 -171.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 24.1 tpp -66.28 -47.81 72.45 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 120.862 1.665 . . . . 0.0 108.595 172.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.09 -28.92 70.4 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 119.403 -0.332 . . . . 0.0 111.581 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -77.67 -37.03 50.65 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.42 1.009 . . . . 0.0 112.297 174.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -67.22 -45.84 75.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 119.475 1.034 . . . . 0.0 109.807 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.13 -32.25 66.16 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.67 -0.644 . . . . 0.0 110.351 171.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.428 ' HA ' ' SG ' ' A' ' 84' ' ' CYS . 0.7 OUTLIER -65.31 -7.92 15.67 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.038 1.335 . . . . 0.0 113.069 177.038 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -123.97 -27.16 3.94 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.712 2.405 . . . . 0.0 111.773 -176.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -72.83 -29.52 63.3 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.286 -0.884 . . . . 0.0 110.902 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -117.25 30.95 7.02 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.748 1.619 . . . . 0.0 110.406 177.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.0 t0 49.91 26.31 1.93 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.811 2.044 . . . . 0.0 113.431 169.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.428 ' SG ' ' HA ' ' A' ' 79' ' ' ASP . 0.8 OUTLIER -71.72 159.89 84.19 Favored Pre-proline 0 CA--C 1.54 0.572 0 O-C-N 120.652 -1.28 . . . . 0.0 109.381 -167.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -68.42 -3.4 5.97 Favored 'Cis proline' 0 CA--C 1.54 0.82 0 CA-C-N 120.979 1.385 . . . . 0.0 113.702 -11.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.4 t -56.34 -68.12 0.24 Allowed 'General case' 0 C--O 1.238 0.488 0 CA-C-N 119.339 0.972 . . . . 0.0 111.443 -173.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 26.8 mtp -77.91 -73.54 0.31 Allowed 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -177.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -97.97 -179.73 4.51 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 124.575 1.15 . . . . 0.0 108.108 173.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -165.45 125.29 1.79 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 -172.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.8 tmm_? -69.92 148.18 49.3 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -173.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.5 m -149.78 168.25 24.22 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 126.37 1.868 . . . . 0.0 107.284 -174.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -123.33 142.62 50.76 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.178 1.791 . . . . 0.0 109.691 172.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.19 174.13 13.61 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.466 1.907 . . . . 0.0 110.53 -173.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -92.63 111.79 23.51 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.973 1.309 . . . . 0.0 109.491 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.1 t -106.17 144.38 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 120.509 1.504 . . . . 0.0 107.754 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -78.81 140.78 38.15 Favored 'General case' 0 C--N 1.341 0.221 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 169.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 40.7 t -93.36 92.57 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 176.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.09 -24.53 67.73 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.876 -0.515 . . . . 0.0 110.746 175.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -165.93 149.52 7.76 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 128.035 2.534 . . . . 0.0 105.546 176.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 63.2 t-105 -125.89 137.72 53.75 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 124.715 1.206 . . . . 0.0 107.794 171.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -108.75 127.12 53.73 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.178 0.991 . . . . 0.0 110.558 174.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.6 -174.9 47.56 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 124.902 1.239 . . . . 0.0 112.385 168.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -62.77 151.82 37.59 Favored 'General case' 0 C--O 1.238 0.48 0 O-C-N 122.709 -0.289 . . . . 0.0 110.623 -170.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 102.56 45.31 1.69 Allowed Glycine 0 CA--C 1.52 0.355 0 CA-C-O 119.393 -0.671 . . . . 0.0 112.785 177.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -101.73 89.51 1.53 Allowed Pre-proline 0 N--CA 1.465 0.283 0 C-N-CA 126.682 1.993 . . . . 0.0 109.525 -156.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -62.35 -29.31 79.44 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 124.03 3.153 . . . . 0.0 112.922 -166.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 120.28 -169.21 13.96 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -163.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -71.39 -10.88 60.48 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.745 1.218 . . . . 0.0 113.039 -168.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.0 p -139.01 165.09 28.03 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 120.252 -1.53 . . . . 0.0 110.277 167.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.9 p -146.3 175.39 2.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 C-N-CA 124.989 1.315 . . . . 0.0 108.048 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -100.71 136.0 41.27 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 155.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 98.0 m -121.81 165.06 16.44 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 165.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -83.31 150.39 26.16 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 160.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.505 HG12 HG23 ' A' ' 116' ' ' THR . 27.3 t -142.22 160.81 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 129.312 3.045 . . . . 0.0 105.295 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -110.31 108.08 18.04 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 171.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.505 HG23 HG12 ' A' ' 114' ' ' VAL . 32.5 p -112.64 -164.74 0.94 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 122.017 0.913 . . . . 0.0 109.286 175.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.52 135.69 28.59 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 174.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -98.69 -3.33 36.16 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.869 1.267 . . . . 0.0 111.309 164.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 16.9 p -92.3 -0.65 57.38 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.461 1.904 . . . . 0.0 113.206 -170.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -55.6 141.23 38.29 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 126.669 1.988 . . . . 0.0 113.171 -164.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.44 147.06 98.87 Favored Pre-proline 0 N--CA 1.446 -0.657 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.137 -177.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.486 ' HA ' HD23 ' A' ' 125' ' ' LEU . 27.8 Cg_endo -65.19 -22.06 61.56 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.101 1.867 . . . . 0.0 113.307 -178.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.481 ' HA ' ' CE2' ' A' ' 126' ' ' PHE . 1.6 pm0 -70.0 -29.04 66.02 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 170.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 46.6 m0 -72.61 3.58 4.83 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.052 -1.03 . . . . 0.0 111.247 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.486 HD23 ' HA ' ' A' ' 122' ' ' PRO . 4.5 mm? -81.24 -22.25 38.88 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.663 1.585 . . . . 0.0 113.83 169.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.481 ' CE2' ' HA ' ' A' ' 123' ' ' GLU . 33.7 p90 -107.12 -16.84 14.32 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 120.474 1.488 . . . . 0.0 112.772 -177.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 26.2 mt -56.29 148.14 43.92 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 123.668 0.787 . . . . 0.0 110.091 173.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.67 147.45 45.27 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.601 2.201 . . . . 0.0 111.712 -173.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -91.23 168.94 11.24 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.201 1.4 . . . . 0.0 111.413 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -143.42 164.26 30.8 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.621 1.568 . . . . 0.0 109.41 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -107.45 -1.73 21.16 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.28 1.832 . . . . 0.0 111.626 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.16 167.97 23.28 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 126.182 1.793 . . . . 0.0 106.948 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.403 ' CD2' ' HA3' ' A' ' 8' ' ' GLY . 1.1 t80 -135.22 96.77 3.56 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 104.357 -2.46 . . . . 0.0 104.357 176.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -150.24 115.12 5.31 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 122.942 0.497 . . . . 0.0 110.18 -170.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 73.5 m -54.82 -16.68 2.79 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.124 1.37 . . . . 0.0 111.303 171.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -103.89 57.31 0.73 Allowed 'General case' 0 C--O 1.237 0.399 0 C-N-CA 126.439 1.895 . . . . 0.0 109.273 -177.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -146.84 177.26 25.27 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 127.914 2.674 . . . . 0.0 109.437 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -79.95 3.48 7.56 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.793 2.996 . . . . 0.0 114.32 -171.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -120.49 85.3 2.37 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 107.31 -1.366 . . . . 0.0 107.31 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -72.14 52.26 1.37 Allowed Glycine 0 CA--C 1.529 0.938 0 C-N-CA 126.587 2.041 . . . . 0.0 115.089 -167.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.49 58.09 1.25 Allowed 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 126.024 1.73 . . . . 0.0 109.621 -174.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 14.0 mmt85 -119.66 -18.07 8.46 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -176.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -166.86 139.9 3.67 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 125.328 1.451 . . . . 0.0 107.965 163.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 CA--C 1.531 0.22 0 O-C-N 124.422 1.076 . . . . 0.0 108.913 179.127 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.174 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -85.68 122.28 29.55 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 171.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.412 HG22 ' HB2' ' A' ' 113' ' ' PHE . 8.0 pt -129.05 174.98 11.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 125.329 1.451 . . . . 0.0 111.426 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -105.02 -167.92 1.4 Allowed 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.949 1.699 . . . . 0.0 110.596 172.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.613 HG12 ' H ' ' A' ' 66' ' ' GLU . 10.7 p -139.74 148.41 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 123.95 0.9 . . . . 0.0 109.132 166.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -59.56 -32.26 70.18 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.636 1.575 . . . . 0.0 113.173 -177.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 142.32 -31.07 2.07 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.65 1.119 . . . . 0.0 111.179 -168.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.425 HG23 ' CE2' ' A' ' 133' ' ' TYR . 2.3 p -59.35 -73.48 0.08 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 130.68 3.592 . . . . 0.0 112.832 -176.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.9 mp -78.72 57.18 2.01 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.843 0.857 . . . . 0.0 108.782 -173.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.59 -66.88 0.36 Allowed 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 127.091 2.156 . . . . 0.0 108.338 -176.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -79.35 -72.59 0.38 Allowed 'General case' 0 C--O 1.223 -0.312 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.703 -178.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -172.84 10.98 0.04 OUTLIER Glycine 0 CA--C 1.531 1.062 0 N-CA-C 115.666 1.027 . . . . 0.0 115.666 -175.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.53 164.99 0.3 Allowed Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 126.569 1.948 . . . . 0.0 114.885 -171.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -56.16 -16.94 18.47 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 124.671 3.581 . . . . 0.0 113.974 -174.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -98.73 -19.58 17.4 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 125.12 1.368 . . . . 0.0 110.769 -165.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -51.36 -40.45 59.19 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.034 0.934 . . . . 0.0 112.413 -162.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.72 -21.68 19.86 Favored 'General case' 0 C--O 1.224 -0.255 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -175.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.5 m -60.49 -40.22 83.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 120.269 1.395 . . . . 0.0 110.905 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.0 ptp -74.22 -13.04 60.73 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 118.645 0.657 . . . . 0.0 112.219 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 72.6 mt -82.7 -4.78 58.34 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 118.574 -0.727 . . . . 0.0 110.61 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -105.35 99.19 8.8 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -178.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 28.3 t-80 -60.7 -18.85 56.75 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.0 t -55.99 -52.71 63.2 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.328 1.051 . . . . 0.0 109.746 168.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -70.67 -21.08 62.64 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.704 0.802 . . . . 0.0 110.87 -177.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.85 177.77 23.34 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 123.992 0.806 . . . . 0.0 111.373 164.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.5 tp -84.27 142.72 30.04 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.63 0.772 . . . . 0.0 110.293 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.28 142.22 31.27 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.248 1.419 . . . . 0.0 107.945 161.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -143.95 131.81 21.46 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.182 1.393 . . . . 0.0 108.111 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -73.84 94.21 2.26 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 127.187 2.195 . . . . 0.0 110.706 -171.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -93.54 61.34 3.18 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 172.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.18 -154.54 53.28 Favored Glycine 0 N--CA 1.441 -0.997 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 174.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 24.5 ptt-85 -143.95 168.13 20.7 Favored 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 122.119 -0.636 . . . . 0.0 112.124 -163.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -173.62 177.51 45.93 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-O 122.432 1.018 . . . . 0.0 114.041 -169.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.7 p -142.54 162.51 35.28 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.947 1.299 . . . . 0.0 109.917 176.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 43.6 p -82.06 95.84 7.57 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 168.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.401 HG22 ' H ' ' A' ' 37' ' ' VAL . 0.2 OUTLIER -62.76 -25.41 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 118.43 0.559 . . . . 0.0 111.686 171.019 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.78 117.32 13.22 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 159.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.4 m -57.1 138.5 54.4 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 172.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.478 ' HB3' ' CD2' ' A' ' 53' ' ' LEU . 36.0 m-85 -129.27 152.43 79.47 Favored Pre-proline 0 C--O 1.234 0.246 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 164.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -77.71 111.78 3.19 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 124.918 3.745 . . . . 0.0 110.479 172.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 33.5 tp -103.81 86.48 2.61 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.92 1.288 . . . . 0.0 107.769 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.556 HG13 ' HB3' ' A' ' 127' ' ' LEU . 48.3 t -84.21 160.78 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.274 0 C-N-CA 125.186 1.394 . . . . 0.0 107.921 177.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 50.3 mt -132.33 118.8 37.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 176.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.71 -172.87 3.91 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.567 0.747 . . . . 0.0 109.082 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.71 175.97 11.33 Favored Glycine 0 N--CA 1.439 -1.138 0 C-N-CA 125.564 1.555 . . . . 0.0 111.316 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -74.59 -8.45 56.39 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -162.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -132.73 40.28 3.27 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 124.021 0.928 . . . . 0.0 110.759 -176.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.8 m120 48.17 61.05 3.2 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.128 -0.983 . . . . 0.0 110.724 174.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 62.4 mt -102.49 89.97 1.97 Allowed Pre-proline 0 C--N 1.329 -0.294 0 N-CA-C 103.422 -2.807 . . . . 0.0 103.422 -160.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -59.62 120.04 7.61 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 N-CA-C 108.132 -1.526 . . . . 0.0 108.132 -176.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -103.27 115.31 30.31 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 177.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.478 ' CD2' ' HB3' ' A' ' 40' ' ' PHE . 0.3 OUTLIER -81.39 94.75 6.85 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 172.737 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.436 ' HG ' ' CD2' ' A' ' 120' ' ' TYR . 10.9 mp -65.45 120.23 12.46 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -70.55 83.58 0.6 Allowed 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -176.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.56 85.74 12.84 Favored Pre-proline 0 N--CA 1.465 0.317 0 C-N-CA 124.168 0.987 . . . . 0.0 109.727 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -58.87 141.07 97.71 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 N-CA-C 108.932 -1.218 . . . . 0.0 108.932 174.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.56 18.96 76.92 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 119.607 -0.551 . . . . 0.0 113.681 176.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -126.62 157.08 39.87 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 119.487 1.643 . . . . 0.0 106.798 161.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.97 -137.27 15.36 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 173.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -140.24 171.49 14.09 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.784 1.292 . . . . 0.0 110.493 -173.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 58.3 m -79.93 107.77 12.97 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 123.884 0.874 . . . . 0.0 111.387 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 73.6 t -88.86 116.35 30.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -169.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.6 p -72.61 161.95 30.12 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.493 0.664 . . . . 0.0 109.278 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -169.58 -156.7 11.11 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 108.116 -1.993 . . . . 0.0 108.116 175.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.613 ' H ' HG12 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -135.09 171.76 13.97 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.619 1.968 . . . . 0.0 106.513 177.603 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 79.5 mt -126.36 127.99 71.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 119.485 1.039 . . . . 0.0 108.512 -170.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -126.08 119.96 28.96 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.456 0.702 . . . . 0.0 111.794 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -66.59 115.66 6.69 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 105.473 -2.047 . . . . 0.0 105.473 156.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.2 m -120.47 165.48 15.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 C-N-CA 123.828 0.851 . . . . 0.0 109.244 178.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -93.56 171.39 8.93 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 122.413 1.101 . . . . 0.0 108.296 169.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -54.07 -37.93 64.74 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.316 -1.311 . . . . 0.0 110.846 167.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -58.68 -40.66 84.22 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.889 0.768 . . . . 0.0 110.943 -176.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 25.8 tpp -72.01 -45.83 59.44 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 176.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.7 tp -58.84 -26.84 64.56 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 50.1 mtt-85 -78.59 -39.27 37.92 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.936 1.694 . . . . 0.0 111.144 173.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -64.15 -50.29 68.79 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 118.881 -0.58 . . . . 0.0 111.351 175.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 91.6 mt -56.41 -36.36 68.85 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 119.106 0.866 . . . . 0.0 110.668 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.73 -23.25 28.09 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.097 1.759 . . . . 0.0 112.891 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -93.22 -31.23 14.82 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.43 1.492 . . . . 0.0 112.287 174.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -71.62 -43.73 65.65 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.333 1.053 . . . . 0.0 109.632 -169.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -92.21 15.41 13.68 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.45 1.1 . . . . 0.0 113.174 176.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.0 t70 44.89 38.29 2.85 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.615 1.566 . . . . 0.0 112.283 -177.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -65.7 158.91 72.33 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 120.075 -1.641 . . . . 0.0 107.403 170.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -74.16 -3.38 17.1 Favored 'Cis proline' 0 N--CA 1.452 -0.953 0 CA-C-N 118.969 0.668 . . . . 0.0 113.488 -13.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.54 -62.81 1.47 Allowed 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.033 1.733 . . . . 0.0 111.8 -175.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 36.5 mtp -86.31 -74.29 0.43 Allowed 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -174.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -89.81 172.91 8.56 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 175.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -134.88 138.66 44.36 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 165.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.574 ' HD3' ' CD1' ' A' ' 113' ' ' PHE . 7.6 tmm_? -74.31 129.94 38.74 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 118.095 -0.955 . . . . 0.0 109.24 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.3 m -133.02 156.27 47.65 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.102 0.865 . . . . 0.0 110.0 -175.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -87.85 139.58 30.38 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.388 1.475 . . . . 0.0 110.426 168.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.495 HD21 HG23 ' A' ' 114' ' ' VAL . 1.8 pt? -160.92 -179.91 7.94 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.657 1.183 . . . . 0.0 112.809 -177.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 12.1 tp60 -99.2 142.44 30.68 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.371 1.068 . . . . 0.0 113.073 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 45.4 t -137.34 134.6 47.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 126.659 1.984 . . . . 0.0 107.781 174.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -76.66 144.73 39.26 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.282 1.433 . . . . 0.0 108.039 165.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.592 HG13 ' HA ' ' A' ' 108' ' ' ASP 0.255 3.5 p -110.93 82.43 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-O 122.366 1.079 . . . . 0.0 108.838 -178.451 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.0 mp -44.79 -42.19 7.6 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 127.057 2.143 . . . . 0.0 110.462 176.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -150.09 152.47 34.83 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 176.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 64.0 t-105 -127.09 137.71 53.06 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 125.59 1.556 . . . . 0.0 107.28 176.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -113.65 106.8 14.95 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 122.964 0.505 . . . . 0.0 110.047 174.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.9 -175.75 16.12 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-O 122.066 0.815 . . . . 0.0 112.304 175.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -79.94 172.76 13.34 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.262 -0.969 . . . . 0.0 109.391 168.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.39 60.44 2.01 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -101.05 88.47 1.06 Allowed Pre-proline 0 CA--C 1.537 0.466 1 C-N-CA 132.721 4.408 . . . . 0.0 109.113 -158.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -73.39 5.04 3.43 Favored 'Trans proline' 0 CA--C 1.544 0.98 1 C-N-CA 126.188 4.592 . . . . 0.0 113.963 -171.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.33 -169.03 54.88 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-N 120.819 1.645 . . . . 0.0 110.031 -163.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.592 ' HA ' HG13 ' A' ' 97' ' ' VAL . 26.9 t70 -96.81 5.48 50.51 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 129.456 3.102 . . . . 0.0 116.001 -166.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.2 p -136.81 122.12 19.33 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 122.025 2.193 . . . . 0.0 114.588 152.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 24.8 m -98.41 153.85 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 125.098 1.359 . . . . 0.0 108.891 -179.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -87.12 125.95 34.47 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 163.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 9.9 m -116.88 172.06 7.49 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.522 1.129 . . . . 0.0 110.428 176.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.574 ' CD1' ' HD3' ' A' ' 90' ' ' ARG . 96.2 m-85 -92.62 139.77 30.22 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 152.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.495 HG23 HD21 ' A' ' 93' ' ' LEU . 24.3 t -142.09 126.05 15.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 129.752 3.221 . . . . 0.0 106.89 172.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -72.23 141.33 48.97 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 170.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.414 HG22 HD13 ' A' ' 53' ' ' LEU . 41.9 p -145.12 -170.0 3.32 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 126.633 1.973 . . . . 0.0 107.319 -177.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -131.76 143.76 50.47 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 166.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -107.05 0.66 23.73 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.726 1.61 . . . . 0.0 110.689 168.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.2 p -121.75 20.52 10.93 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 127.101 2.161 . . . . 0.0 111.646 -159.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.436 ' CD2' ' HG ' ' A' ' 54' ' ' LEU . 7.2 p90 -67.04 152.1 46.41 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 125.691 1.596 . . . . 0.0 111.825 -176.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.59 158.87 65.12 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 124.689 1.196 . . . . 0.0 111.568 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -72.7 -33.91 7.65 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.558 1.505 . . . . 0.0 113.175 -177.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -64.66 -26.97 68.62 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.7 0.682 . . . . 0.0 112.39 172.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 45.7 m0 -69.99 -10.78 59.8 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.767 0.712 . . . . 0.0 112.178 -176.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.26 -29.12 69.29 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.674 1.125 . . . . 0.0 110.821 168.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -90.69 -11.41 39.8 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.497 1.119 . . . . 0.0 112.099 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.556 ' HB3' HG13 ' A' ' 43' ' ' VAL . 11.5 mt -62.64 146.67 94.0 Favored Pre-proline 0 C--O 1.235 0.335 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -64.72 143.49 80.79 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.171 1.914 . . . . 0.0 109.861 175.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -96.82 164.27 12.63 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.751 1.22 . . . . 0.0 108.56 176.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -135.27 162.94 31.15 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.8 0.84 . . . . 0.0 110.103 -176.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -106.29 -17.48 14.28 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 121.392 -0.817 . . . . 0.0 110.364 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 95.2 p -139.44 160.03 40.79 Favored 'General case' 0 N--CA 1.444 -0.771 0 O-C-N 121.282 -0.886 . . . . 0.0 111.07 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.425 ' CE2' HG23 ' A' ' 9' ' ' THR . 3.4 t80 -141.42 101.76 4.06 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 104.005 -2.591 . . . . 0.0 104.005 178.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -151.72 136.86 17.43 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -178.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.01 -43.76 50.85 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.8 0.84 . . . . 0.0 110.784 174.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -89.29 23.78 2.4 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.838 0.855 . . . . 0.0 112.735 -167.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -82.16 155.26 34.37 Favored Glycine 0 CA--C 1.539 1.542 0 CA-C-O 118.701 -1.055 . . . . 0.0 111.892 174.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -71.5 -22.63 24.42 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 124.288 3.325 . . . . 0.0 112.361 175.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -73.33 80.41 1.36 Allowed 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 127.556 2.342 . . . . 0.0 107.031 172.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -72.57 77.35 0.77 Allowed Glycine 0 CA--C 1.522 0.476 0 C-N-CA 127.033 2.254 . . . . 0.0 111.375 -174.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -161.14 71.58 0.41 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 128.573 2.749 . . . . 0.0 105.642 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -133.56 173.15 11.81 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.32 0.648 . . . . 0.0 109.892 -168.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -69.77 123.81 22.38 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.531 -161.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 . . . . . 0 CA--C 1.516 -0.342 0 C-N-CA 125.077 1.351 . . . . 0.0 109.045 -170.535 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -78.11 142.09 38.32 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -177.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.1 pt -126.79 166.5 23.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 176.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -124.96 130.56 52.61 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.476 0.71 . . . . 0.0 109.679 -177.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.8 p -93.14 164.58 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 125.449 1.5 . . . . 0.0 108.922 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.401 ' CE1' HG13 ' A' ' 114' ' ' VAL . 0.4 OUTLIER -113.4 -74.43 0.63 Allowed 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -179.593 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -128.1 -34.98 0.52 Allowed Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.164 1.364 . . . . 0.0 111.306 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p -64.12 -32.72 74.4 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 127.127 2.171 . . . . 0.0 114.276 -159.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 mp -133.37 36.46 3.39 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.947 1.299 . . . . 0.0 107.737 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -112.02 -25.17 9.51 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.63 1.172 . . . . 0.0 113.265 -172.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.3 mmt-85 -140.73 -87.93 0.18 Allowed 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 119.687 1.13 . . . . 0.0 109.419 168.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -128.45 2.58 6.6 Favored Glycine 0 C--N 1.334 0.429 0 O-C-N 120.637 -1.29 . . . . 0.0 111.632 -162.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -50.77 151.9 3.93 Favored Pre-proline 0 N--CA 1.438 -1.069 0 C-N-CA 124.79 1.236 . . . . 0.0 109.654 -173.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.7 -18.1 58.4 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 123.275 2.65 . . . . 0.0 112.285 -169.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -90.2 -25.07 20.81 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 126.924 2.09 . . . . 0.0 110.926 -168.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -49.59 -40.45 38.89 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.653 1.181 . . . . 0.0 111.922 -165.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.73 -27.08 1.8 Allowed 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 125.824 1.65 . . . . 0.0 114.472 -177.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.9 m -62.54 -41.0 90.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 119.716 1.144 . . . . 0.0 110.508 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.59 -14.27 61.16 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 67.6 mt -82.47 -15.33 52.9 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.794 0.838 . . . . 0.0 110.189 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -85.77 95.71 9.49 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 -178.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -63.27 -14.32 48.12 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.781 -0.574 . . . . 0.0 112.401 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 68.1 m -71.83 -27.54 62.97 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 120.548 -1.345 . . . . 0.0 112.937 167.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -83.15 2.79 33.73 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.477 1.111 . . . . 0.0 110.891 171.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.31 177.94 19.46 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 125.357 1.456 . . . . 0.0 110.787 173.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 36.9 tp -85.22 144.38 28.18 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.11 0.564 . . . . 0.0 111.308 -175.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -147.53 120.1 8.54 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.39 1.476 . . . . 0.0 109.131 161.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -134.7 150.93 50.66 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 119.008 0.822 . . . . 0.0 110.931 171.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -66.72 109.02 2.7 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 127.079 2.152 . . . . 0.0 110.191 -177.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.7 tpp85 -118.15 42.14 2.76 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.826 1.651 . . . . 0.0 108.464 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 113.5 175.0 19.09 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-O 122.874 1.263 . . . . 0.0 113.027 167.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -108.97 155.4 20.91 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.67 172.35 37.0 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.243 -0.98 . . . . 0.0 115.049 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.5 p -143.53 131.09 21.16 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 175.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 20.6 p -63.36 106.94 0.99 Allowed 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 173.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.45 -19.32 12.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.879 -177.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -65.79 116.71 7.27 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 155.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.26 132.62 34.09 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 117.641 -1.171 . . . . 0.0 107.915 160.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -135.59 156.49 77.58 Favored Pre-proline 0 N--CA 1.449 -0.5 0 CA-C-N 119.159 0.89 . . . . 0.0 108.683 178.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.467 ' HG2' ' HB2' ' A' ' 54' ' ' LEU . 60.1 Cg_endo -71.55 90.89 0.69 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.996 3.13 . . . . 0.0 110.228 164.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.54 HD11 ' HB2' ' A' ' 51' ' ' PRO . 45.0 tp -90.38 107.55 19.22 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 154.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.4 m -101.91 166.59 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 170.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.42 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -114.63 129.65 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 170.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.55 -170.93 3.41 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.99 0.916 . . . . 0.0 111.7 -176.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.45 -157.65 53.44 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 126.319 1.914 . . . . 0.0 112.336 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.03 -8.35 21.54 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.397 1.479 . . . . 0.0 114.198 -174.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 -127.26 19.6 6.91 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 123.885 0.874 . . . . 0.0 112.677 -170.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 42.8 m-20 55.75 66.6 1.17 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.235 1.814 . . . . 0.0 109.066 -171.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 68.0 mt -104.28 88.94 2.28 Favored Pre-proline 0 N--CA 1.465 0.292 0 C-N-CA 127.695 2.398 . . . . 0.0 106.55 -175.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.54 ' HB2' HD11 ' A' ' 42' ' ' LEU . 96.2 Cg_endo -66.44 150.28 84.33 Favored 'Trans proline' 0 N--CA 1.44 -1.653 0 CA-C-N 119.749 0.946 . . . . 0.0 112.501 174.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -128.81 118.94 23.61 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.63 102.34 3.27 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 165.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.467 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 2.9 mt -78.67 147.07 33.67 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 173.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -87.2 85.93 7.24 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 120.274 -1.516 . . . . 0.0 110.959 -173.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.2 86.8 11.06 Favored Pre-proline 0 N--CA 1.474 0.74 0 C-N-CA 123.72 0.808 . . . . 0.0 112.848 174.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -58.5 150.42 68.78 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 121.143 1.228 . . . . 0.0 110.395 174.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.81 -2.24 75.03 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 124.391 0.996 . . . . 0.0 113.91 174.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.27 127.8 32.55 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 120.122 1.961 . . . . 0.0 106.127 -174.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.76 -143.13 16.45 Favored Glycine 0 CA--C 1.522 0.527 0 CA-C-O 118.338 -1.257 . . . . 0.0 110.235 -168.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -141.35 170.38 15.84 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.051 1.425 . . . . 0.0 111.324 -177.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 7.1 m -72.31 106.59 4.52 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.161 1.384 . . . . 0.0 111.774 -174.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.6 t -77.73 101.36 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.761 0.824 . . . . 0.0 110.524 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.6 p -70.61 164.25 25.31 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 121.878 -0.514 . . . . 0.0 110.253 -177.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 176.59 -159.98 27.16 Favored Glycine 0 C--N 1.343 0.93 0 CA-C-N 119.392 0.996 . . . . 0.0 112.481 -176.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -139.32 160.03 40.78 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 121.499 -1.001 . . . . 0.0 111.785 -176.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 75.8 mt -114.09 124.41 70.71 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -173.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -113.87 119.93 38.97 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 173.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -57.09 114.13 2.0 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 154.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.9 m -115.37 155.35 16.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 173.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.73 173.23 10.23 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 122.011 0.91 . . . . 0.0 109.593 170.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.47 -49.85 60.98 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 125.72 1.608 . . . . 0.0 110.153 170.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -56.79 -39.25 73.78 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 118.922 -0.561 . . . . 0.0 111.679 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 44.2 tpp -72.35 -48.72 39.64 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 118.799 0.727 . . . . 0.0 109.693 179.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.28 -13.58 39.9 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.063 -1.023 . . . . 0.0 113.156 177.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 89.1 mtt-85 -86.34 -57.23 3.09 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 125.328 1.451 . . . . 0.0 110.467 168.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -53.48 -44.89 69.35 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.523 1.129 . . . . 0.0 112.272 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 90.5 mt -65.84 -27.93 68.6 Favored 'General case' 0 N--CA 1.461 0.113 0 O-C-N 121.347 -0.846 . . . . 0.0 110.526 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.472 ' HA ' ' SG ' ' A' ' 84' ' ' CYS . 1.8 t70 -76.64 10.12 2.36 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.099 1.76 . . . . 0.0 111.184 176.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -126.54 -4.77 6.54 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.516 2.326 . . . . 0.0 110.433 167.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.99 -49.05 7.3 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 104.25 -2.5 . . . . 0.0 104.25 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -74.78 0.79 14.21 Favored 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 124.884 1.274 . . . . 0.0 111.683 -173.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 57.77 19.28 5.48 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.814 1.646 . . . . 0.0 113.192 -176.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.472 ' SG ' ' HA ' ' A' ' 79' ' ' ASP . 1.1 p -57.86 157.6 14.81 Favored Pre-proline 0 CA--C 1.546 0.807 0 O-C-N 119.337 -2.102 . . . . 0.0 109.885 167.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -72.23 -4.51 12.99 Favored 'Cis proline' 0 CA--C 1.543 0.974 0 CA-C-N 119.732 0.94 . . . . 0.0 113.857 -6.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.3 m -59.51 -62.3 1.98 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 120.237 1.38 . . . . 0.0 111.776 -178.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 43.2 mtp -75.39 -58.86 3.03 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 122.326 0.251 . . . . 0.0 110.385 -175.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -119.2 174.71 6.17 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 126.285 1.834 . . . . 0.0 109.096 -176.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -127.4 -14.32 5.33 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 115.702 1.741 . . . . 0.0 115.702 -174.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? 62.08 125.12 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 128.641 2.776 . . . . 0.0 114.064 -174.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.6 m -134.67 167.39 20.92 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -174.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -106.91 123.98 48.95 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.155 1.782 . . . . 0.0 108.786 172.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -126.43 -164.51 1.34 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.083 1.753 . . . . 0.0 112.488 -166.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -132.43 134.24 44.85 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 120.363 1.438 . . . . 0.0 113.195 -179.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.624 HG13 HG22 ' A' ' 110' ' ' VAL . 1.5 p -155.3 117.57 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 118.115 2.635 . . . . 0.0 118.115 -166.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -57.53 132.55 53.51 Favored 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 125.294 1.438 . . . . 0.0 109.263 -173.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 84.8 t -70.4 101.86 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 105.423 -2.065 . . . . 0.0 105.423 163.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.37 -34.35 67.89 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 167.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -163.9 149.44 10.91 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.818 2.047 . . . . 0.0 106.134 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 70.2 t-105 -124.93 132.57 53.27 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 125.555 1.542 . . . . 0.0 107.012 173.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -122.47 103.48 8.75 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.87 -174.01 15.64 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 125.28 1.419 . . . . 0.0 112.394 176.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -50.63 156.84 0.85 Allowed 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 126.03 1.732 . . . . 0.0 114.298 170.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.86 65.61 1.39 Allowed Glycine 0 N--CA 1.436 -1.363 0 N-CA-C 108.886 -1.686 . . . . 0.0 108.886 149.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -102.36 89.09 1.56 Allowed Pre-proline 0 CA--C 1.538 0.506 1 C-N-CA 133.301 4.641 . . . . 0.0 108.928 -155.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.468 ' CG ' HG12 ' A' ' 110' ' ' VAL . 87.2 Cg_endo -71.81 -16.12 29.71 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 124.332 3.354 . . . . 0.0 116.14 -168.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 107.16 -167.49 13.76 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 120.541 1.518 . . . . 0.0 110.837 -165.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -68.93 -17.42 63.95 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -161.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.3 p -150.28 157.18 42.79 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 121.946 2.157 . . . . 0.0 109.176 -177.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.624 HG22 HG13 ' A' ' 95' ' ' VAL . 4.2 m -128.03 157.38 40.21 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.968 0 C-N-CA 115.795 -2.362 . . . . 0.0 109.272 -167.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -98.76 82.82 2.85 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 164.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 9.2 m -75.22 166.23 23.96 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 114.485 -1.234 . . . . 0.0 107.785 163.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -82.96 137.33 34.22 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 155.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.401 HG13 ' CE1' ' A' ' 7' ' ' TYR . 22.8 t -131.96 127.56 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 127.373 2.269 . . . . 0.0 107.852 174.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -63.69 118.52 8.38 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 170.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 36.0 p -130.85 179.56 5.91 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.551 1.141 . . . . 0.0 108.554 170.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.7 t -130.41 155.25 46.72 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 124.96 1.304 . . . . 0.0 107.801 170.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -120.09 -6.22 9.97 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 127.776 2.43 . . . . 0.0 111.743 175.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.5 t -130.98 69.57 1.47 Allowed 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -174.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.64 9.14 42.45 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.751 1.22 . . . . 0.0 113.703 -170.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.405 ' HB1' ' HD2' ' A' ' 122' ' ' PRO . . . 67.84 161.88 0.14 Allowed Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 127.302 2.241 . . . . 0.0 111.858 -177.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.405 ' HD2' ' HB1' ' A' ' 121' ' ' ALA . 21.4 Cg_endo -66.97 -32.83 34.36 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 121.456 1.437 . . . . 0.0 113.998 -171.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -61.05 -38.66 86.98 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.568 1.147 . . . . 0.0 112.93 -173.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 46.0 m0 -75.22 -10.07 59.13 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 122.067 -0.396 . . . . 0.0 110.895 -169.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.75 -11.9 60.54 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.22 1.008 . . . . 0.0 111.996 173.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -109.92 -8.81 14.81 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.641 0.776 . . . . 0.0 112.081 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.5 mt -73.09 152.27 90.56 Favored Pre-proline 0 C--O 1.24 0.572 0 O-C-N 121.784 -0.572 . . . . 0.0 109.711 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.75 159.8 38.28 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.89 2.393 . . . . 0.0 110.787 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -102.9 172.79 6.62 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.86 0.864 . . . . 0.0 111.877 -176.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.514 ' CE1' HD11 ' A' ' 141' ' ' LEU . 92.0 m-70 -132.35 170.87 14.47 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 126.894 2.077 . . . . 0.0 108.785 -177.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -111.77 -14.9 13.51 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.808 0.843 . . . . 0.0 111.334 174.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 58.6 m -155.31 169.68 23.64 Favored 'General case' 0 C--O 1.233 0.237 0 O-C-N 120.404 -1.435 . . . . 0.0 110.053 170.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -104.0 -160.45 0.77 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 128.165 2.586 . . . . 0.0 106.797 158.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 23.9 t0 78.95 134.19 0.06 Allowed 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 129.492 3.117 . . . . 0.0 112.183 -171.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.8 -31.38 26.99 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.999 1.32 . . . . 0.0 110.974 173.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -67.61 -15.84 63.86 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.594 0.758 . . . . 0.0 112.844 176.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -77.64 155.92 43.84 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.885 1.231 . . . . 0.0 111.364 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.56 -19.18 32.62 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.771 2.314 . . . . 0.0 113.152 -172.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 43.4 m-70 -71.45 83.83 0.81 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.986 2.114 . . . . 0.0 109.429 -173.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -61.06 68.75 0.01 OUTLIER Glycine 0 CA--C 1.528 0.891 0 C-N-CA 128.527 2.965 . . . . 0.0 113.735 -177.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.514 HD11 ' CE1' ' A' ' 130' ' ' HIS . 0.4 OUTLIER -178.1 57.97 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 130.973 3.709 . . . . 0.0 106.21 179.363 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -90.21 -168.0 2.0 Allowed 'General case' 0 N--CA 1.463 0.188 0 O-C-N 120.933 -1.104 . . . . 0.0 108.234 -176.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -60.32 136.72 58.12 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.585 1.084 . . . . 0.0 108.208 -176.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 . . . . . 0 N--CA 1.453 -0.311 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 -178.495 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.209 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -99.78 138.76 36.41 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 122.953 0.501 . . . . 0.0 110.463 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.4 pt -132.92 174.1 13.81 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 CA-C-O 122.001 0.905 . . . . 0.0 109.38 167.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -131.35 133.44 45.3 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.349 1.46 . . . . 0.0 108.257 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.422 HG21 ' HB2' ' A' ' 11' ' ' LYS . 13.2 m -70.0 119.35 15.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-O 122.024 0.916 . . . . 0.0 109.582 -178.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -54.12 -40.55 67.46 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.393 1.477 . . . . 0.0 111.755 172.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 164.12 -44.19 0.31 Allowed Glycine 0 CA--C 1.526 0.757 0 CA-C-O 122.949 1.305 . . . . 0.0 110.583 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.58 -11.8 3.39 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.715 2.406 . . . . 0.0 115.74 -173.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -134.95 31.1 3.31 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 124.763 1.225 . . . . 0.0 110.638 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.422 ' HB2' HG21 ' A' ' 6' ' ' VAL . 13.7 tmtt? -117.91 -85.48 0.64 Allowed 'General case' 0 C--O 1.224 -0.239 0 CA-C-O 117.359 -1.305 . . . . 0.0 107.989 170.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.516 ' HB2' HE22 ' A' ' 14' ' ' GLN . 2.8 mmm180 -45.3 -84.12 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.446 1.498 . . . . 0.0 113.345 -171.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -167.06 15.58 0.08 OUTLIER Glycine 0 CA--C 1.53 0.997 0 C-N-CA 123.588 0.613 . . . . 0.0 112.229 -175.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.516 HE22 ' HB2' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -51.95 155.44 3.13 Favored Pre-proline 0 C--O 1.233 0.231 0 C-N-CA 125.406 1.482 . . . . 0.0 110.809 177.758 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -64.76 -3.88 7.61 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 124.171 3.247 . . . . 0.0 113.795 -172.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.661 ' O ' HG22 ' A' ' 19' ' ' VAL . 4.2 m-80 -110.4 -9.5 14.61 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-O 116.365 -1.779 . . . . 0.0 111.221 -167.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -53.76 -46.63 71.0 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 121.982 2.173 . . . . 0.0 109.725 -172.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.874 ' HA ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -50.55 -19.34 0.87 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.903 1.681 . . . . 0.0 115.403 175.9 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.661 HG22 ' O ' ' A' ' 16' ' ' ASN . 30.9 m -63.48 -24.11 35.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 121.525 1.966 . . . . 0.0 111.566 176.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.703 ' HG3' HD12 ' A' ' 21' ' ' LEU . 4.1 ptp -89.4 -0.12 57.25 Favored 'General case' 0 C--N 1.345 0.376 0 CA-C-N 120.183 1.356 . . . . 0.0 110.836 -179.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.874 HD13 ' HA ' ' A' ' 18' ' ' LYS . 8.3 mp -96.13 9.29 41.37 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.868 2.067 . . . . 0.0 109.909 -169.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -129.95 110.16 11.46 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 119.119 0.872 . . . . 0.0 108.887 -178.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -58.51 -22.91 56.69 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -175.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.6 m -75.53 -26.04 57.7 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.437 -0.789 . . . . 0.0 112.845 173.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 49.0 m170 -69.63 -49.46 53.66 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 161.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 158.04 179.85 33.22 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-O 122.332 0.962 . . . . 0.0 111.863 172.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 28.9 tp -81.57 138.17 35.43 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.64 1.176 . . . . 0.0 111.303 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -149.77 120.95 7.78 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.225 1.01 . . . . 0.0 109.634 163.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.32 125.43 47.01 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 124.415 1.086 . . . . 0.0 109.864 -178.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -62.66 93.25 0.05 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 126.382 1.873 . . . . 0.0 110.588 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -95.55 61.12 2.27 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.212 1.005 . . . . 0.0 108.463 176.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.85 -160.53 51.69 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-O 122.656 1.142 . . . . 0.0 110.946 174.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.406 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 57.9 mtm180 -128.83 167.91 16.65 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 121.628 -0.924 . . . . 0.0 110.82 -161.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.484 ' HA2' ' H ' ' A' ' 98' ' ' LEU . . . -177.43 175.47 47.61 Favored Glycine 0 C--N 1.336 0.556 0 O-C-N 121.348 -0.845 . . . . 0.0 114.01 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.1 p -142.89 156.86 44.99 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.965 1.306 . . . . 0.0 109.261 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 44.0 p -69.25 119.1 13.0 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 169.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.9 t -70.6 -44.18 77.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 173.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -58.25 123.27 15.48 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 126.142 1.777 . . . . 0.0 108.329 163.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.1 m -60.01 148.7 34.55 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 162.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -141.98 153.25 63.72 Favored Pre-proline 0 CA--C 1.541 0.61 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 165.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.487 ' HA ' ' HA3' ' A' ' 60' ' ' GLY . 45.2 Cg_endo -79.23 82.74 2.42 Favored 'Trans proline' 0 C--O 1.237 0.474 1 C-N-CA 125.58 4.187 . . . . 0.0 112.583 -178.799 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.98 122.99 26.27 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 1.053 HG11 HD13 ' A' ' 127' ' ' LEU . 0.1 OUTLIER -134.39 144.7 34.39 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 C-N-CA 123.2 0.6 . . . . 0.0 110.838 174.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.0 mt -88.7 76.34 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 126.226 1.811 . . . . 0.0 106.882 168.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.75 -172.96 3.58 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 168.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.81 142.12 4.98 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.502 1.049 . . . . 0.0 112.187 165.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -76.69 2.27 14.7 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.182 -1.187 . . . . 0.0 112.861 -173.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 29.1 m-70 -120.26 17.75 12.28 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.094 1.358 . . . . 0.0 111.41 169.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 52.53 70.12 0.61 Allowed 'General case' 0 C--N 1.341 0.202 0 C-N-CA 126.166 1.787 . . . . 0.0 108.736 -174.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 72.9 mt -104.98 86.57 1.55 Allowed Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 102.751 -3.055 . . . . 0.0 102.751 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 37.3 Cg_endo -66.64 144.47 72.38 Favored 'Trans proline' 0 N--CA 1.443 -1.473 0 CA-C-N 121.037 1.406 . . . . 0.0 110.762 175.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 72.3 m95 -112.43 -169.79 1.54 Allowed 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.939 1.296 . . . . 0.0 109.84 -175.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.2 tp -144.32 92.08 2.27 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 168.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.424 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 3.7 mt -71.78 122.21 20.29 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 -177.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -69.93 89.3 0.59 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.105 0.866 . . . . 0.0 110.561 -177.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.06 77.98 54.5 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 124.808 1.243 . . . . 0.0 108.357 176.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.16 121.28 9.4 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.451 2.101 . . . . 0.0 110.618 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.09 -1.38 51.15 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 126.444 1.973 . . . . 0.0 114.121 175.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -109.11 169.49 8.65 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 119.836 1.818 . . . . 0.0 109.835 172.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.487 ' HA3' ' HA ' ' A' ' 41' ' ' PRO . . . 88.69 -8.06 80.3 Favored Glycine 0 CA--C 1.533 1.165 0 N-CA-C 117.56 1.784 . . . . 0.0 117.56 155.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 75.54 167.39 0.28 Allowed 'General case' 0 C--N 1.322 -0.615 1 C-N-CA 134.818 5.247 . . . . 0.0 111.337 -172.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 76.3 m -69.09 170.81 9.27 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 120.988 -1.07 . . . . 0.0 110.607 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 43.0 t -134.78 104.32 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.9 p -72.46 155.79 39.73 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.62 -0.675 . . . . 0.0 109.706 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.56 -155.55 11.44 Favored Glycine 0 C--N 1.337 0.616 0 O-C-N 120.762 -1.211 . . . . 0.0 110.865 -175.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 43.0 mt-10 -144.07 171.22 14.57 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 127.694 2.397 . . . . 0.0 107.786 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 81.8 mt -118.16 139.75 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 120.593 1.542 . . . . 0.0 109.379 -171.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -134.42 125.43 27.48 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.732 0.777 . . . . 0.0 110.082 176.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -72.42 132.94 44.57 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 161.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.6 m -135.38 164.7 32.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 123.755 0.822 . . . . 0.0 110.025 -177.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -115.85 176.14 5.22 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 176.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.33 -37.53 80.93 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 118.99 -0.529 . . . . 0.0 110.121 -168.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 36.0 tp60 -57.82 -40.88 81.03 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.829 0.851 . . . . 0.0 112.152 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.451 ' HE1' ' HA ' ' A' ' 20' ' ' MET . 24.4 tpp -69.02 -48.82 62.04 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.5 tp -58.77 -32.85 69.67 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.1 mtt180 -74.64 -33.98 62.65 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.171 -0.956 . . . . 0.0 112.174 177.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -75.95 -49.11 18.67 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.532 0.733 . . . . 0.0 110.121 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.6 mp -55.89 -41.43 74.46 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -177.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -44.87 -47.83 11.13 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.973 1.709 . . . . 0.0 111.234 174.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -71.47 -40.04 70.52 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.068 0.947 . . . . 0.0 111.911 176.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -65.45 -33.19 75.35 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.685 1.194 . . . . 0.0 110.534 -170.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -101.41 20.06 16.65 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 124.72 1.208 . . . . 0.0 113.291 174.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.1 t70 54.04 17.16 1.31 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.314 1.446 . . . . 0.0 112.776 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 16.2 t -61.99 145.38 92.99 Favored Pre-proline 0 N--CA 1.447 -0.58 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 177.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -80.69 -2.53 43.13 Favored 'Cis proline' 0 CA--C 1.54 0.815 0 N-CA-C 116.15 1.558 . . . . 0.0 116.15 0.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.4 m -63.4 -61.34 2.41 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 120.042 1.292 . . . . 0.0 112.572 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 12.3 mtp -83.12 -76.02 0.29 Allowed 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -177.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -85.34 169.83 13.34 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 176.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -146.18 126.6 14.05 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.858 1.663 . . . . 0.0 106.547 176.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -67.2 131.62 46.15 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.353 1.061 . . . . 0.0 110.048 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.7 m -128.82 177.1 7.32 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.604 1.962 . . . . 0.0 107.681 174.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -116.5 146.24 42.73 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.379 1.471 . . . . 0.0 110.053 167.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.34 178.76 7.36 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.556 1.942 . . . . 0.0 111.771 175.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 37.2 tp60 -109.73 115.89 30.69 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.933 1.693 . . . . 0.0 110.683 -178.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 70.5 t -108.99 145.74 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.57 1.148 . . . . 0.0 108.487 -177.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -85.4 142.74 29.06 Favored 'General case' 0 C--N 1.341 0.206 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 169.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.593 ' CG1' ' HA ' ' A' ' 108' ' ' ASP . 1.9 p -89.82 103.08 13.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 124.978 1.311 . . . . 0.0 109.029 172.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.484 ' H ' ' HA2' ' A' ' 34' ' ' GLY . 0.3 OUTLIER -72.69 -22.0 60.97 Favored 'General case' 0 C--N 1.331 -0.206 0 O-C-N 120.708 -1.245 . . . . 0.0 111.537 172.281 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -160.17 153.39 21.94 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 119.99 1.268 . . . . 0.0 108.437 177.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 48.5 t-105 -136.85 120.84 17.64 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.296 0.638 . . . . 0.0 109.713 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -108.24 99.56 8.96 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 125.269 1.427 . . . . 0.0 110.995 -177.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.69 -173.32 19.26 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 124.432 1.015 . . . . 0.0 110.936 174.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -67.06 171.12 5.87 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.104 0.562 . . . . 0.0 110.832 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.47 57.48 1.75 Allowed Glycine 0 C--O 1.22 -0.743 0 C-N-CA 125.154 1.359 . . . . 0.0 112.179 174.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -100.6 89.65 1.25 Allowed Pre-proline 0 N--CA 1.471 0.598 0 C-N-CA 126.984 2.114 . . . . 0.0 109.272 -167.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -57.93 -27.25 78.13 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.493 2.796 . . . . 0.0 113.514 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 126.3 -176.52 17.5 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 -161.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.593 ' HA ' ' CG1' ' A' ' 97' ' ' VAL . 36.7 t70 -81.44 4.92 19.25 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -173.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.8 p -137.33 156.23 48.48 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 118.802 -1.159 . . . . 0.0 110.783 156.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.2 p -130.92 152.74 38.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 124.305 1.042 . . . . 0.0 111.021 173.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -86.72 128.27 35.01 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.535 1.534 . . . . 0.0 108.216 170.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -137.06 167.95 20.54 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 127.158 2.183 . . . . 0.0 110.596 178.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -102.42 142.36 33.75 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 173.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 40.4 t -138.08 144.63 30.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 177.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -78.17 125.82 29.9 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 173.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 71.7 p -120.39 -173.96 2.69 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.965 1.306 . . . . 0.0 107.87 177.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.8 t -145.86 139.2 26.15 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 162.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -105.36 -8.25 18.31 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.439 0.695 . . . . 0.0 110.729 174.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 44.2 p -86.49 14.57 6.58 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.025 1.33 . . . . 0.0 113.251 -166.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -57.44 134.76 56.33 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.137 1.375 . . . . 0.0 113.343 -162.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.16 147.13 98.76 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.27 172.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.5 -27.28 46.56 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 121.753 1.635 . . . . 0.0 113.15 -174.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -50.57 -35.28 29.19 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.339 1.056 . . . . 0.0 111.141 171.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 0.617 ' O ' HD11 ' A' ' 127' ' ' LEU . 35.8 m0 -82.66 12.73 4.36 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.542 0.61 . . . . 0.0 111.948 -173.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -91.19 -26.09 19.22 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 120.403 1.456 . . . . 0.0 111.506 163.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -89.16 -25.72 21.67 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 120.123 1.329 . . . . 0.0 112.297 -169.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 1.053 HD13 HG11 ' A' ' 43' ' ' VAL 0.459 0.2 OUTLIER -45.43 161.39 0.24 Allowed Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 126.666 1.987 . . . . 0.0 115.178 173.058 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -90.39 142.45 3.58 Favored 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 124.171 3.248 . . . . 0.0 108.557 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.45 ' CD2' ' HA2' ' A' ' 60' ' ' GLY . 9.3 m-30 -98.16 -177.96 3.9 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 124.198 0.999 . . . . 0.0 109.241 -169.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 46.4 m-70 -136.52 -178.69 5.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.608 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -134.24 -15.32 2.24 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 122.96 1.362 . . . . 0.0 111.908 170.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 29.7 p -144.96 153.2 41.27 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 161.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -92.03 157.45 16.77 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 167.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -170.41 139.15 1.63 Allowed 'General case' 0 C--O 1.241 0.607 0 CA-C-N 119.74 1.155 . . . . 0.0 108.989 166.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 66.6 m -81.18 -19.26 43.73 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.245 -0.91 . . . . 0.0 111.164 170.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -88.61 -11.77 44.5 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 120.374 1.443 . . . . 0.0 111.606 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.99 163.49 20.31 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.714 1.149 . . . . 0.0 112.019 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -71.82 -1.35 9.77 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 124.136 3.224 . . . . 0.0 113.637 -176.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -51.38 -29.79 16.78 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 126.425 1.89 . . . . 0.0 115.006 -169.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 74.35 -26.17 1.06 Allowed Glycine 0 CA--C 1.528 0.869 0 CA-C-O 118.458 -1.19 . . . . 0.0 112.963 -177.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.71 120.74 38.65 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 126.162 1.785 . . . . 0.0 109.206 167.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -136.23 162.54 32.68 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 126.475 1.91 . . . . 0.0 109.511 178.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -62.4 119.09 8.44 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 . . . . . 0 N--CA 1.452 -0.336 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -171.053 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.834 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -65.98 123.68 20.5 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -176.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.446 HG22 ' HB2' ' A' ' 113' ' ' PHE . 18.5 pt -119.13 170.63 8.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 124.418 1.087 . . . . 0.0 108.609 173.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -135.99 141.78 44.44 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.572 HG12 ' H ' ' A' ' 66' ' ' GLU . 2.7 p -97.55 137.93 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -173.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -92.47 -46.63 7.55 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.488 1.515 . . . . 0.0 110.183 -178.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -159.09 6.6 0.14 Allowed Glycine 0 C--N 1.344 0.98 0 CA-C-O 116.909 -2.051 . . . . 0.0 117.821 -168.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.478 ' HA ' ' HG3' ' A' ' 14' ' ' GLN . 1.1 p -131.16 -16.7 3.13 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 120.961 2.38 . . . . 0.0 115.995 -161.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.9 mp -140.04 71.17 1.37 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 120.582 1.537 . . . . 0.0 107.915 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.44 -85.46 0.07 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 118.591 -0.719 . . . . 0.0 112.005 -176.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -64.04 -67.42 0.43 Allowed 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.607 1.094 . . . . 0.0 110.152 -177.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 166.21 88.56 0.07 OUTLIER Glycine 0 N--CA 1.429 -1.789 0 N-CA-C 105.607 -2.997 . . . . 0.0 105.607 172.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.478 ' HG3' ' HA ' ' A' ' 9' ' ' THR . 0.3 OUTLIER -129.41 165.34 33.41 Favored Pre-proline 0 N--CA 1.443 -0.79 0 CA-C-O 117.578 -1.201 . . . . 0.0 108.485 -176.321 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -81.66 61.77 8.07 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.04 1.827 . . . . 0.0 113.973 -159.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.517 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -175.21 -5.75 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 129.264 3.026 . . . . 0.0 110.65 -178.061 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 18.5 t-160 -65.8 -46.15 79.75 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 121.839 2.109 . . . . 0.0 110.598 -177.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.407 ' HA ' HD12 ' A' ' 21' ' ' LEU . 0.6 OUTLIER -53.17 -27.35 20.99 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -172.465 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 16' ' ' ASN . 21.1 m -52.69 -42.79 42.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 119.383 0.992 . . . . 0.0 111.467 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.6 ptp -82.44 8.38 11.69 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 120.935 -1.103 . . . . 0.0 112.79 -174.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 18' ' ' LYS . 20.7 mt -118.75 1.63 11.6 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.645 1.578 . . . . 0.0 110.666 -172.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -125.39 4.98 7.68 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.432 1.493 . . . . 0.0 114.264 -171.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . 0.271 9.5 t-80 42.17 26.45 0.06 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.877 2.471 . . . . 0.0 114.753 177.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.23 -32.51 10.48 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.36 1.064 . . . . 0.0 110.357 175.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -80.05 -35.34 37.3 Favored 'General case' 0 N--CA 1.456 -0.16 0 O-C-N 121.102 -0.999 . . . . 0.0 110.094 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 159.49 -174.56 36.38 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 -175.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -98.65 131.66 44.66 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.277 1.031 . . . . 0.0 109.116 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -132.85 156.87 46.37 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.499 1.52 . . . . 0.0 109.276 159.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -141.02 139.15 34.1 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 168.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -61.38 104.54 0.41 Allowed 'General case' 0 C--O 1.233 0.23 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 169.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.2 tpp180 -114.33 65.23 0.67 Allowed 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 -175.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.87 176.23 49.29 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-O 121.965 0.758 . . . . 0.0 111.814 -176.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -120.57 171.85 8.26 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.621 0.768 . . . . 0.0 109.69 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -177.96 178.85 48.53 Favored Glycine 0 C--N 1.333 0.403 0 O-C-N 121.086 -1.008 . . . . 0.0 114.346 -177.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.4 p -146.42 163.93 34.08 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.294 1.838 . . . . 0.0 108.527 172.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 49.9 p -86.91 103.69 15.54 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 168.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.414 HG22 ' H ' ' A' ' 37' ' ' VAL . 0.2 OUTLIER -63.75 -22.33 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 121.774 0.797 . . . . 0.0 111.636 171.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.68 116.44 6.24 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.764 0.792 . . . . 0.0 109.281 159.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.07 129.62 38.73 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.169 1.388 . . . . 0.0 108.219 164.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -138.96 158.35 69.92 Favored Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.15 81.74 2.37 Favored 'Trans proline' 0 N--CA 1.454 -0.85 1 C-N-CA 125.469 4.112 . . . . 0.0 109.165 172.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -80.37 110.94 16.3 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 162.381 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.4 m -127.88 127.92 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 118.818 0.736 . . . . 0.0 109.891 -173.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.5 mt -85.05 105.49 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 177.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.454 ' HB2' ' CD1' ' A' ' 127' ' ' LEU . . . -138.37 130.9 29.12 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 124.517 1.127 . . . . 0.0 109.464 -173.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.23 166.84 27.81 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-O 122.062 0.812 . . . . 0.0 112.629 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -93.28 -6.09 48.27 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 125.959 1.704 . . . . 0.0 113.569 -145.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -121.42 16.78 11.35 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.528 1.131 . . . . 0.0 110.811 177.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.2 m120 60.44 56.79 3.03 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.422 1.489 . . . . 0.0 109.183 175.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 61.0 mt -104.56 87.14 1.62 Allowed Pre-proline 0 C--N 1.322 -0.608 0 C-N-CA 130.128 3.371 . . . . 0.0 103.708 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -63.23 160.4 34.95 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 CA-C-N 120.721 1.293 . . . . 0.0 110.305 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 68.1 m95 -127.4 138.08 52.91 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.449 HD13 HG22 ' A' ' 116' ' ' THR . 0.0 OUTLIER -112.27 98.22 7.16 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 179.334 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.7 mt -80.54 147.79 30.66 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -172.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -83.39 81.31 8.77 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.02 -1.05 . . . . 0.0 109.75 -173.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.6 84.9 32.4 Favored Pre-proline 0 N--CA 1.467 0.424 0 C-N-CA 123.105 0.562 . . . . 0.0 110.03 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -63.46 136.17 53.4 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 121.468 1.445 . . . . 0.0 109.017 178.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.06 13.59 80.79 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 118.597 -1.113 . . . . 0.0 113.635 176.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -127.14 125.61 41.47 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 120.603 2.202 . . . . 0.0 106.538 172.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.28 -140.52 15.09 Favored Glycine 0 N--CA 1.463 0.471 0 CA-C-N 121.13 1.787 . . . . 0.0 111.974 -178.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 46.1 m-70 -133.89 160.99 35.99 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 117.715 0.758 . . . . 0.0 111.649 -166.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 63.2 m -72.45 117.21 13.83 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.166 1.387 . . . . 0.0 109.766 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 44.2 t -85.33 110.58 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.737 1.215 . . . . 0.0 108.671 -174.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 70.7 p -77.3 147.39 36.26 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.923 -1.111 . . . . 0.0 109.803 176.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.77 -150.35 6.25 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 -176.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.572 ' H ' HG12 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -148.49 160.97 42.54 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 126.102 1.761 . . . . 0.0 108.203 170.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 98.5 mt -102.25 134.16 43.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 -171.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -125.93 119.2 27.14 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.1 118.08 17.65 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 104.419 -2.437 . . . . 0.0 104.419 160.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.4 m -123.21 150.45 27.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 124.317 1.047 . . . . 0.0 108.72 -176.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -92.75 165.68 12.82 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 175.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -51.96 -29.99 22.91 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 126.595 1.958 . . . . 0.0 113.446 -174.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 12.0 tp60 -68.15 -42.44 80.08 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 122.244 -0.285 . . . . 0.0 110.701 178.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.2 ttm -71.78 -46.53 58.03 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 118.663 -0.684 . . . . 0.0 109.453 178.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.62 -26.04 67.74 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.39 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 36.6 mtm180 -73.84 -47.84 35.54 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 117.646 -1.169 . . . . 0.0 111.923 171.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -55.72 -47.45 76.85 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.607 1.094 . . . . 0.0 110.515 176.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.6 mp -61.45 -17.82 56.15 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.101 0.961 . . . . 0.0 113.122 176.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -84.5 -5.56 59.3 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.758 1.623 . . . . 0.0 111.972 176.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -125.25 -34.6 2.71 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.428 1.891 . . . . 0.0 111.028 -172.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -58.54 -46.88 85.89 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.582 1.553 . . . . 0.0 111.616 176.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -83.68 4.39 28.81 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 124.887 1.275 . . . . 0.0 112.367 -172.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.1 t0 44.98 25.51 0.16 Allowed 'General case' 0 C--O 1.24 0.554 0 C-N-CA 127.048 2.139 . . . . 0.0 115.497 -164.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 1.6 p -56.96 154.92 17.0 Favored Pre-proline 0 CA--C 1.545 0.776 0 O-C-N 119.592 -1.942 . . . . 0.0 108.56 158.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -74.15 -4.46 18.04 Favored 'Cis proline' 0 CA--C 1.544 0.978 0 N-CA-C 114.541 0.939 . . . . 0.0 114.541 -4.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 10.1 t -62.36 -68.84 0.29 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.506 1.048 . . . . 0.0 110.594 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 28.6 mtp -72.88 -64.57 0.94 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.854 0.862 . . . . 0.0 110.377 -171.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -105.01 176.84 5.03 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.031 0.932 . . . . 0.0 109.084 176.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -139.68 139.28 36.59 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 167.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -78.79 130.08 35.33 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.092 -1.005 . . . . 0.0 108.324 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 86.2 m -135.5 162.83 31.54 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -176.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -98.15 132.58 43.56 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.408 1.083 . . . . 0.0 108.466 173.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.54 HD21 HG23 ' A' ' 114' ' ' VAL . 2.4 pt? -149.42 -176.19 5.29 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.801 1.64 . . . . 0.0 111.892 -171.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 -105.09 135.36 46.58 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -175.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 84.8 t -134.68 128.77 51.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -69.61 121.42 17.08 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 104.188 -2.523 . . . . 0.0 104.188 163.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.49 ' CG1' ' HA ' ' A' ' 108' ' ' ASP . 14.8 p -63.02 119.47 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 156.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.1 -31.99 21.59 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 120.681 -1.262 . . . . 0.0 108.946 170.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -158.35 147.34 19.11 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 104.424 -2.436 . . . . 0.0 104.424 -175.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 66.2 t-105 -124.68 141.32 52.19 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -104.31 104.62 14.54 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.151 0.98 . . . . 0.0 108.687 173.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.28 -164.14 13.63 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-O 122.568 1.093 . . . . 0.0 114.162 165.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -78.36 161.04 27.47 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 114.509 -0.846 . . . . 0.0 109.325 177.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.86 64.38 1.68 Allowed Glycine 0 C--O 1.223 -0.59 0 C-N-CA 124.662 1.125 . . . . 0.0 110.866 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -102.0 89.25 1.52 Allowed Pre-proline 0 C--O 1.237 0.408 0 C-N-CA 129.98 3.312 . . . . 0.0 108.592 -166.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -66.18 -1.14 4.91 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 124.652 3.568 . . . . 0.0 114.495 -168.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.2 172.27 46.95 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-N 120.226 1.376 . . . . 0.0 110.062 -170.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.49 ' HA ' ' CG1' ' A' ' 97' ' ' VAL . 1.6 m-20 -70.91 -1.29 11.35 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -158.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 92.1 p -133.59 142.22 48.03 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 118.427 -1.309 . . . . 0.0 110.726 150.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.9 p -106.71 153.74 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 C-N-CA 125.806 1.642 . . . . 0.0 107.92 175.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 3.8 tm0? -89.8 112.4 23.71 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 161.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 48.4 m -102.9 175.96 5.31 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.854 0.862 . . . . 0.0 109.046 169.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.446 ' HB2' HG22 ' A' ' 4' ' ' ILE . 66.2 m-85 -93.81 144.67 25.21 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 156.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.54 HG23 HD21 ' A' ' 93' ' ' LEU . 25.0 t -136.05 150.3 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 127.656 2.382 . . . . 0.0 105.878 173.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -88.4 119.84 29.21 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 171.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.449 HG22 HD13 ' A' ' 53' ' ' LEU . 43.2 p -124.12 -169.19 1.92 Allowed 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.983 1.313 . . . . 0.0 108.533 -178.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.04 146.59 31.95 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 169.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -112.93 -9.0 13.66 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.882 1.673 . . . . 0.0 111.274 169.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 11.2 t -98.95 16.63 21.88 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.237 1.415 . . . . 0.0 112.418 -169.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -60.92 154.63 21.8 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 125.137 1.375 . . . . 0.0 113.344 -172.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.27 156.51 91.64 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 125.631 1.572 . . . . 0.0 110.088 171.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -70.14 -36.78 9.2 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 121.764 1.643 . . . . 0.0 112.584 177.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -52.3 -33.89 44.38 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 119.283 0.947 . . . . 0.0 112.693 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 38.6 m0 -74.59 -7.09 52.04 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.68 0.792 . . . . 0.0 112.054 -174.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 60.6 mt -78.69 -26.69 44.95 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 121.238 -0.913 . . . . 0.0 111.838 171.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -92.1 -16.09 26.85 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.347 0.659 . . . . 0.0 111.8 -175.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.454 ' CD1' ' HB2' ' A' ' 45' ' ' ALA . 48.4 mt -57.92 157.69 14.89 Favored Pre-proline 0 N--CA 1.465 0.293 0 C-N-CA 125.489 1.516 . . . . 0.0 111.787 -178.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -63.69 157.74 50.07 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.981 2.454 . . . . 0.0 110.113 172.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -111.49 158.95 18.55 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -139.05 148.4 43.31 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.398 0.279 . . . . 0.0 110.656 -177.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -87.13 -5.66 58.93 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.31 1.444 . . . . 0.0 112.175 176.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.6 t -167.69 170.88 10.6 Favored 'General case' 0 C--O 1.237 0.412 0 O-C-N 120.176 -1.577 . . . . 0.0 108.408 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -123.54 92.38 3.67 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 165.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -99.28 97.27 8.36 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 128.512 2.725 . . . . 0.0 108.486 -172.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 7.1 t -65.24 7.74 0.18 Allowed 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.622 -1.299 . . . . 0.0 113.575 177.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -127.57 13.33 6.99 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.453 1.501 . . . . 0.0 110.45 -167.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -96.13 179.83 35.3 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 125.963 1.744 . . . . 0.0 112.52 -176.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -75.91 -3.55 14.0 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 124.201 3.267 . . . . 0.0 112.754 172.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -64.87 -24.28 67.49 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.462 1.028 . . . . 0.0 113.512 -167.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 79.72 -39.4 2.18 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 125.227 1.394 . . . . 0.0 113.659 172.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.71 100.87 4.81 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.542 1.937 . . . . 0.0 110.133 168.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -122.26 162.85 20.69 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 125.525 1.53 . . . . 0.0 109.502 171.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -63.26 127.98 33.75 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -176.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 . . . . . 0 CA--C 1.533 0.307 0 C-N-CA 123.608 0.763 . . . . 0.0 109.171 -177.287 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.428 ' HA ' ' CE2' ' A' ' 113' ' ' PHE . . . . . . . . 0 CA--C 1.533 0.325 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 71.2 m80 69.95 121.67 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 128.082 2.553 . . . . 0.0 107.392 -157.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.6 pt -87.78 -179.43 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 167.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -129.59 140.84 51.09 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 165.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.4 p -106.1 118.05 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 -178.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -70.86 -63.77 1.03 Allowed 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 172.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.5 -21.23 0.11 Allowed Glycine 0 CA--C 1.526 0.747 0 O-C-N 120.933 -1.105 . . . . 0.0 114.449 -165.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.85 -28.52 22.83 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 -159.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.15 55.38 1.86 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 -174.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -160.03 -63.74 0.07 Allowed 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 124.459 1.103 . . . . 0.0 109.743 -173.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -72.31 -86.31 0.03 OUTLIER 'General case' 0 C--N 1.339 0.14 0 C-N-CA 123.975 0.91 . . . . 0.0 108.575 -168.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -161.16 17.79 0.19 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -62.55 148.27 90.94 Favored Pre-proline 0 C--O 1.238 0.49 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 173.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -64.54 -20.36 65.7 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 123.797 2.998 . . . . 0.0 112.922 -169.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.613 ' O ' HG22 ' A' ' 19' ' ' VAL . 47.0 m-80 -84.64 -16.13 43.04 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 117.919 -1.038 . . . . 0.0 112.649 -161.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -48.86 -34.39 12.49 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.134 0.974 . . . . 0.0 111.183 -173.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.66 -30.54 5.57 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 178.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.613 HG22 ' O ' ' A' ' 16' ' ' ASN . 5.5 m -62.37 -23.36 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 120.148 1.34 . . . . 0.0 112.293 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.24 -10.96 53.61 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 119.788 1.176 . . . . 0.0 111.634 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 21.7 mt -94.27 -38.96 10.76 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 -173.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -75.24 83.77 2.4 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 176.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -49.15 -26.76 3.0 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.002 1.721 . . . . 0.0 114.246 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.52 -36.01 63.78 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.459 1.504 . . . . 0.0 111.379 173.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 45.5 m170 -68.51 -47.35 67.2 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.255 1.022 . . . . 0.0 109.439 171.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 167.19 178.12 39.29 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 174.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 64.4 tp -84.3 139.21 32.46 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 122.218 -0.578 . . . . 0.0 111.457 -176.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -142.29 157.95 44.26 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.018 1.327 . . . . 0.0 109.299 160.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -169.43 147.57 3.65 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 131.46 3.904 . . . . 0.0 108.258 178.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -72.61 106.75 4.77 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.797 1.639 . . . . 0.0 111.094 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.9 tpp180 -107.71 66.43 0.66 Allowed 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 177.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.47 -170.51 55.05 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-O 123.518 1.621 . . . . 0.0 113.266 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 77.8 mtm180 -122.52 165.37 16.52 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 125.064 1.345 . . . . 0.0 110.042 -171.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -168.82 177.57 42.6 Favored Glycine 0 C--N 1.334 0.45 0 O-C-N 121.583 -0.698 . . . . 0.0 112.994 173.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 30.2 p -148.43 153.27 38.3 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.219 1.808 . . . . 0.0 107.696 178.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.1 p -82.18 111.16 18.03 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 121.453 1.933 . . . . 0.0 107.154 173.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -76.02 -29.72 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 O-C-N 121.945 -0.472 . . . . 0.0 111.009 170.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -60.72 113.82 2.68 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 154.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 29.2 m -66.09 144.11 56.9 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 168.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.638 ' HB3' HD21 ' A' ' 53' ' ' LEU . 24.3 m-85 -145.46 154.86 53.43 Favored Pre-proline 0 CA--C 1.547 0.853 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -173.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.446 ' HG2' ' HB2' ' A' ' 54' ' ' LEU . 82.0 Cg_endo -84.24 103.79 0.99 Allowed 'Trans proline' 0 CA--C 1.544 1.016 1 C-N-CA 126.224 4.616 . . . . 0.0 115.194 -172.433 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.417 ' HB2' ' HE1' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -105.87 103.23 12.68 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 120.489 -1.382 . . . . 0.0 107.721 179.814 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.1 m -124.97 127.83 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 127.007 2.123 . . . . 0.0 112.543 -174.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.423 HG21 HD12 ' A' ' 141' ' ' LEU . 9.0 mt -93.68 93.84 4.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -172.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.44 -179.54 4.52 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.906 1.282 . . . . 0.0 109.475 172.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.59 144.06 6.41 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.459 1.028 . . . . 0.0 111.914 164.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -72.35 -12.33 61.08 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -172.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 41.6 m-70 -106.4 13.81 28.09 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.325 1.05 . . . . 0.0 111.414 172.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.2 m120 58.32 73.6 0.47 Allowed 'General case' 0 C--N 1.341 0.227 0 C-N-CA 127.147 2.179 . . . . 0.0 108.83 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 64.1 mt -110.02 86.76 5.22 Favored Pre-proline 0 N--CA 1.449 -0.516 0 C-N-CA 125.112 1.365 . . . . 0.0 107.834 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -59.58 126.63 21.16 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.44 1.426 . . . . 0.0 111.879 171.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 67.2 m95 -104.81 126.21 51.66 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 128.239 2.615 . . . . 0.0 108.19 173.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.638 HD21 ' HB3' ' A' ' 40' ' ' PHE . 1.2 tm? -92.08 124.38 36.13 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 168.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.446 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 0.3 OUTLIER -95.47 149.13 21.75 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -179.809 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -76.55 89.99 3.31 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.81 82.91 19.85 Favored Pre-proline 0 N--CA 1.467 0.392 0 O-C-N 120.901 -1.125 . . . . 0.0 110.229 172.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -61.88 134.73 51.61 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 122.236 1.957 . . . . 0.0 109.568 -177.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.94 -1.31 84.97 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-O 117.027 -1.985 . . . . 0.0 114.337 175.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.5 tppt? -128.11 136.26 50.92 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 121.084 2.442 . . . . 0.0 107.243 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 120.51 -113.08 2.31 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 107.378 -2.289 . . . . 0.0 107.378 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.477 ' HB2' ' HG3' ' A' ' 131' ' ' GLU . 2.6 p80 -160.88 172.36 17.1 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.79 1.636 . . . . 0.0 108.785 173.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 41.9 m -73.61 103.27 4.15 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.187 0.995 . . . . 0.0 111.173 170.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.7 t -78.07 107.82 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.733 1.213 . . . . 0.0 111.281 177.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.9 p -65.66 153.46 41.59 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.201 0.6 . . . . 0.0 111.163 177.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -173.58 -157.55 15.53 Favored Glycine 0 C--N 1.343 0.938 0 O-C-N 121.286 -0.884 . . . . 0.0 112.941 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -145.0 167.0 23.7 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.838 1.655 . . . . 0.0 109.569 174.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 71.0 mt -113.69 126.8 71.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 -172.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -117.56 115.52 25.3 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -67.79 81.62 0.19 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.121 1.368 . . . . 0.0 109.049 169.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.2 m -82.6 155.7 3.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 O-C-N 121.047 -1.033 . . . . 0.0 109.088 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.11 -178.8 4.9 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 121.921 0.867 . . . . 0.0 111.544 175.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.86 -45.02 93.78 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.979 1.312 . . . . 0.0 111.452 174.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 42.4 tp60 -59.86 -41.51 91.62 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 119.297 0.953 . . . . 0.0 110.139 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 59.3 tpp -65.88 -51.8 55.64 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 118.596 0.634 . . . . 0.0 110.584 176.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.23 -26.13 66.17 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -76.68 -55.04 5.86 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 123.951 0.9 . . . . 0.0 109.732 171.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -52.68 -48.8 66.29 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.152 0.581 . . . . 0.0 111.255 -177.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 87.7 mt -62.39 -27.04 68.8 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 118.968 -0.539 . . . . 0.0 111.526 -178.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -67.39 -33.39 75.1 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.993 1.27 . . . . 0.0 109.587 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -75.9 -51.04 13.34 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.65 0.78 . . . . 0.0 110.701 172.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -66.17 -27.48 68.04 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.543 0.737 . . . . 0.0 112.572 -174.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.438 ' HG3' ' CE2' ' A' ' 115' ' ' TYR . 63.3 mm-40 -100.46 15.3 28.34 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.851 0.86 . . . . 0.0 111.093 177.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 52.23 28.09 5.29 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.458 1.903 . . . . 0.0 113.028 163.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 7.5 p -72.54 163.35 68.46 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.508 -1.37 . . . . 0.0 109.091 172.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -70.48 -4.01 9.07 Favored 'Cis proline' 0 CA--C 1.547 1.125 0 CA-C-N 119.99 1.032 . . . . 0.0 114.458 -10.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.1 m -60.1 -63.07 1.43 Allowed 'General case' 0 C--N 1.342 0.273 0 CA-C-N 119.561 1.073 . . . . 0.0 110.509 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 1.4 mtm -74.08 -77.69 0.11 Allowed 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.033 0.933 . . . . 0.0 109.683 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -97.83 -178.47 4.11 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.643 1.177 . . . . 0.0 108.934 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -138.13 -7.01 1.59 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 175.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? 61.28 134.22 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 128.459 2.704 . . . . 0.0 111.962 -173.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.9 m -152.73 153.76 33.86 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 120.463 -1.398 . . . . 0.0 110.501 174.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -84.62 126.93 33.78 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 129.137 2.975 . . . . 0.0 112.785 171.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.687 HD21 ' HB ' ' A' ' 114' ' ' VAL . 2.3 pt? -160.29 170.01 21.98 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 126.748 2.019 . . . . 0.0 112.182 -166.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 11.6 tp60 -94.5 131.35 40.3 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -162.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 35.5 t -135.3 119.79 27.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -177.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -67.48 143.16 56.35 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 168.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.597 ' CG1' ' HA ' ' A' ' 108' ' ' ASP . 2.4 p -90.79 126.13 43.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 176.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.53 -14.62 24.88 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 121.45 -0.782 . . . . 0.0 111.665 177.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -176.03 140.34 0.41 Allowed 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 103.582 -2.747 . . . . 0.0 103.582 -175.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 62.5 t-105 -125.47 139.34 53.71 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 171.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -109.44 114.26 27.76 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 123.848 0.718 . . . . 0.0 109.937 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.11 -165.02 42.9 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-O 121.65 0.583 . . . . 0.0 112.102 169.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -64.61 167.34 7.36 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.591 1.156 . . . . 0.0 111.481 -175.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.21 59.24 3.16 Favored Glycine 0 CA--C 1.525 0.688 0 O-C-N 121.931 -0.481 . . . . 0.0 112.267 173.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -101.71 89.15 1.4 Allowed Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 130.626 3.57 . . . . 0.0 110.656 -168.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -60.93 -14.47 32.94 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 124.081 3.187 . . . . 0.0 114.286 -171.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 95.07 176.19 37.84 Favored Glycine 0 CA--C 1.531 1.081 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -165.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.597 ' HA ' ' CG1' ' A' ' 97' ' ' VAL . 10.6 m-20 -69.82 0.91 4.95 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -162.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 61.8 p -137.74 146.66 43.94 Favored 'General case' 0 N--CA 1.427 -1.588 0 C-N-CA 117.124 -1.83 . . . . 0.0 111.725 150.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.1 p -110.27 159.68 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 114.29 -1.323 . . . . 0.0 109.059 173.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -89.37 112.96 24.2 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 156.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 14.1 m -99.89 171.48 7.83 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 165.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.428 ' CE2' ' HA ' ' A' ' 2' ' ' ALA . 19.6 m-85 -90.84 142.5 27.7 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 161.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.687 ' HB ' HD21 ' A' ' 93' ' ' LEU . 53.2 t -129.94 143.73 40.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 172.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.438 ' CE2' ' HG3' ' A' ' 82' ' ' GLU . 8.9 m-85 -70.53 95.78 1.11 Allowed 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 167.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 80.5 p -109.42 173.39 6.34 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.948 171.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.7 t -142.19 121.9 13.44 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 175.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -93.0 4.78 53.42 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.359 0.664 . . . . 0.0 111.476 -178.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 47.3 p -118.83 43.56 2.52 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.085 1.354 . . . . 0.0 107.875 -171.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.407 ' HB3' HD12 ' A' ' 54' ' ' LEU . 40.2 p90 -78.48 171.15 15.52 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.477 -174.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -101.87 151.11 37.91 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 123.839 0.856 . . . . 0.0 110.272 -177.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -66.08 -37.35 25.96 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.916 2.411 . . . . 0.0 110.93 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.94 -0.66 9.73 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.81 1.644 . . . . 0.0 113.172 175.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 44.8 m0 -98.95 -24.72 14.83 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 118.882 0.765 . . . . 0.0 109.491 168.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 12.2 mt -75.89 -30.56 58.86 Favored 'General case' 0 CA--C 1.523 -0.064 0 O-C-N 120.94 -1.1 . . . . 0.0 111.554 177.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -64.25 -24.99 67.86 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.987 0.812 . . . . 0.0 111.965 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.0 mt -64.91 150.99 94.15 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 124.78 1.232 . . . . 0.0 110.429 -172.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -65.52 156.79 61.75 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.932 2.421 . . . . 0.0 110.441 175.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -106.62 159.32 16.28 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.628 0.251 . . . . 0.0 110.497 -172.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -134.06 106.23 7.11 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.754 0.822 . . . . 0.0 111.948 -174.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.477 ' HG3' ' HB2' ' A' ' 61' ' ' HIS . 0.5 OUTLIER -58.33 -13.59 5.58 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.794 1.638 . . . . 0.0 114.173 -174.02 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 56.8 p -150.4 176.46 10.9 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.293 1.837 . . . . 0.0 107.071 173.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -129.16 166.19 19.82 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 168.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -158.11 164.63 36.45 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.218 1.807 . . . . 0.0 109.688 -175.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.3 t -109.32 -3.38 17.19 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.79 1.636 . . . . 0.0 111.061 167.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -140.14 102.72 4.44 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 128.642 2.777 . . . . 0.0 105.643 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -161.48 165.31 35.49 Favored Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 126.983 2.23 . . . . 0.0 111.836 -173.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.32 -18.78 55.87 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.286 2.657 . . . . 0.0 112.543 164.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -77.2 85.84 3.66 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 169.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.27 43.68 0.1 OUTLIER Glycine 0 CA--C 1.535 1.337 0 C-N-CA 127.749 2.595 . . . . 0.0 115.388 178.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.423 HD12 HG21 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -143.23 84.25 1.81 Allowed 'General case' 0 C--O 1.236 0.346 0 C-N-CA 127.316 2.246 . . . . 0.0 108.423 -172.271 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -120.72 155.0 34.84 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 118.193 -0.908 . . . . 0.0 109.727 -169.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -52.13 130.37 30.04 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 124.014 0.821 . . . . 0.0 109.329 -175.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.536 0.409 0 C-N-CA 123.268 0.627 . . . . 0.0 110.808 -169.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.313 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -81.48 124.0 29.08 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 174.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.8 pt -123.77 -176.02 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 123.785 0.834 . . . . 0.0 110.518 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.578 ' CE2' HG23 ' A' ' 36' ' ' THR . 20.4 t80 -124.14 169.43 11.71 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.035 1.334 . . . . 0.0 108.502 174.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.444 HG12 ' H ' ' A' ' 66' ' ' GLU . 7.6 p -122.95 153.54 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 123.837 0.855 . . . . 0.0 109.882 175.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.413 ' CD1' ' N ' ' A' ' 7' ' ' TYR . 0.3 OUTLIER -92.62 -41.11 10.38 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 -171.076 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.444 ' HA3' ' HB3' ' A' ' 133' ' ' TYR . . . 169.45 -19.01 0.07 OUTLIER Glycine 0 CA--C 1.528 0.858 0 C-N-CA 124.743 1.163 . . . . 0.0 113.372 172.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.47 -30.21 71.37 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 128.224 2.609 . . . . 0.0 113.735 -176.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.9 61.1 1.18 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 175.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -151.75 -85.82 0.07 Allowed 'General case' 0 C--O 1.224 -0.279 0 O-C-N 121.239 -0.913 . . . . 0.0 109.86 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 -62.0 -53.62 53.12 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.069 0.85 . . . . 0.0 111.591 -166.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 161.21 30.24 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 -175.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -63.35 155.8 72.89 Favored Pre-proline 0 N--CA 1.45 -0.433 0 C-N-CA 124.83 1.252 . . . . 0.0 108.401 171.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -65.37 -12.58 35.55 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.207 2.604 . . . . 0.0 112.593 -174.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -95.14 24.96 4.53 Favored 'General case' 0 C--O 1.221 -0.415 0 C-N-CA 126.643 1.977 . . . . 0.0 111.454 -175.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -75.89 -55.64 5.43 Favored 'General case' 0 C--N 1.332 -0.18 0 O-C-N 120.442 -1.411 . . . . 0.0 110.116 173.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.04 -24.09 23.11 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -169.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.9 m -60.17 -34.81 58.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 119.675 1.125 . . . . 0.0 112.141 178.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.1 ptp -77.18 -7.7 56.29 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 119.472 1.033 . . . . 0.0 112.76 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 40.5 mt -89.47 7.0 38.32 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.832 1.253 . . . . 0.0 108.974 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -110.23 98.3 7.58 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -59.38 -21.8 60.42 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.867 -0.521 . . . . 0.0 111.563 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.7 t -70.33 -29.19 65.84 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.873 1.269 . . . . 0.0 112.016 175.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 35.1 m170 -79.59 -32.44 41.93 Favored 'General case' 0 CA--C 1.529 0.147 0 O-C-N 121.351 -0.843 . . . . 0.0 109.739 168.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 158.15 175.67 29.34 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 165.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 65.0 tp -74.57 134.0 42.19 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 175.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.8 143.59 31.41 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 155.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -152.01 149.9 29.39 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 165.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -62.18 104.76 0.51 Allowed 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.973 1.709 . . . . 0.0 108.663 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.9 tpp180 -123.56 67.84 1.02 Allowed 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.15 -170.86 45.58 Favored Glycine 0 N--CA 1.435 -1.4 0 CA-C-O 123.824 1.791 . . . . 0.0 111.915 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -131.04 158.91 39.07 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 125.436 1.494 . . . . 0.0 108.257 -170.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.99 173.98 38.4 Favored Glycine 0 CA--C 1.507 -0.463 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.741 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.0 m -141.67 145.95 35.54 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 173.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.578 HG23 ' CE2' ' A' ' 5' ' ' PHE . 25.2 p -71.65 93.17 1.22 Allowed 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 163.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.9 m -63.41 -38.46 82.25 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.106 0 CA-C-O 121.206 0.527 . . . . 0.0 109.892 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.81 118.23 7.43 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 105.218 -2.141 . . . . 0.0 105.218 170.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.74 145.92 50.96 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -141.25 160.62 56.82 Favored Pre-proline 0 N--CA 1.449 -0.475 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 177.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -80.28 67.45 8.62 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 122.532 2.155 . . . . 0.0 113.987 -175.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 53' ' ' LEU . 34.0 tp -72.72 98.63 2.42 Favored 'General case' 0 CA--C 1.553 1.082 0 O-C-N 119.757 -1.839 . . . . 0.0 111.356 178.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.5 m -121.68 126.74 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 119.625 1.102 . . . . 0.0 112.763 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 51.1 mt -69.84 111.67 3.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 173.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -125.98 175.03 8.0 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.457 1.103 . . . . 0.0 108.782 176.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.01 152.74 7.91 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-O 122.61 1.117 . . . . 0.0 111.544 171.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -70.06 -23.41 63.08 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 123.526 0.731 . . . . 0.0 112.34 -176.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -94.44 13.27 24.36 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.429 0.692 . . . . 0.0 111.391 -177.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.567 HD22 ' HB2' ' A' ' 141' ' ' LEU . 2.1 m120 63.22 56.78 1.67 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.04 1.736 . . . . 0.0 107.592 171.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 80.5 mt -107.29 87.91 3.56 Favored Pre-proline 0 CA--C 1.533 0.288 0 C-N-CA 127.253 2.221 . . . . 0.0 107.476 -167.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -54.33 139.76 73.35 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 120.846 1.03 . . . . 0.0 111.652 169.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 6.2 m95 -123.3 146.29 48.02 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 167.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 42' ' ' LEU 0.295 0.9 OUTLIER -97.16 -8.86 29.07 Favored 'General case' 0 C--O 1.219 -0.529 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 -177.741 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 36.7 mt 44.1 -160.8 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.312 1 C-N-CA 134.825 5.25 . . . . 0.0 110.069 -172.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -130.95 91.43 3.05 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 120.848 -1.158 . . . . 0.0 110.225 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.57 85.72 5.22 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 118.968 -0.539 . . . . 0.0 111.616 168.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -59.75 134.41 57.24 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.754 1.636 . . . . 0.0 109.257 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.74 10.43 81.35 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-O 119.568 -0.573 . . . . 0.0 113.618 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? -123.03 155.03 37.68 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.779 1.79 . . . . 0.0 108.444 172.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.54 ' HA2' ' CD2' ' A' ' 129' ' ' TYR . . . 67.96 -146.39 46.39 Favored Glycine 0 C--N 1.334 0.458 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 -174.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -127.45 169.36 13.73 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 117.833 0.816 . . . . 0.0 108.849 -169.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 5.1 p -59.8 169.67 1.35 Allowed 'General case' 0 CA--C 1.512 -0.486 0 O-C-N 121.665 -0.647 . . . . 0.0 112.122 170.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 54.9 t -135.49 118.41 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.792 168.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 72.5 p -74.72 154.76 38.27 Favored 'General case' 0 C--O 1.239 0.512 0 O-C-N 121.756 -0.59 . . . . 0.0 110.237 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.59 -164.96 28.91 Favored Glycine 0 C--N 1.337 0.608 0 CA-C-O 122.202 0.89 . . . . 0.0 111.761 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.444 ' H ' HG12 ' A' ' 6' ' ' VAL . 0.5 OUTLIER -117.57 156.82 27.43 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 124.886 1.274 . . . . 0.0 108.662 179.206 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 73.2 mt -101.34 130.33 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 170.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -116.45 120.96 40.46 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -62.54 116.18 4.91 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 156.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.3 m -123.89 175.53 6.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 CA-C-N 118.429 0.559 . . . . 0.0 109.978 174.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -125.6 176.18 7.05 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.954 0.902 . . . . 0.0 109.208 169.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -53.13 -37.62 61.95 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.682 1.593 . . . . 0.0 112.204 -175.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 42.8 tp60 -61.15 -41.99 97.75 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 118.465 -0.778 . . . . 0.0 111.133 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -67.04 -44.74 79.44 Favored 'General case' 0 C--O 1.225 -0.232 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.2 tp -62.91 -29.53 70.85 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -176.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 62.3 mtt180 -74.69 -38.58 62.33 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 121.949 -0.47 . . . . 0.0 111.992 172.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -66.65 -48.74 68.47 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 119.23 -0.414 . . . . 0.0 110.228 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.8 mp -51.02 -50.32 58.78 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.353 1.461 . . . . 0.0 110.256 174.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -49.67 -43.6 47.31 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.712 0.805 . . . . 0.0 112.016 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -79.35 -13.74 59.44 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.57 2.348 . . . . 0.0 112.709 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -91.12 -42.99 10.16 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.355 1.462 . . . . 0.0 109.664 -175.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . 0.252 0.4 OUTLIER -90.03 9.46 27.92 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.75 1.22 . . . . 0.0 114.009 170.844 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 61.01 36.04 18.7 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.112 1.365 . . . . 0.0 111.105 167.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 6.5 m -79.03 166.53 41.49 Favored Pre-proline 0 C--N 1.323 -0.585 0 C-N-CA 125.061 1.344 . . . . 0.0 108.796 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -64.94 -3.42 2.81 Favored 'Cis proline' 0 CA--C 1.545 1.027 0 CA-C-N 120.082 1.065 . . . . 0.0 113.598 -17.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.76 -66.57 0.37 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.849 1.66 . . . . 0.0 111.193 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 19.4 mtm -83.33 -63.83 1.28 Allowed 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.83 -0.544 . . . . 0.0 110.362 -176.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -103.91 170.11 8.11 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -177.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.91 137.62 38.2 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 120.406 -1.434 . . . . 0.0 107.138 176.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.415 ' HB2' ' CE1' ' A' ' 115' ' ' TYR . 8.4 tmm_? -78.7 123.36 27.07 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 123.899 0.879 . . . . 0.0 108.984 -174.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.6 m -123.96 160.61 27.2 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 123.855 0.862 . . . . 0.0 108.884 -177.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -98.2 140.6 32.25 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 124.018 0.927 . . . . 0.0 109.212 169.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.502 HD11 HG23 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -152.15 169.17 23.08 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.963 0.905 . . . . 0.0 111.483 -177.81 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -95.81 119.86 35.05 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.83 1.652 . . . . 0.0 110.083 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 95.0 t -117.71 136.95 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 177.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -71.9 148.88 45.65 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 123.813 0.845 . . . . 0.0 111.244 172.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.0 t -87.97 95.07 4.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 125.305 1.442 . . . . 0.0 107.306 167.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.35 -24.94 50.64 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.454 1.101 . . . . 0.0 110.724 172.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -162.49 157.32 22.13 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 127.856 2.462 . . . . 0.0 105.096 173.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 75.1 t-105 -145.66 121.83 10.82 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 169.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -105.97 92.55 4.2 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.611 0.764 . . . . 0.0 109.864 176.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 135.66 -179.45 17.76 Favored Glycine 0 C--O 1.227 -0.343 0 C-N-CA 124.233 0.921 . . . . 0.0 112.687 168.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -68.12 155.69 39.06 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 171.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 102.21 56.09 0.84 Allowed Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 124.878 1.228 . . . . 0.0 111.059 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -100.11 91.02 1.5 Allowed Pre-proline 0 C--N 1.327 -0.399 0 C-N-CA 129.591 3.157 . . . . 0.0 106.516 -171.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.567 ' CG ' HG12 ' A' ' 110' ' ' VAL . 61.8 Cg_endo -66.84 -23.82 47.39 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 124.417 3.411 . . . . 0.0 112.362 -178.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 123.23 -172.66 16.12 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 -165.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.66 -6.6 26.91 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -170.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 67.8 p -151.76 157.91 42.62 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 119.072 0.851 . . . . 0.0 111.816 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.567 HG12 ' CG ' ' A' ' 106' ' ' PRO . 3.0 m -136.69 169.05 20.7 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 C-N-CA 125.071 1.348 . . . . 0.0 108.571 -171.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -108.65 93.13 4.36 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 177.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 95.3 m -79.19 176.97 9.18 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.379 0.609 . . . . 0.0 109.915 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -107.72 145.95 32.76 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 158.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.502 HG23 HD11 ' A' ' 93' ' ' LEU . 24.3 t -138.8 143.06 32.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 128.017 2.527 . . . . 0.0 106.44 174.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.415 ' CE1' ' HB2' ' A' ' 90' ' ' ARG . 16.3 m-85 -84.9 104.59 14.99 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 167.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 11.1 p -99.12 -171.49 2.1 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.48 1.912 . . . . 0.0 108.626 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.7 t -147.98 150.88 34.81 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 156.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -114.91 -12.48 12.05 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 128.215 2.606 . . . . 0.0 111.384 176.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 5.8 p -88.81 9.07 25.93 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.329 1.452 . . . . 0.0 113.807 -169.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.549 ' CE1' HD21 ' A' ' 125' ' ' LEU . 30.3 p90 -69.0 164.36 22.53 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.787 1.235 . . . . 0.0 112.72 -170.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -93.82 153.69 40.99 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 125.258 1.423 . . . . 0.0 110.324 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.6 ' HA ' HD23 ' A' ' 125' ' ' LEU . 36.8 Cg_endo -62.14 -27.29 78.64 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.587 2.858 . . . . 0.0 113.548 -174.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -49.77 -43.01 47.91 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.243 1.017 . . . . 0.0 112.113 176.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 42.2 m0 -70.55 -15.85 62.82 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 122.485 0.314 . . . . 0.0 111.339 -172.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.6 HD23 ' HA ' ' A' ' 122' ' ' PRO . 2.7 mm? -82.65 -10.96 58.7 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.059 0.944 . . . . 0.0 112.367 178.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -96.39 -16.02 21.48 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.685 0.794 . . . . 0.0 110.992 175.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 88.4 mt -68.42 155.85 91.7 Favored Pre-proline 0 N--CA 1.469 0.497 0 C-N-CA 124.149 0.979 . . . . 0.0 109.561 176.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -79.62 154.5 23.84 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 121.786 1.657 . . . . 0.0 110.497 173.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.54 ' CD2' ' HA2' ' A' ' 60' ' ' GLY . 44.5 m-85 -85.79 175.87 8.44 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 126.357 1.863 . . . . 0.0 111.108 177.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -142.7 161.11 38.95 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.625 1.97 . . . . 0.0 107.984 -178.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -110.02 -2.65 16.93 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 122.684 1.231 . . . . 0.0 112.544 -177.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.5 t -164.11 154.38 14.91 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.444 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . 7.9 t80 -108.98 116.59 32.28 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.194 167.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -143.51 125.11 14.9 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.576 2.35 . . . . 0.0 108.225 -168.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.2 p -68.64 -47.55 66.31 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 169.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -75.42 43.42 0.23 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.706 2.003 . . . . 0.0 110.61 170.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -110.73 163.03 12.35 Favored Glycine 0 C--N 1.332 0.327 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 166.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.11 -14.61 44.59 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.749 2.3 . . . . 0.0 113.122 -175.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 64.0 m-70 -62.79 -14.52 46.17 Favored 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 116.828 2.158 . . . . 0.0 116.828 -162.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 75.53 -29.85 1.23 Allowed Glycine 0 CA--C 1.537 1.409 0 CA-C-N 120.406 1.457 . . . . 0.0 115.295 172.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.567 ' HB2' HD22 ' A' ' 49' ' ' ASN . 0.3 OUTLIER -97.37 97.37 9.06 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 126.339 1.856 . . . . 0.0 110.949 179.325 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -104.58 162.55 13.16 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 120.865 -1.147 . . . . 0.0 109.872 -173.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -57.35 142.17 44.52 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 119.004 -0.522 . . . . 0.0 110.151 -176.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 31.9 t-20 . . . . . 0 C--O 1.234 0.241 0 C-N-CA 125.295 1.438 . . . . 0.0 107.765 176.96 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.316 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -80.57 142.48 34.05 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 118.492 0.587 . . . . 0.0 111.213 -175.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.419 HG22 ' HB2' ' A' ' 113' ' ' PHE . 21.8 pt -133.62 -176.13 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 124.407 1.083 . . . . 0.0 109.913 178.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.486 ' HB3' HG22 ' A' ' 114' ' ' VAL . 12.4 t80 -120.74 164.68 16.2 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.275 1.43 . . . . 0.0 109.011 172.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 p -111.6 148.84 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.771 0.829 . . . . 0.0 112.309 -175.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -92.24 7.04 44.46 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -168.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 106.84 -33.32 6.51 Favored Glycine 0 N--CA 1.467 0.715 0 O-C-N 120.54 -1.35 . . . . 0.0 110.057 -164.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.412 HG22 ' ND2' ' A' ' 16' ' ' ASN . 1.0 OUTLIER -66.64 -24.05 66.24 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 129.8 3.24 . . . . 0.0 114.771 -170.264 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.407 HD21 HG12 ' A' ' 19' ' ' VAL . 4.1 mp -146.07 48.23 1.22 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.471 1.032 . . . . 0.0 109.258 -173.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -130.97 -85.53 0.51 Allowed 'General case' 0 N--CA 1.468 0.452 0 O-C-N 120.254 -1.529 . . . . 0.0 111.582 176.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.11 -66.79 0.42 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.888 1.222 . . . . 0.0 109.383 -178.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 174.82 86.24 0.06 OUTLIER Glycine 0 N--CA 1.431 -1.691 0 N-CA-C 104.957 -3.257 . . . . 0.0 104.957 -178.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.449 ' HG3' ' HD2' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -107.5 160.27 27.23 Favored Pre-proline 0 N--CA 1.445 -0.701 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 174.211 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.449 ' HD2' ' HG3' ' A' ' 14' ' ' GLN . 12.2 Cg_endo -61.49 -27.4 82.14 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.937 2.425 . . . . 0.0 112.343 -174.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.412 ' ND2' HG22 ' A' ' 9' ' ' THR . 4.0 m-80 -73.52 -16.26 61.28 Favored 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 125.182 1.393 . . . . 0.0 110.842 -173.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -64.36 -32.85 74.63 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 120.115 1.325 . . . . 0.0 112.153 -159.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.94 -19.96 47.76 Favored 'General case' 0 C--O 1.224 -0.279 0 O-C-N 121.409 -0.807 . . . . 0.0 113.044 176.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.487 HG21 ' CE2' ' A' ' 77' ' ' PHE . 1.4 p -55.92 -35.58 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 119.179 0.899 . . . . 0.0 110.956 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.2 ptp -87.97 -4.92 58.77 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -176.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 73.5 mt -90.47 -6.38 54.91 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.505 1.122 . . . . 0.0 110.67 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -106.21 99.91 9.47 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 106.174 -1.788 . . . . 0.0 106.174 172.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 25.6 t-80 -59.03 -18.93 39.11 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.841 1.256 . . . . 0.0 113.285 -176.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.7 m -61.82 -28.34 69.41 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 120.972 -1.08 . . . . 0.0 113.674 169.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -78.69 -1.91 36.7 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 119.241 0.928 . . . . 0.0 111.803 173.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.16 176.65 19.51 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 127.037 2.256 . . . . 0.0 110.571 -176.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -93.76 137.0 33.46 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.521 1.528 . . . . 0.0 110.177 -172.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.16 125.21 15.29 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.474 1.11 . . . . 0.0 110.664 165.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -133.29 126.0 30.51 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 125.228 1.411 . . . . 0.0 109.878 -176.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -60.07 108.53 0.79 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.053 1.741 . . . . 0.0 109.501 -178.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.0 tpp180 -121.15 66.37 0.87 Allowed 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.871 1.268 . . . . 0.0 109.902 -174.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.21 -171.56 55.16 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 176.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.524 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 32.2 mtp85 -123.24 169.19 11.53 Favored 'General case' 0 CA--C 1.511 -0.534 0 O-C-N 121.965 -0.727 . . . . 0.0 111.974 -174.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -166.66 173.52 42.03 Favored Glycine 0 CA--C 1.506 -0.526 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.745 175.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 25.8 p -142.99 161.01 39.25 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.999 -0.6 . . . . 0.0 109.558 171.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.6 p -76.57 103.88 6.79 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 106.328 -1.731 . . . . 0.0 106.328 164.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -62.4 -32.17 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 119.503 1.047 . . . . 0.0 110.435 171.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.23 124.74 23.47 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 167.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.24 131.4 44.84 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 125.479 1.511 . . . . 0.0 108.029 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -140.39 157.1 69.21 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 119.472 1.033 . . . . 0.0 108.406 -177.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -70.04 108.05 2.05 Favored 'Trans proline' 0 N--CA 1.454 -0.851 1 C-N-CA 125.525 4.15 . . . . 0.0 108.438 171.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.492 HD21 ' CE2' ' A' ' 133' ' ' TYR . 3.0 tm? -117.84 99.38 6.89 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 173.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.6 m -132.58 141.46 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 C-N-CA 126.386 1.874 . . . . 0.0 108.864 -167.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.529 ' HB ' HD22 ' A' ' 141' ' ' LEU . 4.7 mp -109.73 121.21 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -171.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.3 -170.11 3.0 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.295 1.438 . . . . 0.0 108.707 -173.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.79 164.29 4.33 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.337 0.97 . . . . 0.0 111.145 -174.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -78.5 2.74 18.03 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.598 1.159 . . . . 0.0 113.271 -172.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -132.14 17.08 4.57 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.836 1.254 . . . . 0.0 112.445 -171.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.0 m120 56.7 72.87 0.48 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.351 1.86 . . . . 0.0 111.117 -177.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 94.4 mt -110.49 89.49 8.93 Favored Pre-proline 0 C--N 1.324 -0.518 0 C-N-CA 129.267 3.027 . . . . 0.0 107.488 -169.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -52.65 134.1 52.24 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 CA-C-N 120.872 1.347 . . . . 0.0 111.927 171.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 70.8 m95 -118.29 137.76 52.84 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.171 1.388 . . . . 0.0 107.309 170.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.469 ' HG ' HD23 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -107.93 94.61 5.17 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 171.661 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.6 mt -76.07 143.86 41.09 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 -176.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -79.64 75.86 6.28 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.764 -0.585 . . . . 0.0 110.496 -175.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.64 83.32 53.98 Favored Pre-proline 0 N--CA 1.468 0.428 0 C-N-CA 123.728 0.811 . . . . 0.0 109.887 -176.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -63.62 148.99 92.0 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 121.363 1.375 . . . . 0.0 108.815 178.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.6 2.34 60.14 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-O 117.637 -1.646 . . . . 0.0 114.898 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.2 tppt? -124.94 121.71 35.24 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 121.75 2.775 . . . . 0.0 106.291 177.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.531 ' HA2' ' CD2' ' A' ' 129' ' ' TYR . . . 108.2 -147.07 16.48 Favored Glycine 0 N--CA 1.459 0.228 0 CA-C-N 120.601 1.546 . . . . 0.0 110.766 -176.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -137.01 173.99 11.1 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 123.936 0.894 . . . . 0.0 110.198 -168.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 61.4 m -78.08 113.6 16.16 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.498 0.719 . . . . 0.0 110.251 -178.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 38.2 t -78.34 111.16 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 124.183 0.993 . . . . 0.0 108.339 -177.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 51.6 p -92.92 151.22 20.07 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 119.17 0.895 . . . . 0.0 111.762 -173.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -178.92 -163.83 30.67 Favored Glycine 0 C--N 1.337 0.605 0 O-C-N 121.277 -0.889 . . . . 0.0 113.588 -163.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 1.5 pt-20 -120.73 177.37 5.11 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 87.7 mt -121.69 115.58 46.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 169.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -89.71 130.84 35.92 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 168.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -70.57 130.16 41.09 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 152.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.3 m -134.04 167.92 25.1 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 CA-C-O 121.144 0.497 . . . . 0.0 110.35 177.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.86 -179.42 4.28 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 122.427 1.108 . . . . 0.0 111.046 167.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.3 -42.76 96.22 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 115.85 -2.024 . . . . 0.0 111.527 177.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.1 mm100 -55.05 -43.16 73.56 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 120.522 1.51 . . . . 0.0 110.763 177.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 39.1 tpp -66.1 -51.46 57.83 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 119.09 -0.481 . . . . 0.0 110.36 178.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.04 -28.16 66.17 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 118.831 0.742 . . . . 0.0 112.034 177.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 35.4 mtt180 -75.19 -43.81 49.99 Favored 'General case' 0 C--N 1.337 0.052 0 C-N-CA 125.625 1.57 . . . . 0.0 111.033 179.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.487 ' CE2' HG21 ' A' ' 19' ' ' VAL . 9.0 t80 -57.94 -54.7 43.94 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 123.541 0.737 . . . . 0.0 109.332 175.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 mp -49.74 -41.15 43.15 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.115 0.966 . . . . 0.0 110.613 178.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -65.94 -1.19 2.79 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.092 1.757 . . . . 0.0 114.277 178.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -129.83 3.85 4.94 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.261 2.224 . . . . 0.0 111.132 178.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -102.59 -47.13 4.54 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.932 1.293 . . . . 0.0 110.166 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -75.17 1.51 13.17 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -175.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.0 t70 54.13 26.2 6.36 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.301 1.441 . . . . 0.0 112.578 -165.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 1.5 p -63.98 159.19 57.48 Favored Pre-proline 0 CA--C 1.542 0.672 0 O-C-N 119.411 -2.055 . . . . 0.0 109.154 166.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -73.24 -4.06 15.04 Favored 'Cis proline' 0 CA--C 1.546 1.096 0 CA-C-N 119.417 0.827 . . . . 0.0 113.583 -10.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.63 -63.39 1.3 Allowed 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.262 1.425 . . . . 0.0 112.966 -177.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 4.2 mtm -82.58 -55.85 4.21 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 122.785 0.434 . . . . 0.0 110.35 -172.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -109.8 173.03 6.51 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 127.6 2.36 . . . . 0.0 106.993 176.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 -132.17 157.67 43.69 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 120.867 1.667 . . . . 0.0 108.224 160.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.0 tmm_? -80.6 142.77 33.72 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 118.897 0.771 . . . . 0.0 109.107 172.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.7 m -143.4 161.49 38.24 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.673 0.749 . . . . 0.0 109.312 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -114.3 125.02 53.41 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 126.64 1.976 . . . . 0.0 108.317 171.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.428 HD21 ' CG2' ' A' ' 114' ' ' VAL . 2.1 pt? -142.99 -167.0 2.43 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 129.918 3.287 . . . . 0.0 108.688 -166.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 20.7 tp60 -107.5 138.97 42.74 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.491 0.716 . . . . 0.0 111.904 177.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 99.5 t -133.87 135.97 54.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 172.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -76.45 153.3 35.73 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.549 1.539 . . . . 0.0 109.653 169.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 80.7 t -87.33 112.68 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 127.565 2.346 . . . . 0.0 107.58 165.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.5 mp -90.51 -17.87 26.3 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.241 1.416 . . . . 0.0 110.641 171.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -172.18 159.85 4.98 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 129.041 2.936 . . . . 0.0 105.672 173.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 62.7 t-105 -141.81 118.02 10.73 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 119.339 0.972 . . . . 0.0 109.708 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -118.04 62.29 0.76 Allowed 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.914 0.864 . . . . 0.0 112.67 -171.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 150.18 155.15 6.71 Favored Glycine 0 C--O 1.228 -0.254 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 158.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -54.24 149.41 9.85 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.598 1.159 . . . . 0.0 112.079 -162.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 98.16 65.98 0.88 Allowed Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -165.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -100.82 89.1 1.15 Allowed Pre-proline 0 C--O 1.24 0.579 1 C-N-CA 132.509 4.324 . . . . 0.0 108.152 -162.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -72.79 -5.19 16.73 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 124.675 3.584 . . . . 0.0 114.126 -163.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.74 -177.19 44.92 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 109.251 -1.539 . . . . 0.0 109.251 -166.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -64.36 -12.02 38.34 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 -168.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.0 p -137.41 161.79 35.37 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 120.726 1.603 . . . . 0.0 112.457 177.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.5 m -142.65 156.71 18.46 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 125.366 1.466 . . . . 0.0 108.913 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -98.08 98.64 9.93 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.444 -1.688 . . . . 0.0 106.444 160.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 18.6 m -92.05 172.37 8.49 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 168.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.419 ' HB2' HG22 ' A' ' 4' ' ' ILE . 69.0 m-85 -85.68 140.4 30.57 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 162.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.486 HG22 ' HB3' ' A' ' 5' ' ' PHE . 25.5 t -134.61 124.9 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 127.461 2.304 . . . . 0.0 106.052 173.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -72.63 141.08 48.33 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 168.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 55.6 p -138.37 -173.2 3.47 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.19 1.796 . . . . 0.0 109.675 -173.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.4 t -134.63 145.04 48.23 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 165.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -113.59 -8.96 13.28 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.864 1.666 . . . . 0.0 112.073 169.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 31.4 p -105.76 15.42 26.81 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.659 1.184 . . . . 0.0 113.11 -172.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -58.9 149.72 26.22 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 125.832 1.653 . . . . 0.0 113.803 -170.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.64 154.59 88.12 Favored Pre-proline 0 CA--C 1.532 0.283 0 C-N-CA 125.444 1.498 . . . . 0.0 110.961 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.08 -30.81 20.22 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.033 1.822 . . . . 0.0 113.335 178.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.07 -30.25 70.23 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 173.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 43.2 m0 -72.36 -17.32 61.84 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 121.453 -0.779 . . . . 0.0 111.446 -171.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -75.29 -21.29 58.6 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 118.48 -0.772 . . . . 0.0 110.978 172.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 8.9 m-30 -86.14 -19.22 30.46 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.175 0.898 . . . . 0.0 111.639 -177.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 97.2 mt -65.77 151.07 95.56 Favored Pre-proline 0 C--O 1.237 0.415 0 C-N-CA 123.836 0.855 . . . . 0.0 110.385 -175.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.67 146.0 53.38 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.834 2.356 . . . . 0.0 109.183 177.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.531 ' CD2' ' HA2' ' A' ' 60' ' ' GLY . 11.6 m-85 -86.96 163.68 16.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 122.079 0.942 . . . . 0.0 110.831 -175.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.515 ' CE1' HD21 ' A' ' 141' ' ' LEU . 26.2 m-70 -136.99 160.22 39.57 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.845 1.658 . . . . 0.0 108.038 177.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -97.5 -5.47 35.86 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.01 1.324 . . . . 0.0 111.192 174.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 80.7 p -169.34 -175.35 2.2 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 120.963 -1.085 . . . . 0.0 109.798 -169.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.492 ' CE2' HD21 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -158.0 61.85 0.46 Allowed 'General case' 0 C--O 1.239 0.527 0 C-N-CA 126.739 2.016 . . . . 0.0 106.493 -167.713 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -112.02 122.88 48.99 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 -157.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 5.2 t -59.13 -32.15 69.59 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.728 -168.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -91.72 11.77 23.47 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 117.931 0.332 . . . . 0.0 111.697 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -68.41 167.06 44.53 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.486 1.041 . . . . 0.0 113.251 -175.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -73.4 -9.54 23.1 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.544 2.829 . . . . 0.0 112.187 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -80.23 -18.56 49.15 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -163.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 77.21 -19.47 3.63 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-O 118.244 -1.309 . . . . 0.0 114.261 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.529 HD22 ' HB ' ' A' ' 44' ' ' ILE . 0.5 OUTLIER -72.74 101.54 3.12 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.733 1.613 . . . . 0.0 110.244 175.358 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 9.9 mmt85 -125.33 138.19 54.06 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 117.794 -1.098 . . . . 0.0 110.495 -174.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -58.02 148.09 27.26 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 . . . . . 0 C--N 1.329 -0.292 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -176.963 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.373 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -96.04 121.2 37.54 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 168.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.9 pt -119.4 175.25 4.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 171.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -120.5 137.26 54.46 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 175.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.4 m -78.55 137.46 21.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -67.51 -26.22 66.23 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.009 0.524 . . . . 0.0 112.241 175.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 135.48 -19.96 3.76 Favored Glycine 0 N--CA 1.472 1.036 0 O-C-N 120.134 -1.604 . . . . 0.0 111.958 -169.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.48 -14.95 54.18 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.335 1.854 . . . . 0.0 112.555 -169.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.737 HD13 ' HA ' ' A' ' 17' ' ' HIS . 3.3 mm? -127.14 41.19 3.57 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 128.592 2.757 . . . . 0.0 106.54 -173.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.79 -85.22 0.18 Allowed 'General case' 0 N--CA 1.469 0.489 0 O-C-N 120.324 -1.485 . . . . 0.0 110.753 -171.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.0 tpt85 -66.42 -69.19 0.32 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 121.149 1.795 . . . . 0.0 111.006 -170.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -155.48 -3.03 0.1 Allowed Glycine 0 N--CA 1.448 -0.504 0 O-C-N 124.157 0.911 . . . . 0.0 114.133 -174.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -49.28 147.52 5.28 Favored Pre-proline 0 N--CA 1.45 -0.438 0 C-N-CA 126.523 1.929 . . . . 0.0 111.847 -167.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -48.99 -29.21 15.02 Favored 'Trans proline' 0 CA--C 1.533 0.436 1 C-N-CA 125.32 4.013 . . . . 0.0 113.967 -176.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.466 ' O ' HG22 ' A' ' 19' ' ' VAL . 49.4 m-80 -81.34 -23.8 37.53 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 125.958 1.703 . . . . 0.0 112.226 -169.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.737 ' HA ' HD13 ' A' ' 10' ' ' LEU . 4.8 t60 -53.41 -31.38 44.79 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.975 1.262 . . . . 0.0 111.019 -171.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.31 -23.55 9.48 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.873 1.269 . . . . 0.0 114.031 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 16' ' ' ASN . 34.1 m -60.07 -49.53 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 CA-C-N 119.652 1.115 . . . . 0.0 110.628 173.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.612 ' HE3' HD12 ' A' ' 10' ' ' LEU . 6.0 ptp -77.68 5.64 8.89 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.704 0.684 . . . . 0.0 112.726 -174.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 69.9 mt -97.34 -6.08 35.07 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.078 0.951 . . . . 0.0 111.582 176.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -121.7 102.83 8.46 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 104.315 -2.476 . . . . 0.0 104.315 175.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -58.16 -16.93 15.29 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.081 1.352 . . . . 0.0 111.996 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.2 m -60.92 -22.42 64.35 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.756 1.622 . . . . 0.0 113.971 169.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 20.2 m170 -86.08 -15.06 42.43 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.251 -0.906 . . . . 0.0 111.107 170.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.1 170.02 12.91 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 127.203 2.335 . . . . 0.0 111.565 176.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -74.1 139.09 44.36 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 124.803 1.241 . . . . 0.0 112.1 -174.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -139.82 138.63 35.96 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.03 1.732 . . . . 0.0 109.053 165.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.16 139.71 27.45 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.77 1.228 . . . . 0.0 108.865 175.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -72.62 87.55 1.23 Allowed 'General case' 0 C--O 1.238 0.481 0 C-N-CA 125.948 1.699 . . . . 0.0 108.033 178.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.2 tpp180 -93.7 64.85 3.57 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -177.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.66 -167.41 54.8 Favored Glycine 0 N--CA 1.44 -1.058 0 CA-C-O 122.967 1.315 . . . . 0.0 111.463 -173.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.3 ptt85 -139.13 170.64 15.59 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.981 0.913 . . . . 0.0 109.668 -177.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.404 ' HA2' ' H ' ' A' ' 98' ' ' LEU . . . -170.96 173.8 44.68 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 119.876 -1.155 . . . . 0.0 111.807 -172.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.468 ' HB3' ' HA ' ' A' ' 64' ' ' THR . 2.3 m -136.89 158.05 45.34 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 170.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.0 p -74.9 121.61 22.15 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 176.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.552 HG22 ' HB2' ' A' ' 96' ' ' GLN . 2.0 t -76.6 -43.88 34.51 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -177.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -71.36 121.72 19.04 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 105.774 -1.935 . . . . 0.0 105.774 174.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 m -55.75 142.49 34.33 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 168.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -135.67 153.41 77.43 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 107.057 -1.461 . . . . 0.0 107.057 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -78.52 91.82 1.17 Allowed 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 124.693 3.595 . . . . 0.0 109.522 176.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.88 88.59 7.73 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 177.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.434 HG13 ' HB3' ' A' ' 127' ' ' LEU 0.287 40.1 t -89.71 166.78 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 C-N-CA 126.982 2.113 . . . . 0.0 107.878 -176.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.2 mt -132.65 126.72 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 168.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.88 175.14 10.06 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 122.32 1.057 . . . . 0.0 111.495 -174.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.9 -172.64 53.18 Favored Glycine 0 CA--C 1.539 1.542 0 C-N-CA 125.794 1.664 . . . . 0.0 111.226 170.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -87.19 -18.46 30.28 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 125.851 1.66 . . . . 0.0 113.076 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 56.6 m-70 -109.2 8.98 26.08 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 122.845 0.458 . . . . 0.0 112.005 -171.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 62.86 63.03 0.99 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.648 1.579 . . . . 0.0 108.079 172.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 81.4 mt -104.11 90.23 2.94 Favored Pre-proline 0 N--CA 1.453 -0.283 0 C-N-CA 127.309 2.243 . . . . 0.0 106.14 -169.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -57.08 138.33 85.81 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 CA-C-N 119.725 0.938 . . . . 0.0 110.374 169.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 57.0 m95 -128.82 132.63 47.84 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.505 1.522 . . . . 0.0 108.692 178.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 34.4 tp -86.13 -3.81 59.04 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.957 0.903 . . . . 0.0 113.101 -173.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 12.9 mt 42.03 89.7 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 129.674 3.19 . . . . 0.0 112.367 172.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -49.5 95.68 0.01 OUTLIER 'General case' 0 C--O 1.241 0.631 0 CA-C-N 119.167 0.894 . . . . 0.0 112.989 -162.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -159.49 85.76 2.18 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 119.032 0.833 . . . . 0.0 113.057 -172.498 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -60.85 147.75 94.35 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.613 2.209 . . . . 0.0 109.739 -177.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.88 15.66 80.82 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 119.074 -0.848 . . . . 0.0 113.056 171.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.38 130.44 32.8 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 119.436 1.618 . . . . 0.0 108.715 -175.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.37 -123.84 7.07 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-N 120.792 1.633 . . . . 0.0 112.628 -178.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 46.4 m-70 -136.32 160.55 38.38 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.889 1.844 . . . . 0.0 112.588 -165.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 77.0 m -91.14 99.49 12.49 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.823 0.849 . . . . 0.0 110.736 -177.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.1 t -72.0 99.19 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 125.97 1.708 . . . . 0.0 113.213 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.468 ' HA ' ' HB3' ' A' ' 35' ' ' CYS . 8.9 p -66.51 157.58 31.83 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.91 0.884 . . . . 0.0 112.631 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -178.05 -147.1 6.71 Favored Glycine 0 C--N 1.343 0.962 0 O-C-N 121.458 -0.776 . . . . 0.0 114.025 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -133.53 171.21 14.4 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.056 1.342 . . . . 0.0 109.253 177.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 92.4 mt -116.59 112.98 41.62 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 -177.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -101.71 115.82 31.37 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 172.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -62.89 136.22 57.73 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 154.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.5 m -135.04 168.69 22.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 C-N-CA 124.732 1.213 . . . . 0.0 108.131 176.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -107.98 172.06 7.05 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 168.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.419 ' HG2' ' HE ' ' A' ' 76' ' ' ARG . 2.5 mt-10 -49.53 -45.73 47.69 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 125.035 1.334 . . . . 0.0 110.244 -176.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.2 tp60 -55.62 -43.57 76.25 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.079 0.952 . . . . 0.0 111.574 -176.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 24.3 tpp -72.48 -48.67 38.9 Favored 'General case' 0 C--O 1.224 -0.264 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.83 -39.4 77.57 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.549 -0.719 . . . . 0.0 110.726 -178.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.419 ' HE ' ' HG2' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -64.56 -44.65 90.09 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 126.918 2.087 . . . . 0.0 110.966 175.451 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -61.69 -46.35 90.08 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.279 0.632 . . . . 0.0 109.815 177.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 95.2 mt -57.79 -37.48 73.8 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.144 0.577 . . . . 0.0 111.468 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -61.11 -21.98 64.21 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.388 0.995 . . . . 0.0 111.837 177.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -100.25 -2.92 32.57 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.803 2.441 . . . . 0.0 111.5 177.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -103.96 -37.98 7.17 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 120.739 -1.226 . . . . 0.0 108.215 -174.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -107.94 28.88 7.8 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.985 1.314 . . . . 0.0 111.586 174.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 57.97 37.68 26.73 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.247 1.419 . . . . 0.0 112.625 156.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 78.1 m -85.92 163.57 42.86 Favored Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 120.934 -1.104 . . . . 0.0 110.646 -176.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 58.0 Cg_endo -65.76 -3.95 3.6 Favored 'Cis proline' 0 CA--C 1.547 1.161 0 N-CA-C 114.849 1.057 . . . . 0.0 114.849 -16.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -46.79 -64.55 0.74 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.835 1.654 . . . . 0.0 112.928 178.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 21.5 mtm -88.18 -59.41 2.25 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 119.195 0.907 . . . . 0.0 110.092 -175.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.409 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 75.0 m-85 -111.56 178.29 4.37 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 176.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.7 mp0 -133.97 150.28 51.27 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 171.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -77.44 114.26 16.09 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 176.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.2 m -113.55 170.91 7.9 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 126.106 1.763 . . . . 0.0 108.835 -179.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -122.13 143.01 49.8 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.622 1.569 . . . . 0.0 110.277 172.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.44 175.91 11.8 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.269 1.428 . . . . 0.0 111.357 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.4 tp60 -101.53 126.79 48.4 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.703 1.601 . . . . 0.0 111.772 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 64.0 t -122.39 144.74 30.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 125.305 1.442 . . . . 0.0 108.141 -176.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.552 ' HB2' HG22 ' A' ' 37' ' ' VAL . 49.4 tt0 -89.32 144.75 25.85 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 176.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.535 HG12 ' C ' ' A' ' 108' ' ' ASP 0.26 7.2 p -111.48 89.89 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -167.36 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.404 ' H ' ' HA2' ' A' ' 34' ' ' GLY . 3.9 mp -65.44 -23.04 66.83 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 120.716 -1.24 . . . . 0.0 111.512 -177.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -160.95 153.43 20.55 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 104.763 -2.31 . . . . 0.0 104.763 174.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 70.2 t-105 -137.59 107.29 6.22 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 126.3 1.84 . . . . 0.0 108.597 178.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -95.18 108.56 20.69 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -177.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.52 -174.77 15.96 Favored Glycine 0 CA--C 1.519 0.311 0 CA-C-O 121.911 0.729 . . . . 0.0 111.387 174.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -71.31 160.64 32.43 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.604 0.716 . . . . 0.0 110.268 -177.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 90.52 69.13 1.2 Allowed Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 124.618 1.104 . . . . 0.0 111.234 165.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -101.58 89.58 1.5 Allowed Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 129.845 3.258 . . . . 0.0 110.352 -162.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -62.73 4.61 0.35 Allowed 'Trans proline' 0 CA--C 1.544 1.0 1 C-N-CA 125.737 4.291 . . . . 0.0 115.266 -176.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.15 -174.43 54.54 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 -163.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.535 ' C ' HG12 ' A' ' 97' ' ' VAL . 14.5 t70 -69.71 5.69 1.39 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 117.336 2.347 . . . . 0.0 117.336 -168.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 83.5 p -125.25 157.45 36.55 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 121.648 -0.658 . . . . 0.0 112.174 155.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.6 p -132.6 153.05 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 123.628 0.771 . . . . 0.0 109.434 161.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -82.09 152.51 26.54 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 168.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 3.9 p -145.14 -173.37 4.07 Favored 'General case' 0 C--O 1.239 0.515 0 O-C-N 121.575 -0.703 . . . . 0.0 110.629 169.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -109.03 151.44 26.35 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.133 1.373 . . . . 0.0 109.504 162.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.3 t -142.88 146.45 21.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 128.883 2.873 . . . . 0.0 106.605 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -89.91 116.05 27.68 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 168.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -139.16 147.61 42.08 Favored 'General case' 0 C--O 1.225 -0.233 0 C-N-CA 124.077 0.951 . . . . 0.0 111.317 -176.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.5 t -92.5 141.16 28.81 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -177.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -110.57 6.45 21.89 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.235 1.414 . . . . 0.0 111.572 162.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.35 19.73 16.74 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.624 1.97 . . . . 0.0 112.729 -160.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -71.61 159.53 34.26 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.737 1.615 . . . . 0.0 113.16 -174.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.35 149.69 89.11 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 124.749 1.22 . . . . 0.0 110.761 173.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -68.52 -24.8 35.71 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.701 2.268 . . . . 0.0 113.561 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -68.69 -24.95 64.56 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 120.919 -1.113 . . . . 0.0 112.777 173.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 45.0 m0 -72.01 -12.75 61.37 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.426 -0.796 . . . . 0.0 112.241 -177.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -65.89 -18.33 65.26 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.347 -0.846 . . . . 0.0 111.233 171.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -99.95 -8.95 23.33 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.059 0.944 . . . . 0.0 112.791 175.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.434 ' HB3' HG13 ' A' ' 43' ' ' VAL . 14.7 mt -64.23 147.01 97.38 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -64.84 149.38 89.68 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.087 1.858 . . . . 0.0 110.371 178.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -103.37 166.1 10.63 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 41.0 m-70 -136.5 169.87 16.98 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 125.048 1.339 . . . . 0.0 108.473 178.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -125.26 -17.33 5.7 Favored 'General case' 0 C--O 1.219 -0.511 0 C-N-CA 124.217 1.007 . . . . 0.0 111.837 -166.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -158.19 132.78 8.28 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 164.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -85.59 131.57 34.33 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 169.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -143.87 158.21 43.84 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.756 154.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.5 t -63.71 -35.86 81.94 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 164.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -86.4 68.63 10.27 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 127.467 2.307 . . . . 0.0 107.665 -177.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -152.65 168.09 31.6 Favored Glycine 0 CA--C 1.522 0.499 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.432 163.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -72.91 -6.93 19.89 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.275 2.65 . . . . 0.0 113.735 -166.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -60.24 -42.13 94.61 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 119.407 1.003 . . . . 0.0 113.425 -169.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 93.09 -50.33 2.48 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-O 118.892 -0.949 . . . . 0.0 111.026 -178.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.5 75.61 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.079 1.751 . . . . 0.0 112.265 173.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -109.37 167.7 9.93 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 120.52 -1.362 . . . . 0.0 109.613 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -60.17 164.03 4.44 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 118.786 -0.626 . . . . 0.0 111.276 -169.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.545 0.752 0 CA-C-O 121.614 0.721 . . . . 0.0 112.317 -175.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.261 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -134.39 148.02 50.59 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 13.0 pt -130.83 179.42 4.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 167.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.561 ' CE2' HG23 ' A' ' 36' ' ' THR . 90.3 t80 -137.83 133.16 33.62 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 176.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.8 m -73.79 134.64 29.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 173.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -73.54 -3.22 26.39 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.77 -0.581 . . . . 0.0 111.701 163.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 136.42 -4.99 3.79 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.95 1.738 . . . . 0.0 112.515 174.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -83.47 -8.62 59.33 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -167.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.0 mp -140.85 58.64 1.55 Allowed 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -139.87 -73.68 0.36 Allowed 'General case' 0 C--N 1.342 0.281 0 CA-C-O 118.463 -0.779 . . . . 0.0 112.346 177.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -67.97 -60.59 2.38 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.911 1.232 . . . . 0.0 109.211 -168.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -177.38 33.33 0.08 OUTLIER Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.611 HE21 ' H ' ' A' ' 135' ' ' SER . 10.5 mp0 -66.25 155.03 88.96 Favored Pre-proline 0 N--CA 1.454 -0.231 0 O-C-N 120.657 -1.496 . . . . 0.0 109.733 -173.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.35 -10.0 19.77 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.649 2.233 . . . . 0.0 113.354 -172.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.515 ' O ' HG22 ' A' ' 19' ' ' VAL . 3.3 m-80 -99.52 -20.76 16.24 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 127.242 2.217 . . . . 0.0 110.956 -175.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -53.68 -41.67 67.14 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 120.955 1.707 . . . . 0.0 109.839 -171.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.7 -29.48 4.49 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.564 1.546 . . . . 0.0 114.145 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 16' ' ' ASN . 20.3 m -59.8 -41.79 86.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 120.097 1.317 . . . . 0.0 111.593 178.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.3 ptp -78.0 -8.59 58.36 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 119.149 0.886 . . . . 0.0 111.76 -177.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 39.6 mt -87.41 5.09 40.48 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.283 1.433 . . . . 0.0 110.64 178.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -115.08 97.61 6.32 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 173.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 22.2 t-80 -60.09 -21.22 61.23 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.424 0.69 . . . . 0.0 112.538 -176.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.5 m -69.44 -23.7 63.72 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.385 1.474 . . . . 0.0 114.342 172.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 36.9 m170 -69.77 -31.71 69.81 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.146 -0.971 . . . . 0.0 108.765 165.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.76 179.53 25.66 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 125.839 1.685 . . . . 0.0 110.775 174.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -81.63 135.69 35.54 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.011 0.924 . . . . 0.0 110.096 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.1 100.68 3.68 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.38 1.472 . . . . 0.0 109.646 167.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -107.4 140.9 39.63 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 125.18 1.392 . . . . 0.0 108.798 -177.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -69.98 77.84 0.49 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.589 2.355 . . . . 0.0 109.986 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -87.37 62.38 7.15 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.39 -176.3 48.24 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-O 123.624 1.68 . . . . 0.0 113.984 170.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -118.0 160.29 21.72 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.781 1.232 . . . . 0.0 109.711 -170.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -169.71 177.58 43.12 Favored Glycine 0 C--N 1.34 0.805 0 N-CA-C 116.383 1.313 . . . . 0.0 116.383 177.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 10.6 p -133.4 158.48 42.92 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.44 1.096 . . . . 0.0 108.206 170.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.561 HG23 ' CE2' ' A' ' 5' ' ' PHE . 3.0 p -78.91 117.28 19.85 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 166.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.3 t -74.24 -41.33 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 175.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -64.89 107.34 1.44 Allowed 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 170.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.0 m -59.63 135.92 57.83 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 106.951 -1.499 . . . . 0.0 106.951 170.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.74 ' HB3' HD22 ' A' ' 53' ' ' LEU . 27.8 m-85 -130.57 153.16 81.39 Favored Pre-proline 0 C--O 1.237 0.422 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -74.29 91.57 0.95 Allowed 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 124.707 3.605 . . . . 0.0 109.675 173.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 tt -81.91 102.94 11.21 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 171.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.569 ' CG2' HD13 ' A' ' 54' ' ' LEU . 2.6 m -122.25 133.14 69.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 125.225 1.41 . . . . 0.0 107.451 -175.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 73.8 mt -99.05 100.14 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -176.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -118.01 171.88 7.79 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 122.378 1.085 . . . . 0.0 111.354 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.3 152.73 7.13 Favored Glycine 0 CA--C 1.523 0.534 0 CA-C-N 113.76 -1.564 . . . . 0.0 110.9 173.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.3 tp10 -72.16 -9.3 58.25 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -162.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 44.2 m170 -102.5 12.63 36.19 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.871 0.869 . . . . 0.0 112.076 175.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 55.45 69.73 0.7 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 127.392 2.277 . . . . 0.0 111.228 -178.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.5 mt -104.12 89.87 2.74 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 128.105 2.562 . . . . 0.0 108.072 -166.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -53.03 129.11 31.74 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 121.757 1.638 . . . . 0.0 111.567 177.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 66.3 m95 -126.62 145.56 50.51 Favored 'General case' 0 C--N 1.332 -0.192 0 O-C-N 121.093 -1.005 . . . . 0.0 109.122 176.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.74 HD22 ' HB3' ' A' ' 40' ' ' PHE . 1.8 mt -96.44 -5.31 39.96 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 117.569 2.433 . . . . 0.0 117.569 -174.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.569 HD13 ' CG2' ' A' ' 43' ' ' VAL . 8.7 mp 42.37 73.39 0.14 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 111.603 -2.544 . . . . 0.0 112.601 173.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -45.26 92.18 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.014 1.726 . . . . 0.0 114.57 -157.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.42 85.23 7.42 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 125.026 1.33 . . . . 0.0 107.643 -174.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -59.04 139.52 91.16 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 121.986 1.79 . . . . 0.0 108.564 176.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.02 -0.7 88.27 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.191 1.376 . . . . 0.0 114.48 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -97.43 144.02 27.58 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.624 1.712 . . . . 0.0 107.78 173.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.33 -143.7 30.91 Favored Glycine 0 C--N 1.337 0.608 0 CA-C-N 119.235 0.925 . . . . 0.0 111.63 177.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -130.99 176.75 7.98 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.313 1.445 . . . . 0.0 108.203 -169.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.2 p -63.0 167.13 5.05 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.512 0.672 . . . . 0.0 111.406 176.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.1 t -133.08 110.95 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 166.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 69.5 p -69.75 152.33 44.75 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.42 -158.37 12.37 Favored Glycine 0 CA--C 1.527 0.791 0 O-C-N 121.15 -0.969 . . . . 0.0 112.486 -177.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -140.98 151.8 44.44 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.621 1.568 . . . . 0.0 108.454 174.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 76.4 mt -95.55 138.49 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -127.34 126.16 42.04 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 172.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -69.87 136.13 50.33 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 161.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.62 164.54 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.95 177.43 4.85 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 122.804 1.288 . . . . 0.0 111.847 168.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -57.16 -42.36 80.94 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 112.916 -1.947 . . . . 0.0 111.751 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 40.1 tp60 -62.99 -44.91 94.72 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 118.473 -0.775 . . . . 0.0 109.989 179.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 24.8 tpp -62.79 -46.41 88.13 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 118.365 0.53 . . . . 0.0 110.109 176.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 75' ' ' LEU . 11.1 tp -65.81 -40.59 92.03 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.647 -174.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 33.9 mtm105 -63.26 -40.16 96.63 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.631 1.173 . . . . 0.0 111.172 173.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -65.97 -50.62 63.7 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 117.984 0.356 . . . . 0.0 110.303 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.7 mp -63.12 -25.87 68.56 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.122 -0.986 . . . . 0.0 111.01 176.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.473 ' HA ' ' SG ' ' A' ' 84' ' ' CYS . 14.8 t70 -73.44 1.3 10.06 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.971 1.309 . . . . 0.0 112.84 176.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -122.04 -47.81 2.14 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 128.352 2.661 . . . . 0.0 110.972 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -65.1 -39.16 92.74 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.445 1.098 . . . . 0.0 112.294 -176.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -77.81 8.56 4.4 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.18 -0.95 . . . . 0.0 111.197 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 58.68 15.44 3.72 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.376 1.871 . . . . 0.0 113.155 178.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.473 ' SG ' ' HA ' ' A' ' 79' ' ' ASP . 1.6 p -61.92 154.12 69.6 Favored Pre-proline 0 N--CA 1.448 -0.558 0 O-C-N 120.518 -1.363 . . . . 0.0 109.219 169.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.39 -4.57 22.09 Favored 'Cis proline' 0 CA--C 1.541 0.826 0 CA-C-N 119.563 0.88 . . . . 0.0 113.638 -2.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.7 -75.42 0.06 Allowed 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.062 1.345 . . . . 0.0 111.095 179.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 38.7 mtp -68.67 -69.09 0.35 Allowed 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -172.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -102.29 174.89 5.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.497 0.665 . . . . 0.0 109.443 179.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -137.89 136.25 36.91 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 165.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -75.03 139.21 42.71 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 175.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.4 m -141.66 154.36 45.31 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -176.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -91.46 137.84 32.05 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.881 0.873 . . . . 0.0 109.7 174.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.504 HD11 HG23 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -148.27 174.84 11.6 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.01 1.324 . . . . 0.0 112.297 -178.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 30.7 tp60 -100.06 117.15 33.72 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.149 1.78 . . . . 0.0 111.196 -178.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 97.1 t -117.81 124.12 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 125.19 1.396 . . . . 0.0 107.944 -172.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -68.43 141.37 55.69 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 119.582 1.083 . . . . 0.0 108.557 175.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 45.9 t -84.78 95.19 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 172.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.86 -30.06 70.13 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.769 -0.582 . . . . 0.0 109.712 167.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -164.75 153.74 12.85 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 60.2 t-105 -132.03 136.94 47.61 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 172.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -116.92 111.15 19.24 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 171.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 114.81 -172.34 14.18 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 124.518 1.056 . . . . 0.0 112.145 172.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -70.87 168.32 17.09 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 114.919 -0.641 . . . . 0.0 110.619 -178.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.05 69.19 1.42 Allowed Glycine 0 C--O 1.222 -0.635 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 168.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -101.1 87.96 0.97 Allowed Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 130.651 3.581 . . . . 0.0 109.399 -171.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -57.12 -38.1 96.46 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.692 2.928 . . . . 0.0 113.2 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 146.59 -160.95 28.33 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-N 119.436 1.016 . . . . 0.0 111.387 -170.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -64.07 -22.56 66.98 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.937 1.295 . . . . 0.0 111.728 175.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.9 t -139.86 164.19 30.64 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 120.467 -1.396 . . . . 0.0 109.233 175.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 10.9 p -141.06 153.06 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 C-N-CA 125.787 1.635 . . . . 0.0 108.959 -174.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -83.3 119.93 25.21 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 168.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 85.8 m -122.22 176.27 5.93 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.746 0.818 . . . . 0.0 109.23 171.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -106.5 144.09 33.68 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 168.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.504 HG23 HD11 ' A' ' 93' ' ' LEU . 27.2 t -137.45 146.83 27.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 127.137 2.175 . . . . 0.0 106.073 175.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -76.54 127.76 33.43 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 165.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 72.4 p -131.62 -164.54 1.46 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 126.008 1.723 . . . . 0.0 106.689 172.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.5 t -149.08 153.97 38.57 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 168.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -116.51 -31.92 5.4 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.672 1.589 . . . . 0.0 111.823 175.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 15.4 t -91.72 20.79 5.23 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.941 0.896 . . . . 0.0 111.795 -165.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.416 ' CG ' ' HG ' ' A' ' 54' ' ' LEU . 31.9 p90 -72.07 153.9 41.44 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 127.78 2.432 . . . . 0.0 113.155 -174.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.89 160.37 55.82 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 126.622 1.969 . . . . 0.0 112.173 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -68.88 -39.04 8.9 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.125 1.883 . . . . 0.0 112.531 178.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -45.46 -41.66 9.67 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 178.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 0.561 ' HA ' HD23 ' A' ' 127' ' ' LEU . 30.7 m0 -64.2 -18.17 64.25 Favored 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 125.513 1.525 . . . . 0.0 112.365 -173.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 28.0 mt -67.47 -17.28 64.63 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 117.808 -1.092 . . . . 0.0 111.672 173.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -102.52 -6.22 23.11 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.976 1.262 . . . . 0.0 112.511 -168.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.561 HD23 ' HA ' ' A' ' 124' ' ' TRP . 1.9 mm? -71.73 156.93 90.62 Favored Pre-proline 0 N--CA 1.448 -0.55 0 C-N-CA 125.651 1.58 . . . . 0.0 108.16 -175.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -61.38 140.31 87.31 Favored 'Trans proline' 0 N--CA 1.449 -1.088 0 C-N-CA 121.586 1.524 . . . . 0.0 108.953 173.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -81.28 158.08 24.9 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 172.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 60.0 m-70 -137.97 155.74 48.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.712 178.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -101.21 -9.04 21.64 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 122.766 1.27 . . . . 0.0 112.932 -175.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -161.23 150.7 16.73 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 126.908 2.083 . . . . 0.0 105.517 175.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -106.27 148.35 28.08 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 167.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.0 170.99 21.06 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.611 ' H ' HE21 ' A' ' 14' ' ' GLN . 0.3 OUTLIER -104.87 -0.1 27.43 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 159.625 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -133.3 68.36 1.5 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.514 1.926 . . . . 0.0 106.897 -172.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -130.66 -170.98 12.81 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 125.615 1.579 . . . . 0.0 112.725 -171.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -57.83 175.9 0.39 Allowed 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 120.805 1.003 . . . . 0.0 110.129 138.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 30.1 m-70 46.99 90.26 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 128.967 2.907 . . . . 0.0 112.221 -178.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.92 61.81 0.73 Allowed Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.414 1.007 . . . . 0.0 112.406 170.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.27 67.49 1.43 Allowed 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 127.477 2.311 . . . . 0.0 106.866 169.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 -116.37 162.31 17.73 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 120.816 -1.178 . . . . 0.0 110.629 -172.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -61.15 140.56 57.87 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 123.806 0.691 . . . . 0.0 111.723 -159.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 30.4 t30 . . . . . 0 N--CA 1.452 -0.334 0 C-N-CA 124.274 1.03 . . . . 0.0 109.129 -174.708 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.228 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.1 m80 -108.34 130.94 55.18 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 176.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.461 HG22 ' HB2' ' A' ' 113' ' ' PHE . 17.4 pt -128.32 167.42 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 124.644 1.178 . . . . 0.0 109.403 176.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -126.75 144.73 50.85 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.586 1.154 . . . . 0.0 110.894 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 m -103.61 123.61 57.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.972 1.309 . . . . 0.0 111.038 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -76.39 -48.1 20.99 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -174.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.26 -1.18 0.03 OUTLIER Glycine 0 CA--C 1.531 1.054 0 CA-C-O 117.575 -1.68 . . . . 0.0 116.486 -172.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.417 ' HA ' ' HG2' ' A' ' 14' ' ' GLN . 0.3 OUTLIER -118.75 -6.93 10.58 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 120.309 2.055 . . . . 0.0 114.834 -163.192 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.7 mp -145.59 47.02 1.28 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.342 1.457 . . . . 0.0 108.363 176.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.22 -78.07 0.46 Allowed 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 117.051 -1.452 . . . . 0.0 109.811 170.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.429 ' CB ' HE22 ' A' ' 14' ' ' GLN . 10.7 mtt180 -50.91 -45.5 60.33 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.051 0.94 . . . . 0.0 111.533 -168.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 148.57 68.94 0.01 OUTLIER Glycine 0 C--N 1.333 0.403 0 N-CA-C 106.944 -2.462 . . . . 0.0 106.944 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.429 HE22 ' CB ' ' A' ' 12' ' ' ARG . 25.1 mp0 -102.89 160.84 24.96 Favored Pre-proline 0 N--CA 1.449 -0.507 0 C-N-CA 124.505 1.122 . . . . 0.0 110.464 -178.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.36 -32.67 89.61 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.737 1.625 . . . . 0.0 110.996 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -70.57 -24.27 62.75 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 124.642 1.177 . . . . 0.0 111.618 -176.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -52.0 -35.06 45.47 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.224 1.01 . . . . 0.0 110.779 -167.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.71 -33.56 7.1 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 124.953 1.301 . . . . 0.0 114.264 176.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.3 m -59.61 -35.53 59.97 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 119.95 1.25 . . . . 0.0 111.439 -176.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.1 ptp -83.09 -12.47 57.05 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 118.979 0.809 . . . . 0.0 112.848 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.2 mt -80.07 -11.82 59.73 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.187 0.595 . . . . 0.0 110.194 177.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -100.17 99.68 10.41 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -177.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 46.3 t-80 -59.32 -19.59 47.74 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.664 1.586 . . . . 0.0 113.376 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.84 -37.35 79.01 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.419 -0.801 . . . . 0.0 111.551 167.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 16.8 m170 -73.98 -35.64 64.48 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 121.393 -0.817 . . . . 0.0 109.475 170.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.93 -175.71 24.4 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.993 1.283 . . . . 0.0 112.738 168.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.5 mt -68.79 149.32 49.13 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.038 0.935 . . . . 0.0 113.144 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -161.95 110.61 1.46 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.091 2.156 . . . . 0.0 108.507 168.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -130.11 146.61 51.77 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.016 0.926 . . . . 0.0 109.848 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -69.01 86.95 0.37 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.568 2.347 . . . . 0.0 109.472 -176.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.07 64.12 0.83 Allowed 'General case' 0 C--O 1.234 0.281 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -178.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.88 -179.12 48.65 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-O 122.053 0.807 . . . . 0.0 112.79 -178.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.4 ptt180 -134.14 172.2 13.18 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.55 -0.971 . . . . 0.0 110.407 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -164.08 -176.79 36.26 Favored Glycine 0 CA--C 1.499 -0.932 0 N-CA-C 115.89 1.116 . . . . 0.0 115.89 -173.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.7 p -145.21 159.56 42.82 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 113.725 -1.237 . . . . 0.0 112.512 166.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.506 HG23 HG13 ' A' ' 63' ' ' VAL . 8.3 p -78.13 101.97 7.28 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 120.086 1.312 . . . . 0.0 107.852 172.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -71.14 -31.05 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 120.576 -1.328 . . . . 0.0 111.894 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -69.99 118.06 12.35 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 152.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.3 m -57.84 146.96 29.92 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 167.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -135.49 153.16 77.56 Favored Pre-proline 0 N--CA 1.466 0.349 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 169.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.441 ' HG2' ' HB2' ' A' ' 54' ' ' LEU . 40.9 Cg_endo -77.01 121.63 5.9 Favored 'Trans proline' 0 CA--C 1.533 0.457 1 C-N-CA 125.774 4.316 . . . . 0.0 113.043 177.293 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.6 tp -116.38 111.92 20.74 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 126.863 2.065 . . . . 0.0 108.858 -176.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.5 m -128.88 148.09 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 120.26 1.391 . . . . 0.0 111.937 -177.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 40.2 mt -86.93 128.07 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 169.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.59 173.47 11.47 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.54 0.686 . . . . 0.0 112.153 174.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.94 -174.72 55.27 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.544 2.021 . . . . 0.0 113.246 171.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -91.0 -3.45 57.25 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -170.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -118.94 12.63 12.89 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.405 1.082 . . . . 0.0 111.779 176.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 53.51 71.27 0.51 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.015 2.126 . . . . 0.0 110.495 -178.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 88.6 mt -103.9 90.58 3.02 Favored Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 131.265 3.826 . . . . 0.0 108.368 -169.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -60.83 125.08 16.31 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 122.379 2.053 . . . . 0.0 112.602 176.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -116.63 156.97 26.13 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.912 1.685 . . . . 0.0 109.882 176.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.9 tp -115.54 114.76 25.41 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.233 1.413 . . . . 0.0 108.441 167.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.548 HD23 HG23 ' A' ' 117' ' ' THR . 26.0 mt -82.27 144.0 30.94 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 177.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -79.75 89.06 5.19 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 121.593 -0.692 . . . . 0.0 109.389 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.25 85.69 21.36 Favored Pre-proline 0 C--O 1.232 0.18 0 C-N-CA 123.534 0.734 . . . . 0.0 110.024 172.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -60.27 128.95 27.96 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.936 2.424 . . . . 0.0 109.598 -177.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.57 8.77 73.26 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 118.09 -1.395 . . . . 0.0 114.074 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.2 tptt -121.3 164.14 17.48 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 120.372 2.086 . . . . 0.0 107.216 172.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 74.51 -131.13 12.72 Favored Glycine 0 CA--C 1.519 0.288 0 O-C-N 120.613 -1.304 . . . . 0.0 109.945 -176.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -145.01 167.24 23.12 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.12 0.968 . . . . 0.0 111.033 -170.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 31.6 m -92.27 80.63 4.99 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 126.717 2.007 . . . . 0.0 112.448 -173.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.506 HG13 HG23 ' A' ' 36' ' ' THR . 1.6 p -70.05 136.21 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.117 0 CA-C-O 118.113 -0.946 . . . . 0.0 113.196 -165.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.2 p -91.06 152.46 20.63 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.88 -175.51 32.99 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 178.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -106.25 158.2 17.03 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 125.736 1.615 . . . . 0.0 106.771 173.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 80.8 mt -113.63 110.07 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -93.17 123.48 36.48 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 118.528 -0.749 . . . . 0.0 109.663 -176.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -68.48 107.93 3.09 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 152.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.8 m -103.72 169.67 2.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 166.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -119.24 177.71 4.79 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 161.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -45.02 -46.43 11.31 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 127.977 2.511 . . . . 0.0 110.835 -170.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -57.64 -45.56 85.31 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.124 0.97 . . . . 0.0 111.367 -175.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.4 tpp -72.52 -45.9 57.18 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -176.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.43 -32.86 73.78 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.778 -178.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 78.0 mtt180 -69.23 -37.73 78.16 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.874 1.215 . . . . 0.0 111.505 176.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -60.19 -48.3 82.32 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 119.113 -0.47 . . . . 0.0 110.002 174.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.6 mp -57.57 -41.37 80.94 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.214 0.461 . . . . 0.0 109.922 176.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -65.9 4.66 0.6 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.054 1.742 . . . . 0.0 114.76 -178.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -129.9 -47.94 1.13 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.323 2.249 . . . . 0.0 109.852 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -63.11 -42.74 99.61 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 125.802 1.641 . . . . 0.0 111.518 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -78.03 11.31 2.32 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.871 0.868 . . . . 0.0 110.808 176.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.2 t0 54.43 16.81 1.38 Allowed 'General case' 0 C--O 1.236 0.387 0 C-N-CA 128.596 2.758 . . . . 0.0 114.625 171.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 6.8 p -62.47 155.76 66.05 Favored Pre-proline 0 N--CA 1.445 -0.721 0 O-C-N 121.227 -0.921 . . . . 0.0 110.035 -178.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -73.76 -4.23 16.71 Favored 'Cis proline' 0 CA--C 1.543 0.93 0 N-CA-C 115.223 1.201 . . . . 0.0 115.223 -2.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 9.5 m -63.96 -63.68 1.09 Allowed 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.072 1.349 . . . . 0.0 112.406 -173.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 27.3 mtp -74.35 -76.7 0.13 Allowed 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -100.01 -176.55 3.27 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 125.354 1.461 . . . . 0.0 109.329 178.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.93 151.55 30.46 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 120.761 -1.212 . . . . 0.0 109.795 158.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -63.93 125.85 25.74 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 118.491 -0.766 . . . . 0.0 109.954 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 43.5 m -132.4 174.79 9.88 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.009 1.724 . . . . 0.0 106.95 167.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -125.23 132.69 52.93 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.711 1.604 . . . . 0.0 109.615 172.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.447 ' CD1' HG11 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -123.83 177.29 5.81 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.731 1.612 . . . . 0.0 109.927 -179.207 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 34.2 tp60 -105.87 114.26 28.31 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.253 2.221 . . . . 0.0 109.685 -178.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 54.3 t -109.29 141.22 25.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 125.65 1.58 . . . . 0.0 107.633 -177.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -76.29 137.29 39.8 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 165.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.523 ' CG1' ' HA ' ' A' ' 108' ' ' ASP 0.254 3.7 p -98.07 83.81 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 179.017 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -61.66 -22.62 65.45 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 125.471 1.509 . . . . 0.0 111.935 -175.734 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -154.46 154.52 33.33 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 170.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 -132.69 124.98 29.23 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.247 1.419 . . . . 0.0 107.408 175.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -91.42 115.62 28.18 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.78 0.832 . . . . 0.0 109.15 177.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.88 -169.24 32.21 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 123.307 0.48 . . . . 0.0 112.129 169.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -68.74 171.96 7.06 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.329 1.451 . . . . 0.0 111.224 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 73.56 67.49 1.78 Allowed Glycine 0 C--O 1.226 -0.385 0 O-C-N 120.469 -1.394 . . . . 0.0 112.79 170.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -101.56 89.76 1.56 Allowed Pre-proline 0 C--O 1.238 0.48 0 C-N-CA 128.741 2.816 . . . . 0.0 110.157 -163.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -54.97 -22.52 30.9 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 124.447 3.432 . . . . 0.0 114.388 -172.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 102.8 157.16 25.44 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 -171.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.523 ' HA ' ' CG1' ' A' ' 97' ' ' VAL . 25.2 t70 -63.85 5.08 0.24 Allowed 'General case' 0 CA--C 1.508 -0.638 0 C-N-CA 129.588 3.155 . . . . 0.0 116.698 -163.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.2 p -134.19 152.15 51.68 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 116.566 -2.054 . . . . 0.0 113.004 146.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 34.8 m -136.94 152.06 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 124.644 1.178 . . . . 0.0 109.353 -173.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -89.33 130.19 35.75 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 168.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 12.0 p -129.5 -179.93 5.45 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 118.482 -0.77 . . . . 0.0 109.059 169.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.461 ' HB2' HG22 ' A' ' 4' ' ' ILE . 40.7 m-85 -101.56 159.72 15.06 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.297 0.953 . . . . 0.0 111.103 164.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.447 HG11 ' CD1' ' A' ' 93' ' ' LEU . 0.1 OUTLIER -163.03 118.02 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 128.911 2.884 . . . . 0.0 104.018 -158.837 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -83.19 86.18 7.08 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 172.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.1 p -94.45 -179.86 5.04 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.018 0.927 . . . . 0.0 108.659 172.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.548 HG23 HD23 ' A' ' 54' ' ' LEU . 1.1 t -133.33 140.81 47.62 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -103.6 -9.77 18.96 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.948 1.299 . . . . 0.0 111.242 166.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . 0.268 3.2 t -103.56 34.94 2.76 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 122.35 1.072 . . . . 0.0 111.052 -161.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.504 ' HB3' HD22 ' A' ' 54' ' ' LEU . 39.4 p90 -65.61 164.29 14.56 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.971 1.709 . . . . 0.0 113.173 -174.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -91.12 149.5 40.02 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 125.364 1.466 . . . . 0.0 108.795 167.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.51 -30.16 71.29 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.17 1.913 . . . . 0.0 113.089 -171.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.511 ' HA ' ' CD2' ' A' ' 126' ' ' PHE . 4.6 pm0 -58.1 -29.86 65.8 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.309 1.044 . . . . 0.0 113.06 177.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 46.2 m0 -71.73 -8.34 53.6 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 122.081 -0.387 . . . . 0.0 111.275 -173.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -89.9 -20.26 23.6 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 117.969 -1.015 . . . . 0.0 112.026 171.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.511 ' CD2' ' HA ' ' A' ' 123' ' ' GLU . 18.0 m-85 -68.88 -36.0 77.55 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 120.14 1.336 . . . . 0.0 110.157 174.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.4 mt -58.21 149.92 55.34 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 125.137 1.375 . . . . 0.0 110.439 -176.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.96 166.61 29.23 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.443 2.096 . . . . 0.0 110.237 173.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -118.75 160.14 22.41 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.868 0.867 . . . . 0.0 110.454 -175.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 59.5 m-70 -139.86 166.64 24.1 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.304 0.642 . . . . 0.0 110.895 -175.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -127.32 -4.92 6.06 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.203 1.401 . . . . 0.0 112.228 -170.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.0 p -138.7 -178.8 5.47 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 153.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -126.58 174.83 8.39 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 122.514 1.149 . . . . 0.0 110.063 157.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.35 88.88 1.74 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 113.132 -1.849 . . . . 0.0 107.76 178.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.08 -22.64 65.94 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.045 -1.034 . . . . 0.0 110.216 167.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -105.17 73.01 1.02 Allowed 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 105.018 -2.215 . . . . 0.0 105.018 170.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -143.93 155.01 25.99 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 177.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -73.71 -6.56 18.86 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.009 2.473 . . . . 0.0 113.229 -167.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 51.9 m-70 -51.88 -33.82 38.32 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.596 1.158 . . . . 0.0 113.048 -170.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 98.47 -19.17 55.48 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.714 1.15 . . . . 0.0 113.53 168.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.545 ' HG ' HH21 ' A' ' 142' ' ' ARG . 0.2 OUTLIER -98.89 57.94 1.13 Allowed 'General case' 0 C--O 1.238 0.49 0 C-N-CA 126.865 2.066 . . . . 0.0 109.216 172.451 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.545 HH21 ' HG ' ' A' ' 141' ' ' LEU . 5.9 mmp_? -84.54 169.57 14.31 Favored 'General case' 0 C--O 1.237 0.408 0 O-C-N 120.386 -1.446 . . . . 0.0 109.941 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -61.83 150.79 36.2 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -173.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 . . . . . 0 CA--C 1.534 0.344 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 177.23 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.392 0 CA-C-O 121.553 0.692 . . . . 0.0 109.235 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -125.77 123.97 39.96 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 177.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.8 pt -130.41 173.57 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 122.776 1.274 . . . . 0.0 110.158 -178.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.41 ' HB3' HG22 ' A' ' 114' ' ' VAL . 37.4 t80 -112.08 155.32 24.04 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 125.744 1.618 . . . . 0.0 107.314 169.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.554 ' CG2' ' HB2' ' A' ' 10' ' ' LEU . 5.0 p -79.3 176.56 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-O 121.785 0.802 . . . . 0.0 109.698 175.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -125.92 174.46 8.38 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 173.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.62 -10.96 20.39 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 115.246 0.858 . . . . 0.0 115.246 -171.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.76 -23.69 36.48 Favored 'General case' 0 N--CA 1.435 -1.184 0 C-N-CA 125.498 1.519 . . . . 0.0 110.876 -175.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.554 ' HB2' ' CG2' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -125.58 -3.23 7.29 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 121.007 1.73 . . . . 0.0 111.915 -169.361 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -82.6 -7.25 59.65 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 -173.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -135.4 -85.96 0.38 Allowed 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 120.652 1.569 . . . . 0.0 107.082 176.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -160.44 15.21 0.19 Allowed Glycine 0 CA--C 1.529 0.922 0 CA-C-O 118.332 -1.26 . . . . 0.0 113.002 -168.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.465 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 3.1 mm-40 -57.83 164.57 3.08 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 119.709 1.755 . . . . 0.0 109.857 -175.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 14' ' ' GLN . 58.8 Cg_endo -68.12 -2.53 9.03 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 123.874 3.049 . . . . 0.0 113.415 -169.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -96.17 -14.46 22.76 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 127.897 2.479 . . . . 0.0 111.953 -177.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -48.71 -33.28 9.86 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 120.04 1.291 . . . . 0.0 110.609 -175.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.8 pttp -44.52 -32.47 1.42 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.049 1.739 . . . . 0.0 114.22 176.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.2 m -66.64 -11.67 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 123.633 0.773 . . . . 0.0 112.348 -177.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.2 ptp -121.56 14.74 11.08 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.279 1.432 . . . . 0.0 112.219 172.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 56.7 mt -115.05 2.99 14.33 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 124.72 1.208 . . . . 0.0 111.971 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -131.46 96.78 4.07 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 123.967 0.907 . . . . 0.0 108.56 -175.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 -55.7 -20.82 15.64 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.73 1.212 . . . . 0.0 112.31 -176.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 t -62.38 -25.79 68.12 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 120.13 1.332 . . . . 0.0 111.65 174.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -83.38 -1.99 54.72 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.401 -0.812 . . . . 0.0 111.794 174.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.93 177.0 19.25 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 124.874 1.226 . . . . 0.0 111.09 -175.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 35.0 tp -93.22 137.96 32.06 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.833 0.853 . . . . 0.0 111.335 -173.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.27 135.13 47.78 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 159.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.9 136.94 37.56 Favored 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 124.782 1.233 . . . . 0.0 109.323 -177.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -64.46 109.28 1.89 Allowed 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.679 0.792 . . . . 0.0 109.407 -179.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 -116.21 51.86 0.94 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 -175.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.15 -153.03 46.14 Favored Glycine 0 N--CA 1.442 -0.961 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -151.13 170.39 19.55 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.688 -0.89 . . . . 0.0 111.945 -171.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -174.18 178.75 45.91 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.029 -1.081 . . . . 0.0 115.478 -175.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 64.4 m -137.48 132.66 33.62 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 177.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.2 p -65.98 101.78 0.72 Allowed 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -69.83 -29.31 40.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 O-C-N 121.877 -0.514 . . . . 0.0 110.211 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -58.68 109.47 0.81 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 156.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.1 m -55.25 140.1 40.17 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 164.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -139.74 153.44 70.05 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 171.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.38 98.44 1.17 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 124.626 3.551 . . . . 0.0 110.077 173.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 54.1 tp -88.89 117.42 27.88 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 166.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.7 m -128.07 149.81 33.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.2 mt -114.23 98.15 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 -177.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.71 135.06 25.93 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.813 1.645 . . . . 0.0 108.797 -167.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.05 147.14 12.84 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 125.427 1.489 . . . . 0.0 110.739 -172.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -63.13 -26.8 68.99 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.807 1.643 . . . . 0.0 114.094 -164.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -90.13 3.85 52.15 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -174.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 51.75 61.87 3.0 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.064 1.345 . . . . 0.0 110.319 -167.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 52.1 mt -107.16 86.88 2.74 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 128.093 2.557 . . . . 0.0 104.149 172.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -62.22 152.92 73.3 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 121.281 1.32 . . . . 0.0 111.095 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -119.92 157.83 27.95 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.874 1.27 . . . . 0.0 109.702 -177.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.3 tp -122.43 94.2 4.22 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 175.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.6 mt -68.02 131.32 45.25 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.567 ' CE1' HG21 ' A' ' 91' ' ' THR . 58.9 t80 -71.64 96.07 1.53 Allowed 'General case' 0 C--O 1.239 0.502 0 C-N-CA 119.825 -0.75 . . . . 0.0 109.476 -176.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.43 85.31 6.81 Favored Pre-proline 0 CA--C 1.535 0.37 0 C-N-CA 123.742 0.817 . . . . 0.0 112.366 175.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -62.89 122.38 10.64 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.073 2.515 . . . . 0.0 109.315 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.75 -4.0 56.2 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 125.713 1.625 . . . . 0.0 114.604 177.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -106.42 167.09 10.07 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 120.552 2.176 . . . . 0.0 109.145 168.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 61.53 -142.54 48.33 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 -170.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -142.04 179.55 6.82 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.583 1.153 . . . . 0.0 110.59 -171.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 77.6 m -77.15 114.51 16.03 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.516 1.126 . . . . 0.0 109.68 178.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.1 t -77.82 112.4 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 172.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.5 p -81.88 145.08 30.55 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.337 -0.852 . . . . 0.0 109.01 177.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -169.81 -172.03 35.95 Favored Glycine 0 C--N 1.342 0.889 0 O-C-N 121.018 -1.051 . . . . 0.0 112.466 -172.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -114.65 161.0 18.68 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 176.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 62.2 mt -111.02 135.46 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 124.709 1.203 . . . . 0.0 108.286 -175.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -124.94 125.06 43.33 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.691 0.796 . . . . 0.0 108.987 175.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -71.39 142.95 50.33 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 158.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.5 m -140.75 153.25 20.98 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -176.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -94.51 174.95 6.86 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 122.585 1.183 . . . . 0.0 111.378 172.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.39 -5.49 40.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 113.493 -1.685 . . . . 0.0 113.051 -175.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -85.62 -46.89 10.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 118.028 -0.986 . . . . 0.0 110.417 164.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 25.3 tpp -63.75 -50.03 70.68 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.772 1.169 . . . . 0.0 111.168 -177.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.06 -17.28 64.82 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 122.237 -0.289 . . . . 0.0 111.071 -175.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 23.6 mtt180 -86.8 -42.94 12.89 Favored 'General case' 0 C--O 1.222 -0.374 0 C-N-CA 127.63 2.372 . . . . 0.0 110.901 172.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -60.57 -44.87 95.7 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.951 1.251 . . . . 0.0 109.562 177.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.5 mp -58.41 -30.73 67.08 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.54 -0.725 . . . . 0.0 110.855 171.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.489 ' HA ' ' SG ' ' A' ' 84' ' ' CYS . 1.1 t70 -70.98 3.71 3.16 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.177 1.391 . . . . 0.0 113.44 176.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -126.97 -43.15 1.69 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 127.129 2.172 . . . . 0.0 109.699 176.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -65.9 -37.98 87.52 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.539 1.536 . . . . 0.0 112.378 177.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -91.01 6.52 44.5 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 123.227 0.611 . . . . 0.0 111.462 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 86' ' ' SER . 10.2 t0 52.06 30.24 7.28 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.776 1.23 . . . . 0.0 113.62 175.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.489 ' SG ' ' HA ' ' A' ' 79' ' ' ASP . 0.8 OUTLIER -74.24 159.63 83.35 Favored Pre-proline 0 CA--C 1.536 0.414 0 O-C-N 118.613 -2.554 . . . . 0.0 109.559 172.024 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -72.77 -4.45 14.16 Favored 'Cis proline' 0 CA--C 1.544 1.011 0 CA-C-N 120.477 1.206 . . . . 0.0 114.205 -6.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 3.0 m -54.62 -72.33 0.07 Allowed 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.24 1.016 . . . . 0.0 111.625 177.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.404 ' HG3' ' HB3' ' A' ' 83' ' ' ASP . 8.6 mtm -74.74 -64.61 1.0 Allowed 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -173.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -101.99 172.16 7.08 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.753 0.821 . . . . 0.0 108.983 178.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -135.23 -14.95 1.97 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 178.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 61.45 148.21 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 128.623 2.769 . . . . 0.0 114.635 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.567 HG21 ' CE1' ' A' ' 55' ' ' TYR . 17.4 m -154.17 170.82 20.3 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -174.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.41 ' O ' HG22 ' A' ' 91' ' ' THR . . . -87.4 159.41 18.72 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.042 1.337 . . . . 0.0 110.196 162.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.606 HD21 ' SG ' ' A' ' 112' ' ' CYS . 0.0 OUTLIER -150.15 -166.6 2.59 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.664 1.185 . . . . 0.0 111.012 176.085 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.77 123.36 32.73 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.022 0.929 . . . . 0.0 110.624 172.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.474 HG13 ' CG1' ' A' ' 110' ' ' VAL . 1.4 p -138.23 111.24 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -170.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -54.03 127.68 27.49 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 124.621 1.168 . . . . 0.0 110.091 -177.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 25.6 t -80.55 82.17 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 C-N-CA 127.503 2.321 . . . . 0.0 107.165 179.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.8 mp -63.1 -30.08 71.31 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.1 0.56 . . . . 0.0 110.227 175.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -154.08 160.48 41.98 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 126.164 1.786 . . . . 0.0 107.741 168.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 54.2 t-105 -144.1 124.56 13.94 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.592 1.557 . . . . 0.0 107.21 174.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -113.48 96.03 5.67 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.482 1.289 . . . . 0.0 114.482 177.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 118.76 -178.92 16.81 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 124.955 1.264 . . . . 0.0 110.868 -176.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -67.85 172.96 4.8 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.67 1.188 . . . . 0.0 110.564 177.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.63 41.18 3.44 Favored Glycine 0 C--O 1.219 -0.84 0 C-N-CA 124.367 0.984 . . . . 0.0 111.689 173.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -101.27 89.17 1.28 Allowed Pre-proline 0 C--N 1.321 -0.647 0 C-N-CA 130.624 3.57 . . . . 0.0 110.02 -155.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -73.81 -26.69 13.19 Favored 'Trans proline' 0 CA--C 1.538 0.708 1 C-N-CA 126.456 4.771 . . . . 0.0 114.807 -159.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 128.71 -164.23 21.92 Favored Glycine 0 CA--C 1.533 1.198 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -160.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -63.96 -23.83 67.49 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 117.932 0.866 . . . . 0.0 113.325 -169.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.75 169.34 17.89 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.878 1.271 . . . . 0.0 109.884 -174.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.474 ' CG1' HG13 ' A' ' 95' ' ' VAL 0.289 11.3 p -130.67 153.54 39.25 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 C-N-CA 117.63 -1.628 . . . . 0.0 108.699 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -96.13 77.78 3.11 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 173.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.606 ' SG ' HD21 ' A' ' 93' ' ' LEU . 1.6 p -82.36 -167.55 1.63 Allowed 'General case' 0 C--O 1.237 0.41 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.9 177.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -120.46 136.6 54.7 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.328 0.651 . . . . 0.0 109.272 162.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.437 HG23 HD11 ' A' ' 93' ' ' LEU . 95.5 t -124.48 153.42 31.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 169.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -84.23 105.0 14.74 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.051 -1.03 . . . . 0.0 109.354 176.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 70.6 p -86.18 175.98 8.21 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.672 1.189 . . . . 0.0 110.35 172.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.7 t -128.49 146.26 50.87 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 149.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -117.42 5.59 12.54 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.383 1.073 . . . . 0.0 111.381 176.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 11.4 t -126.28 47.04 2.33 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 122.805 1.288 . . . . 0.0 110.058 -176.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 14.8 p90 -78.83 156.2 28.83 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.142 0.977 . . . . 0.0 111.866 -178.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.05 157.26 85.45 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 125.153 1.381 . . . . 0.0 110.515 173.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -59.88 -48.36 12.8 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.063 2.509 . . . . 0.0 112.578 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -51.57 -32.38 28.24 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.674 1.19 . . . . 0.0 113.661 -178.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 44.2 m0 -71.14 -14.86 62.42 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.344 -0.847 . . . . 0.0 111.4 -173.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 78.7 mt -71.36 -20.0 62.22 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 118.061 -0.971 . . . . 0.0 111.842 170.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -95.91 -24.74 16.28 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.632 1.106 . . . . 0.0 110.889 -168.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 77.1 mt -60.25 156.93 36.68 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 126.103 1.761 . . . . 0.0 111.961 -173.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -66.74 151.21 82.98 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 121.916 1.744 . . . . 0.0 109.64 175.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -104.92 162.99 12.86 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.335 1.054 . . . . 0.0 111.542 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -137.67 144.48 41.85 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 123.529 0.731 . . . . 0.0 111.938 -173.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -94.64 -12.7 26.87 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.032 1.333 . . . . 0.0 112.181 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 51.9 p -159.23 172.7 17.55 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 120.61 -1.306 . . . . 0.0 109.743 173.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.61 148.0 40.24 Favored 'General case' 0 N--CA 1.434 -1.245 0 C-N-CA 126.649 1.98 . . . . 0.0 107.227 -178.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -156.81 113.68 3.08 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 105.28 -2.118 . . . . 0.0 105.28 172.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.36 1.23 19.56 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.773 -0.579 . . . . 0.0 110.734 173.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -120.35 45.25 2.25 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.013 1.725 . . . . 0.0 106.782 164.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -109.66 155.8 15.91 Favored Glycine 0 CA--C 1.534 1.226 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 166.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -66.76 6.64 0.53 Allowed 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 125.289 3.993 . . . . 0.0 114.71 178.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 61.0 m-70 -58.58 -13.74 6.46 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 120.688 -1.258 . . . . 0.0 114.239 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 86.22 -46.62 3.63 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 124.871 1.224 . . . . 0.0 112.227 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.91 75.55 2.82 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.408 1.083 . . . . 0.0 112.188 179.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -95.92 157.92 15.68 Favored 'General case' 0 N--CA 1.463 0.178 0 O-C-N 121.403 -0.811 . . . . 0.0 110.707 175.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -59.28 156.73 11.99 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.947 1.299 . . . . 0.0 110.834 -176.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 C--O 1.238 0.47 0 C-N-CA 125.748 1.619 . . . . 0.0 107.751 177.575 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.136 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -63.22 138.33 58.51 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 124.698 1.199 . . . . 0.0 109.437 -174.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.3 pt -125.56 167.78 19.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 124.33 1.052 . . . . 0.0 109.221 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -132.69 136.52 46.47 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.474 0.71 . . . . 0.0 109.48 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.599 HG22 ' H ' ' A' ' 66' ' ' GLU . 34.5 m -75.34 114.68 15.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 123.353 0.661 . . . . 0.0 109.933 -172.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -66.45 -3.9 7.15 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.044 0.938 . . . . 0.0 113.122 174.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 145.05 -1.04 1.02 Allowed Glycine 0 CA--C 1.528 0.891 0 CA-C-O 118.972 -0.904 . . . . 0.0 115.045 168.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 p -109.81 -16.59 13.85 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 120.198 1.999 . . . . 0.0 113.5 -160.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.68 30.61 6.62 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.874 1.27 . . . . 0.0 110.859 -171.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.493 ' HB2' HG21 ' A' ' 6' ' ' VAL . 1.8 tmtm? -132.4 -84.87 0.48 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 117.344 -1.313 . . . . 0.0 109.205 -176.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.4 mmt-85 -50.62 -78.71 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.61 1.564 . . . . 0.0 112.3 -173.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -171.72 10.92 0.04 OUTLIER Glycine 0 CA--C 1.52 0.404 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -162.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.13 150.66 91.83 Favored Pre-proline 0 CA--C 1.537 0.449 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 175.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -68.89 -12.36 34.24 Favored 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 123.694 2.929 . . . . 0.0 112.697 -169.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -85.18 -12.5 52.57 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 116.247 -1.835 . . . . 0.0 112.501 -174.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -49.66 -39.02 34.9 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 121.302 1.864 . . . . 0.0 110.098 -176.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -50.65 -24.79 3.57 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 115.343 1.609 . . . . 0.0 115.343 178.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.4 m -56.18 -45.63 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 120.835 1.652 . . . . 0.0 110.698 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.426 ' HA ' ' CE ' ' A' ' 74' ' ' MET . 2.3 mmm -73.02 -7.45 51.29 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -176.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.1 mt -101.43 11.4 39.21 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.653 1.181 . . . . 0.0 108.487 -175.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -127.15 103.28 7.35 Favored 'General case' 0 CA--C 1.513 -0.466 0 O-C-N 121.307 -0.871 . . . . 0.0 109.942 178.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -66.39 -18.86 65.6 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -175.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 m -66.41 -19.93 65.93 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.29 -0.881 . . . . 0.0 112.403 168.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 39.3 m170 -93.44 -17.49 23.41 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.938 0.895 . . . . 0.0 110.994 169.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 130.96 178.73 15.61 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 124.787 1.184 . . . . 0.0 112.114 169.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 37.5 tp -88.42 147.33 24.75 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.242 0.617 . . . . 0.0 111.352 -175.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.95 158.55 44.21 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.361 1.064 . . . . 0.0 109.243 161.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -143.64 136.46 27.44 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 126.826 2.051 . . . . 0.0 108.931 175.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -75.56 79.08 2.57 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.509 1.924 . . . . 0.0 110.0 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -95.5 63.27 2.48 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 121.14 -0.975 . . . . 0.0 109.935 174.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.17 175.0 27.65 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-O 122.598 1.11 . . . . 0.0 113.975 158.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 44.5 mtp85 -113.82 158.01 21.57 Favored 'General case' 0 CA--C 1.516 -0.34 0 O-C-N 121.586 -0.949 . . . . 0.0 108.686 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -171.42 177.54 44.24 Favored Glycine 0 CA--C 1.506 -0.493 0 CA-C-O 122.235 0.908 . . . . 0.0 112.895 -176.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.3 p -140.09 146.17 38.57 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.101 -1.049 . . . . 0.0 108.47 172.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.2 p -71.2 96.99 1.45 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 104.999 -2.222 . . . . 0.0 104.999 170.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -67.28 -36.45 76.74 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.47 111.55 1.02 Allowed 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 160.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -57.5 142.81 42.99 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 174.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -137.48 153.72 74.65 Favored Pre-proline 0 N--CA 1.45 -0.474 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 169.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -80.17 96.69 1.03 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 1 C-N-CA 125.704 4.269 . . . . 0.0 110.792 177.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 51.0 tp -92.4 114.38 26.92 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 169.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.5 m -126.57 149.38 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 177.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.9 mt -94.16 121.62 44.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 177.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.22 -179.73 6.03 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.554 0.741 . . . . 0.0 110.459 176.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.42 153.88 4.25 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 125.31 1.433 . . . . 0.0 111.849 172.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -67.24 -16.93 64.58 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 121.145 -1.209 . . . . 0.0 113.299 -171.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 24.9 m-70 -100.44 9.56 42.44 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.882 0.873 . . . . 0.0 112.998 -173.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 57.44 66.25 1.18 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.705 1.602 . . . . 0.0 108.716 -172.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 96.3 mt -112.23 87.02 8.52 Favored Pre-proline 0 C--N 1.331 -0.202 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.69 145.55 95.07 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 CA-C-N 121.021 1.4 . . . . 0.0 111.749 170.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 22.1 m95 -123.78 161.18 25.74 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.781 1.232 . . . . 0.0 108.641 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.8 tp -116.51 96.02 5.32 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 174.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.76 135.72 57.78 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 172.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -71.24 93.94 1.14 Allowed 'General case' 0 C--O 1.233 0.237 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.85 74.4 14.72 Favored Pre-proline 0 CA--C 1.537 0.444 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -59.88 120.71 8.67 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.233 1.956 . . . . 0.0 109.401 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.03 -1.84 40.99 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 126.953 2.216 . . . . 0.0 114.242 177.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -112.03 160.94 17.0 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 120.672 2.236 . . . . 0.0 108.016 174.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.09 -142.46 34.47 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 109.739 -1.345 . . . . 0.0 109.739 -173.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -140.95 178.14 7.57 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.421 1.088 . . . . 0.0 110.129 -171.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 68.9 m -76.41 109.71 10.35 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 118.887 0.767 . . . . 0.0 111.076 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.5 t -75.26 108.89 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 174.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 59.2 p -72.2 160.83 31.77 Favored 'General case' 0 C--O 1.24 0.56 0 O-C-N 121.321 -0.862 . . . . 0.0 109.291 174.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 174.46 -157.55 25.2 Favored Glycine 0 C--N 1.335 0.505 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 -176.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.599 ' H ' HG22 ' A' ' 6' ' ' VAL . 9.8 mt-10 -134.99 156.47 48.98 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 125.21 1.404 . . . . 0.0 108.158 178.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.3 mt -103.99 128.25 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 -176.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -122.98 126.83 47.91 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 172.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -67.89 151.11 47.67 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 155.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.7 m -144.91 162.86 13.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 124.78 1.232 . . . . 0.0 107.862 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -105.54 171.3 7.4 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.995 0.902 . . . . 0.0 109.102 169.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.31 -32.29 68.34 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.393 1.477 . . . . 0.0 112.287 -163.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -69.91 -38.48 76.27 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-O 117.33 -1.319 . . . . 0.0 110.999 176.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.426 ' CE ' ' HA ' ' A' ' 20' ' ' MET . 43.6 tpp -65.69 -47.05 76.73 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 120.438 1.472 . . . . 0.0 109.18 178.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.05 -31.82 73.15 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.052 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -68.39 -45.02 73.82 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.503 1.047 . . . . 0.0 111.708 170.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -60.47 -50.36 73.87 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.682 0.793 . . . . 0.0 110.064 -176.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.6 mt -62.1 -36.3 81.3 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 122.806 0.442 . . . . 0.0 111.342 -175.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -51.54 -54.67 24.91 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.31 1.844 . . . . 0.0 108.757 172.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -68.88 -41.24 78.6 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.352 1.061 . . . . 0.0 112.296 -177.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -60.81 -53.57 55.77 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.271 1.428 . . . . 0.0 110.777 -168.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -74.79 -5.26 42.45 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.019 0.372 . . . . 0.0 111.594 -177.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.0 t0 75.02 25.31 1.38 Allowed 'General case' 0 C--O 1.233 0.2 0 C-N-CA 128.861 2.865 . . . . 0.0 113.782 -174.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -62.4 161.66 24.56 Favored Pre-proline 0 CA--C 1.547 0.858 0 O-C-N 119.837 -1.789 . . . . 0.0 108.44 165.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -72.21 -3.82 12.38 Favored 'Cis proline' 0 CA--C 1.548 1.224 0 CA-C-N 119.392 0.818 . . . . 0.0 113.004 -12.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.16 -59.6 5.2 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.479 1.912 . . . . 0.0 111.083 -175.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 27.5 mtp -82.83 -76.89 0.25 Allowed 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.859 1.263 . . . . 0.0 108.402 178.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -88.92 -177.4 5.47 Favored 'General case' 0 C--O 1.227 -0.122 0 C-N-CA 125.318 1.447 . . . . 0.0 110.319 -179.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 6.7 mp0 -138.21 176.61 8.55 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.605 2.362 . . . . 0.0 106.72 159.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -117.99 126.02 51.51 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.471 1.509 . . . . 0.0 108.382 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.7 m -126.09 150.91 47.86 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.212 0.605 . . . . 0.0 110.032 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.07 137.75 33.98 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.503 1.521 . . . . 0.0 109.533 166.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.599 HD11 HG23 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -142.68 -164.64 1.87 Allowed 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 127.852 2.461 . . . . 0.0 108.187 -177.254 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -119.42 139.76 51.5 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 123.613 0.765 . . . . 0.0 110.561 173.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 10.8 t -127.46 149.43 32.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 173.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -87.41 137.23 32.51 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 126.706 2.002 . . . . 0.0 105.656 170.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.751 HG13 ' HA ' ' A' ' 108' ' ' ASP 0.324 1.7 p -94.74 92.2 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 176.084 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.68 -45.53 93.59 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 114.358 -1.292 . . . . 0.0 108.802 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -141.58 140.83 33.47 Favored 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 125.651 1.58 . . . . 0.0 107.296 177.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 50.5 t-105 -108.7 141.24 40.97 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 167.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -119.93 101.37 7.81 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 165.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 139.93 177.72 16.09 Favored Glycine 0 C--N 1.331 0.252 0 CA-C-O 122.826 1.237 . . . . 0.0 112.822 164.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -64.67 162.29 16.07 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 168.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 72.44 75.19 0.71 Allowed Glycine 0 CA--C 1.522 0.474 0 O-C-N 120.937 -1.102 . . . . 0.0 111.883 176.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -102.28 90.52 2.12 Favored Pre-proline 0 N--CA 1.471 0.587 0 C-N-CA 128.399 2.68 . . . . 0.0 108.176 -172.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -53.15 -29.67 46.91 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.479 2.119 . . . . 0.0 114.807 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 145.73 -120.29 1.32 Allowed Glycine 0 C--N 1.338 0.694 0 CA-C-N 121.106 1.775 . . . . 0.0 110.729 -175.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.751 ' HA ' HG13 ' A' ' 97' ' ' VAL . 0.9 OUTLIER -143.9 1.04 1.12 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.319 1.848 . . . . 0.0 110.812 179.338 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.2 p -131.93 158.17 42.1 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 122.184 0.992 . . . . 0.0 110.62 148.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.4 m -137.74 167.25 22.85 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 C-N-CA 125.67 1.588 . . . . 0.0 108.444 -177.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -95.58 118.96 33.24 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 163.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 80.1 m -109.41 167.64 9.97 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.465 1.029 . . . . 0.0 109.4 165.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -95.13 141.57 28.59 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 163.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.599 HG23 HD11 ' A' ' 93' ' ' LEU . 84.9 t -135.64 151.42 29.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 170.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -81.17 134.18 35.58 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 173.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 42.3 p -140.37 -177.7 5.15 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.096 1.359 . . . . 0.0 109.575 -172.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.63 141.4 35.1 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 167.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -103.6 -5.59 22.52 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.209 1.003 . . . . 0.0 110.614 167.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.6 p -107.78 17.75 22.17 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.435 1.894 . . . . 0.0 112.715 -156.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -77.8 162.09 27.17 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.562 1.545 . . . . 0.0 113.343 -167.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -81.45 158.19 69.23 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 126.938 2.095 . . . . 0.0 111.405 175.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.464 ' HA ' HD23 ' A' ' 125' ' ' LEU . 46.7 Cg_endo -68.01 -33.22 26.39 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.68 2.253 . . . . 0.0 113.35 -174.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.9 pm0 -58.36 -31.74 67.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 118.806 0.73 . . . . 0.0 112.763 177.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 44.2 m0 -69.37 -14.72 63.07 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.318 0.508 . . . . 0.0 111.215 -176.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.464 HD23 ' HA ' ' A' ' 122' ' ' PRO . 3.4 mm? -78.4 -17.93 55.73 Favored 'General case' 0 CA--C 1.528 0.131 0 O-C-N 121.329 -0.857 . . . . 0.0 111.317 172.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -95.56 -22.7 17.46 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.798 0.727 . . . . 0.0 110.281 -172.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.2 mt -56.91 155.22 15.92 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 126.094 1.758 . . . . 0.0 111.036 178.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -67.64 144.4 66.01 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 121.339 1.359 . . . . 0.0 108.939 177.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -82.16 164.6 21.17 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 122.767 0.427 . . . . 0.0 109.923 172.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 51.8 m-70 -139.47 139.16 36.93 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.296 1.038 . . . . 0.0 109.13 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -82.45 -20.21 37.39 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.914 0.886 . . . . 0.0 112.921 -178.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.04 156.56 7.32 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 119.389 0.995 . . . . 0.0 110.052 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -114.28 127.79 56.04 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.572 1.149 . . . . 0.0 108.768 -175.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -140.18 131.38 26.52 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.434 1.494 . . . . 0.0 108.535 -174.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 7.6 t -69.93 -10.23 57.84 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.951 0.9 . . . . 0.0 110.154 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -131.15 64.22 1.58 Allowed 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 128.567 2.747 . . . . 0.0 104.673 177.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -124.28 171.51 16.53 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.866 1.698 . . . . 0.0 110.871 -176.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -61.96 -22.94 75.25 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.037 2.491 . . . . 0.0 112.877 -172.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -79.7 84.39 5.53 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 128.728 2.811 . . . . 0.0 109.251 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -44.89 -31.56 2.8 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 124.938 1.256 . . . . 0.0 113.683 177.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.5 90.25 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 127.097 2.159 . . . . 0.0 111.37 157.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -102.53 175.93 5.34 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 120.848 -1.158 . . . . 0.0 109.132 166.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -60.13 116.06 3.93 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -173.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 . . . . . 0 C--O 1.226 -0.159 0 C-N-CA 124.05 0.94 . . . . 0.0 109.331 -178.115 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.781 0 N-CA-C 102.514 -3.143 . . . . 0.0 102.514 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -69.91 123.28 21.11 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 -175.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.2 pt -108.18 174.19 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 121.229 -0.919 . . . . 0.0 108.707 176.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.443 ' HB2' ' SG ' ' A' ' 112' ' ' CYS . 14.4 t80 -109.57 165.54 11.59 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.429 0.692 . . . . 0.0 109.37 168.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.2 p -121.45 133.99 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -59.58 -52.15 66.8 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.49 0.662 . . . . 0.0 111.843 -177.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.11 -35.29 0.27 Allowed Glycine 0 CA--C 1.526 0.78 0 CA-C-O 123.708 1.727 . . . . 0.0 110.793 -167.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -55.44 -23.73 26.88 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 129.927 3.291 . . . . 0.0 114.202 178.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -134.92 32.32 3.23 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 119.897 1.226 . . . . 0.0 110.157 -179.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.17 8.58 5.15 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 115.559 1.688 . . . . 0.0 115.559 178.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.69 -86.42 0.14 Allowed 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 117.677 -1.154 . . . . 0.0 109.139 174.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -162.6 18.07 0.15 Allowed Glycine 0 C--N 1.337 0.61 0 CA-C-N 119.366 0.985 . . . . 0.0 113.744 177.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -44.88 156.36 0.36 Allowed Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 126.474 1.91 . . . . 0.0 111.82 173.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -64.87 -2.15 5.1 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 124.471 3.447 . . . . 0.0 115.25 -172.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.512 ' O ' HG22 ' A' ' 19' ' ' VAL . 20.2 m-80 -112.47 -10.52 13.72 Favored 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 125.115 1.366 . . . . 0.0 110.894 -165.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -56.73 -30.15 63.24 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.091 0.859 . . . . 0.0 111.487 -173.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.5 -27.84 27.71 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.512 HG22 ' O ' ' A' ' 16' ' ' ASN . 17.1 m -69.14 -11.09 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 118.785 0.72 . . . . 0.0 112.499 -170.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.5 ptp -102.79 -0.58 31.23 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.168 1.787 . . . . 0.0 113.232 171.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.0 mt -102.77 4.41 37.9 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.735 1.614 . . . . 0.0 110.694 -178.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -117.39 77.88 1.17 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 -172.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -58.9 -15.28 11.94 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.094 1.758 . . . . 0.0 114.066 -165.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.3 m -61.02 -37.1 81.36 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 120.499 -1.375 . . . . 0.0 112.013 166.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 45.3 m170 -65.78 -29.25 69.72 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.599 0.636 . . . . 0.0 110.529 175.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.57 -178.4 22.49 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 124.171 0.891 . . . . 0.0 111.184 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 46.3 tp -95.9 144.55 26.14 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.976 0.91 . . . . 0.0 111.996 -173.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.71 147.38 46.73 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.617 1.167 . . . . 0.0 108.288 163.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -146.07 134.33 21.74 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 125.574 1.549 . . . . 0.0 109.655 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.93 93.27 0.4 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.482 1.113 . . . . 0.0 110.11 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.1 tpp180 -110.63 64.87 0.61 Allowed 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 126.05 1.74 . . . . 0.0 108.146 -176.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.52 179.08 43.81 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-O 122.848 1.249 . . . . 0.0 112.442 172.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 38.3 mtp180 -125.3 165.06 19.03 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 123.423 0.689 . . . . 0.0 110.776 173.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -173.59 176.13 46.21 Favored Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 120.39 -0.91 . . . . 0.0 113.564 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.448 ' C ' HG23 ' A' ' 95' ' ' VAL . 71.6 m -138.85 133.54 32.13 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.371 1.068 . . . . 0.0 108.877 177.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.1 p -63.55 100.87 0.29 Allowed 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -73.12 -23.6 20.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-O 120.83 0.348 . . . . 0.0 110.833 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -60.41 100.74 0.11 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 152.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.5 m -56.6 137.41 53.85 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 167.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.686 ' HB3' HD21 ' A' ' 53' ' ' LEU . 25.0 m-85 -138.58 156.62 73.08 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 -176.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.441 ' HG2' ' HB2' ' A' ' 54' ' ' LEU . 54.9 Cg_endo -76.27 94.91 1.02 Allowed 'Trans proline' 0 CA--C 1.538 0.682 1 C-N-CA 126.032 4.488 . . . . 0.0 111.607 177.342 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 32.0 tp -93.21 114.33 26.78 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 121.134 -0.979 . . . . 0.0 109.96 174.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.4 m -131.66 143.73 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 119.198 0.908 . . . . 0.0 110.463 -173.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 55.6 mt -97.73 108.86 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -178.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -117.62 -179.68 3.8 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.52 0.728 . . . . 0.0 110.346 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.25 161.53 6.6 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 126.424 1.964 . . . . 0.0 115.382 163.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -65.76 -22.54 66.59 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 127.782 2.433 . . . . 0.0 114.303 -170.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 39.1 m-70 -109.85 13.47 23.54 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.813 0.845 . . . . 0.0 111.821 176.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.9 m120 60.38 64.49 1.2 Allowed 'General case' 0 C--N 1.344 0.365 0 CA-C-O 122.262 1.03 . . . . 0.0 108.251 -179.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 55.4 mt -104.72 87.43 1.8 Allowed Pre-proline 0 N--CA 1.45 -0.427 0 C-N-CA 127.874 2.47 . . . . 0.0 105.403 177.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.08 152.0 25.88 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 120.684 0.923 . . . . 0.0 112.825 166.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 22.4 m95 -130.24 166.64 19.9 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.056 1.342 . . . . 0.0 107.391 175.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.686 HD21 ' HB3' ' A' ' 40' ' ' PHE . 1.2 tm? -138.85 119.7 14.27 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.441 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 0.1 OUTLIER -95.89 147.43 23.67 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 113.392 -1.731 . . . . 0.0 107.834 -169.499 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -78.66 87.19 4.59 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.977 -176.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -140.93 77.57 20.88 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 124.036 0.934 . . . . 0.0 111.103 179.024 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.68 115.68 4.33 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 124.885 3.723 . . . . 0.0 110.442 -176.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 117.23 11.81 8.67 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 124.751 1.167 . . . . 0.0 113.595 175.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.2 tpmt? -138.0 149.06 45.76 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 119.599 1.699 . . . . 0.0 108.808 -176.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.96 -135.32 14.87 Favored Glycine 0 CA--C 1.521 0.465 0 CA-C-N 120.601 1.546 . . . . 0.0 109.507 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -134.97 169.89 16.72 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 118.889 1.345 . . . . 0.0 111.787 -167.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 59.2 m -85.48 103.47 14.38 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 125.358 1.463 . . . . 0.0 108.543 -178.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.0 t -69.8 106.23 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 51.3 p -81.88 147.51 29.27 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.286 -0.884 . . . . 0.0 110.026 -173.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -173.46 -156.52 13.32 Favored Glycine 0 C--N 1.342 0.898 0 O-C-N 121.402 -0.811 . . . . 0.0 113.097 -172.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -134.73 162.62 31.85 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -176.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 89.5 mt -114.43 103.27 15.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 106.301 -1.741 . . . . 0.0 106.301 -170.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -86.07 114.08 22.65 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 172.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -61.5 131.9 51.66 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 152.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.9 m -135.52 156.24 38.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.42 177.64 5.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 122.209 1.004 . . . . 0.0 111.505 172.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.57 -36.01 75.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.057 -1.429 . . . . 0.0 111.342 177.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 32.1 tp60 -63.87 -44.46 93.01 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.292 0.951 . . . . 0.0 110.13 177.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 35.2 tpp -66.96 -50.46 62.22 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 118.629 0.649 . . . . 0.0 110.938 177.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.2 mt -64.14 -16.65 62.32 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 118.592 0.633 . . . . 0.0 111.34 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 45.4 mtt180 -82.15 -50.59 8.86 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 120.429 -1.42 . . . . 0.0 111.555 165.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -54.14 -48.21 71.07 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 120.338 1.426 . . . . 0.0 111.041 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.3 tp -64.47 -23.22 67.2 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 121.823 -0.548 . . . . 0.0 110.96 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.545 ' HA ' ' SG ' ' A' ' 84' ' ' CYS . 28.0 t70 -75.98 -5.9 48.48 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 120.858 -1.151 . . . . 0.0 112.503 176.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -105.92 -42.87 5.01 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.765 1.626 . . . . 0.0 110.604 172.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -65.68 -38.96 90.72 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.838 0.855 . . . . 0.0 112.139 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.497 ' HG3' ' CE2' ' A' ' 115' ' ' TYR . 7.5 mm-40 -83.34 10.57 8.33 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.164 0.585 . . . . 0.0 111.406 178.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.9 t70 61.3 0.32 0.42 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 128.522 2.729 . . . . 0.0 114.882 178.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.545 ' SG ' ' HA ' ' A' ' 79' ' ' ASP . 24.6 p -65.99 153.04 92.53 Favored Pre-proline 0 N--CA 1.448 -0.57 0 C-N-CA 124.167 0.987 . . . . 0.0 109.757 -167.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -75.41 -4.96 22.51 Favored 'Cis proline' 0 CA--C 1.54 0.797 0 N-CA-C 115.915 1.467 . . . . 0.0 115.915 9.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 m -54.68 -71.31 0.08 Allowed 'General case' 0 C--O 1.237 0.435 0 CA-C-N 119.601 1.092 . . . . 0.0 112.758 -178.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 46.2 mtp -71.86 -64.84 0.85 Allowed 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -173.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -105.7 167.0 10.06 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.31 1.444 . . . . 0.0 108.908 -178.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -127.72 -14.1 5.19 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -177.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? 61.91 145.78 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 128.3 2.64 . . . . 0.0 111.756 -172.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.402 HG22 ' N ' ' A' ' 92' ' ' ALA . 38.3 m -148.69 178.12 8.92 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 119.797 -1.814 . . . . 0.0 107.261 171.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.402 ' N ' HG22 ' A' ' 91' ' ' THR . . . -116.59 142.09 47.33 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 127.181 2.193 . . . . 0.0 111.062 168.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.497 HD21 ' SG ' ' A' ' 112' ' ' CYS . 0.0 OUTLIER -136.31 -174.17 3.61 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 129.204 3.001 . . . . 0.0 110.674 -170.798 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -115.75 126.36 53.95 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 126.145 1.778 . . . . 0.0 111.614 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.65 HG13 HG22 ' A' ' 110' ' ' VAL 0.321 1.4 p -142.29 115.16 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 121.063 3.727 . . . . 0.0 121.063 -167.085 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.436 ' HA ' ' O ' ' A' ' 108' ' ' ASP . 59.0 tt0 -60.92 118.22 6.43 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 113.986 -1.461 . . . . 0.0 107.184 -169.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.584 HG13 ' HA ' ' A' ' 108' ' ' ASP 0.331 1.6 p -85.69 87.51 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 O-C-N 124.544 1.153 . . . . 0.0 108.623 -178.284 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.425 HD13 ' HA ' ' A' ' 98' ' ' LEU . 1.7 mm? -57.95 -40.12 79.78 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 112.919 -1.946 . . . . 0.0 109.694 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -152.15 152.58 32.47 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 -177.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 -140.3 129.65 23.91 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -179.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -118.2 97.62 5.88 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.023 1.329 . . . . 0.0 114.094 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.98 -175.7 21.56 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -178.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -67.41 178.4 1.58 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.494 0.717 . . . . 0.0 111.203 -174.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.403 ' O ' ' HD3' ' A' ' 106' ' ' PRO . . . 92.38 47.06 3.36 Favored Glycine 0 C--O 1.22 -0.754 0 O-C-N 120.858 -1.151 . . . . 0.0 110.809 169.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -101.63 88.47 1.2 Allowed Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 131.128 3.771 . . . . 0.0 112.228 -153.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.558 ' CG ' HG12 ' A' ' 110' ' ' VAL . 89.8 Cg_endo -70.91 -32.38 13.89 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 124.295 3.33 . . . . 0.0 114.731 -175.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 143.17 -95.75 0.19 Allowed Glycine 0 C--N 1.339 0.717 0 CA-C-N 120.899 1.681 . . . . 0.0 112.783 -178.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.584 ' HA ' HG13 ' A' ' 97' ' ' VAL . 2.1 m-20 -156.44 6.25 0.18 Allowed 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 125.448 1.499 . . . . 0.0 111.066 -172.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -142.86 154.71 44.4 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 117.815 -1.554 . . . . 0.0 109.549 150.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.65 HG22 HG13 ' A' ' 95' ' ' VAL . 3.1 m -126.01 165.31 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.03 0 C-N-CA 117.09 -1.844 . . . . 0.0 109.624 -175.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -101.77 100.2 10.52 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 104.745 -2.317 . . . . 0.0 104.745 167.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.497 ' SG ' HD21 ' A' ' 93' ' ' LEU . 3.0 p -102.36 -166.75 1.32 Allowed 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 172.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -121.79 146.4 47.1 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.677 1.591 . . . . 0.0 108.714 166.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 20.2 t -139.4 137.85 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 129.778 3.231 . . . . 0.0 107.599 177.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.497 ' CE2' ' HG3' ' A' ' 82' ' ' GLU . 4.3 m-85 -79.92 80.33 6.34 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.898 1.279 . . . . 0.0 111.499 -175.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 51.6 p -80.41 175.71 10.42 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.96 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.0 t -136.12 129.79 32.35 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 105.153 -2.166 . . . . 0.0 105.153 162.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -89.67 -0.81 57.77 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.925 0.89 . . . . 0.0 110.709 172.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 10.1 t -116.25 31.75 6.53 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.674 1.989 . . . . 0.0 110.903 -178.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -56.85 163.48 1.92 Allowed 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.672 -0.642 . . . . 0.0 109.819 166.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -98.07 154.97 37.51 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 123.772 0.829 . . . . 0.0 110.572 172.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -64.29 -33.4 59.49 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.572 2.181 . . . . 0.0 111.235 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -67.07 -7.4 22.64 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.918 0.887 . . . . 0.0 112.675 177.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 44.1 m0 -96.88 -18.52 19.46 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 118.809 0.731 . . . . 0.0 111.34 170.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 18.8 mt -79.0 -16.97 56.18 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 120.094 1.315 . . . . 0.0 112.39 175.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -77.74 -25.03 48.92 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.563 0.745 . . . . 0.0 110.722 174.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 88.7 mt -59.79 151.57 62.67 Favored Pre-proline 0 C--N 1.344 0.35 0 C-N-CA 124.569 1.148 . . . . 0.0 110.678 -175.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -74.86 142.47 28.38 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.029 2.486 . . . . 0.0 109.15 179.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -86.78 167.25 14.58 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.893 0.854 . . . . 0.0 111.628 -175.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -136.5 171.2 14.83 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.429 1.492 . . . . 0.0 108.665 175.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 -127.99 -15.27 4.84 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 123.178 1.466 . . . . 0.0 111.572 -167.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 40.1 t -153.89 151.38 29.4 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 163.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -82.95 170.41 14.96 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 162.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 174.92 147.82 0.08 Allowed 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 128.168 2.587 . . . . 0.0 107.771 152.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.53 -31.7 72.89 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 173.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -77.07 66.79 2.95 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 127.911 2.485 . . . . 0.0 107.442 168.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -130.27 154.37 20.56 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 162.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -73.66 -13.78 24.63 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.597 2.198 . . . . 0.0 113.323 -165.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -75.21 -15.66 60.53 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.04 1.336 . . . . 0.0 113.878 -172.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 81.63 -62.0 4.56 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.111 -1.195 . . . . 0.0 110.111 -173.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.7 87.11 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.729 2.012 . . . . 0.0 114.053 -176.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.86 173.69 11.32 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 130.16 3.384 . . . . 0.0 109.256 172.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -64.11 130.61 44.63 Favored 'General case' 0 C--O 1.237 0.404 0 O-C-N 123.605 0.565 . . . . 0.0 110.482 -161.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 . . . . . 0 N--CA 1.453 -0.313 0 O-C-N 124.436 1.085 . . . . 0.0 110.56 -166.095 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.377 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -130.81 152.36 50.23 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 163.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.9 pt -138.59 172.14 14.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 121.849 0.833 . . . . 0.0 109.793 175.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.594 ' CE2' HG23 ' A' ' 36' ' ' THR . 63.8 t80 -118.15 133.27 56.05 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.969 1.708 . . . . 0.0 107.882 179.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.1 m -91.25 138.06 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 118.982 0.81 . . . . 0.0 110.74 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.617 ' HE1' HD22 ' A' ' 53' ' ' LEU . 87.1 m-85 -75.02 -36.03 61.94 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 127.61 2.364 . . . . 0.0 112.156 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 156.29 -37.86 0.59 Allowed Glycine 0 CA--C 1.522 0.505 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -168.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 p -62.13 -23.31 66.49 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.537 1.535 . . . . 0.0 112.993 -167.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.5 mp -134.13 62.51 1.65 Allowed 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 170.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -154.95 -49.2 0.09 Allowed 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.751 1.62 . . . . 0.0 110.647 -176.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -84.45 -86.4 0.12 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.869 0.759 . . . . 0.0 110.221 173.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -172.65 29.87 0.1 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -173.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.61 162.83 13.87 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 125.127 1.371 . . . . 0.0 110.166 -179.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -59.87 -17.48 44.02 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.849 2.366 . . . . 0.0 112.872 -177.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.684 ' O ' HG22 ' A' ' 19' ' ' VAL . 4.6 m-80 -85.09 -17.05 38.55 Favored 'General case' 0 C--O 1.215 -0.729 0 O-C-N 120.877 -1.139 . . . . 0.0 110.575 -175.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -58.5 -35.9 72.96 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 120.981 1.719 . . . . 0.0 112.272 -163.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.64 -16.74 51.26 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 177.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.684 HG22 ' O ' ' A' ' 16' ' ' ASN . 31.7 m -64.08 -38.69 83.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 120.155 1.343 . . . . 0.0 110.54 -176.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.5 ptp -77.31 -10.48 59.46 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.1 mt -82.16 -14.43 55.67 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 122.869 0.468 . . . . 0.0 111.148 -173.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -106.31 100.21 9.76 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 -177.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 22.1 t-80 -56.28 -22.56 30.95 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.334 1.054 . . . . 0.0 113.513 -171.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.9 m -69.37 -20.86 63.83 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 120.482 -1.386 . . . . 0.0 113.539 174.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 30.7 m170 -76.6 -26.46 55.02 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.348 -0.845 . . . . 0.0 109.86 167.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 145.98 175.71 19.25 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 125.333 1.444 . . . . 0.0 111.222 167.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.8 tp -83.59 141.85 31.26 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 124.159 0.984 . . . . 0.0 111.852 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -145.09 92.76 2.3 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.231 1.812 . . . . 0.0 110.234 170.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -103.19 126.97 50.62 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 125.322 1.449 . . . . 0.0 110.072 -174.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -64.68 105.63 1.02 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.119 1.768 . . . . 0.0 110.44 -175.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.438 ' HG3' ' HB2' ' A' ' 69' ' ' GLU . 32.6 mmt180 -119.18 66.36 0.79 Allowed 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 125.755 1.622 . . . . 0.0 109.627 -178.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.65 -177.76 37.59 Favored Glycine 0 CA--C 1.523 0.539 0 CA-C-O 121.727 0.626 . . . . 0.0 112.134 172.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 8.9 ptt180 -131.48 164.49 25.66 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.194 0.998 . . . . 0.0 108.666 178.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -170.75 -178.82 41.66 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 119.447 -1.358 . . . . 0.0 116.417 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.423 ' C ' HG23 ' A' ' 95' ' ' VAL . 22.6 p -140.73 137.32 33.37 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.88 0.872 . . . . 0.0 110.595 173.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.594 HG23 ' CE2' ' A' ' 5' ' ' PHE . 9.9 p -68.32 100.78 1.1 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 176.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.439 ' CG1' ' HB2' ' A' ' 96' ' ' GLN . 2.2 m -68.78 -31.84 52.39 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-O 121.011 0.434 . . . . 0.0 111.031 -175.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.88 119.5 11.4 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 163.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.7 159.11 11.4 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 119.173 -1.011 . . . . 0.0 108.892 168.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -150.62 154.6 35.45 Favored Pre-proline 0 C--N 1.316 -0.87 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 176.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -80.93 88.72 1.36 Allowed 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 124.638 3.558 . . . . 0.0 112.435 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.4 tp -83.13 88.67 6.89 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 120.655 -1.278 . . . . 0.0 110.619 -177.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.537 HG13 ' HB3' ' A' ' 127' ' ' LEU . 61.5 t -92.59 150.82 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.181 0 C-N-CA 126.704 2.002 . . . . 0.0 109.829 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.8 mt -119.5 113.96 42.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 126.312 1.845 . . . . 0.0 107.409 176.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -137.66 158.09 45.11 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.642 0.734 . . . . 0.0 112.051 -172.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.34 169.12 37.09 Favored Glycine 0 CA--C 1.537 1.413 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.818 175.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.9 -28.48 70.08 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -168.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -96.08 2.18 53.07 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.988 0.18 . . . . 0.0 110.813 -161.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.407 HD22 ' HB2' ' A' ' 141' ' ' LEU . 5.1 m120 67.23 59.32 0.52 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.071 2.148 . . . . 0.0 108.52 176.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 61.7 mt -104.3 91.18 3.68 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 129.794 3.237 . . . . 0.0 108.745 -168.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -56.76 136.82 78.46 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 CA-C-N 120.708 1.288 . . . . 0.0 111.264 172.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -123.83 105.94 10.06 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 126.09 1.756 . . . . 0.0 108.566 -177.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.617 HD22 ' HE1' ' A' ' 7' ' ' TYR . 7.9 tp -76.76 81.53 3.37 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -175.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.1 mp -50.78 125.97 14.65 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 127.105 2.162 . . . . 0.0 110.027 174.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -73.97 85.01 1.76 Allowed 'General case' 0 C--O 1.239 0.548 0 CA-C-O 119.034 -0.508 . . . . 0.0 111.656 -173.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.411 HD11 ' HE2' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -136.66 80.21 38.43 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 118.672 0.669 . . . . 0.0 110.651 174.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -63.53 119.97 7.23 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.788 2.325 . . . . 0.0 111.549 -175.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.69 14.69 57.87 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 125.412 1.482 . . . . 0.0 113.262 178.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.411 ' HE2' HD11 ' A' ' 56' ' ' LEU . 0.9 OUTLIER -122.17 140.87 52.06 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 119.601 1.701 . . . . 0.0 109.172 163.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.23 -133.36 11.74 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 118.798 -1.001 . . . . 0.0 110.943 -171.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -141.76 169.6 17.3 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 118.871 1.336 . . . . 0.0 112.523 -157.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 27.3 m -103.33 103.79 13.84 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.621 1.168 . . . . 0.0 112.497 -166.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 14.1 t -70.05 116.25 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 123.825 0.85 . . . . 0.0 109.789 -177.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 67.6 p -80.41 146.9 31.23 Favored 'General case' 0 C--O 1.24 0.562 0 O-C-N 121.619 -0.676 . . . . 0.0 109.72 171.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -170.81 -168.22 32.25 Favored Glycine 0 N--CA 1.447 -0.574 0 O-C-N 121.386 -0.821 . . . . 0.0 111.957 -175.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 17.5 mt-10 -129.64 169.57 14.88 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 125.614 1.566 . . . . 0.0 108.548 -176.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.4 mt -122.89 130.57 74.39 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 O-C-N 121.298 -0.876 . . . . 0.0 108.82 -170.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -122.75 121.93 37.51 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 125.125 1.37 . . . . 0.0 107.67 171.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.438 ' HB2' ' HG3' ' A' ' 31' ' ' ARG . 78.5 tt0 -64.47 135.4 56.02 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 158.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.7 m -135.69 139.01 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -173.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.48 -179.28 5.15 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.7 0.762 . . . . 0.0 110.012 176.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -63.13 -35.08 79.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 118.289 -0.862 . . . . 0.0 111.543 -173.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 44.1 tp60 -64.92 -42.55 94.61 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 118.869 0.758 . . . . 0.0 110.146 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.1 tpp -64.5 -52.37 58.19 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.8 tp -57.67 -44.19 85.57 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 118.688 -0.672 . . . . 0.0 110.822 -176.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.4 mtt180 -64.62 -34.36 78.1 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.674 0.79 . . . . 0.0 112.193 176.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -67.33 -47.5 70.3 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 118.561 0.618 . . . . 0.0 110.416 177.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.7 mt -60.05 -34.95 74.1 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 175.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.98 -6.54 12.99 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.046 1.738 . . . . 0.0 113.787 178.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -115.96 -24.5 8.08 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.501 1.921 . . . . 0.0 110.739 176.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -68.71 -41.02 79.66 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.584 1.154 . . . . 0.0 111.271 -174.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -105.75 14.58 28.05 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.984 0.914 . . . . 0.0 111.258 -170.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 58.13 25.62 12.69 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.21 1.004 . . . . 0.0 112.332 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -70.47 161.62 75.55 Favored Pre-proline 0 CA--C 1.546 0.827 0 O-C-N 119.73 -1.856 . . . . 0.0 109.739 168.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -70.87 -3.76 9.44 Favored 'Cis proline' 0 CA--C 1.545 1.06 0 CA-C-N 119.551 0.875 . . . . 0.0 113.734 -9.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 m -55.16 -60.77 2.93 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.152 1.781 . . . . 0.0 111.277 -176.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 19.2 mtm -81.83 -64.32 1.21 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 122.019 0.914 . . . . 0.0 110.49 -179.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -102.54 169.99 8.31 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 125.525 1.53 . . . . 0.0 109.381 -178.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.1 mp0 -135.34 143.33 46.06 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.975 1.31 . . . . 0.0 108.394 173.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -78.16 130.04 35.86 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 177.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.9 m -132.16 174.29 10.35 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 125.146 1.378 . . . . 0.0 109.052 -175.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -115.44 151.19 35.19 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.485 1.514 . . . . 0.0 111.153 166.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.573 ' HG ' HG21 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -140.24 -160.98 1.13 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.457 1.503 . . . . 0.0 112.351 -178.09 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 38.5 tp60 -136.9 124.11 21.78 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.796 2.039 . . . . 0.0 110.121 174.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.501 HG21 ' CD1' ' A' ' 5' ' ' PHE . 1.4 p -139.21 116.19 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 116.9 2.185 . . . . 0.0 116.9 -168.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.439 ' HB2' ' CG1' ' A' ' 37' ' ' VAL . 64.5 tt0 -54.54 122.45 10.58 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 124.939 1.296 . . . . 0.0 109.222 -174.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.414 ' CG1' ' HB2' ' A' ' 100' ' ' TRP . 93.1 t -76.57 88.64 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 128.654 2.782 . . . . 0.0 106.509 174.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 mp -75.78 -15.56 60.24 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.271 0.628 . . . . 0.0 111.578 177.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.436 ' HB2' ' CZ ' ' A' ' 33' ' ' ARG . 0.4 OUTLIER -160.32 161.33 33.24 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 128.051 2.541 . . . . 0.0 106.626 161.234 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . 0.414 ' HB2' ' CG1' ' A' ' 97' ' ' VAL . 68.7 t-105 -143.49 102.24 3.91 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.584 1.554 . . . . 0.0 109.62 174.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -95.04 77.82 3.54 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.31 1.044 . . . . 0.0 109.987 -178.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 161.7 178.97 36.07 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-O 122.358 0.977 . . . . 0.0 111.651 174.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -70.21 168.4 15.85 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 168.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.65 65.65 1.65 Allowed Glycine 0 CA--C 1.524 0.594 0 O-C-N 121.377 -0.827 . . . . 0.0 111.646 172.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -101.3 90.11 1.58 Allowed Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 128.002 2.521 . . . . 0.0 109.017 -168.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -68.8 5.06 1.47 Allowed 'Trans proline' 0 CA--C 1.54 0.819 1 C-N-CA 126.361 4.707 . . . . 0.0 114.434 -165.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.05 -174.47 27.63 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 108.921 -1.671 . . . . 0.0 108.921 -168.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -65.56 -14.37 60.95 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 117.759 -1.115 . . . . 0.0 113.963 -168.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 75.6 p -138.82 169.17 18.28 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 121.136 1.789 . . . . 0.0 111.061 174.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.455 ' CG1' HG13 ' A' ' 95' ' ' VAL . 14.3 p -133.91 144.8 34.59 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.76 0 CA-C-N 121.616 2.007 . . . . 0.0 110.768 -173.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -92.04 84.77 5.35 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 171.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.463 ' SG ' HD11 ' A' ' 93' ' ' LEU . 1.6 p -89.43 -167.75 1.96 Allowed 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 175.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -109.86 151.66 26.75 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 122.736 1.255 . . . . 0.0 112.285 160.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.573 HG21 ' HG ' ' A' ' 93' ' ' LEU . 0.1 OUTLIER -152.07 119.42 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 104.782 -2.303 . . . . 0.0 104.782 -163.738 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -67.4 129.5 40.09 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 121.828 -0.545 . . . . 0.0 109.966 167.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.579 HG22 HD23 ' A' ' 53' ' ' LEU . 14.2 p -127.56 -170.05 2.16 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 125.807 1.643 . . . . 0.0 107.059 176.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.2 t -144.14 147.39 33.64 Favored 'General case' 0 C--O 1.239 0.535 0 O-C-N 120.699 -1.251 . . . . 0.0 108.33 161.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -108.33 -10.14 15.38 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.0 1.32 . . . . 0.0 111.727 171.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 9.0 t -98.85 25.52 6.54 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.633 1.173 . . . . 0.0 111.909 -172.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -60.38 146.43 44.36 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.501 1.12 . . . . 0.0 111.329 176.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.66 155.27 89.56 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 124.873 1.269 . . . . 0.0 110.634 173.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.18 -33.6 18.41 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 121.398 1.399 . . . . 0.0 112.759 -178.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -58.52 -25.37 62.36 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.45 -0.781 . . . . 0.0 112.611 172.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 41.5 m0 -80.43 -4.88 55.4 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 120.969 -1.082 . . . . 0.0 112.686 -175.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -72.35 -34.09 67.77 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 119.498 1.044 . . . . 0.0 109.979 168.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -81.96 -21.89 36.95 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.996 0.918 . . . . 0.0 111.394 -177.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.537 ' HB3' HG13 ' A' ' 43' ' ' VAL . 15.9 mt -55.93 149.44 33.65 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 124.036 0.934 . . . . 0.0 110.151 177.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.49 156.76 64.5 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.117 1.878 . . . . 0.0 110.924 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -102.51 162.91 12.55 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 126.559 1.944 . . . . 0.0 107.455 173.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -132.49 177.91 7.24 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 173.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -128.0 -14.5 4.97 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.308 1.443 . . . . 0.0 112.422 -169.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.9 p -154.9 173.93 15.83 Favored 'General case' 0 C--O 1.239 0.542 0 O-C-N 120.652 -1.28 . . . . 0.0 109.854 163.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -120.83 136.18 54.98 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 123.795 0.838 . . . . 0.0 111.452 -177.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -163.19 128.61 3.14 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.325 1.05 . . . . 0.0 109.915 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 49.8 m -75.81 -0.32 20.7 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.257 1.423 . . . . 0.0 113.929 177.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -125.95 22.61 7.34 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.57 1.548 . . . . 0.0 109.287 173.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -79.59 164.73 49.23 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 121.604 -0.685 . . . . 0.0 111.509 177.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -60.66 -18.2 53.81 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.62 2.88 . . . . 0.0 112.865 -177.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -58.45 -17.19 18.9 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 127.427 2.291 . . . . 0.0 115.466 -174.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 79.96 -50.84 3.98 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 119.86 1.209 . . . . 0.0 113.462 174.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.407 ' HB2' HD22 ' A' ' 49' ' ' ASN . 0.3 OUTLIER -75.04 110.93 9.75 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.491 1.516 . . . . 0.0 110.306 -179.499 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.8 mmt85 -117.35 149.45 40.48 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 118.22 -0.895 . . . . 0.0 109.932 -176.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -62.61 135.36 57.35 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.687 1.131 . . . . 0.0 110.199 -176.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 . . . . . 0 CA--C 1.533 0.319 0 C-N-CA 123.821 0.848 . . . . 0.0 110.843 -176.045 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.359 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -75.47 152.03 37.96 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.8 pt -130.66 -177.25 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 175.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.444 ' CD1' HG11 ' A' ' 95' ' ' VAL . 63.5 t80 -128.98 167.56 17.28 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 124.441 1.097 . . . . 0.0 108.128 169.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.7 p -124.93 130.89 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 177.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -68.4 -36.68 79.47 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 125.072 1.349 . . . . 0.0 110.501 174.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 147.03 29.16 0.07 OUTLIER Glycine 0 C--N 1.339 0.706 0 CA-C-O 116.738 -2.146 . . . . 0.0 116.428 171.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.8 -27.26 13.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 120.195 1.998 . . . . 0.0 110.14 178.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.0 42.72 2.29 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.881 1.272 . . . . 0.0 108.266 -178.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -133.65 -86.53 0.42 Allowed 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.107 -0.996 . . . . 0.0 110.129 -178.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.518 ' HB2' HE22 ' A' ' 14' ' ' GLN . 0.0 OUTLIER -63.03 -63.56 1.17 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.954 0.797 . . . . 0.0 111.529 -163.911 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 171.73 36.7 0.03 OUTLIER Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -174.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.518 HE22 ' HB2' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -102.29 161.08 24.44 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 124.971 1.308 . . . . 0.0 109.052 -174.165 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -85.72 62.46 5.43 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.224 2.616 . . . . 0.0 110.968 -155.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -150.93 -29.87 0.19 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.888 1.675 . . . . 0.0 109.171 179.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -48.4 -34.37 10.74 Favored 'General case' 0 C--N 1.347 0.476 0 C-N-CA 125.481 1.513 . . . . 0.0 111.554 -172.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.56 -34.61 2.19 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 125.755 1.622 . . . . 0.0 115.266 174.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.8 m -62.61 -35.25 69.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 120.188 1.358 . . . . 0.0 110.797 -178.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.8 ptp -94.28 9.22 38.97 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.447 0.567 . . . . 0.0 111.906 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 68.3 mt -100.66 21.45 13.41 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.217 1.007 . . . . 0.0 108.648 169.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -138.37 99.76 3.93 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 173.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 -58.51 -16.93 17.53 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.473 1.109 . . . . 0.0 112.998 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.65 -22.13 62.54 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.332 1.453 . . . . 0.0 112.064 172.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -81.7 -7.02 59.55 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.858 0.754 . . . . 0.0 111.336 165.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.89 172.26 14.19 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 125.471 1.51 . . . . 0.0 112.212 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -77.99 135.83 37.87 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.888 1.275 . . . . 0.0 110.456 -176.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -141.7 108.78 5.47 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.422 1.089 . . . . 0.0 110.004 162.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -119.33 141.41 49.04 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.871 0.868 . . . . 0.0 109.309 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -64.75 110.78 2.51 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.887 1.275 . . . . 0.0 109.726 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.2 tpp180 -118.06 51.31 1.07 Allowed 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.337 1.455 . . . . 0.0 107.505 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.29 -166.76 44.39 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 122.7 1.167 . . . . 0.0 112.637 175.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 27.6 mtp85 -126.4 164.05 21.96 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.318 -1.107 . . . . 0.0 109.346 -164.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -168.81 175.81 43.2 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 118.845 -1.645 . . . . 0.0 115.692 176.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.4 p -141.7 158.7 43.5 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.886 1.675 . . . . 0.0 109.699 173.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.1 p -80.11 99.47 7.75 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 165.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -61.11 -37.79 78.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 O-C-N 121.254 -0.904 . . . . 0.0 110.741 172.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -60.92 106.49 0.59 Allowed 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 158.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -54.22 140.25 33.28 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 171.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.482 ' HB3' HD21 ' A' ' 53' ' ' LEU . 28.5 m-85 -134.08 154.49 80.21 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 174.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -79.89 95.26 1.02 Allowed 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 123.861 3.041 . . . . 0.0 110.911 173.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.29 115.26 21.9 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 168.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.477 ' CG2' HD13 ' A' ' 54' ' ' LEU . 5.9 m -124.14 133.13 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.325 1.45 . . . . 0.0 108.929 -174.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.5 mt -104.85 89.16 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 -169.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -118.43 166.0 13.2 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 122.3 1.048 . . . . 0.0 112.146 -173.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.58 -172.93 34.86 Favored Glycine 0 CA--C 1.537 1.457 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 -176.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -95.38 -21.84 18.11 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 121.309 -1.112 . . . . 0.0 113.292 -175.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -100.18 8.48 43.81 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -173.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.4 m120 59.94 71.87 0.55 Allowed 'General case' 0 CA--C 1.523 -0.087 0 C-N-CA 127.619 2.368 . . . . 0.0 110.706 -178.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 88.5 mt -106.2 88.38 3.12 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 127.323 2.249 . . . . 0.0 107.069 -177.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -60.61 103.05 0.21 Allowed 'Trans proline' 0 CA--C 1.544 1.025 0 C-N-CA 123.703 2.935 . . . . 0.0 112.086 178.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -89.13 129.87 35.66 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.545 1.138 . . . . 0.0 109.094 -177.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.482 HD21 ' HB3' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -93.69 105.26 17.31 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 122.501 1.144 . . . . 0.0 109.567 176.565 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.5 ' HG ' ' CD1' ' A' ' 120' ' ' TYR . 11.0 mp -79.45 137.82 37.38 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 125.45 1.5 . . . . 0.0 110.066 -178.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -78.96 85.12 4.93 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 120.699 0.285 . . . . 0.0 110.567 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.35 85.38 15.41 Favored Pre-proline 0 CA--C 1.529 0.156 0 C-N-CA 123.877 0.871 . . . . 0.0 108.903 168.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -64.06 142.51 81.33 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 N-CA-C 109.085 -1.16 . . . . 0.0 109.085 177.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.65 14.38 82.48 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-O 119.352 -0.693 . . . . 0.0 113.547 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.3 tppt? -125.01 151.19 45.9 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 119.86 1.83 . . . . 0.0 107.308 168.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.93 -140.09 25.3 Favored Glycine 0 CA--C 1.521 0.463 0 CA-C-N 120.178 1.354 . . . . 0.0 109.999 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -139.59 167.14 22.78 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 118.348 1.074 . . . . 0.0 111.339 -161.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 85.8 m -78.69 98.95 6.41 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 122.848 0.459 . . . . 0.0 111.564 -175.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.1 t -61.64 104.42 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 124.535 1.134 . . . . 0.0 108.508 176.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.6 p -80.9 144.17 32.14 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 121.549 -0.719 . . . . 0.0 110.399 177.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.74 -152.55 6.94 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -167.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -144.97 163.99 32.49 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.878 1.271 . . . . 0.0 109.289 -176.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 84.7 mt -117.75 126.37 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 -176.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -115.07 131.49 56.91 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 175.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -64.06 123.55 19.33 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 103.874 -2.639 . . . . 0.0 103.874 150.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.1 m -122.59 161.52 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 169.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -104.82 172.32 6.85 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 173.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -59.11 -36.17 74.7 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.967 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -57.94 -43.21 86.22 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 119.392 0.996 . . . . 0.0 111.858 176.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.8 tpp -67.6 -49.1 64.75 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.0 tp -58.68 -40.49 83.73 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 119.903 -0.719 . . . . 0.0 111.57 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 35.5 mtt180 -60.01 -56.46 21.43 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 124.641 1.176 . . . . 0.0 109.124 177.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -57.6 -49.21 77.18 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.018 0.927 . . . . 0.0 111.063 -176.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.5 mt -61.33 -25.85 67.41 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 121.906 -0.497 . . . . 0.0 111.196 -177.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -69.39 -20.88 63.81 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.187 0.903 . . . . 0.0 110.986 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -83.92 -50.31 8.17 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.189 1.396 . . . . 0.0 110.254 167.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -58.95 -38.1 78.25 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.718 0.807 . . . . 0.0 111.777 -173.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -95.69 15.66 19.45 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -175.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.429 ' O ' ' HB2' ' A' ' 86' ' ' SER . 20.4 m-20 48.35 35.79 6.17 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 128.18 2.592 . . . . 0.0 112.109 172.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.422 ' SG ' ' HB2' ' A' ' 88' ' ' TYR . 65.8 m -73.81 162.25 74.96 Favored Pre-proline 0 CA--C 1.54 0.588 0 O-C-N 120.154 -1.591 . . . . 0.0 109.669 175.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -71.46 -4.65 11.3 Favored 'Cis proline' 0 CA--C 1.541 0.874 0 CA-C-N 119.65 0.911 . . . . 0.0 113.66 -9.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.429 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 25.7 m -56.0 -72.28 0.08 Allowed 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.264 1.026 . . . . 0.0 111.401 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 5.2 mtm -74.0 -48.48 29.95 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 119.01 -1.076 . . . . 0.0 108.37 -167.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.422 ' HB2' ' SG ' ' A' ' 84' ' ' CYS . 98.6 m-85 -122.1 163.66 19.09 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -122.85 115.5 22.09 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 172.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -63.06 130.36 44.32 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 171.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.6 m -132.45 161.75 32.91 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 126.307 1.843 . . . . 0.0 107.163 -175.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -107.6 126.38 52.49 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 174.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.498 HD21 HG23 ' A' ' 114' ' ' VAL . 1.8 pt? -142.7 -166.64 2.33 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.865 1.666 . . . . 0.0 109.817 -167.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 15.7 tp60 -125.31 138.57 54.08 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.191 0.996 . . . . 0.0 111.464 -177.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.444 HG11 ' CD1' ' A' ' 5' ' ' PHE . 42.9 t -136.11 140.19 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 177.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -77.68 132.27 38.11 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 170.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.669 HG13 ' HA ' ' A' ' 108' ' ' ASP . 2.6 p -84.55 105.34 13.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 112.932 -1.94 . . . . 0.0 106.872 170.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 mp -78.42 -22.95 46.96 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 113.698 -1.592 . . . . 0.0 110.646 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -161.47 139.17 9.06 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 104.209 -2.515 . . . . 0.0 104.209 -179.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 72.4 t-105 -121.36 129.4 53.04 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 174.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -103.62 121.83 43.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.424 0.69 . . . . 0.0 109.25 173.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 98.46 178.36 32.64 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 124.329 0.966 . . . . 0.0 111.107 170.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -87.94 150.55 23.4 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 122.109 0.957 . . . . 0.0 110.998 178.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 113.0 62.54 0.44 Allowed Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 125.715 1.626 . . . . 0.0 109.963 -177.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -102.11 88.72 1.38 Allowed Pre-proline 0 C--O 1.242 0.674 0 C-N-CA 130.659 3.584 . . . . 0.0 111.393 -159.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -66.29 2.42 1.88 Allowed 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 124.89 3.727 . . . . 0.0 116.202 -177.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.32 176.29 35.2 Favored Glycine 0 CA--C 1.525 0.69 0 O-C-N 120.379 -1.45 . . . . 0.0 109.628 -163.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.669 ' HA ' HG13 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -74.48 3.97 6.75 Favored 'General case' 0 CA--C 1.503 -0.857 0 C-N-CA 128.238 2.615 . . . . 0.0 116.375 -156.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 56.8 m -143.08 152.54 41.97 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 122.362 2.346 . . . . 0.0 111.809 155.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.6 m -133.34 156.02 41.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 125.284 1.434 . . . . 0.0 109.113 -163.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -92.31 115.72 28.33 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 170.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -121.5 169.64 10.46 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 125.837 1.655 . . . . 0.0 108.487 174.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -90.75 143.16 27.01 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 158.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.498 HG23 HD21 ' A' ' 93' ' ' LEU . 22.3 t -137.7 139.12 43.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 128.036 2.534 . . . . 0.0 107.789 172.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -73.26 122.58 22.19 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 167.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 11.1 p -123.02 -172.68 2.55 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 173.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.3 t -135.96 146.05 46.84 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 155.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -105.17 -16.64 14.72 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.307 1.843 . . . . 0.0 110.761 171.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.5 t -122.34 71.75 1.03 Allowed 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -175.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.5 ' CD1' ' HG ' ' A' ' 54' ' ' LEU . 0.3 OUTLIER -88.42 -11.55 45.71 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 125.631 1.572 . . . . 0.0 112.366 179.698 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 68.33 158.62 0.15 Allowed Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 126.248 1.819 . . . . 0.0 110.984 -170.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -69.37 -27.26 28.52 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.307 1.338 . . . . 0.0 113.355 -170.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -55.8 -37.95 69.31 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -178.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 0.547 ' HA ' HD23 ' A' ' 127' ' ' LEU . 41.6 m0 -71.98 -10.61 60.02 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 124.646 1.178 . . . . 0.0 111.461 -176.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 38.3 mt -80.39 4.9 16.5 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 120.842 -1.161 . . . . 0.0 112.297 171.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -107.08 -1.66 21.83 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 120.3 1.409 . . . . 0.0 113.235 172.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.547 HD23 ' HA ' ' A' ' 124' ' ' TRP . 1.3 mm? -78.62 148.19 72.7 Favored Pre-proline 0 N--CA 1.446 -0.631 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -173.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -65.18 146.9 87.72 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 121.433 1.422 . . . . 0.0 108.989 169.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 19.6 m-30 -87.9 157.02 19.08 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.409 0.623 . . . . 0.0 109.681 173.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -127.52 165.99 18.82 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.247 1.019 . . . . 0.0 109.16 178.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -110.98 -19.46 12.77 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.708 1.203 . . . . 0.0 111.723 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 13.5 p -155.92 149.32 24.74 Favored 'General case' 0 C--O 1.238 0.477 0 O-C-N 121.263 -0.898 . . . . 0.0 109.514 170.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -97.67 133.47 42.16 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 171.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -140.89 156.24 46.14 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.801 2.04 . . . . 0.0 106.676 176.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.51 -22.71 40.65 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.422 1.489 . . . . 0.0 112.308 176.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -127.4 90.26 3.1 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 103.605 -2.739 . . . . 0.0 103.605 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -130.47 154.72 20.78 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-N 113.922 -1.49 . . . . 0.0 110.808 159.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -64.93 -22.92 62.42 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 123.373 2.715 . . . . 0.0 114.223 -161.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -63.04 -19.5 64.44 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.246 1.418 . . . . 0.0 113.374 178.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 77.67 -29.1 1.78 Allowed Glycine 0 CA--C 1.533 1.16 0 O-C-N 120.755 -1.216 . . . . 0.0 114.311 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.65 83.57 0.07 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.168 1.484 . . . . 0.0 112.193 176.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.95 153.71 50.63 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 128.147 2.579 . . . . 0.0 110.167 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -60.49 133.46 56.12 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 124.081 0.863 . . . . 0.0 110.012 -165.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 . . . . . 0 C--O 1.232 0.162 0 C-N-CA 123.455 0.702 . . . . 0.0 110.154 -171.725 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.46 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -111.19 137.55 48.75 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 162.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.2 pt -129.91 168.14 23.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 175.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -133.67 144.21 49.04 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -178.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.458 ' CG2' ' H ' ' A' ' 66' ' ' GLU . 3.8 m -100.52 169.84 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 124.092 0.957 . . . . 0.0 110.301 -176.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -120.01 -27.88 5.26 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.425 1.09 . . . . 0.0 112.289 172.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 171.72 -56.02 0.17 Allowed Glycine 0 C--N 1.339 0.733 0 C-N-CA 120.583 -0.818 . . . . 0.0 113.082 -161.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.462 HG22 HD22 ' A' ' 16' ' ' ASN . 0.8 OUTLIER -45.28 -45.84 12.33 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 126.063 1.745 . . . . 0.0 111.605 178.092 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.3 mt -125.84 26.36 6.64 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.958 1.303 . . . . 0.0 108.643 -167.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -118.86 -33.32 4.25 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.309 -0.87 . . . . 0.0 113.302 -177.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.562 ' HG3' ' H ' ' A' ' 13' ' ' GLY . 8.9 ptm85 -123.86 -86.39 0.64 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 119.554 1.07 . . . . 0.0 111.176 -178.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.562 ' H ' ' HG3' ' A' ' 12' ' ' ARG . . . -164.63 55.38 0.27 Allowed Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 104.998 -3.241 . . . . 0.0 104.998 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.5 162.36 72.86 Favored Pre-proline 0 N--CA 1.447 -0.618 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 163.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -67.66 4.4 1.4 Allowed 'Trans proline' 0 CA--C 1.53 0.288 0 C-N-CA 123.767 2.978 . . . . 0.0 115.404 -173.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.738 ' O ' HG22 ' A' ' 19' ' ' VAL . 14.2 m-80 -118.68 -8.62 10.36 Favored 'General case' 0 C--O 1.214 -0.79 0 C-N-CA 125.661 1.584 . . . . 0.0 108.609 -166.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -58.29 -45.79 87.28 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 119.613 1.097 . . . . 0.0 111.213 -171.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.895 ' HA ' HD13 ' A' ' 21' ' ' LEU . 0.3 OUTLIER -52.37 -21.3 3.45 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.16 1.384 . . . . 0.0 113.785 178.697 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.738 HG22 ' O ' ' A' ' 16' ' ' ASN . 34.7 m -62.27 -18.18 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 120.944 1.702 . . . . 0.0 112.443 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.625 ' HG3' HD12 ' A' ' 21' ' ' LEU . 3.0 ptp -97.4 -9.07 28.05 Favored 'General case' 0 C--N 1.348 0.508 0 CA-C-N 120.524 1.511 . . . . 0.0 110.948 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.895 HD13 ' HA ' ' A' ' 18' ' ' LYS . 8.4 mp -80.77 -31.1 35.97 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.902 1.681 . . . . 0.0 107.477 -174.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -70.36 97.2 1.22 Allowed 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 165.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 41.7 t-80 -61.35 -20.96 63.58 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.719 0.771 . . . . 0.0 111.322 171.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 m -51.29 -33.05 27.02 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.649 1.98 . . . . 0.0 112.193 166.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 45.1 m170 -93.58 10.95 30.49 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.028 1.331 . . . . 0.0 112.299 178.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.2 175.88 18.94 Favored Glycine 0 C--N 1.335 0.519 0 CA-C-O 122.313 0.952 . . . . 0.0 112.153 175.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -90.28 133.01 35.22 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.7 1.2 . . . . 0.0 109.68 -174.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -141.83 106.73 4.91 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.724 1.21 . . . . 0.0 110.907 169.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -116.87 125.6 51.75 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 125.519 1.527 . . . . 0.0 109.245 -169.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -68.24 112.11 4.95 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.694 1.198 . . . . 0.0 109.548 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -117.03 58.77 0.77 Allowed 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 123.899 0.88 . . . . 0.0 108.807 171.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.99 -165.74 53.65 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.905 168.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 36.7 mtp85 -116.73 167.49 11.05 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.623 0.769 . . . . 0.0 109.994 -156.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 96' ' ' GLN . . . -164.34 -179.26 38.39 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 116.126 1.21 . . . . 0.0 116.126 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.1 p -152.88 157.84 41.29 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 118.19 -0.91 . . . . 0.0 111.573 172.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.598 HG23 HG13 ' A' ' 63' ' ' VAL . 31.1 p -77.02 101.18 5.92 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 119.891 1.223 . . . . 0.0 108.478 167.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.424 HG13 ' HB2' ' A' ' 96' ' ' GLN . 0.3 OUTLIER -58.91 -52.51 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 119.796 1.18 . . . . 0.0 110.518 173.403 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.407 ' H ' HG23 ' A' ' 37' ' ' VAL . 2.8 mp0 -62.92 110.82 1.9 Allowed 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 166.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.6 m -59.33 132.49 54.16 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 178.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -126.75 155.06 75.76 Favored Pre-proline 0 N--CA 1.483 1.2 0 CA-C-N 119.178 0.899 . . . . 0.0 110.621 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.42 ' HG2' ' HB2' ' A' ' 54' ' ' LEU . 72.8 Cg_endo -84.27 107.03 1.2 Allowed 'Trans proline' 0 CA--C 1.532 0.401 1 C-N-CA 125.519 4.146 . . . . 0.0 112.382 -170.696 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.7 tp -106.47 90.72 3.43 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.584 0.754 . . . . 0.0 109.657 -174.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.7 m -108.06 141.93 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.147 0.979 . . . . 0.0 110.206 -167.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.4 mt -103.69 78.51 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -174.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.436 ' HB1' ' CD1' ' A' ' 124' ' ' TRP . . . -110.69 153.67 24.92 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.42 -1.264 . . . . 0.0 110.21 -173.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.87 164.74 39.65 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-O 122.314 0.952 . . . . 0.0 111.537 -175.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -92.18 -7.99 46.77 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.504 1.522 . . . . 0.0 112.986 -166.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 62.5 m-70 -107.87 12.1 27.49 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.1 0.96 . . . . 0.0 111.745 174.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.447 HD22 ' HB2' ' A' ' 141' ' ' LEU . 3.7 m120 60.79 54.29 3.61 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.731 1.212 . . . . 0.0 110.075 165.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 75.3 mt -103.94 87.81 1.69 Allowed Pre-proline 0 N--CA 1.446 -0.632 0 N-CA-C 103.209 -2.886 . . . . 0.0 103.209 -174.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -62.45 124.2 13.81 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 CA-C-N 120.867 1.345 . . . . 0.0 109.419 -176.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -98.93 132.22 44.42 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -178.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.0 tp -97.66 96.2 8.11 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 169.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.42 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 0.3 OUTLIER -61.87 150.23 38.02 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 121.042 -1.036 . . . . 0.0 108.389 171.679 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -80.27 89.58 5.51 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.355 -0.841 . . . . 0.0 108.966 177.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.71 86.58 11.93 Favored Pre-proline 0 N--CA 1.463 0.18 0 C-N-CA 124.597 1.159 . . . . 0.0 111.396 174.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -63.28 147.63 93.61 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 121.603 1.535 . . . . 0.0 109.341 178.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.49 0.76 59.28 Favored Glycine 0 CA--C 1.537 1.463 0 CA-C-O 118.666 -1.074 . . . . 0.0 114.65 176.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.02 112.45 12.38 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 120.833 2.316 . . . . 0.0 108.192 171.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 150.68 -149.78 21.67 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 119.767 -1.206 . . . . 0.0 112.538 -162.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -140.24 168.5 19.67 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 126.938 2.095 . . . . 0.0 109.28 173.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 97.3 m -89.58 78.53 7.02 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 123.596 0.759 . . . . 0.0 111.0 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.598 HG13 HG23 ' A' ' 36' ' ' THR . 1.8 p -61.14 127.38 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.99 0 CA-C-O 118.513 -0.755 . . . . 0.0 109.863 -175.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.91 151.54 25.92 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 177.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -157.4 175.36 34.8 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 175.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.458 ' H ' ' CG2' ' A' ' 6' ' ' VAL . 0.7 OUTLIER -106.09 163.5 12.73 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 168.018 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 68.8 mt -102.42 121.11 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 105.353 -2.092 . . . . 0.0 105.353 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -108.12 119.61 39.96 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 171.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -69.04 127.68 34.0 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.349 -1.722 . . . . 0.0 106.349 161.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.7 m -135.63 163.83 34.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 123.428 0.691 . . . . 0.0 110.258 -174.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.0 179.97 4.12 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 122.276 1.036 . . . . 0.0 112.708 170.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.57 -41.63 90.64 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 125.48 1.512 . . . . 0.0 112.107 175.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -64.6 -43.34 94.1 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 119.9 1.227 . . . . 0.0 110.807 178.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 19.7 tpp -61.29 -49.4 77.19 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 119.167 0.894 . . . . 0.0 108.67 177.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.4 tp -61.66 -38.79 89.04 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 118.816 -0.611 . . . . 0.0 112.033 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 64.2 mtt-85 -70.81 -38.97 73.33 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.835 1.254 . . . . 0.0 111.804 177.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -63.18 -52.54 61.95 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 177.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.1 mp -62.1 -31.53 71.99 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.693 0.797 . . . . 0.0 110.547 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -62.95 -33.02 74.48 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 124.403 1.081 . . . . 0.0 111.044 176.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -79.72 -45.74 18.36 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.071 0.396 . . . . 0.0 111.561 172.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -63.38 -42.88 98.85 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.569 0.747 . . . . 0.0 112.131 -170.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -79.96 9.09 5.78 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.559 -0.713 . . . . 0.0 111.951 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.2 t0 49.0 24.68 0.92 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 127.454 2.301 . . . . 0.0 113.346 -174.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 9.0 p -65.67 162.03 47.23 Favored Pre-proline 0 CA--C 1.54 0.564 0 O-C-N 119.684 -1.885 . . . . 0.0 107.061 165.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -69.06 -2.74 6.36 Favored 'Cis proline' 0 CA--C 1.547 1.165 0 N-CA-C 114.889 1.073 . . . . 0.0 114.889 -11.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.2 t -65.68 -67.41 0.44 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.884 1.22 . . . . 0.0 111.98 -178.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 20.6 mtp -71.51 -58.29 3.64 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 123.619 0.768 . . . . 0.0 109.52 -173.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -110.11 174.17 5.99 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 126.864 2.066 . . . . 0.0 108.345 177.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -128.66 -15.27 4.47 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 177.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 60.5 130.42 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 128.25 2.62 . . . . 0.0 112.651 -171.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 98.5 m -136.03 162.49 32.73 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.275 1.03 . . . . 0.0 108.237 175.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -94.6 128.16 41.04 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.93 1.292 . . . . 0.0 110.001 172.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.31 179.54 5.41 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.478 1.911 . . . . 0.0 111.432 178.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.8 tp60 -106.63 127.22 53.17 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.655 1.982 . . . . 0.0 109.98 178.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.418 ' CG2' ' SG ' ' A' ' 112' ' ' CYS . 64.3 t -126.27 140.65 48.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 -178.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.424 ' HB2' HG13 ' A' ' 37' ' ' VAL . 46.6 tt0 -72.04 135.84 46.47 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 172.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.6 t -82.13 89.0 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 105.974 -1.861 . . . . 0.0 105.974 167.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.67 -23.68 67.33 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 118.603 -0.713 . . . . 0.0 110.658 177.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -165.53 162.49 19.2 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 128.038 2.535 . . . . 0.0 106.896 171.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 62.6 t-105 -135.2 130.17 34.88 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 125.83 1.652 . . . . 0.0 107.935 176.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -118.2 89.34 3.1 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 121.195 0.521 . . . . 0.0 111.36 176.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 137.33 -172.04 22.89 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-O 123.302 1.501 . . . . 0.0 111.495 173.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.28 125.27 23.02 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 122.35 1.071 . . . . 0.0 113.106 166.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 122.29 81.02 0.56 Allowed Glycine 0 N--CA 1.427 -1.962 0 CA-C-N 111.848 -2.433 . . . . 0.0 110.534 142.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -101.57 89.69 1.54 Allowed Pre-proline 0 C--O 1.24 0.587 0 C-N-CA 131.134 3.774 . . . . 0.0 109.773 -156.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -57.56 -54.52 3.32 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.742 2.294 . . . . 0.0 109.778 -178.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 163.97 -166.8 37.71 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 107.711 -2.156 . . . . 0.0 107.711 -173.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -64.88 -12.13 45.51 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 117.773 0.786 . . . . 0.0 111.969 175.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 61.2 p -133.12 156.39 47.53 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 120.087 1.312 . . . . 0.0 111.615 175.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.9 p -142.48 162.67 18.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 123.889 0.876 . . . . 0.0 109.202 178.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -95.39 135.27 37.23 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.69 1.596 . . . . 0.0 107.94 169.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.418 ' SG ' ' CG2' ' A' ' 95' ' ' VAL . 0.5 OUTLIER -141.27 168.7 19.14 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.797 1.239 . . . . 0.0 110.456 174.593 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -100.28 145.49 28.05 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 172.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 30.9 t -138.54 147.39 25.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 125.193 1.397 . . . . 0.0 107.294 177.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -70.3 109.14 4.53 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 167.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 68.8 p -125.92 172.43 9.92 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 124.111 0.964 . . . . 0.0 108.937 176.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.93 145.9 51.32 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 172.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -112.25 -12.23 13.63 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.137 1.775 . . . . 0.0 111.264 171.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 12.2 t -123.43 64.7 1.01 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.497 1.519 . . . . 0.0 107.968 -171.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -101.94 161.06 13.96 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 126.411 1.884 . . . . 0.0 110.523 177.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.49 157.86 87.26 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 125.818 1.647 . . . . 0.0 111.407 172.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -73.86 -33.39 6.34 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 121.97 1.78 . . . . 0.0 112.326 -179.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -46.51 -44.4 17.69 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 125.185 1.394 . . . . 0.0 112.588 175.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 0.436 ' CD1' ' HB1' ' A' ' 45' ' ' ALA . 35.6 m0 -60.48 -22.22 63.27 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 125.723 1.609 . . . . 0.0 112.5 -174.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 32.6 mt -75.22 -10.09 59.15 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 117.699 -1.143 . . . . 0.0 112.787 176.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -95.41 -7.88 37.13 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.437 1.095 . . . . 0.0 112.471 -178.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 124' ' ' TRP . 1.1 mm? -72.9 158.74 86.75 Favored Pre-proline 0 N--CA 1.451 -0.413 0 C-N-CA 125.664 1.585 . . . . 0.0 107.864 -174.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -59.52 140.45 94.06 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.626 1.551 . . . . 0.0 108.805 168.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 5.7 m-30 -92.18 156.47 17.31 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.86 0.864 . . . . 0.0 108.8 171.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -141.08 171.95 13.36 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.516 0.726 . . . . 0.0 110.647 -174.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -136.62 1.14 2.55 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.314 1.445 . . . . 0.0 111.085 -172.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 86.0 p -152.86 171.68 17.92 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 124.907 1.283 . . . . 0.0 108.656 166.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -121.77 102.45 8.21 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 165.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -117.66 114.9 24.06 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.117 -171.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 11.2 t -60.48 -23.69 64.68 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 128.635 2.774 . . . . 0.0 111.654 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -120.57 85.35 2.38 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 127.417 2.287 . . . . 0.0 105.487 175.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -152.49 177.0 30.48 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.037 171.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.62 -15.43 24.42 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.024 1.816 . . . . 0.0 114.247 -174.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -44.96 -62.32 1.28 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.8 2.04 . . . . 0.0 111.339 -176.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 109.34 -59.09 0.37 Allowed Glycine 0 N--CA 1.464 0.555 0 C-N-CA 129.284 3.326 . . . . 0.0 110.302 171.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.613 HD13 ' H ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -49.95 73.67 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 130.616 3.567 . . . . 0.0 114.26 163.008 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -98.12 170.25 9.04 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.654 1.582 . . . . 0.0 111.942 172.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -71.31 150.32 45.25 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 123.182 0.301 . . . . 0.0 111.031 -165.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 . . . . . 0 C--O 1.233 0.195 0 C-N-CA 124.71 1.204 . . . . 0.0 108.822 178.079 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ttm . . . . . 0 N--CA 1.466 0.345 0 N-CA-C 110.448 -0.205 . . . . 0.0 110.448 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.6 171.18 14.73 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.834 0.853 . . . . 0.0 110.535 -169.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -119.67 131.25 55.39 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.166 1.387 . . . . 0.0 107.808 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.409 HG22 ' HB2' ' A' ' 113' ' ' PHE . 44.6 pt -123.36 177.48 4.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -131.89 130.17 41.28 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 174.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.9 p -96.7 135.73 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 176.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -72.79 -78.02 0.09 Allowed 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 164.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -139.75 -19.47 0.42 Allowed Glycine 0 C--N 1.335 0.489 0 O-C-N 121.767 -0.583 . . . . 0.0 114.144 -173.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.457 ' C ' HD22 ' A' ' 10' ' ' LEU . 0.8 OUTLIER -77.04 -16.42 59.28 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 120.505 2.152 . . . . 0.0 112.599 -154.333 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.457 HD22 ' C ' ' A' ' 9' ' ' THR . 0.1 OUTLIER -126.12 14.16 7.84 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 126.378 1.871 . . . . 0.0 107.645 176.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -104.06 -86.91 0.44 Allowed 'General case' 0 C--N 1.351 0.671 0 CA-C-O 117.355 -1.307 . . . . 0.0 109.381 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.482 ' HB3' HE22 ' A' ' 14' ' ' GLN . 42.0 tpt85 -62.39 -59.89 4.34 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-N 120.752 1.614 . . . . 0.0 111.383 -160.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 172.31 69.04 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 106.265 -2.734 . . . . 0.0 106.265 -170.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.482 HE22 ' HB3' ' A' ' 12' ' ' ARG . 2.2 mp0 -117.29 154.87 50.34 Favored Pre-proline 0 N--CA 1.448 -0.544 0 C-N-CA 124.802 1.241 . . . . 0.0 108.392 -175.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.73 -37.11 97.79 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.743 2.962 . . . . 0.0 111.429 -172.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.411 ' O ' HG22 ' A' ' 19' ' ' VAL . 8.7 m-80 -63.99 -25.18 68.01 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 126.229 1.811 . . . . 0.0 111.939 -172.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -52.17 -34.78 46.57 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.587 1.085 . . . . 0.0 111.423 -170.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.81 -25.92 21.67 Favored 'General case' 0 C--N 1.342 0.276 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -176.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 16' ' ' ASN . 34.3 m -57.49 -48.94 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 118.57 0.623 . . . . 0.0 109.544 -176.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 9.0 ptp -79.13 7.25 7.82 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.393 0.677 . . . . 0.0 112.584 -174.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 76.6 mt -99.64 3.23 45.12 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.473 0.709 . . . . 0.0 111.019 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -131.97 109.26 9.92 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 104.388 -2.449 . . . . 0.0 104.388 174.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 23.3 t-80 -54.27 -24.35 18.54 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.063 1.345 . . . . 0.0 111.608 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 m -67.13 -21.86 65.82 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.979 -1.076 . . . . 0.0 112.954 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -85.07 -7.05 59.28 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 119.492 1.042 . . . . 0.0 111.579 167.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 129.19 167.5 12.15 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 126.037 1.779 . . . . 0.0 111.849 175.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -82.38 137.69 34.67 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.29 1.836 . . . . 0.0 109.174 -176.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -133.57 141.96 47.93 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.462 1.105 . . . . 0.0 108.708 162.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -141.29 140.7 33.9 Favored 'General case' 0 C--O 1.231 0.111 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 166.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -67.11 94.65 0.36 Allowed 'General case' 0 C--O 1.232 0.16 0 C-N-CA 125.921 1.689 . . . . 0.0 107.685 177.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -100.19 53.63 0.9 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -176.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.5 -169.15 46.93 Favored Glycine 0 N--CA 1.441 -1.0 0 CA-C-O 122.677 1.154 . . . . 0.0 111.698 -177.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -143.44 173.0 12.01 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 121.557 -0.966 . . . . 0.0 110.221 -175.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -175.15 -179.92 46.01 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 119.487 -1.339 . . . . 0.0 115.337 -169.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.7 p -140.49 160.51 39.84 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 114.098 -1.051 . . . . 0.0 111.257 167.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.1 p -81.52 94.27 6.84 Favored 'General case' 0 C--O 1.223 -0.291 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 169.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -62.59 -26.43 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 O-C-N 120.657 -1.277 . . . . 0.0 110.893 171.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -65.93 116.99 7.66 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 161.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.03 120.07 18.15 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 126.241 1.816 . . . . 0.0 109.947 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -123.05 162.06 41.35 Favored Pre-proline 0 N--CA 1.466 0.359 0 CA-C-N 120.481 1.491 . . . . 0.0 107.842 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -79.6 94.32 1.05 Allowed 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 124.695 3.597 . . . . 0.0 109.245 172.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.8 tp -89.09 111.76 22.58 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 164.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.5 m -125.59 145.69 32.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.601 1.16 . . . . 0.0 108.347 -176.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.401 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 3.3 mt -98.85 121.96 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 176.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.73 -172.19 3.33 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.049 0.94 . . . . 0.0 110.763 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.68 155.67 2.27 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 125.45 1.5 . . . . 0.0 111.664 178.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -79.55 -6.17 56.45 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 121.538 -0.978 . . . . 0.0 111.802 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -106.92 9.33 30.81 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.431 1.093 . . . . 0.0 112.299 174.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.433 HD22 ' HB2' ' A' ' 141' ' ' LEU . 2.3 m120 63.73 61.19 1.0 Allowed 'General case' 0 C--N 1.345 0.401 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 176.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 56.5 mt -107.86 87.6 3.82 Favored Pre-proline 0 N--CA 1.446 -0.673 0 C-N-CA 128.358 2.663 . . . . 0.0 104.01 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . 43.5 Cg_endo -64.54 156.86 58.4 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 CA-C-N 120.832 1.333 . . . . 0.0 109.825 174.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 48.3 m95 -132.21 150.11 52.23 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.9 tp -107.39 102.02 11.34 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 168.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.7 mt -74.39 145.66 43.58 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -81.61 85.6 6.52 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.348 -0.845 . . . . 0.0 109.536 -177.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -137.12 86.49 20.14 Favored Pre-proline 0 C--O 1.234 0.25 0 CA-C-O 118.369 -0.824 . . . . 0.0 110.174 -177.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -60.07 133.98 53.47 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 121.084 1.189 . . . . 0.0 111.201 -177.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.57 17.27 77.85 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-O 118.904 -0.942 . . . . 0.0 114.713 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -118.15 121.52 40.72 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 120.376 2.088 . . . . 0.0 106.131 168.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.561 ' HA2' ' CD2' ' A' ' 129' ' ' TYR . . . 108.95 -139.81 15.37 Favored Glycine 0 CA--C 1.52 0.379 0 CA-C-N 120.208 1.367 . . . . 0.0 112.555 172.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 39.7 m-70 -126.86 171.47 11.24 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 124.044 0.938 . . . . 0.0 112.311 -175.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 57.9 m -88.2 105.49 17.56 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 126.647 1.979 . . . . 0.0 110.428 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 71.1 t -72.95 117.25 16.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 64.8 p -70.81 156.33 39.69 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.865 0.866 . . . . 0.0 109.363 167.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 171.24 -159.04 30.74 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 118.975 0.807 . . . . 0.0 112.312 -172.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -137.35 161.49 36.14 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.992 0.917 . . . . 0.0 110.834 -172.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 70.1 mt -120.54 111.83 33.71 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 -175.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -102.74 129.86 49.51 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 174.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -67.51 141.66 56.83 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 156.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.0 m -137.39 153.44 28.72 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 CA-C-O 121.787 0.803 . . . . 0.0 109.925 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -85.9 174.02 9.57 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 123.873 1.796 . . . . 0.0 109.541 164.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.05 -30.31 70.25 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 112.34 -2.209 . . . . 0.0 112.463 177.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -72.64 -41.98 64.9 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-O 116.681 -1.628 . . . . 0.0 111.242 176.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 19.9 tpp -64.16 -44.44 92.1 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 121.178 1.808 . . . . 0.0 108.513 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.6 tp -60.91 -30.35 70.14 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 177.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 47.1 mtt-85 -80.57 -36.83 32.37 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.873 1.269 . . . . 0.0 113.786 174.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -62.19 -47.66 83.48 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 177.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 85.3 mt -62.77 -24.38 67.68 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.787 -0.571 . . . . 0.0 110.812 175.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.484 ' HA ' ' SG ' ' A' ' 84' ' ' CYS . 4.4 t0 -78.19 10.55 2.9 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.794 1.237 . . . . 0.0 113.165 176.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -143.05 -30.95 0.51 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 125.439 1.496 . . . . 0.0 112.598 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -70.11 -31.92 69.7 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.1 0.96 . . . . 0.0 111.09 172.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -92.86 5.62 50.63 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.436 0.694 . . . . 0.0 112.147 -171.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.0 t70 54.17 15.91 1.04 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.722 2.009 . . . . 0.0 113.867 -175.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.484 ' SG ' ' HA ' ' A' ' 79' ' ' ASP . 2.9 p -62.85 150.03 88.45 Favored Pre-proline 0 N--CA 1.45 -0.474 0 O-C-N 120.181 -1.574 . . . . 0.0 108.252 167.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.94 -8.56 30.09 Favored 'Cis proline' 0 CA--C 1.54 0.813 0 N-CA-C 114.926 1.087 . . . . 0.0 114.926 2.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 12.9 m -60.98 -62.19 2.03 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.792 1.237 . . . . 0.0 110.91 -174.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 23.3 mtp -72.53 -78.17 0.09 Allowed 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -96.03 175.17 6.58 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.579 1.152 . . . . 0.0 110.253 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 6.7 mp0 -130.19 146.49 51.83 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.98 1.712 . . . . 0.0 107.105 164.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -81.63 133.85 35.42 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 175.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.2 m -140.04 168.85 18.85 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.212 1.005 . . . . 0.0 109.481 -174.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -106.45 138.88 41.83 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.141 1.776 . . . . 0.0 110.372 173.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.4 173.2 11.99 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.155 1.382 . . . . 0.0 113.064 175.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -94.95 126.26 40.17 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.041 1.337 . . . . 0.0 111.884 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.4 t -127.61 119.75 52.71 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 C-N-CA 125.688 1.595 . . . . 0.0 107.773 -175.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -63.13 128.85 37.77 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 105.62 -1.992 . . . . 0.0 105.62 169.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.552 HG12 ' C ' ' A' ' 108' ' ' ASP . 4.9 p -75.55 116.67 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 CA-C-N 114.45 -1.25 . . . . 0.0 107.799 166.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.434 HD13 ' HA ' ' A' ' 98' ' ' LEU . 0.7 OUTLIER -88.48 -21.56 24.12 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 120.467 -1.396 . . . . 0.0 110.38 170.241 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -158.27 146.4 18.56 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 170.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -127.93 116.1 19.58 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 125.518 1.527 . . . . 0.0 108.762 177.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -100.39 113.19 25.73 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.16 -167.21 14.84 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 125.453 1.502 . . . . 0.0 112.289 170.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -75.06 171.72 13.61 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.131 0.972 . . . . 0.0 109.201 177.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 79.11 62.76 2.16 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-O 118.5 -1.167 . . . . 0.0 111.409 176.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -100.38 89.91 1.28 Allowed Pre-proline 0 C--O 1.24 0.561 0 C-N-CA 131.242 3.817 . . . . 0.0 110.095 -163.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -62.92 -4.89 6.65 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 124.476 3.451 . . . . 0.0 115.543 -174.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.94 -177.69 44.81 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 108.846 -1.701 . . . . 0.0 108.846 -163.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.552 ' C ' HG12 ' A' ' 97' ' ' VAL . 1.1 m-20 -72.5 5.12 3.21 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 -169.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.09 160.12 39.9 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 122.374 1.083 . . . . 0.0 110.213 154.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.8 p -128.3 163.87 31.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 126.811 2.044 . . . . 0.0 108.994 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -104.19 103.62 13.42 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.954 1.701 . . . . 0.0 106.545 169.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 60.8 m -97.61 166.95 11.26 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 122.714 0.405 . . . . 0.0 110.035 174.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.409 ' HB2' HG22 ' A' ' 4' ' ' ILE . 69.7 m-85 -92.85 149.52 21.21 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 162.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.3 t -146.72 155.93 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 129.161 2.985 . . . . 0.0 107.067 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -89.71 128.17 36.05 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 166.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 81.9 p -130.09 -177.21 4.21 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.281 1.432 . . . . 0.0 109.291 -178.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -138.1 141.29 40.22 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 165.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -112.71 -4.45 14.06 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.226 1.411 . . . . 0.0 110.911 172.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.1 p -107.74 19.81 19.64 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.937 1.695 . . . . 0.0 111.006 -162.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -71.67 161.49 30.91 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.444 1.497 . . . . 0.0 112.105 -168.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -84.28 151.53 59.79 Favored Pre-proline 0 CA--C 1.543 0.687 0 C-N-CA 124.979 1.311 . . . . 0.0 109.995 167.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.01 -25.75 51.5 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 123.369 2.713 . . . . 0.0 113.52 -173.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.523 ' HA ' ' CD2' ' A' ' 126' ' ' PHE . 4.5 pm0 -52.69 -30.83 34.19 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.968 0.907 . . . . 0.0 112.382 177.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 45.3 m0 -76.88 -11.65 59.85 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 119.412 -0.327 . . . . 0.0 111.759 -176.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -85.64 -15.68 41.65 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 119.199 0.909 . . . . 0.0 111.713 171.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.523 ' CD2' ' HA ' ' A' ' 123' ' ' GLU . 4.8 m-85 -84.75 -10.28 57.39 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.364 0.984 . . . . 0.0 111.373 173.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 76.6 mt -72.15 158.36 87.73 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 124.844 1.257 . . . . 0.0 110.96 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -76.86 156.23 34.77 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 124.088 3.192 . . . . 0.0 111.887 176.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.561 ' CD2' ' HA2' ' A' ' 60' ' ' GLY . 21.3 m-85 -107.65 151.89 25.04 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.882 1.273 . . . . 0.0 111.95 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -136.29 167.54 21.12 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.766 1.226 . . . . 0.0 110.863 -175.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -113.64 -7.71 13.32 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.587 1.155 . . . . 0.0 112.631 -171.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 83.2 p -154.36 174.7 14.48 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 125.451 1.5 . . . . 0.0 108.381 168.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -137.97 109.18 6.84 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 174.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -140.11 123.27 16.8 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.617 1.167 . . . . 0.0 108.318 -168.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 9.6 t -59.38 -29.8 67.97 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.442 1.097 . . . . 0.0 110.059 176.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -62.74 -17.4 60.84 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.418 -0.801 . . . . 0.0 113.11 177.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -71.16 154.23 51.72 Favored Glycine 0 CA--C 1.537 1.445 0 CA-C-N 120.025 1.284 . . . . 0.0 112.434 -166.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -65.52 -5.99 12.69 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.811 2.341 . . . . 0.0 115.058 -177.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 30.7 m-70 -49.05 -49.58 40.61 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 120.651 1.569 . . . . 0.0 112.616 -175.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 87.45 1.68 83.35 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 118.258 -1.301 . . . . 0.0 113.689 -168.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.433 ' HB2' HD22 ' A' ' 49' ' ' ASN . 0.7 OUTLIER -103.56 96.37 6.68 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 118.905 1.352 . . . . 0.0 109.519 171.422 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -118.85 162.44 18.48 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.576 -0.702 . . . . 0.0 110.918 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -65.52 144.57 56.92 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -173.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -122.13 84.51 45.79 Favored Pre-proline 0 CA--C 1.53 0.192 0 C-N-CA 123.1 0.56 . . . . 0.0 110.12 175.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -91.0 -47.9 0.02 OUTLIER 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 124.063 3.175 . . . . 0.0 114.393 175.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.502 ' HB3' ' HD2' ' A' ' 149' ' ' ARG 0.288 17.3 ttt85 -134.36 3.16 3.33 Favored 'General case' 0 C--O 1.215 -0.714 0 O-C-N 120.201 -1.562 . . . . 0.0 113.827 168.299 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 44.5 -64.65 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 131.476 3.911 . . . . 0.0 117.384 175.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -53.79 -35.96 61.91 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 127.805 2.442 . . . . 0.0 111.461 161.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.502 ' HD2' ' HB3' ' A' ' 146' ' ' ARG . 24.5 mmm180 . . . . . 0 C--O 1.252 1.211 0 C-N-CA 128.373 2.669 . . . . 0.0 111.529 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.6 ttp . . . . . 0 N--CA 1.468 0.461 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.86 166.39 26.86 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 165.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -128.13 129.31 46.35 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 174.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 41.2 pt -125.19 152.57 31.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -108.31 132.2 53.94 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 172.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.424 HG22 ' H ' ' A' ' 6' ' ' VAL . 2.6 m -81.39 168.29 1.89 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.447 0 C-N-CA 123.69 0.796 . . . . 0.0 111.31 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -112.46 -29.87 7.35 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.043 0.937 . . . . 0.0 112.515 172.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 148.24 -1.9 0.67 Allowed Glycine 0 CA--C 1.526 0.741 0 CA-C-N 118.412 0.551 . . . . 0.0 113.869 168.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 p -53.62 -36.6 62.19 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 124.775 1.23 . . . . 0.0 111.2 160.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.551 HD23 ' HA ' ' A' ' 17' ' ' HIS . 4.0 mt -132.25 48.37 2.42 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.597 1.559 . . . . 0.0 109.179 -166.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -150.02 -59.19 0.2 Allowed 'General case' 0 N--CA 1.467 0.42 0 O-C-N 120.243 -1.535 . . . . 0.0 111.738 178.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 17.1 mmt180 -73.03 -86.1 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 119.339 0.972 . . . . 0.0 108.714 174.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -175.23 50.11 0.13 Allowed Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 175.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.36 162.96 3.79 Favored Pre-proline 0 CA--C 1.544 0.745 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 169.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -64.4 -3.7 6.84 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 123.971 3.114 . . . . 0.0 113.255 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -120.3 10.67 11.33 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 126.827 2.051 . . . . 0.0 108.452 -167.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.551 ' HA ' HD23 ' A' ' 10' ' ' LEU . 39.0 p-80 -85.25 -38.82 18.47 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 121.254 1.843 . . . . 0.0 106.684 -168.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -17.35 55.49 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 120.517 -1.364 . . . . 0.0 114.183 -168.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.434 ' H ' HG22 ' A' ' 19' ' ' VAL . 2.9 m -59.65 -34.66 55.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 118.445 0.566 . . . . 0.0 110.921 176.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -78.98 3.91 15.83 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.039 0.836 . . . . 0.0 113.113 177.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 35.4 mt -120.06 11.96 11.81 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.811 1.644 . . . . 0.0 110.816 -175.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -132.76 3.94 3.84 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 -171.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . 0.265 25.4 t-80 43.22 28.87 0.18 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 128.294 2.638 . . . . 0.0 113.679 176.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.4 m -117.71 -12.02 10.32 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 121.168 -0.957 . . . . 0.0 111.593 179.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -111.17 -1.43 16.17 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.206 1.802 . . . . 0.0 111.065 174.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 131.45 174.33 13.62 Favored Glycine 0 C--N 1.336 0.553 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 41.5 tp -82.23 139.8 34.04 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 123.169 0.588 . . . . 0.0 110.389 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -146.94 153.69 40.39 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 153.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.67 142.05 23.35 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 126.362 1.865 . . . . 0.0 108.286 169.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -59.99 118.83 6.74 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.212 1.405 . . . . 0.0 108.799 176.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.91 39.46 2.16 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.954 0.797 . . . . 0.0 110.321 -174.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 124.52 111.42 1.91 Allowed Glycine 0 N--CA 1.444 -0.79 0 CA-C-O 121.994 0.774 . . . . 0.0 111.328 166.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -61.06 149.62 36.44 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 121.592 -0.946 . . . . 0.0 108.469 173.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.47 175.33 37.22 Favored Glycine 0 C--O 1.238 0.385 0 C-N-CA 120.771 -0.728 . . . . 0.0 113.365 -169.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.407 ' SG ' ' HB3' ' A' ' 96' ' ' GLN . 1.8 p -136.59 147.18 46.83 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 43.4 p -64.48 120.05 11.57 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 105.138 -2.171 . . . . 0.0 105.138 158.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.422 HG22 ' HB2' ' A' ' 96' ' ' GLN . 16.7 t -68.0 -37.09 77.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.641 0.734 . . . . 0.0 109.08 177.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -78.21 140.2 38.93 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 168.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.5 m -60.44 151.05 29.2 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 160.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -134.57 153.84 79.28 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 165.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -76.38 92.08 1.09 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 124.212 3.275 . . . . 0.0 110.133 170.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 28.7 tp -90.63 109.03 20.2 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 118.816 -0.611 . . . . 0.0 109.757 174.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.444 ' CG2' HD13 ' A' ' 54' ' ' LEU . 13.5 m -123.55 135.75 62.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 124.395 1.078 . . . . 0.0 108.641 -171.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.2 mt -109.89 72.88 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 -172.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.83 179.33 7.06 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 122.613 1.197 . . . . 0.0 110.722 173.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.95 153.85 17.49 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-N 113.044 -1.889 . . . . 0.0 110.473 170.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -68.75 -11.62 60.51 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -166.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 37.5 m-70 -114.16 16.78 18.0 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.5 1.12 . . . . 0.0 112.053 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 50.49 74.02 0.24 Allowed 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.778 2.031 . . . . 0.0 109.369 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 87.6 mt -104.55 88.3 2.12 Favored Pre-proline 0 C--N 1.325 -0.493 0 C-N-CA 128.531 2.733 . . . . 0.0 104.991 -169.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.401 ' HG3' ' CE2' ' A' ' 133' ' ' TYR . 55.9 Cg_endo -55.02 107.61 0.24 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.962 2.442 . . . . 0.0 111.148 -178.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -92.02 116.96 29.37 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 124.904 1.281 . . . . 0.0 107.6 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.15 92.15 8.66 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 172.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.444 HD13 ' CG2' ' A' ' 43' ' ' VAL . 11.0 mp -65.52 124.14 21.54 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.525 1.13 . . . . 0.0 108.762 176.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -74.04 84.95 1.79 Allowed 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.065 0.546 . . . . 0.0 110.266 -176.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.55 85.15 17.87 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 125.064 1.346 . . . . 0.0 108.373 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.92 126.68 17.8 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.842 2.361 . . . . 0.0 109.251 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.58 17.3 55.14 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 119.328 -0.707 . . . . 0.0 113.209 175.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -122.81 157.24 32.87 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 119.07 1.435 . . . . 0.0 107.189 172.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.516 ' HA2' ' CD2' ' A' ' 129' ' ' TYR . . . 70.49 -140.04 31.4 Favored Glycine 0 CA--C 1.522 0.511 0 CA-C-N 121.131 1.787 . . . . 0.0 111.603 175.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -131.17 160.24 35.37 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.327 1.064 . . . . 0.0 111.17 -170.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 76.4 m -83.64 106.61 15.5 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.695 -0.628 . . . . 0.0 110.93 -170.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.1 t -78.38 88.59 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 126.708 2.003 . . . . 0.0 111.996 -166.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.9 p -59.56 145.35 44.6 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 120.862 -1.149 . . . . 0.0 111.185 -172.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.03 -150.06 5.98 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-N 118.967 0.803 . . . . 0.0 112.596 -174.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -145.1 157.24 44.16 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.256 1.022 . . . . 0.0 109.058 -178.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 50.2 mt -107.66 91.79 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -80.74 127.16 32.18 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 177.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -74.07 130.45 39.84 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 163.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 23.7 m -144.24 176.3 2.69 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 C-N-CA 125.346 1.458 . . . . 0.0 109.898 -167.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.87 -175.95 3.22 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 122.671 1.224 . . . . 0.0 113.241 177.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -52.85 -52.02 58.8 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.07 1.748 . . . . 0.0 110.841 172.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -62.89 -39.47 94.58 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 117.948 -1.025 . . . . 0.0 110.282 -174.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 38.6 tpp -64.61 -43.64 93.1 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 119.454 1.025 . . . . 0.0 110.289 175.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 13.7 tp -65.03 -42.75 94.08 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.886 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 66.0 mtt180 -58.01 -41.78 83.82 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 124.526 1.13 . . . . 0.0 110.161 174.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -63.62 -52.8 59.3 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -176.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.2 mp -54.05 -39.35 66.14 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.206 0.602 . . . . 0.0 111.305 175.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -57.05 -43.5 82.08 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.714 0.769 . . . . 0.0 110.77 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -86.33 -26.9 24.63 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.306 1.443 . . . . 0.0 113.044 -175.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -93.09 -40.15 10.67 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.558 1.143 . . . . 0.0 111.394 -170.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -82.74 7.26 15.47 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 118.348 0.522 . . . . 0.0 110.462 177.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 59.58 29.61 19.19 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.626 1.571 . . . . 0.0 111.962 175.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 1.8 p -73.25 168.22 27.17 Favored Pre-proline 0 CA--C 1.541 0.624 0 O-C-N 120.237 -1.539 . . . . 0.0 108.218 173.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.4 -4.43 7.77 Favored 'Cis proline' 0 CA--C 1.544 0.988 0 CA-C-N 120.21 1.111 . . . . 0.0 113.545 -13.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.5 m -60.84 -61.64 2.44 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 126.093 1.757 . . . . 0.0 111.313 -177.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 2.7 mtm -75.71 -85.18 0.05 OUTLIER 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -83.8 176.81 8.66 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.501 1.12 . . . . 0.0 109.064 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -137.08 136.88 38.74 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.907 1.683 . . . . 0.0 106.84 161.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -70.29 133.68 47.22 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 171.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.0 m -136.67 175.44 9.61 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.772 2.029 . . . . 0.0 108.523 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.418 ' HB1' ' NE2' ' A' ' 111' ' ' GLN . . . -118.37 137.33 53.19 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 127.921 2.488 . . . . 0.0 109.747 175.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.43 -179.29 6.2 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.019 1.728 . . . . 0.0 110.512 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -113.22 123.86 51.17 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.627 1.571 . . . . 0.0 110.548 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.411 ' CG2' ' SG ' ' A' ' 112' ' ' CYS . 54.1 t -118.54 145.85 23.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 C-N-CA 125.772 1.629 . . . . 0.0 107.335 -177.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.422 ' HB2' HG22 ' A' ' 37' ' ' VAL . 35.3 tt0 -89.65 136.9 32.77 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 171.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 94.8 t -77.61 95.74 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 127.696 2.398 . . . . 0.0 106.15 168.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.6 mp -72.79 -31.26 64.73 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.586 -0.696 . . . . 0.0 109.483 172.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -148.56 164.3 34.64 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 106.298 -1.742 . . . . 0.0 106.298 167.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 75.5 t-105 -139.88 124.54 18.27 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.64 1.576 . . . . 0.0 108.006 175.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -79.02 113.34 17.06 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 171.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 86.69 -148.6 21.91 Favored Glycine 0 C--O 1.235 0.166 0 CA-C-O 121.696 0.609 . . . . 0.0 112.246 153.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -67.01 160.06 27.31 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 126.426 1.89 . . . . 0.0 111.715 -170.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 60.92 76.03 0.26 Allowed Glycine 0 C--O 1.221 -0.672 0 C-N-CA 124.449 1.023 . . . . 0.0 111.727 170.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -102.87 88.77 1.59 Allowed Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 128.734 2.813 . . . . 0.0 108.211 -168.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -56.08 -22.41 39.28 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 124.601 3.534 . . . . 0.0 114.939 -172.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 123.7 176.46 14.76 Favored Glycine 0 C--N 1.333 0.384 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -173.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -64.11 -17.59 63.58 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 118.515 -0.755 . . . . 0.0 112.518 -172.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 39.7 p -130.57 159.78 36.14 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 120.2 1.364 . . . . 0.0 111.971 168.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 28.4 m -141.95 169.56 13.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 125.443 1.497 . . . . 0.0 108.539 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.418 ' NE2' ' HB1' ' A' ' 92' ' ' ALA . 7.0 tt0 -104.14 155.75 18.45 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 159.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.411 ' SG ' ' CG2' ' A' ' 95' ' ' VAL . 0.5 OUTLIER -155.04 162.05 41.16 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 129.142 2.977 . . . . 0.0 108.694 -178.37 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -87.24 153.36 21.55 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 169.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.449 HG12 HG23 ' A' ' 116' ' ' THR . 24.9 t -143.17 150.77 17.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 127.914 2.485 . . . . 0.0 107.2 176.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -94.76 102.76 14.65 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 169.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.449 HG23 HG12 ' A' ' 114' ' ' VAL . 72.7 p -103.41 -167.88 1.44 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.009 1.324 . . . . 0.0 108.7 177.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.7 t -136.05 156.05 49.3 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 155.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -123.46 5.44 9.0 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.151 1.381 . . . . 0.0 110.776 171.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.2 t -132.32 53.55 2.0 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 122.93 1.348 . . . . 0.0 109.415 -173.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -67.39 153.63 43.24 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.009 1.323 . . . . 0.0 110.402 175.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.18 149.43 98.46 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 162.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.09 -35.8 40.56 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 121.451 1.434 . . . . 0.0 112.545 -170.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -57.86 -23.68 54.03 Favored 'General case' 0 C--O 1.225 -0.218 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 177.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 0.571 ' HA ' HD23 ' A' ' 127' ' ' LEU . 44.2 m0 -64.93 -16.26 63.09 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 119.863 1.21 . . . . 0.0 112.015 -178.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 53.7 mt -71.9 2.46 5.51 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.846 1.259 . . . . 0.0 112.418 171.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -113.13 -11.69 13.26 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.612 1.565 . . . . 0.0 113.75 178.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.571 HD23 ' HA ' ' A' ' 124' ' ' TRP . 1.1 mm? -67.81 146.67 98.47 Favored Pre-proline 0 C--N 1.326 -0.436 0 C-N-CA 126.102 1.761 . . . . 0.0 108.092 -177.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -64.32 149.34 90.35 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.223 1.282 . . . . 0.0 109.269 176.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.516 ' CD2' ' HA2' ' A' ' 60' ' ' GLY . 23.0 m-85 -89.28 152.19 21.69 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 175.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 62.6 m-70 -121.91 134.97 54.86 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -83.37 -15.78 48.53 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.924 0.89 . . . . 0.0 111.007 178.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.1 t -164.2 147.58 9.48 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 163.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.401 ' CE2' ' HG3' ' A' ' 51' ' ' PRO . 17.6 t80 -87.37 151.29 23.21 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.3 -0.864 . . . . 0.0 108.695 169.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 35.9 p-10 -153.39 162.25 41.48 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 126.826 2.05 . . . . 0.0 110.797 169.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 9.0 p -93.9 0.74 56.31 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 126.351 1.86 . . . . 0.0 112.791 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -143.04 23.09 1.89 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.954 1.302 . . . . 0.0 109.647 -164.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -94.83 177.74 35.82 Favored Glycine 0 C--O 1.242 0.65 0 C-N-CA 123.876 0.75 . . . . 0.0 113.944 -167.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -64.7 -24.95 61.68 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.689 2.259 . . . . 0.0 111.061 169.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 46.1 m-70 -73.8 80.99 1.6 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.322 1.449 . . . . 0.0 108.401 176.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -59.39 -17.78 40.82 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.639 1.59 . . . . 0.0 114.445 -178.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.91 72.75 0.1 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.213 1.805 . . . . 0.0 111.614 168.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 6.3 mtt85 -99.48 166.03 11.36 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 120.968 -1.083 . . . . 0.0 111.062 -174.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -58.9 142.1 51.67 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -175.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -122.41 84.45 47.35 Favored Pre-proline 0 N--CA 1.455 -0.186 0 O-C-N 123.605 0.565 . . . . 0.0 110.143 -175.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -76.52 -55.34 0.06 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.628 1.552 . . . . 0.0 112.161 176.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.42 14.97 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 117.191 -1.385 . . . . 0.0 112.616 -164.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.36 89.22 0.13 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.844 1.658 . . . . 0.0 109.835 -160.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 52.3 73.78 0.31 Allowed 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.39 1.476 . . . . 0.0 109.308 -159.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 . . . . . 0 C--O 1.248 1.018 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 173.893 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.779 0 CA-C-O 118.168 -0.92 . . . . 0.0 111.439 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.86 91.02 2.77 Favored 'General case' 0 C--O 1.22 -0.5 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 176.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.8 m80 -58.96 140.02 56.06 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 124.127 0.971 . . . . 0.0 108.767 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 39.2 pt -134.86 159.92 41.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 C-N-CA 124.694 1.198 . . . . 0.0 109.401 175.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -87.98 138.61 31.3 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 163.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.4 m -72.05 -177.28 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 156.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -133.1 -57.88 0.91 Allowed 'General case' 0 N--CA 1.447 -0.589 0 O-C-N 121.082 -1.011 . . . . 0.0 111.013 176.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -165.69 -41.99 0.02 OUTLIER Glycine 0 C--N 1.33 0.233 0 CA-C-N 118.629 0.649 . . . . 0.0 111.888 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 p -53.55 -29.31 36.28 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.995 1.318 . . . . 0.0 111.727 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.4 mp -133.19 76.78 1.7 Allowed 'General case' 0 C--O 1.221 -0.406 0 C-N-CA 124.502 1.121 . . . . 0.0 108.533 177.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -149.42 -80.01 0.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 O-C-N 120.895 -1.128 . . . . 0.0 108.878 172.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 25.2 ttt85 -67.43 -85.3 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 123.366 0.666 . . . . 0.0 110.429 -177.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -158.31 26.09 0.41 Allowed Glycine 0 C--N 1.336 0.554 0 CA-C-N 119.642 1.11 . . . . 0.0 113.058 -175.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -55.09 163.13 1.66 Allowed Pre-proline 0 N--CA 1.449 -0.521 0 C-N-CA 125.379 1.472 . . . . 0.0 111.411 175.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.15 -16.01 52.57 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.474 2.116 . . . . 0.0 112.842 -172.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.492 ' O ' HG22 ' A' ' 19' ' ' VAL . 5.1 m-80 -95.16 -17.87 21.41 Favored 'General case' 0 C--O 1.219 -0.512 0 C-N-CA 125.292 1.437 . . . . 0.0 111.245 -164.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -52.78 -40.79 63.5 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 120.088 1.313 . . . . 0.0 112.178 -165.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.96 -25.1 2.98 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -177.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 16' ' ' ASN . 14.3 m -68.94 -29.6 43.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 O-C-N 121.296 -0.878 . . . . 0.0 110.748 -177.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.1 ptp -83.27 6.14 20.67 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 119.045 0.839 . . . . 0.0 112.454 174.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 49.7 mt -114.42 26.74 10.0 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.82 1.648 . . . . 0.0 109.365 -177.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -139.26 99.43 3.74 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.248 1.419 . . . . 0.0 108.598 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 25.4 t-80 -63.58 -22.02 66.67 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -162.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.5 m -70.99 -32.6 69.46 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.835 -0.541 . . . . 0.0 111.988 172.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 40.3 m170 -71.32 -37.74 71.73 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 171.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 158.85 173.72 27.62 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-O 121.955 0.753 . . . . 0.0 111.969 156.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 57.5 tp -70.26 141.34 52.45 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.288 0.635 . . . . 0.0 111.214 177.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -150.95 108.43 3.63 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.694 1.197 . . . . 0.0 108.558 160.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -112.41 135.26 53.33 Favored 'General case' 0 CA--C 1.522 -0.112 0 C-N-CA 124.616 1.167 . . . . 0.0 108.633 175.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -63.68 108.54 1.44 Allowed 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.264 1.026 . . . . 0.0 108.577 177.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.456 ' NH1' ' H ' ' A' ' 103' ' ' ASP . 0.7 OUTLIER -106.55 44.39 1.06 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 -178.722 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.91 -162.2 35.42 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-O 122.515 1.064 . . . . 0.0 111.295 -177.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 63.5 mtp85 -125.57 166.02 17.46 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 121.491 -1.005 . . . . 0.0 110.056 -167.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -168.84 171.31 42.81 Favored Glycine 0 C--N 1.336 0.558 0 C-N-CA 120.234 -0.984 . . . . 0.0 113.637 177.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 91.0 m -138.02 149.57 46.18 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.23 1.012 . . . . 0.0 109.656 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.8 p -69.95 120.81 16.23 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 168.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.6 t -83.11 -48.86 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.108 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 -174.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -57.66 130.18 45.24 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 159.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.2 m -57.98 148.68 25.23 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 162.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -134.9 153.26 78.53 Favored Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 163.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -76.35 95.91 1.06 Allowed 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 125.261 3.974 . . . . 0.0 110.893 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.99 109.4 22.16 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -178.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.3 m -121.51 151.53 24.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 119.013 0.824 . . . . 0.0 109.469 175.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 45.5 mt -88.49 135.22 26.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 165.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.66 167.99 20.95 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 122.371 1.082 . . . . 0.0 110.7 173.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.61 174.76 46.81 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-O 122.829 1.239 . . . . 0.0 113.127 168.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -84.89 -4.59 59.17 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.65 1.18 . . . . 0.0 113.092 -163.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -119.86 10.28 11.54 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.54 1.536 . . . . 0.0 111.803 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 35.3 m-20 58.25 59.24 3.11 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.199 1.8 . . . . 0.0 109.574 176.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 96.8 mt -106.41 88.76 3.49 Favored Pre-proline 0 N--CA 1.455 -0.225 0 C-N-CA 127.142 2.177 . . . . 0.0 107.085 -171.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -58.39 135.14 65.92 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 CA-C-N 119.955 1.02 . . . . 0.0 111.519 172.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 74.7 m95 -101.15 -173.92 2.49 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.084 0.953 . . . . 0.0 108.914 178.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 53' ' ' LEU . 13.9 tp -142.53 101.68 3.92 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 159.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.403 HD13 ' N ' ' A' ' 54' ' ' LEU . 0.1 OUTLIER -62.93 132.28 51.55 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 172.453 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -71.44 92.94 1.12 Allowed 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.451 HD13 ' HA ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -145.15 77.42 12.97 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.699 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -57.63 120.01 7.63 Favored 'Trans proline' 0 C--O 1.239 0.546 0 C-N-CA 122.914 2.409 . . . . 0.0 109.145 176.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.51 7.19 51.94 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 125.86 1.695 . . . . 0.0 114.34 176.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -115.81 167.77 10.64 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 119.824 1.812 . . . . 0.0 108.878 171.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.422 ' HA2' ' CD2' ' A' ' 129' ' ' TYR . . . 66.49 -148.28 50.55 Favored Glycine 0 CA--C 1.518 0.258 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -173.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 63.9 m-70 -124.92 176.91 6.33 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.874 1.27 . . . . 0.0 108.399 -177.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 3.6 p -61.73 161.68 9.74 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 120.444 -0.502 . . . . 0.0 109.798 170.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 38.8 t -135.69 114.29 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 169.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 45.9 p -79.19 157.66 27.81 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 123.301 0.64 . . . . 0.0 109.876 -177.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -177.4 -153.0 10.47 Favored Glycine 0 CA--C 1.526 0.74 0 O-C-N 121.222 -0.924 . . . . 0.0 112.568 -176.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -138.68 165.7 26.27 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.21 1.404 . . . . 0.0 110.98 -174.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.407 HG22 ' HB3' ' A' ' 31' ' ' ARG . 62.2 mt -116.35 128.01 73.8 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 -173.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -122.92 126.98 48.3 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.973 0.892 . . . . 0.0 109.284 172.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -62.78 107.05 0.89 Allowed 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 158.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.1 m -115.41 161.04 14.44 Favored 'Isoleucine or valine' 0 C--O 1.244 0.809 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 171.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -113.43 173.22 6.51 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 176.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -52.04 -42.87 63.45 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 124.578 1.151 . . . . 0.0 110.683 -171.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 -62.59 -36.35 82.44 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 118.828 -0.606 . . . . 0.0 111.468 -174.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 20.4 tpp -67.67 -53.99 23.24 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.45 -38.28 80.34 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.267 -175.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.53 -41.9 75.37 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 125.582 1.553 . . . . 0.0 110.918 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -56.7 -51.44 68.79 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 122.974 0.51 . . . . 0.0 110.54 171.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 93.1 mt -60.5 -32.99 71.97 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.396 -0.815 . . . . 0.0 111.783 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -67.11 -6.52 17.89 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.24 1.816 . . . . 0.0 112.736 177.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -107.95 -49.86 3.15 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.939 1.695 . . . . 0.0 109.454 171.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -62.8 -46.56 87.4 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.253 1.021 . . . . 0.0 112.063 -174.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -72.12 6.66 2.05 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.91 0.884 . . . . 0.0 111.324 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 62.62 20.09 11.77 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 126.341 1.856 . . . . 0.0 113.264 167.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 26.5 p -68.91 157.98 87.49 Favored Pre-proline 0 CA--C 1.541 0.622 0 O-C-N 121.138 -0.976 . . . . 0.0 109.232 175.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -72.3 -4.32 12.98 Favored 'Cis proline' 0 CA--C 1.545 1.057 0 CA-C-N 119.978 1.028 . . . . 0.0 114.606 -5.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.5 m -63.96 -59.02 5.02 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 119.527 1.058 . . . . 0.0 111.979 -174.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 37.6 mtp -78.26 -80.65 0.11 Allowed 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -89.11 174.95 7.59 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.749 0.82 . . . . 0.0 109.918 177.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -132.73 -12.48 2.98 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.637 0.775 . . . . 0.0 113.015 173.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? 63.44 133.46 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 129.542 3.137 . . . . 0.0 112.576 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 61.9 m -143.98 160.48 40.78 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 123.969 0.907 . . . . 0.0 109.374 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -89.84 128.51 36.18 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.943 1.697 . . . . 0.0 110.539 170.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.72 178.53 5.64 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 127.365 2.266 . . . . 0.0 110.004 172.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 44.4 tp60 -116.71 128.43 55.32 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.555 1.542 . . . . 0.0 108.933 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.412 ' CG2' ' SG ' ' A' ' 112' ' ' CYS . 41.8 t -122.38 151.53 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 127.239 2.216 . . . . 0.0 107.114 -171.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -88.73 139.41 30.5 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.682 1.593 . . . . 0.0 107.265 171.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.4 t -87.31 126.44 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 170.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 mp -99.07 -36.61 9.65 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.143 1.777 . . . . 0.0 109.95 -176.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -148.44 153.35 38.39 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 130.44 3.496 . . . . 0.0 104.418 174.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.552 ' HE1' ' N ' ' A' ' 104' ' ' GLY . 74.1 t-105 -141.53 123.29 15.23 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -178.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -130.94 109.19 10.36 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.441 ' HA3' ' HD2' ' A' ' 31' ' ' ARG . . . 169.69 -120.81 0.89 Allowed Glycine 0 C--N 1.343 0.936 0 C-N-CA 114.489 -3.719 . . . . 0.0 121.192 173.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.456 ' H ' ' NH1' ' A' ' 31' ' ' ARG . 37.0 t0 -64.43 -178.05 0.35 Allowed 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 101.482 -3.525 . . . . 0.0 101.482 126.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.552 ' N ' ' HE1' ' A' ' 100' ' ' TRP . . . -108.76 -75.23 0.86 Allowed Glycine 0 N--CA 1.417 -2.572 1 C-N-CA 111.397 -5.192 . . . . 0.0 106.464 -94.149 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -158.89 88.04 2.19 Favored Pre-proline 0 C--N 1.313 -1.002 1 C-N-CA 133.652 4.781 . . . . 0.0 114.966 163.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -51.41 -30.41 34.48 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.001 2.468 . . . . 0.0 114.082 161.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 111.22 179.39 20.21 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.89 1.233 . . . . 0.0 110.557 -169.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -67.61 -11.91 59.23 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.463 1.105 . . . . 0.0 112.056 -171.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.7 p -130.93 159.73 36.58 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 120.786 -1.196 . . . . 0.0 110.979 172.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.2 p -151.1 146.29 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 124.174 0.99 . . . . 0.0 109.924 177.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -87.77 142.39 27.86 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 173.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.412 ' SG ' ' CG2' ' A' ' 95' ' ' VAL . 0.5 OUTLIER -152.19 168.84 24.02 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.392 1.477 . . . . 0.0 110.011 -178.815 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -92.39 151.79 20.07 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.098 0.559 . . . . 0.0 110.149 172.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 51.2 t -138.39 146.03 27.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 C-N-CA 127.6 2.36 . . . . 0.0 106.265 167.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -78.02 92.84 4.38 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.711 0.804 . . . . 0.0 109.51 172.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.0 p -104.45 173.47 6.29 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.369 1.468 . . . . 0.0 111.388 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.85 148.57 52.3 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 126.226 1.811 . . . . 0.0 107.089 175.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -112.8 -2.29 14.44 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.456 1.102 . . . . 0.0 111.296 167.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 13.6 p -111.8 18.26 19.08 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.695 1.598 . . . . 0.0 112.212 -158.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -68.93 158.92 33.66 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.727 1.611 . . . . 0.0 112.314 -170.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.4 157.66 87.67 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 126.343 1.857 . . . . 0.0 111.359 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -52.88 -53.75 6.27 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.533 2.822 . . . . 0.0 113.096 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.493 ' HA ' ' CD2' ' A' ' 126' ' ' PHE . 0.5 OUTLIER -45.67 -33.25 2.82 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 126.458 1.903 . . . . 0.0 114.191 -179.123 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 38.7 m0 -74.28 -3.5 30.47 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.598 -0.688 . . . . 0.0 112.242 -168.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 89.1 mt -97.08 -12.98 22.52 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 118.027 -0.987 . . . . 0.0 113.237 170.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.493 ' CD2' ' HA ' ' A' ' 123' ' ' GLU . 10.3 m-85 -84.34 -30.24 25.66 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 119.511 1.051 . . . . 0.0 110.214 177.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 36.3 mt -58.32 155.55 26.38 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 125.955 1.702 . . . . 0.0 111.428 -174.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.52 156.06 62.14 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 121.693 1.595 . . . . 0.0 109.756 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.422 ' CD2' ' HA2' ' A' ' 60' ' ' GLY . 31.9 m-85 -104.9 161.39 14.23 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.248 1.019 . . . . 0.0 111.945 178.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -138.95 159.9 41.05 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.926 0.891 . . . . 0.0 110.56 -171.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -111.06 -7.65 14.49 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -164.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 33.8 t -164.56 158.67 18.35 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 171.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -103.53 150.06 24.27 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.258 0.552 . . . . 0.0 109.681 172.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -157.9 170.1 23.09 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.515 1.526 . . . . 0.0 108.203 177.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.4 9.44 37.81 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.383 1.873 . . . . 0.0 110.769 167.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -138.05 4.15 2.47 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.551 1.14 . . . . 0.0 113.719 -167.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -89.3 -171.15 45.28 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 127.127 2.299 . . . . 0.0 111.925 -175.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -71.34 5.95 2.09 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 124.648 3.566 . . . . 0.0 114.997 -178.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -87.12 91.44 8.71 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -53.16 -36.69 52.89 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 121.78 -0.575 . . . . 0.0 113.235 -178.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.517 ' CD2' ' H ' ' A' ' 141' ' ' LEU . 0.7 OUTLIER -68.82 119.46 13.21 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 127.347 2.259 . . . . 0.0 109.646 168.691 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.53 163.51 13.63 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 119.65 1.114 . . . . 0.0 110.772 167.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -54.52 139.99 36.06 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 119.164 0.893 . . . . 0.0 110.057 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -120.49 78.02 27.88 Favored Pre-proline 0 C--O 1.235 0.338 0 C-N-CA 123.295 0.638 . . . . 0.0 110.103 -173.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -71.88 -38.51 4.04 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.31 2.673 . . . . 0.0 113.276 -176.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -153.01 20.34 0.58 Allowed 'General case' 0 C--N 1.34 0.16 0 CA-C-N 118.636 0.653 . . . . 0.0 112.73 -172.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -59.54 -57.05 14.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 119.229 0.922 . . . . 0.0 109.444 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -117.85 9.53 12.94 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.384 1.074 . . . . 0.0 111.157 -172.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.243 0.736 0 C-N-CA 124.308 1.043 . . . . 0.0 110.139 -149.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.464 ' HA ' ' HA ' ' A' ' 71' ' ' ASP . 46.0 mtt . . . . . 0 N--CA 1.477 0.889 0 CA-C-O 117.825 -1.083 . . . . 0.0 109.273 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 67.36 167.23 0.24 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 127.614 2.366 . . . . 0.0 112.253 -161.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -130.68 142.9 50.44 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 125.536 1.534 . . . . 0.0 109.346 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 42.2 pt -125.88 171.64 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 124.313 1.045 . . . . 0.0 109.717 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -121.4 127.74 51.48 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.313 1.445 . . . . 0.0 107.713 174.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.3 m -97.86 155.83 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 123.917 0.887 . . . . 0.0 109.371 170.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -147.08 -19.78 0.4 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.755 2.022 . . . . 0.0 111.479 178.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.403 ' HA3' ' CD2' ' A' ' 133' ' ' TYR . . . -120.25 -129.71 3.83 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 127.513 2.482 . . . . 0.0 111.761 -169.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.523 ' HB ' HD22 ' A' ' 16' ' ' ASN . 32.4 p -64.0 -35.95 82.38 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.738 -0.86 . . . . 0.0 112.516 -161.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.721 HD23 ' HA ' ' A' ' 17' ' ' HIS . 77.1 mt -80.94 3.11 23.97 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.432 0.693 . . . . 0.0 111.911 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -89.29 -81.18 0.28 Allowed 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 117.345 -1.312 . . . . 0.0 110.323 178.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.99 -85.76 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 121.052 1.751 . . . . 0.0 111.073 -174.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -169.7 21.11 0.08 OUTLIER Glycine 0 CA--C 1.525 0.717 0 O-C-N 121.307 -0.871 . . . . 0.0 111.149 -164.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -52.81 162.61 0.95 Allowed Pre-proline 0 N--CA 1.452 -0.372 0 C-N-CA 124.53 1.132 . . . . 0.0 110.621 176.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -65.73 1.89 1.97 Allowed 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 124.911 3.741 . . . . 0.0 113.092 -172.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.523 HD22 ' HB ' ' A' ' 9' ' ' THR . 3.0 m-20 -119.66 -17.68 8.56 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 126.289 1.836 . . . . 0.0 107.92 -171.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.721 ' HA ' HD23 ' A' ' 10' ' ' LEU . 6.2 t60 -51.38 -37.31 47.49 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 120.192 1.36 . . . . 0.0 109.991 177.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.23 -21.74 3.71 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-O 117.231 -1.366 . . . . 0.0 114.6 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.514 HG22 HD21 ' A' ' 10' ' ' LEU . 22.0 m -61.73 -41.51 90.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 120.994 1.725 . . . . 0.0 110.122 176.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -74.41 -17.68 60.76 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 119.315 0.962 . . . . 0.0 113.114 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 73.0 mt -75.32 -5.08 42.88 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.103 0.561 . . . . 0.0 111.244 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -102.65 103.75 14.05 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.286 0.565 . . . . 0.0 109.687 169.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 -51.33 -19.85 1.47 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.089 1.355 . . . . 0.0 113.963 173.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.5 t -77.19 -30.27 54.72 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.032 -1.043 . . . . 0.0 112.027 176.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -69.22 -30.33 68.46 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.585 1.084 . . . . 0.0 109.464 166.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.53 177.27 26.01 Favored Glycine 0 N--CA 1.442 -0.922 0 N-CA-C 110.909 -0.877 . . . . 0.0 110.909 167.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 30.1 tp -77.89 142.05 38.7 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 123.639 0.776 . . . . 0.0 111.056 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -145.7 141.36 27.98 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.397 1.079 . . . . 0.0 110.1 165.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.81 148.02 27.98 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.454 1.502 . . . . 0.0 109.815 166.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -67.62 124.35 23.0 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 125.061 1.344 . . . . 0.0 109.118 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.1 tpp180 -120.07 45.7 2.12 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.652 1.181 . . . . 0.0 108.658 -176.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 89.39 -177.79 44.17 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -174.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.82 172.54 11.55 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.518 -0.99 . . . . 0.0 111.813 -173.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -173.82 -178.02 43.45 Favored Glycine 0 CA--C 1.505 -0.542 0 C-N-CA 120.305 -0.95 . . . . 0.0 114.158 -174.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 22.1 p -146.4 154.84 42.09 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 123.909 0.883 . . . . 0.0 109.45 173.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 44.7 p -78.26 83.23 4.52 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 173.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.6 m -59.58 -30.8 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 118.826 0.739 . . . . 0.0 112.195 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.41 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 7.1 tt0 -74.74 22.99 0.1 Allowed 'General case' 0 C--O 1.205 -1.24 0 C-N-CA 127.861 2.465 . . . . 0.0 111.928 173.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 41.46 114.37 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.616 1 C-N-CA 134.393 5.077 . . . . 0.0 114.025 158.377 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.552 ' HB3' HD21 ' A' ' 53' ' ' LEU . 30.5 m-85 -127.85 154.12 78.12 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 120.194 1.361 . . . . 0.0 111.413 -173.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.38 105.81 1.93 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 124.93 3.753 . . . . 0.0 110.724 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.48 100.91 9.13 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 -178.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.3 m -110.33 144.69 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-N 119.179 0.9 . . . . 0.0 110.154 -172.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 97.0 mt -91.98 116.4 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 171.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -129.92 179.58 5.78 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 124.332 1.053 . . . . 0.0 108.7 172.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.4 152.68 25.17 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 124.649 1.118 . . . . 0.0 112.809 161.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.76 -17.56 64.93 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -171.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -105.97 9.01 32.73 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 118.512 -0.756 . . . . 0.0 112.423 -177.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 53.42 79.64 0.12 Allowed 'General case' 0 C--N 1.342 0.239 0 C-N-CA 125.769 1.628 . . . . 0.0 108.391 -162.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 62.2 mt -120.04 86.57 37.28 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -61.31 151.68 77.59 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 CA-C-N 120.781 1.315 . . . . 0.0 112.683 174.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -125.77 128.92 48.47 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.448 1.499 . . . . 0.0 107.56 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.552 HD21 ' HB3' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -92.7 107.08 18.94 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 174.053 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.1 mt -87.12 139.2 30.8 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 105.904 -1.888 . . . . 0.0 105.904 -172.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -73.61 96.99 2.55 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 118.774 0.716 . . . . 0.0 109.865 -175.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.434 HD23 ' HD2' ' A' ' 57' ' ' PRO . 0.4 OUTLIER -152.08 87.13 4.35 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 124.365 1.066 . . . . 0.0 112.982 177.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.434 ' HD2' HD23 ' A' ' 56' ' ' LEU . 31.5 Cg_endo -59.75 145.18 98.87 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.884 2.389 . . . . 0.0 111.49 176.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 47.65 51.34 17.45 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 129.481 3.419 . . . . 0.0 112.533 -174.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.0 tptm -140.55 143.81 35.56 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 126.072 1.749 . . . . 0.0 106.314 173.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.21 -129.43 20.46 Favored Glycine 0 CA--C 1.519 0.299 0 N-CA-C 109.064 -1.615 . . . . 0.0 109.064 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -138.31 170.53 15.86 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 119.212 1.506 . . . . 0.0 111.606 -167.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 73.1 m -84.53 104.44 14.53 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.381 -0.827 . . . . 0.0 108.995 -176.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 18.0 t -70.32 110.71 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 63.9 p -75.09 145.34 42.36 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 120.904 -1.122 . . . . 0.0 110.43 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -167.35 -167.4 27.97 Favored Glycine 0 C--N 1.335 0.473 0 O-C-N 120.446 -1.409 . . . . 0.0 112.364 -169.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -134.93 158.8 43.35 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.222 1.009 . . . . 0.0 109.169 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.8 mt -102.56 132.71 48.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 -177.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -118.21 127.01 53.34 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 118.64 0.654 . . . . 0.0 110.863 172.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -60.25 135.05 57.61 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 150.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.8 m -135.25 173.45 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 170.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.464 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 0.4 OUTLIER -121.06 -178.27 3.71 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.679 0.752 . . . . 0.0 111.193 160.593 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -44.46 -55.59 4.94 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 126.61 1.964 . . . . 0.0 111.888 -171.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -71.28 -27.62 63.55 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 117.298 -1.334 . . . . 0.0 111.215 -171.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 24.1 tpp -66.28 -47.81 72.45 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 120.862 1.665 . . . . 0.0 108.595 172.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.09 -28.92 70.4 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 119.403 -0.332 . . . . 0.0 111.581 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -77.67 -37.03 50.65 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.42 1.009 . . . . 0.0 112.297 174.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -67.22 -45.84 75.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 119.475 1.034 . . . . 0.0 109.807 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.13 -32.25 66.16 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.67 -0.644 . . . . 0.0 110.351 171.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.428 ' HA ' ' SG ' ' A' ' 84' ' ' CYS . 0.7 OUTLIER -65.31 -7.92 15.67 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.038 1.335 . . . . 0.0 113.069 177.038 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -123.97 -27.16 3.94 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.712 2.405 . . . . 0.0 111.773 -176.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -72.83 -29.52 63.3 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.286 -0.884 . . . . 0.0 110.902 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -117.25 30.95 7.02 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.748 1.619 . . . . 0.0 110.406 177.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.0 t0 49.91 26.31 1.93 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.811 2.044 . . . . 0.0 113.431 169.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.428 ' SG ' ' HA ' ' A' ' 79' ' ' ASP . 0.8 OUTLIER -71.72 159.89 84.19 Favored Pre-proline 0 CA--C 1.54 0.572 0 O-C-N 120.652 -1.28 . . . . 0.0 109.381 -167.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -68.42 -3.4 5.97 Favored 'Cis proline' 0 CA--C 1.54 0.82 0 CA-C-N 120.979 1.385 . . . . 0.0 113.702 -11.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.4 t -56.34 -68.12 0.24 Allowed 'General case' 0 C--O 1.238 0.488 0 CA-C-N 119.339 0.972 . . . . 0.0 111.443 -173.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 26.8 mtp -77.91 -73.54 0.31 Allowed 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -177.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -97.97 -179.73 4.51 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 124.575 1.15 . . . . 0.0 108.108 173.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -165.45 125.29 1.79 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 -172.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.8 tmm_? -69.92 148.18 49.3 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -173.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.5 m -149.78 168.25 24.22 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 126.37 1.868 . . . . 0.0 107.284 -174.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -123.33 142.62 50.76 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.178 1.791 . . . . 0.0 109.691 172.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.19 174.13 13.61 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.466 1.907 . . . . 0.0 110.53 -173.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -92.63 111.79 23.51 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.973 1.309 . . . . 0.0 109.491 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.1 t -106.17 144.38 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 120.509 1.504 . . . . 0.0 107.754 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -78.81 140.78 38.15 Favored 'General case' 0 C--N 1.341 0.221 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 169.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 40.7 t -93.36 92.57 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 176.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.09 -24.53 67.73 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.876 -0.515 . . . . 0.0 110.746 175.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -165.93 149.52 7.76 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 128.035 2.534 . . . . 0.0 105.546 176.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 63.2 t-105 -125.89 137.72 53.75 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 124.715 1.206 . . . . 0.0 107.794 171.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -108.75 127.12 53.73 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.178 0.991 . . . . 0.0 110.558 174.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.6 -174.9 47.56 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 124.902 1.239 . . . . 0.0 112.385 168.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -62.77 151.82 37.59 Favored 'General case' 0 C--O 1.238 0.48 0 O-C-N 122.709 -0.289 . . . . 0.0 110.623 -170.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 102.56 45.31 1.69 Allowed Glycine 0 CA--C 1.52 0.355 0 CA-C-O 119.393 -0.671 . . . . 0.0 112.785 177.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -101.73 89.51 1.53 Allowed Pre-proline 0 N--CA 1.465 0.283 0 C-N-CA 126.682 1.993 . . . . 0.0 109.525 -156.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -62.35 -29.31 79.44 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 124.03 3.153 . . . . 0.0 112.922 -166.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 120.28 -169.21 13.96 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -163.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -71.39 -10.88 60.48 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.745 1.218 . . . . 0.0 113.039 -168.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.0 p -139.01 165.09 28.03 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 120.252 -1.53 . . . . 0.0 110.277 167.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.9 p -146.3 175.39 2.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 C-N-CA 124.989 1.315 . . . . 0.0 108.048 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -100.71 136.0 41.27 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 155.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 98.0 m -121.81 165.06 16.44 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 165.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -83.31 150.39 26.16 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 160.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.505 HG12 HG23 ' A' ' 116' ' ' THR . 27.3 t -142.22 160.81 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 129.312 3.045 . . . . 0.0 105.295 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -110.31 108.08 18.04 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 171.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.505 HG23 HG12 ' A' ' 114' ' ' VAL . 32.5 p -112.64 -164.74 0.94 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 122.017 0.913 . . . . 0.0 109.286 175.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.52 135.69 28.59 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 174.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -98.69 -3.33 36.16 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.869 1.267 . . . . 0.0 111.309 164.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 16.9 p -92.3 -0.65 57.38 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.461 1.904 . . . . 0.0 113.206 -170.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -55.6 141.23 38.29 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 126.669 1.988 . . . . 0.0 113.171 -164.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.44 147.06 98.87 Favored Pre-proline 0 N--CA 1.446 -0.657 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.137 -177.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.486 ' HA ' HD23 ' A' ' 125' ' ' LEU . 27.8 Cg_endo -65.19 -22.06 61.56 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.101 1.867 . . . . 0.0 113.307 -178.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.481 ' HA ' ' CE2' ' A' ' 126' ' ' PHE . 1.6 pm0 -70.0 -29.04 66.02 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 170.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 46.6 m0 -72.61 3.58 4.83 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.052 -1.03 . . . . 0.0 111.247 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.486 HD23 ' HA ' ' A' ' 122' ' ' PRO . 4.5 mm? -81.24 -22.25 38.88 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.663 1.585 . . . . 0.0 113.83 169.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.481 ' CE2' ' HA ' ' A' ' 123' ' ' GLU . 33.7 p90 -107.12 -16.84 14.32 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 120.474 1.488 . . . . 0.0 112.772 -177.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 26.2 mt -56.29 148.14 43.92 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 123.668 0.787 . . . . 0.0 110.091 173.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.67 147.45 45.27 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.601 2.201 . . . . 0.0 111.712 -173.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -91.23 168.94 11.24 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.201 1.4 . . . . 0.0 111.413 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -143.42 164.26 30.8 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.621 1.568 . . . . 0.0 109.41 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -107.45 -1.73 21.16 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.28 1.832 . . . . 0.0 111.626 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.16 167.97 23.28 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 126.182 1.793 . . . . 0.0 106.948 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.403 ' CD2' ' HA3' ' A' ' 8' ' ' GLY . 1.1 t80 -135.22 96.77 3.56 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 104.357 -2.46 . . . . 0.0 104.357 176.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -150.24 115.12 5.31 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 122.942 0.497 . . . . 0.0 110.18 -170.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 73.5 m -54.82 -16.68 2.79 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.124 1.37 . . . . 0.0 111.303 171.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -103.89 57.31 0.73 Allowed 'General case' 0 C--O 1.237 0.399 0 C-N-CA 126.439 1.895 . . . . 0.0 109.273 -177.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -146.84 177.26 25.27 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 127.914 2.674 . . . . 0.0 109.437 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -79.95 3.48 7.56 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.793 2.996 . . . . 0.0 114.32 -171.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -120.49 85.3 2.37 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 107.31 -1.366 . . . . 0.0 107.31 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -72.14 52.26 1.37 Allowed Glycine 0 CA--C 1.529 0.938 0 C-N-CA 126.587 2.041 . . . . 0.0 115.089 -167.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.49 58.09 1.25 Allowed 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 126.024 1.73 . . . . 0.0 109.621 -174.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 14.0 mmt85 -119.66 -18.07 8.46 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -176.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -166.86 139.9 3.67 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 125.328 1.451 . . . . 0.0 107.965 163.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -121.4 76.1 33.8 Favored Pre-proline 0 CA--C 1.531 0.22 0 O-C-N 124.422 1.076 . . . . 0.0 108.913 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -80.37 -49.24 0.06 OUTLIER 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 123.911 3.074 . . . . 0.0 113.738 176.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.478 ' HE ' ' C ' ' A' ' 149' ' ' ARG . 11.6 ttt180 -149.3 75.41 1.28 Allowed 'General case' 0 CA--C 1.507 -0.702 0 C-N-CA 126.169 1.787 . . . . 0.0 107.775 -166.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -77.16 -39.6 48.48 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 112.672 -2.058 . . . . 0.0 109.855 170.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -151.95 34.49 0.54 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.017 1.727 . . . . 0.0 110.313 -170.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.478 ' C ' ' HE ' ' A' ' 146' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.847 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 154.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.472 0.67 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.37 115.66 28.94 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 -172.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.4 m80 -85.68 122.28 29.55 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 171.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.412 HG22 ' HB2' ' A' ' 113' ' ' PHE . 8.0 pt -129.05 174.98 11.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 125.329 1.451 . . . . 0.0 111.426 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -105.02 -167.92 1.4 Allowed 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.949 1.699 . . . . 0.0 110.596 172.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.613 HG12 ' H ' ' A' ' 66' ' ' GLU . 10.7 p -139.74 148.41 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 123.95 0.9 . . . . 0.0 109.132 166.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -59.56 -32.26 70.18 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.636 1.575 . . . . 0.0 113.173 -177.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 142.32 -31.07 2.07 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.65 1.119 . . . . 0.0 111.179 -168.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.425 HG23 ' CE2' ' A' ' 133' ' ' TYR . 2.3 p -59.35 -73.48 0.08 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 130.68 3.592 . . . . 0.0 112.832 -176.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.9 mp -78.72 57.18 2.01 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.843 0.857 . . . . 0.0 108.782 -173.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.59 -66.88 0.36 Allowed 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 127.091 2.156 . . . . 0.0 108.338 -176.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 28.8 tpt180 -79.35 -72.59 0.38 Allowed 'General case' 0 C--O 1.223 -0.312 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.703 -178.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -172.84 10.98 0.04 OUTLIER Glycine 0 CA--C 1.531 1.062 0 N-CA-C 115.666 1.027 . . . . 0.0 115.666 -175.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.53 164.99 0.3 Allowed Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 126.569 1.948 . . . . 0.0 114.885 -171.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -56.16 -16.94 18.47 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 124.671 3.581 . . . . 0.0 113.974 -174.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -98.73 -19.58 17.4 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 125.12 1.368 . . . . 0.0 110.769 -165.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -51.36 -40.45 59.19 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.034 0.934 . . . . 0.0 112.413 -162.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.72 -21.68 19.86 Favored 'General case' 0 C--O 1.224 -0.255 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -175.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.5 m -60.49 -40.22 83.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 120.269 1.395 . . . . 0.0 110.905 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.0 ptp -74.22 -13.04 60.73 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 118.645 0.657 . . . . 0.0 112.219 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 72.6 mt -82.7 -4.78 58.34 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 118.574 -0.727 . . . . 0.0 110.61 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -105.35 99.19 8.8 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -178.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 28.3 t-80 -60.7 -18.85 56.75 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.0 t -55.99 -52.71 63.2 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.328 1.051 . . . . 0.0 109.746 168.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -70.67 -21.08 62.64 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.704 0.802 . . . . 0.0 110.87 -177.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.85 177.77 23.34 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 123.992 0.806 . . . . 0.0 111.373 164.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.5 tp -84.27 142.72 30.04 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.63 0.772 . . . . 0.0 110.293 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.28 142.22 31.27 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.248 1.419 . . . . 0.0 107.945 161.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -143.95 131.81 21.46 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.182 1.393 . . . . 0.0 108.111 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -73.84 94.21 2.26 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 127.187 2.195 . . . . 0.0 110.706 -171.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -93.54 61.34 3.18 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 172.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.18 -154.54 53.28 Favored Glycine 0 N--CA 1.441 -0.997 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 174.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 24.5 ptt-85 -143.95 168.13 20.7 Favored 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 122.119 -0.636 . . . . 0.0 112.124 -163.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -173.62 177.51 45.93 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-O 122.432 1.018 . . . . 0.0 114.041 -169.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.7 p -142.54 162.51 35.28 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.947 1.299 . . . . 0.0 109.917 176.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 43.6 p -82.06 95.84 7.57 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 168.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.401 HG22 ' H ' ' A' ' 37' ' ' VAL . 0.2 OUTLIER -62.76 -25.41 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 118.43 0.559 . . . . 0.0 111.686 171.019 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.78 117.32 13.22 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 159.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.4 m -57.1 138.5 54.4 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 172.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.478 ' HB3' ' CD2' ' A' ' 53' ' ' LEU . 36.0 m-85 -129.27 152.43 79.47 Favored Pre-proline 0 C--O 1.234 0.246 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 164.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -77.71 111.78 3.19 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 124.918 3.745 . . . . 0.0 110.479 172.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 33.5 tp -103.81 86.48 2.61 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 124.92 1.288 . . . . 0.0 107.769 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.556 HG13 ' HB3' ' A' ' 127' ' ' LEU . 48.3 t -84.21 160.78 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.274 0 C-N-CA 125.186 1.394 . . . . 0.0 107.921 177.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 50.3 mt -132.33 118.8 37.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 176.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -144.71 -172.87 3.91 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.567 0.747 . . . . 0.0 109.082 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.71 175.97 11.33 Favored Glycine 0 N--CA 1.439 -1.138 0 C-N-CA 125.564 1.555 . . . . 0.0 111.316 178.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -74.59 -8.45 56.39 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -162.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -132.73 40.28 3.27 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 124.021 0.928 . . . . 0.0 110.759 -176.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.8 m120 48.17 61.05 3.2 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.128 -0.983 . . . . 0.0 110.724 174.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 62.4 mt -102.49 89.97 1.97 Allowed Pre-proline 0 C--N 1.329 -0.294 0 N-CA-C 103.422 -2.807 . . . . 0.0 103.422 -160.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -59.62 120.04 7.61 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 N-CA-C 108.132 -1.526 . . . . 0.0 108.132 -176.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -103.27 115.31 30.31 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 177.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.478 ' CD2' ' HB3' ' A' ' 40' ' ' PHE . 0.3 OUTLIER -81.39 94.75 6.85 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 172.737 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.436 ' HG ' ' CD2' ' A' ' 120' ' ' TYR . 10.9 mp -65.45 120.23 12.46 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 173.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -70.55 83.58 0.6 Allowed 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -176.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.56 85.74 12.84 Favored Pre-proline 0 N--CA 1.465 0.317 0 C-N-CA 124.168 0.987 . . . . 0.0 109.727 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -58.87 141.07 97.71 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 N-CA-C 108.932 -1.218 . . . . 0.0 108.932 174.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.56 18.96 76.92 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 119.607 -0.551 . . . . 0.0 113.681 176.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -126.62 157.08 39.87 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 119.487 1.643 . . . . 0.0 106.798 161.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.97 -137.27 15.36 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 173.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -140.24 171.49 14.09 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.784 1.292 . . . . 0.0 110.493 -173.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 58.3 m -79.93 107.77 12.97 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 123.884 0.874 . . . . 0.0 111.387 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 73.6 t -88.86 116.35 30.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -169.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.6 p -72.61 161.95 30.12 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.493 0.664 . . . . 0.0 109.278 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -169.58 -156.7 11.11 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 108.116 -1.993 . . . . 0.0 108.116 175.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.613 ' H ' HG12 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -135.09 171.76 13.97 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.619 1.968 . . . . 0.0 106.513 177.603 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 79.5 mt -126.36 127.99 71.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 119.485 1.039 . . . . 0.0 108.512 -170.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -126.08 119.96 28.96 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.456 0.702 . . . . 0.0 111.794 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -66.59 115.66 6.69 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 105.473 -2.047 . . . . 0.0 105.473 156.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.2 m -120.47 165.48 15.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 C-N-CA 123.828 0.851 . . . . 0.0 109.244 178.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -93.56 171.39 8.93 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 122.413 1.101 . . . . 0.0 108.296 169.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -54.07 -37.93 64.74 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.316 -1.311 . . . . 0.0 110.846 167.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -58.68 -40.66 84.22 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.889 0.768 . . . . 0.0 110.943 -176.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 25.8 tpp -72.01 -45.83 59.44 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 176.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.7 tp -58.84 -26.84 64.56 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 177.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 50.1 mtt-85 -78.59 -39.27 37.92 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.936 1.694 . . . . 0.0 111.144 173.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -64.15 -50.29 68.79 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 118.881 -0.58 . . . . 0.0 111.351 175.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 91.6 mt -56.41 -36.36 68.85 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 119.106 0.866 . . . . 0.0 110.668 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.73 -23.25 28.09 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.097 1.759 . . . . 0.0 112.891 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -93.22 -31.23 14.82 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.43 1.492 . . . . 0.0 112.287 174.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -71.62 -43.73 65.65 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.333 1.053 . . . . 0.0 109.632 -169.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -92.21 15.41 13.68 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.45 1.1 . . . . 0.0 113.174 176.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.0 t70 44.89 38.29 2.85 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.615 1.566 . . . . 0.0 112.283 -177.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -65.7 158.91 72.33 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 120.075 -1.641 . . . . 0.0 107.403 170.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -74.16 -3.38 17.1 Favored 'Cis proline' 0 N--CA 1.452 -0.953 0 CA-C-N 118.969 0.668 . . . . 0.0 113.488 -13.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.54 -62.81 1.47 Allowed 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.033 1.733 . . . . 0.0 111.8 -175.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 36.5 mtp -86.31 -74.29 0.43 Allowed 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -174.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -89.81 172.91 8.56 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 175.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -134.88 138.66 44.36 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 165.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.574 ' HD3' ' CD1' ' A' ' 113' ' ' PHE . 7.6 tmm_? -74.31 129.94 38.74 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 118.095 -0.955 . . . . 0.0 109.24 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.3 m -133.02 156.27 47.65 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.102 0.865 . . . . 0.0 110.0 -175.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -87.85 139.58 30.38 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.388 1.475 . . . . 0.0 110.426 168.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.495 HD21 HG23 ' A' ' 114' ' ' VAL . 1.8 pt? -160.92 -179.91 7.94 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.657 1.183 . . . . 0.0 112.809 -177.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 12.1 tp60 -99.2 142.44 30.68 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.371 1.068 . . . . 0.0 113.073 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 45.4 t -137.34 134.6 47.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 126.659 1.984 . . . . 0.0 107.781 174.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -76.66 144.73 39.26 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.282 1.433 . . . . 0.0 108.039 165.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.592 HG13 ' HA ' ' A' ' 108' ' ' ASP 0.255 3.5 p -110.93 82.43 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-O 122.366 1.079 . . . . 0.0 108.838 -178.451 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.0 mp -44.79 -42.19 7.6 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 127.057 2.143 . . . . 0.0 110.462 176.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -150.09 152.47 34.83 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 176.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 64.0 t-105 -127.09 137.71 53.06 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 125.59 1.556 . . . . 0.0 107.28 176.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -113.65 106.8 14.95 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 122.964 0.505 . . . . 0.0 110.047 174.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.9 -175.75 16.12 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-O 122.066 0.815 . . . . 0.0 112.304 175.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -79.94 172.76 13.34 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.262 -0.969 . . . . 0.0 109.391 168.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.39 60.44 2.01 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -101.05 88.47 1.06 Allowed Pre-proline 0 CA--C 1.537 0.466 1 C-N-CA 132.721 4.408 . . . . 0.0 109.113 -158.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -73.39 5.04 3.43 Favored 'Trans proline' 0 CA--C 1.544 0.98 1 C-N-CA 126.188 4.592 . . . . 0.0 113.963 -171.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.33 -169.03 54.88 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-N 120.819 1.645 . . . . 0.0 110.031 -163.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.592 ' HA ' HG13 ' A' ' 97' ' ' VAL . 26.9 t70 -96.81 5.48 50.51 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 129.456 3.102 . . . . 0.0 116.001 -166.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.2 p -136.81 122.12 19.33 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 122.025 2.193 . . . . 0.0 114.588 152.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 24.8 m -98.41 153.85 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 125.098 1.359 . . . . 0.0 108.891 -179.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -87.12 125.95 34.47 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 163.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 9.9 m -116.88 172.06 7.49 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.522 1.129 . . . . 0.0 110.428 176.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.574 ' CD1' ' HD3' ' A' ' 90' ' ' ARG . 96.2 m-85 -92.62 139.77 30.22 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 152.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.495 HG23 HD21 ' A' ' 93' ' ' LEU . 24.3 t -142.09 126.05 15.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 129.752 3.221 . . . . 0.0 106.89 172.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -72.23 141.33 48.97 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 170.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.414 HG22 HD13 ' A' ' 53' ' ' LEU . 41.9 p -145.12 -170.0 3.32 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 126.633 1.973 . . . . 0.0 107.319 -177.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -131.76 143.76 50.47 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 166.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -107.05 0.66 23.73 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.726 1.61 . . . . 0.0 110.689 168.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.2 p -121.75 20.52 10.93 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 127.101 2.161 . . . . 0.0 111.646 -159.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.436 ' CD2' ' HG ' ' A' ' 54' ' ' LEU . 7.2 p90 -67.04 152.1 46.41 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 125.691 1.596 . . . . 0.0 111.825 -176.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.59 158.87 65.12 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 124.689 1.196 . . . . 0.0 111.568 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -72.7 -33.91 7.65 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.558 1.505 . . . . 0.0 113.175 -177.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -64.66 -26.97 68.62 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.7 0.682 . . . . 0.0 112.39 172.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 45.7 m0 -69.99 -10.78 59.8 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.767 0.712 . . . . 0.0 112.178 -176.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.26 -29.12 69.29 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.674 1.125 . . . . 0.0 110.821 168.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -90.69 -11.41 39.8 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.497 1.119 . . . . 0.0 112.099 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.556 ' HB3' HG13 ' A' ' 43' ' ' VAL . 11.5 mt -62.64 146.67 94.0 Favored Pre-proline 0 C--O 1.235 0.335 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -64.72 143.49 80.79 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.171 1.914 . . . . 0.0 109.861 175.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -96.82 164.27 12.63 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.751 1.22 . . . . 0.0 108.56 176.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 72.0 m-70 -135.27 162.94 31.15 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.8 0.84 . . . . 0.0 110.103 -176.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -106.29 -17.48 14.28 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 121.392 -0.817 . . . . 0.0 110.364 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 95.2 p -139.44 160.03 40.79 Favored 'General case' 0 N--CA 1.444 -0.771 0 O-C-N 121.282 -0.886 . . . . 0.0 111.07 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.425 ' CE2' HG23 ' A' ' 9' ' ' THR . 3.4 t80 -141.42 101.76 4.06 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 104.005 -2.591 . . . . 0.0 104.005 178.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -151.72 136.86 17.43 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -178.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.01 -43.76 50.85 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.8 0.84 . . . . 0.0 110.784 174.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -89.29 23.78 2.4 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.838 0.855 . . . . 0.0 112.735 -167.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -82.16 155.26 34.37 Favored Glycine 0 CA--C 1.539 1.542 0 CA-C-O 118.701 -1.055 . . . . 0.0 111.892 174.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -71.5 -22.63 24.42 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 124.288 3.325 . . . . 0.0 112.361 175.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -73.33 80.41 1.36 Allowed 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 127.556 2.342 . . . . 0.0 107.031 172.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -72.57 77.35 0.77 Allowed Glycine 0 CA--C 1.522 0.476 0 C-N-CA 127.033 2.254 . . . . 0.0 111.375 -174.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -161.14 71.58 0.41 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 128.573 2.749 . . . . 0.0 105.642 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -133.56 173.15 11.81 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 123.32 0.648 . . . . 0.0 109.892 -168.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -69.77 123.81 22.38 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.531 -161.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -119.76 80.28 24.36 Favored Pre-proline 0 CA--C 1.516 -0.342 0 C-N-CA 125.077 1.351 . . . . 0.0 109.045 -170.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -75.4 -15.21 20.02 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 121.54 1.493 . . . . 0.0 111.727 170.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.02 3.33 0.11 Allowed 'General case' 0 C--N 1.345 0.394 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -167.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -73.56 -7.36 51.59 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 120.475 -1.391 . . . . 0.0 113.72 -174.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -121.67 16.02 11.1 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.094 1.757 . . . . 0.0 110.215 -178.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 0.99 0 C-N-CA 125.496 1.518 . . . . 0.0 109.786 -177.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 mmt . . . . . 0 CA--C 1.515 -0.394 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.45 103.09 4.63 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 127.228 2.211 . . . . 0.0 105.413 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -78.11 142.09 38.32 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -177.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.1 pt -126.79 166.5 23.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 176.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -124.96 130.56 52.61 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.476 0.71 . . . . 0.0 109.679 -177.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.8 p -93.14 164.58 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 125.449 1.5 . . . . 0.0 108.922 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.401 ' CE1' HG13 ' A' ' 114' ' ' VAL . 0.4 OUTLIER -113.4 -74.43 0.63 Allowed 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -179.593 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -128.1 -34.98 0.52 Allowed Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.164 1.364 . . . . 0.0 111.306 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p -64.12 -32.72 74.4 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 127.127 2.171 . . . . 0.0 114.276 -159.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 mp -133.37 36.46 3.39 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.947 1.299 . . . . 0.0 107.737 177.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -112.02 -25.17 9.51 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.63 1.172 . . . . 0.0 113.265 -172.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.3 mmt-85 -140.73 -87.93 0.18 Allowed 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 119.687 1.13 . . . . 0.0 109.419 168.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -128.45 2.58 6.6 Favored Glycine 0 C--N 1.334 0.429 0 O-C-N 120.637 -1.29 . . . . 0.0 111.632 -162.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -50.77 151.9 3.93 Favored Pre-proline 0 N--CA 1.438 -1.069 0 C-N-CA 124.79 1.236 . . . . 0.0 109.654 -173.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.7 -18.1 58.4 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 123.275 2.65 . . . . 0.0 112.285 -169.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -90.2 -25.07 20.81 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 126.924 2.09 . . . . 0.0 110.926 -168.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -49.59 -40.45 38.89 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.653 1.181 . . . . 0.0 111.922 -165.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.73 -27.08 1.8 Allowed 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 125.824 1.65 . . . . 0.0 114.472 -177.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.9 m -62.54 -41.0 90.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 119.716 1.144 . . . . 0.0 110.508 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.59 -14.27 61.16 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 67.6 mt -82.47 -15.33 52.9 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.794 0.838 . . . . 0.0 110.189 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -85.77 95.71 9.49 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 -178.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -63.27 -14.32 48.12 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.781 -0.574 . . . . 0.0 112.401 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 68.1 m -71.83 -27.54 62.97 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 120.548 -1.345 . . . . 0.0 112.937 167.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -83.15 2.79 33.73 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.477 1.111 . . . . 0.0 110.891 171.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.31 177.94 19.46 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 125.357 1.456 . . . . 0.0 110.787 173.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 36.9 tp -85.22 144.38 28.18 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.11 0.564 . . . . 0.0 111.308 -175.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -147.53 120.1 8.54 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.39 1.476 . . . . 0.0 109.131 161.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -134.7 150.93 50.66 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 119.008 0.822 . . . . 0.0 110.931 171.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -66.72 109.02 2.7 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 127.079 2.152 . . . . 0.0 110.191 -177.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.7 tpp85 -118.15 42.14 2.76 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.826 1.651 . . . . 0.0 108.464 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 113.5 175.0 19.09 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-O 122.874 1.263 . . . . 0.0 113.027 167.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -108.97 155.4 20.91 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.67 172.35 37.0 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.243 -0.98 . . . . 0.0 115.049 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.5 p -143.53 131.09 21.16 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 175.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 20.6 p -63.36 106.94 0.99 Allowed 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 173.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.45 -19.32 12.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.879 -177.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -65.79 116.71 7.27 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 155.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.26 132.62 34.09 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 117.641 -1.171 . . . . 0.0 107.915 160.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -135.59 156.49 77.58 Favored Pre-proline 0 N--CA 1.449 -0.5 0 CA-C-N 119.159 0.89 . . . . 0.0 108.683 178.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.467 ' HG2' ' HB2' ' A' ' 54' ' ' LEU . 60.1 Cg_endo -71.55 90.89 0.69 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.996 3.13 . . . . 0.0 110.228 164.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.54 HD11 ' HB2' ' A' ' 51' ' ' PRO . 45.0 tp -90.38 107.55 19.22 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 154.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.4 m -101.91 166.59 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 170.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.42 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -114.63 129.65 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 170.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.55 -170.93 3.41 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.99 0.916 . . . . 0.0 111.7 -176.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.45 -157.65 53.44 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 126.319 1.914 . . . . 0.0 112.336 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.03 -8.35 21.54 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.397 1.479 . . . . 0.0 114.198 -174.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 -127.26 19.6 6.91 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 123.885 0.874 . . . . 0.0 112.677 -170.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 42.8 m-20 55.75 66.6 1.17 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.235 1.814 . . . . 0.0 109.066 -171.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 68.0 mt -104.28 88.94 2.28 Favored Pre-proline 0 N--CA 1.465 0.292 0 C-N-CA 127.695 2.398 . . . . 0.0 106.55 -175.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.54 ' HB2' HD11 ' A' ' 42' ' ' LEU . 96.2 Cg_endo -66.44 150.28 84.33 Favored 'Trans proline' 0 N--CA 1.44 -1.653 0 CA-C-N 119.749 0.946 . . . . 0.0 112.501 174.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -128.81 118.94 23.61 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.63 102.34 3.27 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 165.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.467 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 2.9 mt -78.67 147.07 33.67 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 173.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -87.2 85.93 7.24 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 120.274 -1.516 . . . . 0.0 110.959 -173.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.2 86.8 11.06 Favored Pre-proline 0 N--CA 1.474 0.74 0 C-N-CA 123.72 0.808 . . . . 0.0 112.848 174.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -58.5 150.42 68.78 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 121.143 1.228 . . . . 0.0 110.395 174.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.81 -2.24 75.03 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 124.391 0.996 . . . . 0.0 113.91 174.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.27 127.8 32.55 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 120.122 1.961 . . . . 0.0 106.127 -174.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.76 -143.13 16.45 Favored Glycine 0 CA--C 1.522 0.527 0 CA-C-O 118.338 -1.257 . . . . 0.0 110.235 -168.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -141.35 170.38 15.84 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.051 1.425 . . . . 0.0 111.324 -177.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 7.1 m -72.31 106.59 4.52 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.161 1.384 . . . . 0.0 111.774 -174.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.6 t -77.73 101.36 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.761 0.824 . . . . 0.0 110.524 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.6 p -70.61 164.25 25.31 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 121.878 -0.514 . . . . 0.0 110.253 -177.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 176.59 -159.98 27.16 Favored Glycine 0 C--N 1.343 0.93 0 CA-C-N 119.392 0.996 . . . . 0.0 112.481 -176.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -139.32 160.03 40.78 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 121.499 -1.001 . . . . 0.0 111.785 -176.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 75.8 mt -114.09 124.41 70.71 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -173.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -113.87 119.93 38.97 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 173.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -57.09 114.13 2.0 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 154.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.9 m -115.37 155.35 16.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 173.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.73 173.23 10.23 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 122.011 0.91 . . . . 0.0 109.593 170.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.47 -49.85 60.98 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 125.72 1.608 . . . . 0.0 110.153 170.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -56.79 -39.25 73.78 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 118.922 -0.561 . . . . 0.0 111.679 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 44.2 tpp -72.35 -48.72 39.64 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 118.799 0.727 . . . . 0.0 109.693 179.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.28 -13.58 39.9 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.063 -1.023 . . . . 0.0 113.156 177.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 89.1 mtt-85 -86.34 -57.23 3.09 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 125.328 1.451 . . . . 0.0 110.467 168.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -53.48 -44.89 69.35 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.523 1.129 . . . . 0.0 112.272 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 90.5 mt -65.84 -27.93 68.6 Favored 'General case' 0 N--CA 1.461 0.113 0 O-C-N 121.347 -0.846 . . . . 0.0 110.526 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.472 ' HA ' ' SG ' ' A' ' 84' ' ' CYS . 1.8 t70 -76.64 10.12 2.36 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.099 1.76 . . . . 0.0 111.184 176.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -126.54 -4.77 6.54 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 127.516 2.326 . . . . 0.0 110.433 167.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.99 -49.05 7.3 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 104.25 -2.5 . . . . 0.0 104.25 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -74.78 0.79 14.21 Favored 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 124.884 1.274 . . . . 0.0 111.683 -173.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 57.77 19.28 5.48 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.814 1.646 . . . . 0.0 113.192 -176.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.472 ' SG ' ' HA ' ' A' ' 79' ' ' ASP . 1.1 p -57.86 157.6 14.81 Favored Pre-proline 0 CA--C 1.546 0.807 0 O-C-N 119.337 -2.102 . . . . 0.0 109.885 167.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -72.23 -4.51 12.99 Favored 'Cis proline' 0 CA--C 1.543 0.974 0 CA-C-N 119.732 0.94 . . . . 0.0 113.857 -6.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.3 m -59.51 -62.3 1.98 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 120.237 1.38 . . . . 0.0 111.776 -178.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 43.2 mtp -75.39 -58.86 3.03 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 122.326 0.251 . . . . 0.0 110.385 -175.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -119.2 174.71 6.17 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 126.285 1.834 . . . . 0.0 109.096 -176.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -127.4 -14.32 5.33 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 115.702 1.741 . . . . 0.0 115.702 -174.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? 62.08 125.12 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 128.641 2.776 . . . . 0.0 114.064 -174.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.6 m -134.67 167.39 20.92 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -174.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -106.91 123.98 48.95 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.155 1.782 . . . . 0.0 108.786 172.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -126.43 -164.51 1.34 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.083 1.753 . . . . 0.0 112.488 -166.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -132.43 134.24 44.85 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 120.363 1.438 . . . . 0.0 113.195 -179.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.624 HG13 HG22 ' A' ' 110' ' ' VAL . 1.5 p -155.3 117.57 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 118.115 2.635 . . . . 0.0 118.115 -166.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -57.53 132.55 53.51 Favored 'General case' 0 CA--C 1.51 -0.576 0 C-N-CA 125.294 1.438 . . . . 0.0 109.263 -173.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 84.8 t -70.4 101.86 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 105.423 -2.065 . . . . 0.0 105.423 163.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.37 -34.35 67.89 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 167.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -163.9 149.44 10.91 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.818 2.047 . . . . 0.0 106.134 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 70.2 t-105 -124.93 132.57 53.27 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 125.555 1.542 . . . . 0.0 107.012 173.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -122.47 103.48 8.75 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.87 -174.01 15.64 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 125.28 1.419 . . . . 0.0 112.394 176.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -50.63 156.84 0.85 Allowed 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 126.03 1.732 . . . . 0.0 114.298 170.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.86 65.61 1.39 Allowed Glycine 0 N--CA 1.436 -1.363 0 N-CA-C 108.886 -1.686 . . . . 0.0 108.886 149.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -102.36 89.09 1.56 Allowed Pre-proline 0 CA--C 1.538 0.506 1 C-N-CA 133.301 4.641 . . . . 0.0 108.928 -155.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.468 ' CG ' HG12 ' A' ' 110' ' ' VAL . 87.2 Cg_endo -71.81 -16.12 29.71 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 124.332 3.354 . . . . 0.0 116.14 -168.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 107.16 -167.49 13.76 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 120.541 1.518 . . . . 0.0 110.837 -165.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -68.93 -17.42 63.95 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -161.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.3 p -150.28 157.18 42.79 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 121.946 2.157 . . . . 0.0 109.176 -177.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.624 HG22 HG13 ' A' ' 95' ' ' VAL . 4.2 m -128.03 157.38 40.21 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.968 0 C-N-CA 115.795 -2.362 . . . . 0.0 109.272 -167.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -98.76 82.82 2.85 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 164.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 9.2 m -75.22 166.23 23.96 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 114.485 -1.234 . . . . 0.0 107.785 163.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -82.96 137.33 34.22 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 155.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.401 HG13 ' CE1' ' A' ' 7' ' ' TYR . 22.8 t -131.96 127.56 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 127.373 2.269 . . . . 0.0 107.852 174.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -63.69 118.52 8.38 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 170.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 36.0 p -130.85 179.56 5.91 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.551 1.141 . . . . 0.0 108.554 170.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.7 t -130.41 155.25 46.72 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 124.96 1.304 . . . . 0.0 107.801 170.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -120.09 -6.22 9.97 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 127.776 2.43 . . . . 0.0 111.743 175.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.5 t -130.98 69.57 1.47 Allowed 'General case' 0 N--CA 1.462 0.127 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -174.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.64 9.14 42.45 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.751 1.22 . . . . 0.0 113.703 -170.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.405 ' HB1' ' HD2' ' A' ' 122' ' ' PRO . . . 67.84 161.88 0.14 Allowed Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 127.302 2.241 . . . . 0.0 111.858 -177.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.405 ' HD2' ' HB1' ' A' ' 121' ' ' ALA . 21.4 Cg_endo -66.97 -32.83 34.36 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 121.456 1.437 . . . . 0.0 113.998 -171.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -61.05 -38.66 86.98 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.568 1.147 . . . . 0.0 112.93 -173.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 46.0 m0 -75.22 -10.07 59.13 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 122.067 -0.396 . . . . 0.0 110.895 -169.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.75 -11.9 60.54 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.22 1.008 . . . . 0.0 111.996 173.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -109.92 -8.81 14.81 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.641 0.776 . . . . 0.0 112.081 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.5 mt -73.09 152.27 90.56 Favored Pre-proline 0 C--O 1.24 0.572 0 O-C-N 121.784 -0.572 . . . . 0.0 109.711 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.75 159.8 38.28 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.89 2.393 . . . . 0.0 110.787 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -102.9 172.79 6.62 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.86 0.864 . . . . 0.0 111.877 -176.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.514 ' CE1' HD11 ' A' ' 141' ' ' LEU . 92.0 m-70 -132.35 170.87 14.47 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 126.894 2.077 . . . . 0.0 108.785 -177.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -111.77 -14.9 13.51 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.808 0.843 . . . . 0.0 111.334 174.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 58.6 m -155.31 169.68 23.64 Favored 'General case' 0 C--O 1.233 0.237 0 O-C-N 120.404 -1.435 . . . . 0.0 110.053 170.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -104.0 -160.45 0.77 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 128.165 2.586 . . . . 0.0 106.797 158.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 23.9 t0 78.95 134.19 0.06 Allowed 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 129.492 3.117 . . . . 0.0 112.183 -171.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.8 -31.38 26.99 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.999 1.32 . . . . 0.0 110.974 173.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -67.61 -15.84 63.86 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.594 0.758 . . . . 0.0 112.844 176.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -77.64 155.92 43.84 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.885 1.231 . . . . 0.0 111.364 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.56 -19.18 32.62 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.771 2.314 . . . . 0.0 113.152 -172.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 43.4 m-70 -71.45 83.83 0.81 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.986 2.114 . . . . 0.0 109.429 -173.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -61.06 68.75 0.01 OUTLIER Glycine 0 CA--C 1.528 0.891 0 C-N-CA 128.527 2.965 . . . . 0.0 113.735 -177.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.514 HD11 ' CE1' ' A' ' 130' ' ' HIS . 0.4 OUTLIER -178.1 57.97 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 130.973 3.709 . . . . 0.0 106.21 179.363 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -90.21 -168.0 2.0 Allowed 'General case' 0 N--CA 1.463 0.188 0 O-C-N 120.933 -1.104 . . . . 0.0 108.234 -176.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -60.32 136.72 58.12 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.585 1.084 . . . . 0.0 108.208 -176.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.531 ' ND2' HD21 ' A' ' 148' ' ' ASN . 35.6 m-20 -114.95 78.66 5.54 Favored Pre-proline 0 N--CA 1.453 -0.311 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 -178.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -70.35 -49.18 0.5 Allowed 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.012 1.808 . . . . 0.0 109.336 175.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 24.1 ttt180 -164.15 19.59 0.06 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.205 1.402 . . . . 0.0 111.422 -162.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -61.44 -33.25 73.41 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.466 -0.772 . . . . 0.0 110.727 175.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.531 HD21 ' ND2' ' A' ' 144' ' ' ASN . 12.1 p30 -146.11 5.45 0.98 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 127.266 2.227 . . . . 0.0 111.897 -162.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.143 0 C-N-CA 126.131 1.772 . . . . 0.0 112.163 -178.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 mtt . . . . . 0 N--CA 1.456 -0.139 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.98 158.38 43.83 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.933 1.293 . . . . 0.0 108.647 170.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -99.78 138.76 36.41 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 122.953 0.501 . . . . 0.0 110.463 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.4 pt -132.92 174.1 13.81 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 CA-C-O 122.001 0.905 . . . . 0.0 109.38 167.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -131.35 133.44 45.3 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.349 1.46 . . . . 0.0 108.257 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.422 HG21 ' HB2' ' A' ' 11' ' ' LYS . 13.2 m -70.0 119.35 15.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-O 122.024 0.916 . . . . 0.0 109.582 -178.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -54.12 -40.55 67.46 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.393 1.477 . . . . 0.0 111.755 172.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 164.12 -44.19 0.31 Allowed Glycine 0 CA--C 1.526 0.757 0 CA-C-O 122.949 1.305 . . . . 0.0 110.583 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.58 -11.8 3.39 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.715 2.406 . . . . 0.0 115.74 -173.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -134.95 31.1 3.31 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 124.763 1.225 . . . . 0.0 110.638 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.422 ' HB2' HG21 ' A' ' 6' ' ' VAL . 13.7 tmtt? -117.91 -85.48 0.64 Allowed 'General case' 0 C--O 1.224 -0.239 0 CA-C-O 117.359 -1.305 . . . . 0.0 107.989 170.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.516 ' HB2' HE22 ' A' ' 14' ' ' GLN . 2.8 mmm180 -45.3 -84.12 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.446 1.498 . . . . 0.0 113.345 -171.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -167.06 15.58 0.08 OUTLIER Glycine 0 CA--C 1.53 0.997 0 C-N-CA 123.588 0.613 . . . . 0.0 112.229 -175.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.516 HE22 ' HB2' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -51.95 155.44 3.13 Favored Pre-proline 0 C--O 1.233 0.231 0 C-N-CA 125.406 1.482 . . . . 0.0 110.809 177.758 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -64.76 -3.88 7.61 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 124.171 3.247 . . . . 0.0 113.795 -172.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.661 ' O ' HG22 ' A' ' 19' ' ' VAL . 4.2 m-80 -110.4 -9.5 14.61 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-O 116.365 -1.779 . . . . 0.0 111.221 -167.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -53.76 -46.63 71.0 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 121.982 2.173 . . . . 0.0 109.725 -172.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.874 ' HA ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -50.55 -19.34 0.87 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.903 1.681 . . . . 0.0 115.403 175.9 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.661 HG22 ' O ' ' A' ' 16' ' ' ASN . 30.9 m -63.48 -24.11 35.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 121.525 1.966 . . . . 0.0 111.566 176.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.703 ' HG3' HD12 ' A' ' 21' ' ' LEU . 4.1 ptp -89.4 -0.12 57.25 Favored 'General case' 0 C--N 1.345 0.376 0 CA-C-N 120.183 1.356 . . . . 0.0 110.836 -179.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.874 HD13 ' HA ' ' A' ' 18' ' ' LYS . 8.3 mp -96.13 9.29 41.37 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 126.868 2.067 . . . . 0.0 109.909 -169.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -129.95 110.16 11.46 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 119.119 0.872 . . . . 0.0 108.887 -178.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -58.51 -22.91 56.69 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -175.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.6 m -75.53 -26.04 57.7 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.437 -0.789 . . . . 0.0 112.845 173.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 49.0 m170 -69.63 -49.46 53.66 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 161.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 158.04 179.85 33.22 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-O 122.332 0.962 . . . . 0.0 111.863 172.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 28.9 tp -81.57 138.17 35.43 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.64 1.176 . . . . 0.0 111.303 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -149.77 120.95 7.78 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.225 1.01 . . . . 0.0 109.634 163.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.32 125.43 47.01 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 124.415 1.086 . . . . 0.0 109.864 -178.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -62.66 93.25 0.05 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 126.382 1.873 . . . . 0.0 110.588 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -95.55 61.12 2.27 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.212 1.005 . . . . 0.0 108.463 176.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.85 -160.53 51.69 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-O 122.656 1.142 . . . . 0.0 110.946 174.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.406 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 57.9 mtm180 -128.83 167.91 16.65 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 121.628 -0.924 . . . . 0.0 110.82 -161.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.484 ' HA2' ' H ' ' A' ' 98' ' ' LEU . . . -177.43 175.47 47.61 Favored Glycine 0 C--N 1.336 0.556 0 O-C-N 121.348 -0.845 . . . . 0.0 114.01 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.1 p -142.89 156.86 44.99 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 124.965 1.306 . . . . 0.0 109.261 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 44.0 p -69.25 119.1 13.0 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 169.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.9 t -70.6 -44.18 77.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 173.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -58.25 123.27 15.48 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 126.142 1.777 . . . . 0.0 108.329 163.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.1 m -60.01 148.7 34.55 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 162.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -141.98 153.25 63.72 Favored Pre-proline 0 CA--C 1.541 0.61 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 165.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.487 ' HA ' ' HA3' ' A' ' 60' ' ' GLY . 45.2 Cg_endo -79.23 82.74 2.42 Favored 'Trans proline' 0 C--O 1.237 0.474 1 C-N-CA 125.58 4.187 . . . . 0.0 112.583 -178.799 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.98 122.99 26.27 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 1.053 HG11 HD13 ' A' ' 127' ' ' LEU . 0.1 OUTLIER -134.39 144.7 34.39 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 C-N-CA 123.2 0.6 . . . . 0.0 110.838 174.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.0 mt -88.7 76.34 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 126.226 1.811 . . . . 0.0 106.882 168.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -79.75 -172.96 3.58 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 168.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.81 142.12 4.98 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.502 1.049 . . . . 0.0 112.187 165.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -76.69 2.27 14.7 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.182 -1.187 . . . . 0.0 112.861 -173.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 29.1 m-70 -120.26 17.75 12.28 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.094 1.358 . . . . 0.0 111.41 169.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 52.53 70.12 0.61 Allowed 'General case' 0 C--N 1.341 0.202 0 C-N-CA 126.166 1.787 . . . . 0.0 108.736 -174.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 72.9 mt -104.98 86.57 1.55 Allowed Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 102.751 -3.055 . . . . 0.0 102.751 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 37.3 Cg_endo -66.64 144.47 72.38 Favored 'Trans proline' 0 N--CA 1.443 -1.473 0 CA-C-N 121.037 1.406 . . . . 0.0 110.762 175.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 72.3 m95 -112.43 -169.79 1.54 Allowed 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.939 1.296 . . . . 0.0 109.84 -175.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.2 tp -144.32 92.08 2.27 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 168.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.424 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 3.7 mt -71.78 122.21 20.29 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 -177.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -69.93 89.3 0.59 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.105 0.866 . . . . 0.0 110.561 -177.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.06 77.98 54.5 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 124.808 1.243 . . . . 0.0 108.357 176.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.16 121.28 9.4 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.451 2.101 . . . . 0.0 110.618 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.09 -1.38 51.15 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 126.444 1.973 . . . . 0.0 114.121 175.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -109.11 169.49 8.65 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 119.836 1.818 . . . . 0.0 109.835 172.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.487 ' HA3' ' HA ' ' A' ' 41' ' ' PRO . . . 88.69 -8.06 80.3 Favored Glycine 0 CA--C 1.533 1.165 0 N-CA-C 117.56 1.784 . . . . 0.0 117.56 155.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 75.54 167.39 0.28 Allowed 'General case' 0 C--N 1.322 -0.615 1 C-N-CA 134.818 5.247 . . . . 0.0 111.337 -172.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 76.3 m -69.09 170.81 9.27 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 120.988 -1.07 . . . . 0.0 110.607 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 43.0 t -134.78 104.32 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.9 p -72.46 155.79 39.73 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.62 -0.675 . . . . 0.0 109.706 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.56 -155.55 11.44 Favored Glycine 0 C--N 1.337 0.616 0 O-C-N 120.762 -1.211 . . . . 0.0 110.865 -175.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 43.0 mt-10 -144.07 171.22 14.57 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 127.694 2.397 . . . . 0.0 107.786 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 81.8 mt -118.16 139.75 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 120.593 1.542 . . . . 0.0 109.379 -171.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -134.42 125.43 27.48 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.732 0.777 . . . . 0.0 110.082 176.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -72.42 132.94 44.57 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 161.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.6 m -135.38 164.7 32.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 123.755 0.822 . . . . 0.0 110.025 -177.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -115.85 176.14 5.22 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 176.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.33 -37.53 80.93 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 118.99 -0.529 . . . . 0.0 110.121 -168.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 36.0 tp60 -57.82 -40.88 81.03 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.829 0.851 . . . . 0.0 112.152 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.451 ' HE1' ' HA ' ' A' ' 20' ' ' MET . 24.4 tpp -69.02 -48.82 62.04 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.5 tp -58.77 -32.85 69.67 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.1 mtt180 -74.64 -33.98 62.65 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.171 -0.956 . . . . 0.0 112.174 177.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -75.95 -49.11 18.67 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.532 0.733 . . . . 0.0 110.121 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.6 mp -55.89 -41.43 74.46 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -177.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -44.87 -47.83 11.13 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.973 1.709 . . . . 0.0 111.234 174.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -71.47 -40.04 70.52 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.068 0.947 . . . . 0.0 111.911 176.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -65.45 -33.19 75.35 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.685 1.194 . . . . 0.0 110.534 -170.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -101.41 20.06 16.65 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 124.72 1.208 . . . . 0.0 113.291 174.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.1 t70 54.04 17.16 1.31 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.314 1.446 . . . . 0.0 112.776 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 16.2 t -61.99 145.38 92.99 Favored Pre-proline 0 N--CA 1.447 -0.58 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 177.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -80.69 -2.53 43.13 Favored 'Cis proline' 0 CA--C 1.54 0.815 0 N-CA-C 116.15 1.558 . . . . 0.0 116.15 0.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.4 m -63.4 -61.34 2.41 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 120.042 1.292 . . . . 0.0 112.572 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 12.3 mtp -83.12 -76.02 0.29 Allowed 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -177.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -85.34 169.83 13.34 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 176.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -146.18 126.6 14.05 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.858 1.663 . . . . 0.0 106.547 176.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -67.2 131.62 46.15 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.353 1.061 . . . . 0.0 110.048 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.7 m -128.82 177.1 7.32 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.604 1.962 . . . . 0.0 107.681 174.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -116.5 146.24 42.73 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.379 1.471 . . . . 0.0 110.053 167.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.34 178.76 7.36 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.556 1.942 . . . . 0.0 111.771 175.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 37.2 tp60 -109.73 115.89 30.69 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.933 1.693 . . . . 0.0 110.683 -178.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 70.5 t -108.99 145.74 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.57 1.148 . . . . 0.0 108.487 -177.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -85.4 142.74 29.06 Favored 'General case' 0 C--N 1.341 0.206 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 169.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.593 ' CG1' ' HA ' ' A' ' 108' ' ' ASP . 1.9 p -89.82 103.08 13.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 124.978 1.311 . . . . 0.0 109.029 172.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.484 ' H ' ' HA2' ' A' ' 34' ' ' GLY . 0.3 OUTLIER -72.69 -22.0 60.97 Favored 'General case' 0 C--N 1.331 -0.206 0 O-C-N 120.708 -1.245 . . . . 0.0 111.537 172.281 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -160.17 153.39 21.94 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 119.99 1.268 . . . . 0.0 108.437 177.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 48.5 t-105 -136.85 120.84 17.64 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.296 0.638 . . . . 0.0 109.713 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -108.24 99.56 8.96 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 125.269 1.427 . . . . 0.0 110.995 -177.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.69 -173.32 19.26 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 124.432 1.015 . . . . 0.0 110.936 174.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -67.06 171.12 5.87 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.104 0.562 . . . . 0.0 110.832 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.47 57.48 1.75 Allowed Glycine 0 C--O 1.22 -0.743 0 C-N-CA 125.154 1.359 . . . . 0.0 112.179 174.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -100.6 89.65 1.25 Allowed Pre-proline 0 N--CA 1.471 0.598 0 C-N-CA 126.984 2.114 . . . . 0.0 109.272 -167.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -57.93 -27.25 78.13 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.493 2.796 . . . . 0.0 113.514 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 126.3 -176.52 17.5 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 -161.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.593 ' HA ' ' CG1' ' A' ' 97' ' ' VAL . 36.7 t70 -81.44 4.92 19.25 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -173.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.8 p -137.33 156.23 48.48 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 118.802 -1.159 . . . . 0.0 110.783 156.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.2 p -130.92 152.74 38.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 124.305 1.042 . . . . 0.0 111.021 173.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -86.72 128.27 35.01 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.535 1.534 . . . . 0.0 108.216 170.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -137.06 167.95 20.54 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 127.158 2.183 . . . . 0.0 110.596 178.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -102.42 142.36 33.75 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 173.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 40.4 t -138.08 144.63 30.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 177.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -78.17 125.82 29.9 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 173.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 71.7 p -120.39 -173.96 2.69 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.965 1.306 . . . . 0.0 107.87 177.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.8 t -145.86 139.2 26.15 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 162.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -105.36 -8.25 18.31 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.439 0.695 . . . . 0.0 110.729 174.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 44.2 p -86.49 14.57 6.58 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.025 1.33 . . . . 0.0 113.251 -166.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -57.44 134.76 56.33 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.137 1.375 . . . . 0.0 113.343 -162.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.16 147.13 98.76 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.27 172.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.5 -27.28 46.56 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 121.753 1.635 . . . . 0.0 113.15 -174.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -50.57 -35.28 29.19 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.339 1.056 . . . . 0.0 111.141 171.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 0.617 ' O ' HD11 ' A' ' 127' ' ' LEU . 35.8 m0 -82.66 12.73 4.36 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.542 0.61 . . . . 0.0 111.948 -173.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -91.19 -26.09 19.22 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 120.403 1.456 . . . . 0.0 111.506 163.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -89.16 -25.72 21.67 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 120.123 1.329 . . . . 0.0 112.297 -169.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 1.053 HD13 HG11 ' A' ' 43' ' ' VAL 0.459 0.2 OUTLIER -45.43 161.39 0.24 Allowed Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 126.666 1.987 . . . . 0.0 115.178 173.058 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -90.39 142.45 3.58 Favored 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 124.171 3.248 . . . . 0.0 108.557 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.45 ' CD2' ' HA2' ' A' ' 60' ' ' GLY . 9.3 m-30 -98.16 -177.96 3.9 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 124.198 0.999 . . . . 0.0 109.241 -169.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 46.4 m-70 -136.52 -178.69 5.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.608 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -134.24 -15.32 2.24 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 122.96 1.362 . . . . 0.0 111.908 170.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 29.7 p -144.96 153.2 41.27 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 161.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -92.03 157.45 16.77 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 167.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -170.41 139.15 1.63 Allowed 'General case' 0 C--O 1.241 0.607 0 CA-C-N 119.74 1.155 . . . . 0.0 108.989 166.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 66.6 m -81.18 -19.26 43.73 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.245 -0.91 . . . . 0.0 111.164 170.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -88.61 -11.77 44.5 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 120.374 1.443 . . . . 0.0 111.606 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.99 163.49 20.31 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.714 1.149 . . . . 0.0 112.019 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -71.82 -1.35 9.77 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 124.136 3.224 . . . . 0.0 113.637 -176.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -51.38 -29.79 16.78 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 126.425 1.89 . . . . 0.0 115.006 -169.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 74.35 -26.17 1.06 Allowed Glycine 0 CA--C 1.528 0.869 0 CA-C-O 118.458 -1.19 . . . . 0.0 112.963 -177.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.71 120.74 38.65 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 126.162 1.785 . . . . 0.0 109.206 167.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -136.23 162.54 32.68 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 126.475 1.91 . . . . 0.0 109.511 178.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -62.4 119.09 8.44 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -119.92 74.56 19.83 Favored Pre-proline 0 N--CA 1.452 -0.336 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -171.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -67.69 -54.97 0.3 Allowed 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 123.047 2.498 . . . . 0.0 111.837 -173.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -157.94 13.5 0.21 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -174.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.05 -3.44 35.86 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 128.385 2.674 . . . . 0.0 113.239 -178.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 19.5 p30 -136.89 -14.96 1.57 Allowed 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 26.9 mmm-85 . . . . . 0 C--O 1.247 0.967 0 C-N-CA 126.775 2.03 . . . . 0.0 112.134 168.771 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.44 ' HA ' ' OE2' ' A' ' 69' ' ' GLU . 42.9 mtt . . . . . 0 N--CA 1.47 0.545 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.02 97.04 2.64 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 127.071 2.148 . . . . 0.0 105.325 -177.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -65.98 123.68 20.5 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -176.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.446 HG22 ' HB2' ' A' ' 113' ' ' PHE . 18.5 pt -119.13 170.63 8.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 124.418 1.087 . . . . 0.0 108.609 173.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -135.99 141.78 44.44 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.572 HG12 ' H ' ' A' ' 66' ' ' GLU . 2.7 p -97.55 137.93 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -173.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -92.47 -46.63 7.55 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.488 1.515 . . . . 0.0 110.183 -178.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -159.09 6.6 0.14 Allowed Glycine 0 C--N 1.344 0.98 0 CA-C-O 116.909 -2.051 . . . . 0.0 117.821 -168.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.478 ' HA ' ' HG3' ' A' ' 14' ' ' GLN . 1.1 p -131.16 -16.7 3.13 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 120.961 2.38 . . . . 0.0 115.995 -161.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.9 mp -140.04 71.17 1.37 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 120.582 1.537 . . . . 0.0 107.915 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.44 -85.46 0.07 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 118.591 -0.719 . . . . 0.0 112.005 -176.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -64.04 -67.42 0.43 Allowed 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.607 1.094 . . . . 0.0 110.152 -177.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 166.21 88.56 0.07 OUTLIER Glycine 0 N--CA 1.429 -1.789 0 N-CA-C 105.607 -2.997 . . . . 0.0 105.607 172.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.478 ' HG3' ' HA ' ' A' ' 9' ' ' THR . 0.3 OUTLIER -129.41 165.34 33.41 Favored Pre-proline 0 N--CA 1.443 -0.79 0 CA-C-O 117.578 -1.201 . . . . 0.0 108.485 -176.321 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -81.66 61.77 8.07 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.04 1.827 . . . . 0.0 113.973 -159.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.517 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -175.21 -5.75 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 129.264 3.026 . . . . 0.0 110.65 -178.061 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 18.5 t-160 -65.8 -46.15 79.75 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 121.839 2.109 . . . . 0.0 110.598 -177.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.407 ' HA ' HD12 ' A' ' 21' ' ' LEU . 0.6 OUTLIER -53.17 -27.35 20.99 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -172.465 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 16' ' ' ASN . 21.1 m -52.69 -42.79 42.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 119.383 0.992 . . . . 0.0 111.467 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.6 ptp -82.44 8.38 11.69 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 120.935 -1.103 . . . . 0.0 112.79 -174.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 18' ' ' LYS . 20.7 mt -118.75 1.63 11.6 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.645 1.578 . . . . 0.0 110.666 -172.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -125.39 4.98 7.68 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.432 1.493 . . . . 0.0 114.264 -171.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . 0.271 9.5 t-80 42.17 26.45 0.06 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.877 2.471 . . . . 0.0 114.753 177.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.23 -32.51 10.48 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.36 1.064 . . . . 0.0 110.357 175.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -80.05 -35.34 37.3 Favored 'General case' 0 N--CA 1.456 -0.16 0 O-C-N 121.102 -0.999 . . . . 0.0 110.094 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 159.49 -174.56 36.38 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 -175.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -98.65 131.66 44.66 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.277 1.031 . . . . 0.0 109.116 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -132.85 156.87 46.37 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.499 1.52 . . . . 0.0 109.276 159.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -141.02 139.15 34.1 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 168.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -61.38 104.54 0.41 Allowed 'General case' 0 C--O 1.233 0.23 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 169.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.2 tpp180 -114.33 65.23 0.67 Allowed 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 -175.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.87 176.23 49.29 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-O 121.965 0.758 . . . . 0.0 111.814 -176.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -120.57 171.85 8.26 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.621 0.768 . . . . 0.0 109.69 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -177.96 178.85 48.53 Favored Glycine 0 C--N 1.333 0.403 0 O-C-N 121.086 -1.008 . . . . 0.0 114.346 -177.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.4 p -146.42 163.93 34.08 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.294 1.838 . . . . 0.0 108.527 172.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 49.9 p -86.91 103.69 15.54 Favored 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 168.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.414 HG22 ' H ' ' A' ' 37' ' ' VAL . 0.2 OUTLIER -63.75 -22.33 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 121.774 0.797 . . . . 0.0 111.636 171.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.68 116.44 6.24 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.764 0.792 . . . . 0.0 109.281 159.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.07 129.62 38.73 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.169 1.388 . . . . 0.0 108.219 164.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -138.96 158.35 69.92 Favored Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.15 81.74 2.37 Favored 'Trans proline' 0 N--CA 1.454 -0.85 1 C-N-CA 125.469 4.112 . . . . 0.0 109.165 172.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -80.37 110.94 16.3 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 162.381 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.4 m -127.88 127.92 68.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 118.818 0.736 . . . . 0.0 109.891 -173.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.5 mt -85.05 105.49 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 177.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.454 ' HB2' ' CD1' ' A' ' 127' ' ' LEU . . . -138.37 130.9 29.12 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 124.517 1.127 . . . . 0.0 109.464 -173.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.23 166.84 27.81 Favored Glycine 0 CA--C 1.53 1.004 0 CA-C-O 122.062 0.812 . . . . 0.0 112.629 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -93.28 -6.09 48.27 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 125.959 1.704 . . . . 0.0 113.569 -145.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -121.42 16.78 11.35 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.528 1.131 . . . . 0.0 110.811 177.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.2 m120 60.44 56.79 3.03 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.422 1.489 . . . . 0.0 109.183 175.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 61.0 mt -104.56 87.14 1.62 Allowed Pre-proline 0 C--N 1.322 -0.608 0 C-N-CA 130.128 3.371 . . . . 0.0 103.708 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -63.23 160.4 34.95 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 CA-C-N 120.721 1.293 . . . . 0.0 110.305 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 68.1 m95 -127.4 138.08 52.91 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.449 HD13 HG22 ' A' ' 116' ' ' THR . 0.0 OUTLIER -112.27 98.22 7.16 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 179.334 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.7 mt -80.54 147.79 30.66 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -172.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -83.39 81.31 8.77 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.02 -1.05 . . . . 0.0 109.75 -173.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.6 84.9 32.4 Favored Pre-proline 0 N--CA 1.467 0.424 0 C-N-CA 123.105 0.562 . . . . 0.0 110.03 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -63.46 136.17 53.4 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 121.468 1.445 . . . . 0.0 109.017 178.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.06 13.59 80.79 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 118.597 -1.113 . . . . 0.0 113.635 176.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -127.14 125.61 41.47 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 120.603 2.202 . . . . 0.0 106.538 172.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.28 -140.52 15.09 Favored Glycine 0 N--CA 1.463 0.471 0 CA-C-N 121.13 1.787 . . . . 0.0 111.974 -178.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 46.1 m-70 -133.89 160.99 35.99 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 117.715 0.758 . . . . 0.0 111.649 -166.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 63.2 m -72.45 117.21 13.83 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.166 1.387 . . . . 0.0 109.766 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 44.2 t -85.33 110.58 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.737 1.215 . . . . 0.0 108.671 -174.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 70.7 p -77.3 147.39 36.26 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.923 -1.111 . . . . 0.0 109.803 176.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.77 -150.35 6.25 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 -176.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.572 ' H ' HG12 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -148.49 160.97 42.54 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 126.102 1.761 . . . . 0.0 108.203 170.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 98.5 mt -102.25 134.16 43.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 -171.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -125.93 119.2 27.14 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.44 ' OE2' ' HA ' ' A' ' 1' ' ' MET . 0.7 OUTLIER -75.1 118.08 17.65 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 104.419 -2.437 . . . . 0.0 104.419 160.198 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.4 m -123.21 150.45 27.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 124.317 1.047 . . . . 0.0 108.72 -176.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -92.75 165.68 12.82 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 175.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -51.96 -29.99 22.91 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 126.595 1.958 . . . . 0.0 113.446 -174.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 12.0 tp60 -68.15 -42.44 80.08 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 122.244 -0.285 . . . . 0.0 110.701 178.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.2 ttm -71.78 -46.53 58.03 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 118.663 -0.684 . . . . 0.0 109.453 178.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.62 -26.04 67.74 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 119.916 -0.714 . . . . 0.0 111.39 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 36.6 mtm180 -73.84 -47.84 35.54 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 117.646 -1.169 . . . . 0.0 111.923 171.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -55.72 -47.45 76.85 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.607 1.094 . . . . 0.0 110.515 176.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.6 mp -61.45 -17.82 56.15 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.101 0.961 . . . . 0.0 113.122 176.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -84.5 -5.56 59.3 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.758 1.623 . . . . 0.0 111.972 176.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -125.25 -34.6 2.71 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.428 1.891 . . . . 0.0 111.028 -172.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -58.54 -46.88 85.89 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.582 1.553 . . . . 0.0 111.616 176.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -83.68 4.39 28.81 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 124.887 1.275 . . . . 0.0 112.367 -172.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.1 t0 44.98 25.51 0.16 Allowed 'General case' 0 C--O 1.24 0.554 0 C-N-CA 127.048 2.139 . . . . 0.0 115.497 -164.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 1.6 p -56.96 154.92 17.0 Favored Pre-proline 0 CA--C 1.545 0.776 0 O-C-N 119.592 -1.942 . . . . 0.0 108.56 158.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -74.15 -4.46 18.04 Favored 'Cis proline' 0 CA--C 1.544 0.978 0 N-CA-C 114.541 0.939 . . . . 0.0 114.541 -4.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 10.1 t -62.36 -68.84 0.29 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.506 1.048 . . . . 0.0 110.594 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 28.6 mtp -72.88 -64.57 0.94 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.854 0.862 . . . . 0.0 110.377 -171.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -105.01 176.84 5.03 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.031 0.932 . . . . 0.0 109.084 176.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -139.68 139.28 36.59 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 167.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -78.79 130.08 35.33 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.092 -1.005 . . . . 0.0 108.324 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 86.2 m -135.5 162.83 31.54 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -176.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -98.15 132.58 43.56 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.408 1.083 . . . . 0.0 108.466 173.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.54 HD21 HG23 ' A' ' 114' ' ' VAL . 2.4 pt? -149.42 -176.19 5.29 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.801 1.64 . . . . 0.0 111.892 -171.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 -105.09 135.36 46.58 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -175.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 84.8 t -134.68 128.77 51.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -69.61 121.42 17.08 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 104.188 -2.523 . . . . 0.0 104.188 163.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.49 ' CG1' ' HA ' ' A' ' 108' ' ' ASP . 14.8 p -63.02 119.47 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 156.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.1 -31.99 21.59 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 120.681 -1.262 . . . . 0.0 108.946 170.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -158.35 147.34 19.11 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 104.424 -2.436 . . . . 0.0 104.424 -175.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 66.2 t-105 -124.68 141.32 52.19 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -104.31 104.62 14.54 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.151 0.98 . . . . 0.0 108.687 173.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.28 -164.14 13.63 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-O 122.568 1.093 . . . . 0.0 114.162 165.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -78.36 161.04 27.47 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 114.509 -0.846 . . . . 0.0 109.325 177.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 82.86 64.38 1.68 Allowed Glycine 0 C--O 1.223 -0.59 0 C-N-CA 124.662 1.125 . . . . 0.0 110.866 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -102.0 89.25 1.52 Allowed Pre-proline 0 C--O 1.237 0.408 0 C-N-CA 129.98 3.312 . . . . 0.0 108.592 -166.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -66.18 -1.14 4.91 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 124.652 3.568 . . . . 0.0 114.495 -168.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.2 172.27 46.95 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-N 120.226 1.376 . . . . 0.0 110.062 -170.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.49 ' HA ' ' CG1' ' A' ' 97' ' ' VAL . 1.6 m-20 -70.91 -1.29 11.35 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -158.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 92.1 p -133.59 142.22 48.03 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 118.427 -1.309 . . . . 0.0 110.726 150.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.9 p -106.71 153.74 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 C-N-CA 125.806 1.642 . . . . 0.0 107.92 175.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 3.8 tm0? -89.8 112.4 23.71 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 161.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 48.4 m -102.9 175.96 5.31 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.854 0.862 . . . . 0.0 109.046 169.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.446 ' HB2' HG22 ' A' ' 4' ' ' ILE . 66.2 m-85 -93.81 144.67 25.21 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 156.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.54 HG23 HD21 ' A' ' 93' ' ' LEU . 25.0 t -136.05 150.3 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 127.656 2.382 . . . . 0.0 105.878 173.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -88.4 119.84 29.21 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 171.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.449 HG22 HD13 ' A' ' 53' ' ' LEU . 43.2 p -124.12 -169.19 1.92 Allowed 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.983 1.313 . . . . 0.0 108.533 -178.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.04 146.59 31.95 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 169.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -112.93 -9.0 13.66 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.882 1.673 . . . . 0.0 111.274 169.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 11.2 t -98.95 16.63 21.88 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.237 1.415 . . . . 0.0 112.418 -169.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -60.92 154.63 21.8 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 125.137 1.375 . . . . 0.0 113.344 -172.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.27 156.51 91.64 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 125.631 1.572 . . . . 0.0 110.088 171.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -70.14 -36.78 9.2 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 121.764 1.643 . . . . 0.0 112.584 177.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -52.3 -33.89 44.38 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 119.283 0.947 . . . . 0.0 112.693 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 38.6 m0 -74.59 -7.09 52.04 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.68 0.792 . . . . 0.0 112.054 -174.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 60.6 mt -78.69 -26.69 44.95 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 121.238 -0.913 . . . . 0.0 111.838 171.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -92.1 -16.09 26.85 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.347 0.659 . . . . 0.0 111.8 -175.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.454 ' CD1' ' HB2' ' A' ' 45' ' ' ALA . 48.4 mt -57.92 157.69 14.89 Favored Pre-proline 0 N--CA 1.465 0.293 0 C-N-CA 125.489 1.516 . . . . 0.0 111.787 -178.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -63.69 157.74 50.07 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.981 2.454 . . . . 0.0 110.113 172.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -111.49 158.95 18.55 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -139.05 148.4 43.31 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.398 0.279 . . . . 0.0 110.656 -177.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -87.13 -5.66 58.93 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.31 1.444 . . . . 0.0 112.175 176.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.6 t -167.69 170.88 10.6 Favored 'General case' 0 C--O 1.237 0.412 0 O-C-N 120.176 -1.577 . . . . 0.0 108.408 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -123.54 92.38 3.67 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 165.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -99.28 97.27 8.36 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 128.512 2.725 . . . . 0.0 108.486 -172.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 7.1 t -65.24 7.74 0.18 Allowed 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.622 -1.299 . . . . 0.0 113.575 177.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -127.57 13.33 6.99 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.453 1.501 . . . . 0.0 110.45 -167.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -96.13 179.83 35.3 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 125.963 1.744 . . . . 0.0 112.52 -176.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -75.91 -3.55 14.0 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 124.201 3.267 . . . . 0.0 112.754 172.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -64.87 -24.28 67.49 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 119.462 1.028 . . . . 0.0 113.512 -167.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 79.72 -39.4 2.18 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 125.227 1.394 . . . . 0.0 113.659 172.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.71 100.87 4.81 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.542 1.937 . . . . 0.0 110.133 168.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -122.26 162.85 20.69 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 125.525 1.53 . . . . 0.0 109.502 171.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -63.26 127.98 33.75 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -176.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -119.24 76.95 17.05 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 123.608 0.763 . . . . 0.0 109.171 -177.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -76.27 -42.98 0.33 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.56 2.84 . . . . 0.0 113.381 178.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 5.9 ttt180 -135.79 -1.72 2.45 Favored 'General case' 0 CA--C 1.514 -0.427 0 O-C-N 121.541 -0.725 . . . . 0.0 112.709 -172.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -67.32 -34.4 77.28 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 127.103 2.161 . . . . 0.0 108.354 -171.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -132.11 29.73 4.33 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.553 2.341 . . . . 0.0 110.86 169.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 51.8 mmt-85 . . . . . 0 C--O 1.247 0.968 0 C-N-CA 125.314 1.446 . . . . 0.0 111.859 -172.369 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.442 ' HG2' ' H ' ' A' ' 2' ' ' ALA . 8.1 ttt . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.442 ' H ' ' HG2' ' A' ' 1' ' ' MET . . . 45.34 -153.88 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -160.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 71.2 m80 69.95 121.67 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 128.082 2.553 . . . . 0.0 107.392 -157.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.6 pt -87.78 -179.43 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 167.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -129.59 140.84 51.09 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 165.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.4 p -106.1 118.05 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 -178.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -70.86 -63.77 1.03 Allowed 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 172.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.5 -21.23 0.11 Allowed Glycine 0 CA--C 1.526 0.747 0 O-C-N 120.933 -1.105 . . . . 0.0 114.449 -165.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.85 -28.52 22.83 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 -159.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.15 55.38 1.86 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 106.822 -1.548 . . . . 0.0 106.822 -174.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -160.03 -63.74 0.07 Allowed 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 124.459 1.103 . . . . 0.0 109.743 -173.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -72.31 -86.31 0.03 OUTLIER 'General case' 0 C--N 1.339 0.14 0 C-N-CA 123.975 0.91 . . . . 0.0 108.575 -168.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -161.16 17.79 0.19 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -62.55 148.27 90.94 Favored Pre-proline 0 C--O 1.238 0.49 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 173.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -64.54 -20.36 65.7 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 123.797 2.998 . . . . 0.0 112.922 -169.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.613 ' O ' HG22 ' A' ' 19' ' ' VAL . 47.0 m-80 -84.64 -16.13 43.04 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 117.919 -1.038 . . . . 0.0 112.649 -161.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -48.86 -34.39 12.49 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.134 0.974 . . . . 0.0 111.183 -173.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.66 -30.54 5.57 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 178.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.613 HG22 ' O ' ' A' ' 16' ' ' ASN . 5.5 m -62.37 -23.36 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 120.148 1.34 . . . . 0.0 112.293 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.24 -10.96 53.61 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 119.788 1.176 . . . . 0.0 111.634 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 21.7 mt -94.27 -38.96 10.76 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 -173.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -75.24 83.77 2.4 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 176.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -49.15 -26.76 3.0 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.002 1.721 . . . . 0.0 114.246 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.52 -36.01 63.78 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.459 1.504 . . . . 0.0 111.379 173.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 45.5 m170 -68.51 -47.35 67.2 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.255 1.022 . . . . 0.0 109.439 171.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 167.19 178.12 39.29 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 174.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 64.4 tp -84.3 139.21 32.46 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 122.218 -0.578 . . . . 0.0 111.457 -176.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -142.29 157.95 44.26 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.018 1.327 . . . . 0.0 109.299 160.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -169.43 147.57 3.65 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 131.46 3.904 . . . . 0.0 108.258 178.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -72.61 106.75 4.77 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.797 1.639 . . . . 0.0 111.094 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.9 tpp180 -107.71 66.43 0.66 Allowed 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 177.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.47 -170.51 55.05 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-O 123.518 1.621 . . . . 0.0 113.266 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 77.8 mtm180 -122.52 165.37 16.52 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 125.064 1.345 . . . . 0.0 110.042 -171.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -168.82 177.57 42.6 Favored Glycine 0 C--N 1.334 0.45 0 O-C-N 121.583 -0.698 . . . . 0.0 112.994 173.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 30.2 p -148.43 153.27 38.3 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.219 1.808 . . . . 0.0 107.696 178.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.1 p -82.18 111.16 18.03 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 121.453 1.933 . . . . 0.0 107.154 173.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -76.02 -29.72 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 O-C-N 121.945 -0.472 . . . . 0.0 111.009 170.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -60.72 113.82 2.68 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 154.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 29.2 m -66.09 144.11 56.9 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 168.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.638 ' HB3' HD21 ' A' ' 53' ' ' LEU . 24.3 m-85 -145.46 154.86 53.43 Favored Pre-proline 0 CA--C 1.547 0.853 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -173.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.446 ' HG2' ' HB2' ' A' ' 54' ' ' LEU . 82.0 Cg_endo -84.24 103.79 0.99 Allowed 'Trans proline' 0 CA--C 1.544 1.016 1 C-N-CA 126.224 4.616 . . . . 0.0 115.194 -172.433 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.417 ' HB2' ' HE1' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -105.87 103.23 12.68 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 120.489 -1.382 . . . . 0.0 107.721 179.814 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.1 m -124.97 127.83 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 127.007 2.123 . . . . 0.0 112.543 -174.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.423 HG21 HD12 ' A' ' 141' ' ' LEU . 9.0 mt -93.68 93.84 4.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -172.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.44 -179.54 4.52 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.906 1.282 . . . . 0.0 109.475 172.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.59 144.06 6.41 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.459 1.028 . . . . 0.0 111.914 164.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -72.35 -12.33 61.08 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -172.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 41.6 m-70 -106.4 13.81 28.09 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.325 1.05 . . . . 0.0 111.414 172.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.2 m120 58.32 73.6 0.47 Allowed 'General case' 0 C--N 1.341 0.227 0 C-N-CA 127.147 2.179 . . . . 0.0 108.83 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 64.1 mt -110.02 86.76 5.22 Favored Pre-proline 0 N--CA 1.449 -0.516 0 C-N-CA 125.112 1.365 . . . . 0.0 107.834 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -59.58 126.63 21.16 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.44 1.426 . . . . 0.0 111.879 171.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 67.2 m95 -104.81 126.21 51.66 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 128.239 2.615 . . . . 0.0 108.19 173.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.638 HD21 ' HB3' ' A' ' 40' ' ' PHE . 1.2 tm? -92.08 124.38 36.13 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 168.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.446 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 0.3 OUTLIER -95.47 149.13 21.75 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -179.809 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -76.55 89.99 3.31 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.81 82.91 19.85 Favored Pre-proline 0 N--CA 1.467 0.392 0 O-C-N 120.901 -1.125 . . . . 0.0 110.229 172.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -61.88 134.73 51.61 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 122.236 1.957 . . . . 0.0 109.568 -177.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.94 -1.31 84.97 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-O 117.027 -1.985 . . . . 0.0 114.337 175.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.5 tppt? -128.11 136.26 50.92 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 121.084 2.442 . . . . 0.0 107.243 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 120.51 -113.08 2.31 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 107.378 -2.289 . . . . 0.0 107.378 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.477 ' HB2' ' HG3' ' A' ' 131' ' ' GLU . 2.6 p80 -160.88 172.36 17.1 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.79 1.636 . . . . 0.0 108.785 173.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 41.9 m -73.61 103.27 4.15 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.187 0.995 . . . . 0.0 111.173 170.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.7 t -78.07 107.82 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.733 1.213 . . . . 0.0 111.281 177.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.9 p -65.66 153.46 41.59 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.201 0.6 . . . . 0.0 111.163 177.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -173.58 -157.55 15.53 Favored Glycine 0 C--N 1.343 0.938 0 O-C-N 121.286 -0.884 . . . . 0.0 112.941 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -145.0 167.0 23.7 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.838 1.655 . . . . 0.0 109.569 174.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 71.0 mt -113.69 126.8 71.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 -172.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -117.56 115.52 25.3 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -67.79 81.62 0.19 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.121 1.368 . . . . 0.0 109.049 169.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.2 m -82.6 155.7 3.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 O-C-N 121.047 -1.033 . . . . 0.0 109.088 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.11 -178.8 4.9 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 121.921 0.867 . . . . 0.0 111.544 175.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.86 -45.02 93.78 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.979 1.312 . . . . 0.0 111.452 174.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 42.4 tp60 -59.86 -41.51 91.62 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 119.297 0.953 . . . . 0.0 110.139 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 59.3 tpp -65.88 -51.8 55.64 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 118.596 0.634 . . . . 0.0 110.584 176.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.23 -26.13 66.17 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -76.68 -55.04 5.86 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 123.951 0.9 . . . . 0.0 109.732 171.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -52.68 -48.8 66.29 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.152 0.581 . . . . 0.0 111.255 -177.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 87.7 mt -62.39 -27.04 68.8 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 118.968 -0.539 . . . . 0.0 111.526 -178.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -67.39 -33.39 75.1 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.993 1.27 . . . . 0.0 109.587 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -75.9 -51.04 13.34 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.65 0.78 . . . . 0.0 110.701 172.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -66.17 -27.48 68.04 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.543 0.737 . . . . 0.0 112.572 -174.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.438 ' HG3' ' CE2' ' A' ' 115' ' ' TYR . 63.3 mm-40 -100.46 15.3 28.34 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.851 0.86 . . . . 0.0 111.093 177.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 52.23 28.09 5.29 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.458 1.903 . . . . 0.0 113.028 163.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 7.5 p -72.54 163.35 68.46 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 120.508 -1.37 . . . . 0.0 109.091 172.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -70.48 -4.01 9.07 Favored 'Cis proline' 0 CA--C 1.547 1.125 0 CA-C-N 119.99 1.032 . . . . 0.0 114.458 -10.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.1 m -60.1 -63.07 1.43 Allowed 'General case' 0 C--N 1.342 0.273 0 CA-C-N 119.561 1.073 . . . . 0.0 110.509 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 1.4 mtm -74.08 -77.69 0.11 Allowed 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.033 0.933 . . . . 0.0 109.683 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -97.83 -178.47 4.11 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.643 1.177 . . . . 0.0 108.934 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -138.13 -7.01 1.59 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 175.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? 61.28 134.22 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 128.459 2.704 . . . . 0.0 111.962 -173.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.9 m -152.73 153.76 33.86 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 120.463 -1.398 . . . . 0.0 110.501 174.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -84.62 126.93 33.78 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 129.137 2.975 . . . . 0.0 112.785 171.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.687 HD21 ' HB ' ' A' ' 114' ' ' VAL . 2.3 pt? -160.29 170.01 21.98 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 126.748 2.019 . . . . 0.0 112.182 -166.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 11.6 tp60 -94.5 131.35 40.3 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -162.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 35.5 t -135.3 119.79 27.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 -177.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -67.48 143.16 56.35 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 168.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.597 ' CG1' ' HA ' ' A' ' 108' ' ' ASP . 2.4 p -90.79 126.13 43.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 176.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.53 -14.62 24.88 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 121.45 -0.782 . . . . 0.0 111.665 177.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -176.03 140.34 0.41 Allowed 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 103.582 -2.747 . . . . 0.0 103.582 -175.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 62.5 t-105 -125.47 139.34 53.71 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 171.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -109.44 114.26 27.76 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 123.848 0.718 . . . . 0.0 109.937 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.11 -165.02 42.9 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-O 121.65 0.583 . . . . 0.0 112.102 169.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -64.61 167.34 7.36 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.591 1.156 . . . . 0.0 111.481 -175.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.21 59.24 3.16 Favored Glycine 0 CA--C 1.525 0.688 0 O-C-N 121.931 -0.481 . . . . 0.0 112.267 173.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -101.71 89.15 1.4 Allowed Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 130.626 3.57 . . . . 0.0 110.656 -168.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -60.93 -14.47 32.94 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 124.081 3.187 . . . . 0.0 114.286 -171.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 95.07 176.19 37.84 Favored Glycine 0 CA--C 1.531 1.081 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -165.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.597 ' HA ' ' CG1' ' A' ' 97' ' ' VAL . 10.6 m-20 -69.82 0.91 4.95 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -162.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 61.8 p -137.74 146.66 43.94 Favored 'General case' 0 N--CA 1.427 -1.588 0 C-N-CA 117.124 -1.83 . . . . 0.0 111.725 150.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.1 p -110.27 159.68 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 114.29 -1.323 . . . . 0.0 109.059 173.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -89.37 112.96 24.2 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 156.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 14.1 m -99.89 171.48 7.83 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 165.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.428 ' CE2' ' HA ' ' A' ' 2' ' ' ALA . 19.6 m-85 -90.84 142.5 27.7 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 161.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.687 ' HB ' HD21 ' A' ' 93' ' ' LEU . 53.2 t -129.94 143.73 40.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 172.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.438 ' CE2' ' HG3' ' A' ' 82' ' ' GLU . 8.9 m-85 -70.53 95.78 1.11 Allowed 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 167.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 80.5 p -109.42 173.39 6.34 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.948 171.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.7 t -142.19 121.9 13.44 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 104.321 -2.474 . . . . 0.0 104.321 175.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -93.0 4.78 53.42 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.359 0.664 . . . . 0.0 111.476 -178.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 47.3 p -118.83 43.56 2.52 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.085 1.354 . . . . 0.0 107.875 -171.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.407 ' HB3' HD12 ' A' ' 54' ' ' LEU . 40.2 p90 -78.48 171.15 15.52 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.477 -174.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -101.87 151.11 37.91 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 123.839 0.856 . . . . 0.0 110.272 -177.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -66.08 -37.35 25.96 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.916 2.411 . . . . 0.0 110.93 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.94 -0.66 9.73 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.81 1.644 . . . . 0.0 113.172 175.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 44.8 m0 -98.95 -24.72 14.83 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 118.882 0.765 . . . . 0.0 109.491 168.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 12.2 mt -75.89 -30.56 58.86 Favored 'General case' 0 CA--C 1.523 -0.064 0 O-C-N 120.94 -1.1 . . . . 0.0 111.554 177.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -64.25 -24.99 67.86 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.987 0.812 . . . . 0.0 111.965 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.0 mt -64.91 150.99 94.15 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 124.78 1.232 . . . . 0.0 110.429 -172.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -65.52 156.79 61.75 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.932 2.421 . . . . 0.0 110.441 175.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -106.62 159.32 16.28 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.628 0.251 . . . . 0.0 110.497 -172.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -134.06 106.23 7.11 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.754 0.822 . . . . 0.0 111.948 -174.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.477 ' HG3' ' HB2' ' A' ' 61' ' ' HIS . 0.5 OUTLIER -58.33 -13.59 5.58 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.794 1.638 . . . . 0.0 114.173 -174.02 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 56.8 p -150.4 176.46 10.9 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.293 1.837 . . . . 0.0 107.071 173.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -129.16 166.19 19.82 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 168.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -158.11 164.63 36.45 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.218 1.807 . . . . 0.0 109.688 -175.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.3 t -109.32 -3.38 17.19 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.79 1.636 . . . . 0.0 111.061 167.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -140.14 102.72 4.44 Favored 'General case' 0 N--CA 1.436 -1.141 0 C-N-CA 128.642 2.777 . . . . 0.0 105.643 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -161.48 165.31 35.49 Favored Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 126.983 2.23 . . . . 0.0 111.836 -173.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.32 -18.78 55.87 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.286 2.657 . . . . 0.0 112.543 164.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -77.2 85.84 3.66 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 169.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -64.27 43.68 0.1 OUTLIER Glycine 0 CA--C 1.535 1.337 0 C-N-CA 127.749 2.595 . . . . 0.0 115.388 178.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.423 HD12 HG21 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -143.23 84.25 1.81 Allowed 'General case' 0 C--O 1.236 0.346 0 C-N-CA 127.316 2.246 . . . . 0.0 108.423 -172.271 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -120.72 155.0 34.84 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 118.193 -0.908 . . . . 0.0 109.727 -169.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -52.13 130.37 30.04 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 124.014 0.821 . . . . 0.0 109.329 -175.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -119.08 64.5 6.93 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 123.268 0.627 . . . . 0.0 110.808 -169.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.17 -48.39 0.36 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 123.125 2.55 . . . . 0.0 111.716 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.0 tpt180 -150.25 26.91 0.77 Allowed 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.872 0.869 . . . . 0.0 110.886 -169.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -68.14 -67.08 0.49 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 169.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -98.82 2.13 46.5 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.89 0.876 . . . . 0.0 112.722 -176.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.998 0 CA-C-O 115.512 -2.185 . . . . 0.0 107.914 -155.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.499 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.56 117.24 28.45 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 167.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -81.48 124.0 29.08 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 174.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.8 pt -123.77 -176.02 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 123.785 0.834 . . . . 0.0 110.518 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.578 ' CE2' HG23 ' A' ' 36' ' ' THR . 20.4 t80 -124.14 169.43 11.71 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.035 1.334 . . . . 0.0 108.502 174.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.444 HG12 ' H ' ' A' ' 66' ' ' GLU . 7.6 p -122.95 153.54 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 123.837 0.855 . . . . 0.0 109.882 175.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.413 ' CD1' ' N ' ' A' ' 7' ' ' TYR . 0.3 OUTLIER -92.62 -41.11 10.38 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 -171.076 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.444 ' HA3' ' HB3' ' A' ' 133' ' ' TYR . . . 169.45 -19.01 0.07 OUTLIER Glycine 0 CA--C 1.528 0.858 0 C-N-CA 124.743 1.163 . . . . 0.0 113.372 172.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.47 -30.21 71.37 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 128.224 2.609 . . . . 0.0 113.735 -176.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.9 61.1 1.18 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 175.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -151.75 -85.82 0.07 Allowed 'General case' 0 C--O 1.224 -0.279 0 O-C-N 121.239 -0.913 . . . . 0.0 109.86 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 -62.0 -53.62 53.12 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.069 0.85 . . . . 0.0 111.591 -166.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 161.21 30.24 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 -175.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -63.35 155.8 72.89 Favored Pre-proline 0 N--CA 1.45 -0.433 0 C-N-CA 124.83 1.252 . . . . 0.0 108.401 171.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -65.37 -12.58 35.55 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.207 2.604 . . . . 0.0 112.593 -174.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -95.14 24.96 4.53 Favored 'General case' 0 C--O 1.221 -0.415 0 C-N-CA 126.643 1.977 . . . . 0.0 111.454 -175.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -75.89 -55.64 5.43 Favored 'General case' 0 C--N 1.332 -0.18 0 O-C-N 120.442 -1.411 . . . . 0.0 110.116 173.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.04 -24.09 23.11 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -169.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.9 m -60.17 -34.81 58.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 119.675 1.125 . . . . 0.0 112.141 178.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.1 ptp -77.18 -7.7 56.29 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 119.472 1.033 . . . . 0.0 112.76 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 40.5 mt -89.47 7.0 38.32 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.832 1.253 . . . . 0.0 108.974 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -110.23 98.3 7.58 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -59.38 -21.8 60.42 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.867 -0.521 . . . . 0.0 111.563 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.7 t -70.33 -29.19 65.84 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.873 1.269 . . . . 0.0 112.016 175.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 35.1 m170 -79.59 -32.44 41.93 Favored 'General case' 0 CA--C 1.529 0.147 0 O-C-N 121.351 -0.843 . . . . 0.0 109.739 168.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 158.15 175.67 29.34 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 165.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 65.0 tp -74.57 134.0 42.19 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 175.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.8 143.59 31.41 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 155.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -152.01 149.9 29.39 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 165.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -62.18 104.76 0.51 Allowed 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.973 1.709 . . . . 0.0 108.663 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.9 tpp180 -123.56 67.84 1.02 Allowed 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.15 -170.86 45.58 Favored Glycine 0 N--CA 1.435 -1.4 0 CA-C-O 123.824 1.791 . . . . 0.0 111.915 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -131.04 158.91 39.07 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 125.436 1.494 . . . . 0.0 108.257 -170.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.99 173.98 38.4 Favored Glycine 0 CA--C 1.507 -0.463 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.741 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.0 m -141.67 145.95 35.54 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 173.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.578 HG23 ' CE2' ' A' ' 5' ' ' PHE . 25.2 p -71.65 93.17 1.22 Allowed 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 163.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.9 m -63.41 -38.46 82.25 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.106 0 CA-C-O 121.206 0.527 . . . . 0.0 109.892 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.81 118.23 7.43 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 105.218 -2.141 . . . . 0.0 105.218 170.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.74 145.92 50.96 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -141.25 160.62 56.82 Favored Pre-proline 0 N--CA 1.449 -0.475 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 177.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -80.28 67.45 8.62 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 122.532 2.155 . . . . 0.0 113.987 -175.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 53' ' ' LEU . 34.0 tp -72.72 98.63 2.42 Favored 'General case' 0 CA--C 1.553 1.082 0 O-C-N 119.757 -1.839 . . . . 0.0 111.356 178.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.5 m -121.68 126.74 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 119.625 1.102 . . . . 0.0 112.763 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 51.1 mt -69.84 111.67 3.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 173.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -125.98 175.03 8.0 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.457 1.103 . . . . 0.0 108.782 176.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.01 152.74 7.91 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-O 122.61 1.117 . . . . 0.0 111.544 171.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -70.06 -23.41 63.08 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 123.526 0.731 . . . . 0.0 112.34 -176.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -94.44 13.27 24.36 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.429 0.692 . . . . 0.0 111.391 -177.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.567 HD22 ' HB2' ' A' ' 141' ' ' LEU . 2.1 m120 63.22 56.78 1.67 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.04 1.736 . . . . 0.0 107.592 171.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 80.5 mt -107.29 87.91 3.56 Favored Pre-proline 0 CA--C 1.533 0.288 0 C-N-CA 127.253 2.221 . . . . 0.0 107.476 -167.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -54.33 139.76 73.35 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 120.846 1.03 . . . . 0.0 111.652 169.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 6.2 m95 -123.3 146.29 48.02 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 167.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 42' ' ' LEU 0.295 0.9 OUTLIER -97.16 -8.86 29.07 Favored 'General case' 0 C--O 1.219 -0.529 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 -177.741 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 36.7 mt 44.1 -160.8 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.312 1 C-N-CA 134.825 5.25 . . . . 0.0 110.069 -172.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -130.95 91.43 3.05 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 120.848 -1.158 . . . . 0.0 110.225 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.57 85.72 5.22 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 118.968 -0.539 . . . . 0.0 111.616 168.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -59.75 134.41 57.24 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.754 1.636 . . . . 0.0 109.257 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.74 10.43 81.35 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-O 119.568 -0.573 . . . . 0.0 113.618 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? -123.03 155.03 37.68 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.779 1.79 . . . . 0.0 108.444 172.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.54 ' HA2' ' CD2' ' A' ' 129' ' ' TYR . . . 67.96 -146.39 46.39 Favored Glycine 0 C--N 1.334 0.458 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 -174.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -127.45 169.36 13.73 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 117.833 0.816 . . . . 0.0 108.849 -169.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 5.1 p -59.8 169.67 1.35 Allowed 'General case' 0 CA--C 1.512 -0.486 0 O-C-N 121.665 -0.647 . . . . 0.0 112.122 170.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 54.9 t -135.49 118.41 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.792 168.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 72.5 p -74.72 154.76 38.27 Favored 'General case' 0 C--O 1.239 0.512 0 O-C-N 121.756 -0.59 . . . . 0.0 110.237 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.59 -164.96 28.91 Favored Glycine 0 C--N 1.337 0.608 0 CA-C-O 122.202 0.89 . . . . 0.0 111.761 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.444 ' H ' HG12 ' A' ' 6' ' ' VAL . 0.5 OUTLIER -117.57 156.82 27.43 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 124.886 1.274 . . . . 0.0 108.662 179.206 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 73.2 mt -101.34 130.33 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 170.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -116.45 120.96 40.46 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -62.54 116.18 4.91 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 156.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.3 m -123.89 175.53 6.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 CA-C-N 118.429 0.559 . . . . 0.0 109.978 174.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -125.6 176.18 7.05 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.954 0.902 . . . . 0.0 109.208 169.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -53.13 -37.62 61.95 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.682 1.593 . . . . 0.0 112.204 -175.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 42.8 tp60 -61.15 -41.99 97.75 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 118.465 -0.778 . . . . 0.0 111.133 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -67.04 -44.74 79.44 Favored 'General case' 0 C--O 1.225 -0.232 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.2 tp -62.91 -29.53 70.85 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -176.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 62.3 mtt180 -74.69 -38.58 62.33 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 121.949 -0.47 . . . . 0.0 111.992 172.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -66.65 -48.74 68.47 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 119.23 -0.414 . . . . 0.0 110.228 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.8 mp -51.02 -50.32 58.78 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.353 1.461 . . . . 0.0 110.256 174.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -49.67 -43.6 47.31 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.712 0.805 . . . . 0.0 112.016 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -79.35 -13.74 59.44 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.57 2.348 . . . . 0.0 112.709 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -91.12 -42.99 10.16 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.355 1.462 . . . . 0.0 109.664 -175.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . 0.252 0.4 OUTLIER -90.03 9.46 27.92 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.75 1.22 . . . . 0.0 114.009 170.844 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 61.01 36.04 18.7 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.112 1.365 . . . . 0.0 111.105 167.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 6.5 m -79.03 166.53 41.49 Favored Pre-proline 0 C--N 1.323 -0.585 0 C-N-CA 125.061 1.344 . . . . 0.0 108.796 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -64.94 -3.42 2.81 Favored 'Cis proline' 0 CA--C 1.545 1.027 0 CA-C-N 120.082 1.065 . . . . 0.0 113.598 -17.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.76 -66.57 0.37 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.849 1.66 . . . . 0.0 111.193 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 19.4 mtm -83.33 -63.83 1.28 Allowed 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.83 -0.544 . . . . 0.0 110.362 -176.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -103.91 170.11 8.11 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -177.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.91 137.62 38.2 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 120.406 -1.434 . . . . 0.0 107.138 176.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.415 ' HB2' ' CE1' ' A' ' 115' ' ' TYR . 8.4 tmm_? -78.7 123.36 27.07 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 123.899 0.879 . . . . 0.0 108.984 -174.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.6 m -123.96 160.61 27.2 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 123.855 0.862 . . . . 0.0 108.884 -177.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -98.2 140.6 32.25 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 124.018 0.927 . . . . 0.0 109.212 169.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.502 HD11 HG23 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -152.15 169.17 23.08 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.963 0.905 . . . . 0.0 111.483 -177.81 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -95.81 119.86 35.05 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.83 1.652 . . . . 0.0 110.083 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 95.0 t -117.71 136.95 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 177.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -71.9 148.88 45.65 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 123.813 0.845 . . . . 0.0 111.244 172.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.0 t -87.97 95.07 4.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 125.305 1.442 . . . . 0.0 107.306 167.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.35 -24.94 50.64 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.454 1.101 . . . . 0.0 110.724 172.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -162.49 157.32 22.13 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 127.856 2.462 . . . . 0.0 105.096 173.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 75.1 t-105 -145.66 121.83 10.82 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 169.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -105.97 92.55 4.2 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.611 0.764 . . . . 0.0 109.864 176.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 135.66 -179.45 17.76 Favored Glycine 0 C--O 1.227 -0.343 0 C-N-CA 124.233 0.921 . . . . 0.0 112.687 168.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -68.12 155.69 39.06 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 171.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 102.21 56.09 0.84 Allowed Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 124.878 1.228 . . . . 0.0 111.059 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -100.11 91.02 1.5 Allowed Pre-proline 0 C--N 1.327 -0.399 0 C-N-CA 129.591 3.157 . . . . 0.0 106.516 -171.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.567 ' CG ' HG12 ' A' ' 110' ' ' VAL . 61.8 Cg_endo -66.84 -23.82 47.39 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 124.417 3.411 . . . . 0.0 112.362 -178.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 123.23 -172.66 16.12 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 -165.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.66 -6.6 26.91 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -170.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 67.8 p -151.76 157.91 42.62 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 119.072 0.851 . . . . 0.0 111.816 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.567 HG12 ' CG ' ' A' ' 106' ' ' PRO . 3.0 m -136.69 169.05 20.7 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 C-N-CA 125.071 1.348 . . . . 0.0 108.571 -171.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -108.65 93.13 4.36 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 177.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 95.3 m -79.19 176.97 9.18 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.379 0.609 . . . . 0.0 109.915 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -107.72 145.95 32.76 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 158.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.502 HG23 HD11 ' A' ' 93' ' ' LEU . 24.3 t -138.8 143.06 32.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 128.017 2.527 . . . . 0.0 106.44 174.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.415 ' CE1' ' HB2' ' A' ' 90' ' ' ARG . 16.3 m-85 -84.9 104.59 14.99 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 167.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 11.1 p -99.12 -171.49 2.1 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.48 1.912 . . . . 0.0 108.626 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.7 t -147.98 150.88 34.81 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 156.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -114.91 -12.48 12.05 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 128.215 2.606 . . . . 0.0 111.384 176.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 5.8 p -88.81 9.07 25.93 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.329 1.452 . . . . 0.0 113.807 -169.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.549 ' CE1' HD21 ' A' ' 125' ' ' LEU . 30.3 p90 -69.0 164.36 22.53 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.787 1.235 . . . . 0.0 112.72 -170.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -93.82 153.69 40.99 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 125.258 1.423 . . . . 0.0 110.324 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.6 ' HA ' HD23 ' A' ' 125' ' ' LEU . 36.8 Cg_endo -62.14 -27.29 78.64 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.587 2.858 . . . . 0.0 113.548 -174.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -49.77 -43.01 47.91 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.243 1.017 . . . . 0.0 112.113 176.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 42.2 m0 -70.55 -15.85 62.82 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 122.485 0.314 . . . . 0.0 111.339 -172.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.6 HD23 ' HA ' ' A' ' 122' ' ' PRO . 2.7 mm? -82.65 -10.96 58.7 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.059 0.944 . . . . 0.0 112.367 178.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -96.39 -16.02 21.48 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.685 0.794 . . . . 0.0 110.992 175.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 88.4 mt -68.42 155.85 91.7 Favored Pre-proline 0 N--CA 1.469 0.497 0 C-N-CA 124.149 0.979 . . . . 0.0 109.561 176.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -79.62 154.5 23.84 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 121.786 1.657 . . . . 0.0 110.497 173.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.54 ' CD2' ' HA2' ' A' ' 60' ' ' GLY . 44.5 m-85 -85.79 175.87 8.44 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 126.357 1.863 . . . . 0.0 111.108 177.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -142.7 161.11 38.95 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.625 1.97 . . . . 0.0 107.984 -178.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -110.02 -2.65 16.93 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 122.684 1.231 . . . . 0.0 112.544 -177.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.5 t -164.11 154.38 14.91 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.444 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . 7.9 t80 -108.98 116.59 32.28 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.194 167.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -143.51 125.11 14.9 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.576 2.35 . . . . 0.0 108.225 -168.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.2 p -68.64 -47.55 66.31 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 169.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -75.42 43.42 0.23 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.706 2.003 . . . . 0.0 110.61 170.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -110.73 163.03 12.35 Favored Glycine 0 C--N 1.332 0.327 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 166.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.11 -14.61 44.59 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.749 2.3 . . . . 0.0 113.122 -175.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 64.0 m-70 -62.79 -14.52 46.17 Favored 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 116.828 2.158 . . . . 0.0 116.828 -162.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 75.53 -29.85 1.23 Allowed Glycine 0 CA--C 1.537 1.409 0 CA-C-N 120.406 1.457 . . . . 0.0 115.295 172.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.567 ' HB2' HD22 ' A' ' 49' ' ' ASN . 0.3 OUTLIER -97.37 97.37 9.06 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 126.339 1.856 . . . . 0.0 110.949 179.325 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -104.58 162.55 13.16 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 120.865 -1.147 . . . . 0.0 109.872 -173.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -57.35 142.17 44.52 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 119.004 -0.522 . . . . 0.0 110.151 -176.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 31.9 t-20 -114.93 85.17 11.5 Favored Pre-proline 0 C--O 1.234 0.241 0 C-N-CA 125.295 1.438 . . . . 0.0 107.765 176.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.66 -45.33 0.55 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.327 2.018 . . . . 0.0 111.039 172.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -163.18 14.83 0.07 Allowed 'General case' 0 C--O 1.224 -0.285 0 C-N-CA 125.744 1.618 . . . . 0.0 111.622 -174.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -63.73 -13.59 44.81 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 -165.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -131.25 16.7 5.01 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 129.263 3.025 . . . . 0.0 110.849 -178.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.127 0 C-N-CA 124.773 1.229 . . . . 0.0 108.936 -170.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.468 0.434 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.06 121.5 1.24 Allowed 'General case' 0 C--O 1.235 0.316 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 168.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -80.57 142.48 34.05 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 118.492 0.587 . . . . 0.0 111.213 -175.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.419 HG22 ' HB2' ' A' ' 113' ' ' PHE . 21.8 pt -133.62 -176.13 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 124.407 1.083 . . . . 0.0 109.913 178.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.486 ' HB3' HG22 ' A' ' 114' ' ' VAL . 12.4 t80 -120.74 164.68 16.2 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.275 1.43 . . . . 0.0 109.011 172.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 p -111.6 148.84 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.771 0.829 . . . . 0.0 112.309 -175.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -92.24 7.04 44.46 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -168.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 106.84 -33.32 6.51 Favored Glycine 0 N--CA 1.467 0.715 0 O-C-N 120.54 -1.35 . . . . 0.0 110.057 -164.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.412 HG22 ' ND2' ' A' ' 16' ' ' ASN . 1.0 OUTLIER -66.64 -24.05 66.24 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 129.8 3.24 . . . . 0.0 114.771 -170.264 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.407 HD21 HG12 ' A' ' 19' ' ' VAL . 4.1 mp -146.07 48.23 1.22 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.471 1.032 . . . . 0.0 109.258 -173.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -130.97 -85.53 0.51 Allowed 'General case' 0 N--CA 1.468 0.452 0 O-C-N 120.254 -1.529 . . . . 0.0 111.582 176.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.11 -66.79 0.42 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.888 1.222 . . . . 0.0 109.383 -178.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 174.82 86.24 0.06 OUTLIER Glycine 0 N--CA 1.431 -1.691 0 N-CA-C 104.957 -3.257 . . . . 0.0 104.957 -178.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.449 ' HG3' ' HD2' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -107.5 160.27 27.23 Favored Pre-proline 0 N--CA 1.445 -0.701 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 174.211 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.449 ' HD2' ' HG3' ' A' ' 14' ' ' GLN . 12.2 Cg_endo -61.49 -27.4 82.14 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.937 2.425 . . . . 0.0 112.343 -174.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.412 ' ND2' HG22 ' A' ' 9' ' ' THR . 4.0 m-80 -73.52 -16.26 61.28 Favored 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 125.182 1.393 . . . . 0.0 110.842 -173.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -64.36 -32.85 74.63 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 120.115 1.325 . . . . 0.0 112.153 -159.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.94 -19.96 47.76 Favored 'General case' 0 C--O 1.224 -0.279 0 O-C-N 121.409 -0.807 . . . . 0.0 113.044 176.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.487 HG21 ' CE2' ' A' ' 77' ' ' PHE . 1.4 p -55.92 -35.58 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 119.179 0.899 . . . . 0.0 110.956 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.2 ptp -87.97 -4.92 58.77 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -176.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 73.5 mt -90.47 -6.38 54.91 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.505 1.122 . . . . 0.0 110.67 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -106.21 99.91 9.47 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 106.174 -1.788 . . . . 0.0 106.174 172.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 25.6 t-80 -59.03 -18.93 39.11 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.841 1.256 . . . . 0.0 113.285 -176.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.7 m -61.82 -28.34 69.41 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 120.972 -1.08 . . . . 0.0 113.674 169.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -78.69 -1.91 36.7 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 119.241 0.928 . . . . 0.0 111.803 173.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.16 176.65 19.51 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 127.037 2.256 . . . . 0.0 110.571 -176.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -93.76 137.0 33.46 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.521 1.528 . . . . 0.0 110.177 -172.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.16 125.21 15.29 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.474 1.11 . . . . 0.0 110.664 165.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -133.29 126.0 30.51 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 125.228 1.411 . . . . 0.0 109.878 -176.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -60.07 108.53 0.79 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.053 1.741 . . . . 0.0 109.501 -178.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.0 tpp180 -121.15 66.37 0.87 Allowed 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 124.871 1.268 . . . . 0.0 109.902 -174.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.21 -171.56 55.16 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 176.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.524 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 32.2 mtp85 -123.24 169.19 11.53 Favored 'General case' 0 CA--C 1.511 -0.534 0 O-C-N 121.965 -0.727 . . . . 0.0 111.974 -174.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -166.66 173.52 42.03 Favored Glycine 0 CA--C 1.506 -0.526 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.745 175.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 25.8 p -142.99 161.01 39.25 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.999 -0.6 . . . . 0.0 109.558 171.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.6 p -76.57 103.88 6.79 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 106.328 -1.731 . . . . 0.0 106.328 164.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -62.4 -32.17 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 119.503 1.047 . . . . 0.0 110.435 171.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.23 124.74 23.47 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 167.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.24 131.4 44.84 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 125.479 1.511 . . . . 0.0 108.029 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -140.39 157.1 69.21 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 119.472 1.033 . . . . 0.0 108.406 -177.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -70.04 108.05 2.05 Favored 'Trans proline' 0 N--CA 1.454 -0.851 1 C-N-CA 125.525 4.15 . . . . 0.0 108.438 171.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.492 HD21 ' CE2' ' A' ' 133' ' ' TYR . 3.0 tm? -117.84 99.38 6.89 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 173.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.6 m -132.58 141.46 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 C-N-CA 126.386 1.874 . . . . 0.0 108.864 -167.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.529 ' HB ' HD22 ' A' ' 141' ' ' LEU . 4.7 mp -109.73 121.21 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -171.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.3 -170.11 3.0 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.295 1.438 . . . . 0.0 108.707 -173.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.79 164.29 4.33 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.337 0.97 . . . . 0.0 111.145 -174.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -78.5 2.74 18.03 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.598 1.159 . . . . 0.0 113.271 -172.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -132.14 17.08 4.57 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.836 1.254 . . . . 0.0 112.445 -171.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.0 m120 56.7 72.87 0.48 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.351 1.86 . . . . 0.0 111.117 -177.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 94.4 mt -110.49 89.49 8.93 Favored Pre-proline 0 C--N 1.324 -0.518 0 C-N-CA 129.267 3.027 . . . . 0.0 107.488 -169.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -52.65 134.1 52.24 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 CA-C-N 120.872 1.347 . . . . 0.0 111.927 171.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 70.8 m95 -118.29 137.76 52.84 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.171 1.388 . . . . 0.0 107.309 170.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.469 ' HG ' HD23 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -107.93 94.61 5.17 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 171.661 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.6 mt -76.07 143.86 41.09 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 -176.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -79.64 75.86 6.28 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.764 -0.585 . . . . 0.0 110.496 -175.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.64 83.32 53.98 Favored Pre-proline 0 N--CA 1.468 0.428 0 C-N-CA 123.728 0.811 . . . . 0.0 109.887 -176.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -63.62 148.99 92.0 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 121.363 1.375 . . . . 0.0 108.815 178.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.6 2.34 60.14 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-O 117.637 -1.646 . . . . 0.0 114.898 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.2 tppt? -124.94 121.71 35.24 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 121.75 2.775 . . . . 0.0 106.291 177.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.531 ' HA2' ' CD2' ' A' ' 129' ' ' TYR . . . 108.2 -147.07 16.48 Favored Glycine 0 N--CA 1.459 0.228 0 CA-C-N 120.601 1.546 . . . . 0.0 110.766 -176.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -137.01 173.99 11.1 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 123.936 0.894 . . . . 0.0 110.198 -168.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 61.4 m -78.08 113.6 16.16 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.498 0.719 . . . . 0.0 110.251 -178.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 38.2 t -78.34 111.16 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 C-N-CA 124.183 0.993 . . . . 0.0 108.339 -177.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 51.6 p -92.92 151.22 20.07 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 119.17 0.895 . . . . 0.0 111.762 -173.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -178.92 -163.83 30.67 Favored Glycine 0 C--N 1.337 0.605 0 O-C-N 121.277 -0.889 . . . . 0.0 113.588 -163.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 1.5 pt-20 -120.73 177.37 5.11 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 87.7 mt -121.69 115.58 46.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 169.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -89.71 130.84 35.92 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 168.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -70.57 130.16 41.09 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 152.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.3 m -134.04 167.92 25.1 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 CA-C-O 121.144 0.497 . . . . 0.0 110.35 177.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.86 -179.42 4.28 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 122.427 1.108 . . . . 0.0 111.046 167.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.3 -42.76 96.22 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 115.85 -2.024 . . . . 0.0 111.527 177.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.1 mm100 -55.05 -43.16 73.56 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 120.522 1.51 . . . . 0.0 110.763 177.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 39.1 tpp -66.1 -51.46 57.83 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 119.09 -0.481 . . . . 0.0 110.36 178.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.04 -28.16 66.17 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 118.831 0.742 . . . . 0.0 112.034 177.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 35.4 mtt180 -75.19 -43.81 49.99 Favored 'General case' 0 C--N 1.337 0.052 0 C-N-CA 125.625 1.57 . . . . 0.0 111.033 179.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.487 ' CE2' HG21 ' A' ' 19' ' ' VAL . 9.0 t80 -57.94 -54.7 43.94 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 123.541 0.737 . . . . 0.0 109.332 175.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 mp -49.74 -41.15 43.15 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.115 0.966 . . . . 0.0 110.613 178.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -65.94 -1.19 2.79 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.092 1.757 . . . . 0.0 114.277 178.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -129.83 3.85 4.94 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.261 2.224 . . . . 0.0 111.132 178.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -102.59 -47.13 4.54 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.932 1.293 . . . . 0.0 110.166 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -75.17 1.51 13.17 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -175.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.0 t70 54.13 26.2 6.36 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.301 1.441 . . . . 0.0 112.578 -165.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 1.5 p -63.98 159.19 57.48 Favored Pre-proline 0 CA--C 1.542 0.672 0 O-C-N 119.411 -2.055 . . . . 0.0 109.154 166.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -73.24 -4.06 15.04 Favored 'Cis proline' 0 CA--C 1.546 1.096 0 CA-C-N 119.417 0.827 . . . . 0.0 113.583 -10.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.63 -63.39 1.3 Allowed 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.262 1.425 . . . . 0.0 112.966 -177.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 4.2 mtm -82.58 -55.85 4.21 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 122.785 0.434 . . . . 0.0 110.35 -172.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -109.8 173.03 6.51 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 127.6 2.36 . . . . 0.0 106.993 176.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 -132.17 157.67 43.69 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 120.867 1.667 . . . . 0.0 108.224 160.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.0 tmm_? -80.6 142.77 33.72 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 118.897 0.771 . . . . 0.0 109.107 172.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.7 m -143.4 161.49 38.24 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.673 0.749 . . . . 0.0 109.312 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -114.3 125.02 53.41 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 126.64 1.976 . . . . 0.0 108.317 171.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.428 HD21 ' CG2' ' A' ' 114' ' ' VAL . 2.1 pt? -142.99 -167.0 2.43 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 129.918 3.287 . . . . 0.0 108.688 -166.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 20.7 tp60 -107.5 138.97 42.74 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.491 0.716 . . . . 0.0 111.904 177.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 99.5 t -133.87 135.97 54.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 172.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -76.45 153.3 35.73 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.549 1.539 . . . . 0.0 109.653 169.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 80.7 t -87.33 112.68 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 127.565 2.346 . . . . 0.0 107.58 165.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.5 mp -90.51 -17.87 26.3 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.241 1.416 . . . . 0.0 110.641 171.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -172.18 159.85 4.98 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 129.041 2.936 . . . . 0.0 105.672 173.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 62.7 t-105 -141.81 118.02 10.73 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 119.339 0.972 . . . . 0.0 109.708 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -118.04 62.29 0.76 Allowed 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.914 0.864 . . . . 0.0 112.67 -171.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 150.18 155.15 6.71 Favored Glycine 0 C--O 1.228 -0.254 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 158.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -54.24 149.41 9.85 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.598 1.159 . . . . 0.0 112.079 -162.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 98.16 65.98 0.88 Allowed Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -165.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -100.82 89.1 1.15 Allowed Pre-proline 0 C--O 1.24 0.579 1 C-N-CA 132.509 4.324 . . . . 0.0 108.152 -162.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -72.79 -5.19 16.73 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 124.675 3.584 . . . . 0.0 114.126 -163.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.74 -177.19 44.92 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 109.251 -1.539 . . . . 0.0 109.251 -166.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -64.36 -12.02 38.34 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 -168.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.0 p -137.41 161.79 35.37 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 120.726 1.603 . . . . 0.0 112.457 177.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.5 m -142.65 156.71 18.46 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 125.366 1.466 . . . . 0.0 108.913 -178.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -98.08 98.64 9.93 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.444 -1.688 . . . . 0.0 106.444 160.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 18.6 m -92.05 172.37 8.49 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 168.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.419 ' HB2' HG22 ' A' ' 4' ' ' ILE . 69.0 m-85 -85.68 140.4 30.57 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 162.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.486 HG22 ' HB3' ' A' ' 5' ' ' PHE . 25.5 t -134.61 124.9 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 127.461 2.304 . . . . 0.0 106.052 173.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -72.63 141.08 48.33 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 168.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 55.6 p -138.37 -173.2 3.47 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.19 1.796 . . . . 0.0 109.675 -173.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.4 t -134.63 145.04 48.23 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 165.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -113.59 -8.96 13.28 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.864 1.666 . . . . 0.0 112.073 169.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 31.4 p -105.76 15.42 26.81 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.659 1.184 . . . . 0.0 113.11 -172.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -58.9 149.72 26.22 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 125.832 1.653 . . . . 0.0 113.803 -170.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.64 154.59 88.12 Favored Pre-proline 0 CA--C 1.532 0.283 0 C-N-CA 125.444 1.498 . . . . 0.0 110.961 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.08 -30.81 20.22 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.033 1.822 . . . . 0.0 113.335 178.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.07 -30.25 70.23 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 173.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 43.2 m0 -72.36 -17.32 61.84 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 121.453 -0.779 . . . . 0.0 111.446 -171.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -75.29 -21.29 58.6 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 118.48 -0.772 . . . . 0.0 110.978 172.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 8.9 m-30 -86.14 -19.22 30.46 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.175 0.898 . . . . 0.0 111.639 -177.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 97.2 mt -65.77 151.07 95.56 Favored Pre-proline 0 C--O 1.237 0.415 0 C-N-CA 123.836 0.855 . . . . 0.0 110.385 -175.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.67 146.0 53.38 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.834 2.356 . . . . 0.0 109.183 177.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.531 ' CD2' ' HA2' ' A' ' 60' ' ' GLY . 11.6 m-85 -86.96 163.68 16.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 122.079 0.942 . . . . 0.0 110.831 -175.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.515 ' CE1' HD21 ' A' ' 141' ' ' LEU . 26.2 m-70 -136.99 160.22 39.57 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.845 1.658 . . . . 0.0 108.038 177.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -97.5 -5.47 35.86 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.01 1.324 . . . . 0.0 111.192 174.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 80.7 p -169.34 -175.35 2.2 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 120.963 -1.085 . . . . 0.0 109.798 -169.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.492 ' CE2' HD21 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -158.0 61.85 0.46 Allowed 'General case' 0 C--O 1.239 0.527 0 C-N-CA 126.739 2.016 . . . . 0.0 106.493 -167.713 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -112.02 122.88 48.99 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 -157.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 5.2 t -59.13 -32.15 69.59 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.728 -168.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -91.72 11.77 23.47 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 117.931 0.332 . . . . 0.0 111.697 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -68.41 167.06 44.53 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.486 1.041 . . . . 0.0 113.251 -175.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -73.4 -9.54 23.1 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.544 2.829 . . . . 0.0 112.187 178.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -80.23 -18.56 49.15 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -163.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 77.21 -19.47 3.63 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-O 118.244 -1.309 . . . . 0.0 114.261 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.529 HD22 ' HB ' ' A' ' 44' ' ' ILE . 0.5 OUTLIER -72.74 101.54 3.12 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.733 1.613 . . . . 0.0 110.244 175.358 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 9.9 mmt85 -125.33 138.19 54.06 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 117.794 -1.098 . . . . 0.0 110.495 -174.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -58.02 148.09 27.26 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -133.34 85.47 43.89 Favored Pre-proline 0 C--N 1.329 -0.292 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -176.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -70.6 4.39 2.58 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 124.524 3.483 . . . . 0.0 113.836 176.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 26.1 ttt180 61.77 43.35 9.68 Favored 'General case' 0 C--N 1.343 0.285 0 C-N-CA 125.936 1.695 . . . . 0.0 111.174 177.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -56.12 -47.09 78.79 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 121.444 -0.785 . . . . 0.0 111.444 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -143.42 31.32 1.35 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.535 1.134 . . . . 0.0 110.626 -169.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 5.0 ttt-85 . . . . . 0 C--O 1.246 0.875 0 CA-C-O 118.76 -0.638 . . . . 0.0 111.864 -169.459 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.1 mtt . . . . . 0 N--CA 1.472 0.664 0 CA-C-O 119.313 -0.375 . . . . 0.0 110.521 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -94.15 142.82 26.96 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -176.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -96.04 121.2 37.54 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 168.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.9 pt -119.4 175.25 4.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 171.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -120.5 137.26 54.46 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 175.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.4 m -78.55 137.46 21.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -67.51 -26.22 66.23 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.009 0.524 . . . . 0.0 112.241 175.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 135.48 -19.96 3.76 Favored Glycine 0 N--CA 1.472 1.036 0 O-C-N 120.134 -1.604 . . . . 0.0 111.958 -169.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.48 -14.95 54.18 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.335 1.854 . . . . 0.0 112.555 -169.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.737 HD13 ' HA ' ' A' ' 17' ' ' HIS . 3.3 mm? -127.14 41.19 3.57 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 128.592 2.757 . . . . 0.0 106.54 -173.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.79 -85.22 0.18 Allowed 'General case' 0 N--CA 1.469 0.489 0 O-C-N 120.324 -1.485 . . . . 0.0 110.753 -171.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.0 tpt85 -66.42 -69.19 0.32 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 121.149 1.795 . . . . 0.0 111.006 -170.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -155.48 -3.03 0.1 Allowed Glycine 0 N--CA 1.448 -0.504 0 O-C-N 124.157 0.911 . . . . 0.0 114.133 -174.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -49.28 147.52 5.28 Favored Pre-proline 0 N--CA 1.45 -0.438 0 C-N-CA 126.523 1.929 . . . . 0.0 111.847 -167.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -48.99 -29.21 15.02 Favored 'Trans proline' 0 CA--C 1.533 0.436 1 C-N-CA 125.32 4.013 . . . . 0.0 113.967 -176.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.466 ' O ' HG22 ' A' ' 19' ' ' VAL . 49.4 m-80 -81.34 -23.8 37.53 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 125.958 1.703 . . . . 0.0 112.226 -169.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.737 ' HA ' HD13 ' A' ' 10' ' ' LEU . 4.8 t60 -53.41 -31.38 44.79 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.975 1.262 . . . . 0.0 111.019 -171.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.31 -23.55 9.48 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.873 1.269 . . . . 0.0 114.031 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 16' ' ' ASN . 34.1 m -60.07 -49.53 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 CA-C-N 119.652 1.115 . . . . 0.0 110.628 173.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.612 ' HE3' HD12 ' A' ' 10' ' ' LEU . 6.0 ptp -77.68 5.64 8.89 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.704 0.684 . . . . 0.0 112.726 -174.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 69.9 mt -97.34 -6.08 35.07 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.078 0.951 . . . . 0.0 111.582 176.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -121.7 102.83 8.46 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 104.315 -2.476 . . . . 0.0 104.315 175.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -58.16 -16.93 15.29 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.081 1.352 . . . . 0.0 111.996 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.2 m -60.92 -22.42 64.35 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.756 1.622 . . . . 0.0 113.971 169.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 20.2 m170 -86.08 -15.06 42.43 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.251 -0.906 . . . . 0.0 111.107 170.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.1 170.02 12.91 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 127.203 2.335 . . . . 0.0 111.565 176.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -74.1 139.09 44.36 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 124.803 1.241 . . . . 0.0 112.1 -174.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -139.82 138.63 35.96 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.03 1.732 . . . . 0.0 109.053 165.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.16 139.71 27.45 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.77 1.228 . . . . 0.0 108.865 175.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -72.62 87.55 1.23 Allowed 'General case' 0 C--O 1.238 0.481 0 C-N-CA 125.948 1.699 . . . . 0.0 108.033 178.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.2 tpp180 -93.7 64.85 3.57 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -177.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.66 -167.41 54.8 Favored Glycine 0 N--CA 1.44 -1.058 0 CA-C-O 122.967 1.315 . . . . 0.0 111.463 -173.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.3 ptt85 -139.13 170.64 15.59 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.981 0.913 . . . . 0.0 109.668 -177.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.404 ' HA2' ' H ' ' A' ' 98' ' ' LEU . . . -170.96 173.8 44.68 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 119.876 -1.155 . . . . 0.0 111.807 -172.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.468 ' HB3' ' HA ' ' A' ' 64' ' ' THR . 2.3 m -136.89 158.05 45.34 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 170.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.0 p -74.9 121.61 22.15 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 176.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.552 HG22 ' HB2' ' A' ' 96' ' ' GLN . 2.0 t -76.6 -43.88 34.51 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -177.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -71.36 121.72 19.04 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 105.774 -1.935 . . . . 0.0 105.774 174.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 m -55.75 142.49 34.33 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 168.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -135.67 153.41 77.43 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 107.057 -1.461 . . . . 0.0 107.057 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -78.52 91.82 1.17 Allowed 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 124.693 3.595 . . . . 0.0 109.522 176.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.88 88.59 7.73 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 177.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.434 HG13 ' HB3' ' A' ' 127' ' ' LEU 0.287 40.1 t -89.71 166.78 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 C-N-CA 126.982 2.113 . . . . 0.0 107.878 -176.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.2 mt -132.65 126.72 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 168.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.88 175.14 10.06 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 122.32 1.057 . . . . 0.0 111.495 -174.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.9 -172.64 53.18 Favored Glycine 0 CA--C 1.539 1.542 0 C-N-CA 125.794 1.664 . . . . 0.0 111.226 170.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -87.19 -18.46 30.28 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 125.851 1.66 . . . . 0.0 113.076 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 56.6 m-70 -109.2 8.98 26.08 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 122.845 0.458 . . . . 0.0 112.005 -171.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 62.86 63.03 0.99 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.648 1.579 . . . . 0.0 108.079 172.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 81.4 mt -104.11 90.23 2.94 Favored Pre-proline 0 N--CA 1.453 -0.283 0 C-N-CA 127.309 2.243 . . . . 0.0 106.14 -169.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -57.08 138.33 85.81 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 CA-C-N 119.725 0.938 . . . . 0.0 110.374 169.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 57.0 m95 -128.82 132.63 47.84 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.505 1.522 . . . . 0.0 108.692 178.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 34.4 tp -86.13 -3.81 59.04 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.957 0.903 . . . . 0.0 113.101 -173.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 12.9 mt 42.03 89.7 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 129.674 3.19 . . . . 0.0 112.367 172.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -49.5 95.68 0.01 OUTLIER 'General case' 0 C--O 1.241 0.631 0 CA-C-N 119.167 0.894 . . . . 0.0 112.989 -162.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -159.49 85.76 2.18 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 119.032 0.833 . . . . 0.0 113.057 -172.498 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -60.85 147.75 94.35 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.613 2.209 . . . . 0.0 109.739 -177.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.88 15.66 80.82 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 119.074 -0.848 . . . . 0.0 113.056 171.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.38 130.44 32.8 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 119.436 1.618 . . . . 0.0 108.715 -175.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.37 -123.84 7.07 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-N 120.792 1.633 . . . . 0.0 112.628 -178.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 46.4 m-70 -136.32 160.55 38.38 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.889 1.844 . . . . 0.0 112.588 -165.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 77.0 m -91.14 99.49 12.49 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.823 0.849 . . . . 0.0 110.736 -177.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.1 t -72.0 99.19 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 125.97 1.708 . . . . 0.0 113.213 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.468 ' HA ' ' HB3' ' A' ' 35' ' ' CYS . 8.9 p -66.51 157.58 31.83 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.91 0.884 . . . . 0.0 112.631 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -178.05 -147.1 6.71 Favored Glycine 0 C--N 1.343 0.962 0 O-C-N 121.458 -0.776 . . . . 0.0 114.025 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -133.53 171.21 14.4 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.056 1.342 . . . . 0.0 109.253 177.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 92.4 mt -116.59 112.98 41.62 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 -177.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -101.71 115.82 31.37 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 172.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -62.89 136.22 57.73 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 154.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.5 m -135.04 168.69 22.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 C-N-CA 124.732 1.213 . . . . 0.0 108.131 176.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -107.98 172.06 7.05 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 168.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.419 ' HG2' ' HE ' ' A' ' 76' ' ' ARG . 2.5 mt-10 -49.53 -45.73 47.69 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 125.035 1.334 . . . . 0.0 110.244 -176.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.2 tp60 -55.62 -43.57 76.25 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.079 0.952 . . . . 0.0 111.574 -176.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 24.3 tpp -72.48 -48.67 38.9 Favored 'General case' 0 C--O 1.224 -0.264 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.83 -39.4 77.57 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.549 -0.719 . . . . 0.0 110.726 -178.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.419 ' HE ' ' HG2' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -64.56 -44.65 90.09 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 126.918 2.087 . . . . 0.0 110.966 175.451 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -61.69 -46.35 90.08 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.279 0.632 . . . . 0.0 109.815 177.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 95.2 mt -57.79 -37.48 73.8 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.144 0.577 . . . . 0.0 111.468 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -61.11 -21.98 64.21 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.388 0.995 . . . . 0.0 111.837 177.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -100.25 -2.92 32.57 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.803 2.441 . . . . 0.0 111.5 177.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -103.96 -37.98 7.17 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 120.739 -1.226 . . . . 0.0 108.215 -174.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -107.94 28.88 7.8 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.985 1.314 . . . . 0.0 111.586 174.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 57.97 37.68 26.73 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.247 1.419 . . . . 0.0 112.625 156.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 78.1 m -85.92 163.57 42.86 Favored Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 120.934 -1.104 . . . . 0.0 110.646 -176.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 58.0 Cg_endo -65.76 -3.95 3.6 Favored 'Cis proline' 0 CA--C 1.547 1.161 0 N-CA-C 114.849 1.057 . . . . 0.0 114.849 -16.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -46.79 -64.55 0.74 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.835 1.654 . . . . 0.0 112.928 178.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 21.5 mtm -88.18 -59.41 2.25 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 119.195 0.907 . . . . 0.0 110.092 -175.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.409 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 75.0 m-85 -111.56 178.29 4.37 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 176.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.7 mp0 -133.97 150.28 51.27 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 171.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -77.44 114.26 16.09 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 176.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.2 m -113.55 170.91 7.9 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 126.106 1.763 . . . . 0.0 108.835 -179.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -122.13 143.01 49.8 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.622 1.569 . . . . 0.0 110.277 172.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.44 175.91 11.8 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.269 1.428 . . . . 0.0 111.357 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 31.4 tp60 -101.53 126.79 48.4 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.703 1.601 . . . . 0.0 111.772 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 64.0 t -122.39 144.74 30.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 125.305 1.442 . . . . 0.0 108.141 -176.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.552 ' HB2' HG22 ' A' ' 37' ' ' VAL . 49.4 tt0 -89.32 144.75 25.85 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 176.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.535 HG12 ' C ' ' A' ' 108' ' ' ASP 0.26 7.2 p -111.48 89.89 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -167.36 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.404 ' H ' ' HA2' ' A' ' 34' ' ' GLY . 3.9 mp -65.44 -23.04 66.83 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 120.716 -1.24 . . . . 0.0 111.512 -177.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -160.95 153.43 20.55 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 104.763 -2.31 . . . . 0.0 104.763 174.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 70.2 t-105 -137.59 107.29 6.22 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 126.3 1.84 . . . . 0.0 108.597 178.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -95.18 108.56 20.69 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -177.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.52 -174.77 15.96 Favored Glycine 0 CA--C 1.519 0.311 0 CA-C-O 121.911 0.729 . . . . 0.0 111.387 174.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -71.31 160.64 32.43 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.604 0.716 . . . . 0.0 110.268 -177.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 90.52 69.13 1.2 Allowed Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 124.618 1.104 . . . . 0.0 111.234 165.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -101.58 89.58 1.5 Allowed Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 129.845 3.258 . . . . 0.0 110.352 -162.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -62.73 4.61 0.35 Allowed 'Trans proline' 0 CA--C 1.544 1.0 1 C-N-CA 125.737 4.291 . . . . 0.0 115.266 -176.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.15 -174.43 54.54 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 -163.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.535 ' C ' HG12 ' A' ' 97' ' ' VAL . 14.5 t70 -69.71 5.69 1.39 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 117.336 2.347 . . . . 0.0 117.336 -168.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 83.5 p -125.25 157.45 36.55 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 121.648 -0.658 . . . . 0.0 112.174 155.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.6 p -132.6 153.05 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 123.628 0.771 . . . . 0.0 109.434 161.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -82.09 152.51 26.54 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 168.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 3.9 p -145.14 -173.37 4.07 Favored 'General case' 0 C--O 1.239 0.515 0 O-C-N 121.575 -0.703 . . . . 0.0 110.629 169.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -109.03 151.44 26.35 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.133 1.373 . . . . 0.0 109.504 162.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.3 t -142.88 146.45 21.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 128.883 2.873 . . . . 0.0 106.605 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -89.91 116.05 27.68 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 168.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -139.16 147.61 42.08 Favored 'General case' 0 C--O 1.225 -0.233 0 C-N-CA 124.077 0.951 . . . . 0.0 111.317 -176.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.5 t -92.5 141.16 28.81 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -177.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -110.57 6.45 21.89 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.235 1.414 . . . . 0.0 111.572 162.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.35 19.73 16.74 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.624 1.97 . . . . 0.0 112.729 -160.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -71.61 159.53 34.26 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.737 1.615 . . . . 0.0 113.16 -174.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.35 149.69 89.11 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 124.749 1.22 . . . . 0.0 110.761 173.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -68.52 -24.8 35.71 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.701 2.268 . . . . 0.0 113.561 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -68.69 -24.95 64.56 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 120.919 -1.113 . . . . 0.0 112.777 173.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 45.0 m0 -72.01 -12.75 61.37 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.426 -0.796 . . . . 0.0 112.241 -177.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -65.89 -18.33 65.26 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.347 -0.846 . . . . 0.0 111.233 171.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -99.95 -8.95 23.33 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.059 0.944 . . . . 0.0 112.791 175.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.434 ' HB3' HG13 ' A' ' 43' ' ' VAL . 14.7 mt -64.23 147.01 97.38 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -64.84 149.38 89.68 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.087 1.858 . . . . 0.0 110.371 178.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -103.37 166.1 10.63 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 41.0 m-70 -136.5 169.87 16.98 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 125.048 1.339 . . . . 0.0 108.473 178.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -125.26 -17.33 5.7 Favored 'General case' 0 C--O 1.219 -0.511 0 C-N-CA 124.217 1.007 . . . . 0.0 111.837 -166.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -158.19 132.78 8.28 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 164.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -85.59 131.57 34.33 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 169.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -143.87 158.21 43.84 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.756 154.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.5 t -63.71 -35.86 81.94 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 164.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -86.4 68.63 10.27 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 127.467 2.307 . . . . 0.0 107.665 -177.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -152.65 168.09 31.6 Favored Glycine 0 CA--C 1.522 0.499 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.432 163.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -72.91 -6.93 19.89 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.275 2.65 . . . . 0.0 113.735 -166.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -60.24 -42.13 94.61 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 119.407 1.003 . . . . 0.0 113.425 -169.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 93.09 -50.33 2.48 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-O 118.892 -0.949 . . . . 0.0 111.026 -178.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.5 75.61 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.079 1.751 . . . . 0.0 112.265 173.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -109.37 167.7 9.93 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 120.52 -1.362 . . . . 0.0 109.613 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -60.17 164.03 4.44 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 118.786 -0.626 . . . . 0.0 111.276 -169.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -113.42 66.76 1.19 Allowed Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 121.614 0.721 . . . . 0.0 112.317 -175.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -75.49 -17.72 18.27 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 122.017 1.811 . . . . 0.0 113.793 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -168.59 22.28 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.176 1.39 . . . . 0.0 110.653 -172.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -66.87 -46.0 76.34 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 174.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -127.18 -0.62 6.43 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.057 1.743 . . . . 0.0 111.979 -173.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? . . . . . 0 C--O 1.248 0.998 0 C-N-CA 128.227 2.611 . . . . 0.0 112.7 -175.57 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.3 tpt . . . . . 0 N--CA 1.469 0.508 0 N-CA-C 111.197 0.073 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.72 178.45 7.06 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.581 1.552 . . . . 0.0 107.12 178.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -134.39 148.02 50.59 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 13.0 pt -130.83 179.42 4.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 167.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.561 ' CE2' HG23 ' A' ' 36' ' ' THR . 90.3 t80 -137.83 133.16 33.62 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 176.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 20.8 m -73.79 134.64 29.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 173.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -73.54 -3.22 26.39 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.77 -0.581 . . . . 0.0 111.701 163.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 136.42 -4.99 3.79 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.95 1.738 . . . . 0.0 112.515 174.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -83.47 -8.62 59.33 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -167.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.0 mp -140.85 58.64 1.55 Allowed 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -139.87 -73.68 0.36 Allowed 'General case' 0 C--N 1.342 0.281 0 CA-C-O 118.463 -0.779 . . . . 0.0 112.346 177.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -67.97 -60.59 2.38 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.911 1.232 . . . . 0.0 109.211 -168.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -177.38 33.33 0.08 OUTLIER Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.611 HE21 ' H ' ' A' ' 135' ' ' SER . 10.5 mp0 -66.25 155.03 88.96 Favored Pre-proline 0 N--CA 1.454 -0.231 0 O-C-N 120.657 -1.496 . . . . 0.0 109.733 -173.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.35 -10.0 19.77 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.649 2.233 . . . . 0.0 113.354 -172.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.515 ' O ' HG22 ' A' ' 19' ' ' VAL . 3.3 m-80 -99.52 -20.76 16.24 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 127.242 2.217 . . . . 0.0 110.956 -175.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -53.68 -41.67 67.14 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 120.955 1.707 . . . . 0.0 109.839 -171.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.7 -29.48 4.49 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.564 1.546 . . . . 0.0 114.145 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 16' ' ' ASN . 20.3 m -59.8 -41.79 86.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 120.097 1.317 . . . . 0.0 111.593 178.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.3 ptp -78.0 -8.59 58.36 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 119.149 0.886 . . . . 0.0 111.76 -177.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 39.6 mt -87.41 5.09 40.48 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.283 1.433 . . . . 0.0 110.64 178.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -115.08 97.61 6.32 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 173.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 22.2 t-80 -60.09 -21.22 61.23 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.424 0.69 . . . . 0.0 112.538 -176.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.5 m -69.44 -23.7 63.72 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.385 1.474 . . . . 0.0 114.342 172.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 36.9 m170 -69.77 -31.71 69.81 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.146 -0.971 . . . . 0.0 108.765 165.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.76 179.53 25.66 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 125.839 1.685 . . . . 0.0 110.775 174.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -81.63 135.69 35.54 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.011 0.924 . . . . 0.0 110.096 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.1 100.68 3.68 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.38 1.472 . . . . 0.0 109.646 167.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -107.4 140.9 39.63 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 125.18 1.392 . . . . 0.0 108.798 -177.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -69.98 77.84 0.49 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.589 2.355 . . . . 0.0 109.986 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -87.37 62.38 7.15 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.39 -176.3 48.24 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-O 123.624 1.68 . . . . 0.0 113.984 170.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -118.0 160.29 21.72 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.781 1.232 . . . . 0.0 109.711 -170.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -169.71 177.58 43.12 Favored Glycine 0 C--N 1.34 0.805 0 N-CA-C 116.383 1.313 . . . . 0.0 116.383 177.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 10.6 p -133.4 158.48 42.92 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.44 1.096 . . . . 0.0 108.206 170.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.561 HG23 ' CE2' ' A' ' 5' ' ' PHE . 3.0 p -78.91 117.28 19.85 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 166.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.3 t -74.24 -41.33 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 175.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -64.89 107.34 1.44 Allowed 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 170.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.0 m -59.63 135.92 57.83 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 106.951 -1.499 . . . . 0.0 106.951 170.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.74 ' HB3' HD22 ' A' ' 53' ' ' LEU . 27.8 m-85 -130.57 153.16 81.39 Favored Pre-proline 0 C--O 1.237 0.422 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -74.29 91.57 0.95 Allowed 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 124.707 3.605 . . . . 0.0 109.675 173.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 tt -81.91 102.94 11.21 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 171.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.569 ' CG2' HD13 ' A' ' 54' ' ' LEU . 2.6 m -122.25 133.14 69.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 125.225 1.41 . . . . 0.0 107.451 -175.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 73.8 mt -99.05 100.14 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -176.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -118.01 171.88 7.79 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 122.378 1.085 . . . . 0.0 111.354 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.3 152.73 7.13 Favored Glycine 0 CA--C 1.523 0.534 0 CA-C-N 113.76 -1.564 . . . . 0.0 110.9 173.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.3 tp10 -72.16 -9.3 58.25 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -162.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 44.2 m170 -102.5 12.63 36.19 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.871 0.869 . . . . 0.0 112.076 175.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 55.45 69.73 0.7 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 127.392 2.277 . . . . 0.0 111.228 -178.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.5 mt -104.12 89.87 2.74 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 128.105 2.562 . . . . 0.0 108.072 -166.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -53.03 129.11 31.74 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 121.757 1.638 . . . . 0.0 111.567 177.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 66.3 m95 -126.62 145.56 50.51 Favored 'General case' 0 C--N 1.332 -0.192 0 O-C-N 121.093 -1.005 . . . . 0.0 109.122 176.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.74 HD22 ' HB3' ' A' ' 40' ' ' PHE . 1.8 mt -96.44 -5.31 39.96 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 117.569 2.433 . . . . 0.0 117.569 -174.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.569 HD13 ' CG2' ' A' ' 43' ' ' VAL . 8.7 mp 42.37 73.39 0.14 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 111.603 -2.544 . . . . 0.0 112.601 173.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -45.26 92.18 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.014 1.726 . . . . 0.0 114.57 -157.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.42 85.23 7.42 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 125.026 1.33 . . . . 0.0 107.643 -174.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -59.04 139.52 91.16 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 121.986 1.79 . . . . 0.0 108.564 176.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.02 -0.7 88.27 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.191 1.376 . . . . 0.0 114.48 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -97.43 144.02 27.58 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.624 1.712 . . . . 0.0 107.78 173.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.33 -143.7 30.91 Favored Glycine 0 C--N 1.337 0.608 0 CA-C-N 119.235 0.925 . . . . 0.0 111.63 177.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -130.99 176.75 7.98 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.313 1.445 . . . . 0.0 108.203 -169.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.2 p -63.0 167.13 5.05 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.512 0.672 . . . . 0.0 111.406 176.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.1 t -133.08 110.95 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 166.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 69.5 p -69.75 152.33 44.75 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.42 -158.37 12.37 Favored Glycine 0 CA--C 1.527 0.791 0 O-C-N 121.15 -0.969 . . . . 0.0 112.486 -177.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -140.98 151.8 44.44 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.621 1.568 . . . . 0.0 108.454 174.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 76.4 mt -95.55 138.49 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -127.34 126.16 42.04 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 172.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -69.87 136.13 50.33 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 161.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.62 164.54 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.95 177.43 4.85 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 122.804 1.288 . . . . 0.0 111.847 168.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -57.16 -42.36 80.94 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 112.916 -1.947 . . . . 0.0 111.751 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 40.1 tp60 -62.99 -44.91 94.72 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 118.473 -0.775 . . . . 0.0 109.989 179.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 24.8 tpp -62.79 -46.41 88.13 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 118.365 0.53 . . . . 0.0 110.109 176.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 75' ' ' LEU . 11.1 tp -65.81 -40.59 92.03 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.647 -174.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 33.9 mtm105 -63.26 -40.16 96.63 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.631 1.173 . . . . 0.0 111.172 173.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -65.97 -50.62 63.7 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 117.984 0.356 . . . . 0.0 110.303 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.7 mp -63.12 -25.87 68.56 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.122 -0.986 . . . . 0.0 111.01 176.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.473 ' HA ' ' SG ' ' A' ' 84' ' ' CYS . 14.8 t70 -73.44 1.3 10.06 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.971 1.309 . . . . 0.0 112.84 176.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -122.04 -47.81 2.14 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 128.352 2.661 . . . . 0.0 110.972 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -65.1 -39.16 92.74 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.445 1.098 . . . . 0.0 112.294 -176.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -77.81 8.56 4.4 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.18 -0.95 . . . . 0.0 111.197 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 58.68 15.44 3.72 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.376 1.871 . . . . 0.0 113.155 178.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.473 ' SG ' ' HA ' ' A' ' 79' ' ' ASP . 1.6 p -61.92 154.12 69.6 Favored Pre-proline 0 N--CA 1.448 -0.558 0 O-C-N 120.518 -1.363 . . . . 0.0 109.219 169.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.39 -4.57 22.09 Favored 'Cis proline' 0 CA--C 1.541 0.826 0 CA-C-N 119.563 0.88 . . . . 0.0 113.638 -2.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.7 -75.42 0.06 Allowed 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.062 1.345 . . . . 0.0 111.095 179.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 38.7 mtp -68.67 -69.09 0.35 Allowed 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -172.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -102.29 174.89 5.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.497 0.665 . . . . 0.0 109.443 179.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -137.89 136.25 36.91 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 165.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -75.03 139.21 42.71 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 175.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.4 m -141.66 154.36 45.31 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -176.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -91.46 137.84 32.05 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.881 0.873 . . . . 0.0 109.7 174.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.504 HD11 HG23 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -148.27 174.84 11.6 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.01 1.324 . . . . 0.0 112.297 -178.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 30.7 tp60 -100.06 117.15 33.72 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.149 1.78 . . . . 0.0 111.196 -178.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 97.1 t -117.81 124.12 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 125.19 1.396 . . . . 0.0 107.944 -172.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -68.43 141.37 55.69 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 119.582 1.083 . . . . 0.0 108.557 175.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 45.9 t -84.78 95.19 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 172.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.86 -30.06 70.13 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.769 -0.582 . . . . 0.0 109.712 167.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -164.75 153.74 12.85 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 60.2 t-105 -132.03 136.94 47.61 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 172.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -116.92 111.15 19.24 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 171.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 114.81 -172.34 14.18 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 124.518 1.056 . . . . 0.0 112.145 172.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -70.87 168.32 17.09 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 114.919 -0.641 . . . . 0.0 110.619 -178.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.05 69.19 1.42 Allowed Glycine 0 C--O 1.222 -0.635 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 168.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -101.1 87.96 0.97 Allowed Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 130.651 3.581 . . . . 0.0 109.399 -171.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -57.12 -38.1 96.46 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.692 2.928 . . . . 0.0 113.2 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 146.59 -160.95 28.33 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-N 119.436 1.016 . . . . 0.0 111.387 -170.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -64.07 -22.56 66.98 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.937 1.295 . . . . 0.0 111.728 175.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.9 t -139.86 164.19 30.64 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 120.467 -1.396 . . . . 0.0 109.233 175.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 10.9 p -141.06 153.06 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 C-N-CA 125.787 1.635 . . . . 0.0 108.959 -174.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -83.3 119.93 25.21 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 168.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 85.8 m -122.22 176.27 5.93 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.746 0.818 . . . . 0.0 109.23 171.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -106.5 144.09 33.68 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 168.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.504 HG23 HD11 ' A' ' 93' ' ' LEU . 27.2 t -137.45 146.83 27.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 127.137 2.175 . . . . 0.0 106.073 175.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -76.54 127.76 33.43 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 165.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 72.4 p -131.62 -164.54 1.46 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 126.008 1.723 . . . . 0.0 106.689 172.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.5 t -149.08 153.97 38.57 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 168.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -116.51 -31.92 5.4 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.672 1.589 . . . . 0.0 111.823 175.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 15.4 t -91.72 20.79 5.23 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.941 0.896 . . . . 0.0 111.795 -165.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.416 ' CG ' ' HG ' ' A' ' 54' ' ' LEU . 31.9 p90 -72.07 153.9 41.44 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 127.78 2.432 . . . . 0.0 113.155 -174.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.89 160.37 55.82 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 126.622 1.969 . . . . 0.0 112.173 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -68.88 -39.04 8.9 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.125 1.883 . . . . 0.0 112.531 178.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -45.46 -41.66 9.67 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 178.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 0.561 ' HA ' HD23 ' A' ' 127' ' ' LEU . 30.7 m0 -64.2 -18.17 64.25 Favored 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 125.513 1.525 . . . . 0.0 112.365 -173.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 28.0 mt -67.47 -17.28 64.63 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 117.808 -1.092 . . . . 0.0 111.672 173.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -102.52 -6.22 23.11 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.976 1.262 . . . . 0.0 112.511 -168.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.561 HD23 ' HA ' ' A' ' 124' ' ' TRP . 1.9 mm? -71.73 156.93 90.62 Favored Pre-proline 0 N--CA 1.448 -0.55 0 C-N-CA 125.651 1.58 . . . . 0.0 108.16 -175.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -61.38 140.31 87.31 Favored 'Trans proline' 0 N--CA 1.449 -1.088 0 C-N-CA 121.586 1.524 . . . . 0.0 108.953 173.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -81.28 158.08 24.9 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 172.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 60.0 m-70 -137.97 155.74 48.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.712 178.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -101.21 -9.04 21.64 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 122.766 1.27 . . . . 0.0 112.932 -175.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -161.23 150.7 16.73 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 126.908 2.083 . . . . 0.0 105.517 175.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -106.27 148.35 28.08 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 167.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.0 170.99 21.06 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.611 ' H ' HE21 ' A' ' 14' ' ' GLN . 0.3 OUTLIER -104.87 -0.1 27.43 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 159.625 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -133.3 68.36 1.5 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.514 1.926 . . . . 0.0 106.897 -172.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -130.66 -170.98 12.81 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 125.615 1.579 . . . . 0.0 112.725 -171.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -57.83 175.9 0.39 Allowed 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 120.805 1.003 . . . . 0.0 110.129 138.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 30.1 m-70 46.99 90.26 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 128.967 2.907 . . . . 0.0 112.221 -178.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.92 61.81 0.73 Allowed Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.414 1.007 . . . . 0.0 112.406 170.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.27 67.49 1.43 Allowed 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 127.477 2.311 . . . . 0.0 106.866 169.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 -116.37 162.31 17.73 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 120.816 -1.178 . . . . 0.0 110.629 -172.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -61.15 140.56 57.87 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 123.806 0.691 . . . . 0.0 111.723 -159.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -128.51 85.33 60.64 Favored Pre-proline 0 N--CA 1.452 -0.334 0 C-N-CA 124.274 1.03 . . . . 0.0 109.129 -174.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.78 5.62 3.3 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 123.579 2.853 . . . . 0.0 112.872 167.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 61.83 67.97 0.72 Allowed 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 126.82 2.048 . . . . 0.0 111.545 -173.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.73 -71.97 0.68 Allowed 'General case' 0 N--CA 1.436 -1.175 0 C-N-CA 127.925 2.49 . . . . 0.0 111.973 -178.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -74.37 -6.99 51.35 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.281 1.032 . . . . 0.0 113.258 -179.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.414 ' C ' ' HD3' ' A' ' 149' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.459 -2.541 1 C-N-CA 131.908 4.083 . . . . 0.0 103.558 177.611 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 mmm . . . . . 0 N--CA 1.47 0.548 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.96 155.15 49.65 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 120.586 1.539 . . . . 0.0 107.49 148.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.1 m80 -108.34 130.94 55.18 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 176.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.461 HG22 ' HB2' ' A' ' 113' ' ' PHE . 17.4 pt -128.32 167.42 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 124.644 1.178 . . . . 0.0 109.403 176.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -126.75 144.73 50.85 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.586 1.154 . . . . 0.0 110.894 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 m -103.61 123.61 57.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 124.972 1.309 . . . . 0.0 111.038 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -76.39 -48.1 20.99 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -174.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.26 -1.18 0.03 OUTLIER Glycine 0 CA--C 1.531 1.054 0 CA-C-O 117.575 -1.68 . . . . 0.0 116.486 -172.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.417 ' HA ' ' HG2' ' A' ' 14' ' ' GLN . 0.3 OUTLIER -118.75 -6.93 10.58 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 120.309 2.055 . . . . 0.0 114.834 -163.192 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.7 mp -145.59 47.02 1.28 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.342 1.457 . . . . 0.0 108.363 176.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.22 -78.07 0.46 Allowed 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 117.051 -1.452 . . . . 0.0 109.811 170.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.429 ' CB ' HE22 ' A' ' 14' ' ' GLN . 10.7 mtt180 -50.91 -45.5 60.33 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.051 0.94 . . . . 0.0 111.533 -168.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 148.57 68.94 0.01 OUTLIER Glycine 0 C--N 1.333 0.403 0 N-CA-C 106.944 -2.462 . . . . 0.0 106.944 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.429 HE22 ' CB ' ' A' ' 12' ' ' ARG . 25.1 mp0 -102.89 160.84 24.96 Favored Pre-proline 0 N--CA 1.449 -0.507 0 C-N-CA 124.505 1.122 . . . . 0.0 110.464 -178.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.36 -32.67 89.61 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.737 1.625 . . . . 0.0 110.996 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -70.57 -24.27 62.75 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 124.642 1.177 . . . . 0.0 111.618 -176.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -52.0 -35.06 45.47 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.224 1.01 . . . . 0.0 110.779 -167.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.71 -33.56 7.1 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 124.953 1.301 . . . . 0.0 114.264 176.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.3 m -59.61 -35.53 59.97 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 119.95 1.25 . . . . 0.0 111.439 -176.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.1 ptp -83.09 -12.47 57.05 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 118.979 0.809 . . . . 0.0 112.848 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.2 mt -80.07 -11.82 59.73 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.187 0.595 . . . . 0.0 110.194 177.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -100.17 99.68 10.41 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -177.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 46.3 t-80 -59.32 -19.59 47.74 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.664 1.586 . . . . 0.0 113.376 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.84 -37.35 79.01 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.419 -0.801 . . . . 0.0 111.551 167.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 16.8 m170 -73.98 -35.64 64.48 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 121.393 -0.817 . . . . 0.0 109.475 170.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.93 -175.71 24.4 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.993 1.283 . . . . 0.0 112.738 168.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.5 mt -68.79 149.32 49.13 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.038 0.935 . . . . 0.0 113.144 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -161.95 110.61 1.46 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.091 2.156 . . . . 0.0 108.507 168.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -130.11 146.61 51.77 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.016 0.926 . . . . 0.0 109.848 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -69.01 86.95 0.37 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.568 2.347 . . . . 0.0 109.472 -176.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.07 64.12 0.83 Allowed 'General case' 0 C--O 1.234 0.281 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -178.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.88 -179.12 48.65 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-O 122.053 0.807 . . . . 0.0 112.79 -178.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.4 ptt180 -134.14 172.2 13.18 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.55 -0.971 . . . . 0.0 110.407 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -164.08 -176.79 36.26 Favored Glycine 0 CA--C 1.499 -0.932 0 N-CA-C 115.89 1.116 . . . . 0.0 115.89 -173.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.7 p -145.21 159.56 42.82 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 113.725 -1.237 . . . . 0.0 112.512 166.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.506 HG23 HG13 ' A' ' 63' ' ' VAL . 8.3 p -78.13 101.97 7.28 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 120.086 1.312 . . . . 0.0 107.852 172.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -71.14 -31.05 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 120.576 -1.328 . . . . 0.0 111.894 178.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -69.99 118.06 12.35 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 152.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.3 m -57.84 146.96 29.92 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 167.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -135.49 153.16 77.56 Favored Pre-proline 0 N--CA 1.466 0.349 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 169.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.441 ' HG2' ' HB2' ' A' ' 54' ' ' LEU . 40.9 Cg_endo -77.01 121.63 5.9 Favored 'Trans proline' 0 CA--C 1.533 0.457 1 C-N-CA 125.774 4.316 . . . . 0.0 113.043 177.293 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.6 tp -116.38 111.92 20.74 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 126.863 2.065 . . . . 0.0 108.858 -176.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.5 m -128.88 148.09 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 120.26 1.391 . . . . 0.0 111.937 -177.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 40.2 mt -86.93 128.07 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 169.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.59 173.47 11.47 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.54 0.686 . . . . 0.0 112.153 174.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.94 -174.72 55.27 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 126.544 2.021 . . . . 0.0 113.246 171.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -91.0 -3.45 57.25 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -170.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 30.4 m-70 -118.94 12.63 12.89 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.405 1.082 . . . . 0.0 111.779 176.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 53.51 71.27 0.51 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.015 2.126 . . . . 0.0 110.495 -178.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 88.6 mt -103.9 90.58 3.02 Favored Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 131.265 3.826 . . . . 0.0 108.368 -169.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -60.83 125.08 16.31 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 122.379 2.053 . . . . 0.0 112.602 176.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -116.63 156.97 26.13 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.912 1.685 . . . . 0.0 109.882 176.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.9 tp -115.54 114.76 25.41 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.233 1.413 . . . . 0.0 108.441 167.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.548 HD23 HG23 ' A' ' 117' ' ' THR . 26.0 mt -82.27 144.0 30.94 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 177.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -79.75 89.06 5.19 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 121.593 -0.692 . . . . 0.0 109.389 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.25 85.69 21.36 Favored Pre-proline 0 C--O 1.232 0.18 0 C-N-CA 123.534 0.734 . . . . 0.0 110.024 172.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -60.27 128.95 27.96 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.936 2.424 . . . . 0.0 109.598 -177.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.57 8.77 73.26 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 118.09 -1.395 . . . . 0.0 114.074 178.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.2 tptt -121.3 164.14 17.48 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 120.372 2.086 . . . . 0.0 107.216 172.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 74.51 -131.13 12.72 Favored Glycine 0 CA--C 1.519 0.288 0 O-C-N 120.613 -1.304 . . . . 0.0 109.945 -176.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -145.01 167.24 23.12 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.12 0.968 . . . . 0.0 111.033 -170.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 31.6 m -92.27 80.63 4.99 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 126.717 2.007 . . . . 0.0 112.448 -173.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.506 HG13 HG23 ' A' ' 36' ' ' THR . 1.6 p -70.05 136.21 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.117 0 CA-C-O 118.113 -0.946 . . . . 0.0 113.196 -165.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.2 p -91.06 152.46 20.63 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.88 -175.51 32.99 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 178.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -106.25 158.2 17.03 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 125.736 1.615 . . . . 0.0 106.771 173.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 80.8 mt -113.63 110.07 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 104.792 -2.299 . . . . 0.0 104.792 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -93.17 123.48 36.48 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 118.528 -0.749 . . . . 0.0 109.663 -176.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -68.48 107.93 3.09 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 152.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.8 m -103.72 169.67 2.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 166.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -119.24 177.71 4.79 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 161.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -45.02 -46.43 11.31 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 127.977 2.511 . . . . 0.0 110.835 -170.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -57.64 -45.56 85.31 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.124 0.97 . . . . 0.0 111.367 -175.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 22.4 tpp -72.52 -45.9 57.18 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -176.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.43 -32.86 73.78 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.778 -178.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 78.0 mtt180 -69.23 -37.73 78.16 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.874 1.215 . . . . 0.0 111.505 176.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -60.19 -48.3 82.32 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 119.113 -0.47 . . . . 0.0 110.002 174.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.6 mp -57.57 -41.37 80.94 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.214 0.461 . . . . 0.0 109.922 176.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -65.9 4.66 0.6 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.054 1.742 . . . . 0.0 114.76 -178.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -129.9 -47.94 1.13 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.323 2.249 . . . . 0.0 109.852 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -63.11 -42.74 99.61 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 125.802 1.641 . . . . 0.0 111.518 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -78.03 11.31 2.32 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.871 0.868 . . . . 0.0 110.808 176.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.2 t0 54.43 16.81 1.38 Allowed 'General case' 0 C--O 1.236 0.387 0 C-N-CA 128.596 2.758 . . . . 0.0 114.625 171.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 6.8 p -62.47 155.76 66.05 Favored Pre-proline 0 N--CA 1.445 -0.721 0 O-C-N 121.227 -0.921 . . . . 0.0 110.035 -178.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -73.76 -4.23 16.71 Favored 'Cis proline' 0 CA--C 1.543 0.93 0 N-CA-C 115.223 1.201 . . . . 0.0 115.223 -2.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 9.5 m -63.96 -63.68 1.09 Allowed 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.072 1.349 . . . . 0.0 112.406 -173.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 27.3 mtp -74.35 -76.7 0.13 Allowed 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -100.01 -176.55 3.27 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 125.354 1.461 . . . . 0.0 109.329 178.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.93 151.55 30.46 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 120.761 -1.212 . . . . 0.0 109.795 158.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -63.93 125.85 25.74 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 118.491 -0.766 . . . . 0.0 109.954 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 43.5 m -132.4 174.79 9.88 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.009 1.724 . . . . 0.0 106.95 167.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -125.23 132.69 52.93 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.711 1.604 . . . . 0.0 109.615 172.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.447 ' CD1' HG11 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -123.83 177.29 5.81 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.731 1.612 . . . . 0.0 109.927 -179.207 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 34.2 tp60 -105.87 114.26 28.31 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 127.253 2.221 . . . . 0.0 109.685 -178.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 54.3 t -109.29 141.22 25.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 125.65 1.58 . . . . 0.0 107.633 -177.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -76.29 137.29 39.8 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 165.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.523 ' CG1' ' HA ' ' A' ' 108' ' ' ASP 0.254 3.7 p -98.07 83.81 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 179.017 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -61.66 -22.62 65.45 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 125.471 1.509 . . . . 0.0 111.935 -175.734 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -154.46 154.52 33.33 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 170.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 -132.69 124.98 29.23 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.247 1.419 . . . . 0.0 107.408 175.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -91.42 115.62 28.18 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.78 0.832 . . . . 0.0 109.15 177.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.88 -169.24 32.21 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 123.307 0.48 . . . . 0.0 112.129 169.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -68.74 171.96 7.06 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.329 1.451 . . . . 0.0 111.224 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 73.56 67.49 1.78 Allowed Glycine 0 C--O 1.226 -0.385 0 O-C-N 120.469 -1.394 . . . . 0.0 112.79 170.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -101.56 89.76 1.56 Allowed Pre-proline 0 C--O 1.238 0.48 0 C-N-CA 128.741 2.816 . . . . 0.0 110.157 -163.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -54.97 -22.52 30.9 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 124.447 3.432 . . . . 0.0 114.388 -172.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 102.8 157.16 25.44 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 -171.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.523 ' HA ' ' CG1' ' A' ' 97' ' ' VAL . 25.2 t70 -63.85 5.08 0.24 Allowed 'General case' 0 CA--C 1.508 -0.638 0 C-N-CA 129.588 3.155 . . . . 0.0 116.698 -163.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.2 p -134.19 152.15 51.68 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 116.566 -2.054 . . . . 0.0 113.004 146.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 34.8 m -136.94 152.06 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 124.644 1.178 . . . . 0.0 109.353 -173.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -89.33 130.19 35.75 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 168.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 12.0 p -129.5 -179.93 5.45 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 118.482 -0.77 . . . . 0.0 109.059 169.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.461 ' HB2' HG22 ' A' ' 4' ' ' ILE . 40.7 m-85 -101.56 159.72 15.06 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.297 0.953 . . . . 0.0 111.103 164.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.447 HG11 ' CD1' ' A' ' 93' ' ' LEU . 0.1 OUTLIER -163.03 118.02 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 128.911 2.884 . . . . 0.0 104.018 -158.837 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -83.19 86.18 7.08 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 172.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.1 p -94.45 -179.86 5.04 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.018 0.927 . . . . 0.0 108.659 172.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.548 HG23 HD23 ' A' ' 54' ' ' LEU . 1.1 t -133.33 140.81 47.62 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -103.6 -9.77 18.96 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.948 1.299 . . . . 0.0 111.242 166.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . 0.268 3.2 t -103.56 34.94 2.76 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 122.35 1.072 . . . . 0.0 111.052 -161.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.504 ' HB3' HD22 ' A' ' 54' ' ' LEU . 39.4 p90 -65.61 164.29 14.56 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.971 1.709 . . . . 0.0 113.173 -174.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -91.12 149.5 40.02 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 125.364 1.466 . . . . 0.0 108.795 167.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.51 -30.16 71.29 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.17 1.913 . . . . 0.0 113.089 -171.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.511 ' HA ' ' CD2' ' A' ' 126' ' ' PHE . 4.6 pm0 -58.1 -29.86 65.8 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.309 1.044 . . . . 0.0 113.06 177.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 46.2 m0 -71.73 -8.34 53.6 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 122.081 -0.387 . . . . 0.0 111.275 -173.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -89.9 -20.26 23.6 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 117.969 -1.015 . . . . 0.0 112.026 171.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.511 ' CD2' ' HA ' ' A' ' 123' ' ' GLU . 18.0 m-85 -68.88 -36.0 77.55 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 120.14 1.336 . . . . 0.0 110.157 174.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 56.4 mt -58.21 149.92 55.34 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 125.137 1.375 . . . . 0.0 110.439 -176.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.96 166.61 29.23 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.443 2.096 . . . . 0.0 110.237 173.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -118.75 160.14 22.41 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.868 0.867 . . . . 0.0 110.454 -175.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 59.5 m-70 -139.86 166.64 24.1 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.304 0.642 . . . . 0.0 110.895 -175.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -127.32 -4.92 6.06 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.203 1.401 . . . . 0.0 112.228 -170.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.0 p -138.7 -178.8 5.47 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 153.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -126.58 174.83 8.39 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 122.514 1.149 . . . . 0.0 110.063 157.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.35 88.88 1.74 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 113.132 -1.849 . . . . 0.0 107.76 178.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.08 -22.64 65.94 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.045 -1.034 . . . . 0.0 110.216 167.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -105.17 73.01 1.02 Allowed 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 105.018 -2.215 . . . . 0.0 105.018 170.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -143.93 155.01 25.99 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 177.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -73.71 -6.56 18.86 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.009 2.473 . . . . 0.0 113.229 -167.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 51.9 m-70 -51.88 -33.82 38.32 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.596 1.158 . . . . 0.0 113.048 -170.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 98.47 -19.17 55.48 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.714 1.15 . . . . 0.0 113.53 168.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.545 ' HG ' HH21 ' A' ' 142' ' ' ARG . 0.2 OUTLIER -98.89 57.94 1.13 Allowed 'General case' 0 C--O 1.238 0.49 0 C-N-CA 126.865 2.066 . . . . 0.0 109.216 172.451 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.545 HH21 ' HG ' ' A' ' 141' ' ' LEU . 5.9 mmp_? -84.54 169.57 14.31 Favored 'General case' 0 C--O 1.237 0.408 0 O-C-N 120.386 -1.446 . . . . 0.0 109.941 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -61.83 150.79 36.2 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -173.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -114.34 79.33 5.16 Favored Pre-proline 0 CA--C 1.534 0.344 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 177.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.16 -41.18 13.5 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.773 2.315 . . . . 0.0 111.546 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 30.7 ttt-85 -151.15 5.57 0.48 Allowed 'General case' 0 CA--C 1.526 0.057 0 C-N-CA 124.959 1.304 . . . . 0.0 112.195 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -57.78 -42.24 83.71 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.581 1.552 . . . . 0.0 111.93 -164.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -121.75 30.4 6.7 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.552 1.141 . . . . 0.0 109.631 174.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 . . . . . 0 C--O 1.253 1.238 0 CA-C-O 115.823 -2.037 . . . . 0.0 108.472 -157.254 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 mtt . . . . . 0 N--CA 1.467 0.42 0 CA-C-O 118.188 -0.91 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.26 164.5 26.39 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 118.737 0.699 . . . . 0.0 109.235 172.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -125.77 123.97 39.96 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 177.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.8 pt -130.41 173.57 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 122.776 1.274 . . . . 0.0 110.158 -178.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.41 ' HB3' HG22 ' A' ' 114' ' ' VAL . 37.4 t80 -112.08 155.32 24.04 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 125.744 1.618 . . . . 0.0 107.314 169.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.554 ' CG2' ' HB2' ' A' ' 10' ' ' LEU . 5.0 p -79.3 176.56 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-O 121.785 0.802 . . . . 0.0 109.698 175.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -125.92 174.46 8.38 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 173.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.62 -10.96 20.39 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 115.246 0.858 . . . . 0.0 115.246 -171.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.76 -23.69 36.48 Favored 'General case' 0 N--CA 1.435 -1.184 0 C-N-CA 125.498 1.519 . . . . 0.0 110.876 -175.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.554 ' HB2' ' CG2' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -125.58 -3.23 7.29 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 121.007 1.73 . . . . 0.0 111.915 -169.361 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -82.6 -7.25 59.65 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 115.288 1.588 . . . . 0.0 115.288 -173.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -135.4 -85.96 0.38 Allowed 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 120.652 1.569 . . . . 0.0 107.082 176.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -160.44 15.21 0.19 Allowed Glycine 0 CA--C 1.529 0.922 0 CA-C-O 118.332 -1.26 . . . . 0.0 113.002 -168.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.465 ' HB3' ' HD2' ' A' ' 15' ' ' PRO . 3.1 mm-40 -57.83 164.57 3.08 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 119.709 1.755 . . . . 0.0 109.857 -175.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 14' ' ' GLN . 58.8 Cg_endo -68.12 -2.53 9.03 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 123.874 3.049 . . . . 0.0 113.415 -169.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -96.17 -14.46 22.76 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 127.897 2.479 . . . . 0.0 111.953 -177.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -48.71 -33.28 9.86 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 120.04 1.291 . . . . 0.0 110.609 -175.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.8 pttp -44.52 -32.47 1.42 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.049 1.739 . . . . 0.0 114.22 176.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.2 m -66.64 -11.67 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 123.633 0.773 . . . . 0.0 112.348 -177.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.2 ptp -121.56 14.74 11.08 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.279 1.432 . . . . 0.0 112.219 172.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 56.7 mt -115.05 2.99 14.33 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 124.72 1.208 . . . . 0.0 111.971 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -131.46 96.78 4.07 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 123.967 0.907 . . . . 0.0 108.56 -175.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 -55.7 -20.82 15.64 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.73 1.212 . . . . 0.0 112.31 -176.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 t -62.38 -25.79 68.12 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 120.13 1.332 . . . . 0.0 111.65 174.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -83.38 -1.99 54.72 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.401 -0.812 . . . . 0.0 111.794 174.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.93 177.0 19.25 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 124.874 1.226 . . . . 0.0 111.09 -175.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 35.0 tp -93.22 137.96 32.06 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.833 0.853 . . . . 0.0 111.335 -173.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -130.27 135.13 47.78 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 159.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.9 136.94 37.56 Favored 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 124.782 1.233 . . . . 0.0 109.323 -177.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -64.46 109.28 1.89 Allowed 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.679 0.792 . . . . 0.0 109.407 -179.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 -116.21 51.86 0.94 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 -175.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.15 -153.03 46.14 Favored Glycine 0 N--CA 1.442 -0.961 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -151.13 170.39 19.55 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.688 -0.89 . . . . 0.0 111.945 -171.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -174.18 178.75 45.91 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.029 -1.081 . . . . 0.0 115.478 -175.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 64.4 m -137.48 132.66 33.62 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 177.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.2 p -65.98 101.78 0.72 Allowed 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -69.83 -29.31 40.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 O-C-N 121.877 -0.514 . . . . 0.0 110.211 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -58.68 109.47 0.81 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 156.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.1 m -55.25 140.1 40.17 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 164.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -139.74 153.44 70.05 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 171.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.38 98.44 1.17 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 124.626 3.551 . . . . 0.0 110.077 173.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 54.1 tp -88.89 117.42 27.88 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 166.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.7 m -128.07 149.81 33.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.2 mt -114.23 98.15 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 -177.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.71 135.06 25.93 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.813 1.645 . . . . 0.0 108.797 -167.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.05 147.14 12.84 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 125.427 1.489 . . . . 0.0 110.739 -172.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -63.13 -26.8 68.99 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.807 1.643 . . . . 0.0 114.094 -164.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -90.13 3.85 52.15 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -174.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 51.75 61.87 3.0 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.064 1.345 . . . . 0.0 110.319 -167.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 52.1 mt -107.16 86.88 2.74 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 128.093 2.557 . . . . 0.0 104.149 172.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -62.22 152.92 73.3 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 121.281 1.32 . . . . 0.0 111.095 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -119.92 157.83 27.95 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.874 1.27 . . . . 0.0 109.702 -177.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.3 tp -122.43 94.2 4.22 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 175.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.6 mt -68.02 131.32 45.25 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.567 ' CE1' HG21 ' A' ' 91' ' ' THR . 58.9 t80 -71.64 96.07 1.53 Allowed 'General case' 0 C--O 1.239 0.502 0 C-N-CA 119.825 -0.75 . . . . 0.0 109.476 -176.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.43 85.31 6.81 Favored Pre-proline 0 CA--C 1.535 0.37 0 C-N-CA 123.742 0.817 . . . . 0.0 112.366 175.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -62.89 122.38 10.64 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.073 2.515 . . . . 0.0 109.315 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.75 -4.0 56.2 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 125.713 1.625 . . . . 0.0 114.604 177.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -106.42 167.09 10.07 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 120.552 2.176 . . . . 0.0 109.145 168.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 61.53 -142.54 48.33 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 -170.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -142.04 179.55 6.82 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.583 1.153 . . . . 0.0 110.59 -171.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 77.6 m -77.15 114.51 16.03 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.516 1.126 . . . . 0.0 109.68 178.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.1 t -77.82 112.4 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 172.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.5 p -81.88 145.08 30.55 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.337 -0.852 . . . . 0.0 109.01 177.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -169.81 -172.03 35.95 Favored Glycine 0 C--N 1.342 0.889 0 O-C-N 121.018 -1.051 . . . . 0.0 112.466 -172.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -114.65 161.0 18.68 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 176.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 62.2 mt -111.02 135.46 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 124.709 1.203 . . . . 0.0 108.286 -175.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -124.94 125.06 43.33 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 123.691 0.796 . . . . 0.0 108.987 175.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -71.39 142.95 50.33 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 158.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.5 m -140.75 153.25 20.98 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -176.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -94.51 174.95 6.86 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 122.585 1.183 . . . . 0.0 111.378 172.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.39 -5.49 40.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 113.493 -1.685 . . . . 0.0 113.051 -175.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -85.62 -46.89 10.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 118.028 -0.986 . . . . 0.0 110.417 164.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 25.3 tpp -63.75 -50.03 70.68 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.772 1.169 . . . . 0.0 111.168 -177.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.06 -17.28 64.82 Favored 'General case' 0 CA--C 1.547 0.865 0 O-C-N 122.237 -0.289 . . . . 0.0 111.071 -175.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 23.6 mtt180 -86.8 -42.94 12.89 Favored 'General case' 0 C--O 1.222 -0.374 0 C-N-CA 127.63 2.372 . . . . 0.0 110.901 172.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -60.57 -44.87 95.7 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.951 1.251 . . . . 0.0 109.562 177.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.5 mp -58.41 -30.73 67.08 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.54 -0.725 . . . . 0.0 110.855 171.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.489 ' HA ' ' SG ' ' A' ' 84' ' ' CYS . 1.1 t70 -70.98 3.71 3.16 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.177 1.391 . . . . 0.0 113.44 176.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -126.97 -43.15 1.69 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 127.129 2.172 . . . . 0.0 109.699 176.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -65.9 -37.98 87.52 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.539 1.536 . . . . 0.0 112.378 177.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -91.01 6.52 44.5 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 123.227 0.611 . . . . 0.0 111.462 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 86' ' ' SER . 10.2 t0 52.06 30.24 7.28 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.776 1.23 . . . . 0.0 113.62 175.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.489 ' SG ' ' HA ' ' A' ' 79' ' ' ASP . 0.8 OUTLIER -74.24 159.63 83.35 Favored Pre-proline 0 CA--C 1.536 0.414 0 O-C-N 118.613 -2.554 . . . . 0.0 109.559 172.024 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -72.77 -4.45 14.16 Favored 'Cis proline' 0 CA--C 1.544 1.011 0 CA-C-N 120.477 1.206 . . . . 0.0 114.205 -6.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 3.0 m -54.62 -72.33 0.07 Allowed 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.24 1.016 . . . . 0.0 111.625 177.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.404 ' HG3' ' HB3' ' A' ' 83' ' ' ASP . 8.6 mtm -74.74 -64.61 1.0 Allowed 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -173.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -101.99 172.16 7.08 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.753 0.821 . . . . 0.0 108.983 178.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -135.23 -14.95 1.97 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 178.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 61.45 148.21 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 128.623 2.769 . . . . 0.0 114.635 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.567 HG21 ' CE1' ' A' ' 55' ' ' TYR . 17.4 m -154.17 170.82 20.3 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -174.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.41 ' O ' HG22 ' A' ' 91' ' ' THR . . . -87.4 159.41 18.72 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.042 1.337 . . . . 0.0 110.196 162.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.606 HD21 ' SG ' ' A' ' 112' ' ' CYS . 0.0 OUTLIER -150.15 -166.6 2.59 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.664 1.185 . . . . 0.0 111.012 176.085 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.77 123.36 32.73 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.022 0.929 . . . . 0.0 110.624 172.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.474 HG13 ' CG1' ' A' ' 110' ' ' VAL . 1.4 p -138.23 111.24 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -170.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -54.03 127.68 27.49 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 124.621 1.168 . . . . 0.0 110.091 -177.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 25.6 t -80.55 82.17 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 C-N-CA 127.503 2.321 . . . . 0.0 107.165 179.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.8 mp -63.1 -30.08 71.31 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.1 0.56 . . . . 0.0 110.227 175.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -154.08 160.48 41.98 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 126.164 1.786 . . . . 0.0 107.741 168.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 54.2 t-105 -144.1 124.56 13.94 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.592 1.557 . . . . 0.0 107.21 174.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -113.48 96.03 5.67 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.482 1.289 . . . . 0.0 114.482 177.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 118.76 -178.92 16.81 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 124.955 1.264 . . . . 0.0 110.868 -176.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -67.85 172.96 4.8 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.67 1.188 . . . . 0.0 110.564 177.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.63 41.18 3.44 Favored Glycine 0 C--O 1.219 -0.84 0 C-N-CA 124.367 0.984 . . . . 0.0 111.689 173.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -101.27 89.17 1.28 Allowed Pre-proline 0 C--N 1.321 -0.647 0 C-N-CA 130.624 3.57 . . . . 0.0 110.02 -155.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -73.81 -26.69 13.19 Favored 'Trans proline' 0 CA--C 1.538 0.708 1 C-N-CA 126.456 4.771 . . . . 0.0 114.807 -159.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 128.71 -164.23 21.92 Favored Glycine 0 CA--C 1.533 1.198 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -160.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -63.96 -23.83 67.49 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 117.932 0.866 . . . . 0.0 113.325 -169.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.75 169.34 17.89 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.878 1.271 . . . . 0.0 109.884 -174.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.474 ' CG1' HG13 ' A' ' 95' ' ' VAL 0.289 11.3 p -130.67 153.54 39.25 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 C-N-CA 117.63 -1.628 . . . . 0.0 108.699 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -96.13 77.78 3.11 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 173.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.606 ' SG ' HD21 ' A' ' 93' ' ' LEU . 1.6 p -82.36 -167.55 1.63 Allowed 'General case' 0 C--O 1.237 0.41 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.9 177.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -120.46 136.6 54.7 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.328 0.651 . . . . 0.0 109.272 162.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.437 HG23 HD11 ' A' ' 93' ' ' LEU . 95.5 t -124.48 153.42 31.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 169.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -84.23 105.0 14.74 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.051 -1.03 . . . . 0.0 109.354 176.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 70.6 p -86.18 175.98 8.21 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.672 1.189 . . . . 0.0 110.35 172.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.7 t -128.49 146.26 50.87 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 149.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -117.42 5.59 12.54 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.383 1.073 . . . . 0.0 111.381 176.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 11.4 t -126.28 47.04 2.33 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 122.805 1.288 . . . . 0.0 110.058 -176.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 14.8 p90 -78.83 156.2 28.83 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.142 0.977 . . . . 0.0 111.866 -178.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -67.05 157.26 85.45 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 125.153 1.381 . . . . 0.0 110.515 173.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -59.88 -48.36 12.8 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.063 2.509 . . . . 0.0 112.578 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -51.57 -32.38 28.24 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.674 1.19 . . . . 0.0 113.661 -178.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 44.2 m0 -71.14 -14.86 62.42 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.344 -0.847 . . . . 0.0 111.4 -173.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 78.7 mt -71.36 -20.0 62.22 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 118.061 -0.971 . . . . 0.0 111.842 170.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -95.91 -24.74 16.28 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.632 1.106 . . . . 0.0 110.889 -168.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 77.1 mt -60.25 156.93 36.68 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 126.103 1.761 . . . . 0.0 111.961 -173.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -66.74 151.21 82.98 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 121.916 1.744 . . . . 0.0 109.64 175.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -104.92 162.99 12.86 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.335 1.054 . . . . 0.0 111.542 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -137.67 144.48 41.85 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 123.529 0.731 . . . . 0.0 111.938 -173.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -94.64 -12.7 26.87 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.032 1.333 . . . . 0.0 112.181 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 51.9 p -159.23 172.7 17.55 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 120.61 -1.306 . . . . 0.0 109.743 173.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.61 148.0 40.24 Favored 'General case' 0 N--CA 1.434 -1.245 0 C-N-CA 126.649 1.98 . . . . 0.0 107.227 -178.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -156.81 113.68 3.08 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 105.28 -2.118 . . . . 0.0 105.28 172.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.36 1.23 19.56 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.773 -0.579 . . . . 0.0 110.734 173.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -120.35 45.25 2.25 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.013 1.725 . . . . 0.0 106.782 164.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -109.66 155.8 15.91 Favored Glycine 0 CA--C 1.534 1.226 0 N-CA-C 109.921 -1.271 . . . . 0.0 109.921 166.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -66.76 6.64 0.53 Allowed 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 125.289 3.993 . . . . 0.0 114.71 178.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 61.0 m-70 -58.58 -13.74 6.46 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 120.688 -1.258 . . . . 0.0 114.239 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 86.22 -46.62 3.63 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 124.871 1.224 . . . . 0.0 112.227 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.91 75.55 2.82 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.408 1.083 . . . . 0.0 112.188 179.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -95.92 157.92 15.68 Favored 'General case' 0 N--CA 1.463 0.178 0 O-C-N 121.403 -0.811 . . . . 0.0 110.707 175.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -59.28 156.73 11.99 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.947 1.299 . . . . 0.0 110.834 -176.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -114.28 85.1 10.1 Favored Pre-proline 0 C--O 1.238 0.47 0 C-N-CA 125.748 1.619 . . . . 0.0 107.751 177.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -77.1 -46.84 0.14 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 123.761 2.974 . . . . 0.0 111.499 178.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.679 ' HB2' ' HD3' ' A' ' 149' ' ' ARG . 8.8 tpt180 -137.74 -4.07 1.81 Allowed 'General case' 0 CA--C 1.508 -0.646 0 CA-C-O 123.595 1.664 . . . . 0.0 114.385 -176.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 57.07 -1.29 0.06 Allowed 'General case' 0 N--CA 1.425 -1.702 1 C-N-CA 131.988 4.115 . . . . 0.0 114.735 -174.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -159.58 10.03 0.12 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.108 2.163 . . . . 0.0 111.578 -159.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.679 ' HD3' ' HB2' ' A' ' 146' ' ' ARG . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 117.388 -1.291 . . . . 0.0 108.85 178.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.438 ' HA ' ' OE2' ' A' ' 69' ' ' GLU . 8.8 mtt . . . . . 0 N--CA 1.471 0.584 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.81 83.04 1.34 Allowed 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 125.083 1.353 . . . . 0.0 108.011 -169.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -63.22 138.33 58.51 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 124.698 1.199 . . . . 0.0 109.437 -174.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.3 pt -125.56 167.78 19.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 124.33 1.052 . . . . 0.0 109.221 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -132.69 136.52 46.47 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.474 0.71 . . . . 0.0 109.48 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.599 HG22 ' H ' ' A' ' 66' ' ' GLU . 34.5 m -75.34 114.68 15.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 123.353 0.661 . . . . 0.0 109.933 -172.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -66.45 -3.9 7.15 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.044 0.938 . . . . 0.0 113.122 174.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 145.05 -1.04 1.02 Allowed Glycine 0 CA--C 1.528 0.891 0 CA-C-O 118.972 -0.904 . . . . 0.0 115.045 168.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 p -109.81 -16.59 13.85 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 120.198 1.999 . . . . 0.0 113.5 -160.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.68 30.61 6.62 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.874 1.27 . . . . 0.0 110.859 -171.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.493 ' HB2' HG21 ' A' ' 6' ' ' VAL . 1.8 tmtm? -132.4 -84.87 0.48 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 117.344 -1.313 . . . . 0.0 109.205 -176.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.4 mmt-85 -50.62 -78.71 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.61 1.564 . . . . 0.0 112.3 -173.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -171.72 10.92 0.04 OUTLIER Glycine 0 CA--C 1.52 0.404 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -162.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.13 150.66 91.83 Favored Pre-proline 0 CA--C 1.537 0.449 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 175.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -68.89 -12.36 34.24 Favored 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 123.694 2.929 . . . . 0.0 112.697 -169.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -85.18 -12.5 52.57 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 116.247 -1.835 . . . . 0.0 112.501 -174.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -49.66 -39.02 34.9 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 121.302 1.864 . . . . 0.0 110.098 -176.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -50.65 -24.79 3.57 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 115.343 1.609 . . . . 0.0 115.343 178.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.4 m -56.18 -45.63 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 120.835 1.652 . . . . 0.0 110.698 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.426 ' HA ' ' CE ' ' A' ' 74' ' ' MET . 2.3 mmm -73.02 -7.45 51.29 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -176.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.1 mt -101.43 11.4 39.21 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.653 1.181 . . . . 0.0 108.487 -175.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -127.15 103.28 7.35 Favored 'General case' 0 CA--C 1.513 -0.466 0 O-C-N 121.307 -0.871 . . . . 0.0 109.942 178.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -66.39 -18.86 65.6 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -175.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 m -66.41 -19.93 65.93 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.29 -0.881 . . . . 0.0 112.403 168.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 39.3 m170 -93.44 -17.49 23.41 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.938 0.895 . . . . 0.0 110.994 169.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 130.96 178.73 15.61 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 124.787 1.184 . . . . 0.0 112.114 169.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 37.5 tp -88.42 147.33 24.75 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 123.242 0.617 . . . . 0.0 111.352 -175.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.95 158.55 44.21 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.361 1.064 . . . . 0.0 109.243 161.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -143.64 136.46 27.44 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 126.826 2.051 . . . . 0.0 108.931 175.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -75.56 79.08 2.57 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.509 1.924 . . . . 0.0 110.0 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -95.5 63.27 2.48 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 121.14 -0.975 . . . . 0.0 109.935 174.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.17 175.0 27.65 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-O 122.598 1.11 . . . . 0.0 113.975 158.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 44.5 mtp85 -113.82 158.01 21.57 Favored 'General case' 0 CA--C 1.516 -0.34 0 O-C-N 121.586 -0.949 . . . . 0.0 108.686 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -171.42 177.54 44.24 Favored Glycine 0 CA--C 1.506 -0.493 0 CA-C-O 122.235 0.908 . . . . 0.0 112.895 -176.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.3 p -140.09 146.17 38.57 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.101 -1.049 . . . . 0.0 108.47 172.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.2 p -71.2 96.99 1.45 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 104.999 -2.222 . . . . 0.0 104.999 170.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -67.28 -36.45 76.74 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.47 111.55 1.02 Allowed 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 160.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -57.5 142.81 42.99 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 174.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -137.48 153.72 74.65 Favored Pre-proline 0 N--CA 1.45 -0.474 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 169.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -80.17 96.69 1.03 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 1 C-N-CA 125.704 4.269 . . . . 0.0 110.792 177.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 51.0 tp -92.4 114.38 26.92 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 169.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.5 m -126.57 149.38 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 177.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.9 mt -94.16 121.62 44.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 177.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.22 -179.73 6.03 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.554 0.741 . . . . 0.0 110.459 176.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.42 153.88 4.25 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 125.31 1.433 . . . . 0.0 111.849 172.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -67.24 -16.93 64.58 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 121.145 -1.209 . . . . 0.0 113.299 -171.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 24.9 m-70 -100.44 9.56 42.44 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 123.882 0.873 . . . . 0.0 112.998 -173.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 57.44 66.25 1.18 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.705 1.602 . . . . 0.0 108.716 -172.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 96.3 mt -112.23 87.02 8.52 Favored Pre-proline 0 C--N 1.331 -0.202 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.69 145.55 95.07 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 CA-C-N 121.021 1.4 . . . . 0.0 111.749 170.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 22.1 m95 -123.78 161.18 25.74 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.781 1.232 . . . . 0.0 108.641 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.8 tp -116.51 96.02 5.32 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 174.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.76 135.72 57.78 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 172.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -71.24 93.94 1.14 Allowed 'General case' 0 C--O 1.233 0.237 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.85 74.4 14.72 Favored Pre-proline 0 CA--C 1.537 0.444 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -59.88 120.71 8.67 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.233 1.956 . . . . 0.0 109.401 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.03 -1.84 40.99 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 126.953 2.216 . . . . 0.0 114.242 177.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -112.03 160.94 17.0 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 120.672 2.236 . . . . 0.0 108.016 174.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.09 -142.46 34.47 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 109.739 -1.345 . . . . 0.0 109.739 -173.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -140.95 178.14 7.57 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.421 1.088 . . . . 0.0 110.129 -171.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 68.9 m -76.41 109.71 10.35 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 118.887 0.767 . . . . 0.0 111.076 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.5 t -75.26 108.89 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 174.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 59.2 p -72.2 160.83 31.77 Favored 'General case' 0 C--O 1.24 0.56 0 O-C-N 121.321 -0.862 . . . . 0.0 109.291 174.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 174.46 -157.55 25.2 Favored Glycine 0 C--N 1.335 0.505 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 -176.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.599 ' H ' HG22 ' A' ' 6' ' ' VAL . 9.8 mt-10 -134.99 156.47 48.98 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 125.21 1.404 . . . . 0.0 108.158 178.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.3 mt -103.99 128.25 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 -176.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -122.98 126.83 47.91 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 172.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.438 ' OE2' ' HA ' ' A' ' 1' ' ' MET . 4.7 tp10 -67.89 151.11 47.67 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 155.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.7 m -144.91 162.86 13.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 124.78 1.232 . . . . 0.0 107.862 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -105.54 171.3 7.4 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.995 0.902 . . . . 0.0 109.102 169.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.31 -32.29 68.34 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.393 1.477 . . . . 0.0 112.287 -163.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -69.91 -38.48 76.27 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-O 117.33 -1.319 . . . . 0.0 110.999 176.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.426 ' CE ' ' HA ' ' A' ' 20' ' ' MET . 43.6 tpp -65.69 -47.05 76.73 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 120.438 1.472 . . . . 0.0 109.18 178.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.05 -31.82 73.15 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.052 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -68.39 -45.02 73.82 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.503 1.047 . . . . 0.0 111.708 170.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -60.47 -50.36 73.87 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.682 0.793 . . . . 0.0 110.064 -176.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.6 mt -62.1 -36.3 81.3 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 122.806 0.442 . . . . 0.0 111.342 -175.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -51.54 -54.67 24.91 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 126.31 1.844 . . . . 0.0 108.757 172.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -68.88 -41.24 78.6 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.352 1.061 . . . . 0.0 112.296 -177.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -60.81 -53.57 55.77 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.271 1.428 . . . . 0.0 110.777 -168.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -74.79 -5.26 42.45 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.019 0.372 . . . . 0.0 111.594 -177.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.0 t0 75.02 25.31 1.38 Allowed 'General case' 0 C--O 1.233 0.2 0 C-N-CA 128.861 2.865 . . . . 0.0 113.782 -174.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -62.4 161.66 24.56 Favored Pre-proline 0 CA--C 1.547 0.858 0 O-C-N 119.837 -1.789 . . . . 0.0 108.44 165.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -72.21 -3.82 12.38 Favored 'Cis proline' 0 CA--C 1.548 1.224 0 CA-C-N 119.392 0.818 . . . . 0.0 113.004 -12.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.16 -59.6 5.2 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.479 1.912 . . . . 0.0 111.083 -175.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 27.5 mtp -82.83 -76.89 0.25 Allowed 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.859 1.263 . . . . 0.0 108.402 178.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -88.92 -177.4 5.47 Favored 'General case' 0 C--O 1.227 -0.122 0 C-N-CA 125.318 1.447 . . . . 0.0 110.319 -179.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 6.7 mp0 -138.21 176.61 8.55 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.605 2.362 . . . . 0.0 106.72 159.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -117.99 126.02 51.51 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.471 1.509 . . . . 0.0 108.382 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.7 m -126.09 150.91 47.86 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.212 0.605 . . . . 0.0 110.032 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.07 137.75 33.98 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.503 1.521 . . . . 0.0 109.533 166.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.599 HD11 HG23 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -142.68 -164.64 1.87 Allowed 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 127.852 2.461 . . . . 0.0 108.187 -177.254 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -119.42 139.76 51.5 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 123.613 0.765 . . . . 0.0 110.561 173.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 10.8 t -127.46 149.43 32.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 173.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -87.41 137.23 32.51 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 126.706 2.002 . . . . 0.0 105.656 170.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.751 HG13 ' HA ' ' A' ' 108' ' ' ASP 0.324 1.7 p -94.74 92.2 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 176.084 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.68 -45.53 93.59 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 114.358 -1.292 . . . . 0.0 108.802 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -141.58 140.83 33.47 Favored 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 125.651 1.58 . . . . 0.0 107.296 177.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 50.5 t-105 -108.7 141.24 40.97 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 167.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -119.93 101.37 7.81 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 165.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 139.93 177.72 16.09 Favored Glycine 0 C--N 1.331 0.252 0 CA-C-O 122.826 1.237 . . . . 0.0 112.822 164.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -64.67 162.29 16.07 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 168.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 72.44 75.19 0.71 Allowed Glycine 0 CA--C 1.522 0.474 0 O-C-N 120.937 -1.102 . . . . 0.0 111.883 176.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -102.28 90.52 2.12 Favored Pre-proline 0 N--CA 1.471 0.587 0 C-N-CA 128.399 2.68 . . . . 0.0 108.176 -172.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -53.15 -29.67 46.91 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.479 2.119 . . . . 0.0 114.807 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 145.73 -120.29 1.32 Allowed Glycine 0 C--N 1.338 0.694 0 CA-C-N 121.106 1.775 . . . . 0.0 110.729 -175.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.751 ' HA ' HG13 ' A' ' 97' ' ' VAL . 0.9 OUTLIER -143.9 1.04 1.12 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.319 1.848 . . . . 0.0 110.812 179.338 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.2 p -131.93 158.17 42.1 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 122.184 0.992 . . . . 0.0 110.62 148.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.4 m -137.74 167.25 22.85 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 C-N-CA 125.67 1.588 . . . . 0.0 108.444 -177.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -95.58 118.96 33.24 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 163.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 80.1 m -109.41 167.64 9.97 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.465 1.029 . . . . 0.0 109.4 165.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -95.13 141.57 28.59 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 163.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.599 HG23 HD11 ' A' ' 93' ' ' LEU . 84.9 t -135.64 151.42 29.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 170.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -81.17 134.18 35.58 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 173.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 42.3 p -140.37 -177.7 5.15 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.096 1.359 . . . . 0.0 109.575 -172.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.63 141.4 35.1 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 167.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -103.6 -5.59 22.52 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.209 1.003 . . . . 0.0 110.614 167.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.6 p -107.78 17.75 22.17 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.435 1.894 . . . . 0.0 112.715 -156.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -77.8 162.09 27.17 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.562 1.545 . . . . 0.0 113.343 -167.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -81.45 158.19 69.23 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 126.938 2.095 . . . . 0.0 111.405 175.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.464 ' HA ' HD23 ' A' ' 125' ' ' LEU . 46.7 Cg_endo -68.01 -33.22 26.39 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.68 2.253 . . . . 0.0 113.35 -174.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.9 pm0 -58.36 -31.74 67.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 118.806 0.73 . . . . 0.0 112.763 177.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 44.2 m0 -69.37 -14.72 63.07 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.318 0.508 . . . . 0.0 111.215 -176.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.464 HD23 ' HA ' ' A' ' 122' ' ' PRO . 3.4 mm? -78.4 -17.93 55.73 Favored 'General case' 0 CA--C 1.528 0.131 0 O-C-N 121.329 -0.857 . . . . 0.0 111.317 172.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -95.56 -22.7 17.46 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.798 0.727 . . . . 0.0 110.281 -172.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.2 mt -56.91 155.22 15.92 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 126.094 1.758 . . . . 0.0 111.036 178.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -67.64 144.4 66.01 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 121.339 1.359 . . . . 0.0 108.939 177.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -82.16 164.6 21.17 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 122.767 0.427 . . . . 0.0 109.923 172.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 51.8 m-70 -139.47 139.16 36.93 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.296 1.038 . . . . 0.0 109.13 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -82.45 -20.21 37.39 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.914 0.886 . . . . 0.0 112.921 -178.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.04 156.56 7.32 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 119.389 0.995 . . . . 0.0 110.052 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -114.28 127.79 56.04 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.572 1.149 . . . . 0.0 108.768 -175.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -140.18 131.38 26.52 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.434 1.494 . . . . 0.0 108.535 -174.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 7.6 t -69.93 -10.23 57.84 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.951 0.9 . . . . 0.0 110.154 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -131.15 64.22 1.58 Allowed 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 128.567 2.747 . . . . 0.0 104.673 177.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -124.28 171.51 16.53 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.866 1.698 . . . . 0.0 110.871 -176.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -61.96 -22.94 75.25 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.037 2.491 . . . . 0.0 112.877 -172.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -79.7 84.39 5.53 Favored 'General case' 0 N--CA 1.439 -1.005 0 C-N-CA 128.728 2.811 . . . . 0.0 109.251 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -44.89 -31.56 2.8 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 124.938 1.256 . . . . 0.0 113.683 177.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.5 90.25 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 127.097 2.159 . . . . 0.0 111.37 157.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -102.53 175.93 5.34 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 120.848 -1.158 . . . . 0.0 109.132 166.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -60.13 116.06 3.93 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -173.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -121.24 67.96 18.26 Favored Pre-proline 0 C--O 1.226 -0.159 0 C-N-CA 124.05 0.94 . . . . 0.0 109.331 -178.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -73.16 -22.65 18.94 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 121.89 1.726 . . . . 0.0 112.703 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.16 33.22 0.09 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.824 0.849 . . . . 0.0 110.469 -169.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -84.38 99.72 10.82 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 56.39 26.03 10.22 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.998 2.119 . . . . 0.0 114.589 -178.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.045 0 C-N-CA 126.912 2.085 . . . . 0.0 109.577 -176.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 tmm? . . . . . 0 N--CA 1.466 0.328 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.2 96.62 1.21 Allowed 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 102.514 -3.143 . . . . 0.0 102.514 -171.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -69.91 123.28 21.11 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 -175.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.2 pt -108.18 174.19 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 121.229 -0.919 . . . . 0.0 108.707 176.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.443 ' HB2' ' SG ' ' A' ' 112' ' ' CYS . 14.4 t80 -109.57 165.54 11.59 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.429 0.692 . . . . 0.0 109.37 168.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.2 p -121.45 133.99 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -59.58 -52.15 66.8 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.49 0.662 . . . . 0.0 111.843 -177.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.11 -35.29 0.27 Allowed Glycine 0 CA--C 1.526 0.78 0 CA-C-O 123.708 1.727 . . . . 0.0 110.793 -167.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -55.44 -23.73 26.88 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 129.927 3.291 . . . . 0.0 114.202 178.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -134.92 32.32 3.23 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 119.897 1.226 . . . . 0.0 110.157 -179.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.17 8.58 5.15 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 115.559 1.688 . . . . 0.0 115.559 178.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.69 -86.42 0.14 Allowed 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 117.677 -1.154 . . . . 0.0 109.139 174.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -162.6 18.07 0.15 Allowed Glycine 0 C--N 1.337 0.61 0 CA-C-N 119.366 0.985 . . . . 0.0 113.744 177.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -44.88 156.36 0.36 Allowed Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 126.474 1.91 . . . . 0.0 111.82 173.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -64.87 -2.15 5.1 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 124.471 3.447 . . . . 0.0 115.25 -172.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.512 ' O ' HG22 ' A' ' 19' ' ' VAL . 20.2 m-80 -112.47 -10.52 13.72 Favored 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 125.115 1.366 . . . . 0.0 110.894 -165.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -56.73 -30.15 63.24 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.091 0.859 . . . . 0.0 111.487 -173.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.5 -27.84 27.71 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.512 HG22 ' O ' ' A' ' 16' ' ' ASN . 17.1 m -69.14 -11.09 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 118.785 0.72 . . . . 0.0 112.499 -170.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.5 ptp -102.79 -0.58 31.23 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.168 1.787 . . . . 0.0 113.232 171.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.0 mt -102.77 4.41 37.9 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.735 1.614 . . . . 0.0 110.694 -178.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -117.39 77.88 1.17 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 -172.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -58.9 -15.28 11.94 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.094 1.758 . . . . 0.0 114.066 -165.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.3 m -61.02 -37.1 81.36 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 120.499 -1.375 . . . . 0.0 112.013 166.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 45.3 m170 -65.78 -29.25 69.72 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.599 0.636 . . . . 0.0 110.529 175.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.57 -178.4 22.49 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 124.171 0.891 . . . . 0.0 111.184 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 46.3 tp -95.9 144.55 26.14 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.976 0.91 . . . . 0.0 111.996 -173.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -136.71 147.38 46.73 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.617 1.167 . . . . 0.0 108.288 163.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -146.07 134.33 21.74 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 125.574 1.549 . . . . 0.0 109.655 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.93 93.27 0.4 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.482 1.113 . . . . 0.0 110.11 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.1 tpp180 -110.63 64.87 0.61 Allowed 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 126.05 1.74 . . . . 0.0 108.146 -176.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.52 179.08 43.81 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-O 122.848 1.249 . . . . 0.0 112.442 172.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 38.3 mtp180 -125.3 165.06 19.03 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 123.423 0.689 . . . . 0.0 110.776 173.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -173.59 176.13 46.21 Favored Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 120.39 -0.91 . . . . 0.0 113.564 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.448 ' C ' HG23 ' A' ' 95' ' ' VAL . 71.6 m -138.85 133.54 32.13 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.371 1.068 . . . . 0.0 108.877 177.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.1 p -63.55 100.87 0.29 Allowed 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -73.12 -23.6 20.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-O 120.83 0.348 . . . . 0.0 110.833 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -60.41 100.74 0.11 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 152.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.5 m -56.6 137.41 53.85 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 167.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.686 ' HB3' HD21 ' A' ' 53' ' ' LEU . 25.0 m-85 -138.58 156.62 73.08 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 -176.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.441 ' HG2' ' HB2' ' A' ' 54' ' ' LEU . 54.9 Cg_endo -76.27 94.91 1.02 Allowed 'Trans proline' 0 CA--C 1.538 0.682 1 C-N-CA 126.032 4.488 . . . . 0.0 111.607 177.342 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 32.0 tp -93.21 114.33 26.78 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 121.134 -0.979 . . . . 0.0 109.96 174.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.4 m -131.66 143.73 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 119.198 0.908 . . . . 0.0 110.463 -173.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 55.6 mt -97.73 108.86 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -178.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -117.62 -179.68 3.8 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.52 0.728 . . . . 0.0 110.346 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.25 161.53 6.6 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 126.424 1.964 . . . . 0.0 115.382 163.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -65.76 -22.54 66.59 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 127.782 2.433 . . . . 0.0 114.303 -170.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 39.1 m-70 -109.85 13.47 23.54 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.813 0.845 . . . . 0.0 111.821 176.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.9 m120 60.38 64.49 1.2 Allowed 'General case' 0 C--N 1.344 0.365 0 CA-C-O 122.262 1.03 . . . . 0.0 108.251 -179.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 55.4 mt -104.72 87.43 1.8 Allowed Pre-proline 0 N--CA 1.45 -0.427 0 C-N-CA 127.874 2.47 . . . . 0.0 105.403 177.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.08 152.0 25.88 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 120.684 0.923 . . . . 0.0 112.825 166.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 22.4 m95 -130.24 166.64 19.9 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.056 1.342 . . . . 0.0 107.391 175.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.686 HD21 ' HB3' ' A' ' 40' ' ' PHE . 1.2 tm? -138.85 119.7 14.27 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.441 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 0.1 OUTLIER -95.89 147.43 23.67 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 113.392 -1.731 . . . . 0.0 107.834 -169.499 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -78.66 87.19 4.59 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.977 -176.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -140.93 77.57 20.88 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 124.036 0.934 . . . . 0.0 111.103 179.024 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.68 115.68 4.33 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 124.885 3.723 . . . . 0.0 110.442 -176.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 117.23 11.81 8.67 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 124.751 1.167 . . . . 0.0 113.595 175.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.2 tpmt? -138.0 149.06 45.76 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 119.599 1.699 . . . . 0.0 108.808 -176.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.96 -135.32 14.87 Favored Glycine 0 CA--C 1.521 0.465 0 CA-C-N 120.601 1.546 . . . . 0.0 109.507 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -134.97 169.89 16.72 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 118.889 1.345 . . . . 0.0 111.787 -167.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 59.2 m -85.48 103.47 14.38 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 125.358 1.463 . . . . 0.0 108.543 -178.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.0 t -69.8 106.23 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 51.3 p -81.88 147.51 29.27 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.286 -0.884 . . . . 0.0 110.026 -173.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -173.46 -156.52 13.32 Favored Glycine 0 C--N 1.342 0.898 0 O-C-N 121.402 -0.811 . . . . 0.0 113.097 -172.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -134.73 162.62 31.85 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -176.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 89.5 mt -114.43 103.27 15.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 106.301 -1.741 . . . . 0.0 106.301 -170.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -86.07 114.08 22.65 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 172.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -61.5 131.9 51.66 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 152.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.9 m -135.52 156.24 38.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.42 177.64 5.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 122.209 1.004 . . . . 0.0 111.505 172.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.57 -36.01 75.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.057 -1.429 . . . . 0.0 111.342 177.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 32.1 tp60 -63.87 -44.46 93.01 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.292 0.951 . . . . 0.0 110.13 177.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 35.2 tpp -66.96 -50.46 62.22 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 118.629 0.649 . . . . 0.0 110.938 177.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.2 mt -64.14 -16.65 62.32 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 118.592 0.633 . . . . 0.0 111.34 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 45.4 mtt180 -82.15 -50.59 8.86 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 120.429 -1.42 . . . . 0.0 111.555 165.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -54.14 -48.21 71.07 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 120.338 1.426 . . . . 0.0 111.041 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.3 tp -64.47 -23.22 67.2 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 121.823 -0.548 . . . . 0.0 110.96 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.545 ' HA ' ' SG ' ' A' ' 84' ' ' CYS . 28.0 t70 -75.98 -5.9 48.48 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 120.858 -1.151 . . . . 0.0 112.503 176.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -105.92 -42.87 5.01 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.765 1.626 . . . . 0.0 110.604 172.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -65.68 -38.96 90.72 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.838 0.855 . . . . 0.0 112.139 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.497 ' HG3' ' CE2' ' A' ' 115' ' ' TYR . 7.5 mm-40 -83.34 10.57 8.33 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.164 0.585 . . . . 0.0 111.406 178.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.9 t70 61.3 0.32 0.42 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 128.522 2.729 . . . . 0.0 114.882 178.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.545 ' SG ' ' HA ' ' A' ' 79' ' ' ASP . 24.6 p -65.99 153.04 92.53 Favored Pre-proline 0 N--CA 1.448 -0.57 0 C-N-CA 124.167 0.987 . . . . 0.0 109.757 -167.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -75.41 -4.96 22.51 Favored 'Cis proline' 0 CA--C 1.54 0.797 0 N-CA-C 115.915 1.467 . . . . 0.0 115.915 9.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 m -54.68 -71.31 0.08 Allowed 'General case' 0 C--O 1.237 0.435 0 CA-C-N 119.601 1.092 . . . . 0.0 112.758 -178.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 46.2 mtp -71.86 -64.84 0.85 Allowed 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -173.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -105.7 167.0 10.06 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.31 1.444 . . . . 0.0 108.908 -178.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -127.72 -14.1 5.19 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -177.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? 61.91 145.78 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 128.3 2.64 . . . . 0.0 111.756 -172.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.402 HG22 ' N ' ' A' ' 92' ' ' ALA . 38.3 m -148.69 178.12 8.92 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 119.797 -1.814 . . . . 0.0 107.261 171.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.402 ' N ' HG22 ' A' ' 91' ' ' THR . . . -116.59 142.09 47.33 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 127.181 2.193 . . . . 0.0 111.062 168.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.497 HD21 ' SG ' ' A' ' 112' ' ' CYS . 0.0 OUTLIER -136.31 -174.17 3.61 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 129.204 3.001 . . . . 0.0 110.674 -170.798 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -115.75 126.36 53.95 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 126.145 1.778 . . . . 0.0 111.614 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.65 HG13 HG22 ' A' ' 110' ' ' VAL 0.321 1.4 p -142.29 115.16 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 121.063 3.727 . . . . 0.0 121.063 -167.085 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.436 ' HA ' ' O ' ' A' ' 108' ' ' ASP . 59.0 tt0 -60.92 118.22 6.43 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 113.986 -1.461 . . . . 0.0 107.184 -169.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.584 HG13 ' HA ' ' A' ' 108' ' ' ASP 0.331 1.6 p -85.69 87.51 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 O-C-N 124.544 1.153 . . . . 0.0 108.623 -178.284 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.425 HD13 ' HA ' ' A' ' 98' ' ' LEU . 1.7 mm? -57.95 -40.12 79.78 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 112.919 -1.946 . . . . 0.0 109.694 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -152.15 152.58 32.47 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 -177.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 -140.3 129.65 23.91 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -179.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -118.2 97.62 5.88 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.023 1.329 . . . . 0.0 114.094 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.98 -175.7 21.56 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -178.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -67.41 178.4 1.58 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.494 0.717 . . . . 0.0 111.203 -174.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.403 ' O ' ' HD3' ' A' ' 106' ' ' PRO . . . 92.38 47.06 3.36 Favored Glycine 0 C--O 1.22 -0.754 0 O-C-N 120.858 -1.151 . . . . 0.0 110.809 169.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -101.63 88.47 1.2 Allowed Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 131.128 3.771 . . . . 0.0 112.228 -153.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.558 ' CG ' HG12 ' A' ' 110' ' ' VAL . 89.8 Cg_endo -70.91 -32.38 13.89 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 124.295 3.33 . . . . 0.0 114.731 -175.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 143.17 -95.75 0.19 Allowed Glycine 0 C--N 1.339 0.717 0 CA-C-N 120.899 1.681 . . . . 0.0 112.783 -178.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.584 ' HA ' HG13 ' A' ' 97' ' ' VAL . 2.1 m-20 -156.44 6.25 0.18 Allowed 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 125.448 1.499 . . . . 0.0 111.066 -172.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -142.86 154.71 44.4 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 117.815 -1.554 . . . . 0.0 109.549 150.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.65 HG22 HG13 ' A' ' 95' ' ' VAL . 3.1 m -126.01 165.31 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.03 0 C-N-CA 117.09 -1.844 . . . . 0.0 109.624 -175.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -101.77 100.2 10.52 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 104.745 -2.317 . . . . 0.0 104.745 167.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.497 ' SG ' HD21 ' A' ' 93' ' ' LEU . 3.0 p -102.36 -166.75 1.32 Allowed 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 172.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -121.79 146.4 47.1 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.677 1.591 . . . . 0.0 108.714 166.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 20.2 t -139.4 137.85 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 129.778 3.231 . . . . 0.0 107.599 177.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.497 ' CE2' ' HG3' ' A' ' 82' ' ' GLU . 4.3 m-85 -79.92 80.33 6.34 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.898 1.279 . . . . 0.0 111.499 -175.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 51.6 p -80.41 175.71 10.42 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.96 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.0 t -136.12 129.79 32.35 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 105.153 -2.166 . . . . 0.0 105.153 162.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -89.67 -0.81 57.77 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.925 0.89 . . . . 0.0 110.709 172.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 10.1 t -116.25 31.75 6.53 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.674 1.989 . . . . 0.0 110.903 -178.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -56.85 163.48 1.92 Allowed 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.672 -0.642 . . . . 0.0 109.819 166.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -98.07 154.97 37.51 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 123.772 0.829 . . . . 0.0 110.572 172.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -64.29 -33.4 59.49 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.572 2.181 . . . . 0.0 111.235 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -67.07 -7.4 22.64 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.918 0.887 . . . . 0.0 112.675 177.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 44.1 m0 -96.88 -18.52 19.46 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 118.809 0.731 . . . . 0.0 111.34 170.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 18.8 mt -79.0 -16.97 56.18 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 120.094 1.315 . . . . 0.0 112.39 175.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -77.74 -25.03 48.92 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.563 0.745 . . . . 0.0 110.722 174.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 88.7 mt -59.79 151.57 62.67 Favored Pre-proline 0 C--N 1.344 0.35 0 C-N-CA 124.569 1.148 . . . . 0.0 110.678 -175.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -74.86 142.47 28.38 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.029 2.486 . . . . 0.0 109.15 179.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -86.78 167.25 14.58 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.893 0.854 . . . . 0.0 111.628 -175.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -136.5 171.2 14.83 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.429 1.492 . . . . 0.0 108.665 175.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 -127.99 -15.27 4.84 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 123.178 1.466 . . . . 0.0 111.572 -167.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 40.1 t -153.89 151.38 29.4 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 163.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -82.95 170.41 14.96 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 162.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 174.92 147.82 0.08 Allowed 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 128.168 2.587 . . . . 0.0 107.771 152.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.53 -31.7 72.89 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 173.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -77.07 66.79 2.95 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 127.911 2.485 . . . . 0.0 107.442 168.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -130.27 154.37 20.56 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 162.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -73.66 -13.78 24.63 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.597 2.198 . . . . 0.0 113.323 -165.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -75.21 -15.66 60.53 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.04 1.336 . . . . 0.0 113.878 -172.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 81.63 -62.0 4.56 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.111 -1.195 . . . . 0.0 110.111 -173.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.7 87.11 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.729 2.012 . . . . 0.0 114.053 -176.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.86 173.69 11.32 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 130.16 3.384 . . . . 0.0 109.256 172.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -64.11 130.61 44.63 Favored 'General case' 0 C--O 1.237 0.404 0 O-C-N 123.605 0.565 . . . . 0.0 110.482 -161.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -123.65 81.94 54.41 Favored Pre-proline 0 N--CA 1.453 -0.313 0 O-C-N 124.436 1.085 . . . . 0.0 110.56 -166.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -86.55 -19.43 2.87 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.791 2.994 . . . . 0.0 113.752 177.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.7 -3.9 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 118.096 2.628 . . . . 0.0 118.096 -172.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.424 ' HG3' ' H ' ' A' ' 147' ' ' GLU . 0.0 OUTLIER -67.44 -34.41 77.15 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 123.033 0.533 . . . . 0.0 110.022 -168.028 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 -128.53 74.04 1.53 Allowed 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 128.107 2.563 . . . . 0.0 104.193 165.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 5.6 tpt85 . . . . . 0 C--O 1.242 0.678 0 CA-C-O 116.87 -1.538 . . . . 0.0 108.582 169.195 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.8 mtt . . . . . 0 N--CA 1.47 0.552 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.59 176.69 12.29 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.129 1.772 . . . . 0.0 108.093 171.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -130.81 152.36 50.23 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 163.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.9 pt -138.59 172.14 14.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 121.849 0.833 . . . . 0.0 109.793 175.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.594 ' CE2' HG23 ' A' ' 36' ' ' THR . 63.8 t80 -118.15 133.27 56.05 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.969 1.708 . . . . 0.0 107.882 179.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.1 m -91.25 138.06 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 118.982 0.81 . . . . 0.0 110.74 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.617 ' HE1' HD22 ' A' ' 53' ' ' LEU . 87.1 m-85 -75.02 -36.03 61.94 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 127.61 2.364 . . . . 0.0 112.156 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 156.29 -37.86 0.59 Allowed Glycine 0 CA--C 1.522 0.505 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -168.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 p -62.13 -23.31 66.49 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.537 1.535 . . . . 0.0 112.993 -167.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.5 mp -134.13 62.51 1.65 Allowed 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 170.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? -154.95 -49.2 0.09 Allowed 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.751 1.62 . . . . 0.0 110.647 -176.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -84.45 -86.4 0.12 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.869 0.759 . . . . 0.0 110.221 173.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -172.65 29.87 0.1 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -173.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.61 162.83 13.87 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 125.127 1.371 . . . . 0.0 110.166 -179.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -59.87 -17.48 44.02 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.849 2.366 . . . . 0.0 112.872 -177.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.684 ' O ' HG22 ' A' ' 19' ' ' VAL . 4.6 m-80 -85.09 -17.05 38.55 Favored 'General case' 0 C--O 1.215 -0.729 0 O-C-N 120.877 -1.139 . . . . 0.0 110.575 -175.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -58.5 -35.9 72.96 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 120.981 1.719 . . . . 0.0 112.272 -163.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.64 -16.74 51.26 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 177.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.684 HG22 ' O ' ' A' ' 16' ' ' ASN . 31.7 m -64.08 -38.69 83.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 120.155 1.343 . . . . 0.0 110.54 -176.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.5 ptp -77.31 -10.48 59.46 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.1 mt -82.16 -14.43 55.67 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 122.869 0.468 . . . . 0.0 111.148 -173.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -106.31 100.21 9.76 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 -177.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 22.1 t-80 -56.28 -22.56 30.95 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.334 1.054 . . . . 0.0 113.513 -171.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.9 m -69.37 -20.86 63.83 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 120.482 -1.386 . . . . 0.0 113.539 174.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 30.7 m170 -76.6 -26.46 55.02 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.348 -0.845 . . . . 0.0 109.86 167.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 145.98 175.71 19.25 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 125.333 1.444 . . . . 0.0 111.222 167.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.8 tp -83.59 141.85 31.26 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 124.159 0.984 . . . . 0.0 111.852 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -145.09 92.76 2.3 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.231 1.812 . . . . 0.0 110.234 170.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -103.19 126.97 50.62 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 125.322 1.449 . . . . 0.0 110.072 -174.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -64.68 105.63 1.02 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.119 1.768 . . . . 0.0 110.44 -175.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.438 ' HG3' ' HB2' ' A' ' 69' ' ' GLU . 32.6 mmt180 -119.18 66.36 0.79 Allowed 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 125.755 1.622 . . . . 0.0 109.627 -178.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.65 -177.76 37.59 Favored Glycine 0 CA--C 1.523 0.539 0 CA-C-O 121.727 0.626 . . . . 0.0 112.134 172.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 66' ' ' GLU . 8.9 ptt180 -131.48 164.49 25.66 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.194 0.998 . . . . 0.0 108.666 178.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -170.75 -178.82 41.66 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 119.447 -1.358 . . . . 0.0 116.417 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.423 ' C ' HG23 ' A' ' 95' ' ' VAL . 22.6 p -140.73 137.32 33.37 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.88 0.872 . . . . 0.0 110.595 173.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.594 HG23 ' CE2' ' A' ' 5' ' ' PHE . 9.9 p -68.32 100.78 1.1 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 176.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.439 ' CG1' ' HB2' ' A' ' 96' ' ' GLN . 2.2 m -68.78 -31.84 52.39 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-O 121.011 0.434 . . . . 0.0 111.031 -175.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.88 119.5 11.4 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 163.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.7 159.11 11.4 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 119.173 -1.011 . . . . 0.0 108.892 168.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -150.62 154.6 35.45 Favored Pre-proline 0 C--N 1.316 -0.87 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 176.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -80.93 88.72 1.36 Allowed 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 124.638 3.558 . . . . 0.0 112.435 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.4 tp -83.13 88.67 6.89 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 120.655 -1.278 . . . . 0.0 110.619 -177.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.537 HG13 ' HB3' ' A' ' 127' ' ' LEU . 61.5 t -92.59 150.82 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.181 0 C-N-CA 126.704 2.002 . . . . 0.0 109.829 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.8 mt -119.5 113.96 42.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 126.312 1.845 . . . . 0.0 107.409 176.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -137.66 158.09 45.11 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.642 0.734 . . . . 0.0 112.051 -172.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.34 169.12 37.09 Favored Glycine 0 CA--C 1.537 1.413 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.818 175.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.9 -28.48 70.08 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 -168.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -96.08 2.18 53.07 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.988 0.18 . . . . 0.0 110.813 -161.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.407 HD22 ' HB2' ' A' ' 141' ' ' LEU . 5.1 m120 67.23 59.32 0.52 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.071 2.148 . . . . 0.0 108.52 176.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 61.7 mt -104.3 91.18 3.68 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 129.794 3.237 . . . . 0.0 108.745 -168.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -56.76 136.82 78.46 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 CA-C-N 120.708 1.288 . . . . 0.0 111.264 172.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -123.83 105.94 10.06 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 126.09 1.756 . . . . 0.0 108.566 -177.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.617 HD22 ' HE1' ' A' ' 7' ' ' TYR . 7.9 tp -76.76 81.53 3.37 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -175.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.1 mp -50.78 125.97 14.65 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 127.105 2.162 . . . . 0.0 110.027 174.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -73.97 85.01 1.76 Allowed 'General case' 0 C--O 1.239 0.548 0 CA-C-O 119.034 -0.508 . . . . 0.0 111.656 -173.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.411 HD11 ' HE2' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -136.66 80.21 38.43 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 118.672 0.669 . . . . 0.0 110.651 174.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -63.53 119.97 7.23 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.788 2.325 . . . . 0.0 111.549 -175.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.69 14.69 57.87 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 125.412 1.482 . . . . 0.0 113.262 178.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.411 ' HE2' HD11 ' A' ' 56' ' ' LEU . 0.9 OUTLIER -122.17 140.87 52.06 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 119.601 1.701 . . . . 0.0 109.172 163.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.23 -133.36 11.74 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 118.798 -1.001 . . . . 0.0 110.943 -171.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -141.76 169.6 17.3 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 118.871 1.336 . . . . 0.0 112.523 -157.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 27.3 m -103.33 103.79 13.84 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.621 1.168 . . . . 0.0 112.497 -166.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 14.1 t -70.05 116.25 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 123.825 0.85 . . . . 0.0 109.789 -177.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 67.6 p -80.41 146.9 31.23 Favored 'General case' 0 C--O 1.24 0.562 0 O-C-N 121.619 -0.676 . . . . 0.0 109.72 171.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -170.81 -168.22 32.25 Favored Glycine 0 N--CA 1.447 -0.574 0 O-C-N 121.386 -0.821 . . . . 0.0 111.957 -175.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 17.5 mt-10 -129.64 169.57 14.88 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 125.614 1.566 . . . . 0.0 108.548 -176.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.4 mt -122.89 130.57 74.39 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 O-C-N 121.298 -0.876 . . . . 0.0 108.82 -170.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -122.75 121.93 37.51 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 125.125 1.37 . . . . 0.0 107.67 171.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.438 ' HB2' ' HG3' ' A' ' 31' ' ' ARG . 78.5 tt0 -64.47 135.4 56.02 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 158.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.7 m -135.69 139.01 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -173.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.48 -179.28 5.15 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.7 0.762 . . . . 0.0 110.012 176.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -63.13 -35.08 79.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 118.289 -0.862 . . . . 0.0 111.543 -173.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 44.1 tp60 -64.92 -42.55 94.61 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 118.869 0.758 . . . . 0.0 110.146 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.1 tpp -64.5 -52.37 58.19 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.8 tp -57.67 -44.19 85.57 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 118.688 -0.672 . . . . 0.0 110.822 -176.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.4 mtt180 -64.62 -34.36 78.1 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.674 0.79 . . . . 0.0 112.193 176.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -67.33 -47.5 70.3 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 118.561 0.618 . . . . 0.0 110.416 177.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.7 mt -60.05 -34.95 74.1 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 175.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.98 -6.54 12.99 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 126.046 1.738 . . . . 0.0 113.787 178.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -115.96 -24.5 8.08 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.501 1.921 . . . . 0.0 110.739 176.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -68.71 -41.02 79.66 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.584 1.154 . . . . 0.0 111.271 -174.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -105.75 14.58 28.05 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.984 0.914 . . . . 0.0 111.258 -170.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 58.13 25.62 12.69 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.21 1.004 . . . . 0.0 112.332 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -70.47 161.62 75.55 Favored Pre-proline 0 CA--C 1.546 0.827 0 O-C-N 119.73 -1.856 . . . . 0.0 109.739 168.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -70.87 -3.76 9.44 Favored 'Cis proline' 0 CA--C 1.545 1.06 0 CA-C-N 119.551 0.875 . . . . 0.0 113.734 -9.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 m -55.16 -60.77 2.93 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.152 1.781 . . . . 0.0 111.277 -176.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 19.2 mtm -81.83 -64.32 1.21 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 122.019 0.914 . . . . 0.0 110.49 -179.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -102.54 169.99 8.31 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 125.525 1.53 . . . . 0.0 109.381 -178.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.1 mp0 -135.34 143.33 46.06 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.975 1.31 . . . . 0.0 108.394 173.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -78.16 130.04 35.86 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 177.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.9 m -132.16 174.29 10.35 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 125.146 1.378 . . . . 0.0 109.052 -175.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -115.44 151.19 35.19 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.485 1.514 . . . . 0.0 111.153 166.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.573 ' HG ' HG21 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -140.24 -160.98 1.13 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.457 1.503 . . . . 0.0 112.351 -178.09 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 38.5 tp60 -136.9 124.11 21.78 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.796 2.039 . . . . 0.0 110.121 174.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.501 HG21 ' CD1' ' A' ' 5' ' ' PHE . 1.4 p -139.21 116.19 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 116.9 2.185 . . . . 0.0 116.9 -168.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.439 ' HB2' ' CG1' ' A' ' 37' ' ' VAL . 64.5 tt0 -54.54 122.45 10.58 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 124.939 1.296 . . . . 0.0 109.222 -174.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.414 ' CG1' ' HB2' ' A' ' 100' ' ' TRP . 93.1 t -76.57 88.64 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 128.654 2.782 . . . . 0.0 106.509 174.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 mp -75.78 -15.56 60.24 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.271 0.628 . . . . 0.0 111.578 177.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.436 ' HB2' ' CZ ' ' A' ' 33' ' ' ARG . 0.4 OUTLIER -160.32 161.33 33.24 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 128.051 2.541 . . . . 0.0 106.626 161.234 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.414 ' HB2' ' CG1' ' A' ' 97' ' ' VAL . 68.7 t-105 -143.49 102.24 3.91 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.584 1.554 . . . . 0.0 109.62 174.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -95.04 77.82 3.54 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.31 1.044 . . . . 0.0 109.987 -178.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 161.7 178.97 36.07 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-O 122.358 0.977 . . . . 0.0 111.651 174.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -70.21 168.4 15.85 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 168.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.65 65.65 1.65 Allowed Glycine 0 CA--C 1.524 0.594 0 O-C-N 121.377 -0.827 . . . . 0.0 111.646 172.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -101.3 90.11 1.58 Allowed Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 128.002 2.521 . . . . 0.0 109.017 -168.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -68.8 5.06 1.47 Allowed 'Trans proline' 0 CA--C 1.54 0.819 1 C-N-CA 126.361 4.707 . . . . 0.0 114.434 -165.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.05 -174.47 27.63 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 108.921 -1.671 . . . . 0.0 108.921 -168.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -65.56 -14.37 60.95 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 117.759 -1.115 . . . . 0.0 113.963 -168.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 75.6 p -138.82 169.17 18.28 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 121.136 1.789 . . . . 0.0 111.061 174.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.455 ' CG1' HG13 ' A' ' 95' ' ' VAL . 14.3 p -133.91 144.8 34.59 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.76 0 CA-C-N 121.616 2.007 . . . . 0.0 110.768 -173.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -92.04 84.77 5.35 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 171.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.463 ' SG ' HD11 ' A' ' 93' ' ' LEU . 1.6 p -89.43 -167.75 1.96 Allowed 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 175.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -109.86 151.66 26.75 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 122.736 1.255 . . . . 0.0 112.285 160.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.573 HG21 ' HG ' ' A' ' 93' ' ' LEU . 0.1 OUTLIER -152.07 119.42 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 104.782 -2.303 . . . . 0.0 104.782 -163.738 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -67.4 129.5 40.09 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 121.828 -0.545 . . . . 0.0 109.966 167.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.579 HG22 HD23 ' A' ' 53' ' ' LEU . 14.2 p -127.56 -170.05 2.16 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 125.807 1.643 . . . . 0.0 107.059 176.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 9.2 t -144.14 147.39 33.64 Favored 'General case' 0 C--O 1.239 0.535 0 O-C-N 120.699 -1.251 . . . . 0.0 108.33 161.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -108.33 -10.14 15.38 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.0 1.32 . . . . 0.0 111.727 171.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 9.0 t -98.85 25.52 6.54 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.633 1.173 . . . . 0.0 111.909 -172.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -60.38 146.43 44.36 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.501 1.12 . . . . 0.0 111.329 176.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.66 155.27 89.56 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 124.873 1.269 . . . . 0.0 110.634 173.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.18 -33.6 18.41 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 121.398 1.399 . . . . 0.0 112.759 -178.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -58.52 -25.37 62.36 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.45 -0.781 . . . . 0.0 112.611 172.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 41.5 m0 -80.43 -4.88 55.4 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 120.969 -1.082 . . . . 0.0 112.686 -175.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -72.35 -34.09 67.77 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 119.498 1.044 . . . . 0.0 109.979 168.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -81.96 -21.89 36.95 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.996 0.918 . . . . 0.0 111.394 -177.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.537 ' HB3' HG13 ' A' ' 43' ' ' VAL . 15.9 mt -55.93 149.44 33.65 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 124.036 0.934 . . . . 0.0 110.151 177.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.49 156.76 64.5 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.117 1.878 . . . . 0.0 110.924 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -102.51 162.91 12.55 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 126.559 1.944 . . . . 0.0 107.455 173.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -132.49 177.91 7.24 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 173.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -128.0 -14.5 4.97 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.308 1.443 . . . . 0.0 112.422 -169.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.9 p -154.9 173.93 15.83 Favored 'General case' 0 C--O 1.239 0.542 0 O-C-N 120.652 -1.28 . . . . 0.0 109.854 163.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -120.83 136.18 54.98 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 123.795 0.838 . . . . 0.0 111.452 -177.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -163.19 128.61 3.14 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.325 1.05 . . . . 0.0 109.915 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 49.8 m -75.81 -0.32 20.7 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.257 1.423 . . . . 0.0 113.929 177.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -125.95 22.61 7.34 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.57 1.548 . . . . 0.0 109.287 173.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -79.59 164.73 49.23 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 121.604 -0.685 . . . . 0.0 111.509 177.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -60.66 -18.2 53.81 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.62 2.88 . . . . 0.0 112.865 -177.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -58.45 -17.19 18.9 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 127.427 2.291 . . . . 0.0 115.466 -174.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 79.96 -50.84 3.98 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 119.86 1.209 . . . . 0.0 113.462 174.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.407 ' HB2' HD22 ' A' ' 49' ' ' ASN . 0.3 OUTLIER -75.04 110.93 9.75 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.491 1.516 . . . . 0.0 110.306 -179.499 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.8 mmt85 -117.35 149.45 40.48 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 118.22 -0.895 . . . . 0.0 109.932 -176.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -62.61 135.36 57.35 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.687 1.131 . . . . 0.0 110.199 -176.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -131.7 78.65 70.21 Favored Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 123.821 0.848 . . . . 0.0 110.843 -176.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -80.42 -36.17 0.52 Allowed 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 123.609 2.873 . . . . 0.0 112.547 178.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -144.92 -6.01 0.69 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.56 1.144 . . . . 0.0 113.523 -175.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.271 5.5 mt-10 59.27 -58.61 0.05 Allowed 'General case' 0 N--CA 1.424 -1.732 1 C-N-CA 134.294 5.038 . . . . 0.0 112.994 175.191 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -159.55 0.86 0.08 Allowed 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 125.915 1.686 . . . . 0.0 111.807 -171.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? . . . . . 0 C--O 1.252 1.185 0 C-N-CA 126.691 1.996 . . . . 0.0 109.711 -160.327 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ptt? . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.79 105.42 1.6 Allowed 'General case' 0 C--O 1.236 0.359 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -75.47 152.03 37.96 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.8 pt -130.66 -177.25 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 175.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.444 ' CD1' HG11 ' A' ' 95' ' ' VAL . 63.5 t80 -128.98 167.56 17.28 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 124.441 1.097 . . . . 0.0 108.128 169.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.7 p -124.93 130.89 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 177.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -68.4 -36.68 79.47 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 125.072 1.349 . . . . 0.0 110.501 174.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 147.03 29.16 0.07 OUTLIER Glycine 0 C--N 1.339 0.706 0 CA-C-O 116.738 -2.146 . . . . 0.0 116.428 171.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.8 -27.26 13.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 120.195 1.998 . . . . 0.0 110.14 178.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.0 42.72 2.29 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 124.881 1.272 . . . . 0.0 108.266 -178.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -133.65 -86.53 0.42 Allowed 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.107 -0.996 . . . . 0.0 110.129 -178.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.518 ' HB2' HE22 ' A' ' 14' ' ' GLN . 0.0 OUTLIER -63.03 -63.56 1.17 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.954 0.797 . . . . 0.0 111.529 -163.911 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 171.73 36.7 0.03 OUTLIER Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -174.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.518 HE22 ' HB2' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -102.29 161.08 24.44 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 124.971 1.308 . . . . 0.0 109.052 -174.165 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -85.72 62.46 5.43 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.224 2.616 . . . . 0.0 110.968 -155.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -150.93 -29.87 0.19 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.888 1.675 . . . . 0.0 109.171 179.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -48.4 -34.37 10.74 Favored 'General case' 0 C--N 1.347 0.476 0 C-N-CA 125.481 1.513 . . . . 0.0 111.554 -172.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.56 -34.61 2.19 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 125.755 1.622 . . . . 0.0 115.266 174.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.8 m -62.61 -35.25 69.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 120.188 1.358 . . . . 0.0 110.797 -178.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.8 ptp -94.28 9.22 38.97 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.447 0.567 . . . . 0.0 111.906 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 68.3 mt -100.66 21.45 13.41 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.217 1.007 . . . . 0.0 108.648 169.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -138.37 99.76 3.93 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 173.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 -58.51 -16.93 17.53 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.473 1.109 . . . . 0.0 112.998 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.65 -22.13 62.54 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.332 1.453 . . . . 0.0 112.064 172.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -81.7 -7.02 59.55 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.858 0.754 . . . . 0.0 111.336 165.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.89 172.26 14.19 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 125.471 1.51 . . . . 0.0 112.212 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -77.99 135.83 37.87 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.888 1.275 . . . . 0.0 110.456 -176.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -141.7 108.78 5.47 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.422 1.089 . . . . 0.0 110.004 162.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -119.33 141.41 49.04 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.871 0.868 . . . . 0.0 109.309 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -64.75 110.78 2.51 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.887 1.275 . . . . 0.0 109.726 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.2 tpp180 -118.06 51.31 1.07 Allowed 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.337 1.455 . . . . 0.0 107.505 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.29 -166.76 44.39 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 122.7 1.167 . . . . 0.0 112.637 175.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 27.6 mtp85 -126.4 164.05 21.96 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.318 -1.107 . . . . 0.0 109.346 -164.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -168.81 175.81 43.2 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 118.845 -1.645 . . . . 0.0 115.692 176.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.4 p -141.7 158.7 43.5 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.886 1.675 . . . . 0.0 109.699 173.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.1 p -80.11 99.47 7.75 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 165.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -61.11 -37.79 78.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 O-C-N 121.254 -0.904 . . . . 0.0 110.741 172.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -60.92 106.49 0.59 Allowed 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 158.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -54.22 140.25 33.28 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 171.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.482 ' HB3' HD21 ' A' ' 53' ' ' LEU . 28.5 m-85 -134.08 154.49 80.21 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 174.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -79.89 95.26 1.02 Allowed 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 123.861 3.041 . . . . 0.0 110.911 173.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.29 115.26 21.9 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 168.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.477 ' CG2' HD13 ' A' ' 54' ' ' LEU . 5.9 m -124.14 133.13 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.325 1.45 . . . . 0.0 108.929 -174.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.5 mt -104.85 89.16 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 -169.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -118.43 166.0 13.2 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 122.3 1.048 . . . . 0.0 112.146 -173.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.58 -172.93 34.86 Favored Glycine 0 CA--C 1.537 1.457 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 -176.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -95.38 -21.84 18.11 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 121.309 -1.112 . . . . 0.0 113.292 -175.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -100.18 8.48 43.81 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -173.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.4 m120 59.94 71.87 0.55 Allowed 'General case' 0 CA--C 1.523 -0.087 0 C-N-CA 127.619 2.368 . . . . 0.0 110.706 -178.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 88.5 mt -106.2 88.38 3.12 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 127.323 2.249 . . . . 0.0 107.069 -177.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -60.61 103.05 0.21 Allowed 'Trans proline' 0 CA--C 1.544 1.025 0 C-N-CA 123.703 2.935 . . . . 0.0 112.086 178.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -89.13 129.87 35.66 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.545 1.138 . . . . 0.0 109.094 -177.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.482 HD21 ' HB3' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -93.69 105.26 17.31 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 122.501 1.144 . . . . 0.0 109.567 176.565 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.5 ' HG ' ' CD1' ' A' ' 120' ' ' TYR . 11.0 mp -79.45 137.82 37.38 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 125.45 1.5 . . . . 0.0 110.066 -178.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -78.96 85.12 4.93 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 120.699 0.285 . . . . 0.0 110.567 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.35 85.38 15.41 Favored Pre-proline 0 CA--C 1.529 0.156 0 C-N-CA 123.877 0.871 . . . . 0.0 108.903 168.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -64.06 142.51 81.33 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 N-CA-C 109.085 -1.16 . . . . 0.0 109.085 177.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.65 14.38 82.48 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-O 119.352 -0.693 . . . . 0.0 113.547 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.3 tppt? -125.01 151.19 45.9 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 119.86 1.83 . . . . 0.0 107.308 168.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.93 -140.09 25.3 Favored Glycine 0 CA--C 1.521 0.463 0 CA-C-N 120.178 1.354 . . . . 0.0 109.999 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -139.59 167.14 22.78 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 118.348 1.074 . . . . 0.0 111.339 -161.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 85.8 m -78.69 98.95 6.41 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 122.848 0.459 . . . . 0.0 111.564 -175.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.1 t -61.64 104.42 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 124.535 1.134 . . . . 0.0 108.508 176.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.6 p -80.9 144.17 32.14 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 121.549 -0.719 . . . . 0.0 110.399 177.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.74 -152.55 6.94 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -167.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -144.97 163.99 32.49 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.878 1.271 . . . . 0.0 109.289 -176.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 84.7 mt -117.75 126.37 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 -176.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -115.07 131.49 56.91 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 175.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -64.06 123.55 19.33 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 103.874 -2.639 . . . . 0.0 103.874 150.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.1 m -122.59 161.52 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 169.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -104.82 172.32 6.85 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 173.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -59.11 -36.17 74.7 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.967 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -57.94 -43.21 86.22 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 119.392 0.996 . . . . 0.0 111.858 176.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.8 tpp -67.6 -49.1 64.75 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.0 tp -58.68 -40.49 83.73 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 119.903 -0.719 . . . . 0.0 111.57 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 35.5 mtt180 -60.01 -56.46 21.43 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 124.641 1.176 . . . . 0.0 109.124 177.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -57.6 -49.21 77.18 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 124.018 0.927 . . . . 0.0 111.063 -176.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 98.5 mt -61.33 -25.85 67.41 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 121.906 -0.497 . . . . 0.0 111.196 -177.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -69.39 -20.88 63.81 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.187 0.903 . . . . 0.0 110.986 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -83.92 -50.31 8.17 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.189 1.396 . . . . 0.0 110.254 167.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -58.95 -38.1 78.25 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.718 0.807 . . . . 0.0 111.777 -173.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -95.69 15.66 19.45 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -175.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.429 ' O ' ' HB2' ' A' ' 86' ' ' SER . 20.4 m-20 48.35 35.79 6.17 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 128.18 2.592 . . . . 0.0 112.109 172.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.422 ' SG ' ' HB2' ' A' ' 88' ' ' TYR . 65.8 m -73.81 162.25 74.96 Favored Pre-proline 0 CA--C 1.54 0.588 0 O-C-N 120.154 -1.591 . . . . 0.0 109.669 175.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -71.46 -4.65 11.3 Favored 'Cis proline' 0 CA--C 1.541 0.874 0 CA-C-N 119.65 0.911 . . . . 0.0 113.66 -9.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.429 ' HB2' ' O ' ' A' ' 83' ' ' ASP . 25.7 m -56.0 -72.28 0.08 Allowed 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.264 1.026 . . . . 0.0 111.401 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 5.2 mtm -74.0 -48.48 29.95 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 119.01 -1.076 . . . . 0.0 108.37 -167.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.422 ' HB2' ' SG ' ' A' ' 84' ' ' CYS . 98.6 m-85 -122.1 163.66 19.09 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -122.85 115.5 22.09 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 172.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.1 tmm_? -63.06 130.36 44.32 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 171.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.6 m -132.45 161.75 32.91 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 126.307 1.843 . . . . 0.0 107.163 -175.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -107.6 126.38 52.49 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 174.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.498 HD21 HG23 ' A' ' 114' ' ' VAL . 1.8 pt? -142.7 -166.64 2.33 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.865 1.666 . . . . 0.0 109.817 -167.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 15.7 tp60 -125.31 138.57 54.08 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.191 0.996 . . . . 0.0 111.464 -177.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.444 HG11 ' CD1' ' A' ' 5' ' ' PHE . 42.9 t -136.11 140.19 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 177.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -77.68 132.27 38.11 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 170.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.669 HG13 ' HA ' ' A' ' 108' ' ' ASP . 2.6 p -84.55 105.34 13.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 112.932 -1.94 . . . . 0.0 106.872 170.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 mp -78.42 -22.95 46.96 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 113.698 -1.592 . . . . 0.0 110.646 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -161.47 139.17 9.06 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 104.209 -2.515 . . . . 0.0 104.209 -179.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 72.4 t-105 -121.36 129.4 53.04 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 174.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -103.62 121.83 43.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.424 0.69 . . . . 0.0 109.25 173.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 98.46 178.36 32.64 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 124.329 0.966 . . . . 0.0 111.107 170.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -87.94 150.55 23.4 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 122.109 0.957 . . . . 0.0 110.998 178.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 113.0 62.54 0.44 Allowed Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 125.715 1.626 . . . . 0.0 109.963 -177.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -102.11 88.72 1.38 Allowed Pre-proline 0 C--O 1.242 0.674 0 C-N-CA 130.659 3.584 . . . . 0.0 111.393 -159.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -66.29 2.42 1.88 Allowed 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 124.89 3.727 . . . . 0.0 116.202 -177.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.32 176.29 35.2 Favored Glycine 0 CA--C 1.525 0.69 0 O-C-N 120.379 -1.45 . . . . 0.0 109.628 -163.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.669 ' HA ' HG13 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -74.48 3.97 6.75 Favored 'General case' 0 CA--C 1.503 -0.857 0 C-N-CA 128.238 2.615 . . . . 0.0 116.375 -156.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 56.8 m -143.08 152.54 41.97 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 122.362 2.346 . . . . 0.0 111.809 155.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.6 m -133.34 156.02 41.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 125.284 1.434 . . . . 0.0 109.113 -163.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -92.31 115.72 28.33 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 170.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -121.5 169.64 10.46 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 125.837 1.655 . . . . 0.0 108.487 174.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -90.75 143.16 27.01 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 158.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.498 HG23 HD21 ' A' ' 93' ' ' LEU . 22.3 t -137.7 139.12 43.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 128.036 2.534 . . . . 0.0 107.789 172.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -73.26 122.58 22.19 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 167.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 11.1 p -123.02 -172.68 2.55 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 173.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.3 t -135.96 146.05 46.84 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 155.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -105.17 -16.64 14.72 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.307 1.843 . . . . 0.0 110.761 171.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.5 t -122.34 71.75 1.03 Allowed 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -175.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.5 ' CD1' ' HG ' ' A' ' 54' ' ' LEU . 0.3 OUTLIER -88.42 -11.55 45.71 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 125.631 1.572 . . . . 0.0 112.366 179.698 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 68.33 158.62 0.15 Allowed Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 126.248 1.819 . . . . 0.0 110.984 -170.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -69.37 -27.26 28.52 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.307 1.338 . . . . 0.0 113.355 -170.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -55.8 -37.95 69.31 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -178.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 0.547 ' HA ' HD23 ' A' ' 127' ' ' LEU . 41.6 m0 -71.98 -10.61 60.02 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 124.646 1.178 . . . . 0.0 111.461 -176.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 38.3 mt -80.39 4.9 16.5 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 120.842 -1.161 . . . . 0.0 112.297 171.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -107.08 -1.66 21.83 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 120.3 1.409 . . . . 0.0 113.235 172.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.547 HD23 ' HA ' ' A' ' 124' ' ' TRP . 1.3 mm? -78.62 148.19 72.7 Favored Pre-proline 0 N--CA 1.446 -0.631 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -173.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -65.18 146.9 87.72 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 121.433 1.422 . . . . 0.0 108.989 169.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 19.6 m-30 -87.9 157.02 19.08 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.409 0.623 . . . . 0.0 109.681 173.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -127.52 165.99 18.82 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.247 1.019 . . . . 0.0 109.16 178.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -110.98 -19.46 12.77 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.708 1.203 . . . . 0.0 111.723 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 13.5 p -155.92 149.32 24.74 Favored 'General case' 0 C--O 1.238 0.477 0 O-C-N 121.263 -0.898 . . . . 0.0 109.514 170.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -97.67 133.47 42.16 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 171.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -140.89 156.24 46.14 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.801 2.04 . . . . 0.0 106.676 176.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.51 -22.71 40.65 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.422 1.489 . . . . 0.0 112.308 176.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -127.4 90.26 3.1 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 103.605 -2.739 . . . . 0.0 103.605 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -130.47 154.72 20.78 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-N 113.922 -1.49 . . . . 0.0 110.808 159.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -64.93 -22.92 62.42 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 123.373 2.715 . . . . 0.0 114.223 -161.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -63.04 -19.5 64.44 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.246 1.418 . . . . 0.0 113.374 178.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 77.67 -29.1 1.78 Allowed Glycine 0 CA--C 1.533 1.16 0 O-C-N 120.755 -1.216 . . . . 0.0 114.311 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.65 83.57 0.07 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 119.168 1.484 . . . . 0.0 112.193 176.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.95 153.71 50.63 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 128.147 2.579 . . . . 0.0 110.167 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -60.49 133.46 56.12 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 124.081 0.863 . . . . 0.0 110.012 -165.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -121.43 76.99 35.01 Favored Pre-proline 0 C--O 1.232 0.162 0 C-N-CA 123.455 0.702 . . . . 0.0 110.154 -171.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.97 -31.57 2.99 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 122.916 2.411 . . . . 0.0 112.9 176.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -138.9 2.69 2.17 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -168.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -83.2 -24.74 32.28 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.179 -148.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -121.54 24.03 10.02 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 128.079 2.552 . . . . 0.0 107.139 165.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.8 mmm-85 . . . . . 0 C--O 1.252 1.226 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -132.835 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.8 mtt . . . . . 0 N--CA 1.468 0.458 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.49 154.42 38.61 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 158.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -111.19 137.55 48.75 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 162.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.2 pt -129.91 168.14 23.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 175.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -133.67 144.21 49.04 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -178.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.458 ' CG2' ' H ' ' A' ' 66' ' ' GLU . 3.8 m -100.52 169.84 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 124.092 0.957 . . . . 0.0 110.301 -176.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -120.01 -27.88 5.26 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.425 1.09 . . . . 0.0 112.289 172.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 171.72 -56.02 0.17 Allowed Glycine 0 C--N 1.339 0.733 0 C-N-CA 120.583 -0.818 . . . . 0.0 113.082 -161.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.462 HG22 HD22 ' A' ' 16' ' ' ASN . 0.8 OUTLIER -45.28 -45.84 12.33 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 126.063 1.745 . . . . 0.0 111.605 178.092 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.3 mt -125.84 26.36 6.64 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.958 1.303 . . . . 0.0 108.643 -167.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -118.86 -33.32 4.25 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.309 -0.87 . . . . 0.0 113.302 -177.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.562 ' HG3' ' H ' ' A' ' 13' ' ' GLY . 8.9 ptm85 -123.86 -86.39 0.64 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 119.554 1.07 . . . . 0.0 111.176 -178.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.562 ' H ' ' HG3' ' A' ' 12' ' ' ARG . . . -164.63 55.38 0.27 Allowed Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 104.998 -3.241 . . . . 0.0 104.998 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.5 162.36 72.86 Favored Pre-proline 0 N--CA 1.447 -0.618 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 163.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -67.66 4.4 1.4 Allowed 'Trans proline' 0 CA--C 1.53 0.288 0 C-N-CA 123.767 2.978 . . . . 0.0 115.404 -173.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.738 ' O ' HG22 ' A' ' 19' ' ' VAL . 14.2 m-80 -118.68 -8.62 10.36 Favored 'General case' 0 C--O 1.214 -0.79 0 C-N-CA 125.661 1.584 . . . . 0.0 108.609 -166.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -58.29 -45.79 87.28 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 119.613 1.097 . . . . 0.0 111.213 -171.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.895 ' HA ' HD13 ' A' ' 21' ' ' LEU . 0.3 OUTLIER -52.37 -21.3 3.45 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.16 1.384 . . . . 0.0 113.785 178.697 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.738 HG22 ' O ' ' A' ' 16' ' ' ASN . 34.7 m -62.27 -18.18 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 120.944 1.702 . . . . 0.0 112.443 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.625 ' HG3' HD12 ' A' ' 21' ' ' LEU . 3.0 ptp -97.4 -9.07 28.05 Favored 'General case' 0 C--N 1.348 0.508 0 CA-C-N 120.524 1.511 . . . . 0.0 110.948 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.895 HD13 ' HA ' ' A' ' 18' ' ' LYS . 8.4 mp -80.77 -31.1 35.97 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.902 1.681 . . . . 0.0 107.477 -174.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -70.36 97.2 1.22 Allowed 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 165.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 41.7 t-80 -61.35 -20.96 63.58 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.719 0.771 . . . . 0.0 111.322 171.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 m -51.29 -33.05 27.02 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.649 1.98 . . . . 0.0 112.193 166.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 45.1 m170 -93.58 10.95 30.49 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.028 1.331 . . . . 0.0 112.299 178.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.2 175.88 18.94 Favored Glycine 0 C--N 1.335 0.519 0 CA-C-O 122.313 0.952 . . . . 0.0 112.153 175.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -90.28 133.01 35.22 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.7 1.2 . . . . 0.0 109.68 -174.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -141.83 106.73 4.91 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.724 1.21 . . . . 0.0 110.907 169.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -116.87 125.6 51.75 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 125.519 1.527 . . . . 0.0 109.245 -169.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -68.24 112.11 4.95 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.694 1.198 . . . . 0.0 109.548 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -117.03 58.77 0.77 Allowed 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 123.899 0.88 . . . . 0.0 108.807 171.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.99 -165.74 53.65 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.905 168.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 36.7 mtp85 -116.73 167.49 11.05 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.623 0.769 . . . . 0.0 109.994 -156.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 96' ' ' GLN . . . -164.34 -179.26 38.39 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 116.126 1.21 . . . . 0.0 116.126 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.1 p -152.88 157.84 41.29 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 118.19 -0.91 . . . . 0.0 111.573 172.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.598 HG23 HG13 ' A' ' 63' ' ' VAL . 31.1 p -77.02 101.18 5.92 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 119.891 1.223 . . . . 0.0 108.478 167.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.424 HG13 ' HB2' ' A' ' 96' ' ' GLN . 0.3 OUTLIER -58.91 -52.51 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 119.796 1.18 . . . . 0.0 110.518 173.403 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.407 ' H ' HG23 ' A' ' 37' ' ' VAL . 2.8 mp0 -62.92 110.82 1.9 Allowed 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 166.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.6 m -59.33 132.49 54.16 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 178.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -126.75 155.06 75.76 Favored Pre-proline 0 N--CA 1.483 1.2 0 CA-C-N 119.178 0.899 . . . . 0.0 110.621 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.42 ' HG2' ' HB2' ' A' ' 54' ' ' LEU . 72.8 Cg_endo -84.27 107.03 1.2 Allowed 'Trans proline' 0 CA--C 1.532 0.401 1 C-N-CA 125.519 4.146 . . . . 0.0 112.382 -170.696 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.7 tp -106.47 90.72 3.43 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.584 0.754 . . . . 0.0 109.657 -174.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.7 m -108.06 141.93 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.147 0.979 . . . . 0.0 110.206 -167.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.4 mt -103.69 78.51 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -174.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.436 ' HB1' ' CD1' ' A' ' 124' ' ' TRP . . . -110.69 153.67 24.92 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.42 -1.264 . . . . 0.0 110.21 -173.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.87 164.74 39.65 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-O 122.314 0.952 . . . . 0.0 111.537 -175.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -92.18 -7.99 46.77 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.504 1.522 . . . . 0.0 112.986 -166.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 62.5 m-70 -107.87 12.1 27.49 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.1 0.96 . . . . 0.0 111.745 174.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.447 HD22 ' HB2' ' A' ' 141' ' ' LEU . 3.7 m120 60.79 54.29 3.61 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.731 1.212 . . . . 0.0 110.075 165.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 75.3 mt -103.94 87.81 1.69 Allowed Pre-proline 0 N--CA 1.446 -0.632 0 N-CA-C 103.209 -2.886 . . . . 0.0 103.209 -174.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -62.45 124.2 13.81 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 CA-C-N 120.867 1.345 . . . . 0.0 109.419 -176.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -98.93 132.22 44.42 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -178.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.0 tp -97.66 96.2 8.11 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 169.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.42 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 0.3 OUTLIER -61.87 150.23 38.02 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 121.042 -1.036 . . . . 0.0 108.389 171.679 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -80.27 89.58 5.51 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.355 -0.841 . . . . 0.0 108.966 177.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.71 86.58 11.93 Favored Pre-proline 0 N--CA 1.463 0.18 0 C-N-CA 124.597 1.159 . . . . 0.0 111.396 174.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -63.28 147.63 93.61 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 121.603 1.535 . . . . 0.0 109.341 178.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.49 0.76 59.28 Favored Glycine 0 CA--C 1.537 1.463 0 CA-C-O 118.666 -1.074 . . . . 0.0 114.65 176.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.02 112.45 12.38 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 120.833 2.316 . . . . 0.0 108.192 171.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 150.68 -149.78 21.67 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 119.767 -1.206 . . . . 0.0 112.538 -162.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -140.24 168.5 19.67 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 126.938 2.095 . . . . 0.0 109.28 173.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 97.3 m -89.58 78.53 7.02 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 123.596 0.759 . . . . 0.0 111.0 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.598 HG13 HG23 ' A' ' 36' ' ' THR . 1.8 p -61.14 127.38 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.99 0 CA-C-O 118.513 -0.755 . . . . 0.0 109.863 -175.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.91 151.54 25.92 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 177.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -157.4 175.36 34.8 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 175.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.458 ' H ' ' CG2' ' A' ' 6' ' ' VAL . 0.7 OUTLIER -106.09 163.5 12.73 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 168.018 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 68.8 mt -102.42 121.11 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 105.353 -2.092 . . . . 0.0 105.353 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -108.12 119.61 39.96 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 171.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -69.04 127.68 34.0 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.349 -1.722 . . . . 0.0 106.349 161.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.7 m -135.63 163.83 34.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 123.428 0.691 . . . . 0.0 110.258 -174.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.0 179.97 4.12 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 122.276 1.036 . . . . 0.0 112.708 170.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.57 -41.63 90.64 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 125.48 1.512 . . . . 0.0 112.107 175.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -64.6 -43.34 94.1 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 119.9 1.227 . . . . 0.0 110.807 178.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 19.7 tpp -61.29 -49.4 77.19 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 119.167 0.894 . . . . 0.0 108.67 177.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.4 tp -61.66 -38.79 89.04 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 118.816 -0.611 . . . . 0.0 112.033 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 64.2 mtt-85 -70.81 -38.97 73.33 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.835 1.254 . . . . 0.0 111.804 177.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -63.18 -52.54 61.95 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 177.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.1 mp -62.1 -31.53 71.99 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.693 0.797 . . . . 0.0 110.547 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -62.95 -33.02 74.48 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 124.403 1.081 . . . . 0.0 111.044 176.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -79.72 -45.74 18.36 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.071 0.396 . . . . 0.0 111.561 172.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -63.38 -42.88 98.85 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.569 0.747 . . . . 0.0 112.131 -170.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -79.96 9.09 5.78 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.559 -0.713 . . . . 0.0 111.951 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.2 t0 49.0 24.68 0.92 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 127.454 2.301 . . . . 0.0 113.346 -174.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 9.0 p -65.67 162.03 47.23 Favored Pre-proline 0 CA--C 1.54 0.564 0 O-C-N 119.684 -1.885 . . . . 0.0 107.061 165.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -69.06 -2.74 6.36 Favored 'Cis proline' 0 CA--C 1.547 1.165 0 N-CA-C 114.889 1.073 . . . . 0.0 114.889 -11.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.2 t -65.68 -67.41 0.44 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.884 1.22 . . . . 0.0 111.98 -178.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 20.6 mtp -71.51 -58.29 3.64 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 123.619 0.768 . . . . 0.0 109.52 -173.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -110.11 174.17 5.99 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 126.864 2.066 . . . . 0.0 108.345 177.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -128.66 -15.27 4.47 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 177.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 60.5 130.42 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 128.25 2.62 . . . . 0.0 112.651 -171.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 98.5 m -136.03 162.49 32.73 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.275 1.03 . . . . 0.0 108.237 175.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -94.6 128.16 41.04 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.93 1.292 . . . . 0.0 110.001 172.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -127.31 179.54 5.41 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.478 1.911 . . . . 0.0 111.432 178.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.8 tp60 -106.63 127.22 53.17 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.655 1.982 . . . . 0.0 109.98 178.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.418 ' CG2' ' SG ' ' A' ' 112' ' ' CYS . 64.3 t -126.27 140.65 48.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 -178.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.424 ' HB2' HG13 ' A' ' 37' ' ' VAL . 46.6 tt0 -72.04 135.84 46.47 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 172.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.6 t -82.13 89.0 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 105.974 -1.861 . . . . 0.0 105.974 167.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.67 -23.68 67.33 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 118.603 -0.713 . . . . 0.0 110.658 177.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -165.53 162.49 19.2 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 128.038 2.535 . . . . 0.0 106.896 171.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 62.6 t-105 -135.2 130.17 34.88 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 125.83 1.652 . . . . 0.0 107.935 176.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -118.2 89.34 3.1 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 121.195 0.521 . . . . 0.0 111.36 176.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 137.33 -172.04 22.89 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-O 123.302 1.501 . . . . 0.0 111.495 173.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.28 125.27 23.02 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-O 122.35 1.071 . . . . 0.0 113.106 166.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 122.29 81.02 0.56 Allowed Glycine 0 N--CA 1.427 -1.962 0 CA-C-N 111.848 -2.433 . . . . 0.0 110.534 142.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -101.57 89.69 1.54 Allowed Pre-proline 0 C--O 1.24 0.587 0 C-N-CA 131.134 3.774 . . . . 0.0 109.773 -156.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -57.56 -54.52 3.32 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.742 2.294 . . . . 0.0 109.778 -178.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 163.97 -166.8 37.71 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 107.711 -2.156 . . . . 0.0 107.711 -173.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -64.88 -12.13 45.51 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 117.773 0.786 . . . . 0.0 111.969 175.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 61.2 p -133.12 156.39 47.53 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 120.087 1.312 . . . . 0.0 111.615 175.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.9 p -142.48 162.67 18.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 123.889 0.876 . . . . 0.0 109.202 178.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -95.39 135.27 37.23 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.69 1.596 . . . . 0.0 107.94 169.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.418 ' SG ' ' CG2' ' A' ' 95' ' ' VAL . 0.5 OUTLIER -141.27 168.7 19.14 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.797 1.239 . . . . 0.0 110.456 174.593 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -100.28 145.49 28.05 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 172.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 30.9 t -138.54 147.39 25.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 125.193 1.397 . . . . 0.0 107.294 177.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -70.3 109.14 4.53 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 167.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 68.8 p -125.92 172.43 9.92 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 124.111 0.964 . . . . 0.0 108.937 176.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.93 145.9 51.32 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 172.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -112.25 -12.23 13.63 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.137 1.775 . . . . 0.0 111.264 171.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 12.2 t -123.43 64.7 1.01 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.497 1.519 . . . . 0.0 107.968 -171.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -101.94 161.06 13.96 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 126.411 1.884 . . . . 0.0 110.523 177.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.49 157.86 87.26 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 125.818 1.647 . . . . 0.0 111.407 172.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -73.86 -33.39 6.34 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 121.97 1.78 . . . . 0.0 112.326 -179.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -46.51 -44.4 17.69 Favored 'General case' 0 CA--C 1.512 -0.516 0 C-N-CA 125.185 1.394 . . . . 0.0 112.588 175.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 0.436 ' CD1' ' HB1' ' A' ' 45' ' ' ALA . 35.6 m0 -60.48 -22.22 63.27 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 125.723 1.609 . . . . 0.0 112.5 -174.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 32.6 mt -75.22 -10.09 59.15 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 117.699 -1.143 . . . . 0.0 112.787 176.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -95.41 -7.88 37.13 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.437 1.095 . . . . 0.0 112.471 -178.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 124' ' ' TRP . 1.1 mm? -72.9 158.74 86.75 Favored Pre-proline 0 N--CA 1.451 -0.413 0 C-N-CA 125.664 1.585 . . . . 0.0 107.864 -174.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -59.52 140.45 94.06 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.626 1.551 . . . . 0.0 108.805 168.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 5.7 m-30 -92.18 156.47 17.31 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.86 0.864 . . . . 0.0 108.8 171.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -141.08 171.95 13.36 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.516 0.726 . . . . 0.0 110.647 -174.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -136.62 1.14 2.55 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.314 1.445 . . . . 0.0 111.085 -172.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 86.0 p -152.86 171.68 17.92 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 124.907 1.283 . . . . 0.0 108.656 166.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -121.77 102.45 8.21 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 165.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -117.66 114.9 24.06 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.117 -171.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 11.2 t -60.48 -23.69 64.68 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 128.635 2.774 . . . . 0.0 111.654 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -120.57 85.35 2.38 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 127.417 2.287 . . . . 0.0 105.487 175.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -152.49 177.0 30.48 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.037 171.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.62 -15.43 24.42 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.024 1.816 . . . . 0.0 114.247 -174.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -44.96 -62.32 1.28 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.8 2.04 . . . . 0.0 111.339 -176.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 109.34 -59.09 0.37 Allowed Glycine 0 N--CA 1.464 0.555 0 C-N-CA 129.284 3.326 . . . . 0.0 110.302 171.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.613 HD13 ' H ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -49.95 73.67 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 130.616 3.567 . . . . 0.0 114.26 163.008 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -98.12 170.25 9.04 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.654 1.582 . . . . 0.0 111.942 172.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -71.31 150.32 45.25 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 123.182 0.301 . . . . 0.0 111.031 -165.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -122.92 83.39 50.17 Favored Pre-proline 0 C--O 1.233 0.195 0 C-N-CA 124.71 1.204 . . . . 0.0 108.822 178.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.79 -0.15 9.88 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 123.611 2.874 . . . . 0.0 112.095 168.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 48.56 31.29 2.84 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.964 -1.085 . . . . 0.0 112.778 -169.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -57.91 -20.67 38.89 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.951 1.7 . . . . 0.0 114.683 -172.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -156.55 12.41 0.27 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 128.755 2.822 . . . . 0.0 110.342 -169.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.013 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 174.121 . . . . . . . . 1 1 . 1 stop_ save_